Citrus Sinensis ID: 018047

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-
Protein Sequence
MPFGLVSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHALRMV
Secondary Structure (PSIPRED)
cccccccHHHccccccccccccccccccccccccccccccccccccccccccHHHHHHHHccccccccccccccEEEEEEEEccccEEEEEEccccccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEEEEEEEHHcccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEEccccccccccHHHHHHHHHHHHHHHcccHHEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccccEEEEcccHcHEEEcccccccHcHccHHEEccccccEEEEEEEEEccccccHHHHHccccEcccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccccHHHHcccHHccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHccccccccccccccEEc
Coil and Loop (DISEMBL)
MPFGLVSAWnkrrrsksqdqtdpwvykpvehwkledqptqpqkrhrgssvftlKEMEEatcsfsddnflgkggfgrvykgtlrsgeVVAIKKmelprfkeadgehefRVEVDILsrldhpnlvsLIGYCADGKHRFLVYEYMQKGnlqdhlngigepkmdwPLRLKVALGAAKGLAYLhsssavgipivhrdfksTNVLLSANFEAkisdfglaklmpegqeTYVTARVLgtfgyfdpeytstgkltlqsDVYAFGVVLLELLTgrravdlnqgvndqnLVLQVRHILNDRKKlrkvidpelsrssytMESIAMFANLASRCvrtesserpsmAECVKELQLIIYTnskglnmplhalrmv
Flexible Loop (DISEMBL)
mpfglvsawnkrrrsksqdqtdpwvyKPVEhwkledqptqpqkrhrgSSVFTLKEMEEATCsfsddnflgkgGFGRVYKGTLRSGEVVAIKKmelprfkeadgehEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRravdlnqgvndqnlvlqvrhilndrkklrkvidpelsrssytMESIAMFANLASRCVRTESSERPSMAECVKELQLIIytnskglnmplhalrmv
Low Complexity Region (SEG)
MPFGLVSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPlrlkvalgaakglaYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHALRMV
Disordered region (IsUnstruct)
***********************WVYKPVEHW**************************ATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL***SYTMESIAMFANLASRCV**********AECVKELQLIIYTNSKGL**********
Disordered Region (DISOPRED)
*PFGL*********************************************FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFK*ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ********************
Disordered Region (DISEMBL)
*********************DPWVYKPVEHWKLE************SSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRC***********AECVKELQLIIYTNSKGLNMPLHALRMV
Disordered Region (DISPRO)
MPFGLVSAWNKRRR********************************GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHALRMV
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPFGLVSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHALRMV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	361	2.2.26 [Sep-21-2011]
Q9FE20	456	Serine/threonine-protein	no	no	0.797	0.631	0.484	7e-76
Q8RWW0	744	Receptor-like serine/thre	no	no	0.786	0.381	0.486	1e-72
Q9LQQ8	423	Probable serine/threonine	no	no	0.842	0.718	0.443	1e-72
Q9LV48	652	Proline-rich receptor-lik	no	no	0.792	0.438	0.472	3e-71
P46573	412	Protein kinase APK1B, chl	no	no	0.811	0.711	0.458	5e-71
O49839	426	Protein kinase 2A, chloro	no	no	0.789	0.669	0.456	7e-71
Q9C660	762	Proline-rich receptor-lik	no	no	0.781	0.370	0.462	1e-70
Q8GXZ3	410	Serine/threonine-protein	no	no	0.795	0.7	0.467	6e-70
P43293	389	Probable serine/threonine	no	no	0.786	0.730	0.438	2e-69
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.792	0.557	0.466	2e-69

>sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1

 Score =  284 bits (727), Expect = 7e-76,   Method: Compositional matrix adjust.
 Identities = 144/297 (48%), Positives = 203/297 (68%), Gaps = 9/297 (3%)

Query: 50  VFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFR 108
            F  +E+  AT +F  D FLG+GGFGRVYKG L S G+VVA+K+++    +   G  EF 
Sbjct: 73  TFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQ---GNREFL 129

Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPK--MDWPLRLK 166
           VEV +LS L HPNLV+LIGYCADG  R LVYE+M  G+L+DHL+ +   K  +DW +R+K
Sbjct: 130 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMK 189

Query: 167 VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT 226
           +A GAAKGL +LH  +    P+++RDFKS+N+LL   F  K+SDFGLAKL P G +++V+
Sbjct: 190 IAAGAAKGLEFLHDKA--NPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVS 247

Query: 227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH 286
            RV+GT+GY  PEY  TG+LT++SDVY+FGVV LEL+TGR+A+D      +QNLV   R 
Sbjct: 248 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARP 307

Query: 287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
           + NDR+K  K+ DP L +  +   ++     +AS C++ +++ RP +A+ V  L  +
Sbjct: 308 LFNDRRKFIKLADPRL-KGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYL 363

Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  273 bits (699), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 143/294 (48%), Positives = 199/294 (67%), Gaps = 10/294 (3%)

Query: 50  VFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRV 109
            FTL E+E+AT  FS    LG+GGFGRVY+G++  G  VA+K +        + + EF  
Sbjct: 336 TFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTR---DNQNRDREFIA 392

Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL 169
           EV++LSRL H NLV LIG C +G+ R L+YE +  G+++ HL+   E  +DW  RLK+AL
Sbjct: 393 EVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH---EGTLDWDARLKIAL 449

Query: 170 GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
           GAA+GLAYLH  S     ++HRDFK++NVLL  +F  K+SDFGLA+   EG + +++ RV
Sbjct: 450 GAARGLAYLHEDS--NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HISTRV 506

Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN 289
           +GTFGY  PEY  TG L ++SDVY++GVVLLELLTGRR VD++Q   ++NLV   R +L 
Sbjct: 507 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLA 566

Query: 290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
           +R+ L +++DP L+  +Y  + +A  A +AS CV  E S RP M E V+ L+LI
Sbjct: 567 NREGLEQLVDPALA-GTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLI 619

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1

 Score =  273 bits (699), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 141/318 (44%), Positives = 209/318 (65%), Gaps = 14/318 (4%)

Query: 29  VEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS-GEV 87
           V+   L DQ T      + +  FT +E+ EAT +F  D FLG+GGFG+V+KGT+    +V
Sbjct: 74  VKGLNLNDQVT-----GKKAQTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQV 128

Query: 88  VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL 147
           VAIK+++        G  EF VEV  LS  DHPNLV LIG+CA+G  R LVYEYM +G+L
Sbjct: 129 VAIKQLDR---NGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSL 185

Query: 148 QDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE 205
           +DHL+ +  G+  +DW  R+K+A GAA+GL YLH    +  P+++RD K +N+LL  +++
Sbjct: 186 EDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDR--MTPPVIYRDLKCSNILLGEDYQ 243

Query: 206 AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
            K+SDFGLAK+ P G +T+V+ RV+GT+GY  P+Y  TG+LT +SD+Y+FGVVLLEL+TG
Sbjct: 244 PKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 303

Query: 266 RRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRT 325
           R+A+D  +   DQNLV   R +  DR+   K++DP L +  Y +  +     +++ CV+ 
Sbjct: 304 RKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDP-LLQGQYPVRGLYQALAISAMCVQE 362

Query: 326 ESSERPSMAECVKELQLI 343
           + + RP +++ V  L  +
Sbjct: 363 QPTMRPVVSDVVLALNFL 380

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  269 bits (687), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 140/296 (47%), Positives = 195/296 (65%), Gaps = 10/296 (3%)

Query: 49  SVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFR 108
           S FT +E+  AT  FS+ N LG+GGFG V+KG L SG+ VA+K++   +     GE EF+
Sbjct: 266 STFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQL---KAGSGQGEREFQ 322

Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA 168
            EV+I+SR+ H +LVSLIGYC  G  R LVYE++   NL+ HL+G G P M+W  RLK+A
Sbjct: 323 AEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIA 382

Query: 169 LGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
           LG+AKGL+YLH        I+HRD K++N+L+   FEAK++DFGLAK+  +   T+V+ R
Sbjct: 383 LGSAKGLSYLHED--CNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASD-TNTHVSTR 439

Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL 288
           V+GTFGY  PEY ++GKLT +SDV++FGVVLLEL+TGRR VD N    D +LV   R +L
Sbjct: 440 VMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLL 499

Query: 289 N---DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
           N   +      + D ++  + Y  E +A     A+ CVR  +  RP M++ V+ L+
Sbjct: 500 NRASEEGDFEGLADSKMG-NEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  268 bits (685), Expect = 5e-71,   Method: Compositional matrix adjust.
 Identities = 143/312 (45%), Positives = 204/312 (65%), Gaps = 19/312 (6%)

Query: 51  FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR----------SGEVVAIKKMELPRFKE 100
           FT  E++ AT +F  D+ LG+GGFG V+KG +           +G V+A+KK+    ++ 
Sbjct: 57  FTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQ- 115

Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE--PK 158
             G  E+  EV+ L +  HPNLV LIGYC + +HR LVYE+M +G+L++HL   G     
Sbjct: 116 --GHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQP 173

Query: 159 MDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP 218
           + W LRLKVALGAAKGLA+LH++      +++RDFK++N+LL + + AK+SDFGLAK  P
Sbjct: 174 LSWTLRLKVALGAAKGLAFLHNAET---SVIYRDFKTSNILLDSEYNAKLSDFGLAKDGP 230

Query: 219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
            G +++V+ R++GT+GY  PEY +TG LT +SDVY++GVVLLE+L+GRRAVD N+   +Q
Sbjct: 231 TGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQ 290

Query: 279 NLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
            LV   R +L +++KL +VID  L +  Y+ME     A LA RC+  E   RP+M E V 
Sbjct: 291 KLVEWARPLLANKRKLFRVIDNRL-QDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVS 349

Query: 339 ELQLIIYTNSKG 350
            L+ I   N  G
Sbjct: 350 HLEHIQTLNEAG 361

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  267 bits (683), Expect = 7e-71,   Method: Compositional matrix adjust.
 Identities = 138/302 (45%), Positives = 202/302 (66%), Gaps = 17/302 (5%)

Query: 50  VFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR----------SGEVVAIKKMELPRFK 99
            FT  E++ AT +F  DN LG+GGFG V+KG +           SG VVA+K+++   F+
Sbjct: 73  AFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQ 132

Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
              G  E+  EV+ L +L HPNLV L+GYCA+G++R LVYE+M KG+L++HL   G   +
Sbjct: 133 ---GHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPL 189

Query: 160 DWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE 219
            W +R+KVA+GAAKGL +LH + +    +++RDFK+ N+LL A+F AK+SDFGLAK  P 
Sbjct: 190 TWAIRMKVAVGAAKGLTFLHEAKSQ---VIYRDFKAANILLDADFNAKLSDFGLAKAGPT 246

Query: 220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN 279
           G  T+V+ +V+GT GY  PEY +TG+LT +SDVY+FGVVLLEL++GRRA+D + G N+ +
Sbjct: 247 GDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYS 306

Query: 280 LVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE 339
           LV      L D++KL +++D +L    Y  +     ANLA +C+  ++  RP M+E +  
Sbjct: 307 LVDWATPYLGDKRKLFRIMDTKLG-GQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVT 365

Query: 340 LQ 341
           L+
Sbjct: 366 LE 367

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  267 bits (682), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 135/292 (46%), Positives = 196/292 (67%), Gaps = 10/292 (3%)

Query: 50  VFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRV 109
           +F+ +E+  AT  FSD+N LG+GGFGRVYKG L    VVA+K++++       G+ EF+ 
Sbjct: 417 LFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKI---GGGQGDREFKA 473

Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL 169
           EVD +SR+ H NL+S++GYC     R L+Y+Y+   NL  HL+  G P +DW  R+K+A 
Sbjct: 474 EVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKIAA 533

Query: 170 GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
           GAA+GLAYLH        I+HRD KS+N+LL  NF A +SDFGLAKL  +   T++T RV
Sbjct: 534 GAARGLAYLHEDCHPR--IIHRDIKSSNILLENNFHALVSDFGLAKLALDCN-THITTRV 590

Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN 289
           +GTFGY  PEY S+GKLT +SDV++FGVVLLEL+TGR+ VD +Q + D++LV   R +L+
Sbjct: 591 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 650

Query: 290 D---RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           +    ++   + DP+L R+   +E   M    A+ C+R  +++RP M++ V+
Sbjct: 651 NATETEEFTALADPKLGRNYVGVEMFRMI-EAAAACIRHSATKRPRMSQIVR 701

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  265 bits (676), Expect = 6e-70,   Method: Compositional matrix adjust.
 Identities = 138/295 (46%), Positives = 195/295 (66%), Gaps = 8/295 (2%)

Query: 51  FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELP---RFKEA-DGEHE 106
           FTL E+E  T SF  D  LG+GGFG VYKG +     V +K + +      KE   G  E
Sbjct: 57  FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116

Query: 107 FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLK 166
           +  EV+ L +L HPNLV LIGYC +  HR LVYE+M +G+L++HL       + W  R+ 
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMM 176

Query: 167 VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT 226
           +ALGAAKGLA+LH++     P+++RDFK++N+LL +++ AK+SDFGLAK  P+G ET+V+
Sbjct: 177 IALGAAKGLAFLHNAER---PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233

Query: 227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH 286
            RV+GT+GY  PEY  TG LT +SDVY+FGVVLLE+LTGR++VD  +   +QNLV   R 
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293

Query: 287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
            LND++KL ++IDP L  + Y++ +     +LA  C+      RP M++ V+ L+
Sbjct: 294 KLNDKRKLLQIIDPRLE-NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 347

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  263 bits (672), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/303 (43%), Positives = 204/303 (67%), Gaps = 19/303 (6%)

Query: 51  FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR----------SGEVVAIKKMELPRFKE 100
           F+L E++ AT +F  D+ +G+GGFG V+KG +           +G V+A+K++    F+ 
Sbjct: 56  FSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQ- 114

Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPK 158
             G  E+  E++ L +LDHPNLV LIGYC + +HR LVYE+M +G+L++HL   G     
Sbjct: 115 --GHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQP 172

Query: 159 MDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP 218
           + W  R+++ALGAA+GLA+LH++      +++RDFK++N+LL +N+ AK+SDFGLA+  P
Sbjct: 173 LSWNTRVRMALGAARGLAFLHNAQP---QVIYRDFKASNILLDSNYNAKLSDFGLARDGP 229

Query: 219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
            G  ++V+ RV+GT GY  PEY +TG L+++SDVY+FGVVLLELL+GRRA+D NQ V + 
Sbjct: 230 MGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEH 289

Query: 279 NLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           NLV   R  L ++++L +V+DP L +  Y++      A LA  C+  ++  RP+M E VK
Sbjct: 290 NLVDWARPYLTNKRRLLRVMDPRL-QGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVK 348

Query: 339 ELQ 341
            ++
Sbjct: 349 TME 351

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  263 bits (671), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 138/296 (46%), Positives = 193/296 (65%), Gaps = 10/296 (3%)

Query: 49  SVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFR 108
           S FT  E+  AT  FS+ N LG+GGFG VYKG L +G  VA+K++++     A GE EF+
Sbjct: 169 STFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKV---GSAQGEKEFQ 225

Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA 168
            EV+I+S++ H NLVSL+GYC  G  R LVYE++    L+ HL+G G P M+W LRLK+A
Sbjct: 226 AEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIA 285

Query: 169 LGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
           + ++KGL+YLH +      I+HRD K+ N+L+   FEAK++DFGLAK+  +   T+V+ R
Sbjct: 286 VSSSKGLSYLHEN--CNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALD-TNTHVSTR 342

Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL 288
           V+GTFGY  PEY ++GKLT +SDVY+FGVVLLEL+TGRR VD N    D +LV   R +L
Sbjct: 343 VMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLL 402

Query: 289 N---DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
               +      + D +L+ + Y  E +A     A+ CVR  +  RP M + V+ L+
Sbjct: 403 VQALEESNFEGLADIKLN-NEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLE 457

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	361
255581176	361	Serine/threonine-protein kinase PBS1, pu	1.0	1.0	0.889	0.0
356497944	363	PREDICTED: serine/threonine-protein kina	1.0	0.994	0.862	0.0
356501465	363	PREDICTED: serine/threonine-protein kina	1.0	0.994	0.859	0.0
357486023	361	Protein kinase family protein [Medicago	1.0	1.0	0.847	0.0
225424744	353	PREDICTED: serine/threonine-protein kina	0.975	0.997	0.875	0.0
356524071	361	PREDICTED: serine/threonine-protein kina	1.0	1.0	0.853	0.0
356565912	361	PREDICTED: serine/threonine-protein kina	1.0	1.0	0.850	0.0
147776918	353	hypothetical protein VITISV_008440 [Viti	0.975	0.997	0.869	0.0
356497946	372	PREDICTED: serine/threonine-protein kina	1.0	0.970	0.838	0.0
224111312	379	predicted protein [Populus trichocarpa]	0.966	0.920	0.845	1e-179

>gi|255581176|ref|XP_002531401.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223528994|gb|EEF30985.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/361 (88%), Positives = 337/361 (93%)

Query: 1   MPFGLVSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEAT 60
           MPFGLVSAWNKRRRSKSQD TDPW+YKPVE WKL+DQ     K   GSSVFTLKEMEEAT
Sbjct: 1   MPFGLVSAWNKRRRSKSQDHTDPWIYKPVEFWKLDDQTPPSTKPRHGSSVFTLKEMEEAT 60

Query: 61  CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           CSFSD+NFLGKGGFGRVYKGTLRSGEVVAIKKMELP FKEA+GE EFRVEVDILSRLDHP
Sbjct: 61  CSFSDENFLGKGGFGRVYKGTLRSGEVVAIKKMELPSFKEAEGEREFRVEVDILSRLDHP 120

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           NLVSLIGY ADGKHRFLVYEY+QKGNLQDHLNGIGE KMDWP+RLKVALGAA+GLAYLHS
Sbjct: 121 NLVSLIGYSADGKHRFLVYEYLQKGNLQDHLNGIGEEKMDWPMRLKVALGAARGLAYLHS 180

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
           SSAVGIPIVHRDFKSTNVLL+ANFEAKISDFGLAKLMPEGQET+VTARVLGTFGYFDPEY
Sbjct: 181 SSAVGIPIVHRDFKSTNVLLNANFEAKISDFGLAKLMPEGQETFVTARVLGTFGYFDPEY 240

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           TSTGKLTLQSDVYAFGVVLLELLTGRRAVDL+QG +DQNLVLQVRHILNDRKKLRK++DP
Sbjct: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLSQGSSDQNLVLQVRHILNDRKKLRKMLDP 300

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHALRM 360
           ELSRSSYTMESIAMFANLASRCVR ESSERPSM ECVKELQ+IIY NSK L   LH+ + 
Sbjct: 301 ELSRSSYTMESIAMFANLASRCVRIESSERPSMTECVKELQMIIYINSKALGTALHSFKK 360

Query: 361 V 361
           V
Sbjct: 361 V 361

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356497944|ref|XP_003517816.1| PREDICTED: serine/threonine-protein kinase PBS1-like isoform 1 [Glycine max]

 Score =  654 bits (1688), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/363 (86%), Positives = 337/363 (92%), Gaps = 2/363 (0%)

Query: 1   MPFGLVS--AWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEE 58
           MPFGLVS  AWNKRRRSKSQD TDPWVYKP + W+LEDQ  +P KR  GSSV+TLKEMEE
Sbjct: 1   MPFGLVSLSAWNKRRRSKSQDHTDPWVYKPAQLWQLEDQMPRPTKRLHGSSVYTLKEMEE 60

Query: 59  ATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD 118
           ATCSFSD+N LGKGGFG+VY+GTLRSGEVVAIKKMELP  K A+GE EFRVEVDILSRLD
Sbjct: 61  ATCSFSDENLLGKGGFGKVYRGTLRSGEVVAIKKMELPAIKAAEGEREFRVEVDILSRLD 120

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
           HPNLVSLIGYCADGKHRFLVYEYM++GNLQDHLNGIGE  MDWP RL+VALGAAKGLAYL
Sbjct: 121 HPNLVSLIGYCADGKHRFLVYEYMRRGNLQDHLNGIGERNMDWPRRLQVALGAAKGLAYL 180

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HSSS VGIPIVHRDFKSTN+LL  NFEAKISDFGLAKLMPEGQET+VTARVLGTFGYFDP
Sbjct: 181 HSSSDVGIPIVHRDFKSTNILLDDNFEAKISDFGLAKLMPEGQETHVTARVLGTFGYFDP 240

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG NDQNLVLQVRHILNDRKKLRKVI
Sbjct: 241 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGPNDQNLVLQVRHILNDRKKLRKVI 300

Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHAL 358
           DPE++R+SYT++SI MFANLASRCVRTES+ERPSMAEC+KEL +IIYTNSKGL M +H+L
Sbjct: 301 DPEMARNSYTIQSIVMFANLASRCVRTESNERPSMAECIKELLMIIYTNSKGLGMVMHSL 360

Query: 359 RMV 361
           RM+
Sbjct: 361 RMI 363

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356501465|ref|XP_003519545.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max]

 Score =  653 bits (1685), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/363 (85%), Positives = 336/363 (92%), Gaps = 2/363 (0%)

Query: 1   MPFGLVS--AWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEE 58
           MPFGLVS  AWNKRRRSKSQD TDPWVYKP + W+LEDQ  +P KR  GSSV+TLKEMEE
Sbjct: 1   MPFGLVSLSAWNKRRRSKSQDHTDPWVYKPAQLWQLEDQTPRPTKRLHGSSVYTLKEMEE 60

Query: 59  ATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD 118
           ATCSFSD+N LGKGGFG+VY+GTLRSGEVVAIKKMELP  K A+GE EFRVEVDILSRLD
Sbjct: 61  ATCSFSDENLLGKGGFGKVYRGTLRSGEVVAIKKMELPAIKAAEGEREFRVEVDILSRLD 120

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
           HPNLVSLIGYCADGKHRFLVYEYM+KGNLQDHLNGIGE  MDWP RL+VALGAAKGLAYL
Sbjct: 121 HPNLVSLIGYCADGKHRFLVYEYMRKGNLQDHLNGIGERNMDWPRRLQVALGAAKGLAYL 180

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HSSS VGIPIVHRDFKSTN+LL  NFEAKISDFGLAKLMPEGQET+VTARVLGTFGYFDP
Sbjct: 181 HSSSDVGIPIVHRDFKSTNILLDDNFEAKISDFGLAKLMPEGQETHVTARVLGTFGYFDP 240

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG NDQNLVLQVRHILNDRKKLRKVI
Sbjct: 241 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGPNDQNLVLQVRHILNDRKKLRKVI 300

Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHAL 358
           DPE++R+SYT++SI MFANLASRCVRTES+ERPS+ EC+KEL +IIYTNSKGL M +H+L
Sbjct: 301 DPEMARNSYTIQSIVMFANLASRCVRTESNERPSIVECIKELLMIIYTNSKGLGMVMHSL 360

Query: 359 RMV 361
           RM+
Sbjct: 361 RMI 363

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357486023|ref|XP_003613299.1| Protein kinase family protein [Medicago truncatula] gi|355514634|gb|AES96257.1| Protein kinase family protein [Medicago truncatula]

 Score =  650 bits (1676), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 306/361 (84%), Positives = 336/361 (93%)

Query: 1   MPFGLVSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEAT 60
           MPFGLVSAWNKRRRSKSQD TDPW+YKP + W+L+D+  +P K+  GSSV+TL+EMEEAT
Sbjct: 1   MPFGLVSAWNKRRRSKSQDHTDPWIYKPAQLWQLDDKTPRPTKKLHGSSVYTLREMEEAT 60

Query: 61  CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           CSFS++N LGKGGFG+VY+GTLRSGEVVAIKKMELP  KEA+GE EFRVEVDILSRL HP
Sbjct: 61  CSFSEENLLGKGGFGKVYRGTLRSGEVVAIKKMELPAIKEAEGEREFRVEVDILSRLSHP 120

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           NLVSLIGYCADGKHRFLVYEYM  GNLQDHLNGIGE  MDWP RL+VALGAAKGLAYLHS
Sbjct: 121 NLVSLIGYCADGKHRFLVYEYMVNGNLQDHLNGIGERNMDWPRRLQVALGAAKGLAYLHS 180

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
           SS VGIPIVHRDFKSTN+L+ ANFEAKISDFGLAKLMPEGQET+VTARVLGTFGYFDPEY
Sbjct: 181 SSDVGIPIVHRDFKSTNILIDANFEAKISDFGLAKLMPEGQETHVTARVLGTFGYFDPEY 240

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG NDQNLVLQVRHILNDRKKL KVIDP
Sbjct: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGPNDQNLVLQVRHILNDRKKLCKVIDP 300

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHALRM 360
           E++RSSYT++SI MFANLASRCVRTES+ERPSMA+CVKE+Q+IIYTNSKGL M +H+LR+
Sbjct: 301 EMARSSYTIQSIVMFANLASRCVRTESNERPSMADCVKEIQMIIYTNSKGLGMVMHSLRL 360

Query: 361 V 361
           +
Sbjct: 361 I 361

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225424744|ref|XP_002266222.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] gi|296086514|emb|CBI32103.3| unnamed protein product [Vitis vinifera]

 Score =  648 bits (1671), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 309/353 (87%), Positives = 332/353 (94%), Gaps = 1/353 (0%)

Query: 1   MPFGLVSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEAT 60
           MPFGLV+AWNKRRRSKSQD +DPW+YKPVE+W+L+DQ    ++RH  SSVFTLKEMEEAT
Sbjct: 1   MPFGLVTAWNKRRRSKSQDHSDPWMYKPVEYWQLDDQNPSTKRRH-ASSVFTLKEMEEAT 59

Query: 61  CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           CSFSD+  +GKGGFGRVY+GTLRSGEVVAIKKMELP FKEA+GE EFRVEVDILSRLDHP
Sbjct: 60  CSFSDEKLVGKGGFGRVYRGTLRSGEVVAIKKMELPPFKEAEGEREFRVEVDILSRLDHP 119

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           NLVSLIGYCADGK RFLVYEYM  GNLQDHLNGI + KMDWPLRLKVALGAA+GLAYLHS
Sbjct: 120 NLVSLIGYCADGKQRFLVYEYMHNGNLQDHLNGIQDTKMDWPLRLKVALGAARGLAYLHS 179

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
           SS VGIPIVHRDFKSTN+LL++NF+AKISDFGLAKLMPEGQ++YVTARVLGTFGYFDPEY
Sbjct: 180 SSNVGIPIVHRDFKSTNILLNSNFDAKISDFGLAKLMPEGQDSYVTARVLGTFGYFDPEY 239

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG NDQNLVLQVRHILNDRKKLRKVIDP
Sbjct: 240 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGPNDQNLVLQVRHILNDRKKLRKVIDP 299

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           E+ RSSYT+ESIAMFANLASRCVRTESSERPSMAECVKELQLI YTN+KGL M
Sbjct: 300 EMGRSSYTVESIAMFANLASRCVRTESSERPSMAECVKELQLIFYTNTKGLGM 352

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356524071|ref|XP_003530656.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max]

 Score =  648 bits (1671), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 308/361 (85%), Positives = 329/361 (91%)

Query: 1   MPFGLVSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEAT 60
           MPFGLVSAWNKRRRS S D +DPW+YKP E W+LEDQ  QP KR   SSVFTLKEMEEAT
Sbjct: 1   MPFGLVSAWNKRRRSMSHDHSDPWIYKPAEFWQLEDQTPQPTKRRHRSSVFTLKEMEEAT 60

Query: 61  CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           CS SDDN LGKGGFGRVY+ TL+SGEVVAIKKMELP  K A+GE EFRVEVDILSRLDHP
Sbjct: 61  CSLSDDNLLGKGGFGRVYRATLKSGEVVAIKKMELPAIKAAEGEREFRVEVDILSRLDHP 120

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           NLVSLIGYCADGKHRFLVY+YM  GNLQDHLNGIGE KMDWPLRLKVA GAAKGLAYLHS
Sbjct: 121 NLVSLIGYCADGKHRFLVYDYMHNGNLQDHLNGIGERKMDWPLRLKVAFGAAKGLAYLHS 180

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
           SS +GIPIVHRDFKSTNVLL ANFEAKISDFGLAKLMPEGQET+VTARVLGTFGYFDPEY
Sbjct: 181 SSCLGIPIVHRDFKSTNVLLDANFEAKISDFGLAKLMPEGQETHVTARVLGTFGYFDPEY 240

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG NDQNLVLQVRH+LNDRKKL KVIDP
Sbjct: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGPNDQNLVLQVRHLLNDRKKLLKVIDP 300

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHALRM 360
           E++R+SYTMESI  FANLASRCVR+ES+ERPSM +CVKE+Q+I+YTNSKGL M +H LR+
Sbjct: 301 EMARNSYTMESIFTFANLASRCVRSESNERPSMVDCVKEIQMIMYTNSKGLGMVMHRLRL 360

Query: 361 V 361
           V
Sbjct: 361 V 361

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356565912|ref|XP_003551180.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max]

 Score =  646 bits (1666), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 307/361 (85%), Positives = 332/361 (91%)

Query: 1   MPFGLVSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEAT 60
           MPFGLVSAWNKRRRSKSQD +DPW+YKP E W+LEDQ  QP KR   SSVFTL+EME+AT
Sbjct: 1   MPFGLVSAWNKRRRSKSQDHSDPWIYKPAEFWQLEDQTPQPTKRRHRSSVFTLREMEQAT 60

Query: 61  CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
            SFSDDN LGKGGFGRVY+GTL+SGEVVAIKKMELP  K A+GE EFRVEVD+LSRLDHP
Sbjct: 61  FSFSDDNLLGKGGFGRVYRGTLKSGEVVAIKKMELPAIKAAEGEREFRVEVDLLSRLDHP 120

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           NLVSLIGYCADGK+RFLVYEYM  GNLQDHLNGIGE KMDWPLRLKVALGAAKGLAYLHS
Sbjct: 121 NLVSLIGYCADGKNRFLVYEYMHNGNLQDHLNGIGERKMDWPLRLKVALGAAKGLAYLHS 180

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
           SS +GIPIVHRDFKSTNVLL A FEAKISDFGLAKLMPEGQET+VTARVLGTFGYFDPEY
Sbjct: 181 SSCLGIPIVHRDFKSTNVLLDAKFEAKISDFGLAKLMPEGQETHVTARVLGTFGYFDPEY 240

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ  NDQNLVLQVRH+LND+KKLRKVIDP
Sbjct: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQCPNDQNLVLQVRHLLNDQKKLRKVIDP 300

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHALRM 360
           E++R+SYTMESI MF NLASRCVR+ES+ERPSM +CVKE+Q I+YTNSKGL M +H+LR+
Sbjct: 301 EMTRNSYTMESIFMFVNLASRCVRSESNERPSMVDCVKEIQTILYTNSKGLEMVMHSLRL 360

Query: 361 V 361
           V
Sbjct: 361 V 361

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776918|emb|CAN76955.1| hypothetical protein VITISV_008440 [Vitis vinifera]

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 307/353 (86%), Positives = 330/353 (93%), Gaps = 1/353 (0%)

Query: 1   MPFGLVSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEAT 60
           MPFGLV+AWNKRRRSKSQD +DPW+YKPVE+W+L+DQ    ++RH  S+VFTLKEMEEAT
Sbjct: 1   MPFGLVTAWNKRRRSKSQDHSDPWMYKPVEYWQLDDQNPSTKRRH-ASTVFTLKEMEEAT 59

Query: 61  CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           CSFSD+  +GKGGFGRVY+GTLRSGEVVAIKKMELP FKEA+GE EFRVEVDILSRLDHP
Sbjct: 60  CSFSDEKLVGKGGFGRVYRGTLRSGEVVAIKKMELPPFKEAEGEREFRVEVDILSRLDHP 119

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           NLVSLIGYCADGK RFLVYEYM  GNLQDHLNGI + KMDWPLRLKVALGAA+GLAYLHS
Sbjct: 120 NLVSLIGYCADGKQRFLVYEYMHNGNLQDHLNGIXDTKMDWPLRLKVALGAARGLAYLHS 179

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
           SS VGIPIVHRDFKSTN+LL++NF+AKISDFGLAKLMPEGQ+ YVTARVLGTFGYFDPEY
Sbjct: 180 SSNVGIPIVHRDFKSTNILLNSNFDAKISDFGLAKLMPEGQDIYVTARVLGTFGYFDPEY 239

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG NDQNLVLQVRHILNDRKKLRKVIDP
Sbjct: 240 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGPNDQNLVLQVRHILNDRKKLRKVIDP 299

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           E+ RSSYT+ESIA FANLASRCVRTESSERPSMAECVKELQLI YTN+KGL M
Sbjct: 300 EMGRSSYTVESIAXFANLASRCVRTESSERPSMAECVKELQLIFYTNTKGLGM 352

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356497946|ref|XP_003517817.1| PREDICTED: serine/threonine-protein kinase PBS1-like isoform 2 [Glycine max]

 Score =  642 bits (1655), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/372 (83%), Positives = 336/372 (90%), Gaps = 11/372 (2%)

Query: 1   MPFGLVS--AWNKRRRSKSQDQTDPW---------VYKPVEHWKLEDQPTQPQKRHRGSS 49
           MPFGLVS  AWNKRRRSKSQD TDP          VYKP + W+LEDQ  +P KR  GSS
Sbjct: 1   MPFGLVSLSAWNKRRRSKSQDHTDPCIVFFPIHNGVYKPAQLWQLEDQMPRPTKRLHGSS 60

Query: 50  VFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRV 109
           V+TLKEMEEATCSFSD+N LGKGGFG+VY+GTLRSGEVVAIKKMELP  K A+GE EFRV
Sbjct: 61  VYTLKEMEEATCSFSDENLLGKGGFGKVYRGTLRSGEVVAIKKMELPAIKAAEGEREFRV 120

Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL 169
           EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYM++GNLQDHLNGIGE  MDWP RL+VAL
Sbjct: 121 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMRRGNLQDHLNGIGERNMDWPRRLQVAL 180

Query: 170 GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
           GAAKGLAYLHSSS VGIPIVHRDFKSTN+LL  NFEAKISDFGLAKLMPEGQET+VTARV
Sbjct: 181 GAAKGLAYLHSSSDVGIPIVHRDFKSTNILLDDNFEAKISDFGLAKLMPEGQETHVTARV 240

Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN 289
           LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG NDQNLVLQVRHILN
Sbjct: 241 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGPNDQNLVLQVRHILN 300

Query: 290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           DRKKLRKVIDPE++R+SYT++SI MFANLASRCVRTES+ERPSMAEC+KEL +IIYTNSK
Sbjct: 301 DRKKLRKVIDPEMARNSYTIQSIVMFANLASRCVRTESNERPSMAECIKELLMIIYTNSK 360

Query: 350 GLNMPLHALRMV 361
           GL M +H+LRM+
Sbjct: 361 GLGMVMHSLRMI 372

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224111312|ref|XP_002315811.1| predicted protein [Populus trichocarpa] gi|222864851|gb|EEF01982.1| predicted protein [Populus trichocarpa]

 Score =  634 bits (1634), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 307/363 (84%), Positives = 327/363 (90%), Gaps = 14/363 (3%)

Query: 1   MPFGLVSAWNKRRRSKSQDQTDP--------------WVYKPVEHWKLEDQPTQPQKRHR 46
           MPFGLVSAWNKRRRSKSQD +DP              WVYKP+E W+LEDQ  Q  KR  
Sbjct: 1   MPFGLVSAWNKRRRSKSQDHSDPCTPSSSLSFLSLRFWVYKPMEFWQLEDQTPQSTKRRH 60

Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE 106
           GSSVFTLKEMEEATCSFS+ N +GKGGFGRVY+G LRSGEVVAIKKMELP FKEA+GE E
Sbjct: 61  GSSVFTLKEMEEATCSFSEKNLVGKGGFGRVYRGVLRSGEVVAIKKMELPTFKEAEGERE 120

Query: 107 FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLK 166
           FRVEVDILSRL+HPNLVSLIGYCADGK RFLVYEY+Q GNLQDHLNG G+ KM+WPLRLK
Sbjct: 121 FRVEVDILSRLEHPNLVSLIGYCADGKDRFLVYEYLQHGNLQDHLNGYGKAKMEWPLRLK 180

Query: 167 VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT 226
           VALG+A+GLAYLHSSS VGIPIVHRDFKSTN+LL+ANFEAKISDFGLAKLMPEGQE +VT
Sbjct: 181 VALGSARGLAYLHSSSDVGIPIVHRDFKSTNILLNANFEAKISDFGLAKLMPEGQEIFVT 240

Query: 227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH 286
           ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG +DQNLVLQVRH
Sbjct: 241 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGPSDQNLVLQVRH 300

Query: 287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
           ILNDRKKLRKVIDPELSRSSYT+ESIAMFANLASRC+R +SSERPSMAECVKELQ IIYT
Sbjct: 301 ILNDRKKLRKVIDPELSRSSYTLESIAMFANLASRCIRIQSSERPSMAECVKELQTIIYT 360

Query: 347 NSK 349
           NSK
Sbjct: 361 NSK 363

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	361
TAIR|locus:2199857	375	AT1G24030 [Arabidopsis thalian	0.966	0.930	0.766	1.6e-143
TAIR|locus:2179857	456	PBS1 "avrPphB susceptible 1" [	0.795	0.629	0.456	2e-65
TAIR|locus:2085720	386	AT3G20530 [Arabidopsis thalian	0.833	0.779	0.430	5.2e-65
TAIR|locus:2183018	513	AT5G18610 [Arabidopsis thalian	0.822	0.578	0.437	1.1e-64
TAIR|locus:2034344	381	ASG5 "ALTERED SEED GERMINATION	0.806	0.763	0.461	1.4e-64
TAIR|locus:2075517	558	AT3G02810 [Arabidopsis thalian	0.919	0.594	0.411	1.1e-62
TAIR|locus:2099009	400	AT3G58690 [Arabidopsis thalian	0.797	0.72	0.448	1.4e-62
TAIR|locus:2151191	378	CDL1 "CDG1-like 1" [Arabidopsi	0.844	0.806	0.426	1.4e-62
TAIR|locus:2038992	744	ALE2 "Abnormal Leaf Shape 2" [	0.783	0.380	0.457	7.9e-62
TAIR|locus:2059642	414	Kin3 "kinase 3" [Arabidopsis t	0.817	0.712	0.419	1.3e-61

TAIR|locus:2199857 AT1G24030 [Arabidopsis thaliana (taxid:3702)]

 Score = 1403 (498.9 bits), Expect = 1.6e-143, P = 1.6e-143
 Identities = 279/364 (76%), Positives = 307/364 (84%)

Query:     1 MPFGLVSAWNKRRRSKSQDQTDP-----------W---VYKPVEHWKLEDQPTQPQKRHR 46
             M F LVSAWNKRRRSKS D TDP           W   VY+  E W++EDQ +QP+KR  
Sbjct:     1 MHFPLVSAWNKRRRSKSYD-TDPCTFLFSIIFARWHKRVYRTAECWQIEDQASQPRKRRF 59

Query:    47 GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE 106
             GSSV+TLKEMEEAT SFSD+N LGKGGFGRVY+GTL++GEVVAIKKM+LP FK+ADGE E
Sbjct:    60 GSSVYTLKEMEEATSSFSDENLLGKGGFGRVYQGTLKTGEVVAIKKMDLPTFKKADGERE 119

Query:   107 FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXX 166
             FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ GNLQDHLNGI E K+ WP    
Sbjct:   120 FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQNGNLQDHLNGIKEAKISWPIRLR 179

Query:   167 XXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT 226
                       YLHSSS+VGIPIVHRDFKSTNVLL +N+ AKISDFGLAKLMPEG++T VT
Sbjct:   180 IALGAAKGLAYLHSSSSVGIPIVHRDFKSTNVLLDSNYNAKISDFGLAKLMPEGKDTCVT 239

Query:   227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH 286
             ARVLGTFGYFDPEYTSTGKLTLQSD+YAFGVVLLELLTGRRAVDL QG N+QNLVLQVR+
Sbjct:   240 ARVLGTFGYFDPEYTSTGKLTLQSDIYAFGVVLLELLTGRRAVDLTQGPNEQNLVLQVRN 299

Query:   287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
             ILNDRKKLRKVID EL R+SY+ME+I MFA+LASRC+R ES ERPS+ +CVKELQLIIYT
Sbjct:   300 ILNDRKKLRKVIDVELPRNSYSMEAITMFADLASRCIRIESKERPSVMDCVKELQLIIYT 359

Query:   347 NSKG 350
             NSKG
Sbjct:   360 NSKG 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0016926 "protein desumoylation" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

GO:0050665 "hydrogen peroxide biosynthetic process" evidence=RCA

TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
 Identities = 135/296 (45%), Positives = 191/296 (64%)

Query:    51 FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRV 109
             F  +E+  AT +F  D FLG+GGFGRVYKG L S G+VVA+K+++    +   G  EF V
Sbjct:    74 FAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQ---GNREFLV 130

Query:   110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPK--MDWPXXXXX 167
             EV +LS L HPNLV+LIGYCADG  R LVYE+M  G+L+DHL+ +   K  +DW      
Sbjct:   131 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKI 190

Query:   168 XXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA 227
                      +LH  +    P+++RDFKS+N+LL   F  K+SDFGLAKL P G +++V+ 
Sbjct:   191 AAGAAKGLEFLHDKA--NPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVST 248

Query:   228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI 287
             RV+GT+GY  PEY  TG+LT++SDVY+FGVV LEL+TGR+A+D      +QNLV   R +
Sbjct:   249 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPL 308

Query:   288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
              NDR+K  K+ DP L +  +   ++     +AS C++ +++ RP +A+ V  L  +
Sbjct:   309 FNDRRKFIKLADPRL-KGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYL 363

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0006952 "defense response" evidence=TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)]

 Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
 Identities = 134/311 (43%), Positives = 198/311 (63%)

Query:    43 KRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEA 101
             K +  + +FT +E+  AT +F+ DN LG+GGFGRVYKG + + E VVA+K+++   ++  
Sbjct:    62 KGNISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQ-- 119

Query:   102 DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPK--- 158
              G  EF VEV +LS L H NLV+L+GYCADG  R LVYEYMQ G+L+DHL  +   K   
Sbjct:   120 -GNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKP 178

Query:   159 MDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP 218
             +DW               YLH ++    P+++RDFK++N+LL   F  K+SDFGLAK+ P
Sbjct:   179 LDWDTRMKVAAGAARGLEYLHETADP--PVIYRDFKASNILLDEEFNPKLSDFGLAKVGP 236

Query:   219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
              G ET+V+ RV+GT+GY  PEY  TG+LT++SDVY+FGVV LE++TGRR +D  +   +Q
Sbjct:   237 TGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQ 296

Query:   279 NLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
             NLV     +  DR+K   + DP L    Y ++ +     +A+ C++ E++ RP M++ V 
Sbjct:   297 NLVTWASPLFKDRRKFTLMADP-LLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVT 355

Query:   339 ELQLIIYTNSK 349
              L+ +  T ++
Sbjct:   356 ALEYLAVTKTE 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)]

 Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
 Identities = 134/306 (43%), Positives = 191/306 (62%)

Query:    38 PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS-GEVVAIKKMELP 96
             P +    H  +  FT +E+  AT +F  +  LG+GGFGRVYKG L + G++VA+K+++  
Sbjct:    58 PKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRN 117

Query:    97 RFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE 156
               +   G  EF VEV +LS L HPNLV+LIGYCADG  R LVYEYM  G+L+DHL+ +  
Sbjct:   118 GLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP 174

Query:   157 PK--MDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
              K  +DW               YLH  +    P+++RD KS+N+LL   +  K+SDFGLA
Sbjct:   175 DKEPLDWSTRMTIAAGAAKGLEYLHDKA--NPPVIYRDLKSSNILLGDGYHPKLSDFGLA 232

Query:   215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG 274
             KL P G +T+V+ RV+GT+GY  PEY  TG+LTL+SDVY+FGVV LEL+TGR+A+D  + 
Sbjct:   233 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARA 292

Query:   275 VNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMA 334
               + NLV   R +  DR+K  K+ DP L +  Y M  +     +A+ C++ +++ RP + 
Sbjct:   293 PGEHNLVAWARPLFKDRRKFPKMADPSL-QGRYPMRGLYQALAVAAMCLQEQAATRPLIG 351

Query:   335 ECVKEL 340
             + V  L
Sbjct:   352 DVVTAL 357

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 658 (236.7 bits), Expect = 1.4e-64, P = 1.4e-64
 Identities = 138/299 (46%), Positives = 184/299 (61%)

Query:    47 GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE 106
             G+  FT KE+  AT +F + N LG+GGFGRVYKG L SG+VVAIK++  P      G  E
Sbjct:    62 GARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLN-P--DGLQGNRE 118

Query:   107 FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI--GEPKMDWPXX 164
             F VEV +LS L HPNLV+LIGYC  G  R LVYEYM  G+L+DHL  +   +  + W   
Sbjct:   119 FIVEVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTR 178

Query:   165 XXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
                         YLH ++    P+++RD KS N+LL   F  K+SDFGLAKL P G  T+
Sbjct:   179 MKIAVGAARGIEYLHCTA--NPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTH 236

Query:   225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
             V+ RV+GT+GY  PEY  +GKLT++SD+Y FGVVLLEL+TGR+A+DL Q   +QNLV   
Sbjct:   237 VSTRVMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWS 296

Query:   285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
             R  L D+KK   ++DP L R  Y    +     + + C+  E+  RP + + V  L+ +
Sbjct:   297 RPYLKDQKKFGHLVDPSL-RGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYL 354

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

TAIR|locus:2075517 AT3G02810 [Arabidopsis thaliana (taxid:3702)]

 Score = 640 (230.4 bits), Expect = 1.1e-62, P = 1.1e-62
 Identities = 144/350 (41%), Positives = 208/350 (59%)

Query:    11 KRRRSKSQDQT-DPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFL 69
             K ++S + ++T D    KP +  + E+     Q       +FT +E+  AT +F  +  L
Sbjct:    11 KNKKSSTTNETNDNNEPKPDDRRRAEETEEIEQSEGTSLKIFTFRELATATKNFRQECLL 70

Query:    70 GKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
             G+GGFGRVYKGTL+S G+VVA+K+++        G  EF+ EV  L +LDHPNLV LIGY
Sbjct:    71 GEGGFGRVYKGTLKSTGQVVAVKQLDKHGLH---GNKEFQAEVLSLGQLDHPNLVKLIGY 127

Query:   129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPK-----MDWPXXXXXXXXXXXXXXYLHSSSA 183
             CADG  R LVY+Y+  G+LQDHL+   EPK     MDW               YLH  + 
Sbjct:   128 CADGDQRLLVYDYISGGSLQDHLH---EPKADSDPMDWTTRMQIAYAAAQGLDYLHDKA- 183

Query:   184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP-EGQETY-VTARVLGTFGYFDPEYT 241
                P+++RD K++N+LL  +F  K+SDFGL KL P  G +   +++RV+GT+GY  PEYT
Sbjct:   184 -NPPVIYRDLKASNILLDDDFSPKLSDFGLHKLGPGTGDKMMALSSRVMGTYGYSAPEYT 242

Query:   242 STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE 301
               G LTL+SDVY+FGVVLLEL+TGRRA+D  +  ++QNLV   + I  D K+   + DP 
Sbjct:   243 RGGNLTLKSDVYSFGVVLLELITGRRALDTTRPNDEQNLVSWAQPIFRDPKRYPDMADPV 302

Query:   302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGL 351
             L  + ++   +     +AS CV+ E+S RP +++ +  L  +      G+
Sbjct:   303 LE-NKFSERGLNQAVAIASMCVQEEASARPLISDVMVALSFLSMPTEDGI 351

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 134/299 (44%), Positives = 181/299 (60%)

Query:    47 GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE 106
             G  +FT K++  AT  FS  N +G GGFG VY+G L  G  VAIK M+        GE E
Sbjct:    71 GLQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMD---HAGKQGEEE 127

Query:   107 FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL-----NGIGEPKMDW 161
             F++EV++LSRL  P L++L+GYC+D  H+ LVYE+M  G LQ+HL     +G   P++DW
Sbjct:   128 FKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGSVPPRLDW 187

Query:   162 PXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ 221
                            YLH    V  P++HRDFKS+N+LL  NF AK+SDFGLAK+  +  
Sbjct:   188 ETRMRIAVEAAKGLEYLHEQ--VSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKVGSDKA 245

Query:   222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV 281
               +V+ RVLGT GY  PEY  TG LT +SDVY++GVVLLELLTGR  VD+ +   +  LV
Sbjct:   246 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRATGEGVLV 305

Query:   282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
                   L DR K+  ++DP L    Y+ + +   A +A+ CV+ E+  RP MA+ V+ L
Sbjct:   306 SWALPQLADRDKVVDIMDPTLE-GQYSTKEVVQVAAIAAMCVQAEADYRPLMADVVQSL 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 134/314 (42%), Positives = 191/314 (60%)

Query:    45 HRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADG 103
             H  +  FT  E+  AT +F  +  +G+GGFGRVYKG L S  +  AIK+++        G
Sbjct:    55 HIVAQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLD---HNGLQG 111

Query:   104 EHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI--GEPKMDW 161
               EF VEV +LS L HPNLV+LIGYCADG  R LVYEYM  G+L+DHL+ I  G+  +DW
Sbjct:   112 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDW 171

Query:   162 PXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ 221
                            YLH  +    P+++RD K +N+LL  ++  K+SDFGLAKL P G 
Sbjct:   172 NTRMKIAAGAAKGLEYLHDKTMP--PVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGD 229

Query:   222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV 281
             +++V+ RV+GT+GY  PEY  TG+LTL+SDVY+FGVVLLE++TGR+A+D ++   +QNLV
Sbjct:   230 KSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLV 289

Query:   282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
                R +  DR+K  ++ DP L +  Y    +     +A+ CV+ + + RP +A+ V  L 
Sbjct:   290 AWARPLFKDRRKFSQMADPML-QGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALS 348

Query:   342 LIIYTNSKGLNMPL 355
              +       L  P+
Sbjct:   349 YLASQKFDPLAQPV 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=RCA

TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 632 (227.5 bits), Expect = 7.9e-62, P = 7.9e-62
 Identities = 134/293 (45%), Positives = 188/293 (64%)

Query:    51 FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVE 110
             FTL E+E+AT  FS    LG+GGFGRVY+G++  G  VA+K   L R  + + + EF  E
Sbjct:   337 FTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKL--LTRDNQ-NRDREFIAE 393

Query:   111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXX 170
             V++LSRL H NLV LIG C +G+ R L+YE +  G+++ HL+   E  +DW         
Sbjct:   394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH---EGTLDWDARLKIALG 450

Query:   171 XXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL 230
                   YLH  S     ++HRDFK++NVLL  +F  K+SDFGLA+   EG + +++ RV+
Sbjct:   451 AARGLAYLHEDS--NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HISTRVM 507

Query:   231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
             GTFGY  PEY  TG L ++SDVY++GVVLLELLTGRR VD++Q   ++NLV   R +L +
Sbjct:   508 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLAN 567

Query:   291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
             R+ L +++DP L+  +Y  + +A  A +AS CV  E S RP M E V+ L+LI
Sbjct:   568 REGLEQLVDPALA-GTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLI 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010068 "protoderm histogenesis" evidence=IMP

GO:0042335 "cuticle development" evidence=IMP

GO:0048367 "shoot system development" evidence=IGI

GO:0048645 "organ formation" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2059642 Kin3 "kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
 Identities = 131/312 (41%), Positives = 189/312 (60%)

Query:    50 VFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR--------SGEVVAIKKMELPRFKEA 101
             +F+L E+  +T +F  +N LG+GGFG+V+KG L         +G V+A+KK+    F+  
Sbjct:    74 IFSLAELRASTRNFRSENVLGEGGFGKVFKGWLEDKTPGKQSNGTVIAVKKLNAESFQ-- 131

Query:   102 DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKM 159
              G  E++ EV+ L R+ HPNLV L+GYC +G+   LVYEYMQKG+L++HL   G     +
Sbjct:   132 -GFEEWQCEVNFLGRVSHPNLVKLLGYCLEGEELLLVYEYMQKGSLENHLFRKGSAVQPL 190

Query:   160 DWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE 219
              W               +LH+S      +++RDFK++N+LL  ++ AKISDFGLAKL P 
Sbjct:   191 SWEIRLKIAIGAAKGLAFLHASEK---QVIYRDFKASNILLDGSYNAKISDFGLAKLGPS 247

Query:   220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN 279
               ++++T RV+GT GY  PEY +TG L ++SDVY FGVVL E+LTG  A+D  +     N
Sbjct:   248 ASQSHITTRVMGTHGYAAPEYVATGHLYVKSDVYGFGVVLAEILTGLHALDPTRPTGQHN 307

Query:   280 LVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE 339
             L   ++  L++R+KLR ++DP L    Y  +S    A LA +C+  E   RPSM E V+ 
Sbjct:   308 LTEWIKPHLSERRKLRSIMDPRLE-GKYPFKSAFRVAQLALKCLGPEPKNRPSMKEVVES 366

Query:   340 LQLIIYTNSKGL 351
             L+LI   N K L
Sbjct:   367 LELIEAANEKPL 378

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	361
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-55
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-54
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-53
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-53
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-51
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-43
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-36
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-36
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-36
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-36
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-35
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-29
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-29
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-27
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-27
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-25
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-25
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-25
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-25
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-24
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-24
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-23
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-23
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-23
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-22
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-22
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-22
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-22
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-22
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-21
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-21
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-21
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-20
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-17
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-17
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-17
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-14
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  180 bits (460), Expect = 1e-55
 Identities = 75/197 (38%), Positives = 108/197 (54%), Gaps = 13/197 (6%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+GGFG VY    + +G+ VAIK ++           E   E++IL +L+HPN+V L G
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              D  H +LV EY + G+L+D L    E K+     L++ L   +GL YLHS       
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLHS-----NG 112

Query: 188 IVHRDFKSTNVLL-SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-YTSTGK 245
           I+HRD K  N+LL S N + K++DFGL+KL+   +    T    GT  Y  PE     G 
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGY 170

Query: 246 LTLQSDVYAFGVVLLEL 262
            + +SD+++ GV+L EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  178 bits (455), Expect = 3e-54
 Identities = 90/273 (32%), Positives = 134/273 (49%), Gaps = 26/273 (9%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG VYK   +  G++VA+K ++    K    +   R E+ IL RL HPN+V LI 
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLID 65

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              D  H +LV EY + G+L D+L       +      K+AL   +GL YLHS+      
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNG----- 118

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL- 246
           I+HRD K  N+LL  N   KI+DFGLAK + +   +  T   +GT  Y  PE    G   
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGY 176

Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
             + DV++ GV+L ELLTG+                   +IL+  + +R+++ P L    
Sbjct: 177 GPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRILGPPLEFDE 223

Query: 307 YTMESI-AMFANLASRCVRTESSERPSMAECVK 338
               S      +L  +C+  + S+RP+  E ++
Sbjct: 224 PKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  176 bits (448), Expect = 3e-53
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 35/279 (12%)

Query: 69  LGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPN 121
           LG+G FG VYKG L+         VA+K ++    ++A  +   EF  E  I+ +LDHPN
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK----EDASEQQIEEFLREARIMRKLDHPN 62

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V L+G C + +  ++V EYM+ G+L  +L     PK+     L  AL  A+G+ YL S 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLES- 120

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                  +HRD  + N L+  N   KISDFGL++ + +  + Y          +  PE  
Sbjct: 121 ----KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPESL 175

Query: 242 STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE 301
             GK T +SDV++FGV+L E+ T         G++++    +V   L +  +L +   P 
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFT--LGEQPYPGMSNE----EVLEYLKNGYRLPQ---PP 226

Query: 302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
                          +L  +C   +  +RP+ +E V+ L
Sbjct: 227 NCPPE--------LYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  175 bits (447), Expect = 5e-53
 Identities = 85/279 (30%), Positives = 132/279 (47%), Gaps = 34/279 (12%)

Query: 69  LGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPN 121
           LG+G FG VYKGTL+         VA+K ++    ++A  +   EF  E  I+ +LDHPN
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK----EDASEQQIEEFLREARIMRKLDHPN 62

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V L+G C + +   +V EYM  G+L D+L      ++     L  AL  A+G+ YL S 
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES- 121

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                  +HRD  + N L+  N   KISDFGL++ + +  + Y          +  PE  
Sbjct: 122 ----KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYKVKGGKLPIRWMAPESL 176

Query: 242 STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE 301
             GK T +SDV++FGV+L E+ T     +   G+++     +V   L    +L K   P 
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT--LGEEPYPGMSNA----EVLEYLKKGYRLPK---PP 227

Query: 302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
                           L  +C   +  +RP+ +E V+ L
Sbjct: 228 NCPPE--------LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  171 bits (435), Expect = 3e-51
 Identities = 82/294 (27%), Positives = 128/294 (43%), Gaps = 55/294 (18%)

Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG+G FG VYKG L+  +     VA+K   L      +   +F  E  ++ +L HPN+V 
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHL-------NGIGEPKMDWPLRLKVALGAAKGLAY 177
           L+G C + +  +LV EYM+ G+L D+L           +  +     L  A+  AKG+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT----------A 227
           L S        VHRD  + N L+  +   KISDFGL++ + +                 A
Sbjct: 121 LAS-----KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175

Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI 287
                     PE    G  T +SDV++FGV+L E+ T         G++++    +V   
Sbjct: 176 ----------PESLKDGIFTSKSDVWSFGVLLWEIFT--LGATPYPGLSNE----EVLEY 219

Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
           L    +L K   PE                L   C + +  +RP+ +E V+ L+
Sbjct: 220 LRKGYRLPK---PEYCPDE--------LYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  168 bits (427), Expect = 5e-50
 Identities = 92/293 (31%), Positives = 140/293 (47%), Gaps = 62/293 (21%)

Query: 69  LGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHP 120
           LG+G FG VYKGTL+     +   VA+K +     KE   E    EF  E  I+ +L HP
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTL-----KEGASEEEREEFLEEASIMKKLSHP 61

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPLRLKVALGAAKGLAYL 178
           N+V L+G C  G+  ++V EYM  G+L D L  +G    K+     L++AL  AKG+ YL
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYL 118

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV----------TAR 228
            S        VHRD  + N L++ N   KISDFGL++ + E                 A 
Sbjct: 119 ES-----KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA- 172

Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                    PE    GK T +SDV++FGV+L E+ T G +      G++++ ++  +   
Sbjct: 173 ---------PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY---PGMSNEEVLELLE-- 218

Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
             D  +L +   PE        + +     L  +C   +  +RP+ +E V++L
Sbjct: 219 --DGYRLPR---PE-----NCPDEL---YELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (415), Expect = 2e-48
 Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 28/277 (10%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +     LG+G FG+VY     ++G++VAIK ++  + K+         E+ IL +L HPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V L     D    +LV EY + G+L D L      ++               L YLHS 
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 IVHRD K  N+LL  +   K++DFGLA+ +  G++        GT  Y  PE  
Sbjct: 117 G-----IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVL 168

Query: 242 STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE 301
                    D+++ GV+L ELLTG+          D  L+   + I   +       + +
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFP-----GDDQLLELFKKIGKPKPPFPP-PEWD 222

Query: 302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           +S             +L  + +  +  +R +  E ++
Sbjct: 223 ISPE---------AKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  149 bits (378), Expect = 6e-43
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 11/204 (5%)

Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LG+G FG VY    + +GE++A+K +EL    E + E     E+ ILS L HPN+V  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE-ALEREIRILSSLQHPNIVRY 64

Query: 126 IGYC--ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
            G     +     +  EY+  G+L   L   G  K+  P+  K      +GLAYLHS+  
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG- 121

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               IVHRD K  N+L+ ++   K++DFG AK + + +    T  V GT  +  PE    
Sbjct: 122 ----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 244 GKLTLQSDVYAFGVVLLELLTGRR 267
            +    +D+++ G  ++E+ TG+ 
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  137 bits (348), Expect = 2e-38
 Identities = 83/293 (28%), Positives = 132/293 (45%), Gaps = 39/293 (13%)

Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LG+G FG+V           +GE VA+K   L    E     +F  E++IL  LDH N+V
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKS--LNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 124 SLIGYCADGKHRF---LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
              G   +        L+ EY+  G+L+D+L      +++    L  +    KG+ YL S
Sbjct: 70  KYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGS 127

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF--DP 238
                   +HRD  + N+L+ +    KISDFGLAK++PE ++ Y   +  G    F   P
Sbjct: 128 QR-----YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD-YYYVKEPGESPIFWYAP 181

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT-GRRA-------VDLNQGVNDQNLVLQVRHILND 290
           E   T K +  SDV++FGV L EL T G  +       + +      Q +V ++  +L +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241

Query: 291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
            ++L +   P      Y         +L   C   E  +RPS A+ +  +  +
Sbjct: 242 GERLPR--PPSCPDEVY---------DLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (335), Expect = 1e-36
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 13/205 (6%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     +GKGGFG VYK    R+G+ VAIK ++L   ++   + +   E+ IL +  HPN
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK---KEKIINEIQILKKCKHPN 58

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V   G        ++V E+   G+L+D L    +  +       V     KGL YLHS 
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHS- 116

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K+ N+LL+++ E K+ DFGL+  + + +       ++GT  +  PE  
Sbjct: 117 ----NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVI 169

Query: 242 STGKLTLQSDVYAFGVVLLELLTGR 266
           +      ++D+++ G+  +EL  G+
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 2e-36
 Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 19/203 (9%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G FG VYKG  L +G+ VAIK++ L + KE   +     E+D+L  L HPN+V  IG
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALK-SIMQEIDLLKNLKHPNIVKYIG 66

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAA---KGLAYLHSSSAV 184
                   +++ EY + G+L+  +   G     +P  L VA+      +GLAYLH     
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFG----PFPESL-VAVYVYQVLQGLAYLHEQG-- 119

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTST 243
              ++HRD K+ N+L + +   K++DFG+A KL    ++      V+GT  +  PE    
Sbjct: 120 ---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEVIEM 173

Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
              +  SD+++ G  ++ELLTG 
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  132 bits (334), Expect = 2e-36
 Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 55/283 (19%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG FG+VY       G++  +K+++L    E + E     EV IL +L+HPN++    
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYYE 66

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-------GIGEPK-MDWPLRLKVALGAAKGLAYLH 179
              +     +V EY   G+L   +           E + +DW ++L         L YLH
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYLH 120

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR-VLGTFGYFDP 238
           S       I+HRD K  N+ L++N   K+ DFG++K++     T   A+ V+GT  Y  P
Sbjct: 121 SRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSP 172

Query: 239 E------YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK 292
           E      Y        +SD+++ G VL EL T +      +G N   L L++        
Sbjct: 173 ELCQNKPYNY------KSDIWSLGCVLYELCTLKHPF---EGENLLELALKI-------- 215

Query: 293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
            L+    P    S Y+ E      NL S  ++ +  ERPS+A+
Sbjct: 216 -LKGQYPP--IPSQYSSE----LRNLVSSLLQKDPEERPSIAQ 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  135 bits (339), Expect = 2e-36
 Identities = 77/287 (26%), Positives = 125/287 (43%), Gaps = 23/287 (8%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP- 120
           S+     LG+G FG VY    R  ++VA+K +      ++     F  E+ IL+ L+HP 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHL-NGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           N+V L  +  D    +LV EY+  G+L+D L     +  +     L +       L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 180 SSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFGLAKLMPEGQET----YVTARVLGTFG 234
           S       I+HRD K  N+LL  +    K+ DFGLAKL+P+   T     + +  +GT G
Sbjct: 119 SKG-----IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173

Query: 235 YFDPEY---TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR 291
           Y  PE     S    +  SD+++ G+ L ELLTG    +  +  +  +  L++   L   
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233

Query: 292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
                +        S         ++L  + +  +   R S +  + 
Sbjct: 234 SLASPL------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  130 bits (329), Expect = 9e-36
 Identities = 71/201 (35%), Positives = 107/201 (53%), Gaps = 20/201 (9%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG V  G  R G+ VA+K ++     ++     F  E  +++ L HPNLV L+G 
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLK----DDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
              G   ++V EYM KG+L D+L   G   +    +L  AL   +G+ YL   +      
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN-----F 123

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD  + NVL+S +  AK+SDFGLAK   +GQ++       G     +  PE     K 
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-------GKLPVKWTAPEALREKKF 176

Query: 247 TLQSDVYAFGVVLLELLT-GR 266
           + +SDV++FG++L E+ + GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  130 bits (329), Expect = 1e-35
 Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 39/276 (14%)

Query: 68  FLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LG+G  G VYK   + +G++ A+KK+ +    + +   +   E+  L   + P +V   
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 127 G-YCADGKHRFLVYEYMQKGNLQDHL---NGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
           G +  +G+   +V EYM  G+L D L     I EP +       +A    KGL YLH+  
Sbjct: 66  GAFYKEGE-ISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKR 119

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE---TYVTARVLGTFGYFDPE 239
                I+HRD K +N+L+++  E KI+DFG++K++    +   T+V     GT  Y  PE
Sbjct: 120 H----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPE 170

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
                  +  +D+++ G+ LLE   G+            +    ++ I +          
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFELMQAICDGPP------- 220

Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
           P L    ++ E    F +  S C++ +  +RPS AE
Sbjct: 221 PSLPAEEFSPE----FRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 7e-32
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 16/201 (7%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIK--KMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           +GKG FG VYKG L+    VA+K  +  LP     D + +F  E +IL + DHPN+V LI
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLP----PDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR--LKVALGAAKGLAYLHSSSAV 184
           G C   +  ++V E +  G+L   L      K    ++  L+++L AA G+ YL S +  
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKNC- 114

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               +HRD  + N L+  N   KISDFG+++    G  T           +  PE  + G
Sbjct: 115 ----IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 245 KLTLQSDVYAFGVVLLELLTG 265
           + T +SDV+++G++L E  + 
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 2e-30
 Identities = 70/201 (34%), Positives = 108/201 (53%), Gaps = 15/201 (7%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ GT      VA+K ++            F  E  I+ +L H  LV L   
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA----FLQEAQIMKKLRHDKLVQLYAV 69

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
           C++ +  ++V EYM KG+L D L      K+  P  + +A   A+G+AYL S +      
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN-----Y 124

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD  + N+L+  N   KI+DFGLA+L+   ++   TAR    F   +  PE  + G+ 
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLI---EDDEYTAREGAKFPIKWTAPEAANYGRF 181

Query: 247 TLQSDVYAFGVVLLELLT-GR 266
           T++SDV++FG++L E++T GR
Sbjct: 182 TIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  114 bits (286), Expect = 1e-29
 Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 14/204 (6%)

Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHP 120
           F+ +  LG G FG V++G  ++   VAIK +     K  D     +F+ EV  L RL H 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKIL-----KSDDLLKQQDFQKEVQALKRLRHK 62

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           +L+SL   C+ G+  +++ E M+KG+L   L       +     + +A   A+G+AYL  
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            +      +HRD  + N+L+  +   K++DFGLA+L+ E  + Y+++     + +  PE 
Sbjct: 123 QN-----SIHRDLAARNILVGEDLVCKVADFGLARLIKE--DVYLSSDKKIPYKWTAPEA 175

Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            S G  + +SDV++FG++L E+ T
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  114 bits (287), Expect = 2e-29
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 37/220 (16%)

Query: 69  LGKGGFGRVYKGTLRSG------EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG+G FG+V+ G           E+VA+K ++       D   +F  E ++L+   H N+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHENI 70

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHL--NG------IGEPKMDWPLR----LKVALG 170
           V   G C +G    +V+EYM+ G+L   L  +G               L     L++A+ 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 171 AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA--R 228
            A G+ YL S        VHRD  + N L+  +   KI DFG+++      + Y T   R
Sbjct: 131 IASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR------DVYTTDYYR 179

Query: 229 VLGT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           V G       +  PE     K T +SDV++FGVVL E+ T
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 5e-29
 Identities = 64/201 (31%), Positives = 106/201 (52%), Gaps = 15/201 (7%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V++G   +   VA+K ++       D    F  E  I+ +L HP L+ L   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD----FLAEAQIMKKLRHPKLIQLYAV 69

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
           C   +  ++V E M+ G+L ++L G     +  P  + +A   A G+AYL + +      
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN-----Y 124

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD  + NVL+  N   K++DFGLA+++ E  + Y  AR    F   +  PE     + 
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKE--DIY-EAREGAKFPIKWTAPEAALYNRF 181

Query: 247 TLQSDVYAFGVVLLELLT-GR 266
           +++SDV++FG++L E++T GR
Sbjct: 182 SIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  112 bits (281), Expect = 7e-29
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 29/276 (10%)

Query: 69  LGKGGFGR--VYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           LGKG FG   +Y+ T     +V  K++ L R  E     +   E+ ILS L HPN+++  
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQHPNIIAYY 65

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
            +  D     +  EY   G L D +        +  + L         ++Y+H +     
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---- 121

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I+HRD K+ N+ L+     K+ DFG++K++  G E  +   V+GT  Y  PE     K 
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQGVKY 178

Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
             +SD++A G VL ELLT +R  D     N  NLV+++         ++    P +S   
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFD---ATNPLNLVVKI---------VQGNYTPVVSV-- 224

Query: 307 YTMESIAMFANLASRCVRTESSERPSMAECVKELQL 342
           Y+ E I++  +     ++ +  +RP+  E + +  L
Sbjct: 225 YSSELISLVHS----LLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  111 bits (280), Expect = 9e-29
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)

Query: 67  NFLGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           + LG G +G VY+G   +    VA+K ++    ++     EF  E  ++  + HPNLV L
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
           +G C      +++ E+M  GNL D+L      +++  + L +A   +  + YL   +   
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTST 243
              +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  + 
Sbjct: 125 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY-TAHAGAKFPIKWTAPESLAY 179

Query: 244 GKLTLQSDVYAFGVVLLELLT 264
            K +++SDV+AFGV+L E+ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  111 bits (280), Expect = 2e-28
 Identities = 71/214 (33%), Positives = 105/214 (49%), Gaps = 27/214 (12%)

Query: 69  LGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG+G FG+VYKG L       S   VAIK   L    E   + EFR E +++S L HPN+
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKT--LKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHL--------------NGIGEPKMDWPLRLKVA 168
           V L+G C   +   +++EY+  G+L + L              +   +  +D    L +A
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 169 LGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
           +  A G+ YL S        VHRD  + N L+      KISDFGL++ +       V ++
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLEL 262
            L    +  PE    GK T +SD+++FGVVL E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  109 bits (276), Expect = 4e-28
 Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 20/204 (9%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG+V     + +G++ A+K ++  +  +         E +ILSR++HP +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 128 YCA--DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK---GLAYLHSSS 182
           + A    +  +LV EY   G L  HL+  G    +          AA+    L YLHS  
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-----ARFYAAEIVLALEYLHSLG 113

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
                I++RD K  N+LL A+   K++DFGLAK +        T    GT  Y  PE   
Sbjct: 114 -----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166

Query: 243 TGKLTLQSDVYAFGVVLLELLTGR 266
                   D ++ GV+L E+LTG+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 2e-27
 Identities = 71/222 (31%), Positives = 110/222 (49%), Gaps = 53/222 (23%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV----EVDILSRLDHPNLV 123
           +G+G +G+VYK    ++GE+VA+KK+ +   KE      F +    E+ +L +L HPN+V
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKE-----GFPITAIREIKLLQKLRHPNIV 61

Query: 124 SLIG-YCADGKHR-FLVYEYMQKGNLQDH-LNGIGEPKMDWPLRLKVALGAAK------- 173
            L     + GK   ++V+EYM      DH L G+    +D P  +K      K       
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYM------DHDLTGL----LDSPE-VKFTESQIKCYMKQLL 110

Query: 174 -GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLG 231
            GL YLHS+      I+HRD K +N+L++ +   K++DFGLA+         Y T RV+ 
Sbjct: 111 EGLQYLHSNG-----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TNRVI- 163

Query: 232 TFGYFDPE-------YTSTGKLTLQSDVYAFGVVLLELLTGR 266
           T  Y  PE       Y        + D+++ G +L EL  G+
Sbjct: 164 TLWYRPPELLLGATRYGP------EVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 3e-27
 Identities = 79/291 (27%), Positives = 128/291 (43%), Gaps = 46/291 (15%)

Query: 69  LGKGGFGRVYKGTLR---SGEV---VAIKKM-ELPRFKEADGEHEFRVEVDILSRLDHPN 121
           LG+G FG VY+G  +    GE    VAIK + E    +E     EF  E  ++   +  +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE---RIEFLNEASVMKEFNCHH 70

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHL----------NGIGEPKMDWPLRLKVALGA 171
           +V L+G  + G+   +V E M KG+L+ +L           G+G P +     +++A   
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ--KFIQMAAEI 128

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVL 230
           A G+AYL +        VHRD  + N +++ +   KI DFG+ + + E  + Y    + L
Sbjct: 129 ADGMAYLAAKK-----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE-TDYYRKGGKGL 182

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
               +  PE    G  T +SDV++FGVVL E+ T   A    QG++++    +V   + D
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--LAEQPYQGLSNE----EVLKFVID 236

Query: 291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
              L    +                  L   C +     RP+  E V  L+
Sbjct: 237 GGHLDLPENCP-----------DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  107 bits (269), Expect = 4e-27
 Identities = 82/274 (29%), Positives = 120/274 (43%), Gaps = 35/274 (12%)

Query: 63  FSDDNFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F   N +GKG FG V+K   ++   V A+K+++L +    + E     E  +L++LD   
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSSY 60

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNG-IGEPKMD---WPLRLKVALGAAKGLAY 177
           ++       D     +V EY + G+L   L    G P  +   W   +++ LG    LA+
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
           LHS       I+HRD KS N+ L A    KI D G+AKL+     T     ++GT  Y  
Sbjct: 117 LHSKK-----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLS 169

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV 297
           PE         +SDV+A GVVL E  TG+   D N   N   L+          K +R V
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI---------LKIIRGV 217

Query: 298 IDPELSRSSYTMESIAMFANLASRCVRTESSERP 331
             P     S         A L  +C+  +  +RP
Sbjct: 218 FPPVSQMYS------QQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  107 bits (270), Expect = 5e-27
 Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 39/225 (17%)

Query: 69  LGKGGFGRVYKGT---LRSGE---VVAIKKMELPRFKE---ADGEHEFRVEVDILSRLDH 119
           +G+G FGRV++     L   E   +VA+K +     KE   AD + +F+ E  +++  DH
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADMQADFQREAALMAEFDH 67

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLN--------------------GIGEPKM 159
           PN+V L+G CA GK   L++EYM  G+L + L                     G+    +
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 160 DWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE 219
               +L +A   A G+AYL          VHRD  + N L+  N   KI+DFGL++ +  
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                 +        +  PE     + T +SDV+A+GVVL E+ +
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 6e-27
 Identities = 73/201 (36%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 69  LGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           LG G FG V KG     SG+ V +    L +   A G+ EF  E  ++++LDHP +V LI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKV-ALGAAKGLAYLHSSSAVG 185
           G C  G+   LV E    G L  +L    E  +     LK  A   A G+AYL S     
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPV---SDLKELAHQVAMGMAYLESKH--- 115

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTST 243
              VHRD  + NVLL    +AKISDFG+++ +  G   Y  A   G +   ++ PE  + 
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPECINY 172

Query: 244 GKLTLQSDVYAFGVVLLELLT 264
           GK + +SDV+++GV L E  +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  107 bits (269), Expect = 7e-27
 Identities = 90/289 (31%), Positives = 135/289 (46%), Gaps = 31/289 (10%)

Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LGKG FG V           +GEVVA+KK++      A+   +F  E++IL  L H N+V
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ---HSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 124 SLIGYCADGKHR--FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
              G C     R   LV EY+  G+L+D+L    E ++D    L  A    KG+ YL S 
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSK 127

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYFDPEY 240
                  VHRD  + N+L+ +    KI DFGL K++P+ +E Y V         ++ PE 
Sbjct: 128 R-----YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182

Query: 241 TSTGKLTLQSDVYAFGVVLLELLT------GRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
            +  K ++ SDV++FGVVL EL T         A  +    ND+   + V H++   K  
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242

Query: 295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
            ++  P         E  A+       C   + S+RPS +E   +++ I
Sbjct: 243 GRLPAPP----GCPAEIYAIM----KECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  106 bits (267), Expect = 7e-27
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 33/279 (11%)

Query: 69  LGKGGFGRVYKGTLRS--GEV--VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FG V +G   +  G+V  VA+K   L   K +D   +F  E  I+  LDH NL+ 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           L G         +V E    G+L D L                A+  A G+ YL S    
Sbjct: 61  LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-- 117

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT-FGYFDPEYTST 243
               +HRD  + N+LL+++ + KI DFGL + +P+ ++ YV    L   F +  PE   T
Sbjct: 118 ---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174

Query: 244 GKLTLQSDVYAFGVVLLELLT-GRRA-VDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE 301
              +  SDV+ FGV L E+ T G      L+          Q+   + D++  R      
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKI-DKEGER------ 219

Query: 302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
           L R     + I    N+  +C     ++RP+ A   + L
Sbjct: 220 LERPEACPQDI---YNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 4e-26
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE-ADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V+ G  R    VAIK +     +E A  E +F  E  ++ +L HPNLV L G
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI-----REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGI-GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
            C   +  F+V EYM  G L ++L    G+   +W   L +     + + YL S+     
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---- 120

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDPEYTST 243
             +HRD  + N L+  +   K+SDFGLA+ + + Q T       GT     +  PE    
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDY 175

Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
            + + +SDV++FGV++ E+ + 
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  104 bits (262), Expect = 5e-26
 Identities = 91/298 (30%), Positives = 133/298 (44%), Gaps = 51/298 (17%)

Query: 67  NFLGKGGFGRVYKGTLR------SGEV-VAIKKMELPRFKEADGEH-EFRVEVDILSRLD 118
           NFLG G FG VY+GT        SG + VA+K +   R    D E  EF  E  ++S  +
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPL-----RLKVALGAAK 173
           HPN+V L+G C   + ++++ E M+ G+L  +L      +   PL      L + L  AK
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLS-----ANFEAKISDFGLAKLMPEGQETYVTAR 228
           G  YL          +HRD  + N L+S     A+   KI DFGLA+ + +         
Sbjct: 118 GCVYLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ----GVNDQNLVLQV 284
            L    +  PE    GK T QSDV++FGV++ E+LT      L Q     +N+Q    +V
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT------LGQQPYPALNNQ----EV 222

Query: 285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL 342
              +    +L+K   PE                L + C   + SERP+     + LQ 
Sbjct: 223 LQHVTAGGRLQK---PENCPDK--------IYQLMTNCWAQDPSERPTFDRIQEILQN 269

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  104 bits (260), Expect = 5e-26
 Identities = 68/201 (33%), Positives = 111/201 (55%), Gaps = 17/201 (8%)

Query: 68  FLGKGGFGRVYKGTLRSGEVVAIK--KMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
            LGKG FG V+KGTL+    VA+K  K +LP+    + + +F  E  IL + DHPN+V L
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ----ELKIKFLSEARILKQYDHPNIVKL 57

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR--LKVALGAAKGLAYLHSSSA 183
           IG C   +  ++V E +  G   D L+ + + K +   +  +K AL AA G+AYL S + 
Sbjct: 58  IGVCTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
                +HRD  + N L+  N   KISDFG+++   +G  +    + +    +  PE  + 
Sbjct: 115 -----IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNY 168

Query: 244 GKLTLQSDVYAFGVVLLELLT 264
           G+ + +SDV+++G++L E  +
Sbjct: 169 GRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (260), Expect = 9e-26
 Identities = 71/212 (33%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 67  NFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           N +G G FG+VY    L +GE++A+K++ +        + E   E+ +L  L HPNLV  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-EIADEMKVLELLKHPNLVK- 63

Query: 126 IGYCADGKHRFLVY---EYMQKGNLQDHL-NGIGEPKMDWPLRLKV-ALGAAKGLAYLHS 180
             Y     HR  VY   EY   G L++ L +G    +      ++V  L   +GLAYLHS
Sbjct: 64  --YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEH----VIRVYTLQLLEGLAYLHS 117

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT--ARVLGTFGYFDP 238
                  IVHRD K  N+ L  N   K+ DFG A  +     T       + GT  Y  P
Sbjct: 118 HG-----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Query: 239 EYTSTGKLTLQ---SDVYAFGVVLLELLTGRR 267
           E  + GK       +D+++ G V+LE+ TG+R
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 1e-25
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 36/212 (16%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV------EVDILSRLDHPN 121
           LG+G +G VYK    ++GE+VA+KK+ L    E +G     +      E+ +L  L HPN
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEG-----IPSTALREISLLKELKHPN 59

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V L+      +  +LV+EY    +L+ +L+      +   L   +     +GLAY HS 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSH 117

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K  N+L++ +   K++DFGLA+       TY T  V+ T  Y  PE  
Sbjct: 118 R-----ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPE-- 168

Query: 242 STGKLTLQS-------DVYAFGVVLLELLTGR 266
               + L S       D+++ G +  E++TG+
Sbjct: 169 ----ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  103 bits (259), Expect = 1e-25
 Identities = 68/200 (34%), Positives = 95/200 (47%), Gaps = 11/200 (5%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKGGFG V    ++ +G++ A KK++  R K+  GE     E  IL ++    +VSL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 128 YCADGK-HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
           Y  + K    LV   M  G+L+ H+  +GEP       +  A     GL +LH       
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---- 115

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            IV+RD K  NVLL  +   +ISD GLA  +  G++     R  GT GY  PE       
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--KGRA-GTPGYMAPEVLQGEVY 171

Query: 247 TLQSDVYAFGVVLLELLTGR 266
               D +A G  L E++ GR
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  102 bits (255), Expect = 3e-25
 Identities = 82/274 (29%), Positives = 128/274 (46%), Gaps = 32/274 (11%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG V+ G       VAIK +     + A  E +F  E  ++ +L HP LV L G 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR----EGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
           C +     LV+E+M+ G L D+L      K      L + L   +G+AYL SS+     +
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESSN-----V 121

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD  + N L+  N   K+SDFG+ + + + Q T  T        +  PE  S  K + 
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKWSSPEVFSFSKYSS 180

Query: 249 QSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-SRSS 306
           +SDV++FGV++ E+ + G+   +     N  N   +V   +N   +L K   P L S+S 
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYE-----NRSN--SEVVETINAGFRLYK---PRLASQSV 230

Query: 307 YTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
           Y          L   C +    +RPS +  + +L
Sbjct: 231 Y---------ELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (258), Expect = 3e-25
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 21/202 (10%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G  G VYK T R +G+ VAIKKM L        +     E+ I+    HPN+V    
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRL----RKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG----IGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
               G   ++V EYM  G+L D +      + EP++ +     V     +GL YLHS   
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQGLEYLHSQ-- 135

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               ++HRD KS N+LLS +   K++DFG A  + + +    +  V+GT  +  PE    
Sbjct: 136 ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKR 190

Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
                + D+++ G++ +E+  G
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 3e-25
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 15/205 (7%)

Query: 69  LGKGGFGRVYKGTLR-SGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LG G FG VYKG     GE     VAIK   L          E   E  +++ +DHP++V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIK--VLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
            L+G C   + + L+ + M  G L D++    +  +     L   +  AKG++YL     
Sbjct: 73  RLLGICLSSQVQ-LITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEKR- 129

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               +VHRD  + NVL+      KI+DFGLAKL+   ++ Y          +   E    
Sbjct: 130 ----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 244 GKLTLQSDVYAFGVVLLELLT-GRR 267
              T +SDV+++GV + EL+T G +
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  102 bits (257), Expect = 4e-25
 Identities = 68/205 (33%), Positives = 98/205 (47%), Gaps = 21/205 (10%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G  G V+K   R +GE VA+KK+ L R  E    ++   E+  L    HP +V L+ 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAA----KGLAYLHSSSA 183
               G    LV EYM    L + L        + PL             KG+AY+H++  
Sbjct: 67  VFPHGSGFVLVMEYMPSD-LSEVLR-----DEERPLPEAQVKSYMRMLLKGVAYMHANG- 119

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE--YT 241
               I+HRD K  N+L+SA+   KI+DFGLA+L  E +    + +V  T  Y  PE  Y 
Sbjct: 120 ----IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYG 174

Query: 242 STGKLTLQSDVYAFGVVLLELLTGR 266
           +  K     D++A G +  ELL G 
Sbjct: 175 AR-KYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 4e-25
 Identities = 69/249 (27%), Positives = 114/249 (45%), Gaps = 28/249 (11%)

Query: 68  FLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            +G+G +G VYK     +GE+VAIKK++L    E   +   R E+ +L  L+HPN++ L+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLL 64

Query: 127 GYCADGKHRFLVYEYMQKGNL----QDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
                    +LV+E+M   +L    +D   G+ E  +   L         +GLA+ HS  
Sbjct: 65  DVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYL-----YQLLQGLAFCHSHG 118

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE--Y 240
                I+HRD K  N+L++     K++DFGLA+        Y T  V+ T  Y  PE   
Sbjct: 119 -----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY-THYVV-TRWYRAPELLL 171

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
              G  +   D+++ G +  ELL+ R    L  G ++   + Q+  I          + P
Sbjct: 172 GDKG-YSTPVDIWSVGCIFAELLSRR---PLFPGKSE---IDQLFKIFRTLGTPDPEVWP 224

Query: 301 ELSRSSYTM 309
           + +  +   
Sbjct: 225 KFTSLARNY 233

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  101 bits (254), Expect = 6e-25
 Identities = 76/208 (36%), Positives = 109/208 (52%), Gaps = 26/208 (12%)

Query: 69  LGKGGFGRV----YKGTLR-SGEVVAIKKMELPRFKEADGEHE--FRVEVDILSRLDHPN 121
           LG+G FG+V    Y      +GE+VA+K ++    +E   ++   ++ E++IL  L H N
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLK----RECGQQNTSGWKKEINILKTLYHEN 67

Query: 122 LVSLIGYCAD--GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR--LKVALGAAKGLAY 177
           +V   G C++  GK   L+ EY+  G+L+D+L     PK    L   L  A    +G+AY
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAY 122

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYF 236
           LHS        +HRD  + NVLL  +   KI DFGLAK +PEG E Y V         ++
Sbjct: 123 LHSQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             E     K +  SDV++FGV L ELLT
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  105 bits (264), Expect = 7e-25
 Identities = 82/301 (27%), Positives = 138/301 (45%), Gaps = 37/301 (12%)

Query: 56  MEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKME----LPRFKEADGEHEFRVE 110
           + +   S  ++N + +G  G  YKG      +   +K++     +P  + AD        
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-------- 736

Query: 111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG 170
              + +L HPN+V LIG C   K  +L++EY++  NL + L       + W  R K+A+G
Sbjct: 737 ---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIG 788

Query: 171 AAKGLAYLH--SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
            AK L +LH   S AV    V  +     +++    E  +    L  L+    + ++++ 
Sbjct: 789 IAKALRFLHCRCSPAV----VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS- 842

Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL 288
                 Y  PE   T  +T +SD+Y FG++L+ELLTG+   D   GV+  ++V   R+  
Sbjct: 843 -----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCY 896

Query: 289 NDRKKLRKVIDPELSR-SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN 347
           +D   L   IDP +    S     I    NLA  C  T+ + RP   + +K L+    ++
Sbjct: 897 SD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955

Query: 348 S 348
           S
Sbjct: 956 S 956

Length = 968

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  100 bits (251), Expect = 1e-24
 Identities = 82/266 (30%), Positives = 129/266 (48%), Gaps = 32/266 (12%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 69

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P  + +A   A G+AY+   +      
Sbjct: 70  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 123

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180

Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R V     VN        R +L+  ++  ++  P      
Sbjct: 181 TIKSDVWSFGILLTELTTKGR-VPYPGMVN--------REVLDQVERGYRMPCPP----- 226

Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
              E      +L  +C R E  ERP+
Sbjct: 227 ---ECPESLHDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 64/211 (30%), Positives = 110/211 (52%), Gaps = 21/211 (9%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHE---------FRVEVDILSRLD 118
           +GKG +GRVY    + +GE++A+K++ELP      G H+          R E++ L  LD
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPAT--IAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
           H N+V  +G+    ++  +  EY+  G++   L   G  + +  L         +GLAYL
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYL 124

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HS       I+HRD K+ N+L+ A+   KISDFG++K   +  +      + G+  +  P
Sbjct: 125 HSKG-----ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 239 E--YTSTGKLTLQSDVYAFGVVLLELLTGRR 267
           E  ++ +   + + D+++ G V+LE+  GRR
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =   99 bits (250), Expect = 3e-24
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 33/221 (14%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLD-HPNLV 123
           +G+G F  V     + + +  AIK   K +L + K+       ++E ++L+RL+ HP ++
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK---VKYVKIEKEVLTRLNGHPGII 65

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
            L     D ++ + V EY   G L  ++   G        R   A      L YLHS   
Sbjct: 66  KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE-ILLALEYLHS--- 120

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE---------------GQETYVTAR 228
               I+HRD K  N+LL  +   KI+DFG AK++                  Q      R
Sbjct: 121 --KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 229 ---VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
               +GT  Y  PE  +       SD++A G ++ ++LTG+
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 99.3 bits (247), Expect = 4e-24
 Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 19/201 (9%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G+G FG V +G   +G+ VA+K ++     +A     F  E  ++++L H NLV L+G 
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA-----FLEETAVMTKLHHKNLVRLLGV 67

Query: 129 CA-DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              +G +  +V E M KGNL + L   G   +     L+ +L  A+G+ YL S       
Sbjct: 68  ILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK----- 120

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           +VHRD  + N+L+S +  AK+SDFGLA++   G +            +  PE     K +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEALKHKKFS 175

Query: 248 LQSDVYAFGVVLLELLTGRRA 268
            +SDV+++GV+L E+ +  RA
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 98.9 bits (246), Expect = 5e-24
 Identities = 69/200 (34%), Positives = 104/200 (52%), Gaps = 18/200 (9%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG V  G  R G  VA+K +     K       F  E  ++++L H NLV L+G 
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67

Query: 129 CADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
             + K   ++V EYM KG+L D+L   G   +     LK +L   + + YL +++     
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN----- 122

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
            VHRD  + NVL+S +  AK+SDFGL K   E   T  T ++     +  PE     K +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFS 177

Query: 248 LQSDVYAFGVVLLELLT-GR 266
            +SDV++FG++L E+ + GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 6e-24
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 14/204 (6%)

Query: 66  DNFLGKGGFGRVYKGTL----RSGEVVAIKKMELPRFKEADGEH-EFRVEVDILSRLDHP 120
           +  +G G FG V +G L    +    VAIK +   +   +D +  +F  E  I+ + DHP
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL---KAGSSDKQRLDFLTEASIMGQFDHP 65

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           N++ L G     +   ++ EYM+ G+L   L    + K      + +  G A G+ YL  
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYL-- 122

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            S +    VHRD  + N+L+++N   K+SDFGL++ + + + TY T        +  PE 
Sbjct: 123 -SEMNY--VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179

Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K T  SDV++FG+V+ E+++
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 99.6 bits (248), Expect = 6e-24
 Identities = 83/301 (27%), Positives = 129/301 (42%), Gaps = 50/301 (16%)

Query: 69  LGKGGFGRV---------------YKGTLRSGE--VVAIKKMELPRFKEADGEHEFRVEV 111
           LG+G FG V               +   +R G   +VA+K +     K A   ++F  EV
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNA--RNDFLKEV 70

Query: 112 DILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL------NGIGE--------- 156
            ILSRL  PN++ L+G C D     ++ EYM+ G+L   L      +             
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130

Query: 157 --PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
             P + +   L VAL  A G+ YL S     +  VHRD  + N L+  N   KI+DFG++
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSS-----LNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG 274
           + +  G    +  R +    +   E    GK T  SDV+AFGV L E+L   +     + 
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE- 244

Query: 275 VNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMA 334
           + D+ ++        D+   R+V    L R     + +     L  +C   +  ERPS +
Sbjct: 245 LTDEQVIENAGEFFRDQG--RQVY---LFRPPPCPQGL---YELMLQCWSRDCRERPSFS 296

Query: 335 E 335
           +
Sbjct: 297 D 297

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 98.9 bits (246), Expect = 6e-24
 Identities = 71/218 (32%), Positives = 113/218 (51%), Gaps = 17/218 (7%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ GT      VA+K ++ P     +    F  E  I+ +L H  LV L   
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPES---FLEEAQIMKKLRHDKLVQLYAV 69

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L       +  P  + +A   A G+AY+   +      
Sbjct: 70  VSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-----Y 123

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD +S N+L+      KI+DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180

Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
           T++SDV++FG++L EL+T  R      G+N++ ++ QV
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVP--YPGMNNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 98.7 bits (246), Expect = 1e-23
 Identities = 70/200 (35%), Positives = 99/200 (49%), Gaps = 11/200 (5%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKGGFG V    +R +G++ A KK+E  R K+  GE     E  IL +++   +VSL  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 128 YCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
           Y  + K    LV   M  G+L+ H+  +G P  D    +  A     GL  LH       
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---- 122

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            IV+RD K  N+LL      +ISD GLA  +PEG+   +  RV GT GY  PE     + 
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERY 178

Query: 247 TLQSDVYAFGVVLLELLTGR 266
           T   D +  G ++ E++ G+
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 98.5 bits (245), Expect = 1e-23
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 11/200 (5%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKGGFG V    ++ +G++ A KK++  R K+  GE    +E +IL +++ P +V+L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 128 YCADGK-HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
           Y  + K H  LV   M  G+L+ H+  +GE  ++    +  +     G+ +LHS     +
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS-----M 114

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            IV+RD K  NVLL      ++SD GLA  + +G+     A   GT GY  PE       
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA---GTNGYMAPEILKEEPY 171

Query: 247 TLQSDVYAFGVVLLELLTGR 266
           +   D +A G  + E++ GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 98.6 bits (245), Expect = 1e-23
 Identities = 73/207 (35%), Positives = 103/207 (49%), Gaps = 11/207 (5%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           +F     LGKGGFG V    +R +G++ A KK+E  R K+  GE     E  IL +++  
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60

Query: 121 NLVSLIGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
            +VSL  Y  + K    LV   M  G+L+ H+  +GE   +    +  A     GL  LH
Sbjct: 61  FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   IV+RD K  N+LL  +   +ISD GLA  +PEGQ   +  RV GT GY  PE
Sbjct: 120 QER-----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPE 171

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGR 266
                + T   D +A G +L E++ G+
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.8 bits (244), Expect = 1e-23
 Identities = 72/274 (26%), Positives = 131/274 (47%), Gaps = 36/274 (13%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV--EVDILSRLDHPNLVSL 125
           LG G  G V K   R +G+++A+K + L    E +   + ++  E+DIL + + P +V  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL----EINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
            G   +     +  EYM  G+L   L  +     +  L  K+A+   KGL YLH      
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-KIAVAVLKGLTYLHEKHK-- 121

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
             I+HRD K +N+L+++  + K+ DFG++ +L+    +T+V     GT  Y  PE     
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGN 174

Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID---PE 301
             +++SD+++ G+ L+EL TGR         +  + + ++         L+ +++   P 
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR--FPYPPENDPPDGIFEL---------LQYIVNEPPPR 223

Query: 302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
           L    ++ +    F +  + C+  +  ERPS  E
Sbjct: 224 LPSGKFSPD----FQDFVNLCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 97.6 bits (243), Expect = 2e-23
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 18/202 (8%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE-FRVEVDILSRLDHPNLVSLIG 127
           LG G FG V+ G       VAIK +     K+     E F  E +++ +L HP LV L  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL-----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                +  +++ EYM+ G+L D L      K+     + +A   A+G+A++   + +   
Sbjct: 69  VVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI--- 124

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGK 245
             HRD ++ N+L+S     KI+DFGLA+L+   ++   TAR    F   +  PE  + G 
Sbjct: 125 --HRDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGT 179

Query: 246 LTLQSDVYAFGVVLLELLT-GR 266
            T++SDV++FG++L E++T GR
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 81/304 (26%), Positives = 133/304 (43%), Gaps = 62/304 (20%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV----EVDILSRLDHPNLV 123
           +G+G +G V K   + +GE+VAIKK     FKE++ + + +     EV +L +L H N+V
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKK-----FKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHL----NGIGEP---KMDWPLRLKVALGAAKGLA 176
           +L          +LV+EY+++  L + L     G+         W L         + +A
Sbjct: 64  NLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--------LQAIA 114

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           Y HS +     I+HRD K  N+L+S +   K+ DFG A+ +     + +T  V  T  Y 
Sbjct: 115 YCHSHN-----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYR 168

Query: 237 DPE----YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL---- 288
            PE     T+ GK     DV+A G ++ ELL G     L  G +D + +  ++  L    
Sbjct: 169 APELLVGDTNYGK---PVDVWAIGCIMAELLDGE---PLFPGDSDIDQLYLIQKCLGPLP 222

Query: 289 ---------NDRKKLRKVIDPE-----LSRSSYTMESIAMFANLASRCVRTESSERPSMA 334
                    N R       +P        R    + S A+  +    C+R +  ER +  
Sbjct: 223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL--DFLKACLRMDPKERLTCD 280

Query: 335 ECVK 338
           E ++
Sbjct: 281 ELLQ 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.1 bits (242), Expect = 2e-23
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 30/259 (11%)

Query: 68  FLGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LGKG +G VYK   L   +  A+K+++L    + +   +   E+ IL+ ++HPN++S  
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE-REDAVNEIRILASVNHPNIISYK 65

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRL--KVALGAAKGLAYLHSSSAV 184
               DG    +V EY   G+L   ++   + +   P +   ++ +   +GL  LH     
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK-- 123

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
              I+HRD KS N+LL AN   KI D G++K++ +     +    +GT  Y  PE     
Sbjct: 124 ---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGR 176

Query: 245 KLTLQSDVYAFGVVLLELLT------GRRAVDLNQGV-----------NDQNLVLQVRHI 287
             + +SD+++ G +L E+ T       R   DL   V             Q+L   +R +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM 236

Query: 288 LNDRKKLRKVIDPELSRSS 306
           L  + KLR   D  L+  +
Sbjct: 237 LQVKPKLRPNCDKILASPA 255

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.4 bits (242), Expect = 2e-23
 Identities = 70/209 (33%), Positives = 109/209 (52%), Gaps = 22/209 (10%)

Query: 69  LGKGGFGRVYKGTL----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G G FG V++G L    R    VAIK ++ P + E     +F  E  I+ +  H N++ 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQ-RQDFLSEASIMGQFSHHNIIR 70

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHL-NGIGEPKMDWPLRLKVAL-GAAKGLAYLHSSS 182
           L G     K   ++ EYM+ G L  +L +  GE       +L   L G A G+ YL   +
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFS---SYQLVGMLRGIAAGMKYLSDMN 127

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM---PEGQETYVTARVLGTFGYFDPE 239
                 VHRD  + N+L+++N E K+SDFGL++++   PEG  TY T+       +  PE
Sbjct: 128 -----YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAPE 180

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLT-GRR 267
             +  K T  SDV++FG+V+ E+++ G R
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 98.0 bits (245), Expect = 2e-23
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 39/218 (17%)

Query: 66  DNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA-DGEH--EFRVEVDILSRLDHPN 121
              LG+G +  VYK     +G +VAIKK++L   KEA DG +    R E+ +L  L HPN
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPN 63

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA------LGAAKGL 175
           ++ L+       +  LV+E+M+  +L+  +        D  + L  A      L   +GL
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEKVIK-------DKSIVLTPADIKSYMLMTLRGL 115

Query: 176 AYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            YLHS+      I+HRD K  N+L++++   K++DFGLA+          T +V+ T  Y
Sbjct: 116 EYLHSNW-----ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV-TRWY 168

Query: 236 FDPE-------YTSTGKLTLQSDVYAFGVVLLELLTGR 266
             PE       Y          D+++ G +  ELL   
Sbjct: 169 RAPELLFGARHYGVG------VDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 96.8 bits (241), Expect = 5e-23
 Identities = 73/285 (25%), Positives = 130/285 (45%), Gaps = 37/285 (12%)

Query: 69  LGKGGFGRVY----KGTLRSGE--VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG+G FG V+    KG    G   +V +K ++  + K+ + + EFR E+D+  +L H N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ--KTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHL-------NGIGEPKMDWPLRLKVALGAAKGL 175
           V L+G C + +  +++ EY   G+L+  L         +  P +    ++ +    A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 176 AYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            +L ++       VHRD  + N L+S+  E K+S   L+K      E Y     L    +
Sbjct: 131 DHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRW 184

Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR 295
             PE       + +SDV++FGV++ E+ T  +      G++D+ ++ +++       KL 
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFT--QGELPFYGLSDEEVLNRLQA-----GKL- 236

Query: 296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
                EL         +     L +RC      +RPS +E V  L
Sbjct: 237 -----ELPVPEGCPSRL---YKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 96.4 bits (240), Expect = 7e-23
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 69  LGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG G FG VY+G  R          VA+K   LP       E +F +E  I+S+ +H N+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKT--LPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRL------KVALGAAKGLA 176
           V LIG   +   RF++ E M  G+L+  L     P+ + P  L        A   AKG  
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLS---ANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YL  +       +HRD  + N LL+       AKI+DFG+A+ +          R +   
Sbjct: 131 YLEENH-----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            +  PE    G  T ++DV++FGV+L E+ +
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 26/214 (12%)

Query: 67  NFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVS 124
             +GKG FG V K   +S G+++  K+++     E   E +  V EV+IL  L HPN+V 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK--EKQQLVSEVNILRELKHPNIVR 63

Query: 125 LIGYCADGKHR--FLVYEYMQKGNLQDHLNG-------IGEPKMDWPLRLKVALGAAKGL 175
                 D  ++  ++V EY + G+L   +         I E  + W +  ++ L     L
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLLA----L 118

Query: 176 AYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ---ETYVTARVLGT 232
              H+ S  G  ++HRD K  N+ L AN   K+ DFGLAK++       +TYV     GT
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GT 173

Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
             Y  PE  +      +SD+++ G ++ EL    
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 16/204 (7%)

Query: 68  FLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPNLVS 124
            LG G FG VY+G  L  G+  A+K++ L    +   E   +   E+ +LS+L HPN+V 
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
            +G   +  + ++  E +  G+L   L   G      P+          GL YLH  +  
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRN-- 122

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR-VLGTFGYFDPEY-TS 242
               VHRD K  N+L+  N   K++DFG+AK +      +  A+   G+  +  PE    
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAKQV----VEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 243 TGKLTLQSDVYAFGVVLLELLTGR 266
            G   L +D+++ G  +LE+ TG+
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.6 bits (235), Expect = 2e-22
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 16/208 (7%)

Query: 67  NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHPNLV 123
             LGKG +G VY G    G+++A+K++EL        E E+     EVD+L  L H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE-PKMDWPLRLKVALGAAKGLAYLHSSS 182
             +G C D     +  E++  G++   LN  G  P+  +    K  L    G+AYLH++ 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLHNNC 122

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP----EGQETYVTARVLGTFGYFDP 238
                +VHRD K  NV+L  N   K+ DFG A+ +      G  + +   + GT  +  P
Sbjct: 123 -----VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           E  +      +SD+++ G  + E+ TG+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.4 bits (234), Expect = 2e-22
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 15/201 (7%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  I+ +L H  LV L   
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEA---FLQEAQIMKKLRHDKLVPLYAV 69

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
            ++ +  ++V E+M KG+L D L       +  P  + +A   A G+AY+       +  
Sbjct: 70  VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER-----MNY 123

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+  N   KI+DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180

Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L EL+T  R
Sbjct: 181 TIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 93.5 bits (232), Expect = 4e-22
 Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 13/196 (6%)

Query: 69  LGKGGFGRVYKGTLRSGEV-VAIK--KMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G+G FG V+ G LR+    VA+K  +  LP     D + +F  E  IL +  HPN+V L
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLP----PDLKAKFLQEARILKQYSHPNIVRL 58

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
           IG C   +  ++V E +Q G+    L   G P++     +++   AA G+ YL S     
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHC-- 115

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
              +HRD  + N L++     KISDFG+++   +G              +  PE  + G+
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 246 LTLQSDVYAFGVVLLE 261
            + +SDV++FG++L E
Sbjct: 173 YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 94.3 bits (234), Expect = 4e-22
 Identities = 72/207 (34%), Positives = 101/207 (48%), Gaps = 11/207 (5%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           +F     LGKGGFG V    +R +G++ A KK+E  R K+  GE     E  IL +++  
Sbjct: 1   TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60

Query: 121 NLVSLIGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
            +VSL  Y  + K    LV   M  G+L+ H+  +G P  D    +  A     GL  L 
Sbjct: 61  FVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   IV+RD K  N+LL      +ISD GLA  +PEG+   V  RV GT GY  PE
Sbjct: 120 RER-----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPE 171

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGR 266
             +  K T   D +  G ++ E++ G+
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 93.6 bits (232), Expect = 5e-22
 Identities = 62/198 (31%), Positives = 103/198 (52%), Gaps = 14/198 (7%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G   +   VA+K ++ P          F  E +++  L H  LV L   
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQA---FLEEANLMKTLQHDKLVRLYAV 69

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
               +  +++ EYM KG+L D L      K+  P  +  +   A+G+AY+   +      
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-----Y 124

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ NVL+S +   KI+DFGLA+++ + +    TAR    F   +  PE  + G  
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSF 181

Query: 247 TLQSDVYAFGVVLLELLT 264
           T++SDV++FG++L E++T
Sbjct: 182 TIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.9 bits (233), Expect = 5e-22
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 28/216 (12%)

Query: 69  LGKGGFGRVYKGT------LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG+G FG+V+          +   +VA+K ++ P         +F+ E ++L+ L H ++
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHI 69

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM----DWPLRLKVALG-------- 170
           V   G C DG    +V+EYM+ G+L   L   G   M      P + K  LG        
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 171 --AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
              A G+ YL S        VHRD  + N L+ AN   KI DFG+++ +       V   
Sbjct: 130 SQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184

Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            +    +  PE     K T +SDV++FGV+L E+ T
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 93.9 bits (233), Expect = 6e-22
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 27/216 (12%)

Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LG+  FG++YKG L        ++VAIK   L          EF+ E  +++ L HPN+V
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKT--LKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHL---------------NGIGEPKMDWPLRLKVA 168
            L+G     +   +++EY+ +G+L + L               +G  +  +D    L +A
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 169 LGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
           +  A G+ YL S        VH+D  + N+L+      KISD GL++ +       V  +
Sbjct: 131 IQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            L    +  PE    GK +  SD+++FGVVL E+ +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 93.1 bits (232), Expect = 6e-22
 Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 13/200 (6%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG GGFGRV    ++S     A+K ++     E   +     E +IL   +HP +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD-WPLRLKVALGAAKGLAYLHSSSAVGI 186
              D K+ +++ EY   G L   L   G    D +  R  +A        YLH+      
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIA-CVVLAFEYLHNRG---- 113

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I++RD K  N+LL +N   K+ DFG AK +  GQ+T+      GT  Y  PE       
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGY 169

Query: 247 TLQSDVYAFGVVLLELLTGR 266
               D ++ G++L ELLTGR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 94.5 bits (236), Expect = 6e-22
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 59/233 (25%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +     +G G +G V      R+G  VAIKK+        D +   R E+ +L  L H N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHEN 60

Query: 122 LVSLIG-YCADGKHRF----LVYEYMQ---------KGNLQ-DHLNGIGEPKMDWPLRLK 166
           ++ L+          F    +V E M+            L  DH+       +   LR  
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYF----LYQILR-- 114

Query: 167 VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-LMPEGQET-- 223
                  GL YLHS++     ++HRD K +N+L+++N + KI DFGLA+ + P+  E   
Sbjct: 115 -------GLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 224 ---YVTAR-------VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
              YV  R       +L +  Y           T   D+++ G +  ELLT +
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRY-----------TKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.1 bits (232), Expect = 7e-22
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 11/199 (5%)

Query: 70  GKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           GKG FG+V     R + ++ A+K M   +  E         E  IL  L+HP LV+L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
             D ++ +LV + +  G+L+ HL        +  ++  +       L YLHS       I
Sbjct: 69  FQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWIC-EIVLALEYLHSKG-----I 121

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD K  N+LL       I+DF +A  +     T  T+   GT GY  PE       ++
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQGYSV 178

Query: 249 QSDVYAFGVVLLELLTGRR 267
             D ++ GV   E L G+R
Sbjct: 179 AVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.7 bits (231), Expect = 8e-22
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 34/216 (15%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGE-HEFRVEVDILSRLDH 119
            F     LG+G +G VYK   + +G+VVAIK + +      + +  E   E+ IL + D 
Sbjct: 4   VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV------EEDLQEIIKEISILKQCDS 57

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLK------VALGAAK 173
           P +V   G        ++V EY   G++ D +    +        L       +     K
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-------TLTEEEIAAILYQTLK 110

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VL 230
           GL YLHS+       +HRD K+ N+LL+   +AK++DFG++     GQ T   A+   V+
Sbjct: 111 GLEYLHSNK-----KIHRDIKAGNILLNEEGQAKLADFGVS-----GQLTDTMAKRNTVI 160

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           GT  +  PE         ++D+++ G+  +E+  G+
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 93.3 bits (232), Expect = 9e-22
 Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 39/288 (13%)

Query: 69  LGKGGFGRVYKGTLRSGE----VVAIK--KMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           +G+G FG VY+G   S E     VA+K  K             +F  E  I+ + DHP++
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT----SPSVREKFLQEAYIMRQFDHPHI 69

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR--LKVALGAAKGLAYLHS 180
           V LIG   +    ++V E    G L+ +L      K    L   +  +   +  LAYL S
Sbjct: 70  VKLIGVITE-NPVWIVMELAPLGELRSYLQ---VNKYSLDLASLILYSYQLSTALAYLES 125

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
                   VHRD  + NVL+S+    K+ DFGL++ + E +  Y  ++      +  PE 
Sbjct: 126 -----KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAPES 179

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
            +  + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILM--LGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPP 235

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
            L    Y         +L ++C   + S+RP   E   +L  I+    
Sbjct: 236 TL----Y---------SLMTKCWAYDPSKRPRFTELKAQLSDILQEEK 270

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 9e-22
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 29/206 (14%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           +GKG FG VYK    R+ +VVAIK ++L   +EA+ E E    E+  LS+   P +    
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDL---EEAEDEIEDIQQEIQFLSQCRSPYITKYY 65

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPLR--LKVALGAAKGLAYLHSSS 182
           G    G   +++ EY   G+  D L    + E  + + LR  L        GL YLH   
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLL-------GLEYLHEEG 118

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYFDPE 239
            +     HRD K+ N+LLS   + K++DFG++     GQ T   ++    +GT  +  PE
Sbjct: 119 KI-----HRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPE 168

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                    ++D+++ G+  +EL  G
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 92.9 bits (231), Expect = 9e-22
 Identities = 83/290 (28%), Positives = 129/290 (44%), Gaps = 38/290 (13%)

Query: 67  NFLGKGGFGRVYKGTLRSGEV----VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
             +GKG FG VY GTL   +      A+K   L R  + +   +F  E  I+    HPN+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVK--SLNRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 123 VSLIGYCADGKHRFLV-YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG--AAKGLAYLH 179
           +SL+G C   +   LV   YM+ G+L    N I     +  ++  +  G   AKG+ YL 
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYF 236
           S        VHRD  + N +L  +F  K++DFGLA+ + + +E Y      G      + 
Sbjct: 116 SKK-----FVHRDLAARNCMLDESFTVKVADFGLARDIYD-KEYYSVHNHTGAKLPVKWM 169

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK 296
             E   T K T +SDV++FGV+L EL+T  R       V+  ++     ++L  R+ L+ 
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDI---TVYLLQGRRLLQ- 223

Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
              PE                +   C   +   RP+ +E V  ++ I  T
Sbjct: 224 ---PEYCPDP--------LYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 11/207 (5%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           +F     LGKGGFG V    +R +G++ A K++E  R K+  GE     E  IL +++  
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60

Query: 121 NLVSLIGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
            +V+L  Y  + K    LV   M  G+L+ H+  +G P  +    L  A     GL  LH
Sbjct: 61  FVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
             +      V+RD K  N+LL      +ISD GLA  +PEG+   +  RV GT GY  PE
Sbjct: 120 REN-----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPE 171

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGR 266
             +  + TL  D +  G ++ E++ G+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           + KG +GRV+    +S G++ AIK ++       +   +   E DILS+   P +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 128 YCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
           Y   GK   +LV EY+  G+L   L  +G    D   R+ +A      L YLHS      
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-RIYIA-EIVLALEYLHS-----N 112

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA------RVLGTFGYFDPEY 240
            I+HRD K  N+L+ +N   K++DFGL+K+    ++  +        R++GT  Y  PE 
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
                 +   D ++ G +L E L G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 75/307 (24%), Positives = 120/307 (39%), Gaps = 65/307 (21%)

Query: 69  LGKGGFGRVYKGTLRSGE------VVAIKKMELPRFKEADGEHEFRVEVDILSRLD---- 118
           LG+G FG+V K      +       VA+K +     K+   E +     D++S ++    
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKML-----KDDATEKDL---SDLVSEMEMMKM 71

Query: 119 ---HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDW----------PLRL 165
              H N+++L+G C      ++V EY   GNL+D L     P               L  
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 166 K----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ 221
           K     A   A+G+ +L S        +HRD  + NVL++ +   KI+DFGLA+ +    
Sbjct: 132 KDLVSFAYQVARGMEFLASKK-----CIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV 281
               T        +  PE       T QSDV++FGV+L E+ T         G+  + L 
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--LGGSPYPGIPVEELF 244

Query: 282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFAN----LASRCVRTESSERPSMAECV 337
                              +L +  Y ME           L   C     S+RP+  + V
Sbjct: 245 -------------------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285

Query: 338 KELQLII 344
           ++L  ++
Sbjct: 286 EDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 91.9 bits (228), Expect = 3e-21
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 22/207 (10%)

Query: 69  LGKGGFGRVY------KGTLRSGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHP 120
           LG+G FG+V       +G   +GE VA+K ++     E+ G H  + + E++IL  L H 
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLK----PESGGNHIADLKKEIEILRNLYHE 66

Query: 121 NLVSLIGYCADGKHRF--LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
           N+V   G C +       L+ E++  G+L+++L    + K++   +LK A+   KG+ YL
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYL 125

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT-FGYFD 237
            S        VHRD  + NVL+ +  + KI DFGL K +   +E Y     L +   ++ 
Sbjct: 126 GSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLT 264
           PE     K  + SDV++FGV L ELLT
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 91.8 bits (229), Expect = 4e-21
 Identities = 70/207 (33%), Positives = 96/207 (46%), Gaps = 31/207 (14%)

Query: 69  LGKGGFGRV----YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           LG G FGRV    +KG+   G+  A+K   K ++ + K+   EH    E  IL  + HP 
Sbjct: 9   LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQV--EHVLN-EKRILQSIRHPF 62

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK---GLAYL 178
           LV+L G   D  + +LV EY+  G L  HL   G               AA+    L YL
Sbjct: 63  LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-----ARFYAAQVVLALEYL 117

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HS       IV+RD K  N+LL ++   KI+DFG AK +     TY      GT  Y  P
Sbjct: 118 HSLD-----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLC---GTPEYLAP 167

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTG 265
           E   +       D +A G+++ E+L G
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 91.5 bits (227), Expect = 5e-21
 Identities = 78/299 (26%), Positives = 128/299 (42%), Gaps = 42/299 (14%)

Query: 69  LGKGGFGRVY----KGTLRSGE-------------VVAIKKMELPRFKEADGEHEFRVEV 111
           LG+G FG V+    +G  +  +             +VA+K +     K A   ++F  E+
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA--RNDFLKEI 70

Query: 112 DILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL---------QDHLNGIGEPKMDWP 162
            I+SRL  PN++ L+  C       ++ EYM+ G+L         Q+         + + 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 163 LRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE 222
             + +A   A G+ YL S     +  VHRD  + N L+  N+  KI+DFG+++ +  G  
Sbjct: 131 TLIFMATQIASGMKYLSS-----LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 223 TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL 282
             +  R +    +   E    GK T  SDV+AFGV L E+LT  +    +Q ++D+ ++ 
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ-LSDEQVIE 244

Query: 283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
                  D+ +   +  P L   S           L   C R  + ERPS  E    L 
Sbjct: 245 NTGEFFRDQGRQVYLPKPALCPDSLY--------KLMLSCWRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 90.7 bits (225), Expect = 5e-21
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 41/273 (15%)

Query: 69  LGKGGFGR-VYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G FG+ +   +   G+   IK++ + +    + E E R EV +LS + HPN+V    
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE-ESRKEVAVLSNMKHPNIVQYQE 66

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN---GIGEPK---MDWPLRLKVALGAAKGLAYLHSS 181
              +  + ++V +Y + G+L   +N   G+  P+   +DW +++ +AL       ++H  
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVHDR 120

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV-LGTFGYFDPEY 240
                 I+HRD KS N+ L+ +   K+ DFG+A+++     T   AR  +GT  Y  PE 
Sbjct: 121 K-----ILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEI 172

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
                   +SD++A G VL E+ T + A +     N +NLVL++         +R    P
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKI---------IRGSYPP 220

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSM 333
             S  SY +       NL S+  +    +RPS+
Sbjct: 221 VSSHYSYDLR------NLVSQLFKRNPRDRPSV 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 91.2 bits (226), Expect = 5e-21
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 31/217 (14%)

Query: 69  LGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEA--DGEHEFRVEVDILSRLDHP 120
           LG+G FG+V+          +   +VA+K +     KEA      +F+ E ++L+ L H 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-----KEASESARQDFQREAELLTVLQHQ 67

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP-------------KMDWPLRLKV 167
           ++V   G C +G+   +V+EYM+ G+L   L   G               ++     L +
Sbjct: 68  HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 168 ALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA 227
           A   A G+ YL       +  VHRD  + N L+      KI DFG+++ +       V  
Sbjct: 128 ASQIASGMVYL-----ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182

Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           R +    +  PE     K T +SD+++FGVVL E+ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 7e-21
 Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 23/202 (11%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G VYK   + +GE+VAIK ++L   +  D     + E+ +L    HPN+V+  G
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKL---EPGDDFEIIQQEISMLKECRHPNIVAYFG 67

Query: 128 -YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
            Y    K  ++V EY   G+LQD       P +       V     KGLAYLH +     
Sbjct: 68  SYLRRDK-LWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLHETG---- 121

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYFDPEYT-- 241
             +HRD K  N+LL+ + + K++DFG++      Q T   A+    +GT  +  PE    
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 242 -STGKLTLQSDVYAFGVVLLEL 262
              G    + D++A G+  +EL
Sbjct: 176 ERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 90.3 bits (224), Expect = 1e-20
 Identities = 86/282 (30%), Positives = 129/282 (45%), Gaps = 38/282 (13%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F+D   +G G FG VY    +R+ EVVAIKKM     +  +   +   EV  L +L HPN
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 122 LVSLIGYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
            +   G C   +H  +LV EY   G+  D L    +P  +  +   +  GA +GLAYLHS
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA-AICHGALQGLAYLHS 133

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              +     HRD K+ N+LL+     K++DFG A L+     ++V     GT  +  PE 
Sbjct: 134 HERI-----HRDIKAGNILLTEPGTVKLADFGSASLVSPAN-SFV-----GTPYWMAPEV 182

Query: 241 ---TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL-NDRKKLRK 296
                 G+   + DV++ G+  +E L  R+    N      N +  + HI  ND      
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFN-----MNAMSALYHIAQND------ 230

Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
              P LS + ++      F N    C++    +RPS  E +K
Sbjct: 231 --SPTLSSNDWSDY----FRNFVDSCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 89.5 bits (222), Expect = 2e-20
 Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 51/297 (17%)

Query: 69  LGKGGFGRVYKGTLRSGEV----VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG+G FG V +G L   +     VA+K M+L     ++ E EF  E   +   DHPN++ 
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE-EFLSEAACMKDFDHPNVMK 65

Query: 125 LIGYCADGKHR------FLVYEYMQKGNLQDHL--NGIGEPKMDWPLR--LKVALGAAKG 174
           LIG C +           ++  +M+ G+L   L  + +G      PL+  LK  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV----- 229
           + YL + +      +HRD  + N +L  +    ++DFGL+K +  G + Y   R+     
Sbjct: 126 MEYLSNRN-----FIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPV 179

Query: 230 --LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI 287
             +      D  YTS      +SDV+AFGV + E+ T  R      GV +  +   +RH 
Sbjct: 180 KWIAIESLADRVYTS------KSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYLRH- 230

Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                +L++   PE        + +    +L   C R +  +RP+  +  + L+ I+
Sbjct: 231 ---GNRLKQ---PE--------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 39/281 (13%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHE-FRVEVDILSRLDHP 120
           F+    +GKG FG V+KG   R+ +VVAIK ++L   +EA+ E E  + E+ +LS+ D P
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL---EEAEDEIEDIQQEITVLSQCDSP 62

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
            +    G    G   +++ EY+  G+  D L      +      LK  L   KGL YLHS
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHS 119

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ---ETYVTARVLGTFGYFD 237
              +     HRD K+ NVLLS   + K++DFG+A  + + Q    T+V     GT  +  
Sbjct: 120 EKKI-----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMA 169

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV 297
           PE         ++D+++ G+  +EL  G      N  ++   ++  +             
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPP---NSDMHPMRVLFLI------------- 213

Query: 298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
             P+ +  + T E    F      C+  + S RP+  E +K
Sbjct: 214 --PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 88.7 bits (220), Expect = 3e-20
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 23/219 (10%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV-------EVDILSRLDHP 120
           +G G FG VY G    SGE++A+K++ELP    A  +   R        E+ +L  L H 
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSV-SASSKDRKRSMLDALAREIALLKELQHE 66

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           N+V  +G   D  H  +  EY+  G++   LN  G    +  L         KGL YLH+
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHN 124

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR-----VLGTFGY 235
                  I+HRD K  N+L+      KISDFG++K + E              + G+  +
Sbjct: 125 RG-----IIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVFW 178

Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV-DLNQ 273
             PE       T ++D+++ G +++E+LTG+    D  Q
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 88.5 bits (219), Expect = 3e-20
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 15/208 (7%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           S   +  LG G FG V+  T      VA+K M+ P     +    F  E +++  L H  
Sbjct: 7   SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEA---FLAEANVMKTLQHDK 62

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           LV L       +  +++ E+M KG+L D L      K   P  +  +   A+G+A++   
Sbjct: 63  LVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPE 239
           +      +HRD ++ N+L+SA+   KI+DFGLA+++ + +    TAR    F   +  PE
Sbjct: 122 N-----YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPE 173

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRR 267
             + G  T++SDV++FG++L+E++T  R
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 38/221 (17%)

Query: 67  NFLGKGGFGRVYKGTLRSGEV---VAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNL 122
           + +G+G FG+V K  ++   +    AIK+M+   +   D   +F  E+++L +L  HPN+
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR--------------LKVA 168
           ++L+G C    + +L  EY   GNL D L      + D                  L  A
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 169 LGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
              A+G+ YL          +HRD  + N+L+  N+ AKI+DFGL++    GQE YV   
Sbjct: 131 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK- 180

Query: 229 VLGTFGYFDPEYTSTGKL-----TLQSDVYAFGVVLLELLT 264
              T G     + +   L     T  SDV+++GV+L E+++
Sbjct: 181 ---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 88.9 bits (220), Expect = 4e-20
 Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 36/223 (16%)

Query: 69  LGKGGFGRVY----KGTLRSGEV-----------VAIKKMELPRFKEADGEHEFRVEVDI 113
           LG+G FG V+    +G                  VA+K +     K A   ++F  E+ I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA--RNDFLKEIKI 70

Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD------------HLNGIGEPKMDW 161
           +SRL +PN++ L+G C       ++ EYM+ G+L              H N I  P +  
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI--PSVSI 128

Query: 162 PLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ 221
              L +A+  A G+ YL S     +  VHRD  + N L+  ++  KI+DFG+++ +  G 
Sbjct: 129 ANLLYMAVQIASGMKYLAS-----LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183

Query: 222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
              +  R +    +   E    GK T  SDV+AFGV L E+ T
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.0 bits (218), Expect = 4e-20
 Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 23/202 (11%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G  R+   VAIK +     + A  E +F  E  ++ +L HP LV L G 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
           C   K  ++V E+M+ G L ++L    + K+   + L +     +G+ YL  +S      
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERNS-----F 121

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG------YFDPEYTS 242
           +HRD  + N L+S+    K+SDFG+ + + + +  Y +     + G      +  PE  +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTS-----SSGAKFPVKWSPPEVFN 174

Query: 243 TGKLTLQSDVYAFGVVLLELLT 264
             K + +SDV++FGV++ E+ T
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 88.5 bits (219), Expect = 5e-20
 Identities = 80/317 (25%), Positives = 132/317 (41%), Gaps = 66/317 (20%)

Query: 66  DNFLGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRL 117
              LG+G FG+V K T      R+G      KM     KE     E R    E ++L ++
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKM----LKENASSSELRDLLSEFNLLKQV 60

Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------NGIGEPKMDW-------- 161
           +HP+++ L G C+      L+ EY + G+L+  L        + +G              
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 162 --PLRLKVALGAA----KGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK 215
              L +   +  A    +G+ YL         +VHRD  + NVL++   + KISDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMK-----LVHRDLAARNVLVAEGRKMKISDFGLSR 175

Query: 216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGV 275
            + E       ++      +   E       T QSDV++FGV+L E++T     +   G+
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--LGGNPYPGI 233

Query: 276 NDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTME-----SIAMFANLASRCVRTESSER 330
             + L                     L ++ Y ME     S  M+ NL   C + E  +R
Sbjct: 234 APERLF-------------------NLLKTGYRMERPENCSEEMY-NLMLTCWKQEPDKR 273

Query: 331 PSMAECVKELQLIIYTN 347
           P+ A+  KEL+ ++  +
Sbjct: 274 PTFADISKELEKMMVKS 290

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 6e-20
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 37/286 (12%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G  G V K        V  KK+     K +  +   R E+ I+     P +VS  G 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-ELQIMHECRSPYIVSFYGA 71

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRL----KVALGAAKGLAYLHSSSAV 184
             +  +  +  E+M  G     L+ I   K   P+ +    K+A+   +GL YL++    
Sbjct: 72  FLNENNICMCMEFMDCG----SLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYNVHR- 124

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTST 243
              I+HRD K +N+L+++  + K+ DFG++ +L+    +T+V     GT  Y  PE    
Sbjct: 125 ---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQG 176

Query: 244 GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNL----VLQ-VRHILNDRKKLRKVI 298
           GK T++SDV++ G+ ++EL  G+     +   +D       +L  ++ I+ +        
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------ 230

Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
            P L  S +         +    C+  + +ERP+  +       I 
Sbjct: 231 -PRLPSSDFP----EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 87.4 bits (216), Expect = 9e-20
 Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 27/211 (12%)

Query: 63  FSDDNFLGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGEHE-FRVEVDILSRLDHP 120
           F+    +GKG FG VYKG   R+ EVVAIK ++L   +EA+ E E  + E+ +LS+ D P
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL---EEAEDEIEDIQQEITVLSQCDSP 62

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAA------KG 174
            +    G    G   +++ EY+  G+  D L          P  L+    A       KG
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSALDLLK---------PGPLEETYIATILREILKG 113

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
           L YLHS   +     HRD K+ NVLLS   + K++DFG+A  + + Q    T   +GT  
Sbjct: 114 LDYLHSERKI-----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPF 166

Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           +  PE         ++D+++ G+  +EL  G
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 80/293 (27%), Positives = 139/293 (47%), Gaps = 48/293 (16%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV----EVDILSRLDHPNLV 123
           +G+G +G V K   + +G++VAIKK     F E++ +   +     E+ +L +L H NLV
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKK-----FLESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 124 SLIGYCADGKHRFLVYEYMQK---GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           +LI      K  +LV+E++      +L+ + NG+ E ++      K      +G+ + HS
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR-----KYLFQILRGIEFCHS 118

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            +     I+HRD K  N+L+S +   K+ DFG A+ +    E Y T  V  T  Y  PE 
Sbjct: 119 HN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYV-ATRWYRAPEL 171

Query: 241 ----TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ---------NLVLQVRHI 287
               T  G+     D++A G ++ E+LTG      +  + DQ         NL+ + + I
Sbjct: 172 LVGDTKYGRAV---DIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEI 227

Query: 288 LNDRK-----KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
                     +L +V + E     +   S  +  +LA +C+R +  +RPS ++
Sbjct: 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSG-LVLDLAKQCLRIDPDDRPSSSQ 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 79/297 (26%), Positives = 135/297 (45%), Gaps = 41/297 (13%)

Query: 58  EATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRVEVDI 113
           +A+C    +  +G G FG V  G L+     E+ VAIK ++    ++     +F  E  I
Sbjct: 2   DASC-IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ--RRDFLSEASI 58

Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK 173
           + + DHPN++ L G     K   +V EYM+ G+L   L      K D    +   +G  +
Sbjct: 59  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-----KHDGQFTVIQLVGMLR 113

Query: 174 GLA----YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE-TYVTAR 228
           G+A    YL     V     HRD  + N+L+++N   K+SDFGL++++ +  E  Y T  
Sbjct: 114 GIASGMKYLSDMGYV-----HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168

Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+V+ E+++ G R       +++Q+++  +   
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WEMSNQDVIKAIE-- 223

Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                        E  R    M+  A    L   C + + +ERP   + V  L  +I
Sbjct: 224 -------------EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVD---ILSRLDHPNLVS 124
           LG G FG V+KG  +  G+ + I  + +   ++  G   F+   D    +  LDH  +V 
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIP-VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           L+G C  G    LV +    G+L DH+       +D    L   +  AKG+ YL      
Sbjct: 74  LLGICP-GASLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHR-- 129

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
              +VHR+  + N+LL ++   +I+DFG+A L+    + Y  +       +   E    G
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 245 KLTLQSDVYAFGVVLLELLT 264
           + T QSDV+++GV + E+++
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 22/205 (10%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHPNLVS 124
           LG G FG VYKG  +  GE V I  + +    E  G     EF  E  I++ +DHP+LV 
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 125 LIGYCADGKHRFLVYEYMQKGNL----QDHLNGIG-EPKMDWPLRLKVALGAAKGLAYLH 179
           L+G C     + LV + M  G L     +H + IG +  ++W +++      AKG+ YL 
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   +VHRD  + NVL+ +    KI+DFGLA+L+   ++ Y          +   E
Sbjct: 127 ERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLT 264
                K T QSDV+++GV + EL+T
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 38/222 (17%)

Query: 66  DNFLGKGGFGRVYKGTLRSG--EVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNL 122
           ++ +G+G FG+V +  ++    ++ A  KM L  F   +   +F  E+++L +L  HPN+
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKM-LKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHL---------------NGIGEPKMDWPLRLKV 167
           ++L+G C +  + ++  EY   GNL D L               +G         L L+ 
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL-LQF 124

Query: 168 ALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA 227
           A   A G+ YL          +HRD  + NVL+  N  +KI+DFGL++    G+E YV  
Sbjct: 125 ASDVATGMQYLSEKQ-----FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKK 175

Query: 228 RVLGTFGYFDPEYTSTGKL-----TLQSDVYAFGVVLLELLT 264
               T G     + +   L     T +SDV++FGV+L E+++
Sbjct: 176 ----TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 89.1 bits (221), Expect = 3e-19
 Identities = 73/215 (33%), Positives = 106/215 (49%), Gaps = 31/215 (14%)

Query: 84  SGEVVAIKKMELPRFKEADGEHE---FRVEVDILSRLDHPNLVSLI--GYCADGKHRFLV 138
           +G  VAIK +   R    + EH+   FR E  + +RL HPN+V+L+  G    G   F V
Sbjct: 2   TGHEVAIKLL---RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAV 57

Query: 139 YEYMQKGNLQDHL--NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKST 196
           +EY+    L++ L  +G         L L+V       LA  H+       IVHRD K  
Sbjct: 58  FEYVPGRTLREVLAADGALPAGETGRLMLQVL----DALACAHNQG-----IVHRDLKPQ 108

Query: 197 NVLLSAN---FEAKISDFGLAKLMPEGQETYV-----TARVLGTFGYFDPEYTSTGKLTL 248
           N+++S       AK+ DFG+  L+P  ++  V     T  VLGT  Y  PE      +T 
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 249 QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
            SD+YA+G++ LE LTG+R V   QG +   ++ Q
Sbjct: 169 NSDLYAWGLIFLECLTGQRVV---QGASVAEILYQ 200

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 85.3 bits (211), Expect = 6e-19
 Identities = 67/202 (33%), Positives = 93/202 (46%), Gaps = 12/202 (5%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKGGFG V    +R +G++ A KK+   R K+  G     VE  IL+++    +VSL  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 128 YCADGKHRF-LVYEYMQKGNLQDHLNGIGE--PKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           Y    K    LV   M  G+L+ H+  + E  P    P           GL +LH     
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
              I++RD K  NVLL  +   +ISD GLA  + +GQ    T    GT G+  PE     
Sbjct: 118 ---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGE 172

Query: 245 KLTLQSDVYAFGVVLLELLTGR 266
           +     D +A GV L E++  R
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 85.2 bits (211), Expect = 8e-19
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK     +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 66

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  PL         +GLA+ HS       
Sbjct: 67  VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR----- 120

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE------YT 241
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE      Y 
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 178

Query: 242 STGKLTLQSDVYAFGVVLLELLTGRRAV 269
           ST       D+++ G +  E++T RRA+
Sbjct: 179 STA-----VDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 85.1 bits (211), Expect = 8e-19
 Identities = 81/294 (27%), Positives = 117/294 (39%), Gaps = 44/294 (14%)

Query: 69  LGKGGFGRVY---------------KGTLRSGEV--VAIKKMELPRFKEADGE-HEFRVE 110
           LG+G FG V+                    +     VA+K     R   +D    +F  E
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV---LRPDASDNAREDFLKE 69

Query: 111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLK---- 166
           V ILSRL  PN+  L+G C       ++ EYM+ G+L   L              K    
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 167 -----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ 221
                +A   A G+ YL S +      VHRD  + N L+  N+  KI+DFG+++ +    
Sbjct: 130 STLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV 281
              V  R      +   E    GK T +SDV+AFGV L E+LT  R       + DQ ++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH-LTDQQVI 243

Query: 282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
               H   D    R++    L R     + I     L   C R +  +RP+  E
Sbjct: 244 ENAGHFFRDDG--RQIY---LPRPPNCPKDI---YELMLECWRRDEEDRPTFRE 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 71/213 (33%), Positives = 107/213 (50%), Gaps = 32/213 (15%)

Query: 67  NFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           N +G+G +G VY+     SGE+VA+KK+ +   ++       R E+ +L  L HPN+V L
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVEL 71

Query: 126 IGYCADGKHR---FLVYEYMQK--GNLQDHLNGIGEPKMDWPL---RLK-VALGAAKGLA 176
                 GKH    FLV EY ++   +L D+        M  P    ++K + L   +GL 
Sbjct: 72  KEVVV-GKHLDSIFLVMEYCEQDLASLLDN--------MPTPFSESQVKCLMLQLLRGLQ 122

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL--MPEGQETYVTARVLGTFG 234
           YLH +      I+HRD K +N+LL+     KI+DFGLA+   +P      +T +V+ T  
Sbjct: 123 YLHENF-----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP---MTPKVV-TLW 173

Query: 235 YFDPEYT-STGKLTLQSDVYAFGVVLLELLTGR 266
           Y  PE        T   D++A G +L ELL  +
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)

Query: 69  LGKGGFGRVYKGTL----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T     +S  V+ +    L     +        E+ I+S L +H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
           +L+G C  G    ++ EY   G+L + L    E  +     L  +   AKG+A+L S + 
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
           +     HRD  + NVLL+     KI DFGLA+ +       V         +  PE    
Sbjct: 163 I-----HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN 217

Query: 244 GKLTLQSDVYAFGVVLLELLT 264
              T +SDV+++G++L E+ +
Sbjct: 218 CVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 84.2 bits (208), Expect = 1e-18
 Identities = 75/279 (26%), Positives = 128/279 (45%), Gaps = 42/279 (15%)

Query: 69  LGKGGFGRVY--KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           +G+G FG++Y  K    S   V IK+++L +    + E   + EV +L+++ HPN+V+  
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEAS-KKEVILLAKMKHPNIVTFF 65

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLN---GI---GEPKMDWPLRLKVALGAAKGLAYLHS 180
               +    F+V EY   G+L   +N   G+    +  + W +++ +      GL ++H 
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119

Query: 181 SSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                  I+HRD KS N+ LS N   AK+ DFG+A+ + +  E   T   +GT  Y  PE
Sbjct: 120 RK-----ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPYYLSPE 172

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
                    ++D+++ G VL EL T +   + N   N   LVL++          +    
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN---NLHQLVLKI---------CQGYFA 220

Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           P     S  + S      L S+  +    +RPS+   +K
Sbjct: 221 PISPNFSRDLRS------LISQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 14/204 (6%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFK-EADGEHEFRVEVDILSRLDHPNLVSLI 126
           +G G    VY    L + E VAIK+++L + +   D   E R EV  +S+ +HPN+V   
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD---ELRKEVQAMSQCNHPNVVKYY 65

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
                G   +LV  Y+  G+L D +        +D  +   V     KGL YLHS+  + 
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI- 124

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR--VLGTFGYFDPEYTST 243
               HRD K+ N+LL  +   KI+DFG++  + +G +     R   +GT  +  PE    
Sbjct: 125 ----HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 244 GK-LTLQSDVYAFGVVLLELLTGR 266
                 ++D+++FG+  +EL TG 
Sbjct: 181 VHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 22/210 (10%)

Query: 69  LGKGGFGRVYKGTL----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G G FG V +G L    +    VAIK ++    ++     +F  E  I+ + DHPN++ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQFDHPNIIH 69

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL-GAAKGLAYLHSSSA 183
           L G     +   ++ E+M+ G L   L    + +    ++L   L G A G+ YL   + 
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFT-VIQLVGMLRGIAAGMKYLSEMN- 126

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE--TYVTARVLG---TFGYFDP 238
                VHRD  + N+L+++N   K+SDFGL++ + +     TY ++  LG      +  P
Sbjct: 127 ----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKIPIRWTAP 180

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT-GRR 267
           E  +  K T  SDV+++G+V+ E+++ G R
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.0 bits (207), Expect = 2e-18
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 29/215 (13%)

Query: 69  LGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEA--DGEHEFRVEVDILSRLDHP 120
           LG+G FG+V+          +   +VA+K +     K+A  +   +F  E ++L+ L H 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL-----KDASDNARKDFHREAELLTNLQHE 67

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG-----------EPKMDWPLRLKVAL 169
           ++V   G C +G    +V+EYM+ G+L   L   G             ++     L +A 
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 170 GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
             A G+ YL S        VHRD  + N L+  N   KI DFG+++ +       V    
Sbjct: 128 QIAAGMVYLASQH-----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           +    +  PE     K T +SDV++ GVVL E+ T
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 84.4 bits (208), Expect = 3e-18
 Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 34/282 (12%)

Query: 63  FSDDNFLGKGGFGRVY-KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F+D   +G G FG VY    +R+ EVVAIKKM     +  +   +   EV  L R+ HPN
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
            +   G        +LV EY   G+  D L    +P  +  +   +  GA +GLAYLHS 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSH 144

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY- 240
           +     ++HRD K+ N+LL+   + K++DFG A +             +GT  +  PE  
Sbjct: 145 N-----MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVI 193

Query: 241 --TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
                G+   + DV++ G+  +E L  R+    N      N +  + HI  +        
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFN-----MNAMSALYHIAQNES------ 241

Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
            P L  + ++      F N    C++    +RP+  E +K +
Sbjct: 242 -PTLQSNEWS----DYFRNFVDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 30/166 (18%)

Query: 67  NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLD---HPN 121
             +G+G +G VYK   L +G  VA+KK+ +P     +G     + E+ +L +L+   HPN
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVP--LSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 122 LVSLIGYCADGKHR------FLVYEYMQKGNLQDHLN-----GIGEPKMDWPLRLKVALG 170
           +V L+  C  G          LV+E++ + +L  +L+     G+    +   +R  +   
Sbjct: 63  IVRLLDVCH-GPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL--- 117

Query: 171 AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL 216
             +G+ +LHS       IVHRD K  N+L++++ + KI+DFGLA++
Sbjct: 118 --RGVDFLHSHR-----IVHRDLKPQNILVTSDGQVKIADFGLARI 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 39/279 (13%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI-G 127
           LG G FG+VYK   +   + A  K+   + +  +   +F VE+DILS   HPN+V L   
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKI--IQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
           Y  + K   L+ E+   G L   +  +    +  P    V     + L +LHS       
Sbjct: 71  YFYENKLWILI-EFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHK----- 123

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQ--ETYVTARVLGTFGYFDPEY--TS 242
           ++HRD K+ N+LL+ + + K++DFG+ AK     Q  +T++     GT  +  PE     
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEVVACE 178

Query: 243 TGKLT---LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
           T K      ++D+++ G+ L+EL          Q     + +  +R +L    K+ K   
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELA---------QMEPPHHELNPMRVLL----KILKSEP 225

Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           P L + S    S   F +    C+  +  +RP+ AE +K
Sbjct: 226 PTLDQPSKWSSS---FNDFLKSCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 82.6 bits (204), Expect = 4e-18
 Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 38/278 (13%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEAD-GEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V  G  R    VAIK +     KE    E EF  E  ++ +L H  LV L G
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
            C   +  ++V EYM  G L ++L   G+      L L++     +G+AYL S       
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLESKQ----- 120

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGK 245
            +HRD  + N L+      K+SDFGL++ + + +    T+ V   F   +  PE     K
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSK 177

Query: 246 LTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-S 303
            + +SDV+AFGV++ E+ + G+   +     N+   V     +    +  R    P L S
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYER---FNNSETVE---KVSQGLRLYR----PHLAS 227

Query: 304 RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
              Y +    M++     C   ++ ERP+  + +  ++
Sbjct: 228 EKVYAI----MYS-----CWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 82.8 bits (204), Expect = 4e-18
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 36/220 (16%)

Query: 67  NFLGKGGFGRVYKGTLRSG--EVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV 123
           + +G+G FG+V K  ++     + A  K  +  +   D   +F  E+++L +L  HPN++
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR--------------LKVAL 169
           +L+G C    + +L  EY   GNL D L      + D                  L  A 
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 170 GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
             A+G+ YL          +HRD  + N+L+  N+ AKI+DFGL++    GQE YV    
Sbjct: 120 DVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK-- 168

Query: 230 LGTFGYFDPEYTSTGKL-----TLQSDVYAFGVVLLELLT 264
             T G     + +   L     T  SDV+++GV+L E+++
Sbjct: 169 --TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 82.8 bits (204), Expect = 4e-18
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)

Query: 69  LGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRFKEADGEHEFRVEVDILSRLDHP 120
           LG+G FG VY+G  + G V       VAIK + E    +E     EF  E  ++   +  
Sbjct: 14  LGQGSFGMVYEGIAK-GVVKDEPETRVAIKTVNEAASMRE---RIEFLNEASVMKEFNCH 69

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI-----GEPKMDWPL---RLKVALGAA 172
           ++V L+G  + G+   ++ E M +G+L+ +L  +       P    P     +++A   A
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 173 KGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
            G+AYL+++       VHRD  + N +++ +F  KI DFG+ + + E        + L  
Sbjct: 130 DGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.4 bits (203), Expect = 5e-18
 Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 17/200 (8%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHE-FRVEVDILSRLDHPNLVSLI 126
           +GKG FG V+KG   R+ +VVAIK ++L   +EA+ E E  + E+ +LS+ D P +    
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDL---EEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEP-KMDWPLRLKVALGAAKGLAYLHSSSAVG 185
           G        +++ EY+  G+  D L    EP  +D      +     KGL YLHS   + 
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKKI- 123

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
               HRD K+ NVLLS + E K++DFG+A  + + Q        +GT  +  PE      
Sbjct: 124 ----HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSA 177

Query: 246 LTLQSDVYAFGVVLLELLTG 265
              ++D+++ G+  +EL  G
Sbjct: 178 YDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 82.2 bits (203), Expect = 6e-18
 Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 14/205 (6%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGE---HEFRVEVDILSRLDHPNLVS 124
           LG G F   Y+   +++G ++A+K++   R   ++ E      R E+ +++RL+HP+++ 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           ++G   +  H  L  E+M  G++   L+  G  K    + +       +GL+YLH +   
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA--VIINYTEQLLRGLSYLHENQ-- 123

Query: 185 GIPIVHRDFKSTNVLL-SANFEAKISDFGLA-KLMPEGQET-YVTARVLGTFGYFDPEYT 241
              I+HRD K  N+L+ S     +I+DFG A +L  +G        ++LGT  +  PE  
Sbjct: 124 ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 242 STGKLTLQSDVYAFGVVLLELLTGR 266
              +     DV++ G V++E+ T +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 25/203 (12%)

Query: 69  LGKGGFGRVYKG---TLRSGEVVAIKKMELPRFKEADGE---HEFRVEVDILSRLDHPNL 122
           LG G FG V KG     +S + VA+K ++     + +      E   E +++ +LD+P +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILK----NDNNDPALKDELLREANVMQQLDNPYI 58

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           V +IG C + +   LV E  + G L   L  N     K    L  +V++G    + YL  
Sbjct: 59  VRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEE 113

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDP 238
           ++      VHRD  + NVLL     AKISDFGL+K +    E Y  A+  G +   ++ P
Sbjct: 114 TN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHGKWPVKWYAP 167

Query: 239 EYTSTGKLTLQSDVYAFGVVLLE 261
           E  +  K + +SDV++FGV++ E
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 1e-17
 Identities = 67/209 (32%), Positives = 97/209 (46%), Gaps = 30/209 (14%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKM--ELPRFKEADGEHEFRVEVDILSRL-DHPNLVS 124
           LG G FG VY    +  GE+VAIKKM  +   ++E       R EV  L +L +HPN+V 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEEC---MNLR-EVKSLRKLNEHPNIVK 62

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           L     +    + V+EYM +GNL   +           +   +     +GLA++H     
Sbjct: 63  LKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG-- 119

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
                HRD K  N+L+S     KI+DFGLA+ +   +  Y T  V  T  Y  PE     
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPY-TDYV-STRWYRAPE----- 168

Query: 245 KLTLQS-------DVYAFGVVLLELLTGR 266
            + L+S       D++A G ++ EL T R
Sbjct: 169 -ILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 63/276 (22%), Positives = 118/276 (42%), Gaps = 25/276 (9%)

Query: 62  SFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           +F  +  +G+G F  VY+ T L   + VA+KK+++    +A    +   E+D+L +L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRL--KVALGAAKGLAYL 178
           N++  +    +     +V E    G+L   +    + K   P R   K  +     + ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HS       ++HRD K  NV ++A    K+ D GL +      +T     ++GT  Y  P
Sbjct: 123 HSRR-----VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E         +SD+++ G +L E+     A   +    D+  +  +        K+ +  
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM-----AALQSPFYGDKMNLFSLCQ------KIEQCD 224

Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMA 334
            P L    Y+ +       L S C+  +  +RP + 
Sbjct: 225 YPPLPTEHYSEK----LRELVSMCIYPDPDQRPDIG 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 14/219 (6%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILS-RLDHPNLVSLI 126
           LGKG FG+V+   L+ + +  AIK ++       D      VE  +LS   +HP L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
                 ++ F V EY+  G+L  H+      K D P     A     GL +LHS      
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---- 116

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            IV+RD K  N+LL  +   KI+DFG+ K    G     T    GT  Y  PE     K 
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQKY 173

Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR 285
               D ++FGV+L E+L G+       G +++ L   +R
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF---HGHDEEELFQSIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 38/287 (13%)

Query: 69  LGKGGFGRVYKGTLRSGEV---VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           LG+G FG V +G L   +    VA+K M++     ++ E +F  E   +   DHPN++ L
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65

Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHL--NGIGEPKMDWPLRLKVALGA--AKGL 175
           IG C             ++  +M+ G+L   L  + +G+     P ++ V      A G+
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 176 AYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT-FG 234
            YL S S      +HRD  + N +L+ N    ++DFGL+K +  G + Y   R+      
Sbjct: 126 EYLSSKS-----FIHRDLAARNCMLNENMNVCVADFGLSKKIYNG-DYYRQGRIAKMPVK 179

Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
           +   E  +    T +SDV++FGV + E+ T  R      GV +     ++   L    +L
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIAT--RGQTPYPGVENS----EIYDYLRQGNRL 233

Query: 295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
           ++  D            +    +L S C      +RPS      EL+
Sbjct: 234 KQPPD-----------CLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 18/213 (8%)

Query: 65  DDNF---LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           D NF   LGKG FG+V     + + E+ AIK ++     + D      VE  +L+  D P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 121 NLVSLIGYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
             ++ +  C     R + V EY+  G+L  H+  +G  K   P  +  A   + GL +LH
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH 118

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-LMPEGQETYVTARVL-GTFGYFD 237
                   I++RD K  NV+L +    KI+DFG+ K  M +G    VT R   GT  Y  
Sbjct: 119 RRG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIA 169

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVD 270
           PE  +        D +A+GV+L E+L G+   D
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 11/200 (5%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMEL-PRFKEADGE-HEFRVEVDILSRLDHPNLVSL 125
           LG+G FGRVY    + +G  +A+K++   P   E   E +    E+ +L  L H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
            G   D +   +  EYM  G+++D L   G   +   +  K      +G+ YLHS+    
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM--- 124

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAK-LMPEGQETYVTARVLGTFGYFDPEYTSTG 244
             IVHRD K  N+L  +    K+ DFG +K L            V GT  +  PE  S  
Sbjct: 125 --IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 245 KLTLQSDVYAFGVVLLELLT 264
               ++DV++ G  ++E+LT
Sbjct: 183 GYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 24/207 (11%)

Query: 66  DNF--LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           DNF  +G+G  G V   T   +G  VA+KKM+L   K+   E  F  EV I+    HPN+
Sbjct: 22  DNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFN-EVVIMRDYQHPNI 78

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
           V +      G   ++V E+++ G L D    +   +M+      V L   K L++LH+  
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIATVCLAVLKALSFLHAQG 135

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFG----LAKLMPEGQETYVTARVLGTFGYFDP 238
                ++HRD KS ++LL+++   K+SDFG    ++K +P  +       ++GT  +  P
Sbjct: 136 -----VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS------LVGTPYWMAP 184

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTG 265
           E  S      + D+++ G++++E++ G
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 81.2 bits (200), Expect = 2e-17
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 37/234 (15%)

Query: 55  EMEEATCSFSDDNFLGKGGFGRVYKGTL------RSGEVVAIK----KMELPRFKEADGE 104
           E+  +T  F ++  LG+  FG+VYKG L         + VAIK    K E P        
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPL------R 52

Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL------NGIGEPK 158
            EF+ E  + SRL HPN+V L+G     +   +++ Y    +L + L      + +G   
Sbjct: 53  EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112

Query: 159 MDWPLR--------LKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD 210
            D  ++        + +    A G+ +L S       +VH+D  + NVL+      KISD
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISD 167

Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            GL + +       +    L    +  PE    GK ++ SD++++GVVL E+ +
Sbjct: 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 37/289 (12%)

Query: 69  LGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LGKG FG V +  L+    S + VA+K ++   F  +D E EF  E   +   DHPN++ 
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVIK 65

Query: 125 LIGYCADGKHR------FLVYEYMQKGNLQDHL--NGIGEPKMDWPLR--LKVALGAAKG 174
           LIG     + +       ++  +M+ G+L   L  + IGE     PL+  ++  +  A G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
           + YL S +      +HRD  + N +L+ N    ++DFGL+K +  G              
Sbjct: 126 MEYLSSKN-----FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
           +   E  +    T  SDV+AFGV + E++T  R      GV +     ++ + L    +L
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT--RGQTPYAGVENS----EIYNYLIKGNRL 234

Query: 295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
           ++   P+     Y          L  +C   E   RPS      +L+LI
Sbjct: 235 KQ--PPDCLEDVY---------ELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 73/266 (27%), Positives = 122/266 (45%), Gaps = 30/266 (11%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G  G VYK   L +  ++A+K + L    E   + +   E++IL + D P ++   G
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVEL--QKQIMSELEILYKCDSPYIIGFYG 66

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                    +  E+M  G+L D    I E  +      ++A+   KGL YL S     + 
Sbjct: 67  AFFVENRISICTEFMDGGSL-DVYRKIPEHVLG-----RIAVAVVKGLTYLWS-----LK 115

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
           I+HRD K +N+L++   + K+ DFG++ +L+    +TYV     GT  Y  PE  S  + 
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQY 170

Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
            + SDV++ G+  +EL  GR      Q      + LQ+   + D         P L    
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------PVLPVGQ 224

Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           ++      F +  ++C+R +  ERP+
Sbjct: 225 FS----EKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 80.3 bits (198), Expect = 2e-17
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 14/218 (6%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G FG V+    +   ++V IK++ + +  + D     + E  +L  L HPN++    
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              + K   +V EY   G L +++       +D    L   +     L ++H+       
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL----- 121

Query: 188 IVHRDFKSTNVLLSAN-FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
           I+HRD K+ N+LL  +    KI DFG++K++    + Y    V+GT  Y  PE       
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKPY 178

Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
             +SD++A G VL EL + +RA +     N   LVL++
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFE---AANLPALVLKI 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 80.4 bits (198), Expect = 2e-17
 Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 69  LGKGGFGRVYKGT--LRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           LG G FG V KG   +R  ++ VAIK   L    E     E   E +I+ +LD+P +V +
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKV--LKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL--GAAKGLAYLHSSSA 183
           IG C + +   LV E    G L   L+G    K +  +   V L    + G+ YL   + 
Sbjct: 61  IGVC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN- 115

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYT 241
                VHRD  + NVLL     AKISDFGL+K +    ++Y  AR  G +   ++ PE  
Sbjct: 116 ----FVHRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECI 170

Query: 242 STGKLTLQSDVYAFGVVLLELLT 264
           +  K + +SDV+++G+ + E  +
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 76/224 (33%), Positives = 113/224 (50%), Gaps = 50/224 (22%)

Query: 67  NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA-DGEHEFRVEVDILSRL-DHPNLV 123
             LGKG +G V+K    R+ EVVA+KK+    F+ A D +  FR E+  L  L DHPN+V
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTFR-EIMFLQELGDHPNIV 70

Query: 124 SLIG-YCAD-GKHRFLVYEYM--------QKGNLQD-HLNGIGEPKMDWPLRLKVALGAA 172
            L+    A+  K  +LV+EYM        +   L+D H   I    M + L         
Sbjct: 71  KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYI----M-YQL--------L 117

Query: 173 KGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET--------Y 224
           K L Y+HS +     ++HRD K +N+LL+++   K++DFGLA+ + E +E         Y
Sbjct: 118 KALKYIHSGN-----VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172

Query: 225 VTARVLGTFGYFDPE--YTSTGKLTLQSDVYAFGVVLLELLTGR 266
           V  R      Y  PE    ST + T   D+++ G +L E+L G+
Sbjct: 173 VATR-----WYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 36/222 (16%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMEL--PRFKEADGEHEFRVEVDILSRLDH---PNL 122
           +G+G +G VY+G  + +G VVA+K + L  P    +D + E    V +LS+L     PN+
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQRE----VALLSQLRQSQPPNI 64

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNG--IGEPKMDWPLR-LKVALGAAKGLAYLH 179
               G    G   +++ EY + G+++  +    I E  +   +R + VAL       Y+H
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVAL------KYIH 118

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   ++HRD K+ N+L++     K+ DFG+A L+ +      T   +GT  +  PE
Sbjct: 119 KV-----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPE 171

Query: 240 YTSTGKL-TLQSDVYAFGVVLLELLTGR---------RAVDL 271
             + GK    ++D+++ G+ + E+ TG          RA+ L
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 29/213 (13%)

Query: 69  LGKGGFGRVYK--GTLRSGEVVAIKKMEL--PRFKEADGEHEFRVEVDILS-------RL 117
           LG G FG VYK         ++A+K++ +  P F +   E +  +  DI+S       +L
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66

Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD------WPLRLKVALGA 171
            HPN+V       +    ++V + ++   L +H N + E K        W + +++ L  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
              L YLH        IVHRD    N++L  + +  I+DFGLAK   +  E+ +T+ V+G
Sbjct: 126 ---LRYLHKEKR----IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTS-VVG 175

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           T  Y  PE         ++DV+AFG +L ++ T
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 10/197 (5%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F  VYK   L  G VVA+KK+++    +A    +   E+D+L +LDHPN++  + 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRL--KVALGAAKGLAYLHSSSAVG 185
              +     +V E    G+L   +    + K   P R   K  +     L ++HS     
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--- 126

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
             I+HRD K  NV ++A    K+ D GL +      +T     ++GT  Y  PE      
Sbjct: 127 --IMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENG 182

Query: 246 LTLQSDVYAFGVVLLEL 262
              +SD+++ G +L E+
Sbjct: 183 YNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 23/203 (11%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +GE  AIK   K E+ + K+         E  IL  L HP +V+
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ---HVAQEKSILMELSHPFIVN 82

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA--YLHSSS 182
           ++    D    + + E++  G L  HL   G     +P  +     A   LA  YLHS  
Sbjct: 83  MMCSFQDENRVYFLLEFVVGGELFTHLRKAGR----FPNDVAKFYHAELVLAFEYLHSKD 138

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
                I++RD K  N+LL      K++DFG AK +P+   T+    + GT  Y  PE   
Sbjct: 139 -----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTFT---LCGTPEYLAPEVIQ 188

Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
           +       D +  GV+L E + G
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 80.5 bits (198), Expect = 4e-17
 Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 17/204 (8%)

Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           FSD   +G G FG VY    +R+ EVVAIKKM     +  +   +   EV  L +L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
            +   G        +LV EY   G+  D L    +P  +  +   V  GA +GLAYLHS 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHSH 134

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY- 240
           +     ++HRD K+ N+LLS     K+ DFG A +M            +GT  +  PE  
Sbjct: 135 N-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVI 183

Query: 241 --TSTGKLTLQSDVYAFGVVLLEL 262
                G+   + DV++ G+  +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 27/160 (16%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLI 126
           +G+G +G+VYK    ++G++VAIK M++      D E E + E +IL +  +HPN+ +  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDI----IEDEEEEIKEEYNILRKYSNHPNIATFY 69

Query: 127 G------YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL------GAAKG 174
           G         +    +LV E    G++ D + G+         RLK            +G
Sbjct: 70  GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL----RKKGKRLKEEWIAYILRETLRG 125

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
           LAYLH +      ++HRD K  N+LL+ N E K+ DFG++
Sbjct: 126 LAYLHENK-----VIHRDIKGQNILLTKNAEVKLVDFGVS 160

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 79.5 bits (196), Expect = 7e-17
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 28/211 (13%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFR---VEVDILSRLDHPNLVS 124
           LGKG +G VYK   R +G  +A+K++ L    E D E +F    +E+DIL +   P +V 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRL----ELD-ESKFNQIIMELDILHKAVSPYIVD 63

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
             G        ++  EYM  G+L D L   G+    +   +  ++     KGL +L    
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV-LGTFGYFDPEYT 241
                I+HRD K TNVL++ N + K+ DFG++     G      A+  +G   Y  PE  
Sbjct: 123 N----IIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPERI 173

Query: 242 STGKL------TLQSDVYAFGVVLLELLTGR 266
            +G        T+QSDV++ G+ +LE+  GR
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 74/246 (30%), Positives = 106/246 (43%), Gaps = 65/246 (26%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G FG VYK   +++G VVA+KK+ +   K+       R E+ IL +L HPN+V LI 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74

Query: 128 YC---ADGKHR-----FLVYEYMQKGNLQDH-LNGIGEPKMDWPLRLKVALGAAK----- 173
                 D   R     ++V  YM      DH L+G+ E        +K+     K     
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYM------DHDLSGLLENP-----SVKLTESQIKCYMLQ 123

Query: 174 ---GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-----------PE 219
              G+ YLH +      I+HRD K+ N+L+      KI+DFGLA+               
Sbjct: 124 LLEGINYLHENH-----ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 220 GQETYVTARVLGTFGYFDPE-------YTSTGKLTLQSDVYAFGVVLLELLTGRR----A 268
           G   Y T  V+ T  Y  PE       YT+        D++  G V  E+ T R      
Sbjct: 179 GTRKY-TNLVV-TRWYRPPELLLGERRYTTA------VDIWGIGCVFAEMFTRRPILQGK 230

Query: 269 VDLNQG 274
            D++Q 
Sbjct: 231 SDIDQL 236

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 72/228 (31%), Positives = 98/228 (42%), Gaps = 25/228 (10%)

Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV 123
           LGKG FG+V     KGT    E+ A+K ++     + D       E  +L+    HP L 
Sbjct: 3   LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
            L          F V EY+  G+L  H+   G  + D P     A     GL +LH    
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG- 116

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTS 242
               I++RD K  NVLL +    KI+DFG+ K   EG    VT     GT  Y  PE  S
Sbjct: 117 ----IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEILS 169

Query: 243 TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
                   D +A GV+L E+L G+   +   G ++  L    + IL D
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDEL---FQSILED 211

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK     +GE+VA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLLD 65

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                   +LV+E++   +L+ +++      +D PL         +G+AY HS       
Sbjct: 66  VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR----- 119

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE------YT 241
           ++HRD K  N+L+      K++DFGLA+       TY T  V+ T  Y  PE        
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEILLGSRQY 177

Query: 242 STGKLTLQSDVYAFGVVLLELLTGR 266
           ST       D+++ G +  E++  R
Sbjct: 178 STP-----VDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 71/222 (31%), Positives = 103/222 (46%), Gaps = 29/222 (13%)

Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGE----VVAIKKMELPRFKEADGEHEF 107
           LKE E     F     LG G FG VYKG  +  GE     VAIK  EL          E 
Sbjct: 4   LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEI 56

Query: 108 RVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIGEPKM-DWP 162
             E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG   + +W 
Sbjct: 57  LDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 115

Query: 163 LRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE 222
           +++      AKG+ YL         +VHRD  + NVL+      KI+DFGLAKL+   ++
Sbjct: 116 VQI------AKGMNYLEERR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164

Query: 223 TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            Y          +   E       T QSDV+++GV + EL+T
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 35/213 (16%)

Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG +G VY     S +V +AIK++     +     HE   E+ + S L H N+V  +G
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDW-PLRLKVALGA------AKGLAYLHS 180
             ++     +  E +  G+L   L      +  W PL+              +GL YLH 
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 181 SSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFG----LAKLMPEGQETYVTARVLGTFGY 235
           +      IVHRD K  NVL++  +   KISDFG    LA + P       T    GT  Y
Sbjct: 127 NQ-----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQY 175

Query: 236 FDPEYTSTGK--LTLQSDVYAFGVVLLELLTGR 266
             PE    G       +D+++ G  ++E+ TG+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 28/209 (13%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G  G V K  L++  ++   K           +   R E++I      P +V   G 
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKYYGA 67

Query: 129 CADGKHRFL--VYEYMQKGNLQDHL--------NGIGEPKMDWPLRLKVALGAAKGLAYL 178
             D     +    EY + G+L D +          IGE      L  K+A    KGL+YL
Sbjct: 68  FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGE----KVL-GKIAESVLKGLSYL 121

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFD 237
           HS       I+HRD K +N+LL+   + K+ DFG++ +L+     T+      GT  Y  
Sbjct: 122 HSRK-----IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMA 171

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           PE       ++ SDV++ G+ LLE+   R
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 75/230 (32%), Positives = 105/230 (45%), Gaps = 28/230 (12%)

Query: 65  DDNFL---GKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           D NFL   GKG FG+V     + + E+ AIK ++     + D      VE  +L+    P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 121 NLVSLIGYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
             ++ +  C     R + V EY+  G+L  H+  +G  K   P  +  A   A GL +LH
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH 118

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDP 238
           S       I++RD K  NV+L A    KI+DFG+ K   E      T R   GT  Y  P
Sbjct: 119 SKG-----IIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYIAP 170

Query: 239 E---YTSTGKLTLQSDVYAFGVVLLELLTGRRAVD------LNQGVNDQN 279
           E   Y   GK     D +AFGV+L E+L G+   D      L Q + + N
Sbjct: 171 EIIAYQPYGK---SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 38/212 (17%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV----EVDILSRLDHPNLV 123
           +G+G +G V+K   R +G++VAIKK     F E++ +   +     E+ +L +L HPNLV
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKK-----FVESEDDPVIKKIALREIRMLKQLKHPNLV 63

Query: 124 SLIGYCADGKHRFLVYEYMQK---GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           +LI      +   LV+EY        L+ +  G+ E  +      K+     + + + H 
Sbjct: 64  NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNFCHK 118

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM--PEGQET-YVTARVLGTFGYFD 237
            + +     HRD K  N+L++   + K+ DFG A+++  P    T YV  R      Y  
Sbjct: 119 HNCI-----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRA 168

Query: 238 PEY----TSTGKLTLQSDVYAFGVVLLELLTG 265
           PE     T  G      DV+A G V  ELLTG
Sbjct: 169 PELLVGDTQYGPPV---DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 10/204 (4%)

Query: 62  SFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           +F  +  +G+G F  VY+ T L  G  VA+KK+++    +A    +   E+D+L +L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRL--KVALGAAKGLAYL 178
           N++       +     +V E    G+L   +    + K   P +   K  +     L ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HS       ++HRD K  NV ++A    K+ D GL +      +T     ++GT  Y  P
Sbjct: 123 HSRR-----VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Query: 239 EYTSTGKLTLQSDVYAFGVVLLEL 262
           E         +SD+++ G +L E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 18/215 (8%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G V+K   R + E+VA+K++ L    E       R E+ +L  L H N+V L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66

Query: 128 YCADGKHRFLVYEYMQKGNLQ---DHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
                K   LV+EY  + +L+   D  NG     +D  +         KGLA+ HS +  
Sbjct: 67  VLHSDKKLTLVFEYCDQ-DLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAFCHSHN-- 119

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
              ++HRD K  N+L++ N E K++DFGLA+        Y +A V+ T  Y  P+     
Sbjct: 120 ---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFGA 174

Query: 245 KLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
           KL   S D+++ G +  EL    R +     V+DQ
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 33/223 (14%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL-- 125
           +G+G +G+VYK   + +GE+VA+KK+ L   KE       R E+ IL +L+H N+V+L  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNLKE 73

Query: 126 --------IGYCADGKHRFLVYEYMQKGNLQDH-LNGIGEPKM-----DWPLRLKVALGA 171
                   + +  D    +LV+EYM      DH L G+ E  +     D        L  
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFSEDHIKSFMKQL-- 125

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
            +GL Y H  +      +HRD K +N+LL+   + K++DFGLA+L    +    T +V+ 
Sbjct: 126 LEGLNYCHKKN-----FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179

Query: 232 TFGYFDPE-YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ 273
           T  Y  PE      +     DV++ G +L EL T +     NQ
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 34/280 (12%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F   + +G G FG VY  T   + EVVA+KKM     +  +   +   EV  L +L HPN
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
            +   G        +LV EY   G+  D L    +P  +  +   +  GA +GLAYLHS 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSH 140

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY- 240
           +     ++HRD K+ N+LL+   + K++DFG A               +GT  +  PE  
Sbjct: 141 N-----MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVI 189

Query: 241 --TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
                G+   + DV++ G+  +EL   +        + + N +  + HI  +        
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPP------LFNMNAMSALYHIAQNDS------ 237

Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
            P L  + +T      F      C++    ERP+ AE ++
Sbjct: 238 -PTLQSNEWTDS----FRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 76.8 bits (189), Expect = 5e-16
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 33/248 (13%)

Query: 69  LGKGGFGRVYKGTLRSGEVVA---IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G FG+V  G    G   A   +K  EL      D +  F  EV     L+HPN++  
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVK--ELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKMDWP-LRLKVALGAAKGLAYLHSSS 182
           +G C +     LV E+   G+L+++L  N     +M    +  ++A   A GL +LH + 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT-FGYFDPEYT 241
                 +H D    N  L+A+   KI D+GLA L    ++ Y+T         +  PE  
Sbjct: 121 -----FIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV 174

Query: 242 S-------TGKLTLQSDVYAFGVVLLELLT-GRRAVD-------LNQGVNDQNLVL---Q 283
                       T +S++++ GV + EL T   +          L Q V +Q++ L   Q
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234

Query: 284 VRHILNDR 291
           +    +DR
Sbjct: 235 LDLKYSDR 242

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 66/202 (32%), Positives = 93/202 (46%), Gaps = 15/202 (7%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILS-RLDHPNLVSLI 126
           LGKG FG+V    L+ + E  AIK ++     E D      VE  +L+   +HP L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61

Query: 127 GYCA--DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
            +C     +H F V EY+  G+L  H+   G  + D       A     GL +LH     
Sbjct: 62  -FCTFQTKEHLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG-- 116

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
              I++RD K  NVLL  +   KI+DFG+ K    G+     +   GT  Y  PE     
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQ 171

Query: 245 KLTLQSDVYAFGVVLLELLTGR 266
           K     D ++FGV+L E+L G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 53/223 (23%)

Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           + +G G +G+V       +G  VAIKK+  P       +  +R E+ +L  +DH N++ L
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGL 79

Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKV---------ALG 170
           +               +LV   M      D LN I        ++ +             
Sbjct: 80  LDVFTPASSLEDFQDVYLVTHLMG----AD-LNNI--------VKCQKLSDDHIQFLVYQ 126

Query: 171 AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL 230
             +GL Y+HS+      I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R  
Sbjct: 127 ILRGLKYIHSAG-----IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-- 179

Query: 231 GTFGYFDPE-------YTSTGKLTLQSDVYAFGVVLLELLTGR 266
               Y  PE       Y  T       D+++ G ++ ELLTG+
Sbjct: 180 ---WYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 76.9 bits (189), Expect = 6e-16
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 23/211 (10%)

Query: 69  LGKGGFGRVYKGTLR---SGEV---VAIKKM-ELPRFKEADGEHEFRVEVDILSRLDHPN 121
           LG+G FG VY+G  R    GE    VA+K + E    +E     EF  E  ++      +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE---RIEFLNEASVMKGFTCHH 70

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------NGIGEPKMDWPLRLKVALGAAK 173
           +V L+G  + G+   +V E M  G+L+ +L        N  G P       +++A   A 
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           G+AYL++        VHRD  + N +++ +F  KI DFG+ + + E        + L   
Sbjct: 131 GMAYLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            +  PE    G  T  SD+++FGVVL E+ +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 9e-16
 Identities = 58/198 (29%), Positives = 86/198 (43%), Gaps = 13/198 (6%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G FGRV+    R S    A+K M +P       E     E  +L  + HP ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              D +  +++ EY+  G L  +L   G  +      L  A      L YLHS       
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE----- 121

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IV+RD K  N+LL      K++DFG AK + +   T     + GT  Y  PE   +    
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAPEVIQSKGHN 176

Query: 248 LQSDVYAFGVVLLELLTG 265
              D +A G+++ E+L G
Sbjct: 177 KAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 74/278 (26%), Positives = 125/278 (44%), Gaps = 54/278 (19%)

Query: 69  LGKGGFGR-VYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI- 126
           +G+G FGR +    + S +  A+K++ LP  K +    + R E  +L+++ HPN+V+   
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLP--KSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPK---------MDWPLRLKVALGAAKGLAY 177
            + ADG H ++V EY   G+L   +  I   +         + W +++ +      G+ +
Sbjct: 66  SFEADG-HLYIVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQMCL------GVQH 115

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE---TYVTARVLGTFG 234
           +H        ++HRD KS N+ L+ N + K+ DFG A+L+        TYV     GT  
Sbjct: 116 IHEKR-----VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-----GTPY 165

Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
           Y  PE         +SD+++ G +L EL T +     N     +NL+L+V          
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLILKV---------C 213

Query: 295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPS 332
           +    P  S  SY + S      L  +  +     RPS
Sbjct: 214 QGSYKPLPSHYSYELRS------LIKQMFKRNPRSRPS 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 17/203 (8%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILS-RLDHPNLVSLI 126
           LGKG FG+V    L+  GE  A+K ++       D      VE  +L+   ++P L  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK---GLAYLHSSSA 183
                 +H F V E++  G+L  H+   G   +      +    AA+   GL +LHS   
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGLQFLHSKG- 116

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               I++RD K  NV+L  +   KI+DFG+ K    G     T    GT  Y  PE    
Sbjct: 117 ----IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQG 170

Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
            K T   D ++FGV+L E+L G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 42/213 (19%)

Query: 72  GGFGRVYKGT-LRSGEVVAIK--KMELPRFKEADGEHEFRV----EVDILSRLDHPNLVS 124
           G +G VY+    ++GE+VA+K  KME    KE +G   F +    E++IL +L HPN+V+
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKME----KEKEG---FPITSLREINILLKLQHPNIVT 68

Query: 125 L--IGYCADGKHRFLVYEYMQ---KGNLQDHLNG---IGEPK--MDWPLRLKVALGAAKG 174
           +  +   ++    ++V EY++   K  L + +       E K  M   L          G
Sbjct: 69  VKEVVVGSNLDKIYMVMEYVEHDLKS-LMETMKQPFLQSEVKCLMLQLLS---------G 118

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
           +A+LH +      I+HRD K++N+LL+     KI DFGLA+      + Y T  V+ T  
Sbjct: 119 VAHLHDNW-----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVV-TLW 171

Query: 235 YFDPE-YTSTGKLTLQSDVYAFGVVLLELLTGR 266
           Y  PE      + +   D+++ G +  ELLT +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 27/236 (11%)

Query: 45  HRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADG 103
              SS+  L+ + + T ++     +GKG +G+VYK T  + G + A+K ++       D 
Sbjct: 6   PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DV 61

Query: 104 EHEFRVEVDILSRL-DHPNLVSLIG--YCAD---GKHRFLVYEYMQKGNLQDHLNGI--- 154
           + E   E +IL  L +HPN+V   G  Y AD   G   +LV E    G++ + + G+   
Sbjct: 62  DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121

Query: 155 GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
           G+ ++D  +   +  GA  GL +LH++      I+HRD K  N+LL+     K+ DFG++
Sbjct: 122 GQ-RLDEAMISYILYGALLGLQHLHNNR-----IIHRDVKGNNILLTTEGGVKLVDFGVS 175

Query: 215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGK-----LTLQSDVYAFGVVLLELLTG 265
             +   +    T+  +GT  +  PE  +  +        + DV++ G+  +EL  G
Sbjct: 176 AQLTSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 58/183 (31%), Positives = 91/183 (49%), Gaps = 21/183 (11%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G FG V+K   + + ++VA+KK+ +   KE       R E+ IL  L H N+V+LI 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 78

Query: 128 YC---ADGKHR-----FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
            C   A   +R     +LV+E+ +  +L   L+     K       KV      GL Y+H
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK---LMPEGQETYVTARVLGTFGYF 236
            +      I+HRD K+ N+L++ +   K++DFGLA+   L    +    T RV+ T  Y 
Sbjct: 137 RNK-----ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYR 190

Query: 237 DPE 239
            PE
Sbjct: 191 PPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 16/203 (7%)

Query: 66  DNFL--GKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           DNF+  G+G  G V   T++S G++VA+KKM+L   K+   E  F  EV I+    H N+
Sbjct: 23  DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFN-EVVIMRDYQHENV 79

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
           V +      G   ++V E+++ G L D    +   +M+      V L   K L+ LH+  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLKALSVLHAQG 136

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
                ++HRD KS ++LL+ +   K+SDFG    +   +E      ++GT  +  PE  S
Sbjct: 137 -----VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPELIS 189

Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++ G++++E++ G
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 12/201 (5%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYKG   ++G++VA+KK+ L   +E       R E+ +L  L HPN+V L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCLQD 66

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL-GAAKGLAYLHSSSAVGI 186
                   +L++E++   +L+ +L+ + + +      +K  L    +G+ + HS      
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---- 121

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-YTSTGK 245
            ++HRD K  N+L+      K++DFGLA+    G    V    + T  Y  PE    + +
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLGSPR 178

Query: 246 LTLQSDVYAFGVVLLELLTGR 266
            +   D+++ G +  E+ T +
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 4e-15
 Identities = 50/199 (25%), Positives = 80/199 (40%), Gaps = 15/199 (7%)

Query: 71  KGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDIL-SRLDHPNLVSLIGY 128
           KG FG VY    R +G+  AIK ++       +     + E  I+  + + P +  L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
                + +LV EY+  G+    +  +G    DW    +       G+  LH        I
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQRG-----I 118

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD K  N+L+      K++DFGL++            + +GT  Y  PE         
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVGDDK 172

Query: 249 QSDVYAFGVVLLELLTGRR 267
            SD ++ G V+ E L G  
Sbjct: 173 MSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.4 bits (182), Expect = 5e-15
 Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 18/200 (9%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           +G+G  G V+    + +G+ VAIK++ L    +   + E  + E+ ++  L +PN+V+ +
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINL----QKQPKKELIINEILVMKELKNPNIVNFL 82

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
                G   F+V EY+  G+L D    + E  MD      V     + L +LH++     
Sbjct: 83  DSFLVGDELFVVMEYLAGGSLTDV---VTETCMDEAQIAAVCRECLQALEFLHANQ---- 135

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            ++HRD KS NVLL  +   K++DFG  A++ PE  +    + ++GT  +  PE  +   
Sbjct: 136 -VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA 191

Query: 246 LTLQSDVYAFGVVLLELLTG 265
              + D+++ G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 42/221 (19%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV---------EVDILSRLD 118
           +G G +G V      RSG+ VAIKK+           H F V         E+ IL    
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIP----------HAFDVPTLAKRTLRELKILRHFK 62

Query: 119 HPNLVS----LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR--LKVALGAA 172
           H N+++    L    AD K  ++V + M+  +L  H+    +P  +  +R  L   L   
Sbjct: 63  HDNIIAIRDILRPPGADFKDVYVVMDLME-SDLH-HIIHSDQPLTEEHIRYFLYQLL--- 117

Query: 173 KGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM---PEGQETYVTARV 229
           +GL Y+HS++     ++HRD K +N+L++ + E +I DFG+A+ +   P   + ++T  V
Sbjct: 118 RGLKYIHSAN-----VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 230 LGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAV 269
             T  Y  PE   S  + T   D+++ G +  E+L GRR +
Sbjct: 173 -ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.5 bits (183), Expect = 7e-15
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)

Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV------EVDILSRLDH 119
           N +G G  G VYK   R +G + A+K +         G HE  V      E++IL  ++H
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIY--------GNHEDTVRRQICREIEILRDVNH 131

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQD-HLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
           PN+V             ++ E+M  G+L+  H+        D      VA     G+AYL
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA-------DEQFLADVARQILSGIAYL 184

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           H        IVHRD K +N+L+++    KI+DFG+++++ +  +   ++  +GT  Y  P
Sbjct: 185 HRRH-----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSP 237

Query: 239 EYTST----GKLT-LQSDVYAFGVVLLELLTGR 266
           E  +T    G       D+++ GV +LE   GR
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.8 bits (181), Expect = 7e-15
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 16/199 (8%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G  G VY    + +G+ VAIK+M L   ++   +     E+ ++    HPN+V+ + 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNL---QQQPKKELIINEILVMRENKHPNIVNYLD 83

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
               G   ++V EY+  G+L D    + E  MD      V     + L +LHS+      
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSNQ----- 135

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
           ++HRD KS N+LL  +   K++DFG  A++ PE Q    T  ++GT  +  PE  +    
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST--MVGTPYWMAPEVVTRKAY 192

Query: 247 TLQSDVYAFGVVLLELLTG 265
             + D+++ G++ +E++ G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 66/205 (32%), Positives = 86/205 (41%), Gaps = 22/205 (10%)

Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDIL---SRLDHPN 121
           LG+G FG+V    YK T   GE+ AIK ++       D       E  I    +   HP 
Sbjct: 7   LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           LV+L        H   V EY   G+L  H   I       P  +  A     GL YLH +
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMH---IHTDVFSEPRAVFYAACVVLGLQYLHEN 120

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYVTARVLGTFGYFDPEY 240
                 IV+RD K  N+LL      KI+DFGL K  M  G     T+   GT  +  PE 
Sbjct: 121 K-----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLAPEV 172

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +    T   D +  GV++ E+L G
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 73.3 bits (180), Expect = 9e-15
 Identities = 66/223 (29%), Positives = 113/223 (50%), Gaps = 16/223 (7%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +  VYKG  R +GE+VA+K++ L   +E       R E+ ++  L H N+V L  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDA-EEGTPSTAIR-EISLMKELKHENIVRLHD 65

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLK-VALGAAKGLAYLHSSSAVGI 186
                    LV+EYM K +L+ +++  G      P  +K       KG+A+ H +     
Sbjct: 66  VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---- 120

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            ++HRD K  N+L++   E K++DFGLA+       T+    V  T  Y  P+     + 
Sbjct: 121 -VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRT 177

Query: 247 TLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL 288
              S D+++ G ++ E++TGR    L  G N+++ +L++  I+
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR---PLFPGTNNEDQLLKIFRIM 217

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 20/211 (9%)

Query: 63  FSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
             DD+F     LG G  G V+K + +   ++  +K+     K A      R E+ +L   
Sbjct: 2   LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHEC 60

Query: 118 DHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA 176
           + P +V   G + +DG+   +  E+M  G+L   L   G  ++   +  KV++   KGL 
Sbjct: 61  NSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 117

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGY 235
           YL         I+HRD K +N+L+++  E K+ DFG++ +L+     ++V     GT  Y
Sbjct: 118 YLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSY 168

Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
             PE       ++QSD+++ G+ L+E+  GR
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 16/203 (7%)

Query: 66  DNFL--GKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           D+F+  G+G  G V   T + +G+ VA+KKM+L   K+   E  F  EV I+    H N+
Sbjct: 25  DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFN-EVVIMRDYHHENV 81

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
           V +      G   ++V E+++ G L D    +   +M+      V L   + L+YLH+  
Sbjct: 82  VDMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIATVCLSVLRALSYLHNQG 138

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
                ++HRD KS ++LL+++   K+SDFG    +   +E      ++GT  +  PE  S
Sbjct: 139 -----VIHRDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKSLVGTPYWMAPEVIS 191

Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++ G++++E++ G
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 13/205 (6%)

Query: 68  FLGKGGFGRVYKG-TLRSGEVVAIKKMEL-PRFKEADGE-HEFRVEVDILSRLDHPNLVS 124
            LG+G FGRVY    + +G  +A K+++  P   E   E      E+ +L  L H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 125 LIGYCADGKHRFLV--YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
             G   D   + L    EYM  G+++D L   G   +   +  K      +G++YLHS+ 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM 126

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR-VLGTFGYFDPEYT 241
                IVHRD K  N+L  +    K+ DFG +K +     +    R V GT  +  PE  
Sbjct: 127 -----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 242 STGKLTLQSDVYAFGVVLLELLTGR 266
           S      ++DV++ G  ++E+LT +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 26/216 (12%)

Query: 58  EATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR 116
           E T  + D   +G G FG V       +G+ VAIKK+  P       +  +R E+ +L  
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65

Query: 117 LDHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA----LGA 171
           L H N++SL   + +  +  + V E +        L+ +   +   PL  +         
Sbjct: 66  LRHENIISLSDIFISPLEDIYFVTELLGT-----DLHRLLTSR---PLEKQFIQYFLYQI 117

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
            +GL Y+HS+      +VHRD K +N+L++ N + KI DFGLA++       YV+ R   
Sbjct: 118 LRGLKYVHSAG-----VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-- 170

Query: 232 TFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGR 266
              Y  PE   T  K  ++ D+++ G +  E+L G+
Sbjct: 171 ---YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG+VYK   +   V+A  K  +   K  +   ++ VE+DIL+  DHPN+V L+  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAK--VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
                + +++ E+   G +   +  +  P  +  +R+ V     + L YLH +      I
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHENK-----I 124

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYFDPEYT--ST 243
           +HRD K+ N+L + + + K++DFG++      + T    R    +GT  +  PE     T
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 244 GK---LTLQSDVYAFGVVLLEL 262
            K      ++DV++ G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 68/211 (32%), Positives = 98/211 (46%), Gaps = 22/211 (10%)

Query: 65  DDNFL---GKGGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
           D NFL   GKG FG+V     KGT    E+ AIK ++     + D      VE  +L+  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 118 DHPNLVSLIGYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA 176
             P  ++ +  C     R + V EY+  G+L   +  +G  +   P  +  A   A GL 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLF 115

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGY 235
           +LHS       I++RD K  NV+L +    KI+DFG+ K   E     VT +   GT  Y
Sbjct: 116 FLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDY 167

Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
             PE  +        D +AFGV+L E+L G+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G  G V K   R SG ++A K + L   K A      R E+ +L   + P +V   G
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHL-EIKPAIRNQIIR-ELKVLHECNSPYIVGFYG 66

Query: 128 -YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
            + +DG+    + E+M  G+L   L   G  ++   +  K+++   +GL YL        
Sbjct: 67  AFYSDGEISICM-EHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREK----H 119

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            I+HRD K +N+L+++  E K+ DFG++ +L+     ++V     GT  Y  PE      
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTH 174

Query: 246 LTLQSDVYAFGVVLLELLTGR 266
            T+QSD+++ G+ L+E+  GR
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 29/206 (14%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG+VYK   + +G + A K +E    K  +   ++ VE++IL+  +HP +V L+G
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIET---KSEEELEDYMVEIEILATCNHPYIVKLLG 76

Query: 128 -YCADGKHRFLVYEYMQKGNLQDHL----NGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
            +  DGK   ++ E+   G +   +     G+ EP++    R  +     + L YLHS  
Sbjct: 77  AFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSMK 130

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYT 241
                I+HRD K+ NVLL+ + + K++DFG+ AK +   Q        +GT  +  PE  
Sbjct: 131 -----IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPYWMAPEVV 182

Query: 242 --STGKLT---LQSDVYAFGVVLLEL 262
              T K T    ++D+++ G+ L+E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 68  FLGKGGFGRVYKG-TLRSGEVVAIKKMEL-PRFKEADGE-HEFRVEVDILSRLDHPNLVS 124
            LG+G FGRVY      +G  +A+K+++  P   E   E +    E+ +L  L H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 125 LIGYCADGKHRFL--VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
             G   D   R L    E+M  G+++D L   G   +   +  K      +G++YLHS+ 
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM 126

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA----RVLGTFGYFDP 238
                IVHRD K  N+L  +    K+ DFG +K +   Q   ++      V GT  +  P
Sbjct: 127 -----IVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKSVTGTPYWMSP 178

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           E  S      ++D+++ G  ++E+LT +
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 42/225 (18%)

Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 74

Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDW----------PL 163
                H N+++L+G C      +++ EY  KGNL+++L     P M++           +
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 164 RLKVALGA----AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE 219
             K  +      A+G+ YL S        +HRD  + NVL++ N   KI+DFGLA+ +  
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDVNN 189

Query: 220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                 T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL---DHPNLVS 124
           +G G +G VYK     SG  VA+K + +   ++       R EV +L RL   DHPN+V 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIVR 66

Query: 125 LIGYCADGK-----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           L+  CA  +        LV+E++ + +L+ +L+ +  P +       +     +GL +LH
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA--RVLGTFGYFD 237
           ++      IVHRD K  N+L+++  + K++DFGLA++      +   A   V+ T  Y  
Sbjct: 126 ANC-----IVHRDLKPENILVTSGGQVKLADFGLARIY-----SCQMALTPVVVTLWYRA 175

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELL 263
           PE           D+++ G +  E+ 
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 19/160 (11%)

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR-------------- 164
           H N+++L+G C      +++ EY  KGNL+++L     P MD+                 
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 165 LKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
           +  A   A+G+ YL S        +HRD  + NVL++ +   KI+DFGLA+ +       
Sbjct: 137 VSCAYQVARGMEYLASQKC-----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191

Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV+L E+ T
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 47/233 (20%)

Query: 66  DNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV-----------EVDI 113
              LG+G +G+V K     +G++VAIKK+++        +    V           E+ I
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA----- 168
           ++ + H N++ L+    +G    LV + M   +L+  ++          +RL  +     
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR--------KIRLTESQVKCI 124

Query: 169 -LGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA------------- 214
            L    GL  LH         +HRD    N+ +++    KI+DFGLA             
Sbjct: 125 LLQILNGLNVLHKWY-----FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 215 KLMPEGQETYVTARVLGTFGYFDPE-YTSTGKLTLQSDVYAFGVVLLELLTGR 266
           K     +   +T++V+ T  Y  PE      K     D+++ G +  ELLTG+
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.1 bits (176), Expect = 3e-14
 Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 18/200 (9%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           +G+G  G VY    + +G+ VAIK+M L    +   + E  + E+ ++    +PN+V+ +
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 82

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
                G   ++V EY+  G+L D    + E  MD      V     + L +LHS+     
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALDFLHSNQ---- 135

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            ++HRD KS N+LL  +   K++DFG  A++ PE  +    + ++GT  +  PE  +   
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA 191

Query: 246 LTLQSDVYAFGVVLLELLTG 265
              + D+++ G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.7 bits (175), Expect = 4e-14
 Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 18/200 (9%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           +G+G  G VY    + +G+ VAI++M L    +   + E  + E+ ++    +PN+V+ +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
                G   ++V EY+  G+L D    + E  MD      V     + L +LHS+     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSNQ---- 136

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            ++HRD KS N+LL  +   K++DFG  A++ PE  +    + ++GT  +  PE  +   
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA 192

Query: 246 LTLQSDVYAFGVVLLELLTG 265
              + D+++ G++ +E++ G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 21/202 (10%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+GG+G+V+    + +GE+VA+K+M+     + +       E DIL+      LV L+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD----WPLRLKVALGAAKGLAYLHSSSA 183
              D ++ +L  EY+  G+ +  LN +G    D    +   +  A+ A   L Y      
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY------ 122

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
                +HRD K  N L+ A+   K++DFGL+K    G  TY  + V+G+  Y  PE    
Sbjct: 123 -----IHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANS-VVGSPDYMAPEVLRG 172

Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
                  D ++ G +L E L G
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 28/204 (13%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G VYK   L +GE+ A+K ++L   +  D     + E+ ++    H N+V+  G
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKL---EPGDDFSLIQQEIFMVKECKHCNIVAYFG 73

Query: 128 YCADGKHRFLVYEYMQKGNLQD--HLNG-IGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
                +  ++  EY   G+LQD  H+ G + E ++ +  R  +     +GLAYLHS   +
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM 128

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYFDPEYT 241
                HRD K  N+LL+ N + K++DFG+A      + T   A+    +GT  +  PE  
Sbjct: 129 -----HRDIKGANILLTDNGDVKLADFGVA-----AKITATIAKRKSFIGTPYWMAPEVA 178

Query: 242 S---TGKLTLQSDVYAFGVVLLEL 262
           +    G      D++A G+  +EL
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 47/230 (20%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE-----FRVEVDILSRLDHPNLV 123
           +GKGG G VY       + V  +++ L + +E   E+      F  E  I + L HP +V
Sbjct: 10  IGKGGMGEVYLAY----DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE----PKMDWPLRLKVALGA-------- 171
            +   C+DG   +    Y++   L+  L  + +     K    L  K ++GA        
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK---ELAEKTSVGAFLSIFHKI 122

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY------- 224
              + Y+HS       ++HRD K  N+LL    E  I D+G A +  + +E         
Sbjct: 123 CATIEYVHSKG-----VLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVD 176

Query: 225 ----------VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                     +  +++GT  Y  PE       +  +D+YA GV+L ++LT
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 25/206 (12%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV------EVDILSRLDHPN 121
           LG+G +  VYKG  + +  +VA+K++ L        EHE         EV +L  L H N
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRL--------EHEEGAPCTAIREVSLLKDLKHAN 65

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V+L       K   LV+EY+ K +L+ +L+  G       ++L +     +GL Y H  
Sbjct: 66  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHRR 123

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-Y 240
                 ++HRD K  N+L++   E K++DFGLA+      +TY    V  T  Y  P+  
Sbjct: 124 K-----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGR 266
             +   + Q D++  G +  E+ TGR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 68/229 (29%), Positives = 103/229 (44%), Gaps = 47/229 (20%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHE-------FRVEVDILSRLDHP 120
           LG+G +  VYKG  + +G++VA+K++ L        EHE        R E  +L  L H 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRL--------EHEEGAPFTAIR-EASLLKDLKHA 63

Query: 121 NLVSLIGYCADGKHRFLVYEYMQ---KGNLQDHLNGIGEPKMDWPLRLKVAL-GAAKGLA 176
           N+V+L       K   LV+EY+    K  + D   G+          +++ L    +GLA
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLS------MHNVRLFLFQLLRGLA 117

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           Y H        ++HRD K  N+L+S   E K++DFGLA+      +TY    V  T  Y 
Sbjct: 118 YCHQRR-----VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYR 170

Query: 237 DP-------EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
            P       EY++        D++  G +  E+ TGR     +  V DQ
Sbjct: 171 PPDVLLGSTEYST------SLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 32/220 (14%)

Query: 69  LGKGGFGRVYKGT---LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------- 118
           LG+G FG+V       L   +   + K+ +   K    E +     D++S ++       
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 82

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDW-------PLRL------ 165
           H N+++L+G C      +++ EY  KGNL+++L     P M++       P         
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 166 -KVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
              A   A+G+ YL S        +HRD  + NVL++ +   KI+DFGLA+ +       
Sbjct: 143 VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197

Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV+L E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 20/170 (11%)

Query: 110 EVDILSRLD-HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDW------- 161
           E++++  +  H N+++L+G C      +++ EY  KGNL++ L     P  D+       
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 162 ---PLRLK----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
               L  K     A   A+G+ YL S        +HRD  + NVL++ +   KI+DFGLA
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRRC-----IHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           + + +      T+       +  PE       T QSDV++FG+++ E+ T
Sbjct: 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 25/206 (12%)

Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRV------EVDILSRLDHPN 121
           LG+G +  V+KG  +  E +VA+K++ L        EHE         EV +L  L H N
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRL--------EHEEGAPCTAIREVSLLKDLKHAN 65

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V+L       K   LV+EY+ K +L+ +++  G       +++ +     +GLAY H  
Sbjct: 66  IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHRR 123

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-Y 240
                 ++HRD K  N+L++   E K++DFGLA+      +TY    V  T  Y  P+  
Sbjct: 124 K-----VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGR 266
             + + + Q D++  G +  E+ +GR
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)

Query: 69  LGKGGFGRVYKGT-LRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LG G FG VYKG  +  GE     VAIK +      +A+   E   E  +++ +  P + 
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPYVC 72

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHL----NGIGEPKM-DWPLRLKVALGAAKGLAYL 178
            L+G C     + LV + M  G L D++    + IG   + +W +++      AKG++YL
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
                  + +VHRD  + NVL+ +    KI+DFGLA+L+   +  Y          +   
Sbjct: 126 EE-----VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT 264
           E     + T QSDV+++GV + EL+T
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 20/211 (9%)

Query: 63  FSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
             DD+F     LG G  G V K   +   ++  +K+     K A      R E+ +L   
Sbjct: 2   LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHEC 60

Query: 118 DHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA 176
           + P +V   G + +DG+   +  E+M  G+L   L      ++   +  KV++   +GLA
Sbjct: 61  NSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLA 117

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGY 235
           YL         I+HRD K +N+L+++  E K+ DFG++ +L+     ++V     GT  Y
Sbjct: 118 YLREKHQ----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSY 168

Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
             PE       ++QSD+++ G+ L+EL  GR
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 69/287 (24%), Positives = 127/287 (44%), Gaps = 52/287 (18%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLI 126
           LG+G +G V K     +G ++A+K++       +  +    +++DI  R    P  V+  
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 127 GYCADGKHRFLVYEYMQKG------NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           G        ++  E M          + D    I E  +      K+A+   K L YLHS
Sbjct: 67  GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLHS 121

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFG--------LAKLMPEGQETYVTA-RVLG 231
             +V    +HRD K +NVL++ N + K+ DFG        +AK +  G + Y+   R+  
Sbjct: 122 KLSV----IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI-- 175

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR 291
                +PE    G   ++SDV++ G+ ++EL TGR   D     + +    Q++ ++ + 
Sbjct: 176 -----NPELNQKG-YDVKSDVWSLGITMIELATGRFPYD-----SWKTPFQQLKQVVEEP 224

Query: 292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
                   P+L    ++ E    F +  ++C++    ERP+  E ++
Sbjct: 225 S-------PQLPAEKFSPE----FQDFVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 38/220 (17%)

Query: 68  FLGKGGFGRVYKG---TLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
            +G+G +GRVYK      + G+  AIKK +    ++  G  +   R E+ +L  L H N+
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACR-EIALLRELKHENV 64

Query: 123 VSLIGYCADGKHR--FLVYEYMQKGNLQ---DHLNGIGEPKMDWPLRLKVAL-GAAKGLA 176
           VSL+    +   +  +L+++Y +    Q    H           P  +K  L     G+ 
Sbjct: 65  VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKR--VSIPPSMVKSLLWQILNGVH 122

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEA----KISDFGLAKLM-PEGQETYVTARVLG 231
           YLHS+      ++HRD K  N+L+          KI D GLA+L     +       V+ 
Sbjct: 123 YLHSNW-----VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 232 TFGYFDPE-------YTSTGKLTLQSDVYAFGVVLLELLT 264
           T  Y  PE       YT         D++A G +  ELLT
Sbjct: 178 TIWYRAPELLLGARHYTKA------IDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 68/282 (24%), Positives = 126/282 (44%), Gaps = 28/282 (9%)

Query: 69  LGKGGFGRVYKGT--LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD---HPNLV 123
           +G+G +G+V+K       G  VA+K++ +   +E       R EV +L  L+   HPN+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67

Query: 124 SLIGYCA----DGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
            L   C     D + +  LV+E++ + +L  +L+ + EP +       +     +GL +L
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HS       +VHRD K  N+L++++ + K++DFGLA++            V+ T  Y  P
Sbjct: 127 HSHR-----VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 178

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E           D+++ G +  E+   +     +  V+    +L V  +  +    R V 
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 299 DPELSRSSYTMESIAMFA--------NLASRCVRTESSERPS 332
            P  +  S + + I  F         +L  +C+    ++R S
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 42/292 (14%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSR-LDHPNLVSLI 126
           +G G  G+VYK   + +G V+A+K+M   R    +      +++D++ +  D P +V   
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRL--KVALGAAKGLAYL---HSS 181
           GY       F+  E M    L   L  I  P    P  +  K+ +   K L YL   H  
Sbjct: 81  GYFITDSDVFICMELMSTC-LDKLLKRIQGP---IPEDILGKMTVAIVKALHYLKEKHG- 135

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY- 240
                 ++HRD K +N+LL A+   K+ DFG++  + + +    +A   G   Y  PE  
Sbjct: 136 ------VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA---GCAAYMAPERI 186

Query: 241 ---TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV 297
                  K  +++DV++ G+ L+EL TG+      +                + + L K+
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---------------EFEVLTKI 231

Query: 298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +  E             F +    C+  +  +RP   E ++   +  Y  ++
Sbjct: 232 LQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 38/213 (17%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI- 126
           +G G +G V      R+GE VAIKK+  P   E   +  +R E+ +L  + H N++ L+ 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81

Query: 127 ----GYCADGKHRF-LVYEYMQKGNLQDHLNG-IGEPKMDWPLRLKVALGAAKGLAYLHS 180
                   D    F LV  YMQ  +LQ  +   + E K+ +     +      GL Y+HS
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHS 135

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE- 239
           +      I+HRD K  N+ ++ + E KI DFGLA+        YV  R      Y  PE 
Sbjct: 136 AG-----IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEV 185

Query: 240 ------YTSTGKLTLQSDVYAFGVVLLELLTGR 266
                 Y  T       D+++ G ++ E+LTG+
Sbjct: 186 ILNWMHYNQT------VDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 75/302 (24%), Positives = 118/302 (39%), Gaps = 57/302 (18%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G FG V+    + +G+V A+K +      + +     R E DIL+  D P +V L  
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN--GIGEPKMDWPLRLKVA-LGAAKGLAYLHSSSAV 184
              D +H +LV EYM  G+L + L    +   +     R  +A L  A  L  +H     
Sbjct: 69  SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET---ARFYIAELVLA--LDSVHK---- 119

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE-GQETYVTAR--------------- 228
            +  +HRD K  N+L+ A+   K++DFGL K M +     Y                   
Sbjct: 120 -LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178

Query: 229 -----------VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND 277
                       +GT  Y  PE        L+ D ++ GV+L E+L G            
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP------FYS 232

Query: 278 QNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECV 337
             L      I+N ++ LR   DP +S             +L  R +  +  +R    E +
Sbjct: 233 DTLQETYNKIINWKESLRFPPDPPVSPE---------AIDLICRLL-CDPEDRLGSFEEI 282

Query: 338 KE 339
           K 
Sbjct: 283 KS 284

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 28/209 (13%)

Query: 69  LGKGGFGRVY---KGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           LGKGG+G+V+   K T   +G++ A+K   K  + R  + D  H  + E +IL  + HP 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-NQKDTAHT-KAERNILEAVKHPF 61

Query: 122 LVSLI-GYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPL-RLKVALGAAKGLA 176
           +V LI  +   GK  +L+ EY+  G L  HL   G   E    + L  + +AL       
Sbjct: 62  IVDLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------ 114

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           +LH        I++RD K  N+LL A    K++DFGL K      E  VT    GT  Y 
Sbjct: 115 HLHQQG-----IIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYM 167

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
            PE           D ++ G ++ ++LTG
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)

Query: 68  FLGKGGFGRVYKG-TLRSGEVVAIKKMEL-PRFKEADGE-HEFRVEVDILSRLDHPNLVS 124
            LG+G FG VY      +G  +A+K++   P  +E   E +    E+ +L  L H  +V 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 125 LIGYCADGKHRFL--VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
             G   D + + L    EYM  G+++D L   G   +   +  +      +G++YLHS+ 
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM 126

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA----RVLGTFGYFDP 238
                IVHRD K  N+L  +    K+ DFG +K +   Q   ++      V GT  +  P
Sbjct: 127 -----IVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVTGTPYWMSP 178

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT 264
           E  S      ++DV++    ++E+LT
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 38/234 (16%)

Query: 110 EVDILSRLDHPNLVSLIGY---CADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPLRL 165
           E+  L R+D  N++ + G+     D   R  L+ EY  +G L++ L+   E  + +  +L
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKL 125

Query: 166 KVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV 225
            +A+   KGL  L+  +    P  +++  S + L++ N++ KI   GL K++       V
Sbjct: 126 DMAIDCCKGLYNLYKYT--NKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV 181

Query: 226 TARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
              V     YF  +  +    + T++ D+Y+ GVVL E+ TG+        +  +NL  +
Sbjct: 182 NFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK--------IPFENLTTK 228

Query: 284 --VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
                I+N    L+  +D  L               +   C   +S +RP++ E
Sbjct: 229 EIYDLIINKNNSLKLPLDCPL-----------EIKCIVEACTSHDSIKRPNIKE 271

Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.4 bits (164), Expect = 9e-13
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 28/204 (13%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G VYK   + +GE+ AIK ++L   ++     +   E+ ++    H N+V+  G
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSNIVAYFG 73

Query: 128 YCADGKHRFLVYEYMQKGNLQD--HLNG-IGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
                   ++  E+   G+LQD  H+ G + E ++ +  R  +     +GL YLHS   +
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGKM 128

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYFDPEYT 241
                HRD K  N+LL+ N   K++DFG++      Q T   A+    +GT  +  PE  
Sbjct: 129 -----HRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSFIGTPYWMAPEVA 178

Query: 242 ST---GKLTLQSDVYAFGVVLLEL 262
           +    G      D++A G+  +EL
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 39/212 (18%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LGKG FG VY    K  +    +  +K++ +      +       E  +LS+LDHP +V 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 125 -------------LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM-DWPLRLKVALG 170
                        +  YC        + E    G        + E ++ +W ++L +   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT------LSENQVCEWFIQLLL--- 117

Query: 171 AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL 230
              G+ Y+H        I+HRD K+ N+ L  N   KI DFG+++L+    +   T    
Sbjct: 118 ---GVHYMHQRR-----ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FT 166

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLEL 262
           GT  Y  PE         +SD+++ G +L E+
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 38/216 (17%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS--- 124
           +GKG +G V     R+ G+   IKK+ L R            E  +LS+L HPN+V+   
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNL-RNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 125 -----------LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPK-MDWPLRLKVALGAA 172
                      ++G+C  G     + E  QKG L      + E + ++W +++ +AL   
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKL------LPENQVVEWFVQIAMAL--- 115

Query: 173 KGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
               YLH        I+HRD K+ NV L+     K+ D G+A+++    +   T  ++GT
Sbjct: 116 ---QYLHEKH-----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRA 268
             Y  PE  S      +SDV+A G  + E+ T + A
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 29/214 (13%)

Query: 66  DNFLGKGGFGRVYKGT-LRSGEVVAIKKM-----ELPRFKEADGEHEFRVEVDILSRLDH 119
           D  +G G FG V+  T  R G+ VA+KKM      L   K       FR E+ +L    H
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV-----FR-ELKMLCFFKH 58

Query: 120 PNLVSLIGYCADG-----KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL-GAAK 173
            N++S +           +  ++V E MQ     D    I  P+      +KV L    +
Sbjct: 59  DNVLSALDILQPPHIDPFEEIYVVTELMQ----SDLHKIIVSPQPLSSDHVKVFLYQILR 114

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           GL YLHS+      I+HRD K  N+L+++N   KI DFGLA++    +  ++T  V+  +
Sbjct: 115 GLKYLHSAG-----ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169

Query: 234 GYFDPE-YTSTGKLTLQSDVYAFGVVLLELLTGR 266
            Y  PE    +   T   D+++ G +  ELL  R
Sbjct: 170 -YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 34/215 (15%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLI 126
           +G G +G+VYKG  +++G++ AIK M++      D E E ++E+++L +  H  N+ +  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYY 79

Query: 127 GY------CADGKHRFLVYEYMQKGNLQDHL-NGIGEP-KMDWPLRLKVALGAAKGLAYL 178
           G              +LV E+   G++ D + N  G   K DW   +   +   +GLA+L
Sbjct: 80  GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI--LRGLAHL 137

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG---QETYVTARVLGTFGY 235
           H+       ++HRD K  NVLL+ N E K+ DFG++  +      + T++     GT  +
Sbjct: 138 HAHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYW 187

Query: 236 FDPEYTST-----GKLTLQSDVYAFGVVLLELLTG 265
             PE  +           +SD+++ G+  +E+  G
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 27/211 (12%)

Query: 72  GGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           G +G VY    K T +     A+KK+        +   +  VE DIL+  ++P +VS+  
Sbjct: 12  GAYGAVYLVRHKETRQR---FAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                +H  +V EY++ G+    L  IG   +D   R+  A      L YLH+       
Sbjct: 69  SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-ARMYFA-ETVLALEYLHNYG----- 121

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKL--------MPEGQ-----ETYVTARVLGTFG 234
           IVHRD K  N+L+++    K++DFGL+K+        + EG        ++  +V GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           Y  PE           D +A G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 25/206 (12%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV------EVDILSRLDHPN 121
           LG+G +  V+KG  + +  +VA+K++ L        EHE         EV +L  L H N
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRL--------EHEEGAPCTAIREVSLLKNLKHAN 64

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V+L       +   LV+EY+   +L+ +L+  G       +++       +GL+Y H  
Sbjct: 65  IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHKR 122

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-Y 240
                 I+HRD K  N+L++   E K++DFGLA+      +TY    V  T  Y  P+  
Sbjct: 123 K-----ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 175

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGR 266
             + + +   D++  G +L E+ TGR
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 63/201 (31%), Positives = 86/201 (42%), Gaps = 15/201 (7%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILS-RLDHPNLVSLI 126
           LGKG FG+V    L+ SG + A+K ++     + D       E  ILS   +HP L  L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 127 GYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
             C     R F V E++  G+L  H+      + D       A      L +LH      
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKG--- 116

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG-QETYVTARVLGTFGYFDPEYTSTG 244
             I++RD K  NVLL      K++DFG+ K   EG      T+   GT  Y  PE     
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV+L E+L G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 62/205 (30%), Positives = 107/205 (52%), Gaps = 22/205 (10%)

Query: 69  LGKGGFGRVY-----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LG+G FG+V+      G   +G++ A+K ++    K  D     ++E DIL+ ++HP +V
Sbjct: 4   LGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRD-RVRTKMERDILAEVNHPFIV 61

Query: 124 SL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA-AKGLAYLHSS 181
            L   +  +GK  +L+ ++++ G+L   L+   +  M     +K  L   A  L +LHS 
Sbjct: 62  KLHYAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHS- 116

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-LMPEGQETYVTARVLGTFGYFDPEY 240
               + I++RD K  N+LL      K++DFGL+K  +   ++ Y      GT  Y  PE 
Sbjct: 117 ----LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEV 169

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +    T  +D ++FGV++ E+LTG
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 69/237 (29%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHE------FRVEVDILS 115
           + + +++G+G +G V   T   +G  VAIKK+  P F     EH+       R E+ IL 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-P-F-----EHQTFCQRTLR-EIKILR 58

Query: 116 RLDHPNLVSL------IGYCADGKHRFLVYEYMQKG--------NLQ-DH----LNGIGE 156
           R  H N++ +        + +     ++V E M+          +L  DH    L  I  
Sbjct: 59  RFKHENIIGILDIIRPPSFES-FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQI-- 115

Query: 157 PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL 216
                 LR         GL Y+HS++     ++HRD K +N+LL+ N + KI DFGLA++
Sbjct: 116 ------LR---------GLKYIHSAN-----VLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Query: 217 M-PEGQET-----YVTARVLGTFGYFDPEYTSTGKLTLQS-DVYAFGVVLLELLTGR 266
             PE   T     YV  R      Y  PE     K   ++ D+++ G +L E+L+ R
Sbjct: 156 ADPEHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 51/186 (27%), Positives = 94/186 (50%), Gaps = 21/186 (11%)

Query: 84  SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ 143
           SG  VA+K M+L   K+   E  F  EV I+    H N+V +      G+  +++ E++Q
Sbjct: 45  SGRQVAVKMMDLR--KQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101

Query: 144 KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN 203
            G L D    + + +++      V     + L YLHS       ++HRD KS ++LL+ +
Sbjct: 102 GGALTDI---VSQTRLNEEQIATVCESVLQALCYLHSQG-----VIHRDIKSDSILLTLD 153

Query: 204 FEAKISDFG----LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVL 259
              K+SDFG    ++K +P+ +       ++GT  +  PE  S      + D+++ G+++
Sbjct: 154 GRVKLSDFGFCAQISKDVPKRKS------LVGTPYWMAPEVISRTPYGTEVDIWSLGIMV 207

Query: 260 LELLTG 265
           +E++ G
Sbjct: 208 IEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 54/223 (24%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G V       + E VAIKK+        D +   R E+ +L  LDH N++++  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71

Query: 128 YCADGKHR------FLVYEYMQKGNLQ----------DH----LNGIGEPKMDWPLRLKV 167
                 HR      ++VYE M     Q          DH    L  +        LR   
Sbjct: 72  -IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQL--------LR--- 119

Query: 168 ALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE---TY 224
                 GL Y+HS++     ++HRD K +N+LL+AN + KI DFGLA+   E  +    Y
Sbjct: 120 ------GLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168

Query: 225 VTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGR 266
           V  R      Y  PE   +  + T   DV++ G +  ELL  +
Sbjct: 169 VVTR-----WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.5 bits (159), Expect = 4e-12
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 24/211 (11%)

Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSL 125
            +G G +G+VYKG  +++G++ AIK M++      D E E + E+++L +  H  N+ + 
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQEINMLKKYSHHRNIATY 68

Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
            G              +LV E+   G++ D +       +       +     +GL++LH
Sbjct: 69  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   ++HRD K  NVLL+ N E K+ DFG++  +        T   +GT  +  PE
Sbjct: 129 QHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPE 181

Query: 240 YTST-----GKLTLQSDVYAFGVVLLELLTG 265
             +           +SD+++ G+  +E+  G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 8e-12
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 24/206 (11%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV----EVDILSRLDHPNLV 123
           +G+G +G V K   + + E+VAIKK     FK+++   E +     E+ +L  L   N+V
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKK-----FKDSEENEEVKETTLRELKMLRTLKQENIV 63

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQ---DHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
            L          +LV+EY++K  L+   +  NG+   K+             K + + H 
Sbjct: 64  ELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-----SYIYQLIKAIHWCHK 118

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
           +      IVHRD K  N+L+S N   K+ DFG A+ + EG     T  V  T  Y  PE 
Sbjct: 119 ND-----IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPEL 172

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGR 266
                     D+++ G +L EL  G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 17/214 (7%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           LG+G +  VYKG  + +G++VA+K +   R +E +G     + E  +L  L H N+V L 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLLH 69

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL-GAAKGLAYLHSSSAVG 185
                 +   LV+EY+   +L  +++    P    P  +K+ L    +GL+Y+H      
Sbjct: 70  DIIHTKETLTLVFEYVHT-DLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY--- 123

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-YTSTG 244
             I+HRD K  N+L+S   E K++DFGLA+       TY    V  T  Y  P+    + 
Sbjct: 124 --ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGST 179

Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
           + +   D++  G + +E++ G  A    + + DQ
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 63/231 (27%), Positives = 93/231 (40%), Gaps = 43/231 (18%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG  GRV+   L+ +G++ A+K ++     + +       E +IL+ LDHP L +L  
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEP-KMDWPLRLKVA-LGAAK---GLAYLHSSS 182
                 +  LV +Y   G L   L    +P K    L  +VA   AA+    L YLH   
Sbjct: 69  SFQTETYLCLVMDYCPGGELFRLLQ--RQPGKC---LSEEVARFYAAEVLLALEYLH--- 120

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG----------------QETYVT 226
            +G  IV+RD K  N+LL  +    +SDF L+K                       +  +
Sbjct: 121 LLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 227 ARVL-----------GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
                          GT  Y  PE  S        D +  G++L E+L G 
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 19/209 (9%)

Query: 63  FSDDNF---LGKGGFGRVYKGTLRSGEV--VAIKKMELPRF-KEADGEHEFRVEVDILSR 116
           + D NF   LG G FGRV   T ++ +   VAIK+ E  +  K+   +H F  E  IL+ 
Sbjct: 29  YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNY 87

Query: 117 LDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA 176
           ++HP  V+L G   D  + +LV E++  G     L         +P  +     A   L 
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL----RRNKRFPNDVGCFYAAQIVLI 143

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           + +  S   + IV+RD K  N+LL  +   K++DFG AK++     TY    + GT  Y 
Sbjct: 144 FEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--TRTYT---LCGTPEYI 195

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
            PE          +D +  G+ + E+L G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 39/214 (18%)

Query: 69  LGKGGFGRV-YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      R+G  VAIKK+  P   E   +  +R E+ +L  + H N++ L+ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81

Query: 128 YCA-----DGKHRF-LVYEYMQK--GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
                   D  H F LV  +M    G L  H   + E ++ +     +     KGL Y+H
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQF-----LVYQMLKGLKYIH 135

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           ++      I+HRD K  N+ ++ + E KI DFGLA+        YV  R      Y  PE
Sbjct: 136 AAG-----IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPE 185

Query: 240 -------YTSTGKLTLQSDVYAFGVVLLELLTGR 266
                  YT T       D+++ G ++ E+LTG+
Sbjct: 186 VILNWMHYTQT------VDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 40/212 (18%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLI 126
           +G+G F  V K  + ++G+  AIK M+   FK  +  +  R E+  L RL  HPN++ LI
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLR-EIQALRRLSPHPNILRLI 64

Query: 127 GYCADGKHR--FLVYEYMQKGNLQDHLNG----IGEPKMDWPLRLKVALGAAKGLAYLHS 180
               D K     LV+E M   NL + + G    + E ++   +   +     K L ++H 
Sbjct: 65  EVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLL-----KSLDHMHR 118

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ--ETYVTAR------VLGT 232
           +      I HRD K  N+L+  +   K++DFG  + +        Y++ R       L T
Sbjct: 119 NG-----IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT 172

Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            GY+ P+           D++A G V  E+L+
Sbjct: 173 DGYYGPKM----------DIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 17/202 (8%)

Query: 69  LGKGGFGRVYKGTLRSGEVV-AIKKMELPRFKEADGEHEFRVEVDILSR-LDHPNLVSLI 126
           +GKG FG+V     ++ E   A+K ++     +   E     E ++L + + HP LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNG---IGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
                    + V +Y+  G L  HL       EP+  +      A   A  L YLHS   
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-----YAAEIASALGYLHS--- 114

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
             + IV+RD K  N+LL +     ++DFGL K   E   T  T+   GT  Y  PE    
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHK 170

Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
                  D +  G VL E+L G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 78/268 (29%), Positives = 116/268 (43%), Gaps = 29/268 (10%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILS-RLDHPNLVSLI 126
           LGKG FG+V    L+ + EV AIK ++     + D       E  IL+    HP L +L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 127 GYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
             C   K R F V EY+  G+L   +      K D P     A      L +LH      
Sbjct: 63  C-CFQTKDRLFFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHG--- 116

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG-QETYVTARVLGTFGYFDPEYTSTG 244
             +++RD K  N+LL A    K++DFG+ K   EG      T    GT  Y  PE     
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQEL 171

Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE-LS 303
           +     D +A GV++ E++ G+   + +   N+ +L      IL+D      V+ P  LS
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEAD---NEDDL---FESILHD-----DVLYPVWLS 220

Query: 304 RSSYTMESIAMFANLASR--CVRTESSE 329
           + + ++    M  N   R  CV ++  E
Sbjct: 221 KEAVSILKAFMTKNPNKRLGCVASQGGE 248

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 62.6 bits (152), Expect = 3e-11
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 18/206 (8%)

Query: 69  LGKGGFGRVYKGTL----RSGEVVAIKKMELPRFKEADGEHE-FRVEVDILSRLDHPNLV 123
           LG G FG + +G L    +    VAI  +   R   +D +   F  E   L + DH N+V
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
            L G    G    +V EYM  G L   L    E ++     + +  G A G+ YL   S 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYL---SE 125

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET-YVTARVLGTFGYFDPEYTS 242
           +G   VH+   +  VL++++   KIS F   +L  +  E  Y T        +  PE   
Sbjct: 126 MG--YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 243 TGKLTLQSDVYAFGVVLLELLT-GRR 267
               +  SDV++FG+V+ E+++ G R
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 61/199 (30%), Positives = 86/199 (43%), Gaps = 11/199 (5%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPR-FKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           +GKG FG+V     +S G   A+K ++     K+ +  H       +L  L HP LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
                 +  + V +Y+  G L  HL    E     P     A   A  + YLHS +    
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLN---- 116

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I++RD K  N+LL +     ++DFGL K   E +ET  T+   GT  Y  PE       
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEPY 173

Query: 247 TLQSDVYAFGVVLLELLTG 265
               D +  G VL E+L G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 14/202 (6%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   R + E +A+KK+ L +  E       R E+ +L  + H N+V L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL-GAAKGLAYLHSSSAVGI 186
                K  +LV+EY+   +L+ H++   +   + P  +K  L    +G+AY HS      
Sbjct: 69  VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKN-PRLIKTYLYQILRGIAYCHSHR---- 122

Query: 187 PIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            ++HRD K  N+L+     A K++DFGLA+       T+    V  T  Y  PE     +
Sbjct: 123 -VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGSR 179

Query: 246 -LTLQSDVYAFGVVLLELLTGR 266
             +   D+++ G +  E++  +
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 69  LGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLI 126
           +GKG +G+V+K    ++G   A+K ++       D + E   E +IL  L DHPN+V   
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD----PIHDIDEEIEAEYNILKALSDHPNVVKFY 81

Query: 127 G--YCAD---GKHRFLVYEYMQKGNLQDHLNGI---GEPKMDWPLRLKVALGAAKGLAYL 178
           G  Y  D   G   +LV E    G++ D + G    GE +M+ P+   +   A  GL +L
Sbjct: 82  GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE-RMEEPIIAYILHEALMGLQHL 140

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           H +  +     HRD K  N+LL+     K+ DFG++  +   +    T+  +GT  +  P
Sbjct: 141 HVNKTI-----HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAP 193

Query: 239 EYTSTGK-----LTLQSDVYAFGVVLLELLTG 265
           E  +  +        + DV++ G+  +EL  G
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 8/147 (5%)

Query: 71  KGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYC 129
           +G FG+VY G  + + ++ A+K ++       +  H+ + E D L+    P +V L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 130 ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIV 189
               + +LV EY+  G+++  L+  G    D  + +K     A  L YLH        I+
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG-----II 126

Query: 190 HRDFKSTNVLLSANFEAKISDFGLAKL 216
           HRD K  N+L+S     K++DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 41/227 (18%)

Query: 61  CSFSDDNFLGKGGFGRVYKGTLRSGEV-----VAIKKMELPRFKEADGEHEFRV-----E 110
              +  + L +G FGR++ G L   +      V +K +        D   E +V     E
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-------KDHASEIQVTLLLQE 58

Query: 111 VDILSRLDHPNLVSLIGYCA-DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLK--- 166
             +L  L H N++ ++  C  DG+  F++Y YM  GNL+  L      + + P  L    
Sbjct: 59  SCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ 118

Query: 167 ---VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-LMPE--- 219
              +A+  A G++YLH        ++H+D  + N ++    + KI+D  L++ L P    
Sbjct: 119 LVHMAIQIACGMSYLHKRG-----VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173

Query: 220 --GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             G       +      +   E     + +  SDV++FGV+L EL+T
Sbjct: 174 CLGDNENRPVK------WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV--EVDILSRLDHPNLVSL 125
           LG+G +  VYKG  R +G++VA+K + +    + +    F    E  +L  L H N+V L
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISM----KTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL-GAAKGLAYLHSSSAV 184
                  +    V+EYM   +L  ++  I  P    P  +++ +    +GLAY+H     
Sbjct: 69  HDIIHTKETLTFVFEYMHT-DLAQYM--IQHPGGLHPYNVRLFMFQLLRGLAYIH----- 120

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-YTST 243
           G  I+HRD K  N+L+S   E K++DFGLA+      +TY +  V  T  Y  P+     
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGA 178

Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
              +   D++  G + +E+L G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 34/257 (13%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           + D   LG G  G V+        + VA+KK+ L   +    +H  R E+ I+ RLDH N
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV--KHALR-EIKIIRRLDHDN 63

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNG--IGEPKMDWPLRLKVALGAA------- 172
           +V +                 +       LN   I +  M+  L   +  G         
Sbjct: 64  IVKVYEVLGPSGSDL-----TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL 118

Query: 173 ------KGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLM-PEGQETY 224
                 +GL Y+HS++     ++HRD K  NV ++  +   KI DFGLA+++ P      
Sbjct: 119 FMYQLLRGLKYIHSAN-----VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173

Query: 225 VTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
             +  L T  Y  P    S    T   D++A G +  E+LTG+        +    L+L+
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233

Query: 284 VRHIL--NDRKKLRKVI 298
              ++   DR +L  VI
Sbjct: 234 SVPVVREEDRNELLNVI 250

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 69/256 (26%), Positives = 110/256 (42%), Gaps = 36/256 (14%)

Query: 63  FSDDNFLGKGGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHE----FRVEVDIL 114
           F   + +G+G FG V     K T   G++ A+K M+    K      E    F  E DIL
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMK----KSVLLAQETVSFFEEERDIL 55

Query: 115 SRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA-LGAAK 173
           S  + P +  L     D  + +LV EY   G+L   LN     + +      +A    A+
Sbjct: 56  SISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN-----RYEDQFDEDMAQFYLAE 110

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
            +  +HS   +G   VHRD K  NVL+      K++DFG A  +   +       V GT 
Sbjct: 111 LVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTP 167

Query: 234 GYFDPEYTST------GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI 287
            Y  PE  +T      G   ++ D ++ GV+  E++ GR         ++        +I
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP------FHEGTSAKTYNNI 221

Query: 288 LNDRKKLRKVIDPELS 303
           +N ++ L+   DP++S
Sbjct: 222 MNFQRFLKFPEDPKVS 237

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.0 bits (153), Expect = 7e-11
 Identities = 80/317 (25%), Positives = 124/317 (39%), Gaps = 71/317 (22%)

Query: 66  DNFLGKGGFGRV-YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------ 118
              LG G  G V     +  GE  A+K +++    EAD ++  + EV  L   D      
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD-KNRAQAEVCCLLNCDFFSIVK 95

Query: 119 -----------HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKV 167
                      +P  V +I          LV +Y   G+L+  +      K +   R   
Sbjct: 96  CHEDFAKKDPRNPENVLMIA---------LVLDYANAGDLRQEIKS--RAKTNRTFREHE 144

Query: 168 ALGAAKGLAYLHSSSAV----GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
           A     GL ++    AV       ++HRD KS N+LL +N   K+ DFG +K+       
Sbjct: 145 A-----GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199

Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
            V     GT  Y  PE       + ++D+++ GV+L ELLT +R  D   G N       
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GEN------- 249

Query: 284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
           +  +++  K L    DP     S  M+ I       +  + ++   RPS           
Sbjct: 250 MEEVMH--KTLAGRYDPLPPSISPEMQEI------VTALLSSDPKRRPS----------- 290

Query: 344 IYTNSKGLNMPLHALRM 360
              +SK LNMP+  L +
Sbjct: 291 ---SSKLLNMPICKLFI 304

Length = 496

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRF---KEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G+G FG V     +S + V   K+ L +F   K +D    F  E DI++  + P +V L
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKL-LSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQL 108

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
                D K+ ++V EYM  G+L + ++    P+  W          A+ +  L +  ++G
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KW-----AKFYTAEVVLALDAIHSMG 162

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-- 243
             ++HRD K  N+LL  +   K++DFG    M E         V GT  Y  PE   +  
Sbjct: 163 --LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQG 219

Query: 244 --GKLTLQSDVYAFGVVLLELLTG 265
             G    + D ++ GV L E+L G
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 44/220 (20%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS--- 124
           +GKG +G V       +GE VAIKK+    F+          E+ +L  L HP++V    
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 125 --LIGYCADGKHRFLVYEYMQ-------KGNLQDHLNGIGEPKMDWPLRLKVAL-GAAKG 174
             L     + K  ++V+E M+       K N  D L          P   +  L    + 
Sbjct: 67  IMLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLT---------PEHHQFFLYQLLRA 115

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET------YVTAR 228
           L Y+H+++     + HRD K  N+L +A+ + KI DFGLA++      T      YV  R
Sbjct: 116 LKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 229 VLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGR 266
                 Y  PE   +   K T   D+++ G +  E+LTG+
Sbjct: 171 -----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 22/209 (10%)

Query: 69  LGKGGFGRVYKGTLRSG---EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G FG+V  G + SG     V +K  EL        + +F  E      L H NL+  
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVK--ELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNG--IGEPKMDWPLRL-KVALGAAKGLAYLHSSS 182
           +G C +     LV E+   G+L+ +L      E     P  L ++A   A GL +LH ++
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA-RVLGTFGYFDPEYT 241
                 +H D    N LL+A+   KI D+GL+    + ++ YVT  ++     +  PE  
Sbjct: 121 -----FIHSDLALRNCLLTADLTVKIGDYGLSHNKYK-EDYYVTPDQLWVPLRWIAPELV 174

Query: 242 ST--GKL-----TLQSDVYAFGVVLLELL 263
               G L     T +S+V++ GV + EL 
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 32/210 (15%)

Query: 69  LGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHPNLV 123
           +G+GGFG VY G  +  +G++ A+K ++  R K   GE      R+ + ++S  D P +V
Sbjct: 2   IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAKGLAYLHS 180
            +            + + M  G+L  HL+  G   E +M +      A     GL ++H+
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMHN 115

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA----KLMPEGQETYVTARVLGTFGYF 236
                  +V+RD K  N+LL  +   +ISD GLA    K  P           +GT GY 
Sbjct: 116 RF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYM 162

Query: 237 DPEYTSTGKLTLQS-DVYAFGVVLLELLTG 265
            PE    G     S D ++ G +L +LL G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 70/249 (28%), Positives = 111/249 (44%), Gaps = 38/249 (15%)

Query: 69  LGKGGFGRV----YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +G+G FG V    +K    S +V A+K   K E+   K +D    F  E DI++  +   
Sbjct: 51  IGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEM--IKRSDSAF-FWEERDIMAHANSEW 104

Query: 122 LVSLIGYCA--DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           +V L  + A  D K+ ++V EYM  G+L + ++    P+  W       +  A  L  +H
Sbjct: 105 IVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVLA--LDAIH 159

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDP 238
           S     +  +HRD K  N+LL  +   K++DFG   K+   G     TA  +GT  Y  P
Sbjct: 160 S-----MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISP 212

Query: 239 EYTST----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
           E   +    G    + D ++ GV L E+L G      +      +LV     I++ +  L
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG------DTPFYADSLVGTYSKIMDHKNSL 266

Query: 295 RKVIDPELS 303
               D E+S
Sbjct: 267 TFPDDIEIS 275

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 74/283 (26%), Positives = 118/283 (41%), Gaps = 39/283 (13%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHE-----FRVEVDILSRLDHPNL 122
           LG+G F +++KG  R  G+   + K E+   K  D  H      F     ++S+L H +L
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEV-LLKVLDKSHRNYSESFFEAASMMSQLSHKHL 61

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           V   G C  G    +V EY++ G+L  +L  N        W  +L+VA   A  L +L  
Sbjct: 62  VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W--KLEVAKQLAWALHFLED 118

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR--VLGTFGYFDP 238
                  + H +  + NVLL    + K  +    KL   G    V  +  +L    +  P
Sbjct: 119 KG-----LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPP 173

Query: 239 EYTSTGK-LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV 297
           E     + L+L +D ++FG  L E+ +G           D+ L       L+ +KKL+  
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG----------GDKPLSA-----LDSQKKLQFY 218

Query: 298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
            D    R           ANL ++C+  E   RPS    +++L
Sbjct: 219 ED----RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 65/202 (32%), Positives = 86/202 (42%), Gaps = 14/202 (6%)

Query: 68  FLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LGKG FG+V     + SG+  A+K ++       D       E  +L    HP L SL 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60

Query: 127 GYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
            Y    K R   V EY+  G L  HL+       D        + +A  L YLHS     
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLHSGK--- 115

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTSTG 244
             IV+RD K  N++L  +   KI+DFGL K   EG     T +   GT  Y  PE     
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDN 170

Query: 245 KLTLQSDVYAFGVVLLELLTGR 266
                 D +  GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 34/211 (16%)

Query: 69  LGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHPNLV 123
           +G+GGFG VY G  +  +G++ A+K ++  R K   GE      R+ + ++S  D P +V
Sbjct: 2   IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 124 SLI-GYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAKGLAYLH 179
            +   +    K  F++ + M  G+L  HL+  G   E +M +      A     GL ++H
Sbjct: 61  CMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAEMRF-----YAAEIILGLEHMH 114

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA----KLMPEGQETYVTARVLGTFGY 235
           +       +V+RD K  N+LL  +   +ISD GLA    K  P           +GT GY
Sbjct: 115 NRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGY 161

Query: 236 FDPEYTSTGKLTLQS-DVYAFGVVLLELLTG 265
             PE    G     S D ++ G +L +LL G
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 62/206 (30%), Positives = 84/206 (40%), Gaps = 24/206 (11%)

Query: 69  LGKGGFGRV-YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG+V       +G+  A+K ++       D       E  +L    HP L +L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-K 61

Query: 128 YCADGKHRF-LVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGA--AKGLAYLHSS 181
           Y      R   V EY   G L  HL+      E +  +        GA     L YLHS 
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALGYLHSC 114

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEY 240
                 +V+RD K  N++L  +   KI+DFGL K   EG     T +   GT  Y  PE 
Sbjct: 115 D-----VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGR 266
                     D +  GVV+ E++ GR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 17/202 (8%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDIL-SRLDHPNLVSLI 126
           +GKG FG+V     ++ G+  A+K ++     +   +     E ++L   + HP LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLN---GIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
                    + V +Y+  G L  HL       EP+  +      A   A  L YLHS   
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-----YAAEIASALGYLHS--- 114

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
             + I++RD K  N+LL +     ++DFGL K   E  +T  T+   GT  Y  PE    
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRK 170

Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
                  D +  G VL E+L G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 24/244 (9%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIKKMELPRF--KEADGEHEFRVEVDILSRLDH-PN 121
           LG G +G+V+     G   +G++ A+K ++      K    EH  R E  +L  +   P 
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLEAVRRCPF 66

Query: 122 LVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA-AKGLAYLH 179
           LV+L   +  D K   L+ +Y+  G L  HL             ++V +      L +LH
Sbjct: 67  LVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLALDHLH 122

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                 + I++RD K  N+LL +     ++DFGL+K      E        GT  Y  PE
Sbjct: 123 Q-----LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMAPE 176

Query: 240 YTSTGKLTLQS--DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV 297
               G        D ++ GV+  ELLTG     ++   N Q+ +   R IL  +    K 
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSKPPFPKT 234

Query: 298 IDPE 301
           +  E
Sbjct: 235 MSAE 238

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 63/203 (31%), Positives = 86/203 (42%), Gaps = 19/203 (9%)

Query: 69  LGKGGFGRVYKGTL-RSGEVVAIK----KMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +GKG FG+V        G+  A+K    K+ L R ++     E  V   +L  + HP LV
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV---LLKNVKHPFLV 59

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
            L       +  + V +++  G L  HL    E     P     A   A  L YLHS   
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHS--- 114

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG-QETYVTARVLGTFGYFDPEYTS 242
             I IV+RD K  N+LL +     ++DFGL K   EG  ++  T    GT  Y  PE   
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIR 169

Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                   D +  G VL E+L G
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 9e-10
 Identities = 64/206 (31%), Positives = 86/206 (41%), Gaps = 22/206 (10%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR---LDHPN 121
           +GKG FG+VY    K T R   +  + K E+   KE    H    E +IL R    + P 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV--AHTIG-ERNILVRTLLDESPF 57

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA-AKGLAYLHS 180
           +V L          +LV +YM  G L  HL   G    D   R K  +      L +LH 
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVLALEHLHK 114

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
                  IV+RD K  N+LL A     + DFGL+K      +   T    GT  Y  PE 
Sbjct: 115 YD-----IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEV 167

Query: 241 TSTGK-LTLQSDVYAFGVVLLELLTG 265
               K  T   D ++ GV++ E+  G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 37/221 (16%)

Query: 62  SFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S+   N +G G FG VY+   + + E VAIKK ++ P++K          E+ I+  L+H
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR--------ELLIMKNLNH 118

Query: 120 PNLVSLIGYC------ADGKHRFL--VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA 171
            N++ L  Y        + K+ FL  V E++ +  +  ++          PL L V L +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFL-VKLYS 176

Query: 172 ---AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYV 225
               + LAY+HS       I HRD K  N+L+  N    K+ DFG AK +  GQ   +Y+
Sbjct: 177 YQLCRALAYIHSKF-----ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231

Query: 226 TARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTG 265
            +R      Y  PE        T   D+++ G ++ E++ G
Sbjct: 232 CSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 23/224 (10%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLK------VALGAAKGLAYLHSS 181
                +      E      L  HL G     +    +L       +     +GL Y+HS+
Sbjct: 84  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 140 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 189

Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 68/242 (28%), Positives = 98/242 (40%), Gaps = 48/242 (19%)

Query: 68  FLGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNL 122
            LG+G +G V       T    E VAIKK+     K+   +   R E+ +L     H N+
Sbjct: 7   ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNI 64

Query: 123 VSLIGY--CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK------- 173
             L        G     +Y Y +   ++  L+ I        +R    L  A        
Sbjct: 65  TCLYDMDIVFPGNFNE-LYLYEEL--MEADLHQI--------IRSGQPLTDAHFQSFIYQ 113

Query: 174 ---GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET------- 223
              GL Y+HS++     ++HRD K  N+L++A+ E KI DFGLA+   E           
Sbjct: 114 ILCGLKYIHSAN-----VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168

Query: 224 YVTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL 282
           YV  R      Y  PE   S    T   DV++ G +L ELL  +        V+  N +L
Sbjct: 169 YVATR-----WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL 223

Query: 283 QV 284
           QV
Sbjct: 224 QV 225

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 69  LGKGGFGRVYKGTLRSGEVVA-IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G FG+V    + +   VA +   EL     +  ++EF  + D    L HPN++  +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRL--KVALGAAKGLAYLHSSSAVG 185
            C +     LV+EY + G+L+ +L+     + +  L L  ++A   A G+ ++H  +   
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA--RVLGTFGYFDPEYTS- 242
              +H D    N  L+++   K+ D+G+       +E Y+           +  PE    
Sbjct: 120 --FLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 243 ------TGKLTLQSDVYAFGVVLLELL 263
                 T + T  S+V+A GV L EL 
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 63/291 (21%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADG--EHEFRVEVD-ILSRLDHPNLVS 124
           +G+G FG V K   + SG ++A+K++        D   +    +++D ++   D P +V 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRS----TVDEKEQKRLLMDLDVVMRSSDCPYIVK 67

Query: 125 LIG---------YCAD------GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL 169
             G          C +       K    VYE + K  + + + G            K+A+
Sbjct: 68  FYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILG------------KIAV 114

Query: 170 GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
              K L YL       + I+HRD K +N+LL  N   K+ DFG++  +    ++    R 
Sbjct: 115 ATVKALNYLKEE----LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRD 167

Query: 230 LGTFGYFDPEYTSTG---KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH 286
            G   Y  PE           ++SDV++ G+ L E+ TG+        V DQ        
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ-------- 219

Query: 287 ILNDRKKLRKVI--DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
                  L +V+  DP +  +S   E    F N  + C+  + S+RP   E
Sbjct: 220 -------LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKE 263

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 14/221 (6%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEF-RVEVDILSRLD-HPNLVSLI 126
           +G+G + +V    L+  + +   K+        D + ++ + E  +  +   +P LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
                    FLV EY+  G+L  H+    + K+        A      L +LH       
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERG---- 116

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I++RD K  NVLL A+   K++D+G+ K      +T  T+   GT  Y  PE     + 
Sbjct: 117 -IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEY 173

Query: 247 TLQSDVYAFGVVLLELLTGRRAVDL---NQGVNDQNLVLQV 284
               D +A GV++ E++ GR   D+   N  +N ++ + QV
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 22/206 (10%)

Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V    +K T +   +  + K E+   K +D    F  E DI++  + P +V 
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAF-FWEERDIMAFANSPWVVQ 107

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           L     D ++ ++V EYM  G+L + ++    P+  W  R   A      L  +HS    
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWA-RFYTA-EVVLALDAIHS---- 160

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTST 243
            +  +HRD K  N+LL  +   K++DFG   K+  EG     TA  +GT  Y  PE   +
Sbjct: 161 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKS 217

Query: 244 ----GKLTLQSDVYAFGVVLLELLTG 265
               G    + D ++ GV L E+L G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 28/207 (13%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +GKG FG+V     + T R   +  I+K  +    E    H    E  +L++++ P +V 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVT--HTL-AERTVLAQVNCPFIVP 57

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD------WPLRLKVALGAAKGLAYL 178
           L       +  +LV  ++  G L  HL    E + D      +   L  AL        L
Sbjct: 58  LKFSFQSPEKLYLVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCAL------ENL 109

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           H        +++RD K  N+LL       + DFGL KL  +  +   T    GT  Y  P
Sbjct: 110 HK-----FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAP 162

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTG 265
           E       T   D +  GV+L E+LTG
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 50/174 (28%), Positives = 74/174 (42%), Gaps = 18/174 (10%)

Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA- 176
           +HP LV L          F V EY+  G+L  H+    + +   P        A   LA 
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLAL 109

Query: 177 -YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            YLH        I++RD K  NVLL +    K++D+G+ K      +T  T+   GT  Y
Sbjct: 110 NYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162

Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDL-----NQGVNDQNLVLQV 284
             PE           D +A GV++ E++ GR   D+     N   N ++ + QV
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 216

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 18/158 (11%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLI 126
           +G+G +G+VYK     +G++VA+KK  L   +E       R E+ +L  L     +V L+
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRLL 67

Query: 127 GY----CADGKHR-FLVYEYMQ---KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
                   +GK   +LV+EY+    K  +  +  G G P +             KG+A+ 
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQLLKGVAHC 126

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAK 215
           H        ++HRD K  N+L+       KI+D GL +
Sbjct: 127 HKHG-----VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 62/204 (30%), Positives = 84/204 (41%), Gaps = 18/204 (8%)

Query: 68  FLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LGKG FG+V     + +G   A+K +        D       E  +L    HP L +L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60

Query: 127 GYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA--AKGLAYLHSSSA 183
            Y      R   V EY   G L  HL+     ++    R +   GA     L YLHS   
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARF-YGAEIVSALEYLHSRD- 115

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTS 242
               +V+RD K  N++L  +   KI+DFGL K   EG     T +   GT  Y  PE   
Sbjct: 116 ----VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLE 168

Query: 243 TGKLTLQSDVYAFGVVLLELLTGR 266
                   D +  GVV+ E++ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 51/168 (30%), Positives = 74/168 (44%), Gaps = 19/168 (11%)

Query: 118 DHPNLVSLIGYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA 176
           +HP LV L   C   + R F V E++  G+L  H+    + +   P        A   LA
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHM----QRQRKLPEEHARFYSAEISLA 108

Query: 177 --YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG-QETYVTARVLGTF 233
             +LH        I++RD K  NVLL A    K++D+G+ K   EG +    T+   GT 
Sbjct: 109 LNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTP 160

Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDL--NQGVNDQN 279
            Y  PE           D +A GV++ E++ GR   D+       DQN
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 15/112 (13%)

Query: 160 DWPLR----LKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK 215
            WPL     L+ +   A+G+ +L S + +     HRD  + NVLL+    AKI DFGLA+
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNCI-----HRDVAARNVLLTDGRVAKICDFGLAR 260

Query: 216 LMPEGQETYV---TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            +      YV    AR+     +  PE       T+QSDV+++G++L E+ +
Sbjct: 261 DI-MNDSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 71/290 (24%), Positives = 114/290 (39%), Gaps = 52/290 (17%)

Query: 69  LGKGGFGRVYKGTLR--SGEVVAIKKMELP-RFKEADGEH----EFRVEVDILSRLDHPN 121
           LG+G F  +YKG LR  S   +     E+    K    +H     F     ++S+L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           LV L G C   ++  +V EY++ G L    H        + W  +L VA   A  L YL 
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNN-VSLHW--KLDVAKQLASALHYLE 118

Query: 180 SSSAVGIPIVHRDFKSTNVLL-------SANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
                   +VH +    N+L+             K+SD G+   +          R+   
Sbjct: 119 DKK-----LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERI--- 168

Query: 233 FGYFDPEYTSTG--KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
             +  PE    G   LT+ +D ++FG  LLE+ +      L+               L+ 
Sbjct: 169 -PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE-PLST--------------LSS 212

Query: 291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
            +K R   D    +    M   A  ANL ++C   + ++RPS    +++L
Sbjct: 213 SEKERFYQD----QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 50/196 (25%), Positives = 74/196 (37%), Gaps = 61/196 (31%)

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
           A+G+ +L S   +     HRD  + N+LLS N   KI DFGLA+ +              
Sbjct: 183 ARGMEFLASRKCI-----HRDLAARNILLSENNVVKICDFGLARDI-------------- 223

Query: 232 TFGYFDPEYTSTGK-----------------LTLQSDVYAFGVVLLELLTGRRAVDLNQG 274
              Y DP+Y   G                   T QSDV++FGV+L E+ +         G
Sbjct: 224 ---YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS--LGASPYPG 278

Query: 275 VN-DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESI--AMFANLASRCVRTESSERP 331
           V  D+    +++     R        PE     Y    I   M       C      +RP
Sbjct: 279 VQIDEEFCRRLKEGTRMRA-------PE-----YATPEIYSIMLD-----CWHNNPEDRP 321

Query: 332 SMAECVKELQLIIYTN 347
           + +E V+ L  ++  N
Sbjct: 322 TFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 19/170 (11%)

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD KS N+ L      K+ DFG +K   +     V +   GT  Y  PE     + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND------RKKLRKVIDPE 301
            ++D+++ GV+L ELLT  R     +G + + ++ QV +   D         ++ ++DP 
Sbjct: 250 KKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPL 306

Query: 302 LSRSS---------YTMESIAMFANLASRCVR-TESSERPSMAECVKELQ 341
           LS++             E +   ANL    VR +E+       E +++LQ
Sbjct: 307 LSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQLQ 356

Length = 478

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 69  LGKGGFGRVYKGTLRSGE-VVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V    L++ + V A+K   K E+ +  E      FR E D+L   D+  + +
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVNGDNQWITT 65

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE--PKMDWPLRLKVALGAAKGLAYLHSSS 182
           L     D  + +LV +Y   G+L   L+   +  P+      L   + A   +  LH   
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--- 122

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFG-LAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 VHRD K  N+L+  N   +++DFG   KLM +G  T  ++  +GT  Y  PE  
Sbjct: 123 -----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEIL 175

Query: 242 ST-----GKLTLQSDVYAFGVVLLELLTG 265
                  GK   + D ++ GV + E+L G
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 63/204 (30%), Positives = 86/204 (42%), Gaps = 17/204 (8%)

Query: 68  FLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LGKG FG+V     + +G   A+K ++       D       E  +L    HP L +L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60

Query: 127 GYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA--AKGLAYLHSSSA 183
            Y      R   V EY   G L  HL+     ++    R +   GA     L YLHS   
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARF-YGAEIVSALDYLHSEKN 116

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTS 242
           V    V+RD K  N++L  +   KI+DFGL K   EG +   T +   GT  Y  PE   
Sbjct: 117 V----VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLE 169

Query: 243 TGKLTLQSDVYAFGVVLLELLTGR 266
                   D +  GVV+ E++ GR
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 31/212 (14%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V    ++ +G+V A+K   K E+ +  E      FR E D+L   D   + +
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC---FREERDVLVNGDRRWITN 65

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE---PKMD--WPLRLKVALGAAKGLAYLH 179
           L     D  + +LV +Y   G+L   L+   +     M   +   + +A+ +   L Y  
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY-- 123

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG-LAKLMPEGQETYVTARVLGTFGYFDP 238
                    VHRD K  NVLL  N   +++DFG   +L+ +G  T  +   +GT  Y  P
Sbjct: 124 ---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGTPDYISP 172

Query: 239 EY-----TSTGKLTLQSDVYAFGVVLLELLTG 265
           E         G+   + D ++ GV + E+L G
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 25/209 (11%)

Query: 69  LGKGGFGRVYKGTLRSGE-VVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V    ++  E + A+K   K E+ +  E      FR E ++L   D   + +
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC---FREERNVLVNGDCQWITT 65

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA--LGAAKGLAYLHSSS 182
           L     D  + +LV +Y   G+L   L+   +   +   R  +A  + A   +  LH   
Sbjct: 66  LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--- 122

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFG-LAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 VHRD K  NVLL  N   +++DFG   K+  +G  T  ++  +GT  Y  PE  
Sbjct: 123 -----YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISPEIL 175

Query: 242 ST-----GKLTLQSDVYAFGVVLLELLTG 265
                  GK   + D ++ GV + E+L G
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 72/251 (28%), Positives = 107/251 (42%), Gaps = 39/251 (15%)

Query: 69  LGKGGFGRVY---------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-D 118
           LG G +G+V+          G L + +V  ++K  L + K    EH  R E ++L  +  
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKV--LQKAALVQ-KAKTVEHT-RTERNVLEHVRQ 63

Query: 119 HPNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAA-KGLA 176
            P LV+L   +  + K   L+ +Y+  G +  HL        D    ++   G     L 
Sbjct: 64  SPFLVTLHYAFQTEAKLH-LILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILALE 119

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK--LMPEGQETYVTARVLGTFG 234
           +LH      + IV+RD K  N+LL +     ++DFGL+K  L  E + TY      GT  
Sbjct: 120 HLHK-----LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFCGTIE 171

Query: 235 YFDPEY----TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
           Y  PE        GK     D ++ G+++ ELLTG     L    N Q+ V   R IL  
Sbjct: 172 YMAPEIIRGKGGHGKAV---DWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILKC 226

Query: 291 RKKLRKVIDPE 301
                  I PE
Sbjct: 227 DPPFPSFIGPE 237

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 24/205 (11%)

Query: 88  VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR------FLVYEY 141
           VA+KK+  P   +   +  +R E+ +L  ++H N++SL+      K        +LV E 
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107

Query: 142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS 201
           M     Q     +   +M + L   +      G+ +LHS+      I+HRD K +N+++ 
Sbjct: 108 MDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSAG-----IIHRDLKPSNIVVK 157

Query: 202 ANFEAKISDFGLAKLMPEG--QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVL 259
           ++   KI DFGLA+          YV  R      Y  PE           D+++ G ++
Sbjct: 158 SDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIM 212

Query: 260 LELLTGRRAVDLNQGVNDQNLVLQV 284
            EL+ G         ++  N V++ 
Sbjct: 213 GELVKGSVIFQGTDHIDQWNKVIEQ 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 5/93 (5%)

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
           AKG+ +L S   +     HRD  + N+LLS N   KI DFGLA+ + +  +         
Sbjct: 189 AKGMEFLASRKCI-----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
              +  PE       T+QSDV++FGV+L E+ +
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 19/100 (19%)

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV---TAR 228
           A+G+ +L S   +     HRD  + N+LLS N   KI DFGLA+ + +  + YV   +AR
Sbjct: 184 ARGMEFLASRKCI-----HRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSAR 237

Query: 229 V----LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           +    +     FD  YT+      QSDV++FGV+L E+ +
Sbjct: 238 LPLKWMAPESIFDKVYTT------QSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G +G V   Y   LR  + VA+KK+  P          +R E+ +L  + H N++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGL 79

Query: 126 IGY------CADGKHRFLVYEYMQKGNLQDHLNGIGEPK--MDWPLRLKVALGAAKGLAY 177
           +          +    +LV   M        LN I + +   D  ++  +     +GL Y
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGA-----DLNNIVKCQKLSDEHVQFLI-YQLLRGLKY 133

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
           +HS+      I+HRD K +NV ++ + E +I DFGLA+   +    YV  R      Y  
Sbjct: 134 IHSAG-----IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRA 183

Query: 238 PEYTSTGKLTLQS-DVYAFGVVLLELLTGR 266
           PE         Q+ D+++ G ++ ELL G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 51.3 bits (122), Expect = 5e-07
 Identities = 69/295 (23%), Positives = 125/295 (42%), Gaps = 48/295 (16%)

Query: 69  LGKGGFGRVY-KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G FG V+     R+ E    K +     KE + + +  +EV+++  L H N+V  I 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE-KSQLVIEVNVMRELKHKNIVRYID 79

Query: 128 YCADGKHR--FLVYEYMQKGNLQDHLNGIGE--PKMDWPLRLKVALGAAKGLAYLHS--S 181
              +  ++  +++ E+   G+L  ++    +   K++    + +       LAY H+   
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139

Query: 182 SAVGIPIVHRDFKSTNVLLSANFE-----------------AKISDFGLAKLMPEGQETY 224
              G  ++HRD K  N+ LS                     AKI DFGL+K +  G E+ 
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI--GIESM 197

Query: 225 VTARVLGTFGYFDPEYT--STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL 282
             + V GT  Y+ PE     T     +SD++A G ++ EL +G+     ++  N   L+ 
Sbjct: 198 AHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKANNFSQLIS 254

Query: 283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECV 337
           +++              P+L     + E   +  NL +      + ERPS  +C+
Sbjct: 255 ELKR------------GPDLPIKGKSKELNILIKNLLN----LSAKERPSALQCL 293

Length = 1021

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 46/167 (27%), Positives = 70/167 (41%), Gaps = 46/167 (27%)

Query: 69  LGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           +G+G FG V     R      +G + A+KK+      E +     R E DIL+  D+P +
Sbjct: 9   IGRGAFGEV-----RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV 63

Query: 123 VSLIGYCA--DGKHRFLVYEYMQKGNL------QDHLNG------IGEPKMDWPLRLKVA 168
           V L  Y +  D  + +L+ EY+  G++      +D          I E  +        A
Sbjct: 64  VKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL--------A 113

Query: 169 LGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK 215
           + +   L Y           +HRD K  N+LL A    K+SDFGL  
Sbjct: 114 IDSIHKLGY-----------IHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 40/209 (19%), Positives = 82/209 (39%), Gaps = 30/209 (14%)

Query: 72  GGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHPNLVSLIGY 128
                + K    +  +VA+KK+ L    ++  + + ++   E+    +L HPN++  +  
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINL----DSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67

Query: 129 CADGKHRFLVYEYMQKGNLQDHL-----NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
                  ++V   M  G+ +D L      G+ E  + + L+          L Y+HS   
Sbjct: 68  FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNALDYIHSKG- 121

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
                +HR  K++++LLS + +  +S    +  M +  +              +  + S 
Sbjct: 122 ----FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 244 GKL-------TLQSDVYAFGVVLLELLTG 265
             L         +SD+Y+ G+   EL  G
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.5 bits (120), Expect = 6e-07
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 36/237 (15%)

Query: 88  VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK------HRFLVYEY 141
           VAIKK+  P   +   +  +R E+ ++  ++H N++SL+      K        +LV E 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103

Query: 142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS 201
           M     Q     +   +M + L   +      G+ +LHS+      I+HRD K +N+++ 
Sbjct: 104 MDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-----IIHRDLKPSNIVVK 153

Query: 202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLE 261
           ++   KI DFGLA+    G    +T  V+  + Y  PE           D+++ G ++ E
Sbjct: 154 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 262 ------LLTGRRAVDLNQGVNDQ----------NLVLQVRHILNDRKKLRKVIDPEL 302
                 L  GR  +D    V +Q           L   VR+ + +R K   +  P+L
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.9 bits (119), Expect = 9e-07
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)

Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA 168
           +E  +L  ++HP+++ +      G    +V  +    +L  +L      K   PL +  A
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLT-----KRSRPLPIDQA 159

Query: 169 LGAAK----GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
           L   K    GL YLH        I+HRD K+ N+ ++   +  I D G A+         
Sbjct: 160 LIIEKQILEGLRYLH-----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214

Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELL 263
             A   GT     PE  +  K   ++D+++ G+VL E+L
Sbjct: 215 GLA---GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 5/93 (5%)

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
           AKG+++L S + +     HRD  + N+LL+     KI DFGLA+ +       V      
Sbjct: 224 AKGMSFLASKNCI-----HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
              +  PE       T +SDV+++G++L E+ +
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)

Query: 69  LGKGGFGRVYKGTLR------SGEVVAIKKMELPRF--KEADGEHEFRVEVDILSRLDH- 119
           LG G +G+V+   +R      SG++ A+K ++      K    EH  R E  +L  +   
Sbjct: 8   LGTGAYGKVF--LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEHIRQS 64

Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA-AKGLAY 177
           P LV+L   +  D K   L+ +Y+  G L  HL+     K      +++  G     L +
Sbjct: 65  PFLVTLHYAFQTDTKLH-LILDYINGGELFTHLSQRERFKEQ---EVQIYSGEIVLALEH 120

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
           LH      + I++RD K  N+LL +N    ++DFGL+K   E  E        GT  Y  
Sbjct: 121 LHK-----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMA 174

Query: 238 PEYTSTGKLTLQS--DVYAFGVVLLELLTG 265
           P+    G        D ++ GV++ ELLTG
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 45/185 (24%), Positives = 84/185 (45%), Gaps = 20/185 (10%)

Query: 88  VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR------FLVYEY 141
           VAIKK+  P   +   +  +R E+ ++  ++H N++ L+      K        ++V E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS 201
           M     Q     +   +M + L   +      G+ +LHS+      I+HRD K +N+++ 
Sbjct: 111 MDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-----IIHRDLKPSNIVVK 160

Query: 202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLE 261
           ++   KI DFGLA+    G    +T  V+  + Y  PE           D+++ G ++ E
Sbjct: 161 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 262 LLTGR 266
           ++ G 
Sbjct: 218 MIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 46/155 (29%), Positives = 65/155 (41%), Gaps = 26/155 (16%)

Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAY 177
           D+PN + L       K   L+ +Y++ G+L D L    E K+      K+     + L  
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALND 124

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLS-ANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGY 235
           LH  +     I+H D K  NVL   A     + D+GL K    G  +        GT  Y
Sbjct: 125 LHKHN-----IIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPS-----CYDGTLDY 172

Query: 236 FDPEYTSTGKLTLQS-----DVYAFGVVLLELLTG 265
           F PE     K+   +     D +A GV+  ELLTG
Sbjct: 173 FSPE-----KIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 17/99 (17%)

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-LMPEGQ-----ETYV 225
           A+G+ +L S + V     HRD  + NVLL+     KI DFGLA+ +M +        T++
Sbjct: 247 ARGMEFLASKNCV-----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             + +     FD  YT+       SDV+++G++L E+ +
Sbjct: 302 PVKWMAPESIFDNLYTTL------SDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 43/238 (18%)

Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     +G+G FG V     + +G + A+K +      E +     R E DIL   D   
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V +     D ++ +L+ E++  G++   L      K D           A+ +  + + 
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-----KKDTLSEEATQFYIAETVLAIDAI 117

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ-------------------- 221
             +G   +HRD K  N+LL A    K+SDFGL   + +                      
Sbjct: 118 HQLGF--IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 222 -------ETYVTAR------VLGTFGYFDPE-YTSTGKLTLQSDVYAFGVVLLELLTG 265
                  ET+   R       +GT  Y  PE +  TG   L  D ++ GV++ E+L G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 22/160 (13%)

Query: 63  FSDDNFLGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLD 118
           F     +GKG FG V       +G++ A+K   K E+  FK+    H  + E D+L+  D
Sbjct: 3   FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAH-VKAERDVLAESD 59

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD----WPLRLKVALGAAKG 174
            P +VSL     D ++ +L+ E++  G+L   L        D    +     +A+ A   
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
           L +           +HRD K  N+L+      K+SDFGL+
Sbjct: 120 LGF-----------IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 29/93 (31%), Positives = 42/93 (45%), Gaps = 5/93 (5%)

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
           A G+ +L S + V     HRD  + NVL+      KI DFGLA+ +              
Sbjct: 249 ANGMEFLASKNCV-----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
              +  PE       T  SDV++FG++L E+ T
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 8/162 (4%)

Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     +G+G FG V     + +G V A+K +      E +     R E DIL   D   
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V +     D  + +L+ E++  G++   L      K D     +     A+ +  + S 
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-----KKDTLTEEETQFYIAETVLAIDSI 117

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
             +G   +HRD K  N+LL +    K+SDFGL   + +   T
Sbjct: 118 HQLGF--IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 21/210 (10%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL--I 126
           +G+G +G VYK   + G+    K+  L + +          E+ +L  L HPN+++L  +
Sbjct: 9   VGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 127 GYCADGKHRFLVYEYMQKG---NLQDHLNGIGEPK-MDWPLRLKVAL--GAAKGLAYLHS 180
                 +  +L+++Y +      ++ H       K M  P  +  +L      G+ YLH+
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 181 SSAVGIPIVHRDFKSTNVLLSAN----FEAKISDFGLAKLMPEGQETYVTAR-VLGTFGY 235
           +      ++HRD K  N+L+          KI+D G A+L     +       V+ TF Y
Sbjct: 127 NW-----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLT 264
             PE     +  T   D++A G +  ELLT
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 33/216 (15%)

Query: 69  LGKGGFGRVYKGTLRSGEV---VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G+G +G VYK   + G+     A+K++E      +        E+ +L  L HPN++SL
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-----EIALLRELKHPNVISL 63

Query: 126 IGYCADGKHR--FLVYEYMQKG---NLQDHLNGIGEPKMDWPLRLKVALGAA------KG 174
                    R  +L+++Y +      ++ H       K   P++L   +  +       G
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKK---PVQLPRGMVKSLLYQILDG 120

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSAN----FEAKISDFGLAKLMPEGQETYVTAR-V 229
           + YLH++      ++HRD K  N+L+          KI+D G A+L     +       V
Sbjct: 121 IHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175

Query: 230 LGTFGYFDPEYTSTGK-LTLQSDVYAFGVVLLELLT 264
           + TF Y  PE     +  T   D++A G +  ELLT
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 22/165 (13%)

Query: 110 EVDILSRLDHPNLVSLI-GYCADGKHRFLVYEYMQ--KGNLQDHLNGIGEPKMDWPLRLK 166
           E+DIL  + H  +++LI  Y    + +  V   M   K +L  +++  G      PL L+
Sbjct: 136 EIDILKTISHRAIINLIHAY----RWKSTVCMVMPKYKCDLFTYVDRSG------PLPLE 185

Query: 167 VALGAAKGL----AYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE 222
            A+   + L    AYLH     G  I+HRD K+ N+ L     A + DFG A  +    +
Sbjct: 186 QAITIQRRLLEALAYLH-----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240

Query: 223 TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRR 267
           T       GT     PE  +      ++D+++ G+VL E+     
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 44/200 (22%), Positives = 80/200 (40%), Gaps = 37/200 (18%)

Query: 110 EVDILSRLDHPNLVSL--------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDW 161
           E+  L RL+H N++ +          Y    K+ F +Y +M             +  +  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-----WKDRPLLK 267

Query: 162 PLR--LKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE 219
             R  +K  L A   + Y+H        ++HRD K  N+ L+ + +  + DFG A    +
Sbjct: 268 QTRAIMKQLLCA---VEYIHDKK-----LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319

Query: 220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN 279
            +E +    V GT     PE  +       +D+++ G++LL++L+      +  G     
Sbjct: 320 EREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS-HDFCPIGDGGG--- 374

Query: 280 LVLQVRHILNDRKKLRKVID 299
                       K+L K+ID
Sbjct: 375 ---------KPGKQLLKIID 385

Length = 501

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 29/143 (20%)

Query: 85  GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY------CADGKHRFLV 138
           G+ VAIKK+  P       +  +R E+ ++  ++H N++ L+          + +  +LV
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99

Query: 139 YEYMQKGNLQ------DHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRD 192
            E M     Q      DH       +M + L   +      G+ +LHS+      I+HRD
Sbjct: 100 MELMDANLCQVIQMDLDH------ERMSYLLYQMLC-----GIKHLHSAG-----IIHRD 143

Query: 193 FKSTNVLLSANFEAKISDFGLAK 215
            K +N+++ ++   KI DFGLA+
Sbjct: 144 LKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 40/151 (26%), Positives = 61/151 (40%), Gaps = 20/151 (13%)

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNG---IGEPKMD-WPLRLKVALGAAKGL 175
           PN+V L  Y       FLV ++ + G L  H++    I E  +  W   + VAL A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 176 AYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
             LH        IV RD    N+LL      +++ F     + +  +      +     Y
Sbjct: 101 --LHREG-----IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----Y 148

Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
             PE     + T   D ++ G +L ELLTG+
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 67/303 (22%), Positives = 116/303 (38%), Gaps = 63/303 (20%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEA----DGEHEFRVEVDIL---------- 114
           LG+G    +Y G LR       ++ E+          +   E RV + +L          
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 115 --------SRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL-NGIGEPKMDWPLRL 165
                   S++ H +L  + G C  G    +V E+++ G L   L    G   + W  ++
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 166 KVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-------KISDFGLAKLMP 218
            VA   A  L+YL   +     +VH +  + N+LL+    A       K+SD G++    
Sbjct: 121 TVAQQLASALSYLEDKN-----LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL 175

Query: 219 EGQETYVTARVLGTFGYFDPE-YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND 277
             +E     RV     +  PE       L+  +D ++FG  LLE+          +  ++
Sbjct: 176 SREE-----RV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229

Query: 278 QNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECV 337
           +    + +H L           PE         S    A L S+C+  E ++RPS    +
Sbjct: 230 KERFYEKKHRL-----------PE--------PSCKELATLISQCLTYEPTQRPSFRTIL 270

Query: 338 KEL 340
           ++L
Sbjct: 271 RDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 48/196 (24%), Positives = 85/196 (43%), Gaps = 25/196 (12%)

Query: 84  SGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY 141
           +G +V ++  +L    E   EH    + EV +     HPN+++       G   +++  +
Sbjct: 24  TGTLVTVRITDLENCTE---EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80

Query: 142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS 201
           M  G+    L       M   L   +  GA +GL YLH +       +HR+ K++++L+S
Sbjct: 81  MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY-----IHRNIKASHILIS 135

Query: 202 ANFEAKISDFG-LAKLMPEGQETYVTARVLGTF--------GYFDPEY--TSTGKLTLQS 250
            +    +S    L  L+  GQ+    A+V+  F         +  PE          ++S
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQK----AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191

Query: 251 DVYAFGVVLLELLTGR 266
           D+Y+ G+   EL TGR
Sbjct: 192 DIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 27/169 (15%)

Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--------KHRFLVYEYMQKGNLQDHLN 152
           A   HE R    +L RL HP +++L+     G        K+R  +Y Y+        L 
Sbjct: 205 ASSVHEAR----LLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGA-----RLR 255

Query: 153 GIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG 212
            +G  ++       VA      + Y+H     G  I+HRD K+ NVL++   +  + DFG
Sbjct: 256 PLGLAQVT-----AVARQLLSAIDYIH-----GEGIIHRDIKTENVLVNGPEDICLGDFG 305

Query: 213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLE 261
            A        T     + GT     PE  +    T   D+++ G+V+ E
Sbjct: 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 19/165 (11%)

Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPL--RLKV 167
           E  IL  ++HP+++ L G     K   L+     K +L  +L      K +  +   L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAA----KRNIAICDILAI 187

Query: 168 ALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP---EGQETY 224
                + + YLH +      I+HRD K+ N+ ++   +  + DFG A   P      + Y
Sbjct: 188 ERSVLRAIQYLHENR-----IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYY 241

Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV 269
             A   GT     PE  +        D+++ G+VL E+ T   ++
Sbjct: 242 GWA---GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 11/92 (11%)

Query: 69  LGKGGFGRVYKGTL------RSGEVVAIKKME-LPRFKEADGEHEFRVEVDILSRLD-HP 120
           LG G FGRV + T       +S   VA+K ++   R  E   +     E+ I+S L  H 
Sbjct: 45  LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE---KQALMSELKIMSHLGPHL 101

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLN 152
           N+V+L+G C  G   +++ EY + G+L D+L+
Sbjct: 102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 51/190 (26%), Positives = 69/190 (36%), Gaps = 51/190 (26%)

Query: 62  SFSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR 116
           SF  D+F     LG+G FG VYK +L + +     K  L +  E  G     VE+ +  R
Sbjct: 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY-GA----VEIWMNER 182

Query: 117 LDHPNLVSLIGYCADGKHRF-------------LVYEYMQKGNLQDHLNGIGEPKMDWPL 163
           +      +    CAD  + F             LV+ Y  +  L D +     P    P 
Sbjct: 183 VRR----ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPY 238

Query: 164 RLKVALGAAKG------------------LAYLHSSSAVGIPIVHRDFKSTNVLLSANFE 205
            L       KG                  L  LHS+      IVHRD K  N++ S    
Sbjct: 239 LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-----IVHRDVKPQNIIFSEGSG 293

Query: 206 A-KISDFGLA 214
           + KI D G A
Sbjct: 294 SFKIIDLGAA 303

Length = 566

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 38/146 (26%), Positives = 64/146 (43%), Gaps = 8/146 (5%)

Query: 69  LGKGGFGRV-YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V     + +  + A+K +        +     + E DIL+  D+  +V L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              D  + + V +Y+  G++   L  +      +P  L     A   LA + S   +G  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEV----FPEVLARFYIAELTLA-IESVHKMGF- 122

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGL 213
            +HRD K  N+L+  +   K++DFGL
Sbjct: 123 -IHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 27/75 (36%), Positives = 37/75 (49%), Gaps = 11/75 (14%)

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           GL  LH      I IVHRD K  N+L++ + + KI DFG A  M  G    +    L  +
Sbjct: 321 GLRKLHR-----IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG----INFNPL--Y 369

Query: 234 GYFDPEYTSTGKLTL 248
           G  DP Y+   +L +
Sbjct: 370 GMLDPRYSPPEELVM 384

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	361
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
smart00090	237	RIO RIO-like kinase.	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.6
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.58
KOG1243	690	consensus Protein kinase [General function predict	99.54
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.51
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
KOG3087	229	consensus Serine/threonine protein kinase [General	99.39
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.37
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.29
COG4248	637	Uncharacterized protein with protein kinase and he	99.25
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.19
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.17
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.09
PRK09902	216	hypothetical protein; Provisional	98.99
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.91
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.88
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.83
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.78
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.72
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.7
PF01636	239	APH: Phosphotransferase enzyme family This family	98.59
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.54
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.48
PLN02876	822	acyl-CoA dehydrogenase	98.44
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.42
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.41
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.4
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.38
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.36
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.32
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.29
PRK10593	297	hypothetical protein; Provisional	98.25
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.17
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.04
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.02
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.99
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.95
PRK05231	319	homoserine kinase; Provisional	97.89
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.84
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.74
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.51
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.48
PLN02236	344	choline kinase	97.43
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.37
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.3
PLN02756	418	S-methyl-5-thioribose kinase	97.16
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.14
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.11
KOG2270	520	consensus Serine/threonine protein kinase involved	97.1
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.06
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.04
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.04
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.0
COG2334	331	Putative homoserine kinase type II (protein kinase	96.97
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.72
PRK11768	325	serine/threonine protein kinase; Provisional	96.53
PRK06148	1013	hypothetical protein; Provisional	96.39
PRK12396	409	5-methylribose kinase; Reviewed	96.27
PTZ00384	383	choline kinase; Provisional	96.26
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.21
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.1
PTZ00296	442	choline kinase; Provisional	95.56

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-54  Score=398.00  Aligned_cols=291  Identities=52%  Similarity=0.899  Sum_probs=251.7

Q ss_pred             CCcccCHHHHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEE
Q 018047           47 GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI  126 (361)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~  126 (361)
                      ....|++.++..++++|...++||+|+||.||+|...+|..||||++......  . ..+|.+|++++.+++|||+|+++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ--G-EREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc--c-hhHHHHHHHHHhcCCCcCcccEE
Confidence            45679999999999999999999999999999999998899999987543211  1 45699999999999999999999


Q ss_pred             EEEEcCC-EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc
Q 018047          127 GYCADGK-HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE  205 (361)
Q Consensus       127 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~  205 (361)
                      |||.+.+ ..+||+||+++|+|.+++.......++|..+.+|+.++|+||+|||+..  ..+||||||||+|||||++.+
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~--~~~iiHrDiKssNILLD~~~~  215 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC--PPPIIHRDIKSSNILLDEDFN  215 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC--CCCEecCCCCHHHeeECCCCC
Confidence            9999998 5999999999999999998754338899999999999999999999966  446999999999999999999


Q ss_pred             EEEeecCccccCCC-CCceeeeeec-ccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 018047          206 AKISDFGLAKLMPE-GQETYVTARV-LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ  283 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  283 (361)
                      .||+|||+|+..+. ...   .... .||.+|+|||+...+..+.|+||||||++++||+||+.+.+.........+..|
T Consensus       216 aKlsDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w  292 (361)
T KOG1187|consen  216 AKLSDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW  292 (361)
T ss_pred             EEccCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence            99999999976543 221   1122 799999999999889999999999999999999999999877665566668888


Q ss_pred             HHHHhhhhhhhhhhcCccccCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          284 VRHILNDRKKLRKVIDPELSRSSYTM-ESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      ++...... .+.+++|+.+....++. .....+..+..+|++.+|++||+|.||++.|+.+...
T Consensus       293 ~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  293 AKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            87766664 89999999987555554 6778899999999999999999999999999766544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-55  Score=403.06  Aligned_cols=253  Identities=30%  Similarity=0.479  Sum_probs=221.9

Q ss_pred             CCCCCCceecccCceEEEEEEE-cCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ..|..+++||+|||+.||.++. .+|+.||+|++.+....+....+.+.+|+++.++|+|||||+++++|+|.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4699999999999999999998 689999999999888888888899999999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |+|+.|+|..+++.  .+.+.+.+++.+++||+.||.|||+++     |+|||||..|+|++++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~-----IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLG-----IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcC-----ceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999999985  458999999999999999999999999     99999999999999999999999999999865


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ...+.+|||.|.|||++....++..+||||+||+||.|+.|++||+.      ..+.+....+.....       
T Consensus       171 ~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet------k~vkety~~Ik~~~Y-------  235 (592)
T KOG0575|consen  171 DGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET------KTVKETYNKIKLNEY-------  235 (592)
T ss_pred             ccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc------chHHHHHHHHHhcCc-------
Confidence            433  34567999999999999999999999999999999999999999952      233333333332222       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                            ..|...+.+..+||.++|+.||.+|||++++|.|-.
T Consensus       236 ------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F  271 (592)
T KOG0575|consen  236 ------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF  271 (592)
T ss_pred             ------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence                  223344455789999999999999999999998754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-55  Score=383.59  Aligned_cols=259  Identities=28%  Similarity=0.471  Sum_probs=220.7

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-EEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-HRFLVY  139 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~  139 (361)
                      +.+..+.||+|..|+||++.++ +++.+|+|++...  .+....+++.+|+++++..+||+||.+||.|.+++ ..+|+|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            4566788999999999999988 7999999999543  45566788999999999999999999999999999 599999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||.+|||.+++...  ..+++..+..++.++++||.|||+ ++     ||||||||+|||+++.|+|||||||.+..+.
T Consensus       158 EYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~-----IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK-----IIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             hhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC-----eeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            999999999999765  379999999999999999999996 77     9999999999999999999999999999875


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +.    ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||.... .......+.+..+..+.       
T Consensus       231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~p-------  298 (364)
T KOG0581|consen  231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDEP-------  298 (364)
T ss_pred             hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcCC-------
Confidence            54    3456899999999999999999999999999999999999999997652 22334444444444321       


Q ss_pred             CccccCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          299 DPELSRSSYTM-ESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       299 ~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      .|.+     |. .++.+++.+|..||++||.+|||+.|+++|-+--.+.
T Consensus       299 pP~l-----P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  299 PPRL-----PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             CCCC-----CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            1222     22 3667799999999999999999999999998755433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-55  Score=389.16  Aligned_cols=260  Identities=27%  Similarity=0.377  Sum_probs=213.7

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc----hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA----DGEHEFRVEVDILSRLDHPNLVSLIGYCADGK  133 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  133 (361)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+......    .....+.+|+++|++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            5567888999999999999999876 799999999987654432    23445779999999999999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC---CcEEEee
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN---FEAKISD  210 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~---~~~kl~D  210 (361)
                      ..|+||||+.||+|.+.+-..+  .+.+..-..+++|++.|+.|||++|     |+||||||+|||++.+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G-----I~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG-----IIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC-----cccccCCcceEEeccCCcceEEEecc
Confidence            9999999999999999997754  6777778889999999999999999     9999999999999876   7899999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccccCCCCC---ccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT---LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      ||+|+.....   ....+.+|||.|.|||++......   .+.|||||||+||-+++|.+||.....  +..+.+++.  
T Consensus       323 FGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~eQI~--  395 (475)
T KOG0615|consen  323 FGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKEQIL--  395 (475)
T ss_pred             cchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHHHHh--
Confidence            9999987533   356778999999999998776543   477999999999999999999964432  222333322  


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                       .....+.         ...-...+++..+||.+||..||++|||++|+|+|.|-
T Consensus       396 -~G~y~f~---------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~  440 (475)
T KOG0615|consen  396 -KGRYAFG---------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF  440 (475)
T ss_pred             -cCccccc---------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence             2111111         11223556778999999999999999999999999883

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-53  Score=371.90  Aligned_cols=252  Identities=26%  Similarity=0.381  Sum_probs=213.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.++||+|+||+||.++.+ +++.+|+|++++.........+....|..+|..++||.||+++..|++.+.+|||+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            46999999999999999999876 69999999999887777777888999999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+.||.|..+|++.+  .+++..+..++..|+.||.|||++|     ||||||||+|||+|.+|+++|+|||+++..-.
T Consensus       105 d~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g-----IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG-----IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             eccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC-----eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999998754  7999999999999999999999999     99999999999999999999999999985433


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  .+.+.+||+.|||||++....|+..+|+||||+++|||++|.+||...+      .....+.+....        
T Consensus       178 ~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k--------  241 (357)
T KOG0598|consen  178 DGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK--------  241 (357)
T ss_pred             CCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc--------
Confidence            222  3455899999999999999999999999999999999999999996432      222233322221        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERP----SMAECVKE  339 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp----t~~ell~~  339 (361)
                        +  ...+.-.+.+..++++++|..||++|.    ++.++-+|
T Consensus       242 --~--~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  242 --L--PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             --C--CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence              0  112222345589999999999999995    55555444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-52  Score=371.92  Aligned_cols=254  Identities=27%  Similarity=0.432  Sum_probs=206.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+.+... .....+.+..|+.+|+.++|||||.+++++.+++.+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            457888999999999999999987 689999999987654 344566788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC------CcEEEeecC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN------FEAKISDFG  212 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~------~~~kl~Dfg  212 (361)
                      ||||.||+|.+|+.+.+  .+++.++..++.|++.||++||+++     ||||||||.||||+..      -.+||+|||
T Consensus        88 MEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~-----IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN-----IIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            99999999999999865  7999999999999999999999999     9999999999999865      469999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      +|+.+..+.   ...+.+|+|.|||||++..+.|+.|+|+||+|+|+|++++|+.||.....      .+....+..+ .
T Consensus       161 fAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~------~eL~~~~~k~-~  230 (429)
T KOG0595|consen  161 FARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP------KELLLYIKKG-N  230 (429)
T ss_pred             hhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHHHhcc-c
Confidence            999987554   45678999999999999999999999999999999999999999963322      1222111111 1


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      .+...         .+......+.+|+...+..+|.+|-+..+...+.
T Consensus       231 ~~~~~---------~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~  269 (429)
T KOG0595|consen  231 EIVPV---------LPAELSNPLRELLISLLQRNPKDRISFEDFFDHP  269 (429)
T ss_pred             cccCc---------hhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence            11111         1222222355677777777777777666655543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-51  Score=378.16  Aligned_cols=264  Identities=36%  Similarity=0.575  Sum_probs=217.0

Q ss_pred             CCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-EEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-HRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~  141 (361)
                      ....+.||+|+||+||+|.++....||||++......... ...|.+|+.+|.+++|||||+++|++.+.. .+.+||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3444569999999999999994444999999876544444 779999999999999999999999999987 79999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-cEEEeecCccccCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-EAKISDFGLAKLMPEG  220 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~~  220 (361)
                      +++|+|.+++.......+++..++.++.+||.||+|||+++    +||||||||+|||++.++ ++||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~----~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG----PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC----CeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            99999999998754568999999999999999999999988    289999999999999997 9999999999876543


Q ss_pred             CceeeeeecccccCccCccccc--CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          221 QETYVTARVLGTFGYFDPEYTS--TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .  .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....      ...+......        
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~--------  261 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVG--------  261 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhc--------
Confidence            2  1222367999999999999  56999999999999999999999999964332      1111111111        


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG  350 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~  350 (361)
                         ..+...+..++..+..|+.+||+.||.+||++.+++..|+.+.......
T Consensus       262 ---~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~  310 (362)
T KOG0192|consen  262 ---GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA  310 (362)
T ss_pred             ---CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence               1112333446677999999999999999999999999999888765543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-51  Score=376.36  Aligned_cols=257  Identities=25%  Similarity=0.365  Sum_probs=220.8

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  136 (361)
                      ...+|..++.||+|+|++|++|+.+ +++.||||++.+...........+..|-.+|.+| .||.|++|+..|+|...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3457999999999999999999976 7999999999988777777788899999999999 7999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +|+||+++|+|.++|++.+  .+++.-.+.++.+|+.||+|||++|     ||||||||+|||||.|++++|+|||.|+.
T Consensus       151 FvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G-----IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG-----IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC-----ceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999999876  7999999999999999999999999     99999999999999999999999999998


Q ss_pred             CCCCCce---------ee--eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 018047          217 MPEGQET---------YV--TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       217 ~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      +......         ..  ...++||..|.+||++..+..+..+|+|+||||+|+|+.|.+||...++      ...++
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yliFq  297 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLIFQ  297 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHHHH
Confidence            8543221         11  2458999999999999999999999999999999999999999964332      22222


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .++.-.             -.++...+....+||.+.|..||++|+|.+|+-+|..
T Consensus       298 kI~~l~-------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF  340 (604)
T KOG0592|consen  298 KIQALD-------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF  340 (604)
T ss_pred             HHHHhc-------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence            222211             1223333456899999999999999999999988753

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-53  Score=355.66  Aligned_cols=259  Identities=23%  Similarity=0.389  Sum_probs=210.7

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEE-EEEcC-CEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG-YCADG-KHRFLV  138 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~-~~~~lv  138 (361)
                      +|+++++||+|+||+||++... +|..+|.|.+..... +.....+...|+.+|++|+|||||++++ .|.++ ..++||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3777889999999999999865 899999999975433 3445667888999999999999999998 34444 458999


Q ss_pred             EEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          139 YEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      ||||.+|+|...|+..  ....+++.++|+++.|++.||..+|++- ++-.|+||||||.||+++.+|.+||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999754  3557999999999999999999999932 011399999999999999999999999999998


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +....  ....+.+|||.||+||.+...+|+.++||||+||++|||+.-..||...      ++...-+.+.+.      
T Consensus       178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg------  243 (375)
T KOG0591|consen  178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG------  243 (375)
T ss_pred             hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC------
Confidence            85543  3566789999999999999999999999999999999999999999532      333222222111      


Q ss_pred             hcCccccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          297 VIDPELSRSSYT-MESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       297 ~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                            .....+ ...+..+..||..|+..||+.||+...+++.+..
T Consensus       244 ------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  244 ------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                  112233 5677789999999999999999997666666554

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=371.18  Aligned_cols=258  Identities=29%  Similarity=0.453  Sum_probs=216.0

Q ss_pred             CCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEec
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      +..++.||+|.||+||.|.++....||+|.+...    ....++|.+|+++|++|+|+|||+++++|..++.+|||||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            4456789999999999999997779999998754    333467889999999999999999999999999999999999


Q ss_pred             CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCc
Q 018047          143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE  222 (361)
Q Consensus       143 ~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (361)
                      +.|+|.+|++...+..++..+.+.++.|||+|++||++++     +|||||.+.||||++++.+||+|||+|+...++..
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~-----~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN-----YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC-----ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            9999999999866778999999999999999999999999     99999999999999999999999999995544332


Q ss_pred             eeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          223 TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      . ......-...|+|||.+..+.++.||||||||++||||+| |+.||...   ...+.+..+.+              .
T Consensus       359 ~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m---sn~ev~~~le~--------------G  420 (468)
T KOG0197|consen  359 T-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM---SNEEVLELLER--------------G  420 (468)
T ss_pred             e-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC---CHHHHHHHHhc--------------c
Confidence            2 2222223568999999999999999999999999999999 67777422   22223332221              1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      . +-..|..||..+.+|+..||+.+|++|||++.+...|+++...+.
T Consensus       421 y-Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~  466 (468)
T KOG0197|consen  421 Y-RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE  466 (468)
T ss_pred             C-cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence            1 134566678889999999999999999999999999998876543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.9e-50  Score=366.46  Aligned_cols=260  Identities=22%  Similarity=0.300  Sum_probs=216.1

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ..++|+.+++||+|+||.||+|+-+ +|+.+|+|++.+...........++.|..+|...++|+||+++..|++..++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            3478999999999999999999976 799999999999888888888999999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+|||++..+|.+.+  .+++..+..++.+++.|++.||+.|     +|||||||+|+|||..|++||+|||++.-+
T Consensus       219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g-----yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG-----YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC-----cccccCChhheeecCCCCEeeccccccchh
Confidence            999999999999998865  8999999999999999999999999     999999999999999999999999998643


Q ss_pred             CC-----------------------CCc-----ee-----------------eeeecccccCccCcccccCCCCCccchh
Q 018047          218 PE-----------------------GQE-----TY-----------------VTARVLGTFGYFDPEYTSTGKLTLQSDV  252 (361)
Q Consensus       218 ~~-----------------------~~~-----~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di  252 (361)
                      ..                       ...     ..                 .....+|||.|||||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            21                       000     00                 0113589999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-
Q 018047          253 YAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP-  331 (361)
Q Consensus       253 wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-  331 (361)
                      ||||||+||||.|.+||....+...-..+..++..+.-               +.....+.+..+||.+||. ||++|. 
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------------P~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------------PEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------------CCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999999999765544333333332222211               1111222568899999999 999996 


Q ss_pred             --CHHHHHHHHH
Q 018047          332 --SMAECVKELQ  341 (361)
Q Consensus       332 --t~~ell~~l~  341 (361)
                        .++||-+|..
T Consensus       436 ~~G~~EIK~HPf  447 (550)
T KOG0605|consen  436 SKGAEEIKKHPF  447 (550)
T ss_pred             cccHHHHhcCCc
Confidence              4777766643

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=338.34  Aligned_cols=238  Identities=28%  Similarity=0.395  Sum_probs=208.7

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||.|+||.|.+++.+ +|..+|+|++.+...-+....+...+|..+|+.+.||.++++++.|.+.+.+|+|||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            4888899999999999999987 689999999988877777778889999999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |.+||.|..++++.+  ++++..++.++.||+.||+|||+.+     |++|||||+|||+|.+|.+||+|||+|+.+...
T Consensus       125 yv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~-----iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD-----IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             ccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC-----eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            999999999998854  8999999999999999999999999     999999999999999999999999999987543


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                           +.+.+|||.|+|||++...+++.++|+||||+++|||+.|.+||...+.      ......+....-        
T Consensus       198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~v--------  258 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGKV--------  258 (355)
T ss_pred             -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCcc--------
Confidence                 4457999999999999999999999999999999999999999964433      222222222222        


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSER  330 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  330 (361)
                           .+|...+..+.+|+..+|+.|-.+|
T Consensus       259 -----~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 -----KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -----cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                 2334444558999999999999999

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.3e-50  Score=342.36  Aligned_cols=268  Identities=24%  Similarity=0.364  Sum_probs=211.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +.|+...++|+|+||+||+++++ +|+.||||++.... .+....+-..+|+..|++|+|+|+|.++++|.....++||+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            35888899999999999999988 69999999996432 22334455678999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |||+. ++.+-++... ..++.+.+..+++|++.|+.|+|+++     +|||||||+|||++.+|.+||||||+|+.+..
T Consensus        81 E~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n-----~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNN-----CIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             eecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcC-----eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            99987 5555565543 47899999999999999999999999     99999999999999999999999999998863


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHH--------HHHHHhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL--------QVRHILND  290 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~--------~~~~~~~~  290 (361)
                      ...  .....+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+.|...++.+....+.        ....++..
T Consensus       154 pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  154 PGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             Ccc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            222  4556788999999997766 789999999999999999999999997666544322222        12233333


Q ss_pred             hhhhhhhcCcccc-----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          291 RKKLRKVIDPELS-----RSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       291 ~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ...+..+.-|...     ...++ ..+.-+.+++..||+.||.+|++-++++.|
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            3333322222211     11111 223468899999999999999999999976

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=352.91  Aligned_cols=262  Identities=31%  Similarity=0.489  Sum_probs=210.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC--EEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK--HRFL  137 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l  137 (361)
                      .+|...+.||+|+||+||++... +|...|||.+....   ....+.+.+|+.+|.+++|||||+++|......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            45788899999999999999977 58999999987541   122567889999999999999999999754444  6899


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-CCcEEEeecCcccc
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKL  216 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~  216 (361)
                      .|||+++|+|.+++.+.+. .+++..+..++.|+++||+|||++|     ++||||||+|||++. ++.+||+|||++..
T Consensus        94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g-----~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG-----IVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCcccceEEEeCCCCeEEeccCccccc
Confidence            9999999999999998876 8999999999999999999999999     999999999999999 79999999999987


Q ss_pred             CCC-CCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          217 MPE-GQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       217 ~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ... ...........||+.|||||++..+ ..+.++|||||||++.||+||+.||...     ......+-.+...    
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~----  238 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRE----  238 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhcc----
Confidence            653 1111223457899999999999863 3345999999999999999999999532     1111111111111    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                           ...  ...+...+.+..+++.+|+..||++|||++++|+|........
T Consensus       239 -----~~~--P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  239 -----DSL--PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -----CCC--CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                 101  1344445667899999999999999999999999998655444

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-48  Score=348.22  Aligned_cols=266  Identities=23%  Similarity=0.358  Sum_probs=215.5

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .+.|+...+||.|..++||+|+.. .+..||||+++......  ..+.+++|+..|+.++||||++++..|..+..+|+|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            356999999999999999999966 68999999998875543  378899999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |.||.+||+.+.+...-...+++..+..+++++++||.|||.+|     .||||||+.||||+++|.|||+|||.+..+-
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G-----~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG-----HIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC-----ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999999999998766667999999999999999999999999     9999999999999999999999999876554


Q ss_pred             CCC-ceeee-eecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          219 EGQ-ETYVT-ARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       219 ~~~-~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      +.. ..... ...+||++|||||++..  ..|+.|+||||||++..||++|..||....+.     -..+..+.++....
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----kvLl~tLqn~pp~~  252 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----KVLLLTLQNDPPTL  252 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----HHHHHHhcCCCCCc
Confidence            332 22222 56789999999998644  47899999999999999999999999644332     12222222322211


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .   ...+ ........+..+..++..||..||++|||+++++++-.
T Consensus       253 ~---t~~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F  295 (516)
T KOG0582|consen  253 L---TSGL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF  295 (516)
T ss_pred             c---cccC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence            1   0000 01111223346899999999999999999999998754

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=358.97  Aligned_cols=259  Identities=29%  Similarity=0.393  Sum_probs=213.5

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc--hhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCC
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA--DGEHEFRVEVDILSRLD-HPNLVSLIGYCADGK  133 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  133 (361)
                      ...+.|..++.||+|+||+|+.|.+. +|..||+|++........  .....+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34567999999999999999999876 789999998766422211  23456678999999998 999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEeecC
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFG  212 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg  212 (361)
                      .+|+||||+.||+|.+++.+.  .++.+..+..++.|++.|++|||++|     |+||||||+|||++.+ +++||+|||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~g-----i~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRG-----IVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCC-----EeeCCCCHHHEEecCCCCCEEEeccc
Confidence            999999999999999999883  47899999999999999999999999     9999999999999999 999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-LT-LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      ++.....  ......+.+||+.|+|||++.... |+ .++||||+|++||.|++|+.||..      .+.......+...
T Consensus       167 ~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~~l~~ki~~~  238 (370)
T KOG0583|consen  167 LSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVPNLYRKIRKG  238 (370)
T ss_pred             cccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHHHHHHHHhcC
Confidence            9998741  112455679999999999998877 75 789999999999999999999964      2222222223322


Q ss_pred             hhhhhhhcCccccCCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          291 RKKLRKVIDPELSRSSYTMES-IAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      ...+             +... +.++..|+.+||..||.+|+|+.+++.+-|-..
T Consensus       239 ~~~~-------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 EFKI-------------PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CccC-------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            2222             2222 556899999999999999999999997776443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.1e-48  Score=325.52  Aligned_cols=268  Identities=25%  Similarity=0.337  Sum_probs=212.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .+|...++||+|.||+||+|++. +|+.||||++......+.-. ....+|++.|+.++|+||+.++++|.+.+.+.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            35888899999999999999976 79999999998876554433 34567999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||++. +|...|+... ..++...+..++.++++||+|||++.     |+||||||+|+|++++|.+||+|||+++.+..
T Consensus        81 Efm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~-----IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW-----ILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             Eeccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh-----hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            99976 9999998753 47889999999999999999999999     99999999999999999999999999999876


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh---------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN---------  289 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---------  289 (361)
                      .......  .+.|.+|.|||.+.+ ..|+...||||.|||+.||+-|.+-|.+.++.++...+..+-....         
T Consensus       154 p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  154 PNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            6544322  367999999997654 5789999999999999999999988876655433333322211000         


Q ss_pred             --hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          290 --DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       290 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                        +..++..  -|..+....=..++....+|+.+||..||.+|+|++|+++|-
T Consensus       232 lpdY~~~~~--~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  232 LPDYVKIQQ--FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             cccHHHHhc--CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence              0011110  111111112223445679999999999999999999999874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=358.88  Aligned_cols=253  Identities=24%  Similarity=0.417  Sum_probs=213.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ..|..-..||+|+.|.||.|... +++.||||++.+..   ....+-+.+|+.+|+..+|+|||++++.|...+.+++||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            45777889999999999999865 68999999998643   233456889999999999999999999999899999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||++||+|.|.+...   .+++.++..+++++++||+|||.+|     |+|||||.+|||++.+|.+||+|||++..+..
T Consensus       350 Eym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g-----IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG-----IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             eecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc-----eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999999999999764   5999999999999999999999999     99999999999999999999999999988755


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ...+.+|||+|||||++....|+++.||||||++++||+-|.+||-...+.   .....+          .....
T Consensus       422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl---rAlyLI----------a~ng~  486 (550)
T KOG0578|consen  422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLI----------ATNGT  486 (550)
T ss_pred             ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH---HHHHHH----------hhcCC
Confidence            443  345679999999999999999999999999999999999999999642211   111111          11111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      +.   -..+...+..+.+++.+||+.|+++|+++.|+|+|-.-
T Consensus       487 P~---lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  487 PK---LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             CC---cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence            22   23455666779999999999999999999999998764

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-48  Score=357.63  Aligned_cols=251  Identities=29%  Similarity=0.430  Sum_probs=218.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+... .+...+.+.+|+++++.++||||+.++++|+...++++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            46778888999999999999987 689999999976543 3345677899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+.| +|..++...  ..++++.+..++.+++.||.|||+++     |+|||+||.|||++.+|.+|+||||+|+.+..
T Consensus        81 e~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~r-----ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNR-----ILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcC-----cccccCCcceeeecCCCceeechhhhhhhccc
Confidence            99976 999999874  48999999999999999999999999     99999999999999999999999999998755


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +  .....+..|||.|||||+..+++|+..+|+||||||+||+.+|++||.      .......++.+.++.        
T Consensus       153 ~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------a~si~~Lv~~I~~d~--------  216 (808)
T KOG0597|consen  153 N--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------ARSITQLVKSILKDP--------  216 (808)
T ss_pred             C--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------HHHHHHHHHHHhcCC--------
Confidence            3  345667789999999999999999999999999999999999999993      333344444444432        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           ...+...+..+.+++...|..||.+|.|..+++.|-.
T Consensus       217 -----v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF  253 (808)
T KOG0597|consen  217 -----VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF  253 (808)
T ss_pred             -----CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence                 2234466677999999999999999999999998865

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-47  Score=352.22  Aligned_cols=262  Identities=24%  Similarity=0.384  Sum_probs=205.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcC-
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADG-  132 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-  132 (361)
                      ++|++.+.||+|+||.||+|.+.      +++.||+|++...  ........+.+|+.++..+ +||||+++++++... 
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            46899999999999999999742      3568999998643  2233456788899999999 899999999988764 


Q ss_pred             CEEEEEEEecCCCchhhhcccCC---------------------------------------------------------
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIG---------------------------------------------------------  155 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  155 (361)
                      +.++++|||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46899999999999999986431                                                         


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccc
Q 018047          156 ---EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT  232 (361)
Q Consensus       156 ---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  232 (361)
                         ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+++...............++
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence               124778889999999999999999999     999999999999999999999999999865433222222233457


Q ss_pred             cCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHH
Q 018047          233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMES  311 (361)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (361)
                      +.|+|||++....++.++|||||||++|||++ |..||......  ...   ....... ..           ...+...
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~---~~~~~~~-~~-----------~~~~~~~  302 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEF---CQRLKDG-TR-----------MRAPENA  302 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHH---HHHHhcC-CC-----------CCCCCCC
Confidence            88999999988899999999999999999997 99999643221  111   1111111 00           0112233


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          312 IAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       312 ~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      +..+.+|+.+||+.||++|||+.|+++.|++++..
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            45689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-48  Score=343.66  Aligned_cols=254  Identities=25%  Similarity=0.383  Sum_probs=220.2

Q ss_pred             HcCCCCCCceecccCceEEEEEEE-cCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ...+|++.+.||+|.||.|-+|.. ..|+.||||.+.+....+....-.+++|+++|..|+||||++++++|+..+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            345688889999999999999986 5799999999999988888888889999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||..+|.|.||+...+  .+++.....+++||+.|+.|+|.++     ++|||||.+|||+|.++++||+|||++..+
T Consensus       131 vMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr-----VvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR-----VVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc-----ceecccchhheeecCCCCeeeeccchhhhh
Confidence            999999999999998754  8999999999999999999999999     999999999999999999999999999988


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      .+..   ...+++|+|.|.+||++.+.+| ++..|.||||++||.|+.|.+||+..+   -.   ..++++...  .+. 
T Consensus       204 ~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk---~lvrQIs~G--aYr-  271 (668)
T KOG0611|consen  204 ADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HK---RLVRQISRG--AYR-  271 (668)
T ss_pred             cccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HH---HHHHHhhcc--ccc-
Confidence            6655   4556899999999999998887 688999999999999999999995432   22   233332221  111 


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                                 ..+.+....-||++||..||++|.|+.++..|-|-
T Consensus       272 -----------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  272 -----------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             -----------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence                       11223336789999999999999999999999873

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-49  Score=352.94  Aligned_cols=268  Identities=25%  Similarity=0.342  Sum_probs=213.4

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCC-EE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGK-HR  135 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~  135 (361)
                      ..++|...+.||.|+||.||+|+.. +|+.||||+++..... .+.. .-.+|+..|++|+ ||||+++.+++.+.+ .+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            3457888999999999999999976 7999999999765433 2222 2346999999998 999999999998887 99


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |+|||||+. +|.+.++.. ...+++..+..|++||++||+|+|.+|     +.|||+||+|||+.....+||+|||+|+
T Consensus        86 ~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G-----fFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG-----FFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC-----cccccCChhheEecccceeEeccccccc
Confidence            999999965 999999887 668999999999999999999999999     9999999999999999999999999999


Q ss_pred             cCCCCCceeeeeecccccCccCcccc-cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh---
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR---  291 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  291 (361)
                      .+.+..   -....+.|.+|.|||++ ..+.|+.+.|||++|||++|+.+-++.|.+.++.++...+-   ..+...   
T Consensus       159 ev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc---~VLGtP~~~  232 (538)
T KOG0661|consen  159 EVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC---EVLGTPDKD  232 (538)
T ss_pred             ccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH---HHhCCCccc
Confidence            876544   34567889999999965 55778999999999999999999999997665433322222   221111   


Q ss_pred             -----hhhhhhcCcccc------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 -----KKLRKVIDPELS------RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 -----~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           ..+...+.-.++      ....-...+.++.++|.+||..||.+|||+.|+|+|.-
T Consensus       233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf  293 (538)
T KOG0661|consen  233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF  293 (538)
T ss_pred             cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence                 111111111111      01111225677899999999999999999999999864

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-47  Score=356.50  Aligned_cols=260  Identities=28%  Similarity=0.375  Sum_probs=220.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +-|+.++-||.|+.|.|-+|++. +|+.+|||++.+..-........+.+|+-+|+.+.|||++.+|+++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45888899999999999999976 89999999998764344445667889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|.|++|+..++  .+++..+.+++.||+.|+.|+|..+     |+|||+||+|+|||..++|||+|||.|..-..
T Consensus        92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~-----icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN-----ICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc-----ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            9999999999998865  7999999999999999999999999     99999999999999999999999999986443


Q ss_pred             CCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +.   ...+.||+|.|.|||++.+.+| +.++||||-|||||.|+||+.||+   +..-..+...+++   +.       
T Consensus       165 gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~---G~-------  228 (786)
T KOG0588|consen  165 GK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQR---GV-------  228 (786)
T ss_pred             Cc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHc---Cc-------
Confidence            33   4456789999999999999888 588999999999999999999995   2222222222222   11       


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                            -++|...+.+..+|+++||..||++|.|++||++|.+-..+....
T Consensus       229 ------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  229 ------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             ------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence                  233445556689999999999999999999999999977765543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-48  Score=318.63  Aligned_cols=255  Identities=28%  Similarity=0.408  Sum_probs=220.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++++.||+|.||.||.|+.+ ++-.||+|++.+.........+.+.+|+++...|+||||+++|++|.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            46999999999999999999976 68899999998877777777889999999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||.++|+|...+.......+++.....++.|+|.|+.|+|..+     +|||||||+|+|++.++.+|++|||-+..-+.
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~-----VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR-----VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC-----cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            9999999999998766778999999999999999999999999     99999999999999999999999999976543


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +    ...+.+||..|.+||...+..++...|+|++|++.||++.|.+||.....      -+..+++..-.        
T Consensus       177 ~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~------~etYkrI~k~~--------  238 (281)
T KOG0580|consen  177 N----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH------SETYKRIRKVD--------  238 (281)
T ss_pred             C----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh------HHHHHHHHHcc--------
Confidence            3    24457899999999999999999999999999999999999999964331      11122221111        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                           -.+|...+....++|.+|+..+|.+|.+..|+++|.+..
T Consensus       239 -----~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  239 -----LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV  277 (281)
T ss_pred             -----ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence                 112233344588999999999999999999999998754

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-46  Score=341.00  Aligned_cols=256  Identities=28%  Similarity=0.404  Sum_probs=208.3

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |+..+.||+|+||+||+|... +|+.||+|.+.............+.+|+.++..++|+|++++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            677889999999999999976 7999999998765444334445677899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++|+|.+++.......+++..+..++.|++.||+|||+.+     ++||||||+|||++.++.++|+|||++.......
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER-----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999998886544457899999999999999999999999     9999999999999999999999999998764432


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ...+......         . 
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~---------~-  220 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKE---------D-  220 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhc---------c-
Confidence            2   2235689999999999989999999999999999999999999965432111   1111111100         0 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                        ...++...+..+.+|+++||+.||++||+     ++++++|.+
T Consensus       221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~  263 (285)
T cd05631         221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI  263 (285)
T ss_pred             --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence              01122334556899999999999999997     899998854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=353.29  Aligned_cols=282  Identities=27%  Similarity=0.456  Sum_probs=227.3

Q ss_pred             HHHHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC
Q 018047           53 LKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG  132 (361)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  132 (361)
                      ..+.+...+...++..||+|+||+||+|.+.  ..||||+++...... +..+.|++|+.++++.+|.||+=+.|+|..+
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            3555666667888899999999999999997  579999998876544 4788999999999999999999999999988


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      .. .||+.||+|.+|+.++.-.. ..++....+.|+.|+++|+.|||.++     |||||||..|||+.+++.|||+|||
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~-----IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN-----IIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh-----hhhhhccccceEEccCCcEEEeccc
Confidence            87 89999999999999997653 57999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTST---GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      ++.....-..........|...|||||++..   .+|+..+||||||+++|||++|..||.....   ...+.++.+   
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIifmVGr---  607 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQIIFMVGR---  607 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheEEEecc---
Confidence            9986433222222334567889999998764   4789999999999999999999999973221   111111111   


Q ss_pred             hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCCcccc
Q 018047          290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHAL  358 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~~~~~  358 (361)
                        +    .+.+.+  ......++..+.+|+..||..++++||++.+++..|+.++....+-.+.+++++
T Consensus       608 --G----~l~pd~--s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~  668 (678)
T KOG0193|consen  608 --G----YLMPDL--SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPV  668 (678)
T ss_pred             --c----ccCccc--hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccc
Confidence              1    111111  223456677899999999999999999999999999999987555555566554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-47  Score=341.95  Aligned_cols=264  Identities=27%  Similarity=0.390  Sum_probs=209.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KHRFL  137 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l  137 (361)
                      +.|+.++.||+|+||.||+|++. +|+.||+|++........ ...-..+||.+|++|+||||++|.+...+.  +.+||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            35778889999999999999966 799999999987654333 345567799999999999999999998776  79999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      |+|||++ +|.-++.+. .-.+++.++..++.|++.||+|+|++|     |+|||||.+|||||.+|.+||+|||+|+.+
T Consensus       196 VFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g-----vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG-----VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC-----eeeccccccceEEcCCCCEEeccccceeec
Confidence            9999987 898888764 347999999999999999999999999     999999999999999999999999999977


Q ss_pred             CCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ....... ....+.|++|.|||.+.+ ..|+.+.|+||.||||.||+.|++.|....+.++...+..+.      +...+
T Consensus       269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc------GSP~e  341 (560)
T KOG0600|consen  269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC------GSPTE  341 (560)
T ss_pred             cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh------CCCCh
Confidence            5544332 344567999999997655 579999999999999999999999997665544433333222      11111


Q ss_pred             hcCc--ccc-------CCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          297 VIDP--ELS-------RSSYTM-------ESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       297 ~~~~--~~~-------~~~~~~-------~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      -..+  .++       ...+..       ..+....+|+..+|..||.+|.|+.++|++
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            1111  110       111111       122456889999999999999999999875

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-48  Score=346.06  Aligned_cols=250  Identities=27%  Similarity=0.435  Sum_probs=212.3

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .|+..+.||+|+||.||+|.+. +++.||+|++....  ......++..|+.+|.+++++||.++|+.+..+..++++||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            4777789999999999999976 79999999998763  34456788999999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      ||.||++.+.++...  .+++..+.-++++++.|+.|||+++     .+|||||+.|||+..+|.+||+|||.+-.+.+.
T Consensus        92 y~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~-----kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK-----KIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc-----eecccccccceeEeccCcEEEEecceeeeeech
Confidence            999999999998643  4578888889999999999999999     999999999999999999999999999887654


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ...  ..+++|||.|||||++....|+.|+||||||++.+||++|.+|+....++.-.             ..+.+...|
T Consensus       165 ~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------------flIpk~~PP  229 (467)
T KOG0201|consen  165 VKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------------FLIPKSAPP  229 (467)
T ss_pred             hhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------------EeccCCCCC
Confidence            433  36789999999999999889999999999999999999999999655442110             111222222


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      .+     ....+..+.++|..||+.||+.||++.++|+|=
T Consensus       230 ~L-----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~  264 (467)
T KOG0201|consen  230 RL-----DGDFSPPFKEFVEACLDKNPEFRPSAKELLKHK  264 (467)
T ss_pred             cc-----ccccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence            22     224455699999999999999999999999873

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-47  Score=343.19  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=207.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|... +|+.||+|++.............+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999987 68999999987543333344567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE-----IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999997643  6899999999999999999999999     99999999999999999999999999986643


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..     ....|++.|+|||++....++.++|||||||++|+|++|+.||.....      ......+.....       
T Consensus       154 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~-------  215 (291)
T cd05612         154 RT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILAGKL-------  215 (291)
T ss_pred             Cc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCc-------
Confidence            22     234689999999999888899999999999999999999999964321      111111111111       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                            ..+...+..+.+|+.+||+.||.+||+     ++++++|.+
T Consensus       216 ------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  256 (291)
T cd05612         216 ------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW  256 (291)
T ss_pred             ------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence                  112222455899999999999999995     999999875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=351.07  Aligned_cols=246  Identities=28%  Similarity=0.380  Sum_probs=212.5

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  136 (361)
                      ...+|...++||+|+||+|+++..+ +++.+|||++++..+...+..+....|..|+.... ||.+++++..|+..+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3457999999999999999999988 68899999999988888888899999999999885 999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+.||++..++..   ..+++..+..++..++.||+|||++|     ||+||||.+|||||.+|++||+|||+++.
T Consensus       446 fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~-----IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENG-----IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcC-----ceeeecchhheEEcccCcEEecccccccc
Confidence            99999999995555543   37999999999999999999999999     99999999999999999999999999986


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ......  .+++++|||.|||||++....|+.++|+|||||+||||+.|..||...++      .+....+.++.     
T Consensus       518 ~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------ee~FdsI~~d~-----  584 (694)
T KOG0694|consen  518 GMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------EEVFDSIVNDE-----  584 (694)
T ss_pred             cCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHhcCC-----
Confidence            542222  46678999999999999999999999999999999999999999964332      12222333321     


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSM  333 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  333 (361)
                              ..+|...+.+..++++++|..+|++|..+
T Consensus       585 --------~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 --------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                    33566667778999999999999999755

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-46  Score=346.88  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=206.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++.............+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            35888999999999999999987 68999999987543333344567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.....
T Consensus        98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD-----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            9999999999997643  6889999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..     ....||+.|+|||++....++.++|||||||++|+|++|..||.....      ......+.....       
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~-------  232 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILAGRL-------  232 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhcCCc-------
Confidence            32     234689999999999888899999999999999999999999953221      111111111111       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                            ..+...+..+.+|+.+||+.||.+||+     +++++.|.+
T Consensus       233 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~  273 (329)
T PTZ00263        233 ------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY  273 (329)
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence                  111223345889999999999999986     799998853

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=337.24  Aligned_cols=264  Identities=28%  Similarity=0.397  Sum_probs=210.1

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCc-----------chhHHHHHHHHHHHHhcCCCcceeE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKE-----------ADGEHEFRVEVDILSRLDHPNLVSL  125 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~  125 (361)
                      ...+.|++++.||+|.||.|-+|+.. +++.||||++.+.....           ....+.+++|+.+|++|+|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34567999999999999999999977 79999999987643211           1124588999999999999999999


Q ss_pred             EEEEEcC--CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC
Q 018047          126 IGYCADG--KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN  203 (361)
Q Consensus       126 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~  203 (361)
                      +++..+.  +.+|||+|||..|.+...=..  ...+++.+++.++.+++.||+|||.+|     ||||||||+|+||+++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~Qg-----iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQG-----IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcC-----eeccccchhheEEcCC
Confidence            9999874  589999999998887655432  223899999999999999999999999     9999999999999999


Q ss_pred             CcEEEeecCccccCCCCCcee---eeeecccccCccCcccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 018047          204 FEAKISDFGLAKLMPEGQETY---VTARVLGTFGYFDPEYTSTGK----LTLQSDVYAFGVVLLELLTGRRAVDLNQGVN  276 (361)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~p~~~~~~~~  276 (361)
                      |++||+|||.+..+..+....   .....+|||.|+|||....+.    .+.+.||||+||+||.|+.|+.||..     
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-----  321 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-----  321 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-----
Confidence            999999999998774332111   122368999999999876632    35778999999999999999999942     


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                       .........+.++.          +.... ..+..+.+.+||.+||++||++|.++.++..|.+..-.
T Consensus       322 -~~~~~l~~KIvn~p----------L~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  322 -DFELELFDKIVNDP----------LEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             -chHHHHHHHHhcCc----------ccCCC-cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence             22333333443332          22111 22456779999999999999999999999999986544

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=331.94  Aligned_cols=258  Identities=26%  Similarity=0.320  Sum_probs=218.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +.|+..+.||+|.-|+||++..+ ++..+|+|++.+...........+..|.+||..++||.++.||..|+.+...|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            34677788999999999999988 47899999998877766777788889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |||+||+|....++.....++++.+..++..++-||+|||-.|     ||+|||||+||||.++|+|.|+||.++....-
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG-----ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG-----IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc-----eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            9999999999999988889999999999999999999999999     99999999999999999999999998754310


Q ss_pred             ---------------------------------CCce---------------------eeeeecccccCccCcccccCCC
Q 018047          220 ---------------------------------GQET---------------------YVTARVLGTFGYFDPEYTSTGK  245 (361)
Q Consensus       220 ---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~  245 (361)
                                                       ....                     .....++||..|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0000                     0122468999999999999999


Q ss_pred             CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCC
Q 018047          246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRT  325 (361)
Q Consensus       246 ~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  325 (361)
                      .+.++|+|+||+++|||+.|..||......                ..+..++...+.....+ ..+..+.+||+++|.+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVK  374 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhcc
Confidence            999999999999999999999999654322                22333343444333333 6667799999999999


Q ss_pred             CCCCCCC----HHHHHHHH
Q 018047          326 ESSERPS----MAECVKEL  340 (361)
Q Consensus       326 dp~~Rpt----~~ell~~l  340 (361)
                      ||++|..    +.||-+|-
T Consensus       375 dP~kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKRHP  393 (459)
T ss_pred             ChhhhhccccchHHhhcCc
Confidence            9999998    88887764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.8e-46  Score=343.38  Aligned_cols=246  Identities=24%  Similarity=0.289  Sum_probs=201.2

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKG  145 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g  145 (361)
                      ++||+|+||+||+|... +|+.||+|++.............+.+|+.+++.++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999976 68999999997643333344566778999999999999999999999999999999999999


Q ss_pred             chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceee
Q 018047          146 NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV  225 (361)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (361)
                      +|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++........  .
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  151 (323)
T cd05571          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence            999998764  37899999999999999999999999     99999999999999999999999999875322211  2


Q ss_pred             eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCC
Q 018047          226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS  305 (361)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.      ...........             .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~~-------------~  212 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEE-------------I  212 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC-------------C
Confidence            2345799999999999888999999999999999999999999953221      11111111110             1


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 018047          306 SYTMESIAMFANLASRCVRTESSERP-----SMAECVKEL  340 (361)
Q Consensus       306 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l  340 (361)
                      ..+...+..+.+++.+||+.||++||     ++.++++|-
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~  252 (323)
T cd05571         213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR  252 (323)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence            12223445689999999999999999     899999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4e-45  Score=333.72  Aligned_cols=263  Identities=29%  Similarity=0.448  Sum_probs=204.0

Q ss_pred             CCCCCCceecccCceEEEEEEEcC-----------------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcce
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS-----------------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV  123 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv  123 (361)
                      ++|.+.+.||+|+||.||+|.+.+                 +..||+|.+...  ........+.+|+.++..++||||+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--ANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC--CCHHHHHHHHHHHHHHhhcCCCCee
Confidence            468889999999999999997532                 336999988643  2233456788999999999999999


Q ss_pred             eEEEEEEcCCEEEEEEEecCCCchhhhcccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC
Q 018047          124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG-----------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGI  186 (361)
Q Consensus       124 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~  186 (361)
                      ++++++.+.+..++||||+++|+|.+++....                 ...+++..+..++.|++.||.|||++|    
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~----  158 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN----  158 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC----
Confidence            99999999999999999999999999885421                 124678889999999999999999999    


Q ss_pred             CeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhC-
Q 018047          187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG-  265 (361)
Q Consensus       187 ~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-  265 (361)
                       ++||||||+|||++.++.+||+|||++..+.............++..|+|||++....++.++||||||+++|+|+++ 
T Consensus       159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             -ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence             999999999999999999999999999876544433333344567899999998888899999999999999999974 


Q ss_pred             -CCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          266 -RRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       266 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       ..||....   .......+..........   ..     ...+..++..+.+|+.+||+.||++|||+.++.+.|+
T Consensus       238 ~~~p~~~~~---~~~~~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         238 KEQPYGELT---DEQVIENAGEFFRDQGRQ---VY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCCcCC---HHHHHHHHHHHhhhcccc---cc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence             55664322   222222222211111000   00     0112233456899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.7e-45  Score=331.46  Aligned_cols=251  Identities=21%  Similarity=0.357  Sum_probs=202.7

Q ss_pred             CCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc----CCEEEEEE
Q 018047           64 SDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD----GKHRFLVY  139 (361)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~  139 (361)
                      .....||+|++|.||+|... |+.||||.+...........+.+.+|+.+|.+++||||+++++++.+    ....++||
T Consensus        23 ~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         23 YTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             CCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            33367999999999999985 89999999876543333345678899999999999999999999876    45789999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS-SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      ||+++|+|.+++...  ..+++.....++.+++.||.|||+. +     ++||||||+|||++.++.+||+|||++..+.
T Consensus       102 Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~-----~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        102 EYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN-----KPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             EeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC-----CCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            999999999999764  3789999999999999999999985 6     8899999999999999999999999998664


Q ss_pred             CCCceeeeeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ...     ....|+..|+|||++..  ..++.++|||||||++|||++|+.||.....   ....   ........    
T Consensus       175 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~---~~i~~~~~----  239 (283)
T PHA02988        175 SPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIY---DLIINKNN----  239 (283)
T ss_pred             ccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHhcCC----
Confidence            322     12457899999998865  6889999999999999999999999964321   1111   11111100    


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                             ....+..++..+.+++.+||+.||++|||++|+++.|+..-
T Consensus       240 -------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        240 -------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                   01122234567999999999999999999999999998764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-46  Score=343.06  Aligned_cols=258  Identities=22%  Similarity=0.323  Sum_probs=208.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.............+..|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999987 58999999997653333344567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||.|||++|     ++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG-----YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999997643  6899999999999999999999999     99999999999999999999999999986543


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                           ......||+.|+|||++....++.++|||||||++|||++|..||.....   ......+..   ....+.   .
T Consensus       154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~---~~~~~~---~  219 (333)
T cd05600         154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKY---WKETLQ---R  219 (333)
T ss_pred             -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHh---cccccc---C
Confidence                 12335689999999999888999999999999999999999999964322   111111111   000000   0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +..  .......+..+.+++.+||..+|++||++.++++|.+
T Consensus       220 ~~~--~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         220 PVY--DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             CCC--CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence            100  0001233556899999999999999999999999853

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-46  Score=342.55  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=219.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE-EEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH-RFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv  138 (361)
                      ++|..++++|+|+||.++.++++ +++.+++|.+......... .+....|+.++++++|||||.+.+.|..++. .+||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            46889999999999999999987 6889999999887654443 3467789999999999999999999998887 9999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |+||+||+|.+.|....+..++++.++.|+.|++.|++|||+++     |+|||||+.|||++.++.|+|+|||+|+.+.
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~-----iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR-----VLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh-----hhcccchhhhhhccccCceeecchhhhhhcC
Confidence            99999999999998877778999999999999999999999988     9999999999999999999999999999986


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  ...+.+||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...      +....+..+....       
T Consensus       158 ~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~------~m~~Li~ki~~~~-------  222 (426)
T KOG0589|consen  158 PEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS------NMSELILKINRGL-------  222 (426)
T ss_pred             Cchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc------chHHHHHHHhhcc-------
Confidence            6542  345678999999999999999999999999999999999999999532      2222222222111       


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           ..+.+...+.++..+|..||..+|..||++.++|.+.-
T Consensus       223 -----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~  260 (426)
T KOG0589|consen  223 -----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPH  260 (426)
T ss_pred             -----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence                 14455666777999999999999999999999999843

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-45  Score=333.47  Aligned_cols=268  Identities=22%  Similarity=0.320  Sum_probs=204.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|+++ +++.+|+|++...... ......+.+|+.+++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            36889999999999999999987 6889999998754322 233556788999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||++++.|..+...  ...+++..+..++.|++.||.|||+.+     ++||||||+||+++.++.+||+|||++..+..
T Consensus        80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND-----IVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            99998777655443  236899999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh----------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN----------  289 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----------  289 (361)
                      .... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......   .....+.....          
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07848         153 GSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI---DQLFTIQKVLGPLPAEQMKLF  228 (287)
T ss_pred             cccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhCCCCHHHHHhh
Confidence            3221 222356899999999998888999999999999999999999999643321   11111111100          


Q ss_pred             -hhhhhhhhcCccccC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          290 -DRKKLRKVIDPELSR-----SSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       290 -~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                       ..........+....     .......+..+.+|+++||+.||++|||++|+++|-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp  285 (287)
T cd07848         229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP  285 (287)
T ss_pred             hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence             000000000000000     000112345699999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=337.34  Aligned_cols=244  Identities=23%  Similarity=0.301  Sum_probs=199.6

Q ss_pred             ecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCch
Q 018047           69 LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL  147 (361)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  147 (361)
                      ||+|+||+||+|... +++.||+|++.............+..|+.++..++||||+++++++.+.+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999987 6889999998754333344556778899999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeee
Q 018047          148 QDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA  227 (361)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (361)
                      .+++...  ..+++..+..++.|++.||+|||+++     ++||||||+|||++.++.++|+|||++........  ...
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  151 (312)
T cd05585          81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFN-----VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN  151 (312)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence            9999764  36899999999999999999999999     99999999999999999999999999975432221  223


Q ss_pred             ecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCC
Q 018047          228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY  307 (361)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (361)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||....      ............             ...
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~-------------~~~  212 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEP-------------LRF  212 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCC-------------CCC
Confidence            4578999999999988899999999999999999999999996322      112222222111             112


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHH
Q 018047          308 TMESIAMFANLASRCVRTESSERP---SMAECVKEL  340 (361)
Q Consensus       308 ~~~~~~~l~~li~~cl~~dp~~Rp---t~~ell~~l  340 (361)
                      +...+..+.+++.+||+.||++||   ++.|++.|.
T Consensus       213 ~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp  248 (312)
T cd05585         213 PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP  248 (312)
T ss_pred             CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence            223445689999999999999997   467887764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.9e-45  Score=345.15  Aligned_cols=259  Identities=25%  Similarity=0.385  Sum_probs=203.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  133 (361)
                      ++|++.+.||+|+||+||+|++.      ++..||||++....  .......+.+|+.++..+ +||||+++++++.+++
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            46888999999999999999741      35689999986432  223345688899999999 8999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCC----------------------------------------------------------
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIG----------------------------------------------------------  155 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  155 (361)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999885421                                                          


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          156 ---------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       156 ---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                                     ...+++..+..++.|++.||+|||+++     ++||||||+|||++.++.+||+|||++..+...
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                           124788899999999999999999999     999999999999999999999999999876443


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..........++..|+|||++....++.++|||||||++|||++ |..||.....  .......+    ....      .
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~~----~~~~------~  335 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMI----KEGY------R  335 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHHH----HhCc------c
Confidence            32222222345667999999988899999999999999999998 8888854321  11111111    1100      0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                           ...+...+.++.+|+.+||+.||++|||+.|+++.|++.
T Consensus       336 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 -----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                 001112245689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.7e-46  Score=319.58  Aligned_cols=263  Identities=23%  Similarity=0.320  Sum_probs=209.2

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CCEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GKHRFLV  138 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv  138 (361)
                      .|+..+.|++|+||.||+|+++ +++.||+|+++...-...-... -.+|+.+|.+++|||||.+-.+..-  -+.+|+|
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIt-sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPIT-SLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcch-hHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4788899999999999999987 7999999999776433332232 3569999999999999999998754  4579999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      ||||+. +|..++.+.. +++...++..++.|++.|++|||.+.     |+||||||+|+|++..|.+||+|||+|+.+.
T Consensus       156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w-----ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW-----ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce-----eEecccchhheeeccCCcEEecccchhhhhc
Confidence            999987 9999998765 58999999999999999999999999     9999999999999999999999999999886


Q ss_pred             CCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      +...  .....+.|.+|.|||.+.+ ..|+.+.|+||+|||+.||+++++.|......++.+.+...      -+.-.+.
T Consensus       229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l------lGtPte~  300 (419)
T KOG0663|consen  229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL------LGTPSEA  300 (419)
T ss_pred             CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH------hCCCccc
Confidence            6532  3445678999999997654 57899999999999999999999999766554443333332      2222222


Q ss_pred             cCccccCC------------------CCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          298 IDPELSRS------------------SYTME-SIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       298 ~~~~~~~~------------------~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      +.|.+...                  .++.. .++.-++|++.+|..||.+|.|++|.|+|=
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~  362 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE  362 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence            22222100                  01111 345678999999999999999999999874

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-45  Score=342.14  Aligned_cols=249  Identities=25%  Similarity=0.302  Sum_probs=205.3

Q ss_pred             CCCCCceecccCceEEEEEEEcC--CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRS--GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +|++.+.||+|+||.||+|.++.  +..||+|++.............+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            58889999999999999998653  3689999987654334445567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++..+..
T Consensus       111 Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        111 EFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN-----IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            9999999999997643  6899999999999999999999999     99999999999999999999999999987643


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..     ....||+.|+|||++.+..++.++|||||||++|||++|..||.....      ......+.....       
T Consensus       184 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~i~~~~~-------  245 (340)
T PTZ00426        184 RT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------LLIYQKILEGII-------  245 (340)
T ss_pred             Cc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------HHHHHHHhcCCC-------
Confidence            22     235689999999999888899999999999999999999999964321      111111111110       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                            .++...+..+.+++++||+.||++|+     +++++++|.+
T Consensus       246 ------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~  286 (340)
T PTZ00426        246 ------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW  286 (340)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence                  11222334578999999999999995     8999998843

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.1e-45  Score=344.63  Aligned_cols=260  Identities=27%  Similarity=0.377  Sum_probs=204.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  133 (361)
                      ++|.+.+.||+|+||.||+|.+.      ++..||+|++....  .......+.+|+.+++.+ +|+||+++++++...+
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            46889999999999999999853      23579999986542  223356688899999999 8999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCC----------------------------------------------------------
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIG----------------------------------------------------------  155 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  155 (361)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999885321                                                          


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceee
Q 018047          156 ----------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV  225 (361)
Q Consensus       156 ----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (361)
                                ...+++..++.++.|++.||+|||++|     ++||||||+|||++.++.++|+|||++..+........
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN-----CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                      124788899999999999999999999     99999999999999999999999999986644332222


Q ss_pred             eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .....++..|+|||++....++.++|||||||++|+|++ |+.||......  .......    ...      ..+    
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~~~~~~----~~~------~~~----  334 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKFYKMV----KRG------YQM----  334 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HHHHHHH----Hcc------cCc----
Confidence            222345678999999988899999999999999999997 99999643221  1111111    100      000    


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                       ..+...+..+.+++.+||+.||++|||+.++++.|++++
T Consensus       335 -~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 -SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence             011112355899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.5e-45  Score=336.78  Aligned_cols=267  Identities=24%  Similarity=0.337  Sum_probs=207.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|+..+.||+|+||.||++.+. +|..+|+|.+...  ........+.+|+++++.++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            357999999999999999999987 6889999998653  2233456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++....  .+++..+..++.|++.||.|||+.+    .++||||||+|||++.++.++|+|||++..+.
T Consensus        82 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          82 MEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH----QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             eecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC----CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999999999997643  6899999999999999999999853    19999999999999999999999999997664


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh-hhh-----
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRK-----  292 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~-----  292 (361)
                      ...    .....|++.|+|||++.+..++.++|||||||++|+|++|+.||......   .+...+..... ...     
T Consensus       156 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~  228 (331)
T cd06649         156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDGEEGEPHS  228 (331)
T ss_pred             ccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccccCCccc
Confidence            332    22356899999999998888999999999999999999999999543211   11100000000 000     


Q ss_pred             --------------------------hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 --------------------------KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 --------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                                                .+...+.............+.++.+|+.+||+.||++|||++++++|.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence                                      0000000000000011124456899999999999999999999999976

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.5e-45  Score=337.55  Aligned_cols=246  Identities=26%  Similarity=0.294  Sum_probs=201.5

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKG  145 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g  145 (361)
                      +.||+|+||.||++... +|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999976 68999999997654334445567888999999999999999999999999999999999999


Q ss_pred             chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceee
Q 018047          146 NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV  225 (361)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (361)
                      +|.+++...  ..+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++........  .
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  151 (328)
T cd05593          81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK-----IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T  151 (328)
T ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence            999988654  36899999999999999999999999     99999999999999999999999999875422211  2


Q ss_pred             eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCC
Q 018047          226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS  305 (361)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .....||+.|+|||++....++.++|||||||++|+|++|+.||.....      ...........             .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~~-------------~  212 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMED-------------I  212 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccCC-------------c
Confidence            2345789999999999888999999999999999999999999953221      11111111110             1


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 018047          306 SYTMESIAMFANLASRCVRTESSERP-----SMAECVKEL  340 (361)
Q Consensus       306 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l  340 (361)
                      ..+...+..+.+++.+||+.||++||     ++.++++|.
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  252 (328)
T cd05593         213 KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS  252 (328)
T ss_pred             cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence            12223345689999999999999997     899999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-45  Score=337.55  Aligned_cols=258  Identities=26%  Similarity=0.352  Sum_probs=218.1

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHR  135 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  135 (361)
                      .....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+...........+.+|+.+|+.+. |||||.++++|++...+
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            34456999999999999999999988 59999999998877666556788999999999998 99999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC----CcEEEeec
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN----FEAKISDF  211 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~----~~~kl~Df  211 (361)
                      ++|||++.||.|.+.+...   .+++..+..++.|++.++.|||+.|     ++||||||+|+|+...    +.+|++||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g-----vvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG-----VVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            9999999999999999875   3999999999999999999999999     9999999999999643    47999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      |++.....+   ......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..........      .+....
T Consensus       184 Gla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~  254 (382)
T KOG0032|consen  184 GLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGD  254 (382)
T ss_pred             CCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCC
Confidence            999987652   24566799999999999999999999999999999999999999997544321111      111111


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .        .+. ...=...+....++|+.||..||..|+|+.++|+|.|
T Consensus       255 ~--------~f~-~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  255 F--------DFT-SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             C--------CCC-CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence            1        111 1111233567899999999999999999999999987

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-45  Score=337.19  Aligned_cols=246  Identities=24%  Similarity=0.285  Sum_probs=200.2

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKG  145 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g  145 (361)
                      +.||+|+||.||++... +|+.||+|++.............+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999976 68999999997643333344566778999999999999999999999999999999999999


Q ss_pred             chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceee
Q 018047          146 NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV  225 (361)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (361)
                      +|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++........  .
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  151 (323)
T cd05595          81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence            999988654  36899999999999999999999999     99999999999999999999999999875322211  1


Q ss_pred             eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCC
Q 018047          226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS  305 (361)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ...........             .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~~~~~~-------------~  212 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEE-------------I  212 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC-------------C
Confidence            2235689999999999888999999999999999999999999953321      11111111110             0


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 018047          306 SYTMESIAMFANLASRCVRTESSERP-----SMAECVKEL  340 (361)
Q Consensus       306 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l  340 (361)
                      ..+...+..+.+++.+||+.||++||     ++.++++|-
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~  252 (323)
T cd05595         213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  252 (323)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence            11223345688999999999999998     899998874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-44  Score=336.82  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=199.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .+|+..+.||+|+||+||+|.+. +|+.||||++...  ........+.+|+++++.++|+||+++++++.+++..++||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC--CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            34677789999999999999976 6899999998643  22334567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+..      ..++..+..++.||+.||+|||++|     ++||||||+|||++.++.+||+|||++..+..
T Consensus       152 e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        152 EFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH-----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             ecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999999987542      3567788899999999999999999     99999999999999999999999999986643


Q ss_pred             CCceeeeeecccccCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ...  ......||..|+|||++..     ...+.++|||||||++|||++|+.||.......   ...........    
T Consensus       221 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~----  291 (353)
T PLN00034        221 TMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMS----  291 (353)
T ss_pred             ccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhcc----
Confidence            221  1223468999999998643     234568999999999999999999997332211   11111111000    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                         .     ....+...+..+.+|+.+||+.||++|||+.|+++|-+-...
T Consensus       292 ---~-----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        292 ---Q-----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ---C-----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence               0     011222344568999999999999999999999999764433

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.2e-45  Score=331.88  Aligned_cols=266  Identities=23%  Similarity=0.336  Sum_probs=201.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|...+.||+|+||+||+|... ++..||+|++.....  ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            46899999999999999999977 689999999865421  222345678999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++ +|.+++...+ ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.....
T Consensus        83 e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          83 EYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK-----ILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             eCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            99975 9999886543 35788999999999999999999999     99999999999999999999999999976543


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh--------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND--------  290 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  290 (361)
                      ...  ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||......   .....+......        
T Consensus       156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07871         156 PTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK---EELHLIFRLLGTPTEETWPG  230 (288)
T ss_pred             CCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhc
Confidence            221  1223467999999998754 56899999999999999999999999643321   111111111100        


Q ss_pred             ---hhhhhhhcCccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          291 ---RKKLRKVIDPELSRSS---YTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       291 ---~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                         ...+.....+......   .....+.++.+|+.+||+.||.+|||++|+++|-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp  286 (288)
T cd07871         231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS  286 (288)
T ss_pred             cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence               0001111111100000   0012235688999999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-45  Score=343.81  Aligned_cols=258  Identities=24%  Similarity=0.328  Sum_probs=205.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||+||+|... +|+.||||++.............+.+|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36889999999999999999987 68999999997643333444566788999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG-----YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999997643  6899999999999999999999999     99999999999999999999999999876532


Q ss_pred             CCcee------------------------------------eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHH
Q 018047          220 GQETY------------------------------------VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELL  263 (361)
Q Consensus       220 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  263 (361)
                      .....                                    .....+||+.|+|||++....++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            21100                                    011246899999999998899999999999999999999


Q ss_pred             hCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHH
Q 018047          264 TGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPS---MAECVKEL  340 (361)
Q Consensus       264 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~ell~~l  340 (361)
                      +|..||.....      .............+      ..+   .....+..+.+++.+|+. +|.+|++   +.++++|-
T Consensus       234 ~G~~Pf~~~~~------~~~~~~i~~~~~~~------~~~---~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~  297 (364)
T cd05599         234 VGYPPFCSDNP------QETYRKIINWKETL------QFP---DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP  297 (364)
T ss_pred             cCCCCCCCCCH------HHHHHHHHcCCCcc------CCC---CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence            99999964321      11111111111100      000   011223458899999997 8999997   99999875


Q ss_pred             H
Q 018047          341 Q  341 (361)
Q Consensus       341 ~  341 (361)
                      +
T Consensus       298 ~  298 (364)
T cd05599         298 F  298 (364)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.8e-45  Score=327.57  Aligned_cols=256  Identities=30%  Similarity=0.504  Sum_probs=207.1

Q ss_pred             CCCCCceecccCceEEEEEEEcC-C-----CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRS-G-----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      +|++.+.||+|+||.||+|.... +     ..+|+|.+...  ........+.+|+.++..++||||+++++++.+.+..
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            58888999999999999998652 2     57999988643  2334456788999999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC
Q 018047          136 FLVYEYMQKGNLQDHLNGIGE--------------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS  201 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~  201 (361)
                      +++|||+++|+|.+++.....              ..+++..+..++.|++.||+|||+++     ++|+||||+||+++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~-----i~H~dlkp~Nil~~  158 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVG  158 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccccceEEEc
Confidence            999999999999999865321              46888999999999999999999999     99999999999999


Q ss_pred             CCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 018047          202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNL  280 (361)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~  280 (361)
                      .++.++|+|||++................+++.|+|||.+....++.++|||||||++|||++ |..||.....   ...
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~  235 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEV  235 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence            999999999999986644333223334456889999999888889999999999999999998 9999854321   111


Q ss_pred             HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ...+.   .           .. ....+..++..+.+|+.+||+.||.+||+++|++++|+.
T Consensus       236 ~~~i~---~-----------~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 IEMIR---S-----------RQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHH---c-----------CC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11111   0           00 012234556779999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8e-45  Score=339.83  Aligned_cols=257  Identities=22%  Similarity=0.317  Sum_probs=200.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||+||+|... +++.||+|++.+...........+..|+.++..++|+||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36889999999999999999876 68999999997543333444567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g-----ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG-----FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            999999999999764  37899999999999999999999999     99999999999999999999999999976532


Q ss_pred             CCce---------------------------------eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCC
Q 018047          220 GQET---------------------------------YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR  266 (361)
Q Consensus       220 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  266 (361)
                      ....                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            1100                                 0012357999999999998889999999999999999999999


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 018047          267 RAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVR--TESSERPSMAECVKE  339 (361)
Q Consensus       267 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rpt~~ell~~  339 (361)
                      .||.....      ......+......+  .+.+..       ..+..+.+++.+|+.  .++..||+++|+++|
T Consensus       234 ~Pf~~~~~------~~~~~~i~~~~~~~--~~p~~~-------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETP------QETYKKVMNWKETL--IFPPEV-------PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCH------HHHHHHHHcCcCcc--cCCCcC-------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            99964321      11111111110000  011110       123447778877654  233356899999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.5e-45  Score=342.15  Aligned_cols=258  Identities=20%  Similarity=0.271  Sum_probs=202.5

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .|..++.||+|+||+||+|... +++.||+|++.............+..|+.+++.++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999876 689999999976544444556678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG-----FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            999999999997643  6889999999999999999999999     999999999999999999999999997643210


Q ss_pred             Cce---------------------------------------------eeeeecccccCccCcccccCCCCCccchhHHH
Q 018047          221 QET---------------------------------------------YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAF  255 (361)
Q Consensus       221 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  255 (361)
                      ...                                             ......+||+.|+|||++....++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            000                                             00123479999999999988889999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHc--cCCCCCCCCCH
Q 018047          256 GVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRC--VRTESSERPSM  333 (361)
Q Consensus       256 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~dp~~Rpt~  333 (361)
                      ||++|||++|..||......   .   ...........+      ..   ......+.++.+|+.+|  +..+|..||++
T Consensus       235 G~il~elltG~~Pf~~~~~~---~---~~~~i~~~~~~~------~~---~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPT---E---TQLKVINWENTL------HI---PPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHH---H---HHHHHHcccccc------CC---CCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            99999999999999643321   1   111111100000      00   00112234578888884  45566669999


Q ss_pred             HHHHHHHH
Q 018047          334 AECVKELQ  341 (361)
Q Consensus       334 ~ell~~l~  341 (361)
                      .+++.|-.
T Consensus       300 ~~~l~hp~  307 (381)
T cd05626         300 DDIKAHPF  307 (381)
T ss_pred             HHHhcCcc
Confidence            99999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=327.82  Aligned_cols=257  Identities=28%  Similarity=0.406  Sum_probs=208.0

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .|+..++||+|+||+||++... +++.||+|++.............+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3778899999999999999976 689999999875443333334567789999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+.+     ++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER-----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            999999999886654457999999999999999999999999     999999999999999999999999999876433


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ..   .....|++.|+|||++....++.++||||||+++|+|++|+.||......   .....+.....          .
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~~~~~~~----------~  219 (285)
T cd05605         156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREEVERRVK----------E  219 (285)
T ss_pred             Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHHHHHHhh----------h
Confidence            22   12346899999999998888999999999999999999999999643221   11111111100          0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                      .  ...++...+..+.+|+.+||..||++||     ++.++++|.+
T Consensus       220 ~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~  263 (285)
T cd05605         220 D--QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF  263 (285)
T ss_pred             c--ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence            0  0112333455689999999999999999     8999988743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.2e-45  Score=335.29  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=201.3

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      ++||+|+||+||+|.+. +++.||+|++.............+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999977 6899999999765444444556788899999998 699999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++........  
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--  151 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--  151 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence            9999988654  37999999999999999999999999     99999999999999999999999999874322111  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC--chhHHHHHHH-HhhhhhhhhhhcCcc
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN--DQNLVLQVRH-ILNDRKKLRKVIDPE  301 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~  301 (361)
                      ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......  .......... .....          
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------  221 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------  221 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----------
Confidence            2234578999999999998899999999999999999999999996432211  1111111111 11110          


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPS------MAECVKELQ  341 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt------~~ell~~l~  341 (361)
                         ...+...+..+.+++.+||+.||.+|||      +.++++|-+
T Consensus       222 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~  264 (329)
T cd05588         222 ---IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF  264 (329)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence               0112223445889999999999999987      788887743

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-44  Score=333.28  Aligned_cols=247  Identities=26%  Similarity=0.332  Sum_probs=199.4

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.||+|+||+||+|..+ +++.||+|++.............+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999987 6899999998754333334456677788888876 699999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||+++     ++||||||+|||++.++.++|+|||++........  
T Consensus        81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~-----ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--  151 (320)
T cd05590          81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG-----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--  151 (320)
T ss_pred             chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence            9999998764  36899999999999999999999999     99999999999999999999999999875422211  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++....++.++|||||||++|+|++|+.||.....      ......+.....            
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~------------  213 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEV------------  213 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCC------------
Confidence            22345789999999999888999999999999999999999999964321      111122211111            


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSM------AECVKELQ  341 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~ell~~l~  341 (361)
                       ..+...+..+.+++.+||+.||++||++      +++++|-+
T Consensus       214 -~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~  255 (320)
T cd05590         214 -VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF  255 (320)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence             1122234568999999999999999998      77777743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-45  Score=342.28  Aligned_cols=258  Identities=22%  Similarity=0.318  Sum_probs=202.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+.+.||+|+||+||++... +++.||||++.+...........+.+|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888999999999999999876 68999999986543333344567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.++|+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG-----FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999999764  36899999999999999999999999     99999999999999999999999999964321


Q ss_pred             CCce---------------------------------------------eeeeecccccCccCcccccCCCCCccchhHH
Q 018047          220 GQET---------------------------------------------YVTARVLGTFGYFDPEYTSTGKLTLQSDVYA  254 (361)
Q Consensus       220 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  254 (361)
                      ....                                             ......+||+.|+|||++....++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            1000                                             0001246899999999998889999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCC---C
Q 018047          255 FGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSER---P  331 (361)
Q Consensus       255 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---p  331 (361)
                      |||++|||++|..||.....   .   .....+......+      .++   .....+..+.+++.+||. +|.+|   +
T Consensus       234 lGvil~elltG~~Pf~~~~~---~---~~~~~i~~~~~~~------~~p---~~~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENS---H---ETYRKIINWRETL------YFP---DDIHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCH---H---HHHHHHHccCCcc------CCC---CCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            99999999999999964322   1   1111111110000      000   001123458899999998 66665   5


Q ss_pred             CHHHHHHHHH
Q 018047          332 SMAECVKELQ  341 (361)
Q Consensus       332 t~~ell~~l~  341 (361)
                      |+.|+++|.+
T Consensus       298 ~~~~~l~hp~  307 (377)
T cd05629         298 GAHEIKSHPF  307 (377)
T ss_pred             CHHHHhcCCC
Confidence            9999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-45  Score=340.90  Aligned_cols=258  Identities=26%  Similarity=0.333  Sum_probs=209.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+.+.||+|+||+||+|... +|+.||+|++.............+..|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36889999999999999999987 69999999997654334345667889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++..+..
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g-----iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG-----FIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999999765  47899999999999999999999999     99999999999999999999999999987644


Q ss_pred             CC---------------------------ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 018047          220 GQ---------------------------ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLN  272 (361)
Q Consensus       220 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  272 (361)
                      ..                           .........||+.|+|||++....++.++|||||||++|+|++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                           001123356899999999999889999999999999999999999999643


Q ss_pred             CCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHH
Q 018047          273 QGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPS-MAECVKELQ  341 (361)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~ell~~l~  341 (361)
                      ..      ......+......+   ..+.      ....+..+.+++.+||. ||.+||+ +.++++|.+
T Consensus       234 ~~------~~~~~~i~~~~~~~---~~p~------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         234 TL------QETYNKIINWKESL---RFPP------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             CH------HHHHHHHhccCCcc---cCCC------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            31      11111111100000   0000      01134568999999997 9999999 999999854

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.3e-45  Score=335.58  Aligned_cols=247  Identities=24%  Similarity=0.284  Sum_probs=200.0

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKG  145 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g  145 (361)
                      +.||+|+||+||++... +|+.||+|++.............+..|+.++..++||||+++++++.+++..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999976 68999999997654333444566778999999999999999999999999999999999999


Q ss_pred             chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          146 NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      +|.+++...  ..+++..+..++.|++.||+|||+ +|     ++||||||+|||++.++.+||+|||++........  
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~-----ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--  151 (325)
T cd05594          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--  151 (325)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC-----EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence            999988654  368999999999999999999997 68     99999999999999999999999999875422211  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ...........             
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~~~~~~i~~~~-------------  212 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEE-------------  212 (325)
T ss_pred             ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH------HHHHHHHhcCC-------------
Confidence            12235689999999999888999999999999999999999999954321      11111111110             


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                      ...+...+..+.+++.+||+.||++|+     ++.++++|.+
T Consensus       213 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         213 IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence            111222345589999999999999996     9999998843

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-44  Score=329.18  Aligned_cols=269  Identities=22%  Similarity=0.324  Sum_probs=200.7

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|... +++.||+|++.....  ......+.+|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            357999999999999999999987 689999999865422  22234567899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||++ ++|.+++... ...+++..+..++.|++.||+|||+++     ++||||||+|||++.++.+||+|||++....
T Consensus        82 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          82 FEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY-----ILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            99996 5888877653 236889999999999999999999999     9999999999999999999999999987543


Q ss_pred             CCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh-----
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK-----  292 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  292 (361)
                      ....  ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||....+.  ......+........     
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         155 VPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             CCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhcc
Confidence            2221  1223467999999998754 45788999999999999999999999643221  111111111100000     


Q ss_pred             ---hhhhhcCcccc---CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 ---KLRKVIDPELS---RSSYT-----MESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ---~~~~~~~~~~~---~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         ...........   .....     ...+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~  290 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY  290 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence               00000000000   00000     001245789999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-44  Score=332.41  Aligned_cols=249  Identities=28%  Similarity=0.364  Sum_probs=199.5

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHH---HhcCCCcceeEEEEEEcCCEEEEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDIL---SRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      |++.+.||+|+||.||+|.+. +|+.||||++.............+..|+.++   +.++||||+++++++.+++..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999976 6899999999754333333445666676665   456799999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|..++..   ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK-----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999988864   36899999999999999999999999     9999999999999999999999999987542


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.....      ......+.....      
T Consensus       153 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~~~------  218 (324)
T cd05589         153 GFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVNDEV------  218 (324)
T ss_pred             CCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC------
Confidence            2211  22345789999999999888999999999999999999999999964321      111111111110      


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKEL  340 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l  340 (361)
                             ..+...+..+.+++.+||+.||++||     ++.+++++.
T Consensus       219 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         219 -------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             -------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence                   11222345588999999999999999     688888875

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.2e-44  Score=331.78  Aligned_cols=250  Identities=28%  Similarity=0.377  Sum_probs=201.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC-CcceeEEEEEEcCCEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +|++.+.||+|+||.||+|... +++.||+|++.+...........+..|..++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999977 578999999976433334445677889999999976 46888999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999999997643  6899999999999999999999999     99999999999999999999999999875322


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   .   .....+....        
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~---~~~~~i~~~~--------  217 (324)
T cd05587         154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---D---ELFQSIMEHN--------  217 (324)
T ss_pred             CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---H---HHHHHHHcCC--------
Confidence            211  22345789999999999988999999999999999999999999964321   1   1111111111        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSM-----AECVKE  339 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~ell~~  339 (361)
                           ...+...+..+.+++.+||..||++|++.     +++++|
T Consensus       218 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 -----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 11122234558899999999999999976     778776

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.8e-44  Score=321.11  Aligned_cols=256  Identities=25%  Similarity=0.380  Sum_probs=204.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      .+|++.+.||+|+||.||+|.++    .+..||+|.+...  ........+.+|+.++..++||||+++++++..++..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG--CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC--CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            45888999999999999999764    3568999998653  22233467889999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++     ++||||||+|||++.++.++++|||.+..
T Consensus        83 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~-----iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG-----YVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeeccccHhhEEEcCCCcEEECCCccccc
Confidence            9999999999999987643 36899999999999999999999999     99999999999999999999999998765


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      ...... .......++..|+|||.+....++.++|||||||++||+++ |..||.....   ..   ..... .+..   
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~---~~~~~-~~~~---  225 (266)
T cd05064         157 DKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QD---VIKAV-EDGF---  225 (266)
T ss_pred             ccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HH---HHHHH-HCCC---
Confidence            432211 11112335678999999988999999999999999999775 9999954321   11   11111 1100   


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                              ....+..++..+.+++.+||+.+|++|||++++++.|.++
T Consensus       226 --------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 --------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                    0112334556699999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.2e-44  Score=320.88  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=206.5

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|...+.||+|+||.||+|... +++.+|+|.+...    ......+.+|+++++.++|+||+++++++..++..+++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            4778889999999999999976 5889999988632    2235678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++.......+++..++.++.|+++||+|||+++     ++|+||||+||+++.++.+||+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            999999999997655567899999999999999999999999     999999999999999999999999999876543


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ... ......++..|+|||.+....++.++|||||||++|||++ |..||....   ....   .......       ..
T Consensus       158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~~---~~~~~~~-------~~  223 (263)
T cd05052         158 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQV---YELLEKG-------YR  223 (263)
T ss_pred             eee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHH---HHHHHCC-------CC
Confidence            221 1112234567999999988889999999999999999998 888885321   1111   1111100       00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                           ...+...+..+.+++.+||+.||++|||+.++++.|+.++
T Consensus       224 -----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         224 -----MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence                 1122234456899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.1e-45  Score=337.53  Aligned_cols=258  Identities=23%  Similarity=0.314  Sum_probs=207.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+.+.||+|+||+||++... +|+.||+|++.............+..|+.+++.++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999977 68999999997654333445567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++..+..
T Consensus        81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~-----i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG-----YVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            9999999999997652 37899999999999999999999999     99999999999999999999999999987654


Q ss_pred             CCceeeeeecccccCccCccccc------CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTS------TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      .... ......||+.|+|||++.      ...++.++|||||||++|+|++|+.||.....      ......+......
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~  227 (330)
T cd05601         155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRF  227 (330)
T ss_pred             CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCc
Confidence            3322 223346899999999876      45678999999999999999999999954321      1111221111000


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                          +  ..   ......+..+.+|+.+||+ +|++|||+++++.|-.
T Consensus       228 ----~--~~---~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~  265 (330)
T cd05601         228 ----L--KF---PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF  265 (330)
T ss_pred             ----c--CC---CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence                0  00   0111234558899999998 9999999999998744

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.4e-44  Score=332.11  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.||+|+||+||+|... +++.+|+|++.+...........+..|+.++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999977 6889999999865444445556778899988877 799999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|..++...  ..+++..+..++.|++.||+|||+++     ++||||||+|||++.++.+||+|||++........  
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--  151 (329)
T cd05618          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--  151 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence            9999988654  37899999999999999999999999     99999999999999999999999999875322111  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC--chhHHHHHH-HHhhhhhhhhhhcCcc
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN--DQNLVLQVR-HILNDRKKLRKVIDPE  301 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~  301 (361)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .......+. ......          
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------  221 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------  221 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------
Confidence            2234578999999999999999999999999999999999999995322111  111111111 111110          


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPS------MAECVKEL  340 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt------~~ell~~l  340 (361)
                         ...+...+..+.+++.+||+.||++||+      +.++++|-
T Consensus       222 ---~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp  263 (329)
T cd05618         222 ---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  263 (329)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence               1122233455889999999999999998      57887774

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.3e-44  Score=321.34  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=206.9

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|++.+.||+|+||.||+|...++..||+|.+...    ......+.+|+.+++.++|+||+++++.+.+.+..+++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            468889999999999999999887888999987542    2235678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.......+++..+..++.|++.||+|||+.+     ++|+||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-----YIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            999999999997655567899999999999999999999999     999999999999999999999999999876543


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ... ......++..|+|||.+....++.++||||||+++|+|++ |..||....   .......+.   ..       ..
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~---~~-------~~  222 (261)
T cd05072         157 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSALQ---RG-------YR  222 (261)
T ss_pred             cee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHHHH---cC-------CC
Confidence            321 1222345678999999888889999999999999999998 999985321   111111111   00       00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                           .......+..+.+++.+||+.+|++|||++++++.|++
T Consensus       223 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         223 -----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 01111234568999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-44  Score=330.51  Aligned_cols=245  Identities=29%  Similarity=0.421  Sum_probs=195.3

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      ++||+|+||+||+|... +++.||+|++.............+..|..++..+ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999976 5889999998764333333444556677777654 899999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++....  .+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++........  
T Consensus        81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~-----ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--  151 (316)
T cd05592          81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG-----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--  151 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence            99999987643  6899999999999999999999999     99999999999999999999999999976433221  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..   ....+....             
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~---~~~~i~~~~-------------  212 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DE---LFDSILNDR-------------  212 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HH---HHHHHHcCC-------------
Confidence            23345789999999999888899999999999999999999999964321   11   111111111             


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSMA-ECVKE  339 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ell~~  339 (361)
                      ...+...+..+.+++.+||+.||++||++. ++++|
T Consensus       213 ~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         213 PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            112223345588999999999999999875 66664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.8e-45  Score=318.14  Aligned_cols=263  Identities=24%  Similarity=0.347  Sum_probs=204.4

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc-ceeEEEEEEcCC------
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN-LVSLIGYCADGK------  133 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~------  133 (361)
                      .|...++||+|+||+||+|+.+ +|+.||+|++......+. .-....+|+.+++.|+|+| |+.+++++...+      
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4666677999999999999977 799999999987643211 2334567999999999999 999999998877      


Q ss_pred             EEEEEEEecCCCchhhhcccCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGE--PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      .+++|+||+.. +|..|+.....  ..++...+..+++||+.||+|||+++     |+||||||.|||++++|.+||+||
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~-----IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG-----ILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCcceEEECCCCcEeeecc
Confidence            89999999965 99999987653  36777899999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      |+|+.+.-...  .....++|..|.|||++.+. .|+...||||+|||++||+++++.|....+      ..++..++.-
T Consensus       165 GlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se------~~ql~~If~~  236 (323)
T KOG0594|consen  165 GLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE------IDQLFRIFRL  236 (323)
T ss_pred             chHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH------HHHHHHHHHH
Confidence            99997643332  24456789999999987766 799999999999999999999999975544      2222222221


Q ss_pred             hhhhhhhcCccc----------c----CCCCCHHHH---HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          291 RKKLRKVIDPEL----------S----RSSYTMESI---AMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       291 ~~~~~~~~~~~~----------~----~~~~~~~~~---~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .+.-.+..-|..          .    ........+   ....+++.+||+.+|.+|.|++.+++|
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111111111100          0    001111111   367899999999999999999999998

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.1e-44  Score=322.83  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=198.4

Q ss_pred             ecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCch
Q 018047           69 LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL  147 (361)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  147 (361)
                      ||+|+||+||++..+ +|+.||+|.+.............+..|+++++.++||||+++++++.++...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999976 6999999998654333333344566799999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeee
Q 018047          148 QDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA  227 (361)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (361)
                      .+++.......+++..+..++.|++.||+|||+.|     ++||||||+||+++.++.++|+|||++........   ..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~  152 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD-----IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT  152 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC-----EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence            99887655567899999999999999999999999     99999999999999999999999999987654322   22


Q ss_pred             ecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCC
Q 018047          228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY  307 (361)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (361)
                      ...|+..|+|||++....++.++|||||||++|+|++|+.||.......  ...........          .....  .
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~----------~~~~~--~  218 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE----------DEVKF--E  218 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc----------ccccc--c
Confidence            3468999999999988889999999999999999999999996432211  11111111111          01100  0


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          308 TMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       308 ~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ....+.++.+|+.+||+.||++||++.|+++.+
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            112344589999999999999999996655433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-45  Score=319.40  Aligned_cols=283  Identities=25%  Similarity=0.385  Sum_probs=215.4

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc-----
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD-----  131 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----  131 (361)
                      .+...|...+.||+|+||.|..+..+ +|+.||||++..+. ..........+|+++|+.++|+||+.+.+++..     
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            34456777789999999999999987 79999999986443 444556677789999999999999999999855     


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      -+.+|+|+|+|+ -+|...++..  +.++...+..+++|++.||.|+|+-+     ++||||||.|+|++.+..+||+||
T Consensus        98 f~DvYiV~elMe-tDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn-----ViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   98 FNDVYLVFELME-TDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN-----VIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             cceeEEehhHHh-hHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc-----ccccccchhheeeccCCCEEeccc
Confidence            357899999994 5999999874  35999999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccc-cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH-----
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR-----  285 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----  285 (361)
                      |+|+..............+.|.+|.|||++ ....|+.+.||||.|||+.||++|++.|.+.+...+..++..+-     
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            999987543222334567889999999965 55789999999999999999999999997765433333322211     


Q ss_pred             ----HHhhhhhhhhhhc--CccccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 018047          286 ----HILNDRKKLRKVI--DPELSRSSY---TMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGL  351 (361)
Q Consensus       286 ----~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~  351 (361)
                          .+.++  .....+  .+..+..++   =...+....+|+.+||..||.+|+|++|+|.|.--.-+.+....
T Consensus       250 e~l~~i~s~--~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE  322 (359)
T KOG0660|consen  250 EDLQKIRSE--KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE  322 (359)
T ss_pred             HHHHHhccH--HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence                00000  000000  011111110   11333567899999999999999999999999765554444433

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.2e-44  Score=318.43  Aligned_cols=261  Identities=21%  Similarity=0.375  Sum_probs=211.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+.............+.+|+.+++.++|||++++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47899999999999999999976 68999999886544444455667888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          140 EYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       140 e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++...
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            999999999888532  2345889999999999999999999999     999999999999999999999999999876


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....  ......|++.|+|||.+....++.++|+||||+++|+|++|+.||.....    ........ ..      ..
T Consensus       157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~-~~------~~  223 (267)
T cd08228         157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQK-IE------QC  223 (267)
T ss_pred             cchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHH-Hh------cC
Confidence            44322  11234678899999998888899999999999999999999999853221    11111111 00      00


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ..+    .......+..+.+++.+||+.+|++||++.++++.++++
T Consensus       224 ~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         224 DYP----PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCC----CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            011    111234556799999999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.6e-44  Score=346.37  Aligned_cols=252  Identities=20%  Similarity=0.267  Sum_probs=203.9

Q ss_pred             CCCCCceecccCceEEEEEEEc-C-CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-S-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .|...+.||+|++|.||+|... + +..||+|.+..   ........+.+|+.++..++||||+++++++.+++..|+||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML---NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            3888999999999999999865 4 67888887643   23344456788999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          140 EYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       140 e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||+++|+|.+++...  ....+++..+..++.|++.||.|||+++     |+||||||+|||++.++.+||+|||++..+
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK-----MMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            999999999987542  2346889999999999999999999999     999999999999999999999999999877


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ............+||+.|+|||++....++.++|||||||++|+|++|+.||.....      ...........      
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~------  287 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGK------  287 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC------
Confidence            544332233456799999999999888999999999999999999999999953221      11111111110      


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .      ...+...+..+.+++.+||+.||++||++.+++.+
T Consensus       288 ~------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        288 Y------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             C------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            0      11122234568999999999999999999999865

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-44  Score=341.20  Aligned_cols=257  Identities=21%  Similarity=0.272  Sum_probs=201.1

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .|+..+.||+|+||+||+|... +++.||+|++.............+.+|+.+++.++||||+++++.+.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999976 688999999875433334456678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.+.+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~-----ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999997643  6889999999999999999999999     999999999999999999999999997533110


Q ss_pred             C---------------------------------------------ceeeeeecccccCccCcccccCCCCCccchhHHH
Q 018047          221 Q---------------------------------------------ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAF  255 (361)
Q Consensus       221 ~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  255 (361)
                      .                                             ........+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                             0000123468999999999988899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---
Q 018047          256 GVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPS---  332 (361)
Q Consensus       256 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---  332 (361)
                      ||++|||++|+.||......      .............      ..   ......+..+.+++.+|+ .+|.+|++   
T Consensus       235 Gvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~------~~---p~~~~~s~~~~~li~~l~-~~p~~R~~~~~  298 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPL------ETQMKVINWQTSL------HI---PPQAKLSPEASDLIIKLC-RGPEDRLGKNG  298 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHH------HHHHHHHccCCCc------CC---CCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence            99999999999999643211      1111111100000      00   011122345778888876 59999987   


Q ss_pred             HHHHHHHHH
Q 018047          333 MAECVKELQ  341 (361)
Q Consensus       333 ~~ell~~l~  341 (361)
                      +.++++|-.
T Consensus       299 ~~ei~~hp~  307 (382)
T cd05625         299 ADEIKAHPF  307 (382)
T ss_pred             HHHHhcCCC
Confidence            999988743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-44  Score=331.81  Aligned_cols=247  Identities=26%  Similarity=0.334  Sum_probs=200.0

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      ++||+|+||+||+|+.. +++.||+|++.............+..|.+++..+ +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999987 5889999998764333344456677789998876 799999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||.|||++|     ++||||||+|||++.++.++|+|||++........  
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  151 (321)
T cd05591          81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG-----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--  151 (321)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence            9999998764  36899999999999999999999999     99999999999999999999999999875432221  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++....++.++|||||||++|+|++|+.||.....   .   .....+.....            
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~---~~~~~i~~~~~------------  213 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---D---DLFESILHDDV------------  213 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---H---HHHHHHHcCCC------------
Confidence            22335689999999999888999999999999999999999999964321   1   11122211110            


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERP-------SMAECVKELQ  341 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-------t~~ell~~l~  341 (361)
                       ..+...+..+.+++.+||+.||++||       ++.++++|.+
T Consensus       214 -~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~  256 (321)
T cd05591         214 -LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF  256 (321)
T ss_pred             -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence             11122345588999999999999999       8999998853

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.9e-44  Score=325.68  Aligned_cols=265  Identities=22%  Similarity=0.375  Sum_probs=198.6

Q ss_pred             CCCCCceecccCceEEEEEEEc--CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc---CCCcceeEEEEEE-----c
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL---DHPNLVSLIGYCA-----D  131 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~-----~  131 (361)
                      +|++.+.||+|+||+||+|...  ++..||+|.+....... .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            6889999999999999999874  46789999987543222 2233455677777766   6999999999985     3


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      ....++||||++ ++|.+++.......+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~-----iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999996 59999997765567899999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      |++.......   ......||+.|+|||.+....++.++|||||||++|||++|+.||......   .....+.......
T Consensus       155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~  228 (290)
T cd07862         155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLP  228 (290)
T ss_pred             cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCC
Confidence            9998664332   223456899999999998888999999999999999999999999654321   1111111110000


Q ss_pred             --hhhh-------hhcCcccc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          292 --KKLR-------KVIDPELS--RSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       292 --~~~~-------~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                        ....       ..+.+...  ........+..+.+++.+||+.||++|||+.|+++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence              0000       00000000  000011234567899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.6e-45  Score=341.66  Aligned_cols=258  Identities=21%  Similarity=0.278  Sum_probs=202.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.............+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999976 68999999986543333334566888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999997643  6889999999999999999999999     99999999999999999999999999853310


Q ss_pred             CCc-----------------------------------------eeeeeecccccCccCcccccCCCCCccchhHHHHHH
Q 018047          220 GQE-----------------------------------------TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVV  258 (361)
Q Consensus       220 ~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  258 (361)
                      ...                                         ........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            000                                         000123479999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHH
Q 018047          259 LLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP---SMAE  335 (361)
Q Consensus       259 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---t~~e  335 (361)
                      +|||++|+.||......   .   ............      .   .......+..+.+++.+|+ .+|.+|+   |+.+
T Consensus       234 lyell~G~~Pf~~~~~~---~---~~~~i~~~~~~~------~---~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e  297 (376)
T cd05598         234 LYEMLVGQPPFLADTPA---E---TQLKVINWETTL------H---IPSQAKLSREASDLILRLC-CGAEDRLGKNGADE  297 (376)
T ss_pred             eeehhhCCCCCCCCCHH---H---HHHHHhccCccc------c---CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence            99999999999643321   1   111111100000      0   0001123345778888876 5999999   9999


Q ss_pred             HHHHHH
Q 018047          336 CVKELQ  341 (361)
Q Consensus       336 ll~~l~  341 (361)
                      +++|.+
T Consensus       298 ll~h~~  303 (376)
T cd05598         298 IKAHPF  303 (376)
T ss_pred             HhCCCC
Confidence            999854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-44  Score=339.06  Aligned_cols=258  Identities=22%  Similarity=0.284  Sum_probs=204.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||++... +++.||+|++.............+..|+.+++.++||||+++++++.+++..|+|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            356899999999999999999987 6899999998654333333445677899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++...   .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++....
T Consensus       122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999998653   5788899999999999999999999     9999999999999999999999999998664


Q ss_pred             CCCceeeeeecccccCccCcccccCC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTG----KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .... .......||+.|+|||++...    .++.++|||||||++|||++|+.||.....      ......+......+
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~  266 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSL  266 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcC
Confidence            3221 112235699999999987543    478899999999999999999999964321      11122221111100


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSE--RPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~l~  341 (361)
                            .++   .....+..+.+++.+||+.+|++  |+|++++++|.+
T Consensus       267 ------~~~---~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~  306 (370)
T cd05596         267 ------TFP---DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF  306 (370)
T ss_pred             ------CCC---CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence                  000   01123456899999999999988  999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4e-44  Score=331.61  Aligned_cols=262  Identities=26%  Similarity=0.384  Sum_probs=205.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc-C
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD-G  132 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~  132 (361)
                      ++|++.+.||+|+||.||+|...      +++.||+|++....  .......+..|+.++.++ +|+||+++++++.. +
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            36899999999999999999642      25789999986432  223345677899999999 79999999998865 4


Q ss_pred             CEEEEEEEecCCCchhhhcccCC---------------------------------------------------------
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIG---------------------------------------------------------  155 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  155 (361)
                      ..++++|||+++|+|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            57889999999999999885321                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeeccccc
Q 018047          156 --EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF  233 (361)
Q Consensus       156 --~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  233 (361)
                        ...+++..+..++.|++.||+|||+++     |+||||||+|||++.++.++|+|||++..+.............++.
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~-----ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence              126789999999999999999999999     9999999999999999999999999998764433222223345677


Q ss_pred             CccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHH
Q 018047          234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESI  312 (361)
Q Consensus       234 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (361)
                      .|+|||++....++.++|||||||++|||++ |..||......  ......    .....      .     ...+...+
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~----~~~~~------~-----~~~~~~~~  302 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRR----LKEGT------R-----MRAPEYAT  302 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHH----HhccC------C-----CCCCccCC
Confidence            8999999989999999999999999999998 99998643221  111111    11100      0     01122334


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          313 AMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       313 ~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      ..+.+++.+||+.+|++||++.|++++|.+++..
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            5689999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3e-44  Score=331.31  Aligned_cols=253  Identities=22%  Similarity=0.323  Sum_probs=201.3

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.||+|+||+||+|... +++.||+|++.............+..|+.++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 6889999999765444444566788899999888 699999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++........  
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  151 (327)
T cd05617          81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG-----IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--  151 (327)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence            9999988654  36999999999999999999999999     99999999999999999999999999875322111  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......................         .   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~---  219 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK---------P---  219 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC---------C---
Confidence            2234578999999999988999999999999999999999999996543322222222211111110         0   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPS------MAECVKEL  340 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt------~~ell~~l  340 (361)
                      ...+...+..+.+++.+||+.||++|++      ++++++|-
T Consensus       220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence            1122223455889999999999999998      46777764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.5e-44  Score=330.84  Aligned_cols=266  Identities=24%  Similarity=0.353  Sum_probs=205.2

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||++.+. ++..+|+|.+...  ........+.+|+++++.++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            357999999999999999999987 6889999988653  2233456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS-SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+. +     ++|+||||+|||++.++.+||+|||++..+
T Consensus        82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          82 MEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC-----EEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            9999999999999764  3688999999999999999999975 6     999999999999999999999999999765


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh------
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR------  291 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  291 (361)
                      ....    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.......   ....+.......      
T Consensus       155 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  227 (333)
T cd06650         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE---LELMFGCPVEGDPAESET  227 (333)
T ss_pred             hhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH---HHHHhcCcccCCcccccc
Confidence            3321    223468999999999988889999999999999999999999996432210   000000000000      


Q ss_pred             ------------------------hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 ------------------------KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 ------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                                              ..+...+.............+.++.+|+.+||+.||++|||+.|+++|-.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~  301 (333)
T cd06650         228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF  301 (333)
T ss_pred             CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence                                    00000000000000001112456889999999999999999999998866

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-43  Score=317.64  Aligned_cols=258  Identities=28%  Similarity=0.475  Sum_probs=206.9

Q ss_pred             CCCCCCceecccCceEEEEEEEcC----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|+..+.||+|+||+||+|.+..    ...||+|.+...  ........+.+|+.+++.++||||+++++++.+++..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC--CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            468899999999999999998752    357999988643  23334567888999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      ++|||+++++|.+++.... ..+++..+..++.|++.||+|||+++     ++|+||||+||+++.++.++|+|||++..
T Consensus        82 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~-----i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          82 IITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCCEEECccchhhc
Confidence            9999999999999997643 37899999999999999999999999     99999999999999999999999999988


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      +.............+++.|+|||.+....++.++||||||+++|+|++ |..||....   .......   .... .   
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~---~~~~-~---  225 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKA---VEDG-Y---  225 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHH---HHcC-C---
Confidence            753222222222344678999999988889999999999999999998 999984321   1111111   1100 0   


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                        .      ...+...+..+.+++.+||+.+|++||+++|++++|++++
T Consensus       226 --~------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         226 --R------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             --C------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence              0      0112233456899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.2e-44  Score=322.63  Aligned_cols=251  Identities=27%  Similarity=0.373  Sum_probs=201.4

Q ss_pred             ecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCch
Q 018047           69 LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL  147 (361)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  147 (361)
                      ||+|+||+||++.+. +|+.+|+|.+.............+..|+.+++.++|+||+++.+++..+...|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999976 6899999998754433333445677899999999999999999999999999999999999999


Q ss_pred             hhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceee
Q 018047          148 QDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV  225 (361)
Q Consensus       148 ~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (361)
                      .+++...  ....+++..+..++.|++.||+|||+++     ++||||||+||+++.++.++|+|||++..+......  
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--  153 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-----IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--  153 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence            9887432  2346899999999999999999999999     999999999999999999999999999866543321  


Q ss_pred             eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCC
Q 018047          226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS  305 (361)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........  .........          ...   .
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~----------~~~---~  218 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL----------NDS---V  218 (280)
T ss_pred             ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc----------ccC---C
Confidence            2234689999999999989999999999999999999999999964332111  001111110          000   1


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          306 SYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       306 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                      ..+...+..+.+++.+||+.||++||     +++++++|-+
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~  259 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL  259 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence            12233455689999999999999999     8899998854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.9e-44  Score=336.62  Aligned_cols=262  Identities=23%  Similarity=0.363  Sum_probs=206.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADG  132 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  132 (361)
                      .++|.++++||+|+||+||+|++.      .+..||||++...  ........+.+|++++..++ ||||+++++++.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            457889999999999999999863      1347999998643  22334567889999999996 99999999999999


Q ss_pred             CEEEEEEEecCCCchhhhcccCC---------------------------------------------------------
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIG---------------------------------------------------------  155 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  155 (361)
                      +..|+||||+++|+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999998875321                                                         


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCe
Q 018047          156 -------------------------------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNV  198 (361)
Q Consensus       156 -------------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Ni  198 (361)
                                                           ...+++..+..++.|++.||+|||+.+     ++|+||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dikp~Ni  268 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN-----CVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChHhE
Confidence                                                 124778888999999999999999999     99999999999


Q ss_pred             eeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 018047          199 LLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVND  277 (361)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~  277 (361)
                      |++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.....  .
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~--~  346 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV--D  346 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch--h
Confidence            999999999999999986643322222223456788999999988889999999999999999997 8898853221  1


Q ss_pred             hhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          278 QNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      ......+    ...      ..     ...+...+..+.+++.+||+.||++|||+.++.+.|++++.
T Consensus       347 ~~~~~~~----~~~------~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 STFYNKI----KSG------YR-----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHHH----hcC------CC-----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            1111110    000      00     11223345668999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-45  Score=308.90  Aligned_cols=258  Identities=27%  Similarity=0.428  Sum_probs=210.0

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCc-----chhHHHHHHHHHHHHhc-CCCcceeEEEEEEc
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKE-----ADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD  131 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  131 (361)
                      .-..|...++||+|..++|.++.++ +|+.+|+|++.......     ..-.+.-..|+.+|+++ .||+|+.+.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3346788889999999999999876 79999999986542211     12234556799999998 69999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      +.-+++|+|.|+.|.|.||+.+.-  .+++.....++.|+.+|++|||.++     |+||||||+|||++++.+++|+||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~-----IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN-----IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh-----hhhcccChhheeeccccceEEecc
Confidence            999999999999999999998754  7999999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccC------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTST------GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      |+++.+..+..   ....+|||+|+|||.+..      ..|+...|+|+.|+|+|.|+.|.+||....      ....++
T Consensus       168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------QmlMLR  238 (411)
T KOG0599|consen  168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QMLMLR  238 (411)
T ss_pred             ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHHHHH
Confidence            99999987764   445789999999997643      468889999999999999999999995321      122222


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      -+..+...+..   |      .=.+.+....+||.+||+.||.+|.|++|+|.|..
T Consensus       239 ~ImeGkyqF~s---p------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf  285 (411)
T KOG0599|consen  239 MIMEGKYQFRS---P------EWADISATVKDLISRLLQVDPTKRITAKEALAHPF  285 (411)
T ss_pred             HHHhcccccCC---c------chhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence            22222222111   1      11233456889999999999999999999999876

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-44  Score=330.47  Aligned_cols=246  Identities=26%  Similarity=0.378  Sum_probs=198.2

Q ss_pred             ceecccCceEEEEEEEc----CCCEEEEEEeecCCC-CcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           67 NFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRF-KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      +.||+|+||.||++...    +++.||+|++..... ........+..|+.+++.++||||+++++++.+++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999853    478999999875322 1222345577899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++|+|.+++...+  .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG-----IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999999997643  6788899999999999999999999     9999999999999999999999999987542222


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .  ......||+.|+|||++....++.++|||||||++|||++|+.||.....      ...........          
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~----------  216 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGK----------  216 (323)
T ss_pred             C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC----------
Confidence            1  22335689999999999888899999999999999999999999964321      11112211111          


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKEL  340 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l  340 (361)
                         ...+...+..+.+++.+||+.||++||     ++.++++|.
T Consensus       217 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         217 ---LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence               111222344589999999999999999     899998875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.6e-44  Score=329.14  Aligned_cols=246  Identities=28%  Similarity=0.395  Sum_probs=195.9

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      ++||+|+||.||+|.++ +|+.||+|.+.............+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999987 6899999999754322233445566788888765 899999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.++|+|||++........  
T Consensus        81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05620          81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG-----IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--  151 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence            9999998764  36899999999999999999999999     99999999999999999999999999875322221  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||....   .....   ..+...        .+    
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~---~~~~~~--------~~----  213 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELF---ESIRVD--------TP----  213 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHH---HHHHhC--------CC----
Confidence            2234578999999999998899999999999999999999999995332   11111   111111        01    


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCH-HHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSM-AECVKEL  340 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-~ell~~l  340 (361)
                       ..+...+..+.+++.+||+.||++||++ +++++|.
T Consensus       214 -~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~  249 (316)
T cd05620         214 -HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHP  249 (316)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence             1112234558899999999999999998 4676553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.7e-44  Score=322.01  Aligned_cols=256  Identities=27%  Similarity=0.485  Sum_probs=205.3

Q ss_pred             CCCCCCceecccCceEEEEEEEcC------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      .+|.+.+.||+|+||.||+|...+      +..||+|.+...  ........+.+|+++++.++|+||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            357888999999999999998642      478999998643  223345788999999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC
Q 018047          135 RFLVYEYMQKGNLQDHLNGIG------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA  202 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~  202 (361)
                      .+++|||+++|+|.+++...+            ...+++..+..++.|++.|++|||++|     ++|+||||+||+++.
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~h~dlkp~nili~~  157 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGY  157 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-----eeccccccceEEEcC
Confidence            999999999999999997542            245788999999999999999999999     999999999999999


Q ss_pred             CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 018047          203 NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~  281 (361)
                      ++.++|+|||++................+++.|+|||++....++.++||||||+++|+|++ |..||.....   ....
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~  234 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVI  234 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH
Confidence            99999999999976543322222223345788999999988999999999999999999998 9999853321   1111


Q ss_pred             HHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         ......  ..          ...+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       235 ---~~~~~~--~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ---ECITQG--RL----------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---HHHHcC--Cc----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               111110  00          1112234456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.8e-44  Score=327.45  Aligned_cols=261  Identities=27%  Similarity=0.418  Sum_probs=206.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCC----EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      .+|+..+.||+|+||+||+|++. ++.    .||+|.+...  ........+.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            36899999999999999999865 343    3899988532  2233456788899999999999999999998765 56


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++     ++||||||+|||++.++.+||+|||++.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~-----iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR-----LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC-----eeccccchhheEecCCCcEEEccccccc
Confidence            79999999999999997643 36889999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+.............++..|+|||.+....++.++||||||+++|||++ |..||.....   ..    +......... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---~~----~~~~~~~~~~-  229 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SE----ISSILEKGER-  229 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HH----HHHHHhCCCC-
Confidence            7754333222222334678999999988999999999999999999998 9999853221   11    1111111100 


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                                ...+..++..+.+++.+||..||.+|||+.+++..+.++.....
T Consensus       230 ----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         230 ----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence                      01112233458899999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-44  Score=337.82  Aligned_cols=259  Identities=23%  Similarity=0.302  Sum_probs=204.4

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ..++|+..+.||+|+||.||++... +++.+|+|++.+...........+.+|+.+++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999987 688999999865433333345567889999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++|+|.+++...   .+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++..+
T Consensus       121 v~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~-----IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG-----LIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEECCCCCEEEEecccceec
Confidence            99999999999999653   5889999999999999999999999     999999999999999999999999999876


Q ss_pred             CCCCceeeeeecccccCccCcccccCC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTG----KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      ..... .......||+.|+|||++...    .++.++|||||||++|+|++|+.||.....      ......+......
T Consensus       193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~  265 (370)
T cd05621         193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNS  265 (370)
T ss_pred             ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCcc
Confidence            43221 122345799999999987653    378899999999999999999999964321      1111222111110


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSE--RPSMAECVKELQ  341 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~l~  341 (361)
                      +      .+   ......+..+.+++.+||..++.+  |+|+.|+++|.+
T Consensus       266 ~------~~---p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~  306 (370)
T cd05621         266 L------NF---PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF  306 (370)
T ss_pred             c------CC---CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence            0      00   011123455889999999865544  899999999965

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=337.30  Aligned_cols=241  Identities=29%  Similarity=0.475  Sum_probs=204.6

Q ss_pred             CCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           65 DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      .++.||.|+.|.||+|+.+ ++.||||+++.          .-..+|+.|+.|+||||+.+.|+|.....++||||||+.
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            3567999999999999988 78999998742          112488999999999999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |.|.+.++..  ..+....+..|..+||.|++|||.+.     |||||||.-||||+.+..|||+|||.++...+-.   
T Consensus       197 GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK-----IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---  266 (904)
T KOG4721|consen  197 GQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK-----IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---  266 (904)
T ss_pred             ccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh-----HhhhccCCCceEeeccceEEeccccchHhhhhhh---
Confidence            9999999874  47899999999999999999999999     9999999999999999999999999998775432   


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ..-.+.||..|||||++.+.+.+.|+|||||||+||||+||..||...+..   .+             +-.+-...+ .
T Consensus       267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AI-------------IwGVGsNsL-~  329 (904)
T KOG4721|consen  267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AI-------------IWGVGSNSL-H  329 (904)
T ss_pred             hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---ee-------------EEeccCCcc-c
Confidence            233578999999999999999999999999999999999999999543221   11             111111111 1


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      -..|..++.-+.-|+++||+..|..||++.+++.||+.+
T Consensus       330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            345666777799999999999999999999999999854

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4e-44  Score=329.96  Aligned_cols=250  Identities=26%  Similarity=0.360  Sum_probs=201.4

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +|.+.+.||+|+||+||+|... +++.||+|++.+...........+..|..++..+ +|++|+++++++.+.+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999977 5889999999765433334445567788888877 5899999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999999987643  6899999999999999999999999     99999999999999999999999999975432


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ......||+.|+|||++....++.++|||||||++|||++|+.||.....   ...   ...+....        
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~---~~~i~~~~--------  217 (323)
T cd05616         154 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DEL---FQSIMEHN--------  217 (323)
T ss_pred             CCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHH---HHHHHhCC--------
Confidence            211  22345789999999999999999999999999999999999999964321   111   11111111        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSM-----AECVKE  339 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~ell~~  339 (361)
                           ..++...+..+.+++.+||+.||++|++.     .++++|
T Consensus       218 -----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         218 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             -----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                 11222344568999999999999999984     677765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.6e-44  Score=322.37  Aligned_cols=256  Identities=29%  Similarity=0.431  Sum_probs=207.2

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |+..+.||+|+||+||++... +++.||+|.+.............+..|+.+++.++|++++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999977 6899999998765444334445677899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++.......+++..+..++.|++.||.|||+.+     ++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER-----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999999987655557999999999999999999999999     9999999999999999999999999997654332


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .   .....|++.|+|||++....++.++||||||+++|+|++|+.||..........   ........   ..      
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~~---~~------  221 (285)
T cd05630         157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKE---VQ------  221 (285)
T ss_pred             c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhhh---hh------
Confidence            2   123468999999999988899999999999999999999999996432211111   11111110   00      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                         ...+...+..+.+|+.+||+.||++|||     ++|+++|-+
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~  263 (285)
T cd05630         222 ---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL  263 (285)
T ss_pred             ---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence               0112223445889999999999999999     899999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.3e-45  Score=349.79  Aligned_cols=265  Identities=31%  Similarity=0.494  Sum_probs=221.1

Q ss_pred             CCCCCCceecccCceEEEEEEEcC------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      .+....+.||+|+||+||+|....      ...||||.++..  .+.....+|++|++++..++|||||+++|+|.+++.
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            345556789999999999998542      357999998643  344467899999999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCC--------CC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC
Q 018047          135 RFLVYEYMQKGNLQDHLNGIG--------EP----KMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA  202 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~--------~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~  202 (361)
                      .++|+|||..|+|.+||....        ..    .++..+.+.|+.|||.|++||-++.     ++||||...|+||.+
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~-----FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH-----FVHRDLATRNCLVGE  638 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-----ccccchhhhhceecc
Confidence            999999999999999996432        22    3888999999999999999999999     999999999999999


Q ss_pred             CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 018047          203 NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~  281 (361)
                      +..|||+|||+++.....+.......-.-..+|||||.+..+.|++++||||+||+|||+++ |+.||...   ..+..+
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl---Sn~EVI  715 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL---SNQEVI  715 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc---chHHHH
Confidence            99999999999998776665544433344679999999999999999999999999999999 78888533   333333


Q ss_pred             HHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 018047          282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG  350 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~  350 (361)
                      +.++.             ..+  -..|..+|.++..|+..||+.+|++||+++||-..|+......+..
T Consensus       716 e~i~~-------------g~l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~  769 (774)
T KOG1026|consen  716 ECIRA-------------GQL--LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY  769 (774)
T ss_pred             HHHHc-------------CCc--ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence            33332             111  3467788888999999999999999999999999999887766544

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9e-44  Score=334.96  Aligned_cols=264  Identities=20%  Similarity=0.253  Sum_probs=200.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..+|.+.+.||+|+||.||+|.+. +++.||+|...         ...+.+|+.+++.++||||+++++++..+...++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            357999999999999999999976 68999999643         12456799999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      +|++. ++|.+++...  ..+++..++.++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++....
T Consensus       162 ~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~-----IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        162 LPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR-----IIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            99995 6898888654  36889999999999999999999999     9999999999999999999999999997543


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCch-hHHHHHHHHhhhhh-----
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ-NLVLQVRHILNDRK-----  292 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~-----  292 (361)
                      .... .......||+.|+|||++....++.++|||||||++|||++|..||......... .....+..+....+     
T Consensus       234 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        234 DINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             cccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            2211 1223457999999999998889999999999999999999999887543221110 00011111100000     


Q ss_pred             -------hhhhhc-----CccccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 -------KLRKVI-----DPELSRSSY-----TMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 -------~~~~~~-----~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                             .+....     .........     ....+..+.+|+.+||+.||++|||++|+|+|-+
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~  378 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA  378 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence                   000000     000000000     1134567899999999999999999999998876

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.6e-44  Score=327.37  Aligned_cols=245  Identities=30%  Similarity=0.428  Sum_probs=195.3

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.||+|+||+||+|.+. +++.||+|++.............+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999987 5889999998754322223344566688888764 899999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||+++     ++||||||+|||++.++.+||+|||++........  
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~-----ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG-----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--  151 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence            9999999763  36889999999999999999999999     99999999999999999999999999875422221  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||....   ....   .......        .+    
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~---~~~i~~~--------~~----  213 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEEL---FQSIRMD--------NP----  213 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHH---HHHHHhC--------CC----
Confidence            2234578999999999988899999999999999999999999996432   1111   1111110        01    


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSMA-ECVKE  339 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ell~~  339 (361)
                       ..+...+..+.+++.+||+.||++||++. ++++|
T Consensus       214 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         214 -CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             -CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence             11222345588999999999999999997 77665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.5e-44  Score=321.05  Aligned_cols=255  Identities=28%  Similarity=0.460  Sum_probs=209.2

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .+|+..+.||.|+||.||+|...+++.+|+|.+....   ......+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            4588899999999999999998888999999986432   2234578889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.......+++..+..++.|++.||+|||++|     ++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN-----SIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            999999999998765667899999999999999999999999     999999999999999999999999999876443


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  .....++..|+|||......++.++||||||+++|+|++ |+.||.....   ......+   ...       ..
T Consensus       158 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~---~~~-------~~  222 (261)
T cd05148         158 VYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQI---TAG-------YR  222 (261)
T ss_pred             ccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHH---HhC-------Cc
Confidence            221  123345678999999888889999999999999999998 8999854321   1111111   110       00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                           ...+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 -----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                 111233445689999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.8e-44  Score=328.68  Aligned_cols=246  Identities=28%  Similarity=0.384  Sum_probs=199.7

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.||+|+||+||+|.+. +++.||+|++.+...........+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999987 5889999999765433344456677899999888 699999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++....  .+++..+..++.|++.||.|||+++     ++||||||+|||++.++.++|+|||++........  
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  151 (318)
T cd05570          81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG-----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--  151 (318)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence            99999987643  6899999999999999999999999     99999999999999999999999999865322211  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....   ...   ....+....             
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~---~~~~i~~~~-------------  212 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDE---LFQSILEDE-------------  212 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHH---HHHHHHcCC-------------
Confidence            1223468999999999998999999999999999999999999995332   111   111111110             


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSM-----AECVKEL  340 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~ell~~l  340 (361)
                      ...+...+..+.+|+.+||+.||++|||+     .+++++-
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~  253 (318)
T cd05570         213 VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP  253 (318)
T ss_pred             CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence            11122334568999999999999999999     9998874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.8e-44  Score=331.32  Aligned_cols=268  Identities=22%  Similarity=0.357  Sum_probs=199.0

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----CEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----KHR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  135 (361)
                      +|++.+.||+|+||.||+|... +|..||||++.... ........+.+|+.+++.++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            4788899999999999999976 68999999986432 2223345678899999999999999999987543     358


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |+||||+. ++|.+++...  ..+++..+..++.|+++||+|||++|     ++||||||+|||++.++.+||+|||++.
T Consensus        80 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          80 YVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCcEEEccCcccc
Confidence            99999995 6899988754  36899999999999999999999999     9999999999999999999999999997


Q ss_pred             cCCCCCc-eeeeeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh---
Q 018047          216 LMPEGQE-TYVTARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN---  289 (361)
Q Consensus       216 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---  289 (361)
                      ....... ........||+.|+|||++..  ..++.++|||||||++|+|++|+.||.......   ....+.....   
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~  228 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPS  228 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence            6432211 112234578999999998765  678899999999999999999999996433211   1111100000   


Q ss_pred             ---------h-hhhhhhhcCccccC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          290 ---------D-RKKLRKVIDPELSR--SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       290 ---------~-~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                               . .......+......  ...-...+..+.+++.+||+.||++|||+.|+++|-+
T Consensus       229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~  292 (338)
T cd07859         229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY  292 (338)
T ss_pred             HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence                     0 00000000000000  0000012345789999999999999999999999865

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.3e-44  Score=346.36  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=207.8

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC--
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK--  133 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  133 (361)
                      ....++|.+.+.||+|+||+||+|... +|+.||||++...... ......+.+|+.++..++|+|++++++.+...+  
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            334568999999999999999999876 6999999999765432 334556788999999999999999988765432  


Q ss_pred             ------EEEEEEEecCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc
Q 018047          134 ------HRFLVYEYMQKGNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE  205 (361)
Q Consensus       134 ------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~  205 (361)
                            .+++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+++     |+||||||+|||++.++.
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~-----IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH-----MIHRDIKSANILLCSNGL  181 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEeCCCC
Confidence                  3689999999999999986432  346889999999999999999999999     999999999999999999


Q ss_pred             EEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 018047          206 AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      +||+|||+++.+.............||+.|+|||++....++.++|||||||++|||++|+.||....      ....+.
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~  255 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMH  255 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHH
Confidence            99999999987644322223344679999999999998899999999999999999999999995321      111111


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ......      .      ...+...+..+.+++.+||+.||.+||++.+++++.
T Consensus       256 ~~~~~~------~------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        256 KTLAGR------Y------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             HHhcCC------C------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence            111110      0      112233455689999999999999999999999874

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.1e-44  Score=331.98  Aligned_cols=257  Identities=25%  Similarity=0.324  Sum_probs=203.0

Q ss_pred             CCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCC-CcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRF-KEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  135 (361)
                      +|++.+.||+|+||+||++...    +++.||+|++.+... ........+..|+.++..+ +|+||+++++++.+++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788899999999999998753    578999999875322 2223345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG-----IVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999998753  36899999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........  ........    
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~--~~~~~~~~----  226 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE--VSRRILKC----  226 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH--HHHHHhcC----
Confidence            65333221 22345789999999988764 478899999999999999999999964433222111  11111111    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                          ++.     .+...+..+.+++.+||+.||++||     +++++++|.+
T Consensus       227 ----~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         227 ----DPP-----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             ----CCC-----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence                111     1222345588999999999999999     7889998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-43  Score=315.56  Aligned_cols=250  Identities=27%  Similarity=0.427  Sum_probs=201.3

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      +|+..+.||+|+||.||++.++++..+|+|.+...    ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG----AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccC----CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            47888999999999999999887788999987533    22345788899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          81 MENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS-----FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            99999999987543 36899999999999999999999999     9999999999999999999999999998654332


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .. ......++..|+|||.+....++.++|+||||+++|+|++ |+.||....   .   ...+........        
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~---~~~~~~i~~~~~--------  219 (256)
T cd05114         155 YT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---N---YEVVEMISRGFR--------  219 (256)
T ss_pred             ee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---H---HHHHHHHHCCCC--------
Confidence            21 1112234568999999988889999999999999999999 899985332   1   111111111100        


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                          ...+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       220 ----~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 ----LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                001112234589999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-45  Score=320.04  Aligned_cols=271  Identities=27%  Similarity=0.357  Sum_probs=205.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-----EE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-----HR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~  135 (361)
                      .|...+++|+|+||.||+|... +++.||||+.....-       .-.+|+.+|+.++|||||++.-+|....     ..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            4777899999999999999976 689999999865421       1235999999999999999998886432     33


Q ss_pred             EEEEEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEeecC
Q 018047          136 FLVYEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFG  212 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg  212 (361)
                      .+||||+|. +|.++++..  ....++.-.+.-+++||.+||+|||+.|     |+||||||.|+|+|.+ |.+||||||
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~-----IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG-----ICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC-----cccCCCChheEEEcCCCCeEEeccCC
Confidence            589999987 999998743  2457888888889999999999999999     9999999999999977 999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH----
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI----  287 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----  287 (361)
                      .|+.+..+....   +...|..|.|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.++.++...+..+-..    
T Consensus       172 SAK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e  248 (364)
T KOG0658|consen  172 SAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE  248 (364)
T ss_pred             cceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence            999987666542   3457889999996654 67999999999999999999999999775543332222222110    


Q ss_pred             --hhhhhhhhhhcCccccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-HHHhhcC
Q 018047          288 --LNDRKKLRKVIDPELSRSS----YTMESIAMFANLASRCVRTESSERPSMAECVKELQ-LIIYTNS  348 (361)
Q Consensus       288 --~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~-~i~~~~~  348 (361)
                        ..-.....+.-.+.+....    .....+.+..+|+.++|..+|.+|.++.|++.|-- +.+.+.+
T Consensus       249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence              0001111111112222111    23344567899999999999999999999998754 5555553

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=311.33  Aligned_cols=256  Identities=25%  Similarity=0.355  Sum_probs=211.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +.|++-++||+|.|+.|+++.+. +|+.+|+|+++...+... ..+++.+|+.+-+.|+||||+++.+.+.+.+..|+|+
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45777788999999999999876 799999999987665544 5678999999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC---CcEEEeecCcccc
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN---FEAKISDFGLAKL  216 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~~~  216 (361)
                      |++.||+|..-|...  .-+++..+..++.||++||.|+|.++     |+|||+||+|+++.+.   .-+||+|||+|..
T Consensus        90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~-----IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG-----IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC-----ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999998766442  36888889999999999999999999     9999999999999653   5699999999998


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +.++.   ......|||.|||||++...+|+..+|||+-|+|||-|+.|++||...   +...+.+.+..   ....+..
T Consensus       163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rlye~I~~---g~yd~~~  233 (355)
T KOG0033|consen  163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYEQIKA---GAYDYPS  233 (355)
T ss_pred             eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhc---cccCCCC
Confidence            87443   344568999999999999999999999999999999999999999642   33344444332   2111111


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      .   ..      ....++..+|+++||..||.+|.|+.|.|+|.|.
T Consensus       234 ~---~w------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi  270 (355)
T KOG0033|consen  234 P---EW------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI  270 (355)
T ss_pred             c---cc------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence            1   11      1233457899999999999999999999999874

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.9e-44  Score=330.05  Aligned_cols=246  Identities=25%  Similarity=0.344  Sum_probs=194.8

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHH-HHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVD-ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.||+|+||+||+|... +|+.||+|++.............+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999987 68999999997643333333344555555 45778999999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++........  
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g-----ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (323)
T cd05575          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN-----IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--  151 (323)
T ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence            9999998763  37899999999999999999999999     99999999999999999999999999875422221  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||....      .......+.....            
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~------------  213 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNILNKPL------------  213 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHHcCCC------------
Confidence            2234568999999999988899999999999999999999999995322      1112222211110            


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSM----AECVKEL  340 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~----~ell~~l  340 (361)
                       ..+...+..+.+++.+||+.||++||++    .+++++.
T Consensus       214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~  252 (323)
T cd05575         214 -RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHV  252 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCC
Confidence             1111224558999999999999999988    4666653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.4e-44  Score=336.16  Aligned_cols=264  Identities=22%  Similarity=0.297  Sum_probs=206.3

Q ss_pred             HHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC
Q 018047           54 KEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG  132 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  132 (361)
                      .++....++|++.+.||+|+||.||++.++ +++.+|+|++.+...........+.+|+.+++.++||||+++++.+.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344445578999999999999999999987 6889999998654333333455677899999999999999999999999


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      +..|+||||+++|+|.+++...   .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999998653   5888999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTG----KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      ++..+...... ......||+.|+|||++...    .++.++|||||||++|||++|..||.....      ......+.
T Consensus       188 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~  260 (371)
T cd05622         188 TCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM  260 (371)
T ss_pred             ceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence            99876433211 12345799999999987653    378899999999999999999999964321      11222222


Q ss_pred             hhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHH
Q 018047          289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSE--RPSMAECVKELQ  341 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~l~  341 (361)
                      .....+.      +   ......+..+.+++.+||..++.+  |+++.++++|.+
T Consensus       261 ~~~~~~~------~---~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         261 NHKNSLT------F---PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             cCCCccc------C---CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence            1111000      0   011133455889999999844443  789999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-43  Score=314.54  Aligned_cols=249  Identities=29%  Similarity=0.469  Sum_probs=197.5

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKG  145 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g  145 (361)
                      +.||+|+||+||+|++. +++.+|+|.+...  ........+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            36899999999999976 6899999987533  22344567889999999999999999999999999999999999999


Q ss_pred             chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceee
Q 018047          146 NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV  225 (361)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (361)
                      +|.+++.... ..+++..++.++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++...........
T Consensus        79 ~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          79 DFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH-----CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            9999986542 36899999999999999999999999     99999999999999999999999999976543221111


Q ss_pred             eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      .....++..|+|||.+....++.++||||||+++|+|++ |..||.....   ...    ......      ...     
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~----~~~~~~------~~~-----  214 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQT----REAIEQ------GVR-----  214 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHH----HHHHHc------CCC-----
Confidence            111122456999999988889999999999999999998 8888853221   111    110100      000     


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...+...+..+.+++.+||+.+|++|||++++++.|.
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1122334556899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-43  Score=315.96  Aligned_cols=255  Identities=26%  Similarity=0.435  Sum_probs=205.7

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .++|++.+.||+|++|.||+|...+++.||+|.+....    .....+.+|+.++++++|||++++++++...+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            34688899999999999999998777889999986432    23456888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++.......+++..+..++.|++.||.+||+.|     ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN-----YIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999999999997655557899999999999999999999999     99999999999999999999999999987653


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .... .......+..|+|||+.....++.++|+||||+++|+|++ |+.||....   .......+.   .. ..     
T Consensus       156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~---~~-~~-----  222 (261)
T cd05068         156 DIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQVD---QG-YR-----  222 (261)
T ss_pred             Cccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH---cC-CC-----
Confidence            2211 1111122457999999988889999999999999999999 998885321   111111111   00 00     


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                            ...+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       223 ------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 ------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                  11122334568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=334.70  Aligned_cols=268  Identities=28%  Similarity=0.423  Sum_probs=215.3

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEcC--C--CE-EEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLRS--G--EV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD  131 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  131 (361)
                      +...++-...++||+|+||.||+|..+.  +  .. ||||..............++..|+.+|+.++|||||++||++.+
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            3344556666899999999999998762  2  23 89998875444556778899999999999999999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      ...+++|||+|+||+|.+|+...+. .++..+...++++.|.||+|||+++     +|||||...|+|++.++.+||+||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~-----~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN-----CIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC-----CcchhHhHHHheecCCCeEEeCcc
Confidence            9999999999999999999988653 6999999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      |+++.-...  ........-...|+|||.+....|+.++|||||||++||+.+ |..||.....   .   .....+...
T Consensus       307 GLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~---~v~~kI~~~  378 (474)
T KOG0194|consen  307 GLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---Y---EVKAKIVKN  378 (474)
T ss_pred             ccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---H---HHHHHHHhc
Confidence            998754311  111111123578999999999999999999999999999999 7888854321   1   111111111


Q ss_pred             hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                      .          . +...+...+..+..++.+||..+|++||||.++.+.++.+......
T Consensus       379 ~----------~-r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  379 G----------Y-RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             C----------c-cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            1          0 1223335566789999999999999999999999999988877653

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.5e-44  Score=319.39  Aligned_cols=250  Identities=31%  Similarity=0.570  Sum_probs=195.6

Q ss_pred             CceecccCceEEEEEEEc-----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           66 DNFLGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .+.||.|.||.||+|.+.     .+..|+||.+...  ........+.+|++.+++++||||++++|++.+.+..++|||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccccc
Confidence            467999999999999976     2567999999532  333447789999999999999999999999998888999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+++     ++|+||+++|||++.++.+||+|||++......
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN-----IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT-----EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc-----ccccccccccccccccccccccccccccccccc
Confidence            999999999998875568999999999999999999999999     999999999999999999999999999877433


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..........+...|+|||.+....++.++||||||+++|||++ |+.||...   ........+    .....      
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~----~~~~~------  223 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKL----KQGQR------  223 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHH----HTTEE------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc----ccccc------
Confidence            33323333456778999999988889999999999999999999 67887432   222222221    11111      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                           ...+..++..+.+++.+||+.||++|||+.++++.|
T Consensus       224 -----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 -----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 111223345589999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.5e-43  Score=319.45  Aligned_cols=262  Identities=26%  Similarity=0.434  Sum_probs=207.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      .+|.+.+.||+|+||+||++...      ++..+|+|.+...   .......+.+|++++..++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            46888999999999999999752      2456899987532   23345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC
Q 018047          135 RFLVYEYMQKGNLQDHLNGIG-----------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN  203 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~  203 (361)
                      .++||||+++++|.+++...+           ...+++..+..++.|++.||+|||++|     ++||||||+||+++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~-----i~H~dlkp~Nili~~~  156 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH-----FVHRDLATRNCLVGEN  156 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccCcceEEEccC
Confidence            999999999999999986432           125899999999999999999999999     9999999999999999


Q ss_pred             CcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHH
Q 018047          204 FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVL  282 (361)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~  282 (361)
                      +.++|+|||++................++..|+|||++....++.++|||||||++|+|++ |..||.....   .....
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~  233 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE  233 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH
Confidence            9999999999986644332222223345778999999988889999999999999999998 8888853321   11111


Q ss_pred             HHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      .   .....  .     ..     .+...+..+.+|+.+||+.||.+|||+.+++..|+++.....
T Consensus       234 ~---i~~~~--~-----~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~  284 (288)
T cd05093         234 C---ITQGR--V-----LQ-----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP  284 (288)
T ss_pred             H---HHcCC--c-----CC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence            1   11110  0     00     111233458999999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.5e-43  Score=319.06  Aligned_cols=258  Identities=26%  Similarity=0.432  Sum_probs=202.7

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  132 (361)
                      ..++|+..+.||+|+||+||+|.+.      ++..+|+|++...  ........+.+|+.+++.++||||+++++++.++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3457999999999999999998753      2467999987532  2223345688899999999999999999999999


Q ss_pred             CEEEEEEEecCCCchhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIG--------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF  204 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~  204 (361)
                      ...++||||+++|+|.+++.+..        ...+++..+..++.|++.||+|||+.+     ++|+||||+||+++.++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDF  156 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCcchheEEEcCCC
Confidence            99999999999999999986532        124678889999999999999999999     99999999999999999


Q ss_pred             cEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 018047          205 EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQ  283 (361)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~  283 (361)
                      .++|+|||++................+++.|+|||++....++.++||||||+++|||++ |..||.....   .   ..
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~---~~  230 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---E---QV  230 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---H---HH
Confidence            999999999986644332222222345778999999988889999999999999999999 6888853221   1   11


Q ss_pred             HHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ........          .  ...+...+..+.+++.+||+.||++|||+.|++++|+
T Consensus       231 ~~~~~~~~----------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         231 LRFVMEGG----------L--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHcCC----------c--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            11111110          0  1112233456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-44  Score=345.21  Aligned_cols=268  Identities=24%  Similarity=0.320  Sum_probs=215.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCC-CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEE-Ec-----
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSG-EVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYC-AD-----  131 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~-----  131 (361)
                      ..++++.++|.+|||+.||+|....+ ..||+|++-.   .++...+.+.+|+.+|+.|+ |+|||.+++.. ..     
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            34577889999999999999998754 9999999854   46677889999999999996 99999999932 11     


Q ss_pred             -CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 018047          132 -GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD  210 (361)
Q Consensus       132 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~D  210 (361)
                       .-+++|.||||+||+|.|+++......+++.++++|++++++|+.+||...   .+|||||||-+||||+.+|+.||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~---pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK---PPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC---CccchhhhhhhheEEcCCCCEEeCc
Confidence             136789999999999999999777778999999999999999999999987   5699999999999999999999999


Q ss_pred             cCccccCCCCCceee-------eeecccccCccCcccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 018047          211 FGLAKLMPEGQETYV-------TARVLGTFGYFDPEYT---STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNL  280 (361)
Q Consensus       211 fg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  280 (361)
                      ||.++..-.......       .-...-|+.|.|||.+   .+...+.|+|||+|||+||-|+....||+..-.      
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------  263 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------  263 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence            999974422211000       0012358999999954   577899999999999999999999999964311      


Q ss_pred             HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 018047          281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMP  354 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~  354 (361)
                                    -.++...+.... ....+..|.+||+.||+.||.+||++-+++..+.++........+..
T Consensus       264 --------------laIlng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  264 --------------LAILNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             --------------eeEEeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                          011222222111 14567779999999999999999999999999999988766555444

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=326.20  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=218.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +-|...+.||+|.|++|-+|++- +|..||||++.+....... ...+..|+..|+.++|||||++|++......+|||+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            34778888999999999999977 8999999999887655443 445667999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-CCcEEEeecCccccCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLMP  218 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~~~  218 (361)
                      |+-.+|+|+|||.++. ..++++...+++.||+.|+.|+|+..     ++||||||+|+.+.+ -|-+||+|||++..+.
T Consensus        97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH-----VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH-----VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh-----hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            9999999999998764 47999999999999999999999988     999999999998765 5899999999999887


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLT-LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .+..   ..+.+|++.|.|||++.+..|+ ++.||||||||||-|++|++||+..++.+                .+..+
T Consensus       171 PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------------TLTmI  231 (864)
T KOG4717|consen  171 PGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------------TLTMI  231 (864)
T ss_pred             Ccch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----------------hhhhh
Confidence            6653   4457899999999999988886 67899999999999999999997655432                22223


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      .|=.   -..|...+.++.+||..||..||++|.+.+|+..+-|--
T Consensus       232 mDCK---YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  232 MDCK---YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             hccc---ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence            3222   345677888899999999999999999999999887743

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3e-43  Score=321.82  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=207.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc--------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR--------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD  131 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  131 (361)
                      ++|.+.+.||+|+||.||++...        ++..+|+|.+...  ........+..|+.+++.+ +||||+++++++..
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC--CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            46899999999999999999753        1346999988643  2233456688899999999 79999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCC
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~N  197 (361)
                      .+..|+||||+++|+|.+++....              ...+++..++.++.|++.||+|||++|     ++|+||||+|
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-----i~H~dlkp~N  170 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-----CIHRDLAARN  170 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccHHh
Confidence            999999999999999999997542              135888999999999999999999999     9999999999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVN  276 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  276 (361)
                      |+++.++.++|+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||....   
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---  247 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---  247 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence            9999999999999999976643221111122234568999999888889999999999999999998 888884321   


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                         ........... .           ....+...+..+.+++.+||..+|++|||+.++++.|++++..++.
T Consensus       248 ---~~~~~~~~~~~-~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~  305 (307)
T cd05098         248 ---VEELFKLLKEG-H-----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN  305 (307)
T ss_pred             ---HHHHHHHHHcC-C-----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence               11111111110 0           0112223445689999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.8e-43  Score=316.78  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=202.1

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCC----EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      +|++.+.||+|+||+||+|.+. +++    .+++|.+...  .......++..|+..+..++||||+++++++.. ...+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            5788899999999999999975 454    4677776422  122334567788889999999999999998754 5578


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +++||+++|+|.+++.... ..+++..+..++.|++.||+|||+++     ++|+||||+|||++.++.+||+|||++..
T Consensus        85 ~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR-----MVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----EeccccCcceEEEcCCCcEEEcCCcccee
Confidence            9999999999999997543 36899999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      +.............++..|+|||.+....++.++||||||+++|||++ |..||.....   ...    .........  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~----~~~~~~~~~--  229 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEV----PDLLEKGER--  229 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHCCCc--
Confidence            644332222233456778999999988889999999999999999998 9999853321   111    111111000  


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                               ...+..++..+.+++.+||..||++|||+.|+++.|..+..+.
T Consensus       230 ---------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         230 ---------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence                     0011123345788999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.5e-43  Score=318.58  Aligned_cols=256  Identities=28%  Similarity=0.477  Sum_probs=203.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      .+|++.+.||+|+||+||+|...     ++..+|+|.+...  ........+.+|+.+++.++||||+++++++..+...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            35788899999999999999852     4678999998643  2233446788899999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee
Q 018047          136 FLVYEYMQKGNLQDHLNGIG---------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill  200 (361)
                      |++|||+++|+|.+++....               ...+++..+..++.|++.||+|||+++     ++|+||||+|||+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~nili  157 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILI  157 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-----eehhccccceEEE
Confidence            99999999999999985321               235788899999999999999999999     9999999999999


Q ss_pred             CCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 018047          201 SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQN  279 (361)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~  279 (361)
                      +.++.+||+|||++..+.............++..|+|||++....++.++||||||+++|||++ |..||....   ...
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~  234 (283)
T cd05090         158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQE  234 (283)
T ss_pred             cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHH
Confidence            9999999999999987644332222333445678999999888889999999999999999998 888885322   111


Q ss_pred             HHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          280 LVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ....+.    ....           ...+...+..+.+++.+||+.||.+||++.+++++|.
T Consensus       235 ~~~~~~----~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         235 VIEMVR----KRQL-----------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HHHHHH----cCCc-----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            111111    0000           1112233456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.4e-43  Score=311.29  Aligned_cols=252  Identities=28%  Similarity=0.425  Sum_probs=207.9

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|++|.||+|... +++.|++|.+...... ......+..|+++++.++|||++++++.+.+++..|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            4777889999999999999976 6899999998754333 3345678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++.......+++..++.++.|++.||.|||+.|     ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~-----i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK-----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            999999999998754567999999999999999999999999     999999999999999999999999999876543


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ..  ......|++.|+|||+.....++.++|+||||+++|+|++|+.||.....   .   .........          
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~~----------  216 (256)
T cd08529         155 TN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---G---ALILKIIRG----------  216 (256)
T ss_pred             cc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHcC----------
Confidence            22  12234678999999999888899999999999999999999999964321   1   111111110          


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ..  ...+...+..+.+++.+||+.+|++||++.+++++
T Consensus       217 ~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 VF--PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CC--CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            00  11222345568999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.7e-43  Score=321.40  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=206.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  133 (361)
                      ++|...+.||+|+||.||++...      ++..+|+|.+....  .......+.+|+.+++++ +||||+++++++...+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            35888999999999999999742      35579999876432  233456788999999999 7999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..+++|||+++|+|.+++.......+++..+..++.|++.||+|||+++     ++|+||||+|||++.++.++|+|||+
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eehhhhccceEEEcCCCeEEECCCcc
Confidence            9999999999999999997654445899999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      +..+.............++..|+|||.+....++.++|||||||++|+|++ |..||......  ...    ......  
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~----~~~~~~--  259 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKF----YKLIKE--  259 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHH----HHHHHc--
Confidence            986654332222223346788999999988889999999999999999998 99998543221  111    111110  


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                              ... ...+...+..+.+++.+||+.+|++|||+.|+++.|++.
T Consensus       260 --------~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         260 --------GYR-MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --------CCc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                    000 011112345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.1e-42  Score=311.26  Aligned_cols=260  Identities=24%  Similarity=0.393  Sum_probs=211.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+.............+.+|+++++.++|+|++++++.+.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999987 79999999987544444445677889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          140 EYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       140 e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||+++|+|.+++...  ....+++..+..++.+++.||.|||+.|     ++|+||+|+||+++.++.++|+|||++..+
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-----IMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC-----EecCCcChhhEEECCCCcEEEeccceeeec
Confidence            999999999988642  2346899999999999999999999999     999999999999999999999999998766


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ......  .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....    ............       
T Consensus       157 ~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~-------  223 (267)
T cd08224         157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEKC-------  223 (267)
T ss_pred             cCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhcC-------
Confidence            433221  2234678899999998888899999999999999999999999853221    111111111000       


Q ss_pred             cCccccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          298 IDPELSRSSYT-MESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       298 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ..     ...+ ...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       224 ~~-----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         224 DY-----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CC-----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            00     1111 24455689999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2e-43  Score=320.66  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=206.6

Q ss_pred             HcCCCCCCceecccCceEEEEEEEcC------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLRS------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD  131 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  131 (361)
                      ..++|+..+.||+|+||.||++....      ...+|+|.+...  ........+.+|+.++..+ +|+||+++++++.+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC--CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            34468888999999999999998642      367999988643  2223345688899999999 79999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCC
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGI--------------GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~N  197 (361)
                      ++..+++|||+++|+|.+++...              ....+++..++.++.|++.||+|||+.+     ++|+||||+|
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivH~dlkp~N  162 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-----CIHRDLAARN  162 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-----ccccccceee
Confidence            99999999999999999998642              2346889999999999999999999999     9999999999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVN  276 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  276 (361)
                      ||++.++.++|+|||++..+.............++..|+|||++....++.++|||||||++|+|++ |..||.....  
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  240 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  240 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence            9999999999999999987654332222222334678999999888889999999999999999998 8888853221  


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                          ...... .....      .     ...+...+..+.+|+.+||..||++|||+.|+++.|+.++
T Consensus       241 ----~~~~~~-~~~~~------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 ----EELFKL-LKEGY------R-----MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ----HHHHHH-HHcCC------c-----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                111111 11000      0     1122233456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.4e-43  Score=311.96  Aligned_cols=251  Identities=23%  Similarity=0.353  Sum_probs=205.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|++.+.||+|+||.||++.+. +++.+|+|.+....  .....+.+..|+.+++.++|+|++++++.+.+++..|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4778899999999999999977 68999999986542  23345678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.......+++..+..++.|++.||.|||++|     ++|+||||+||+++.++.++|+|||.+..+...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR-----VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            999999999987655557899999999999999999999999     999999999999999999999999999866432


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ..  ......|++.|+|||++....++.++|+||||+++|+|++|..||.....      ...........         
T Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~~---------  216 (255)
T cd08219         154 GA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQGS---------  216 (255)
T ss_pred             cc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcCC---------
Confidence            21  22335688999999999888899999999999999999999999953221      11111111110         


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                         ....+...+..+.+++.+||+.||++|||+.+++..
T Consensus       217 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 ---YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence               011223344568999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.6e-44  Score=333.81  Aligned_cols=258  Identities=24%  Similarity=0.335  Sum_probs=202.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||+||++... +++.||+|++.............+..|+.++..++||||+++++.+.+++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999977 68999999997543333445667888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g-----ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG-----FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            999999999999764  36899999999999999999999999     99999999999999999999999999875532


Q ss_pred             CCce---------------------------------eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCC
Q 018047          220 GQET---------------------------------YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR  266 (361)
Q Consensus       220 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  266 (361)
                      ....                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            1100                                 0011346999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHH
Q 018047          267 RAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP---SMAECVKELQ  341 (361)
Q Consensus       267 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---t~~ell~~l~  341 (361)
                      .||......      .....+......+  .+.+.       ...+..+.+++.+|+ .||.+|+   ++.++++|-+
T Consensus       234 ~Pf~~~~~~------~~~~~i~~~~~~~--~~p~~-------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~  295 (360)
T cd05627         234 PPFCSETPQ------ETYRKVMNWKETL--VFPPE-------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF  295 (360)
T ss_pred             CCCCCCCHH------HHHHHHHcCCCce--ecCCC-------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence            999643221      1111111100000  01111       012345788888876 4999998   4788888853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-43  Score=312.88  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=205.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCc--chhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKE--ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ++|...+.||+|++|.||.|... +++.+|+|.+.......  ......+.+|+.+++.++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46899999999999999999876 68999999986543222  1234568889999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      |+||+++++|.+++....  .+++..+..++.|++.||.|||+.|     ++|+||+|+||+++.++.++|+|||++...
T Consensus        82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999999987643  6889999999999999999999999     999999999999999999999999999765


Q ss_pred             CCCCceee-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          218 PEGQETYV-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       218 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ........ .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....      ...........     
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-----  223 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQP-----  223 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccC-----
Confidence            43211111 1234578899999999888899999999999999999999999853211      11111111000     


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                       .     ....+...+..+.+++.+||..+|++|||+.+++++.
T Consensus       224 -~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         224 -T-----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             -C-----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence             0     0122334455689999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.5e-43  Score=321.81  Aligned_cols=265  Identities=26%  Similarity=0.436  Sum_probs=206.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCE--EEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEV--VAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++.+.||+|+||+||+|.+. ++..  +|+|.+..  .........+.+|++++.++ +||||+++++++.+++..|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            36888899999999999999976 4544  56666542  22334456788899999999 8999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC
Q 018047          137 LVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA  202 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~  202 (361)
                      +||||+++|+|.+++....              ...+++..++.++.|++.||+|||++|     ++||||||+|||++.
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-----i~H~dlkp~Nili~~  159 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE  159 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchheEEecC
Confidence            9999999999999986432              235789999999999999999999999     999999999999999


Q ss_pred             CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 018047          203 NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~  281 (361)
                      ++.++|+|||++.......   ......++..|+|||++....++.++|||||||++|+|+| |..||.....   ... 
T Consensus       160 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~-  232 (303)
T cd05088         160 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL-  232 (303)
T ss_pred             CCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHH-
Confidence            9999999999986432111   1111223567999999888888999999999999999998 9999853221   111 


Q ss_pred             HHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCC
Q 018047          282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM  353 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~  353 (361)
                        ..... .          ... ...+...+..+.+|+.+||+.+|++||++++++..|.+++.......+.
T Consensus       233 --~~~~~-~----------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~  290 (303)
T cd05088         233 --YEKLP-Q----------GYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT  290 (303)
T ss_pred             --HHHHh-c----------CCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhh
Confidence              11110 0          000 1111223456899999999999999999999999999998887765553

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.4e-43  Score=317.36  Aligned_cols=255  Identities=27%  Similarity=0.401  Sum_probs=205.0

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |+..+.||+|+||+||++.+. +++.+|+|.+.............+.+|+.+++.++|+|++.+.+.+.+++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667788999999999999976 6899999998765443334445677899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++...+...+++..+..++.|++.||.|||+++     |+||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-----iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN-----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            99999999887655557999999999999999999999999     9999999999999999999999999997654332


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .   .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......   .....+......   ..      
T Consensus       157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~---~~~~~~~~~~~~---~~------  221 (285)
T cd05632         157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK---VKREEVDRRVLE---TE------  221 (285)
T ss_pred             c---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhhc---cc------
Confidence            1   12346899999999998888999999999999999999999999643211   111111110000   00      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKEL  340 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l  340 (361)
                         ..++...+..+.+|+.+||+.||++||+     +.+++.+-
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~  262 (285)
T cd05632         222 ---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHP  262 (285)
T ss_pred             ---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcCh
Confidence               1112233445889999999999999999     78888873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.8e-43  Score=317.50  Aligned_cols=260  Identities=27%  Similarity=0.456  Sum_probs=207.3

Q ss_pred             CCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      +|...+.||+|+||.||+|...      ++..+++|.+...   .......+.+|+.+++.++|+||+++++++..++..
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            5778889999999999999753      2456888887532   223345788999999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC
Q 018047          136 FLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS  201 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~  201 (361)
                      ++||||+++++|.+++....              ...+++..++.++.|++.||+|||++|     ++||||||+||+++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~Nil~~  157 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVG  157 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccCcceEEEc
Confidence            99999999999999996532              235889999999999999999999999     99999999999999


Q ss_pred             CCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 018047          202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNL  280 (361)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~  280 (361)
                      .++.++|+|||++................++..|+|||++....++.++||||||+++|+|++ |..||.....   ...
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~  234 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEV  234 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence            999999999999986644332222333456788999999988899999999999999999999 9999854321   111


Q ss_pred             HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                         .......          ..  ...+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       235 ---~~~~~~~----------~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         235 ---IECITQG----------RV--LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             ---HHHHhCC----------CC--CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence               1111110          00  0111223456899999999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2e-43  Score=325.16  Aligned_cols=250  Identities=27%  Similarity=0.370  Sum_probs=200.0

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +|+..+.||+|+||+||+|... +|+.||+|++.+...........+..|..++..+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3777899999999999999976 68999999987543333344556777888988885 577889999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.++|+|||++.....
T Consensus        81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~-----ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999999987643  6999999999999999999999999     99999999999999999999999999875432


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ......||+.|+|||++....++.++|||||||++|+|++|+.||.....   ..   ....+....        
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~---~~~~i~~~~--------  217 (323)
T cd05615         154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DE---LFQSIMEHN--------  217 (323)
T ss_pred             CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HH---HHHHHHhCC--------
Confidence            211  12335689999999999888899999999999999999999999964321   11   111111111        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSM-----AECVKE  339 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~ell~~  339 (361)
                           ..++...+..+.+++.+||+.+|.+|++.     +++++|
T Consensus       218 -----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         218 -----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             -----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence                 11122234558899999999999999974     566665

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.6e-43  Score=317.42  Aligned_cols=260  Identities=27%  Similarity=0.392  Sum_probs=204.6

Q ss_pred             CCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      +|++.+.||+|+||+||+|...      ....+++|.+...  ........+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC--CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            4778899999999999999863      1356888887543  2223356788899999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCC
Q 018047          136 FLVYEYMQKGNLQDHLNGIG----------------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDF  193 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Di  193 (361)
                      ++++||+++|+|.+++....                      ...+++..++.++.|++.||+|||+++     ++||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----ivH~di  153 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK-----LVHRDL  153 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC-----eehhhh
Confidence            99999999999999875421                      135788999999999999999999999     999999


Q ss_pred             CCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 018047          194 KSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLN  272 (361)
Q Consensus       194 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~  272 (361)
                      ||+|||++.++.++|+|||++................++..|+|||.+....++.++||||||+++|+|++ |..||...
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999986543322211222345678999999888889999999999999999998 99998532


Q ss_pred             CCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          273 QGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      .   .......    ....      ..     ...+...+..+.+++.+||+.+|++||++.|+++.|++++..
T Consensus       234 ~---~~~~~~~----~~~~------~~-----~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         234 A---PERLFNL----LKTG------YR-----MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             C---HHHHHHH----HhCC------CC-----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            2   1111111    1110      00     111223345689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.5e-43  Score=313.39  Aligned_cols=261  Identities=22%  Similarity=0.380  Sum_probs=211.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|++|.||++... +++.+|||.+.............+.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999975 79999999887654444445567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          140 EYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       140 e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||+++++|.+++...  ....+++..++.++.|++.||.|||++|     ++|+||+|+||+++.++.++|+|||++...
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            999999999988642  2346899999999999999999999999     999999999999999999999999998866


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....  ......|+..|+|||.+....++.++|+||||+++|+|++|..||.....    ........       +...
T Consensus       157 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-------~~~~  223 (267)
T cd08229         157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-------IEQC  223 (267)
T ss_pred             ccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhh-------hhcC
Confidence            44322  12234688999999999888899999999999999999999999853221    11111111       1111


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ..+..    .....+..+.+++.+||..||++|||++++++.+.+.
T Consensus       224 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         224 DYPPL----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCCC----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11111    1223456799999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-42  Score=312.50  Aligned_cols=258  Identities=25%  Similarity=0.415  Sum_probs=202.2

Q ss_pred             CCCCceecccCceEEEEEEEc-C---CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE----
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-S---GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH----  134 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----  134 (361)
                      |.+.+.||+|+||.||+|... +   +..||+|.+..... .......+.+|+..++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            567889999999999999865 2   36799999865322 23345678899999999999999999998866554    


Q ss_pred             --EEEEEEecCCCchhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEE
Q 018047          135 --RFLVYEYMQKGNLQDHLNGI----GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI  208 (361)
Q Consensus       135 --~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl  208 (361)
                        .+++|||+++|+|..++...    ....+++..+..++.|++.||+|||+++     ++||||||+||++++++.+||
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl  154 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-----FIHRDLAARNCMLREDMTVCV  154 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccchheEEECCCCeEEE
Confidence              79999999999999988432    2346899999999999999999999999     999999999999999999999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHH
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      +|||+++.+.............++..|+|||.+....++.++|||||||++|||++ |..||....   .....   ...
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~---~~~  228 (273)
T cd05035         155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIY---DYL  228 (273)
T ss_pred             CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHH---HHH
Confidence            99999987654332211222234678999999988889999999999999999999 888885322   11111   111


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      ... .      .     ...+...+..+.+++.+||+.||++|||+.|++++|++++
T Consensus       229 ~~~-~------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         229 RHG-N------R-----LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             HcC-C------C-----CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            111 0      0     1122334556899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5e-43  Score=313.13  Aligned_cols=255  Identities=30%  Similarity=0.468  Sum_probs=204.4

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|++.+.||+|+||+||+|.+.++..||+|++....    .....+.+|+.+++.++||||+++++.+.+ ...++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc----cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            4689999999999999999998766789999986432    223568889999999999999999998754 55789999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.......+++..+..++.|++.||+|||+.+     ++|+||||+||+++.++.++|+|||.+..+...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            999999999997654456899999999999999999999999     999999999999999999999999999876543


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ... ......++..|+|||+.....++.++||||||+++|+|++ |..||.....   ....   ......       . 
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~---~~~~~~-------~-  220 (262)
T cd05071         156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVL---DQVERG-------Y-  220 (262)
T ss_pred             ccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHH---HHHhcC-------C-
Confidence            321 1122345678999999888889999999999999999999 7888853221   1111   111100       0 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                          ....+...+..+.+++.+||+.||++|||+.++++.|+..+
T Consensus       221 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         221 ----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                01122345566899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.1e-43  Score=325.90  Aligned_cols=271  Identities=22%  Similarity=0.301  Sum_probs=201.9

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC----
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK----  133 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----  133 (361)
                      ..++|+..+.||+|+||+||++... +|..||+|++.... ........+.+|+.+++.++||||+++++++...+    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            4467999999999999999999976 68999999986542 22334556778999999999999999999986543    


Q ss_pred             --EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          134 --HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       134 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                        ..|+||||+++ +|.+.+..    .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEecC
Confidence              57999999975 66666543    5788999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchh------------
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN------------  279 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~------------  279 (361)
                      |++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......            
T Consensus       168 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         168 GLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             CCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence            9997543221   2233568999999999988899999999999999999999999997543211000            


Q ss_pred             HHHH----HHHHhhhhhhh-----hhhcCccc-c-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          280 LVLQ----VRHILNDRKKL-----RKVIDPEL-S-RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       280 ~~~~----~~~~~~~~~~~-----~~~~~~~~-~-~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ....    +..........     .+...... . ........+..+.+|+.+||+.||++|||+.|+++|.+-.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence            0000    00000000000     00000000 0 0001112235689999999999999999999999998744

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=299.06  Aligned_cols=264  Identities=23%  Similarity=0.335  Sum_probs=207.6

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  132 (361)
                      ..++|.+.+.||+|||+-||+++.- +++.||+|++....   .+..+...+|++..++++|||+++++++...+     
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            3467999999999999999999844 79999999997643   45567788899999999999999998875432     


Q ss_pred             CEEEEEEEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD  210 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~D  210 (361)
                      ...||+++|+..|+|.++++..  ++..+++.+++.|+.++++||++||+..   .+++||||||.|||+++++.++|.|
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~---~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE---PPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC---CcccccCCCcceeEecCCCceEEEe
Confidence            3589999999999999999754  3447999999999999999999999987   3599999999999999999999999


Q ss_pred             cCccccCCCCCceee-------eeecccccCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 018047          211 FGLAKLMPEGQETYV-------TARVLGTFGYFDPEYTST---GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNL  280 (361)
Q Consensus       211 fg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  280 (361)
                      ||.++...-......       ......|..|.|||.+.-   ...+.++|||||||+||+|+.|..||+...+. .   
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-G---  248 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-G---  248 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-C---
Confidence            999986542211111       112346889999997653   45678999999999999999999999643331 1   


Q ss_pred             HHHHHHHhhhhhhhhhhc-CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          281 VLQVRHILNDRKKLRKVI-DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                                 +.+.--+ .+.+... .....++.+.++|.+||+.||.+||++.+++.++++++
T Consensus       249 -----------gSlaLAv~n~q~s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 -----------GSLALAVQNAQISIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -----------CeEEEeeeccccccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                       1111111 1111111 11125667999999999999999999999999998764

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.9e-43  Score=314.61  Aligned_cols=260  Identities=27%  Similarity=0.388  Sum_probs=204.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCC----EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      .+|+..+.||+|+||+||+|.+. +|.    .||+|.+...  ........+.+|+.++..++||||+++++++... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence            46888899999999999999865 444    4899988643  2233456788899999999999999999998754 56


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+++     ++||||||+|||++.++.+||+|||+++
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~-----iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR-----LVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccccceEEEcCCCcEEECCCCcee
Confidence            79999999999999987542 36899999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+.............+++.|+|||......++.++|||||||++|||++ |..||.....   ......    ...... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~-  229 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDL----LEKGER-  229 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCc-
Confidence            7754332222222234678999999988889999999999999999998 8888853221   111111    111000 


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                                ...+...+..+.+++.+||+.||++||++.++++.|..+....
T Consensus       230 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         230 ----------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                      1111223456889999999999999999999999998886554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-43  Score=326.27  Aligned_cols=241  Identities=26%  Similarity=0.334  Sum_probs=189.9

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHH-HHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVD-ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.||+|+||+||+|.+. +++.||+|++.............+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999987 57889999987543222222334444444 46778999999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++........  
T Consensus        81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g-----iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--  151 (325)
T cd05602          81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--  151 (325)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence            9999999763  36888899999999999999999999     99999999999999999999999999975432221  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ......+.....            
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~------------  213 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPL------------  213 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhCCc------------
Confidence            22345789999999999988999999999999999999999999953221      111122111110            


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSMAE  335 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e  335 (361)
                       ..+...+..+.+++.+||+.||.+||++.+
T Consensus       214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         214 -QLKPNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence             111123445899999999999999998773

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-43  Score=312.51  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=200.8

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      +|++.+.||+|+||.||++.++++..+|+|.+.....    ....+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            4788899999999999999988777899999864322    234677899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++.... ..+++..+..++.|++.||+|||++|     ++|+||||+||+++.++.+||+|||+++...+..
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          81 MANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG-----FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             CCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            99999999997543 36899999999999999999999999     9999999999999999999999999997654322


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .. ......++..|+|||.+....++.++||||||+++|+|++ |..||.....   ......   ....       .. 
T Consensus       155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~---~~~~-------~~-  219 (256)
T cd05059         155 YT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVES---VSAG-------YR-  219 (256)
T ss_pred             cc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHH---HHcC-------Cc-
Confidence            11 1111123457999999988889999999999999999999 7888854321   111111   1110       00 


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                          ...+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus       220 ----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 ----LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                111122455699999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.4e-43  Score=312.40  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=204.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .++|++.++||+|+||.||+|..++++.+|+|.+....    .....+.+|+.+++.++|+|++++++++. .+..+++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            34688999999999999999998888999999986432    23457888999999999999999999874 45689999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++.......+++..+..++.|++.||+|||+.|     ++|+||||+||+++.++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-----YIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            9999999999987655567899999999999999999999999     99999999999999999999999999987653


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .... ......++..|+|||++....++.++||||||+++|+|++ |+.||.....   ......+.   ..       .
T Consensus       155 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---~~-------~  220 (260)
T cd05067         155 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLE---RG-------Y  220 (260)
T ss_pred             CCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHH---cC-------C
Confidence            2211 1122345678999999988889999999999999999999 9999953321   11111111   00       0


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      .     ...+...+..+.+++.+||+.+|++|||++++++.|++
T Consensus       221 ~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 R-----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             C-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            0     11122234569999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.3e-43  Score=318.46  Aligned_cols=262  Identities=24%  Similarity=0.373  Sum_probs=206.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc--------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR--------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD  131 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  131 (361)
                      .+|.+.+.||+|+||.||+|+..        ++..+|+|.+...  ........+.+|+.+++.+ +||||+++++++..
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            45888899999999999999742        2447999987533  2233456788999999999 89999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCC
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~N  197 (361)
                      ....|++|||+++|+|.+++....              ...+++..+..++.|++.||+|||++|     ++||||||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-----ivH~dlkp~N  167 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-----CIHRDLAARN  167 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-----eeecccccce
Confidence            999999999999999999986532              235788899999999999999999999     9999999999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVN  276 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  276 (361)
                      |+++.++.++|+|||++..+.............+++.|+|||++....++.++||||||+++|+|++ |..||....   
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---  244 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---  244 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---
Confidence            9999999999999999987654332222222345678999999988889999999999999999998 778874321   


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                         ........... ..           ...+...+..+.+++.+||+.+|++|||+.|+++.|.+++.-.
T Consensus       245 ---~~~~~~~~~~~-~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         245 ---VEELFKLLKEG-HR-----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             ---HHHHHHHHHcC-Cc-----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence               11111111111 00           1112234556899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.9e-43  Score=312.09  Aligned_cols=251  Identities=26%  Similarity=0.412  Sum_probs=201.4

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      +|.+.+.||+|+||+||.|...++..+|+|.+....    .....+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            478888999999999999988766779999876432    2245688899999999999999999999998999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++|+|.+++..... .+++..++.++.|++.||+|||+.+     ++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          81 MSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ-----FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            999999999976433 6899999999999999999999999     9999999999999999999999999998664432


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .. ......++..|+|||......++.++||||||+++|+|++ |..||.....   ...   .........        
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~---~~~~~~~~~--------  219 (256)
T cd05113         155 YT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SET---VEKVSQGLR--------  219 (256)
T ss_pred             ee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHH---HHHHhcCCC--------
Confidence            21 1112235567999999988889999999999999999998 9999853221   111   111111100        


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                          ...+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       220 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ----LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                0111123456899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-43  Score=326.83  Aligned_cols=245  Identities=25%  Similarity=0.345  Sum_probs=192.4

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHH-HHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVD-ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      ++||+|+||+||+|+.. +|+.||+|++.+...........+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999987 68899999987543322333344555554 57788999999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||+++     ++||||||+||+++.++.+||+|||++........  
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (321)
T cd05603          81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN-----IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--  151 (321)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence            9999888653  46889999999999999999999999     99999999999999999999999999875322211  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++....++.++|||||||++|+|++|..||...+      ............             
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~-------------  212 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHKP-------------  212 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcCC-------------
Confidence            2234578999999999988889999999999999999999999996432      111111111110             


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSMA----ECVKE  339 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~----ell~~  339 (361)
                      ...+...+..+.+++.+||+.||.+||++.    +++++
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         213 LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence            111222344588999999999999998764    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.4e-43  Score=329.95  Aligned_cols=260  Identities=25%  Similarity=0.389  Sum_probs=204.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  133 (361)
                      ++|.+.+.||+|+||.||+|++.      .++.||+|++....  .......+.+|+.+|..+. ||||+++++++...+
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            35778899999999999999864      24689999997542  2233456888999999997 999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCC----------------------------------------------------------
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIG----------------------------------------------------------  155 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  155 (361)
                      ..++||||+++|+|.+++....                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999985421                                                          


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCC
Q 018047          156 --------------------------------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       156 --------------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~N  197 (361)
                                                            ...+++..+..++.|++.||+|||+.+     ++||||||+|
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrdlkp~N  269 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN-----CVHRDLAARN  269 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cCcccCCcce
Confidence                                                  124677788999999999999999999     9999999999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVN  276 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  276 (361)
                      ||++.++.++|+|||++................++..|+|||.+....++.++||||||+++|||++ |..||...... 
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~-  348 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-  348 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-
Confidence            9999999999999999986533222112223356788999999988889999999999999999998 88888533211 


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                           .........          ... ...+...+..+.+|+.+||+.+|.+||+++++++.|++++
T Consensus       349 -----~~~~~~~~~----------~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 -----EQFYNAIKR----------GYR-MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -----HHHHHHHHc----------CCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                 111111110          000 1112233456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.9e-43  Score=315.70  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=201.0

Q ss_pred             CCCCCCceecccCceEEEEEEEcC------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      ++|.+.+.||+|++|.||+|.+..      +..||+|.+...  ........+..|+.+++.++|+||+++++++.+.+.
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            468889999999999999998753      467888877532  223344678889999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC---cE
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGE-----PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF---EA  206 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~---~~  206 (361)
                      .++||||+++++|.+++.....     ..+++..+..++.|++.||+|||+++     ++|+||||+||+++.++   .+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-----FIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccchheEEEeccCCCcce
Confidence            9999999999999999865431     25899999999999999999999999     99999999999998754   69


Q ss_pred             EEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 018047          207 KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      ||+|||++..+..............+..|+|||++....++.++|||||||++|+|++ |..||.....   ......  
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~--  233 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEF--  233 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH--
Confidence            9999999987643322111122233567999999988889999999999999999997 9999864321   111111  


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       .... ..           ...+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus       234 -~~~~-~~-----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 -VTGG-GR-----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -HHcC-Cc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             1110 00           1112233456899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.5e-43  Score=311.47  Aligned_cols=253  Identities=28%  Similarity=0.460  Sum_probs=203.0

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|++.+.||+|+||.||+|...++..+|+|.+.....    ....+.+|+.+++.++|+|++++++++.. ...+++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence            36888999999999999999988788899999864322    23568899999999999999999998854 56789999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++.......+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-----YIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            999999999997654556899999999999999999999999     999999999999999999999999999876443


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ... ......++..|+|||......++.++|+||||+++|+|++ |..||....   ...   ........       ..
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~---~~~~~~~~-------~~  221 (260)
T cd05070         156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NRE---VLEQVERG-------YR  221 (260)
T ss_pred             ccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHH---HHHHHHcC-------CC
Confidence            211 1122235567999999888889999999999999999999 888885321   111   11111100       00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                           ...+...+..+.+|+.+||..+|++|||+.++++.|++
T Consensus       222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 -----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 11223345569999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-42  Score=313.21  Aligned_cols=253  Identities=26%  Similarity=0.402  Sum_probs=202.0

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..++||+|+||.||+|.+. +++.||+|.+....  .......+.+|+.++.+++||||+++++.+...+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            5788899999999999999876 68999999986542  23345678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|..+.      .+++..+..++.|++.||+|||+.|     ++|+||||+|||++.++.++|+|||++..+...
T Consensus        80 ~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          80 FMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK-----ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             cCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC-----EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            99999997652      4788899999999999999999999     999999999999999999999999999865433


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .    .....|+..|+|||++....++.++|+||||+++|+|++|+.||.....................      ...+
T Consensus       149 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~  218 (279)
T cd06619         149 I----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD------EDPP  218 (279)
T ss_pred             c----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc------cCCC
Confidence            2    22346899999999998888999999999999999999999999653322211111111110000      0011


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .+.    ....+..+.+++.+||+.||++||+++|++++.+
T Consensus       219 ~~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~  255 (279)
T cd06619         219 VLP----VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF  255 (279)
T ss_pred             CCC----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence            111    1123345899999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-42  Score=311.16  Aligned_cols=258  Identities=25%  Similarity=0.390  Sum_probs=199.4

Q ss_pred             CCCCceecccCceEEEEEEEcC-CC--EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC------C
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRS-GE--VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG------K  133 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  133 (361)
                      |.+++.||+|+||.||+|.+.. +.  .+|+|.+.... ........+..|+.+++.++|+||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3567889999999999999764 33  68999886542 2334456788899999999999999999987432      2


Q ss_pred             EEEEEEEecCCCchhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 018047          134 HRFLVYEYMQKGNLQDHLNGI----GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKIS  209 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~  209 (361)
                      ..+++|||+++|+|.+++...    ....+++..+..++.|++.||+|||+++     ++||||||+|||++.++.++|+
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-----FIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhheEEcCCCCEEEC
Confidence            568999999999999887421    1235889999999999999999999999     9999999999999999999999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHh
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      |||++..+.............+++.|+|||......++.++||||||+++|+|++ |..||....   .......+   .
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~---~  228 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDYL---R  228 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH---H
Confidence            9999987654432211222345678999999988889999999999999999999 788885321   11111111   1


Q ss_pred             hhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      .. ..           ...+...+..+.+++.+||+.||++|||+.++++.|++++
T Consensus       229 ~~-~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         229 QG-NR-----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             cC-CC-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            11 00           0111223455899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.9e-44  Score=326.65  Aligned_cols=244  Identities=24%  Similarity=0.341  Sum_probs=196.3

Q ss_pred             ceecccCceEEEEEEEc----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEec
Q 018047           67 NFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      +.||+|+||.||++...    +|+.+|+|++...... ......+..|++++++++||||+++++++.+++..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            57999999999998752    5889999999754322 122345677999999999999999999999999999999999


Q ss_pred             CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCc
Q 018047          143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE  222 (361)
Q Consensus       143 ~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (361)
                      ++|+|.+++...  ..+++..+..++.|++.||+|||+++     ++||||||+|||++.++.++|+|||++........
T Consensus        81 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          81 RGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG-----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            999999998653  36899999999999999999999999     99999999999999999999999999976543321


Q ss_pred             eeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccc
Q 018047          223 TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL  302 (361)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                        ......|++.|+|||.+....++.++|||||||++|+|++|+.||.....      ......+....           
T Consensus       154 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~-----------  214 (318)
T cd05582         154 --KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAK-----------  214 (318)
T ss_pred             --ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCC-----------
Confidence              22345789999999999888899999999999999999999999964321      11111111111           


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 018047          303 SRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKE  339 (361)
Q Consensus       303 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~  339 (361)
                        ...+...+..+.+|+++||+.||++||+     +.+++++
T Consensus       215 --~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         215 --LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence              1122233455889999999999999999     5566655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.1e-43  Score=316.45  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=202.7

Q ss_pred             CCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      +|.+.+.||+|+||+||+|...      ++..||+|++...  ........+..|+.++..++||||+++++++.+.+..
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            3666788999999999999864      2478999998643  2223346688899999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC
Q 018047          136 FLVYEYMQKGNLQDHLNGI--------------GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS  201 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~  201 (361)
                      ++++||+++++|.+++...              ....+++..+..++.|++.||+|||++|     ++||||||+||+++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g-----i~H~dlkp~Nil~~  158 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVF  158 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC-----ccccccchhheEec
Confidence            9999999999999998421              1235788899999999999999999999     99999999999999


Q ss_pred             CCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 018047          202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNL  280 (361)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~  280 (361)
                      .++.+||+|||++..+.............+++.|+|||.+....++.++|||||||++|||++ |..||....   ....
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~  235 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDV  235 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHH
Confidence            999999999999987654433222333456789999999888889999999999999999998 777875321   1111


Q ss_pred             HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ...+   ..          ...  ...+..++..+.+++.+||+.+|++||++++++..|+.
T Consensus       236 ~~~i---~~----------~~~--~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMI---RN----------RQV--LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHH---Hc----------CCc--CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111   11          110  12233455668999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-43  Score=324.57  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=202.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||++... +++.||+|++.+...........+.+|+.++..++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36889999999999999999977 68999999987533333344566888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||+++     ++||||||+|||++.++.+||+|||++..+..
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG-----YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999999753 236899999999999999999999999     99999999999999999999999999876543


Q ss_pred             CCceeeeeecccccCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .... ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||.....      ......+......+
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~  227 (331)
T cd05597         155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHF  227 (331)
T ss_pred             CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence            3221 1222468999999998753     4578899999999999999999999953221      11111111111000


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSE--RPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~l~  341 (361)
                            .+  .......+..+.+++++||..++++  ||++.++++|-+
T Consensus       228 ------~~--~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~  268 (331)
T cd05597         228 ------QF--PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF  268 (331)
T ss_pred             ------cC--CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence                  00  1111124456889999988664443  789999999954

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.6e-43  Score=315.37  Aligned_cols=265  Identities=24%  Similarity=0.358  Sum_probs=197.4

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc---CCCcceeEEEEEEc-----C
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL---DHPNLVSLIGYCAD-----G  132 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~  132 (361)
                      +|++.+.||+|+||+||+|... +|+.||+|.+....... .....+.+|+.+++.+   +||||+++++++.+     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            4788899999999999999977 68999999986543222 2223455677777665   79999999998864     3


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      ...+++|||+++ +|.+++.......+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC-----IVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECccC
Confidence            468999999975 8999887655557999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-  291 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  291 (361)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|++||......   .....+....... 
T Consensus       154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~  227 (288)
T cd07863         154 LARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGLPP  227 (288)
T ss_pred             ccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH---HHHHHHHHHhCCCC
Confidence            998664322   122346789999999998888999999999999999999999998543221   1111111111000 


Q ss_pred             -hhhhh-------hcCcccc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          292 -KKLRK-------VIDPELS--RSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       292 -~~~~~-------~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                       .....       ...+...  ........+..+.+++.+||+.||++|||+.|++.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             00000       0000000  000111334568899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.5e-43  Score=329.84  Aligned_cols=267  Identities=24%  Similarity=0.293  Sum_probs=201.4

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-----EE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-----HR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~  135 (361)
                      +|+..+.||+|+||+||++... +|+.||+|++.... ........+.+|+.+++.++||||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            4788899999999999999976 79999999985432 22334557888999999999999999999998776     78


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |+||||+. ++|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.
T Consensus        80 ~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG-----ILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChHHEEECCCCCEEecccccee
Confidence            99999996 5888887653  37899999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh---
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR---  291 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  291 (361)
                      ........ ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.......   ....+.......   
T Consensus       152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~  227 (372)
T cd07853         152 VEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLE  227 (372)
T ss_pred             ecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence            65433221 22234678999999987664 57899999999999999999999996543221   111111110000   


Q ss_pred             ------hhhhhhcCccc-cC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 ------KKLRKVIDPEL-SR------SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 ------~~~~~~~~~~~-~~------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                            ......+.... ..      .......+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  290 (372)
T cd07853         228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY  290 (372)
T ss_pred             HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence                  00000000000 00      0011122456889999999999999999999999865

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8e-43  Score=312.43  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=201.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||.||+|+.. +++.+|+|++...   .......+.+|+.+++.++||||+++++++..++..++||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE---PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC---ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            46999999999999999999976 6889999998643   2233456788999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          86 EYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG-----KMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            999999999998653  36899999999999999999999999     99999999999999999999999999986643


Q ss_pred             CCceeeeeecccccCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTS---TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ...  ......|++.|+|||.+.   ...++.++|+|||||++|+|++|..||........   ....    .. .   .
T Consensus       159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~~----~~-~---~  225 (267)
T cd06646         159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLM----SK-S---N  225 (267)
T ss_pred             ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---heee----ec-C---C
Confidence            221  122346888999999874   44577899999999999999999999853221100   0000    00 0   0


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ...+..   ......+..+.+++.+||+.+|++|||+++++++|
T Consensus       226 ~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 FQPPKL---KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCC---ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000111   01122345689999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.5e-43  Score=320.98  Aligned_cols=268  Identities=24%  Similarity=0.352  Sum_probs=202.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|...+.||+|+||+||+|..+ +++.||+|.+.....  ......+.+|+.+++.++||||+++++++..++..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            46888999999999999999977 688999999875422  222345677999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++ +|.+++...+ ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.....
T Consensus        84 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          84 EYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK-----VLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             eCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            99975 8888876543 35889999999999999999999999     99999999999999999999999999976533


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh--------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND--------  290 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  290 (361)
                      ...  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......+.   ...+......        
T Consensus       157 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~  231 (309)
T cd07872         157 PTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE---LHLIFRLLGTPTEETWPG  231 (309)
T ss_pred             Ccc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhh
Confidence            221  1223457899999998754 5688999999999999999999999964432211   1111111100        


Q ss_pred             ---hhhhhhhcCccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          291 ---RKKLRKVIDPELSRS---SYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       291 ---~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                         .......-.+.....   ......+..+.+|+.+||+.||.+|||+.|+++|.+-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  289 (309)
T cd07872         232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF  289 (309)
T ss_pred             hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence               000000000000000   0011234568899999999999999999999998763

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-44  Score=325.11  Aligned_cols=255  Identities=23%  Similarity=0.361  Sum_probs=205.1

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ..|++++.||+||.+.||++...+.+.||+|++.... .+.....-+.+|++.|.+|+ |.+|+++++|-..++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            4599999999999999999998878889988875432 34456778999999999995 999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||= ..+|...|+........| .+..++.||+.|+.++|.+|     |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g-----IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG-----IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc-----eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            976 459999998765433333 78899999999999999999     99999999999885 46999999999999887


Q ss_pred             CCceeeeeecccccCccCcccccCC-----------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTG-----------KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      ..........+||+.||+||.+...           ..+.++||||||||||+|+.|++||...               .
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------------~  576 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------------I  576 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------------H
Confidence            7766677788999999999965322           2567899999999999999999999521               1


Q ss_pred             hhhhhhhhhcCcccc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          289 NDRKKLRKVIDPELS--RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +...++..+.+|...  ....+.  ..++.+++..||..||++|||+.|+|+|..
T Consensus       577 n~~aKl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpF  629 (677)
T KOG0596|consen  577 NQIAKLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPF  629 (677)
T ss_pred             HHHHHHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence            112233334444321  111111  122899999999999999999999998753

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.5e-43  Score=323.68  Aligned_cols=262  Identities=25%  Similarity=0.376  Sum_probs=202.3

Q ss_pred             CCCCCCceecccCceEEEEEEE------cCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc-C
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD-G  132 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~  132 (361)
                      ++|++.+.||+|+||+||+|.+      .+++.||||++....  .......+.+|+.++..+ +||||+++++++.. +
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            4699999999999999999974      246789999986432  223355688899999999 68999999998765 4


Q ss_pred             CEEEEEEEecCCCchhhhcccCC---------------------------------------------------------
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIG---------------------------------------------------------  155 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  155 (361)
                      ...+++|||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56789999999999999886421                                                         


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeee
Q 018047          156 --------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA  227 (361)
Q Consensus       156 --------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (361)
                              ...+++..+..++.|+++||+|||+++     ++||||||+|||++.++.++|+|||++..+..........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                    123678888999999999999999999     9999999999999999999999999998653332211222


Q ss_pred             ecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCC
Q 018047          228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS  306 (361)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (361)
                      ...++..|+|||.+....++.++||||||+++|+|++ |..||......  .....   ..... ..      .     .
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~---~~~~~-~~------~-----~  302 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCR---RLKEG-TR------M-----R  302 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHH---HHhcc-CC------C-----C
Confidence            2345678999999888889999999999999999997 88888543211  11111   11110 00      0     0


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          307 YTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       307 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      .+...+..+.+++.+||+.||++|||+.|++++|+.++..
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1111234588999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-42  Score=315.96  Aligned_cols=263  Identities=29%  Similarity=0.432  Sum_probs=205.1

Q ss_pred             CCCCCCceecccCceEEEEEEEcC-----------------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcce
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS-----------------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV  123 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv  123 (361)
                      .+|++.+.||+|+||.||+|....                 +..||+|.+....  .......+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEe
Confidence            468999999999999999988652                 2458999886442  224456788999999999999999


Q ss_pred             eEEEEEEcCCEEEEEEEecCCCchhhhcccCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCC
Q 018047          124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFK  194 (361)
Q Consensus       124 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dik  194 (361)
                      ++++++..++..+++|||+++++|.+++....         ...+++..++.++.|++.||+|||+++     ++|+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-----i~H~dlk  157 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-----FVHRDLA  157 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccccc
Confidence            99999999999999999999999999986543         126899999999999999999999999     9999999


Q ss_pred             CCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCC
Q 018047          195 STNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT--GRRAVDLN  272 (361)
Q Consensus       195 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~  272 (361)
                      |+||+++.++.++|+|||++................+++.|+|||++....++.++|||||||++|+|++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999999986644433223334456788999999888889999999999999999998  66676432


Q ss_pred             CCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          273 QGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .   .......+........       .... ...+...+.++.+++.+||+.||++|||+.|+++.|+
T Consensus       238 ~---~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         238 T---DQQVIENAGHFFRDDG-------RQIY-LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             C---hHHHHHHHHhcccccc-------cccc-CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            2   1222222111111000       0000 1112233456999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-42  Score=313.28  Aligned_cols=261  Identities=23%  Similarity=0.343  Sum_probs=207.8

Q ss_pred             cCCCCCCceecccCceEEEEEEEcC-----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc-CC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRS-----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD-GK  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~  133 (361)
                      .++|++.++||+|+||.||+|.+..     +..|++|.+...  ........+.+|+.+++.++|||++++++++.. +.
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            3468889999999999999999764     678999987532  334456778889999999999999999998765 56


Q ss_pred             EEEEEEEecCCCchhhhcccCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEE
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGE------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAK  207 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~k  207 (361)
                      ..+++++|+++|+|.+++.....      ..+++..++.++.|++.||+|||+++     ++|+||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-----VIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccCHhhEEEcCCCcEE
Confidence            78999999999999999865322      46899999999999999999999999     99999999999999999999


Q ss_pred             EeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHH
Q 018047          208 ISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRH  286 (361)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  286 (361)
                      |+|||+++.+.............++..|+|||++....++.++||||||+++|++++ |+.||.....   ......   
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~---  231 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY---  231 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHH---
Confidence            999999986644332222223345678999999988889999999999999999999 9999853221   111111   


Q ss_pred             HhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                       ......           ...+...+..+.+++.+||+.||++|||+.++++.|..+..
T Consensus       232 -~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         232 -LKDGYR-----------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -HHcCCC-----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             111100           01112234568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.5e-42  Score=345.95  Aligned_cols=267  Identities=24%  Similarity=0.360  Sum_probs=209.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.++||+|+||+||+|.+. +|+.||+|++.............+.+|+.+++.++||||+++++++.+++..|++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999977 68999999987543333344567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 018047          140 EYMQKGNLQDHLNGIG---------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD  210 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~D  210 (361)
                      ||++||+|.+++....         ...+++..++.++.|+++||+|||++|     ++||||||+|||++.++.++|+|
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-----IIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-----VLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchheEEEcCCCCEEEEe
Confidence            9999999999886421         124567788999999999999999999     99999999999999999999999


Q ss_pred             cCccccCCCCCc----------------eeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 018047          211 FGLAKLMPEGQE----------------TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG  274 (361)
Q Consensus       211 fg~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  274 (361)
                      ||++........                ........||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            999986621110                0011234699999999999888999999999999999999999999964222


Q ss_pred             CCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHHHHhhcC
Q 018047          275 VNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSER-PSMAECVKELQLIIYTNS  348 (361)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-pt~~ell~~l~~i~~~~~  348 (361)
                      ..   . .. .....         .+.-  .......+..+.+++.+||+.||++| ++++++++.|+..+....
T Consensus       237 ~k---i-~~-~~~i~---------~P~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p  295 (932)
T PRK13184        237 RK---I-SY-RDVIL---------SPIE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP  295 (932)
T ss_pred             hh---h-hh-hhhcc---------Chhh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence            10   0 00 00000         0000  00011334558899999999999999 578888888988876543

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.6e-43  Score=324.85  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=193.0

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHH-HHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVD-ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.||+|+||+||+|... +|+.+|+|++.............+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999976 68999999987543333333445555655 46778999999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++........  
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g-----ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  151 (325)
T cd05604          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN-----IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--  151 (325)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence            9999988753  37899999999999999999999999     99999999999999999999999999875422211  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||....      ............          +  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~~~~~~----------~--  213 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD------VAEMYDNILHKP----------L--  213 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC------HHHHHHHHHcCC----------c--
Confidence            2234568999999999998899999999999999999999999995332      111111111110          0  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSMA----ECVKE  339 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~----ell~~  339 (361)
                       ..+...+..+.+++.+||+.||.+||++.    ++++|
T Consensus       214 -~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         214 -VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             -cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence             01112334578999999999999999875    55554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-43  Score=314.78  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=203.3

Q ss_pred             CCCCCCceecccCceEEEEEEEcC------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      ++|.+.+.||+|+||.||+|....      +..||+|.+...  ........+.+|+.++..++||||+++++++.+...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc--cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            468889999999999999998652      368999997543  222334568889999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcE
Q 018047          135 RFLVYEYMQKGNLQDHLNGIG--------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA  206 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~  206 (361)
                      .++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+.+     ++|+||||+||+++.++.+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~di~p~nill~~~~~~  158 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-----FVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccChheEEEcCCCCE
Confidence            999999999999999986532        224788899999999999999999999     9999999999999999999


Q ss_pred             EEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 018047          207 KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      ||+|||+++.+.............++..|+|||.+....++.++|||||||++|||++ |..||.....   ....... 
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~-  234 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFV-  234 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHH-
Confidence            9999999986644332222233456788999999888889999999999999999998 8888853221   1111111 


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                        . ...      .     ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       235 --~-~~~------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 --I-DGG------H-----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             --h-cCC------C-----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence              1 100      0     1112223566899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-43  Score=314.08  Aligned_cols=256  Identities=32%  Similarity=0.498  Sum_probs=201.3

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |+..+.||+|+||+||++... +++.+|+|.+......... ......|+.+++.++||||+++++++.+....++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            566789999999999999988 5778999999765322221 22334599999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++..  ...+++..+..++.|+++||.+||+++     ++|+||||+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~-----i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   80 CPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKG-----IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             ETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTT-----EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             cccccccccccc--ccccccccccccccccccccccccccc-----cccccccccccccccccccccccccccccccccc
Confidence            999999999983  337899999999999999999999999     9999999999999999999999999997642211


Q ss_pred             ceeeeeecccccCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          222 ETYVTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                        .......++..|+|||+.. ...++.++||||||+++|+|++|..||....   ..+................  .. 
T Consensus       153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~--~~-  224 (260)
T PF00069_consen  153 --ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN---SDDQLEIIEKILKRPLPSS--SQ-  224 (260)
T ss_dssp             --SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS---HHHHHHHHHHHHHTHHHHH--TT-
T ss_pred             --ccccccccccccccccccccccccccccccccccccccccccccccccccc---chhhhhhhhhccccccccc--cc-
Confidence              1333456899999999987 7889999999999999999999999996441   1122222221111110000  00 


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                            ........+.+++.+||+.||++|||+.+++++-
T Consensus       225 ------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  225 ------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             ------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             ------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence                  0001125699999999999999999999999763

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-42  Score=313.92  Aligned_cols=269  Identities=29%  Similarity=0.423  Sum_probs=202.8

Q ss_pred             CCCCceecccCceEEEEEEE-----cCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KHR  135 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~  135 (361)
                      |...+.||+|+||+||++..     .+++.||+|.+....  .......+.+|+++++.++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            48889999999999988653     257889999986432  223456788899999999999999999987653  468


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      +++|||+++|+|.+++...   .+++..+..++.|++.||.|||+++     ++|+||||+|||++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccChheEEEcCCCcEEEeeccccc
Confidence            9999999999999999653   5899999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceee-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYV-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+........ .....++..|+|||.+....++.++||||||+++|+|++|+.|+........ ........ ......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~-~~~~~~~  233 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQG-QMTVVRL  233 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccc-ccchhhh
Confidence            7654322111 1122356679999998888899999999999999999999999854322100 00000000 0000011


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      ...+..... ...+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus       234 ~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111110 1123334567999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.8e-42  Score=308.25  Aligned_cols=248  Identities=29%  Similarity=0.449  Sum_probs=200.3

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE-cCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA-DGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e  140 (361)
                      +|.+.+.||+|+||.||++... |..+|+|.+...     .....+.+|+.+++.++|+|++++++++. .++..+++||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            5888899999999999999876 788999987532     23456888999999999999999999754 5567899999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++.......+++..+..++.|++.||+|||++|     ++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccccchheEEEcCCCcEEecCCccceecccc
Confidence            999999999997765556899999999999999999999999     999999999999999999999999998765332


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..     ...++..|+|||++....++.++|||||||++|+|++ |+.||....      ...........       ..
T Consensus       156 ~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~-------~~  217 (256)
T cd05082         156 QD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKG-------YK  217 (256)
T ss_pred             CC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcC-------CC
Confidence            21     1234567999999988889999999999999999998 899885321      11111111110       00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                           ...+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       218 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 -----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                 111223345689999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.4e-43  Score=315.67  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=203.8

Q ss_pred             cCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  133 (361)
                      .++|++.+.||+|+||.||+|..+      .+..||+|.+...  ........+.+|+.+++.++||||+++++++.+++
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            457999999999999999999754      2457999987543  22233446778999999999999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIG--------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE  205 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~  205 (361)
                      ..|+||||+++|+|.+++....        ....++..+..++.|++.||.|||+++     ++||||||+||+++.++.
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dikp~nili~~~~~  157 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcCCCCChheEEEcCCCc
Confidence            9999999999999999996532        234567788999999999999999999     999999999999999999


Q ss_pred             EEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHH
Q 018047          206 AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~  284 (361)
                      ++|+|||+++...............++..|+|||.+....++.++|+|||||++|||++ |..||.....   ...   .
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~---~  231 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQV---L  231 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHH---H
Confidence            99999999986543332222222345678999999888889999999999999999999 6888853221   111   1


Q ss_pred             HHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      .....          ...  ...+...+..+.+++.+||+.||++|||+.++++.|.+.+.
T Consensus       232 ~~~~~----------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         232 KFVMD----------GGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             HHHHc----------CCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence            11110          000  01122334569999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2e-42  Score=314.92  Aligned_cols=263  Identities=25%  Similarity=0.408  Sum_probs=204.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCC--EEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGE--VVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++.++||+|+||.||+|... ++.  .+++|.+..  .........+.+|+.++.++ +||||+++++++.+.+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            46889999999999999999876 343  468887652  12333456788899999999 7999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC
Q 018047          137 LVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA  202 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~  202 (361)
                      ++|||+++|+|.+++....              ...+++..+..++.|++.||+|||++|     ++||||||+|||++.
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~  154 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-----FIHRDLAARNVLVGE  154 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCcCCcceEEECC
Confidence            9999999999999986432              125888999999999999999999999     999999999999999


Q ss_pred             CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 018047          203 NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~  281 (361)
                      ++.+||+|||++.......   .......+..|+|||+.....++.++|||||||++|||++ |..||.....   ... 
T Consensus       155 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~-  227 (297)
T cd05089         155 NLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AEL-  227 (297)
T ss_pred             CCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH-
Confidence            9999999999986432111   1111123457999999988889999999999999999997 9999953321   111 


Q ss_pred             HHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 018047          282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGL  351 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~  351 (361)
                        .......       ..     ...+...+..+.+|+.+||+.+|.+|||+.++++.|..++...+...
T Consensus       228 --~~~~~~~-------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~  283 (297)
T cd05089         228 --YEKLPQG-------YR-----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV  283 (297)
T ss_pred             --HHHHhcC-------CC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence              1111100       00     11122344568999999999999999999999999999887654433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.8e-42  Score=317.79  Aligned_cols=264  Identities=24%  Similarity=0.386  Sum_probs=206.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc--------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR--------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD  131 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  131 (361)
                      .+|.+.+.||+|+||.||+|...        .+..+|+|.+...  ........+..|+.+++.+ +||||+++++++.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            35888999999999999999752        2456899987643  2233456788899999999 69999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCC
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~N  197 (361)
                      .+..+++|||+++|+|.+++....              ...+++..+..++.|++.||.|||++|     ++|+||||+|
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-----i~H~dlkp~N  164 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-----CIHRDLAARN  164 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-----eeecccccee
Confidence            999999999999999999996532              235889999999999999999999999     9999999999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVN  276 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  276 (361)
                      ||++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|+|++ |..||.....  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--  242 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--  242 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999986643322111222234567999999888889999999999999999999 8888853221  


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                       ........   .. ..           ...+..++..+.+++.+||+.+|++|||+.++++.|+++....+.
T Consensus       243 -~~~~~~~~---~~-~~-----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~  299 (314)
T cd05099         243 -EELFKLLR---EG-HR-----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE  299 (314)
T ss_pred             -HHHHHHHH---cC-CC-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence             11111111   00 00           111223345688999999999999999999999999998765433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-42  Score=308.44  Aligned_cols=255  Identities=29%  Similarity=0.473  Sum_probs=206.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .++|.+.+.||+|+||+||+|..+++..+|+|.+....    ....++.+|+.+++.++|+|++++++++.+....+++|
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            45789999999999999999998877889999986432    23467889999999999999999999999989999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++.......+++..+..++.|++.|+.|||+++     ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~-----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN-----YIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcchheEEEcCCCCEEECccccceeccc
Confidence            9999999999998765567999999999999999999999999     99999999999999999999999999987643


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||....   ......   .....   .    
T Consensus       156 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~---~~~~~---~----  221 (261)
T cd05034         156 DEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLE---QVERG---Y----  221 (261)
T ss_pred             hhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH---HHHcC---C----
Confidence            2111 1112234568999999988889999999999999999998 999985322   111111   11110   0    


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      .     ...+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       222 ~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 R-----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             C-----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0     11122234568999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.6e-43  Score=313.34  Aligned_cols=253  Identities=24%  Similarity=0.440  Sum_probs=200.1

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcC----
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADG----  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----  132 (361)
                      +.+.|+..+.||+|+||.||+|... +++.+|+|.+...    ......+..|+.++..+ +|+|++++++++...    
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            4556888899999999999999976 6889999998643    22345678899999998 699999999998653    


Q ss_pred             --CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 018047          133 --KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD  210 (361)
Q Consensus       133 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~D  210 (361)
                        ...|++|||+++|+|.+++.......+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~-----ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-----VIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHEEECCCCCEEEcc
Confidence              46899999999999999998755557899999999999999999999999     99999999999999999999999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      ||++........  ......|++.|+|||++.     ...++.++|||||||++|+|++|..||......   ...... 
T Consensus       155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~~~-  228 (272)
T cd06637         155 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLI-  228 (272)
T ss_pred             CCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHH-
Confidence            999986543221  122356889999999875     345788999999999999999999999532211   111000 


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                        ..       ......    .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       229 --~~-------~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 --PR-------NPAPRL----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             --hc-------CCCCCC----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence              00       001111    111234568999999999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-42  Score=332.30  Aligned_cols=264  Identities=23%  Similarity=0.338  Sum_probs=195.6

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  132 (361)
                      ...+|+..+.||+|+||+||+|... +++.||||++....       ....+|+.+|+.++||||+++++++...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3457999999999999999999976 68999999885321       1234699999999999999999886432     


Q ss_pred             ---CEEEEEEEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-cE
Q 018047          133 ---KHRFLVYEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-EA  206 (361)
Q Consensus       133 ---~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-~~  206 (361)
                         ..+++||||+++ +|.+++...  ....+++..+..++.|++.||+|||+++     |+||||||+|||++.++ .+
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~-----IiHrDLKp~NILl~~~~~~v  210 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF-----ICHRDLKPQNLLIDPNTHTL  210 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCcCHHHEEEcCCCCce
Confidence               246799999975 777766432  2347899999999999999999999999     99999999999999664 79


Q ss_pred             EEeecCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 018047          207 KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      ||+|||+++.+.....   .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||......   .....+.
T Consensus       211 kL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~  284 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV---DQLVRII  284 (440)
T ss_pred             eeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHH
Confidence            9999999987654332   223568999999998755 46899999999999999999999999643321   1111111


Q ss_pred             HHhhhh---------hhhhhhcCccccC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          286 HILNDR---------KKLRKVIDPELSR----SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       286 ~~~~~~---------~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ......         ..+....-+....    ..++...+.++.+|+.+||..||.+|||+.|+++|.+
T Consensus       285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence            111000         0000000000000    0112223457899999999999999999999999876

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=348.34  Aligned_cols=271  Identities=31%  Similarity=0.479  Sum_probs=221.3

Q ss_pred             CCCCCceecccCceEEEEEEEc--CCC----EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR--SGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      ..+..+.||+|+||.||.|...  +|.    .||||.+...  .+.....+|.+|..+|+.++|||||+++|++.+....
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4556788999999999999876  344    3888887643  5567788999999999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 018047          136 FLVYEYMQKGNLQDHLNGIG-----EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD  210 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~D  210 (361)
                      +|++|||.+|+|..||++..     ...++...++.++.++|+|++||++++     +|||||...|+||+....+||+|
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~-----fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH-----FVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC-----CcCcchhhhheeecccCcEEEcc
Confidence            99999999999999998642     346888999999999999999999999     99999999999999999999999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      ||+|+.+.+.+.........-...|||||.+..+.++.|+|||||||++||++| |..||...+   .......+   ..
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~---n~~v~~~~---~~  919 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS---NFEVLLDV---LE  919 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc---hHHHHHHH---Hh
Confidence            999996655554444333233468999999999999999999999999999999 788885332   22222211   11


Q ss_pred             hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCCccc
Q 018047          290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHA  357 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~~~~  357 (361)
                      + +           +-..|..++..+.+++.+||+.+|++||++..+++.+..+.+.....-+.+..+
T Consensus       920 g-g-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a  975 (1025)
T KOG1095|consen  920 G-G-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPA  975 (1025)
T ss_pred             C-C-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccccccc
Confidence            1 1           233455677779999999999999999999999999999988776655554443

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.4e-42  Score=307.26  Aligned_cols=253  Identities=29%  Similarity=0.447  Sum_probs=202.3

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|.+...||+|++|.||+|...++..+|+|.+....    .....+.+|+.+++.++|+|++++++++.. +..+++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence            3588889999999999999998877789999875322    234567889999999999999999998754 56789999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.......+++..+..++.|++.||+|||+.|     ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN-----YIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            999999999997655556899999999999999999999999     999999999999999999999999999866433


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ... ......++..|+|||......++.++||||||+++|+|++ |..||....   .......   ....       ..
T Consensus       156 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~---~~~~-------~~  221 (260)
T cd05069         156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV---NREVLEQ---VERG-------YR  221 (260)
T ss_pred             ccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH---HHcC-------CC
Confidence            211 1112345678999999888889999999999999999999 888885322   1111111   1110       00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                           ...+...+..+.+++.+||..||++||+++++++.|++
T Consensus       222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 -----MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 11223345669999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2e-42  Score=308.26  Aligned_cols=249  Identities=27%  Similarity=0.433  Sum_probs=197.4

Q ss_pred             eecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           68 FLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      .||+|+||.||+|.++   +++.+|+|++.... ........+..|+.+++.++||||+++++++. .+..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            5899999999999753   57889999886432 23344567889999999999999999999885 4567899999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||.||+++.++.++|+|||++..+.......
T Consensus        80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            9999999653  36899999999999999999999999     9999999999999999999999999998765443221


Q ss_pred             e-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccc
Q 018047          225 V-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL  302 (361)
Q Consensus       225 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      . .....++..|+|||.+....++.++|+||||+++|||++ |..||.....   ......+.   .. .      .   
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~---~~-~------~---  216 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIE---SG-E------R---  216 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH---CC-C------C---
Confidence            1 112234578999999888889999999999999999998 9999853321   11111111   10 0      0   


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       303 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                        ...+...+..+.++|.+||+.||++||++++|.+.|++.
T Consensus       217 --~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 --MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              112223456689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=314.71  Aligned_cols=263  Identities=27%  Similarity=0.440  Sum_probs=201.9

Q ss_pred             CCCCCCceecccCceEEEEEEEcC---------------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS---------------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL  125 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~  125 (361)
                      .+|++.+.||+|+||.||++....               ...||+|.+...  ........+.+|+++++.++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            468999999999999999987642               235899988643  223345678899999999999999999


Q ss_pred             EEEEEcCCEEEEEEEecCCCchhhhcccCC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCC
Q 018047          126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKS  195 (361)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp  195 (361)
                      ++++...+..++||||+++++|.+++....          ...+++..++.++.|++.||+|||+++     ++|+||||
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp  157 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-----FVHRDLAT  157 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-----eeccccCh
Confidence            999999999999999999999999985432          124788999999999999999999999     99999999


Q ss_pred             CCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCCC
Q 018047          196 TNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT--GRRAVDLNQ  273 (361)
Q Consensus       196 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~~  273 (361)
                      +||+++.++.+||+|||++..+.............++..|+|||+.....++.++|+||||+++|+|++  |..||....
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            999999999999999999986644332222233445778999999888889999999999999999998  556664322


Q ss_pred             CCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          274 GVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .   ................  ...      ...+...+..+.+|+.+||+.||++|||++++++.|.
T Consensus       238 ~---~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         238 D---EQVIENTGEFFRNQGR--QIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             h---HHHHHHHHHhhhhccc--ccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1   1122211111110000  000      0011123356999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.9e-42  Score=309.67  Aligned_cols=255  Identities=27%  Similarity=0.460  Sum_probs=203.4

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCC---cchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFK---EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      +|...+.||+|+||+||+|...+|+.+|+|.+......   .......+.+|+.+++.++|+||+++.+++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47888999999999999998878999999998654221   122345688899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      +||+++++|.+++.+..  .+++..+..++.|++.||+|||+.+     ++|+||+|+||++++++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC-----VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            99999999999997643  6889999999999999999999999     9999999999999999999999999987653


Q ss_pred             CCC----ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          219 EGQ----ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       219 ~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ...    .........|+..|+|||++....++.++|+||||+++|+|++|..||......      ...........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~--  225 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL------AAMFYIGAHRG--  225 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH------HHHHHhhhccC--
Confidence            211    111122346889999999998888999999999999999999999999532211      11111000000  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                         ..+     ..+...+..+.+++++||+.+|++||++.+++++
T Consensus       226 ---~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         226 ---LMP-----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ---CCC-----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               011     1122344558999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.8e-42  Score=316.80  Aligned_cols=261  Identities=24%  Similarity=0.383  Sum_probs=204.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|++.+.||+|+||.||++.+. ++..+|+|.+...  ........+.+|+++++.++||||+++++.+.+++..++|||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            6889999999999999999976 6888999988643  223345668889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |+++++|.+++...  ..+++..+..++.|+++||.|||+ .+     ++|+||||+|||++.++.++|+|||++.....
T Consensus        80 y~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          80 HMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC-----EEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            99999999999764  368999999999999999999998 47     99999999999999999999999999876533


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh--------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR--------  291 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  291 (361)
                      ..    .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......   .............        
T Consensus       153 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  225 (308)
T cd06615         153 SM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRP  225 (308)
T ss_pred             cc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCccc
Confidence            22    23356889999999988888999999999999999999999998543211   1111000000000        


Q ss_pred             ------------------hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          292 ------------------KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       292 ------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                                        ..+.....+..+    ....+..+.+++.+||..||++|||+.+++++.+-
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  290 (308)
T cd06615         226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLP----SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI  290 (308)
T ss_pred             ccCCCCCccchhhHHHHHHHHhcCCCccCc----CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence                              000000001110    11234568999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-42  Score=306.60  Aligned_cols=250  Identities=30%  Similarity=0.497  Sum_probs=203.8

Q ss_pred             ceecccCceEEEEEEEcC----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEec
Q 018047           67 NFLGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      +.||+|+||.||+|....    +..+++|.+......  .....+.+|++.+..++|+|++++++++.+....+++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            468999999999999763    789999998654322  24678889999999999999999999999999999999999


Q ss_pred             CCCchhhhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          143 QKGNLQDHLNGIG-------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       143 ~~g~L~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++++|.+++....       ...+++..++.++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||.+.
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-----FVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC-----cccCccCcceEEECCCCcEEEccccccc
Confidence            9999999997642       257999999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ...............+++.|+|||.+....++.++||||||+++|+|++ |..||....   ......   ..... .  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~---~~~~~-~--  224 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVLE---YLRKG-Y--  224 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHHH---HHHcC-C--
Confidence            7765432222333457889999999888889999999999999999999 588886431   111111   11110 0  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                               ....+...+..+.+++.+||+.+|++|||+.+++++|+
T Consensus       225 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ---------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                     01223333566999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-42  Score=324.72  Aligned_cols=268  Identities=21%  Similarity=0.277  Sum_probs=201.3

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  132 (361)
                      ..++|...+.||+|+||.||++... +++.+|+|++.... ........+.+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4568999999999999999999876 68999999986543 2233345677899999999999999999988643     


Q ss_pred             -CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          133 -KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       133 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                       ...|+||||+++ +|.+.+..    .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHHEEECCCCCEEEeeC
Confidence             357999999965 67776643    5888999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH-----
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH-----  286 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----  286 (361)
                      |++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ....+..     
T Consensus       164 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~  238 (355)
T cd07874         164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPC  238 (355)
T ss_pred             cccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence            9998654332   22335689999999999888999999999999999999999999964321110  0000000     


Q ss_pred             -------------HhhhhhhhhhhcCccc-cC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          287 -------------ILNDRKKLRKVIDPEL-SR------SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       287 -------------~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                                   .............+.. ..      .......+..+.+|+.+||+.||++|||+.|+++|.+-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence                         0000000000000000 00      00111234568999999999999999999999999653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.8e-43  Score=322.96  Aligned_cols=259  Identities=22%  Similarity=0.312  Sum_probs=201.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||++..+ +++.+|+|++.+...........+..|+.++..++|++|+++++.+.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888999999999999999987 58889999986532223333456788999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||+++     ++||||||+|||++.++.+||+|||++..+..
T Consensus        81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~-----iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            9999999999997632 36899999999999999999999999     99999999999999999999999999876533


Q ss_pred             CCceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||....      .......+.......
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~  227 (332)
T cd05623         155 DGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERF  227 (332)
T ss_pred             CCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCccc
Confidence            222 1223357899999999875     3467889999999999999999999995332      112222221111000


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSE--RPSMAECVKEL  340 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~l  340 (361)
                              .........+..+.+|+.+||..+++.  |+++.|+++|-
T Consensus       228 --------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~  267 (332)
T cd05623         228 --------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP  267 (332)
T ss_pred             --------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence                    001111233556889999988765444  68999999994

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-42  Score=306.95  Aligned_cols=250  Identities=31%  Similarity=0.501  Sum_probs=204.8

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|+..+.||.|+||.||+|... |+.||+|.+....    .....+.+|+.+++.++|+|++++++++.+.+..++|||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            46888999999999999999876 8899999986432    145678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++.......+++..+..++.|++.||.|||+++     ++|+||||+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN-----FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            999999999997765557999999999999999999999999     999999999999999999999999999876332


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..     ...++..|+|||.+....++.++||||||+++|+|++ |..||....   .......+   ...       ..
T Consensus       156 ~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~---~~~-------~~  217 (256)
T cd05039         156 QD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPHV---EKG-------YR  217 (256)
T ss_pred             cc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH---hcC-------CC
Confidence            21     1234567999999888889999999999999999997 999985321   11111111   110       00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                           ...+...+..+.+++.+||..+|++|||+.+++..|+.+
T Consensus       218 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         218 -----MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -----CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                 111223345689999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.7e-42  Score=311.38  Aligned_cols=255  Identities=26%  Similarity=0.454  Sum_probs=201.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      .+|...+.||+|+||.||++...      ++..+|+|.+...   .......+.+|+++++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            35777889999999999999642      3567899987532   23445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGE-------------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS  201 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~  201 (361)
                      .+++|||+++|+|.+++.....             ..+++..+..++.|++.|++|||++|     ++|+||||+|||++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-----i~H~dlkp~nil~~  156 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-----FVHRDLATRNCLVG  156 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-----eecccccHhhEEEc
Confidence            9999999999999999865421             35889999999999999999999999     99999999999999


Q ss_pred             CCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 018047          202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNL  280 (361)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~  280 (361)
                      .++.++|+|||++................+++.|+|||++....++.++|||||||++|+|++ |..||.....   ...
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~  233 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEA  233 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHH
Confidence            999999999999976543322222222345678999999988889999999999999999998 8888853221   111


Q ss_pred             HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .   .......       .     ...+...+..+.+++.+||+.||++||++.++++.|+
T Consensus       234 ~---~~~~~~~-------~-----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 I---ECITQGR-------E-----LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H---HHHHcCc-------c-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1   1111000       0     0111223455889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-42  Score=309.16  Aligned_cols=258  Identities=27%  Similarity=0.469  Sum_probs=204.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCC---EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGE---VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      .+|+..+.||+|+||.||+|... +++   .+|+|.+...  ........+..|+.+++.++|+|++++.+++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            36788899999999999999976 333   6899988543  12334567889999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++++|.+++.... ..+++..+..++.|++.|++|||+.+     ++|+||||+||+++.++.++|+|||++..
T Consensus        83 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          83 IITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN-----YVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhhEEEcCCCcEEECCCcccee
Confidence            9999999999999986542 46899999999999999999999999     99999999999999999999999999986


Q ss_pred             CCCCCceeee-eecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          217 MPEGQETYVT-ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       217 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .......... .....+..|+|||++....++.++|||||||++|||++ |..||.....   ..   ....+... .  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~---~~~~i~~~-~--  227 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HE---VMKAINDG-F--  227 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HH---HHHHHhcC-C--
Confidence            6443222111 11123457999999888889999999999999999997 9999853321   11   11111110 0  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                               ....+...+..+.+++.+||+.+|++||++.++++.|++++
T Consensus       228 ---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         228 ---------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                     01112234456899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.4e-42  Score=308.24  Aligned_cols=254  Identities=26%  Similarity=0.446  Sum_probs=204.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .++|...+.||+|+||.||++...++..+|+|.+...    ....+.+.+|+.+++.++|+|++++++.+.+ ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            4578899999999999999999777788999987532    2345678889999999999999999999887 7789999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++.......+++..+..++.|++.||+|||+.|     ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-----YIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            9999999999997755557889999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .... ......++..|+|||++....++.++|+||||+++|++++ |..||....   .......+    .....     
T Consensus       155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~----~~~~~-----  221 (260)
T cd05073         155 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRAL----ERGYR-----  221 (260)
T ss_pred             CCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH----hCCCC-----
Confidence            3221 1122335677999999988889999999999999999999 899985322   11111111    11000     


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                            ...+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       222 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 ------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  01112334568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.5e-42  Score=305.10  Aligned_cols=252  Identities=24%  Similarity=0.394  Sum_probs=203.9

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc-CCEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD-GKHRFLVY  139 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  139 (361)
                      +|++.+.||+|++|.||++... +++.+|+|.+...... ......+..|+++++.++|+|++++.+.+.. +...|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            4888999999999999999976 5889999998654322 2334567889999999999999999998764 44689999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++.......+++.++..++.+++.|+++||+.|     ++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~-----i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            9999999999997654556899999999999999999999999     99999999999999999999999999986643


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ......+++.|+|||+.....++.++|+||||+++|+|++|+.||...+      ...........  .    . 
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~--~----~-  219 (257)
T cd08223         155 QCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEG--K----L-  219 (257)
T ss_pred             cCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc--C----C-
Confidence            221  2233568899999999988889999999999999999999999985322      11111111111  0    0 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                           ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus       220 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 -----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                 11223445668999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.3e-42  Score=313.38  Aligned_cols=254  Identities=24%  Similarity=0.403  Sum_probs=205.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..+|+..+.||+|+||.||+|... +++.+|+|.+.....   .....+.+|+.+++.++|+|++++++.+.++...|+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            347889999999999999999976 689999999875432   2345678899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++++|.+++..   ..+++..+..++.|++.||+|||+.|     ++|+||||+||+++.++.++|+|||++....
T Consensus        96 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g-----i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          96 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             ecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            999999999999864   25889999999999999999999999     9999999999999999999999999987654


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  ......|++.|+|||.+....++.++|||||||++|+|++|+.||......  ....    .....       .
T Consensus       168 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~----~~~~~-------~  232 (296)
T cd06654         168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALY----LIATN-------G  232 (296)
T ss_pred             cccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHH----HHhcC-------C
Confidence            3221  112346889999999988888899999999999999999999999643221  0000    00000       0


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      .+.   ...+...+..+.+++.+||..||++|||+.+++++-.-
T Consensus       233 ~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~  273 (296)
T cd06654         233 TPE---LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL  273 (296)
T ss_pred             CCC---CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence            000   11223345668999999999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.8e-43  Score=322.38  Aligned_cols=259  Identities=22%  Similarity=0.294  Sum_probs=202.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+.+.||+|+||+||+++.. +++.||+|.+.+...........+..|..++..++|+||+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36889999999999999999977 68899999986532223334456788999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~-----iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH-----YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999997642 36899999999999999999999999     99999999999999999999999999986644


Q ss_pred             CCceeeeeecccccCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .... ......||+.|+|||++..     +.++.++|||||||++|+|++|+.||.....      ......+...... 
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~-  226 (331)
T cd05624         155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEER-  226 (331)
T ss_pred             CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCc-
Confidence            3221 2223568999999998765     4678899999999999999999999953321      1111121111100 


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSE--RPSMAECVKEL  340 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~l  340 (361)
                             +.........+..+.+++.+||..++++  |++++++++|.
T Consensus       227 -------~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~  267 (331)
T cd05624         227 -------FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA  267 (331)
T ss_pred             -------ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence                   0001111123456889999999876654  46899998874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.5e-42  Score=310.54  Aligned_cols=263  Identities=28%  Similarity=0.435  Sum_probs=204.1

Q ss_pred             CCCCCceecccCceEEEEEEEc-----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KH  134 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~  134 (361)
                      .|++.+.||+|+||.||++...     ++..||+|.+...  ........+.+|+.+++.++|||++++.+++.+.  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            4788899999999999999742     4788999998643  2233456788999999999999999999998775  57


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|     ++||||||+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g-----i~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccchheEEEcCCCCEEECCCccc
Confidence            899999999999999986542 36899999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCce-eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC---------CchhHHHHH
Q 018047          215 KLMPEGQET-YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGV---------NDQNLVLQV  284 (361)
Q Consensus       215 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---------~~~~~~~~~  284 (361)
                      ..+...... .......++..|+|||.+.+..++.++||||||+++|+|++++.|.......         ........+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            876543321 1122345677899999988888999999999999999999988765321110         000111111


Q ss_pred             HHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      .. .....           ....+...+..+.+|+.+||+.||++|||++++++.|+.++
T Consensus       237 ~~-~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         237 RV-LEEGK-----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HH-HHcCc-----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            11 00000           01112234566999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=312.41  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=212.3

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |.+..+||+|+||.||+|.++ +|+.+|||.+..     .....++..|+.+|++++.|++|++||.|.....+++||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            566778999999999999987 799999999853     34567888999999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      |..|++.+.++.. .+.+++..+..++...++||+|||...     -||||||..|||++.+|..||+|||.+-.+.+..
T Consensus       110 CGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~-----KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  110 CGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK-----KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             cCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH-----HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            9999999998764 458999999999999999999999987     7999999999999999999999999998775543


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .  ...+..|||.|||||++..-.|+.++||||||++..||.-|++||....+...   +          -.+...-.| 
T Consensus       184 A--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---I----------FMIPT~PPP-  247 (502)
T KOG0574|consen  184 A--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---I----------FMIPTKPPP-  247 (502)
T ss_pred             H--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---e----------EeccCCCCC-
Confidence            2  23457899999999999999999999999999999999999999964433210   0          001111111 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                        .-..++..+.++.+++++||-.+|++|-|+.++++|..
T Consensus       248 --TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F  285 (502)
T KOG0574|consen  248 --TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF  285 (502)
T ss_pred             --CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence              12346778889999999999999999999999999854

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.7e-43  Score=326.99  Aligned_cols=268  Identities=25%  Similarity=0.362  Sum_probs=208.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-C-----CcceeEEEEEEcCC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-H-----PNLVSLIGYCADGK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~~~~~~~~~~  133 (361)
                      .+|++.++||+|+||.|.+|.+. +++.||||+++    +...-..+...|+.+|..|+ |     -|+|+++++|...+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK----N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK----NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeec----cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            46788999999999999999876 79999999997    33444566677999999996 4     48999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC--CcEEEeec
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN--FEAKISDF  211 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~--~~~kl~Df  211 (361)
                      +.|||+|++.. +|.++++......++...++.++.||+.||.+||+.+     |||+||||+||||...  ..|||+||
T Consensus       262 HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~-----IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  262 HLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG-----IIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             ceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCChhheeeccCCcCceeEEec
Confidence            99999999955 9999999887778999999999999999999999999     9999999999999753  47999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH-----
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH-----  286 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----  286 (361)
                      |.++.......     +.+-+..|.|||++.+.+|+.+.||||||||++||.+|.+.|.+.+..+....+..+..     
T Consensus       336 GSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~  410 (586)
T KOG0667|consen  336 GSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK  410 (586)
T ss_pred             ccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence            99997654432     45668889999999999999999999999999999999888876554332222221100     


Q ss_pred             Hhhhh----hhhhh--------------------------------hcCc-ccc--CCCCCHHHHHHHHHHHHHccCCCC
Q 018047          287 ILNDR----KKLRK--------------------------------VIDP-ELS--RSSYTMESIAMFANLASRCVRTES  327 (361)
Q Consensus       287 ~~~~~----~~~~~--------------------------------~~~~-~~~--~~~~~~~~~~~l~~li~~cl~~dp  327 (361)
                      ++...    ..+..                                ...| ...  ...........+.+++.+||..||
T Consensus       411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP  490 (586)
T KOG0667|consen  411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP  490 (586)
T ss_pred             HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence            00000    00000                                0000 000  000111233568999999999999


Q ss_pred             CCCCCHHHHHHHHHHH
Q 018047          328 SERPSMAECVKELQLI  343 (361)
Q Consensus       328 ~~Rpt~~ell~~l~~i  343 (361)
                      .+|+|+.|.|+|-+--
T Consensus       491 ~~R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  491 AERITPAQALNHPFLT  506 (586)
T ss_pred             hhcCCHHHHhcCcccc
Confidence            9999999999998743

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.2e-42  Score=306.29  Aligned_cols=251  Identities=28%  Similarity=0.460  Sum_probs=196.7

Q ss_pred             eecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           68 FLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      .||+|+||.||+|.+.   ++..||+|++...  ........+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            3899999999999764   3557999988643  223345678899999999999999999998864 567899999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++... ...+++..++.++.|++.||+|||++|     ++|+||||+||+++.++.+||+|||++..+.......
T Consensus        79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN-----FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC-----eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            9999998653 347899999999999999999999999     9999999999999999999999999998654332211


Q ss_pred             e-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccc
Q 018047          225 V-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL  302 (361)
Q Consensus       225 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      . .....+++.|+|||.+....++.++||||||+++|++++ |..||.....   ......+    ....          
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~----------  215 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMSFI----EQGK----------  215 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHH----HCCC----------
Confidence            1 111123568999999888889999999999999999996 9999853321   1111111    1100          


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       303 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                       ....+..++..+.+++.+||..||++||++.++.+.|+.+.+
T Consensus       216 -~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~~  257 (257)
T cd05115         216 -RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY  257 (257)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhcC
Confidence             011223345668999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.5e-42  Score=312.06  Aligned_cols=267  Identities=22%  Similarity=0.337  Sum_probs=199.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|++|+||+|+.. ++..||+|++..... .......+.+|+.+++.++|||++++++++.+++..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            4788899999999999999976 689999999865432 22234567789999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          141 YMQKGNLQDHLNGIG-EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |++ ++|.+++.... ...+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-----VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            997 58988886543 257899999999999999999999999     99999999999999999999999999976543


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh----------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL----------  288 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~----------  288 (361)
                      ...  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  ..........          
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         154 PVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             Ccc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcc
Confidence            221  1223457889999997754 457889999999999999999999996432211  0000000000          


Q ss_pred             hhhhhhhhhcCcccc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          289 NDRKKLRKVIDPELS--RSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ...............  ........+.++.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000000000000  000011234567899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.5e-42  Score=312.45  Aligned_cols=263  Identities=27%  Similarity=0.437  Sum_probs=202.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-----------------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcce
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-----------------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV  123 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv  123 (361)
                      ++|++.+.||+|+||+||++...                 ++..+|+|.+...  ........+.+|+.+++.++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            46899999999999999998532                 2346899988643  2233456788999999999999999


Q ss_pred             eEEEEEEcCCEEEEEEEecCCCchhhhcccCCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCC
Q 018047          124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE---------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFK  194 (361)
Q Consensus       124 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dik  194 (361)
                      ++++++.+++..+++|||+++|+|.+++.....         ..+++..+..++.|++.||+|||++|     ++|+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dlk  157 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-----FVHRDLA  157 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-----eecccCC
Confidence            999999999999999999999999999865321         24678889999999999999999999     9999999


Q ss_pred             CCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCC
Q 018047          195 STNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT--GRRAVDLN  272 (361)
Q Consensus       195 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~  272 (361)
                      |+|||++.++.++|+|||++..+.............+++.|+|||....+.++.++|+|||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999986644332222223344678999998888889999999999999999998  66777532


Q ss_pred             CCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          273 QGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..   ................  ...      ...+..++..+.+|+.+||+.||++|||+.++++.|+
T Consensus       238 ~~---~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         238 SD---EQVIENTGEFFRDQGR--QVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             Ch---HHHHHHHHHHHhhccc--ccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            21   1111111111111000  000      0111223456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.5e-42  Score=306.47  Aligned_cols=253  Identities=26%  Similarity=0.446  Sum_probs=203.8

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc------hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA------DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      +|.+...||+|++|.||+|... +++.+|+|.+........      .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999876 688999999866533221      123568889999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .+++|||+++++|.+++...  ..+++..+..++.|++.||+|||++|     ++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~-----ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG-----IIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC-----cccccCCHHHEEEcCCCCEEecccCCC
Confidence            99999999999999999764  36889999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCce----eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          215 KLMPEGQET----YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       215 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      .........    .......|+..|+|||.+....++.++|+||||+++|+|++|..||.....      ...+....  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~--  225 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIG--  225 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHh--
Confidence            876532111    111234578899999999888899999999999999999999999964321      11111100  


Q ss_pred             hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                           ....     ...+...+..+.+++.+||+.||++||++.|++++
T Consensus       226 -----~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         226 -----ENAS-----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -----ccCC-----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                 0111     12223345668999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.9e-42  Score=304.01  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=208.1

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..++||.|+||.||.++.. +++.+++|.+....... .....+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            4788899999999999999866 68999999987654333 345678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.......+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-----ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            999999999998754557899999999999999999999999     999999999999999999999999999876443


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ..  ......|++.|+|||...+..++.++|+||||+++|+|++|..||.....      ..........          
T Consensus       155 ~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~----------  216 (256)
T cd08221         155 YS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQG----------  216 (256)
T ss_pred             cc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcC----------
Confidence            32  22345689999999998888889999999999999999999999854221      1111111111          


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ..  ...+...+..+.+++.+||+.+|++||++.++++++
T Consensus       217 ~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         217 NY--TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CC--CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            01  111233455689999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=324.39  Aligned_cols=246  Identities=23%  Similarity=0.267  Sum_probs=192.5

Q ss_pred             ecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc---CCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           69 LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL---DHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      ||+|+||+||+|... +++.||+|++.............+..|..++..+   +||||+++++++.+.+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999977 6899999998654333333344455677777665   699999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.++|+|||++........  
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~-----ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--  151 (330)
T cd05586          81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD-----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--  151 (330)
T ss_pred             ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence            9999998764  36899999999999999999999999     99999999999999999999999999875432221  


Q ss_pred             eeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcccc
Q 018047          225 VTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELS  303 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (361)
                      ......||+.|+|||++... .++.++|||||||++|+|++|..||.....      ......+.....        .+.
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~--------~~~  217 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGKV--------RFP  217 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCCC--------CCC
Confidence            12345789999999987654 578999999999999999999999954321      111111111110        111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHHHH
Q 018047          304 RSSYTMESIAMFANLASRCVRTESSERP----SMAECVKELQ  341 (361)
Q Consensus       304 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp----t~~ell~~l~  341 (361)
                          ....+..+.+++.+||+.||++||    ++.++++|.+
T Consensus       218 ----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~  255 (330)
T cd05586         218 ----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF  255 (330)
T ss_pred             ----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence                112344588999999999999998    6888888643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-42  Score=309.02  Aligned_cols=261  Identities=26%  Similarity=0.420  Sum_probs=206.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCC----EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      .+|+..+.||+|+||+||+|.++ +|+    .+|+|.+....  .......+.+|+.++..++|||++++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            35788899999999999999865 343    58999876542  23345678889999999999999999999987 788


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++     ++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~-----i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             EEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC-----EEecccCcceEEEcCCCeEEECCCcccc
Confidence            99999999999999997643 35899999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+.............++..|+|||......++.++|+||||+++||+++ |+.||.....   ...    ......... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~----~~~~~~~~~-  229 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEI----PDLLEKGER-  229 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHH----HHHHhCCCC-
Confidence            7654332222222223568999999888889999999999999999998 9999854321   111    111111000 


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                                ...+..++..+.+++.+||..||++|||+.++++.|.++..+..
T Consensus       230 ----------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         230 ----------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence                      11112233458899999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-42  Score=303.93  Aligned_cols=249  Identities=31%  Similarity=0.461  Sum_probs=199.7

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCc
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGN  146 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~  146 (361)
                      ++||+|+||.||++...+++.||+|.+......  .....+.+|+.+++.++|+||+++++++.+....++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            368999999999999877999999988654322  345678899999999999999999999999999999999999999


Q ss_pred             hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeee
Q 018047          147 LQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT  226 (361)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  226 (361)
                      |.+++.... ..+++..+..++.+++.||+|||+++     ++||||+|+||+++.++.++|+|||++............
T Consensus        79 l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~-----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          79 LLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN-----CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC-----EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            999996543 36889999999999999999999999     999999999999999999999999999866432222111


Q ss_pred             eecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCC
Q 018047          227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS  305 (361)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ....++..|+|||.+..+.++.++|+||||+++|+|++ |..||.....   ......+    ..          .. ..
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~~----~~----------~~-~~  214 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRERI----ES----------GY-RM  214 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHHH----hc----------CC-CC
Confidence            22233567999999888889999999999999999999 7888853321   1111111    00          00 01


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          306 SYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       306 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            122334556999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.5e-42  Score=307.14  Aligned_cols=258  Identities=28%  Similarity=0.469  Sum_probs=204.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-C---CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-S---GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      .+|++.+.||+|+||.||+|.+. +   +..+|+|.+....  .......+.+|+.++..++||||+++++++.+++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            46888999999999999999865 2   3379999886432  2334567888999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++++|.+++.... ..+++..+..++.|++.||+|||+++     ++|+||||+|||++.++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            9999999999999997643 36899999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCceee-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          217 MPEGQETYV-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       217 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      +........ .....++..|+|||.+....++.++|+||||+++|++++ |..||.....   ....   ......    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~---~~~~~~----  225 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVI---KAIEEG----  225 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHH---HHHhCC----
Confidence            654322111 111223567999999988889999999999999999886 9999853321   1111   111111    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                         ..     ...+...+..+.+++.+||+.+|++||++.++++.|++++
T Consensus       226 ---~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         226 ---YR-----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             ---Cc-----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence               00     1112233456899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.6e-42  Score=332.13  Aligned_cols=268  Identities=18%  Similarity=0.292  Sum_probs=196.6

Q ss_pred             HHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC------CcceeEEEE
Q 018047           56 MEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH------PNLVSLIGY  128 (361)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~  128 (361)
                      +....++|++.+.||+|+||+||+|.+. +++.||||++...    ......+..|+.+++.++|      .++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3445678999999999999999999976 5889999998532    1223445667777777654      458889998


Q ss_pred             EEcC-CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCC--
Q 018047          129 CADG-KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANF--  204 (361)
Q Consensus       129 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~--  204 (361)
                      +... +..++|||++ +++|.+++...  ..+++..+..++.|++.||+|||+ .|     |+||||||+|||++.++  
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g-----IiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH-----LMHTDLKPENILMETSDTV  271 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC-----eecCCCCHHHEEEecCCcc
Confidence            8764 5789999988 67899988764  368999999999999999999998 48     99999999999998765  


Q ss_pred             --------------cEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 018047          205 --------------EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVD  270 (361)
Q Consensus       205 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~  270 (361)
                                    .+||+|||.+......     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                          4999999988643221     224578999999999999999999999999999999999999996


Q ss_pred             CCCCCCchhHHHHHHHHhh--------------------hhhhhhhhcCcc----ccC-C-CCCHHHHHHHHHHHHHccC
Q 018047          271 LNQGVNDQNLVLQVRHILN--------------------DRKKLRKVIDPE----LSR-S-SYTMESIAMFANLASRCVR  324 (361)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~----~~~-~-~~~~~~~~~l~~li~~cl~  324 (361)
                      .....   .....+.....                    ....+....++.    +.. . .........+.+||.+||+
T Consensus       347 ~~~~~---~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  423 (467)
T PTZ00284        347 THDNL---EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH  423 (467)
T ss_pred             CCChH---HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence            54321   11111111100                    000000000000    000 0 0000123457899999999


Q ss_pred             CCCCCCCCHHHHHHHHHHH
Q 018047          325 TESSERPSMAECVKELQLI  343 (361)
Q Consensus       325 ~dp~~Rpt~~ell~~l~~i  343 (361)
                      .||++|||++|+|+|-+-.
T Consensus       424 ~dP~~R~ta~e~L~Hp~~~  442 (467)
T PTZ00284        424 YDRQKRLNARQMTTHPYVL  442 (467)
T ss_pred             cChhhCCCHHHHhcCcccc
Confidence            9999999999999987743

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=316.51  Aligned_cols=257  Identities=28%  Similarity=0.389  Sum_probs=219.1

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .+.|..-++||+|+||.||-++.+ +|+.||.|.+.+...+.........+|-.+|.+++.+.||.+-..|+..+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356888899999999999999876 7999999999888777777777888999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |..|.||+|.-+|.+.+.+.++++.+..++.+|+.||++||+.+     |++||+||+|||+|+.|+++|+|+|+|..++
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~-----iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR-----IVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc-----eeeccCChhheeeccCCCeEeeccceEEecC
Confidence            99999999999999998889999999999999999999999999     9999999999999999999999999999987


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .+...   ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||...-..   ...+.+.+...         
T Consensus       339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~eEvdrr~~---------  403 (591)
T KOG0986|consen  339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKREEVDRRTL---------  403 (591)
T ss_pred             CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---hhHHHHHHHHh---------
Confidence            77643   2348999999999999999999999999999999999999999532221   11111111111         


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKE  339 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~  339 (361)
                       ..  ...++...+++..+|.+..|+.||++|..     ++++-+|
T Consensus       404 -~~--~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  404 -ED--PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             -cc--hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence             10  14456677778999999999999999964     4455554

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.7e-42  Score=315.88  Aligned_cols=267  Identities=24%  Similarity=0.339  Sum_probs=201.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|...+.||+|+||.||+|... +++.||+|.+.....  ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999976 689999999865422  222345678999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||++ ++|.+++.... ..+++..+..++.|+++||+|||+++     ++|+||||+||+++.++.++|+|||++.....
T Consensus        84 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          84 EYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK-----VLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             eccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            9997 58988886542 36889999999999999999999999     99999999999999999999999999976533


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh--hhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK--KLRK  296 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  296 (361)
                      ...  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......   .....+........  ....
T Consensus       157 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~  231 (301)
T cd07873         157 PTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPG  231 (301)
T ss_pred             CCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchh
Confidence            221  1222356889999998754 45788999999999999999999999643321   11111111111000  0000


Q ss_pred             hc---------CccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VI---------DPELSR---SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~---------~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..         .+....   .......+..+.+|+.+||+.||.+|||++|+++|-+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~  288 (301)
T cd07873         232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY  288 (301)
T ss_pred             hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            00         000000   0011123456889999999999999999999998765

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-42  Score=322.84  Aligned_cols=270  Identities=21%  Similarity=0.288  Sum_probs=201.0

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  132 (361)
                      ..++|...+.||+|+||.||++... +++.||||++.... ........+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            3467999999999999999999976 68899999986543 2233345677899999999999999999987543     


Q ss_pred             -CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          133 -KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       133 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                       ...|+||||+++ +|.+++..    .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC-----eecCCCCHHHEEECCCCcEEEEeC
Confidence             357999999965 77777643    5788999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHH---------
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL---------  282 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~---------  282 (361)
                      |++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.         
T Consensus       171 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         171 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             CCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9998654322   2233568999999999988899999999999999999999999996433211100000         


Q ss_pred             HHH-------HHhhhhhhhh-----hhcCcccc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          283 QVR-------HILNDRKKLR-----KVIDPELS--RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       283 ~~~-------~~~~~~~~~~-----~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ...       ..........     ........  ...........+.+|+.+||+.||++|||+.|+++|-+-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence            000       0000000000     00000000  000111123468899999999999999999999999663

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.8e-42  Score=311.63  Aligned_cols=257  Identities=29%  Similarity=0.440  Sum_probs=202.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      ++|+..+.||+|+||.||+|...      ++..+|+|.+...  ........+.+|+.+++.++|||++++++++.++..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC--cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            46889999999999999999864      4678999988643  223345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCC
Q 018047          135 RFLVYEYMQKGNLQDHLNGIG--------------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFK  194 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dik  194 (361)
                      .+++|||+++|+|.+++....                    ...+++..++.++.|++.||+|||+++     ++|||||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~-----i~H~dl~  157 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-----FVHRDLA  157 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-----eeccccc
Confidence            999999999999999986421                    134788899999999999999999999     9999999


Q ss_pred             CCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 018047          195 STNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQ  273 (361)
Q Consensus       195 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~  273 (361)
                      |+||+++.++.++|+|||++..+..............+..|+|||.+....++.++|||||||++|+|++ |..||....
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999876543322111122234567999999888889999999999999999998 778874321


Q ss_pred             CCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          274 GVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      .   .   .........          ..  ...+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       238 ~---~---~~~~~~~~~----------~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 H---E---EVIYYVRDG----------NV--LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H---H---HHHHHHhcC----------CC--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1   1   111111110          00  01122344568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-42  Score=328.55  Aligned_cols=264  Identities=22%  Similarity=0.271  Sum_probs=198.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ..|.+.+.||+|+||.||++.+. +++.||||....         ..+.+|+.++++++|+||+++++++..++..++||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            46889999999999999999987 588999996421         23567999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |++. ++|.+++.... ..+++..++.++.|++.||+|||++|     |+||||||+|||++.++.++|+|||+++.+..
T Consensus       240 e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g-----IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        240 PKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG-----IIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            9995 68988886532 36999999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC-CCCchhHHHHHHHHhhhhhh----h
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ-GVNDQNLVLQVRHILNDRKK----L  294 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~----~  294 (361)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|..|+.... ..........+.++......    +
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            332222234569999999999988899999999999999999999887653322 11111111112111111000    0


Q ss_pred             hh----------------hcCccccCCCCC--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          295 RK----------------VIDPELSRSSYT--MESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       295 ~~----------------~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ..                ...+........  ......+.+||.+||+.||++|||+.|+|+|-
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp  456 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP  456 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence            00                000000000000  01223588999999999999999999999874

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.2e-42  Score=308.97  Aligned_cols=256  Identities=26%  Similarity=0.480  Sum_probs=203.2

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCC---EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGE---VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      .|++.+.||+|+||.||+|... +++   .||+|.+...  ........+..|+.+++.++||||+++++++.+++..++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            4778899999999999999976 333   6999998643  233445678999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||+|||++|     ++|+||||+||+++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g-----~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          83 ITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccChheEEEcCCCcEEECCCcccccc
Confidence            999999999999987643 46899999999999999999999999     999999999999999999999999998766


Q ss_pred             CCCCceeeeeecc---cccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          218 PEGQETYVTARVL---GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       218 ~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      .............   .+..|+|||.+....++.++|||||||++||+++ |..||.....   ......+.   ..   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~---~~---  227 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIE---QD---  227 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHH---cC---
Confidence            4432211111111   1357999999988889999999999999999886 9999853321   11111111   00   


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                          .  .   ...+.+.+..+.+++.+||+.+|++||++.+++..|+++
T Consensus       228 ----~--~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 ----Y--R---LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----C--c---CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                0  0   111223455689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-42  Score=326.05  Aligned_cols=266  Identities=19%  Similarity=0.213  Sum_probs=203.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...        ....+|+.+++.++||||+++++++......+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            457999999999999999999754   3678999987532        23457999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      ++||++. ++|.+++..  ...+++..+..++.|++.||.|||++|     |+||||||+|||++.++.++|+|||++..
T Consensus       163 lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g-----ivHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRG-----IIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            9999995 689888854  347999999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh-hh---
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND-RK---  292 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~---  292 (361)
                      +.............||+.|+|||++....++.++|||||||++|||++|+.||..............+...... ..   
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            65443332333467999999999998889999999999999999999999999654433222221111111100 00   


Q ss_pred             ------------hhhhhcCccccCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 ------------KLRKVIDPELSRSS--YTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ------------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                                  .+.....+......  .....+..+.++|.+||..||++|||+.|++.|-+
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~  377 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL  377 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence                        00000000000000  00122346789999999999999999999999864

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.9e-42  Score=317.54  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=206.0

Q ss_pred             CCCCCCceecccCceEEEEEEEcC--------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS--------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD  131 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  131 (361)
                      .+|++++.||+|+||.||+|....        +..+|+|.+...  ........+.+|+.+++++ +||||+++++++.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            358899999999999999997531        236899987532  2233456788999999999 79999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCC
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~N  197 (361)
                      ++..+++|||+++|+|.+++....              ...+++..+..++.|++.||+|||++|     ++||||||+|
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-----ivH~dlkp~N  164 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-----CIHRDLAARN  164 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccccce
Confidence            999999999999999999986532              235788899999999999999999999     9999999999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVN  276 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  276 (361)
                      ||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..||....   
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---  241 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---  241 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---
Confidence            9999999999999999986644322211222234567999999988889999999999999999998 788885322   


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                         ........... .      .     ...+...+..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus       242 ---~~~~~~~~~~~-~------~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         242 ---VEELFKLLKEG-H------R-----MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             ---HHHHHHHHHcC-C------C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence               11111111110 0      0     11122334568899999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.8e-42  Score=310.21  Aligned_cols=254  Identities=23%  Similarity=0.359  Sum_probs=202.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +.|++.+.||+|+||.||+|... ++..+++|.+...   .......+.+|+.+++.++|||++++++.+..++..++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            46889999999999999999987 5899999998643   3344567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|..++.+.. ..+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++.....
T Consensus        89 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          89 EFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK-----IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             ecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC-----eeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            9999999988875532 36899999999999999999999999     99999999999999999999999999875432


Q ss_pred             CCceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ...  ......+++.|+|||++.     ...++.++|+|||||++|+|++|..||.....      ..........    
T Consensus       163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~----  230 (292)
T cd06644         163 TLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKS----  230 (292)
T ss_pred             ccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcC----
Confidence            211  122346788999999874     34567899999999999999999999853221      1111111110    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         ..+.   ...+...+..+.+++.+||+.||++||++.+++++-.
T Consensus       231 ---~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  271 (292)
T cd06644         231 ---EPPT---LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF  271 (292)
T ss_pred             ---CCcc---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence               0111   1112233456899999999999999999999998754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-42  Score=304.96  Aligned_cols=249  Identities=30%  Similarity=0.492  Sum_probs=197.3

Q ss_pred             ceecccCceEEEEEEEc-C---CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEec
Q 018047           67 NFLGKGGFGRVYKGTLR-S---GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      ++||+|+||.||+|... .   +..+|+|.+......  .....+.+|+.+++.++|+|++++++++. .+..++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            46999999999999864 2   268999998754322  34567888999999999999999999876 45679999999


Q ss_pred             CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCc
Q 018047          143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE  222 (361)
Q Consensus       143 ~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (361)
                      ++|+|.+++....  .+++..+..++.|++.||+|||+++     ++|+||||+|||++.++.++|+|||++..+.....
T Consensus        78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH-----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC-----eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            9999999997643  7899999999999999999999999     99999999999999999999999999987644332


Q ss_pred             eee-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          223 TYV-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       223 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ... .....++..|+|||.+....++.++||||||+++|+|++ |..||.....   ......+.   .. .        
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~---~~-~--------  215 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE---SG-E--------  215 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH---cC-C--------
Confidence            211 111223467999999988889999999999999999998 9999854321   11111111   10 0        


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                         ....+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       216 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 ---RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence               0112223345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.3e-42  Score=303.14  Aligned_cols=248  Identities=30%  Similarity=0.462  Sum_probs=197.6

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCc
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGN  146 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~  146 (361)
                      ++||+|+||.||+|...++..+|+|.+....  .......+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            3689999999999998788999999876432  23334568889999999999999999999999999999999999999


Q ss_pred             hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeee
Q 018047          147 LQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT  226 (361)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  226 (361)
                      |.+++.... ..+++..+..++.|++.||.|||++|     ++|+||+|+||+++.++.++|+|||++......... ..
T Consensus        79 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-----~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~  151 (250)
T cd05085          79 FLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN-----CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SS  151 (250)
T ss_pred             HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccChheEEEcCCCeEEECCCccceeccccccc-cC
Confidence            999987543 36889999999999999999999999     999999999999999999999999998754332211 11


Q ss_pred             eecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCC
Q 018047          227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS  305 (361)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ....++..|+|||++....++.++||||||+++|++++ |..||.....   .....   .....       ..     .
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~---~~~~~-------~~-----~  213 (250)
T cd05085         152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQARE---QVEKG-------YR-----M  213 (250)
T ss_pred             CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHH---HHHcC-------CC-----C
Confidence            11234567999999988889999999999999999998 9999853221   11111   11100       00     1


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          306 SYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       306 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            112233456999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.1e-42  Score=315.96  Aligned_cols=263  Identities=19%  Similarity=0.299  Sum_probs=198.2

Q ss_pred             CCceeccc--CceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           65 DDNFLGKG--GFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        65 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      ++++||+|  +||+||++..+ +|+.||+|++...... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            45679999  78999999876 7999999998654322 23345677899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++|+|.+++.......+++..+..++.|++.||+|||+++     ++||||||+|||++.++.++++||+.+.......
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG-----YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            99999999997654456899999999999999999999999     9999999999999999999999998765432211


Q ss_pred             cee-----eeeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          222 ETY-----VTARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       222 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ...     ......++..|+|||++..  ..++.++|||||||++|+|++|+.||......  ........      ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~------~~~  227 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKLN------GTV  227 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HHHHHHhc------CCc
Confidence            100     0112346778999998865  46889999999999999999999999642211  00100000      000


Q ss_pred             hhhcC--------------------------------c---cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          295 RKVID--------------------------------P---ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       295 ~~~~~--------------------------------~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ...++                                +   ...........+..+.+|+.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            00000                                0   000001122334578999999999999999999999987


Q ss_pred             HH
Q 018047          340 LQ  341 (361)
Q Consensus       340 l~  341 (361)
                      .+
T Consensus       308 p~  309 (327)
T cd08227         308 SF  309 (327)
T ss_pred             hh
Confidence            55

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=326.61  Aligned_cols=249  Identities=32%  Similarity=0.449  Sum_probs=208.5

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |..++.||.|+||.||.|++. +...||||++....-...+...++..|+..|++++|||++.+.|+|..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            777788999999999999976 7899999999876555556677899999999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      |- ||-.|.+.-. .+++.+..+..|+.+.+.||+|||+++     .||||||..|||+++.|.|||+|||.|..+... 
T Consensus       108 Cl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~-----~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  108 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN-----RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             Hh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh-----HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            95 5777777654 347889999999999999999999999     999999999999999999999999999876432 


Q ss_pred             ceeeeeecccccCccCcccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          222 ETYVTARVLGTFGYFDPEYT---STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                           .+++|||+|||||++   ..+.|+-++||||||++..||.-.++|+..-      +....+-++.       ..-
T Consensus       180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALYHIA-------QNe  241 (948)
T KOG0577|consen  180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIA-------QNE  241 (948)
T ss_pred             -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHHHHH-------hcC
Confidence                 347899999999976   4678999999999999999999999998532      2222222222       111


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .|.+.    ..+.+..+++++..||+.-|.+|||..++++|..
T Consensus       242 sPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f  280 (948)
T KOG0577|consen  242 SPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF  280 (948)
T ss_pred             CCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence            22332    4466677999999999999999999999998854

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.2e-42  Score=305.46  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=207.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||.|+||+||+|... ++..+|+|++......  .....+.+|+++++.++|+|++++++.+..++..+++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            36889999999999999999976 6889999998654322  25678899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          140 EYMQKGNLQDHLNGIGE-PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |++++++|.+++..... ..+++..+..++.|++.||+|||++|     ++|+||+|+||++++++.++|+|||++..+.
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~-----i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG-----QIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            99999999999976432 46899999999999999999999999     9999999999999999999999999998765


Q ss_pred             CCCcee--eeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          219 EGQETY--VTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       219 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      ......  ......|+..|+|||++... .++.++|+||||+++|+|++|..||.......      ........     
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~-----  222 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQN-----  222 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcC-----
Confidence            433221  22334688999999988766 78999999999999999999999996432211      11111110     


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                        ..+.+.........+..+.+++.+||+.||++|||+.++++|
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         223 --DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              011111111112345668999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-42  Score=308.00  Aligned_cols=251  Identities=27%  Similarity=0.427  Sum_probs=205.4

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||.|++|.||+|... +++.+|+|.+....  .......+.+|+.+++.++|+|++++.+++.++...|+|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            5888899999999999999977 68999999986542  23345678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++...   .+++..+..++.|++.|+.|||+++     ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          80 YCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG-----KIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            99999999999753   7899999999999999999999999     999999999999999999999999999877543


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ..  ......+++.|+|||.+....++.++||||||+++|+|++|..||.....   ....   ...       .....+
T Consensus       152 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~---~~~-------~~~~~~  216 (274)
T cd06609         152 MS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVL---FLI-------PKNNPP  216 (274)
T ss_pred             cc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHH---HHh-------hhcCCC
Confidence            21  22234678899999999888899999999999999999999999964321   1111   110       011111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .+...    ..+..+.+++.+||..+|++|||+++++++-.
T Consensus       217 ~~~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~  253 (274)
T cd06609         217 SLEGN----KFSKPFKDFVSLCLNKDPKERPSAKELLKHKF  253 (274)
T ss_pred             CCccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence            11111    14456899999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5e-42  Score=305.44  Aligned_cols=250  Identities=28%  Similarity=0.441  Sum_probs=199.8

Q ss_pred             ceecccCceEEEEEEEcC--CC--EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEec
Q 018047           67 NFLGKGGFGRVYKGTLRS--GE--VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      +.||+|++|+||+|.+.+  ++  .+|+|.+......  .....+..|+.++++++||||+++++.+.+ ...+++|||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            368999999999998753  33  6899998764332  456788899999999999999999999988 8899999999


Q ss_pred             CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCc
Q 018047          143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE  222 (361)
Q Consensus       143 ~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (361)
                      ++|+|.+++.......+++..++.++.|++.||+|||+++     ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-----FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcccEEEecCCEEEecccccccccccccc
Confidence            9999999997654347899999999999999999999999     99999999999999999999999999987754322


Q ss_pred             ee-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          223 TY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       223 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .. ......++..|+|||.+....++.++|||||||++|+|++ |..||.....   ......+   ....        .
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~---~~~~--------~  218 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKI---DKEG--------E  218 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---HhcC--------C
Confidence            21 1112346788999999988889999999999999999998 9999853321   1111111   1100        0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .   ...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       219 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 R---LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             c---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            0   1112234456899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.2e-42  Score=314.08  Aligned_cols=263  Identities=22%  Similarity=0.322  Sum_probs=188.6

Q ss_pred             CceecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CCEEEEEEE
Q 018047           66 DNFLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GKHRFLVYE  140 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e  140 (361)
                      +..||+|+||+||+|...   +++.+|+|.+....     ....+.+|+.+++.++||||+++++++.+  +...+++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            467999999999999865   46789999985432     22356789999999999999999999854  457899999


Q ss_pred             ecCCCchhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee----CCCCcEEEe
Q 018047          141 YMQKGNLQDHLNGI-------GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL----SANFEAKIS  209 (361)
Q Consensus       141 ~~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill----~~~~~~kl~  209 (361)
                      |+. ++|.+++...       ....+++..+..++.|++.||+|||++|     |+||||||+|||+    +.++.+||+
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivHrDlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----EEcCCCCHHHEEEecCCCCcCcEEEe
Confidence            986 4888876432       1235889999999999999999999999     9999999999999    456789999


Q ss_pred             ecCccccCCCCCce-eeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchh---HHHHH
Q 018047          210 DFGLAKLMPEGQET-YVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN---LVLQV  284 (361)
Q Consensus       210 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---~~~~~  284 (361)
                      |||++..+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........   .....
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~  234 (317)
T cd07868         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  234 (317)
T ss_pred             ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHH
Confidence            99999876443211 12234578999999998866 458899999999999999999999996543221100   00111


Q ss_pred             HHHhhhh-----------hhh------hhhcCc-cccCC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          285 RHILNDR-----------KKL------RKVIDP-ELSRS-------SYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       285 ~~~~~~~-----------~~~------~~~~~~-~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .......           ...      ...... .....       .........+.+|+.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             HHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1110000           000      000000 00000       0000112357899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.9e-42  Score=308.79  Aligned_cols=252  Identities=23%  Similarity=0.382  Sum_probs=199.5

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|...+.||+|+||.||+|... +++.||+|.+....   ......+.+|+.+++.++||||+++++.+.+.+..|++||
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            5777888999999999999876 68999999986532   2334567789999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++...+  .+++..++.++.|++.||.|||++|     ++|+||||+||+++.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          87 FCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG-----KMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            999999999987643  6899999999999999999999999     999999999999999999999999998765432


Q ss_pred             CceeeeeecccccCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          221 QETYVTARVLGTFGYFDPEYTS---TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ..  ......|+..|+|||++.   ...++.++|+|||||++|+|++|..||.......   ....   ....  ..   
T Consensus       160 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~---~~~~--~~---  226 (267)
T cd06645         160 IA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFL---MTKS--NF---  226 (267)
T ss_pred             cc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHh---hhcc--CC---
Confidence            21  223356899999999864   4568889999999999999999999985332110   0000   0000  00   


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ..+... .  ....+..+.+++.+||+.+|++|||++++++|
T Consensus       227 ~~~~~~-~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         227 QPPKLK-D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCCccc-c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            001110 0  11233458899999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4e-42  Score=310.47  Aligned_cols=260  Identities=24%  Similarity=0.439  Sum_probs=204.6

Q ss_pred             CHHHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEE
Q 018047           52 TLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYC  129 (361)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  129 (361)
                      ++.++....+.|+..+.||+|+||.||+|.+. +++.+|+|.+...    ......+..|+.++..+ +|+|++++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            44555556678999999999999999999976 6889999998643    23345678899999998 699999999998


Q ss_pred             Ec------CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC
Q 018047          130 AD------GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN  203 (361)
Q Consensus       130 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~  203 (361)
                      ..      ....|++|||+++|+|.+++.......+++..+..++.|++.||+|||+++     ++|+||+|+||+++.+
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-----ivH~dl~~~nili~~~  157 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK-----VIHRDIKGQNVLLTEN  157 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCC
Confidence            53      467899999999999999997655557889999999999999999999999     9999999999999999


Q ss_pred             CcEEEeecCccccCCCCCceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCch
Q 018047          204 FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ  278 (361)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  278 (361)
                      +.++|+|||++........  ......|++.|+|||.+.     ...++.++|+|||||++|+|++|..||......   
T Consensus       158 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---  232 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM---  232 (282)
T ss_pred             CCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---
Confidence            9999999999876532221  122356889999999875     346788999999999999999999999532211   


Q ss_pred             hHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          279 NLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ....   .       ......+..    .....+..+.+++.+||+.||.+|||+.|++++
T Consensus       233 ~~~~---~-------~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         233 RALF---L-------IPRNPPPKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hhhh---h-------HhhCCCCCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            0000   0       001111111    112344569999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-42  Score=318.18  Aligned_cols=263  Identities=21%  Similarity=0.273  Sum_probs=194.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..+|++.+.||+|+||.||+|... +++.||+|+....         ....|+.+++.++||||+++++++.+.+..++|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            457999999999999999999987 5788999975321         124589999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      ||++. ++|.+++... ...+++..+..++.|++.||.|||++|     |+||||||+|||++.++.++|+|||++....
T Consensus       136 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        136 LPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR-----IIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            99995 5888888653 347899999999999999999999999     9999999999999999999999999997543


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHH----HHHHHHhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV----LQVRHILNDRKKL  294 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~  294 (361)
                      ...   ......||+.|+|||++....++.++|||||||++|||+++..++............    ..+..........
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~  285 (357)
T PHA03209        209 VAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH  285 (357)
T ss_pred             cCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence            221   122346899999999998889999999999999999999976555322221111110    0111111000000


Q ss_pred             hhhcC--------------ccccCCCC-------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RKVID--------------PELSRSSY-------TMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~--------------~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...+.              ........       ....+..+.+||.+||+.||++|||+.|+++|-+
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~  353 (357)
T PHA03209        286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM  353 (357)
T ss_pred             hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence            00000              00000000       0112334667999999999999999999998853

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.4e-42  Score=310.49  Aligned_cols=250  Identities=27%  Similarity=0.355  Sum_probs=207.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||.||++.+. +++.+|+|.+.............+.+|++++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888999999999999999977 68999999987654434445667889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++...  ..+++..+..++.|+++||+|||+.|     ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~-----i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD-----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999999764  37899999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      .     .....|++.|+|||.+.....+.++||||||+++|+|++|..||.....      ...........        
T Consensus       154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~--------  214 (290)
T cd05580         154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEGK--------  214 (290)
T ss_pred             C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC--------
Confidence            3     2234688999999998888889999999999999999999999964331      11111111111        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                           ...+...+..+.+++.+||..||.+|+     +++|+++|-.
T Consensus       215 -----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~  256 (290)
T cd05580         215 -----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW  256 (290)
T ss_pred             -----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence                 111222345689999999999999999     8899988754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.8e-42  Score=312.26  Aligned_cols=254  Identities=24%  Similarity=0.410  Sum_probs=206.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .+|+..+.||.|++|+||+|... +|+.|++|.+....   ......+.+|+.+++.++|||++++++++..++..|+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            46888999999999999999875 68999999986532   233467788999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++...   .+++..+..++.|++.||+|||++|     ++|+||+|+||+++.++.++|+|||++.....
T Consensus        96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~-----i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          96 EYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ-----VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            999999999998643   5899999999999999999999999     99999999999999999999999999876543


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ......+++.|+|||.+....++.++|+|||||++|+|++|+.||......   ......   ...       ..
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---~~~~~~---~~~-------~~  232 (296)
T cd06655         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLI---ATN-------GT  232 (296)
T ss_pred             ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---Hhc-------CC
Confidence            322  122346788999999998888999999999999999999999999643321   111110   000       00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      +.   ...+...+..+.+++.+||..||++|||+.+++.+-+--
T Consensus       233 ~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         233 PE---LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             cc---cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence            00   111223445688999999999999999999999887653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.5e-42  Score=306.26  Aligned_cols=254  Identities=23%  Similarity=0.361  Sum_probs=190.7

Q ss_pred             ceecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecC
Q 018047           67 NFLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ  143 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (361)
                      +.||+|+||.||+|...   ++..+|+|.+....  .......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            35899999999999865   34679999876442  22334578889999999999999999999999999999999999


Q ss_pred             CCchhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          144 KGNLQDHLNGIG---EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       144 ~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      +|+|.+++....   ....++..+..++.|++.||+|||+.+     ++|+||||+||+++.+++++|+|||++......
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-----FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-----EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence            999999986532   224667788899999999999999999     999999999999999999999999999765433


Q ss_pred             CceeeeeecccccCccCcccccCC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTG-------KLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ..........++..|+|||++...       .++.++||||||+++|||++ |+.||......   .....   ...  .
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~---~~~--~  225 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTY---TVR--E  225 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHH---Hhh--c
Confidence            222222234567889999987532       35789999999999999996 99999543211   11111   000  0


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .......+.+     ....+..+.+++..|| .+|++|||++||++.|.
T Consensus       226 ~~~~~~~~~~-----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQLKLPKPRL-----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCCCCCCcc-----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0001111111     1122345788999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-42  Score=313.77  Aligned_cols=257  Identities=25%  Similarity=0.312  Sum_probs=208.2

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|++|+||+|... +++.+|+|.+.............+..|+++++.++|+||+++++.+.++...|+|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            6888899999999999999977 589999999987654444456778899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+.+++|.+++.......+++..+..++.|+++||+|||+.|     ++|+||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG-----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999997655567999999999999999999999999     999999999999999999999999998755322


Q ss_pred             Ccee---------------------------eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 018047          221 QETY---------------------------VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ  273 (361)
Q Consensus       221 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  273 (361)
                      ....                           ......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1100                           1112467889999999988889999999999999999999999996433


Q ss_pred             CCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHHH
Q 018047          274 GVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPS----MAECVKEL  340 (361)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt----~~ell~~l  340 (361)
                      ..      ........          .... .......+..+.+++.+||+.||++|||    +.|++.+-
T Consensus       237 ~~------~~~~~~~~----------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~  290 (316)
T cd05574         237 RD------ETFSNILK----------KEVT-FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP  290 (316)
T ss_pred             hH------HHHHHHhc----------CCcc-CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence            21      11111111          1110 0011114566999999999999999999    88888874

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.8e-42  Score=311.42  Aligned_cols=253  Identities=24%  Similarity=0.383  Sum_probs=205.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..+|+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.+++.++|+|++++++.+..++..|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            357999999999999999999975 69999999986532   22345678899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++++|.+++..   ..+++..+..++.|++.||.|||+.+     ++|+||||+|||++.++.++|+|||++....
T Consensus        95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~-----i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          95 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             ecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            999999999999864   35889999999999999999999999     9999999999999999999999999987654


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  ......+++.|+|||.+....++.++|+||||+++|+|++|..||.........  ..    ...         
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~----~~~---------  229 (297)
T cd06656         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL----IAT---------  229 (297)
T ss_pred             CCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--ee----ecc---------
Confidence            3321  122346788999999998888999999999999999999999999643321100  00    000         


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       ........+...+..+.+++.+||..||++||++.+++++-+
T Consensus       230 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (297)
T cd06656         230 -NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF  271 (297)
T ss_pred             -CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence             000001122334456889999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-42  Score=309.43  Aligned_cols=258  Identities=23%  Similarity=0.379  Sum_probs=206.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||++... +|+.+|+|++...  ........+.+|+++++.++||||+++++.+...+..++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec--CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            45778889999999999999976 6889999988653  22334567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      ||+++++|.+++...  ..+++..+..++.+++.||.|||+ ++     ++|+||+|+||+++.++.++|+|||++....
T Consensus        83 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~-----i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          83 EFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             ecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC-----eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            999999999998764  368999999999999999999997 57     9999999999999999999999999987553


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc-----hhHHHHHHHHhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND-----QNLVLQVRHILNDRKK  293 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~  293 (361)
                      ...    .....|+..|+|||++....++.++|+|||||++|+|++|+.||.......+     .............   
T Consensus       156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  228 (284)
T cd06620         156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE---  228 (284)
T ss_pred             hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc---
Confidence            221    1234689999999998888899999999999999999999999975433211     1111111111110   


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                          ..+.+    .....+..+.+|+.+||+.||++|||+.|++++..-
T Consensus       229 ----~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         229 ----PPPRL----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             ----cCCCC----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                01111    112245668999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9e-42  Score=303.63  Aligned_cols=252  Identities=24%  Similarity=0.407  Sum_probs=206.4

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|+||.||++... +|+.+|+|.+...... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            4788899999999999999876 6899999998754332 2344578889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++.......+++..+..++.|++.||.|||+++     ++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK-----ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            999999999987654456899999999999999999999999     999999999999999999999999999876443


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ..  ......|++.|+|||+.....++.++|+||||+++|+|++|+.||....      ....+......          
T Consensus       155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~----------  216 (256)
T cd08218         155 VE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRG----------  216 (256)
T ss_pred             hh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcC----------
Confidence            22  1223457889999999988889999999999999999999999985321      11111111111          


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ..  ...+...+..+.+++.+||+.+|++||++.+++++
T Consensus       217 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         217 SY--PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CC--CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            00  11223345568999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.6e-42  Score=310.62  Aligned_cols=264  Identities=24%  Similarity=0.414  Sum_probs=203.9

Q ss_pred             cCHHHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEE
Q 018047           51 FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGY  128 (361)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  128 (361)
                      +.++.+..+.++|++.+.||+|+||+||++... +++.+|+|++...    ......+.+|+.+++.+ +||||++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   83 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHPNVVKFYGM   83 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc----cchHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence            344556667788999999999999999999976 5889999987532    12235677899999999 69999999998


Q ss_pred             EE-----cCCEEEEEEEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC
Q 018047          129 CA-----DGKHRFLVYEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS  201 (361)
Q Consensus       129 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~  201 (361)
                      +.     .++..++||||+++++|.+++...  ....+++..+..++.|++.||.|||+++     ++||||||+||+++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nili~  158 (286)
T cd06638          84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK-----TIHRDVKGNNILLT  158 (286)
T ss_pred             eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCHHhEEEC
Confidence            73     456789999999999999987532  2346889999999999999999999999     99999999999999


Q ss_pred             CCCcEEEeecCccccCCCCCceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 018047          202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN  276 (361)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  276 (361)
                      .++.++|+|||++..+.....  ......|++.|+|||++.     ...++.++|||||||++|+|++|..||...... 
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-  235 (286)
T cd06638         159 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-  235 (286)
T ss_pred             CCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-
Confidence            999999999999986643321  122346899999999874     245788999999999999999999998533211 


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           ..+....       ....+..   ..+...+..+.+++.+||+.||++|||+.|+++++.
T Consensus       236 -----~~~~~~~-------~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         236 -----RALFKIP-------RNPPPTL---HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             -----HHHhhcc-------ccCCCcc---cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence                 1111000       0000111   011122345899999999999999999999998763

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=305.15  Aligned_cols=250  Identities=27%  Similarity=0.448  Sum_probs=194.9

Q ss_pred             ceecccCceEEEEEEEc-CCC--EEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEec
Q 018047           67 NFLGKGGFGRVYKGTLR-SGE--VVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      ++||+|+||.||+|... ++.  .+++|.+...  ........+.+|+.++.++ +||||+++++++...+..+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            35899999999999976 344  4677876522  2334456788899999999 7999999999999999999999999


Q ss_pred             CCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEE
Q 018047          143 QKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI  208 (361)
Q Consensus       143 ~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl  208 (361)
                      ++|+|.+++....              ...+++..+..++.|++.||+|||++|     ++|+||||+||+++.++.+||
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~-----i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccccceEEEcCCCeEEE
Confidence            9999999986432              135789999999999999999999999     999999999999999999999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHH
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      +|||++.......   .......+..|+|||++....++.++||||||+++|+|++ |..||....   ...   .....
T Consensus       154 ~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~---~~~~~  224 (270)
T cd05047         154 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAE---LYEKL  224 (270)
T ss_pred             CCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHH---HHHHH
Confidence            9999986332111   1111223567999999888889999999999999999997 999985321   111   11111


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      ..           ... ...+...+..+.+++.+||+.||.+|||+.+++..|.+++
T Consensus       225 ~~-----------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 PQ-----------GYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             hC-----------CCC-CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            10           000 1112233456899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-42  Score=319.15  Aligned_cols=268  Identities=22%  Similarity=0.335  Sum_probs=199.9

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC---
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG---  132 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  132 (361)
                      ....++|...+.||+|+||+||+|... +++.||||++.... ........+.+|+.+++.++||||+++++++...   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            345678999999999999999999876 68899999986532 1222345677899999999999999999987543   


Q ss_pred             ---CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 018047          133 ---KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKIS  209 (361)
Q Consensus       133 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~  209 (361)
                         ...|++++++ +++|.+++..   ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG-----IIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCChhhEEECCCCCEEEc
Confidence               4578999988 7799888754   36999999999999999999999999     9999999999999999999999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      |||++.......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......   .....+....
T Consensus       161 Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~  232 (343)
T cd07878         161 DFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---DQLKRIMEVV  232 (343)
T ss_pred             CCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHh
Confidence            999998664322     23468999999998766 56889999999999999999999999643211   1111111100


Q ss_pred             hhh-hhhhhhcC-----------ccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          289 NDR-KKLRKVID-----------PELSRSS---YTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       289 ~~~-~~~~~~~~-----------~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ... ......+.           +......   .....+..+.+|+.+||+.||++|||+.|++.|-+-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~  301 (343)
T cd07878         233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF  301 (343)
T ss_pred             CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence            000 00000000           0000000   000122347899999999999999999999998653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-41  Score=302.43  Aligned_cols=250  Identities=25%  Similarity=0.422  Sum_probs=204.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||.||+|... ++..+++|.+...     .....+.+|+.+++.++|||++++++.+.++...|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            46889999999999999999987 4889999998543     12678899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++.... ..+++..+..++.|++.||.|||+.+     ++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~-----i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          78 EYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK-----KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             ecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            9999999999986543 47899999999999999999999999     99999999999999999999999999987654


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ......++..|+|||++.+..++.++||||||+++|+|++|+.||.......   .....          .....
T Consensus       152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~~----------~~~~~  216 (256)
T cd06612         152 TMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFMI----------PNKPP  216 (256)
T ss_pred             Ccc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhhh----------ccCCC
Confidence            321  1223457889999999988889999999999999999999999996432211   00000          00000


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      +.   ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus       217 ~~---~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         217 PT---LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CC---CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            11   11223344568999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1e-41  Score=307.90  Aligned_cols=252  Identities=22%  Similarity=0.382  Sum_probs=200.2

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |++.+.||+|+||.||+|... ++..+++|.+...   .......+.+|+++++.++|||++++++.+..++..++||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            667788999999999999987 5788899988542   233456788899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|..++.+. ...+++..+..++.|+++||+|||+.|     ++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          84 CAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK-----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            9999999887643 246899999999999999999999999     9999999999999999999999999987653322


Q ss_pred             ceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          222 ETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      .  ......+++.|+|||++.     ...++.++|||||||++|+|++|+.||.....   ...   .......      
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~---~~~~~~~------  223 (282)
T cd06643         158 Q--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRV---LLKIAKS------  223 (282)
T ss_pred             c--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHH---HHHHhhc------
Confidence            1  122346889999999873     34577899999999999999999999853221   111   1111110      


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       ..+.   ...+...+..+.+++.+||+.||.+|||+.+++++..
T Consensus       224 -~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         224 -EPPT---LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             -CCCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence             0011   1112234456899999999999999999999998865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.4e-42  Score=308.65  Aligned_cols=269  Identities=30%  Similarity=0.436  Sum_probs=201.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~  133 (361)
                      ..|++.+.||+|+||+||++..+     ++..||+|.+...   .......+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            36888899999999999999742     4789999998642   23445678899999999999999999998754  35


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|     ++|+||||+||+++.++.++|+|||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~-----i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR-----YVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCHhhEEECCCCeEEECCCcc
Confidence            7899999999999999996542 36899999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCceeee-eecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh---
Q 018047          214 AKLMPEGQETYVT-ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN---  289 (361)
Q Consensus       214 ~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---  289 (361)
                      +..+......... ....++..|+|||...+..++.++||||||+++|||++|..++......    ....+.....   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~  230 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQM  230 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhccccccccc
Confidence            9877544322111 1122345699999998888999999999999999999988765322110    0000000000   


Q ss_pred             hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ....+...+.... ....+...+..+.+|+.+||+.+|++|||+.|+++.|+.+
T Consensus       231 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         231 IVYHLIELLKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             chHHHHHHHhcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000000010000 0111223445699999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-41  Score=305.30  Aligned_cols=252  Identities=23%  Similarity=0.382  Sum_probs=188.6

Q ss_pred             eecccCceEEEEEEEcC---CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           68 FLGKGGFGRVYKGTLRS---GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      .||+|+||+||+|...+   ...+++|.+...  ........+.+|+.+++.++||||+++++.+.+....++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            58999999999997543   346888876532  2233455678899999999999999999999999999999999999


Q ss_pred             CchhhhcccCCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          145 GNLQDHLNGIGE---PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       145 g~L~~~l~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      |+|.+++.....   ...++..+..++.|++.||+|||+++     ++||||||+|||++.++.+||+|||++.......
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC-----EecccccHhheEecCCCcEEEeccccccccccch
Confidence            999999976432   23567888999999999999999999     9999999999999999999999999987543322


Q ss_pred             ceeeeeecccccCccCccccc-------CCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          222 ETYVTARVLGTFGYFDPEYTS-------TGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      .........++..|+|||+..       ...++.++|||||||++|||++ |..||.....   ...   .......   
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~---~~~~~~~---  225 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQV---LKQVVRE---  225 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHH---HHHHhhc---
Confidence            111122234567899999763       3456789999999999999999 7788753321   111   1111110   


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                          ....+.....+...+..+.+++..|| .||++|||+++|++.|
T Consensus       226 ----~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         226 ----QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ----cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence                11111112223334456788999998 5999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-41  Score=301.56  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=204.9

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|+||.||++... +++.+|+|.+...... ......+.+|+.+++.++|||++++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            4788899999999999999876 6899999999765433 2345678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEeecCccccCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFGLAKLMPE  219 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~~~~~~~  219 (361)
                      |+++++|.+++.......+++..+..++.+++.+|+|||+++     ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL-----ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            999999999997755556899999999999999999999999     9999999999999865 4689999999987654


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...   .....|+..|+|||.+....++.++||||||+++|+|++|+.||.....      ...........        
T Consensus       155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~--------  217 (256)
T cd08220         155 KSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIMSGT--------  217 (256)
T ss_pred             Ccc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHHhcC--------
Confidence            322   2234678899999999888889999999999999999999999854321      11111111100        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                          ....+...+..+.+++.+||+.+|++|||+.|++.+
T Consensus       218 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 ----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ----CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                011122244568999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-42  Score=308.48  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=203.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||.|+||+||++... ++..+|+|.+...   .......+..|+++++.++|||++++++.+.++...|+||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            45888899999999999999976 6899999998642   3344567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++.... ..+++..+..++.|++.||.|||+++     ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          82 EFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK-----VIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            9999999999987643 36899999999999999999999999     99999999999999999999999999876533


Q ss_pred             CCceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ...  ......|++.|+|||.+.     ...++.++|+||||+++|+|++|+.||.....   .   .........    
T Consensus       156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~~----  223 (280)
T cd06611         156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---M---RVLLKILKS----  223 (280)
T ss_pred             ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---H---HHHHHHhcC----
Confidence            221  122346899999999864     34577899999999999999999999954321   1   111111110    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         ..+.+   ..+...+..+.+++.+||+.+|++||++.+++++-+
T Consensus       224 ---~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (280)
T cd06611         224 ---EPPTL---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF  264 (280)
T ss_pred             ---CCCCc---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence               00111   112233456889999999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-41  Score=309.00  Aligned_cols=263  Identities=26%  Similarity=0.428  Sum_probs=205.2

Q ss_pred             ccCHHHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEE
Q 018047           50 VFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIG  127 (361)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  127 (361)
                      .+...++..+.++|.+.+.||+|+||.||++... +++.+|+|.+...    ......+..|+.+++.+ +|||++++++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~l~~h~ni~~~~~   86 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPNHPNVVKFYG   86 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc----ccHHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence            3555666677889999999999999999999976 6889999998532    12345677899999998 7999999999


Q ss_pred             EEEcC-----CEEEEEEEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee
Q 018047          128 YCADG-----KHRFLVYEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       128 ~~~~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill  200 (361)
                      ++...     +..++||||+++|+|.+++...  ....+++..++.++.|++.||+|||+++     ++|+||||+||++
T Consensus        87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~nili  161 (291)
T cd06639          87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR-----IIHRDVKGNNILL  161 (291)
T ss_pred             EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEE
Confidence            98653     4689999999999999988642  2346899999999999999999999999     9999999999999


Q ss_pred             CCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 018047          201 SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-----KLTLQSDVYAFGVVLLELLTGRRAVDLNQGV  275 (361)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~p~~~~~~~  275 (361)
                      +.++.++|+|||++........  ......|+..|+|||.+...     .++.++|||||||++|+|++|+.||..... 
T Consensus       162 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-  238 (291)
T cd06639         162 TTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-  238 (291)
T ss_pred             cCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-
Confidence            9999999999999986543221  11224578899999987543     367899999999999999999999953221 


Q ss_pred             CchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          276 NDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                           ...+......       ..+.+   ..+......+.+++.+||+.+|++||++.|+++|
T Consensus       239 -----~~~~~~~~~~-------~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         239 -----VKTLFKIPRN-------PPPTL---LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -----HHHHHHHhcC-------CCCCC---CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                 1111111110       00111   1122334568999999999999999999999987

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-41  Score=306.76  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=205.2

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|++.+.||+|+||+||++.+. +|..+|+|.+...  ........+.+|+.++++++||||+++++.+..++..|+|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            5888899999999999999987 7899999988643  233345678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          141 YMQKGNLQDHLNGIG-EPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |+++++|..++.... ...+++..+..++.|++.||.|||+ .+     ++|+||+|+||+++.++.++|+|||++..+.
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC-----EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            999999999886531 2368999999999999999999997 47     9999999999999999999999999997664


Q ss_pred             CCCceeeeeecccccCccCcccccCC------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTG------KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ...    .....+++.|+|||.+...      .++.++|+|||||++|+|++|+.||.....   ......+.....   
T Consensus       155 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~---  224 (286)
T cd06622         155 ASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSAIVD---  224 (286)
T ss_pred             CCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHHHhh---
Confidence            332    2234578899999987543      357899999999999999999999954321   111111111111   


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                             ..  ....+...+..+.+++.+||+.+|++||++.+++.+.+-...
T Consensus       225 -------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         225 -------GD--PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             -------cC--CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence                   00  012233456678999999999999999999999998764333

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.4e-41  Score=301.88  Aligned_cols=253  Identities=27%  Similarity=0.406  Sum_probs=193.7

Q ss_pred             ceecccCceEEEEEEEc----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE-cCCEEEEEEEe
Q 018047           67 NFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA-DGKHRFLVYEY  141 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~  141 (361)
                      +.||+|+||+||+|.+.    .+..+|+|.+...  ........+..|+.+++.++|||++++++++. .++..+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            36899999999999864    2457999987432  22334567888999999999999999999775 45678999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++|+|.+++.... ...++..+..++.|+++||+|||+.+     ++||||||+|||++.++.+||+|||++..+....
T Consensus        79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK-----FVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            99999999997543 35677888899999999999999999     9999999999999999999999999997654322


Q ss_pred             cee--eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          222 ETY--VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG-RRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       222 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ...  ......++..|+|||.+....++.++||||||+++|||++| .+||....   ...   ........ .      
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~---~~~~~~~~-~------  219 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFD---ITVYLLQG-R------  219 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHH---HHHHHhcC-C------
Confidence            111  11123456789999998888899999999999999999995 45553211   111   11111111 0      


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      .     ...+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus       220 ~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         220 R-----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             C-----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            0     11112234568899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-41  Score=303.62  Aligned_cols=258  Identities=23%  Similarity=0.434  Sum_probs=205.4

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCc---chhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKE---ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      +|+..+.||+|++|.||++... +++.+|+|++.......   ......+..|+.+++.++|+|++++++++.+++..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999875 68999999986543221   1235678899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-cEEEeecCcccc
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-EAKISDFGLAKL  216 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~  216 (361)
                      ||||+++++|.+++...+  .+++..+..++.|++.||+|||++|     ++|+||+|+||+++.++ .++|+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~-----i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ-----IIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            999999999999997643  6889999999999999999999999     99999999999998775 699999999977


Q ss_pred             CCCCCce--eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          217 MPEGQET--YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       217 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .......  .......|+..|+|||.+....++.++|+||||+++|+|++|..||.........   ........     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~-----  225 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIAS-----  225 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhc-----
Confidence            6433111  1122346788999999988888999999999999999999999999643321111   11111100     


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                            .......+...+..+.+++.+||..+|++|||+.+++++-
T Consensus       226 ------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~  265 (268)
T cd06630         226 ------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP  265 (268)
T ss_pred             ------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence                  0011223444556789999999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.1e-41  Score=302.13  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=200.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCc--chhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKE--ADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~  135 (361)
                      .+|+..+.||+|+||.||+|... +++.||+|.+.......  ......+.+|+.+++.++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46899999999999999999876 68999999986543222  2234568889999999999999999998875  4678


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++++||+++++|.+++....  .+++...+.++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~-----i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            99999999999999997643  5889999999999999999999999     9999999999999999999999999987


Q ss_pred             cCCCCCc-eeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQE-TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+..... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....      ...+......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~----  224 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQ----  224 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcC----
Confidence            6532111 1112234578899999999888899999999999999999999999953211      1111111000    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                        ..     ....+......+.+++ +||..+|++||+++|+++|-
T Consensus       225 --~~-----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp  262 (266)
T cd06651         225 --PT-----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP  262 (266)
T ss_pred             --CC-----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence              00     1122334445577787 68889999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-42  Score=306.40  Aligned_cols=254  Identities=27%  Similarity=0.465  Sum_probs=201.3

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCC---
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGK---  133 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~---  133 (361)
                      ..++|++.+.||+|++|.||+|..+ +++.+++|++....    .....+.+|+.+++++ +|+||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            4568999999999999999999986 68899999986432    2346788999999999 6999999999986544   


Q ss_pred             ---EEEEEEEecCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEE
Q 018047          134 ---HRFLVYEYMQKGNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI  208 (361)
Q Consensus       134 ---~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl  208 (361)
                         ..++||||+++++|.+++....  ...+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~-----i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK-----VIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHHHEEEccCCeEEE
Confidence               5899999999999999886543  457899999999999999999999999     999999999999999999999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ  283 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  283 (361)
                      +|||++........  ......|+..|+|||++..     ..++.++||||||+++|+|++|..||.....   .   ..
T Consensus       155 ~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~---~~  226 (275)
T cd06608         155 VDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---M---RA  226 (275)
T ss_pred             CCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---H---HH
Confidence            99999876543221  2223468899999997643     3467889999999999999999999953221   1   11


Q ss_pred             HHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .......       ..+.   ...+...+..+.+++.+||..||++|||+.+++++
T Consensus       227 ~~~~~~~-------~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         227 LFKIPRN-------PPPT---LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HHHhhcc-------CCCC---CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1111111       0111   11122345678999999999999999999999976

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-41  Score=303.59  Aligned_cols=250  Identities=28%  Similarity=0.438  Sum_probs=205.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .|+..+.||.|+||.||+|.+. ++..+|+|.+....  .......+.+|+.+++.++||||+++++.+.++...++|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            4777889999999999999976 58899999986532  23345678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++...   .+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~-----ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          83 YLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK-----KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             cCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            99999999998652   5888999999999999999999999     999999999999999999999999999766443


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ..  ......++..|+|||++....++.++|+||||+++|+|++|..||......   .....              +..
T Consensus       155 ~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~--------------~~~  215 (277)
T cd06640         155 QI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLFL--------------IPK  215 (277)
T ss_pred             cc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhhh--------------hhc
Confidence            21  122345788999999998888999999999999999999999998533211   11000              000


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      . .........+..+.+++.+||+.+|++||++.+++++..
T Consensus       216 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06640         216 N-NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF  255 (277)
T ss_pred             C-CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence            0 012234456677999999999999999999999999854

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3e-41  Score=302.81  Aligned_cols=258  Identities=26%  Similarity=0.398  Sum_probs=203.7

Q ss_pred             CCCCCCceecccCceEEEEEEEcC----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      .+|.+.+.||+|+||.||+|.+.+    ...+|+|.....  ......+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            357888999999999999998653    246899987543  223445678899999999999999999999876 4568


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+     ++|+||||+||+++.++.++|+|||++..
T Consensus        83 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-----~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          83 IVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR-----FVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccChheEEEecCCCeEEccCceeee
Confidence            9999999999999997643 36899999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      ....... ......++..|+|||.+....++.++||||||+++|+|++ |..||.....   .....   ..... ..  
T Consensus       157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~---~~~~~-~~--  226 (270)
T cd05056         157 LEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIG---RIENG-ER--  226 (270)
T ss_pred             cccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHH---HHHcC-Cc--
Confidence            6443221 1112234567999999888889999999999999999986 9999954321   11111   11111 00  


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                               ...+...+..+.+++.+||..+|++|||+.++++.|+.+...
T Consensus       227 ---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         227 ---------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                     111223445699999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.2e-42  Score=306.48  Aligned_cols=250  Identities=32%  Similarity=0.503  Sum_probs=197.3

Q ss_pred             ceecccCceEEEEEEEcC-------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           67 NFLGKGGFGRVYKGTLRS-------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +.||+|+||.||+|+..+       +..+|+|.+...  ........+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc--cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            358999999999998652       257999987543  21234567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-----cEEEe
Q 018047          140 EYMQKGNLQDHLNGIG-----EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-----EAKIS  209 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-----~~kl~  209 (361)
                      ||+++|+|.+++.+..     ...+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++     .++|+
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChheEEEecCCCCCCcceEEC
Confidence            9999999999996532     234788999999999999999999999     99999999999999887     89999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHh
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      |||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.....   ......+.   
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~---  227 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVT---  227 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHh---
Confidence            9999976644332222223345778999999988899999999999999999998 9999853221   11111110   


Q ss_pred             hhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       ...           ....+...+..+.+++.+||..+|++||+++++++.|+
T Consensus       228 -~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 -AGG-----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -cCC-----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             000           01122334567899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=301.37  Aligned_cols=254  Identities=24%  Similarity=0.401  Sum_probs=204.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||.||+|... +++.+++|.+....   ......+.+|+.+++.++||||+++++.+.+.+..|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            46889999999999999999976 58899999987542   224567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++... ...+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        80 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          80 EYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG-----KIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             eCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999998764 237899999999999999999999999     99999999999999999999999999986643


Q ss_pred             CCceeeeeecccccCccCcccccCC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTG---KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ...  ......++..|+|||.+...   .++.++|+||||+++|+|++|..||......   .......   ..  .+  
T Consensus       154 ~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~~~~~---~~--~~--  221 (262)
T cd06613         154 TIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RALFLIS---KS--NF--  221 (262)
T ss_pred             hhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---hc--cC--
Confidence            221  12234678899999988766   7889999999999999999999999643211   1111100   00  00  


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                       ..+.   .......+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       222 -~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         222 -PPPK---LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             -CCcc---ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0001   11223445679999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-41  Score=310.19  Aligned_cols=261  Identities=30%  Similarity=0.437  Sum_probs=202.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCC----EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      .+|+..+.||+|+||.||+|.+. +|.    .+|+|.+....  .......+.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            35788899999999999999875 444    47888775432  223344678899999999999999999998764 46


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+++     ++|+||||+||+++.++.+||+|||++.
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC-----eeccccccceeeecCCCceEEccccccc
Confidence            79999999999999987642 36889999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+.............++..|+|||.+....++.++||||||+++|||++ |..||....   .......    .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~----~~~~~~~  230 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDL----LEKGERL  230 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----HHCCCCC
Confidence            7654332212222345678999999988889999999999999999997 888885321   1111111    1111100


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                                 ..+...+..+.+++.+||..+|++||++.++++.|+.+....+
T Consensus       231 -----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         231 -----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence                       0111233458899999999999999999999999998876553

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-41  Score=310.33  Aligned_cols=259  Identities=25%  Similarity=0.342  Sum_probs=201.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||.||++... +++.|++|.+.............+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999987 58899999987653333344567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++...+  .+++..+..++.|++.||.|||+++     ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999997643  6899999999999999999999999     99999999999999999999999998863211


Q ss_pred             CCc-------------eeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 018047          220 GQE-------------TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH  286 (361)
Q Consensus       220 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  286 (361)
                      ...             ........++..|+|||.+....++.++|+||||+++|+|++|..||....   ..   .....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~---~~~~~  227 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PE---ELFGQ  227 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HH---HHHHH
Confidence            100             001112357889999999888889999999999999999999999995321   11   11111


Q ss_pred             HhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      .....     ...+     ......+..+.+++.+||+.||++||+..++++.|+.
T Consensus       228 ~~~~~-----~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         228 VISDD-----IEWP-----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHhcc-----cCCC-----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11110     0000     0111234558999999999999999995555544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.2e-42  Score=342.07  Aligned_cols=263  Identities=23%  Similarity=0.375  Sum_probs=201.8

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CC
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GK  133 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~  133 (361)
                      +....+|.+.+.||+|+||+||+|.+. ++..+|+|.+...... ......+..|+.++..|+||||++++++|.+  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            344567999999999999999999987 5788999998754332 2345678889999999999999999998854  45


Q ss_pred             EEEEEEEecCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCC--CCCeEecCCCCCCeeeCCC------
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSSSAV--GIPIVHRDFKSTNVLLSAN------  203 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~--~~~iiH~Dikp~Nill~~~------  203 (361)
                      .+||||||+++|+|.++|....  ...+++..++.|+.||+.||+|||+.+..  ...|+||||||+||||+.+      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            7899999999999999986531  24699999999999999999999984310  0129999999999999642      


Q ss_pred             -----------CcEEEeecCccccCCCCCceeeeeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 018047          204 -----------FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVD  270 (361)
Q Consensus       204 -----------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~  270 (361)
                                 +.+||+|||++..+....   ......||+.|+|||++..  ..++.++||||||||||+|++|..||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                       359999999998664322   2234578999999998753  458899999999999999999999996


Q ss_pred             CCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          271 LNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ....     ....+..+. .        .+.+...    ..+..+.+||..||+.+|.+||++.|+|.+-.
T Consensus       245 ~~~~-----~~qli~~lk-~--------~p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~  297 (1021)
T PTZ00266        245 KANN-----FSQLISELK-R--------GPDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQI  297 (1021)
T ss_pred             cCCc-----HHHHHHHHh-c--------CCCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence            4321     111111111 1        0111111    12355899999999999999999999997644

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-41  Score=303.28  Aligned_cols=259  Identities=27%  Similarity=0.465  Sum_probs=201.8

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc-------hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA-------DGEHEFRVEVDILSRLDHPNLVSLIGYCADGK  133 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  133 (361)
                      +|...+.||+|+||.||+|... +|+.+|+|.+..+.....       ...+.+..|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999876 689999998864322111       12346788999999999999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+++     ++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG-----ILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC-----eeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999999765  36899999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGK--LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      +................|+..|+|||.+....  ++.++|+||||+++|++++|..||.....      .......... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~-  227 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNK-  227 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhcc-
Confidence            98654322221222345788999999876654  78999999999999999999999852211      1111111100 


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                       ..    .+.+. .......+..+.+++.+||..+|++|||+.++++|.
T Consensus       228 -~~----~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (272)
T cd06629         228 -RS----APPIP-PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP  270 (272)
T ss_pred             -cc----CCcCC-ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence             00    00110 111123356689999999999999999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-41  Score=311.39  Aligned_cols=264  Identities=21%  Similarity=0.318  Sum_probs=188.3

Q ss_pred             CceecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CCEEEEEEE
Q 018047           66 DNFLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GKHRFLVYE  140 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e  140 (361)
                      +..||+|+||+||+|...   ++..||+|.+...     .....+.+|+.+++.++||||+++++++..  +...++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC-----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            367999999999999865   3578999988543     123456789999999999999999998853  567899999


Q ss_pred             ecCCCchhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee----CCCCcEEEe
Q 018047          141 YMQKGNLQDHLNGI-------GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL----SANFEAKIS  209 (361)
Q Consensus       141 ~~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill----~~~~~~kl~  209 (361)
                      |+++ +|.+++...       ....+++..+..++.|++.||.|||+++     ++||||||+|||+    +.++.+||+
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-----EEcCCCCHHHEEEccCCCCCCcEEEe
Confidence            9865 787776421       1235888999999999999999999999     9999999999999    456799999


Q ss_pred             ecCccccCCCCCce-eeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhH---HHHH
Q 018047          210 DFGLAKLMPEGQET-YVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNL---VLQV  284 (361)
Q Consensus       210 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~---~~~~  284 (361)
                      |||++......... .......||+.|+|||++.+ ..++.++|||||||++|||+||..||...........   ....
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  234 (317)
T cd07867         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL  234 (317)
T ss_pred             eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence            99999876543221 11233568999999998765 4578999999999999999999999965432111000   0000


Q ss_pred             HHHhhhh-----------------hhhhhhc-CccccC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          285 RHILNDR-----------------KKLRKVI-DPELSR-------SSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       285 ~~~~~~~-----------------~~~~~~~-~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .......                 ....... ......       ..........+.+|+.+||+.||.+|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            0000000                 0000000 000000       00011122457889999999999999999999986


Q ss_pred             H
Q 018047          340 L  340 (361)
Q Consensus       340 l  340 (361)
                      .
T Consensus       315 p  315 (317)
T cd07867         315 P  315 (317)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.5e-41  Score=299.84  Aligned_cols=250  Identities=29%  Similarity=0.484  Sum_probs=200.1

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      +|+..+.||+|+||.||++.+.++..+|+|.+.....    ....+..|+++++.++|||++++++++......+++|||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            5778899999999999999887788999998864322    235688899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++.... ..++++.+..++.|++.|++|||+.+     ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          81 MEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN-----VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            99999999987543 36889999999999999999999999     9999999999999999999999999987654332


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .. ......++..|+|||.+....++.++||||||+++|+|++ |..||....   ...   .........    ....+
T Consensus       155 ~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~---~~~~~~~~~----~~~~~  223 (256)
T cd05112         155 YT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSE---VVETINAGF----RLYKP  223 (256)
T ss_pred             cc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHH---HHHHHhCCC----CCCCC
Confidence            11 1112234568999999988889999999999999999998 899985322   111   111111100    00011


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                              ...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus       224 --------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 --------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             --------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                    11235689999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3e-41  Score=300.30  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=203.3

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCC--cchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFK--EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      +|+..+.||+|++|+||+|... +++.|++|.+......  .......+.+|+.+++.++|+|++++++++.++...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999987 7899999998654321  123456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      +||+++++|.+++.+..  .+++..+..++.|++.||+|||+.|     ++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN-----TVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999997643  6889999999999999999999999     9999999999999999999999999988654


Q ss_pred             CCCceeeeeecccccCccCcccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGK-LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ...   ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.....   ....   ...... ..    
T Consensus       154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~---~~~~~~-~~----  219 (258)
T cd06632         154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAV---FKIGRS-KE----  219 (258)
T ss_pred             ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHH---HHHHhc-cc----
Confidence            332   123346889999999877666 89999999999999999999999954321   1111   110000 00    


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                            ....+...+..+.+++.+||+.+|++||++.+++++
T Consensus       220 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         220 ------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                  011222344568899999999999999999999876

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.2e-41  Score=302.31  Aligned_cols=257  Identities=24%  Similarity=0.330  Sum_probs=200.4

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      +..++++.....||+|+||.||+|.+. ++..||+|.+...   .......+.+|+.+++.++|+||+++++++..++..
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            344455666678999999999999976 5788999987643   233456788999999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-CCcEEEeecC
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKM--DWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFG  212 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg  212 (361)
                      ++++||+++++|.+++.... ..+  ++..+..++.|++.||+|||+.+     ++|+||||+||+++. ++.++|+|||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ-----IVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCeEEEecch
Confidence            99999999999999997542 234  78888999999999999999999     999999999999986 6799999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTG--KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      ++........  ......|++.|+|||++...  .++.++|+||||+++|+|++|+.||......   ........... 
T Consensus       155 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~-  228 (268)
T cd06624         155 TSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFK-  228 (268)
T ss_pred             hheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhc-
Confidence            9976543222  12234578999999987654  3788999999999999999999998532211   00000000000 


Q ss_pred             hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                             ..     ...+...+..+.+++.+||+.+|++|||+.|+++|-
T Consensus       229 -------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  266 (268)
T cd06624         229 -------IH-----PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP  266 (268)
T ss_pred             -------cC-----CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence                   00     112333456689999999999999999999999873

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-41  Score=306.30  Aligned_cols=249  Identities=28%  Similarity=0.453  Sum_probs=202.4

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |+..+.||+|+||.||+|.+. ++..||+|.+....  .......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            566678999999999999876 58899999886432  223456788999999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++..   ..+++..+..++.|++.|+.|||+++     ++|+||+|+||+++.++.++|+|||++..+....
T Consensus        84 ~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          84 LGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER-----KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC-----eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            999999999864   36899999999999999999999999     9999999999999999999999999998664332


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .  ......|+..|+|||++....++.++|+||||+++|+|++|+.|+......   ....   ..       .....  
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~---~~-------~~~~~--  218 (277)
T cd06642         156 I--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLF---LI-------PKNSP--  218 (277)
T ss_pred             h--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHh---hh-------hcCCC--
Confidence            1  112245788999999998888999999999999999999999998532211   0000   00       00001  


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         .......+..+.+++.+||+.+|++|||+.+++++.+
T Consensus       219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         219 ---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence               1122334556899999999999999999999999866

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.9e-41  Score=300.09  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=201.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCC--CcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRF--KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~  135 (361)
                      .+|++.+.||+|+||.||.+... +|..||+|.+.....  ........+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46889999999999999999976 589999998864321  1123356788899999999999999999998763  568


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      +++|||+++++|.+++....  .+++.....++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM-----IVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEecCCCCEEECcCcccc
Confidence            89999999999999987643  5788999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCce-eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQET-YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+...... .......|+..|+|||++....++.++|+||||+++|+|++|+.||....      ...........    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~----  224 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE------AMAAIFKIATQ----  224 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc------hHHHHHHHhcC----
Confidence            65321111 11223458889999999888889999999999999999999999995321      11111111100    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                           +  .....+...+..+.+++++||. +|++||++++++++.
T Consensus       225 -----~--~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         225 -----P--TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             -----C--CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence                 0  0122344555678899999995 899999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8e-42  Score=308.71  Aligned_cols=267  Identities=23%  Similarity=0.321  Sum_probs=199.3

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|+||.||+|... +|+.+|+|.+..... .......+.+|+.+++.++|||++++++++.+.+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            4788899999999999999987 689999999865432 22233567789999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |++ ++|.+++.... ..+++..+..++.|+++||.|||+++     ++|+||||+||+++.++.++|+|||++..+...
T Consensus        80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          80 YCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            997 58888776532 36899999999999999999999999     999999999999999999999999999865433


Q ss_pred             CceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh-----hh
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK-----KL  294 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~  294 (361)
                      ..  ......+++.|+|||.+.+. .++.++|||||||++|+|++|..|+....+.  ......+........     ..
T Consensus       153 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         153 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             CC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHh
Confidence            22  12234578899999987654 4689999999999999999999987433221  111111110000000     00


Q ss_pred             hhhcCc----ccc----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          295 RKVIDP----ELS----RSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       295 ~~~~~~----~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ....+.    ...    ........+..+.+++.+||+.||.+|||++++++|.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            000000    000    0011112346788999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.5e-41  Score=304.21  Aligned_cols=263  Identities=29%  Similarity=0.440  Sum_probs=205.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CCE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GKH  134 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~  134 (361)
                      .|+..+.||+|+||.||+|.+.     +++.+|+|.+......  .....+.+|+++++.++|+||+++++++..  +..
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            5777889999999999999854     3688999998654221  346788999999999999999999999887  568


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .+++|||+++++|.+++.... ..+++..+..++.|++.||+|||++|     ++|+||||+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR-----YIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHhEEEcCCCCEEEcccccc
Confidence            899999999999999997643 26899999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCceee-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCch--------hHHHHHH
Q 018047          215 KLMPEGQETYV-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ--------NLVLQVR  285 (361)
Q Consensus       215 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--------~~~~~~~  285 (361)
                      ........... .....++..|+|||......++.++||||||+++|+|++|..|+.........        .....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            87753322211 11223456799999988888999999999999999999999998543221100        0011111


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ...          ..... ...+..++..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       237 ~~~----------~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELL----------KEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHH----------HcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111          11110 111233446699999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.5e-41  Score=302.23  Aligned_cols=255  Identities=26%  Similarity=0.428  Sum_probs=206.9

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|++|.||++.++ +++.+|+|.+.....  ......+.+|+++++.++||||+++++.+..++..++++|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            5777889999999999999987 689999999875422  2445678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |+++++|.+++.... ..+++..+..++.|++.||+|||+ .+     ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~-----i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          80 YMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK-----IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             ecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC-----eecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            999999999997643 478999999999999999999999 88     99999999999999999999999999876533


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...    ....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ......+......       ..
T Consensus       154 ~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-------~~  221 (265)
T cd06605         154 SLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE-------PP  221 (265)
T ss_pred             HHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC-------CC
Confidence            221    11567889999999988899999999999999999999999996443211 1122222221111       00


Q ss_pred             ccccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTME-SIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +.     .+.. .+..+.++|.+||..||++|||+.+++.+-+
T Consensus       222 ~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  259 (265)
T cd06605         222 PR-----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF  259 (265)
T ss_pred             CC-----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence            11     1111 4556899999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-41  Score=300.97  Aligned_cols=246  Identities=29%  Similarity=0.444  Sum_probs=197.9

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      +|++.+.||+|+||.||++.. +++.+|+|.+...     .....+.+|+.+++.++|||++++++++..++ .+++|||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~   79 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMEL   79 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-CCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEEC
Confidence            588899999999999999875 4788999988532     23456888999999999999999999987654 7899999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++.......+++..+..++.|++.||.|||+.|     ++||||||+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK-----LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            99999999998765557899999999999999999999999     9999999999999999999999999987643321


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                           .....+..|+|||.+....++.++|+||||+++|+|++ |+.||.....      ...... ....         
T Consensus       155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~-~~~~---------  213 (254)
T cd05083         155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKEC-VEKG---------  213 (254)
T ss_pred             -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHH-HhCC---------
Confidence                 11234567999999888889999999999999999998 8999853321      111111 1110         


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                       .. ...+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       214 -~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 -YR-MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CC-CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             00 01122334568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=320.04  Aligned_cols=267  Identities=27%  Similarity=0.426  Sum_probs=222.6

Q ss_pred             HHHHHcCCCCCCceecccCceEEEEEEEcC-CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC
Q 018047           55 EMEEATCSFSDDNFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK  133 (361)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  133 (361)
                      +++--..+.....+||-|.||.||.|.|+. .-.||||.++    .+....++|..|+.+|+.++|||+|+++|+|..+.
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK----EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh----hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            333334456677899999999999999984 6789999986    44566889999999999999999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..|||+|||..|+|.+|++..+...++.-.++.++.||..|++||..++     +|||||...|.|+.++..+|++|||+
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn-----FIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh-----hhhhhhhhhhccccccceEEeeccch
Confidence            9999999999999999999988888999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ++.+.... ....+...-...|.|||.+....++.|+|||+|||+|||+.| |..||...+   -    .++-.+++.  
T Consensus       412 sRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---l----SqVY~LLEk--  481 (1157)
T KOG4278|consen  412 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---L----SQVYGLLEK--  481 (1157)
T ss_pred             hhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---H----HHHHHHHhc--
Confidence            99885443 223333344678999999999999999999999999999998 567774321   1    222222221  


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                              .+ +-..++.|+....+|++.||+.+|.+||++.|+-+.++..+.+++.
T Consensus       482 --------gy-RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi  529 (1157)
T KOG4278|consen  482 --------GY-RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI  529 (1157)
T ss_pred             --------cc-cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence                    11 1334566777899999999999999999999999999988766554

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.8e-41  Score=303.70  Aligned_cols=256  Identities=26%  Similarity=0.476  Sum_probs=201.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      ++|.....||+|+||+||+|+.+      +.+.+++|.+...  ........+.+|+.++++++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            46888999999999999999864      2467899987532  222245678899999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEE
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGE-------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAK  207 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~k  207 (361)
                      .++||||+++|+|.+++.....       ..+++..+..++.|++.||+|||+.+     ++|+||||+||+++.++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC-----cccCcCccceEEEeCCCcEE
Confidence            9999999999999999976441       25899999999999999999999999     99999999999999999999


Q ss_pred             EeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHH
Q 018047          208 ISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRH  286 (361)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  286 (361)
                      ++|||++........ .......++..|+|||.+....++.++||||||+++|+|++ |..||....   ........  
T Consensus       158 l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~~~~~--  231 (275)
T cd05046         158 VSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEVLNRL--  231 (275)
T ss_pred             EcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHHHHHH--
Confidence            999999875432211 12223356778999999888888999999999999999999 778884322   11111111  


Q ss_pred             HhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       ...  ...         ...+...+..+.+++.+||+.+|++|||+.|++..|.
T Consensus       232 -~~~--~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 -QAG--KLE---------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -HcC--CcC---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence             100  000         0111223456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.7e-41  Score=304.40  Aligned_cols=250  Identities=29%  Similarity=0.394  Sum_probs=201.1

Q ss_pred             ecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCch
Q 018047           69 LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL  147 (361)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  147 (361)
                      ||+|+||+||+|... +|+.+|+|.+.............+..|+++++.++|||++++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999876 6899999998765433344455667899999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeee
Q 018047          148 QDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA  227 (361)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (361)
                      .+++.......+++..+..++.|++.||.|||+.|     ++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~  152 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR-----IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK  152 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence            99997765557999999999999999999999999     9999999999999999999999999987654321   122


Q ss_pred             ecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCC
Q 018047          228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY  307 (361)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (361)
                      ...++..|+|||+..+..++.++||||||+++|+|++|+.||.............  ......             ....
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~-------------~~~~  217 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLEM-------------AVEY  217 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hccccc-------------cccC
Confidence            3457889999999888889999999999999999999999996543321111110  000000             0112


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          308 TMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       308 ~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                      +...+..+.+++.+||+.||++||     ++.+++.|.+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~  256 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL  256 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChh
Confidence            223355689999999999999999     8888887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.8e-41  Score=304.38  Aligned_cols=265  Identities=25%  Similarity=0.354  Sum_probs=201.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|++|.||+|... +|+.||+|++...... ......+.+|+.+++.++|+|++++++++..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            36888999999999999999987 6899999998654211 223345778999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|..++...  ..+++..+..++.|++.||+|||+++     ++|+||||+||+++.++.++|+|||++.....
T Consensus        80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN-----CIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            999998888877543  36899999999999999999999999     99999999999999999999999999987654


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-------  291 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  291 (361)
                      ...  ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......   .....+.......       
T Consensus       153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07847         153 PGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV---DQLYLIRKTLGDLIPRHQQI  227 (286)
T ss_pred             Ccc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChHHhhh
Confidence            332  1223457889999998765 55788999999999999999999999643321   1111111111000       


Q ss_pred             ----hhhhhhcCccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          292 ----KKLRKVIDPELSRSSYT-----MESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       292 ----~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                          ........+... ...+     ...+..+.+|+.+||+.+|++|||+.|++.|
T Consensus       228 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         228 FSTNQFFKGLSIPEPE-TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccccccCCCcc-cccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                000000000000 0000     1224568899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.5e-41  Score=306.85  Aligned_cols=264  Identities=24%  Similarity=0.383  Sum_probs=200.2

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||.|++|.||+|+.. +|+.||||++..... .......+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            4788899999999999999976 689999998865432 22233568889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |++ ++|.+++.......+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            996 58999887655567899999999999999999999999     999999999999999999999999998765433


Q ss_pred             CceeeeeecccccCccCcccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh--------
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGK-LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR--------  291 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  291 (361)
                      ..  ......+++.|+|||.+.+.. ++.++||||||+++|+|+||+.||......   .............        
T Consensus       154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         154 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             cc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhhhh
Confidence            22  122235688999999876544 588899999999999999999999643211   1111111100000        


Q ss_pred             -------hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          292 -------KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       292 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                             ..+.......+  .......+..+.+++.+||+.||++|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         229 TSLPDYKPSFPKWARQDF--SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hHHHHHHhhcccccccCH--HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                   00000000000  00011233457899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.1e-42  Score=305.17  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=207.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|++.+.||.|+||.||+|.+. +++.+|+|.+...........+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999987 699999999976544444556788999999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++...  ..+++..+..++.|+++||.|||+++     ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG-----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999999764  47899999999999999999999999     999999999999999999999999999876543


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      .   ......|+..|+|||.+....++.++|+||||+++|+|++|..||.......    ..........          
T Consensus       154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------  216 (258)
T cd05578         154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------  216 (258)
T ss_pred             c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------
Confidence            2   1223457889999999888889999999999999999999999996544321    1111111110          


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSM--AECVKE  339 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~--~ell~~  339 (361)
                        .....+...+..+.+++.+||+.||.+||++  +|++++
T Consensus       217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         217 --ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             --ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence              0122233345679999999999999999999  777654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=315.99  Aligned_cols=267  Identities=29%  Similarity=0.439  Sum_probs=224.1

Q ss_pred             HcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..+...+.+.||+|.||.|.++....+..||||+++..  .......+|.+|+++|.+|+||||++++|+|..++.+++|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~--a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD--ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcc--cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            34557778899999999999999987899999999754  3344568899999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      +||+++|+|..|+..+..+...-+....|+.||+.|++||.+.+     ++||||.+.|+|++.++++||+|||.++.+.
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n-----fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN-----FVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc-----hhhccccccceeecCcccEEecCcccccccc
Confidence            99999999999998875445566777889999999999999999     9999999999999999999999999999888


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT--GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      .++......+.+-...|||+|.+..++++.++|+|+||+++||+++  ...||...   .+.+.++.....+.+.+.-  
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l---t~e~vven~~~~~~~~~~~--  763 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL---TDEQVVENAGEFFRDQGRQ--  763 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh---hHHHHHHhhhhhcCCCCcc--
Confidence            8888777777778899999999999999999999999999999876  56777432   3333444444333322111  


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                            .....|.-++..+.+++.+||..|-++||+++++-.+|.+.
T Consensus       764 ------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 ------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                  11234556677799999999999999999999999998754

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.4e-41  Score=297.24  Aligned_cols=252  Identities=31%  Similarity=0.510  Sum_probs=201.3

Q ss_pred             CCCCceecccCceEEEEEEEcC-C----CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRS-G----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      +++.+.||.|+||.||++.... +    ..+|+|.+...  ........+..|+..+..++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED--ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC--CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            3567889999999999999763 3    88999998543  222246688899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      +|||+++++|.+++.......+++..+..++.|++.||++||+.+     ++|+||+|+||+++.++.++|+|||++...
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~-----~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN-----FIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC-----eeecccccceEEEccCCeEEEcccCCceec
Confidence            999999999999997654333899999999999999999999999     999999999999999999999999999876


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ........ ....+++.|+|||......++.++|+||||+++|+|++ |..||...   ........   .....     
T Consensus       154 ~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~~---~~~~~-----  221 (258)
T smart00219      154 YDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLEY---LKKGY-----  221 (258)
T ss_pred             cccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHH---HhcCC-----
Confidence            54422211 12236789999999888889999999999999999998 77887532   11111111   11110     


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                             ....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus       222 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 -------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   0111222456699999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.1e-41  Score=307.07  Aligned_cols=266  Identities=23%  Similarity=0.334  Sum_probs=201.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCC--cchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFK--EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      +|+..+.||+|++|.||+|... +|+.||+|.+......  .......+..|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999976 6899999999765433  122344567899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+ +|+|.+++.... ..+++..+..++.|+++||.|||++|     ++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW-----ILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 889999997643 36999999999999999999999999     9999999999999999999999999998765


Q ss_pred             CCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh-----
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK-----  292 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  292 (361)
                      ....  ......+++.|+|||.+.. ..++.++|+|||||++|+|++|.+||....+.   ..............     
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhh
Confidence            4322  1222356788999998754 46788999999999999999998777543321   11111111000000     


Q ss_pred             ---hhhhhc----CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          293 ---KLRKVI----DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       293 ---~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                         ......    .+...........+..+.+++.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence               000000    00000011112335678999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=299.17  Aligned_cols=251  Identities=26%  Similarity=0.301  Sum_probs=209.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|..+++||+|.||.|.+++.+ +|+.+|+|++++......+....-..|-.+|+..+||.+..+...|+..+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            356888999999999999999977 7999999999888777777777788899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC-
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-  217 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~-  217 (361)
                      |||..||.|.-++.+.  ..+++.....+-..|+.||.|||+++     |+.||||.+|.|+|.||++||+|||+++.- 
T Consensus       247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~-----ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN-----IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC-----eeeeechhhhheeccCCceEeeecccchhcc
Confidence            9999999999999874  47999999999999999999999999     999999999999999999999999999742 


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ..+.   ...+++|||.|+|||++....|+.+.|+|.+||++|||++|+.||...+...   +.+.+-            
T Consensus       320 ~~g~---t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLIl------------  381 (516)
T KOG0690|consen  320 KYGD---TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELIL------------  381 (516)
T ss_pred             cccc---eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHHH------------
Confidence            2222   4567899999999999999999999999999999999999999996433221   111110            


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKE  339 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~  339 (361)
                       ...   -.+|...+.+...|+..+|..||.+|.     .+.|+.+|
T Consensus       382 -~ed---~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  382 -MED---LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             -hhh---ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence             001   112333344578899999999999995     34555444

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.7e-41  Score=303.26  Aligned_cols=267  Identities=28%  Similarity=0.362  Sum_probs=203.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|++.+.||+|++|.||+|.+. +|+.||+|++...... ......+.+|+.+++.++|||++++++++.++...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            4788899999999999999976 6899999998765322 2334678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+ +++|.+++.... ..+++..++.++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG-----IMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            99 999999986543 46999999999999999999999999     999999999999999999999999999876543


Q ss_pred             CceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh------
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK------  293 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  293 (361)
                      .. .......|+..|+|||.+... .++.++||||||+++|+|++|.+||.....   ................      
T Consensus       153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         153 EP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             CC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhc
Confidence            32 122334689999999987544 468999999999999999999877753321   1111111111100000      


Q ss_pred             -----hhhhcCcccc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          294 -----LRKVIDPELS---RSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       294 -----~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                           ......+...   ......+.+..+.+++.+||+.||++|||++++++|.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                 0000000000   0000112346789999999999999999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.2e-41  Score=299.36  Aligned_cols=248  Identities=27%  Similarity=0.351  Sum_probs=203.5

Q ss_pred             ecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCch
Q 018047           69 LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL  147 (361)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  147 (361)
                      ||.|++|.||++... +++.+|+|++.............+.+|+.+++.++||||+++++.+.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999987 5899999999765544445567889999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeee
Q 018047          148 QDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA  227 (361)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (361)
                      .+++.+.  ..+++..+..++.|+++||+|||+++     ++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~-----~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG-----IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            9999764  35899999999999999999999999     9999999999999999999999999998775442   122


Q ss_pred             ecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCC
Q 018047          228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY  307 (361)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (361)
                      ...|++.|+|||.+....++.++|+||||+++|+|++|..||......    ............           .....
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-----------~~~~~  215 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGN-----------GKLEF  215 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccC-----------CCCCC
Confidence            346789999999988888999999999999999999999999654321    111111111000           01122


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          308 TMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       308 ~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                      +...+..+.+++.+||+.+|++||+     +.|+++|-+
T Consensus       216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~  254 (262)
T cd05572         216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW  254 (262)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence            2233566999999999999999999     899988765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.9e-41  Score=300.31  Aligned_cols=240  Identities=21%  Similarity=0.377  Sum_probs=186.5

Q ss_pred             ceecccCceEEEEEEEcC-------------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC
Q 018047           67 NFLGKGGFGRVYKGTLRS-------------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK  133 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  133 (361)
                      +.||+|+||+||+|+..+             ...+++|.+...   .......+..|+.++..++||||+++++++.++.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            358999999999998542             225888876542   2233456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc-------E
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE-------A  206 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~-------~  206 (361)
                      ..+++|||+++|+|..++.... ..+++..+..++.|+++||+|||+++     ++||||||+|||++.++.       +
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD-----LVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC-----eECCCCCcccEEEecCCccCCCCcee
Confidence            9999999999999999886542 36899999999999999999999999     999999999999987664       8


Q ss_pred             EEeecCccccCCCCCceeeeeecccccCccCccccc-CCCCCccchhHHHHHHHHHHH-hCCCCCCCCCCCCchhHHHHH
Q 018047          207 KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELL-TGRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-~g~~p~~~~~~~~~~~~~~~~  284 (361)
                      +++|||++......      ....++..|+|||.+. ...++.++|||||||++|+|+ +|..||......      . .
T Consensus       152 ~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~-~  218 (262)
T cd05077         152 KLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------E-K  218 (262)
T ss_pred             EeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------H-H
Confidence            99999998755322      1235788899999876 467889999999999999998 577777432111      0 0


Q ss_pred             HHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .......          ..   .....+..+.+|+.+||+.||++||++.+++++|+
T Consensus       219 ~~~~~~~----------~~---~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 ERFYEGQ----------CM---LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHHhcC----------cc---CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1111100          00   00112345889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-40  Score=304.63  Aligned_cols=251  Identities=29%  Similarity=0.425  Sum_probs=201.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ..|...+.||+|+||+||+|... +|+.||+|.+.............+.+|+++++.++|||++++.+++.+++..|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999976 68999999986544344444567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+     ++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~-----i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE-----RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 57777765432 36899999999999999999999999     99999999999999999999999999876532


Q ss_pred             CCceeeeeecccccCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTS---TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ..      ...+++.|+|||++.   ...++.++||||||+++|+|++|..||.....      ..........      
T Consensus       168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~------  229 (307)
T cd06607         168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN------  229 (307)
T ss_pred             CC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcC------
Confidence            21      245788999999863   45688899999999999999999999853221      1111111000      


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       ..+    .......+..+.+++.+||+.||++||++.+++.+.+
T Consensus       230 -~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         230 -DSP----TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             -CCC----CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence             011    1112335567999999999999999999999999765

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-40  Score=296.71  Aligned_cols=254  Identities=27%  Similarity=0.436  Sum_probs=208.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|++.+.||+|++|.||+|+.. +++.+++|++......  .....+.+|+..+..++|+|++++++++..++..++|||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            5888899999999999999987 5999999998754321  446778899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |+++++|.+++...  ..+++..+..++.|+++|++|||+ .+     ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~-----~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH-----IIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC-----CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999764  478999999999999999999999 99     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ....  .....++..|+|||.+....++.++|+||||+++|+|++|..||.......   ...........       ..
T Consensus       153 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~-------~~  220 (264)
T cd06623         153 TLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAICDG-------PP  220 (264)
T ss_pred             CCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHhcC-------CC
Confidence            3322  123457889999999988889999999999999999999999996543211   11111111110       00


Q ss_pred             ccccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTME-SIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           ...+.. .+..+.+++.+||+.+|++|||+.+++++-.
T Consensus       221 -----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~  258 (264)
T cd06623         221 -----PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF  258 (264)
T ss_pred             -----CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence                 111222 4566999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=324.07  Aligned_cols=252  Identities=24%  Similarity=0.392  Sum_probs=204.8

Q ss_pred             CCCCceecccCceEEEEEEEcC-CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |+++..||.|+||.||+|..+. +-..|.|++..   ...+...++.-|+++|..++||+||++++.|...+.+++..||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            5556679999999999999874 55667777753   4566778899999999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      |.||-+...+-..+ ..+.+.++..+++|++.||.|||+++     |||||||..|||++-+|.++|+|||.+.....  
T Consensus       111 C~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~-----iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--  182 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN-----IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--  182 (1187)
T ss_pred             cCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc-----hhhhhccccceEEEecCcEeeecccccccchh--
Confidence            99999988776553 47999999999999999999999999     99999999999999999999999999865422  


Q ss_pred             ceeeeeecccccCccCcccc-----cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          222 ETYVTARVLGTFGYFDPEYT-----STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ......+++|||+|||||+.     ...+|+.++||||||++|.||..+.+|-...+.   ...+.          ++.+
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVll----------KiaK  249 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLL----------KIAK  249 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHH----------HHhh
Confidence            22234467899999999974     457899999999999999999999998742221   11111          1111


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .-+|.+   .-|...+..+.+++.+||..||..||++.++++|.+
T Consensus       250 SePPTL---lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf  291 (1187)
T KOG0579|consen  250 SEPPTL---LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF  291 (1187)
T ss_pred             cCCCcc---cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence            122222   224455667999999999999999999999999865

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.4e-40  Score=296.76  Aligned_cols=252  Identities=22%  Similarity=0.377  Sum_probs=203.7

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CCEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GKHRFLV  138 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv  138 (361)
                      +|++.+.||.|+||.||++... ++..+|+|.+..... .......+..|+.+++.++|||++++++++..  +...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            4788899999999999999876 688999999875433 23345678889999999999999999998754  4578999


Q ss_pred             EEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          139 YEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLH-----SSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH-----~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      |||+++++|.+++...  ....+++..++.++.|++.||+|||     +.+     ++|+||+|+||+++.++.++|+||
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-----i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-----VLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc-----ceecCCCHHHEEEecCCCEEEecc
Confidence            9999999999998653  2347899999999999999999999     777     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      |++........  ......+++.|+|||.+....++.++|+||||+++|+|++|+.||....   ...   ........ 
T Consensus       155 g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~---~~~~~~~~-  225 (265)
T cd08217         155 GLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQ---LASKIKEG-  225 (265)
T ss_pred             cccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHH---HHHHHhcC-
Confidence            99987754332  1223468999999999988889999999999999999999999996432   111   11111110 


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                            .     ....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       226 ------~-----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 ------K-----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------C-----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  0     012233445678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.2e-41  Score=302.25  Aligned_cols=254  Identities=24%  Similarity=0.427  Sum_probs=195.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHH-HHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDI-LSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ++|++.+.||+|+||.||++.+. +|+.||+|.+.....  ......+..|+.. ++.++|||++++++++..++..|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            36888999999999999999987 699999999875422  2223445556665 5667899999999999999999999


Q ss_pred             EEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          139 YEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSS-SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |||++ |+|.+++...  ....+++..++.++.|++.||+|||++ +     ++||||||+||+++.++.+||+|||++.
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-----i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-----VIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99996 5888777542  234689999999999999999999997 7     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccC----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTST----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      ......   ......|+..|+|||.+..    ..++.++|+|||||++|+|++|+.||.....  .   .......... 
T Consensus       153 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~---~~~~~~~~~~-  223 (283)
T cd06617         153 YLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--P---FQQLKQVVEE-  223 (283)
T ss_pred             cccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--C---HHHHHHHHhc-
Confidence            654322   1122457889999998754    4568899999999999999999999853211  1   1111111110 


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                            ..+.+.    ....+..+.+++.+||..+|++|||+.+++++-+
T Consensus       224 ------~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  263 (283)
T cd06617         224 ------PSPQLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF  263 (283)
T ss_pred             ------CCCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence                  111111    1123456899999999999999999999998755

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.2e-41  Score=301.60  Aligned_cols=247  Identities=24%  Similarity=0.344  Sum_probs=192.6

Q ss_pred             eecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHh---cCCCcceeEEEEEEcCCEEEEEEEecC
Q 018047           68 FLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSR---LDHPNLVSLIGYCADGKHRFLVYEYMQ  143 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (361)
                      +||+|+||.||++... +++.+|+|.+.............+.+|..+++.   .+|||++.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999976 689999999876543333323334445444433   479999999999999999999999999


Q ss_pred             CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCce
Q 018047          144 KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET  223 (361)
Q Consensus       144 ~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (361)
                      +|+|.+++...+  .+++..+..++.|++.||+|||+++     ++|+||||+|||++.++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~-----ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            999999987643  6999999999999999999999999     9999999999999999999999999987654322  


Q ss_pred             eeeeecccccCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccc
Q 018047          224 YVTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL  302 (361)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                        .....|++.|+|||... +..++.++|||||||++|+|++|..||.........    .+.....       ...   
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~-------~~~---  215 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTL-------TVN---  215 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhh-------cCC---
Confidence              12246899999999875 456889999999999999999999999644322111    1111100       001   


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          303 SRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       303 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                        ...+...+..+.+++.+||+.||++||     |++|+++|..
T Consensus       216 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~  257 (279)
T cd05633         216 --VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF  257 (279)
T ss_pred             --cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence              112333456689999999999999999     6999999854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-41  Score=306.92  Aligned_cols=266  Identities=26%  Similarity=0.383  Sum_probs=201.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||.||+|.+. +++.+|+|++....... .....+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            36888899999999999999987 58999999986543222 33456788999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.++....  ..+++..+..++.|++.||+|||+.+     ++|+||+|+||++++++.++|+|||++..+..
T Consensus        80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            999999998876543  35899999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh--------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND--------  290 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  290 (361)
                      ...  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.....   ......+......        
T Consensus       153 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07846         153 PGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQEI  227 (286)
T ss_pred             Ccc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhHHH
Confidence            322  2223467889999998764 4567899999999999999999998853321   1111111100000        


Q ss_pred             ---hhhhhhhcCccccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          291 ---RKKLRKVIDPELSRS----SYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       291 ---~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                         .........+.....    ......+..+.+++.+||+.+|++||++.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence               000000000110000    0011234668999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-40  Score=299.06  Aligned_cols=262  Identities=24%  Similarity=0.380  Sum_probs=204.0

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CCEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GKHRFLV  138 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv  138 (361)
                      +|...+.||.|++|.||++... +++.+|+|.+....  .......+.+|+++++.++||||+++++++.+  .+.+++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            5778899999999999999986 68999999987542  22445678899999999999999999998865  4478999


Q ss_pred             EEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          139 YEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      |||+++++|.+++...  ....+++..+..++.|++.||.|||+.+     ++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-----i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK-----IIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEecCCeEEEeecccccc
Confidence            9999999999887532  2346889999999999999999999999     99999999999999999999999999876


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ......    ....++..|+|||.+....++.++||||||+++|+|++|..||....... ............. .    
T Consensus       155 ~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-~----  224 (287)
T cd06621         155 LVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNM-P----  224 (287)
T ss_pred             cccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcC-C----
Confidence            533221    23457889999999988889999999999999999999999997543211 1111111111110 0    


Q ss_pred             hcCccccC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          297 VIDPELSR-SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       297 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                        .+.+.. .......+..+.+++.+||..+|++|||+.|++++-+-
T Consensus       225 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         225 --NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             --chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence              011100 01011235668999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.7e-40  Score=297.76  Aligned_cols=253  Identities=22%  Similarity=0.390  Sum_probs=186.7

Q ss_pred             eecccCceEEEEEEEcCC---CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           68 FLGKGGFGRVYKGTLRSG---EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      .||+|+||+||++...++   ..+++|.+...  ........+.+|+.+++.++||||+++++.+.+....|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCC--CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            589999999999975533   34566665432  2223456788999999999999999999999999999999999999


Q ss_pred             CchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCc
Q 018047          145 GNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE  222 (361)
Q Consensus       145 g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (361)
                      |+|.+++....  ....++..+..++.|++.||+|||+++     ++|+||||+|||++.++.++|+|||++........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-----eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            99999997532  234667788899999999999999999     99999999999999999999999999864322221


Q ss_pred             eeeeeecccccCccCcccccC-------CCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          223 TYVTARVLGTFGYFDPEYTST-------GKLTLQSDVYAFGVVLLELLTG-RRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ........++..|+|||++..       ..++.++||||||+++|||+++ ..||....   ..   .........  ..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~---~~~~~~~~~--~~  226 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DR---EVLNHVIKD--QQ  226 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC---HH---HHHHHHHhh--cc
Confidence            112223467889999998642       2457789999999999999975 66764321   11   111111111  11


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ....++.+.     ...+..+.+++..|| .+|++||+++++++.|.
T Consensus       227 ~~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         227 VKLFKPQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cccCCCccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111222221     123345788999999 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-41  Score=316.18  Aligned_cols=255  Identities=26%  Similarity=0.369  Sum_probs=213.7

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      .-...|.+...||+|.|++|.++++. ++..||||.+.+....... ...+.+|+++|..|+|||||+++.+......+|
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            34567999999999999999999977 7999999999876654443 344888999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+.+|.+++|+.+.+  .+.+..+..++.|+..|++|||+++     |+|||||++||||+.+.++||+|||++..
T Consensus       132 lV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~-----ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKN-----IVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             EEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcc-----eeccccchhhcccccccceeeecccccee
Confidence            9999999999999998865  6777999999999999999999999     99999999999999999999999999998


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      +..+.   ...+++|++.|.|||+..+..| ++++|+||+|+++|.|+.|..||+...-.      +.-.+.+..     
T Consensus       205 ~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk------~Lr~rvl~g-----  270 (596)
T KOG0586|consen  205 FDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK------ELRPRVLRG-----  270 (596)
T ss_pred             ecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc------cccchheee-----
Confidence            86443   4566899999999999888776 58899999999999999999999643221      110000000     


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                           .   --.+.-.+.++.++++++|-.+|.+|++++++.++-+.
T Consensus       271 -----k---~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~  309 (596)
T KOG0586|consen  271 -----K---YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR  309 (596)
T ss_pred             -----e---ecccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence                 0   11222334458899999999999999999999988773

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.9e-40  Score=298.84  Aligned_cols=248  Identities=27%  Similarity=0.415  Sum_probs=202.1

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |...+.||+|+||.||+|... ++..+|+|.+....  .......+.+|+.++..++||||+++++++..+...++||||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            778889999999999999876 68899999876432  223456788999999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++...   .+++..+..++.|++.|+.+||+.+     ++|+||+|+||+++.++.++|+|||++..+....
T Consensus        84 ~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          84 LGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK-----KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC-----eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            9999999998642   6899999999999999999999999     9999999999999999999999999987664332


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .  ......++..|+|||.+....++.++|+|||||++|+|++|..||.....   .   .........       .   
T Consensus       156 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~---~~~~~~~~~-------~---  217 (277)
T cd06641         156 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---M---KVLFLIPKN-------N---  217 (277)
T ss_pred             h--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---H---HHHHHHhcC-------C---
Confidence            1  12234678899999998888889999999999999999999999853221   1   111111000       0   


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                        ....+...+..+.+++.+||+.+|++||++.+++++-
T Consensus       218 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~  254 (277)
T cd06641         218 --PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  254 (277)
T ss_pred             --CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence              0112233455689999999999999999999999973

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=320.91  Aligned_cols=249  Identities=27%  Similarity=0.369  Sum_probs=203.9

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKG  145 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g  145 (361)
                      -+||+|.||+||.|++. +...+|||.+...   ......-+..|+.+.+.|+|.|||+++|.+.+++..-|.||-.|||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            46999999999999977 4667899988643   2334456778999999999999999999999999999999999999


Q ss_pred             chhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC-CCCcEEEeecCccccCCCCCce
Q 018047          146 NLQDHLNGI-GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS-ANFEAKISDFGLAKLMPEGQET  223 (361)
Q Consensus       146 ~L~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~  223 (361)
                      ||.+++++. +.-.-++.++..+..||++||.|||.+.     |+|||||-+|+|++ -.|.+||+|||.++.+..-.  
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~-----IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--  730 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK-----IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--  730 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc-----eeeccccCCcEEEeeccceEEecccccchhhccCC--
Confidence            999999864 3223378889999999999999999999     99999999999996 57999999999999875432  


Q ss_pred             eeeeecccccCccCcccccCC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          224 YVTARVLGTFGYFDPEYTSTG--KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      ..+.++.||.-|||||++..+  .|+.++|||||||++.||.||++||-.....  +  ....+-     +.      -.
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--q--AAMFkV-----Gm------yK  795 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--Q--AAMFKV-----GM------YK  795 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--h--Hhhhhh-----cc------ee
Confidence            256678899999999999765  5889999999999999999999999432211  1  111110     00      00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       .-...|.+.+.+..++|.+|+.+||.+||+++++|+...
T Consensus       796 -vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpF  834 (1226)
T KOG4279|consen  796 -VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPF  834 (1226)
T ss_pred             -cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcc
Confidence             114578888999999999999999999999999998643

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-41  Score=303.55  Aligned_cols=266  Identities=25%  Similarity=0.385  Sum_probs=197.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|++|+||+|..+ +++.||+|.+......  .....+.+|+++++.++|+||+++++++.+++..++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            56889999999999999999977 6899999998654221  12234667999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++ +|.+++..... .+++..+..++.|+++||.|||+.+     ++|+||||+||+++.++.++|+|||++.....
T Consensus        83 e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          83 EYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR-----VLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             ecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            99975 99998875433 6889999999999999999999999     99999999999999999999999999875432


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-hhh---
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-KKL---  294 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~---  294 (361)
                      ...  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......  ......+....... ...   
T Consensus       156 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07844         156 PSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPG  231 (291)
T ss_pred             CCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhh
Confidence            211  1122346888999998764 45788999999999999999999999643311  11111111100000 000   


Q ss_pred             -------hhhcCccccCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          295 -------RKVIDPELSRSS-----YTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       295 -------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                             .....+......     ........+.+++.+||+.+|++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                   000000000000     000111457899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.8e-41  Score=306.64  Aligned_cols=251  Identities=24%  Similarity=0.386  Sum_probs=200.3

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |.....||+|+||.||++... ++..||||.+...   .......+.+|+.+++.++|+|++++++.+..++..++||||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            334466999999999999876 6899999998542   233455688899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++..   ..+++..+..++.|++.||+|||+++     ++||||||+||+++.++.++|+|||++.......
T Consensus       101 ~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658         101 LEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG-----VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            999999998854   25889999999999999999999999     9999999999999999999999999987654322


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .  ......|+..|+|||......++.++|+||||+++|||++|+.||.....   ......+.          ....+.
T Consensus       173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~----------~~~~~~  237 (292)
T cd06658         173 P--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIR----------DNLPPR  237 (292)
T ss_pred             c--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----------hcCCCc
Confidence            2  12234688999999999888899999999999999999999999963321   11111111          111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ..   .....+..+.+++.+||..||++|||+++++++-.-
T Consensus       238 ~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  275 (292)
T cd06658         238 VK---DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL  275 (292)
T ss_pred             cc---cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence            11   111234458899999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.2e-41  Score=306.24  Aligned_cols=252  Identities=23%  Similarity=0.379  Sum_probs=200.9

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |.....||+|+||.||++... +++.||+|.+....   ......+.+|+.++..++|||++++++.+..++..|++|||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            444457999999999999876 68999999986532   22345678899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++..   ..+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++.......
T Consensus       100 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659         100 LQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG-----VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            999999998754   36899999999999999999999999     9999999999999999999999999987654332


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .  ......|+..|+|||++....++.++||||||+++|+|++|..||.....   .   .........       ..+.
T Consensus       172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~---~~~~~~~~~-------~~~~  236 (297)
T cd06659         172 P--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---V---QAMKRLRDS-------PPPK  236 (297)
T ss_pred             c--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHhcc-------CCCC
Confidence            1  12235688999999999888899999999999999999999999963221   1   111111100       0000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                         .......+..+.+++.+||+.+|++||++++++++-.-.
T Consensus       237 ---~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~  275 (297)
T cd06659         237 ---LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLL  275 (297)
T ss_pred             ---ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence               001112344588999999999999999999999975533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=299.05  Aligned_cols=251  Identities=24%  Similarity=0.434  Sum_probs=201.8

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC---CCcceeEEEEEEcCCEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD---HPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~l  137 (361)
                      .|+..+.||+|+||.||+|.+. +++.+|+|.+....  .......+.+|+.+++.++   |||++++++++.++...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4778889999999999999975 68999999986542  2334567888999999986   9999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++++|.+++...   .+++..++.++.|++.||.|||+.|     ++|+||+|+||+++.++.++|+|||++..+
T Consensus        80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG-----VIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            99999999999998653   6899999999999999999999999     999999999999999999999999999877


Q ss_pred             CCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      .....  ......|+..|+|||.+.. ..++.++|+||||+++|+|++|..||......      ....       .+..
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~-------~~~~  216 (277)
T cd06917         152 NQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMM-------LIPK  216 (277)
T ss_pred             CCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhh-------cccc
Confidence            54432  1223468899999998754 45688999999999999999999999643211      0000       0000


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...+.+...    ..+..+.+++.+||+.||++||++.+++++-+
T Consensus       217 ~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~  257 (277)
T cd06917         217 SKPPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLKSKW  257 (277)
T ss_pred             CCCCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence            111111111    13456899999999999999999999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8e-41  Score=297.50  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=204.2

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|+||.||+|..+ +|..+|+|.+....... .....+.+|+.+++.++|+|++++++.+.+++..++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4778899999999999999987 58899999987643222 334567889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-cEEEeecCccccCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-EAKISDFGLAKLMPE  219 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~  219 (361)
                      |+++++|.+++.......+++..+..++.|++.||.|||+.+     ++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK-----ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            999999999997655556899999999999999999999999     99999999999999886 469999999987654


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ......|++.|+|||+.....++.++|+||||+++|+|++|..||....      ...........      .. 
T Consensus       155 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~------~~-  219 (257)
T cd08225         155 SME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQG------YF-  219 (257)
T ss_pred             Ccc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc------cC-
Confidence            322  1223458899999999888889999999999999999999999985322      11111111111      00 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                           .......+..+.+++.+||..+|++|||+.+++++.
T Consensus       220 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~  255 (257)
T cd08225         220 -----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP  255 (257)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence                 111122335689999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.3e-40  Score=303.14  Aligned_cols=258  Identities=28%  Similarity=0.429  Sum_probs=205.0

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .|...+.||+|+||.||++... ++..+|+|.+.............+.+|+.+++.++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777889999999999999976 689999999876544444445678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++ +|.+++... ...+++..+..++.|++.||.|||+++     ++|+||+|+||+++.++.++|+|||++......
T Consensus       106 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            9974 787777543 236899999999999999999999999     999999999999999999999999998754332


Q ss_pred             CceeeeeecccccCccCcccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          221 QETYVTARVLGTFGYFDPEYT---STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                            ....|++.|+|||++   ..+.++.++|||||||++|+|++|+.||.....   .   ..........      
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~---~~~~~~~~~~------  240 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---M---SALYHIAQNE------  240 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---H---HHHHHHHhcc------
Confidence                  123578899999986   345688999999999999999999999853211   1   1111111110      


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                       .+    .......+..+.+++.+||+.+|.+||++.++++++.......++
T Consensus       241 -~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         241 -SP----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             -CC----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence             00    111223445689999999999999999999999998876655544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-41  Score=301.92  Aligned_cols=240  Identities=26%  Similarity=0.438  Sum_probs=186.8

Q ss_pred             ceecccCceEEEEEEEc-CC-------CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           67 NFLGKGGFGRVYKGTLR-SG-------EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      +.||+|+||+||+|... .+       ..+|+|.+...   .......+..|+.+++.++|||++++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            36899999999999865 22       34788876432   223345678899999999999999999999998999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc--------EEEee
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE--------AKISD  210 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~--------~kl~D  210 (361)
                      |||+++|+|.+++...+ ..+++..+..++.|++.||+|||+++     ++||||||+||+++.++.        ++++|
T Consensus        78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG-----LTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCccceEEEecccccccCCCceEEecc
Confidence            99999999999997643 36899999999999999999999999     999999999999987765        69999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCchhHHHHHHHHh
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGR-RAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~-~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      ||++......      ....++..|+|||++.. ..++.++||||||+++|+|++|. .|+.....   ...    ....
T Consensus       152 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~----~~~~  218 (258)
T cd05078         152 PGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKK----LQFY  218 (258)
T ss_pred             cccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHH----HHHH
Confidence            9998755322      12357889999998876 45789999999999999999995 55432111   000    0001


Q ss_pred             hhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...             ...+.....++.+++.+||+.||++|||++++++.|+
T Consensus       219 ~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 EDR-------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             Hcc-------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            110             1111122345899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-40  Score=297.38  Aligned_cols=255  Identities=22%  Similarity=0.386  Sum_probs=201.2

Q ss_pred             CCCCCceecccCceEEEEEEEcC--CCEEEEEEeecCCC-------CcchhHHHHHHHHHHHHh-cCCCcceeEEEEEEc
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRS--GEVVAIKKMELPRF-------KEADGEHEFRVEVDILSR-LDHPNLVSLIGYCAD  131 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~  131 (361)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+.....       .......++..|+.++.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999999764  78899998754321       112234556778888875 799999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEE
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKI  208 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl  208 (361)
                      ++..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||+ .+     ++|+||+|+||+++.++.++|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-----i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-----IVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc-----eeecCCCHHHEEECCCCcEEE
Confidence            99999999999999999987532  23468999999999999999999996 66     999999999999999999999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      +|||++.......   ......|+..|+|||.+....++.++|+||||+++|+|++|+.||....      .........
T Consensus       156 ~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~  226 (269)
T cd08528         156 TDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIV  226 (269)
T ss_pred             ecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHHh
Confidence            9999998764432   2234568899999999988889999999999999999999999985321      111111111


Q ss_pred             hhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...      ..     .......+..+.+++.+||+.||++||++.|+..++.
T Consensus       227 ~~~------~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 EAV------YE-----PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hcc------CC-----cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            110      00     0011123456899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.2e-40  Score=297.46  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=198.5

Q ss_pred             CCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-----
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-----  133 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  133 (361)
                      |.+.+.||+|+||+||+|.+.    ++..+|||.+.... ......+.+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            567788999999999999854    36789999986433 22334567888999999999999999999886532     


Q ss_pred             -EEEEEEEecCCCchhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEE
Q 018047          134 -HRFLVYEYMQKGNLQDHLNGI----GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI  208 (361)
Q Consensus       134 -~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl  208 (361)
                       ..++++||+++|+|.+++...    ....+++..+..++.|++.||+|||+.+     ++||||||+||+++.++.++|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~nili~~~~~~kl  154 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-----FIHRDLAARNCMLNENMTVCV  154 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccchhhEEEcCCCCEEE
Confidence             347899999999999887421    1235788999999999999999999999     999999999999999999999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHH
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      +|||++................+++.|++||.+....++.++||||||+++|+|++ |..||....   .......   .
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~---~~~~~~~---~  228 (273)
T cd05074         155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNY---L  228 (273)
T ss_pred             CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC---HHHHHHH---H
Confidence            99999987644332222222345678999999988889999999999999999999 888875321   1111111   1


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ... ..           ...+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       229 ~~~-~~-----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IKG-NR-----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HcC-Cc-----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110 00           011122345689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.4e-40  Score=302.26  Aligned_cols=252  Identities=24%  Similarity=0.410  Sum_probs=204.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|...+.||+|+||+||++... +++.+|+|.+...   .......+.+|+.+++.++|||++++++.+...+..|+|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            57889999999999999999865 6889999998543   2233467888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++.+.   .+++..+..++.|++.||.|||++|     ++|+||+|+||+++.++.++|+|||++.....
T Consensus        96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g-----i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC-----EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            999999999998653   5789999999999999999999999     99999999999999999999999999876543


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ......|++.|+|||.+....++.++|+||||+++|++++|..||........   ....   ... .      .
T Consensus       168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~~---~~~-~------~  232 (293)
T cd06647         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLI---ATN-G------T  232 (293)
T ss_pred             ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eeeh---hcC-C------C
Confidence            322  12234688899999998888889999999999999999999999964332110   0000   000 0      0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +.   ...+...+..+.+++++||..+|++||++.+++.|-.
T Consensus       233 ~~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~  271 (293)
T cd06647         233 PE---LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (293)
T ss_pred             CC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            00   1122234456889999999999999999999998853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=326.78  Aligned_cols=267  Identities=27%  Similarity=0.485  Sum_probs=223.0

Q ss_pred             CCCCCceecccCceEEEEEEEc-CC---CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SG---EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ...+.++||.|.||.|++|+++ .|   ..||||.++..  ..+....+|..|+.||-+.+||||++|.|+........|
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            3556789999999999999987 33   46999998654  344567899999999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      |+|||++|+|+.||+...+ .+.+.++..+++.|+.|++||.+.+     ++||||...|||++++..+|++|||+++.+
T Consensus       708 iTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~-----YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC-----chhhhhhhhheeeccceEEEeccccceeec
Confidence            9999999999999988754 6999999999999999999999999     999999999999999999999999999988


Q ss_pred             CCCCceeeeeeccc--ccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          218 PEGQETYVTARVLG--TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       218 ~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .++... ...+.-|  ...|.|||.+....++.++||||+|++|||.++ |..||..   +.+++.+..+.+        
T Consensus       782 edd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd---mSNQdVIkaIe~--------  849 (996)
T KOG0196|consen  782 EDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD---MSNQDVIKAIEQ--------  849 (996)
T ss_pred             ccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc---cchHHHHHHHHh--------
Confidence            665422 1222222  468999999999999999999999999999887 8888853   233444333322        


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCCc
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPL  355 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~~  355 (361)
                            .+ +-+.|.+++..|.+|+..||+.|..+||++.+++..|++++.+...=+..+.
T Consensus       850 ------gy-RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~  903 (996)
T KOG0196|consen  850 ------GY-RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAP  903 (996)
T ss_pred             ------cc-CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCC
Confidence                  11 1345678888899999999999999999999999999999988765554443

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-41  Score=303.01  Aligned_cols=266  Identities=24%  Similarity=0.343  Sum_probs=203.4

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+++++.++|+||+++++++.+++..+++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            6888999999999999999987 688999998864322 23345678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |++++.+..+....  ..+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN-----IIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            99987777666542  35899999999999999999999999     999999999999999999999999999876544


Q ss_pred             CceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh--------
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR--------  291 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  291 (361)
                      ... ......++..|+|||++... .++.++|+||||+++|+|++|+.||.....   .+............        
T Consensus       154 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         154 PAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD---IDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             ccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHhhhc
Confidence            321 12235678899999998777 788999999999999999999999864322   11111111111000        


Q ss_pred             ---hhhh-----hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          292 ---KKLR-----KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       292 ---~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                         ....     ....+......++...+..+.+++++||..+|++|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence               0000     00000000001122235679999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.3e-40  Score=299.31  Aligned_cols=267  Identities=24%  Similarity=0.299  Sum_probs=197.1

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..+|...+.||+|+||.||+|... +|+.||+|.+.....  ......+.+|+.+++.++|+||+++++++.+++..|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            467999999999999999999876 689999999865422  22234567899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+. ++|.+++.... ..+++..+..++.|++.||.|||+++     ++|+||||+||+++.++.++|+|||++....
T Consensus        82 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          82 FEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH-----ILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             Eeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            99996 67777665432 35788889999999999999999999     9999999999999999999999999987643


Q ss_pred             CCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh-------
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND-------  290 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-------  290 (361)
                      .....  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......  .............       
T Consensus       155 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         155 IPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             CCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhh
Confidence            32211  223357889999998765 45788999999999999999999999643321  1111111110000       


Q ss_pred             -----hhhhhhhcCcc----ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          291 -----RKKLRKVIDPE----LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       291 -----~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                           ...........    +.........+..+.+++.+|+..||++|||++|++.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                 00000000000    00000000113467899999999999999999999876

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.5e-40  Score=299.37  Aligned_cols=250  Identities=24%  Similarity=0.406  Sum_probs=201.0

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |...+.||+|++|.||++... +++.+++|++...   .......+.+|+.+++.++|||++++++++..++..++++||
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            555578999999999999976 6889999988542   223345678899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++..   ..+++..+..++.|++.||+|||++|     ++||||+|+||+++.++.++|+|||.+.......
T Consensus        98 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          98 LEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG-----VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            999999999876   36899999999999999999999999     9999999999999999999999999887654322


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      .  ......|++.|+|||......++.++|+||||+++|+|++|..||...+.      ..........       ..+.
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-------~~~~  234 (285)
T cd06648         170 P--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-------LPPK  234 (285)
T ss_pred             c--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-------CCCC
Confidence            1  12234688999999999888899999999999999999999999853221      1111111111       1111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .   ..+...+..+.+++.+||+.+|++|||+.+++++-.
T Consensus       235 ~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  271 (285)
T cd06648         235 L---KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPF  271 (285)
T ss_pred             C---cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence            1   111224456999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.2e-40  Score=292.43  Aligned_cols=255  Identities=28%  Similarity=0.447  Sum_probs=208.8

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KHRFLV  138 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  138 (361)
                      +|...+.||+|++|.||+|... +++.+++|++...... ......+.+|+.++++++||||+++++.+.+.  +..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            4777899999999999999987 6899999998754322 34567888999999999999999999999988  899999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      +||+++++|.+++....  .+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~-----~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG-----IVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            99999999999998754  8999999999999999999999999     9999999999999999999999999998775


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ............++..|+|||.......+.++||||||+++|+|++|..||....     ...........         
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~---------  218 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGS---------  218 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccc---------
Confidence            5432111233467889999999888889999999999999999999999996443     11111111110         


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                       .. .....+...+..+.+++.+||+.||++||++.+++++-
T Consensus       219 -~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~  258 (260)
T cd06606         219 -SG-EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP  258 (260)
T ss_pred             -cC-CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence             00 01222333456799999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-40  Score=299.39  Aligned_cols=239  Identities=24%  Similarity=0.384  Sum_probs=184.7

Q ss_pred             eecccCceEEEEEEEcC-------------------------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcc
Q 018047           68 FLGKGGFGRVYKGTLRS-------------------------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL  122 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  122 (361)
                      .||+|+||.||+|.+..                         ...|++|.+...   .......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence            58999999999997531                         124888887532   22334567789999999999999


Q ss_pred             eeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC
Q 018047          123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA  202 (361)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~  202 (361)
                      +++++++.++...++||||+++|+|..++... ...+++..+..++.|++.||+|||+++     ++||||||+|||++.
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~Nill~~  152 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN-----LVHGNVCAKNILLAR  152 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC-----ccCCCCCcccEEEec
Confidence            99999999999999999999999999998653 346899999999999999999999999     999999999999976


Q ss_pred             CC-------cEEEeecCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHH-hCCCCCCCCC
Q 018047          203 NF-------EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELL-TGRRAVDLNQ  273 (361)
Q Consensus       203 ~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-~g~~p~~~~~  273 (361)
                      .+       .++++|||++......      ....++..|+|||.+.. ..++.++||||||+++|||+ +|..||....
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             cCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            43       4899999988644221      12346788999998765 56889999999999999995 6888885432


Q ss_pred             CCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          274 GVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...   ....    .....        ..     +......+.+++.+||+.+|++|||+.++++.|.
T Consensus       227 ~~~---~~~~----~~~~~--------~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         227 PSE---KERF----YEKKH--------RL-----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             hHH---HHHH----HHhcc--------CC-----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            211   1111    00000        00     1111235889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.4e-40  Score=308.49  Aligned_cols=267  Identities=21%  Similarity=0.283  Sum_probs=202.1

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  132 (361)
                      ..++|+..+.||+|+||+||+|... +|+.||+|.+.... ........+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4567999999999999999999976 68999999986432 2233345677899999999999999999988643     


Q ss_pred             -CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          133 -KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       133 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                       ...|+||||+. ++|.+++..    .++...+..++.|++.||+|||++|     ++||||||+||+++.++.+||+||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g-----i~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEccC
Confidence             35799999996 488888754    3888999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh---
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL---  288 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~---  288 (361)
                      |++........   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...   ....+....   
T Consensus       163 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~  236 (353)
T cd07850         163 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID---QWNKIIEQLGTP  236 (353)
T ss_pred             ccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCC
Confidence            99986643321   223457889999999988899999999999999999999999996432110   000000000   


Q ss_pred             ----------------hhhh-----hhhhhcCccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          289 ----------------NDRK-----KLRKVIDPELSR---SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       289 ----------------~~~~-----~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                                      ....     .+.+........   ...+...+..+.+++.+||+.||++|||+.|+|.+-+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence                            0000     000000000000   00012345568899999999999999999999999763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-40  Score=295.87  Aligned_cols=238  Identities=27%  Similarity=0.450  Sum_probs=187.1

Q ss_pred             ceecccCceEEEEEEEcC-C----------CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           67 NFLGKGGFGRVYKGTLRS-G----------EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      +.||+|+||.||+|.+.. +          ..+++|.+....    .....+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            368999999999999873 3          247777664321    115678889999999999999999999988 778


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-------cEEE
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-------EAKI  208 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-------~~kl  208 (361)
                      ++||||+++|+|.+++..... .+++..+..++.|++.||+|||+++     ++|+||||+|||++.++       .++|
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK-----LVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC-----eecccCccceEEEecCccccCCceeEEe
Confidence            999999999999999976432 6899999999999999999999999     99999999999999887       7999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCcccccCC--CCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG--KLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      +|||++......      ....++..|+|||++...  .++.++||||||+++|+|++ |..||......   .....  
T Consensus       150 ~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~--  218 (259)
T cd05037         150 SDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERF--  218 (259)
T ss_pred             CCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHH--
Confidence            999999865431      123467789999998766  78899999999999999999 46666433211   11110  


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                        .....        ...     ......+.+++.+||..+|++|||+.++++.|+
T Consensus       219 --~~~~~--------~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         219 --YQDQH--------RLP-----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --HhcCC--------CCC-----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              00000        000     001156899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-42  Score=336.96  Aligned_cols=264  Identities=25%  Similarity=0.295  Sum_probs=216.2

Q ss_pred             HHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC
Q 018047           54 KEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG  132 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  132 (361)
                      .++.-...+|.+.++||+|+||.|..++++ +++.||+|++++-...+......|..|..+|..-+.+.|+++...|+|+
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344445678999999999999999999987 6999999999764444445567899999999999999999999999999


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      +++|+|||||+||+|..++.++.  .+++..+.+++..|+-||..||+.|     +|||||||+|||+|..|++||+|||
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg-----yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG-----YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc-----ceeccCCcceeEecccCcEeeccch
Confidence            99999999999999999998875  7999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCccccc----C-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTS----T-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      .+-.+... ........+|||.|.+||++.    + +.|+..+|+||+||++|||++|..||.      ...++.-...+
T Consensus       221 sClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~KI  293 (1317)
T KOG0612|consen  221 SCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGKI  293 (1317)
T ss_pred             hHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHHH
Confidence            99887533 223445578999999999764    2 678999999999999999999999994      23333333333


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHH
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPS---MAECVKELQ  341 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~ell~~l~  341 (361)
                      .+....+        ..+ -....+.+..+||.+.+.. |+.|..   ++++-.|..
T Consensus       294 m~hk~~l--------~FP-~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpF  340 (1317)
T KOG0612|consen  294 MNHKESL--------SFP-DETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPF  340 (1317)
T ss_pred             hchhhhc--------CCC-cccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCcc
Confidence            3331111        111 1133667789999988764 788887   888887764

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.3e-40  Score=293.94  Aligned_cols=255  Identities=28%  Similarity=0.467  Sum_probs=203.8

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|...+.||+|+||.||+|... +++.+++|.+...... ......+..|+.+++.++|+||+++++.+.+.+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            4788899999999999999876 6899999998765332 3456788999999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++...  ..+++..+..++.+++.||.|||+.|     ++|+||+|+||+++.++.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG-----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            99999999999764  35888999999999999999999999     999999999999999999999999999876543


Q ss_pred             Cceee--eeecccccCccCcccccCCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          221 QETYV--TARVLGTFGYFDPEYTSTGK---LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       221 ~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .....  .....++..|+|||++....   .+.++||||||+++|++++|+.||.....  .....   .....      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~---~~~~~------  221 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIM---FHVGA------  221 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHH---HHHhc------
Confidence            32211  11245788999999887665   78999999999999999999999964321  11110   00000      


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                       ...+.++   .....+..+.+++.+||+.+|++|||+.+++.+
T Consensus       222 -~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         222 -GHKPPIP---DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             -CCCCCCC---cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0011111   111235568899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-42  Score=290.82  Aligned_cols=269  Identities=25%  Similarity=0.300  Sum_probs=210.4

Q ss_pred             HcCCCCCC-ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc----
Q 018047           59 ATCSFSDD-NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD----  131 (361)
Q Consensus        59 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----  131 (361)
                      ++++|.+. ++||-|-.|.|..+.++ +|+.+|+|++.-        ....++|+++.-.. .|||||+++++|+.    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            45566664 67999999999999987 799999998741        23566788887766 69999999998764    


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---CCcEEE
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKI  208 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---~~~~kl  208 (361)
                      ...+.+|||.|+||.|+..|+..+...+.+.++..|+.||..|+.|||+.+     |.||||||+|+|...   +..+||
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n-----IAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN-----IAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc-----hhhccCChhheeeecCCCCcceEe
Confidence            457889999999999999999999999999999999999999999999999     999999999999964   567999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      +|||+|+......   ...+.+-||+|.|||++....|+..+|+||+||++|-|++|.+||....+..-.  .-.-.++.
T Consensus       206 tDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais--pgMk~rI~  280 (400)
T KOG0604|consen  206 TDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKRRIR  280 (400)
T ss_pred             cccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC--hhHHhHhh
Confidence            9999998654322   344567899999999999999999999999999999999999999654432110  00111111


Q ss_pred             hhhhhhhhhcCccccCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCCccc
Q 018047          289 NDRKKLRKVIDPELSRSSYTM-ESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPLHA  357 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~~~~  357 (361)
                      ..          .+......+ ..++...++|+.+|..+|.+|.|+.+++.|-+.  +..+.--+.|.++
T Consensus       281 ~g----------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi--~~~~~vp~tpl~t  338 (400)
T KOG0604|consen  281 TG----------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI--NQYEAVPQTPLST  338 (400)
T ss_pred             cc----------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh--cccccCCCCCchh
Confidence            11          111111122 455678899999999999999999999999874  3333333444443

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-40  Score=302.33  Aligned_cols=265  Identities=24%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KHRFL  137 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l  137 (361)
                      ++|+..+.||+|+||.||+|... +++.+|+|.+...... ......+.+|+.++++++||||+++++++...  +..|+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            36888899999999999999987 6889999998754322 22234567799999999999999999998877  89999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++ +|.+++.... ..+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++..+
T Consensus        84 v~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          84 VMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW-----ILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            9999974 9999887643 36899999999999999999999999     999999999999999999999999999876


Q ss_pred             CCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-----
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-----  291 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----  291 (361)
                      .....  ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......   .....+.......     
T Consensus       157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~  231 (293)
T cd07843         157 GSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTEKIW  231 (293)
T ss_pred             cCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchHHH
Confidence            54321  12234578899999987654 4688999999999999999999999643321   1111111100000     


Q ss_pred             ------h-----hhhhhcCccccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          292 ------K-----KLRKVIDPELSRSSYTME-SIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       292 ------~-----~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                            .     .........+ ...++.. .+..+.+++++||+.||++|||+.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         232 PGFSELPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHhhccchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                  0     0000000000 0111111 35568899999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-40  Score=321.02  Aligned_cols=277  Identities=19%  Similarity=0.247  Sum_probs=192.7

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc--CCCEEEEEE--------------eecCCCCcchhHHHHHHHHHHHHhcCCCc
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR--SGEVVAIKK--------------MELPRFKEADGEHEFRVEVDILSRLDHPN  121 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  121 (361)
                      ....+|++.+.||+|+||+||++..+  ++...+.|.              +.+...........+.+|+.+|+.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34568999999999999999998754  222222221              11111112223456788999999999999


Q ss_pred             ceeEEEEEEcCCEEEEEEEecCCCchhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCe
Q 018047          122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNV  198 (361)
Q Consensus       122 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Ni  198 (361)
                      |+++++++.+.+..|+|++++. ++|.+++....   ........+..++.|++.||+|||++|     |+||||||+||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g-----IiHrDLKP~NI  298 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-----LIHRDIKLENI  298 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHE
Confidence            9999999999999999999995 57777764321   123345677889999999999999999     99999999999


Q ss_pred             eeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC-CCc
Q 018047          199 LLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG-VND  277 (361)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-~~~  277 (361)
                      |++.++.+||+|||++..+...... ......||..|+|||++.+..++.++|||||||++|||++|..++..... ...
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            9999999999999999876543221 22335799999999999988999999999999999999999865432221 111


Q ss_pred             hhHHHHHHHHhhhhh-------hhhhhcCc-ccc--CCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          278 QNLVLQVRHILNDRK-------KLRKVIDP-ELS--RSSY-----TMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       278 ~~~~~~~~~~~~~~~-------~~~~~~~~-~~~--~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..+...+........       .+...+.. .+.  ....     ....+..+.+++.+||+.||++|||+.|++.|.+
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            111111111000000       00000000 000  0000     0012235678899999999999999999998754

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.2e-40  Score=290.18  Aligned_cols=250  Identities=27%  Similarity=0.477  Sum_probs=204.3

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|++|.||++... ++..+++|++.....   .....+.+|+..++.++|+|++++++++..+...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4778889999999999999987 688999999865422   345678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++.... ..+++..+..++.|++.||++||+.+     ++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC-----EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            999999999987643 47899999999999999999999999     999999999999999999999999999876544


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ..   .....++..|+|||.+.....+.++|+||||+++|+|++|+.||.....   .........          ...+
T Consensus       152 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~----------~~~~  215 (253)
T cd05122         152 KA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIAT----------NGPP  215 (253)
T ss_pred             cc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHh----------cCCC
Confidence            32   2234678899999998888889999999999999999999999864321   111111100          0001


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ..   ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus       216 ~~---~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         216 GL---RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             Cc---CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11   1111124568999999999999999999999976

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=300.17  Aligned_cols=265  Identities=23%  Similarity=0.361  Sum_probs=199.7

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |+..+.||.|++|+||+|... +|..||+|++...... ......+.+|+++++.++|||++++++++.+++..|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            667889999999999999976 6999999998754322 22335677899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      ++ ++|.+++.......+++..+..++.|+++||+|||+++     ++|+||+|+||+++.++.++|+|||++..+....
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~-----~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            95 69999987655457899999999999999999999999     9999999999999999999999999997654322


Q ss_pred             ceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh---------
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR---------  291 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------  291 (361)
                      ..  .....+++.|+|||++... .++.++|+||||+++|+|++|..||.......  ........ ....         
T Consensus       154 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~  228 (283)
T cd07835         154 RT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRT-LGTPDEDVWPGVT  228 (283)
T ss_pred             cc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH-hCCCChHHhhhhh
Confidence            11  1223568899999977554 57889999999999999999999996432211  11111000 0000         


Q ss_pred             --hhhhhhcCcc--ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          292 --KKLRKVIDPE--LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       292 --~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                        ......+...  ..........+..+.+++.+||+.||++|||++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0000000000  00001112233568899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-40  Score=301.53  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=197.7

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +|...+.||+|+||.||++... +++.+|+|.+.....  ......+.+|+.++.++. |+||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            4556678999999999999976 689999999875432  244567888999999996 999999999999999999999


Q ss_pred             EecCCCchhhh---cccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          140 EYMQKGNLQDH---LNGIGEPKMDWPLRLKVALGAAKGLAYLHSS-SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       140 e~~~~g~L~~~---l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ||+.. +|.++   +.......+++..+..++.|++.||+|||+. +     ++||||||+||+++.++.++|+|||++.
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK-----IIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eeccCCCHHHEEEccCCcEEEeecchhH
Confidence            99864 55543   3222335799999999999999999999975 7     9999999999999999999999999997


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTG---KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      .+.....   .....|++.|+|||++...   .++.++||||||+++|+|++|+.||....     .....+......  
T Consensus       157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~--  226 (288)
T cd06616         157 QLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG--  226 (288)
T ss_pred             HhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC--
Confidence            6543321   1223578899999988765   68899999999999999999999995322     111111111110  


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           ..+.+. .......+..+.+|+.+||+.||++|||+++++.+-.
T Consensus       227 -----~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~  269 (288)
T cd06616         227 -----DPPILS-NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF  269 (288)
T ss_pred             -----CCCcCC-CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                 011111 1112335567999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.2e-40  Score=297.89  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=206.1

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ..+.|+..+.||+|++|.||+|.+. +++.+++|++.....    ....+.+|++.++.++|+|++++++.+...+..|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            4456888889999999999999987 689999999865322    45678889999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ++||+++++|.+++.... ..+++..+..++.|++.||+|||+.|     ++|+||+|+||+++.++.++|+|||++...
T Consensus        93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            999999999999998753 37999999999999999999999999     999999999999999999999999998765


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....  ......++..|+|||.+....++.++|+||||+++|+|++|..||......      .........  .    
T Consensus       167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~~--~----  232 (286)
T cd06614         167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITTK--G----  232 (286)
T ss_pred             ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc--C----
Confidence            43321  122345788999999988888999999999999999999999998532211      111111000  0    


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       .+.   .......+..+.+++.+||+.+|.+|||+.+++++..
T Consensus       233 -~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  272 (286)
T cd06614         233 -IPP---LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF  272 (286)
T ss_pred             -CCC---CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence             000   1111224456899999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.6e-42  Score=318.35  Aligned_cols=249  Identities=29%  Similarity=0.426  Sum_probs=197.4

Q ss_pred             CCCceecccCceEEEEEEEc-CCCEEEEEEeecCCC-CcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC--EEEEEE
Q 018047           64 SDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRF-KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK--HRFLVY  139 (361)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~  139 (361)
                      +...+||+|+|-+||+|.+. +|-.||=-.+....+ ........|..|+.+|+.|+||||+++++++.+..  ..-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34567999999999999976 577776433322222 33445678999999999999999999999998765  478999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEeecCccccCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFGLAKLMP  218 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~~~~~~  218 (361)
                      |++..|+|..|+++++  .++...+..|++||++||.|||++.   +||||||||.+||||+.. |.|||+|+|+|+.+.
T Consensus       123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~---PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQD---PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCC---CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            9999999999998865  7899999999999999999999987   569999999999999854 999999999999875


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh--hhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR--KKLRK  296 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  296 (361)
                      ...    ....+|||.|||||... ..|+...||||||+.++||+|+.+||..-     .+.+...+....+.  ..+.+
T Consensus       198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~SGiKP~sl~k  267 (632)
T KOG0584|consen  198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTSGIKPAALSK  267 (632)
T ss_pred             ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHcCCCHHHhhc
Confidence            443    33468999999999875 88999999999999999999999999522     11222222211111  11111


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +-             ..+..++|.+||.. .++|||+.|+|.+-.
T Consensus       268 V~-------------dPevr~fIekCl~~-~~~R~sa~eLL~d~F  298 (632)
T KOG0584|consen  268 VK-------------DPEVREFIEKCLAT-KSERLSAKELLKDPF  298 (632)
T ss_pred             cC-------------CHHHHHHHHHHhcC-chhccCHHHHhhChh
Confidence            11             23478999999999 999999999998643

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-40  Score=300.73  Aligned_cols=272  Identities=22%  Similarity=0.309  Sum_probs=198.4

Q ss_pred             CCCCCceecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KHRF  136 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~  136 (361)
                      +|.+.+.||+|+||.||+|...   ++..||+|.+.............+.+|+.++..++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778889999999999999975   3789999998764322233345677899999999999999999999988  8899


Q ss_pred             EEEEecCCCchhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC----CCcEEEe
Q 018047          137 LVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA----NFEAKIS  209 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~----~~~~kl~  209 (361)
                      +||||+++ +|.+++....   ...+++..+..++.|++.||+|||+.+     ++||||||+||+++.    ++.+||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW-----VLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC-----EeeCCCCHHHEEEcCCCCccceEEEC
Confidence            99999975 6776664321   236889999999999999999999999     999999999999999    8999999


Q ss_pred             ecCccccCCCCCc-eeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHH---HHH
Q 018047          210 DFGLAKLMPEGQE-TYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV---LQV  284 (361)
Q Consensus       210 Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---~~~  284 (361)
                      |||++..+..... ........+++.|+|||++.+ ..++.++||||||+++|+|++|+.||............   ..+
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999987644322 111223467889999997755 45789999999999999999999999754432210000   000


Q ss_pred             HHHhhh--------------hhhhhh---hc-CccccCCCCCH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          285 RHILND--------------RKKLRK---VI-DPELSRSSYTM------ESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       285 ~~~~~~--------------~~~~~~---~~-~~~~~~~~~~~------~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ......              ......   .. ...........      ..+..+.+++.+||+.||++|||+.|+++|
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000              000000   00 00000000000      223468899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-41  Score=310.23  Aligned_cols=257  Identities=27%  Similarity=0.446  Sum_probs=210.5

Q ss_pred             CCCCCCceecccCceEEEEEEEcC---CC--EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS---GE--VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      ......+.||.|.||.||+|...+   |+  -||||.++..  ...+..+.|..|..+|+.++||||++++|+|.+. ..
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence            334456789999999999998642   33  4888888653  2334477899999999999999999999999875 45


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      +||||+++.|.|..|++.. ...++......+++||+.||.|||+..     ++||||...|||+.+...+||+|||+++
T Consensus       466 WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkr-----fVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKR-----FVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhc-----hhhhhhhhhheeecCcceeeecccchhh
Confidence            7999999999999999875 348999999999999999999999999     9999999999999999999999999999


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+.+....... ...-...|||||.+.-..++.++|||.|||.+||+++ |..||......   +             .+
T Consensus       540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---D-------------VI  602 (974)
T KOG4257|consen  540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---D-------------VI  602 (974)
T ss_pred             hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---c-------------eE
Confidence            98766543222 2233568999999999999999999999999999987 88999643211   1             11


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      .. +. .-.+.+.|..|+..|..|+.+||..+|.+||+++|+...|..++.
T Consensus       603 ~~-iE-nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  603 GH-IE-NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EE-ec-CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            11 11 112345677888889999999999999999999999999998876

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=292.03  Aligned_cols=255  Identities=23%  Similarity=0.354  Sum_probs=201.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCC--CcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRF--KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~  135 (361)
                      .+|.+.+.||+|+||.||+|.+. +++.+|+|.+.....  ........+.+|+.+++.++|+||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999976 689999998754321  2233456788999999999999999999998764  568


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++++||+++++|.+++...+  .+++..+..++.|++.||.|||+++     ++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEECcccccc
Confidence            89999999999999987643  5889999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCce-eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQET-YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ........ .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.....      ...+......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~----  224 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQ----  224 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcC----
Confidence            65321110 111234688999999999888889999999999999999999999953211      1111111100    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                            . .....+...+..+.+++.+||. +|..|||+.++++|.
T Consensus       225 ------~-~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         225 ------P-TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             ------C-CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence                  0 0122344455669999999999 579999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7e-40  Score=295.38  Aligned_cols=247  Identities=24%  Similarity=0.334  Sum_probs=192.3

Q ss_pred             eecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHH---HHHhcCCCcceeEEEEEEcCCEEEEEEEecC
Q 018047           68 FLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVD---ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ  143 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (361)
                      +||+|+||.||+|... +++.||+|.+.............+..|..   .++...||+++.+++.+.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999876 68999999987654332222222333433   3444579999999999999999999999999


Q ss_pred             CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCce
Q 018047          144 KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET  223 (361)
Q Consensus       144 ~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (361)
                      +|+|.+++...  ..+++..+..++.|++.||+|||+.+     ++|+||||+||+++.++.++|+|||++..+....  
T Consensus        81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            99999998754  36999999999999999999999999     9999999999999999999999999987654322  


Q ss_pred             eeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccc
Q 018047          224 YVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL  302 (361)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                        .....|+..|+|||.+..+ .++.++||||+|+++|+|++|+.||............   ....        ....  
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~--------~~~~--  216 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL--------TMAV--  216 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhh--------ccCC--
Confidence              1234689999999988644 6889999999999999999999999654322211110   0000        0011  


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          303 SRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       303 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                         ..+...+..+.+++.+||..+|.+||     ++.+++++.+
T Consensus       217 ---~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~  257 (278)
T cd05606         217 ---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF  257 (278)
T ss_pred             ---CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence               11222355699999999999999999     9999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.6e-40  Score=299.98  Aligned_cols=269  Identities=26%  Similarity=0.332  Sum_probs=199.8

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KHRF  136 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~  136 (361)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+....... .....+.+|+.+++.++|+|++++++++.+.  +..+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            356999999999999999999986 69999999986543222 2223456799999999999999999998764  5789


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.|     ++|+||+|+||+++.++.++|+|||++..
T Consensus        85 lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF-----IIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECccceeee
Confidence            99999964 8888876542 46899999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-hhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-KKL  294 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  294 (361)
                      .......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....+   ......+....... ...
T Consensus       158 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~  232 (309)
T cd07845         158 YGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---IEQLDLIIQLLGTPNESI  232 (309)
T ss_pred             cCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChhh
Confidence            6543211  122345788999998754 5678999999999999999999999964332   22222111111000 000


Q ss_pred             -------hhhcCccccCCCC------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 -------RKVIDPELSRSSY------TMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 -------~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                             ...-...+.....      ....+..+.++|.+||+.||++|||++++++|-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~  292 (309)
T cd07845         233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY  292 (309)
T ss_pred             chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence                   0000000000000      0112456789999999999999999999998755

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.1e-41  Score=301.11  Aligned_cols=253  Identities=25%  Similarity=0.401  Sum_probs=207.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ++|...+.||+|+||.||+|... +|..+|+|++.............+..|+++++.++ ||||+++++++.+++..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888999999999999999976 69999999987654444455677888999999998 99999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++++|.+++.+.+  .+++..+..++.|++.||.+||+.|     ++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~-----~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG-----IIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999998753  7999999999999999999999999     9999999999999999999999999998664


Q ss_pred             CCCce------------------eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 018047          219 EGQET------------------YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNL  280 (361)
Q Consensus       219 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  280 (361)
                      .....                  .......++..|+|||......++.++|+||||++++++++|+.||.....   .  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~--  228 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---Y--  228 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---H--
Confidence            43211                  122234678899999998888899999999999999999999999964431   1  


Q ss_pred             HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 018047          281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSM----AECVKE  339 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~----~ell~~  339 (361)
                       .........             ....+...+..+.+++.+||+.+|++|||+    .++++|
T Consensus       229 -~~~~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         229 -LTFQKILKL-------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             -HHHHHHHhc-------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence             111111100             011222335568999999999999999999    888875

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-39  Score=289.59  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=206.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|...+.||+|+||.||++.+. +++.+++|++..... .......+..|+++++.++|||++++.+.+..++..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            4778889999999999999976 689999999875432 23445678889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          141 YMQKGNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |+++++|.+++....  ...+++..+..++.++++||.|||++|     ++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC-----EecccCChHHeEEcCCCcEEECCccceeecc
Confidence            999999999997643  357999999999999999999999999     9999999999999999999999999998764


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ...  .......|++.|+|||......++.++|+||||+++++|++|..||....      ...........       .
T Consensus       155 ~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~-------~  219 (258)
T cd08215         155 STV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKG-------Q  219 (258)
T ss_pred             cCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcC-------C
Confidence            432  12233468899999999888889999999999999999999999985332      11111111110       0


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .     ...+...+..+.+++.+||..+|++|||+.+++++
T Consensus       220 ~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 Y-----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             C-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0     11222344568999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=314.21  Aligned_cols=255  Identities=29%  Similarity=0.433  Sum_probs=210.6

Q ss_pred             CCCCceecccCceEEEEEEEc--CCC--EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR--SGE--VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ....++||+|+||+|++|.|.  +|+  .||||.+......  ....+|.+|+.+|.+|+|+|+++|||+..+ ....+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            344577999999999999987  455  5899998754332  267899999999999999999999999987 566799


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      ||+++.|||.+.+.......+....+..++.|||.|+.||.+++     +|||||...|+||.....|||+|||+.+.++
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr-----lvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR-----LVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh-----hhhhhhhhhhheecccceeeeecccceeccC
Confidence            99999999999998865668889999999999999999999999     9999999999999999999999999999998


Q ss_pred             CCCceeeeee-cccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          219 EGQETYVTAR-VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       219 ~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      .+........ ..-...|+|||.+....++.++|+|++||+||||+| |..||-...+                 ..+-+
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~  326 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILK  326 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHH
Confidence            7766554332 233568999999999999999999999999999999 5677754332                 11222


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      .+| .-.+-..+..|++.+.+++..||..+|++|||+..+.+.+-..
T Consensus       327 ~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  327 NID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             hcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            233 1122445677889999999999999999999999998655433

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.3e-40  Score=295.80  Aligned_cols=264  Identities=25%  Similarity=0.401  Sum_probs=199.6

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||.|++|+||+|+.. +|..||+|.+.....  ......+.+|+.+++.++|+|++++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            4788899999999999999987 689999999875432  2234566789999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          141 YMQKGNLQDHLNGIG-EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |+++ +|.+++.... ...+++..+..++.|++.||+|||+.|     ++|+||+|+||++++++.++|+|||++.....
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-----VLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            9985 8988886543 346899999999999999999999999     99999999999999999999999999976543


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-------  291 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  291 (361)
                      ...  ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||......   .....+.......       
T Consensus       153 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07836         153 PVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE---DQLLKIFRIMGTPTESTWPG  227 (284)
T ss_pred             Ccc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhHHH
Confidence            221  1122356889999997754 45688999999999999999999999644321   1111111100000       


Q ss_pred             -hhhhhhcCccccC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          292 -KKLRKVIDPELSR------SSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       292 -~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                       ..... .......      .......+..+.+++.+||+.||.+||++.+++++
T Consensus       228 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         228 ISQLPE-YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             HhcCch-hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             00000 0000000      00111234568899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=284.69  Aligned_cols=252  Identities=24%  Similarity=0.442  Sum_probs=199.4

Q ss_pred             CCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEEEec
Q 018047           65 DDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      .+..||.|+-|+|++++.+ +|...|||.+...  ...+....+...+.++.... +|.||+.+|+|..+..+++.||.|
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            3456999999999999987 6899999999765  44455677788888877764 899999999999999999999998


Q ss_pred             CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCc
Q 018047          143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE  222 (361)
Q Consensus       143 ~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (361)
                      .. .+..++... ..++++..+-++...+++||.||..+.    .|+|||+||+|||+|+.|++||||||++-.+-+...
T Consensus       174 s~-C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH----~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  174 ST-CAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH----GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc----ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            43 556665543 347999999999999999999998876    399999999999999999999999999988766543


Q ss_pred             eeeeeecccccCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          223 TYVTARVLGTFGYFDPEYTST---GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                         .....|-+.|||||-+..   ..|+.++||||||++++||+||..||.....    ++.. +..+.++       ..
T Consensus       248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----dFe~-ltkvln~-------eP  312 (391)
T KOG0983|consen  248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----DFEV-LTKVLNE-------EP  312 (391)
T ss_pred             ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----cHHH-HHHHHhc-------CC
Confidence               334568899999997754   4688999999999999999999999964321    1211 1111111       11


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      |.+.   .....+..+.+++..||..|+.+||...++++|-..
T Consensus       313 P~L~---~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi  352 (391)
T KOG0983|consen  313 PLLP---GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFI  352 (391)
T ss_pred             CCCC---cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcce
Confidence            2222   122256679999999999999999999999988643

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.8e-40  Score=294.58  Aligned_cols=261  Identities=23%  Similarity=0.294  Sum_probs=194.5

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcC--CEEEEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADG--KHRFLV  138 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv  138 (361)
                      |++.+.||+|+||.||+|... +++.+|+|++.... .... .....+|+.++.++. |+|++++++++.++  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~-~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc-CCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            567788999999999999976 68999999886532 1222 223456888999885 99999999999987  899999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||++ |+|.+++.... ..+++..+..++.|++.||+|||+.+     ++|+||+|+||+++. +.++|+|||++..+.
T Consensus        79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG-----IFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            99997 58888876532 36899999999999999999999999     999999999999999 999999999998764


Q ss_pred             CCCceeeeeecccccCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh-hhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK-KLRK  296 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  296 (361)
                      ....   .....++..|+|||.+. ...++.++|||||||++|||++|..||...+.   ............... ....
T Consensus       151 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07831         151 SKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLK  224 (282)
T ss_pred             cCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHH
Confidence            3322   12245788999999654 45678899999999999999999999964332   111111111110000 0000


Q ss_pred             hc------CccccC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          297 VI------DPELSR------SSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       297 ~~------~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .+      ....+.      .......+..+.+++.+||+.+|++|||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00      000000      00012345779999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=291.19  Aligned_cols=246  Identities=23%  Similarity=0.324  Sum_probs=189.9

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHH-hcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILS-RLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.||+|+||.||+|... +|+.||+|.+.............+..|..++. ..+|+|++++++++..++..|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999976 68999999986543222223334455555544 45899999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      ++|.+++....  .+++..+..++.|++.||.|||+.+     ++|+||+|+||+++.++.++|+|||++.....     
T Consensus        82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG-----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            99999997643  6899999999999999999999999     99999999999999999999999999875432     


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                       .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.....   .....   .........    .     
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~---~~~~~~~~~----~-----  213 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFD---NILSRRINW----P-----  213 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHhcccCC----C-----
Confidence             1224578899999998888889999999999999999999999953321   11111   111110000    0     


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSM---AECVKEL  340 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~---~ell~~l  340 (361)
                      .......+..+.+++.+||+.||++||++   .|++.|.
T Consensus       214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~  252 (260)
T cd05611         214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP  252 (260)
T ss_pred             CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence            11112334568999999999999999966   4555553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.6e-39  Score=300.02  Aligned_cols=262  Identities=21%  Similarity=0.332  Sum_probs=196.8

Q ss_pred             ceeccc--CceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecC
Q 018047           67 NFLGKG--GFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ  143 (361)
Q Consensus        67 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (361)
                      ..||+|  +||+||++.+. +|+.||+|++...... ....+.+.+|+.+++.++||||++++++|..++..++||||++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            346666  99999999976 7999999998754322 2345678889999999999999999999999999999999999


Q ss_pred             CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCce
Q 018047          144 KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET  223 (361)
Q Consensus       144 ~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (361)
                      +|+|.+++.......+++..+..++.|++.||+|||+.|     ++||||||+||+++.++.++++||+.+.........
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG-----YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            999999998765556899999999999999999999999     999999999999999999999999865433221110


Q ss_pred             -ee----eeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh----
Q 018047          224 -YV----TARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK----  292 (361)
Q Consensus       224 -~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  292 (361)
                       ..    .....++..|+|||++.+  ..++.++|||||||++|+|++|+.||......  .    ..........    
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~----~~~~~~~~~~~~~~  231 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--Q----MLLQKLKGPPYSPL  231 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--H----HHHHHhcCCCCCCc
Confidence             00    001234567999998865  34788999999999999999999999643211  0    0000000000    


Q ss_pred             -----------------hhh--------------hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 -----------------KLR--------------KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 -----------------~~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                                       ...              ......+ ........+..+.+|+++||+.||++|||+.|++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             cccccchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence                             000              0000000 11123345677899999999999999999999998877

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.3e-40  Score=297.14  Aligned_cols=268  Identities=22%  Similarity=0.347  Sum_probs=199.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|++|+||+|... +|+.||+|.+...... ......+.+|+++++.++||||+++++++.++...|+||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            46888999999999999999977 6899999998654322 223456778999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-CCcEEEeecCccccCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLMP  218 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~~~  218 (361)
                      ||++ ++|.+++.......+++..+..++.|++.||+|||+++     ++|+||+|+||+++. ++.+||+|||++....
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            9996 58888886655555788899999999999999999999     999999999999985 5679999999997653


Q ss_pred             CCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-h----
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-K----  292 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~----  292 (361)
                      ....  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......   .....+....... .    
T Consensus       155 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~  229 (294)
T PLN00009        155 IPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETWP  229 (294)
T ss_pred             CCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhcc
Confidence            3211  1122456889999998755 45788999999999999999999999643221   1111110000000 0    


Q ss_pred             ---hhhhh--cCccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          293 ---KLRKV--IDPELSR---SSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       293 ---~~~~~--~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                         .+...  ..+....   .......+..+.+++.+||+.+|++||++.+++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~  285 (294)
T PLN00009        230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE  285 (294)
T ss_pred             ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence               00000  0000000   001112345588999999999999999999999864

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.7e-40  Score=300.71  Aligned_cols=269  Identities=23%  Similarity=0.322  Sum_probs=195.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC------
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK------  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  133 (361)
                      ++|+..+.||+|+||.||+|... +++.||||.+...... ......+.+|+.+++.++||||+++++++...+      
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            46999999999999999999977 6899999998654322 222334567999999999999999999987643      


Q ss_pred             --EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          134 --HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       134 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                        ..++||||+.+ +|.+++.... ..+++..++.++.|+++||+|||++|     ++|+||+|+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK-----ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEECCCCcEEECcC
Confidence              45999999964 8888876542 36899999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCce--eeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          212 GLAKLMPEGQET--YVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       212 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      |++..+......  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......   .....+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~---~~~~~~~~~~  240 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ---HQLTLISQLC  240 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence            999866433211  111234578889999987554 4688999999999999999999998644321   1111111111


Q ss_pred             hhh--------hhhhhhcCccccCCC---C-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          289 NDR--------KKLRKVIDPELSRSS---Y-----TMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       289 ~~~--------~~~~~~~~~~~~~~~---~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ...        ......-........   .     .......+.+++.+||+.||.+|||++|+++|-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~  308 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD  308 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence            000        000000000000000   0     001123567999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-39  Score=338.33  Aligned_cols=271  Identities=28%  Similarity=0.496  Sum_probs=211.2

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      .....|...++||+|+||.||+|... ++..||||++.....       ....|++.+++++|||||++++++.+++..|
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            33456888899999999999999975 789999998853211       1124688999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++|+|.+++.     .++|..+..++.|++.||+|||+..  ..+++||||||+||+++.++..++. ||....
T Consensus       760 lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        760 LIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRC--SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             EEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCC--CCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            9999999999999985     3789999999999999999999442  1129999999999999999888775 665543


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ....      ....||+.|+|||++....++.++|||||||++|||+||+.||....+. ......+.+.... ......
T Consensus       832 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~  903 (968)
T PLN00113        832 LCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYS-DCHLDM  903 (968)
T ss_pred             cccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcC-ccchhh
Confidence            2211      1235789999999999899999999999999999999999999543332 2233344333222 223444


Q ss_pred             hcCccccCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 018047          297 VIDPELSRS-SYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGL  351 (361)
Q Consensus       297 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~  351 (361)
                      .+++.+... ..+.....++.+++.+||+.||++|||+.|+++.|+++....+.+.
T Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~  959 (968)
T PLN00113        904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCV  959 (968)
T ss_pred             eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccc
Confidence            555554322 2345666788999999999999999999999999999987665443

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-40  Score=305.10  Aligned_cols=268  Identities=22%  Similarity=0.340  Sum_probs=198.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----C
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----K  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  133 (361)
                      .++|++.+.||+|+||+||+|.+. +|+.||+|.+...  ........+..|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            467999999999999999999876 6899999998532  2233455677899999999999999999887543     3


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..|+++||+++ +|.+++..   ..+++..+..++.|+++||+|||++|     ++||||||+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             eEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEECCCCCEEECcccc
Confidence            58999999964 88887754   36899999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCcee-eeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          214 AKLMPEGQETY-VTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       214 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      +.......... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.   ......+.......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~  229 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTP  229 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCC
Confidence            97654322111 1123468899999997644 5688999999999999999999999954321   11111111111000


Q ss_pred             --hhhhhhcCc-------ccc-CCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 --KKLRKVIDP-------ELS-RSSY-----TMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 --~~~~~~~~~-------~~~-~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                        .........       ... ....     ....+..+.+++.+||+.||++|||+.|+++|-.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~  294 (336)
T cd07849         230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY  294 (336)
T ss_pred             CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence              000000000       000 0000     0122456889999999999999999999999944

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.5e-39  Score=290.05  Aligned_cols=251  Identities=22%  Similarity=0.308  Sum_probs=194.8

Q ss_pred             HHHHHHcCCCCCCcee--cccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEE
Q 018047           54 KEMEEATCSFSDDNFL--GKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYC  129 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  129 (361)
                      .+.....++|.+.+.+  |+|+||.||++..+ ++..+|+|.+.......        .|+.....+ +|||++++++.+
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEE
Confidence            3344445567776666  99999999999976 68899999986532211        123233323 699999999999


Q ss_pred             EcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-cEEE
Q 018047          130 ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-EAKI  208 (361)
Q Consensus       130 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-~~kl  208 (361)
                      ..++..|+||||+++|+|.+++....  .+++..+..++.|+++||.|||+.|     ++||||+|+||+++.++ .++|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN-----IIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEEeCCCCeEEE
Confidence            99999999999999999999997643  7999999999999999999999999     99999999999999998 9999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      +|||++.......      ...|+..|+|||++....++.++||||||+++|+|++|+.||...... .... ..+....
T Consensus       152 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~-~~~~~~~  223 (267)
T PHA03390        152 CDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDL-ESLLKRQ  223 (267)
T ss_pred             ecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhH-HHHHHhh
Confidence            9999987664322      235789999999998888999999999999999999999999733221 1111 1111100


Q ss_pred             hhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHH
Q 018047          289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPS-MAECVKEL  340 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~ell~~l  340 (361)
                                ...   .......+..+.+++.+||+.+|.+||+ ++|+++|-
T Consensus       224 ----------~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~  263 (267)
T PHA03390        224 ----------QKK---LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP  263 (267)
T ss_pred             ----------ccc---CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence                      000   1112244566899999999999999996 69998763

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-39  Score=296.04  Aligned_cols=267  Identities=21%  Similarity=0.305  Sum_probs=196.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCE----
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKH----  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~----  134 (361)
                      ++|+..+.||+|+||.||+|.+. +++.||+|.+..... .......+.+|+.+++.++ ||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            36888999999999999999976 689999998865422 2223456778999999995 6999999999877655    


Q ss_pred             -EEEEEEecCCCchhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-CCcEEEe
Q 018047          135 -RFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKIS  209 (361)
Q Consensus       135 -~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-~~~~kl~  209 (361)
                       .|+||||+++ +|.+++....   ...+++..++.++.|+++||+|||+++     ++||||+|+||+++. ++.++|+
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dl~~~nil~~~~~~~~kl~  153 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-----VMHRDLKPQNLLVDKQKGLLKIA  153 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChHHEEEecCCCeEEEe
Confidence             8999999985 8888875432   236899999999999999999999999     999999999999998 8999999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      |||++..+......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......   .....+....
T Consensus       154 dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~  228 (295)
T cd07837         154 DLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---QQLLHIFKLL  228 (295)
T ss_pred             ecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHh
Confidence            99999765332211  112356888999997754 45789999999999999999999999643221   1111110000


Q ss_pred             hhhhh--------hhhhc-CccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          289 NDRKK--------LRKVI-DPELSR---SSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       289 ~~~~~--------~~~~~-~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .....        ..... .+....   .......+..+.++|.+||..||++|||+.|++.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000        00000 000000   00011244568999999999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.8e-40  Score=290.84  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=205.0

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|++.+.||+|+||.||++... +++.+|+|.+...... ......+..|+.+++.++|+||+++.+++.+....++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            4778899999999999999876 6889999998754332 2335567789999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          141 YMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       141 ~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |+++++|.+++...  ....+++..+..++.|++.||+|||+.|     ++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~-----i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK-----ILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            99999999998652  1346899999999999999999999999     9999999999999999999999999998765


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ...    .....+++.|+|||.+....++.++|+||||+++|+|++|+.||.....   ......+   ..  .      
T Consensus       155 ~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~~--~------  216 (256)
T cd08530         155 KNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKV---QR--G------  216 (256)
T ss_pred             cCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---hc--C------
Confidence            441    2224578899999999888899999999999999999999999954321   1111110   00  0      


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                        .  ....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       217 --~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         217 --K--YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --C--CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              0  012233556679999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-40  Score=327.58  Aligned_cols=257  Identities=27%  Similarity=0.395  Sum_probs=192.2

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC---
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG---  132 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  132 (361)
                      .....+|+...+||+||||.||+++++ +|..||||++....  .......+.+|+.++.+|+|||||+++..+.+.   
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence            345567889999999999999999998 89999999998764  455667888999999999999999987433110   


Q ss_pred             --------------------------------------------------------------------------------
Q 018047          133 --------------------------------------------------------------------------------  132 (361)
Q Consensus       133 --------------------------------------------------------------------------------  132 (361)
                                                                                                      
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------------------CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHH
Q 018047          133 ------------------------------------KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA  176 (361)
Q Consensus       133 ------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~  176 (361)
                                                          -.+||-||||+...|.+++..... .-.....++++++|++||.
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHHHHHHHH
Confidence                                                125889999998777777765321 1146788999999999999


Q ss_pred             HHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC----------------CCCceeeeeecccccCccCccc
Q 018047          177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP----------------EGQETYVTARVLGTFGYFDPEY  240 (361)
Q Consensus       177 ~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~  240 (361)
                      |+|++|     +|||||||.|||+|+++.|||+|||+|+...                .+.........+||..|+|||+
T Consensus       712 YIH~~g-----iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  712 YIHDQG-----IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHhCc-----eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            999999     9999999999999999999999999998721                0111123345689999999998


Q ss_pred             ccCC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHH
Q 018047          241 TSTG---KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFAN  317 (361)
Q Consensus       241 ~~~~---~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  317 (361)
                      +...   .|+.|+||||||+|++||+.   ||...     ..-+..+..+.  .+.+...  +.+     .......=..
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-----MERa~iL~~LR--~g~iP~~--~~f-----~~~~~~~e~s  849 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS-----MERASILTNLR--KGSIPEP--ADF-----FDPEHPEEAS  849 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCch-----HHHHHHHHhcc--cCCCCCC--ccc-----ccccchHHHH
Confidence            7654   49999999999999999987   46422     11122221111  1112111  111     1112223467


Q ss_pred             HHHHccCCCCCCCCCHHHHHH
Q 018047          318 LASRCVRTESSERPSMAECVK  338 (361)
Q Consensus       318 li~~cl~~dp~~Rpt~~ell~  338 (361)
                      +|++|++.||++|||+.|+|.
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhh
Confidence            999999999999999999986

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=291.31  Aligned_cols=264  Identities=24%  Similarity=0.361  Sum_probs=198.4

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc---CCCcceeEEEEEEcCCE----
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL---DHPNLVSLIGYCADGKH----  134 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~----  134 (361)
                      |++.+.||+|+||.||+|.++ +++.+|+|++..... .......+.+|+.+++.+   +|||++++++++.+.+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            567789999999999999987 589999999975432 222234566788777766   59999999999988776    


Q ss_pred             -EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          135 -RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       135 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                       .+++|||+++ +|.+++.......+++..++.++.|+++||.|||+.+     ++|+||+|+||+++.++.++|+|||+
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~-----i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR-----IVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCChhhEEEccCCCEEEeccCc
Confidence             9999999974 8999887654457999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      +........   .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......   .....+-........
T Consensus       154 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  227 (287)
T cd07838         154 ARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSE  227 (287)
T ss_pred             ceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCCh
Confidence            987643321   12234788999999998888999999999999999999999998643321   111111110000000


Q ss_pred             hh---------hhcCcccc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          294 LR---------KVIDPELS--RSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       294 ~~---------~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ..         ........  ........+..+.+++.+||+.||++||++.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            00         00000000  011112345678899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=311.79  Aligned_cols=275  Identities=25%  Similarity=0.364  Sum_probs=213.2

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC------CE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG------KH  134 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~  134 (361)
                      .|...+.||+|+||.||+|+++ +|+.||||.++...  .....+...+|+++|++++|+|||+++++-+..      ..
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            3566678999999999999976 79999999997653  334456788899999999999999999986543      35


Q ss_pred             EEEEEEecCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC--CC--cEEEe
Q 018047          135 RFLVYEYMQKGNLQDHLNGI-GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA--NF--EAKIS  209 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~--~~--~~kl~  209 (361)
                      ..+|||||++|||...+++- +...+++..++.++.+++.||.|||.+|     |+||||||.||++..  +|  ..||+
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~-----IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG-----IVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEEeecCCCceEEeee
Confidence            68999999999999999864 3457999999999999999999999999     999999999999853  33  48999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      |||+|+.+.++.   ...+..||+.|.+||... .+.|+..+|.|||||++|+++||..||....+........+. .+.
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~-~~t  242 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH-IIT  242 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh-hhc
Confidence            999999987665   455678999999999988 588999999999999999999999999765543221111111 111


Q ss_pred             hhhhhhhhhcCc----------ccc-CCCCCHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHHHHhhc
Q 018047          289 NDRKKLRKVIDP----------ELS-RSSYTMESIAMFANLASRCVRTESSERP--SMAECVKELQLIIYTN  347 (361)
Q Consensus       289 ~~~~~~~~~~~~----------~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rp--t~~ell~~l~~i~~~~  347 (361)
                      ...........+          .++ ...........+...+..+|..+|++|-  ...++...+..|++..
T Consensus       243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence            111000000000          011 1223344456778889999999999998  8889999999988764

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-39  Score=285.62  Aligned_cols=250  Identities=26%  Similarity=0.482  Sum_probs=205.0

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|+..+.||+|++|.||++... +++.+++|.+...... ......+.+|+++++.++|+|++++++++.+++..+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            4778899999999999999876 6889999999765432 2345678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++...  ..+++..+..++.|++.||.+||+.|     ++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG-----VIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            99999999999765  47899999999999999999999999     999999999999999999999999999877544


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ...  .....++..|+|||......++.++|+||||+++|+|++|..||.....     ..........        .. 
T Consensus       153 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~--------~~-  216 (254)
T cd06627         153 SKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFRIVQD--------DH-  216 (254)
T ss_pred             ccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhcc--------CC-
Confidence            321  2234678899999988777788999999999999999999999863321     1111110000        00 


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                          ...+...+..+.+++.+||..+|++|||+.+++.+
T Consensus       217 ----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         217 ----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             ----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                11222334568999999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.8e-40  Score=292.41  Aligned_cols=247  Identities=26%  Similarity=0.408  Sum_probs=197.2

Q ss_pred             ecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCch
Q 018047           69 LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL  147 (361)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  147 (361)
                      ||.|+||.||++... +|+.+++|.+.............+.+|+.+++.++|||++++++.+..+...|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 5999999998755443345567788899999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCc-----
Q 018047          148 QDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE-----  222 (361)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----  222 (361)
                      .+++.+.+  .+++..+..++.|+++||+|||+++     ++|+||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~-----i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG-----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC-----eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            99997654  7899999999999999999999999     99999999999999999999999999876533211     


Q ss_pred             -eeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          223 -TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       223 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                       ........++..|+|||.......+.++|+||||+++|+|++|..||.....   .   ..........          
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~---~~~~~~~~~~----------  217 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---E---EIFQNILNGK----------  217 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHhcCC----------
Confidence             1122334678899999998888889999999999999999999999954321   1   1111111100          


Q ss_pred             ccCCCCCHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          302 LSRSSYTME--SIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       302 ~~~~~~~~~--~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .   ..+..  .+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       218 ~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         218 I---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             c---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            0   01111  2556899999999999999999944444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.2e-39  Score=294.63  Aligned_cols=247  Identities=30%  Similarity=0.446  Sum_probs=196.8

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |...+.||+|+||+||+|+.. +|+.+++|++.............+.+|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666778999999999999976 6899999998765444444456788899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +. |+|.+++.... ..+++..+..++.|++.||.|||++|     ++|+||+|+||+++.++.++|+|||++...... 
T Consensus       103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g-----i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-  174 (313)
T cd06633         103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-  174 (313)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence            96 57877775432 36899999999999999999999999     999999999999999999999999998643221 


Q ss_pred             ceeeeeecccccCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          222 ETYVTARVLGTFGYFDPEYTS---TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                           ....|+..|+|||++.   ...++.++||||||+++|+|++|..||.....      ..........       .
T Consensus       175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~-------~  236 (313)
T cd06633         175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-------D  236 (313)
T ss_pred             -----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc-------C
Confidence                 2346788999999873   45688899999999999999999999854321      1111111100       0


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .+..    .....+..+.+++.+||+.+|.+||++.+++++
T Consensus       237 ~~~~----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 SPTL----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111    111223458899999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.2e-40  Score=302.33  Aligned_cols=277  Identities=21%  Similarity=0.324  Sum_probs=204.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc----CCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD----GKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~  135 (361)
                      .+|++.+.||+|++|.||+|... +|+.||+|++..... .......+.+|+.+++.++||||+++++++..    ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            57999999999999999999976 699999999875422 22334567789999999999999999988753    4578


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||+. |+|.+++...  ..+++..+..++.|++.||+|||+++     ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999995 6899998654  35999999999999999999999999     9999999999999999999999999997


Q ss_pred             cCCCCCce--eeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh--
Q 018047          216 LMPEGQET--YVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND--  290 (361)
Q Consensus       216 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--  290 (361)
                      ........  .......|+..|+|||.+.. ..++.++||||||+++|+|++|+.||.......   ....+......  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~  232 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPS  232 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCCh
Confidence            65432211  11223468899999998755 468899999999999999999999995432211   11110000000  


Q ss_pred             --------hhhhhhhcCccccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          291 --------RKKLRKVIDPELSRSSY-----TMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       291 --------~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                              ...+.......-.....     ....+..+.+++.+||+.+|++|||+.+++.+.+-.-.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                    00000000000000111     122356799999999999999999999999988754444333

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-39  Score=301.08  Aligned_cols=268  Identities=24%  Similarity=0.340  Sum_probs=201.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----C
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----K  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  133 (361)
                      ..+|.+.+.||+|+||+||+|... +++.||||.+.... ........+..|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            457899999999999999999976 68999999986542 2223345667899999999999999999987654     3


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..|+++||+. ++|.+++...  ..+++..+..++.|++.||.|||+++     ++|+||||+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEECcCcc
Confidence            5899999996 6899988764  36999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-  291 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  291 (361)
                      +.......  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+.   ......+....... 
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~  229 (337)
T cd07858         155 ARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY---VHQLKLITELLGSPS  229 (337)
T ss_pred             ccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCC
Confidence            98664332  12233467889999997754 4688999999999999999999999964321   11111111110000 


Q ss_pred             ---------hhhhh---hcC--ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 ---------KKLRK---VID--PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 ---------~~~~~---~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                               .....   .+.  +...........+..+.+++++||+.+|++|||++++++|-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~  293 (337)
T cd07858         230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY  293 (337)
T ss_pred             hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence                     00000   000  000000011234566899999999999999999999999954

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-42  Score=338.13  Aligned_cols=258  Identities=25%  Similarity=0.374  Sum_probs=209.0

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ..+-+|..+.+||.|.||.||-|... +|...|+|.+...... ......+.+|..++..++|||+|+++|+-.+.+..+
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34456788899999999999999966 6999999988765433 555667888999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      |.||||.+|+|.+.++..+  ..++.....+..|++.|++|||++|     ||||||||+||+++.+|.+|++|||.|..
T Consensus      1311 IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g-----IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG-----IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC-----ceecCCCccceeeecCCcEEeecccceeE
Confidence            9999999999999997643  5677777778899999999999999     99999999999999999999999999998


Q ss_pred             CCCCCcee--eeeecccccCccCcccccCC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          217 MPEGQETY--VTARVLGTFGYFDPEYTSTG---KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       217 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      +.......  ......||+-|||||++.+.   ....++|||||||++.||+||+.||...+.      .+++.-.+.. 
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~V~~- 1456 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYHVAA- 1456 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhHHhc-
Confidence            76542111  12246799999999988653   456789999999999999999999953321      1111111110 


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      +          .....|...+.+-.+++..||..||+.|-++.|++++=
T Consensus      1457 g----------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1457 G----------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             c----------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            0          01345556777889999999999999999999888763

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.5e-39  Score=295.23  Aligned_cols=247  Identities=25%  Similarity=0.385  Sum_probs=198.1

Q ss_pred             CceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           66 DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      ...||+|+||.||++... +|+.+|+|++...   .......+.+|+.+++.++|+|++++++.+..++..+++|||+++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            356999999999999876 6899999987532   233456788899999999999999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      ++|.+++...   .+++..+..++.|++.||+|||+.|     ++|+||+|+||+++.++.++|+|||++........  
T Consensus       102 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g-----ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--  171 (292)
T cd06657         102 GALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  171 (292)
T ss_pred             CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEcccccceecccccc--
Confidence            9999987542   5899999999999999999999999     99999999999999999999999999876543221  


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                      ......|++.|+|||.+....++.++|+||||+++|+|++|..||.....   ......+.          ....+.+. 
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~----------~~~~~~~~-  237 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIR----------DNLPPKLK-  237 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----------hhCCcccC-
Confidence            12234688999999998888889999999999999999999999863221   11111111          01111111 


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                        .....+..+.+++.+||+.||.+||++.+++++-.
T Consensus       238 --~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~  272 (292)
T cd06657         238 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  272 (292)
T ss_pred             --CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence              11123445889999999999999999999999744

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=292.02  Aligned_cols=266  Identities=23%  Similarity=0.372  Sum_probs=200.1

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CEEEEEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KHRFLVY  139 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~  139 (361)
                      |++.+.||+|++|.||+|... +++.+|+|.+.... ........+.+|+.+++.++|+|++++++++.+.  +..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            567788999999999999987 58999999997653 2233345678899999999999999999999888  8999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++ +|.+++.... ..+++..++.++.|+++||+|||+.|     ++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~-----~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          80 EYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG-----ILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             ccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            99975 8998886642 47899999999999999999999999     99999999999999999999999999987654


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh-----h
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK-----K  293 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~  293 (361)
                      .... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......   .....+........     .
T Consensus       153 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07840         153 RNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPG  228 (287)
T ss_pred             CCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhccc
Confidence            4321 1222356788999997654 46789999999999999999999999643321   11111111100000     0


Q ss_pred             hhh-----hcCcccc-----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          294 LRK-----VIDPELS-----RSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       294 ~~~-----~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ...     ...+...     ........+..+.+++.+||+.+|++||++.+++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~  285 (287)
T cd07840         229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE  285 (287)
T ss_pred             cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence            000     0000000     0001111255689999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.1e-39  Score=298.37  Aligned_cols=270  Identities=25%  Similarity=0.362  Sum_probs=200.2

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc--CCE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD--GKH  134 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~  134 (361)
                      +.++|++.+.||+|+||.||+|.+. +|+.+|+|++.... ........+.+|+.++.++ +||||+++++++..  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            3457889999999999999999976 68899999885432 2223345677899999999 99999999999864  347


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .|+||||++ ++|.+++...   .+++..+..++.|++.||+|||+.|     ++|+||+|+||+++.++.++|+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~-----i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN-----VIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEEeeccch
Confidence            899999997 5999988653   6888999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCce---eeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          215 KLMPEGQET---YVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       215 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      ..+......   .......|+..|+|||.+.. ..++.++|+||||+++|+|++|+.||.......   ...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~  231 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGP  231 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Confidence            866443221   12233568899999997654 567889999999999999999999996433211   11111000000


Q ss_pred             -------------hhhhhhhcCc-cc-cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 -------------RKKLRKVIDP-EL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 -------------~~~~~~~~~~-~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                                   ...+...+.. .. .........+..+.+++.+||+.||++|||+.+++++-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~  297 (337)
T cd07852         232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY  297 (337)
T ss_pred             CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence                         0000000000 00 000001113566899999999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.3e-39  Score=296.31  Aligned_cols=252  Identities=30%  Similarity=0.427  Sum_probs=199.3

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |...+.||+|+||.||+|+.. ++..+|+|.+............++.+|+++++.++|+|++++.+++.+....++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            666778999999999999976 6889999998654333334455678899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +. |+|.+++.... ..+++..+..++.|++.|+.|||+++     ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        97 ~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          97 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             cC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            96 58887775432 36889999999999999999999999     999999999999999999999999998765322 


Q ss_pred             ceeeeeecccccCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          222 ETYVTARVLGTFGYFDPEYTS---TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                           ....|++.|+|||.+.   ...++.++|||||||++|+|++|..||.....      ..........       .
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~-------~  230 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-------E  230 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhhc-------C
Confidence                 1235788999999863   35678899999999999999999999853211      0111111100       0


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      .+    .......+..+.+++.+||+.+|++||++.+++++.+...
T Consensus       231 ~~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         231 SP----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             CC----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            01    1112234456899999999999999999999999877554

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=292.17  Aligned_cols=264  Identities=23%  Similarity=0.353  Sum_probs=202.0

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |...+.||+|++|.||+|... +++.+++|.+...... ......+..|+.+++.++|+||+++++++.+++..++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            566788999999999999976 6899999998654322 23356778899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++ +|.+++.... ..+++..+..++.|++.||.|||+++     ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          80 MDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG-----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             cCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            975 8888886643 47899999999999999999999999     9999999999999999999999999998765443


Q ss_pred             ceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-h----hhh
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-K----KLR  295 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~----~~~  295 (361)
                      .  ......++..|+|||.+... .++.++|+||||+++|+|++|+.||......   ............. .    .+.
T Consensus       153 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd05118         153 R--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTPDPEVWPKFT  227 (283)
T ss_pred             c--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCchHhcccch
Confidence            1  12234578899999987666 7889999999999999999999998543321   1111111110000 0    000


Q ss_pred             h-------hcC--ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          296 K-------VID--PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       296 ~-------~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .       .+.  ............+..+.+++.+||+.||.+||++.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            0       000  0000011122456789999999999999999999999976

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.3e-39  Score=295.97  Aligned_cols=261  Identities=19%  Similarity=0.267  Sum_probs=193.0

Q ss_pred             CceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCchhhhc
Q 018047           73 GFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL  151 (361)
Q Consensus        73 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l  151 (361)
                      ++|.||.++.. +++.||+|++..... .......+..|+.+++.++|+||+++++++.+.+..+++|||+++|+|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            44555555544 599999999976432 3345678999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCce-----eee
Q 018047          152 NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET-----YVT  226 (361)
Q Consensus       152 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----~~~  226 (361)
                      .......+++..+..++.|+++||+|||+++     |+|+||||+||+++.++.++|+|||.+..+......     ...
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~-----ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~  165 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKG-----FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP  165 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence            8654456899999999999999999999999     999999999999999999999999988755322110     111


Q ss_pred             eecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh----------hhhhh
Q 018047          227 ARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN----------DRKKL  294 (361)
Q Consensus       227 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~  294 (361)
                      ....++..|+|||.+..  ..++.++|+|||||++|+|++|..||...+..  ............          .....
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhhcCCc
Confidence            22356778999998765  45788999999999999999999999643221  111111100000          00000


Q ss_pred             hh----hcCc---cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RK----VIDP---ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~----~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..    ...+   ..............+.+++.+||+.||++|||+++++++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF  297 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence            00    0000   00011223344567889999999999999999999999887

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.7e-39  Score=294.13  Aligned_cols=254  Identities=24%  Similarity=0.426  Sum_probs=196.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ++|++.+.||+|+||+||+|.+. +++.||||.+.....  ......+..|+.++..+. ||||+++++++.+....|++
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            46888999999999999999987 489999999875422  223445666787777764 99999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      |||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+     ++||||+|+||+++.++.++|+|||++..+
T Consensus        93 ~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~-----i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          93 MELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             eeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC-----EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            99985 47777765533 378999999999999999999997 57     999999999999999999999999999766


Q ss_pred             CCCCceeeeeecccccCccCcccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGK----LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      ......   ....++..|+|||.+....    ++.++||||||+++|+|++|+.||.....    . ...........  
T Consensus       166 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~-~~~~~~~~~~~--  235 (296)
T cd06618         166 VDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----E-FEVLTKILQEE--  235 (296)
T ss_pred             cCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----H-HHHHHHHhcCC--
Confidence            433221   2235788999999876543    78899999999999999999999953211    0 11111111110  


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           .+..   ......+..+.+++.+||+.||++||++.+++++.+
T Consensus       236 -----~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         236 -----PPSL---PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             -----CCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence                 0111   011123456899999999999999999999999876

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.4e-39  Score=293.40  Aligned_cols=270  Identities=26%  Similarity=0.336  Sum_probs=200.1

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC---
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK---  133 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---  133 (361)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|.+...... ......+.+|+.+++.++|||++++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            34567999999999999999999987 5899999998754322 223346678999999999999999999987654   


Q ss_pred             -------EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcE
Q 018047          134 -------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA  206 (361)
Q Consensus       134 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~  206 (361)
                             ..++|+||+++ +|.+++.+. ...+++..+..++.|++.||+|||+.+     ++|+||+|+||+++.++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN-----FLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCcE
Confidence                   78999999976 777777654 347899999999999999999999999     9999999999999999999


Q ss_pred             EEeecCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 018047          207 KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      ||+|||++..+...... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.....   ......+.
T Consensus       156 kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~  231 (302)
T cd07864         156 KLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELIS  231 (302)
T ss_pred             EeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHH
Confidence            99999999876443321 1112345778999997754 4568899999999999999999999964322   22222222


Q ss_pred             HHhhhhhh--hhhhc--------Cccc--cC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          286 HILNDRKK--LRKVI--------DPEL--SR--SSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       286 ~~~~~~~~--~~~~~--------~~~~--~~--~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ........  .....        ++..  ..  .......+..+.+++.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            21111000  00000        0000  00  00001134568999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.2e-39  Score=290.83  Aligned_cols=256  Identities=25%  Similarity=0.356  Sum_probs=200.4

Q ss_pred             CCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCC-cchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFK-EADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  135 (361)
                      +|++.+.||.|+||.||.+...    +|+.||+|.+...... .......+.+|+.++..+ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4778899999999999999863    5889999998654322 223345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |+||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|     ++||||+|+|||++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999999764  36889999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      ....... .......|+..|+|||.+..  ..++.++||||||+++|+|++|..||.......  .............  
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~--  228 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE--  228 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC--
Confidence            6643321 12233568899999998764  346788999999999999999999996432211  1111111111110  


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKEL  340 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l  340 (361)
                                 ...+...+..+.+++.+||+.||++||     ++.+++.+-
T Consensus       229 -----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~  269 (290)
T cd05613         229 -----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP  269 (290)
T ss_pred             -----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCc
Confidence                       112223345688999999999999997     788888873

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=289.88  Aligned_cols=262  Identities=17%  Similarity=0.213  Sum_probs=185.1

Q ss_pred             cCCCCCCceecccCceEEEEEEEcC----CCEEEEEEeecCCCCcchh--------HHHHHHHHHHHHhcCCCcceeEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADG--------EHEFRVEVDILSRLDHPNLVSLIG  127 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~  127 (361)
                      .++|.+.+.||+|+||+||+|...+    +..+|+|+...........        ......+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3579999999999999999999763    4566777543221110000        011122344556678999999998


Q ss_pred             EEEcCC----EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC
Q 018047          128 YCADGK----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN  203 (361)
Q Consensus       128 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~  203 (361)
                      .+....    ..+++++++.. ++.+.+...  ...++..+..++.|++.||+|||+++     ++||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG-----ISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCC
Confidence            765443    34678887743 666666543  24678889999999999999999999     9999999999999999


Q ss_pred             CcEEEeecCccccCCCCCce-----eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCch
Q 018047          204 FEAKISDFGLAKLMPEGQET-----YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ  278 (361)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  278 (361)
                      +.++|+|||+++.+......     .......||+.|+|||+..+..++.++|||||||++|||++|..||.......  
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--  240 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--  240 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence            99999999999876432211     11122468999999999988999999999999999999999999996542211  


Q ss_pred             hHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          279 NLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      .........     .+.....+.....    ..+..+.+++..||+.+|++||+++++++.|
T Consensus       241 ~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 NLIHAAKCD-----FIKRLHEGKIKIK----NANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhHHH-----HHHHhhhhhhccC----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            111111100     0000111111111    2245689999999999999999999999876

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=289.82  Aligned_cols=263  Identities=26%  Similarity=0.390  Sum_probs=197.5

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      |.+.+.||+|++|+||+|+.. +++.|+||++......  .......+|+..+..++ |+|++++++++.+++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            567789999999999999986 5889999998654221  12234456899999998 9999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+ +|+|.+++.......+++..+..++.|++.+|.|||+++     ++|+||+|+||+++.++.++|+|||++......
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~-----i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG-----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            99 789999887654457899999999999999999999999     999999999999999999999999999866433


Q ss_pred             CceeeeeecccccCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh--------hh
Q 018047          221 QETYVTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN--------DR  291 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~  291 (361)
                      ..   .....++..|+|||.+. ...++.++|+||||+++++|++|+.||......+.   .........        ..
T Consensus       153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  226 (283)
T cd07830         153 PP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPEG  226 (283)
T ss_pred             CC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH---HHHHHHhcCCCChhhhhhH
Confidence            21   12345788999999764 45578999999999999999999999854432111   110000000        00


Q ss_pred             hhhhhhcCccccC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          292 KKLRKVIDPELSR------SSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       292 ~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ..........+..      .......+..+.+++++||+.||++|||++|++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000000      00001114568999999999999999999999876

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=302.61  Aligned_cols=248  Identities=27%  Similarity=0.410  Sum_probs=208.0

Q ss_pred             CceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           66 DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      .++||+|.||+||-|+++ +|+.||||++.+-.+... ....+++|+.+|+.+.||.||.+...|+..+.+++|||-+ +
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence            478999999999999976 799999999988776544 3478999999999999999999999999999999999999 5


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC---CcEEEeecCccccCCCCC
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN---FEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~~~~~~~~  221 (361)
                      |++.+.|-+....++++.....++.||+.||.|||.++     |+|+||||+|||+.+.   -++||||||+|+.++...
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn-----IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN-----IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc-----eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            68888776666678999999999999999999999999     9999999999999754   479999999999886543


Q ss_pred             ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                         .....+|||.|+|||++..+.|...-|+||.|+|+|--++|..||....+     ...+++.   ..-.        
T Consensus       722 ---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQN---AaFM--------  782 (888)
T KOG4236|consen  722 ---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQN---AAFM--------  782 (888)
T ss_pred             ---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhc---cccc--------
Confidence               45567899999999999999999999999999999999999999953322     2222221   1100        


Q ss_pred             ccCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          302 LSRSSYTM-ESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       302 ~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                        ...-|+ +.+....+||..+|+..-++|-|.+..+.|.|
T Consensus       783 --yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W  821 (888)
T KOG4236|consen  783 --YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW  821 (888)
T ss_pred             --cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence              011122 33456789999999999999999999998876

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-39  Score=296.15  Aligned_cols=268  Identities=22%  Similarity=0.314  Sum_probs=203.7

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-----EE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-----HR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~  135 (361)
                      +|.+.+.||+|++|.||+|+.. +++.+|+|++.... ........+.+|+.+++.++|+||+++.+++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            4788899999999999999976 58999999986532 22334567888999999999999999999988775     78


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |++|||++ ++|.+++....  .+++..+..++.|++.||+|||++|     ++|+||||+|||++.++.++|+|||++.
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g-----i~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             EEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            99999997 48999887643  7999999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCce-eeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh--
Q 018047          216 LMPEGQET-YVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR--  291 (361)
Q Consensus       216 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  291 (361)
                      ........ .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||......   .....+.......  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~  228 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSE  228 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCCh
Confidence            76543210 112334678899999998777 7899999999999999999999999644321   1111111100000  


Q ss_pred             --------hhhhhhcC---c--cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 --------KKLRKVID---P--ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 --------~~~~~~~~---~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                              ......+.   .  ...........+..+.+++.+||+.+|++|||+.+++.+.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  291 (330)
T cd07834         229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY  291 (330)
T ss_pred             hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence                    00000000   0  00000011123556899999999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-39  Score=297.72  Aligned_cols=268  Identities=23%  Similarity=0.333  Sum_probs=199.6

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC--
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK--  133 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  133 (361)
                      ....++|+..+.||+|+||+||++... +|..||||++.... ........+.+|+.+++.++||||+++++++..+.  
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            345678999999999999999999866 68999999986432 22223456778999999999999999999987654  


Q ss_pred             ----EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 018047          134 ----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKIS  209 (361)
Q Consensus       134 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~  209 (361)
                          ..++||||+ +++|.+++..   ..+++..+..++.|++.||+|||++|     ++||||||+||+++.++.++|+
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g-----i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG-----IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEe
Confidence                458999999 6799988864   36899999999999999999999999     9999999999999999999999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      |||++.......     ....+++.|+|||.+.. ..++.++|+||||+++|+|++|..||......  ...........
T Consensus       161 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~  233 (343)
T cd07880         161 DFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTG  233 (343)
T ss_pred             ecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcC
Confidence            999998654321     22457889999998765 45788999999999999999999999643211  00000000000


Q ss_pred             hhhhhhhhhcC-----------ccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          289 NDRKKLRKVID-----------PELSRS---SYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       289 ~~~~~~~~~~~-----------~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .....+...+.           +.....   ......+..+.+++.+||+.||++|||+.+++.+-+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~  300 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY  300 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            00000000000           000000   001123345889999999999999999999997755

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-39  Score=282.88  Aligned_cols=243  Identities=29%  Similarity=0.378  Sum_probs=199.5

Q ss_pred             ecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCch
Q 018047           69 LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL  147 (361)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  147 (361)
                      ||+|+||.||++... +++.+|+|.+.............+..|+.+++.++|+|++++++.+.+++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999977 5899999998776555555667889999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeee
Q 018047          148 QDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA  227 (361)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (361)
                      .+++....  .+++..+..++.|+++||.|||+.+     ++|+||+|+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~-----~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~  151 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG-----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN  151 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence            99997643  6899999999999999999999999     99999999999999999999999999987644321  223


Q ss_pred             ecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCC
Q 018047          228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY  307 (361)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (361)
                      ...++..|+|||.......+.++|+||||+++|+|++|..||.....      ..........          .   ...
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~----------~---~~~  212 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKD----------P---LRF  212 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcC----------C---CCC
Confidence            34678899999998888889999999999999999999999954321      1111111111          0   112


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCH---HHHHHH
Q 018047          308 TMESIAMFANLASRCVRTESSERPSM---AECVKE  339 (361)
Q Consensus       308 ~~~~~~~l~~li~~cl~~dp~~Rpt~---~ell~~  339 (361)
                      +...+..+.+++.+||..||++||++   .+++++
T Consensus       213 ~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         213 PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             CCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            22224568999999999999999999   666654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8e-39  Score=289.81  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=202.3

Q ss_pred             CCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCC-cchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFK-EADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  135 (361)
                      +|++.+.||+|++|.||++...    +++.||||.+...... .......+..|+.++..+ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3777889999999999999753    4788999998653221 223345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||+++|+|.+++...  ..+++..+..++.|++++|.|||+.+     ++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~-----~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG-----IIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999998653  36889999999999999999999999     9999999999999999999999999987


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGK--LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      .+...... ......|+..|+|||......  .+.++|+||||+++|+|++|..||........  ...........   
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~---  227 (288)
T cd05583         154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS---  227 (288)
T ss_pred             cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc---
Confidence            65433211 122345789999999876554  78899999999999999999999953322111  11111111111   


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                           .     ...+...+..+.+++.+||+.||++|||+.++.+.|+...+.+
T Consensus       228 -----~-----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~  271 (288)
T cd05583         228 -----K-----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG  271 (288)
T ss_pred             -----C-----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence                 0     1112223455889999999999999999877766666554433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=291.30  Aligned_cols=272  Identities=27%  Similarity=0.414  Sum_probs=212.1

Q ss_pred             CCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHh--cCCCcceeEEEEEEcCC----EEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR--LDHPNLVSLIGYCADGK----HRF  136 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~----~~~  136 (361)
                      .+...+||+|.||.||+|++. ++.||||++..      .....+.+|.++...  ++|+||+++++.-....    .++
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            444577999999999999988 69999999853      345677778888776  48999999999866554    889


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC----CCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS----SAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      ||++|.+.|+|.+|+..+   .++|....+++..+++||+|||+-    ++.+++|+|||||..||||-+|++..|+|||
T Consensus       285 LVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999999875   799999999999999999999984    3446779999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCC-CC-----ccchhHHHHHHHHHHHhCCCCCCC-CCCCCchhH-----
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-LT-----LQSDVYAFGVVLLELLTGRRAVDL-NQGVNDQNL-----  280 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~ell~g~~p~~~-~~~~~~~~~-----  280 (361)
                      +|..+..+.........+||.+|||||++.+.- +.     .+.||||+|.+||||++...-+.. ..+.-...+     
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            999987666655566689999999999886532 11     358999999999999998765532 111111111     


Q ss_pred             ----HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          281 ----VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       281 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                          .+.++.     ....+...|.++...........+++.+..||..||+-|.|+.=+-+.+..+.-..+.
T Consensus       442 ~hPt~e~mq~-----~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  442 NHPTLEEMQE-----LVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCCCHHHHHH-----HHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence                111111     1122233444443444445566799999999999999999999999999988777765

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.8e-39  Score=297.08  Aligned_cols=270  Identities=21%  Similarity=0.308  Sum_probs=198.1

Q ss_pred             CCCC-CCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcch-----------hHHHHHHHHHHHHhcCCCcceeEEE
Q 018047           61 CSFS-DDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEAD-----------GEHEFRVEVDILSRLDHPNLVSLIG  127 (361)
Q Consensus        61 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~  127 (361)
                      ++|. +.+.||.|+||+||+|.+. +++.||+|++.........           ....+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3555 4577999999999999976 6899999998654322110           1124678999999999999999999


Q ss_pred             EEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEE
Q 018047          128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAK  207 (361)
Q Consensus       128 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~k  207 (361)
                      ++..++..++||||++ |+|.+++...  ..+++.....++.|++.||+|||+.|     ++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~-----i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY-----FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccccHHHeEECCCCCEE
Confidence            9999999999999996 5999998653  36899999999999999999999999     99999999999999999999


Q ss_pred             EeecCccccCCCCC------------ceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 018047          208 ISDFGLAKLMPEGQ------------ETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQG  274 (361)
Q Consensus       208 l~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~  274 (361)
                      |+|||++.......            .........+++.|+|||.+.+. .++.++|+|||||++|+|++|..||....+
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999997654110            00111223467889999987654 468899999999999999999999964432


Q ss_pred             CCchhHHHHHHHHhhhhhh--hhhh--------cCccccC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          275 VNDQNLVLQVRHILNDRKK--LRKV--------IDPELSR--SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         ......+.........  ....        .......  .......+..+.+++.+||+.+|++|||+++++.+.+
T Consensus       240 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        240 ---IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             ---HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence               1111111111110000  0000        0000000  0001122456889999999999999999999998765

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-38  Score=294.35  Aligned_cols=267  Identities=25%  Similarity=0.343  Sum_probs=200.6

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc-CCE
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD-GKH  134 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~  134 (361)
                      ..+.++|+..+.||.|+||.||+|... +++.||+|++.+.. ........+..|+.+++.++|||++++.+++.. ...
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            346678999999999999999999976 79999999986543 222334567789999999999999999999865 567


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .|+++||+ +++|.+++...   .+++..+..++.|+++||+|||+++     ++|+||+|+||+++.++.++|+|||++
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~-----iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG-----VVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEeECCCCCEEeCccccc
Confidence            89999998 56898887642   5788888999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-h
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-K  292 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~  292 (361)
                      .......     ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......   .....+....... .
T Consensus       156 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~  227 (328)
T cd07856         156 RIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV---NQFSIITDLLGTPPD  227 (328)
T ss_pred             cccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence            7543221     22357889999998755 56889999999999999999999999643221   1111111110000 0


Q ss_pred             ---------hhhhhcCccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 ---------KLRKVIDPELSRSSYT-----MESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ---------~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                               .....+.........+     ...+..+.+++.+||+.+|++|||+.+++.+-+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~  290 (328)
T cd07856         228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY  290 (328)
T ss_pred             HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCc
Confidence                     0000000000001111     123456899999999999999999999998843

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-38  Score=295.85  Aligned_cols=271  Identities=22%  Similarity=0.334  Sum_probs=202.1

Q ss_pred             HHHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc
Q 018047           53 LKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD  131 (361)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  131 (361)
                      ..++..+.++|.+.+.||+|+||.||+|... +|+.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            4556677889999999999999999999865 689999999865321 22234567789999999999999999998864


Q ss_pred             C------CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc
Q 018047          132 G------KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE  205 (361)
Q Consensus       132 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~  205 (361)
                      .      ...|++++++ +++|.+++...   .+++..+..++.|++.||+|||++|     ++||||||+||+++.++.
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChHHEEEcCCCC
Confidence            3      3468888887 77998887642   5899999999999999999999999     999999999999999999


Q ss_pred             EEEeecCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 018047          206 AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  284 (361)
                      ++|+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......   .....+
T Consensus       159 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~  230 (345)
T cd07877         159 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLI  230 (345)
T ss_pred             EEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence            999999998765332     123467889999998755 56888999999999999999999999543221   111111


Q ss_pred             HHHhh-hhhhhhhhcC-----------ccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          285 RHILN-DRKKLRKVID-----------PELSR---SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       285 ~~~~~-~~~~~~~~~~-----------~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..... ....+...+.           +....   .......+..+.+++.+||+.||.+|||+.+++++-.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  302 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  302 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence            11000 0000000000           00000   0000112446889999999999999999999999876

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=302.12  Aligned_cols=244  Identities=23%  Similarity=0.292  Sum_probs=201.3

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  136 (361)
                      ....|.....+|.|+|+.|-.+... +++..++|++....       .+..+|+.++... +|||++++.+.+.++.+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence            3567888888999999999999876 68899999997542       1233477666666 6999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee-CCCCcEEEeecCccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL-SANFEAKISDFGLAK  215 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill-~~~~~~kl~Dfg~~~  215 (361)
                      +|||.+.++-|.+.+....  .+. ..+..|+.+|+.|+.|||++|     ++||||||+|||+ ++.++++|+|||.++
T Consensus       393 ~v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~g-----vvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQG-----VVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcC-----eeecCCChhheeecCCCCcEEEEEechhh
Confidence            9999999999999887643  233 777889999999999999999     9999999999999 689999999999999


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .+...     ....+-|..|.|||++....|+.++||||||++||+|++|+.||......     ......+.       
T Consensus       465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~-------  527 (612)
T KOG0603|consen  465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQ-------  527 (612)
T ss_pred             hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhc-------
Confidence            87654     12235588999999999999999999999999999999999999755443     11111110       


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                              ...+....+....+|+++||+.||.+||++.+++.|-+.
T Consensus       528 --------~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  528 --------MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             --------CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                    122225556668999999999999999999999999887

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.2e-38  Score=318.35  Aligned_cols=148  Identities=30%  Similarity=0.466  Sum_probs=134.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+.+.||+|+||+||+|.+. +++.||||++.............+..|+.++..++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56889999999999999999987 68999999997655444555677889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ||+++++|.+++...+  .+++..++.++.||+.||+|||+++     |+||||||+|||++.++.++|+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g-----IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG-----IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997643  6889999999999999999999999     9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-38  Score=296.19  Aligned_cols=261  Identities=23%  Similarity=0.351  Sum_probs=194.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC------
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG------  132 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------  132 (361)
                      ..+|...+.||+|+||.||+|... +|+.||+|++..... .......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            467999999999999999999976 689999999865422 222345677899999999999999999998754      


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      ...++|+||+.. +|..+..    ..+++..+..++.|++.||+|||+++     ++||||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~-----i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG-----IIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeCC
Confidence            356999999964 7776653    26899999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh-h
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-D  290 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~  290 (361)
                      ++.......     ....+++.|+|||.+.. ..++.++|||||||++|||++|+.||.....   ......+..... .
T Consensus       163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~  234 (342)
T cd07879         163 LARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVP  234 (342)
T ss_pred             CCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence            997653321     12457889999998765 4688899999999999999999999964321   111111111000 0


Q ss_pred             hhhhhhhc-----------CccccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          291 RKKLRKVI-----------DPELSRSSY---TMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       291 ~~~~~~~~-----------~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ...+...+           .+.......   ....+..+.+++.+||+.||++||++.+++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000           000000000   01123458899999999999999999999988

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.1e-39  Score=279.56  Aligned_cols=273  Identities=22%  Similarity=0.311  Sum_probs=202.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-C----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc-CCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-S----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD-GKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~  134 (361)
                      ..|+....||+|.||.||+|..+ +    .+.+|||++.-....... .....+|+.+++.++|||++.+..+|.. +..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-SMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            35889999999999999999644 2    237999998755322222 2345679999999999999999998876 789


Q ss_pred             EEEEEEecCCCchhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC----CcEE
Q 018047          135 RFLVYEYMQKGNLQDHLNGI---GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN----FEAK  207 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~----~~~k  207 (361)
                      +++++||.+. +|...|.-+   ....++...+..++.||+.|+.|||++.     |+||||||.|||+..+    |.+|
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-----vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-----VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh-----eeeccCCcceEEEeccCCccCeeE
Confidence            9999999987 898888533   2357888999999999999999999999     9999999999999877    9999


Q ss_pred             EeecCccccCCCCCcee-eeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchh---HHH
Q 018047          208 ISDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN---LVL  282 (361)
Q Consensus       208 l~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---~~~  282 (361)
                      |+|||+++.+.+.-... .....+.|.+|.|||.+.+ ..|+.+.|||++|||+.||+|-.+.|..........   -..
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            99999999886654332 2334567999999997765 468889999999999999999998886544322211   223


Q ss_pred             HHHHHhhhhhhhhhhcCccccCCC------------CCHH------------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 018047          283 QVRHILNDRKKLRKVIDPELSRSS------------YTME------------SIAMFANLASRCVRTESSERPSMAECVK  338 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~------------~~~~l~~li~~cl~~dp~~Rpt~~ell~  338 (361)
                      ++.++++--+.-....-|.+..-+            +-..            -+..-.+|+.+||+.||-+|.|+++.++
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            333333322211111111110000            0000            0012678999999999999999999988


Q ss_pred             HH
Q 018047          339 EL  340 (361)
Q Consensus       339 ~l  340 (361)
                      +.
T Consensus       337 h~  338 (438)
T KOG0666|consen  337 HP  338 (438)
T ss_pred             cc
Confidence            74

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.5e-38  Score=290.85  Aligned_cols=269  Identities=25%  Similarity=0.327  Sum_probs=195.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC------
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG------  132 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------  132 (361)
                      .++|++.+.||+|+||.||+|... +++.+|+|++........ ....+.+|+++++.++||||+++++++.+.      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            457999999999999999999977 689999999865432222 223566799999999999999999887543      


Q ss_pred             --CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 018047          133 --KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD  210 (361)
Q Consensus       133 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~D  210 (361)
                        ...++||||+.+ +|...+... ...+++..+..++.|+++||+|||++|     ++|+||||+||+++.++.++|+|
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH-----ILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECc
Confidence              356999999965 677766543 347999999999999999999999999     99999999999999999999999


Q ss_pred             cCccccCCCCCcee---------eeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 018047          211 FGLAKLMPEGQETY---------VTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNL  280 (361)
Q Consensus       211 fg~~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  280 (361)
                      ||++..........         ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......   .
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~  235 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---Q  235 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence            99997654322111         1122356888999997654 457899999999999999999999996433321   1


Q ss_pred             HHHHHHHhhhh--------hhhhhhc----CccccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          281 VLQVRHILNDR--------KKLRKVI----DPELSRS--SYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       281 ~~~~~~~~~~~--------~~~~~~~----~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ...+.......        ..+....    .......  ..-......+.+++.+||+.||.+|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            11111110000        0000000    0000000  0001122468899999999999999999999876

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.6e-38  Score=283.49  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=196.8

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCC--cchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFK--EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      +|.+.+.||+|+||+||++... .+..+++|.+......  .......+..|+.+++.++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999876 3555666665432211  122334566799999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          139 YEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      |||+++++|.+++...  ....+++..+..++.|++.||.|||+.|     ++|+||+|+||+++. +.++|+|||++..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR-----ILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCChhheEeec-CCEeecccCceee
Confidence            9999999999988642  2347899999999999999999999999     999999999999975 5799999999876


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ......  ......|++.|+|||......++.++|+||||+++|+|++|..||....      ...........      
T Consensus       155 ~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~------  220 (260)
T cd08222         155 LMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG------  220 (260)
T ss_pred             cCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC------
Confidence            643322  2223457889999999888888999999999999999999999985221      11111111110      


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                          .  ....+...+..+.+++.+||+.||++||++.+++++
T Consensus       221 ----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         221 ----P--TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ----C--CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                0  112234455678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=287.27  Aligned_cols=267  Identities=21%  Similarity=0.300  Sum_probs=206.6

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC--CC----cceeEEEEE
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD--HP----NLVSLIGYC  129 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~----~iv~~~~~~  129 (361)
                      ....++|.+...+|+|+||.|-.+.+. ++..||||+++.    ...-.+...-|+++|.++.  .|    .+|++.+||
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            344778999999999999999999866 588999999852    2223345567999999993  23    378899999


Q ss_pred             EcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-------
Q 018047          130 ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-------  202 (361)
Q Consensus       130 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-------  202 (361)
                      +-.++.+||+|.+ |-|+.+++...+..+++...+..+++|+++++++||+.+     ++|-||||+|||+.+       
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k-----l~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK-----LTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc-----eeecCCChheEEEeccceEEEe
Confidence            9999999999998 559999999888889999999999999999999999999     999999999999843       


Q ss_pred             -------------CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 018047          203 -------------NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV  269 (361)
Q Consensus       203 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~  269 (361)
                                   ...|+|+|||.|+.-....     ...+.|..|.|||++.+-+++..+||||+||||+||.+|...|
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence                         2349999999998654332     3456799999999999999999999999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHHhhhhhh--hhh----------hcC------------------ccccCCCCCHHHHHHHHHHH
Q 018047          270 DLNQGVNDQNLVLQVRHILNDRKK--LRK----------VID------------------PELSRSSYTMESIAMFANLA  319 (361)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~----------~~~------------------~~~~~~~~~~~~~~~l~~li  319 (361)
                      +..+..+.   ...+..++.....  +..          .++                  |.-............|++|+
T Consensus       310 qtHen~EH---LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  310 QTHENLEH---LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             ccCCcHHH---HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            76653221   1222222211000  000          000                  00000112234446799999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHH
Q 018047          320 SRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       320 ~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ++||..||.+|+|+.|+|.|..
T Consensus       387 ~~mL~fDP~~RiTl~EAL~HpF  408 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALSHPF  408 (415)
T ss_pred             HHHHccCccccccHHHHhcCHH
Confidence            9999999999999999998854

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.8e-38  Score=292.13  Aligned_cols=269  Identities=23%  Similarity=0.288  Sum_probs=195.7

Q ss_pred             CCCCCceecccCceEEEEEEEc-C--CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc----CC
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-S--GEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD----GK  133 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~  133 (361)
                      +|++.+.||+|+||.||++... +  +..||+|++.... ........+.+|+.+++.+ +||||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            4778889999999999999976 4  7899999986432 2222345677899999999 59999999987533    24


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..|++++|+. ++|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.++|+|||+
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g-----ivH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN-----VLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            6789999986 6899988653  36899999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCce--eeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh-
Q 018047          214 AKLMPEGQET--YVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-  289 (361)
Q Consensus       214 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-  289 (361)
                      +..+......  .......|++.|+|||...+ ..++.++||||||+++|+|++|..||......   .....+..... 
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~  228 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGT  228 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCC
Confidence            9866432211  11223468999999997654 56889999999999999999999998643211   11111000000 


Q ss_pred             -----------hhh-hhhhhc--CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          290 -----------DRK-KLRKVI--DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       290 -----------~~~-~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                                 ... ......  .+...........+..+.+++.+||+.||++|||+.+++.+-+-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence                       000 000000  00000000001124568999999999999999999999988763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.7e-39  Score=296.41  Aligned_cols=270  Identities=23%  Similarity=0.322  Sum_probs=195.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC------
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG------  132 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------  132 (361)
                      ..+|...+.||.|+||.||+|... +|+.||+|++....   ....+.+.+|+++++.++||||+++++.+...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            357999999999999999999976 68999999986543   23456678899999999999999999776543      


Q ss_pred             --------CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-C
Q 018047          133 --------KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-N  203 (361)
Q Consensus       133 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-~  203 (361)
                              ...|+||||++ ++|.+++..   ..+++..+..++.|+++||+|||++|     ++||||||+||+++. +
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivH~dikp~Nili~~~~  151 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN-----VLHRDLKPANVFINTED  151 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEcCCC
Confidence                    36799999997 589888754   26899999999999999999999999     999999999999984 5


Q ss_pred             CcEEEeecCccccCCCCCcee-eeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 018047          204 FEAKISDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  281 (361)
                      +.++|+|||++..+....... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||............
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            679999999997653321111 1122357889999997543 56788999999999999999999999643321110000


Q ss_pred             HH---------HHHHhhhhh-hhh-hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          282 LQ---------VRHILNDRK-KLR-KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       282 ~~---------~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..         ......... ... ....+..+........+..+.+++.+||+.||++|||+.|++.+-+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~  302 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY  302 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence            00         000000000 000 0000000000001123356889999999999999999999998755

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=285.69  Aligned_cols=265  Identities=26%  Similarity=0.403  Sum_probs=200.2

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |+..+.||+|++|.||+|+.. +++.+|+|.+.... ........+..|+.+++.++|+|++++++++.+.+..++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            556778999999999999977 59999999987643 2233345677899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      ++ ++|.+++.... ..+++..+..++.|++.||+|||+++     ++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR-----ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            97 59999997643 36999999999999999999999999     9999999999999999999999999998764432


Q ss_pred             ceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh--------h
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR--------K  292 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~  292 (361)
                      .  ......++..|+|||.+... .++.++|+||||+++|+|++|+.||......   .....+.......        .
T Consensus       153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07829         153 R--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVT  227 (282)
T ss_pred             c--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhc
Confidence            2  12223457789999987666 7889999999999999999999998543321   1111111100000        0


Q ss_pred             hhh--hhcCccccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          293 KLR--KVIDPELSRSSY---TMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       293 ~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      .+.  ...-+.......   -...+..+.+++.+||..||++||++.+++.+-
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p  280 (282)
T cd07829         228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP  280 (282)
T ss_pred             ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence            000  000000000000   011245699999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-39  Score=297.32  Aligned_cols=265  Identities=22%  Similarity=0.365  Sum_probs=199.2

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE--
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH--  134 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--  134 (361)
                      .+.++|+..+.||+|++|+||+|... +++.||+|++.... ........+.+|+.+++.++|||++++.+++...+.  
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            34567999999999999999999987 68899999886542 222334567789999999999999999988766554  


Q ss_pred             ----EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 018047          135 ----RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD  210 (361)
Q Consensus       135 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~D  210 (361)
                          .++|+||+ +++|.+++..   ..+++..+..++.|+++||+|||+.|     ++|+||+|+||+++.++.++|+|
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g-----i~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG-----IIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEcc
Confidence                89999998 5699998875   36899999999999999999999999     99999999999999999999999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      ||++......     .....++..|+|||.+.. ..++.++||||||+++|+|++|+.||......   .....+.....
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~  233 (343)
T cd07851         162 FGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVG  233 (343)
T ss_pred             cccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcC
Confidence            9999866432     122457889999998754 46788999999999999999999999643221   11111110000


Q ss_pred             h-h------------hhhhhhcCccccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          290 D-R------------KKLRKVIDPELSRSSY---TMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       290 ~-~------------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      . .            ..+...+.. .....+   ....+..+.+++.+||+.||++|||+.|+++|-+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~  300 (343)
T cd07851         234 TPDEELLQKISSESARNYIQSLPQ-MPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY  300 (343)
T ss_pred             CCCHHHHhhccchhHHHHHHhccc-cCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence            0 0            000000000 000000   0112456899999999999999999999998754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=279.37  Aligned_cols=260  Identities=21%  Similarity=0.329  Sum_probs=200.8

Q ss_pred             ceecccCceEEEEEE-EcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.||+|+|+.|--+. ..+|..||||++.+.   .......+.+|++++...+ |+||+++++||+++...|||||-|.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G  160 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG  160 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence            579999999999987 458999999999764   4455677888999999995 99999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC---cEEEeecCccccCCCCC
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF---EAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~---~~kl~Dfg~~~~~~~~~  221 (361)
                      |+|..+|...  ..+++.++.++..+|+.||.+||.+|     |.|||+||+|||....+   -+|||||.++.......
T Consensus       161 GplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg-----IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  161 GPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG-----IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             chHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC-----cccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            9999999874  37999999999999999999999999     99999999999987554   48999999886543221


Q ss_pred             -----ceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCC----CCchhHHHHHHHH
Q 018047          222 -----ETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG----VNDQNLVLQVRHI  287 (361)
Q Consensus       222 -----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----~~~~~~~~~~~~~  287 (361)
                           .+....+.+|+..|||||+..     ...|+.++|.||||+|+|-|++|.+||...=+    ++.......-+..
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence                 112234568999999999643     34688999999999999999999999965322    1222111111111


Q ss_pred             hhhhhhhhhhcCccccCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          288 LNDRKKLRKVIDPELSRSSYTM-ESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +     +..+-+..+......+ ..+.+..++++.+|..|+.+|.++.+++.|.+
T Consensus       314 L-----FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  314 L-----FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             H-----HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence            0     1111111111111111 34456789999999999999999999999765

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=299.47  Aligned_cols=254  Identities=25%  Similarity=0.313  Sum_probs=218.2

Q ss_pred             CCCCCCceecccCceEEEEEEEcCC-CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSG-EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .+++.+..||-|+||.|-++..++. ..+|+|.+++...-+....+.+..|-.+|..++.|.||++|..|.++..+|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            3456667799999999999987743 359999999888888888889999999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |-|-||.|+..++..+  .++..+...++..+++|++|||++|     ||+|||||+|.+++.+|.+||.|||+|+.+..
T Consensus       500 EaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~-----iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG-----IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC-----ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            9999999999998765  7999999999999999999999999     99999999999999999999999999999877


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      +..   +.+++|||.|.|||++.+...+.++|.||||+++|||++|++||...++....+++..      ....      
T Consensus       573 g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk------Gid~------  637 (732)
T KOG0614|consen  573 GRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK------GIDK------  637 (732)
T ss_pred             CCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh------hhhh------
Confidence            763   4568999999999999999999999999999999999999999987766544433321      1111      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                           -.+|........+||++++..+|.+|..     +.++-+|-|
T Consensus       638 -----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  638 -----IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             -----hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence                 1223333444788999999999999976     777777766

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-39  Score=299.65  Aligned_cols=212  Identities=24%  Similarity=0.354  Sum_probs=184.7

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |..++-||-|+||+|.++... +...||+|.+.+..+........+..|..||..-+.+.||+||..|++.+++|+||||
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            555678999999999999744 6788999999988877778888899999999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC---
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP---  218 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~---  218 (361)
                      ++||++..+|-+.+  -+.+..++.++..+..|+++.|..|     +|||||||+|||||.+|+|||+|||+++-+.   
T Consensus       711 IPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG-----FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             cCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc-----ceecccCccceEEccCCceeeeeccccccceecc
Confidence            99999999987765  7899999999999999999999999     9999999999999999999999999998552   


Q ss_pred             ------CCCce-------------------------------eeeeecccccCccCcccccCCCCCccchhHHHHHHHHH
Q 018047          219 ------EGQET-------------------------------YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLE  261 (361)
Q Consensus       219 ------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  261 (361)
                            .++..                               ...+..+||+.|+|||++....++.-+|+||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                  11100                               11234689999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCCchhHH
Q 018047          262 LLTGRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       262 ll~g~~p~~~~~~~~~~~~~  281 (361)
                      |+.|+.||-.......+..+
T Consensus       864 m~~g~~pf~~~tp~~tq~kv  883 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKV  883 (1034)
T ss_pred             HhhCCCCccCCCCCcceeee
Confidence            99999999665554444333

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-41  Score=280.40  Aligned_cols=260  Identities=22%  Similarity=0.358  Sum_probs=202.5

Q ss_pred             CCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEEec
Q 018047           65 DDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      .+..||.|+||+|++-.++ +|+..|||++.....  .....+++.|.+...+- +.||||++||.+..++..|+.||+|
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            3456999999999999887 799999999986533  34456777788765554 7999999999999999999999999


Q ss_pred             CCCchhhhc---ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          143 QKGNLQDHL---NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       143 ~~g~L~~~l---~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      .- ||..+.   .......+++..+..|+...+.||.||...-    .|||||+||+|||++..|.+||||||++-.+.+
T Consensus       146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l----kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL----KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh----hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            54 766543   2333457999999999999999999998753    499999999999999999999999999977654


Q ss_pred             CCceeeeeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      +.   ....-.|-..|||||-+..  ..|+.++|+||||++|||+.||..|+...     .+..+++.......      
T Consensus       221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----~svfeql~~Vv~gd------  286 (361)
T KOG1006|consen  221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----DSVFEQLCQVVIGD------  286 (361)
T ss_pred             HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----HHHHHHHHHHHcCC------
Confidence            43   2223357778999997653  35899999999999999999999999643     33555555444332      


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                       .|.+.......+.+..+..+|..||..|.+.||...+++++-..-.+.
T Consensus       287 -pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  287 -PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             -CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence             122222333344566799999999999999999999999876544443

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=285.95  Aligned_cols=244  Identities=28%  Similarity=0.390  Sum_probs=204.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .+|..+.+||+|+||.|.++..+ +.+.+|||++.+......+..+--..|-.+|... +-|.++++...|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46899999999999999999877 5789999999887766666666666788888876 578899999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+.||+|..+|+..+  .+.+..+..++..||-||-+||++|     ||.||||.+|||+|.+|++||+|||+++.--
T Consensus       429 MEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg-----IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC-----eeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999999999876  6888889999999999999999999     9999999999999999999999999997432


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      -+.  ..+.+++|||.|+|||++..++|+..+|+||+|++||||+.|.+||+..+   +..+...+   ....       
T Consensus       502 ~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI---~ehn-------  566 (683)
T KOG0696|consen  502 FDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAI---MEHN-------  566 (683)
T ss_pred             cCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHH---HHcc-------
Confidence            222  24567899999999999999999999999999999999999999996543   22232222   2221       


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPS  332 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  332 (361)
                            ..+|...+.+...+....|...|.+|..
T Consensus       567 ------vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 ------VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence                  3345555566788999999999999953

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=277.93  Aligned_cols=277  Identities=27%  Similarity=0.377  Sum_probs=210.0

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHh--cCCCcceeEEEEEEcC--
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR--LDHPNLVSLIGYCADG--  132 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~--  132 (361)
                      ..+.......+.||+|.||.||+|.++ |+.||||+|..      .....+.+|.++.+.  |+|+||+.+++.-..+  
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s------rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS------RDERSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc------cchhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            445567788899999999999999999 99999999852      223455567777775  5999999999874322  


Q ss_pred             --CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC--C-CCCCCeEecCCCCCCeeeCCCCcEE
Q 018047          133 --KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS--S-AVGIPIVHRDFKSTNVLLSANFEAK  207 (361)
Q Consensus       133 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~-~~~~~iiH~Dikp~Nill~~~~~~k  207 (361)
                        ..++||++|.+.|||.||+++.   .++.+..++++..+|.||++||..  | +.++.|.|||||..|||+..++.+.
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence              2679999999999999999873   799999999999999999999973  1 1245599999999999999999999


Q ss_pred             EeecCccccCCCCCcee--eeeecccccCccCcccccCCC----C-C-ccchhHHHHHHHHHHHhC----------CCCC
Q 018047          208 ISDFGLAKLMPEGQETY--VTARVLGTFGYFDPEYTSTGK----L-T-LQSDVYAFGVVLLELLTG----------RRAV  269 (361)
Q Consensus       208 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~-~-~~~DiwslG~il~ell~g----------~~p~  269 (361)
                      |+|+|+|..........  .....+||-.|||||++...-    + + ..+||||||+++||++..          ..||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            99999998765432221  223468999999999876432    1 2 348999999999999873          3566


Q ss_pred             CCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          270 DLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                      ....+.+. . .+.++..++.     +.+.|.++......+....+.+|++.||..||.-|.|+=-+-+.|.++....++
T Consensus       437 yd~Vp~DP-s-~eeMrkVVCv-----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek  509 (513)
T KOG2052|consen  437 YDVVPSDP-S-FEEMRKVVCV-----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK  509 (513)
T ss_pred             ccCCCCCC-C-HHHHhcceee-----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence            43332221 1 2222222221     223445555556667788899999999999999999999999999998865544


Q ss_pred             C
Q 018047          350 G  350 (361)
Q Consensus       350 ~  350 (361)
                      .
T Consensus       510 ~  510 (513)
T KOG2052|consen  510 I  510 (513)
T ss_pred             h
Confidence            3

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-38  Score=248.94  Aligned_cols=264  Identities=23%  Similarity=0.340  Sum_probs=202.8

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|...++||+|.||+||+|+.+ +++.||+|.+......+.. -....+|+-+++.++|.|||+++++...++.+.+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-pssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-cHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            3555678999999999999976 6899999999876543333 3456679999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      ||.. +|..|..+.++ .++.+....++.|++.||.++|+++     +.|||+||.|.|++.+|.+||+|||+++.++-.
T Consensus        82 ~cdq-dlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshn-----vlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHN-----VLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             HhhH-HHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhh-----hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            9965 89988876543 7999999999999999999999999     999999999999999999999999999987543


Q ss_pred             CceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                        .......+.|..|.+|.++.+. -|++..|+||-|||+.|+.....|.....+.+     .++++++..-+...+--.
T Consensus       155 --vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-----dqlkrif~~lg~p~ed~w  227 (292)
T KOG0662|consen  155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-----DQLKRIFRLLGTPTEDQW  227 (292)
T ss_pred             --eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-----HHHHHHHHHhCCCccccC
Confidence              2233445679999999987654 57899999999999999998666654333322     223333322221111111


Q ss_pred             cccc-------CCCCC---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          300 PELS-------RSSYT---------MESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       300 ~~~~-------~~~~~---------~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      |.+.       ...++         ...+..-++|+++.|.-+|.+|.++++.+++.
T Consensus       228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp  284 (292)
T KOG0662|consen  228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP  284 (292)
T ss_pred             CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence            1110       01111         12223567899999999999999999998864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=298.65  Aligned_cols=263  Identities=25%  Similarity=0.430  Sum_probs=213.2

Q ss_pred             CHHHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEE
Q 018047           52 TLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYC  129 (361)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  129 (361)
                      .++.+..-++-|++.++||.|.+|.||+++.. +++..|+|+....    .+..+++..|.++++.+ .|||++.++++|
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            33444445567999999999999999999966 6899999998643    33345677899999988 599999999998


Q ss_pred             Ec-----CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC
Q 018047          130 AD-----GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF  204 (361)
Q Consensus       130 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~  204 (361)
                      ..     ++.+|||||||.+||..|++++..+..+.|+.+..|++.++.|+.+||.+.     ++|||||=.|||++.++
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk-----viHRDikG~NiLLT~e~  160 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK-----VIHRDIKGQNVLLTENA  160 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc-----eeeecccCceEEEeccC
Confidence            53     578999999999999999999877889999999999999999999999998     99999999999999999


Q ss_pred             cEEEeecCccccCCCCCceeeeeecccccCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 018047          205 EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN  279 (361)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  279 (361)
                      .+||+|||++..+.....  ...+.+|||.|||||++..     ..|+..+|+||||++..||.-|.+|+....+.    
T Consensus       161 ~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----  234 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----  234 (953)
T ss_pred             cEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----
Confidence            999999999987754432  3445689999999998754     34778899999999999999999998533321    


Q ss_pred             HHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          280 LVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           +       .+-.+....-+....+.....++.++|..||..|..+||++.++|+|-.
T Consensus       235 -----r-------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF  284 (953)
T KOG0587|consen  235 -----R-------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF  284 (953)
T ss_pred             -----h-------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence                 0       0111111111112235677788999999999999999999999998743

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.7e-37  Score=273.32  Aligned_cols=225  Identities=20%  Similarity=0.210  Sum_probs=179.7

Q ss_pred             cCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCchhhh
Q 018047           72 GGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDH  150 (361)
Q Consensus        72 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~  150 (361)
                      |.+|.||++.+. +++.+|+|.+....        ....|...+....|||++++++++.+.+..+++|||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            899999999987 68999999986432        223355555566799999999999999999999999999999999


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecc
Q 018047          151 LNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL  230 (361)
Q Consensus       151 l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  230 (361)
                      +....  .+++..+..++.|+++||+|||+++     ++||||||+||+++.++.++++|||.+..+....     ....
T Consensus        76 l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~  143 (237)
T cd05576          76 ISKFL--NIPEECVKRWAAEMVVALDALHREG-----IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEA  143 (237)
T ss_pred             HHHhc--CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCC
Confidence            87643  5899999999999999999999999     9999999999999999999999999887654321     1234


Q ss_pred             cccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHH
Q 018047          231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTME  310 (361)
Q Consensus       231 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (361)
                      ++..|+|||......++.++|+||+|+++|+|++|+.|+.......            ....      .     ...+..
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~------~-----~~~~~~  200 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHT------T-----LNIPEW  200 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccc------c-----cCCccc
Confidence            5778999999888888999999999999999999998874321100            0000      0     011222


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 018047          311 SIAMFANLASRCVRTESSERPSM-----AECVKE  339 (361)
Q Consensus       311 ~~~~l~~li~~cl~~dp~~Rpt~-----~ell~~  339 (361)
                      .+..+.+++.+||+.||++||++     +++++|
T Consensus       201 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         201 VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             CCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence            34558899999999999999996     565544

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=299.48  Aligned_cols=259  Identities=30%  Similarity=0.417  Sum_probs=212.5

Q ss_pred             CCCCceecccCceEEEEEEEc-CC----CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ....++||+|+||+||+|.+- .|    -+||||++...  .......++..|+.+|.+++|||++++++++.... +-|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            456789999999999999874 33    36899988643  33444678899999999999999999999998766 779


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      |++|+|.|+|.||++..+ ..+-.+..+.|.+|||+|+.|||.+.     ++||||...||||.+-..+|++|||+++.+
T Consensus       775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr-----lVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR-----LVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc-----hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            999999999999998754 47888999999999999999999999     999999999999999999999999999988


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      .............-.+.|||-|.+....|+.++|||||||++||++| |..|++....       ..+...++....   
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-------~eI~dlle~geR---  918 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-------EEIPDLLEKGER---  918 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-------HHhhHHHhcccc---
Confidence            66554444333344678999999999999999999999999999999 7888864432       222222222111   


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                              -.-|..++.++..++.+||..|+..||+++++...+.+...+..
T Consensus       919 --------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  919 --------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             --------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence                    23355666779999999999999999999999999988776543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=268.20  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=204.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ..+|...++||+|+|++|..++++ +.+.||+|++++..+++.+..+.+..|-.+..+- +||.+|-+...|+....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357899999999999999999977 6889999999998888888888888999998887 69999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      |.||.+||+|.-++++..  .++++.+..+...|+.||.|||++|     ||.||||.+|+|+|..|++||+|+|.++.-
T Consensus       329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg-----iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC-----eeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999999887744  7999999999999999999999999     999999999999999999999999999743


Q ss_pred             -CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC-CCCchhHHHHH-HHHhhhhhhh
Q 018047          218 -PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ-GVNDQNLVLQV-RHILNDRKKL  294 (361)
Q Consensus       218 -~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~  294 (361)
                       ..++   .+.+++|||.|.|||++.+..|+...|+|+||++++||+.|+.||+..- +..+.+....+ +-+++..-.+
T Consensus       402 l~~gd---~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri  478 (593)
T KOG0695|consen  402 LGPGD---TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI  478 (593)
T ss_pred             CCCCc---ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence             3333   3567899999999999999999999999999999999999999997532 11111111111 1111111111


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP  331 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  331 (361)
                                   |...+-....+++.-|+.||.+|.
T Consensus       479 -------------prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  479 -------------PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -------------cceeehhhHHHHHHhhcCCcHHhc
Confidence                         111122245688889999999995

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-39  Score=268.26  Aligned_cols=271  Identities=24%  Similarity=0.363  Sum_probs=198.7

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--------C
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--------G  132 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~  132 (361)
                      .|+...+||+|.||.||+|+.+ +|+.||+|++-...-+..-. ....+|+.+|..|+|+|++.+++.|..        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-italreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4666778999999999999976 68889999764432222222 244569999999999999999877643        3


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      ..+|+||++|+. +|.-.+.+. ..+++...+..++.++.+||.|+|+..     |+|||+||+|+|++.+|.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k-----ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK-----ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh-----HHhhcccHhhEEEcCCceEEeeccc
Confidence            468999999987 888888654 357999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCce--eeeeecccccCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          213 LAKLMPEGQET--YVTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       213 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      +++.+......  ......+.|..|.+||.+. ...|+++.|||+-|||+.||+++.+.++.+.......++..+..-..
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            99876543322  1223456799999999655 46789999999999999999999999876654333333333221110


Q ss_pred             -----h--hhhhhhhcCcc-ccCCCC--------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          290 -----D--RKKLRKVIDPE-LSRSSY--------TMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       290 -----~--~~~~~~~~~~~-~~~~~~--------~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                           .  ...+-+.+..+ +....+        +..-.....+|+.+++..||.+|+++++++.|.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence                 0  00011111000 110100        000112567999999999999999999998874

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=296.21  Aligned_cols=262  Identities=27%  Similarity=0.441  Sum_probs=208.1

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc--C------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR--S------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYC  129 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~--~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  129 (361)
                      ..++..+.+.||+|.||.|++|...  .      ...||||.+.....  ......+..|+++|..+ +|+||+.++|+|
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3344556669999999999999754  1      34689998865432  35678899999999999 599999999999


Q ss_pred             EcCCEEEEEEEecCCCchhhhcccCC------------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCC
Q 018047          130 ADGKHRFLVYEYMQKGNLQDHLNGIG------------E--PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKS  195 (361)
Q Consensus       130 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp  195 (361)
                      ...+..++|+||+..|+|.+|++..+            .  ..++...++.++.|||.|++||++..     ++||||..
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-----~vHRDLAa  446 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-----CVHRDLAA  446 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-----ccchhhhh
Confidence            99999999999999999999997654            0  13888899999999999999999998     99999999


Q ss_pred             CCeeeCCCCcEEEeecCccccCCCCCceeeeeeccc--ccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 018047          196 TNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG--TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLN  272 (361)
Q Consensus       196 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~  272 (361)
                      .|||+..+..+|++|||+++............ ..|  ...|||||.+....|+.++||||||++|||++| |..||...
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            99999999999999999998655443332111 112  346999999999999999999999999999999 67787531


Q ss_pred             CCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          273 QGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      ..  ..++...    +....           +...|..+..++.++++.||+.+|++||++.++.+.+...+.
T Consensus       526 ~~--~~~l~~~----l~~G~-----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  526 PP--TEELLEF----LKEGN-----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             Cc--HHHHHHH----HhcCC-----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            11  1122111    11111           133455566779999999999999999999999999999764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=277.37  Aligned_cols=261  Identities=28%  Similarity=0.383  Sum_probs=200.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc----hhHHHHHHHHHHHHhcCCCcceeEEEEEE-cCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA----DGEHEFRVEVDILSRLDHPNLVSLIGYCA-DGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~  134 (361)
                      ++|-.+.+||+|||+.||+|.+- ..+.||+|+-........    .-.....+|..+.+.|+||.||++|++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            45666788999999999999865 478899998654322222    22345678999999999999999999986 5678


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC---CcEEEeec
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN---FEAKISDF  211 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~---~~~kl~Df  211 (361)
                      .+-|+|||+|.+|.-|++...  .+++..+..|+.||+.||.||....   .||||.||||.|||+.++   |.+||+||
T Consensus       543 FCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEik---pPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIK---PPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccC---CCeeeeccCCccEEEecCcccceeEeeec
Confidence            899999999999999998754  7999999999999999999999876   569999999999999654   78999999


Q ss_pred             CccccCCCCCce-----eeeeecccccCccCccccc----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 018047          212 GLAKLMPEGQET-----YVTARVLGTFGYFDPEYTS----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL  282 (361)
Q Consensus       212 g~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  282 (361)
                      |+++++.+....     ..+....||.+|++||.+.    ....+.|+||||+|||+|+.+.|+.||......  ++.+ 
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdIL-  694 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDIL-  694 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHH-
Confidence            999988654322     2344567999999999543    335788999999999999999999999765432  1111 


Q ss_pred             HHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .-..+++..         +.. .+....++.+..++|++||...-++|.+..++..+
T Consensus       695 qeNTIlkAt---------EVq-FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  695 QENTILKAT---------EVQ-FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             hhhchhcce---------ecc-CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            111111111         111 11122344557899999999999999999887654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.4e-36  Score=292.65  Aligned_cols=266  Identities=22%  Similarity=0.223  Sum_probs=170.8

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-C----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEE-----
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-S----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY-----  128 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-----  128 (361)
                      ..++|...+.||+|+||+||+|++. +    +..||+|++....     ..+....|  .+....+.++..+...     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            4568999999999999999999976 5    7899999875321     11111111  1222222222222211     


Q ss_pred             -EEcCCEEEEEEEecCCCchhhhcccCCCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeE
Q 018047          129 -CADGKHRFLVYEYMQKGNLQDHLNGIGEP------------------KMDWPLRLKVALGAAKGLAYLHSSSAVGIPIV  189 (361)
Q Consensus       129 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ii  189 (361)
                       ...+...++|+||+++++|.+++......                  ......+..++.|++.||+|||+++     |+
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-----Ii  277 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-----IV  277 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC-----EE
Confidence             24567889999999999999988653210                  1123446679999999999999999     99


Q ss_pred             ecCCCCCCeeeCC-CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCC----------------------CC
Q 018047          190 HRDFKSTNVLLSA-NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG----------------------KL  246 (361)
Q Consensus       190 H~Dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~  246 (361)
                      ||||||+|||++. ++.+||+|||++..+..+... ......+++.|+|||.+...                      .+
T Consensus       278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~  356 (566)
T PLN03225        278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL  356 (566)
T ss_pred             eCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence            9999999999986 589999999999866443222 23346789999999954321                      23


Q ss_pred             CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCC-----CCCHHHHHHHHHHHHH
Q 018047          247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS-----SYTMESIAMFANLASR  321 (361)
Q Consensus       247 ~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~  321 (361)
                      ..++|||||||++|||+++..++...    ...+...+.....+.......+.+.....     ...........+|+.+
T Consensus       357 ~~k~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        357 PDRFDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             CCCcccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence            44679999999999999977654211    01111111110000001111111110000     0000011234589999


Q ss_pred             ccCCCCCCCCCHHHHHHHHH
Q 018047          322 CVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       322 cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ||+.||++|||++|+|+|-+
T Consensus       433 mL~~dP~kR~ta~e~L~Hpf  452 (566)
T PLN03225        433 MMRFKGRQRISAKAALAHPY  452 (566)
T ss_pred             HccCCcccCCCHHHHhCCcC
Confidence            99999999999999999855

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.2e-35  Score=258.16  Aligned_cols=240  Identities=30%  Similarity=0.451  Sum_probs=192.8

Q ss_pred             CceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCchhhhc
Q 018047           73 GFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL  151 (361)
Q Consensus        73 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l  151 (361)
                      +||.||+|... +|+.+++|++.......  ....+.+|+..++.++|+|++++++++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999987 58999999986543221  1578899999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeeccc
Q 018047          152 NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG  231 (361)
Q Consensus       152 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  231 (361)
                      ....  .+++..++.++.+++.++.+||+.+     ++|+||+|+||+++.++.++|+|||.+.......   ......+
T Consensus        79 ~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~  148 (244)
T smart00220       79 KKRG--RLSEDEARFYARQILSALEYLHSNG-----IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG  148 (244)
T ss_pred             Hhcc--CCCHHHHHHHHHHHHHHHHHHHHcC-----eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence            7643  3899999999999999999999999     9999999999999999999999999998765432   2233467


Q ss_pred             ccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHH
Q 018047          232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMES  311 (361)
Q Consensus       232 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (361)
                      +..|+|||......++.++||||||+++++|++|..||.....  .......   ...          ............
T Consensus       149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~---~~~----------~~~~~~~~~~~~  213 (244)
T smart00220      149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKK---IGK----------PKPPFPPPEWKI  213 (244)
T ss_pred             CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHH---Hhc----------cCCCCccccccC
Confidence            8899999998888889999999999999999999999854211  1111111   110          000000000014


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          312 IAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       312 ~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      +..+.+++.+||..+|++||++.+++++
T Consensus       214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      214 SPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             CHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            4568999999999999999999999974

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=242.54  Aligned_cols=202  Identities=23%  Similarity=0.384  Sum_probs=167.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  137 (361)
                      .++...+..||+|+||.|-+.++. +|...|+|.+...  ......+...+|+.+..+. .+|.+|.++|.+...+..++
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            344555677999999999999877 7999999998754  2234456677788887776 69999999999999999999


Q ss_pred             EEEecCCCchhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          138 VYEYMQKGNLQDHLNG--IGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      .||.|.. ||..+-..  ..+..+++..+-+|+..++.||.|||++=    .+||||+||+|||++.+|++|+||||++-
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL----~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL----SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh----hhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999965 88776543  12457999999999999999999999974    49999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCccccc----CCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTS----TGKLTLQSDVYAFGVVLLELLTGRRAVDL  271 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~p~~~  271 (361)
                      .+.++....   -..|-..|||||.+.    +..|+.++||||||+++.||.+++.||+.
T Consensus       198 ~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  198 YLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            876554221   134667899999654    45799999999999999999999999963

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-34  Score=274.82  Aligned_cols=270  Identities=23%  Similarity=0.275  Sum_probs=180.3

Q ss_pred             cCCCCCCceecccCceEEEEEEE-----------------cCCCEEEEEEeecCCCCcc-----------hhHHHHHHHH
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTL-----------------RSGEVVAIKKMELPRFKEA-----------DGEHEFRVEV  111 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~  111 (361)
                      .++|.+.++||+|+||+||+|..                 ..++.||||++........           ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            45899999999999999999964                 1356799999864321100           0112233466


Q ss_pred             HHHHhcCCCcc-----eeEEEEEEc--------CCEEEEEEEecCCCchhhhcccCC----------------------C
Q 018047          112 DILSRLDHPNL-----VSLIGYCAD--------GKHRFLVYEYMQKGNLQDHLNGIG----------------------E  156 (361)
Q Consensus       112 ~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------~  156 (361)
                      ..+.+++|.++     ++++++|..        .+..+|||||+++|+|.+++....                      .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766544     667777643        356899999999999999886421                      1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCcc
Q 018047          157 PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF  236 (361)
Q Consensus       157 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  236 (361)
                      ..+++..+..++.|++.+|.|||+.+     ++||||||+|||++.++.+||+|||++..+..+... ......+++.|+
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~-----ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~  377 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG-----IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS  377 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence            23467788999999999999999999     999999999999999999999999999765433211 111223478999


Q ss_pred             CcccccCCC--------------------C--CccchhHHHHHHHHHHHhCCC-CCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          237 DPEYTSTGK--------------------L--TLQSDVYAFGVVLLELLTGRR-AVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       237 aPE~~~~~~--------------------~--~~~~DiwslG~il~ell~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      |||.+....                    +  ..+.||||+||++|+|++|.. ||........     ..+...++...
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-----~~~~~~~~~~~  452 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-----ELRQYDNDLNR  452 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-----HHhhccchHHH
Confidence            999764322                    1  124699999999999999875 6532111000     00000000000


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTES---SERPSMAECVKELQ  341 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rpt~~ell~~l~  341 (361)
                      ............ .....+....+|+.+||..+|   .+|+|++|+|+|.+
T Consensus       453 ~r~~~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        453 WRMYKGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             HHhhcccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence            000000111101 112234568899999999766   68999999999854

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=257.87  Aligned_cols=268  Identities=22%  Similarity=0.302  Sum_probs=196.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-----C---CcceeEEEEEEc
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-----H---PNLVSLIGYCAD  131 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~~~~~~~~  131 (361)
                      .+|.+.++||.|.|++||++-+. +.+.||+|+.+..    ..-.+....||++|++++     |   ..||+|++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            67888999999999999999876 5789999998632    223345677999999883     3   359999999975


Q ss_pred             ----CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC----
Q 018047          132 ----GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN----  203 (361)
Q Consensus       132 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~----  203 (361)
                          +.++++|+|++ |.+|..+|.......++...+..|++||+.||.|||...    .|||-||||+|||+..+    
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec----gIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC----GIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc----CccccCCCcceeeeeccccch
Confidence                45899999999 679999998887788999999999999999999999976    49999999999999421    


Q ss_pred             -------C------------------------------------------------------------------------
Q 018047          204 -------F------------------------------------------------------------------------  204 (361)
Q Consensus       204 -------~------------------------------------------------------------------------  204 (361)
                             +                                                                        
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                   0                                                                        


Q ss_pred             --------------------------------------------------------------------------------
Q 018047          205 --------------------------------------------------------------------------------  204 (361)
Q Consensus       205 --------------------------------------------------------------------------------  204 (361)
                                                                                                      
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence                                                                                            


Q ss_pred             ---cEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 018047          205 ---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       205 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  281 (361)
                         .+||+|||-|+-+...     ...-+.|..|.|||++.+..|++.+||||++|+++||+||...|+...+..-..-.
T Consensus       389 ~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE  463 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE  463 (590)
T ss_pred             cceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence               0222222222211100     01123456799999999999999999999999999999999999776543221111


Q ss_pred             HHHHHHhhhhhh-----------hhhhcCcc------------------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 018047          282 LQVRHILNDRKK-----------LRKVIDPE------------------LSRSSYTMESIAMFANLASRCVRTESSERPS  332 (361)
Q Consensus       282 ~~~~~~~~~~~~-----------~~~~~~~~------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  332 (361)
                      .-+..+.+--+.           -+..+...                  ...-..+.+.+.++.+++.-||+.+|++|||
T Consensus       464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t  543 (590)
T KOG1290|consen  464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT  543 (590)
T ss_pred             HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence            111111111111           11111110                  0122467788899999999999999999999


Q ss_pred             HHHHHHHHHH
Q 018047          333 MAECVKELQL  342 (361)
Q Consensus       333 ~~ell~~l~~  342 (361)
                      +.++|+|.+-
T Consensus       544 A~~cl~hPwL  553 (590)
T KOG1290|consen  544 AAQCLKHPWL  553 (590)
T ss_pred             HHHHhcCccc
Confidence            9999999873

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=283.34  Aligned_cols=247  Identities=29%  Similarity=0.419  Sum_probs=190.8

Q ss_pred             CCCCceecccCce-EEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEE
Q 018047           63 FSDDNFLGKGGFG-RVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        63 ~~~~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      |...+++|.|+.| .||+|... |+.||||++..      +...-..+|+..|+.- .|||||++++.-.+....||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            5555779999987 67899887 88999998753      2234567899999998 59999999999999999999999


Q ss_pred             ecCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---C--CcEEEeecCc
Q 018047          141 YMQKGNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---N--FEAKISDFGL  213 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---~--~~~kl~Dfg~  213 (361)
                      .|.. +|.++++...  .........+.+..|+++||++||+.+     |+||||||.||||+.   +  ..++|+|||+
T Consensus       584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~-----iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK-----IVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc-----cccccCCCceEEEEccCCCcceeEEeccccc
Confidence            9965 9999998741  111111345778899999999999998     999999999999976   3  4799999999


Q ss_pred             cccCCCCCceee-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          214 AKLMPEGQETYV-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG-RRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       214 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      ++.+..+..... .....||.+|+|||++.......++|||||||++|+.++| ..||...-..        -..++.+.
T Consensus       658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--------~~NIl~~~  729 (903)
T KOG1027|consen  658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--------QANILTGN  729 (903)
T ss_pred             ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--------hhhhhcCc
Confidence            999876554322 3456799999999999988888899999999999999997 8999633221        11122222


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ..+..+       .... ++  +..+||.+|++++|..||++.+||.|.
T Consensus       730 ~~L~~L-------~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP  768 (903)
T KOG1027|consen  730 YTLVHL-------EPLP-DC--EAKDLISRMLNPDPQLRPSATDVLNHP  768 (903)
T ss_pred             cceeee-------ccCc-hH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence            222111       1111 11  578999999999999999999998763

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=8.8e-35  Score=239.74  Aligned_cols=261  Identities=21%  Similarity=0.311  Sum_probs=199.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcC--CEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADG--KHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~  136 (361)
                      ++|++.+.+|+|.|+.||.|..- +++.++||++..      .....+.+|+.+|+.|. ||||++++++..+.  ....
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            46888899999999999999854 688999998752      34567899999999996 99999999998775  4667


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEeecCccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFGLAK  215 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~~~  215 (361)
                      ||+||+.+-+......     .++...+..++.+++.||.|+||.|     |.|||+||.|+++|.. ..++|+|+|+|.
T Consensus       112 LiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G-----ImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC-----cccccCCcceeeechhhceeeeeecchHh
Confidence            9999998877776643     5677788999999999999999999     9999999999999965 579999999999


Q ss_pred             cCCCCCceeeeeecccccCccCcccc-cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH-----HHhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR-----HILN  289 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----~~~~  289 (361)
                      ....+....   ..+.+..|-.||.+ ..+.|+..-|+|||||++..|+..+.||....+..++ ++..++     +...
T Consensus       182 FYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el~~  257 (338)
T KOG0668|consen  182 FYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDELYA  257 (338)
T ss_pred             hcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHHHH
Confidence            887665432   33567789999965 4567899999999999999999999999766554332 211111     1111


Q ss_pred             hhhhhhhhcCcccc---------------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          290 DRKKLRKVIDPELS---------------RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       290 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...+....++|.+.               ......-.+.+..+|+.+.|..|-++|||++|.+.|.-
T Consensus       258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hpy  324 (338)
T KOG0668|consen  258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPY  324 (338)
T ss_pred             HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCch
Confidence            11111222233221               01111122356889999999999999999999998754

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=263.51  Aligned_cols=199  Identities=27%  Similarity=0.383  Sum_probs=175.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHH-----HHHHHHHHHHhcC---CCcceeEEEEEEc
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEH-----EFRVEVDILSRLD---HPNLVSLIGYCAD  131 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~---h~~iv~~~~~~~~  131 (361)
                      .+|...+.||.|+||.|+.|.++ +...|+||.+.+.......+.+     .+-.|+.+|..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            45888999999999999999988 5778999998776655444443     3556999999997   9999999999999


Q ss_pred             CCEEEEEEEe-cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 018047          132 GKHRFLVYEY-MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD  210 (361)
Q Consensus       132 ~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~D  210 (361)
                      ++.+||+||- -++-+|+++|+.+  +.+++.+...|+.|++-|+++||++|     |+|||||-+|+.++.+|.+||+|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~-----ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQG-----IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccC-----ceecccccccEEEecCCeEEEee
Confidence            9999999997 4566999999874  48999999999999999999999999     99999999999999999999999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVD  270 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~  270 (361)
                      ||.+....++.    ...++||..|.|||++.+..| +..-|||+||++||.++....||.
T Consensus       714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99998876664    334689999999999998877 566899999999999999988873

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=248.49  Aligned_cols=269  Identities=23%  Similarity=0.330  Sum_probs=201.5

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-----EE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-----HR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~  135 (361)
                      +.+..+-||-|+||+||.+++. +|+.||+|++..- +..-...+.+.+|++.|...+|.|++..+++.+-..     ++
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            3455688999999999999987 7999999998532 233344567788999999999999999988865432     56


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |+++|++.. +|...|.+  .+.++.+.+.-+++||+.||+|||+.+     |.||||||.|.|++++..+||||||+++
T Consensus       133 YV~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~-----ILHRDIKPGNLLVNSNCvLKICDFGLAR  204 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTAN-----ILHRDIKPGNLLVNSNCILKICDFGLAR  204 (449)
T ss_pred             HHHHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcc-----hhhccCCCccEEeccCceEEeccccccc
Confidence            889999965 99998876  457888999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH--------
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH--------  286 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--------  286 (361)
                      .....+.. .....+.|.+|.|||++.+. .|+.+.||||.|||+.||+..+-.|....+....+++..+-.        
T Consensus       205 vee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr  283 (449)
T KOG0664|consen  205 TWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK  283 (449)
T ss_pred             ccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence            76544333 33345679999999988764 689999999999999999999999876554444333322210        


Q ss_pred             HhhhhhhhhhhcCccccCC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          287 ILNDRKKLRKVIDPELSRS--------SYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..++ +....++.......        .-+.....+-..+..+++..||++|.+..+.+.++.
T Consensus       284 ~ACE-GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  284 YACE-GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHhh-hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            0011 01111111111100        111123345678889999999999999999988764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=4.3e-32  Score=232.62  Aligned_cols=212  Identities=36%  Similarity=0.615  Sum_probs=183.5

Q ss_pred             ecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCch
Q 018047           69 LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL  147 (361)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  147 (361)
                      ||+|++|.||++... +++.+++|++.......  ....+.+|+..++.++|++++++++++......++++||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999987 48999999986542211  346788999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-CCcEEEeecCccccCCCCCceeee
Q 018047          148 QDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLMPEGQETYVT  226 (361)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~  226 (361)
                      .+++.... ..+++..+..++.++++++++||+.+     ++|+||+|.||+++. ++.++|+|||.+........  ..
T Consensus        79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~-----~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~  150 (215)
T cd00180          79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG-----IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL  150 (215)
T ss_pred             HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence            99987642 36899999999999999999999999     999999999999999 89999999999987654321  12


Q ss_pred             eecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCC
Q 018047          227 ARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS  305 (361)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (361)
                      ....+...|++||..... ..+.++|+|+||+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            234578899999988776 788999999999999999                                           


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          306 SYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       306 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                             ..+.+++.+|++.||++||++.++++++
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                   1277899999999999999999999764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=4e-34  Score=260.06  Aligned_cols=273  Identities=20%  Similarity=0.235  Sum_probs=206.6

Q ss_pred             HHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC------CCcceeEEE
Q 018047           55 EMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------HPNLVSLIG  127 (361)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~  127 (361)
                      ..+....+|.+....|+|-|++|..|.+. .|..||||++..    .+.-...=..|+++|++|+      ..++++++.
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn----NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN----NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec----chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            33455667888888999999999999976 488999999974    2333344567999999994      358999999


Q ss_pred             EEEcCCEEEEEEEecCCCchhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-Cc
Q 018047          128 YCADGKHRFLVYEYMQKGNLQDHLNGIGE-PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FE  205 (361)
Q Consensus       128 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~  205 (361)
                      .|.+.+++|||+|-+. -+|.+.+..++. -.+....+..++.|+.-||..|...|     |+|.||||+|||+++. ..
T Consensus       502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~-----vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG-----VLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC-----eeecccCccceEeccCcce
Confidence            9999999999999884 499999987763 35788889999999999999999999     9999999999999875 67


Q ss_pred             EEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 018047          206 AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      +||||||.|.....+..    ..+..+..|.|||++.+.+|+...|+||.||+||||.||+..|.+........+...++
T Consensus       576 LKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             eeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            99999999987765542    22455678999999999999999999999999999999999997554322222222221


Q ss_pred             HHhhh-----hhhhhhhcCccc--------------------------------c----CCCCCHHHHHHHHHHHHHccC
Q 018047          286 HILND-----RKKLRKVIDPEL--------------------------------S----RSSYTMESIAMFANLASRCVR  324 (361)
Q Consensus       286 ~~~~~-----~~~~~~~~~~~~--------------------------------~----~~~~~~~~~~~l~~li~~cl~  324 (361)
                      ..+..     ..-+.+-+|..+                                .    ...-.......|.+|+.+||.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            11100     000111111110                                0    011122334678999999999


Q ss_pred             CCCCCCCCHHHHHHHHH
Q 018047          325 TESSERPSMAECVKELQ  341 (361)
Q Consensus       325 ~dp~~Rpt~~ell~~l~  341 (361)
                      .||++|.|..+.|.|..
T Consensus       732 LdP~KRit~nqAL~HpF  748 (752)
T KOG0670|consen  732 LDPEKRITVNQALKHPF  748 (752)
T ss_pred             cChhhcCCHHHHhcCCc
Confidence            99999999999998854

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=241.67  Aligned_cols=266  Identities=20%  Similarity=0.302  Sum_probs=199.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC------C
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG------K  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  133 (361)
                      .+|...+.+|.|.- .|..+.+. .+..||+|+...+. ......+...+|..++..+.|+|+++++.+|.-.      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            45777788899988 66666654 68999999998873 4444556677899999999999999999998543      3


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..|+|||+|. ++|...+..    .++-..+..+++|++.|++|||+.|     |+||||||+||++..++.+||.|||+
T Consensus        95 e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~-----IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG-----IIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc-----eeecccCcccceecchhheeeccchh
Confidence            5799999995 599988863    5777889999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc------------hhHH
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND------------QNLV  281 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------~~~~  281 (361)
                      +..-...   ......+.|..|.|||++.+-.+...+||||+||++.||++|+..|.+.+..+.            ..+.
T Consensus       165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            9854322   344557889999999998888899999999999999999999999864432111            1111


Q ss_pred             HHHHHH----hhhh-----hhhhhhcCcc-ccC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          282 LQVRHI----LNDR-----KKLRKVIDPE-LSR-SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       282 ~~~~~~----~~~~-----~~~~~~~~~~-~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .++...    ....     ..+.+.+... +.. ...+........+++.+||-.||++|.+++++|+|.=
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY  312 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY  312 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence            111100    0000     0111111111 100 0011123346789999999999999999999999853

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=242.87  Aligned_cols=266  Identities=23%  Similarity=0.335  Sum_probs=208.7

Q ss_pred             HHHHHHcCCCCCCceecccCceEEEEEEEcC------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEE
Q 018047           54 KEMEEATCSFSDDNFLGKGGFGRVYKGTLRS------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG  127 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  127 (361)
                      +++....++++...++-+|.||.||.|.+.+      .+.|-+|.+...  ...-....+..|.-.+..+.|||+.++.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            4444556678888889999999999997652      234556655322  23345667888988999999999999999


Q ss_pred             EEE-cCCEEEEEEEecCCCchhhhccc------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee
Q 018047          128 YCA-DGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       128 ~~~-~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill  200 (361)
                      ++. +....++++.++.-|+|..|+.-      ...+.+.-.+...++.|++.|++|||+++     +||.||...|.++
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~-----ViHkDiAaRNCvI  429 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG-----VIHKDIAARNCVI  429 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC-----cccchhhhhccee
Confidence            875 45688899999999999999972      22345677788899999999999999999     9999999999999


Q ss_pred             CCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 018047          201 SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQN  279 (361)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~  279 (361)
                      |+..++||+|=.+++.+-..+.............||+||.+....|+.++|+||||++||||+| |+.|+...++   . 
T Consensus       430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---f-  505 (563)
T KOG1024|consen  430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---F-  505 (563)
T ss_pred             hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---H-
Confidence            9999999999999987655555444333344668999999999999999999999999999999 8888853332   1 


Q ss_pred             HHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          280 LVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                         .+...+++...+           .-|.+++.+++.++..||..+|++||+++++..-|.+.-
T Consensus       506 ---Em~~ylkdGyRl-----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  506 ---EMEHYLKDGYRL-----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             ---HHHHHHhcccee-----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence               122223333222           235567788999999999999999999999998887643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=2e-33  Score=262.20  Aligned_cols=255  Identities=24%  Similarity=0.381  Sum_probs=202.7

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ...+|+....+|.|+||.||+++++ +++..|+|+++..   ..+...-+..|+-+++..+||||+.+++.+......++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            3457889999999999999999977 7999999998763   33445566779999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      +||||.+|+|.+.-.-  ...+++.++..+.+..+++++|||++|     =+|||||-.|||+++.|.+|+.|||.+-.+
T Consensus        90 cMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g-----k~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG-----KIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             EEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC-----cccccccccceeecccCceeecccCchhhh
Confidence            9999999999997654  348999999999999999999999999     799999999999999999999999998765


Q ss_pred             CCCCceeeeeecccccCccCcccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYT---STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ....  .....+.||++|||||+.   ..+.|...+|||++|++..|+.--.+|.....+.  +.+....+.        
T Consensus       163 tati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~LmTkS--------  230 (829)
T KOG0576|consen  163 TATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALFLMTKS--------  230 (829)
T ss_pred             hhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHHHhhcc--------
Confidence            3322  123457899999999964   5678999999999999999998877775432221  111111100        


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                       ..-.+.+   .-+......+.++++.||..+|++|||++-+|+|
T Consensus       231 -~~qpp~l---kDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  231 -GFQPPTL---KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             -CCCCCcc---cCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence             0001111   1223344568999999999999999999988875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=7.9e-32  Score=240.30  Aligned_cols=268  Identities=25%  Similarity=0.331  Sum_probs=200.8

Q ss_pred             HHHHcCCCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEE
Q 018047           56 MEEATCSFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCA  130 (361)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  130 (361)
                      +....+.|..+++||.|+|++||++++.    ..+.||+|.+..     ......+.+|++.|..+. +.||+++.+.+.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~-----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR-----TSSPSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc-----ccCchHHHHHHHHHHHhccchhhhcchhhhc
Confidence            4455667999999999999999999754    367899999854     344556889999999994 999999999999


Q ss_pred             cCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEe
Q 018047          131 DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKIS  209 (361)
Q Consensus       131 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~  209 (361)
                      .++...+|+||++..+..++...     ++...+..+++.++.||.++|++|     ||||||||.|+|.+.. +.-.|.
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G-----IvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG-----IVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC-----ccccCCCccccccccccCCceEE
Confidence            99999999999999999998764     668889999999999999999999     9999999999999864 788999


Q ss_pred             ecCccccCCC-------------------C-----------------------CceeeeeecccccCccCcccccC-CCC
Q 018047          210 DFGLAKLMPE-------------------G-----------------------QETYVTARVLGTFGYFDPEYTST-GKL  246 (361)
Q Consensus       210 Dfg~~~~~~~-------------------~-----------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~  246 (361)
                      |||+|.....                   +                       ..........||++|.|||++.. ...
T Consensus       176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q  255 (418)
T KOG1167|consen  176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ  255 (418)
T ss_pred             echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence            9999972100                   0                       00011223569999999998754 556


Q ss_pred             CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh-----------hh-------------------hhh-h
Q 018047          247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-----------DR-------------------KKL-R  295 (361)
Q Consensus       247 ~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~-------------------~~~-~  295 (361)
                      +++.||||-|+|++.+++++.||....+..+. +.+.+ .++.           +.                   ..+ .
T Consensus       256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~a-l~ei~-tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADA-LAEIA-TIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             CCccceeeccceeehhhccccccccCccccch-HHHHH-HHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence            88999999999999999999999765432221 11111 0000           00                   000 0


Q ss_pred             hhcCc----cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          296 KVIDP----ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       296 ~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      +.+.+    ...........+..+.+|+.+||+.||.+|.|+++.|+|.
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence            00000    0111122223345789999999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.1e-30  Score=225.28  Aligned_cols=199  Identities=35%  Similarity=0.528  Sum_probs=171.7

Q ss_pred             CCCCceecccCceEEEEEEEcC-CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |...+.||.|++|+||++.... ++.+|+|.+......  .....+.+|++.++.++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            5567889999999999999874 899999998754322  2467888999999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +++++|.+++..... .+++..+..++.+++.++.+||+++     ++|+||+|.||+++.++.++|+|||.+.......
T Consensus        79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       79 CEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG-----IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            999999999976432 2889999999999999999999999     9999999999999999999999999998775442


Q ss_pred             ceeeeeecccccCccCcccc-cCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 018047          222 ETYVTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAVD  270 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~p~~  270 (361)
                      .. ......++..|++||.. ....++.++|+||||+++++|++|+.||.
T Consensus       153 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      153 AA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            11 12234578889999987 66778889999999999999999999995

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=224.71  Aligned_cols=251  Identities=20%  Similarity=0.312  Sum_probs=187.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEE-EEcCCEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGY-CADGKHRFL  137 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-~~~~~~~~l  137 (361)
                      +.|.+.+.||+|.||.+-++.++ +...+++|-+..+    ....++|.+|+..--.|. |.||+.-|++ |+..+.+++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            45888999999999999999988 6788999988744    456778999998877774 8999988765 677788899


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC-C-CCcEEEeecCccc
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS-A-NFEAKISDFGLAK  215 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~-~-~~~~kl~Dfg~~~  215 (361)
                      ++||+|.|+|.+-+...   .+-+.....++.|+++||.|+|+++     ++|||||.+|||+- . ...+||||||+..
T Consensus       100 ~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHskn-----lVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKN-----LVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             eeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccc-----hhhcccccceEEEecCCccEEEeeeccccc
Confidence            99999999999988764   4777888899999999999999999     99999999999984 3 3589999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccC---C--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTST---G--KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      ..+..-.     ...-+..|.|||....   +  ...+.+|+|.||+++|.++||+.||+. ....+..+..+.+-....
T Consensus       172 k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  172 KVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKRK  245 (378)
T ss_pred             ccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhccc
Confidence            6543211     1223567999996432   2  235779999999999999999999984 333444454444322211


Q ss_pred             hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ...+...+      ..    .++.+..+.++-|..+|++|=...++-+.
T Consensus       246 ~~~~P~~F------~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  246 NPALPKKF------NP----FSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             CccCchhh------cc----cCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            11111111      11    12346778899999999999444444443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.4e-29  Score=258.87  Aligned_cols=199  Identities=22%  Similarity=0.241  Sum_probs=140.9

Q ss_pred             hcCC-CcceeEEEEE-------EcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCC
Q 018047          116 RLDH-PNLVSLIGYC-------ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP  187 (361)
Q Consensus       116 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~  187 (361)
                      .++| +||++++++|       .+.+.+++++||+ +++|.+++... ...+++..+..++.||++||+|||++|     
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g-----  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG-----  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC-----
Confidence            3455 5788888877       2335677889988 56999999753 346999999999999999999999999     


Q ss_pred             eEecCCCCCCeeeCCCCc-------------------EEEeecCccccCCCCCc--------------eeeeeecccccC
Q 018047          188 IVHRDFKSTNVLLSANFE-------------------AKISDFGLAKLMPEGQE--------------TYVTARVLGTFG  234 (361)
Q Consensus       188 iiH~Dikp~Nill~~~~~-------------------~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~  234 (361)
                      |+||||||+||||+..+.                   +|++|||+++.......              ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999965444                   55555555543211000              000112357889


Q ss_pred             ccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHH
Q 018047          235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAM  314 (361)
Q Consensus       235 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (361)
                      |||||++....++.++|||||||+||||++|..|+...     ......+..         ...++..      ......
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~~~---------~~~~~~~------~~~~~~  240 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSLRH---------RVLPPQI------LLNWPK  240 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHHHH---------hhcChhh------hhcCHH
Confidence            99999998899999999999999999999988876311     111111110         0011110      011223


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          315 FANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       315 l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...++.+||+.+|.+||++.|+++|.+
T Consensus       241 ~~~~~~~~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        241 EASFCLWLLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             HHHHHHHhCCCChhhCcChHHHhhchh
Confidence            567889999999999999999999875

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.6e-28  Score=206.07  Aligned_cols=169  Identities=21%  Similarity=0.228  Sum_probs=127.9

Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++...+ ..+++..++.++.|++.||+|||+++           ||+|||++.++.+++  ||++.......   
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~-----------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA-----------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC-----------CcccEeEcCccceee--ccceEeecccc---
Confidence            68999997643 36999999999999999999999854           999999999999999  99998654322   


Q ss_pred             eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccC
Q 018047          225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR  304 (361)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (361)
                          ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......     ............    ..+.  .
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~----~~~~--~  128 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILEILLNGMPA----DDPR--D  128 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHHHHHHHhcc----CCcc--c
Confidence                258999999999999999999999999999999999999995432211     111111111000    0000  0


Q ss_pred             CCCCHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          305 SSYTMESIA--MFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       305 ~~~~~~~~~--~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      .........  .+.+++.+||+.||.+|||+.|+++++..+..
T Consensus       129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            011222233  58999999999999999999999999987754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-26  Score=213.15  Aligned_cols=264  Identities=19%  Similarity=0.239  Sum_probs=199.7

Q ss_pred             CCCCCceecccCceEEEEEEEcCC--CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC----CcceeEEEEE-EcCCE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSG--EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH----PNLVSLIGYC-ADGKH  134 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~~~~~~-~~~~~  134 (361)
                      .|.+.+.||+|+||.||.+.....  ..+|+|..........  . .+..|..++..+..    .++..+++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--S-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--c-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            799999999999999999997743  4788888754321111  1 56678888888863    6899999998 57788


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-----CcEEEe
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-----FEAKIS  209 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-----~~~kl~  209 (361)
                      .|+||+.+ |.+|.++........++..++..++.|++.+|++||+.|     ++||||||+|+++...     ..+.|.
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G-----~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG-----FIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC-----cccCCcCHHHeeecCCCCcccceEEEE
Confidence            89999998 779999887665678999999999999999999999999     9999999999999865     469999


Q ss_pred             ecCccc--cCCCCCce----e-e-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 018047          210 DFGLAK--LMPEGQET----Y-V-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       210 Dfg~~~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  281 (361)
                      |||+++  .+......    . . .....||..|+++....+...+.+.|+||++.++.++..|..||.........   
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---  246 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---  246 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---
Confidence            999998  33222111    0 1 12355999999999999999999999999999999999999999654432221   


Q ss_pred             HHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      ..+......     .....      .....+..+..+...+-..+..++|....+...+........
T Consensus       247 ~~~~~~~~~-----~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~  302 (322)
T KOG1164|consen  247 SKFEKDPRK-----LLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG  302 (322)
T ss_pred             HHHHHHhhh-----hcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence            111111110     00000      112223446666666667899999999999999998887763

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=8.3e-27  Score=202.33  Aligned_cols=264  Identities=18%  Similarity=0.213  Sum_probs=208.4

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .|.++++||+|+||+++.|+.- ++++||||.-...     ...-.+..|....+.|. .++|..++.+...+.+-.||+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            6999999999999999999865 7999999975432     23346777998888884 799999999999998999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-----CcEEEeecCcc
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-----FEAKISDFGLA  214 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-----~~~kl~Dfg~~  214 (361)
                      |++ |.||.|++.-. +..++..++..++.|++.-++|+|++.     +|.|||||+|+||..-     ..|.++|||+|
T Consensus       104 dLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~-----LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKD-----LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcc-----eeecccCccceeecCCCCCCCceEEEEeccch
Confidence            998 67888877644 348999999999999999999999999     9999999999999743     46999999999


Q ss_pred             ccCCCCCcee-----eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          215 KLMPEGQETY-----VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       215 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      +.+.+.....     -.....||..||+-....+...+.+.|+-|||-++.+++-|..||+..-........+.+.....
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr  256 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR  256 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence            9886654332     23457899999999988899999999999999999999999999976544333333332221110


Q ss_pred             hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      . ..+          .......+.++..-+.-.-..+-.+-|+.+-+...+..++.+..
T Consensus       257 ~-T~i----------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  257 S-TPI----------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             c-CCH----------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            0 001          11223345567777777778889999999998888888877654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-27  Score=196.10  Aligned_cols=265  Identities=20%  Similarity=0.216  Sum_probs=204.7

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC-CcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l  137 (361)
                      .++|...+.||+|+||.+|.|..- +|..||||+-...     .....+..|..+.+.|++ ..|..+..+..+...-.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            467999999999999999999854 7999999986432     223456779999999975 778888888888888899


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC---CcEEEeecCcc
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN---FEAKISDFGLA  214 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~  214 (361)
                      |||++ |.||.++++-. ...++..+++-++-|++.-++|+|.++     +|||||||+|+|..-+   ..+.|+|||++
T Consensus        89 VMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~-----fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN-----FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc-----cccccCCccceeeccccccceEEEEeccch
Confidence            99998 77999887644 347999999999999999999999999     9999999999998754   57999999999


Q ss_pred             ccCCCCCcee-----eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          215 KLMPEGQETY-----VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       215 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      +.+.+.....     ......||..|.+--...+...+...|+-|+|.+|.++.-|..||+...........+.+.+..-
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~  241 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM  241 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence            9876543221     12346799999988777677788899999999999999999999987665555555544433211


Q ss_pred             hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      .  ...+.         .....|.++...+..|-..--++-|+...+.+.+..+++.-
T Consensus       242 s--~~ie~---------LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  242 S--TPIEV---------LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             C--CCHHH---------HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence            1  11111         12223455888999999999999999977666655554443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=8.6e-27  Score=214.11  Aligned_cols=169  Identities=20%  Similarity=0.231  Sum_probs=129.6

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc--CCCEEEEEEeecCCC--CcchhHHHHHHHHHHHHhcCCCccee-EEEEEEc
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR--SGEVVAIKKMELPRF--KEADGEHEFRVEVDILSRLDHPNLVS-LIGYCAD  131 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~  131 (361)
                      .....+|...+.||+|+||+||+|.+.  ++..+|||++.....  ........+.+|+++|+.++|+|++. ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            344567999999999999999999875  477789998753211  12233566899999999999999985 4432   


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCC-CCCCeeeCCCCcEEEee
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDF-KSTNVLLSANFEAKISD  210 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Di-kp~Nill~~~~~~kl~D  210 (361)
                       +..|+||||++|++|... ..     ..   ...++.+++++|.|||++|     |+|||| ||+|||++.++.++|+|
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~g-----IiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAG-----ITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCC-----CeeCCCCCcceEEEcCCCCEEEEE
Confidence             457999999999999732 11     11   1457889999999999999     999999 99999999999999999


Q ss_pred             cCccccCCCCCceee------eeecccccCccCcccccC
Q 018047          211 FGLAKLMPEGQETYV------TARVLGTFGYFDPEYTST  243 (361)
Q Consensus       211 fg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  243 (361)
                      ||+++.+........      .....+++.|+|||.+..
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999997754321111      124567888999998654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=6.9e-25  Score=200.45  Aligned_cols=264  Identities=30%  Similarity=0.444  Sum_probs=200.8

Q ss_pred             CCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCC-cceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP-NLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      |.....||.|+||.||++...  ..+++|.+.............+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999987  88999998766444333567888999999999988 799999999888888999999


Q ss_pred             cCCCchhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-cEEEeecCccccCCC
Q 018047          142 MQKGNLQDHLNGIGE-PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-EAKISDFGLAKLMPE  219 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~  219 (361)
                      +.+++|.+++..... ..+.......++.|++.++.|+|+.+     ++|||+||+||+++..+ .++++|||.+..+..
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~-----~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG-----IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence            999999977765322 26888999999999999999999999     99999999999999988 799999999986654


Q ss_pred             CCcee----eeeecccccCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          220 GQETY----VTARVLGTFGYFDPEYTST---GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       220 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      .....    ......|+..|+|||.+..   ...+...|+||+|++++++++|..||......  ...............
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~  232 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPT  232 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCC
Confidence            43221    2345689999999998877   57889999999999999999999997543321  001111111111100


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      .   ....... ..........+.+++..|+..+|..|.+..+....
T Consensus       233 ~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P---SLASPLS-PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c---ccccccC-ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0   0000000 00002223468899999999999999999888776

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.2e-27  Score=231.71  Aligned_cols=260  Identities=19%  Similarity=0.213  Sum_probs=193.2

Q ss_pred             CCCceecccCceEEEEEEEc-CCCEEEEEEeecC---CCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           64 SDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELP---RFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ....++|.|++|.|+.+... ..+.++.|.+...   ..........+..|+-+-..+.|||++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988887755 4555666654421   1111111112556777777889999988877777666666669


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |||++ +|...+.+.  ..+....+..++.|++.|++|+|+.|     +.|||+|++|++++.+|.+||+|||.+..+.-
T Consensus       401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G-----iahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG-----LAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC-----ceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 999999874  26888889999999999999999999     99999999999999999999999999987654


Q ss_pred             CCce--eeeeecccccCccCcccccCCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          220 GQET--YVTARVLGTFGYFDPEYTSTGKLTLQ-SDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       220 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ....  ......+|+..|+|||++....|++. .||||.|+++..|++|+.||..+...++......        .  ..
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~--------~--~~  542 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN--------Y--SD  542 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc--------c--cc
Confidence            4333  34556789999999999999998764 7999999999999999999976654433220000        0  00


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...-.......-...+.....++.+||+.||.+|.|++++++.-|
T Consensus       543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence            000001112223344566889999999999999999999998655

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.9e-27  Score=198.71  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=190.8

Q ss_pred             CCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           65 DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      ...+|.+...|..|+|++. |..+++|++...... ....++|..|.-.|+...||||+.+++.|....++.++..|||.
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhccCCCccccccccc-Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            3456899999999999998 566677877654332 33457899999999999999999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeE-ecCCCCCCeeeCCCCcEEEe--ecCccccCCCCC
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIV-HRDFKSTNVLLSANFEAKIS--DFGLAKLMPEGQ  221 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ii-H~Dikp~Nill~~~~~~kl~--Dfg~~~~~~~~~  221 (361)
                      |||...+.....-..+-.++.+++.+++.|++|||+..    +++ ---|....+++|++.+.+|+  |--++-      
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsle----p~ipr~~lns~hvmidedltarismad~kfsf------  341 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE----PMIPRFYLNSKHVMIDEDLTARISMADTKFSF------  341 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc----hhhhhhhcccceEEecchhhhheecccceeee------
Confidence            99999998766666788899999999999999999976    233 33688999999999877764  211111      


Q ss_pred             ceeeeeecccccCccCcccccCCCCC---ccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          222 ETYVTARVLGTFGYFDPEYTSTGKLT---LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                         ......-.|.||+||.+...+-+   .++|+|||++++|||.|...||....+.+-.-.+..        ..++   
T Consensus       342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial--------eglr---  407 (448)
T KOG0195|consen  342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL--------EGLR---  407 (448)
T ss_pred             ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh--------cccc---
Confidence               11112236889999988765543   578999999999999999999976655433222211        1122   


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                            ...|...+..+..|+.-|.+.||.+||.++.++-.|++.
T Consensus       408 ------v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  408 ------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                  334445556699999999999999999999999888875

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=8.9e-26  Score=221.59  Aligned_cols=250  Identities=24%  Similarity=0.288  Sum_probs=180.1

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCC-CcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRF-KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +|...+.||++.|=+|.+|+++.|. |+||++-+... ..-....+...|++ ...+++||++++..+...+...|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777889999999999999988665 99999876531 11122223333444 455689999999988888888899999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC--C
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM--P  218 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~--~  218 (361)
                      |..+ +|.|.+...  +-+...+...|+.|++.||..+|..|     |+|||||.+|||+++.+.+.|+||...+..  +
T Consensus       102 yvkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~g-----VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLG-----VCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcC-----ccccccccceEEEeeechhhhhcccccCCccCC
Confidence            9976 999999763  46777888889999999999999999     999999999999999999999999987643  2


Q ss_pred             CCCc---eeeeeecccccCccCcccccC----------CC-CCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 018047          219 EGQE---TYVTARVLGTFGYFDPEYTST----------GK-LTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQ  283 (361)
Q Consensus       219 ~~~~---~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~  283 (361)
                      ..+.   .....+..-..+|.|||-+..          .. ..++.||||+||+++||++ |++||...+      +...
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aY  247 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAY  247 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhH
Confidence            2211   111122223458999995432          12 5678999999999999999 577774211      1111


Q ss_pred             HHHHhhhh-hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          284 VRHILNDR-KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       284 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      -..-..+. ..+.++-|.             .+++++..|++.||++|.++++.|+.-
T Consensus       248 r~~~~~~~e~~Le~Ied~-------------~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  248 RSGNADDPEQLLEKIEDV-------------SLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             hccCccCHHHHHHhCcCc-------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence            00000000 011111111             278999999999999999999999983

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=8.9e-25  Score=187.25  Aligned_cols=176  Identities=13%  Similarity=0.094  Sum_probs=136.1

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHH------HHHHHHHHHhcCCCcceeEEEEEEc
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE------FRVEVDILSRLDHPNLVSLIGYCAD  131 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~  131 (361)
                      ...++|...++||.|+||.||++.. +++.+|+|.+.............      +.+|+..+.++.|++|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4567899999999999999999655 57789999997543333322222      5789999999999999999888654


Q ss_pred             C--------CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC
Q 018047          132 G--------KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN  203 (361)
Q Consensus       132 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~  203 (361)
                      .        +..+|+|||++|.+|.++..      ++.    ....+++.++..+|+.|     ++|||++|.||+++.+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g-----i~H~Dikp~Nili~~~  171 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG-----MVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC-----CccCCCChHHEEEeCC
Confidence            3        35789999999999988732      232    24569999999999999     9999999999999999


Q ss_pred             CcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh
Q 018047          204 FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT  264 (361)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  264 (361)
                      | ++|+|||...........              ..+.....++.++|+||||+++..+..
T Consensus       172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            8 999999988755321110              013344556789999999999876654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=4.6e-24  Score=180.53  Aligned_cols=143  Identities=18%  Similarity=0.152  Sum_probs=109.9

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchh-----------------------HHHHHHHHHHHHhcCCCcc
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG-----------------------EHEFRVEVDILSRLDHPNL  122 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~~i  122 (361)
                      ...||+|+||.||+|...+|+.||||++..........                       ......|+..+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            45799999999999998789999999997542211110                       1223459999999987776


Q ss_pred             eeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCCeEecCCCCCCeeeC
Q 018047          123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL-HSSSAVGIPIVHRDFKSTNVLLS  201 (361)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~~~iiH~Dikp~Nill~  201 (361)
                      .....+...  ..+|||||+++++|......  ...++...+..++.|++.+|.++ |+.|     |+||||||+|||++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g-----iiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR-----LVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEE
Confidence            433322222  23899999998877655332  23688999999999999999999 6888     99999999999998


Q ss_pred             CCCcEEEeecCccccCC
Q 018047          202 ANFEAKISDFGLAKLMP  218 (361)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~  218 (361)
                       ++.++|+|||++....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             5789999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=1.1e-23  Score=185.77  Aligned_cols=234  Identities=23%  Similarity=0.322  Sum_probs=152.7

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC----------CcceeEEEEE--
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH----------PNLVSLIGYC--  129 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~~iv~~~~~~--  129 (361)
                      +..+..||.|+++.||.+++. +|+.+|+|++..+........+.+.+|.-....+.+          -.++--++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            445678999999999999988 699999999987765555566777776655544322          1222222221  


Q ss_pred             -------EcC---C-----EEEEEEEecCCCchhhhccc---CCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeE
Q 018047          130 -------ADG---K-----HRFLVYEYMQKGNLQDHLNG---IGEP--KMDWPLRLKVALGAAKGLAYLHSSSAVGIPIV  189 (361)
Q Consensus       130 -------~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ii  189 (361)
                             ...   .     +.+++|+-+. ++|.+++..   ....  .+.......+..|+++.+++||+.|     ++
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G-----lV  167 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG-----LV  167 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-----EE
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-----eE
Confidence                   111   1     2367888774 588887642   1111  2223344666789999999999999     99


Q ss_pred             ecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccC--------CCCCccchhHHHHHHHHH
Q 018047          190 HRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST--------GKLTLQSDVYAFGVVLLE  261 (361)
Q Consensus       190 H~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e  261 (361)
                      |+||+|+|++++.+|.++|+||+.....+..    ... ...+..|.+||....        -.++.+.|.|+||+++|.
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            9999999999999999999999888754321    111 334678999996533        246788999999999999


Q ss_pred             HHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 018047          262 LLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSER  330 (361)
Q Consensus       262 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  330 (361)
                      |++|+.||....+......                      ....+. +.++.+..||..+|+.||.+|
T Consensus       243 lWC~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999975543222111                      224455 778889999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.2e-25  Score=206.85  Aligned_cols=227  Identities=26%  Similarity=0.327  Sum_probs=186.4

Q ss_pred             eecccCceEEEEEEE----cCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEEEec
Q 018047           68 FLGKGGFGRVYKGTL----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      ++|+|+||.|+++..    ..|..+|+|+..+......... ....|..++...+ ||.+|++...++.+...+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            479999999998752    2478899999877655544433 4556888888887 999999999999999999999999


Q ss_pred             CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCc
Q 018047          143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE  222 (361)
Q Consensus       143 ~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (361)
                      .+|.|...+...  ..+.......+...++-+++++|+.+     ++|||+|++||+++.+|++++.|||+++..-....
T Consensus        80 rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~-----iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   80 RGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG-----IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             ccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH-----HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            999999988764  35677777888889999999999999     99999999999999999999999999987644332


Q ss_pred             eeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccc
Q 018047          223 TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL  302 (361)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                      .      +||..|||||++.  .....+|+||||++++||+||..||..          +....+...            
T Consensus       153 ~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~------------  202 (612)
T KOG0603|consen  153 A------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA------------  202 (612)
T ss_pred             c------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh------------
Confidence            1      7999999999987  677889999999999999999999963          112222111            


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 018047          303 SRSSYTMESIAMFANLASRCVRTESSERPSM  333 (361)
Q Consensus       303 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  333 (361)
                       ....|.+......+++..++..+|..|.-.
T Consensus       203 -~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  203 -ELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             -ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence             134567777788999999999999999654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=9.7e-23  Score=172.95  Aligned_cols=143  Identities=17%  Similarity=0.151  Sum_probs=111.9

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcch-----------------------hHHHHHHHHHHHHhcCCCcc
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEAD-----------------------GEHEFRVEVDILSRLDHPNL  122 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~i  122 (361)
                      ...||+|++|+||+|...+|+.||||++.........                       ....+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999878999999998764211000                       01224578999999999987


Q ss_pred             eeEEEEEEcCCEEEEEEEecCCCchhhh-cccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeee
Q 018047          123 VSLIGYCADGKHRFLVYEYMQKGNLQDH-LNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill  200 (361)
                      .....+....  .|+||||++++++... +..   ..++......++.|++.++.++|+ .|     ++||||||+||++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g-----ivHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG-----LVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC-----EecCCCChhhEEE
Confidence            5444333332  4899999998865443 322   357788899999999999999999 99     9999999999999


Q ss_pred             CCCCcEEEeecCccccCCC
Q 018047          201 SANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~  219 (361)
                      + ++.++|+|||++..+..
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            9 88999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.8e-23  Score=206.27  Aligned_cols=257  Identities=22%  Similarity=0.267  Sum_probs=184.6

Q ss_pred             HHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC---CCcceeEEEEEEc
Q 018047           55 EMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD---HPNLVSLIGYCAD  131 (361)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~  131 (361)
                      +.+.....|.+.+.||+|+||+||.|...+|+.||+|+-..+...+--      -=.+++.+|+   -+.|..+...+.-
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY------I~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY------ICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee------ehHHHHHhhchhhhcchHHHHHHHcc
Confidence            344445678888999999999999999888999999987665443322      2234455555   2334444444455


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-------CC
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-------NF  204 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-------~~  204 (361)
                      .+.-+||+||.+.|+|.++++.  ...+++..++.++.|++.-++.||..+     |||+||||+|+||..       .-
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~-----IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMG-----IIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             CCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcc-----eecccCCcceeEeecccCCCCccc
Confidence            6667899999999999999985  458999999999999999999999999     999999999999943       24


Q ss_pred             cEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 018047          205 EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  284 (361)
                      -++|+|||.+..+..-.........++|-.|-.+|...+..++.++|.|.|+.+++-|+.|+..- ...+.         
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~g~---------  908 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKNGS---------  908 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcCCc---------
Confidence            59999999987553221112333456888999999999999999999999999999999998532 00000         


Q ss_pred             HHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                                ...+...++ +-...+   ...+++..+|+.|-..=|...++...|+.++..-.
T Consensus       909 ----------~~~~~~~~~-Ry~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~  958 (974)
T KOG1166|consen  909 ----------SWMVKTNFP-RYWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF  958 (974)
T ss_pred             ----------ceeccccch-hhhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence                      000111111 000111   14456667777444444889999988888877543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.2e-22  Score=168.02  Aligned_cols=188  Identities=18%  Similarity=0.133  Sum_probs=138.4

Q ss_pred             CCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcc-hhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEEEe
Q 018047           64 SDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEA-DGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      .....|++|+||+|+.+.. .+.+++.+.+........ .....+.+|+++|++|+ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3557899999999997765 578888777653322111 11225788999999995 5889999886    346899999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCC-CCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDF-KSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Di-kp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      +.|.+|...+..         ....++.|++.+|+++|++|     |+|||| ||+|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G-----IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG-----VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc-----CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999998754321         11347789999999999999     999999 799999999999999999999865433


Q ss_pred             Cce----e-------eeeecccccCccCcccccCC-CCC-ccchhHHHHHHHHHHHhCCCCCC
Q 018047          221 QET----Y-------VTARVLGTFGYFDPEYTSTG-KLT-LQSDVYAFGVVLLELLTGRRAVD  270 (361)
Q Consensus       221 ~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~ell~g~~p~~  270 (361)
                      ...    .       .......++.+++|+...-. ..+ ...++++.|+-+|.++|++.+..
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            211    0       01112356778888743221 233 56799999999999999998874

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=1.8e-22  Score=189.01  Aligned_cols=220  Identities=31%  Similarity=0.490  Sum_probs=168.4

Q ss_pred             HHhcCCCcceeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCe-EecC
Q 018047          114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI-VHRD  192 (361)
Q Consensus       114 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i-iH~D  192 (361)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...+++-....++.+++.||+|||+..     | .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~-----i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP-----IGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc-----ceeeee
Confidence            45789999999999999999999999999999999999873 558999999999999999999999976     4 9999


Q ss_pred             CCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCC-------CCCccchhHHHHHHHHHHHhC
Q 018047          193 FKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-------KLTLQSDVYAFGVVLLELLTG  265 (361)
Q Consensus       193 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~g  265 (361)
                      +++.|.++|....+||+|||+.................-...|.|||.+...       ..+.+.|+||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999999876431111111122235679999987653       146679999999999999999


Q ss_pred             CCCCCCCCCCCch-hHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          266 RRAVDLNQGVNDQ-NLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       266 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      ..||.......+. ..+..++.      .-...+.|.+...   .+.+..+..++.+||..+|.+||+++++-..++.+.
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cCccccccccCChHHHHHHHHh------cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9999764433332 22222222      0111122222211   144446899999999999999999999999998877


Q ss_pred             hhcC
Q 018047          345 YTNS  348 (361)
Q Consensus       345 ~~~~  348 (361)
                      ....
T Consensus       226 ~~~~  229 (484)
T KOG1023|consen  226 KGGS  229 (484)
T ss_pred             cccc
Confidence            6654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=6.5e-22  Score=175.84  Aligned_cols=202  Identities=18%  Similarity=0.229  Sum_probs=144.5

Q ss_pred             CCCcceeEEEEEEc---------------------------CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHH
Q 018047          118 DHPNLVSLIGYCAD---------------------------GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG  170 (361)
Q Consensus       118 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~  170 (361)
                      +|||||++.++|.+                           +..+|+||..++. +|..|+-..   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence            69999999887644                           2467999999976 999998654   4666777788999


Q ss_pred             HHHHHHHHhcCCCCCCCeEecCCCCCCeeeC--CCC--cEEEeecCccccCCCCC----ceeeeeecccccCccCccccc
Q 018047          171 AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS--ANF--EAKISDFGLAKLMPEGQ----ETYVTARVLGTFGYFDPEYTS  242 (361)
Q Consensus       171 i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~--~~~--~~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~  242 (361)
                      +++|+.|||.+|     +.|||+|.+|||+.  +|+  .+.++|||++-.-....    .....-..-|+-..||||+..
T Consensus       350 lLEav~hL~~hg-----vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  350 LLEAVTHLHKHG-----VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHcc-----chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            999999999999     99999999999984  443  58899999986432210    011112235778899999764


Q ss_pred             CCC------CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHH
Q 018047          243 TGK------LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFA  316 (361)
Q Consensus       243 ~~~------~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  316 (361)
                      .-+      .-.|+|.|+.|.+.||+++...||...-..   .+  ..       ..+++.-     ....+..++..+.
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L--~~-------r~Yqe~q-----LPalp~~vpp~~r  487 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LL--DT-------RTYQESQ-----LPALPSRVPPVAR  487 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---ee--ch-------hhhhhhh-----CCCCcccCChHHH
Confidence            322      124799999999999999999999541110   00  00       1111111     1344556666789


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          317 NLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       317 ~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      +++...|+.||++|++..=....|.-.+.
T Consensus       488 qlV~~lL~r~pskRvsp~iAANvl~LsLw  516 (598)
T KOG4158|consen  488 QLVFDLLKRDPSKRVSPNIAANVLNLSLW  516 (598)
T ss_pred             HHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence            99999999999999998766666654443

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=3.9e-21  Score=164.24  Aligned_cols=136  Identities=18%  Similarity=0.244  Sum_probs=106.1

Q ss_pred             CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-----CCCcceeEEEEEEcCC---
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-----DHPNLVSLIGYCADGK---  133 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---  133 (361)
                      ......||+|+||.||.  +. ++.. +||++....   ....+.+.+|+.+++.+     +||||++++++++++.   
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            34567899999999995  44 3444 799886532   22346789999999999     5799999999998863   


Q ss_pred             EEE-EEEEe--cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCCCeEecCCCCCCeeeCC----CCc
Q 018047          134 HRF-LVYEY--MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGL-AYLHSSSAVGIPIVHRDFKSTNVLLSA----NFE  205 (361)
Q Consensus       134 ~~~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~~~~~iiH~Dikp~Nill~~----~~~  205 (361)
                      ..+ +|+||  +++|+|.+++.+.   .+++.  ..++.+++.++ +|||+++     |+||||||+|||++.    ++.
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~-----IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR-----IVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEeccCCCCCc
Confidence            434 78999  5689999999653   35555  35677888777 9999999     999999999999974    348


Q ss_pred             EEEeecCcc
Q 018047          206 AKISDFGLA  214 (361)
Q Consensus       206 ~kl~Dfg~~  214 (361)
                      ++|+||+.+
T Consensus       148 ~~LiDg~G~  156 (210)
T PRK10345        148 PVVCDNIGE  156 (210)
T ss_pred             EEEEECCCC
Confidence            999995444

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=1.2e-21  Score=192.54  Aligned_cols=210  Identities=24%  Similarity=0.336  Sum_probs=147.3

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ...+|+.++.|..|+||-||.++++ +.+.+|+| +++...        +.+.  ++.....|.+|              
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------ilRn--ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------ILRN--ILTFAGNPFVV--------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------hhhc--cccccCCccee--------------
Confidence            3457999999999999999999988 57788884 432211        1111  33333444444              


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                             |+-...++..+  .++..        ++.+++|||+.|     |+|||+||+|.+|..-|++|++|||+++..
T Consensus       136 -------gDc~tllk~~g--~lPvd--------mvla~Eylh~yg-----ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 -------GDCATLLKNIG--PLPVD--------MVLAVEYLHSYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             -------chhhhhcccCC--CCcch--------hhHHhHhhccCC-----eecCCCCCCcceeeecccccccchhhhhhh
Confidence                   45555555433  33332        277899999999     999999999999999999999999998753


Q ss_pred             CCCCc-------------eeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 018047          218 PEGQE-------------TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       218 ~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  284 (361)
                      .....             .......+|||.|.|||++..+.|+..+|+|++|+|+||++.|+.||....+.      +.+
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe------elf  267 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELF  267 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH------HHH
Confidence            21110             01123458999999999999999999999999999999999999999654321      122


Q ss_pred             HHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 018047          285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP  331 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  331 (361)
                      ...+.+.....+          ..+..+.+..+++.++|..+|..|.
T Consensus       268 g~visd~i~wpE----------~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  268 GQVISDDIEWPE----------EDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhhhhccccc----------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence            222222111111          1333345588999999999999994

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=8.8e-20  Score=159.57  Aligned_cols=145  Identities=17%  Similarity=0.127  Sum_probs=112.3

Q ss_pred             CCCCCceecccCceEEEEEE--EcCCCEEEEEEeecCCCCcc-----------------h----hHHHHHHHHHHHHhcC
Q 018047           62 SFSDDNFLGKGGFGRVYKGT--LRSGEVVAIKKMELPRFKEA-----------------D----GEHEFRVEVDILSRLD  118 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~~-----------------~----~~~~~~~E~~~l~~l~  118 (361)
                      -|.+.+.||+|++|.||+|.  ..+|..||+|++........                 .    ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48889999999999999998  34799999999875421100                 0    1123568999999997


Q ss_pred             CC--cceeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCC
Q 018047          119 HP--NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKST  196 (361)
Q Consensus       119 h~--~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~  196 (361)
                      +.  .+.+++++    ...++||||+++++|.......  ..........++.|++.++.+||++|    .++|+||||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g----~iiH~Dikp~  178 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG----ELVHGDLSEY  178 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC----CEEeCCCChh
Confidence            53  34455543    2348999999998887765332  24566677889999999999999987    3999999999


Q ss_pred             CeeeCCCCcEEEeecCccccC
Q 018047          197 NVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||+++ ++.++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.4e-19  Score=156.37  Aligned_cols=137  Identities=26%  Similarity=0.403  Sum_probs=113.8

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcc-----hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEA-----DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      +.||+|++|.||+|.. .|..+++|+.........     .....+.+|+.++..+.|+++.....++.+.+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5699999999999987 478899998654332221     1234577899999999999988777777777788999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      ++|++|.+++....     . ....++.+++.+|.++|+.+     ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~-----i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG-----IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC-----cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986432     2 77889999999999999999     99999999999999 78999999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=2e-19  Score=153.74  Aligned_cols=141  Identities=20%  Similarity=0.117  Sum_probs=110.8

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcc-------------------hhHHHHHHHHHHHHhcCCC--
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEA-------------------DGEHEFRVEVDILSRLDHP--  120 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~--  120 (361)
                      -|...+.||+|+||.||++...+|+.+|||++........                   ........|+.++..+.|+  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            4778899999999999999988899999999765321000                   0112356789999999777  


Q ss_pred             cceeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee
Q 018047          121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       121 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill  200 (361)
                      .++..++.    ...++||||+++++|.+....        .....++.+++.++.++|+.|     ++|+||+|+||++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g-----i~H~Dl~p~Nill  158 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG-----IIHGDLSEFNILV  158 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC-----CCcCCCCcccEEE
Confidence            44455542    345899999999999776431        234678889999999999999     9999999999999


Q ss_pred             CCCCcEEEeecCccccCCC
Q 018047          201 SANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~  219 (361)
                      +.++.++|+|||++..+..
T Consensus       159 ~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         159 DDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cCCCcEEEEECCccccCCC
Confidence            9999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=7.6e-21  Score=175.23  Aligned_cols=174  Identities=25%  Similarity=0.407  Sum_probs=130.9

Q ss_pred             CEEEEEEEecCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          133 KHRFLVYEYMQKGNLQDHLNG-IGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      ..+|+.|++|..++|.+++.. ......++.....++.|++.|++|   ++     .+|+|+||.||++..+..+||+||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~-----~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG-----LIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc-----chhhhccccccccccchhhhhhhh
Confidence            357899999999999999974 334567888999999999999999   77     999999999999999999999999


Q ss_pred             CccccCCCCC----ceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHH
Q 018047          212 GLAKLMPEGQ----ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRH  286 (361)
Q Consensus       212 g~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  286 (361)
                      |+.+......    ........+||..||+||.+.+..|+.++||||||+||+||++ -...+..      ....     
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~-----  469 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATL-----  469 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhh-----
Confidence            9998775443    1123345689999999999999999999999999999999999 2332210      0000     


Q ss_pred             Hhhhhhhhhh-hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 018047          287 ILNDRKKLRK-VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAEC  336 (361)
Q Consensus       287 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~el  336 (361)
                           ..++. .+++... ..+|.     =..|+.+++...|.+||++.+.
T Consensus       470 -----~d~r~g~ip~~~~-~d~p~-----e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 -----TDIRDGIIPPEFL-QDYPE-----EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             -----hhhhcCCCChHHh-hcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence                 01111 1111111 22222     2479999999999999955443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.5e-19  Score=153.27  Aligned_cols=133  Identities=23%  Similarity=0.378  Sum_probs=106.7

Q ss_pred             eecccCceEEEEEEEcCCCEEEEEEeecCCCCcc-----hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEec
Q 018047           68 FLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEA-----DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      .||+|+||+||+|... |..+++|..........     .....+.+|++++..++|+++....-++.+.+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            3899999999999854 78899998654322211     12356778999999999887654444445566678999999


Q ss_pred             CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       143 ~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +|++|.+++....  .       .++.+++.+|.+||+.|     ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~g-----i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAG-----IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCC-----eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999875421  0       78899999999999999     99999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=6.7e-19  Score=172.44  Aligned_cols=139  Identities=24%  Similarity=0.332  Sum_probs=112.1

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCc-----chhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE-----ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      ..|...+.||+|+||+||++.+.. ..+++|+........     ......+.+|++++..++|++++....++.+....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            345678899999999999998764 344445432221111     12235678899999999999998887777777778


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||+++++|.+++.          ....++.+++.+|.+||+.+     ++||||||+|||+ .++.++|+|||++.
T Consensus       412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g-----iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG-----IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC-----CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999999874          34678999999999999999     9999999999999 67899999999997


Q ss_pred             c
Q 018047          216 L  216 (361)
Q Consensus       216 ~  216 (361)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=4.2e-20  Score=180.76  Aligned_cols=263  Identities=23%  Similarity=0.284  Sum_probs=199.3

Q ss_pred             CCCCCceecccCceEEEEEEEc--CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .|...+.||+|+|+.|-.....  ....+|+|.+..+. ...........|..+-..+. |.|++.+++...+.+..+++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4677777999999999988764  34567777665543 33344455666888888886 99999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCCCeEecCCCCCCeeeCCCC-cEEEeecCcccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH-SSSAVGIPIVHRDFKSTNVLLSANF-EAKISDFGLAKL  216 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~  216 (361)
                      ++|..++++.+-+........+......++.|+..++.|+| ..+     +.|+||||+|.+++..+ .++++|||+|+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~-----~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG-----VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc-----cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999999984322335677778889999999999999 888     99999999999999999 999999999998


Q ss_pred             CCC-CCceeeeeeccc-ccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          217 MPE-GQETYVTARVLG-TFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       217 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      +.. ..........+| ++.|+|||...+. ......|+||.|+++..+++|..|+........ ....+....    ..
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~----~~  249 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK----GR  249 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc----cc
Confidence            876 444445556678 9999999988774 557789999999999999999999976554331 111111110    00


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      .....         -........+++.+++..+|..|.+.+++-..-+...
T Consensus       250 ~~~~~---------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  250 FTQLP---------WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCc---------cccCChhhhhcccccccCCchhccccccccccccccc
Confidence            00011         1111223678899999999999999999877666544

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=4.6e-18  Score=143.91  Aligned_cols=140  Identities=20%  Similarity=0.179  Sum_probs=100.6

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHH---------------------HHHHHHHHHhcCCC--cc
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE---------------------FRVEVDILSRLDHP--NL  122 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--~i  122 (361)
                      .+.||+|+||+||+|...+|+.||||++.............                     ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998789999999986532211111111                     13566666666443  34


Q ss_pred             eeEEEEEEcCCEEEEEEEecCCCchhhh-cccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeee
Q 018047          123 VSLIGYCADGKHRFLVYEYMQKGNLQDH-LNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill  200 (361)
                      .+.++.    ...++||||++++++... +....   .. .....++.+++.++.++|+ .+     ++|+||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~-----ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG-----LVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC-----cCcCCCChhhEEE
Confidence            455543    235899999999654321 21111   11 5678899999999999999 88     9999999999999


Q ss_pred             CCCCcEEEeecCccccCCC
Q 018047          201 SANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~  219 (361)
                      + ++.++|+|||.+.....
T Consensus       149 ~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         149 D-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             E-CCcEEEEECcccccccC
Confidence            9 89999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=5.3e-17  Score=142.30  Aligned_cols=139  Identities=17%  Similarity=0.167  Sum_probs=107.0

Q ss_pred             Cceec-ccCceEEEEEEEcCCCEEEEEEeecCCC-----C-----cchhHHHHHHHHHHHHhcCCCcc--eeEEEEEEcC
Q 018047           66 DNFLG-KGGFGRVYKGTLRSGEVVAIKKMELPRF-----K-----EADGEHEFRVEVDILSRLDHPNL--VSLIGYCADG  132 (361)
Q Consensus        66 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~-----~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~  132 (361)
                      ...|| .|+.|+||.+... +..++||.+..+..     .     .......+.+|+.++..|.|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 8999999999876 78899998864321     0     11233567789999999998775  6677664332


Q ss_pred             -C---EEEEEEEecCC-CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEE
Q 018047          133 -K---HRFLVYEYMQK-GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAK  207 (361)
Q Consensus       133 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~k  207 (361)
                       .   ..++|||++++ .+|.+++...   .++..    .+.+++.+|.+||+.|     |+|+||||+|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G-----I~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG-----VYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC-----CCCCCCCchhEEEcCCCCEE
Confidence             2   23599999997 6899887642   34544    3568999999999999     99999999999999999999


Q ss_pred             EeecCccccC
Q 018047          208 ISDFGLAKLM  217 (361)
Q Consensus       208 l~Dfg~~~~~  217 (361)
                      |+|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999998753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=1.1e-16  Score=130.03  Aligned_cols=135  Identities=21%  Similarity=0.190  Sum_probs=112.5

Q ss_pred             CCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC--CcceeEEEEEEcCCEEEEEEEec
Q 018047           65 DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH--PNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      +.+.||+|.++.||++... +..+++|.......     ...+..|+..++.++|  .++++++++....+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            3567999999999999986 47899998754321     4568889999999976  58999999988888899999999


Q ss_pred             CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       143 ~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +++++..+         +......++.+++++++++|...  ...++|+|++|+||+++..+.++++|||.+..
T Consensus        76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~--~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLP--LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCC--ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            98877655         45667778999999999999852  11299999999999999999999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=3.4e-16  Score=147.14  Aligned_cols=249  Identities=22%  Similarity=0.265  Sum_probs=184.9

Q ss_pred             CCCCCceecc--cCceEEEEEEE--c-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEE
Q 018047           62 SFSDDNFLGK--GGFGRVYKGTL--R-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHR  135 (361)
Q Consensus        62 ~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  135 (361)
                      .|.....+|.  |.+|.||.+..  . ++..+|+|+-..+.-........ .+|+.....++ |+|.++.+..++..+..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k-~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRK-LREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccc-cchhhcccccCccccccccCcccccCCcc
Confidence            4667788999  99999999987  4 68899999854443222222222 34666666774 99999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEee
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK----GLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISD  210 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~D  210 (361)
                      |+-+|++. .+|.++..... ..++...++..+.+...    ||..+|+.+     ++|-|+||.||+...+ ..++++|
T Consensus       194 fiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~-----~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNN-----IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             eeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCc-----ccccccchhheecccccceeecCC
Confidence            99999995 69998887643 34777888888888888    999999999     9999999999999999 8999999


Q ss_pred             cCccccCCCCCceee---eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC--CCCCchhHHHHHH
Q 018047          211 FGLAKLMPEGQETYV---TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLN--QGVNDQNLVLQVR  285 (361)
Q Consensus       211 fg~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~--~~~~~~~~~~~~~  285 (361)
                      ||+...+.++.....   ..+..|...|++||.. .+.++...|+|+||.++.+..++..++...  ..+.+        
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--------  337 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--------  337 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--------
Confidence            999998876542222   2233578889999976 567788999999999999999998776433  22111        


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                              ++...    ....+...-...+...+..|+..+|..|++.+.++.+
T Consensus       338 --------~r~~~----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  338 --------LRQGY----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             --------ccccc----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                    11101    0111111122335568999999999999999777653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.60  E-value=6.4e-14  Score=133.25  Aligned_cols=144  Identities=21%  Similarity=0.206  Sum_probs=99.4

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcc---------------------------h----------hHHHHH
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEA---------------------------D----------GEHEFR  108 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------~----------~~~~~~  108 (361)
                      .+.||.|++|.||+|+.++|+.||||+........-                           .          ..-++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999754210000                           0          001344


Q ss_pred             HHHHHHHhc----CCCcceeEEEEEE-cCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHH-HHHHHhcCC
Q 018047          109 VEVDILSRL----DHPNLVSLIGYCA-DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK-GLAYLHSSS  182 (361)
Q Consensus       109 ~E~~~l~~l----~h~~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~-~l~~lH~~~  182 (361)
                      .|...+.++    +|.+-+.+-.++. .....+|||||++|++|.++...... ..+   ...++..++. .+..+|..|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC
Confidence            566655555    2333333323332 23456899999999999987643211 122   2345555655 478899999


Q ss_pred             CCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       183 ~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                           ++|+|++|.||+++.++.++++|||++..+.
T Consensus       278 -----~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 -----FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -----ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence                 9999999999999999999999999997653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=1.9e-15  Score=131.99  Aligned_cols=210  Identities=21%  Similarity=0.270  Sum_probs=146.5

Q ss_pred             HHHHHHHHHHhcCCCcceeEEEEEEcC-----CEEEEEEEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHH
Q 018047          106 EFRVEVDILSRLDHPNLVSLIGYCADG-----KHRFLVYEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYL  178 (361)
Q Consensus       106 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~l  178 (361)
                      ..+.-+.-|-++.|.|||++..++.+.     ....+++||+..|+|..++++.  ....+......+|+.||+.||.||
T Consensus       113 k~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yL  192 (458)
T KOG1266|consen  113 KRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYL  192 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence            344455666777899999999888654     3578999999999999999753  345677788899999999999999


Q ss_pred             hcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCc---eeeeeecccccCccCcccccCCCCCccchhHHH
Q 018047          179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE---TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAF  255 (361)
Q Consensus       179 H~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  255 (361)
                      |+..   ++++|+++..+.|++..+|-+|++--. .........   ..-.....+.++|.|||+-.......++|||+|
T Consensus       193 hs~~---PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f  268 (458)
T KOG1266|consen  193 HSCD---PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF  268 (458)
T ss_pred             hccC---CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence            9976   569999999999999999888884321 111111100   001122356789999998777777889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 018047          256 GVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE  335 (361)
Q Consensus       256 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e  335 (361)
                      |...++|..+..-........  ...+.+..       ....+...+            -..++.+|++..|..||+|.+
T Consensus       269 gmcAlemailEiq~tnseS~~--~~ee~ia~-------~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~  327 (458)
T KOG1266|consen  269 GMCALEMAILEIQSTNSESKV--EVEENIAN-------VIIGLENGL------------QRGSITKCLEGEPNGRPDARL  327 (458)
T ss_pred             hHHHHHHHHheeccCCCccee--ehhhhhhh-------heeeccCcc------------ccCcCcccccCCCCCCcchhh
Confidence            999999998864322111100  00000000       000111111            245889999999999999999


Q ss_pred             HHHHH
Q 018047          336 CVKEL  340 (361)
Q Consensus       336 ll~~l  340 (361)
                      ++.|+
T Consensus       328 llfHp  332 (458)
T KOG1266|consen  328 LLFHP  332 (458)
T ss_pred             hhcCc
Confidence            98875

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.54  E-value=3.2e-13  Score=128.59  Aligned_cols=169  Identities=20%  Similarity=0.261  Sum_probs=129.0

Q ss_pred             EEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCC
Q 018047           79 KGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP  157 (361)
Q Consensus        79 ~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~  157 (361)
                      .|..+ ++.+|.|.......   ........+-++.|+.++||||+++++.++..+..|||+|-+  -.|..+++..+  
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~--  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG--  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH--
Confidence            34444 68888888875432   244566788899999999999999999999999999999987  36888886533  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccC
Q 018047          158 KMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD  237 (361)
Q Consensus       158 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  237 (361)
                         ...+...+.||+.||.+||+.+    .++|++|.-+.|+|+..|..||++|.++........  ......-...|..
T Consensus       103 ---~~~v~~Gl~qIl~AL~FL~~d~----~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~  173 (690)
T KOG1243|consen  103 ---KEEVCLGLFQILAALSFLNDDC----NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDD  173 (690)
T ss_pred             ---HHHHHHHHHHHHHHHHHHhccC----CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccC
Confidence               6677778899999999998765    399999999999999999999999998865433221  0111112234667


Q ss_pred             cccccCCCCCccchhHHHHHHHHHHHhC
Q 018047          238 PEYTSTGKLTLQSDVYAFGVVLLELLTG  265 (361)
Q Consensus       238 PE~~~~~~~~~~~DiwslG~il~ell~g  265 (361)
                      |+.+....  ...|.|.|||++++++.|
T Consensus       174 P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  174 PEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            76543333  347999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.52  E-value=8.5e-14  Score=134.10  Aligned_cols=145  Identities=17%  Similarity=0.149  Sum_probs=95.5

Q ss_pred             CCCCCCceecccCceEEEEEEEcC-CCEEEEEEeecCCCC---------------------c------c----hhH----
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFK---------------------E------A----DGE----  104 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---------------------~------~----~~~----  104 (361)
                      .+|+. +.||+|++|+||+|+.++ |+.||||+..+....                     .      .    +..    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 789999999999999986 999999998643100                     0      0    001    


Q ss_pred             --HHHHHHHHHHHhcC----CCcceeEEEEEEc-CCEEEEEEEecCCCchhhhc--ccCCC--CCCCHHHHHHHHHHHHH
Q 018047          105 --HEFRVEVDILSRLD----HPNLVSLIGYCAD-GKHRFLVYEYMQKGNLQDHL--NGIGE--PKMDWPLRLKVALGAAK  173 (361)
Q Consensus       105 --~~~~~E~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~--~~~~~~~~~~i~~~i~~  173 (361)
                        -++.+|+..+.+++    +.+.+.+-.++.+ ....+|||||+.|++|.++-  ...+.  ..+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence              12444555555542    3444444444433 45668999999999998742  22110  112223333333443  


Q ss_pred             HHHHHhcCCCCCCCeEecCCCCCCeeeCCCC----cEEEeecCccccCC
Q 018047          174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANF----EAKISDFGLAKLMP  218 (361)
Q Consensus       174 ~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~----~~kl~Dfg~~~~~~  218 (361)
                           ...|     ++|+|+||.||+++.++    .++++|||++..+.
T Consensus       277 -----f~~G-----ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -----FRDG-----FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----HhCC-----eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 4577     99999999999999988    99999999997663

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.51  E-value=1.2e-13  Score=114.90  Aligned_cols=131  Identities=17%  Similarity=0.103  Sum_probs=96.4

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcc-eeEEEEEEcCCEEEEEEEecCCC
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL-VSLIGYCADGKHRFLVYEYMQKG  145 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g  145 (361)
                      +.|+.|.++.||++... ++.+++|......    .....+..|+.+++.+.+.++ .+++.+..  ...++||||++|.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~   76 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT----ELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS   76 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCc----ccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence            56899999999999876 7889999875321    112346779999999865554 45555433  3357999999998


Q ss_pred             chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          146 NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++.+.-       .   ....++.+++++|+.||+.+.....++|+|++|.||+++ ++.++++|||.+.
T Consensus        77 ~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            876530       1   112356789999999999872222259999999999999 6789999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.47  E-value=1.1e-14  Score=144.19  Aligned_cols=256  Identities=20%  Similarity=0.228  Sum_probs=181.8

Q ss_pred             HHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           56 MEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      +....+.+.+.+-+-+|+++.++.+.-. +|...++|+..+.........+....+-.++-.-.+|.++...-.+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            4445566777788899999999988755 576677776544322222223333344444444456666655555556778


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .+|+++|+.+++|...+.+.+  ..+.+-.......+.+++++||+..     +.|+|++|.|++...++..+++|||..
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~-----r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL-----RKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch-----hhcccccccchhhcccCCcccCccccc
Confidence            899999999999999887754  5666666677778899999999987     899999999999999999999999844


Q ss_pred             ccCCCC-----------------------------CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhC
Q 018047          215 KLMPEG-----------------------------QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG  265 (361)
Q Consensus       215 ~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  265 (361)
                      .....-                             +.........||+.|.+||...+......+|+|++|++++|.++|
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence            322110                             000112345789999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 018047          266 RRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMA  334 (361)
Q Consensus       266 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  334 (361)
                      .+||......                ..++.++....+-...+...+....+++...+..+|.+|..+.
T Consensus      1032 ~pp~na~tpq----------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQ----------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCcchh----------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999644321                1112222222222333445555678899999999999997776

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=2.7e-12  Score=107.98  Aligned_cols=139  Identities=17%  Similarity=0.175  Sum_probs=100.5

Q ss_pred             ceecccCceEEEEEEEcC-------CCEEEEEEeecCC--CC-----------------cchhHHHHH----HHHHHHHh
Q 018047           67 NFLGKGGFGRVYKGTLRS-------GEVVAIKKMELPR--FK-----------------EADGEHEFR----VEVDILSR  116 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~--~~-----------------~~~~~~~~~----~E~~~l~~  116 (361)
                      ..||.|..+.||.|...+       +..+|||+.....  ++                 .......+.    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998553       4799999874321  00                 112233333    89999999


Q ss_pred             cCC--CcceeEEEEEEcCCEEEEEEEecCCCchhh-hcccCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCCeEecC
Q 018047          117 LDH--PNLVSLIGYCADGKHRFLVYEYMQKGNLQD-HLNGIGEPKMDWPLRLKVALGAAKGLAYL-HSSSAVGIPIVHRD  192 (361)
Q Consensus       117 l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~~~iiH~D  192 (361)
                      +..  -++.+.+++    ..-+|||||+.++.+.. .+..   ..++.+....+..+++.+|..| |..|     ++|+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g-----lVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN-----LVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC-----eecCC
Confidence            853  456677765    44579999997654432 2222   1345556677889999999999 8888     99999


Q ss_pred             CCCCCeeeCCCCcEEEeecCccccCC
Q 018047          193 FKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       193 ikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |++.||+++ ++.+.|+|||.+....
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 4689999999987553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=4.8e-14  Score=132.80  Aligned_cols=250  Identities=18%  Similarity=0.182  Sum_probs=179.9

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc--CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKH  134 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  134 (361)
                      ....+|..+..||.|.|+.|+....+  ++..|++|............... ..|+.+...+ .|.+++.++..+...+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccccc
Confidence            34457888899999999999998744  68899999876554433333322 2366666666 58999998888888888


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEeecCc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFGL  213 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~  213 (361)
                      .|+-.||+.++++...+..  ...+++..++.+..|++.++.++|+..     ++|+|++|+||++..+ +..+++|||+
T Consensus       341 ~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~-----~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKL-----FVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchh-----hhcccccccceeeccchhhhhcccccc
Confidence            8899999999988876632  336778888999999999999999998     9999999999999886 8899999999


Q ss_pred             cccCCCCCceeeeeecccccCcc--CcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          214 AKLMPEGQETYVTARVLGTFGYF--DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      ++.+.-...     ...+.-++.  +++......+..++|++|||..+.+.+++...-......                
T Consensus       414 ~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----------------  472 (524)
T KOG0601|consen  414 WTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----------------  472 (524)
T ss_pred             ccccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcccccc----------------
Confidence            975322111     112233344  555666677889999999999999999987543221110                


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ..+..-..+     ..+... ..+..+...+...++..||.+.++..+..-
T Consensus       473 ~~i~~~~~p-----~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  473 LTIRSGDTP-----NLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             eeeeccccc-----CCCchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            000000001     111111 446778899999999999999998877653

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.39  E-value=3.4e-12  Score=103.49  Aligned_cols=146  Identities=19%  Similarity=0.279  Sum_probs=108.6

Q ss_pred             CCceecccCceEEEEEEEcCCCEEEEEEe-----ecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           65 DDNFLGKGGFGRVYKGTLRSGEVVAIKKM-----ELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~-----~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ...+|-+|+.+.|+++.+. |+.+.||.=     ..+.....-......+|+..|.++.--.|.--.=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5677899999999999887 777777742     2222222334556778999999886444433333344555667999


Q ss_pred             EecCC-CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC---cEEEeecCccc
Q 018047          140 EYMQK-GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF---EAKISDFGLAK  215 (361)
Q Consensus       140 e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~---~~kl~Dfg~~~  215 (361)
                      ||++| .++.+++..........+....++..+-+.+.-||..+     |||+||..+||++.+++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd-----iiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND-----IIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC-----eecccccccceEEecCCCcCceEEEeecchh
Confidence            99976 47888887665555555556788999999999999999     99999999999997654   45899999986


Q ss_pred             c
Q 018047          216 L  216 (361)
Q Consensus       216 ~  216 (361)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            3

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.37  E-value=1.5e-11  Score=106.61  Aligned_cols=145  Identities=25%  Similarity=0.299  Sum_probs=111.8

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC--CcceeEEEEEEcC---CEEEEEEEe
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH--PNLVSLIGYCADG---KHRFLVYEY  141 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~  141 (361)
                      +.|+.|..+.||++...+|+.+++|........  .....+..|++++..+.+  .++.+++.+....   +..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            568999999999998776689999987543211  134567889999999975  4467788877654   366899999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--------------------------------------
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA--------------------------------------  183 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--------------------------------------  183 (361)
                      ++|+++.+.+..   ..++......++.+++++|..||+...                                      
T Consensus        82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            999998887642   257777888888899999999986421                                      


Q ss_pred             -------------CCCCeEecCCCCCCeeeCC--CCcEEEeecCcccc
Q 018047          184 -------------VGIPIVHRDFKSTNVLLSA--NFEAKISDFGLAKL  216 (361)
Q Consensus       184 -------------~~~~iiH~Dikp~Nill~~--~~~~kl~Dfg~~~~  216 (361)
                                   ....++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         0234799999999999998  66789999998863

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=1.7e-11  Score=99.95  Aligned_cols=134  Identities=24%  Similarity=0.374  Sum_probs=98.5

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcc-----hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEA-----DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      ..+++|+-+.++.+.+. |..+.+|.=..+.+...     -......+|+.++..++--.|.--.=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 44566664322222221     1234566799999988655544333344466777799999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      ++|..|.+++...         ...++..+=.-+.-||..|     |+|+||.++||+++.++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g-----ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG-----IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC-----eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999898764         2446667777788999999     99999999999998775 99999999973

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.29  E-value=9.6e-11  Score=108.82  Aligned_cols=221  Identities=19%  Similarity=0.209  Sum_probs=153.1

Q ss_pred             CceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE----cCCEEEEEEEecCC-Cc
Q 018047           73 GFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA----DGKHRFLVYEYMQK-GN  146 (361)
Q Consensus        73 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-g~  146 (361)
                      --.+.|++... +|..|++|++........   .....-++.++++.|+|+|++.++|.    .+..+++|++|+|+ ++
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            34688999866 899999999843221111   12223577889999999999998876    35688999999886 57


Q ss_pred             hhhhcc-cC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          147 LQDHLN-GI------------GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       147 L~~~l~-~~------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      |.++.- ..            .....++..+|.++.|++.||.++|+.|     +..+-|.|.+|+++.+.+++|+..|+
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG-----LAck~L~~~kIlv~G~~RIriS~C~i  439 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG-----LACKTLDLKKILVTGKMRIRISGCGI  439 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC-----ceeecccHhHeEeeCcceEEEecccc
Confidence            776442 11            1235778999999999999999999999     89999999999999999999998887


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      ...+....              .  |.+.   --.+-|.=.||.+++.|.||..--..    .+...-..+         
T Consensus       440 ~Dvl~~d~--------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~----~d~~~~s~~---------  487 (655)
T KOG3741|consen  440 MDVLQEDP--------------T--EPLE---SQQQNDLRDLGLLLLALATGTENSNR----TDSTQSSHL---------  487 (655)
T ss_pred             eeeecCCC--------------C--cchh---HHhhhhHHHHHHHHHHHhhccccccc----ccchHHHHH---------
Confidence            76553322              0  1111   12256899999999999999753210    000000001         


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                                 .......+.++.+++......++++ -++.+++.++-.-++
T Consensus       488 -----------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff  527 (655)
T KOG3741|consen  488 -----------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFF  527 (655)
T ss_pred             -----------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHH
Confidence                       1122233445778888888888887 678888777654333

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.25  E-value=2.6e-10  Score=103.60  Aligned_cols=274  Identities=18%  Similarity=0.175  Sum_probs=168.0

Q ss_pred             CCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEE------EcC-CEEE
Q 018047           65 DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYC------ADG-KHRF  136 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~-~~~~  136 (361)
                      .++.||+|+.+.+|-.-.- +. .+.|+...+...  . ..+   .++.|... .||-+-.-+.|=      .+. ...-
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa--~-~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPA--A-QAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecchh-hc-hhheeecCCCch--H-HHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            3567999999999964322 22 345666554221  1 111   12222332 455333212221      122 2356


Q ss_pred             EEEEecCCC-chhhhcc----cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          137 LVYEYMQKG-NLQDHLN----GIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       137 lv~e~~~~g-~L~~~l~----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      +.|..+++- ...++.+    +...+...|...++.++.++.+.+.||..|     .+-+|++++|+|+++++.+.|.|-
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G-----h~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG-----HVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC-----CcccccCccceeeecCceEEEEcc
Confidence            788887664 2233332    223456889999999999999999999999     899999999999999999999986


Q ss_pred             CccccCCCCCceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCC--chhHHHH
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTG-RRAVDLNQGVN--DQNLVLQ  283 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~--~~~~~~~  283 (361)
                      .....-.++   ......+|.+.|++||.-.     +..-+...|.|.||+++++|+.| +.||.......  .......
T Consensus       162 Dsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         162 DSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             cceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            655543222   2344568999999999532     34456779999999999999997 99997644221  1222212


Q ss_pred             HHHHh-hhhhhhhhhcCccccCCCCCH-HHHHHHHHHHHHccCCC--CCCCCCHHHHHHHHHHHHhhcCCCCCCCcc
Q 018047          284 VRHIL-NDRKKLRKVIDPELSRSSYTM-ESIAMFANLASRCVRTE--SSERPSMAECVKELQLIIYTNSKGLNMPLH  356 (361)
Q Consensus       284 ~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~d--p~~Rpt~~ell~~l~~i~~~~~~~~~~~~~  356 (361)
                      +.... .+..+ ...-... .....+. -.+..+..|..+|+...  +.-|||++..+..|..+-.+--++..+.-|
T Consensus       239 Ia~g~f~ya~~-~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H  313 (637)
T COG4248         239 IAHGRFAYASD-QRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH  313 (637)
T ss_pred             hhcceeeechh-ccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence            22111 11111 0000000 0111121 22344667788888653  678999999999988777766666655554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.19  E-value=7e-10  Score=98.48  Aligned_cols=144  Identities=17%  Similarity=0.148  Sum_probs=101.4

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCc--------chhHHHHHHHHHHHHhcCCCc--ceeEEEEEEc-----
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE--------ADGEHEFRVEVDILSRLDHPN--LVSLIGYCAD-----  131 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~-----  131 (361)
                      +++-......|++.... |+.|.||.........        ......+.+|...+..|..-+  .+..+++...     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            44444444556676554 7889999764322110        011124678888888884333  3344555443     


Q ss_pred             CCEEEEEEEecCCC-chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-------C
Q 018047          132 GKHRFLVYEYMQKG-NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-------N  203 (361)
Q Consensus       132 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-------~  203 (361)
                      ...-+||||++++. +|.+++........+......++.+++..+.-||..|     ++|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G-----i~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG-----INHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc-----CccCCCChhhEEEeccccCCCCC
Confidence            23568999999875 8999886533335666778899999999999999999     999999999999975       4


Q ss_pred             CcEEEeecCcccc
Q 018047          204 FEAKISDFGLAKL  216 (361)
Q Consensus       204 ~~~kl~Dfg~~~~  216 (361)
                      ..+.|+||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6899999998863

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.17  E-value=3.8e-10  Score=94.60  Aligned_cols=129  Identities=25%  Similarity=0.245  Sum_probs=83.9

Q ss_pred             EEEEEEEcCCCEEEEEEeecCC--CCc---------------------chhHHHHHHHHHHHHhcCCC--cceeEEEEEE
Q 018047           76 RVYKGTLRSGEVVAIKKMELPR--FKE---------------------ADGEHEFRVEVDILSRLDHP--NLVSLIGYCA  130 (361)
Q Consensus        76 ~V~~~~~~~~~~vavK~~~~~~--~~~---------------------~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~  130 (361)
                      .||.|...+|..+|+|+.....  +..                     ........+|+..|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999875421  100                     01234567899999999765  466776552 


Q ss_pred             cCCEEEEEEEecC--CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCCCeEecCCCCCCeeeCCCCcEE
Q 018047          131 DGKHRFLVYEYMQ--KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAY-LHSSSAVGIPIVHRDFKSTNVLLSANFEAK  207 (361)
Q Consensus       131 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~~~~~~iiH~Dikp~Nill~~~~~~k  207 (361)
                         .-+|||||++  |..+..+...    .++.+....++.+++..+.. +|..|     ++|+|+.+.||+++.+ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~g-----ivHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAG-----IVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTT-----EEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcC-----ceecCCChhhEEeecc-eEE
Confidence               2369999998  5455443322    12234456677777775555 57888     9999999999999988 999


Q ss_pred             EeecCccccCC
Q 018047          208 ISDFGLAKLMP  218 (361)
Q Consensus       208 l~Dfg~~~~~~  218 (361)
                      ++|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.09  E-value=1.4e-09  Score=94.10  Aligned_cols=140  Identities=21%  Similarity=0.195  Sum_probs=101.8

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCC--CC-----------------cchhHHHHHHHHHHHHhcCCC--
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPR--FK-----------------EADGEHEFRVEVDILSRLDHP--  120 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~-----------------~~~~~~~~~~E~~~l~~l~h~--  120 (361)
                      -..++..||-|.-|.||.|....|.++|||.=....  +.                 -........+|+++|..|...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            356678899999999999999999999999532210  00                 011234567899999999754  


Q ss_pred             cceeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee
Q 018047          121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       121 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill  200 (361)
                      .+.+.+++    +.-.+||||+.|-.|...-       ++.+..-.++..|++-+..+-..|     ++|+|+++-||++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G-----iVHGDlSefNIlV  235 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG-----IVHGDLSEFNILV  235 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC-----ccccCCchheEEE
Confidence            67777766    4446999999886665442       123333445555555555555777     9999999999999


Q ss_pred             CCCCcEEEeecCccccC
Q 018047          201 SANFEAKISDFGLAKLM  217 (361)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~  217 (361)
                      +.+|.+.++||-.+...
T Consensus       236 ~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         236 TEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             ecCCCEEEEeCcccccC
Confidence            99999999999887654

>PRK09902 hypothetical protein; Provisional

Probab=98.99  E-value=9.1e-09  Score=86.90  Aligned_cols=141  Identities=16%  Similarity=0.160  Sum_probs=104.9

Q ss_pred             ecccCceEEEEEEEcCCCEEEEEEeecCCCCc---chhHHHHHHHHHHHHhcCCCc--ceeEEEEEE---cC--CEEEEE
Q 018047           69 LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE---ADGEHEFRVEVDILSRLDHPN--LVSLIGYCA---DG--KHRFLV  138 (361)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~---~~--~~~~lv  138 (361)
                      -|+||.+.|+..... |+.+-+|.-.......   ......|.+|+..+..|..-+  +.+.. ++.   .+  -.-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            377999999997766 5578888754111111   235567889999999985322  44444 222   11  245799


Q ss_pred             EEecCC-CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc--EEEeecCccc
Q 018047          139 YEYMQK-GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE--AKISDFGLAK  215 (361)
Q Consensus       139 ~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~--~kl~Dfg~~~  215 (361)
                      +|-+++ -+|.+++......+.+......++.+++.++.-||+.|     +.|+|+.+.||+++.++.  +.++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G-----v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN-----RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997753 58999887655556788888999999999999999999     999999999999987777  9999998765


Q ss_pred             c
Q 018047          216 L  216 (361)
Q Consensus       216 ~  216 (361)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            3

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=1.9e-08  Score=86.38  Aligned_cols=126  Identities=19%  Similarity=0.223  Sum_probs=92.2

Q ss_pred             CCEEEEEEeecCCCCc----chhHHHHHHHHHHHHhcCCC--cceeEEEEEEcC----CEEEEEEEecCCC-chhhhccc
Q 018047           85 GEVVAIKKMELPRFKE----ADGEHEFRVEVDILSRLDHP--NLVSLIGYCADG----KHRFLVYEYMQKG-NLQDHLNG  153 (361)
Q Consensus        85 ~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~  153 (361)
                      ++.+-+|.........    .-......+|...+..|..-  .+++.+++.+..    ...++|+|++++. +|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            5666666543221111    12334567788888887533  345566665542    2458999999874 89999876


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC---cEEEeecCccccC
Q 018047          154 IGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF---EAKISDFGLAKLM  217 (361)
Q Consensus       154 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~---~~kl~Dfg~~~~~  217 (361)
                      ..  ..+......++.+++..+.-||..|     ++|+|+++.|||++.++   .+.|+||+-+...
T Consensus       112 ~~--~~~~~~~~~ll~~l~~~i~~lH~~g-----i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  112 WE--QLDPSQRRELLRALARLIAKLHDAG-----IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hc--ccchhhHHHHHHHHHHHHHHHHHCc-----CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            43  2667778899999999999999999     99999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.88  E-value=6.2e-10  Score=106.93  Aligned_cols=151  Identities=20%  Similarity=0.310  Sum_probs=105.0

Q ss_pred             HHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee-------eeeecccccCccCcccc
Q 018047          169 LGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-------VTARVLGTFGYFDPEYT  241 (361)
Q Consensus       169 ~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~  241 (361)
                      .+++.|+.|+|...    .+||++|.|++|.++..+..||+.|+.+.....+....       ...-..-...|.|||++
T Consensus       106 ~~v~dgl~flh~sA----k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA----KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hcccchhhhhccCc----ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            34558999999976    49999999999999999999999999987654421110       00011235689999999


Q ss_pred             cCCCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHH
Q 018047          242 STGKLTLQSDVYAFGVVLLELLTGRR-AVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLAS  320 (361)
Q Consensus       242 ~~~~~~~~~DiwslG~il~ell~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  320 (361)
                      .......++|+||||+++|.+..|.. .+.........    .... .          .-......+..+.+.++.+=+.
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~----~~~~-~----------~~~~~~~~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY----SFSR-N----------LLNAGAFGYSNNLPSELRESLK  246 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCcchh----hhhh-c----------ccccccccccccCcHHHHHHHH
Confidence            88888899999999999999995544 44322111100    0000 0          0111123445666777999999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 018047          321 RCVRTESSERPSMAECVK  338 (361)
Q Consensus       321 ~cl~~dp~~Rpt~~ell~  338 (361)
                      +++..++..||++.+++.
T Consensus       247 k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHhcCCcccCcchhhhhc
Confidence            999999999998877654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.83  E-value=2e-08  Score=96.59  Aligned_cols=145  Identities=19%  Similarity=0.195  Sum_probs=93.9

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCC---------------------------Ccch----------hHHHHHH
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRF---------------------------KEAD----------GEHEFRV  109 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------------------------~~~~----------~~~~~~~  109 (361)
                      .-|+.++-|.||+|+.++|+.||||+....-.                           ....          ..-++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            56899999999999999999999998643210                           0000          1112445


Q ss_pred             HHHHHHhcC----CCcceeEEEEEE-cCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 018047          110 EVDILSRLD----HPNLVSLIGYCA-DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV  184 (361)
Q Consensus       110 E~~~l~~l~----h~~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~  184 (361)
                      |...+.+++    +..-+.+=.++. -.+...|+|||++|-.+.+...-.. ..++...+.....++.  +..+=..|  
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dg--  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDG--  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcC--
Confidence            666665552    222223333332 2455679999999999988743221 2455433333332222  22333356  


Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       185 ~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                         +.|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               99999999999999999999999999987754

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.78  E-value=2.1e-07  Score=80.98  Aligned_cols=133  Identities=17%  Similarity=0.142  Sum_probs=85.2

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc--ceeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN--LVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      ..||+|..+.||+.   .|..+++|.....     .....+.+|.++++.+..-+  +.+.+++..+.+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCC-----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            46899999999984   2556788877432     12345688999999986443  46778888888888899999988


Q ss_pred             Cc-hhhhcccCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHhcCCCC
Q 018047          145 GN-LQDHLNGIGEPKMDWPLRLKVALGAAKG---------------------------------------LAYLHSSSAV  184 (361)
Q Consensus       145 g~-L~~~l~~~~~~~~~~~~~~~i~~~i~~~---------------------------------------l~~lH~~~~~  184 (361)
                      .+ +...+..      +......++..+++.                                       ..+|.... .
T Consensus        79 ~~~~~~~~~~------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~-~  151 (226)
T TIGR02172        79 KRSFSRIISD------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVP-D  151 (226)
T ss_pred             ccchhhhhcC------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCC-C
Confidence            63 2211110      000111111111111                                       12222111 1


Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       185 ~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ...++|+|+.|.||+++.++ +.++||+.+.
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            22379999999999999888 9999999885

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.72  E-value=2e-07  Score=79.21  Aligned_cols=140  Identities=15%  Similarity=0.103  Sum_probs=91.4

Q ss_pred             HcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhH------HHHHHHHHHHHhcCCCc---ceeEEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE------HEFRVEVDILSRLDHPN---LVSLIGYC  129 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~------~~~~~E~~~l~~l~h~~---iv~~~~~~  129 (361)
                      ..++|...+++-......|.+.... |+.+.+|.............      ....+++..+..+...+   ...++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            4567888888888777777766655 78999998754321111110      11233444444443322   22222222


Q ss_pred             -----EcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC
Q 018047          130 -----ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF  204 (361)
Q Consensus       130 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~  204 (361)
                           .-....+++|||++|..|.++..      +++    .+...+++++.-||+.|     +.|+|.+|.|++++.++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G-----~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG-----FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC-----CccCCCCcCcEEEECCc
Confidence                 22345578999999988887642      222    24456778899999999     99999999999998654


Q ss_pred             cEEEeecCccc
Q 018047          205 EAKISDFGLAK  215 (361)
Q Consensus       205 ~~kl~Dfg~~~  215 (361)
                       ++++||+..+
T Consensus       173 -i~iID~~~k~  182 (229)
T PF06176_consen  173 -IRIIDTQGKR  182 (229)
T ss_pred             -EEEEECcccc
Confidence             9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.70  E-value=4.4e-07  Score=77.98  Aligned_cols=154  Identities=19%  Similarity=0.164  Sum_probs=104.1

Q ss_pred             CHHHHHHHcCCCCCCce---ecccCceEEEEEEEcCCCEEEEEEeecCCCCcc---------------------hhHHHH
Q 018047           52 TLKEMEEATCSFSDDNF---LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEA---------------------DGEHEF  107 (361)
Q Consensus        52 ~~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------~~~~~~  107 (361)
                      +...+........+...   |++|.-+.||+|...++..+|+|++......-.                     ......
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            44555555555555544   556777899999988899999999854321110                     012335


Q ss_pred             HHHHHHHHhcC--CCcceeEEEEEEcCCEEEEEEEecCCCch-hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCC
Q 018047          108 RVEVDILSRLD--HPNLVSLIGYCADGKHRFLVYEYMQKGNL-QDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSA  183 (361)
Q Consensus       108 ~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~  183 (361)
                      .+|+..|+++.  +=.+.+-+++.    .-.|||||+....+ .-.+.   .-.+.......+..++++.+.-|-. .+ 
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~-  187 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAG-  187 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence            67888888884  33445555553    33599999865311 11222   1133333567778888888888877 55 


Q ss_pred             CCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       184 ~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                          ++|+||+.-|||+. ++.+.++|||-+....
T Consensus       188 ----LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         188 ----LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             ----cccccchhhheEEE-CCeEEEEECccccccC
Confidence                99999999999999 8899999999997654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.59  E-value=1.1e-06  Score=76.49  Aligned_cols=77  Identities=22%  Similarity=0.302  Sum_probs=57.0

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCC--cceeEEEEEE---cCCEEEEEEEe
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP--NLVSLIGYCA---DGKHRFLVYEY  141 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~---~~~~~~lv~e~  141 (361)
                      +.|+.|..+.||++...+ +.+++|....     ......+..|..+++.+...  .+.+++....   .....+++|++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~-----~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRP-----PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESS-----HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCC-----CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            568999999999999886 6999998642     24566788899999888533  3556666443   33467899999


Q ss_pred             cCCCchhh
Q 018047          142 MQKGNLQD  149 (361)
Q Consensus       142 ~~~g~L~~  149 (361)
                      +++.++..
T Consensus        77 i~g~~~~~   84 (239)
T PF01636_consen   77 IPGRPLDD   84 (239)
T ss_dssp             ESSEEHHH
T ss_pred             eccccccc
Confidence            99988877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.54  E-value=1.8e-06  Score=76.10  Aligned_cols=75  Identities=16%  Similarity=0.139  Sum_probs=53.8

Q ss_pred             ecccCc-eEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEEEecCCCc
Q 018047           69 LGKGGF-GRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVYEYMQKGN  146 (361)
Q Consensus        69 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~  146 (361)
                      |..|.. ..||+.... +..+.+|......      ...+.+|+.+++.+. +--+.+++++...++..++|||+++|.+
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            444555 789998765 4778888764321      235667999998884 4446678888877777899999999987


Q ss_pred             hhhh
Q 018047          147 LQDH  150 (361)
Q Consensus       147 L~~~  150 (361)
                      |...
T Consensus        79 l~~~   82 (244)
T cd05150          79 AAAL   82 (244)
T ss_pred             HhHh
Confidence            7644

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.48  E-value=1.5e-08  Score=96.73  Aligned_cols=186  Identities=18%  Similarity=0.181  Sum_probs=134.8

Q ss_pred             CCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc-ceeEEEEEEcCCEEEEEEEe
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN-LVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~  141 (361)
                      +..-+-+++|++++++|.+-...+....+.+...        ....-++++|.+++||| .+..++-++-+...++.+++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            3334558999999999987543333335554321        34456899999999999 66677777777888999999


Q ss_pred             cCCC-chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          142 MQKG-NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       142 ~~~g-~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      +.++ +-..-... ....+..-+...+...-+++++++|+..     =+|+|    ||+.++ +..+++||+....+...
T Consensus       316 ~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~-----~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  316 CSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSY-----KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hcCCccccccCCh-hhHhhhhhhhhhhhhhhccccccccccc-----ccCcc----cccccc-cccccccccCCcccCcc
Confidence            9877 32222211 1223444455666777788999999964     38888    777665 68999999999877655


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVD  270 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~  270 (361)
                      .   ......+++.++|||+.....+..+.|.|++|.-..++.-|-+|-.
T Consensus       385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            3   3345678999999999999999999999999987778877776653

>PLN02876 acyl-CoA dehydrogenase

Probab=98.44  E-value=5.2e-06  Score=85.80  Aligned_cols=81  Identities=17%  Similarity=0.339  Sum_probs=58.4

Q ss_pred             CceecccCceEEEEEEEcCC---CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcc--eeEEEEEEcC---CEEE
Q 018047           66 DNFLGKGGFGRVYKGTLRSG---EVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNL--VSLIGYCADG---KHRF  136 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~  136 (361)
                      .+.++.|.+..+|+....++   ..+++|+......  ......+.+|+.+|+.+. |.++  .+++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            46689999999999877643   4677787543211  122356889999999995 6665  7888888764   4678


Q ss_pred             EEEEecCCCchh
Q 018047          137 LVYEYMQKGNLQ  148 (361)
Q Consensus       137 lv~e~~~~g~L~  148 (361)
                      +||||++|..+.
T Consensus       121 lVME~v~G~~~~  132 (822)
T PLN02876        121 YIMEYLEGRIFV  132 (822)
T ss_pred             EEEEecCCcccC
Confidence            999999886543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.42  E-value=1.2e-05  Score=68.05  Aligned_cols=137  Identities=19%  Similarity=0.231  Sum_probs=94.8

Q ss_pred             CCceecccCceEEEEEEEcCCCEEEEEEeecCCC-------------CcchhHHHHHHHHHHHHhcC------CCcceeE
Q 018047           65 DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRF-------------KEADGEHEFRVEVDILSRLD------HPNLVSL  125 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~------h~~iv~~  125 (361)
                      ....||+|+.-.||.  +.+....+||+......             ......++..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            345799999999995  45556678898865440             11123456677777777665      7789999


Q ss_pred             EEEEEcCCEEEEEEEecCC------CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCee
Q 018047          126 IGYCADGKHRFLVYEYMQK------GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVL  199 (361)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nil  199 (361)
                      +|+.+.+--.-+|+|.+.+      -+|.+++...   .++. ...   ..+-+-.+||-+++     |+.+|++|.||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~---~~L~~f~~~l~~~~-----Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELR---QALDEFKRYLLDHH-----IVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHH---HHHHHHHHHHHHcC-----CeecCCCcccEE
Confidence            9999999888999998643      2677887543   3444 333   33344556666766     999999999999


Q ss_pred             eCCC---C-cEEEee-cCccc
Q 018047          200 LSAN---F-EAKISD-FGLAK  215 (361)
Q Consensus       200 l~~~---~-~~kl~D-fg~~~  215 (361)
                      +...   . .+.|+| ||...
T Consensus       151 ~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             EEecCCCceEEEEEeCCCCcc
Confidence            9643   2 577777 44443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.5e-06  Score=83.64  Aligned_cols=142  Identities=20%  Similarity=0.250  Sum_probs=90.8

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcch-----------------------------------hHHHHHHHH
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEAD-----------------------------------GEHEFRVEV  111 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----------------------------------~~~~~~~E~  111 (361)
                      +-||..+.|.|++|+.++|+.||||+-+.. .....                                   ..-+|..|+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            569999999999999999999999975432 11100                                   011234454


Q ss_pred             HHHHhc----CCCc---ceeEEEEEEc-CCEEEEEEEecCCCchhhh--cccCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 018047          112 DILSRL----DHPN---LVSLIGYCAD-GKHRFLVYEYMQKGNLQDH--LNGIGEPKMDWPLRLKVALGAAKGLAYLHSS  181 (361)
Q Consensus       112 ~~l~~l----~h~~---iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  181 (361)
                      +-..+.    .|-+   -|.+=.++.+ .....|+|||++|..+.|.  +.+.   .++...+..-+.+..  ++-+=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~--~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAY--LEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHH--HHHHHhc
Confidence            444333    3444   1222233322 3466899999999988764  3333   456554444433333  2223334


Q ss_pred             CCCCCCeEecCCCCCCeeeCC----CCcEEEeecCccccCCC
Q 018047          182 SAVGIPIVHRDFKSTNVLLSA----NFEAKISDFGLAKLMPE  219 (361)
Q Consensus       182 ~~~~~~iiH~Dikp~Nill~~----~~~~kl~Dfg~~~~~~~  219 (361)
                      |     ++|+|-+|.||+++.    ++.+.+.|||+...+..
T Consensus       321 G-----ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 G-----FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             C-----CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            5     899999999999984    67899999999987644

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.40  E-value=3.3e-06  Score=68.78  Aligned_cols=130  Identities=25%  Similarity=0.268  Sum_probs=93.7

Q ss_pred             CCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcce-eEEEEEEcCCEEEEEEEec
Q 018047           64 SDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV-SLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~  142 (361)
                      ...+.||+|++|.||++.+. |..+|+|+-..     ......+..|+++|..+.-.++. +++.+-.+    ++.|||+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~-----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i   94 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR-----DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI   94 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecC-----CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence            34567999999999999998 66889998643     23456788899999999866654 45555332    3569999


Q ss_pred             CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCC-CCCeeeCCCCcEEEeecCccccC
Q 018047          143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFK-STNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       143 ~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dik-p~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      .|-+|.+.-...     +-    +-...++++---|-..|     |-|+.|. |..+++..++.+.|+||.-|+..
T Consensus        95 ~G~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~~G-----I~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          95 DGRPLGKLEIGG-----DR----KHLLRVLEKAYKLDRLG-----IEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cCcchhhhhhcc-----cH----HHHHHHHHHHHHHHHhc-----cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            988888765421     22    23344555555555666     8899886 77777777779999999999843

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.38  E-value=7e-06  Score=69.00  Aligned_cols=128  Identities=26%  Similarity=0.384  Sum_probs=90.5

Q ss_pred             CCCCCCceecccCc-eEEEEEEEcCCCEEEEEEeec---CC-------CCcc--------hhHHHHHHHHHHHHhcC---
Q 018047           61 CSFSDDNFLGKGGF-GRVYKGTLRSGEVVAIKKMEL---PR-------FKEA--------DGEHEFRVEVDILSRLD---  118 (361)
Q Consensus        61 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~-------~~~~--------~~~~~~~~E~~~l~~l~---  118 (361)
                      .+++.++.||.|.- |.||++... |+.+|+|.+..   ..       +...        .....|..|.....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            57888999999999 999999987 78999999322   10       0000        11235777887777774   


Q ss_pred             CCcc--eeEEEEEEcC------------------CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 018047          119 HPNL--VSLIGYCADG------------------KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL  178 (361)
Q Consensus       119 h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~l  178 (361)
                      +.++  |+++||..-.                  ....||.||.+...           .+.    ..-+.+|.+-+..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence            5566  8999997321                  12357777766533           122    23456777889999


Q ss_pred             hcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       179 H~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      |..|     |+-+|+++.|..     .-+|+|||.+
T Consensus       181 ~k~g-----I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLG-----IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCC-----eeeccCcccccc-----CCEEEecccC
Confidence            9999     999999999986     4589999864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.36  E-value=2.1e-05  Score=66.25  Aligned_cols=102  Identities=25%  Similarity=0.309  Sum_probs=80.8

Q ss_pred             HHHHHHHHhcCC-CcceeEEEEEEcCCEEEEEEEecCCCchhhh---cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 018047          108 RVEVDILSRLDH-PNLVSLIGYCADGKHRFLVYEYMQKGNLQDH---LNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA  183 (361)
Q Consensus       108 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~  183 (361)
                      ..|.-+++.+++ +++++++|+|.+    +++.||.+.+++...   +...  ...+|..+.+++.++++.+++|++.-.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            358888888875 699999999843    578999987766421   1111  257899999999999999999988431


Q ss_pred             CCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       184 ~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                       +. +.-.|++|+|+-+++++.+|++|...+...
T Consensus        81 -~~-~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 -GF-FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             -Cc-EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence             22 888999999999999999999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.32  E-value=7.7e-06  Score=71.69  Aligned_cols=75  Identities=17%  Similarity=0.263  Sum_probs=46.9

Q ss_pred             ceecccCce-EEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCC---cceeEEEEEEcC---CEEEEEE
Q 018047           67 NFLGKGGFG-RVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP---NLVSLIGYCADG---KHRFLVY  139 (361)
Q Consensus        67 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~  139 (361)
                      +.|+.|+.. .||+.    +..+++|....     ......+.+|.+++..+...   .+.++++.....   ...+++|
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~   73 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA-----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY   73 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc-----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence            456766665 58875    34567776432     22345788899999888532   344555544332   2458899


Q ss_pred             EecCCCchhhh
Q 018047          140 EYMQKGNLQDH  150 (361)
Q Consensus       140 e~~~~g~L~~~  150 (361)
                      ++++|.++.+.
T Consensus        74 ~~i~G~~l~~~   84 (235)
T cd05155          74 RWLEGETATAA   84 (235)
T ss_pred             EeecCCCCCcc
Confidence            99999777543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.29  E-value=5.5e-06  Score=84.60  Aligned_cols=204  Identities=22%  Similarity=0.261  Sum_probs=141.5

Q ss_pred             HHHHHHHHHhcCCCcceeEEEEEEcCCE----EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 018047          107 FRVEVDILSRLDHPNLVSLIGYCADGKH----RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS  182 (361)
Q Consensus       107 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  182 (361)
                      ...|+..+..+.|+|++.++.|-.....    ..+..++++.-++...+...+  ..+..+.+.+..++.+|+.|+|+..
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            3456777778899999999988654332    234556788888888887754  7888999999999999999999986


Q ss_pred             CCCCCeEecCCCCC---CeeeCCCCcEEEe--ecCccccCCCCCceeeeeecccccCccCcccccCCCCC--ccchhHHH
Q 018047          183 AVGIPIVHRDFKST---NVLLSANFEAKIS--DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT--LQSDVYAF  255 (361)
Q Consensus       183 ~~~~~iiH~Dikp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Diwsl  255 (361)
                           ..|.-+...   +.-.+.++.+..+  ||+....+++....   ....-+..+.|||........  ...|+|++
T Consensus       307 -----l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  307 -----LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             -----cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence                 555544444   4445566677777  99988877654432   122345567888876655544  44799999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 018047          256 GVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE  335 (361)
Q Consensus       256 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e  335 (361)
                      |.....+..|..+-....                   .....++..         ....+.+...+|+..++++|+++.+
T Consensus       379 gll~~~~~~~~~i~~~~~-------------------~~~~~l~~~---------~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSA-------------------VPVSLLDVL---------STSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHhhhhhcCccccccc-------------------chhhhhccc---------cchhhhhhhhhhcchhhhhccchhh
Confidence            999999999876542111                   000011110         0013678899999999999999999


Q ss_pred             HHHHHHHHHhhcC
Q 018047          336 CVKELQLIIYTNS  348 (361)
Q Consensus       336 ll~~l~~i~~~~~  348 (361)
                      ++.+...-.....
T Consensus       431 ll~~~f~~~~~~~  443 (1351)
T KOG1035|consen  431 LLTHPFLRFPTDN  443 (1351)
T ss_pred             hhhchhccccccc
Confidence            9998875444433

>PRK10593 hypothetical protein; Provisional

Probab=98.25  E-value=4.5e-05  Score=69.27  Aligned_cols=77  Identities=10%  Similarity=0.024  Sum_probs=56.3

Q ss_pred             CCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC---CcceeEEEEEEc---CCEEEEE
Q 018047           65 DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH---PNLVSLIGYCAD---GKHRFLV  138 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv  138 (361)
                      ..+.||.|..+.||.....++ .+.+|... .    ......+..|...|+.|..   -.+.++++++.+   .+..+||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMAR-S----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEec-c----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            345699999999999876544 46667642 1    1123578889999998853   357788888764   3668999


Q ss_pred             EEecCCCch
Q 018047          139 YEYMQKGNL  147 (361)
Q Consensus       139 ~e~~~~g~L  147 (361)
                      ||+++++++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.17  E-value=2.6e-05  Score=68.21  Aligned_cols=74  Identities=15%  Similarity=0.148  Sum_probs=48.8

Q ss_pred             ceecccCceEEEEEEEcC--CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc-ceeEEEEEEcCCEEEEEEEecC
Q 018047           67 NFLGKGGFGRVYKGTLRS--GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN-LVSLIGYCADGKHRFLVYEYMQ  143 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~  143 (361)
                      +.|..|-...+|++...+  ++.|++|+....    .....+..+|+.+++.+...+ .+++++.+..    .++|||++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~----~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~   75 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK----TELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP   75 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCC----ccceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence            457888889999998664  678999976432    111123346888888885333 4455554332    38999999


Q ss_pred             CCchh
Q 018047          144 KGNLQ  148 (361)
Q Consensus       144 ~g~L~  148 (361)
                      |.++.
T Consensus        76 G~~l~   80 (235)
T cd05157          76 GRTLE   80 (235)
T ss_pred             CCcCC
Confidence            87663

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.04  E-value=5.9e-05  Score=67.00  Aligned_cols=138  Identities=15%  Similarity=0.112  Sum_probs=76.8

Q ss_pred             ecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcc-eeEEEEEEcCCEEEEEEEecCCCch
Q 018047           69 LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL-VSLIGYCADGKHRFLVYEYMQKGNL  147 (361)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g~L  147 (361)
                      +..|-.+.+|+... +++.+++|......   ....-+..+|..+++.+...++ .+++....    -++||||++|..+
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence            56688889998874 46788888753221   1100134678889998864333 34454432    2689999998766


Q ss_pred             hhh-------c-------c---cCC--CCCCCHH-HHHHHHHHH---------HHHHHHHhcCC---CCCCCeEecCCCC
Q 018047          148 QDH-------L-------N---GIG--EPKMDWP-LRLKVALGA---------AKGLAYLHSSS---AVGIPIVHRDFKS  195 (361)
Q Consensus       148 ~~~-------l-------~---~~~--~~~~~~~-~~~~i~~~i---------~~~l~~lH~~~---~~~~~iiH~Dikp  195 (361)
                      ..-       +       .   +..  ...++.. .+..+..++         ...+..+-...   .....++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            431       0       0   100  1111211 111211111         11122221110   0122389999999


Q ss_pred             CCeeeCCCCcEEEeecCccc
Q 018047          196 TNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       196 ~Nill~~~~~~kl~Dfg~~~  215 (361)
                      .||+++.++ +.|+||..+.
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcEEEeCCC-CEEEeccccC
Confidence            999999877 7899999886

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.02  E-value=0.00012  Score=66.95  Aligned_cols=157  Identities=16%  Similarity=0.113  Sum_probs=87.4

Q ss_pred             HHHHHHHcCCCCC-----CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc--ceeE
Q 018047           53 LKEMEEATCSFSD-----DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN--LVSL  125 (361)
Q Consensus        53 ~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~  125 (361)
                      .+.+......|.+     .+.++.|....+|++...+ +.+++|+....     .....+..|.+++..|...+  +.++
T Consensus         9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~-~~~vLK~~~~~-----~~~~~i~~e~~~l~~L~~~g~pvp~~   82 (307)
T TIGR00938         9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDV-GRYILTLYEKR-----VKAEELPFFLALTTHLAARGLPVPKP   82 (307)
T ss_pred             HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCC-CcEEEEEecCC-----CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            3444444444544     3457777778999987654 46788876431     11334556777777774222  3444


Q ss_pred             EEE------EEcCCEEEEEEEecCCCchhhh-----------cc-------cCCCC------CCCHHHHH----------
Q 018047          126 IGY------CADGKHRFLVYEYMQKGNLQDH-----------LN-------GIGEP------KMDWPLRL----------  165 (361)
Q Consensus       126 ~~~------~~~~~~~~lv~e~~~~g~L~~~-----------l~-------~~~~~------~~~~~~~~----------  165 (361)
                      +..      ....+..+++++|++|.++...           +.       .....      .-.|....          
T Consensus        83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l  162 (307)
T TIGR00938        83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL  162 (307)
T ss_pred             ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence            432      1234667899999988654311           00       00000      00111100          


Q ss_pred             --HHHHHHHHHHHHHhcCC--CCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          166 --KVALGAAKGLAYLHSSS--AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       166 --~i~~~i~~~l~~lH~~~--~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                        .....+...++++....  .....+||+|+++.||+++.++...|+||+.+.
T Consensus       163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence              00112333455553210  011239999999999999988877899999885

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.99  E-value=8.5e-05  Score=67.42  Aligned_cols=143  Identities=17%  Similarity=0.118  Sum_probs=83.9

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc--ceeEEEE------EEcCCEEEE
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN--LVSLIGY------CADGKHRFL  137 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~------~~~~~~~~l  137 (361)
                      .+.|..|....+|+.... ++.+++|+...      .....+..|+.++..+.+.+  +.+++..      ...++..++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            455777888899998765 45788898642      12345667888888874322  4444431      233456789


Q ss_pred             EEEecCCCchhhh----cc--------------cCCCC-----CCCHHHHH----------HHHHHHHHHHHHHhcC--C
Q 018047          138 VYEYMQKGNLQDH----LN--------------GIGEP-----KMDWPLRL----------KVALGAAKGLAYLHSS--S  182 (361)
Q Consensus       138 v~e~~~~g~L~~~----l~--------------~~~~~-----~~~~~~~~----------~i~~~i~~~l~~lH~~--~  182 (361)
                      +++|++|.++...    ..              .....     ...|....          .....+..++.++...  .
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9999998765430    00              00000     01111100          0111223344444431  1


Q ss_pred             CCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       183 ~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      .....++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            111239999999999999998778999999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.95  E-value=8.5e-05  Score=67.67  Aligned_cols=75  Identities=19%  Similarity=0.177  Sum_probs=49.1

Q ss_pred             ceecccCceEEEEEEEcC-------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc-ceeEEEEEEcCCEEEEE
Q 018047           67 NFLGKGGFGRVYKGTLRS-------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN-LVSLIGYCADGKHRFLV  138 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv  138 (361)
                      +.|..|-...+|++...+       ++.+++|+.....    ....+..+|..++..+...+ ..++++++..    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            346667778999988654       5789999865321    12234567888888885333 3456666542    268


Q ss_pred             EEecCCCchhh
Q 018047          139 YEYMQKGNLQD  149 (361)
Q Consensus       139 ~e~~~~g~L~~  149 (361)
                      +||++|.++..
T Consensus        76 ~e~i~G~~l~~   86 (302)
T cd05156          76 EEFIPSRTLTT   86 (302)
T ss_pred             hheeCCCcCCH
Confidence            99998877643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.89  E-value=0.00035  Score=64.16  Aligned_cols=157  Identities=14%  Similarity=0.132  Sum_probs=82.7

Q ss_pred             CHHHHHHHcCCCCC-----CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc--cee
Q 018047           52 TLKEMEEATCSFSD-----DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN--LVS  124 (361)
Q Consensus        52 ~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~  124 (361)
                      +..++......|..     .+.|+.|....+|+....+| .+++|++..   .   ....+..|+.++..|...+  +.+
T Consensus         8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~---~~~~l~~~~~~l~~L~~~glpvP~   80 (319)
T PRK05231          8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---L---TAEDLPFFLGLMQHLAARGVPVPA   80 (319)
T ss_pred             CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---C---ChHHhHHHHHHHHHHHHCCCCCCc
Confidence            34444444445544     24466777789999876644 688898741   1   1223444566666653211  333


Q ss_pred             EEE------EEEcCCEEEEEEEecCCCchhh-----------hcc-------cCCCC-----CCCH-HHHHH--------
Q 018047          125 LIG------YCADGKHRFLVYEYMQKGNLQD-----------HLN-------GIGEP-----KMDW-PLRLK--------  166 (361)
Q Consensus       125 ~~~------~~~~~~~~~lv~e~~~~g~L~~-----------~l~-------~~~~~-----~~~~-~~~~~--------  166 (361)
                      .+.      +....+..+++++|++|..+..           .+.       .....     .+.+ .....        
T Consensus        81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (319)
T PRK05231         81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD  160 (319)
T ss_pred             ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence            332      1233567789999998875421           110       00000     0111 11100        


Q ss_pred             ----HHHH-HHHHHHHHhcC--CCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          167 ----VALG-AAKGLAYLHSS--SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       167 ----i~~~-i~~~l~~lH~~--~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                          .+.+ +...++.+.+.  ......+||+|+.|.||+++.+...-++||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                1111 11122333211  0012239999999999999976666899999886

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.84  E-value=0.00043  Score=64.97  Aligned_cols=77  Identities=19%  Similarity=0.261  Sum_probs=54.3

Q ss_pred             ceecccCceEEEEEEEcCC-CEEEEEEeecCCCC---c--chhHHHHHHHHHHHHhcC---CCcceeEEEEEEcCCEEEE
Q 018047           67 NFLGKGGFGRVYKGTLRSG-EVVAIKKMELPRFK---E--ADGEHEFRVEVDILSRLD---HPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~---~--~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~l  137 (361)
                      +.||.|.+..||++...+| +.++||.-. +...   .  ....+....|.+.|..+.   ..++++++.+  +.+..++
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~-p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQAL-PYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecC-cccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            5689999999999998766 489999853 1111   1  123456677888888763   2457777777  4456789


Q ss_pred             EEEecCCCc
Q 018047          138 VYEYMQKGN  146 (361)
Q Consensus       138 v~e~~~~g~  146 (361)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.74  E-value=7.9e-05  Score=66.67  Aligned_cols=140  Identities=19%  Similarity=0.179  Sum_probs=97.6

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCC--C-------------Ccch----hHHHHHHHHHHHHhcC-C-C
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPR--F-------------KEAD----GEHEFRVEVDILSRLD-H-P  120 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~-------------~~~~----~~~~~~~E~~~l~~l~-h-~  120 (361)
                      -+..++.||-|.-+-||.+....|++.++|.-....  +             ....    ..-...+|+..|+.|. | -
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            477789999999999999999889999999532211  0             0011    1123456899999885 3 2


Q ss_pred             cceeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee
Q 018047          121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       121 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill  200 (361)
                      -+.+.+++    +.-++|||++.+-.|...-.     -.+...   +...+..-+--|-.+|     +||+|..-=||++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~~---ly~~lm~~Iv~la~~G-----lIHgDFNEFNimv  235 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPPT---LYDDLMGLIVRLANHG-----LIHGDFNEFNIMV  235 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee-----cCChHH---HHHHHHHHHHHHHHcC-----ceecccchheeEE
Confidence            24445544    44579999998888776532     122333   3334445556677888     9999999999999


Q ss_pred             CCCCcEEEeecCccccCC
Q 018047          201 SANFEAKISDFGLAKLMP  218 (361)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~  218 (361)
                      +.++.++++||--+....
T Consensus       236 ~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  236 KDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             ecCCCEEEeechHhhccC
Confidence            999999999998776543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.51  E-value=0.003  Score=57.42  Aligned_cols=140  Identities=22%  Similarity=0.302  Sum_probs=88.9

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC--CcceeEEEEEEcCC--EEEEEEEec
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH--PNLVSLIGYCADGK--HRFLVYEYM  142 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~e~~  142 (361)
                      +.+..|-.-.+|..... ++.+++. .. +.........+..+|+.+++.+.-  --+...++.|.++.  ..|.||+|+
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P-~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLR-KP-PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEe-cC-CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            33433333444444443 7788888 22 222344556677789999998743  23445567776665  779999999


Q ss_pred             CCCchhhhcccCCCCCCCHHHHHHHHH-HHHHHHHHHhcCCC--------------------------------------
Q 018047          143 QKGNLQDHLNGIGEPKMDWPLRLKVAL-GAAKGLAYLHSSSA--------------------------------------  183 (361)
Q Consensus       143 ~~g~L~~~l~~~~~~~~~~~~~~~i~~-~i~~~l~~lH~~~~--------------------------------------  183 (361)
                      +|..+.+.....     +..  .+++. .++..|..||+--.                                      
T Consensus       108 eGe~~~~~~~~~-----~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         108 EGEVVWSALPPE-----SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             cceeccCcCCcc-----cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            986555443221     111  22223 66666666665211                                      


Q ss_pred             ---------------CCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          184 ---------------VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       184 ---------------~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                                     ....++|+|+.+.|++++.++-+-+.||+.+..
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                           023389999999999999998899999999975

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.48  E-value=0.0024  Score=57.38  Aligned_cols=30  Identities=23%  Similarity=0.448  Sum_probs=25.3

Q ss_pred             CeEecCCCCCCeeeCCCCc-EEEeecCcccc
Q 018047          187 PIVHRDFKSTNVLLSANFE-AKISDFGLAKL  216 (361)
Q Consensus       187 ~iiH~Dikp~Nill~~~~~-~kl~Dfg~~~~  216 (361)
                      .++|+|++|.||+++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3899999999999997555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.43  E-value=0.002  Score=59.78  Aligned_cols=141  Identities=16%  Similarity=0.196  Sum_probs=80.1

Q ss_pred             ceecccCceEEEEEEEcC-----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcc-eeEEEEEEcCCEEEEEEE
Q 018047           67 NFLGKGGFGRVYKGTLRS-----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL-VSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e  140 (361)
                      ..|-.|-.-.+|++...+     ++.|++|+.....    ...-+...|..+++.+...++ .++++.+..+    .|.+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e  113 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE  113 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence            345567788999987542     3678888775321    111223568889888864444 3566666443    5799


Q ss_pred             ecCCCchhhh-c----------------ccCC---CC-CCCHHHHHHHHHHH-----------------HHHHHHHh---
Q 018047          141 YMQKGNLQDH-L----------------NGIG---EP-KMDWPLRLKVALGA-----------------AKGLAYLH---  179 (361)
Q Consensus       141 ~~~~g~L~~~-l----------------~~~~---~~-~~~~~~~~~i~~~i-----------------~~~l~~lH---  179 (361)
                      |+++.+|... +                .+..   .. ...+..+..+..++                 ...+..|.   
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            9987666421 0                0000   00 11122332332111                 11122221   


Q ss_pred             cCCCCCCCeEecCCCCCCeeeCC-CCcEEEeecCccc
Q 018047          180 SSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAK  215 (361)
Q Consensus       180 ~~~~~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~  215 (361)
                      ........++|+|+++.||+++. ++.+.++||..+.
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            11112234899999999999986 4789999998885

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.37  E-value=0.0016  Score=58.57  Aligned_cols=73  Identities=19%  Similarity=0.305  Sum_probs=47.8

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC---CCcceeEEEEEEcCCEEEEEEEec
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD---HPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      .+.++-|....+|+.. .+++.+.||.-.      ......|..|.+-|+.|.   .-.+.+++++....+..||+|||+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS------ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE------GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC------hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            3568889999999987 558899999864      223346788999888883   345778899888777779999998


Q ss_pred             CCC
Q 018047          143 QKG  145 (361)
Q Consensus       143 ~~g  145 (361)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.30  E-value=2.6e-05  Score=81.84  Aligned_cols=161  Identities=17%  Similarity=0.063  Sum_probs=117.7

Q ss_pred             HHHHHHHHHhcCCCcceeEEEEEEc--CCEEEEEEEecCCCchhhhcccCCC--CCCCHHHHHHHHHHHHHHHHHHhcCC
Q 018047          107 FRVEVDILSRLDHPNLVSLIGYCAD--GKHRFLVYEYMQKGNLQDHLNGIGE--PKMDWPLRLKVALGAAKGLAYLHSSS  182 (361)
Q Consensus       107 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~  182 (361)
                      ...|..-++...|+++.....-...  ....+.+++|+.+|.+.+.|-+..+  +..+...+.....+.+.+..-+|++.
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3345555556789988877665543  3456889999999999998865322  22333333333334367777777766


Q ss_pred             CCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHH
Q 018047          183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLEL  262 (361)
Q Consensus       183 ~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  262 (361)
                      ..+..-+|+++|+.|.++..+.+++++++|+.+.....  ....+...+++.|++|+....-.++.++|+|..|+-+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence            55666899999999999999999999999999843221  1133445778899999988877888889999999999999


Q ss_pred             HhCCCCC
Q 018047          263 LTGRRAV  269 (361)
Q Consensus       263 l~g~~p~  269 (361)
                      .-|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            9988776

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.16  E-value=0.011  Score=55.67  Aligned_cols=76  Identities=12%  Similarity=0.060  Sum_probs=50.3

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCC-Ccc---hhHHHHHHHHHHHHhcC---CCcceeEEEEEEcCCEEEEE
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRF-KEA---DGEHEFRVEVDILSRLD---HPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .+.||.|....||+.... ++.++||.-..... ...   ........|...|+.+.   ...+.+++.++.+  ..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            456899999999998865 56788997542111 111   12334445677777663   2478888888763  45688


Q ss_pred             EEecCC
Q 018047          139 YEYMQK  144 (361)
Q Consensus       139 ~e~~~~  144 (361)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.14  E-value=0.0088  Score=54.67  Aligned_cols=29  Identities=17%  Similarity=0.233  Sum_probs=26.9

Q ss_pred             CeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          187 PIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       187 ~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      .+||+|+.++|+|++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            39999999999999999999999998886

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.11  E-value=0.0073  Score=55.74  Aligned_cols=76  Identities=17%  Similarity=0.165  Sum_probs=48.6

Q ss_pred             eecccCceEEEEEEEcCC-CEEEEEEeecCC--C--CcchhHHHHHHHHHHHHhcC--CC-cceeEEEEEEcCCEEEEEE
Q 018047           68 FLGKGGFGRVYKGTLRSG-EVVAIKKMELPR--F--KEADGEHEFRVEVDILSRLD--HP-NLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~--~--~~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv~  139 (361)
                      .||.|-...||++...+| +.++||.-..-.  .  .-.-.......|.+.|+...  -| .+++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999997644 689999643110  0  11223445556888887763  34 45555544  556667999


Q ss_pred             EecCCC
Q 018047          140 EYMQKG  145 (361)
Q Consensus       140 e~~~~g  145 (361)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.10  E-value=0.0087  Score=54.86  Aligned_cols=140  Identities=19%  Similarity=0.216  Sum_probs=91.8

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCC--CCcc-----------------h----hHHHHHHHHHHHHhcCCCcce
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPR--FKEA-----------------D----GEHEFRVEVDILSRLDHPNLV  123 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~-----------------~----~~~~~~~E~~~l~~l~h~~iv  123 (361)
                      ..|..|.-+.||-|+..+|..+|||++.-+.  +.+.                 .    ..-....|+.-|.++....|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            4578899999999998899999999874321  1110                 1    122345688888888655543


Q ss_pred             eEEEEEEcCCEEEEEEEecCCCchh-hhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC
Q 018047          124 SLIGYCADGKHRFLVYEYMQKGNLQ-DHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA  202 (361)
Q Consensus       124 ~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~  202 (361)
                      ----+. - ..-.|||+|+....-. -.|+   ...++...+..+-.+++.-+.-|-+.+    .+||.||+--|+|+. 
T Consensus       230 ~PePIl-L-k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c----~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  230 CPEPIL-L-KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC----RLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCCcee-e-ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh----ceeccchhhhhheEE-
Confidence            111010 1 2236999998532211 1222   235666677777778888887776655    499999999999886 


Q ss_pred             CCcEEEeecCcccc
Q 018047          203 NFEAKISDFGLAKL  216 (361)
Q Consensus       203 ~~~~kl~Dfg~~~~  216 (361)
                      +|.+.++|.+-+..
T Consensus       300 dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVE  313 (520)
T ss_pred             CCEEEEEEcccccc
Confidence            45899999887654

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.06  E-value=0.0028  Score=54.46  Aligned_cols=29  Identities=31%  Similarity=0.502  Sum_probs=21.0

Q ss_pred             CeEecCCCCCCeee-CCCCcEEEeecCccc
Q 018047          187 PIVHRDFKSTNVLL-SANFEAKISDFGLAK  215 (361)
Q Consensus       187 ~iiH~Dikp~Nill-~~~~~~kl~Dfg~~~  215 (361)
                      .++|+|+.|.|||+ +.++.++|+||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            38999999999999 888999999999885

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.04  E-value=0.0074  Score=55.69  Aligned_cols=141  Identities=15%  Similarity=0.181  Sum_probs=77.7

Q ss_pred             eecccCceEEEEEEEcC----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcc-eeEEEEEEcCCEEEEEEEec
Q 018047           68 FLGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL-VSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~  142 (361)
                      .|..|=...+|+....+    +..|++|+.....    ...-+-.+|..+++.+..-++ .++++++. ++   +|.+|+
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi   92 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI   92 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCc----CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence            35557777889887542    2378888764321    112233568888888865444 45666653 22   588998


Q ss_pred             CCCchhh--h-----c-------c---cCC---CCCC-CHHHHHHHHHHH----------------------HH---HHH
Q 018047          143 QKGNLQD--H-----L-------N---GIG---EPKM-DWPLRLKVALGA----------------------AK---GLA  176 (361)
Q Consensus       143 ~~g~L~~--~-----l-------~---~~~---~~~~-~~~~~~~i~~~i----------------------~~---~l~  176 (361)
                      ++.+|..  .     +       .   +..   .... -+..+..+..++                      ..   .+.
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            7765532  1     1       0   000   0001 122222222111                      11   111


Q ss_pred             HHhcCCCCCCCeEecCCCCCCeeeCC-CCcEEEeecCcccc
Q 018047          177 YLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKL  216 (361)
Q Consensus       177 ~lH~~~~~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~  216 (361)
                      .+......+.-++|+|+.+.|||++. ++.++++||..|..
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11111111233899999999999975 57899999998853

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.04  E-value=0.0015  Score=62.10  Aligned_cols=167  Identities=20%  Similarity=0.256  Sum_probs=94.2

Q ss_pred             HHHHHHHHHHHHhcCCCcceeEEEEEEc-CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 018047          104 EHEFRVEVDILSRLDHPNLVSLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS  182 (361)
Q Consensus       104 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  182 (361)
                      ...+..-+..++.+.|+|...++++-.. .....+|||++. -||.+.+....   +.....          +    .++
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~---l~~~s~----------~----~~~   87 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN---LKDESL----------L----AHG   87 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc---cchhhh----------c----ccc
Confidence            3456677889999999999999988653 345789999994 59999886542   111110          0    111


Q ss_pred             CCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHH
Q 018047          183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLEL  262 (361)
Q Consensus       183 ~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  262 (361)
                           +.|     -|+       ++.+| .++..                  |  |-     ...+|+||||+|.++.++
T Consensus        88 -----~~~-----~~~-------~~~td-~~~t~------------------~--~~-----~~~pKsdVwsl~~i~~el  124 (725)
T KOG1093|consen   88 -----VLH-----LNI-------IYITD-HFLTK------------------Y--PS-----PIGPKSDVWSLGFIILEL  124 (725)
T ss_pred             -----cce-----ehh-------hhccc-ccccc------------------C--CC-----CCCcchhhhhHHHHHHHH
Confidence                 222     222       22233 11110                  0  11     111499999999999999


Q ss_pred             HhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 018047          263 LTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK  338 (361)
Q Consensus       263 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~  338 (361)
                      .-|...+...   ...+....+................    .....++...++++..+|+-..|..||...++.+
T Consensus       125 ~L~~~l~~~~---~~s~~l~~i~k~~~~d~~~~~~a~e----~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  125 YLGISLEAEL---TESEYLEILLKYYTDDQELLSTAME----HLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHhhHHHHHH---HHHHHHHHHHHhccCchhHHHHHHH----HHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            9998765311   1111122222211111111111000    0123455567889999999999999987665543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.00  E-value=0.02  Score=52.17  Aligned_cols=28  Identities=29%  Similarity=0.489  Sum_probs=24.7

Q ss_pred             CeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          187 PIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       187 ~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      .++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            3899999999999987 678999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.97  E-value=0.015  Score=53.41  Aligned_cols=140  Identities=20%  Similarity=0.278  Sum_probs=81.7

Q ss_pred             ecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc------ceeEEE----EEEcCCEEEEE
Q 018047           69 LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN------LVSLIG----YCADGKHRFLV  138 (361)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~----~~~~~~~~~lv  138 (361)
                      |.+ .-..+|+....+|+. ++|+....     ....++..|.+.|..|.-.+      +..+-|    ....+...+-+
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l  106 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL  106 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence            444 567899988876655 88887532     33456677888888773211      222222    12222377889


Q ss_pred             EEecCCCchhh-hcc------------------cCC------CCCCCHHH----H---------HHHHHHHHHHHHHHhc
Q 018047          139 YEYMQKGNLQD-HLN------------------GIG------EPKMDWPL----R---------LKVALGAAKGLAYLHS  180 (361)
Q Consensus       139 ~e~~~~g~L~~-~l~------------------~~~------~~~~~~~~----~---------~~i~~~i~~~l~~lH~  180 (361)
                      ++|++|..+.. -..                  ...      .....|..    .         .....++...+..+.+
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99999988773 110                  110      00122221    0         1122334444444444


Q ss_pred             CCC---CC--CCeEecCCCCCCeeeCCCCc-EEEeecCccc
Q 018047          181 SSA---VG--IPIVHRDFKSTNVLLSANFE-AKISDFGLAK  215 (361)
Q Consensus       181 ~~~---~~--~~iiH~Dikp~Nill~~~~~-~kl~Dfg~~~  215 (361)
                      .-.   +.  ..+||+|+.|.||+++.+.. +-++||+.+.
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            211   11  23899999999999999885 9999999885

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.72  E-value=0.037  Score=47.57  Aligned_cols=73  Identities=22%  Similarity=0.311  Sum_probs=51.1

Q ss_pred             ecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC---CCcceeEEEEEEcCCEEEEEEEecCCC
Q 018047           69 LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD---HPNLVSLIGYCADGKHRFLVYEYMQKG  145 (361)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~g  145 (361)
                      +.-|.--..|...+ +..++.||.-      .......|..|+.-|+.+.   .-++.+++.+-.+.++.|+||||++-|
T Consensus        24 v~gG~inea~~v~d-g~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          24 VSGGDINEAWRLRD-GTDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             cCCccccceeEeec-CCcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            33333334443332 3678888873      3445567888888777773   456788899989999999999999987


Q ss_pred             chh
Q 018047          146 NLQ  148 (361)
Q Consensus       146 ~L~  148 (361)
                      .+.
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            765

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.53  E-value=0.14  Score=47.25  Aligned_cols=95  Identities=17%  Similarity=0.098  Sum_probs=54.2

Q ss_pred             cccCHHHHHHHcCCCCCC---c-eecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc--c
Q 018047           49 SVFTLKEMEEATCSFSDD---N-FLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN--L  122 (361)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~---~-~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i  122 (361)
                      ..++...+..+...+...   + ..=.+....||+....+|..+++|+.....    .....+..|.+.+..|....  +
T Consensus         9 ~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv   84 (325)
T PRK11768          9 QTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPV   84 (325)
T ss_pred             CCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCC
Confidence            345555555555444331   1 122344568999988778889999875321    23445667888877763211  2


Q ss_pred             eeEE---E--EEEcCCEEEEEEEecCCCch
Q 018047          123 VSLI---G--YCADGKHRFLVYEYMQKGNL  147 (361)
Q Consensus       123 v~~~---~--~~~~~~~~~lv~e~~~~g~L  147 (361)
                      +...   |  +...++..+.++++++|...
T Consensus        85 ~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         85 VAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             CCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            2211   1  12335677889999987643

>PRK06148 hypothetical protein; Provisional

Probab=96.39  E-value=0.068  Score=56.79  Aligned_cols=141  Identities=18%  Similarity=0.258  Sum_probs=77.3

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-------CCcceeE-----EEEEEc-CC
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-------HPNLVSL-----IGYCAD-GK  133 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-------h~~iv~~-----~~~~~~-~~  133 (361)
                      +.|+ |..-.+|+....+|..+++|+.+..     ........|...|..|.       -|.+++-     +..... ++
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~-----~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G  104 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPS-----EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDG  104 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCc-----cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCC
Confidence            4454 3557889988777889999998643     12223444555665542       2333321     111222 22


Q ss_pred             --EEEEEEEecCCCchhhhcc---------------------cCCC----CCCCHHH-----------------HHHHHH
Q 018047          134 --HRFLVYEYMQKGNLQDHLN---------------------GIGE----PKMDWPL-----------------RLKVAL  169 (361)
Q Consensus       134 --~~~lv~e~~~~g~L~~~l~---------------------~~~~----~~~~~~~-----------------~~~i~~  169 (361)
                        ..+-+++|++|..|.+...                     .+..    ..+.|..                 ...++.
T Consensus       105 ~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~  184 (1013)
T PRK06148        105 EPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVE  184 (1013)
T ss_pred             ceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHH
Confidence              4667899999977765110                     1110    1122211                 112222


Q ss_pred             HHHHHHH-----HHhcCCCCCCCeEecCCCCCCeeeCCCC--cEE-EeecCcccc
Q 018047          170 GAAKGLA-----YLHSSSAVGIPIVHRDFKSTNVLLSANF--EAK-ISDFGLAKL  216 (361)
Q Consensus       170 ~i~~~l~-----~lH~~~~~~~~iiH~Dikp~Nill~~~~--~~k-l~Dfg~~~~  216 (361)
                      ++++...     .+.+   ....+||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       185 ~~~~~~~~~v~p~l~~---Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        185 RFLARFERNVAPRLAA---LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHHHhc---CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2222222     1211   122399999999999999875  555 999998863

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.27  E-value=0.028  Score=52.62  Aligned_cols=77  Identities=17%  Similarity=0.190  Sum_probs=50.9

Q ss_pred             CceecccCceEEEEEEEcC-CCEEEEEEeecCC-C--CcchhHHHHHHHHHHHHhcC--CC-cceeEEEEEEcCCEEEEE
Q 018047           66 DNFLGKGGFGRVYKGTLRS-GEVVAIKKMELPR-F--KEADGEHEFRVEVDILSRLD--HP-NLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~--~~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv  138 (361)
                      .+.||.|--.-||++...+ ++.++||.-..-. .  .-.-..+....|.+.|+...  .| .+++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3568999999999999753 5689999642210 0  11234556667888888763  34 45556654  55566789


Q ss_pred             EEecCC
Q 018047          139 YEYMQK  144 (361)
Q Consensus       139 ~e~~~~  144 (361)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PTZ00384 choline kinase; Provisional

Probab=96.26  E-value=0.051  Score=51.09  Aligned_cols=74  Identities=24%  Similarity=0.328  Sum_probs=45.0

Q ss_pred             ceecccCceEEEEEEEcCC--CE-----EEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc-ceeEEEEEEcCCEEEEE
Q 018047           67 NFLGKGGFGRVYKGTLRSG--EV-----VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN-LVSLIGYCADGKHRFLV  138 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv  138 (361)
                      +.|..|-...+|++...++  ..     |.++...    ......-+-..|+.+++.+...+ -.++++.+..    +++
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g----~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS----TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEecc----CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence            4465688899999976532  23     3333321    11111123345899999996544 4566777643    599


Q ss_pred             EEecCCCchh
Q 018047          139 YEYMQKGNLQ  148 (361)
Q Consensus       139 ~e~~~~g~L~  148 (361)
                      .||++|.+|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999987664

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.21  E-value=0.021  Score=52.34  Aligned_cols=111  Identities=19%  Similarity=0.229  Sum_probs=71.0

Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      ...|++|++- |++|. .+.     ...+++...++.+-+..+.-+..+-    +.-|||+.-.|||++ +|+|.|+||-
T Consensus       299 ~y~yl~~kdh-gt~is-~ik-----~~~~~e~lsff~s~~sil~~lekkf----~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         299 LYLYLHFKDH-GTPIS-IIK-----ADRSEEELSFFWSCISILDILEKKF----PFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             eEEEEEEecC-Cceee-eee-----cccHHHHHHHHHHHHHHHhhhhhcC----Ccccccccccceeee-cCceEEEEee
Confidence            3556677754 44443 222     3567888889888888777776643    589999999999999 9999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCC
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR  266 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  266 (361)
                      +++.-.+... .      ....+--|-.+. +.-+.+-+||-+   |--|+.|+
T Consensus       367 lsRl~~~q~~-i------sy~rldhp~lF~-G~dd~QFeIYrl---Mr~l~~g~  409 (488)
T COG5072         367 LSRLSYSQGI-I------SYNRLDHPDLFN-GVDDYQFEIYRL---MRRLLKGR  409 (488)
T ss_pred             eeecccCCce-e------eccccCchhhhc-CccceeeeHHHH---HHHHhcCc
Confidence            9984322211 1      111233344443 333666777753   34444454

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.10  E-value=0.044  Score=46.88  Aligned_cols=118  Identities=14%  Similarity=0.096  Sum_probs=70.4

Q ss_pred             cCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCCCchhhhc
Q 018047           72 GGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL  151 (361)
Q Consensus        72 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l  151 (361)
                      |+-++.-.+..+- .+..+|++......  -...-+..+..++.++.  .|+++..-  ++-.+-+|+|+|-...     
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~--~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCC--INDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----  140 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcc--cchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----
Confidence            3444444444332 23445555322111  12234567788887765  37777632  3446678999884311     


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          152 NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       152 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                               .. ...++..=+++|.-.|+...   ..+|+|-.|+||+-|..|.+||.|-+..
T Consensus       141 ---------i~-~~N~i~agi~~L~~fH~~~~---~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  141 ---------IN-FSNFITAGIKDLMDFHSENQ---HCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ---------cc-hhHHHHHhHHHHHHhhccCC---CeecCCCChhheeecCCCCEEecChhhh
Confidence                     11 11122222567888885432   3999999999999999999999997754

The function of this family is unknown.

>PTZ00296 choline kinase; Provisional

Probab=95.56  E-value=0.19  Score=48.28  Aligned_cols=74  Identities=14%  Similarity=0.165  Sum_probs=45.0

Q ss_pred             ceecccCceEEEEEEEcC---------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcce-eEEEEEEcCCEEE
Q 018047           67 NFLGKGGFGRVYKGTLRS---------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV-SLIGYCADGKHRF  136 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~  136 (361)
                      +.|..|-.-.+|++...+         ++.|.+++.-..    ....-.-..|..+++.+...+|- ++++.+. +   +
T Consensus       111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~----te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g  182 (442)
T PTZ00296        111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKD----VDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---G  182 (442)
T ss_pred             EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCC----ccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---C
Confidence            456667778899887542         357888876432    11122344588888887544443 4566553 2   3


Q ss_pred             EEEEecCCCchh
Q 018047          137 LVYEYMQKGNLQ  148 (361)
Q Consensus       137 lv~e~~~~g~L~  148 (361)
                      .|.||++|.+|.
T Consensus       183 ~I~efi~g~~l~  194 (442)
T PTZ00296        183 RIEEWLYGDPLR  194 (442)
T ss_pred             EEEEeeCCccCC
Confidence            578999886443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	361
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-53
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-46
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-45
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-33
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-21
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-20
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-20
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-20
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-20
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-20
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-20
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-20
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-20
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-20
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-16
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-14
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-14
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-14
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-14
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-14
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-09
3soa_A	444	Full-Length Human Camkii Length = 444		5e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  204 bits (520), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 117/295 (39%), Positives = 178/295 (60%), Gaps = 11/295 (3%)
Query: 51  FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVE 110
           F+L+E++ A+ +FS+ N LG+GGFG+VYKG L  G +VA+K+++  R +   GE +F+ E
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQ--GGELQFQTE 85
Query: 111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE--PKMDWPXXXXXX 168
           V+++S   H NL+ L G+C     R LVY YM  G++   L    E  P +DWP      
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
                   YLH        I+HRD K+ N+LL   FEA + DFGLAKLM + ++ +V   
Sbjct: 146 LGSARGLAYLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXHVXXA 202
Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL--QVRH 286
           V GT G+  PEY STGK + ++DV+ +GV+LLEL+TG+RA DL +  ND +++L   V+ 
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
           +L + KKL  ++D +L + +Y  E +     +A  C ++   ERP M+E V+ L+
Sbjct: 263 LLKE-KKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  200 bits (509), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 115/295 (38%), Positives = 176/295 (59%), Gaps = 11/295 (3%)
Query: 51  FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVE 110
           F+L+E++ A+ +F + N LG+GGFG+VYKG L  G +VA+K+++  R +   GE +F+ E
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQ--GGELQFQTE 77
Query: 111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE--PKMDWPXXXXXX 168
           V+++S   H NL+ L G+C     R LVY YM  G++   L    E  P +DWP      
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
                   YLH        I+HRD K+ N+LL   FEA + DFGLAKLM + ++ +V   
Sbjct: 138 LGSARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXHVXXA 194
Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL--QVRH 286
           V G  G+  PEY STGK + ++DV+ +GV+LLEL+TG+RA DL +  ND +++L   V+ 
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
           +L + KKL  ++D +L + +Y  E +     +A  C ++   ERP M+E V+ L+
Sbjct: 255 LLKE-KKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  180 bits (457), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 114/291 (39%), Positives = 163/291 (56%), Gaps = 12/291 (4%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVD 112
           L ++EEAT +F     +G G FG+VYKG LR G  VA+K+   P  + + G  EF  E++
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTP--ESSQGIEEFETEIE 87
Query: 113 ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP--KMDWPXXXXXXXX 170
            LS   HP+LVSLIG+C +     L+Y+YM+ GNL+ HL G   P   M W         
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 171 XXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL 230
                 YLH+ +     I+HRD KS N+LL  NF  KI+DFG++K   E  +T++   V 
Sbjct: 148 AARGLHYLHTRA-----IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVK 202
Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
           GT GY DPEY   G+LT +SDVY+FGVVL E+L  R A+  +      NL        N+
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
             +L +++DP L+      ES+  F + A +C+   S +RPSM + + +L+
Sbjct: 263 -GQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 114/291 (39%), Positives = 163/291 (56%), Gaps = 12/291 (4%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVD 112
           L ++EEAT +F     +G G FG+VYKG LR G  VA+K+   P  + + G  EF  E++
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTP--ESSQGIEEFETEIE 87
Query: 113 ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP--KMDWPXXXXXXXX 170
            LS   HP+LVSLIG+C +     L+Y+YM+ GNL+ HL G   P   M W         
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 171 XXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL 230
                 YLH+ +     I+HRD KS N+LL  NF  KI+DFG++K   E  +T++   V 
Sbjct: 148 AARGLHYLHTRA-----IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVK 202
Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
           GT GY DPEY   G+LT +SDVY+FGVVL E+L  R A+  +      NL        N+
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
             +L +++DP L+      ES+  F + A +C+   S +RPSM + + +L+
Sbjct: 263 -GQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 161/298 (54%), Gaps = 17/298 (5%)
Query: 51  FTLKEMEEATCSFSD------DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE 104
           F+  E++  T +F +       N +G+GGFG VYKG + +  V   K   +      + +
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI-GEPKMDWPX 163
            +F  E+ ++++  H NLV L+G+ +DG    LVY YM  G+L D L+ + G P + W  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        +LH +       +HRD KS N+LL   F AKISDFGLA+   +  +T
Sbjct: 135 RCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
            + +R++GT  Y  PE    G++T +SD+Y+FGVVLLE++TG  AVD ++    Q L+  
Sbjct: 190 VMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLLDI 246
Query: 284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
              I ++ K +   ID +++ +  T  S+    ++AS+C+  + ++RP + +  + LQ
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADST--SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 97/298 (32%), Positives = 160/298 (53%), Gaps = 17/298 (5%)
Query: 51  FTLKEMEEATCSFSD------DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE 104
           F+  E++  T +F +       N +G+GGFG VYKG + +  V   K   +      + +
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI-GEPKMDWPX 163
            +F  E+ ++++  H NLV L+G+ +DG    LVY YM  G+L D L+ + G P + W  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        +LH +       +HRD KS N+LL   F AKISDFGLA+   +  +T
Sbjct: 135 RCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
            +  R++GT  Y  PE    G++T +SD+Y+FGVVLLE++TG  AVD ++    Q L+  
Sbjct: 190 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLLDI 246
Query: 284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
              I ++ K +   ID +++ +  T  S+    ++AS+C+  + ++RP + +  + LQ
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADST--SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 159/298 (53%), Gaps = 17/298 (5%)
Query: 51  FTLKEMEEATCSFSD------DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE 104
           F+  E++  T +F +       N +G+GGFG VYKG + +  V   K   +      + +
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI-GEPKMDWPX 163
            +F  E+ ++++  H NLV L+G+ +DG    LVY YM  G+L D L+ + G P + W  
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        +LH +       +HRD KS N+LL   F AKISDFGLA+   +  + 
Sbjct: 129 RCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
            +  R++GT  Y  PE    G++T +SD+Y+FGVVLLE++TG  AVD ++    Q L+  
Sbjct: 184 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLLDI 240
Query: 284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
              I ++ K +   ID +++ +  T  S+    ++AS+C+  + ++RP + +  + LQ
Sbjct: 241 KEEIEDEEKTIEDYIDKKMNDADST--SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 156/298 (52%), Gaps = 17/298 (5%)
Query: 51  FTLKEMEEATCSFSD------DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE 104
           F+  E++  T +F +       N  G+GGFG VYKG + +  V   K   +      + +
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI-GEPKMDWPX 163
            +F  E+ + ++  H NLV L+G+ +DG    LVY Y   G+L D L+ + G P + W  
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        +LH +       +HRD KS N+LL   F AKISDFGLA+   +  + 
Sbjct: 126 RCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
              +R++GT  Y  PE    G++T +SD+Y+FGVVLLE++TG  AVD ++    Q L+  
Sbjct: 181 VXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLLDI 237
Query: 284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
              I ++ K +   ID + + +  T  S+    ++AS+C+  + ++RP + +  + LQ
Sbjct: 238 KEEIEDEEKTIEDYIDKKXNDADST--SVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 122/278 (43%), Gaps = 36/278 (12%)
Query: 59  ATC------SFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEV 111
           ATC       F   N LGKG F  VY+  ++ +G  VAIK ++     +A      + EV
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 112 DILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXX 171
            I  +L HP+++ L  Y  D  + +LV E    G +  +L    +P              
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQI 121
Query: 172 XXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
                YLHS       I+HRD   +N+LL+ N   KI+DFGLA  +    E + T  + G
Sbjct: 122 ITGMLYLHSHG-----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCG 174
Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN------------ 279
           T  Y  PE  +     L+SDV++ G +   LL GR   D +   N  N            
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF 234
Query: 280 LVLQVRHILN--------DRKKLRKVID-PELSRSSYT 308
           L ++ + +++        DR  L  V+D P +SR+S T
Sbjct: 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY  +G +   L  +   K D                Y HS       
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLS--KFDEQRTATYITELANALSYCHSKR----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 189
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 78
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 79  VSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN-----Y 132
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 189
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 241
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R E  ERP+
Sbjct: 242 H---------DLMCQCWRKEPEERPT 258

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 74
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 75  VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 128
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 185
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 186 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 237
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R E  ERP+
Sbjct: 238 H---------DLMCQCWRKEPEERPT 254

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 78
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 79  VSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN-----Y 132
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---WTARQGAKFPIKWTAPEAALYGRF 189
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 241
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R E  ERP+
Sbjct: 242 H---------DLMCQCWRKEPEERPT 258

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 124/276 (44%), Gaps = 26/276 (9%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 76
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
                   +V ++ +  +L  HL+   E K +                YLH+ S     I
Sbjct: 77  STK-PQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS-----I 129
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA +      ++   ++ G+  +  PE      +  
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS 305
            + QSDVYAFG+VL EL+TG+        +N+++ ++++          R  + P+LS+ 
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIEMVG--------RGSLSPDLSKV 238
Query: 306 SYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
                       L + C++ +  ERPS    + E++
Sbjct: 239 RSNCPK--RMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 28/279 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 72
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            +      +V ++ +  +L  HL+ I E K +                YLH+ S     I
Sbjct: 73  -STAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS-----I 125
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA +      ++   ++ G+  +  PE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+     N    DQ + +  R  L+ D  K+R      + R
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        L + C++ +  ERP   + +  ++L+
Sbjct: 245 -------------LMAECLKKKRDERPLFPQILASIELL 270

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 247
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+       +  
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-----MNY 301
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 358
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPES- 409
Query: 307 YTMESIAMFANLASRCVRTESSERPSM 333
                     +L  +C R E  ERP+ 
Sbjct: 410 --------LHDLMCQCWRKEPEERPTF 428

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 247
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+       +  
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-----MNY 301
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 358
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPES- 409
Query: 307 YTMESIAMFANLASRCVRTESSERPSM 333
                     +L  +C R E  ERP+ 
Sbjct: 410 --------LHDLMCQCWRKEPEERPTF 428

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    R  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   + D                Y HS       
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLS--RFDEQRTATYITELANALSYCHSKR----- 132
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +N E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 188
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ GV+  E L G    + +                  ++  R++   E +   +
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAH----------------TYQETYRRISRVEFTFPDF 232
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVK 338
             E      +L SR ++  +S+R ++AE ++
Sbjct: 233 VTEGA---RDLISRLLKHNASQRLTLAEVLE 260

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 154
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 210
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 145
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 146 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 201
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFEAN 226

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T     + GT  Y  PE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----ELCGTLDYLPPEMIEGRMHD 184
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 32/285 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEXIEGRXHD 189
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ GV+  E L G+   + N                  ++  +++   E +   +
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQETYKRISRVEFTFPDF 233
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLN 352
             E      +L SR ++   S+RP + E V E   I   +SK  N
Sbjct: 234 VTEGA---RDLISRLLKHNPSQRPXLRE-VLEHPWITANSSKPSN 274

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 28/279 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 74
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +   +V ++ +  +L  HL+ I E K +                YLH+ S     I
Sbjct: 75  STKPQ-LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS-----I 127
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA +      ++   ++ G+  +  PE         
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+     N    DQ + +  R  L+ D  K+R      + R
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 246
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        L + C++ +  ERP   + +  ++L+
Sbjct: 247 -------------LMAECLKKKRDERPLFPQILASIELL 272

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 129
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T ++    GT  Y  PE        
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYLPPEMIEGRMHD 185
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 189
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 131
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 187
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 77
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
                   +V ++ +  +L  HL+ I E K +                YLH+ S     I
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS-----I 130
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA +      ++   ++ G+  +  PE         
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+     N    DQ + +  R  L+ D  K+R      + R
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 249
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        L + C++ +  ERP   + +  ++L+
Sbjct: 250 -------------LMAECLKKKRDERPLFPQILASIELL 275

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 28/279 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 72
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +   +V ++ +  +L  HL+ I E K +                YLH+ S     I
Sbjct: 73  STKPQLA-IVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS-----I 125
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA +      ++   ++ G+  +  PE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+     N    DQ + +  R  L+ D  K+R      + R
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        L + C++ +  ERP   + +  ++L+
Sbjct: 245 -------------LMAECLKKKRDERPLFPQILASIELL 270

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 131/293 (44%), Gaps = 29/293 (9%)
Query: 55  EMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDIL 114
           +M+   C  +    +G G FG V++     G  VA+K +    F  A+  +EF  EV I+
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF-HAERVNEFLREVAIM 88
Query: 115 SRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG-EPKMDWPXXXXXXXXXXX 173
            RL HPN+V  +G      +  +V EY+ +G+L   L+  G   ++D             
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              YLH+ +    PIVHRD KS N+L+   +  K+ DFGL++L  +      +    GT 
Sbjct: 149 GMNYLHNRNP---PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTP 203
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            +  PE         +SDVY+FGV+L EL T      L Q   + N    V  +    K+
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELAT------LQQPWGNLNPAQVVAAVGFKCKR 257
Query: 294 LR--KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
           L   + ++P++             A +   C   E  +RPS A  +  L+ +I
Sbjct: 258 LEIPRNLNPQV-------------AAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 124/276 (44%), Gaps = 26/276 (9%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 88
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            +      +V ++ +  +L  HL+   E K +                YLH+ S     I
Sbjct: 89  -STAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS-----I 141
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA        ++   ++ G+  +  PE      +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS 305
            + QSDVYAFG+VL EL+TG+        +N+++ ++++          R  + P+LS+ 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIEMVG--------RGSLSPDLSKV 250
Query: 306 SYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
                       L + C++ +  ERPS    + E++
Sbjct: 251 RSNCPK--RMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 28/279 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 77
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +   +V ++ +  +L  HL+ I E K +                YLH+ S     I
Sbjct: 78  STKPQ-LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS-----I 130
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA +      ++   ++ G+  +  PE         
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+     N    DQ + +  R  L+ D  K+R      + R
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 249
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        L + C++ +  ERP   + +  ++L+
Sbjct: 250 -------------LMAECLKKKRDERPLFPQILASIELL 275

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 247
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+       +  
Sbjct: 248 VSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-----MNY 301
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 358
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPES- 409
Query: 307 YTMESIAMFANLASRCVRTESSERPSM 333
                     +L  +C R E  ERP+ 
Sbjct: 410 --------LHDLMCQCWRKEPEERPTF 428

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 184
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 120/267 (44%), Gaps = 32/267 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++            F  E  ++ +L H  LV L   
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+       +  
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-----MNY 384
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+   ++   TAR    F   +  PE    G+ 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPES- 492
Query: 307 YTMESIAMFANLASRCVRTESSERPSM 333
                     +L  +C R E  ERP+ 
Sbjct: 493 --------LHDLMCQCWRKEPEERPTF 511

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY  +G +   L  +   K D                Y HS       
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLS--KFDEQRTATYITELANALSYCHSKR----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  +   +     GT  Y  PE        
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX----GTLDYLPPEMIEGRMHD 189
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 122/266 (45%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 71
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +   +V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 72  VSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 125
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAALYGRF 182
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 183 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 234
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R E  ERP+
Sbjct: 235 H---------DLMCQCWRKEPEERPT 251

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 31/271 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLDYLPPEMIEGRMHD 184
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ GV+  E L G+   + N                  ++  +++   E +   +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQETYKRISRVEFTFPDF 228
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVK 338
             E      +L SR ++   S+RP + E ++
Sbjct: 229 VTEGA---RDLISRLLKHNPSQRPMLREVLE 256

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 82  VSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 135
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAALYGRF 192
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 244
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R +  ERP+
Sbjct: 245 H---------DLMCQCWRKDPEERPT 261

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T     + GT  Y  PE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----DLCGTLDYLPPEMIEGRMHD 184
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 129
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T     + GT  Y  PE        
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----DLCGTLDYLPPEMIEGRMHD 185
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 28/279 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 99
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +   +V ++ +  +L  HL+ I E K +                YLH+ S     I
Sbjct: 100 STKPQ-LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS-----I 152
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA +      ++   ++ G+  +  PE         
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+     N    DQ + +  R  L+ D  K+R      + R
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 271
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        L + C++ +  ERP   + +  ++L+
Sbjct: 272 -------------LMAECLKKKRDERPLFPQILASIELL 297

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T     + GT  Y  PE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----DLCGTLDYLPPEMIEGRMHD 184
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 82  VSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 135
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 192
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 244
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R +  ERP+
Sbjct: 245 H---------DLMCQCWRKDPEERPT 261

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 31/271 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 127
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 183
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ GV+  E L G+   + N                  ++  +++   E +   +
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQETYKRISRVEFTFPDF 227
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVK 338
             E      +L SR ++   S+RP + E ++
Sbjct: 228 VTEGA---RDLISRLLKHNPSQRPMLREVLE 255

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 135
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 192
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 244
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R +  ERP+
Sbjct: 245 H---------DLMCQCWRKDPEERPT 261

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 12/220 (5%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVD 112
           K+ + A   F     LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 113 ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX 172
           I S L HPN++ L GY  D    +L+ EY   G +   L  +   K D            
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELA 121
Query: 173 XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
               Y HS       ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT
Sbjct: 122 NALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 172
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLN 272
             Y  PE         + D+++ GV+  E L G+   + N
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T     + GT  Y  PE        
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----DLCGTLDYLPPEMIEGRMHD 189
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 82  VSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 135
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 192
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 244
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R +  ERP+
Sbjct: 245 H---------DLMCQCWRKDPEERPT 261

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 72
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 73  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 126
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 183
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 184 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 235
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R +  ERP+
Sbjct: 236 H---------DLMCQCWRKDPEERPT 252

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 70
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 71  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 124
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 182 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 233
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R +  ERP+
Sbjct: 234 H---------DLMCQCWRKDPEERPT 250

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 100
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
                   +V ++ +  +L  HL+ I E K +                YLH+ S     I
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS-----I 153
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA +      ++   ++ G+  +  PE         
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+     N    DQ + +  R  L+ D  K+R      + R
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 272
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        L + C++ +  ERP   + +  ++L+
Sbjct: 273 -------------LMAECLKKKRDERPLFPQILASIELL 298

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 31/271 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    ++ + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKK----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  +     A + GT  Y  PE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMHD 184
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ GV+  E L G+   + N   +    + +V                E +   +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV----------------EFTFPDF 228
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVK 338
             E      +L SR ++   S+RP + E ++
Sbjct: 229 VTEGA---RDLISRLLKHNPSQRPMLREVLE 256

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 131
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  +     A + GT  Y  PE        
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMHD 187
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 31/271 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 132
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 188
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ GV+  E L G+   + N                  ++  +++   E +   +
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQETYKRISRVEFTFPDF 232
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVK 338
             E      +L SR ++   S+RP + E ++
Sbjct: 233 VTEGA---RDLISRLLKHNPSQRPMLREVLE 260

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  +     A + GT  Y  PE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMHD 184
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 135/294 (45%), Gaps = 31/294 (10%)
Query: 55  EMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDIL 114
           +M+   C  +    +G G FG V++     G  VA+K +    F  A+  +EF  EV I+
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF-HAERVNEFLREVAIM 88
Query: 115 SRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG-EPKMDWPXXXXXXXXXXX 173
            RL HPN+V  +G      +  +V EY+ +G+L   L+  G   ++D             
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR-VLGT 232
              YLH+ +    PIVHR+ KS N+L+   +  K+ DFGL++L      T+++++   GT
Sbjct: 149 GMNYLHNRNP---PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGT 202
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK 292
             +  PE         +SDVY+FGV+L EL T      L Q   + N    V  +    K
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELAT------LQQPWGNLNPAQVVAAVGFKCK 256
Query: 293 KLR--KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
           +L   + ++P++             A +   C   E  +RPS A  +  L+ +I
Sbjct: 257 RLEIPRNLNPQV-------------AAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 26/276 (9%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 88
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
                   +V ++ +  +L  HL+   E K +                YLH+ S     I
Sbjct: 89  STK-PQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS-----I 141
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA        ++   ++ G+  +  PE      +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS 305
            + QSDVYAFG+VL EL+TG+        +N+++ ++++          R  + P+LS+ 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIEMVG--------RGSLSPDLSKV 250
Query: 306 SYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
                       L + C++ +  ERPS    + E++
Sbjct: 251 RSNCPK--RMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 31/271 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 125
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  + T +     GT  Y  PE        
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 181
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ GV+  E L G+   + N                  ++  +++   E +   +
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQETYKRISRVEFTFPDF 225
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVK 338
             E      +L SR ++   S+RP + E ++
Sbjct: 226 VTEGA---RDLISRLLKHNPSQRPMLREVLE 253

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG L D L G     +  P              Y+   +      
Sbjct: 82  VSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 135
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 192
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 244
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R +  ERP+
Sbjct: 245 H---------DLMCQCWRKDPEERPT 261

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ ++ H  LV L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKIRHEKLVQLYAV 81
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 135
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 192
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 244
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R +  ERP+
Sbjct: 245 H---------DLMCQCWRKDPEERPT 261

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG L D L G     +  P              Y+   +      
Sbjct: 82  VSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 135
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 192
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 244
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R +  ERP+
Sbjct: 245 H---------DLMCQCWRKDPEERPT 261

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 130
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI++FG +   P  + T +     GT  Y  PE        
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 186
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 32/266 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++ P     +    F  E  ++ +L H  LV L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+   +      
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-----Y 135
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD  + N+L+  N   K++DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 192
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPESL 244
Query: 307 YTMESIAMFANLASRCVRTESSERPS 332
           +         +L  +C R +  ERP+
Sbjct: 245 H---------DLMCQCWRKDPEERPT 261

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 72
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +   +V ++ +  +L  HL+ I E K +                YLH+ S     I
Sbjct: 73  STKPQ-LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS-----I 125
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA        ++   ++ G+  +  PE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+     N    DQ + +  R  L+ D  K+R      + R
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        L + C++ +  ERP   + +  ++L+
Sbjct: 245 -------------LMAECLKKKRDERPLFPQILASIELL 270

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 130
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  +   +     GT  Y  PE        
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMHD 186
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 124/280 (44%), Gaps = 38/280 (13%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG+  K T R +GEV+ +K  EL RF E + +  F  EV ++  L+HPN++  IG
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMK--ELIRFDE-ETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                K    + EY++ G L+  +  + + +  W               YLHS +     
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLM------PEGQETYVTA------RVLGTFGY 235
           I+HRD  S N L+  N    ++DFGLA+LM      PEG  +           V+G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR 295
             PE  +      + DV++FG+VL E++ GR   D +      +  L VR  L+      
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNVRGFLD------ 241
Query: 296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
           +   P    S         F  +  RC   +  +RPS  +
Sbjct: 242 RYCPPNCPPS---------FFPITVRCCDLDPEKRPSFVK 272

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 119/271 (43%), Gaps = 31/271 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    R  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   + D                Y HS       
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLS--RFDEQRTATYITELANALSYCHSKR----- 132
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +N E KI+DFG +   P  +   +     GT  Y  PE        
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMIEGRMHD 188
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ GV+  E L G    + +                  ++  R++   E +   +
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAH----------------TYQETYRRISRVEFTFPDF 232
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVK 338
             E      +L SR ++  +S+R ++AE ++
Sbjct: 233 VTEGA---RDLISRLLKHNASQRLTLAEVLE 260

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 28/279 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 92
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +   +V ++ +  +L  HL+ I E K +                YLH+ S     I
Sbjct: 93  STKPQ-LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS-----I 145
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA        ++   ++ G+  +  PE         
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+     N    DQ + +  R  L+ D  K+R      + R
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 264
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        L + C++ +  ERP   + +  ++L+
Sbjct: 265 -------------LMAECLKKKRDERPLFPQILASIELL 290

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 131/294 (44%), Gaps = 36/294 (12%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE 104
           +GS  +   EME    +      LG G +G VY+G  +   + VA+K +     KE   E
Sbjct: 13  QGSPNYDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTME 65
Query: 105 -HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPX 163
             EF  E  ++  + HPNLV L+G C      +++ E+M  GNL D+L      +++   
Sbjct: 66  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 125
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL   +      +HRD  + N L+  N   K++DFGL++LM    +T
Sbjct: 126 LLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDT 178
Query: 224 YVTARVLGTF--GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV 281
           Y TA     F   +  PE  +  K +++SDV+AFGV+L E+ T    +    G++    +
Sbjct: 179 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----L 231
Query: 282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
            QV  +L          D  + R     E +     L   C +   S+RPS AE
Sbjct: 232 SQVYELLEK--------DYRMERPEGCPEKV---YELMRACWQWNPSDRPSFAE 274

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 44/287 (15%)
Query: 69  LGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGE-------HEFRVEVDILSRLDHP 120
           +GKGGFG V+KG L +   VVAIK + L    +++GE        EF+ EV I+S L+HP
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLIL---GDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
           N+V L G   +     +V E++  G+L   L     P + W               Y+ +
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN 140
Query: 181 SSAVGIPIVHRDFKSTNVLL-----SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            +    PIVHRD +S N+ L     +A   AK++DFGL++     Q  +  + +LG F +
Sbjct: 141 QNP---PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQW 192
Query: 236 FDPEYTSTGK--LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
             PE     +   T ++D Y+F ++L  +LTG       +G  D+    +++ I      
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTG-------EGPFDEYSYGKIKFI------ 239
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
              +I  E  R +   +      N+   C   +  +RP  +  VKEL
Sbjct: 240 --NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 12/220 (5%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVD 112
           K+ + A   F     LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 113 ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX 172
           I S L HPN++ L GY  D    +L+ EY   G +   L  +   K D            
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELA 121
Query: 173 XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
               Y HS       ++HRD K  N+LL +  E KI++FG +   P  + T +     GT
Sbjct: 122 NALSYCHSKR-----VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GT 172
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLN 272
             Y  PE         + D+++ GV+  E L G+   + N
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 154
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  +       + GT  Y  PE        
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----DLCGTLDYLPPEMIEGRMHD 210
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 122/279 (43%), Gaps = 28/279 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V +  +  P  ++      F+ EV +L +  H N++  +GY
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFMGY 100
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
                   +V ++ +  +L  HL+ I E K +                YLH+ S     I
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS-----I 153
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L  +   KI DFGLA        ++   ++ G+  +  PE         
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN-DRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+     N    DQ + +  R  L+ D  K+R      + R
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 272
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        L + C++ +  ERP   + +  ++L+
Sbjct: 273 -------------LMAECLKKKRDERPLFPQILASIELL 298

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 12/220 (5%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVD 112
           K+ + A   F     LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 113 ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX 172
           I S L HPN++ L GY  D    +L+ EY   G +   L  +   K D            
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELA 121
Query: 173 XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
               Y HS       ++HRD K  N+LL +  E KI+DFG +   P  +   +     GT
Sbjct: 122 NALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GT 172
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLN 272
             Y  PE         + D+++ GV+  E L G+   + N
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 129
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  +   +     GT  Y  PE        
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMIEGRMHD 185
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLN 272
            + D+++ GV+  E L G+   + N
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 123/271 (45%), Gaps = 34/271 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 136
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 137 -FIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTY-TAHAGAKFPIKWTAPESLAYN 192
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           K +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMER 238
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAE 335
                E +     L   C +   S+RPS AE
Sbjct: 239 PEGCPEKV---YELMRACWQWNPSDRPSFAE 266

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 122/282 (43%), Gaps = 30/282 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G FG VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      ++                 YL   +    
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---- 129
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
             +HRD  + N L+  N   K++DFGL++LM  G      A       +  PE  +  K 
Sbjct: 130 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           +++SDV+AFGV+L E+ T    +    G++      QV  +L          D  + R  
Sbjct: 188 SIKSDVWAFGVLLWEIAT--YGMSPYPGIDPS----QVYELLEK--------DYRMERPE 233
Query: 307 YTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
              E +     L   C +   S+RPS AE  +  + +   +S
Sbjct: 234 GCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQESS 272

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 31/271 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  +   +     GT  Y  PE        
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMHD 184
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ GV+  E L G+   + N                  ++  +++   E +   +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQETYKRISRVEFTFPDF 228
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVK 338
             E      +L SR ++   S+RP + E ++
Sbjct: 229 VTEGA---RDLISRLLKHNPSQRPMLREVLE 256

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 123/271 (45%), Gaps = 34/271 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 131
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 132 -FIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTY-TAHAGAKFPIKWTAPESLAYN 187
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           K +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMER 233
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAE 335
                E +     L   C +   S+RPS AE
Sbjct: 234 PEGCPEKV---YELMRACWQWNPSDRPSFAE 261

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 123/271 (45%), Gaps = 34/271 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 131
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 132 -FIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTY-TAHAGAKFPIKWTAPESLAYN 187
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           K +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMER 233
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAE 335
                E +     L   C +   S+RPS AE
Sbjct: 234 PEGCPEKV---YELMRACWQWNPSDRPSFAE 261

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 123/271 (45%), Gaps = 34/271 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 136
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 137 -FIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTY-TAHAGAKFPIKWTAPESLAYN 192
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           K +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMER 238
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAE 335
                E +     L   C +   S+RPS AE
Sbjct: 239 PEGCPEKV---YELMRACWQWNPSDRPSFAE 266

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 123/271 (45%), Gaps = 34/271 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 135
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 136 -FIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTY-TAHAGAKFPIKWTAPESLAYN 191
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           K +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R
Sbjct: 192 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMER 237
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAE 335
                E +     L   C +   S+RPS AE
Sbjct: 238 PEGCPEKV---YELMRACWQWNPSDRPSFAE 265

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 134/306 (43%), Gaps = 36/306 (11%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE- 104
           GS  +   EME    +      LG G +G VY+G  +   + VA+K +     KE   E 
Sbjct: 1   GSPNYDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEV 53
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXX 164
            EF  E  ++  + HPNLV L+G C      +++ E+M  GNL D+L      ++     
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 165 XXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
                       YL   +      +HRD  + N L+  N   K++DFGL++LM    +TY
Sbjct: 114 LYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTY 166
Query: 225 VTARVLGTF--GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL 282
            TA     F   +  PE  +  K +++SDV+AFGV+L E+ T    +    G++    + 
Sbjct: 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LS 219
Query: 283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL 342
           QV  +L          D  + R     E +     L   C +   S+RPS AE  +  + 
Sbjct: 220 QVYELLEK--------DYRMERPEGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFET 268
Query: 343 IIYTNS 348
           +   +S
Sbjct: 269 MFQESS 274

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 128/284 (45%), Gaps = 34/284 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 136
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 137 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTY-TAHAGAKFPIKWTAPESLAYN 192
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           K +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMER 238
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
                E +     L   C +   S+RPS AE  +  + +   +S
Sbjct: 239 PEGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQESS 279

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 128/284 (45%), Gaps = 34/284 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 133
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 134 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTY-TAHAGAKFPIKWTAPESLAYN 189
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           K +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMER 235
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
                E +     L   C +   S+RPS AE  +  + +   +S
Sbjct: 236 PEGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQESS 276

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 124/282 (43%), Gaps = 30/282 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 132
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
             +HRD  + N L+  N   K++DFGL++LM  G      A       +  PE  +  K 
Sbjct: 133 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKF 190
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R  
Sbjct: 191 SIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMERPE 236
Query: 307 YTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
              E +     L   C +   S+RPS AE  +  + +   +S
Sbjct: 237 GCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQESS 275

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 128/284 (45%), Gaps = 34/284 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 133
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 134 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTY-TAHAGAKFPIKWTAPESLAYN 189
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           K +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMER 235
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
                E +     L   C +   S+RPS AE  +  + +   +S
Sbjct: 236 PEGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQESS 276

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 129/293 (44%), Gaps = 36/293 (12%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE- 104
           GS  +   EME    +      LG G +G VY+G  +   + VA+K +     KE   E 
Sbjct: 1   GSPNYDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEV 53
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXX 164
            EF  E  ++  + HPNLV L+G C      +++ E+M  GNL D+L      ++     
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 165 XXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
                       YL   +      +HRD  + N L+  N   K++DFGL++LM    +TY
Sbjct: 114 LYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTY 166
Query: 225 VTARVLGTF--GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL 282
            TA     F   +  PE  +  K +++SDV+AFGV+L E+ T    +    G++    + 
Sbjct: 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LS 219
Query: 283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
           QV  +L          D  + R     E +     L   C +   S+RPS AE
Sbjct: 220 QVYELLEK--------DYRMERPEGCPEKV---YELMRACWQWNPSDRPSFAE 261

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 30/269 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 132
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
             +HRD  + N L+  N   K++DFGL++LM  G      A       +  PE  +  K 
Sbjct: 133 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKF 190
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R  
Sbjct: 191 SIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMERPE 236
Query: 307 YTMESIAMFANLASRCVRTESSERPSMAE 335
              E +     L   C +   S+RPS AE
Sbjct: 237 GCPEKV---YELMRACWQWNPSDRPSFAE 262

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 32/267 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG+G FG V+ GT      VAIK ++            F  E  ++ +L H  LV L   
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP----EAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L G     +  P              Y+       +  
Sbjct: 249 VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-----MNY 302
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           VHRD ++ N+L+  N   K++DFGL +L+ + +    TAR    F   +  PE    G+ 
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 359
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE   S 
Sbjct: 360 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV------ERGYRMPCPPECPES- 410
Query: 307 YTMESIAMFANLASRCVRTESSERPSM 333
                     +L  +C R +  ERP+ 
Sbjct: 411 --------LHDLMCQCWRKDPEERPTF 429

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 134/306 (43%), Gaps = 36/306 (11%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE- 104
           GS  +   EME    +      LG G +G VY+G  +   + VA+K +     KE   E 
Sbjct: 1   GSPNYDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEV 53
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXX 164
            EF  E  ++  + HPNLV L+G C      +++ E+M  GNL D+L      ++     
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 165 XXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
                       YL   +      +HRD  + N L+  N   K++DFGL++LM    +TY
Sbjct: 114 LYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTY 166
Query: 225 VTARVLGTF--GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL 282
            TA     F   +  PE  +  K +++SDV+AFGV+L E+ T    +    G++    + 
Sbjct: 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LS 219
Query: 283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL 342
           QV  +L          D  + R     E +     L   C +   S+RPS AE  +  + 
Sbjct: 220 QVYELLEK--------DYRMERPEGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFET 268
Query: 343 IIYTNS 348
           +   +S
Sbjct: 269 MFQESS 274

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 121/297 (40%), Gaps = 56/297 (18%)
Query: 66  DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +  +G GGFG+VY+      EV        P    +      R E  + + L HPN+++L
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPK---MDWPXXXXXXXXXXXXXXYLHSSS 182
            G C    +  LV E+ + G L   L+G   P    ++W               YLH  +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEA 125
Query: 183 AVGIPIVHRDFKSTNVLLSANFE--------AKISDFGLAKLMPEGQETYVTARV--LGT 232
            V  PI+HRD KS+N+L+    E         KI+DFGLA+      E + T ++   G 
Sbjct: 126 IV--PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAGA 177
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR---RAVD---LNQGVNDQNLVLQVRH 286
           + +  PE       +  SDV+++GV+L ELLTG    R +D   +  GV    L L +  
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                        PE             FA L   C   +   RPS    + +L  I
Sbjct: 238 TC-----------PE------------PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 30/269 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 136
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
             +HRD  + N L+  N   K++DFGL++LM  G      A       +  PE  +  K 
Sbjct: 137 -FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKF 194
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R  
Sbjct: 195 SIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMERPE 240
Query: 307 YTMESIAMFANLASRCVRTESSERPSMAE 335
              E +     L   C +   S+RPS AE
Sbjct: 241 GCPEKV---YELMRACWQWNPSDRPSFAE 266

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 124/282 (43%), Gaps = 30/282 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 133
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
             +HRD  + N L+  N   K++DFGL++LM  G      A       +  PE  +  K 
Sbjct: 134 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKF 191
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R  
Sbjct: 192 SIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMERPE 237
Query: 307 YTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
              E +     L   C +   S+RPS AE  +  + +   +S
Sbjct: 238 GCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQESS 276

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 129/293 (44%), Gaps = 36/293 (12%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE- 104
           GS  +   EME    +      LG G +G VY+G  +   + VA+K +     KE   E 
Sbjct: 1   GSPNYDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEV 53
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXX 164
            EF  E  ++  + HPNLV L+G C      +++ E+M  GNL D+L      ++     
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 165 XXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
                       YL   +      +HRD  + N L+  N   K++DFGL++LM    +TY
Sbjct: 114 LYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTY 166
Query: 225 VTARVLGTF--GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL 282
            TA     F   +  PE  +  K +++SDV+AFGV+L E+ T    +    G++    + 
Sbjct: 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LS 219
Query: 283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
           QV  +L          D  + R     E +     L   C +   S+RPS AE
Sbjct: 220 QVYELLEK--------DYRMERPEGCPEKV---YELMRACWQWNPSDRPSFAE 261

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 31/271 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY    +  + ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D                Y HS       
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 131
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+LL +  E KI+DFG +   P  +       + GT  Y  PE        
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----DLCGTLDYLPPEMIEGRMHD 187
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ GV+  E L G+   + N                  ++  +++   E +   +
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQETYKRISRVEFTFPDF 231
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVK 338
             E      +L SR ++   S+RP + E ++
Sbjct: 232 VTEGA---RDLISRLLKHNPSQRPMLREVLE 259

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 34/284 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      ++                 YL   +    
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---- 136
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 137 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTY-TAHAGAKFPIKWTAPESLAYN 192
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           K +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMER 238
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
                E +     L   C +   S+RPS AE  +  + +   +S
Sbjct: 239 PEGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQESS 279

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 122/282 (43%), Gaps = 30/282 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      ++                 YL   +    
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---- 129
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
             +HRD  + N L+  N   K++DFGL++LM  G      A       +  PE  +  K 
Sbjct: 130 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           +++SDV+AFGV+L E+ T    +    G++      QV  +L          D  + R  
Sbjct: 188 SIKSDVWAFGVLLWEIAT--YGMSPYPGIDPS----QVYELLEK--------DYRMERPE 233
Query: 307 YTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
              E +     L   C +   S+RPS AE  +  + +   +S
Sbjct: 234 GCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQESS 272

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 69  LGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGE-------HEFRVEVDILSRLDHP 120
           +GKGGFG V+KG L +   VVAIK + L    +++GE        EF+ EV I+S L+HP
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLIL---GDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
           N+V L G   +     +V E++  G+L   L     P + W               Y+ +
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN 140
Query: 181 SSAVGIPIVHRDFKSTNVLL-----SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            +    PIVHRD +S N+ L     +A   AK++DFG ++     Q  +  + +LG F +
Sbjct: 141 QNP---PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQW 192
Query: 236 FDPEYTSTGK--LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
             PE     +   T ++D Y+F ++L  +LTG       +G  D+    +++ I      
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTG-------EGPFDEYSYGKIKFI------ 239
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
              +I  E  R +   +      N+   C   +  +RP  +  VKEL
Sbjct: 240 --NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKK 92
           PTQ ++RH       LK +++          LGKG FG V           +GEVVA+KK
Sbjct: 7   PTQFEERH-------LKFLQQ----------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK 49
Query: 93  MELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQ 148
           ++      +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+
Sbjct: 50  LQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI 208
           D+L    E ++D                YL +        +HRD  + N+L+      KI
Sbjct: 105 DYLQAHAE-RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKI 158
Query: 209 SDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            DFGL K++P+ +E   V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 122/282 (43%), Gaps = 30/282 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      ++                 YL   +    
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---- 129
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
             +HRD  + N L+  N   K++DFGL++LM  G      A       +  PE  +  K 
Sbjct: 130 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAYNKF 187
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           +++SDV+AFGV+L E+ T    +    G++      QV  +L          D  + R  
Sbjct: 188 SIKSDVWAFGVLLWEIAT--YGMSPYPGIDPS----QVYELLEK--------DYRMERPE 233
Query: 307 YTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
              E +     L   C +   S+RPS AE  +  + +   +S
Sbjct: 234 GCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQESS 272

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 122/283 (43%), Gaps = 36/283 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       V I K+  P  ++      FR EV +L +  H N++  +GY
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQA---FRNEVAVLRKTRHVNILLFMGY 100
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
                +  +V ++ +  +L  HL+ + E K                  YLH+ +     I
Sbjct: 101 MTK-DNLAIVTQWCEGSSLYKHLH-VQETKFQMFQLIDIARQTAQGMDYLHAKN-----I 153
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGK 245
           +HRD KS N+ L      KI DFGLA +      +    +  G+  +  PE         
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP 213
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL-----RKVIDP 300
            + QSDVY++G+VL EL+TG                L   HI N+R ++     R    P
Sbjct: 214 FSFQSDVYSYGIVLYELMTGE---------------LPYSHI-NNRDQIIFMVGRGYASP 257
Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
           +LS+  Y     AM   L + CV+    ERP   + +  ++L+
Sbjct: 258 DLSK-LYKNCPKAM-KRLVADCVKKVKEERPLFPQILSSIELL 298

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 69  LGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGE-------HEFRVEVDILSRLDHP 120
           +GKGGFG V+KG L +   VVAIK + L    +++GE        EF+ EV I+S L+HP
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLIL---GDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
           N+V L G   +     +V E++  G+L   L     P + W               Y+ +
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN 140
Query: 181 SSAVGIPIVHRDFKSTNVLL-----SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            +    PIVHRD +S N+ L     +A   AK++DF L++     Q  +  + +LG F +
Sbjct: 141 QNP---PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQW 192
Query: 236 FDPEYTSTGK--LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
             PE     +   T ++D Y+F ++L  +LTG       +G  D+    +++ I      
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTG-------EGPFDEYSYGKIKFI------ 239
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
              +I  E  R +   +      N+   C   +  +RP  +  VKEL
Sbjct: 240 --NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 112/237 (47%), Gaps = 38/237 (16%)
Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKK 92
           PTQ ++RH       LK +++          LGKG FG V           +GEVVA+KK
Sbjct: 4   PTQFEERH-------LKFLQQ----------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK 46
Query: 93  MELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQ 148
           ++      +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+
Sbjct: 47  LQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI 208
           D+L    E ++D                YL +        +HRD  + N+L+      KI
Sbjct: 102 DYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKI 155
Query: 209 SDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            DFGL K++P+ +E + V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 17/218 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ GT      VAIK ++            F  E  I+ +L H  LV L   
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK----PGTMSPESFLEEAQIMKKLKHDKLVQLYAV 72
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
            ++ +  ++V EYM KG+L D L       +  P              Y+   +      
Sbjct: 73  VSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-----Y 126
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD +S N+L+      KI+DFGLA+L+ + +    TAR    F   +  PE    G+ 
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNE---XTARQGAKFPIKWTAPEAALYGRF 183
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
           T++SDV++FG++L EL+T  R      G+N++ ++ QV
Sbjct: 184 TIKSDVWSFGILLTELVTKGRVP--YPGMNNREVLEQV 219

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 112/237 (47%), Gaps = 38/237 (16%)
Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKK 92
           PTQ ++RH       LK +++          LGKG FG V           +GEVVA+KK
Sbjct: 5   PTQFEERH-------LKFLQQ----------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK 47
Query: 93  MELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQ 148
           ++      +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+
Sbjct: 48  LQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI 208
           D+L    E ++D                YL +        +HR+  + N+L+      KI
Sbjct: 103 DYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRNLATRNILVENENRVKI 156
Query: 209 SDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            DFGL K++P+ +E Y V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 157 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 130/282 (46%), Gaps = 47/282 (16%)
Query: 66  DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +  +G+G FG V K   R+ +V AIK++E    ++A     F VE+  LSR++HPN+V L
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDV-AIKQIESESERKA-----FIVELRQLSRVNHPNIVKL 66
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP--------KMDWPXXXXXXXXXXXXXXY 177
            G C +     LV EY + G+L + L+G  EP         M W               Y
Sbjct: 67  YGACLNPV--CLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSW------CLQCSQGVAY 117
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           LHS       ++HRD K  N+LL A     KI DFG A  +    +T++T    G+  + 
Sbjct: 118 LHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNK-GSAAWM 170
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK 296
            PE       + + DV+++G++L E++T R+  D   G   +  ++   H       ++ 
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHNGTRPPLIKN 228
Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           +  P                +L +RC   + S+RPSM E VK
Sbjct: 229 LPKP--------------IESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 130/282 (46%), Gaps = 47/282 (16%)
Query: 66  DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +  +G+G FG V K   R+ +V AIK++E    ++A     F VE+  LSR++HPN+V L
Sbjct: 14  EEVVGRGAFGVVCKAKWRAKDV-AIKQIESESERKA-----FIVELRQLSRVNHPNIVKL 67
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP--------KMDWPXXXXXXXXXXXXXXY 177
            G C +     LV EY + G+L + L+G  EP         M W               Y
Sbjct: 68  YGACLNPV--CLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSW------CLQCSQGVAY 118
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           LHS       ++HRD K  N+LL A     KI DFG A  +    +T++T    G+  + 
Sbjct: 119 LHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNN-KGSAAWM 171
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK 296
            PE       + + DV+++G++L E++T R+  D   G   +  ++   H       ++ 
Sbjct: 172 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHNGTRPPLIKN 229
Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           +  P                +L +RC   + S+RPSM E VK
Sbjct: 230 LPKP--------------IESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKE 100
           RGS   T  + EE    F     LGKG FG V           +GEVVA+KK++      
Sbjct: 17  RGSHNMT--QFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----H 67
Query: 101 ADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQDHLNGIGE 156
           +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+D+L    E
Sbjct: 68  STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 127
Query: 157 PKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL 216
            ++D                YL +        +HRD  + N+L+      KI DFGL K+
Sbjct: 128 -RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKIGDFGLTKV 181
Query: 217 MPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           +P+ +E   V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 182 LPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKK 92
           PTQ ++RH       LK +++          LGKG FG V           +GEVVA+KK
Sbjct: 3   PTQFEERH-------LKFLQQ----------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK 45
Query: 93  MELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQ 148
           ++      +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+
Sbjct: 46  LQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI 208
           D+L    E ++D                YL +        +HRD  + N+L+      KI
Sbjct: 101 DYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKI 154
Query: 209 SDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            DFGL K++P+ +E   V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 155 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKE 100
           RGS   T  + EE    F     LGKG FG V           +GEVVA+KK++      
Sbjct: 17  RGSHNMT--QFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----H 67
Query: 101 ADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQDHLNGIGE 156
           +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+D+L    E
Sbjct: 68  STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 127
Query: 157 PKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL 216
            ++D                YL +        +HRD  + N+L+      KI DFGL K+
Sbjct: 128 -RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKIGDFGLTKV 181
Query: 217 MPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           +P+ +E   V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 182 LPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 128/284 (45%), Gaps = 34/284 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      +++                YL   +    
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---- 377
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HR+  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 378 -FIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTY-TAHAGAKFPIKWTAPESLAYN 433
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           K +++SDV+AFGV+L E+ T    +    G++    + QV  +L          D  + R
Sbjct: 434 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGID----LSQVYELLEK--------DYRMER 479
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
                E +     L   C +   S+RPS AE  +  + +   +S
Sbjct: 480 PEGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQESS 520

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPN 121
           LGKG FG V           +GEVVA+KK++      +  EH  +F  E++IL  L H N
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 76
Query: 122 LVSLIGYCADGKHRFL--VYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +V   G C     R L  + EY+  G+L+D+L    E ++D                YL 
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLG 135
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYFDP 238
           +        +HRD  + N+L+      KI DFGL K++P+ +E   V         ++ P
Sbjct: 136 TKR-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 190
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT 264
           E  +  K ++ SDV++FGVVL EL T
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKK 92
           PTQ ++RH       LK +++          LGKG FG V           +GEVVA+KK
Sbjct: 4   PTQFEERH-------LKFLQQ----------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK 46
Query: 93  MELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQ 148
           ++      +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+
Sbjct: 47  LQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI 208
           D+L    E ++D                YL +        +HRD  + N+L+      KI
Sbjct: 102 DYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKI 155
Query: 209 SDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            DFGL K++P+ +E   V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPN 121
           LGKG FG V           +GEVVA+KK++      +  EH  +F  E++IL  L H N
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 70
Query: 122 LVSLIGYCADGKHRFL--VYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +V   G C     R L  + EY+  G+L+D+L    E ++D                YL 
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLG 129
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYFDP 238
           +        +HRD  + N+L+      KI DFGL K++P+ +E   V         ++ P
Sbjct: 130 TKR-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 184
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT 264
           E  +  K ++ SDV++FGVVL EL T
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKK 92
           PTQ ++RH       LK +++          LGKG FG V           +GEVVA+KK
Sbjct: 4   PTQFEERH-------LKFLQQ----------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK 46
Query: 93  MELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQ 148
           ++      +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+
Sbjct: 47  LQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI 208
           D+L    E ++D                YL +        +HRD  + N+L+      KI
Sbjct: 102 DYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKI 155
Query: 209 SDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            DFGL K++P+ +E   V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKK 92
           PTQ ++RH       LK +++          LGKG FG V           +GEVVA+KK
Sbjct: 10  PTQFEERH-------LKFLQQ----------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK 52
Query: 93  MELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQ 148
           ++      +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+
Sbjct: 53  LQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI 208
           D+L    E ++D                YL +        +HRD  + N+L+      KI
Sbjct: 108 DYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKI 161
Query: 209 SDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            DFGL K++P+ +E   V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 162 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKK 92
           PTQ ++RH       LK +++          LGKG FG V           +GEVVA+KK
Sbjct: 11  PTQFEERH-------LKFLQQ----------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK 53
Query: 93  MELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQ 148
           ++      +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+
Sbjct: 54  LQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI 208
           D+L    E ++D                YL +        +HRD  + N+L+      KI
Sbjct: 109 DYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKI 162
Query: 209 SDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            DFGL K++P+ +E   V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 163 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPN 121
           LGKG FG V           +GEVVA+KK++      +  EH  +F  E++IL  L H N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 122 LVSLIGYCADGKHRFL--VYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +V   G C     R L  + EY+  G+L+D+L    E ++D                YL 
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLG 134
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYFDP 238
           +        +HRD  + N+L+      KI DFGL K++P+ +E   V         ++ P
Sbjct: 135 TKR-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT 264
           E  +  K ++ SDV++FGVVL EL T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKK 92
           PTQ ++RH       LK +++          LGKG FG V           +GEVVA+KK
Sbjct: 35  PTQFEERH-------LKFLQQ----------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK 77
Query: 93  MELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQ 148
           ++      +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+
Sbjct: 78  LQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI 208
           D+L    E ++D                YL +        +HRD  + N+L+      KI
Sbjct: 133 DYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKI 186
Query: 209 SDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            DFGL K++P+ +E   V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 187 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKK 92
           PTQ ++RH       LK +++          LGKG FG V           +GEVVA+KK
Sbjct: 9   PTQFEERH-------LKFLQQ----------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK 51
Query: 93  MELPRFKEADGEH--EFRVEVDILSRLDHPNLVSLIGYCADGKHRFL--VYEYMQKGNLQ 148
           ++      +  EH  +F  E++IL  L H N+V   G C     R L  + EY+  G+L+
Sbjct: 52  LQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI 208
           D+L    E ++D                YL +        +HRD  + N+L+      KI
Sbjct: 107 DYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKI 160
Query: 209 SDFGLAKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            DFGL K++P+ +E   V         ++ PE  +  K ++ SDV++FGVVL EL T
Sbjct: 161 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      ++                 YL   +    
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---- 338
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HR+  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 339 -FIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTY-TAHAGAKFPIKWTAPESLAYN 394
Query: 245 KLTLQSDVYAFGVVLLELLT 264
           K +++SDV+AFGV+L E+ T
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 136/295 (46%), Gaps = 45/295 (15%)
Query: 69  LGKGGFGRV----YKGTLR-SGEVVAIKKMELPRFKEADGEHE--FRVEVDILSRLDHPN 121
           LG+G FG+V    Y  T   +GE+VA+K ++     +A  +H   ++ E+DIL  L H +
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----ADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 122 LVSLIGYCADGKHRFL--VYEYMQKGNLQDHL--NGIGEPKMDWPXXXXXXXXXXXXXXY 177
           ++   G C D     L  V EY+  G+L+D+L  + IG  ++                 Y
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAY 149
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYF 236
           LH+        +HRD  + NVLL  +   KI DFGLAK +PEG E Y V         ++
Sbjct: 150 LHAQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY 204
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTG--------RRAVDLNQGVNDQNLVLQVRHIL 288
            PE     K    SDV++FGV L ELLT          + ++L      Q  VL++  +L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
              ++L +   P+        +  A   +L   C  TE+S RP+    +  L+ +
Sbjct: 265 ERGERLPR---PD--------KCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY G  +   + VA+K +     KE   E  EF  E  ++  + HPNLV L+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 94
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G C      ++V EYM  GNL D+L      ++                 YL   +    
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN---- 150
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F   +  PE  +  
Sbjct: 151 -FIHRDLAARNCLVGENHVVKVADFGLSRLMT--GDTY-TAHAGAKFPIKWTAPESLAYN 206
Query: 245 KLTLQSDVYAFGVVLLELLTGRRA----VDLNQ 273
             +++SDV+AFGV+L E+ T   +    +DL+Q
Sbjct: 207 TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 239

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 69  LGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG+G FG+V+          +   +VA+K ++ P         +F+ E ++L+ L H ++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHI 79
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM---DWPXXXXXXXXXXXXXXYLH 179
           V   G C DG    +V+EYM+ G+L   L   G   M   D                ++ 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 180 SSSAVGIP------IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           S  A G+        VHRD  + N L+ AN   KI DFG+++ +       V    +   
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            +  PE     K T +SDV++FGV+L E+ T
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 69  LGKGGFGRVY--KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           LG GG   VY  + T+ + +V AIK + +P  ++ +    F  EV   S+L H N+VS+I
Sbjct: 19  LGGGGMSTVYLAEDTILNIKV-AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
               +    +LV EY++   L +++   G   +D                      A  +
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI-------KHAHDM 130
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            IVHRD K  N+L+ +N   KI DFG+AK + E   T  T  VLGT  YF PE       
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEAT 189
Query: 247 TLQSDVYAFGVVLLELLTGR 266
              +D+Y+ G+VL E+L G 
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPN 121
           LGKG FG V           +GEVVA+KK++      +  EH  +F  E++IL  L H N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 122 LVSLIGYCADGKHRFL--VYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +V   G C     R L  + E++  G+L+++L    E ++D                YL 
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKE-RIDHIKLLQYTSQICKGMEYLG 134
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYFDP 238
           +        +HRD  + N+L+      KI DFGL K++P+ +E   V         ++ P
Sbjct: 135 TKR-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT 264
           E  +  K ++ SDV++FGVVL EL T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 135/295 (45%), Gaps = 45/295 (15%)
Query: 69  LGKGGFGRV----YKGTLR-SGEVVAIKKMELPRFKEADGEHE--FRVEVDILSRLDHPN 121
           LG+G FG+V    Y  T   +GE+VA+K ++     +   +H   ++ E+DIL  L H +
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----ADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 122 LVSLIGYCADG--KHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPXXXXXXXXXXXXXXY 177
           ++   G C D   K   LV EY+  G+L+D+L  + IG  ++                 Y
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAY 132
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYF 236
           LHS        +HR+  + NVLL  +   KI DFGLAK +PEG E Y V         ++
Sbjct: 133 LHSQH-----YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 187
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTG--------RRAVDLNQGVNDQNLVLQVRHIL 288
            PE     K    SDV++FGV L ELLT          + ++L      Q  VL++  +L
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 247
Query: 289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
              ++L +   P+        +      +L   C  TE+S RP+    +  L+ +
Sbjct: 248 ERGERLPR---PD--------KCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 69  LGKGGFGRVYK----GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FGRV++    G L       +    L     AD + +F+ E  +++  D+PN+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGI----------------------GEPKMDWP 162
           L+G CA GK   L++EYM  G+L + L  +                      G P +   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 163 XXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE 222
                         YL          VHRD  + N L+  N   KI+DFGL++ +     
Sbjct: 175 EQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 223 TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                       +  PE     + T +SDV+A+GVVL E+ +
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+  T      VA+K M+ P     +    F  E +++  L H  LV L   
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEA---FLAEANVMKTLQHDKLVKLHAV 78
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ E+M KG+L D L      K   P              ++   +      
Sbjct: 79  VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-----Y 132
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+SA+   KI+DFGLA+++ + +    TAR    F   +  PE  + G  
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSF 189
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L+E++T  R
Sbjct: 190 TIKSDVWSFGILLMEIVTYGR 210

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 45/295 (15%)
Query: 69  LGKGGFGRV----YKGTLR-SGEVVAIKKMELPRFKEADGEHE--FRVEVDILSRLDHPN 121
           LG+G FG+V    Y  T   +GE+VA+K ++     +   +H   ++ E+DIL  L H +
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----ADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 122 LVSLIGYCADG--KHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPXXXXXXXXXXXXXXY 177
           ++   G C D   K   LV EY+  G+L+D+L  + IG  ++                 Y
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAY 132
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYF 236
           LH+        +HR+  + NVLL  +   KI DFGLAK +PEG E Y V         ++
Sbjct: 133 LHAQH-----YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 187
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTG--------RRAVDLNQGVNDQNLVLQVRHIL 288
            PE     K    SDV++FGV L ELLT          + ++L      Q  VL++  +L
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 247
Query: 289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
              ++L +   P+        +      +L   C  TE+S RP+    +  L+ +
Sbjct: 248 ERGERLPR---PD--------KCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+  T      VA+K M+ P     +    F  E +++  L H  LV L   
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEA---FLAEANVMKTLQHDKLVKLHAV 251
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ E+M KG+L D L      K   P              ++   +      
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-----Y 305
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+SA+   KI+DFGLA+++ + +    TAR    F   +  PE  + G  
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSF 362
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L+E++T  R
Sbjct: 363 TIKSDVWSFGILLMEIVTYGR 383

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G   +   VA+K ++            F  E +++  L H  LV L   
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM KG+L D L      K+  P              Y+   +      
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-----Y 131
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ NVL+S +   KI+DFGLA+++ + +    TAR    F   +  PE  + G  
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGCF 188
Query: 247 TLQSDVYAFGVVLLELLT 264
           T++SDV++FG++L E++T
Sbjct: 189 TIKSDVWSFGILLYEIVT 206

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 116/266 (43%), Gaps = 38/266 (14%)
Query: 69  LGKGGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV+    +   R   +  +KK  + R K+ +  ++ R+   +LS + HP ++ 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL---MLSIVTHPFIIR 70
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           + G   D +  F++ +Y++ G L   L      +   P              YLHS    
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKD-- 126
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
              I++RD K  N+LL  N   KI+DFG AK +P+     VT  + GT  Y  PE  ST 
Sbjct: 127 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIAPEVVSTK 178
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
                 D ++FG+++ E+L G                    +  N  K   K+++ EL  
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPF----------------YDSNTMKTYEKILNAELRF 222
Query: 305 SSYTMESIAMFANLASRCVRTESSER 330
             +  E +    +L SR +  + S+R
Sbjct: 223 PPFFNEDV---KDLLSRLITRDLSQR 245

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 91/297 (30%), Positives = 129/297 (43%), Gaps = 53/297 (17%)
Query: 69  LGKGGFGRV----YKGTLR-SGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHP 120
           LG+G FG+V    Y  T   +GE+VA+K +     KE  G      ++ E++IL  L H 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-----KEGCGPQLRSGWQREIEILRTLYHE 70
Query: 121 NLVSLIGYCADGKHRF--LVYEYMQKGNLQDHL--NGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++V   G C D   +   LV EY+  G+L+D+L  + +G  ++                 
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMA 125
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGY 235
           YLH+        +HR   + NVLL  +   KI DFGLAK +PEG E Y V         +
Sbjct: 126 YLHAQH-----YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 180
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG-----------VNDQNLVLQV 284
           + PE     K    SDV++FGV L ELLT     D NQ               Q  VL++
Sbjct: 181 YAPECLKECKFYYASDVWSFGVTLYELLT---YCDSNQSPHTKFTELIGHTQGQMTVLRL 237
Query: 285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
             +L   ++L     P   R            +L   C  TE+S RP+    V  LQ
Sbjct: 238 TELLERGERL-----PRPDRCP------CEIYHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 91/297 (30%), Positives = 129/297 (43%), Gaps = 53/297 (17%)
Query: 69  LGKGGFGRV----YKGTLR-SGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHP 120
           LG+G FG+V    Y  T   +GE+VA+K +     KE  G      ++ E++IL  L H 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-----KEGCGPQLRSGWQREIEILRTLYHE 71
Query: 121 NLVSLIGYCADGKHRF--LVYEYMQKGNLQDHL--NGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++V   G C D   +   LV EY+  G+L+D+L  + +G  ++                 
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMA 126
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGY 235
           YLH+        +HR   + NVLL  +   KI DFGLAK +PEG E Y V         +
Sbjct: 127 YLHAQH-----YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 181
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG-----------VNDQNLVLQV 284
           + PE     K    SDV++FGV L ELLT     D NQ               Q  VL++
Sbjct: 182 YAPECLKECKFYYASDVWSFGVTLYELLT---YCDSNQSPHTKFTELIGHTQGQMTVLRL 238
Query: 285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
             +L   ++L     P   R            +L   C  TE+S RP+    V  LQ
Sbjct: 239 TELLERGERL-----PRPDRCP------CEIYHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG V  G  R G  VA+K +     K       F  E  ++++L H NLV L+G 
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 129 CADGKH-RFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             + K   ++V EYM KG+L D+L   G   +                 YL  ++     
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----- 122
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
            VHRD  + NVL+S +  AK+SDFGL K   E   T  T ++     +  PE     K +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFS 177
Query: 248 LQSDVYAFGVVLLELLTGRR 267
            +SDV++FG++L E+ +  R
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I + L+H N+V   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 124
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG V  G  R G  VA+K +     K       F  E  ++++L H NLV L+G 
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 129 CADGKH-RFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             + K   ++V EYM KG+L D+L   G   +                 YL  ++     
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----- 137
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
            VHRD  + NVL+S +  AK+SDFGL K   E   T  T ++     +  PE     K +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFS 192
Query: 248 LQSDVYAFGVVLLELLTGRR 267
            +SDV++FG++L E+ +  R
Sbjct: 193 TKSDVWSFGILLWEIYSFGR 212

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG V  G  R G  VA+K +     K       F  E  ++++L H NLV L+G 
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 129 CADGKH-RFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             + K   ++V EYM KG+L D+L   G   +                 YL  ++     
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----- 309
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
            VHRD  + NVL+S +  AK+SDFGL K   E   T  T ++     +  PE     K +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFS 364
Query: 248 LQSDVYAFGVVLLELLTGRR 267
            +SDV++FG++L E+ +  R
Sbjct: 365 TKSDVWSFGILLWEIYSFGR 384

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 134/297 (45%), Gaps = 34/297 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 40  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 95
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V EYM+ G+L   L    + +           
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLR 154
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL   S +G   VHRD  + N+L+++N   K+SDFGLA+++ +  E   T R 
Sbjct: 155 GIASGMKYL---SDMGY--VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRG 209
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+VL E+++ G R       +++Q+++      
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDVI------ 260
Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   K +D E  R    M+  A    L   C + + + RP   + V  L  +I
Sbjct: 261 --------KAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 124
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 124
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 17/214 (7%)
Query: 63  FSDDNF-----LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSR 116
           F+ D+F     LGKG FG VY    +  + ++A+K +   + ++   EH+ R E++I S 
Sbjct: 11  FTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 117 LDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           L HPN++ +  Y  D K  +L+ E+  +G L   L   G  + D                
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALH 128
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           Y H        ++HRD K  N+L+    E KI+DFG +   P  +   +     GT  Y 
Sbjct: 129 YCHERK-----VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYL 179
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVD 270
            PE         + D++  GV+  E L G    D
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 122
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 124
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 124
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 32/288 (11%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 YL S 
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDP 238
                  VHRD  + N +L   F  K++DFGLA+ M + +E Y      G      +   
Sbjct: 145 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTGAKLPVKWMAL 198
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E   T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+   
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEY 253
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
            P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 254 CPD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 289

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 32/288 (11%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 YL S 
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK 170
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDP 238
                  VHRD  + N +L   F  K++DFGLA+ M + +E Y      G      +   
Sbjct: 171 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTGAKLPVKWMAL 224
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E   T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+   
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEY 279
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
            P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 280 CPD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 315

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 32/288 (11%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 YL S 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK 152
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDP 238
                  VHRD  + N +L   F  K++DFGLA+ M + +E Y      G      +   
Sbjct: 153 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTGAKLPVKWMAL 206
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E   T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+   
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEY 261
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
            P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 262 CPD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 297

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 17/214 (7%)
Query: 63  FSDDNF-----LGKGGFGRVYKGTLRSGE-VVAIKKMELPRFKEADGEHEFRVEVDILSR 116
           F+ D+F     LGKG FG VY    +  + ++A+K +   + ++   EH+ R E++I S 
Sbjct: 12  FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 71
Query: 117 LDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           L HPN++ +  Y  D K  +L+ E+  +G L   L   G  + D                
Sbjct: 72  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALH 129
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           Y H        ++HRD K  N+L+    E KI+DFG +   P  +   +     GT  Y 
Sbjct: 130 YCHERK-----VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYL 180
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVD 270
            PE         + D++  GV+  E L G    D
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 124
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 124
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 124
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 32/288 (11%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 YL S 
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK 171
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDP 238
                  VHRD  + N +L   F  K++DFGLA+ M + +E Y      G      +   
Sbjct: 172 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTGAKLPVKWMAL 225
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E   T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+   
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEY 280
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
            P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 281 CPD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 316

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 69  LGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEAD--GEHEFRVEVDILSRLDHP 120
           LG+G FG+V+          +   +VA+K +     KEA      +F+ E ++L+ L H 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-----KEASESARQDFQREAELLTMLQHQ 80
Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
           ++V   G C +G+   +V+EYM+ G+L   L   G                      L  
Sbjct: 81  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 181 SSAV--------GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
           +S V        G+  VHRD  + N L+      KI DFG+++ +       V  R +  
Sbjct: 141 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 200
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             +  PE     K T +SDV++FGVVL E+ T
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 32/288 (11%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 YL S 
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK 150
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDP 238
                  VHRD  + N +L   F  K++DFGLA+ M + +E Y      G      +   
Sbjct: 151 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTGAKLPVKWMAL 204
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E   T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+   
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEY 259
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
            P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 260 CPD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 295

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 32/288 (11%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 YL S 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK 152
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDP 238
                  VHRD  + N +L   F  K++DFGLA+ M + +E Y      G      +   
Sbjct: 153 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTGAKLPVKWMAL 206
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E   T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+   
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEY 261
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
            P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 262 CPD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 297

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 32/288 (11%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 YL S 
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDP 238
                  VHRD  + N +L   F  K++DFGLA+ M + +E Y      G      +   
Sbjct: 150 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTGAKLPVKWMAL 203
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E   T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+   
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEY 258
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
            P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 259 CPD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 32/288 (11%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 YL S 
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK 147
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDP 238
                  VHRD  + N +L   F  K++DFGLA+ M + +E Y      G      +   
Sbjct: 148 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTGAKLPVKWMAL 201
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E   T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+   
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEY 256
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
            P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 257 CPD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 32/288 (11%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 YL S 
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK 151
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDP 238
                  VHRD  + N +L   F  K++DFGLA+ M + +E Y      G      +   
Sbjct: 152 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTGAKLPVKWMAL 205
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E   T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+   
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEY 260
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
            P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 261 CPD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 296

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 34/297 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 40  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 95
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V EYM+ G+L   L    + +           
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLR 154
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL   S +G   VHRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 155 GIASGMKYL---SDMGF--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+VL E+++ G R       +++Q+++      
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDVI------ 260
Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   K +D E  R    M+  A    L   C + + + RP   + V  L  +I
Sbjct: 261 --------KAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 123/287 (42%), Gaps = 30/287 (10%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 YL S 
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLASK 151
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPE 239
                  VHRD  + N +L   F  K++DFGLA+ M + +   V  +        +   E
Sbjct: 152 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
              T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+    
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEYC 261
Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
           P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 262 PD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 296

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 69  LGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEAD--GEHEFRVEVDILSRLDHP 120
           LG+G FG+V+          +   +VA+K +     KEA      +F+ E ++L+ L H 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-----KEASESARQDFQREAELLTMLQHQ 74
Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
           ++V   G C +G+   +V+EYM+ G+L   L   G                      L  
Sbjct: 75  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 181 SSAV--------GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
           +S V        G+  VHRD  + N L+      KI DFG+++ +       V  R +  
Sbjct: 135 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 194
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             +  PE     K T +SDV++FGVVL E+ T
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG V  G  R G  VA+K +     K       F  E  ++++L H NLV L+G 
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 129 CADGKH-RFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             + K   ++V EYM KG+L D+L   G   +                 YL  ++     
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
            VHRD  + NVL+S +  AK+SDFGL K   E   T  T ++     +  PE       +
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREAAFS 183
Query: 248 LQSDVYAFGVVLLELLTGRR 267
            +SDV++FG++L E+ +  R
Sbjct: 184 TKSDVWSFGILLWEIYSFGR 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 11  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 66
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V EYM+ G+L   L    + +           
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLR 125
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL       +  VHRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 126 GIASGMKYLSD-----MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                 +  PE  +  K T  SDV+++G+VL E+++
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 28  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 83
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V EYM+ G+L   L    + +           
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLR 142
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL       +  VHRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 143 GIASGMKYLSD-----MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 197
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                 +  PE  +  K T  SDV+++G+VL E+++
Sbjct: 198 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 34/297 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 38  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 93
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V EYM+ G+L   L    + +           
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLR 152
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL   S +G   VHRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 153 GIASGMKYL---SDMGY--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 207
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+VL E+++ G R       +++Q+++      
Sbjct: 208 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDVI------ 258
Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   K +D E  R    M+  A    L   C + + + RP   + V  L  +I
Sbjct: 259 --------KAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG V+ G   + + VAIK +     + A  E +F  E +++ +L HP LV L G 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 129 CADGKHRFLVYEYMQKGNLQDHL---NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
           C +     LV+E+M+ G L D+L    G+   +                  YL  +S   
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEGMAYLEEAS--- 123
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
             ++HRD  + N L+  N   K+SDFG+ + + + Q T  T        +  PE  S  +
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 180
Query: 246 LTLQSDVYAFGVVLLELLT 264
            + +SDV++FGV++ E+ +
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 67  NFLGKGGFGRVYKGTLRSGEV---VAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNL 122
           + +G+G FG+V K  ++   +    AIK+M+   +   D   +F  E+++L +L H PN+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWP-XXXXXXXXXXXXXXYLHSS 181
           ++L+G C    + +L  EY   GNL D L      + D                  LH +
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 182 SAVGIPI--------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           + V   +        +HRD  + N+L+  N+ AKI+DFGL++    GQE YV  + +G  
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 203
Query: 234 G--YFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
              +   E  +    T  SDV+++GV+L E+++
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 34/297 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 40  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 95
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V EYM+ G+L   L    + +           
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLR 154
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL   S +G   VHRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 155 GIASGMKYL---SDMGY--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+VL E+++ G R       +++Q+++      
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDVI------ 260
Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   K +D E  R    M+  A    L   C + + + RP   + V  L  +I
Sbjct: 261 --------KAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 67  NFLGKGGFGRVYKGTLRSGEV---VAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNL 122
           + +G+G FG+V K  ++   +    AIK+M+   +   D   +F  E+++L +L  HPN+
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWP-XXXXXXXXXXXXXXYLHSS 181
           ++L+G C    + +L  EY   GNL D L      + D                  LH +
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 182 SAVGIPI--------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           + V   +        +HRD  + N+L+  N+ AKI+DFGL++    GQE YV  + +G  
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 193
Query: 234 G--YFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
              +   E  +    T  SDV+++GV+L E+++
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 34/297 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 40  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 95
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V EYM+ G+L   L    + +           
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLR 154
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL   S +G   VHRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 155 GIASGMKYL---SDMGY--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+VL E+++ G R       +++Q+++      
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDVI------ 260
Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   K +D E  R    M+  A    L   C + + + RP   + V  L  +I
Sbjct: 261 --------KAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 34/297 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 40  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 95
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V EYM+ G+L   L    + +           
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLR 154
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL   S +G   VHRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 155 GIASGMKYL---SDMGY--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+VL E+++ G R       +++Q+++      
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDVI------ 260
Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   K +D E  R    M+  A    L   C + + + RP   + V  L  +I
Sbjct: 261 --------KAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 69  LGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEAD--GEHEFRVEVDILSRLDHP 120
           LG+G FG+V+          +   +VA+K +     KEA      +F+ E ++L+ L H 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-----KEASESARQDFQREAELLTMLQHQ 103
Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
           ++V   G C +G+   +V+EYM+ G+L   L   G                      L  
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 181 SSAV--------GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
           +S V        G+  VHRD  + N L+      KI DFG+++ +       V  R +  
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             +  PE     K T +SDV++FGVVL E+ T
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 34/297 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 40  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 95
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V EYM+ G+L   L    + +           
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLR 154
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL   S +G   VHRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 155 GIASGMKYL---SDMGY--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+VL E+++ G R       +++Q+++      
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDVI------ 260
Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   K +D E  R    M+  A    L   C + + + RP   + V  L  +I
Sbjct: 261 --------KAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 35/256 (13%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEADG--E 104
           LKE+  +   F ++  LG+  FG+VYKG L         + VAIK ++     +A+G   
Sbjct: 20  LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK----DKAEGPLR 73
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL------NGIG--- 155
            EFR E  + +RL HPN+V L+G     +   +++ Y   G+L + L      + +G   
Sbjct: 74  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133
Query: 156 -----EPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD 210
                +  ++ P              YL S       +VH+D  + NVL+      KISD
Sbjct: 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISD 188
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVD 270
            GL + +       +    L    +  PE    GK ++ SD++++GVVL E+ +    + 
Sbjct: 189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQ 246
Query: 271 LNQGVNDQNLVLQVRH 286
              G ++Q++V  +R+
Sbjct: 247 PYCGYSNQDVVEMIRN 262

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 133/297 (44%), Gaps = 34/297 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 40  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 95
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V EYM+ G+L   L    + +           
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLR 154
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL   S +G   VHRD  + N+L+++N   K+SDFGL +++ +  E   T R 
Sbjct: 155 GIASGMKYL---SDMGY--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+VL E+++ G R       +++Q+++      
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDVI------ 260
Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   K +D E  R    M+  A    L   C + + + RP   + V  L  +I
Sbjct: 261 --------KAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG+V  G    +G  VA+K +   + +  D   + R E+  L    HP+++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             +     F+V EY+  G L D++   G  ++D                Y H        
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM----- 136
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           +VHRD K  NVLL A+  AKI+DFGL+ +M +G+    +    G+  Y  PE  S G+L 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPEVIS-GRLY 192
Query: 248 L--QSDVYAFGVVLLELLTGRRAVD 270
              + D+++ GV+L  LL G    D
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 30/278 (10%)
Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKME--LPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G+G FG V+ G LR+   +VA+K     LP     D + +F  E  IL +  HPN+V L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLP----PDLKAKFLQEARILKQYSHPNIVRL 177
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
           IG C   +  ++V E +Q G+    L   G  ++                 YL S     
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCC-- 234
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
              +HRD  + N L++     KISDFG+++   +G              +  PE  + G+
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS 305
            + +SDV++FG++L E  +   +   N  +++Q    Q R  +    +L     PEL   
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPN--LSNQ----QTREFVEKGGRLPC---PELCPD 342
Query: 306 SYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                  A+F  L  +C   E  +RPS +   +ELQ I
Sbjct: 343 -------AVF-RLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 33/293 (11%)
Query: 58  EATCSFSDDNFLGKGGFGRVYKGTLR-SGE---VVAIKKMELPRFKEADGEHEFRVEVDI 113
           EA+C  + +  +G G FG V  G L+  G+    VAIK +++   ++     +F  E  I
Sbjct: 20  EASC-ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ--RRDFLGEASI 76
Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
           + + DHPN++ L G     K   +V EYM+ G+L   L    + +               
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKK-NDGQFTVIQLVGMLRGISA 135
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT- 232
              YL   S +G   VHRD  + N+L+++N   K+SDFGL++++ +  E   T R     
Sbjct: 136 GMKYL---SDMGY--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 190
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDR 291
             +  PE  +  K T  SDV+++G+V+ E+++ G R       + +Q+++  V       
Sbjct: 191 IRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY---WEMTNQDVIKAVE------ 241
Query: 292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                    E  R    M+  A    L   C + E + RP   E V  L  +I
Sbjct: 242 ---------EGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 78
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 79  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 132
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 189
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 190 TIKSDVWSFGILLTEIVTHGR 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G   +   VA+K ++            F  E +++  L H  LV L   
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ E+M KG+L D L      K+  P              Y+   +      
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-----Y 130
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ NVL+S +   KI+DFGLA+++ + +    TAR    F   +  PE  + G  
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGCF 187
Query: 247 TLQSDVYAFGVVLLELLT 264
           T++S+V++FG++L E++T
Sbjct: 188 TIKSNVWSFGILLYEIVT 205

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 83  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 136
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 193
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 194 TIKSDVWSFGILLTEIVTHGR 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 85
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 86  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 139
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 196
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 197 TIKSDVWSFGILLTEIVTHGR 217

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 130
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 187
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR 208

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 35/256 (13%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEADG--E 104
           LKE+  +   F ++  LG+  FG+VYKG L         + VAIK ++     +A+G   
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK----DKAEGPLR 56
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL------NGIG--- 155
            EFR E  + +RL HPN+V L+G     +   +++ Y   G+L + L      + +G   
Sbjct: 57  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 116
Query: 156 -----EPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD 210
                +  ++ P              YL S       +VH+D  + NVL+      KISD
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISD 171
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVD 270
            GL + +       +    L    +  PE    GK ++ SD++++GVVL E+ +    + 
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQ 229
Query: 271 LNQGVNDQNLVLQVRH 286
              G ++Q++V  +R+
Sbjct: 230 PYCGYSNQDVVEMIRN 245

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 77
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 78  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 131
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 188
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 189 TIKSDVWSFGILLTEIVTHGR 209

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 84
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 85  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 138
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 195
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 196 TIKSDVWSFGILLTEIVTHGR 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 83  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 136
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 193
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 194 TIKSDVWSFGILLTEIVTHGR 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 81
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 82  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 135
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 192
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 193 TIKSDVWSFGILLTEIVTHGR 213

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG V+ G   + + VAIK +     + A  E +F  E +++ +L HP LV L G 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 129 CADGKHRFLVYEYMQKGNLQDHL---NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
           C +     LV+E+M+ G L D+L    G+   +                  YL  +    
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEGMAYLEEAC--- 126
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
             ++HRD  + N L+  N   K+SDFG+ + + + Q T  T        +  PE  S  +
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 183
Query: 246 LTLQSDVYAFGVVLLELLT 264
            + +SDV++FGV++ E+ +
Sbjct: 184 YSSKSDVWSFGVLMWEVFS 202

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 13/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G  G V     R + E VA+K +++ R    D     + E+ I   L+H N+V   G
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           +  +G  ++L  EY   G L D +   IG P+   P              YLH     GI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-----GI 123
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE     + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 TLQS-DVYAFGVVLLELLTGRRAVD 270
             +  DV++ G+VL  +L G    D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 30/278 (10%)
Query: 69  LGKGGFGRVYKGTLRS-GEVVAIK--KMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G+G FG V+ G LR+   +VA+K  +  LP     D + +F  E  IL +  HPN+V L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLP----PDLKAKFLQEARILKQYSHPNIVRL 177
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
           IG C   +  ++V E +Q G+    L   G  ++                 YL S     
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCC-- 234
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
              +HRD  + N L++     KISDFG+++   +G              +  PE  + G+
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS 305
            + +SDV++FG++L E  +   +   N  +++Q    Q R  +    +L     PEL   
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPN--LSNQ----QTREFVEKGGRLPC---PELCPD 342
Query: 306 SYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                  A+F  L  +C   E  +RPS +   +ELQ I
Sbjct: 343 -------AVF-RLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 86
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 87  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 140
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 197
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 198 TIKSDVWSFGILLTEIVTHGR 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 130
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 187
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR 208

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG V+ G   + + VAIK +     + A  E +F  E +++ +L HP LV L G 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 129 CADGKHRFLVYEYMQKGNLQDHL---NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
           C +     LV+E+M+ G L D+L    G+   +                  YL  +    
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEGMAYLEEAC--- 121
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
             ++HRD  + N L+  N   K+SDFG+ + + + Q T  T        +  PE  S  +
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 178
Query: 246 LTLQSDVYAFGVVLLELLT 264
            + +SDV++FGV++ E+ +
Sbjct: 179 YSSKSDVWSFGVLMWEVFS 197

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 35/284 (12%)
Query: 69  LGKGGFGRVYKGTLRSG----EV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +G G FG VYKG L++     EV VAIK ++    ++     +F  E  I+ +  H N++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQFSHHNII 109
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
            L G  +  K   ++ EYM+ G L   L    + +                  YL + + 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN- 167
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE-TYVTARVLGTFGYFDPEYTS 242
                VHRD  + N+L+++N   K+SDFGL++++ +  E TY T+       +  PE  S
Sbjct: 168 ----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 243 TGKLTLQSDVYAFGVVLLELLT-GRRAV-DLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
             K T  SDV++FG+V+ E++T G R   +L+          +V   +ND  +L      
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGFRL------ 269
Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   M+  +    L  +C + E + RP  A+ V  L  +I
Sbjct: 270 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG V+ G   + + VAIK +     + A  E +F  E +++ +L HP LV L G 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 129 CADGKHRFLVYEYMQKGNLQDHL---NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
           C +     LV+E+M+ G L D+L    G+   +                  YL  +    
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEGMAYLEEAC--- 123
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
             ++HRD  + N L+  N   K+SDFG+ + + + Q T  T        +  PE  S  +
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 180
Query: 246 LTLQSDVYAFGVVLLELLT 264
            + +SDV++FGV++ E+ +
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 130
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 187
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 71
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 72  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 125
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 182
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 183 TIKSDVWSFGILLTEIVTHGR 203

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 131/297 (44%), Gaps = 34/297 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 40  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 95
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V E M+ G+L   L    + +           
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK-HDAQFTVIQLVGMLR 154
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL    AV     HRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 155 GIASGMKYLSDMGAV-----HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+VL E+++ G R       +++Q+++      
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDVI------ 260
Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   K +D E  R    M+  A    L   C + + + RP   + V  L  +I
Sbjct: 261 --------KAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 67  NFLGKGGFGRVYKGTLRSGEV---VAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNL 122
           + +G+G FG+V K  ++   +    AIK+M+   +   D   +F  E+++L +L H PN+
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWP-XXXXXXXXXXXXXXYLHSS 181
           ++L+G C    + +L  EY   GNL D L      + D                  LH +
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 182 SAVGIPI--------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           + V   +        +HR+  + N+L+  N+ AKI+DFGL++    GQE YV  + +G  
Sbjct: 146 ADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 200
Query: 234 G--YFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
              +   E  +    T  SDV+++GV+L E+++
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 128/293 (43%), Gaps = 33/293 (11%)
Query: 58  EATCSFSDDNFLGKGGFGRVYKGTLR-SGE---VVAIKKMELPRFKEADGEHEFRVEVDI 113
           +A+C    +  +G G FG V  G L+  G+    VAIK ++     +     +F  E  I
Sbjct: 27  DASC-IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ--RRDFLSEASI 83
Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
           + + DHPN++ L G     K   ++ EYM+ G+L   L    + +               
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGS 142
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT- 232
              YL   SAV     HRD  + N+L+++N   K+SDFG+++++ +  E   T R     
Sbjct: 143 GMKYLSDMSAV-----HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 197
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDR 291
             +  PE  +  K T  SDV+++G+V+ E+++ G R       +++Q+++  +       
Sbjct: 198 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVIKAIE------ 248
Query: 292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                    E  R    M+       L   C + E S+RP   + V  L  +I
Sbjct: 249 ---------EGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 292

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG V+ G   + + VAIK ++     E D    F  E +++ +L HP LV L G 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD----FIEEAEVMMKLSHPKLVQLYGV 90
Query: 129 CADGKHRFLVYEYMQKGNLQDHL---NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
           C +     LV+E+M+ G L D+L    G+   +                  YL  +    
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEGMAYLEEAC--- 143
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
             ++HRD  + N L+  N   K+SDFG+ + + + Q T  T        +  PE  S  +
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 200
Query: 246 LTLQSDVYAFGVVLLELLT 264
            + +SDV++FGV++ E+ +
Sbjct: 201 YSSKSDVWSFGVLMWEVFS 219

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 68  FLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LG GG   V+    LR    VA+K +     ++      FR E    + L+HP +V++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 127 ----GYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
                    G   ++V EY+    L+D  H  G   PK                  + H 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK----RAIEVIADACQALNFSHQ 134
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE-GQETYVTARVLGTFGYFDPE 239
           +      I+HRD K  N+L+SA    K+ DFG+A+ + + G     TA V+GT  Y  PE
Sbjct: 135 NG-----IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                 +  +SDVY+ G VL E+LTG
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 30/287 (10%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 +L S 
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLASK 157
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPE 239
                  VHRD  + N +L   F  K++DFGLA+ M + +   V  +        +   E
Sbjct: 158 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
              T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+    
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEYC 267
Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
           P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 268 PD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 302

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 30/287 (10%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 +L S 
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLASK 153
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPE 239
                  VHRD  + N +L   F  K++DFGLA+ M + +   V  +        +   E
Sbjct: 154 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
              T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+    
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEYC 263
Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
           P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 264 PD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 298

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHPNLVS 124
           LG G FG VYKG  +  GE V I  + +    E  G     EF  E  I++ +DHP+LV 
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 125 LIGYCADGKHRFLVYEYMQKGNL----QDHLNGIG-EPKMDWPXXXXXXXXXXXXXXYLH 179
           L+G C     + LV + M  G L     +H + IG +  ++W               YL 
Sbjct: 105 LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 157
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   +VHRD  + NVL+ +    KI+DFGLA+L+   ++ Y          +   E
Sbjct: 158 ERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLT 264
                K T QSDV+++GV + EL+T
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 30/287 (10%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 +L S 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLASK 152
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPE 239
                  VHRD  + N +L   F  K++DFGLA+ M + +   V  +        +   E
Sbjct: 153 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
              T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+    
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEYC 262
Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
           P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 263 PD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 297

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 122/284 (42%), Gaps = 30/284 (10%)
Query: 69  LGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++SL+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 127 GYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           G C   +    +V  YM+ G+L++ + N    P +                 +L S    
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLASKK-- 151
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTS 242
               VHRD  + N +L   F  K++DFGLA+ M + +   V  +        +   E   
Sbjct: 152 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 243 TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL 302
           T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+    P+ 
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEYCPD- 262
Query: 303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
                          +  +C   ++  RPS +E V  +  I  T
Sbjct: 263 -----------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 295

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 30/287 (10%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 +L S 
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLASK 211
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPE 239
                  VHRD  + N +L   F  K++DFGLA+ M + +   V  +        +   E
Sbjct: 212 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
              T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+    
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEYC 321
Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
           P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 322 PD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHPNLVS 124
           LG G FG VYKG  +  GE V I  + +    E  G     EF  E  I++ +DHP+LV 
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 125 LIGYCADGKHRFLVYEYMQKGNL----QDHLNGIG-EPKMDWPXXXXXXXXXXXXXXYLH 179
           L+G C     + LV + M  G L     +H + IG +  ++W               YL 
Sbjct: 82  LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 134
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   +VHRD  + NVL+ +    KI+DFGLA+L+   ++ Y          +   E
Sbjct: 135 ERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLT 264
                K T QSDV+++GV + EL+T
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 30/287 (10%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 +L S 
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLASK 153
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPE 239
                  VHRD  + N +L   F  K++DFGLA+ M + +   V  +        +   E
Sbjct: 154 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
              T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+    
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEYC 263
Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
           P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 264 PD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 298

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG V+ G   + + VAIK +     + A  E +F  E +++ +L HP LV L G 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 129 CADGKHRFLVYEYMQKGNLQDHL---NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
           C +     LV E+M+ G L D+L    G+   +                  YL  +    
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEGMAYLEEAC--- 124
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
             ++HRD  + N L+  N   K+SDFG+ + + + Q T  T        +  PE  S  +
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 181
Query: 246 LTLQSDVYAFGVVLLELLT 264
            + +SDV++FGV++ E+ +
Sbjct: 182 YSSKSDVWSFGVLMWEVFS 200

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 30/287 (10%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  +G+G FG VY GTL    G+ +      L R  +     +F  E  I+    HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 124 SLIGYCADGKHR-FLVYEYMQKGNLQDHL-NGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           SL+G C   +    +V  YM+ G+L++ + N    P +                 +L S 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLASK 152
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPE 239
                  VHRD  + N +L   F  K++DFGLA+ M + +   V  +        +   E
Sbjct: 153 K-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
              T K T +SDV++FGV+L EL+T  R       VN  ++ +   ++L  R+ L+    
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITV---YLLQGRRLLQPEYC 262
Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
           P+                +  +C   ++  RPS +E V  +  I  T
Sbjct: 263 PD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 297

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 11  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 66
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V E M+ G+L   L    + +           
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK-HDAQFTVIQLVGMLR 125
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL       +  VHRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 126 GIASGMKYLSD-----MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                 +  PE  +  K T  SDV+++G+VL E+++
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 69  LGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG+G FG+V+          +   +VA+K +   +    +   +F  E ++L+ L H ++
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQHEHI 77
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V   G C +G    +V+EYM+ G+L   L   G   +                 ++    
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 183 AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           A G+        VHRD  + N L+  N   KI DFG+++ +       V    +    + 
Sbjct: 138 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            PE     K T +SDV++ GVVL E+ T
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 127/293 (43%), Gaps = 33/293 (11%)
Query: 58  EATCSFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDI 113
           +A+C    +  +G G FG V  G L+        VAIK +++   ++     +F  E  I
Sbjct: 41  DASC-IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ--RRDFLCEASI 97
Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
           + + DHPN+V L G    GK   +V E+M+ G L   L    + +               
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRK-HDGQFTVIQLVGMLRGIAA 156
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET-YVTARVLGT 232
              YL       +  VHRD  + N+L+++N   K+SDFGL++++ +  E  Y T      
Sbjct: 157 GMRYLAD-----MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIP 211
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDR 291
             +  PE     K T  SDV+++G+V+ E+++ G R       +++Q+++  +       
Sbjct: 212 VRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVIKAIE------ 262
Query: 292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                    E  R    M+  A    L   C + E +ERP   + V  L  +I
Sbjct: 263 ---------EGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 68  FLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LG GG   V+    LR    VA+K +     ++      FR E    + L+HP +V++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 127 ----GYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
                    G   ++V EY+    L+D  H  G   PK                  + H 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK----RAIEVIADACQALNFSHQ 134
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE-GQETYVTARVLGTFGYFDPE 239
           +      I+HRD K  N+++SA    K+ DFG+A+ + + G     TA V+GT  Y  PE
Sbjct: 135 NG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                 +  +SDVY+ G VL E+LTG
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 73  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 126
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HR+ ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 183
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 184 TIKSDVWSFGILLTEIVTHGR 204

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 68  FLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LG GG   V+    LR    VA+K +     ++      FR E    + L+HP +V++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 127 ----GYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
                    G   ++V EY+    L+D  H  G   PK                  + H 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK----RAIEVIADACQALNFSHQ 134
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE-GQETYVTARVLGTFGYFDPE 239
           +      I+HRD K  N+++SA    K+ DFG+A+ + + G     TA V+GT  Y  PE
Sbjct: 135 NG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                 +  +SDVY+ G VL E+LTG
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 34/297 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR---SGEV-VAIKKMELPRFKEADGEHEFRV 109
           KE++    S   D  +G G FG V  G L+     E+ VAIK +++   ++     +F  
Sbjct: 40  KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLG 95
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           E  I+ + DHPN++ L G     K   +V E M+ G+L   L    + +           
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK-HDAQFTVIQLVGMLR 154
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  YL   S +G   VHRD  + N+L+++N   K+SDFGL++++ +  E   T R 
Sbjct: 155 GIASGMKYL---SDMGY--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 230 LGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHI 287
                 +  PE  +  K T  SDV+++G+VL E+++ G R       +++Q+++      
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDVI------ 260
Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   K +D E  R    M+  A    L   C + + + RP   + V  L  +I
Sbjct: 261 --------KAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 21/199 (10%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+  T      VA+K M+ P     +    F  E +++  L H  LV L   
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEA---FLAEANVMKTLQHDKLVKLHAV 245
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ E+M KG+L D L      K   P              ++   +      
Sbjct: 246 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-----Y 299
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD ++ N+L+SA+   KI+DFGLA+         V A+      +  PE  + G  T+
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLAR---------VGAKF--PIKWTAPEAINFGSFTI 348
Query: 249 QSDVYAFGVVLLELLTGRR 267
           +SDV++FG++L+E++T  R
Sbjct: 349 KSDVWSFGILLMEIVTYGR 367

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LGKG FG V           +G +VA+K+++       D + +F+ E+ IL  L    +V
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIV 74
Query: 124 SLIG--YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
              G  Y    +   LV EY+  G L+D L      ++D                YL S 
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG--TFGYFDPE 239
             V     HRD  + N+L+ +    KI+DFGLAKL+P  ++ YV  R  G     ++ PE
Sbjct: 134 RCV-----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-REPGQSPIFWYAPE 187
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLT 264
             S    + QSDV++FGVVL EL T
Sbjct: 188 SLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LGKG FG V           +G +VA+K+++       D + +F+ E+ IL  L    +V
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIV 87
Query: 124 SLIG--YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
              G  Y    +   LV EY+  G L+D L      ++D                YL S 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG--TFGYFDPE 239
             V     HRD  + N+L+ +    KI+DFGLAKL+P  ++ YV  R  G     ++ PE
Sbjct: 147 RCV-----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-REPGQSPIFWYAPE 200
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLT 264
             S    + QSDV++FGVVL EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 147
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++    A V GT  Y  PE 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-GTAQYVSPEL 203
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 60  TCSFSDDNF-----LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDI 113
           T  F+ D+F     LGKG FG VY     +S  +VA+K +   + ++   EH+ R E++I
Sbjct: 17  TRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEI 76
Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
            + L HPN++ L  Y  D +  +L+ EY  +G L   L        D             
Sbjct: 77  QAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQ--KSCTFDEQRTATIMEELAD 134
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              Y H     G  ++HRD K  N+LL    E KI+DFG +   P  +   +     GT 
Sbjct: 135 ALMYCH-----GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC----GTL 185
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
            Y  PE         + D++  GV+  ELL G
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LGKG FG V           +G +VA+K+++       D + +F+ E+ IL  L    +V
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIV 75
Query: 124 SLIG--YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
              G  Y    +   LV EY+  G L+D L      ++D                YL S 
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG--TFGYFDPE 239
             V     HRD  + N+L+ +    KI+DFGLAKL+P  ++ YV  R  G     ++ PE
Sbjct: 135 RCV-----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-REPGQSPIFWYAPE 188
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLT 264
             S    + QSDV++FGVVL EL T
Sbjct: 189 SLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 68  FLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LG GG   V+    LR    VA+K +     ++      FR E    + L+HP +V++ 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 127 GY----CADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
                    G   ++V EY+    L+D  H  G   PK                  + H 
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK----RAIEVIADACQALNFSHQ 134
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE-GQETYVTARVLGTFGYFDPE 239
           +      I+HRD K  N+++SA    K+ DFG+A+ + + G     TA V+GT  Y  PE
Sbjct: 135 NG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                 +  +SDVY+ G VL E+LTG
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G  G V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               +  +++ EYM+ G+L D L      K+                 ++   +      
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----Y 130
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKL 246
           +HRD ++ N+L+S     KI+DFGLA+L+ + +    TAR    F   +  PE  + G  
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAE---XTAREGAKFPIKWTAPEAINYGTF 187
Query: 247 TLQSDVYAFGVVLLELLTGRR 267
           T++SDV++FG++L E++T  R
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 66  DNFLGKGGFGRVYKGT--LRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           D  LG G FG V +G   +R  ++ VAIK ++    K AD E   R E  I+ +LD+P +
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMR-EAQIMHQLDNPYI 72
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V LIG C   +   LV E    G L   L G  E ++                 YL   +
Sbjct: 73  VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +    ++Y TAR  G +   ++ PE 
Sbjct: 131 -----FVHRDLAARNVLLVNRHYAKISDFGLSKALG-ADDSYYTARSAGKWPLKWYAPEC 184
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV+++GV + E L+
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALS 208

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 68  FLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LG GG   V+    LR    VA+K +     ++      FR E    + L+HP +V++ 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 127 ----GYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
                    G   ++V EY+    L+D  H  G   PK                  + H 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK----RAIEVIADACQALNFSHQ 134
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE-GQETYVTARVLGTFGYFDPE 239
           +      I+HRD K  N+++SA    K+ DFG+A+ + + G     TA V+GT  Y  PE
Sbjct: 135 NG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                 +  +SDVY+ G VL E+LTG
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 20/228 (8%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGE 104
           RGS + T   + +    +     LG GG   V+    LR    VA+K +     ++    
Sbjct: 17  RGSHMTTPSHLSD---RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFY 73
Query: 105 HEFRVEVDILSRLDHPNLVSLI----GYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPK 158
             FR E    + L+HP +V++          G   ++V EY+    L+D  H  G   PK
Sbjct: 74  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 133
Query: 159 MDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP 218
                             + H +      I+HRD K  N+++SA    K+ DFG+A+ + 
Sbjct: 134 ----RAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIA 184
Query: 219 E-GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           + G     TA V+GT  Y  PE      +  +SDVY+ G VL E+LTG
Sbjct: 185 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 127/293 (43%), Gaps = 33/293 (11%)
Query: 58  EATCSFSDDNFLGKGGFGRVYKGTLR-SGE---VVAIKKMELPRFKEADGEHEFRVEVDI 113
           +A+C    +  +G G FG V  G L+  G+    VAIK ++     +     +F  E  I
Sbjct: 12  DASC-IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ--RRDFLSEASI 68
Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
           + + DHPN++ L G     K   ++ EYM+ G+L   L    + +               
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGS 127
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT- 232
              YL   S      VHRD  + N+L+++N   K+SDFG+++++ +  E   T R     
Sbjct: 128 GMKYLSDMS-----YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 182
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDR 291
             +  PE  +  K T  SDV+++G+V+ E+++ G R       +++Q+++  +       
Sbjct: 183 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVIKAIE------ 233
Query: 292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                    E  R    M+       L   C + E S+RP   + V  L  +I
Sbjct: 234 ---------EGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 277

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 127/293 (43%), Gaps = 33/293 (11%)
Query: 58  EATCSFSDDNFLGKGGFGRVYKGTLR-SGE---VVAIKKMELPRFKEADGEHEFRVEVDI 113
           +A+C    +  +G G FG V  G L+  G+    VAIK ++     +     +F  E  I
Sbjct: 6   DASC-IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ--RRDFLSEASI 62
Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
           + + DHPN++ L G     K   ++ EYM+ G+L   L    + +               
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGS 121
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT- 232
              YL   S      VHRD  + N+L+++N   K+SDFG+++++ +  E   T R     
Sbjct: 122 GMKYLSDMS-----YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 176
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDR 291
             +  PE  +  K T  SDV+++G+V+ E+++ G R       +++Q+++  +       
Sbjct: 177 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVIKAIE------ 227
Query: 292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                    E  R    M+       L   C + E S+RP   + V  L  +I
Sbjct: 228 ---------EGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 271

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+D ++      +  P              + HS       
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 182 STAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVD---ILSRLDHPNLVS 124
           LG G FG V+KG  +  GE + I  + +   ++  G   F+   D    +  LDH ++V 
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIP-VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLN---GIGEPKM--DWPXXXXXXXXXXXXXXYLH 179
           L+G C  G    LV +Y+  G+L DH+    G   P++  +W               YL 
Sbjct: 98  LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYLE 150
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   +VHR+  + NVLL +  + +++DFG+A L+P   +  + +       +   E
Sbjct: 151 EHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLT 264
               GK T QSDV+++GV + EL+T
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 62  SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           +F     LGKGGFG V    +R +G++ A KK+E  R K+  GE     E  IL +++  
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 121 NLVSLIGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
            +VSL  Y  + K    LV   M  G+L+ H+  +G+                     LH
Sbjct: 245 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   IV+RD K  N+LL  +   +ISD GLA  +PEGQ   +  RV GT GY  PE
Sbjct: 304 RER-----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPE 355
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGR 266
                + T   D +A G +L E++ G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 146
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++    + V GT  Y  PE 
Sbjct: 147 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 202
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH-- 126
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 127 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 182
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 183 LTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH-- 127
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 128 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 183
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 184 LTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++    + V GT  Y  PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 205
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +    +  SD++A G ++ +L+ G
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH-- 125
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 126 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 181
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 150
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++    + V GT  Y  PE 
Sbjct: 151 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 206
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 62  SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           +F     LGKGGFG V    +R +G++ A KK+E  R K+  GE     E  IL +++  
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 121 NLVSLIGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
            +VSL  Y  + K    LV   M  G+L+ H+  +G+                     LH
Sbjct: 245 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   IV+RD K  N+LL  +   +ISD GLA  +PEGQ   +  RV GT GY  PE
Sbjct: 304 RER-----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPE 355
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGR 266
                + T   D +A G +L E++ G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVD---ILSRLDHPNLVS 124
           LG G FG V+KG  +  GE + I  + +   ++  G   F+   D    +  LDH ++V 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIP-VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLN---GIGEPKM--DWPXXXXXXXXXXXXXXYLH 179
           L+G C  G    LV +Y+  G+L DH+    G   P++  +W               YL 
Sbjct: 80  LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYLE 132
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   +VHR+  + NVLL +  + +++DFG+A L+P   +  + +       +   E
Sbjct: 133 EHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLT 264
               GK T QSDV+++GV + EL+T
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH-- 124
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 125 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 180
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 181 LTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFK---EADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    G+  A+ K+ +   K    AD +     E+ I+S L  H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDW---PXXXXXXXXXXXXXXYLHS 180
           +L+G C  G    ++ EY   G+L + L     P +++   P              +  S
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 181 SSAVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
             A G+        +HRD  + NVLL+    AKI DFGLA+ +       V         
Sbjct: 174 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 233
Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           +  PE       T+QSDV+++G++L E+ +
Sbjct: 234 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 131
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 132 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 187
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 188 LTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 39/219 (17%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK--KMEL-PRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG GGFG V +   + +GE VAIK  + EL P+ +E      + +E+ I+ +L+HPN+VS
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRE-----RWCLEIQIMKKLNHPNVVS 77
Query: 125 LIGYCADGKHRF-------LVYEYMQKGNLQDHLN------GIGEPKMDWPXXXXXXXXX 171
                 DG  +        L  EY + G+L+ +LN      G+ E  +            
Sbjct: 78  -AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI-----RTLLSDI 131
Query: 172 XXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTAR 228
                YLH +      I+HRD K  N++L    +    KI D G AK + +G+   +   
Sbjct: 132 SSALRYLHENR-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTE 183
Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRR 267
            +GT  Y  PE     K T+  D ++FG +  E +TG R
Sbjct: 184 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG+V  G  + +G  VA+K +   + +  D   + + E+  L    HP+++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             +     F+V EY+  G L D++   G  +++                Y H        
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM----- 131
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           +VHRD K  NVLL A+  AKI+DFGL+ +M +G+    +    G+  Y  PE  S G+L 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVIS-GRLY 187
Query: 248 L--QSDVYAFGVVLLELLTGRRAVD 270
              + D+++ GV+L  LL G    D
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK--KMEL-PRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG GGFG V +   + +GE VAIK  + EL P+ +E      + +E+ I+ +L+HPN+VS
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRE-----RWCLEIQIMKKLNHPNVVS 76
Query: 125 L------IGYCADGKHRFLVYEYMQKGNLQDHLN------GIGEPKMDWPXXXXXXXXXX 172
                  +   A      L  EY + G+L+ +LN      G+ E  +             
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI-----RTLLSDIS 131
Query: 173 XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARV 229
               YLH +      I+HRD K  N++L    +    KI D G AK + +G+   +    
Sbjct: 132 SALRYLHENR-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEF 183
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRR 267
           +GT  Y  PE     K T+  D ++FG +  E +TG R
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 146
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 147 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 202
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 114/243 (46%), Gaps = 26/243 (10%)
Query: 38  PTQPQKRHRGSSVFT-----LKEMEEATCSFSDDNFL------GKGGFGRVYKGT--LRS 84
           P +P+     +SVF       +E+++       DN L      G G FG V +G   +R 
Sbjct: 302 PDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRK 361
Query: 85  GEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ 143
            ++ VAIK ++    K AD E   R E  I+ +LD+P +V LIG C   +   LV E   
Sbjct: 362 KQIDVAIKVLKQGTEK-ADTEEMMR-EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAG 418
Query: 144 KGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSAN 203
            G L   L G  E ++                 YL   +      VHR+  + NVLL   
Sbjct: 419 GGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNVLLVNR 472
Query: 204 FEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTSTGKLTLQSDVYAFGVVLLE 261
             AKISDFGL+K +    ++Y TAR  G +   ++ PE  +  K + +SDV+++GV + E
Sbjct: 473 HYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 531
Query: 262 LLT 264
            L+
Sbjct: 532 ALS 534

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 147
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 203
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++   +L+D ++      +  P              + HS       
Sbjct: 72  VIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 125
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 183
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 184 STAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 150
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 151 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 206
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++   +L+D ++      +  P              + HS       
Sbjct: 73  VIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 126
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 185 STAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 147
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 203
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 154
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 155 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 210
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 152
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 153 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 208
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LGKG FG V           +G +VA+K+++       D + +F+ E+ IL  L    +V
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIV 71
Query: 124 SLIG--YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
              G  Y        LV EY+  G L+D L      ++D                YL S 
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV-LGTFGYFDPEY 240
             V     HRD  + N+L+ +    KI+DFGLAKL+P  ++  V          ++ PE 
Sbjct: 131 RCV-----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            S    + QSDV++FGVVL EL T
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFK---EADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    G+  A+ K+ +   K    AD +     E+ I+S L  H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           +L+G C  G    ++ EY   G+L + L    E  +D                 LH SS 
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLD-----KEDGRPLELRDLLHFSSQ 160
Query: 184 VGIPI--------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
           V   +        +HRD  + NVLL+    AKI DFGLA+ +       V         +
Sbjct: 161 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             PE       T+QSDV+++G++L E+ +
Sbjct: 221 MAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFK---EADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    G+  A+ K+ +   K    AD +     E+ I+S L  H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           +L+G C  G    ++ EY   G+L + L    E  +D                 LH SS 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLD-----KEDGRPLELRDLLHFSSQ 168
Query: 184 VGIPI--------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
           V   +        +HRD  + NVLL+    AKI DFGLA+ +       V         +
Sbjct: 169 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             PE       T+QSDV+++G++L E+ +
Sbjct: 229 MAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 23/232 (9%)
Query: 48  SSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS---GEV---VAIKKM-ELPRFKE 100
           SSVF   E E +    +    LG+G FG VY+G  R    GE    VA+K + E    +E
Sbjct: 1   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 60
Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------N 152
                EF  E  ++      ++V L+G  + G+   +V E M  G+L+ +L        N
Sbjct: 61  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 117
Query: 153 GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG 212
             G P                   YL++        VHRD  + N +++ +F  KI DFG
Sbjct: 118 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFG 172
Query: 213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           + + + E        + L    +  PE    G  T  SD+++FGVVL E+ +
Sbjct: 173 MTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGR-VYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F   V    L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 147
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 203
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 10/205 (4%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G F  V     L +    AIK +E     + +       E D++SRLDHP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            V L     D +  +    Y + G L  ++  IG    D                YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH-- 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGYFDPEY 240
              G  I+HRD K  N+LL+ +   +I+DFG AK++ PE ++      V GT  Y  PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +       SD++A G ++ +L+ G
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 101/240 (42%), Gaps = 44/240 (18%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F +   +G GGFG+V+K   R  G+   IK++   ++     E E    V  L++LDH N
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAERE----VKALAKLDHVN 65
Query: 122 LVSLIGYCADG-----------------KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXX 164
           +V   G C DG                 K  F+  E+  KG L+  +      K+D    
Sbjct: 66  IVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 165 XXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQET 223
                       Y+HS       +++RD K +N+ L    + KI DFGL   L  +G+  
Sbjct: 125 LELFEQITKGVDYIHSKK-----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR- 178
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELL--------TGRRAVDLNQGV 275
               R  GT  Y  PE  S+     + D+YA G++L ELL        T +   DL  G+
Sbjct: 179 ---XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI 235

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPN 121
           LG+G FG+V           +GE VA+K ++     E+ G H  + + E++IL  L H N
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK----PESGGNHIADLKKEIEILRNLYHEN 72
Query: 122 LVSLIGYCAD--GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +V   G C +  G    L+ E++  G+L+++L    + K++                YL 
Sbjct: 73  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLG 131
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE--TYVTARVLGTFGYFD 237
           S        VHRD  + NVL+ +  + KI DFGL K +   +E  T    R    F ++ 
Sbjct: 132 SRQ-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF-WYA 185
Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLT 264
           PE     K  + SDV++FGV L ELLT
Sbjct: 186 PECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 20/224 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G+G +G VYK     G +VA+K++ L    E       R E+ +L  L HPN+VSLI  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87
Query: 129 CADGKHRFLVYEYMQKG---NLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
               +   LV+E+M+K     L ++  G+ + ++                 + H      
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQI-----KIYLYQLLRGVAHCHQHR--- 139
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-YTSTG 244
             I+HRD K  N+L++++   K++DFGLA+       +Y    V  T  Y  P+    + 
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSK 195
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL 288
           K +   D+++ G +  E++TG+    L  GV D + + ++  IL
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK---PLFPGVTDDDQLPKIFSIL 236

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPN 121
           LG+G FG+V           +GE VA+K ++     E+ G H  + + E++IL  L H N
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK----PESGGNHIADLKKEIEILRNLYHEN 84
Query: 122 LVSLIGYCAD--GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +V   G C +  G    L+ E++  G+L+++L    + K++                YL 
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLG 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE--TYVTARVLGTFGYFD 237
           S        VHRD  + NVL+ +  + KI DFGL K +   +E  T    R    F ++ 
Sbjct: 144 SRQ-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF-WYA 197
Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLT 264
           PE     K  + SDV++FGV L ELLT
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 69  LGKGGFGR-VYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G FG+ +   +   G    IK++ + R    + E E R EV +L+ + HPN+V    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE-ESRREVAVLANMKHPNIVQYRE 90
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIG------EPKMDWPXXXXXXXXXXXXXXYLHSS 181
              +    ++V +Y + G+L   +N         +  +DW               ++H  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHDR 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD KS N+ L+ +   ++ DFG+A+++    E  +    +GT  Y  PE  
Sbjct: 145 K-----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEIC 197
Query: 242 STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  +SD++A G VL EL T + A +     + +NLVL++
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKI 237

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 23/232 (9%)
Query: 48  SSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS---GEV---VAIKKM-ELPRFKE 100
           SSVF   E E +    +    LG+G FG VY+G  R    GE    VA+K + E    +E
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------N 152
                EF  E  ++      ++V L+G  + G+   +V E M  G+L+ +L        N
Sbjct: 64  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 120
Query: 153 GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG 212
             G P                   YL++        VHRD  + N +++ +F  KI DFG
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFG 175
Query: 213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           + + + E        + L    +  PE    G  T  SD+++FGVVL E+ +
Sbjct: 176 MTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 20/224 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G+G +G VYK     G +VA+K++ L    E       R E+ +L  L HPN+VSLI  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87
Query: 129 CADGKHRFLVYEYMQKG---NLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
               +   LV+E+M+K     L ++  G+ + ++                 + H      
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQI-----KIYLYQLLRGVAHCHQHR--- 139
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-YTSTG 244
             I+HRD K  N+L++++   K++DFGLA+       +Y    V  T  Y  P+    + 
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSK 195
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL 288
           K +   D+++ G +  E++TG+    L  GV D + + ++  IL
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK---PLFPGVTDDDQLPKIFSIL 236

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 182 STAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 68
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 69  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 180
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 181 STAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 182 STAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 70
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 71  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 124
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 182
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 183 STAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 68
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 69  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 180
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 181 STAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG+V  G  + +G  VA+K +   + +  D   + + E+  L    HP+++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             +     F+V EY+  G L D++   G  +++                Y H        
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM----- 131
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           +VHRD K  NVLL A+  AKI+DFGL+ +M +G+    +    G+  Y  PE  S G+L 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPEVIS-GRLY 187
Query: 248 L--QSDVYAFGVVLLELLTGRRAVD 270
              + D+++ GV+L  LL G    D
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGXKYY 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 182 STAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR----- 123
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 182 STAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 104 LIGVITENP-VWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR-- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+S+N   K+ DFGL++ M E    Y  ++      +  PE  +  
Sbjct: 160 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 215
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 216 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 269
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 270 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 298

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 73
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 74  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 127
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 185
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 186 STAVDIWSLGCIFAEMVT-RRAL 207

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+S+N   K+ DFGL++ M E    Y  ++      +  PE  +  
Sbjct: 132 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 187
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 188 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 241
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 242 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 76
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 77  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 130
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 188
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 189 STAVDIWSLGCIFAEMVT-RRAL 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 76
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 77  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 130
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGXKYY 188
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 189 STAVDIWSLGCIFAEMVT-RRAL 210

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 182 STAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 81  LIGVITENP-VWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR-- 136
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+S+N   K+ DFGL++ M E    Y  ++      +  PE  +  
Sbjct: 137 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 192
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 193 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 246
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 247 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 275

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 182 STAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 68
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 69  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 180
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 181 STAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 70
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 71  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 124
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 182
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 183 STAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+S+N   K+ DFGL++ M E    Y  ++      +  PE  +  
Sbjct: 132 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 187
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 188 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 241
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 242 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 73  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 126
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 185 STAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 72  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 125
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 183
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 184 STAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 78  LIGVITENP-VWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR-- 133
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+S+N   K+ DFGL++ M E    Y  ++      +  PE  +  
Sbjct: 134 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 189
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 190 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 243
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 244 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 272

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 182 STAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 27/235 (11%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRF 98
            + V+   E E A    +    LG+G FG VY+G  + G V       VAIK + E    
Sbjct: 5   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 63
Query: 99  KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPK 158
           +E     EF  E  ++   +  ++V L+G  + G+   ++ E M +G+L+ +L  +  P+
Sbjct: 64  RE---RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPE 119
Query: 159 MD---------WPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKIS 209
           M+                         YL+++       VHRD  + N +++ +F  KI 
Sbjct: 120 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIG 174
Query: 210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           DFG+ + + E        + L    +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 175 DFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 72  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 125
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 183
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 184 STAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 79  LIGVITENP-VWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR-- 134
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+S+N   K+ DFGL++ M E    Y  ++      +  PE  +  
Sbjct: 135 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 190
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 191 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 244
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 245 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 273

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 68
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 69  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 180
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 181 STAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 63  FSDDNFL---GKGGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILS 115
            +D NFL   GKG FG+V     KGT    E+ AIK ++     + D      VE  +L+
Sbjct: 18  LTDFNFLMVLGKGSFGKVMLADRKGT---EELYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 116 RLDHPNLVSLIGYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXX 174
            LD P  ++ +  C     R + V EY+  G+L  H+  +G  K   P            
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISIG 132
Query: 175 XXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR-VLGTF 233
             +LH        I++RD K  NV+L +    KI+DFG+ K   E     VT R   GT 
Sbjct: 133 LFFLHKRG-----IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCGTP 184
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVD 270
            Y  PE  +        D +A+GV+L E+L G+   D
Sbjct: 185 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 73  LIGVITENP-VWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR-- 128
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+S+N   K+ DFGL++ M E    Y  ++      +  PE  +  
Sbjct: 129 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 184
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 185 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 238
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 239 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 70
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 71  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 124
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 182
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 183 STAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 71
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 72  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 125
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 183
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 184 STAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 73  VIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 126
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 185 STAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 70
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 71  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 124
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 182
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 183 STAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 102/253 (40%), Gaps = 57/253 (22%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F +   +G GGFG+V+K   R  G+   I+++   ++     E E    V  L++LDH N
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV---KYNNEKAERE----VKALAKLDHVN 66
Query: 122 LVSLIGYCADG------------------------------KHRFLVYEYMQKGNLQDHL 151
           +V   G C DG                              K  F+  E+  KG L+  +
Sbjct: 67  IVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI 125
Query: 152 NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF 211
                 K+D                Y+HS       ++HRD K +N+ L    + KI DF
Sbjct: 126 EKRRGEKLDKVLALELFEQITKGVDYIHSKK-----LIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 212 GL-AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELL------- 263
           GL   L  +G+ T    R  GT  Y  PE  S+     + D+YA G++L ELL       
Sbjct: 181 GLVTSLKNDGKRT----RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 236
Query: 264 -TGRRAVDLNQGV 275
            T +   DL  G+
Sbjct: 237 ETSKFFTDLRDGI 249

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 182 STAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 73
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 74  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 127
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 185
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 186 STAVDIWSLGCIFAEMVT-RRAL 207

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 73  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 126
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 185 STAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 66  DNFLGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +  +G G FG V +G L++       VAIK ++   + E     EF  E  I+ + +HPN
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLK-GGYTERQ-RREFLSEASIMGQFEHPN 78
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           ++ L G   +     ++ E+M+ G L   L  + + +                  YL   
Sbjct: 79  IIRLEGVVTNSMPVMILTEFMENGALDSFLR-LNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG---TFGYFDP 238
           S      VHRD  + N+L+++N   K+SDFGL++ + E          LG      +  P
Sbjct: 138 S-----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT 264
           E  +  K T  SD +++G+V+ E+++
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 100/230 (43%), Gaps = 28/230 (12%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGE-------HEFRVEVDILSRL 117
           LG G +G V     ++G     +  IKK +  + + +D          E   E+ +L  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXY 177
           DHPN++ L     D K+ +LV E+ + G L + +  I   K D                Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANIMKQILSGICY 161
Query: 178 LHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
           LH  +     IVHRD K  N+LL   ++    KI DFGL+       + Y     LGT  
Sbjct: 162 LHKHN-----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRDRLGTAY 213
Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
           Y  PE     K   + DV++ GV++  LL G        G NDQ+++ +V
Sbjct: 214 YIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPF---GGQNDQDIIKKV 259

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 23/232 (9%)
Query: 48  SSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS---GEV---VAIKKM-ELPRFKE 100
           SSV+   E E +    +    LG+G FG VY+G  R    GE    VA+K + E    +E
Sbjct: 4   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------N 152
                EF  E  ++      ++V L+G  + G+   +V E M  G+L+ +L        N
Sbjct: 64  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 120
Query: 153 GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG 212
             G P                   YL++        VHRD  + N +++ +F  KI DFG
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFG 175
Query: 213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           + + + E        + L    +  PE    G  T  SD+++FGVVL E+ +
Sbjct: 176 MTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 66  DNFLGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +  +G G FG V +G L++       VAIK ++   + E     EF  E  I+ + +HPN
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLK-GGYTERQ-RREFLSEASIMGQFEHPN 76
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           ++ L G   +     ++ E+M+ G L   L  + + +                  YL   
Sbjct: 77  IIRLEGVVTNSMPVMILTEFMENGALDSFLR-LNDGQFTVIQLVGMLRGIASGMRYLAEM 135
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG---TFGYFDP 238
           S      VHRD  + N+L+++N   K+SDFGL++ + E          LG      +  P
Sbjct: 136 S-----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT 264
           E  +  K T  SD +++G+V+ E+++
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRF 98
            + VF   E E A    +    LG+G FG VY+G  + G V       VAIK + E    
Sbjct: 2   AADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 60
Query: 99  KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI---- 154
           +E     EF  E  ++   +  ++V L+G  + G+   ++ E M +G+L+ +L  +    
Sbjct: 61  RE---RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 117
Query: 155 -GEPKMDWPXXXXXXXXXXXXX---XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD 210
              P +  P                 YL+++       VHRD  + N +++ +F  KI D
Sbjct: 118 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGD 172
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+ + + E        + L    +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 173 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
           +D  LG G FG V KG  +  +VV    +++ + +  D   + E   E +++ +LD+P +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +IG C + +   LV E  + G L  +L      K                  YL  S+
Sbjct: 89  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN 145
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +    E Y  A+  G +   ++ PE 
Sbjct: 146 -----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPEC 199
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV++FGV++ E  +
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 68
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 69  VIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 180
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 181 STAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
           +D  LG G FG V KG  +  +VV    +++ + +  D   + E   E +++ +LD+P +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +IG C + +   LV E  + G L  +L      K                  YL  S+
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN 147
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +    E Y  A+  G +   ++ PE 
Sbjct: 148 -----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPEC 201
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV++FGV++ E  +
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
           +D  LG G FG V KG  +  +VV    +++ + +  D   + E   E +++ +LD+P +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +IG C + +   LV E  + G L  +L      K                  YL  S+
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN 147
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +    E Y  A+  G +   ++ PE 
Sbjct: 148 -----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPEC 201
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV++FGV++ E  +
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRF-----KEADGEHEFRVEVDILSRLDHPNL 122
           LG G  G V     R + + VAIK +   +F     +EAD       E++IL +L+HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           + +  +  D +  ++V E M+ G L D +  +G  ++                 YLH + 
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 183 AVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I+HRD K  NVLLS+  E    KI+DFG +K++    ET +   + GT  Y  PE
Sbjct: 135 -----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPE 186
Query: 240 Y---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 T       D ++ GV+L   L+G
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
           +D  LG G FG V KG  +  +VV    +++ + +  D   + E   E +++ +LD+P +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +IG C + +   LV E  + G L  +L      K                  YL  S+
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN 137
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +    E Y  A+  G +   ++ PE 
Sbjct: 138 -----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPEC 191
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV++FGV++ E  +
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F+    +GKG FG V+KG   R+ +VVAIK ++L   ++   + +   E+ +LS+ D P 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 66
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP-KMDWPXXXXXXXXXXXXXXYLHS 180
           +    G        +++ EY+  G+  D L    EP  +D                YLHS
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS 122
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              +     HRD K+ NVLLS + E K++DFG+A  + + Q    T   +GT  +  PE 
Sbjct: 123 EKKI-----HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEV 175
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
                   ++D+++ G+  +EL  G
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARG 200

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRF-----KEADGEHEFRVEVDILSRLDHPNL 122
           LG G  G V     R + + VAIK +   +F     +EAD       E++IL +L+HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           + +  +  D +  ++V E M+ G L D +  +G  ++                 YLH + 
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 183 AVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I+HRD K  NVLLS+  E    KI+DFG +K++    ET +   + GT  Y  PE
Sbjct: 135 -----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPE 186
Query: 240 Y---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 T       D ++ GV+L   L+G
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
           +D  LG G FG V KG  +  +VV    +++ + +  D   + E   E +++ +LD+P +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +IG C + +   LV E  + G L  +L      K                  YL  S+
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN 127
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +    E Y  A+  G +   ++ PE 
Sbjct: 128 -----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPEC 181
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV++FGV++ E  +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
           +D  LG G FG V KG  +  +VV    +++ + +  D   + E   E +++ +LD+P +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +IG C + +   LV E  + G L  +L      K                  YL  S+
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN 131
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +    E Y  A+  G +   ++ PE 
Sbjct: 132 -----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPEC 185
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV++FGV++ E  +
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
           +D  LG G FG V KG  +  +VV    +++ + +  D   + E   E +++ +LD+P +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +IG C + +   LV E  + G L  +L      K                  YL  S+
Sbjct: 69  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN 125
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +    E Y  A+  G +   ++ PE 
Sbjct: 126 -----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPEC 179
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV++FGV++ E  +
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 37  QPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGE---VVAIKK 92
           +P   ++  R    FT +E+E +      +  +G G  G V  G LR  G+    VAIK 
Sbjct: 28  EPHTYEEPGRAGRSFT-REIEASRIHI--EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA 84
Query: 93  MELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLN 152
           ++    +      +F  E  I+ + DHPN++ L G    G+   +V EYM+ G+L   L 
Sbjct: 85  LKAGYTERQ--RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 153 GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG 212
              + +                  YL       +  VHRD  + NVL+ +N   K+SDFG
Sbjct: 143 -THDGQFTIMQLVGMLRGVGAGMRYLSD-----LGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 213 LAKLM---PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           L++++   P+   T    ++     +  PE  +    +  SDV++FGVV+ E+L 
Sbjct: 197 LSRVLEDDPDAAXTTTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRF-----KEADGEHEFRVEVDILSRLDHPNL 122
           LG G  G V     R + + VAIK +   +F     +EAD       E++IL +L+HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           + +  +  D +  ++V E M+ G L D +  +G  ++                 YLH + 
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 183 AVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I+HRD K  NVLLS+  E    KI+DFG +K++    ET +   + GT  Y  PE
Sbjct: 135 -----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPE 186
Query: 240 Y---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 T       D ++ GV+L   L+G
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRF-----KEADGEHEFRVEVDILSRLDHPNL 122
           LG G  G V     R + + VAIK +   +F     +EAD       E++IL +L+HP +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           + +  +  D +  ++V E M+ G L D +  +G  ++                 YLH + 
Sbjct: 77  IKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENG 133
Query: 183 AVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I+HRD K  NVLLS+  E    KI+DFG +K++    ET +   + GT  Y  PE
Sbjct: 134 -----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPE 185
Query: 240 Y---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 T       D ++ GV+L   L+G
Sbjct: 186 VLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+SA    K+ DFGL++ M E    Y  ++      +  PE  +  
Sbjct: 132 ---FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 187
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 188 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 241
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 242 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRFKEADGEHEFRVEVDILSRLDHP 120
           LG+G FG VY+G  + G V       VAIK + E    +E     EF  E  ++   +  
Sbjct: 18  LGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASMRE---RIEFLNEASVMKEFNCH 73
Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI-----GEPKMDWPXXXXXXXXXXXXX 175
           ++V L+G  + G+   ++ E M +G+L+ +L  +       P +  P             
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 176 ---XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
               YL+++       VHRD  + N +++ +F  KI DFG+ + + E        + L  
Sbjct: 134 DGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 188
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 189 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRF-----KEADGEHEFRVEVDILSRLDHPNL 122
           LG G  G V     R + + VAIK +   +F     +EAD       E++IL +L+HP +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           + +  +  D +  ++V E M+ G L D +  +G  ++                 YLH + 
Sbjct: 84  IKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENG 140
Query: 183 AVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I+HRD K  NVLLS+  E    KI+DFG +K++    ET +   + GT  Y  PE
Sbjct: 141 -----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPE 192
Query: 240 Y---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 T       D ++ GV+L   L+G
Sbjct: 193 VLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 117/295 (39%), Gaps = 27/295 (9%)
Query: 40  QPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRF 98
           QPQK  R    +          +F  +  +G+G F  VY+   L  G  VA+KK+++   
Sbjct: 17  QPQKALRPDMGYN------TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL 70
Query: 99  KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPK 158
            +A    +   E+D+L +L+HPN++       +     +V E    G+L   +    + K
Sbjct: 71  MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 130
Query: 159 MDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP 218
              P                H  S     ++HRD K  NV ++A    K+ D GL +   
Sbjct: 131 RLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF- 186
Query: 219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
              +T     ++GT  Y  PE         +SD+++ G +L E +   ++      +N  
Sbjct: 187 -SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE-MAALQSPFYGDKMNLY 244
Query: 279 NLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSM 333
           +L           KK+ +   P L    Y+ E       L + C+  +  +RP +
Sbjct: 245 SLC----------KKIEQCDYPPLPSDHYSEE----LRQLVNMCINPDPEKRPDV 285

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 70
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++   +L+  ++      +  P              + HS       
Sbjct: 71  VIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 124
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 182
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 183 STAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++   +L+  ++      +  P              + HS       
Sbjct: 73  VIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 126
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 185 STAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
           +D  LG G FG V KG  +  +VV    +++ + +  D   + E   E +++ +LD+P +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +IG C + +   LV E  + G L  +L      K                  YL  S+
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN 489
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +    E Y  A+  G +   ++ PE 
Sbjct: 490 -----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPEC 543
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV++FGV++ E  +
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKR-- 511
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+S+N   K+ DFGL++ M E    Y  ++      +  PE  +  
Sbjct: 512 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 567
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 568 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 621
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 622 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 23/232 (9%)
Query: 48  SSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS---GEV---VAIKKM-ELPRFKE 100
           SSVF   E E +    +    LG+G FG VY+G  R    GE    VA+K + E    +E
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------N 152
                EF  E  ++      ++V L+G  + G+   +V E M  G+L+ +L        N
Sbjct: 64  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 120
Query: 153 GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG 212
             G P                   YL++        VHRD  + N +++ +F  KI DFG
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFG 175
Query: 213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           + + + E        + L    +  PE    G  T  SD+++FGVVL E+ +
Sbjct: 176 MTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 23/232 (9%)
Query: 48  SSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS---GEV---VAIKKM-ELPRFKE 100
           SSVF   E E +    +    LG+G FG VY+G  R    GE    VA+K + E    +E
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------N 152
                EF  E  ++      ++V L+G  + G+   +V E M  G+L+ +L        N
Sbjct: 64  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 120
Query: 153 GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG 212
             G P                   YL++        VHRD  + N +++ +F  KI DFG
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFG 175
Query: 213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           + + + E        + L    +  PE    G  T  SD+++FGVVL E+ +
Sbjct: 176 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG FG V+KG   R+ +VVAIK ++L   ++     + + E+ +LS+ D P +    G
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 92
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEP-KMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                   +++ EY+  G+  D L    EP  +D                YLHS   +  
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKKI-- 146
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
              HRD K+ NVLLS + E K++DFG+A  + + Q    T   +GT  +  PE       
Sbjct: 147 ---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAY 201
Query: 247 TLQSDVYAFGVVLLELLTGR 266
             ++D+++ G+  +EL  G 
Sbjct: 202 DSKADIWSLGITAIELARGE 221

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 11/196 (5%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V  G  R    VAIK ++    + +  E EF  E  ++  L H  LV L G 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
           C   +  F++ EYM  G L ++L  +   +                  YL S        
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ-----F 141
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD  + N L++     K+SDFGL++ + + +ET           +  PE     K + 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF-PVRWSPPEVLMYSKFSS 200
Query: 249 QSDVYAFGVVLLELLT 264
           +SD++AFGV++ E+ +
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
           +D  LG G FG V KG  +  +VV    +++ + +  D   + E   E +++ +LD+P +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +IG C + +   LV E  + G L  +L      K                  YL  S+
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN 490
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +    E Y  A+  G +   ++ PE 
Sbjct: 491 -----FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPEC 544
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV++FGV++ E  +
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+KK+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 72
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 73  VIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 126
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYY 184
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 185 STAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+ K+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 123
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 181
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 182 STAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G VYK   + +GEVVA+ K+ L    E       R E+ +L  L+HPN+V L+ 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 68
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   +LV+E++ + +L+  ++      +  P              + HS       
Sbjct: 69  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----- 122
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-L 246
           ++HRD K  N+L++     K++DFGLA+       TY    V  T  Y  PE     K  
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 180
Query: 247 TLQSDVYAFGVVLLELLTGRRAV 269
           +   D+++ G +  E++T RRA+
Sbjct: 181 STAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 37  QPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGE---VVAIKK 92
           +P   ++  R    FT +E+E +      +  +G G  G V  G LR  G+    VAIK 
Sbjct: 28  EPHTYEEPGRAGRSFT-REIEASRIHI--EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA 84
Query: 93  MELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLN 152
           ++    +      +F  E  I+ + DHPN++ L G    G+   +V EYM+ G+L   L 
Sbjct: 85  LKAGYTERQ--RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 153 GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG 212
              + +                  YL       +  VHRD  + NVL+ +N   K+SDFG
Sbjct: 143 -THDGQFTIMQLVGMLRGVGAGMRYLSD-----LGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 213 LAKLM---PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           L++++   P+   T    ++     +  PE  +    +  SDV++FGVV+ E+L 
Sbjct: 197 LSRVLEDDPDAAYTTTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F+    +GKG FG V+KG   R+ +VVAIK ++L   +  D   + + E+ +LS+ D P 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL--EEAEDEIEDIQQEITVLSQCDSPY 81
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP-KMDWPXXXXXXXXXXXXXXYLHS 180
           +    G        +++ EY+  G+  D L    EP  +D                YLHS
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS 137
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              +     HRD K+ NVLLS + E K++DFG+A  + + Q        +GT  +  PE 
Sbjct: 138 EKKI-----HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNXFVGTPFWMAPEV 190
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
                   ++D+++ G+  +EL  G
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARG 215

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRF 98
            + V+   E E A    +    LG+G FG VY+G  + G V       VAIK + E    
Sbjct: 4   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 62
Query: 99  KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI---- 154
           +E     EF  E  ++   +  ++V L+G  + G+   ++ E M +G+L+ +L  +    
Sbjct: 63  RE---RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 119
Query: 155 -GEPKMDWPXXXXXXXXXXXXX---XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD 210
              P +  P                 YL+++       VHRD  + N +++ +F  KI D
Sbjct: 120 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGD 174
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+ + + E        + L    +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 175 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+S+N   K+ DFGL++ M +      +   L    +  PE  +  
Sbjct: 132 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESINFR 187
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 188 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 241
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 242 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRF 98
            + V+   E E A    +    LG+G FG VY+G  + G V       VAIK + E    
Sbjct: 11  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 69
Query: 99  KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI---- 154
           +E     EF  E  ++   +  ++V L+G  + G+   ++ E M +G+L+ +L  +    
Sbjct: 70  RE---RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 126
Query: 155 -GEPKMDWPXXXXXXXXXXXXX---XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD 210
              P +  P                 YL+++       VHRD  + N +++ +F  KI D
Sbjct: 127 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGD 181
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+ + + E        + L    +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + Y+ T + + EV A K +      +   + +   E+ I   LD+P++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 127 GYCADGKHRFLVYEYMQKGNL---QDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           G+  D    ++V E  ++ +L         + EP+  +               YLH++  
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-----FMRQTIQGVQYLHNNR- 162
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               ++HRD K  N+ L+ + + KI DFGLA  +    E   T  + GT  Y  PE    
Sbjct: 163 ----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCK 216
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
              + + D+++ G +L  LL G+
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 134/312 (42%), Gaps = 46/312 (14%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEH 105
           G+     + ME+    + +   +G+G +G V K   + +G +VAIKK     F E+D + 
Sbjct: 15  GTENLYFQSMEK----YENLGLVGEGSYGMVMKCRNKDTGRIVAIKK-----FLESDDDK 65
Query: 106 EFRV----EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD---HLNGIGEPK 158
             +     E+ +L +L H NLV+L+  C   K  +LV+E++    L D     NG     
Sbjct: 66  MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG----- 120
Query: 159 MDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP 218
           +D+               + HS +     I+HRD K  N+L+S +   K+ DFG A+ + 
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
Query: 219 EGQETYVTARVLGTFGYFDPE-YTSTGKLTLQSDVYAFGVVLLELLTGRRAV----DLNQ 273
              E Y     + T  Y  PE      K     DV+A G ++ E+  G        D++Q
Sbjct: 176 APGEVYDDE--VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ 233
Query: 274 GVNDQ----NLVLQVRHILNDRKKLRKVIDPE------LSRSSYTMESIAMFANLASRCV 323
             +      NL+ + + + N       V  PE      L R    +  + +  +LA +C+
Sbjct: 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVI--DLAKKCL 291
Query: 324 RTESSERPSMAE 335
             +  +RP  AE
Sbjct: 292 HIDPDKRPFCAE 303

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRF 98
            + V+   E E A    +    LG+G FG VY+G  + G V       VAIK + E    
Sbjct: 4   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 62
Query: 99  KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI---- 154
           +E     EF  E  ++   +  ++V L+G  + G+   ++ E M +G+L+ +L  +    
Sbjct: 63  RE---RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 119
Query: 155 -GEPKMDWPXXXXXXXXXXXXX---XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD 210
              P +  P                 YL+++       VHRD  + N +++ +F  KI D
Sbjct: 120 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGD 174
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+ + + E        + L    +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 175 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRF 98
            + V+   E E A    +    LG+G FG VY+G  + G V       VAIK + E    
Sbjct: 1   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 59
Query: 99  KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI---- 154
           +E     EF  E  ++   +  ++V L+G  + G+   ++ E M +G+L+ +L  +    
Sbjct: 60  RE---RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 116
Query: 155 -GEPKMDWPXXXXXXXXXXXXX---XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD 210
              P +  P                 YL+++       VHRD  + N +++ +F  KI D
Sbjct: 117 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGD 171
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+ + + E        + L    +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 172 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + Y+ T + + EV A K +      +   + +   E+ I   LD+P++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 127 GYCADGKHRFLVYEYMQKGNL---QDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           G+  D    ++V E  ++ +L         + EP+  +               YLH++  
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-----FMRQTIQGVQYLHNNR- 162
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTS 242
               ++HRD K  N+ L+ + + KI DFGLA K+  +G+       + GT  Y  PE   
Sbjct: 163 ----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIAPEVLC 215
Query: 243 TGKLTLQSDVYAFGVVLLELLTGR 266
               + + D+++ G +L  LL G+
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F+    +GKG FG V+KG   R+ +VVAIK ++L   ++   + +   E+ +LS+ D P 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 66
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP-KMDWPXXXXXXXXXXXXXXYLHS 180
           +    G        +++ EY+  G+  D L    EP  +D                YLHS
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS 122
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              +     HRD K+ NVLLS + E K++DFG+A  + + Q        +GT  +  PE 
Sbjct: 123 EKKI-----HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNXFVGTPFWMAPEV 175
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
                   ++D+++ G+  +EL  G
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARG 200

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F +V     + +G+ VA+K ++  +   +  +  FR EV I+  L+HPN+V L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                K  +LV EY   G + D+L  +   +M                 Y H        
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKF----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K+ N+LL A+   KI+DFG +     G +        G+  Y  PE     K  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPELFQGKKYD 190
Query: 248 -LQSDVYAFGVVLLELLTGRRAVD 270
             + DV++ GV+L  L++G    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRF 98
            + V+   E E A    +    LG+G FG VY+G  + G V       VAIK + E    
Sbjct: 33  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 91
Query: 99  KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI---- 154
           +E     EF  E  ++   +  ++V L+G  + G+   ++ E M +G+L+ +L  +    
Sbjct: 92  RE---RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 148
Query: 155 -GEPKMDWPXXXXXXXXXXXXX---XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD 210
              P +  P                 YL+++       VHRD  + N +++ +F  KI D
Sbjct: 149 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGD 203
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+ + + E        + L    +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 204 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 27/235 (11%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRF 98
            + V+   E E A    +    LG+G FG VY+G  + G V       VAIK + E    
Sbjct: 5   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 63
Query: 99  KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPK 158
           +E     EF  E  ++   +  ++V L+G  + G+   ++ E M +G+L+ +L  +  P+
Sbjct: 64  RE---RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPE 119
Query: 159 MD---------WPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKIS 209
           M+                         YL+++       VHRD  + N +++ +F  KI 
Sbjct: 120 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIG 174
Query: 210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           DFG+ + + E        + L    +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 175 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F +V     + +G+ VA+K ++  +   +  +  FR EV I+  L+HPN+V L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                K  +LV EY   G + D+L  +   +M                 Y H        
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKF----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K+ N+LL A+   KI+DFG +     G +        G+  Y  PE     K  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPELFQGKKYD 190
Query: 248 -LQSDVYAFGVVLLELLTGRRAVD 270
             + DV++ GV+L  L++G    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRF 98
            + V+   E E A    +    LG+G FG VY+G  + G V       VAIK + E    
Sbjct: 11  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASM 69
Query: 99  KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI---- 154
           +E     EF  E  ++   +  ++V L+G  + G+   ++ E M +G+L+ +L  +    
Sbjct: 70  RE---RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 126
Query: 155 -GEPKMDWPXXXXXXXXXXXXX---XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD 210
              P +  P                 YL+++       VHRD  + N +++ +F  KI D
Sbjct: 127 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGD 181
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+ + + E        + L    +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFK---EADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    G+  A+ K+ +   K    AD +     E+ I+S L  H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE--------PKMDWPXXXXXXXXXXXXX 175
           +L+G C  G    ++ EY   G+L + L    E        P  D               
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 176 XYLHSSSAVGIPI--------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA 227
             LH SS V   +        +HRD  + NVLL+    AKI DFGLA+ +       V  
Sbjct: 159 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 218
Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                  +  PE       T+QSDV+++G++L E+ +
Sbjct: 219 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + Y+ T + + EV A K +      +   + +   E+ I   LD+P++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 127 GYCADGKHRFLVYEYMQKGNL---QDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           G+  D    ++V E  ++ +L         + EP+  +               YLH++  
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-----FMRQTIQGVQYLHNNR- 162
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTS 242
               ++HRD K  N+ L+ + + KI DFGLA K+  +G+       + GT  Y  PE   
Sbjct: 163 ----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLC 215
Query: 243 TGKLTLQSDVYAFGVVLLELLTGR 266
               + + D+++ G +L  LL G+
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + Y+ T + + EV A K +      +   + +   E+ I   LD+P++V   
Sbjct: 33  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 127 GYCADGKHRFLVYEYMQKGNL---QDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           G+  D    ++V E  ++ +L         + EP+  +               YLH++  
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-----FMRQTIQGVQYLHNNR- 146
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTS 242
               ++HRD K  N+ L+ + + KI DFGLA K+  +G+       + GT  Y  PE   
Sbjct: 147 ----VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLC 199
Query: 243 TGKLTLQSDVYAFGVVLLELLTGR 266
               + + D+++ G +L  LL G+
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 31/280 (11%)
Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S E     VAIK  +           +F  E   + + DHP++V 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           LIG   +    +++ E    G L+  L  + +  +D                YL S    
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKR-- 511
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+SA    K+ DFGL++ M E    Y  ++      +  PE  +  
Sbjct: 512 ---FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 567
Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L     V   QGV + +++ ++ +   +R  +     P L  
Sbjct: 568 RFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 621
Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 622 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G FG+V   T  ++ + VA+K +     K++D       E+  L  L HP+++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                    +V EY   G L D++  + + +M                 Y H        
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYI--VEKKRMTEDEGRRFFQQIICAIEYCHRHK----- 128
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K  N+LL  N   KI+DFGL+ +M +G     +    G+  Y  PE  + GKL 
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVIN-GKLY 184
Query: 248 L--QSDVYAFGVVLLELLTGRRAVD 270
              + DV++ G+VL  +L GR   D
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F +V     + +G+ VA+K ++  +   +  +  FR EV I+  L+HPN+V L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                K  +LV EY   G + D+L  +   +M                 Y H        
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKF----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K+ N+LL A+   KI+DFG +     G +        G   Y  PE     K  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYD 190
Query: 248 -LQSDVYAFGVVLLELLTGRRAVD 270
             + DV++ GV+L  L++G    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRF-----KEADGEHEFRVEVDILSRLDHPNL 122
           LG G  G V     R + + VAI+ +   +F     +EAD       E++IL +L+HP +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           + +  +  D +  ++V E M+ G L D +  +G  ++                 YLH + 
Sbjct: 217 IKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENG 273
Query: 183 AVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I+HRD K  NVLLS+  E    KI+DFG +K++    ET +   + GT  Y  PE
Sbjct: 274 -----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPE 325
Query: 240 Y---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 T       D ++ GV+L   L+G
Sbjct: 326 VLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 14/219 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILS-RLDHPNLVSLI 126
           LGKG FG+V+    + + +  AIK ++       D      VE  +LS   +HP L  + 
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 85
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                 ++ F V EY+  G+L  H+      K D                +LHS      
Sbjct: 86  CTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---- 139
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            IV+RD K  N+LL  +   KI+DFG+ K    G     T    GT  Y  PE     K 
Sbjct: 140 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYIAPEILLGQKY 196
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR 285
               D ++FGV+L E+L G+       G +++ L   +R
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPF---HGQDEEELFHSIR 232

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F +V     + +G+ VA++ ++  +   +  +  FR EV I+  L+HPN+V L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                K  +LV EY   G + D+L  +   +M                 Y H        
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKF----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K+ N+LL A+   KI+DFG +     G +        G+  Y  PE     K  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYD 190
Query: 248 -LQSDVYAFGVVLLELLTGRRAVD 270
             + DV++ GV+L  L++G    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 69  LGKGGFGRVYKGTLRSG------EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG G  G V     R         +++ +K  +   +EAD       E++IL +L+HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           + +  +  D +  ++V E M+ G L D +  +G  ++                 YLH + 
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENG 259
Query: 183 AVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I+HRD K  NVLLS+  E    KI+DFG +K++    ET +   + GT  Y  PE
Sbjct: 260 -----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPE 311
Query: 240 Y---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 T       D ++ GV+L   L+G
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 14/219 (6%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILS-RLDHPNLVSLI 126
           LGKG FG+V+    + + +  AIK ++       D      VE  +LS   +HP L  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                 ++ F V EY+  G+L  H+      K D                +LHS      
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---- 138
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            IV+RD K  N+LL  +   KI+DFG+ K    G     T    GT  Y  PE     K 
Sbjct: 139 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAPEILLGQKY 195
Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR 285
               D ++FGV+L E+L G+       G +++ L   +R
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPF---HGQDEEELFHSIR 231

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFK---EADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    G+  A+ K+ +   K    AD +     E+ I+S L  H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           +L+G C  G    ++ EY   G+L + L       ++                 LH SS 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR-VLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 184 VGIPI--------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
           V   +        +HRD  + NVLL+    AKI DFGLA+ +       V         +
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 232
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             PE       T+QSDV+++G++L E+ +
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 111/253 (43%), Gaps = 48/253 (18%)
Query: 49  SVFTLKEMEEATCSFSDDNF-----LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRF 98
           SV   K +E+    F   N      LG+G FG+V K T      R+G      KM     
Sbjct: 6   SVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM----L 61
Query: 99  KEADGEHEFR---VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLN--- 152
           KE     E R    E ++L +++HP+++ L G C+      L+ EY + G+L+  L    
Sbjct: 62  KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 153 --GIG---------EPKMDWPXXXXXXXXXXXXXXYLHSSSA---VGIPIVHRDFKSTNV 198
             G G            +D P              +  S        + +VHRD  + N+
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181
Query: 199 LLSANFEAKISDFGLAKLMPEGQETYVT-------ARVLGTFGYFDPEYTSTGKLTLQSD 251
           L++   + KISDFGL++ + E +++YV         + +     FD  YT+      QSD
Sbjct: 182 LVAEGRKMKISDFGLSRDVYE-EDSYVKRSQGRIPVKWMAIESLFDHIYTT------QSD 234
Query: 252 VYAFGVVLLELLT 264
           V++FGV+L E++T
Sbjct: 235 VWSFGVLLWEIVT 247

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 30/291 (10%)
Query: 66  DNFLGKGGFGRVYKG--TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  LG+G FG VY+G  T   GE + +      +    D + +F  E  I+  LDHP++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
            LIG   + +  +++ E    G L  +L    +  +                 YL S   
Sbjct: 89  KLIGI-IEEEPTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLES--- 143
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
             I  VHRD    N+L+++    K+ DFGL++ + E ++ Y  +       +  PE  + 
Sbjct: 144 --INCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINF 200
Query: 244 GKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL 302
            + T  SDV+ F V + E+L+ G++              L+ + ++   +K  ++  P+L
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPF----------FWLENKDVIGVLEKGDRLPKPDL 250
Query: 303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
                      +   L +RC   + S+RP   E V  L   +Y   K + M
Sbjct: 251 CP--------PVLYTLMTRCWDYDPSDRPRFTELVCSLS-DVYQMEKDIAM 292

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           +G+G  G VY    + +G+ VAI++M L    +   + E  + E+ ++    +PN+V+ +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                G   ++V EY+  G+L D    + E  MD                +LHS+     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSNQ---- 136
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            ++HRD KS N+LL  +   K++DFG  A++ PE  +    + ++GT  +  PE  +   
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAPEVVTRKA 192
Query: 246 LTLQSDVYAFGVVLLELLTG 265
              + D+++ G++ +E++ G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFK---EADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    G+  A+ K+ +   K    AD +     E+ I+S L  H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           +L+G C  G    ++ EY   G+L + L       ++                 LH SS 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR-VLETDPAFAIANSTLSTRDLLHFSSQ 172
Query: 184 VGIPI--------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
           V   +        +HRD  + NVLL+    AKI DFGLA+ +       V         +
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 232
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             PE       T+QSDV+++G++L E+ +
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 30/291 (10%)
Query: 66  DNFLGKGGFGRVYKG--TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  LG+G FG VY+G  T   GE + +      +    D + +F  E  I+  LDHP++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
            LIG   + +  +++ E    G L  +L    +  +                 YL S   
Sbjct: 73  KLIGI-IEEEPTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLES--- 127
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
             I  VHRD    N+L+++    K+ DFGL++ + E ++ Y  +       +  PE  + 
Sbjct: 128 --INCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINF 184
Query: 244 GKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL 302
            + T  SDV+ F V + E+L+ G++              L+ + ++   +K  ++  P+L
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPF----------FWLENKDVIGVLEKGDRLPKPDL 234
Query: 303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
                      +   L +RC   + S+RP   E V  L   +Y   K + M
Sbjct: 235 CP--------PVLYTLMTRCWDYDPSDRPRFTELVCSLS-DVYQMEKDIAM 276

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F +V     + +G+ VA++ ++  +   +  +  FR EV I+  L+HPN+V L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                K  +LV EY   G + D+L  +   +M                 Y H        
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKF----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K+ N+LL A+   KI+DFG +     G +        G+  Y  PE     K  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPELFQGKKYD 190
Query: 248 -LQSDVYAFGVVLLELLTGRRAVD 270
             + DV++ GV+L  L++G    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG V K   R + +  A+K +     K  D     R EV++L +LDHPN++ L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFE 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
              D    ++V E    G L D +  I   +                  Y+H  +     
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHN----- 141
Query: 188 IVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
           IVHRD K  N+LL +   + + KI DFGL+      Q T +  R+ GT  Y  PE    G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI-GTAYYIAPEVLR-G 197
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
               + DV++ GV+L  LL+G
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 30/291 (10%)
Query: 66  DNFLGKGGFGRVYKG--TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           +  LG+G FG VY+G  T   GE + +      +    D + +F  E  I+  LDHP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
            LIG   + +  +++ E    G L  +L    +  +                 YL S   
Sbjct: 77  KLIGI-IEEEPTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLES--- 131
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
             I  VHRD    N+L+++    K+ DFGL++ + E ++ Y  +       +  PE  + 
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINF 188
Query: 244 GKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL 302
            + T  SDV+ F V + E+L+ G++              L+ + ++   +K  ++  P+L
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPF----------FWLENKDVIGVLEKGDRLPKPDL 238
Query: 303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
                      +   L +RC   + S+RP   E V  L   +Y   K + M
Sbjct: 239 CP--------PVLYTLMTRCWDYDPSDRPRFTELVCSLS-DVYQMEKDIAM 280

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F+  + +GKG FG VYKG    + EVVAIK ++L   ++   + +   E+ +LS+ D P 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 78
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           +    G        +++ EY+  G+  D L       ++                YLHS 
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE 135
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
             +     HRD K+ NVLLS   + K++DFG+A  + + Q        +GT  +  PE  
Sbjct: 136 RKI-----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNXFVGTPFWMAPEVI 188
Query: 242 STGKLTLQSDVYAFGVVLLELLTG 265
                  ++D+++ G+  +EL  G
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKG 212

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F +V     + +G  VAIK ++  +      +  FR EV I+  L+HPN+V L  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 78
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                K  +L+ EY   G + D+L  +   +M                 Y H        
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKR----- 131
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K+ N+LL A+   KI+DFG +     G +        G+  Y  PE     K  
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDTFCGSPPYAAPELFQGKKYD 188
Query: 248 -LQSDVYAFGVVLLELLTGRRAVD 270
             + DV++ GV+L  L++G    D
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V  G  R    VAIK ++    + +  E EF  E  ++  L H  LV L G 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
           C   +  F++ EYM  G L ++L  +   +                  YL S        
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ-----F 121
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG--YFDPEYTSTGKL 246
           +HRD  + N L++     K+SDFGL++ + + +    T+ V   F   +  PE     K 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 247 TLQSDVYAFGVVLLELLT 264
           + +SD++AFGV++ E+ +
Sbjct: 179 SSKSDIWAFGVLMWEIYS 196

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           +G+G  G VY    + +G+ VAI++M L    +   + E  + E+ ++    +PN+V+ +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                G   ++V EY+  G+L D    + E  MD                +LHS+     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSNQ---- 136
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            ++HRD KS N+LL  +   K++DFG  A++ PE  +    + ++GT  +  PE  +   
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKA 192
Query: 246 LTLQSDVYAFGVVLLELLTG 265
              + D+++ G++ +E++ G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 69  LGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRFKEADGEHEFRVEVDILSRLDHP 120
           LG+G FG VY+G  + G V       VAIK + E    +E     EF  E  ++   +  
Sbjct: 20  LGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASMRE---RIEFLNEASVMKEFNCH 75
Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD---------WPXXXXXXXXX 171
           ++V L+G  + G+   ++ E M +G+L+ +L  +  P+M+                    
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 172 XXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
                YL+++       VHRD  + N +++ +F  KI DFG+ + + E        + L 
Sbjct: 135 ADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 189
Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
              +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           +G+G  G VY    + +G+ VAI++M L    +   + E  + E+ ++    +PN+V+ +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                G   ++V EY+  G+L D    + E  MD                +LHS+     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSNQ---- 136
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            ++HRD KS N+LL  +   K++DFG  A++ PE  +    + ++GT  +  PE  +   
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA 192
Query: 246 LTLQSDVYAFGVVLLELLTG 265
              + D+++ G++ +E++ G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           +G+G  G VY    + +G+ VAI++M L    +   + E  + E+ ++    +PN+V+ +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                G   ++V EY+  G+L D    + E  MD                +LHS+     
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSNQ---- 137
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            ++HRD KS N+LL  +   K++DFG  A++ PE  +    + ++GT  +  PE  +   
Sbjct: 138 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKA 193
Query: 246 LTLQSDVYAFGVVLLELLTG 265
              + D+++ G++ +E++ G
Sbjct: 194 YGPKVDIWSLGIMAIEMIEG 213

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V  G  R    VAIK ++    + +  E EF  E  ++  L H  LV L G 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
           C   +  F++ EYM  G L ++L  +   +                  YL S        
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ-----F 125
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG--YFDPEYTSTGKL 246
           +HRD  + N L++     K+SDFGL++ + + +    T+ V   F   +  PE     K 
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 247 TLQSDVYAFGVVLLELLT 264
           + +SD++AFGV++ E+ +
Sbjct: 183 SSKSDIWAFGVLMWEIYS 200

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 59  ATCSFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
           AT  +     +G G +G VYK     SG  VA+K + +P  +E       R EV +L RL
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRL 60
Query: 118 D---HPNLVSLIGYCADGK-----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           +   HPN+V L+  CA  +        LV+E++ + +L+ +L+    P +          
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  +LH++      IVHRD K  N+L+++    K++DFGLA++          A V
Sbjct: 120 QFLRGLDFLHANC-----IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPV 171
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELL 263
           + T  Y  PE           D+++ G +  E+ 
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNL 122
           +D  LG G FG V KG  +  +VV    +++ + +  D   + E   E +++ +LD+P +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +IG C + +   LV E  + G L  +L      K                  YL  S+
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN 131
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEY 240
                 VHRD  + NVLL     AKISDFGL+K +   +  Y  A+  G +   ++ PE 
Sbjct: 132 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY-KAQTHGKWPVKWYAPEC 185
Query: 241 TSTGKLTLQSDVYAFGVVLLELLT 264
            +  K + +SDV++FGV++ E  +
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 13/226 (5%)
Query: 47  GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEH 105
           G+S+ +  + +    ++     +GKG F +V     + +G  VA+K ++  +      + 
Sbjct: 1   GNSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQK 60
Query: 106 EFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXX 165
            FR EV I+  L+HPN+V L       K  +LV EY   G + D+L  +   +M      
Sbjct: 61  LFR-EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEAR 117
Query: 166 XXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV 225
                      Y H        IVHRD K+ N+LL  +   KI+DFG +     G +   
Sbjct: 118 AKFRQIVSAVQYCHQKY-----IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK--- 169
Query: 226 TARVLGTFGYFDPEYTSTGKLT-LQSDVYAFGVVLLELLTGRRAVD 270
                G+  Y  PE     K    + DV++ GV+L  L++G    D
Sbjct: 170 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V  G  R    VAIK ++    + +  E EF  E  ++  L H  LV L G 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
           C   +  F++ EYM  G L ++L  +   +                  YL S        
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ-----F 126
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG--YFDPEYTSTGKL 246
           +HRD  + N L++     K+SDFGL++ + + +    T+ V   F   +  PE     K 
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 247 TLQSDVYAFGVVLLELLT 264
           + +SD++AFGV++ E+ +
Sbjct: 184 SSKSDIWAFGVLMWEIYS 201

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F +V     + +G  VAIK ++  +      +  FR EV I+  L+HPN+V L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                K  +L+ EY   G + D+L  +   +M                 Y H        
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKR----- 134
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K+ N+LL A+   KI+DFG +     G +        G   Y  PE     K  
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYD 191
Query: 248 -LQSDVYAFGVVLLELLTGRRAVD 270
             + DV++ GV+L  L++G    D
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 52  TLKEMEEATCSFSDDNF------LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEH 105
           ++K+ E  T   + ++F      LG G FG+VYK   +   V+A  K  +   K  +   
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK--VIDTKSEEELE 79
Query: 106 EFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXX 165
           ++ VE+DIL+  DHPN+V L+       + +++ E+   G +   +  +  P  +     
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE-SQIQ 138
Query: 166 XXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV 225
                      YLH +      I+HRD K+ N+L + + + K++DFG++      + T  
Sbjct: 139 VVCKQTLDALNYLHDNK-----IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRT 188
Query: 226 TAR---VLGTFGYFDPEYT--STGK---LTLQSDVYAFGVVLLEL 262
             R    +GT  +  PE     T K      ++DV++ G+ L+E+
Sbjct: 189 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAI--KKMELPRFKEADGEHEFRV 109
           LKE E     F     LG G FG VYKG  +  GE V I    MEL          E   
Sbjct: 46  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILD 100
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPXX 164
           E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W   
Sbjct: 101 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW--- 156
Query: 165 XXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
                       YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ Y
Sbjct: 157 ---CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 208
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                     +   E       T QSDV+++GV + EL+T
Sbjct: 209 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 25/231 (10%)
Query: 50  VFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-------VAIKKM-ELPRFKEA 101
           V+   E E A    +    LG+G FG VY+G  + G V       VAIK + E    +E 
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASMRE- 58
Query: 102 DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI-----GE 156
               EF  E  ++   +  ++V L+G  + G+   ++ E M +G+L+ +L  +       
Sbjct: 59  --RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 116
Query: 157 PKMDWPXXXXXXXXXXXXX---XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL 213
           P +  P                 YL+++       VHRD  + N  ++ +F  KI DFG+
Sbjct: 117 PVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCXVAEDFTVKIGDFGM 171
Query: 214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            + + E        + L    +  PE    G  T  SDV++FGVVL E+ T
Sbjct: 172 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 69  LGKGGFGRVYKGTLRS---GEV---VAIKKM-ELPRFKEADGEHEFRVEVDILSRLDHPN 121
           LG+G FG VY+G  R    GE    VA+K + E    +E     EF  E  ++      +
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE---RIEFLNEASVMKGFTCHH 80
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------NGIGEPKMDWPXXXXXXXXXXX 173
           +V L+G  + G+   +V E M  G+L+ +L        N  G P                
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              YL++        VHRD  + N +++ +F  KI DFG+ + + E        + L   
Sbjct: 141 GMAYLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            +  PE    G  T  SD+++FGVVL E+ +
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 24/230 (10%)
Query: 51  FTLKEMEEATCSFSDD---------NFLGKGGFGRVYKGTLR-SGE---VVAIKKMELPR 97
           FT ++  EA   F+ +           +G G FG V  G L+  G+    VAIK ++   
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 98  FKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP 157
            ++     +F  E  I+ + DHPN++ L G         ++ E+M+ G+L   L    + 
Sbjct: 74  TEKQ--RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDG 130
Query: 158 KMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM 217
           +                  YL   +      VHRD  + N+L+++N   K+SDFGL++ +
Sbjct: 131 QFTVIQLVGMLRGIAAGMKYLADMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRFL 185
Query: 218 PEGQETYVTARVLG---TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            +          LG      +  PE     K T  SDV+++G+V+ E+++
Sbjct: 186 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V  G  +    VA+K ++    + +  E EF  E   + +L HP LV   G 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK----EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
           C+     ++V EY+  G L ++L   G+  ++                +L S        
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQ-----F 125
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDPEYTSTGK 245
           +HRD  + N L+  +   K+SDFG+ + + + Q  YV++  +GT     +  PE     K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSS--VGTKFPVKWSAPEVFHYFK 181
Query: 246 LTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQV 284
            + +SDV+AFG+++ E+ + G+   DL     +  +VL+V
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDL---YTNSEVVLKV 218

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V  G  R    VAIK ++    + +  E EF  E  ++  L H  LV L G 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
           C   +  F++ EYM  G L ++L  +   +                  YL S        
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ-----F 141
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG--YFDPEYTSTGKL 246
           +HRD  + N L++     K+SDFGL++ + + +    T+ V   F   +  PE     K 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 247 TLQSDVYAFGVVLLELLT 264
           + +SD++AFGV++ E+ +
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G VYK   + +G++VAIK++ +    E+D + E   E+ I+ + D P++V   G
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPV----ESDLQ-EIIKEISIMQQCDSPHVVKYYG 91
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                   ++V EY   G++ D +  +    +                 YLH    +   
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIR-LRNKTLTEDEIATILQSTLKGLEYLHFMRKI--- 147
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYFDPEYTSTG 244
             HRD K+ N+LL+    AK++DFG+A     GQ T   A+   V+GT  +  PE     
Sbjct: 148 --HRDIKAGNILLNTEGHAKLADFGVA-----GQLTDXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 245 KLTLQSDVYAFGVVLLELLTGR 266
                +D+++ G+  +E+  G+
Sbjct: 201 GYNCVADIWSLGITAIEMAEGK 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG V K   R + +  A+K +     K  D     R EV++L +LDHPN++ L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFE 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
              D    ++V E    G L D +  I   +                  Y+H  +     
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHN----- 141
Query: 188 IVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
           IVHRD K  N+LL +   + + KI DFGL+      Q T +  R+ GT  Y  PE    G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI-GTAYYIAPEVLR-G 197
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
               + DV++ GV+L  LL+G
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG V K   R + +  A+K +     K  D     R EV++L +LDHPN++ L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFE 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
              D    ++V E    G L D +  I   +                  Y+H  +     
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHN----- 141
Query: 188 IVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
           IVHRD K  N+LL +   + + KI DFGL+      Q T +  R+ GT  Y  PE    G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI-GTAYYIAPEVLR-G 197
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
               + DV++ GV+L  LL+G
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 52  TLKEMEEATCSFSDDNF------LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEH 105
           ++K+ E  T   + ++F      LG G FG+VYK   +   V+A  K  +   K  +   
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK--VIDTKSEEELE 79
Query: 106 EFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXX 165
           ++ VE+DIL+  DHPN+V L+       + +++ E+   G +   +  +  P  +     
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE-SQIQ 138
Query: 166 XXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV 225
                      YLH +      I+HRD K+ N+L + + + K++DFG++      + T  
Sbjct: 139 VVCKQTLDALNYLHDNK-----IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRX 188
Query: 226 TAR---VLGTFGYFDPEYT--STGK---LTLQSDVYAFGVVLLEL 262
             R    +GT  +  PE     T K      ++DV++ G+ L+E+
Sbjct: 189 IQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V  G  R    VAIK ++    + +  E EF  E  ++  L H  LV L G 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
           C   +  F++ EYM  G L ++L  +   +                  YL S        
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ-----F 132
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG--YFDPEYTSTGKL 246
           +HRD  + N L++     K+SDFGL++ + + +    T+ V   F   +  PE     K 
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKF 189
Query: 247 TLQSDVYAFGVVLLELLT 264
           + +SD++AFGV++ E+ +
Sbjct: 190 SSKSDIWAFGVLMWEIYS 207

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 52  TLKEMEEATCSFSDDNF------LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEH 105
           ++K+ E  T   + ++F      LG G FG+VYK   +   V+A  K  +   K  +   
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK--VIDTKSEEELE 79
Query: 106 EFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXX 165
           ++ VE+DIL+  DHPN+V L+       + +++ E+   G +   +  +  P  +     
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE-SQIQ 138
Query: 166 XXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV 225
                      YLH +      I+HRD K+ N+L + + + K++DFG++      + T  
Sbjct: 139 VVCKQTLDALNYLHDNK-----IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRX 188
Query: 226 TAR---VLGTFGYFDPEYT--STGK---LTLQSDVYAFGVVLLEL 262
             R    +GT  +  PE     T K      ++DV++ G+ L+E+
Sbjct: 189 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 66  DNFL--GKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           DNF+  G+G  G V   T+RS G++VA+KKM+L   K+   E  F  EV I+    H N+
Sbjct: 32  DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFN-EVVIMRDYQHENV 88
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +      G   ++V E+++ G L D    +   +M+                 LH+  
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
                ++HRD KS ++LL+ +   K+SDFG    +   +E      ++GT  +  PE  S
Sbjct: 146 -----VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELIS 198
Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++ G++++E++ G
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 66  DNFL--GKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           DNF+  G+G  G V   T+RS G++VA+KKM+L   K+   E  F  EV I+    H N+
Sbjct: 154 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFN-EVVIMRDYQHENV 210
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +      G   ++V E+++ G L D +      +M+                 LH+  
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
                ++HRD KS ++LL+ +   K+SDFG    +   +E      ++GT  +  PE  S
Sbjct: 268 -----VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELIS 320
Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++ G++++E++ G
Sbjct: 321 RLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG FG V+KG   R+ +VVAIK ++L   ++   + +   E+ +LS+ D   +    G
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSSYVTKYYG 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
               G   +++ EY+  G+  D L        D                YLHS   +   
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKI--- 142
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
             HRD K+ NVLLS   + K++DFG+A  + + Q    T   +GT  +  PE        
Sbjct: 143 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYD 198
Query: 248 LQSDVYAFGVVLLELLTG 265
            ++D+++ G+  +EL  G
Sbjct: 199 SKADIWSLGITAIELAKG 216

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V  G  R    VAIK ++    + +  E EF  E  ++  L H  LV L G 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
           C   +  F++ EYM  G L ++L  +   +                  YL S        
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ-----F 126
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT---FGYFDPEYTSTGK 245
           +HRD  + N L++     K+SDFGL++ + + +  Y ++R  G+     +  PE     K
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSR--GSKFPVRWSPPEVLMYSK 182
Query: 246 LTLQSDVYAFGVVLLELLT 264
            + +SD++AFGV++ E+ +
Sbjct: 183 FSSKSDIWAFGVLMWEIYS 201

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +GR  K   +S G+++  K+++     EA+ +     EV++L  L HPN+V    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHPNIVRYYD 72
Query: 128 YCADGKHR--FLVYEYMQKGNLQDHLN-GIGEPK-MDWPXXXXXXXXXXXXXXYLHSSSA 183
              D  +   ++V EY + G+L   +  G  E + +D                  H  S 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
            G  ++HRD K  NV L      K+ DFGLA+++    +T      +GT  Y  PE  + 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 244 GKLTLQSDVYAFGVVLLEL 262
                +SD+++ G +L EL
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F +V     + +G+ VA+K ++  +   +  +  FR EV I+  L+HPN+V L  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 73
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                K  +LV EY   G + D+L  +    M                 Y H        
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYL--VAHGWMKEKEARAKFRQIVSAVQYCHQKF----- 126
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K+ N+LL A+   KI+DFG +     G +        G+  Y  PE     K  
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPELFQGKKYD 183
Query: 248 -LQSDVYAFGVVLLELLTGRRAVD 270
             + DV++ GV+L  L++G    D
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +GR  K   +S G+++  K+++     EA+ +     EV++L  L HPN+V    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHPNIVRYYD 72
Query: 128 YCADGKHR--FLVYEYMQKGNLQDHLN-GIGEPK-MDWPXXXXXXXXXXXXXXYLHSSSA 183
              D  +   ++V EY + G+L   +  G  E + +D                  H  S 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
            G  ++HRD K  NV L      K+ DFGLA+++    +T      +GT  Y  PE  + 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 244 GKLTLQSDVYAFGVVLLEL 262
                +SD+++ G +L EL
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 66  DNFL--GKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           DNF+  G+G  G V   T+RS G++VA+KKM+L   K+   E  F  EV I+    H N+
Sbjct: 34  DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFN-EVVIMRDYQHENV 90
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +      G   ++V E+++ G L D    +   +M+                 LH+  
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
                ++HRD KS ++LL+ +   K+SDFG    +   +E      ++GT  +  PE  S
Sbjct: 148 -----VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELIS 200
Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++ G++++E++ G
Sbjct: 201 RLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 23/232 (9%)
Query: 48  SSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS---GEV---VAIKKM-ELPRFKE 100
           SSV+   E E +    +    LG+G FG VY+G  R    GE    VA+K + E    +E
Sbjct: 4   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------N 152
                EF  E  ++      ++V L+G  + G+   +V E M  G+L+ +L        N
Sbjct: 64  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 120
Query: 153 GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG 212
             G P                   YL++        VHR+  + N +++ +F  KI DFG
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRNLAARNCMVAHDFTVKIGDFG 175
Query: 213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           + + + E        + L    +  PE    G  T  SD+++FGVVL E+ +
Sbjct: 176 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 23/232 (9%)
Query: 48  SSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS---GEV---VAIKKM-ELPRFKE 100
           SSV+   E E +    +    LG+G FG VY+G  R    GE    VA+K + E    +E
Sbjct: 5   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 64
Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------N 152
                EF  E  ++      ++V L+G  + G+   +V E M  G+L+ +L        N
Sbjct: 65  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 121
Query: 153 GIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG 212
             G P                   YL++        VHR+  + N +++ +F  KI DFG
Sbjct: 122 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRNLAARNCMVAHDFTVKIGDFG 176
Query: 213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           + + + E        + L    +  PE    G  T  SD+++FGVVL E+ +
Sbjct: 177 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 108/252 (42%), Gaps = 46/252 (18%)
Query: 49  SVFTLKEMEEATCSFSDDNF-----LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRF 98
           SV   K +E+    F   N      LG+G FG+V K T      R+G      KM     
Sbjct: 6   SVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM----L 61
Query: 99  KEADGEHEFR---VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLN--- 152
           KE     E R    E ++L +++HP+++ L G C+      L+ EY + G+L+  L    
Sbjct: 62  KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 153 --GIG---------EPKMDWPXXXXXXXXXXXXXXYLHSSSA---VGIPIVHRDFKSTNV 198
             G G            +D P              +  S        + +VHRD  + N+
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181
Query: 199 LLSANFEAKISDFGLAKLMPEG------QETYVTARVLGTFGYFDPEYTSTGKLTLQSDV 252
           L++   + KISDFGL++ + E        +  +  + +     FD  YT+      QSDV
Sbjct: 182 LVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTT------QSDV 235
Query: 253 YAFGVVLLELLT 264
           ++FGV+L E++T
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 98/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 18  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 73
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+L+H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 74  SEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 127
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 128 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 187
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 188 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 108/252 (42%), Gaps = 46/252 (18%)
Query: 49  SVFTLKEMEEATCSFSDDNF-----LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRF 98
           SV   K +E+    F   N      LG+G FG+V K T      R+G      KM     
Sbjct: 6   SVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM----L 61
Query: 99  KEADGEHEFR---VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLN--- 152
           KE     E R    E ++L +++HP+++ L G C+      L+ EY + G+L+  L    
Sbjct: 62  KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 153 --GIG---------EPKMDWPXXXXXXXXXXXXXXYLHSSSA---VGIPIVHRDFKSTNV 198
             G G            +D P              +  S        + +VHRD  + N+
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNI 181
Query: 199 LLSANFEAKISDFGLAKLMPEG------QETYVTARVLGTFGYFDPEYTSTGKLTLQSDV 252
           L++   + KISDFGL++ + E        +  +  + +     FD  YT+      QSDV
Sbjct: 182 LVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTT------QSDV 235
Query: 253 YAFGVVLLELLT 264
           ++FGV+L E++T
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLI 126
           LGKG +G V+K    R+GEVVA+KK+        D +  FR E+ IL+ L  H N+V+L+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 127 GYCADGKHR--FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX-XXXXXXXYLHSSSA 183
                   R  +LV++YM+       L+ +    +  P               YLHS   
Sbjct: 76  NVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG- 129
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAK--------------LMPEGQETY----- 224
               ++HRD K +N+LL+A    K++DFGL++               + E  E +     
Sbjct: 130 ----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 225 VTARVLGTFGYFDPEY-TSTGKLTLQSDVYAFGVVLLELLTGR 266
           +    + T  Y  PE    + K T   D+++ G +L E+L G+
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 66  DNFL--GKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           DNF+  G+G  G V   T+RS G++VA+KKM+L   K+   E  F  EV I+    H N+
Sbjct: 23  DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFN-EVVIMRDYQHENV 79
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +      G   ++V E+++ G L D    +   +M+                 LH+  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
                ++HRD KS ++LL+ +   K+SDFG    +   +E      ++GT  +  PE  S
Sbjct: 137 -----VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELIS 189
Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++ G++++E++ G
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 66  DNFL--GKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           DNF+  G+G  G V   T+RS G++VA+KKM+L   K+   E  F  EV I+    H N+
Sbjct: 77  DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFN-EVVIMRDYQHENV 133
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +      G   ++V E+++ G L D    +   +M+                 LH+  
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
                ++HRD KS ++LL+ +   K+SDFG    +   +E      ++GT  +  PE  S
Sbjct: 191 -----VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELIS 243
Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++ G++++E++ G
Sbjct: 244 RLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 66  DNFL--GKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           DNF+  G+G  G V   T+RS G++VA+KKM+L   K+   E  F  EV I+    H N+
Sbjct: 27  DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL--RKQQRRELLFN-EVVIMRDYQHENV 83
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V +      G   ++V E+++ G L D    +   +M+                 LH+  
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
                ++HRD KS ++LL+ +   K+SDFG    +   +E      ++GT  +  PE  S
Sbjct: 141 -----VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELIS 193
Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++ G++++E++ G
Sbjct: 194 RLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 98/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 32  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 87
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+L+H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 88  SEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 141
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 142 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 14/217 (6%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG FG+V       + ++ A+K M   +  E +       E+ I+  L+HP LV+L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
              D +  F+V + +  G+L+ HL      K +                YL +       
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE--TVKLFICELVMALDYLQNQR----- 135
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK-- 245
           I+HRD K  N+LL  +    I+DF +A ++P  +ET +T  + GT  Y  PE  S+ K  
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITT-MAGTKPYMAPEMFSSRKGA 192
Query: 246 -LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV 281
             +   D ++ GV   ELL GRR   +    + + +V
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 27/238 (11%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           LG+G FG+V   Y  T  +G+ VA+K +      ++D +     E+  L  L HP+++ L
Sbjct: 22  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 126 IGYCADGKHRFLVYEYMQKGN-LQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
                      +V EY   GN L D++  +   KM                 Y H     
Sbjct: 80  YDVIKSKDEIIMVIEY--AGNELFDYI--VQRDKMSEQEARRFFQQIISAVEYCHRHK-- 133
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
              IVHRD K  N+LL  +   KI+DFGL+ +M +G     +    G+  Y  PE  S G
Sbjct: 134 ---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVIS-G 186
Query: 245 KLTL--QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           KL    + DV++ GV+L  +L  R   D      D+++ +  ++I N    L K + P
Sbjct: 187 KLYAGPEVDVWSCGVILYVMLCRRLPFD------DESIPVLFKNISNGVYTLPKFLSP 238

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 27/238 (11%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           LG+G FG+V   Y  T  +G+ VA+K +      ++D +     E+  L  L HP+++ L
Sbjct: 12  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 126 IGYCADGKHRFLVYEYMQKGN-LQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
                      +V EY   GN L D++  +   KM                 Y H     
Sbjct: 70  YDVIKSKDEIIMVIEY--AGNELFDYI--VQRDKMSEQEARRFFQQIISAVEYCHRHK-- 123
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
              IVHRD K  N+LL  +   KI+DFGL+ +M +G     +    G+  Y  PE  S G
Sbjct: 124 ---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVIS-G 176
Query: 245 KLTL--QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           KL    + DV++ GV+L  +L  R   D      D+++ +  ++I N    L K + P
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRRLPFD------DESIPVLFKNISNGVYTLPKFLSP 228

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 27/238 (11%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           LG+G FG+V   Y  T  +G+ VA+K +      ++D +     E+  L  L HP+++ L
Sbjct: 21  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 126 IGYCADGKHRFLVYEYMQKGN-LQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
                      +V EY   GN L D++  +   KM                 Y H     
Sbjct: 79  YDVIKSKDEIIMVIEY--AGNELFDYI--VQRDKMSEQEARRFFQQIISAVEYCHRHK-- 132
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
              IVHRD K  N+LL  +   KI+DFGL+ +M +G     +    G+  Y  PE  S G
Sbjct: 133 ---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVIS-G 185
Query: 245 KLTL--QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           KL    + DV++ GV+L  +L  R   D      D+++ +  ++I N    L K + P
Sbjct: 186 KLYAGPEVDVWSCGVILYVMLCRRLPFD------DESIPVLFKNISNGVYTLPKFLSP 237

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 59  ATCSFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
           AT  +     +G G +G VYK     SG  VA+K + +P  +E       R EV +L RL
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRL 60
Query: 118 D---HPNLVSLIGYCADGK-----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           +   HPN+V L+  CA  +        LV+E++ + +L+ +L+    P +          
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA-- 227
                  +LH++      IVHRD K  N+L+++    K++DFGLA++      +Y  A  
Sbjct: 120 QFLRGLDFLHANC-----IVHRDLKPENILVTSGGTVKLADFGLARIY-----SYQMALD 169
Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELL 263
            V+ T  Y  PE           D+++ G +  E+ 
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           +G+G  G VY    + +G+ VAI++M L    +   + E  + E+ ++    +PN+V+ +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                G   ++V EY+  G+L D    + E  MD                +LHS+     
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSNQ---- 137
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            ++HR+ KS N+LL  +   K++DFG  A++ PE  +    + ++GT  +  PE  +   
Sbjct: 138 -VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA 193
Query: 246 LTLQSDVYAFGVVLLELLTG 265
              + D+++ G++ +E++ G
Sbjct: 194 YGPKVDIWSLGIMAIEMIEG 213

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 56  MEEATCSFSD----DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVE 110
           ++ +T  FSD       LGKG FG V     + +G+  A+K +   + K+   +     E
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 82
Query: 111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXX 170
           V +L +LDHPN++ L  +  D  + +LV E    G L D +  I   +            
Sbjct: 83  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQ 140
Query: 171 XXXXXXYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTA 227
                 Y+H +      IVHRD K  N+LL   S +   +I DFGL+      ++     
Sbjct: 141 VLSGITYMHKNK-----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MK 192
Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
             +GT  Y  PE    G    + DV++ GV+L  LL+G
Sbjct: 193 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F D   LG+GGFG V+   ++ +G++ A KK+   R K+  G     VE  IL+++ H  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSR 245
Query: 122 LVSLIGYCADGKHRF-LVYEYMQKGNLQDHLNGIGE--PKMDWPXXXXXXXXXXXXXXYL 178
            +  + Y  + K    LV   M  G+++ H+  + E  P    P              +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           H  +     I++RD K  NVLL  +   +ISD GLA  +  GQ    T    GT G+  P
Sbjct: 306 HQRN-----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAP 358
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           E     +     D +A GV L E++  R
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +GR  K   +S G+++  K+++     EA+ +     EV++L  L HPN+V    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHPNIVRYYD 72
Query: 128 YCADGKHR--FLVYEYMQKGNLQDHLN-GIGEPK-MDWPXXXXXXXXXXXXXXYLHSSSA 183
              D  +   ++V EY + G+L   +  G  E + +D                  H  S 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
            G  ++HRD K  NV L      K+ DFGLA+++   ++       +GT  Y  PE  + 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYYMSPEQMNR 190
Query: 244 GKLTLQSDVYAFGVVLLEL 262
                +SD+++ G +L EL
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F D   LG+GGFG V+   ++ +G++ A KK+   R K+  G     VE  IL+++ H  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSR 245
Query: 122 LVSLIGYCADGKHRF-LVYEYMQKGNLQDHLNGIGE--PKMDWPXXXXXXXXXXXXXXYL 178
            +  + Y  + K    LV   M  G+++ H+  + E  P    P              +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           H  +     I++RD K  NVLL  +   +ISD GLA  +  GQ    T    GT G+  P
Sbjct: 306 HQRN-----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAP 358
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           E     +     D +A GV L E++  R
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 111/274 (40%), Gaps = 34/274 (12%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           FSD   +G G FG VY    +R+ EVVAIKKM     +  +   +   EV  L +L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            +   G        +LV EY   G+  D L    +P  +                YLHS 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE-VEIAAVTHGALQGLAYLHSH 134
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
           +     ++HRD K+ N+LLS     K+ DFG A +M            +GT  +  PE  
Sbjct: 135 N-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVI 183
Query: 242 ---STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
                G+   + DV++ G+  +EL       +    + + N +  + HI  +        
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQNES------ 231
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPS 332
            P L    ++      F N    C++    +RP+
Sbjct: 232 -PALQSGHWS----EYFRNFVDSCLQKIPQDRPT 260

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F D   LG+GGFG V+   ++ +G++ A KK+   R K+  G     VE  IL+++ H  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSR 245
Query: 122 LVSLIGYCADGKHRF-LVYEYMQKGNLQDHLNGIGE--PKMDWPXXXXXXXXXXXXXXYL 178
            +  + Y  + K    LV   M  G+++ H+  + E  P    P              +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           H  +     I++RD K  NVLL  +   +ISD GLA  +  GQ    T    GT G+  P
Sbjct: 306 HQRN-----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAP 358
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           E     +     D +A GV L E++  R
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 59  ATCSFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
           AT  +     +G G +G VYK     SG  VA+K + +P  +E       R EV +L RL
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRL 60
Query: 118 D---HPNLVSLIGYCADGK-----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           +   HPN+V L+  CA  +        LV+E++ + +L+ +L+    P +          
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
                  +LH++      IVHRD K  N+L+++    K++DFGLA++       +    V
Sbjct: 120 QFLRGLDFLHANC-----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALF---PV 171
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELL 263
           + T  Y  PE           D+++ G +  E+ 
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F D   LG+GGFG V+   ++ +G++ A KK+   R K+  G     VE  IL+++ H  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSR 245
Query: 122 LVSLIGYCADGKHRF-LVYEYMQKGNLQDHLNGIGE--PKMDWPXXXXXXXXXXXXXXYL 178
            +  + Y  + K    LV   M  G+++ H+  + E  P    P              +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           H  +     I++RD K  NVLL  +   +ISD GLA  +  GQ    T    GT G+  P
Sbjct: 306 HQRN-----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAP 358
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           E     +     D +A GV L E++  R
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 68  FLGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + ++     + EV A K +      +     +  +E+ I   L H ++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 127 GYCADGKHRFLVYEYMQKGNL---QDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           G+  D    F+V E  ++ +L         + EP+  +               YLH +  
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-----YLRQIVLGCQYLHRNR- 159
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTS 242
               ++HRD K  N+ L+ + E KI DFGLA K+  +G+   V   + GT  Y  PE  S
Sbjct: 160 ----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLS 212
Query: 243 TGKLTLQSDVYAFGVVLLELLTGR 266
               + + DV++ G ++  LL G+
Sbjct: 213 KKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 111/274 (40%), Gaps = 34/274 (12%)
Query: 63  FSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           FSD   +G G FG VY    +R+ EVVAIKKM     +  +   +   EV  L +L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            +   G        +LV EY   G+  D L    +P  +                YLHS 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE-VEIAAVTHGALQGLAYLHSH 173
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
           +     ++HRD K+ N+LLS     K+ DFG A +M            +GT  +  PE  
Sbjct: 174 N-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVI 222
Query: 242 ---STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
                G+   + DV++ G+  +EL       +    + + N +  + HI  +        
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQNES------ 270
Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPS 332
            P L    ++      F N    C++    +RP+
Sbjct: 271 -PALQSGHWS----EYFRNFVDSCLQKIPQDRPT 299

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 68  FLGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + ++     + EV A K +      +     +  +E+ I   L H ++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 127 GYCADGKHRFLVYEYMQKGNL---QDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           G+  D    F+V E  ++ +L         + EP+  +               YLH +  
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-----YLRQIVLGCQYLHRNR- 161
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTS 242
               ++HRD K  N+ L+ + E KI DFGLA K+  +G+   V   + GT  Y  PE  S
Sbjct: 162 ----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLS 214
Query: 243 TGKLTLQSDVYAFGVVLLELLTGR 266
               + + DV++ G ++  LL G+
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 44  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 99
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 100 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 153
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 154 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 213
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 214 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 68  FLGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + ++     + EV A K +      +     +  +E+ I   L H ++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 127 GYCADGKHRFLVYEYMQKGNL---QDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           G+  D    F+V E  ++ +L         + EP+  +               YLH +  
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-----YLRQIVLGCQYLHRNR- 135
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTS 242
               ++HRD K  N+ L+ + E KI DFGLA K+  +G+   V   + GT  Y  PE  S
Sbjct: 136 ----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLS 188
Query: 243 TGKLTLQSDVYAFGVVLLELLTGR 266
               + + DV++ G ++  LL G+
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 17  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 72
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 73  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL------RE 126
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 127 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 27/238 (11%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           LG+G FG+V   Y  T  +G+ VA+K +      ++D +     E+  L  L HP+++ L
Sbjct: 16  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 126 IGYCADGKHRFLVYEYMQKGN-LQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
                      +V EY   GN L D++  +   KM                 Y H     
Sbjct: 74  YDVIKSKDEIIMVIEY--AGNELFDYI--VQRDKMSEQEARRFFQQIISAVEYCHRHK-- 127
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
              IVHRD K  N+LL  +   KI+DFGL+ +M +G     +    G+  Y  PE  S G
Sbjct: 128 ---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVIS-G 180
Query: 245 KLTL--QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           KL    + DV++ GV+L  +L  R   D      D+++ +  ++I N    L K + P
Sbjct: 181 KLYAGPEVDVWSCGVILYVMLCRRLPFD------DESIPVLFKNISNGVYTLPKFLSP 232

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 56  MEEATCSFSD----DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVE 110
           ++ +T  FSD       LGKG FG V     + +G+  A+K +   + K+   +     E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXX 170
           V +L +LDHPN++ L  +  D  + +LV E    G L D +  I   +            
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQ 134
Query: 171 XXXXXXYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTA 227
                 Y+H +      IVHRD K  N+LL   S +   +I DFGL+      ++     
Sbjct: 135 VLSGITYMHKN-----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MK 186
Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
             +GT  Y  PE    G    + DV++ GV+L  LL+G
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 70  GKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR--LDHPNLVSLIG 127
            +G FG V+K  L + + VA+K   L        +  ++ E +I S   + H NL+  I 
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPL------QDKQSWQSEREIFSTPGMKHENLLQFIA 76
Query: 128 YCADGKHR----FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
               G +     +L+  +  KG+L D+L G     + W               YLH    
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYLKG---NIITWNELCHVAETMSRGLSYLHED-- 131
Query: 184 VGIP----------IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
             +P          I HRDFKS NVLL ++  A ++DFGLA     G+    T   +GT 
Sbjct: 132 --VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 234 GYFDPEYTSTGKLTLQS------DVYAFGVVLLELLTGRRAVD 270
            Y  PE    G +  Q       D+YA G+VL EL++  +A D
Sbjct: 190 RYMAPEVLE-GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 17  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 72
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 73  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 126
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 127 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 9   KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 64
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 65  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 118
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 119 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 178
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 179 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 34  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 89
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 90  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 143
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 144 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 203
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 204 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 18  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 73
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 74  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 127
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 128 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 187
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 188 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 24  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 79
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 80  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 133
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 134 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 193
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 194 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 32  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 87
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 88  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL------RE 141
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 142 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 13  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 66
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNW-- 123
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 124 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 175 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 22  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 75
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 76  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 132
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 133 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 183
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 184 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 29/206 (14%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG+VYK   + +G + A K +E    +E +   ++ VE++IL+  DHP +V L+G
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE---DYIVEIEILATCDHPYIVKLLG 83
Query: 128 -YCADGKHRFLVYEYMQKGNLQDHL----NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
            Y  DGK  +++ E+   G +   +     G+ EP++                 +LHS  
Sbjct: 84  AYYHDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VVCRQMLEALNFLHSKR 137
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYT 241
                I+HRD K+ NVL++   + +++DFG+ AK +   Q+       +GT  +  PE  
Sbjct: 138 -----IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPYWMAPEVV 189
Query: 242 STGKLT-----LQSDVYAFGVVLLEL 262
               +       ++D+++ G+ L+E+
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 13  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 66
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW-- 123
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 124 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 175 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 12  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 65
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 122
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 123 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 29/206 (14%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG+VYK   + +G + A K +E    +E +   ++ VE++IL+  DHP +V L+G
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE---DYIVEIEILATCDHPYIVKLLG 75
Query: 128 -YCADGKHRFLVYEYMQKGNLQDHL----NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
            Y  DGK  +++ E+   G +   +     G+ EP++                 +LHS  
Sbjct: 76  AYYHDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VVCRQMLEALNFLHSKR 129
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTARVLGTFGYFDPEYT 241
                I+HRD K+ NVL++   + +++DFG+ AK +   Q+       +GT  +  PE  
Sbjct: 130 -----IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPYWMAPEVV 181
Query: 242 STGKLT-----LQSDVYAFGVVLLEL 262
               +       ++D+++ G+ L+E+
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 56  MEEATCSFSD----DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVE 110
           ++ +T  FSD       LGKG FG V     + +G+  A+K +   + K+   +     E
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 99
Query: 111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXX 170
           V +L +LDHPN++ L  +  D  + +LV E    G L D +  I   +            
Sbjct: 100 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQ 157
Query: 171 XXXXXXYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTA 227
                 Y+H +      IVHRD K  N+LL   S +   +I DFGL+      ++     
Sbjct: 158 VLSGITYMHKN-----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MK 209
Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
             +GT  Y  PE    G    + DV++ GV+L  LL+G
Sbjct: 210 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 12  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 65
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW-- 122
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 123 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 32  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVY 87
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 88  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 141
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 142 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G+G +G VYK     GE  A+KK+ L +  E       R E+ IL  L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               K   LV+E++ + +L+  L+ + E  ++                Y H        +
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR-----V 121
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-YTSTGKLT 247
           +HRD K  N+L++   E KI+DFGLA+        Y    V  T  Y  P+    + K +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYS 179
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL 288
              D+++ G +  E++ G     L  GV++ + ++++  IL
Sbjct: 180 TTIDIWSVGCIFAEMVNG---TPLFPGVSEADQLMRIFRIL 217

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 18  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 73
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 74  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 127
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 128 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 187
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 188 FGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 94
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N+++L+G C      +++ EY  KGNL+++L     P M++            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   KI+DFGLA+ +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 12  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 65
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNW-- 122
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 123 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 15  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 68
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW-- 125
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 126 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 177 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 42/225 (18%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 94
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------------NGIGEPKM 159
                H N+++L+G C      +++ EY  KGNL+++L              N + E +M
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE 219
            +               YL S        +HRD  + NVL++ N   KI+DFGLA+ +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                 T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G+G +G VYK     GE  A+KK+ L +  E       R E+ IL  L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               K   LV+E++ + +L+  L+ + E  ++                Y H        +
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR-----V 121
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-YTSTGKLT 247
           +HRD K  N+L++   E KI+DFGLA+        Y    V  T  Y  P+    + K +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYS 179
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL 288
              D+++ G +  E++ G     L  GV++ + ++++  IL
Sbjct: 180 TTIDIWSVGCIFAEMVNG---APLFPGVSEADQLMRIFRIL 217

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 56  MEEATCSFSD----DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVE 110
           ++ +T  FSD       LGKG FG V     + +G+  A+K +   + K+   +     E
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 100
Query: 111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXX 170
           V +L +LDHPN++ L  +  D  + +LV E    G L D +  I   +            
Sbjct: 101 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQ 158
Query: 171 XXXXXXYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTA 227
                 Y+H +      IVHRD K  N+LL   S +   +I DFGL+      ++     
Sbjct: 159 VLSGITYMHKN-----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MK 210
Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
             +GT  Y  PE    G    + DV++ GV+L  LL+G
Sbjct: 211 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 14  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 67
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW-- 124
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 125 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 176 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G+G +G VYK     GE  A+KK+ L +  E       R E+ IL  L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPI 188
               K   LV+E++ + +L+  L+ + E  ++                Y H        +
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR-----V 121
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-YTSTGKLT 247
           +HRD K  N+L++   E KI+DFGLA+        Y    V  T  Y  P+    + K +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKKYS 179
Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL 288
              D+++ G +  E++ G     L  GV++ + ++++  IL
Sbjct: 180 TTIDIWSVGCIFAEMVNG---TPLFPGVSEADQLMRIFRIL 217

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F +V     + +G+ VA+K ++  +   +  +  FR EV I   L+HPN+V L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLFE 80
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                K  +LV EY   G + D+L   G  K                  Y H        
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK--EARAKFRQIVSAVQYCHQKF----- 133
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K+ N+LL A+   KI+DFG +     G +        G   Y  PE     K  
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYD 190
Query: 248 -LQSDVYAFGVVLLELLTGRRAVD 270
             + DV++ GV+L  L++G    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 16  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 69
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIGEPKM-DWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG   + +W  
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW-- 126
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 127 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 177
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 178 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 12  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 65
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 122
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 123 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 68  FLGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + ++     + EV A K +      +     +  +E+ I   L H ++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 127 GYCADGKHRFLVYEYMQKGNL---QDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           G+  D    F+V E  ++ +L         + EP+  +               YLH +  
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-----YLRQIVLGCQYLHRNR- 137
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               ++HRD K  N+ L+ + E KI DFGLA  +    E   T  + GT  Y  PE  S 
Sbjct: 138 ----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSK 191
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
              + + DV++ G ++  LL G+
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 15  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 68
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 125
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 126 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 177 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 68  FLGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + ++     + EV A K +      +     +  +E+ I   L H ++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 127 GYCADGKHRFLVYEYMQKGNL---QDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           G+  D    F+V E  ++ +L         + EP+  +               YLH +  
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-----YLRQIVLGCQYLHRNR- 141
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               ++HRD K  N+ L+ + E KI DFGLA  +    E   T  + GT  Y  PE  S 
Sbjct: 142 ----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSK 195
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
              + + DV++ G ++  LL G+
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 14  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 67
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 124
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 125 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 176 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 15  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 68
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 125
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 126 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 177 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 68  FLGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + ++     + EV A K +      +     +  +E+ I   L H ++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 127 GYCADGKHRFLVYEYMQKGNL---QDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           G+  D    F+V E  ++ +L         + EP+  +               YLH +  
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-----YLRQIVLGCQYLHRNR- 137
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               ++HRD K  N+ L+ + E KI DFGLA  +    E   T  + GT  Y  PE  S 
Sbjct: 138 ----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSK 191
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
              + + DV++ G ++  LL G+
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 15  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 68
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 125
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 126 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 177 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 91/220 (41%), Gaps = 32/220 (14%)
Query: 70  GKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYC 129
            +G FG V+K  L + E VA+K   +   +    E+E    V  L  + H N++  IG  
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYE----VYSLPGMKHENILQFIGAE 87
Query: 130 ADGKH----RFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
             G       +L+  + +KG+L D L       + W               YLH      
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHED---- 140
Query: 186 IP---------IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           IP         I HRD KS NVLL  N  A I+DFGLA     G+    T   +GT  Y 
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 237 DPEYTSTGKLTLQS------DVYAFGVVLLELLTGRRAVD 270
            PE    G +  Q       D+YA G+VL EL +   A D
Sbjct: 201 APEVLE-GAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 35  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 90
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 91  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 144
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 145 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 204
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 205 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 6   LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 59
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 116
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 117 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 19  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 72
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 129
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 130 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 181 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFK 99
           + SS+  LKE+     +      LG G FG VY+G +       S   VA+K   LP   
Sbjct: 58  KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC 113
Query: 100 EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM 159
               E +F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      + 
Sbjct: 114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL------RE 167
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIP------IVHRDFKSTNVLLSANFE---AKISD 210
             P              ++    A G         +HRD  + N LL+       AKI D
Sbjct: 168 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227
Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           FG+A+ +            +    +  PE    G  T ++D ++FGV+L E+ +
Sbjct: 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 18  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 71
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 72  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 128
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 129 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 179
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 180 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 9   LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 62
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 63  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 119
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 120 ----CVQIAEGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 170
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 171 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 37  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 90
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 91  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 147
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 148 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 198
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 199 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 94
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N+++L+G C      +++ EY  KGNL+++L     P M++            
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   KI+DFGLA+ +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 131/301 (43%), Gaps = 36/301 (11%)
Query: 42  QKRHRGSSVFTLKEMEEATCSFSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELP 96
           Q+R R  +  T K+         DD+F     LG G  G V+K + +   +V  +K+   
Sbjct: 4   QQRKRLEAFLTQKQ---KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 60
Query: 97  RFKEADGEHEFRVEVDILSRLDHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIG 155
             K A      R E+ +L   + P +V   G + +DG+   +  E+M  G+L   L   G
Sbjct: 61  EIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAG 118
Query: 156 EPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA- 214
             ++                 YL         I+HRD K +N+L+++  E K+ DFG++ 
Sbjct: 119 --RIPEQILGKVSIAVIKGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSG 172
Query: 215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG 274
           +L+     ++V     GT  Y  PE       ++QSD+++ G+ L+E+  GR  +    G
Sbjct: 173 QLIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI--GSG 225
Query: 275 VNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMA 334
                +   + +I+N+         P+L    +++E    F +  ++C+    +ER  + 
Sbjct: 226 SGSMAIFELLDYIVNEPP-------PKLPSGVFSLE----FQDFVNKCLIKNPAERADLK 274
Query: 335 E 335
           +
Sbjct: 275 Q 275

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 35/234 (14%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV----EVDILSRLDHPNLV 123
           +G+G +G V+K   R +G++VAIKK     F E++ +   +     E+ +L +L HPNLV
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKK-----FLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQD---HLNGIGE---PKMDWPXXXXXXXXXXXXXXY 177
           +L+      +   LV+EY     L +   +  G+ E     + W               +
Sbjct: 66  NLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW--------QTLQAVNF 117
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
            H  +      +HRD K  N+L++ +   K+ DFG A+L+  G   Y    V  T  Y  
Sbjct: 118 CHKHNC-----IHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEV-ATRWYRS 170
Query: 238 PE-YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
           PE      +     DV+A G V  ELL+G   V L  G +D + +  +R  L D
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSG---VPLWPGKSDVDQLYLIRKTLGD 221

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 66  DNFLGKGGFGRVYKGTLR-SGE---VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +  +G G FG V  G L+  G+    VAIK ++   + E     +F  E  I+ + DHPN
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQ-RRDFLSEASIMGQFDHPN 69
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
           ++ L G         ++ E+M+ G+L   L    + +                  YL   
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYL--- 125
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG---TFGYFDP 238
               +  VHR   + N+L+++N   K+SDFGL++ + +          LG      +  P
Sbjct: 126 --ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT 264
           E     K T  SDV+++G+V+ E+++
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 60  TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD 118
           +  F   + LG+G +G V   T + +GE+VAIKK+E P  K        R E+ IL    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLR-EIKILKHFK 67
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM-DWPXXXXXXXXXXXXXXY 177
           H N++++               Y+ +  +Q  L+ +   +M                   
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM---------PEGQETYVTAR 228
           LH S+     ++HRD K +N+L+++N + K+ DFGLA+++         P GQ++ +T  
Sbjct: 128 LHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEX 182
Query: 229 VLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGR 266
           V  T  Y  PE   ++ K +   DV++ G +L EL   R
Sbjct: 183 V-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEEDLS---DLVSEMEMM 94
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N+++L+G C      +++ EY  KGNL+++L     P M++            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   KI+DFGLA+ +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 130/310 (41%), Gaps = 43/310 (13%)
Query: 69  LGKGGFGRVYKGT---LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------- 118
           LG+G FG+V       L   +   + K+ +   K    E +     D++S ++       
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 92
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           H N+++L+G C      +++ EY  KGNL+++L     P +++                L
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 179 HSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
            S +   A G+        +HRD  + NVL++ +   KI+DFGLA+ +        T   
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN 289
                +  PE       T QSDV++FGV+L E+ T      L         V ++  +L 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLLK 266
Query: 290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +  ++ K        S+ T E   M  +    C     S+RP+  + V++L  I+   S 
Sbjct: 267 EGHRMDK-------PSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLDRIVALTSN 315
Query: 350 ----GLNMPL 355
                L+MPL
Sbjct: 316 QEXLDLSMPL 325

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 140
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N+++L+G C      +++ EY  KGNL+++L     P M++            
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   KI+DFGLA+ +       
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 60  TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD 118
           +  F   + LG+G +G V   T + +GE+VAIKK+E P  K        R E+ IL    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLR-EIKILKHFK 67
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM-DWPXXXXXXXXXXXXXXY 177
           H N++++               Y+ +  +Q  L+ +   +M                   
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM---------PEGQETYVTAR 228
           LH S+     ++HRD K +N+L+++N + K+ DFGLA+++         P GQ++ +T  
Sbjct: 128 LHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 229 VLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGR 266
           V  T  Y  PE   ++ K +   DV++ G +L EL   R
Sbjct: 183 V-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHE-----FRVEVDILSR 116
           +   + +G+G    V +   R +G   A+K ME+   + +  + E      R E  IL +
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 117 L-DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXX 175
           +  HP++++LI         FLV++ M+KG L D+L    +  +                
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAV 213
Query: 176 XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            +LH+++     IVHRD K  N+LL  N + ++SDFG +  +  G++      + GT GY
Sbjct: 214 SFLHANN-----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGY 265
Query: 236 FDPE---------YTSTGKLTLQSDVYAFGVVLLELLTG 265
             PE         +   GK   + D++A GV+L  LL G
Sbjct: 266 LAPEILKCSMDETHPGYGK---EVDLWACGVILFTLLAG 301

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 19/218 (8%)
Query: 56  MEEATCSFSD----DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVE 110
           ++ +T  FSD       LGKG FG V     + +G+  A+K +   + K+   +     E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXX 170
           V +L +LDHPN+  L  +  D  + +LV E    G L D +  I   +            
Sbjct: 77  VQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQ 134
Query: 171 XXXXXXYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTA 227
                 Y H +      IVHRD K  N+LL   S +   +I DFGL+      ++     
Sbjct: 135 VLSGITYXHKN-----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---XK 186
Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
             +GT  Y  PE    G    + DV++ GV+L  LL+G
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 94
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N+++L+G C      +++ EY  KGNL+++L     P M++            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   KI+DFGLA+ +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 26/263 (9%)
Query: 86  EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKG 145
           E VAIK++ L + + +    E   E+  +S+  HPN+VS           +LV + +  G
Sbjct: 36  EKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 93
Query: 146 NLQD---HLNGIGEPK---MDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVL 199
           ++ D   H+   GE K   +D                YLH +  +     HRD K+ N+L
Sbjct: 94  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI-----HRDVKAGNIL 148
Query: 200 LSANFEAKISDFGLAKLMPEGQETY---VTARVLGTFGYFDPEYTSTGK-LTLQSDVYAF 255
           L  +   +I+DFG++  +  G +     V    +GT  +  PE     +    ++D+++F
Sbjct: 149 LGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 208
Query: 256 GVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMF 315
           G+  +EL TG         +    L LQ     ND   L   +  +     Y       F
Sbjct: 209 GITAIELATGAAPYHKYPPMKVLMLTLQ-----NDPPSLETGVQDKEMLKKYGKS----F 259
Query: 316 ANLASRCVRTESSERPSMAECVK 338
             + S C++ +  +RP+ AE ++
Sbjct: 260 RKMISLCLQKDPEKRPTAAELLR 282

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 42/225 (18%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 81
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------------NGIGEPKM 159
                H N+++L+G C      +++ EY  KGNL+++L              N + E +M
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 160 DWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE 219
            +               YL S        +HRD  + NVL++ N   KI+DFGLA+ +  
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKC-----IHRDLTARNVLVTENNVMKIADFGLARDINN 196
Query: 220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                 T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 197 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 67  NFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           + LG G F  V      R+ ++VAIK +     +  +G  E   E+ +L ++ HPN+V+L
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAVLHKIKHPNIVAL 81
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIG-EPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
                 G H +L+ + +  G L D +   G   + D                YLH     
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRLIFQVLDAVKYLHD---- 134
Query: 185 GIPIVHRDFKSTNVL---LSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
            + IVHRD K  N+L   L  + +  ISDFGL+K+   G    V +   GT GY  PE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVL 190
Query: 242 STGKLTLQSDVYAFGVVLLELLTG 265
           +    +   D ++ GV+   LL G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 83
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N+++L+G C      +++ EY  KGNL+++L     P M++            
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   KI+DFGLA+ +       
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 203
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 204 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 94
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N++ L+G C      +++ EY  KGNL+++L     P M++            
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   KI+DFGLA+ +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 26/263 (9%)
Query: 86  EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKG 145
           E VAIK++ L + + +    E   E+  +S+  HPN+VS           +LV + +  G
Sbjct: 41  EKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98
Query: 146 NLQD---HLNGIGEPK---MDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVL 199
           ++ D   H+   GE K   +D                YLH +  +     HRD K+ N+L
Sbjct: 99  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI-----HRDVKAGNIL 153
Query: 200 LSANFEAKISDFGLAKLMPEGQETY---VTARVLGTFGYFDPEYTSTGK-LTLQSDVYAF 255
           L  +   +I+DFG++  +  G +     V    +GT  +  PE     +    ++D+++F
Sbjct: 154 LGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213
Query: 256 GVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMF 315
           G+  +EL TG         +    L LQ     ND   L   +  +     Y       F
Sbjct: 214 GITAIELATGAAPYHKYPPMKVLMLTLQ-----NDPPSLETGVQDKEMLKKYGKS----F 264
Query: 316 ANLASRCVRTESSERPSMAECVK 338
             + S C++ +  +RP+ AE ++
Sbjct: 265 RKMISLCLQKDPEKRPTAAELLR 287

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 86
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N+++L+G C      +++ EY  KGNL+++L     P M++            
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   KI+DFGLA+ +       
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 206
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 207 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 16  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 69
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW-- 126
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFG AKL+   ++ 
Sbjct: 127 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 177
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 178 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 63  FSDDNFL---GKGGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILS 115
            +D NFL   GKG FG+V     KGT    E+ A+K ++     + D      VE  +L+
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 116 RLDHPNLVSLIGYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXX 174
               P  ++ +  C     R + V EY+  G+L  H+  +G  +   P            
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIG 454
Query: 175 XXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
             +L S       I++RD K  NV+L +    KI+DFG+ K      +   T    GT  
Sbjct: 455 LFFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPD 507
Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           Y  PE  +        D +AFGV+L E+L G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA-DGEHEFRV-EVDILSRLDHPNLV 123
           +FLG+G F  VYK   + + ++VAIKK++L    EA DG +   + E+ +L  L HPN++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 124 SLIGYCADGKHRFLVYEYMQKG---NLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
            L+       +  LV+++M+      ++D+ + +  P                   YLH 
Sbjct: 76  GLLDAFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPS----HIKAYMLMTLQGLEYLHQ 130
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
                  I+HRD K  N+LL  N   K++DFGLAK        Y    V  T  Y  PE 
Sbjct: 131 HW-----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPEL 183
Query: 241 TSTGKL-TLQSDVYAFGVVLLELL 263
               ++  +  D++A G +L ELL
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELL 207

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 94
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N+++L+G C      +++ EY  KGNL+++L     P M++            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   +I+DFGLA+ +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYK 214
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     L  G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 19  LKETE-----FKKIKVLSSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 72
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW-- 129
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 130 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 181 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 122/280 (43%), Gaps = 27/280 (9%)
Query: 63  FSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
             DD+F     LG G  G V+K + +   +V  +K+     K A      R E+ +L   
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHEC 61
Query: 118 DHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           + P +V   G + +DG+   +  E+M  G+L   L   G  ++                 
Sbjct: 62  NSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 118
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGY 235
           YL         I+HRD K +N+L+++  E K+ DFG++ +L+     ++V     GT  Y
Sbjct: 119 YLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSY 169
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR 295
             PE       ++QSD+++ G+ L+E+  GR  +       D    + +  +L+    + 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLD---YIV 226
Query: 296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
               P+L    +++E    F +  ++C+    +ER  + +
Sbjct: 227 NEPPPKLPSGVFSLE----FQDFVNKCLIKNPAERADLKQ 262

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 67  NFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           + LG G F  V      R+ ++VAIK +     +  +G  E   E+ +L ++ HPN+V+L
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAVLHKIKHPNIVAL 81
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIG-EPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
                 G H +L+ + +  G L D +   G   + D                YLH     
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRLIFQVLDAVKYLHD---- 134
Query: 185 GIPIVHRDFKSTNVL---LSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
            + IVHRD K  N+L   L  + +  ISDFGL+K+   G    V +   GT GY  PE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVL 190
Query: 242 STGKLTLQSDVYAFGVVLLELLTG 265
           +    +   D ++ GV+   LL G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 14  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 67
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW-- 124
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFG AKL+   ++ 
Sbjct: 125 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 176 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 109/244 (44%), Gaps = 23/244 (9%)
Query: 33  KLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNF-----LGKGGFGRVYKGTLRSGEV 87
           KLE+     Q+R R  +  T K+         DD+F     LG G  G V+K + +   +
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQ---KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGL 59
Query: 88  VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG-YCADGKHRFLVYEYMQKGN 146
           V  +K+     K A      R E+ +L   + P +V   G + +DG+   +  E+M  G+
Sbjct: 60  VMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEIS-ICMEHMDGGS 117
Query: 147 LQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA 206
           L   L   G  ++                 YL         I+HRD K +N+L+++  E 
Sbjct: 118 LDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK----IMHRDVKPSNILVNSRGEI 171
Query: 207 KISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           K+ DFG++ +L+     ++V     GT  Y  PE       ++QSD+++ G+ L+E+  G
Sbjct: 172 KLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
Query: 266 RRAV 269
           R  +
Sbjct: 227 RYPI 230

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 18/217 (8%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVD 112
           K+ E+    +   + LG G F  V      R+ ++VAIK +     +  +G  E   E+ 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME--NEIA 68
Query: 113 ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG-EPKMDWPXXXXXXXXX 171
           +L ++ HPN+V+L      G H +L+ + +  G L D +   G   + D           
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRLIFQV 125
Query: 172 XXXXXYLHSSSAVGIPIVHRDFKSTNVL---LSANFEAKISDFGLAKLMPEGQETYVTAR 228
                YLH      + IVHRD K  N+L   L  + +  ISDFGL+K+   G    V + 
Sbjct: 126 LDAVKYLHD-----LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLST 177
Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
             GT GY  PE  +    +   D ++ GV+   LL G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     L  G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 12  LKETE-----FKKIKVLSSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 65
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 122
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 123 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 64  SDDNFL---GKGGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR 116
           +D NFL   GKG FG+V     KGT    E+ A+K ++     + D      VE  +L+ 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 117 LDHPNLVSLIGYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXX 175
              P  ++ +  C     R + V EY+  G+L  H+  +G  +   P             
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGL 134
Query: 176 XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            +L S       I++RD K  NV+L +    KI+DFG+ K      +   T    GT  Y
Sbjct: 135 FFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDY 187
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
             PE  +        D +AFGV+L E+L G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 130/310 (41%), Gaps = 43/310 (13%)
Query: 69  LGKGGFGRVYKGT---LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------- 118
           LG+G FG+V       L   +   + K+ +   K    E +     D++S ++       
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 92
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           H N+++L+G C      +++ EY  KGNL+++L     P +++                L
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 179 HSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
            S +   A G+        +HRD  + NVL++ +   KI+DFGLA+ +        T   
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN 289
                +  PE       T QSDV++FGV+L E+ T      L         V ++  +L 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLLK 266
Query: 290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +  ++ K        S+ T E   M  +    C     S+RP+  + V++L  I+   S 
Sbjct: 267 EGHRMDK-------PSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLDRIVALTSN 315
Query: 350 ----GLNMPL 355
                L+MPL
Sbjct: 316 QEYLDLSMPL 325

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 59  ATCSFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV--EVDILS 115
           AT  +     +G G +G VYK     SG  VA+K + +P      G        EV +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 116 RLD---HPNLVSLIGYCADGK-----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXX 167
           RL+   HPN+V L+  CA  +        LV+E++ + +L+ +L+    P +        
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 168 XXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA 227
                    +LH++      IVHRD K  N+L+++    K++DFGLA++           
Sbjct: 126 MRQFLRGLDFLHANC-----IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177
Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELL 263
            V+ T  Y  PE           D+++ G +  E+ 
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 14  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 67
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIGEPKM-DWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG   + +W  
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW-- 124
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFG AKL+   ++ 
Sbjct: 125 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 176 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     L  G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 19  LKETE-----FKKIKVLSSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 72
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 129
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFGLAKL+   ++ 
Sbjct: 130 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 181 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 67  NFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           + LG G F  V      R+ ++VAIK +     +  +G  E   E+ +L ++ HPN+V+L
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAVLHKIKHPNIVAL 81
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIG-EPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
                 G H +L+ + +  G L D +   G   + D                YLH     
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD---ASRLIFQVLDAVKYLHD---- 134
Query: 185 GIPIVHRDFKSTNVL---LSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
            + IVHRD K  N+L   L  + +  ISDFGL+K+   G    V +   GT GY  PE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVL 190
Query: 242 STGKLTLQSDVYAFGVVLLELLTG 265
           +    +   D ++ GV+   LL G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 14  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 67
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIGEPKM-DWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG   + +W  
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 124
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFG AKL+   ++ 
Sbjct: 125 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 176 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 12  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 65
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 122
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFG AKL+   ++ 
Sbjct: 123 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 173
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 67  NFL--GKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           NF+  G+G  G V   T + +G+ VA+KKM+L   K+   E  F  EV I+    H N+V
Sbjct: 49  NFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL--RKQQRRELLFN-EVVIMRDYHHDNVV 105
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
            +      G   ++V E+++ G L D    +   +M+                YLH+   
Sbjct: 106 DMYSSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIATVCLSVLRALSYLHNQG- 161
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               ++HRD KS ++LL+++   K+SDFG    +   +E      ++GT  +  PE  S 
Sbjct: 162 ----VIHRDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKXLVGTPYWMAPEVISR 215
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
                + D+++ G++++E++ G
Sbjct: 216 LPYGTEVDIWSLGIMVIEMIDG 237

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA---DGEHEFR 108
           LKE E     F     LG G FG VYKG  +  GE V I  + +   +EA       E  
Sbjct: 19  LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEIL 72
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIG-EPKMDWPX 163
            E  +++ +D+P++  L+G C     + L+ + M  G L D    H + IG +  ++W  
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-- 129
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                        YL         +VHRD  + NVL+      KI+DFG AKL+   ++ 
Sbjct: 130 ----CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 180
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           Y          +   E       T QSDV+++GV + EL+T
Sbjct: 181 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+GGFG V++   +  +   AIK++ LP  +E   E   R EV  L++L+HP 
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMR-EVKALAKLEHPG 64
Query: 122 LVSLI-GYCADGKHRFL------VYEYMQ-----KGNLQDHLNG-IGEPKMDWPXXXXXX 168
           +V     +        L      VY Y+Q     K NL+D +NG     + +        
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE--TYVT 226
                   +LHS       ++HRD K +N+  + +   K+ DFGL   M + +E  T +T
Sbjct: 125 LQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 227 -----ARVLGTFG---YFDPEYTSTGKLTLQSDVYAFGVVLLELL 263
                AR  G  G   Y  PE       + + D+++ G++L ELL
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 17/219 (7%)
Query: 56  MEEATCSFSDDNF-----LGKGGFGRVYKGTLR--SGEVV--AIKKMELPRFKEADGEHE 106
           ++  TC   + +      LG G FG V +G     SG+ V  A+K ++     + +   +
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 107 FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXX 166
           F  EV+ +  LDH NL+ L G       + +V E    G+L D L    +          
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSR 125
Query: 167 XXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT 226
                     YL S        +HRD  + N+LL+     KI DFGL + +P+  + YV 
Sbjct: 126 YAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 227 ARVLGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                  F +  PE   T   +  SD + FGV L E+ T
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 85/201 (42%), Gaps = 12/201 (5%)
Query: 69  LGKGGFGRVYKGTLR--SGEVV--AIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FG V +G     SG+ V  A+K ++     + +   +F  EV+ +  LDH NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L G       + +V E    G+L D L    +                    YL S    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR-- 135
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT-FGYFDPEYTST 243
               +HRD  + N+LL+     KI DFGL + +P+  + YV        F +  PE   T
Sbjct: 136 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 244 GKLTLQSDVYAFGVVLLELLT 264
              +  SD + FGV L E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 69  LGKGGFGRVYKGT---LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------- 118
           LG+G FG+V       L   +   + K+ +   K    E +     D++S ++       
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 85
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           H N+++L+G C      +++ EY  KGNL+++L     P +++                L
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 179 HSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
            S +   A G+        +HRD  + NVL++ +   KI+DFGLA+ +        T   
Sbjct: 146 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                +  PE       T QSDV++FGV+L E+ T
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 69  LGKGGFGRVYKGT---LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------- 118
           LG+G FG+V       L   +   + K+ +   K    E +     D++S ++       
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 81
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           H N+++L+G C      +++ EY  KGNL+++L     P +++                L
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 179 HSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
            S +   A G+        +HRD  + NVL++ +   KI+DFGLA+ +        T   
Sbjct: 142 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                +  PE       T QSDV++FGV+L E+ T
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 85/201 (42%), Gaps = 12/201 (5%)
Query: 69  LGKGGFGRVYKGTLR--SGEVV--AIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FG V +G     SG+ V  A+K ++     + +   +F  EV+ +  LDH NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L G       + +V E    G+L D L    +                    YL S    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR-- 131
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT-FGYFDPEYTST 243
               +HRD  + N+LL+     KI DFGL + +P+  + YV        F +  PE   T
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 244 GKLTLQSDVYAFGVVLLELLT 264
              +  SD + FGV L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G V+K   R + E+VA+K++ L    E       R E+ +L  L H N+V L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 128 YCADGKHRFLVYEYMQKG--NLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
                K   LV+E+  +      D  NG  +P++                 + HS +   
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI----VKSFLFQLLKGLGFCHSRN--- 121
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
             ++HRD K  N+L++ N E K++DFGLA+        Y +A V+ T  Y  P+     K
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFGAK 177
Query: 246 LTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
           L   S D+++ G +  EL    R +     V+DQ
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQ 211

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 113/259 (43%), Gaps = 20/259 (7%)
Query: 69  LGKGGFGRVYKG--TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD---HPNLV 123
           +G+G +G+V+K       G  VA+K++ +   +E       R EV +L  L+   HPN+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77
Query: 124 SLIGYCA----DGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
            L   C     D + +  LV+E++ + +L  +L+ + EP +                 +L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HS       +VHRD K  N+L++++ + K++DFGLA++            V+ T  Y  P
Sbjct: 137 HSHR-----VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 188
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E           D+++ G +  E+   +     +  V+    +L V  +  +    R V 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 299 DPELSRSSYTMESIAMFAN 317
            P  +  S + + I  F  
Sbjct: 249 LPRQAFHSKSAQPIEKFVT 267

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 69  LGKGGFGRVYKGT---LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------- 118
           LG+G FG+V       L   +   + K+ +   K    E +     D++S ++       
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 92
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           H N+++L+G C      +++ EY  KGNL+++L     P +++                L
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 179 HSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
            S +   A G+        +HRD  + NVL++ +   KI+DFGLA+ +        T   
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                +  PE       T QSDV++FGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 85/201 (42%), Gaps = 12/201 (5%)
Query: 69  LGKGGFGRVYKGTLR--SGEVV--AIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FG V +G     SG+ V  A+K ++     + +   +F  EV+ +  LDH NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L G       + +V E    G+L D L    +                    YL S    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR-- 131
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT-FGYFDPEYTST 243
               +HRD  + N+LL+     KI DFGL + +P+  + YV        F +  PE   T
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 244 GKLTLQSDVYAFGVVLLELLT 264
              +  SD + FGV L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 69  LGKGGFGRVYKGT---LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------- 118
           LG+G FG+V       L   +   + K+ +   K    E +     D++S ++       
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 84
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           H N+++L+G C      +++ EY  KGNL+++L     P +++                L
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 179 HSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
            S +   A G+        +HRD  + NVL++ +   KI+DFGLA+ +        T   
Sbjct: 145 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                +  PE       T QSDV++FGV+L E+ T
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 69  LGKGGFGRVYKGT---LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------- 118
           LG+G FG+V       L   +   + K+ +   K    E +     D++S ++       
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 92
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           H N+++L+G C      +++ EY  KGNL+++L     P +++                L
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 179 HSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
            S +   A G+        +HRD  + NVL++ +   KI+DFGLA+ +        T   
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                +  PE       T QSDV++FGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 69  LGKGGFGRVYKGT---LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------- 118
           LG+G FG+V       L   +   + K+ +   K    E +     D++S ++       
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 77
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           H N+++L+G C      +++ EY  KGNL+++L     P +++                L
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 179 HSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
            S +   A G+        +HRD  + NVL++ +   KI+DFGLA+ +        T   
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                +  PE       T QSDV++FGV+L E+ T
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 113/259 (43%), Gaps = 20/259 (7%)
Query: 69  LGKGGFGRVYKG--TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD---HPNLV 123
           +G+G +G+V+K       G  VA+K++ +   +E       R EV +L  L+   HPN+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77
Query: 124 SLIGYCA----DGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
            L   C     D + +  LV+E++ + +L  +L+ + EP +                 +L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HS       +VHRD K  N+L++++ + K++DFGLA++            V+ T  Y  P
Sbjct: 137 HSHR-----VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 188
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E           D+++ G +  E+   +     +  V+    +L V  +  +    R V 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 299 DPELSRSSYTMESIAMFAN 317
            P  +  S + + I  F  
Sbjct: 249 LPRQAFHSKSAQPIEKFVT 267

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 113/259 (43%), Gaps = 20/259 (7%)
Query: 69  LGKGGFGRVYKG--TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD---HPNLV 123
           +G+G +G+V+K       G  VA+K++ +   +E       R EV +L  L+   HPN+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77
Query: 124 SLIGYCA----DGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
            L   C     D + +  LV+E++ + +L  +L+ + EP +                 +L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HS       +VHRD K  N+L++++ + K++DFGLA++            V+ T  Y  P
Sbjct: 137 HSHR-----VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 188
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E           D+++ G +  E+   +     +  V+    +L V  +  +    R V 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 299 DPELSRSSYTMESIAMFAN 317
            P  +  S + + I  F  
Sbjct: 249 LPRQAFHSKSAQPIEKFVT 267

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 85/201 (42%), Gaps = 12/201 (5%)
Query: 69  LGKGGFGRVYKGTLR--SGEVV--AIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FG V +G     SG+ V  A+K ++     + +   +F  EV+ +  LDH NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L G       + +V E    G+L D L    +                    YL S    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR-- 135
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT-FGYFDPEYTST 243
               +HRD  + N+LL+     KI DFGL + +P+  + YV        F +  PE   T
Sbjct: 136 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 244 GKLTLQSDVYAFGVVLLELLT 264
              +  SD + FGV L E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKME-LPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           LG G F  V+    R +G++ A+K ++  P F+++  E+E    + +L ++ H N+V+L 
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENE----IAVLKKIKHENIVTLE 72
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
                  H +LV + +  G L D +   G+   K                  YLH +   
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEK----DASLVIQQVLSAVKYLHENG-- 126
Query: 185 GIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
              IVHRD K  N+L      N +  I+DFGL+K+   G    + +   GT GY  PE  
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVL 179
Query: 242 STGKLTLQSDVYAFGVVLLELLTG 265
           +    +   D ++ GV+   LL G
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFR-VEVDILSRLDHPNLVSLIG 127
           +GKG +G V++G L  GE VA+K      F   D +  FR  E+     L H N++  I 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKI-----FSSRDEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 128 YCADGKHR----FLVYEYMQKGNLQDHLN-GIGEPKMDWPXXXXXXXXXXXXXXYLHSS- 181
                ++     +L+  Y + G+L D L     EP +                 +LH   
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL----ALRLAVSAACGLAHLHVEI 125
Query: 182 -SAVGIP-IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR--VLGTFGYFD 237
               G P I HRDFKS NVL+ +N +  I+D GLA +  +G +         +GT  Y  
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 238 PEY------TSTGKLTLQSDVYAFGVVLLELLTGRRAV 269
           PE       T   +    +D++AFG+VL E+   RR +
Sbjct: 186 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 94
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N+++L+G C      +++  Y  KGNL+++L     P M++            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   KI+DFGLA+ +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 60  TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD 118
           +  F   + LG+G +G V   T + +GE+VAIKK+E P  K        R E+ IL    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLR-EIKILKHFK 67
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKM-DWPXXXXXXXXXXXXXXY 177
           H N++++               Y+ +  +Q  L+ +   +M                   
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM---------PEGQETYVTAR 228
           LH S+     ++HRD K +N+L+++N + K+ DFGLA+++         P GQ++ +   
Sbjct: 128 LHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 229 VLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGR 266
           V  T  Y  PE   ++ K +   DV++ G +L EL   R
Sbjct: 183 V-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG+G FG+V+     SG    ++ A+K ++    K  D     ++E DIL  ++HP +V 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVK 90
Query: 125 L-IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           L   +  +GK  +L+ ++++ G+L   L+   E                    +LHS   
Sbjct: 91  LHYAFQTEGK-LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
             + I++RD K  N+LL      K++DFGL+K   + ++   +    GT  Y  PE  + 
Sbjct: 145 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNR 200
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
              T  +D ++FGV++ E+LTG
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTG 222

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 69  LGKGGFGRVYK----GTLRSGEVVAIKKMELPRF-KEADGEHEFRVEVDILSRLDHPNLV 123
           LGKGG+G+V++        +G++ A+K ++     + A      + E +IL  + HP +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
            LI     G   +L+ EY+  G L   L   G    D                +LH    
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED--TACFYLAEISMALGHLHQKG- 141
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               I++RD K  N++L+     K++DFGL K      +  VT    GT  Y  PE    
Sbjct: 142 ----IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPEILMR 195
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
                  D ++ G ++ ++LTG
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTG 217

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG+G FG+V+     SG    ++ A+K ++    K  D     ++E DIL  ++HP +V 
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVK 91
Query: 125 L-IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           L   +  +GK  +L+ ++++ G+L   L+   E                    +LHS   
Sbjct: 92  LHYAFQTEGK-LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHS--- 145
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
             + I++RD K  N+LL      K++DFGL+K   + ++   +    GT  Y  PE  + 
Sbjct: 146 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNR 201
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
              T  +D ++FGV++ E+LTG
Sbjct: 202 RGHTQSADWWSFGVLMFEMLTG 223

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 69  LGKGGFGRVYK----GTLRSGEVVAIKKMELPRF-KEADGEHEFRVEVDILSRLDHPNLV 123
           LGKGG+G+V++        +G++ A+K ++     + A      + E +IL  + HP +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
            LI     G   +L+ EY+  G L   L   G    D                +LH    
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED--TACFYLAEISMALGHLHQKG- 141
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               I++RD K  N++L+     K++DFGL K      +  VT    GT  Y  PE    
Sbjct: 142 ----IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILMR 195
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
                  D ++ G ++ ++LTG
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTG 217

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG +G V+ G  R GE VA+K       +EA    E  +   +L R  H N++  I  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTT--EEASWFRETEIYQTVLMR--HENILGFIAA 99
Query: 129 CADGK----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS--S 182
              G       +L+ +Y + G+L D+L       +D                +LH+   S
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 183 AVGIP-IVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARV-LGTFGYFDPE 239
             G P I HRD KS N+L+  N    I+D GLA K + +  E  +     +GT  Y  PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 240 YTSTG------KLTLQSDVYAFGVVLLELLTGRRAV 269
                      +  + +D+Y+FG++L E+   RR V
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCV 250

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 106
Query: 120 PNLVSL------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX- 172
            N+V L       G   D  +  LV +Y+ +  +          K   P           
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 173 -XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYVTAR 228
                Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R
Sbjct: 166 FRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 229 VLGT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                   FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 221 YYRAPELIFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 109/239 (45%), Gaps = 37/239 (15%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 85
Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXX-- 172
            N+V L   + + G+ +  VY  +    + + +  +       K   P            
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 173 XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYVTARV 229
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R 
Sbjct: 146 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 200
Query: 230 LGT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 201 YRAPELIFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 251

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 69  LGKGGFGRVY--------KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-- 118
           LG+G FG+V         K   +    VA+K +     K+   E +     D++S ++  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLS---DLVSEMEMM 94
Query: 119 -----HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
                H N+++L+G C      +++  Y  KGNL+++L     P M++            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 174 XXXYLHSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
               L S +   A G+        +HRD  + NVL++ N   KI+DFGLA+ +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            T        +  PE       T QSDV++FGV++ E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 108
Query: 120 PNLVSL------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX- 172
            N+V L       G   D  +  LV +Y+ +  +          K   P           
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 167
Query: 173 -XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYVTAR 228
                Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R
Sbjct: 168 FRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 222
Query: 229 VLGT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                   FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 223 YYRAPELIFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 274

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 122/296 (41%), Gaps = 37/296 (12%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLD 118
           F+    LGKG FG V +  L+  +     VA+K ++      +D E EF  E   +   D
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLREAACMKEFD 83
Query: 119 HPNLVSLIGYCADGKHR------FLVYEYMQKGNLQDHL--NGIGEPKMDWPXXXXX--X 168
           HP++  L+G     + +       ++  +M+ G+L   L  + IGE   + P        
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
                   YL S +      +HRD  + N +L+ +    ++DFGL++ +  G        
Sbjct: 144 VDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 229 VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL 288
                 +   E  +    T+ SDV+AFGV + E++T  R      G+ +     ++ + L
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT--RGQTPYAGIENA----EIYNYL 252
Query: 289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
               +L++   PE     Y         +L  +C   +  +RPS      EL+ I+
Sbjct: 253 IGGNRLKQ--PPECMEEVY---------DLMYQCWSADPKQRPSFTCLRMELENIL 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EYM  G++  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      K++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EYM  G++  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      K++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 110
Query: 120 PNLVSL------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX- 172
            N+V L       G   D  +  LV +Y+ +  +          K   P           
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 169
Query: 173 -XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYVTAR 228
                Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R
Sbjct: 170 FRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 224
Query: 229 VLGT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                   FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 225 YYRAPELIFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 276

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG+G FG+V+     SG    ++ A+K ++    K  D     ++E DIL  ++HP +V 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVK 90
Query: 125 L-IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           L   +  +GK  +L+ ++++ G+L   L+   E                    +LHS   
Sbjct: 91  LHYAFQTEGK-LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
             + I++RD K  N+LL      K++DFGL+K   + ++   +    GT  Y  PE  + 
Sbjct: 145 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNR 200
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
              T  +D ++FGV++ E+LTG
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTG 222

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 100
Query: 120 PNLVSL------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX- 172
            N+V L       G   D  +  LV +Y+ +  +          K   P           
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 159
Query: 173 -XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYVTAR 228
                Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R
Sbjct: 160 FRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 214
Query: 229 VLGT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                   FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 215 YYRAPELIFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 266

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 151
Query: 120 PNLVSL------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX- 172
            N+V L       G   D  +  LV +Y+ +  +          K   P           
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 210
Query: 173 -XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYVTAR 228
                Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R
Sbjct: 211 FRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 265
Query: 229 VLGT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                   FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 266 YYRAPELIFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 317

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 109/239 (45%), Gaps = 37/239 (15%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 72
Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXXX- 173
            N+V L   + + G+ +  VY  +    + + +  +       K   P            
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 174 -XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYVTARV 229
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R 
Sbjct: 133 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 230 LGT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 188 YRAPELIFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 77
Query: 120 PNLVSL------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
            N+V L       G   D  +  LV +Y+ +  +          K   P           
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 136
Query: 174 --XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYVTAR 228
                Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R
Sbjct: 137 FRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 191
Query: 229 VLGT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                   FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 192 YYRAPELIFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 243

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 96/231 (41%), Gaps = 36/231 (15%)
Query: 68  FLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE-FRVEVDILSRLDHPNLVSLI 126
            +G+G +G VYKG+L     VA+K       +    E   +RV +     ++H N+   I
Sbjct: 20  LIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKNIYRVPL-----MEHDNIARFI 73
Query: 127 ----GYCADGKHRFL-VYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                  ADG+  +L V EY   G+L  +L+       DW               YLH+ 
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 182 SAVG----IPIVHRDFKSTNVLLSANFEAKISDFGLA------KLMPEGQETYVTARVLG 231
              G      I HRD  S NVL+  +    ISDFGL+      +L+  G+E       +G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 232 TFGYFDPEYTSTGKLTL--------QSDVYAFGVVLLELLTGRRAVDLNQG 274
           T  Y  PE    G + L        Q D+YA G++  E+    R  DL  G
Sbjct: 191 TIRYMAPEVLE-GAVNLRDXESALKQVDMYALGLIYWEIFM--RCTDLFPG 238

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 69  LGKGGFGRVYKGT---LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD------- 118
           LG+G FG+V       L   +   + K+ +   K    E +     D++S ++       
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 133
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           H N+++L+G C      +++ EY  KGNL+++L     P +++                L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 179 HSSS---AVGI------PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
            S +   A G+        +HRD  + NVL++ +   KI+DFGLA+ +        T   
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                +  PE       T QSDV++FGV+L E+ T
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 69  LGKGGFGRVY--KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           LG G +G V   K  L   E  AIK ++               EV +L +LDHPN++ L 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAER-AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
            +  D ++ +LV E  + G L D +  I   K                  YLH  +    
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEI--ILRQKFSEVDAAVIMKQVLSGTTYLHKHN---- 141
Query: 187 PIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
            IVHRD K  N+LL   S +   KI DFGL+     G +       LGT  Y  PE    
Sbjct: 142 -IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGTAYYIAPEVLRK 197
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
            K   + DV++ GV+L  LL G
Sbjct: 198 -KYDEKCDVWSCGVILYILLCG 218

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVSLI 126
           LG+G +  VYKG  + +  +VA+K++   R +  +G     + EV +L  L H N+V+L 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                 K   LV+EY+ K +L+ +L+  G   ++                Y H       
Sbjct: 67  DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLLRGLAYCHRQK---- 120
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-YTSTGK 245
            ++HRD K  N+L++   E K++DFGLA+      +TY    V  T  Y  P+    +  
Sbjct: 121 -VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTD 177
Query: 246 LTLQSDVYAFGVVLLELLTGR 266
            + Q D++  G +  E+ TGR
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 14/201 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      RSGE VAIKK+  P   E   +  +R E+ +L  + H N++ L+ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 90
Query: 128 YCADGKHRFLVYE-YMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                      Y+ Y+    +Q  L  I   K                  Y+HS+     
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---- 146
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            +VHRD K  N+ ++ + E KI DFGLA+        YV  R      Y  PE   +   
Sbjct: 147 -VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMH 200
Query: 247 TLQS-DVYAFGVVLLELLTGR 266
             Q+ D+++ G ++ E+LTG+
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + KE   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY   G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+++      K++DFGLAK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 23/235 (9%)
Query: 42  QKRHRGSSVFTLKEMEEATCSFSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELP 96
           Q+R R  +  T K+         DD+F     LG G  G V+K + +   +V  +K+   
Sbjct: 47  QQRKRLEAFLTQKQ---KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 103
Query: 97  RFKEADGEHEFRVEVDILSRLDHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIG 155
             K A      R E+ +L   + P +V   G + +DG+   +  E+M  G+L   L   G
Sbjct: 104 EIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAG 161
Query: 156 EPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA- 214
             ++                 YL         I+HRD K +N+L+++  E K+ DFG++ 
Sbjct: 162 --RIPEQILGKVSIAVIKGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSG 215
Query: 215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV 269
           +L+     ++V     GT  Y  PE       ++QSD+++ G+ L+E+  GR  +
Sbjct: 216 QLIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 69  LGKGGFGRVY--KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           LG G +G V   K  L   E  AIK ++               EV +L +LDHPN++ L 
Sbjct: 12  LGSGAYGEVLLCKDKLTGAER-AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
            +  D ++ +LV E  + G L D +  I   K                  YLH  +    
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEI--ILRQKFSEVDAAVIMKQVLSGTTYLHKHN---- 124
Query: 187 PIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
            IVHRD K  N+LL   S +   KI DFGL+     G +       LGT  Y  PE    
Sbjct: 125 -IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGTAYYIAPEVLRK 180
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
            K   + DV++ GV+L  LL G
Sbjct: 181 -KYDEKCDVWSCGVILYILLCG 201

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 33/297 (11%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +               +L   S
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 183 ---AVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              A G+        +HRD  + N+LLS     KI DFGLA+ + +  +           
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRK 292
            +  PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R 
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRM 261
Query: 293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +      PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 262 RAPDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 305

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 96/233 (41%), Gaps = 24/233 (10%)
Query: 66  DNF-----LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-D 118
           DNF     LGKG FG+V    ++ +G++ A+K ++     + D       E  ILS   +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           HP L  L          F V E++  G+L  H+      + D                +L
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFL 140
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV-TARVLGTFGYFD 237
           H        I++RD K  NVLL      K++DFG+ K   EG    V TA   GT  Y  
Sbjct: 141 HDKG-----IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYIA 192
Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
           PE           D +A GV+L E+L G       +  N+ +L      ILND
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF---EAENEDDL---FEAILND 239

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 40/290 (13%)
Query: 66  DNFLGKGGFGRVYKGTL--RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           D  +GKG FG VY G    ++   +      L R  E      F  E  ++  L+HPN++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 124 SLIGYC--ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX---XXXXXXXYL 178
           +LIG     +G    L+  YM  G+L   L  I  P+ + P                 YL
Sbjct: 86  ALIGIMLPPEGLPHVLL-PYMCHGDL---LQFIRSPQRN-PTVKDLISFGLQVARGMEYL 140
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ----ETYVTARVLGTFG 234
                     VHRD  + N +L  +F  K++DFGLA+ + + +    + +  AR+   + 
Sbjct: 141 AEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
               E   T + T +SDV++FGV+L ELLT  R     + ++  +L     H L   ++L
Sbjct: 196 AL--ESLQTYRFTTKSDVWSFGVLLWELLT--RGAPPYRHIDPFDLT----HFLAQGRRL 247
Query: 295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
            +   PE    S           +  +C   + + RP+    V E++ I+
Sbjct: 248 PQ---PEYCPDS--------LYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 33/297 (11%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +               +L   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 183 ---AVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              A G+        +HRD  + N+LLS     KI DFGLA+ + +  +           
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRK 292
            +  PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R 
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRM 270
Query: 293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +      PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 271 RAPDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 69  LGKGGFGRVY--KGTLR--SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG+G FG+V+  +   R  SG + A+K ++    K  D     ++E DIL+ ++HP +V 
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFVVK 94
Query: 125 L-IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           L   +  +GK  +L+ ++++ G+L   L+   E                    +LHS   
Sbjct: 95  LHYAFQTEGK-LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALGLDHLHS--- 148
Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
             + I++RD K  N+LL      K++DFGL+K   + ++   +    GT  Y  PE  + 
Sbjct: 149 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNR 204
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
              +  +D +++GV++ E+LTG
Sbjct: 205 QGHSHSADWWSYGVLMFEMLTG 226

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G V+K   R + E+VA+K++ L    E       R E+ +L  L H N+V L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 128 YCADGKHRFLVYEYMQKG--NLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
                K   LV+E+  +      D  NG  +P++                 + HS +   
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI----VKSFLFQLLKGLGFCHSRN--- 121
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
             ++HRD K  N+L++ N E K+++FGLA+        Y +A V+ T  Y  P+     K
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFGAK 177
Query: 246 LTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
           L   S D+++ G +  EL    R +     V+DQ
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 33/297 (11%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +               +L   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 183 ---AVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              A G+        +HRD  + N+LLS     KI DFGLA+ + +  +           
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRK 292
            +  PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R 
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRM 261
Query: 293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +      PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 262 RAPDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 305

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 34/240 (14%)
Query: 39  TQPQKRHRGSSVFTLKEMEEATCSFSDD----NFLGKGGFGRVYK------GTLRSGEVV 88
           T  Q+  RGS       M  A+  FSD+      LGKG F  V +      G   + +++
Sbjct: 8   TGGQQMGRGSEF-----MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 89  AIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQ 148
             KK+    F++         E  I  +L HPN+V L     +    +LV++ +  G L 
Sbjct: 63  NTKKLSARDFQK------LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116
Query: 149 DHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-- 206
           + +  +                      Y HS+      IVHR+ K  N+LL++  +   
Sbjct: 117 EDI--VAREFYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAA 169
Query: 207 -KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
            K++DFGLA  + + +  +  A   GT GY  PE       +   D++A GV+L  LL G
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 104/234 (44%), Gaps = 27/234 (11%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 72
Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXXX- 173
            N+V L   + + G+ + +VY  +    + + +  +       K   P            
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 174 -XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQETYVTARVLG 231
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+        + 
Sbjct: 133 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXIC 184
Query: 232 TFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
           +  Y  PE        T   DV++ G VL ELL G+     + GV+    +++V
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 119/297 (40%), Gaps = 33/297 (11%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGE---PKMDWPXXXXXXXXXXXXXXYLH 179
           +L+G C   G    ++ E+ + GNL  +L        P  + P                 
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 180 SSSAVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              A G+        +HRD  + N+LLS     KI DFGLA+ + +  +           
Sbjct: 157 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRK 292
            +  PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R 
Sbjct: 217 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRM 272
Query: 293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +      PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 273 RAPDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 316

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 110 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXX 169
           EV +L  LDHPN++ L  +  D ++ +LV E  + G L D +  I   K +         
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAAVIIK 143
Query: 170 XXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAKLMPEGQETYVT 226
                  YLH  +     IVHRD K  N+LL +  +    KI DFGL+ +  E Q+    
Sbjct: 144 QVLSGVTYLHKHN-----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKK--M 195
Query: 227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
              LGT  Y  PE     K   + DV++ GV+L  LL G
Sbjct: 196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 107/238 (44%), Gaps = 35/238 (14%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           S++D   +G G FG VY+  L  SGE+VAIKK+         G+     E+ I+ +LDH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKNRELQIMRKLDHC 73
Query: 121 NLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXXX-- 173
           N+V L   + + G+ +  VY  +    + + +  +       K   P             
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYVTARVL 230
              Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R  
Sbjct: 134 SLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 231 GT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                 FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 189 RAPELIFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 33/297 (11%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +               +L   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 183 ---AVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              A G+        +HRD  + N+LLS     KI DFGLA+ + +  +           
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRK 292
            +  PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R 
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRM 270
Query: 293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +      PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 271 RAPDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 17/219 (7%)
Query: 56  MEEATCSFSDDNF-----LGKGGFGRVYKGTLR--SGEVV--AIKKMELPRFKEADGEHE 106
           ++  TC   + +      LG G FG V +G     SG+ V  A+K ++     + +   +
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 107 FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXX 166
           F  EV+ +  LDH NL+ L G       + +V E    G+L D L    +          
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSR 125
Query: 167 XXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT 226
                     YL S        +HRD  + N+LL+     KI DFGL + +P+  +  V 
Sbjct: 126 YAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM 180
Query: 227 ARVLGT-FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                  F +  PE   T   +  SD + FGV L E+ T
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 20/218 (9%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVD 112
           K+ E+    F     LG G F  V     + +G++ A+K   +P+      E     E+ 
Sbjct: 15  KQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKC--IPKKALKGKESSIENEIA 72
Query: 113 ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPXXXXXXXX 170
           +L ++ H N+V+L        H +LV + +  G L D +   G    K            
Sbjct: 73  VLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEK----DASTLIRQ 128
Query: 171 XXXXXXYLHSSSAVGIPIVHRDFKSTNVL-LSANFEAK--ISDFGLAKLMPEGQETYVTA 227
                 YLH      + IVHRD K  N+L  S + E+K  ISDFGL+K+  +G    V +
Sbjct: 129 VLDAVYYLHR-----MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMS 180
Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
              GT GY  PE  +    +   D ++ GV+   LL G
Sbjct: 181 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 107/238 (44%), Gaps = 35/238 (14%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           S++D   +G G FG VY+  L  SGE+VAIKK+         G+     E+ I+ +LDH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKNRELQIMRKLDHC 73
Query: 121 NLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXXX-- 173
           N+V L   + + G+ +  VY  +    + + +  +       K   P             
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQE--TYVTARVL 230
              Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R  
Sbjct: 134 SLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 231 GT----FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                 FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 189 RAPELIFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + KE   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY   G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+++      +++DFGLAK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 59  ATCSFSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDI 113
           A     DD+F     LG G  G V+K + +   +V  +K+     K A      R E+ +
Sbjct: 2   ALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQV 60
Query: 114 LSRLDHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX 172
           L   + P +V   G + +DG+   +  E+M  G+L   L   G  ++             
Sbjct: 61  LHECNSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVI 117
Query: 173 XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLG 231
               YL         I+HRD K +N+L+++  E K+ DFG++ +L+ E    +V     G
Sbjct: 118 KGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV-----G 168
Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           T  Y  PE       ++QSD+++ G+ L+E+  GR
Sbjct: 169 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 12/201 (5%)
Query: 69  LGKGGFGRVYKGTLR--SGEVV--AIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FG V +G     SG+ V  A+K ++     + +   +F  EV+ +  LDH NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L G       + +V E    G+L D L    +                    YL S    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR-- 131
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT-FGYFDPEYTST 243
               +HRD  + N+LL+     KI DFGL + +P+  +  V        F +  PE   T
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 244 GKLTLQSDVYAFGVVLLELLT 264
              +  SD + FGV L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 15/202 (7%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+    RS  +  + K  + + +      +   E+++L  LDHPN++ +   
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKT-INKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGE--PKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
             D  + ++V E  + G L + +         +                 Y HS      
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---- 144
Query: 187 PIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
            +VH+D K  N+L    S +   KI DFGLA+L    + +   A   GT  Y  PE    
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPEVFKR 200
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
             +T + D+++ GVV+  LLTG
Sbjct: 201 -DVTFKCDIWSAGVVMYFLLTG 221

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 32/296 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +                +  S 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 183 AVGIPI--------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
            V   +        +HRD  + N+LLS     KI DFGLA+ + +  +            
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRKK 293
           +  PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R +
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRMR 271
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
                 PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 272 APDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 119/295 (40%), Gaps = 31/295 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDW-PXXXXXXXXXXXXXXYLHSS 181
           +L+G C   G    ++ E+ + GNL  +L       + + P                   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 182 SAVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            A G+        +HRD  + N+LLS     KI DFGLA+ + +  +            +
Sbjct: 157 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRKKL 294
             PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R + 
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRMRA 272
Query: 295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
                PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 273 PDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 14/201 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      RSGE VAIKK+  P   E   +  +R E+ +L  + H N++ L+ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 108
Query: 128 YCADGKHRFLVYE-YMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                      Y+ Y+    +Q  L  I   +                  Y+HS+     
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---- 164
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            +VHRD K  N+ ++ + E KI DFGLA+        YV  R      Y  PE   +   
Sbjct: 165 -VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMH 218
Query: 247 TLQS-DVYAFGVVLLELLTGR 266
             Q+ D+++ G ++ E+LTG+
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGK 239

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 33/297 (11%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +               +L   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 183 ---AVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              A G+        +HRD  + N+LLS     KI DFGLA+ + +  +           
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRK 292
            +  PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R 
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRM 270
Query: 293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +      PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 271 RAPDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G  G V     + SG  VA+K M+L   K+   E  F  EV I+    H N+V +  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFN-EVVIMRDYQHFNVVEMYK 109
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
               G+  +++ E++Q G L D ++ +   +++                YLH+       
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG----- 161
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD KS ++LL+ +   K+SDFG    +   ++      ++GT  +  PE  S     
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 248 LQSDVYAFGVVLLELLTG 265
            + D+++ G++++E++ G
Sbjct: 220 TEVDIWSLGIMVIEMVDG 237

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 33/297 (11%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +               +L   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 183 ---AVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              A G+        +HRD  + N+LLS     KI DFGLA+ + +  +           
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRK 292
            +  PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R 
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRM 261
Query: 293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +      PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 262 RAPDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 305

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNLVSL 125
           +GKG F  V +   R +G+  A+K +++ +F  + G    + + E  I   L HP++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 126 I-GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXX--XXXXXXXXXYLHSSS 182
           +  Y +DG   ++V+E+M   +L   +    +    +                 Y H ++
Sbjct: 92  LETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 183 AVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I+HRD K  NVLL++   +   K+ DFG+A  +  G+   V    +GT  +  PE
Sbjct: 151 -----IIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHFMAPE 203
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      DV+  GV+L  LL+G
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 33/297 (11%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +               +L   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 183 ---AVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              A G+        +HRD  + N+LLS     KI DFGLA+ + +  +           
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRK 292
            +  PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R 
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRM 261
Query: 293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +      PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 262 RAPDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 305

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 98
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 152
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 153 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 206
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 207 GYNKAVDWWALGVLIYEMAAG 227

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 33/297 (11%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +               +L   S
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 183 ---AVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              A G+        +HRD  + N+LLS     KI DFGLA+ + +  +           
Sbjct: 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRK 292
            +  PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R 
Sbjct: 252 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRM 307
Query: 293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           +      PE+ ++                C   E S+RP+ +E V+ L  ++  N++
Sbjct: 308 RAPDYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 351

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      K++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY   G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+++      K++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 21/217 (9%)
Query: 69  LGKGGFGRVYKGTL----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V   T     ++G  + +    L    ++        E+ ++++L  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNG----IGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +L+G C      +L++EY   G+L ++L        E ++++                  
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 180 SSSAVGIPI------------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA 227
                   +            VHRD  + NVL++     KI DFGLA+ +       V  
Sbjct: 173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 232
Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
                  +  PE    G  T++SDV+++G++L E+ +
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 126
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 180
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 181 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 234
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 235 GYNKAVDWWALGVLIYEMAAG 255

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 98
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 152
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 153 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 206
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 207 GYNKAVDWWALGVLIYEMAAG 227

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 40/289 (13%)
Query: 68  FLGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
            LG+G FG V +G L+  +     VA+K M+L    + + E EF  E   +    HPN++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE-EFLSEAACMKDFSHPNVI 99
Query: 124 SLIGYCADGKHR-----FLVYEYMQKGNLQDHL----NGIGEPKMDWPXXXXXXXXXXXX 174
            L+G C +   +      ++  +M+ G+L  +L       G   +               
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 175 XXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT-F 233
             YL + +      +HRD  + N +L  +    ++DFGL+K +  G + Y   R+     
Sbjct: 160 MEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPV 213
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            +   E  +    T +SDV+AFGV + E+ T  R +    GV +  +   + H    R K
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEMYDYLLH--GHRLK 269
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL 342
             +    EL    Y+             C RT+  +RP+ +  V  LQL
Sbjct: 270 QPEDCLDELYEIMYS-------------CWRTDPLDRPTFS--VLRLQL 303

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 126
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 180
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK +        T  + GT  Y  PE   + 
Sbjct: 181 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA-----TWTLCGTPEYLAPEIILSK 234
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 235 GYNKAVDWWALGVLIYEMAAG 255

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP-NLVSL 125
            +G G +G+VYKG  +++G++ AIK M++      D E E + E+++L +  H  N+ + 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
            G              +LV E+   G++ D +       +                 +LH
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR--VLGTFGYFD 237
                   ++HRD K  NVLL+ N E K+ DFG++  +    +  V  R   +GT  +  
Sbjct: 147 QHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMA 197
Query: 238 PEYTST-----GKLTLQSDVYAFGVVLLELLTG 265
           PE  +           +SD+++ G+  +E+  G
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVY-KGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWTLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 91
Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXX-- 172
            N+V L   + + G+ +  VY  +    + + +  +       K   P            
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 173 XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQET-------Y 224
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+         Y
Sbjct: 152 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 206
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
             A  L  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 207 YRAPEL-IFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 257

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 84
Query: 120 PNLVSL------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX- 172
            N+V L       G   D  +  LV +Y+ +  +          K   P           
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 173 -XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQET------- 223
                Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+         
Sbjct: 144 FRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
           Y  A  L  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++
Sbjct: 199 YYRAPEL-IFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 249
Query: 284 V 284
           V
Sbjct: 250 V 250

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVY-KGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 106
Query: 120 PNLVSL------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXX- 172
            N+V L       G   D  +  LV +Y+ +  +          K   P           
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 173 -XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQET------- 223
                Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+         
Sbjct: 166 FRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 220
Query: 224 YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
           Y  A  L  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++
Sbjct: 221 YYRAPEL-IFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271
Query: 284 V 284
           V
Sbjct: 272 V 272

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 80
Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXX-- 172
            N+V L   + + G+ +  VY  +    + + +  +       K   P            
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 173 XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQET-------Y 224
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+         Y
Sbjct: 141 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 195
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
             A  L  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 196 YRAPEL-IFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 246

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 91
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 145
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 146 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWTLCGTPEYLAPEIILSK 199
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 200 GYNKAVDWWALGVLIYEMAAG 220

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 73
Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXXX- 173
            N+V L   + + G+ +  VY  +    + + +  +       K   P            
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 174 -XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQET-------Y 224
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+         Y
Sbjct: 134 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 188
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
             A  L  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 189 YRAPEL-IFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 239

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 72
Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXXX- 173
            N+V L   + + G+ +  VY  +    + + +  +       K   P            
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 174 -XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQET-------Y 224
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+         Y
Sbjct: 133 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
             A  L  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 188 YRAPEL-IFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 92
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 146
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 147 -LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 200
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 201 GYNKAVDWWALGVLIYEMAAG 221

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLXGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 103/234 (44%), Gaps = 27/234 (11%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 72
Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXXX- 173
            N+V L   + + G+ +  VY  +    + + +  +       K   P            
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 174 -XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQETYVTARVLG 231
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+        + 
Sbjct: 133 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXIC 184
Query: 232 TFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
           +  Y  PE        T   DV++ G VL ELL G+     + GV+    +++V
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 63  FSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
             DD+F     LG G  G V+K + +   +V  +K+     K A      R E+ +L   
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHEC 61
Query: 118 DHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           + P +V   G + +DG+   +  E+M  G+L   L   G  ++                 
Sbjct: 62  NSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 118
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGY 235
           YL         I+HRD K +N+L+++  E K+ DFG++ +L+     ++V     GT  Y
Sbjct: 119 YLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSY 169
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV 269
             PE       ++QSD+++ G+ L+E+  GR  +
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 84
Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXX-- 172
            N+V L   + + G+ +  VY  +    + + +  +       K   P            
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 173 XXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQET-------Y 224
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+         Y
Sbjct: 145 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 199
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
             A  L  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 200 YRAPEL-IFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 250

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V    +K + +   +  + K E+   K +D    F  E DI++  + P +V 
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEM--IKRSDSAF-FWEERDIMAFANSPWVVQ 139
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D K+ ++V EYM  G+L + ++    P+  W                +HS    
Sbjct: 140 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEVVLALDA--IHS---- 192
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST- 243
            + ++HRD K  N+LL  +   K++DFG    M E    +    V GT  Y  PE   + 
Sbjct: 193 -MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLKSQ 250
Query: 244 ---GKLTLQSDVYAFGVVLLELLTG 265
              G    + D ++ GV L E+L G
Sbjct: 251 GGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDH 119
           S++D   +G G FG VY+  L  SGE+VAIKK ++  RFK          E+ I+ +LDH
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDH 76
Query: 120 PNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG----EPKMDWPXXXXXXXXXXX- 173
            N+V L   + + G+ +  VY  +    + + +  +       K   P            
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 174 -XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQET-------Y 224
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+         Y
Sbjct: 137 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 191
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
             A  L  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 192 YRAPEL-IFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 242

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 114/282 (40%), Gaps = 31/282 (10%)
Query: 64  SDDNFL---GKGGFGRVYKGTLRSGEVV-AIKKMELPRFKEADGEHEFRVEVDILSR-LD 118
           SD +FL   GKG FG+V     ++ EV  A+K ++     +   E     E ++L + + 
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
           HP LV L          + V +Y+  G L  HL    E     P              YL
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYL 155
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HS     + IV+RD K  N+LL +     ++DFGL K   E   T  T+   GT  Y  P
Sbjct: 156 HS-----LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAP 208
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTG------RRAVDLNQGVNDQNLVLQ------VRH 286
           E           D +  G VL E+L G      R   ++   + ++ L L+       RH
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH 268
Query: 287 IL-----NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCV 323
           +L      DR K     D  +   S+   S+  + +L ++ +
Sbjct: 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKI 310

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 63  FSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
             DD+F     LG G  G V+K + +   +V  +K+     K A      R E+ +L   
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHEC 61
Query: 118 DHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           + P +V   G + +DG+   +  E+M  G+L   L   G  ++                 
Sbjct: 62  NSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 118
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGY 235
           YL         I+HRD K +N+L+++  E K+ DFG++ +L+     ++V     GT  Y
Sbjct: 119 YLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSY 169
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV 269
             PE       ++QSD+++ G+ L+E+  GR  +
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLAGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVY-KGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY   G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+++      K++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 63  FSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
             DD+F     LG G  G V+K + +   +V  +K+     K A      R E+ +L   
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHEC 61
Query: 118 DHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           + P +V   G + +DG+   +  E+M  G+L   L   G  ++                 
Sbjct: 62  NSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 118
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGY 235
           YL         I+HRD K +N+L+++  E K+ DFG++ +L+     ++V     GT  Y
Sbjct: 119 YLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSY 169
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV 269
             PE       ++QSD+++ G+ L+E+  GR  +
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 63  FSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
             DD+F     LG G  G V+K + +   +V  +K+     K A      R E+ +L   
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHEC 61
Query: 118 DHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           + P +V   G + +DG+   +  E+M  G+L   L   G  ++                 
Sbjct: 62  NSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 118
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGY 235
           YL         I+HRD K +N+L+++  E K+ DFG++ +L+     ++V     GT  Y
Sbjct: 119 YLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSY 169
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV 269
             PE       ++QSD+++ G+ L+E+  GR  +
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 69  LGKGGFGRVYKGT-LRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           LG G FG VYKG  +  GE     VAIK +      +A+   E   E  +++ +  P + 
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPYVS 82
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHL----NGIG-EPKMDWPXXXXXXXXXXXXXXYL 178
            L+G C     + LV + M  G L DH+      +G +  ++W               YL
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYL 135
Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
                  + +VHRD  + NVL+ +    KI+DFGLA+L+   +  Y          +   
Sbjct: 136 ED-----VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT 264
           E     + T QSDV+++GV + EL+T
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 100
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 154
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 155 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 208
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 209 GYNKAVDWWALGVLIYEMAAG 229

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+++      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIIISK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVY-KGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY   G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+++      K++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 126
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 180
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 181 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 234
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 235 GYNKAVDWWALGVLIYEMAAG 255

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFAEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 84/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V     KGT +      IKK  L   +      E   EV+IL  + HPN+++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHSKR-- 128
Query: 185 GIPIVHRDFKSTNVLL----SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              I H D K  N++L      N   K+ DFG+A  +  G E      + GT  +  PE 
Sbjct: 129 ---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEI 182
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 31/293 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +               Y     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY-SFQV 153
Query: 183 AVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           A G+        +HRD  + N+LLS     KI DFGLA+ + +  +            + 
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRKKLR 295
            PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R +  
Sbjct: 214 APETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRMRAP 269
Query: 296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
               PE+ ++                C   E S+RP+ +E V+ L  ++  N+
Sbjct: 270 DYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 84/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V     KGT +      IKK  L   +      E   EV+IL  + HPN+++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHSKR-- 135
Query: 185 GIPIVHRDFKSTNVLL----SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              I H D K  N++L      N   K+ DFG+A  +  G E      + GT  +  PE 
Sbjct: 136 ---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEI 189
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 85/202 (42%), Gaps = 17/202 (8%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE-FRVEVDILSRLDHPNLV---- 123
           +G+G F  VYKG L +   V +   EL   K    E + F+ E + L  L HPN+V    
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
           S        K   LV E    G L+ +L      K+                 +LH+ + 
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKI--KVLRSWCRQILKGLQFLHTRTP 150
Query: 184 VGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
              PI+HRD K  N+ ++      KI D GLA L    + ++  A V+GT  +  PE   
Sbjct: 151 ---PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKA-VIGTPEFXAPEXYE 203
Query: 243 TGKLTLQSDVYAFGVVLLELLT 264
             K     DVYAFG   LE  T
Sbjct: 204 E-KYDESVDVYAFGXCXLEXAT 224

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ ++  G
Sbjct: 214 GYNKAVDWWALGVLIYQMAAG 234

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 14/201 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG F  V +   + +G+  A K +   +    D + +   E  I   L HPN+V L  
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ-KLEREARICRLLKHPNIVRLHD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             ++  H +L+++ +  G L + +      +  +                LH      + 
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ---MG 141
Query: 188 IVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
           +VHRD K  N+LL++  +    K++DFGLA  +   Q+ +      GT GY  PE     
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKD 199
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D++A GV+L  LL G
Sbjct: 200 PYGKPVDLWACGVILYILLVG 220

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 115/265 (43%), Gaps = 32/265 (12%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V    +K T +   +  + K E+   K +D    F  E DI++  + P +V 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAF-FWEERDIMAFANSPWVVQ 133
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D ++ ++V EYM  G+L + ++    P+  W                +HS    
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-WARFYTAEVVLALDA--IHS---- 186
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTST 243
            +  +HRD K  N+LL  +   K++DFG   K+  EG     TA  +GT  Y  PE   +
Sbjct: 187 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKS 243
Query: 244 ----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
               G    + D ++ GV L E+L G      +      +LV     I+N +  L    D
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVG------DTPFYADSLVGTYSKIMNHKNSLTFPDD 297
Query: 300 PELSRSSYTMESIAMFANLASRCVR 324
            ++S+ +  +    + A L  R VR
Sbjct: 298 NDISKEAKNL----ICAFLTDREVR 318

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 31/293 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHP-NLV 123
           LG+G FG+V +       +    + + +   KE     E R    E+ IL  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           +L+G C   G    ++ E+ + GNL  +L       + +               Y     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY-SFQV 153
Query: 183 AVGIPI------VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           A G+        +HRD  + N+LLS     KI DFGLA+ + +  +            + 
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRKKLR 295
            PE       T+QSDV++FGV+L E+ +         GV  D+    +++     R +  
Sbjct: 214 APETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFXRRLKE--GTRMRAP 269
Query: 296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
               PE+ ++                C   E S+RP+ +E V+ L  ++  N+
Sbjct: 270 DYTTPEMYQTMLD-------------CWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 115/265 (43%), Gaps = 32/265 (12%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V    +K T +   +  + K E+   K +D    F  E DI++  + P +V 
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAF-FWEERDIMAFANSPWVVQ 138
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D ++ ++V EYM  G+L + ++    P+  W                +HS    
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-WARFYTAEVVLALDA--IHS---- 191
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTST 243
            +  +HRD K  N+LL  +   K++DFG   K+  EG     TA  +GT  Y  PE   +
Sbjct: 192 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKS 248
Query: 244 ----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
               G    + D ++ GV L E+L G      +      +LV     I+N +  L    D
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVG------DTPFYADSLVGTYSKIMNHKNSLTFPDD 302
Query: 300 PELSRSSYTMESIAMFANLASRCVR 324
            ++S+ +  +    + A L  R VR
Sbjct: 303 NDISKEAKNL----ICAFLTDREVR 323

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 84/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V     KGT +      IKK  L   +      E   EV+IL  + HPN+++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHSKR-- 149
Query: 185 GIPIVHRDFKSTNVLL----SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              I H D K  N++L      N   K+ DFG+A  +  G E      + GT  +  PE 
Sbjct: 150 ---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEI 203
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV    +K T     +  + K ++ + K+   EH    E  I   ++ P LV 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRIQQAVNFPFLVK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY   G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      K++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 115/265 (43%), Gaps = 32/265 (12%)
Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V    +K T +   +  + K E+   K +D    F  E DI++  + P +V 
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAF-FWEERDIMAFANSPWVVQ 138
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D ++ ++V EYM  G+L + ++    P+  W                +HS    
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-WARFYTAEVVLALDA--IHS---- 191
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTST 243
            +  +HRD K  N+LL  +   K++DFG   K+  EG     TA  +GT  Y  PE   +
Sbjct: 192 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKS 248
Query: 244 ----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
               G    + D ++ GV L E+L G      +      +LV     I+N +  L    D
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVG------DTPFYADSLVGTYSKIMNHKNSLTFPDD 302
Query: 300 PELSRSSYTMESIAMFANLASRCVR 324
            ++S+ +  +    + A L  R VR
Sbjct: 303 NDISKEAKNL----ICAFLTDREVR 323

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVY-KGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY   G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+++      +++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 160 -LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRVYK------GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LGKG F  V +      G   + +++  KK+    F++         E  I  +L HPN+
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK------LEREARICRKLQHPNI 66
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V L     +    +LV++ +  G L + +  +                      Y HS+ 
Sbjct: 67  VRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSNG 124
Query: 183 AVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                IVHR+ K  N+LL++  +    K++DFGLA  + + +  +  A   GT GY  PE
Sbjct: 125 -----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPE 176
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                  +   D++A GV+L  LL G
Sbjct: 177 VLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLTK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY   G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+++      K++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLTK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY   G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+++      K++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRVYK------GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LGKG F  V +      G   + +++  KK+    F++         E  I  +L HPN+
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK------LEREARICRKLQHPNI 67
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V L     +    +LV++ +  G L + +  +                      Y HS+ 
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 183 AVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                IVHR+ K  N+LL++  +    K++DFGLA  + + +  +  A   GT GY  PE
Sbjct: 126 -----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPE 177
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                  +   D++A GV+L  LL G
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 16/212 (7%)
Query: 69  LGKGGFGRVYKGT----LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    ++S   + +    L              E+ +LS L +H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLN--------GIGEPKMDWPXXXXXXXXXXXXX 175
           +L+G C  G    ++ EY   G+L + L             P +                
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 176 XYLHSSSAVGIP---IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
            Y  +     +     +HRD  + N+LL+     KI DFGLA+ +       V       
Sbjct: 167 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             +  PE       T +SDV+++G+ L EL +
Sbjct: 227 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 102/240 (42%), Gaps = 39/240 (16%)
Query: 62  SFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           S++D   +G G FG VY+  L  SGE+VAIKK+         G+     E+ I+ +LDH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKNRELQIMRKLDHC 73
Query: 121 NLVSL------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX- 173
           N+V L       G   D  +  LV +Y+    +          K   P            
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PATVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 174 -XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA-KISDFGLAKLMPEGQET-------Y 224
               Y+HS       I HRD K  N+LL  +    K+ DFG AK +  G+         Y
Sbjct: 133 RSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
             A  L  FG  D  YTS+       DV++ G VL ELL G+     + GV+    +++V
Sbjct: 188 YRAPEL-IFGATD--YTSS------IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 16/212 (7%)
Query: 69  LGKGGFGRVYKGT----LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    ++S   + +    L              E+ +LS L +H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLN--------GIGEPKMDWPXXXXXXXXXXXXX 175
           +L+G C  G    ++ EY   G+L + L             P +                
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 176 XYLHSSSAVGIP---IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
            Y  +     +     +HRD  + N+LL+     KI DFGLA+ +       V       
Sbjct: 169 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             +  PE       T +SDV+++G+ L EL +
Sbjct: 229 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 16/212 (7%)
Query: 69  LGKGGFGRVYKGT----LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    ++S   + +    L              E+ +LS L +H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLN--------GIGEPKMDWPXXXXXXXXXXXXX 175
           +L+G C  G    ++ EY   G+L + L             P +                
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 176 XYLHSSSAVGIP---IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
            Y  +     +     +HRD  + N+LL+     KI DFGLA+ +       V       
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             +  PE       T +SDV+++G+ L EL +
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + +G   A+K   K ++ + K+   EH    E  IL  ++ P L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLTK 106
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY   G +  HL  IG  +   P              YLHS    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHS---- 160
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+++      K++DFG AK + +G+    T  + GT  Y  PE   + 
Sbjct: 161 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGR----TWXLCGTPEYLAPEIILSK 214
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRVYK------GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LGKG F  V +      G   + +++  KK+    F++         E  I  +L HPN+
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK------LEREARICRKLQHPNI 67
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V L     +    +LV++ +  G L + +  +                      Y HS+ 
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 183 AVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                IVHR+ K  N+LL++  +    K++DFGLA  + + +  +  A   GT GY  PE
Sbjct: 126 -----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPE 177
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                  +   D++A GV+L  LL G
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 17/215 (7%)
Query: 59  ATCS-FSDD----NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDI 113
           ATC+ F+DD      LGKG F  V +   ++       K+   +   A    +   E  I
Sbjct: 24  ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXX 173
              L HPN+V L    ++    +LV++ +  G L + +  +                   
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASHCIHQILE 141
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVL 230
              ++H        IVHRD K  N+LL++  +    K++DFGLA  +   Q+ +      
Sbjct: 142 SVNHIHQHD-----IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG--FA 194
Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           GT GY  PE           D++A GV+L  LL G
Sbjct: 195 GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/297 (22%), Positives = 130/297 (43%), Gaps = 43/297 (14%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDI---LSRLDHPNLVS 124
           LG+G +G V K   + SG+++A+K++        + + + R+ +D+   +  +D P  V+
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDISMRTVDCPFTVT 114
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             G        ++  E M   +L      + +     P                H  S +
Sbjct: 115 FYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGL--------AKLMPEGQETYVTARVLGTFGYF 236
            +  +HRD K +NVL++A  + K+ DFG+        AK +  G + Y+    +      
Sbjct: 174 SV--IHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERI------ 225
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK 296
           +PE    G  +++SD+++ G+ ++EL   R   D + G   Q L           K++ +
Sbjct: 226 NPELNQKG-YSVKSDIWSLGITMIELAILRFPYD-SWGTPFQQL-----------KQVVE 272
Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
              P+L    ++ E    F +  S+C++  S ERP+  E ++     ++  SKG ++
Sbjct: 273 EPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPELMQHPFFTLH-ESKGTDV 324

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 16/212 (7%)
Query: 69  LGKGGFGRVYKGT----LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    ++S   + +    L              E+ +LS L +H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLN--------GIGEPKMDWPXXXXXXXXXXXXX 175
           +L+G C  G    ++ EY   G+L + L             P +                
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 176 XYLHSSSAVGIP---IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
            Y  +     +     +HRD  + N+LL+     KI DFGLA+ +       V       
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             +  PE       T +SDV+++G+ L EL +
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V++ T R +G   A K +  P   E+D E   R E+  +S L HP LV+L  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKE-TVRKEIQTMSVLRHPTLVNLHD 115
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
              D     ++YE+M  G L + +      KM                 ++H ++     
Sbjct: 116 AFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMHENN----- 169
Query: 188 IVHRDFKSTNVLLSA--NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            VH D K  N++ +   + E K+ DFGL   +   Q   VT    GT  +  PE      
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 226
Query: 246 LTLQSDVYAFGVVLLELLTG 265
           +   +D+++ GV+   LL+G
Sbjct: 227 VGYYTDMWSVGVLSYILLSG 246

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT  Y  P    + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEYLAPAIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 16/212 (7%)
Query: 69  LGKGGFGRVYKGT----LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV 123
           LG G FG+V + T    ++S   + +    L              E+ +LS L +H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLN--------GIGEPKMDWPXXXXXXXXXXXXX 175
           +L+G C  G    ++ EY   G+L + L             P +                
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 176 XYLHSSSAVGIP---IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
            Y  +     +     +HRD  + N+LL+     KI DFGLA+ +       V       
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             +  PE       T +SDV+++G+ L EL +
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIK----KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +GKG FG V++G  R GE VA+K    + E   F+EA        E+     L H N++ 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREA--------EIYQTVMLRHENILG 62
Query: 125 LIGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
            I   AD K        +LV +Y + G+L D+LN      ++                ++
Sbjct: 63  FIA--ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 119
Query: 179 HSSSAVGIP-IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA--RVLGTFGY 235
                 G P I HRD KS N+L+  N    I+D GLA       +T   A    +GT  Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 236 FDPEYTSTG------KLTLQSDVYAFGVVLLEL 262
             PE           +   ++D+YA G+V  E+
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V++ T R +G   A K +  P   E+D E   R E+  +S L HP LV+L  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKE-TVRKEIQTMSVLRHPTLVNLHD 221
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
              D     ++YE+M  G L + +      KM                 ++H ++     
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMHENN----- 275
Query: 188 IVHRDFKSTNVLLSA--NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            VH D K  N++ +   + E K+ DFGL   +   Q   VT    GT  +  PE      
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 332
Query: 246 LTLQSDVYAFGVVLLELLTG 265
           +   +D+++ GV+   LL+G
Sbjct: 333 VGYYTDMWSVGVLSYILLSG 352

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIK----KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +GKG FG V++G  R GE VA+K    + E   F+EA        E+     L H N++ 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREA--------EIYQTVMLRHENILG 61
Query: 125 LIGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
            I   AD K        +LV +Y + G+L D+LN      ++                ++
Sbjct: 62  FIA--ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 118
Query: 179 HSSSAVGIP-IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA--RVLGTFGY 235
                 G P I HRD KS N+L+  N    I+D GLA       +T   A    +GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 236 FDPEYTSTG------KLTLQSDVYAFGVVLLEL 262
             PE           +   ++D+YA G+V  E+
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIK----KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +GKG FG V++G  R GE VA+K    + E   F+EA        E+     L H N++ 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREA--------EIYQTVMLRHENILG 64
Query: 125 LIGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
            I   AD K        +LV +Y + G+L D+LN      ++                ++
Sbjct: 65  FIA--ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 121
Query: 179 HSSSAVGIP-IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA--RVLGTFGY 235
                 G P I HRD KS N+L+  N    I+D GLA       +T   A    +GT  Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 236 FDPEYTSTG------KLTLQSDVYAFGVVLLEL 262
             PE           +   ++D+YA G+V  E+
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIK----KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +GKG FG V++G  R GE VA+K    + E   F+EA        E+     L H N++ 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREA--------EIYQTVMLRHENILG 67
Query: 125 LIGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
            I   AD K        +LV +Y + G+L D+LN      ++                ++
Sbjct: 68  FIA--ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 124
Query: 179 HSSSAVGIP-IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA--RVLGTFGY 235
                 G P I HRD KS N+L+  N    I+D GLA       +T   A    +GT  Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 236 FDPEYTSTG------KLTLQSDVYAFGVVLLEL 262
             PE           +   ++D+YA G+V  E+
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 17/206 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           F  ++ LG+G    VY+   +  +    K   L   K+   +   R E+ +L RL HPN+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQ----KPYALKVLKKTVDKKIVRTEIGVLLRLSHPNI 110
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           + L           LV E +  G L D +  + +                    YLH + 
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 183 AVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                IVHRD K  N+L +    +   KI+DFGL+K++   +   +   V GT GY  PE
Sbjct: 169 -----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPE 220
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                    + D+++ G++   LL G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 102
Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXX 175
           ++ +     +   R    E M+   L  HL G      +    +                
Sbjct: 103 IIGI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 157
Query: 176 XYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFG 234
            Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  
Sbjct: 158 KYIHSAN-----VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 235 YFDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
           Y  PE     K  T   D+++ G +L E+L+ R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 54  KEMEEATCSFSDD-------NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEH 105
           K+ +   C F D+         +G+G FG V+K   R +G+ VA+KK+ +   KE     
Sbjct: 4   KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 63
Query: 106 EFRVEVDILSRLDHPNLVSLIGYC---ADGKHR-----FLVYEYMQKGNLQDHLNGIGEP 157
             R E+ IL  L H N+V+LI  C   A   +R     +LV+++ +  +L   L+ +   
Sbjct: 64  ALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LV 120
Query: 158 KMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-- 215
           K                  Y+H +      I+HRD K+ NVL++ +   K++DFGLA+  
Sbjct: 121 KFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLARAF 175
Query: 216 -LMPEGQETYVTARVLGTFGYFDPEYTSTGK-LTLQSDVYAFGVVLLELLT 264
            L    Q      RV+ T  Y  PE     +      D++  G ++ E+ T
Sbjct: 176 SLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 54  KEMEEATCSFSDD-------NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEH 105
           K+ +   C F D+         +G+G FG V+K   R +G+ VA+KK+ +   KE     
Sbjct: 3   KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62
Query: 106 EFRVEVDILSRLDHPNLVSLIGYC---ADGKHR-----FLVYEYMQKGNLQDHLNGIGEP 157
             R E+ IL  L H N+V+LI  C   A   +R     +LV+++ +  +L   L+ +   
Sbjct: 63  ALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LV 119
Query: 158 KMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-- 215
           K                  Y+H +      I+HRD K+ NVL++ +   K++DFGLA+  
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 216 -LMPEGQETYVTARVLGTFGYFDPEYTSTGK-LTLQSDVYAFGVVLLELLT 264
            L    Q      RV+ T  Y  PE     +      D++  G ++ E+ T
Sbjct: 175 SLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 33/220 (15%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFR-VEVDILSRLDHPNLVSLIG 127
           +GKG +G V++G+ + GE VA+K      F   D +  FR  E+     L H N++  I 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 128 YCADGKHR----FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS-- 181
                +H     +L+  Y + G+L D+L       +D                +LH    
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 182 SAVGIP-IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR--VLGTFGYFDP 238
              G P I HRD KS N+L+  N +  I+D GLA +  +            +GT  Y  P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 239 EYTSTGKLTLQ---------SDVYAFGVVLLELLTGRRAV 269
           E       T+Q          D++AFG+VL E+   RR V
Sbjct: 187 EVLDE---TIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 54  KEMEEATCSFSDD-------NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEH 105
           K+ +   C F D+         +G+G FG V+K   R +G+ VA+KK+ +   KE     
Sbjct: 4   KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 63
Query: 106 EFRVEVDILSRLDHPNLVSLIGYC---ADGKHR-----FLVYEYMQKGNLQDHLNGIGEP 157
             R E+ IL  L H N+V+LI  C   A   +R     +LV+++ +  +L   L+ +   
Sbjct: 64  ALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LV 120
Query: 158 KMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-- 215
           K                  Y+H +      I+HRD K+ NVL++ +   K++DFGLA+  
Sbjct: 121 KFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLARAF 175
Query: 216 -LMPEGQETYVTARVLGTFGYFDPEYTSTGK-LTLQSDVYAFGVVLLELLT 264
            L    Q      RV+ T  Y  PE     +      D++  G ++ E+ T
Sbjct: 176 SLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 33/220 (15%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFR-VEVDILSRLDHPNLVSLIG 127
           +GKG +G V++G+ + GE VA+K      F   D +  FR  E+     L H N++  I 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 128 YCADGKHR----FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS-- 181
                +H     +L+  Y + G+L D+L       +D                +LH    
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 182 SAVGIP-IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR--VLGTFGYFDP 238
              G P I HRD KS N+L+  N +  I+D GLA +  +            +GT  Y  P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 239 EYTSTGKLTLQ---------SDVYAFGVVLLELLTGRRAV 269
           E       T+Q          D++AFG+VL E+   RR V
Sbjct: 187 EVLDE---TIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 54  KEMEEATCSFSDD-------NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEH 105
           K+ +   C F D+         +G+G FG V+K   R +G+ VA+KK+ +   KE     
Sbjct: 4   KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 63
Query: 106 EFRVEVDILSRLDHPNLVSLIGYC---ADGKHR-----FLVYEYMQKGNLQDHLNGIGEP 157
             R E+ IL  L H N+V+LI  C   A   +R     +LV+++ +  +L   L+ +   
Sbjct: 64  ALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNV-LV 120
Query: 158 KMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-- 215
           K                  Y+H +      I+HRD K+ NVL++ +   K++DFGLA+  
Sbjct: 121 KFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLARAF 175
Query: 216 -LMPEGQETYVTARVLGTFGYFDPEYTSTGK-LTLQSDVYAFGVVLLELLT 264
            L    Q      RV+ T  Y  PE     +      D++  G ++ E+ T
Sbjct: 176 SLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIK----KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +GKG FG V++G  R GE VA+K    + E   F+EA        E+     L H N++ 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREA--------EIYQTVMLRHENILG 87
Query: 125 LIGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
            I   AD K        +LV +Y + G+L D+LN      ++                ++
Sbjct: 88  FIA--ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 144
Query: 179 HSSSAVGIP-IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA--RVLGTFGY 235
                 G P I HRD KS N+L+  N    I+D GLA       +T   A    +GT  Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 236 FDPEYTSTG------KLTLQSDVYAFGVVLLEL 262
             PE           +   ++D+YA G+V  E+
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 29/224 (12%)
Query: 56  MEEATCSFSDDNF-----LGKGGFG------RVYKGTLRSGEVVAIKKMELPRFKEADGE 104
           M   TC+   + +     LGKG F       +V  G   +  ++  KK+       A   
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS------ARDH 54
Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXX 164
            +   E  I   L HPN+V L    ++  H +L+++ +  G L + +      +  +   
Sbjct: 55  QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEA 110
Query: 165 XXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQ 221
                        LH      + +VHR+ K  N+LL++  +    K++DFGLA  +   Q
Sbjct: 111 DASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           + +      GT GY  PE           D++A GV+L  LL G
Sbjct: 168 QAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIK----KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +GKG FG V++G  R GE VA+K    + E   F+EA        E+     L H N++ 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREA--------EIYQTVMLRHENILG 100
Query: 125 LIGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYL 178
            I   AD K        +LV +Y + G+L D+LN      ++                ++
Sbjct: 101 FIA--ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157
Query: 179 HSSSAVGIP-IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA--RVLGTFGY 235
                 G P I HRD KS N+L+  N    I+D GLA       +T   A    +GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 236 FDPEYTSTG------KLTLQSDVYAFGVVLLEL 262
             PE           +   ++D+YA G+V  E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 85  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 141 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 190
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLN-EKRILQAVNFPFLVK 105
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + ++V EY+  G +  HL  IG  +   P              YLHS    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---- 159
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
            + +++RD K  N+L+      +++DFG AK + +G+    T  + GT     PE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGR----TWXLCGTPEALAPEIILSK 213
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D +A GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 33/220 (15%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFR-VEVDILSRLDHPNLVSLIG 127
           +GKG +G V++G+ + GE VA+K      F   D +  FR  E+     L H N++  I 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFIA 98
Query: 128 YCADGKHR----FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS-- 181
                +H     +L+  Y + G+L D+L       +D                +LH    
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 182 SAVGIP-IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR--VLGTFGYFDP 238
              G P I HRD KS N+L+  N +  I+D GLA +  +            +GT  Y  P
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 239 EYTSTGKLTLQ---------SDVYAFGVVLLELLTGRRAV 269
           E       T+Q          D++AFG+VL E+   RR V
Sbjct: 216 EVLDE---TIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 250

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 38/289 (13%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLI 126
           +G+G +G V K   + SG+++A+K++      +   + +  +++D++ R  D P +V   
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 127 GYCADGKHRFLVYEYMQKG--NLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           G        ++  E M         ++  + +  +                 +L  +   
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--- 144
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ--ETYVTARVLGTFGYFDPE--- 239
            + I+HRD K +N+LL  +   K+ DFG++     GQ  ++    R  G   Y  PE   
Sbjct: 145 -LKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPERID 198
Query: 240 -YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
              S     ++SDV++ G+ L EL TGR        V DQ               L +V+
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------------LTQVV 243
Query: 299 --DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY 345
             DP    +S   E    F N  + C+  + S+RP   E +K   +++Y
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 85  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 141 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 190
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 123/282 (43%), Gaps = 42/282 (14%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDI---LSRLDHPNLVS 124
           LG+G +G V K   + SG+++A+K++        + + + R+ +D+   +  +D P  V+
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             G        ++  E M   +L      + +     P                H  S +
Sbjct: 71  FYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGL--------AKLMPEGQETYVTARVLGTFGYF 236
            +  +HRD K +NVL++A  + K+ DFG+        AK +  G + Y+    +      
Sbjct: 130 SV--IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI------ 181
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK 296
           +PE    G  +++SD+++ G+ ++EL   R   D + G   Q L           K++ +
Sbjct: 182 NPELNQKG-YSVKSDIWSLGITMIELAILRFPYD-SWGTPFQQL-----------KQVVE 228
Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
              P+L    ++ E    F +  S+C++  S ERP+  E ++
Sbjct: 229 EPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 95  VFTPAR----SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 151 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 200
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 244

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 71/172 (41%), Gaps = 14/172 (8%)
Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXY 177
           +HP LV L          F V EY+  G+L  H+    + K+                 Y
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNY 136
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
           LH        I++RD K  NVLL +    K++D+G+ K      +T  T+   GT  Y  
Sbjct: 137 LHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIA 189
Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDL-----NQGVNDQNLVLQV 284
           PE           D +A GV++ E++ GR   D+     N   N ++ + QV
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 241

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 58  EATCSFSDDNFLGKGGFGRVYKGTL-RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR 116
           E    + D   +G G +G V      R+G  VAIKK+  P   E   +  +R E+ +L  
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKH 80
Query: 117 LDHPNLVSLIGYCA------DGKHRFLVYEYMQK--GNLQDHLNGIGEPKMDWPXXXXXX 168
           + H N++ L+          D    +LV  +M    G L  H   +GE ++ +       
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQF-----LV 134
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
                   Y+H++      I+HRD K  N+ ++ + E KI DFGLA+         V  R
Sbjct: 135 YQMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR 189
Query: 229 VLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGR 266
                 Y  PE   +  + T   D+++ G ++ E++TG+
Sbjct: 190 -----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 71/172 (41%), Gaps = 14/172 (8%)
Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXY 177
           +HP LV L          F V EY+  G+L  H+    + K+                 Y
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNY 168
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
           LH        I++RD K  NVLL +    K++D+G+ K      +T  T+   GT  Y  
Sbjct: 169 LHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIA 221
Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDL-----NQGVNDQNLVLQV 284
           PE           D +A GV++ E++ GR   D+     N   N ++ + QV
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 65  DDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           D   LGKG +G VY G   S +V +AIK  E+P  +++        E+ +   L H N+V
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIK--EIPE-RDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP-KMDWPXXXXXXXXXXXXXXYLHSSS 182
             +G  ++     +  E +  G+L   L     P K +                YLH + 
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 183 AVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                IVHRD K  NVL++  +   KISDFG +K +        T    GT  Y  PE  
Sbjct: 143 -----IVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEII 195
Query: 242 STGKLTL--QSDVYAFGVVLLELLTGR 266
             G       +D+++ G  ++E+ TG+
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 99  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 154
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 155 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 204
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 248

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 71/172 (41%), Gaps = 14/172 (8%)
Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXY 177
           +HP LV L          F V EY+  G+L  H+    + K+                 Y
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNY 121
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
           LH        I++RD K  NVLL +    K++D+G+ K      +T  T+   GT  Y  
Sbjct: 122 LHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIA 174
Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDL-----NQGVNDQNLVLQV 284
           PE           D +A GV++ E++ GR   D+     N   N ++ + QV
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 109 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 165 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 214
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 258

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 71/172 (41%), Gaps = 14/172 (8%)
Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXY 177
           +HP LV L          F V EY+  G+L  H+    + K+                 Y
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNY 125
Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
           LH        I++RD K  NVLL +    K++D+G+ K      +T  T+   GT  Y  
Sbjct: 126 LHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIA 178
Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDL-----NQGVNDQNLVLQV 284
           PE           D +A GV++ E++ GR   D+     N   N ++ + QV
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRL 117
           FS    +G+GGFG VY G  +  +G++ A+K ++  R K   GE      R+ + ++S  
Sbjct: 191 FSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 118 DHPNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPXXXXXXXXXXX 173
           D P +V +   +    K  F++ + M  G+L  HL+  G   E  M +            
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRF-----YAAEIIL 303
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA----KLMPEGQETYVTARV 229
              ++H+       +V+RD K  N+LL  +   +ISD GLA    K  P           
Sbjct: 304 GLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------- 350
Query: 230 LGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTG 265
           +GT GY  PE    G      +D ++ G +L +LL G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRL 117
           FS    +G+GGFG VY G  +  +G++ A+K ++  R K   GE      R+ + ++S  
Sbjct: 191 FSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 118 DHPNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPXXXXXXXXXXX 173
           D P +V +   +    K  F++ + M  G+L  HL+  G   E  M +            
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRF-----YAAEIIL 303
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA----KLMPEGQETYVTARV 229
              ++H+       +V+RD K  N+LL  +   +ISD GLA    K  P           
Sbjct: 304 GLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------- 350
Query: 230 LGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTG 265
           +GT GY  PE    G      +D ++ G +L +LL G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRL 117
           FS    +G+GGFG VY G  +  +G++ A+K ++  R K   GE      R+ + ++S  
Sbjct: 191 FSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 118 DHPNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPXXXXXXXXXXX 173
           D P +V +   +    K  F++ + M  G+L  HL+  G   E  M +            
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRF-----YAAEIIL 303
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA----KLMPEGQETYVTARV 229
              ++H+       +V+RD K  N+LL  +   +ISD GLA    K  P           
Sbjct: 304 GLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------- 350
Query: 230 LGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTG 265
           +GT GY  PE    G      +D ++ G +L +LL G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 110/256 (42%), Gaps = 32/256 (12%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           + D   LG GG G V+       +  VAIKK+ L   +    +H  R E+ I+ RLDH N
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV--KHALR-EIKIIRRLDHDN 69
Query: 122 LVSL--------------IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXX 167
           +V +              +G   +    ++V EYM+     D  N + +  +        
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEHARLF 125
Query: 168 XXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLM-PEGQETYV 225
                    Y+HS++     ++HRD K  N+ ++  +   KI DFGLA++M P       
Sbjct: 126 MYQLLRGLKYIHSAN-----VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 226 TARVLGTFGYFDPE-YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
            +  L T  Y  P    S    T   D++A G +  E+LTG+        +    L+L+ 
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
Query: 285 RHILN--DRKKLRKVI 298
             +++  DR++L  VI
Sbjct: 241 IPVVHEEDRQELLSVI 256

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 108 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 164 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 213
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 257

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 63  FSDDNFLGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRL 117
           FS    +G+GGFG VY G  +  +G++ A+K ++  R K   GE      R+ + ++S  
Sbjct: 190 FSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 248
Query: 118 DHPNLVSL-IGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPXXXXXXXXXXX 173
           D P +V +   +    K  F++ + M  G+L  HL+  G   E  M +            
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRF-----YAAEIIL 302
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA----KLMPEGQETYVTARV 229
              ++H+       +V+RD K  N+LL  +   +ISD GLA    K  P           
Sbjct: 303 GLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------- 349
Query: 230 LGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTG 265
           +GT GY  PE    G      +D ++ G +L +LL G
Sbjct: 350 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 96  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 152 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIM 201
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 96  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 152 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIM 201
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 96  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 152 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIM 201
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 94  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 150 D-----IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 199
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 243

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 110 EVDILSRLD-HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
           EVDIL ++  HPN++ L          FLV++ M+KG L D+L    +  +         
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIM 117
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
                    LH      + IVHRD K  N+LL  +   K++DFG +  +  G++      
Sbjct: 118 RALLEVICALHK-----LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRE 169
Query: 229 VLGTFGYFDPE---------YTSTGKLTLQSDVYAFGVVLLELLTG 265
           V GT  Y  PE         +   GK   + D+++ GV++  LL G
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAG 212

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 63  FSDDNF-----LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
             DD+F     LG G  G V K   R   ++  +K+     K A      R E+ +L   
Sbjct: 13  LKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHEC 71
Query: 118 DHPNLVSLIG-YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           + P +V   G + +DG+   +  E+M  G+L   L      ++                 
Sbjct: 72  NSPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLA 128
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA-KLMPEGQETYVTARVLGTFGY 235
           YL         I+HRD K +N+L+++  E K+ DFG++ +L+     ++V     GT  Y
Sbjct: 129 YLREKHQ----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSY 179
Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV 269
             PE       ++QSD+++ G+ L+EL  GR  +
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 85  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 141 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 190
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 110 EVDILSRLD-HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
           EVDIL ++  HPN++ L          FLV++ M+KG L D+L    +  +         
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIM 130
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
                    LH      + IVHRD K  N+LL  +   K++DFG +  +  G++      
Sbjct: 131 RALLEVICALHK-----LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRE 182
Query: 229 VLGTFGYFDPE---------YTSTGKLTLQSDVYAFGVVLLELLTG 265
           V GT  Y  PE         +   GK   + D+++ GV++  LL G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAG 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 94  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 150 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 199
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 243

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 96  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 152 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 201
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 64  SDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
            D   LGKG +G VY G   S +V +AIK  E+P  +++        E+ +   L H N+
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIK--EIPE-RDSRYSQPLHEEIALHKHLKHKNI 67
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP-KMDWPXXXXXXXXXXXXXXYLHSS 181
           V  +G  ++     +  E +  G+L   L     P K +                YLH +
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 182 SAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
                 IVHRD K  NVL++  +   KISDFG +K +        T    GT  Y  PE 
Sbjct: 128 Q-----IVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEI 180
Query: 241 TSTGKLTL--QSDVYAFGVVLLELLTGR 266
              G       +D+++ G  ++E+ TG+
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 86  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 142 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 191
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 235

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 86  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 142 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 191
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 235

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 108/261 (41%), Gaps = 28/261 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 108 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 164 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 213
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
                  Q+ D+++ G ++ ELLTGR        ++   L+L  R +     +L K I  
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL--RLVGTPGAELLKKISS 271
Query: 301 ELSRS---SYTMESIAMFANL 318
           E +R+   S T      FAN+
Sbjct: 272 ESARNYIQSLTQMPKMNFANV 292

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 71/161 (44%), Gaps = 14/161 (8%)
Query: 110 EVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
           E++IL R   HPN+++L     DGKH +LV E M+ G L D +  + +            
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI--LRQKFFSEREASFVL 127
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLL---SANFEA-KISDFGLAKLMPEGQETY 224
                   YLHS       +VHRD K +N+L    S N E  +I DFG AK +       
Sbjct: 128 HTIGKTVEYLHSQG-----VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           +T     T  +  PE           D+++ G++L  +L G
Sbjct: 183 MTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 101 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 157 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 206
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 250

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 91  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 147 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 196
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 240

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 108/261 (41%), Gaps = 28/261 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 112 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 168 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 217
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
                  Q+ D+++ G ++ ELLTGR        ++   L+L  R +     +L K I  
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL--RLVGTPGAELLKKISS 275
Query: 301 ELSRS---SYTMESIAMFANL 318
           E +R+   S T      FAN+
Sbjct: 276 ESARNYIQSLTQMPKMNFANV 296

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 101 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 157 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 206
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 250

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 110 EVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
           E++IL R   HPN+++L     DGK+ ++V E M+ G L D +  + +            
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVL 122
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLL---SANFEA-KISDFGLAKLMPEGQETY 224
                   YLH+       +VHRD K +N+L    S N E+ +I DFG AK +       
Sbjct: 123 FTITKTVEYLHAQG-----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           +T     T  +  PE           D+++ GV+L  +LTG
Sbjct: 178 MTP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 100 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 156 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 205
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 249

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 94  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 150 D-----IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 199
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 243

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 87  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 142
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 143 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 192
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 236

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 22/207 (10%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVD---ILSRLDHPNLVS 124
           +G G  G+V+K   R +G V+A+K+M     +  + E   R+ +D   +L   D P +V 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEENKRILMDLDVVLKSHDCPYIVQ 88
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             G        F+  E M  G   + L    +  +                 YL     V
Sbjct: 89  CFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               +HRD K +N+LL    + K+ DFG++  + + +      R  G   Y  PE     
Sbjct: 147 ----IHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPP 199
Query: 245 KLT-----LQSDVYAFGVVLLELLTGR 266
             T     +++DV++ G+ L+EL TG+
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 95  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 151 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 200
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 244

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 94  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 150 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 199
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 243

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 88  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 143
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 144 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 193
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 237

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 101 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 157 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 206
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 250

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 100 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 156 D-----IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 205
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 249

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 95  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 151 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 200
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 244

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 91  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 147 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 196
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 240

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 110 EVDILSRLD-HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
           EVDIL ++  HPN++ L          FLV++ M+KG L D+L    +  +         
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIM 130
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
                    LH      + IVHRD K  N+LL  +   K++DFG +  +  G++      
Sbjct: 131 RALLEVICALHK-----LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRS 182
Query: 229 VLGTFGYFDPE---------YTSTGKLTLQSDVYAFGVVLLELLTG 265
           V GT  Y  PE         +   GK   + D+++ GV++  LL G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAG 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 85  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    +V  R      Y  PE  
Sbjct: 141 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIM 190
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 108/261 (41%), Gaps = 28/261 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 109 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 165 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 214
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
                  Q+ D+++ G ++ ELLTGR        ++   L+L  R +     +L K I  
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL--RLVGTPGAELLKKISS 272
Query: 301 ELSRS---SYTMESIAMFANL 318
           E +R+   S T      FAN+
Sbjct: 273 ESARNYIQSLTQMPKMNFANV 293

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 91  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 147 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 196
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 240

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 21/223 (9%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFR 108
           +KEM+     F     +G+G FG V     K T R   +  + K E+ +  E      FR
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC---FR 122
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
            E D+L   D   + +L     D  H +LV +Y   G+L   L+   E K+         
Sbjct: 123 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKF-EDKLPEDMARFYI 181
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG-LAKLMPEGQETYVTA 227
                    +H      +  VHRD K  NVLL  N   +++DFG   K+  +G  T  ++
Sbjct: 182 GEMVLAIDSIHQ-----LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG--TVQSS 234
Query: 228 RVLGTFGYFDPEYTST-----GKLTLQSDVYAFGVVLLELLTG 265
             +GT  Y  PE         GK   + D ++ GV + E+L G
Sbjct: 235 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    +V  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 112 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 168 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRAPEIM 217
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 261

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 21/223 (9%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFR 108
           +KEM+     F     +G+G FG V     K T R   +  + K E+ +  E      FR
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC---FR 138
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
            E D+L   D   + +L     D  H +LV +Y   G+L   L+   E K+         
Sbjct: 139 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKF-EDKLPEDMARFYI 197
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG-LAKLMPEGQETYVTA 227
                    +H      +  VHRD K  NVLL  N   +++DFG   K+  +G  T  ++
Sbjct: 198 GEMVLAIDSIHQ-----LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG--TVQSS 250
Query: 228 RVLGTFGYFDPEYTST-----GKLTLQSDVYAFGVVLLELLTG 265
             +GT  Y  PE         GK   + D ++ GV + E+L G
Sbjct: 251 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    +V  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 91  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 147 D-----IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 196
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 240

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 95  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 151 D-----IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 200
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 244

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 70/161 (43%), Gaps = 14/161 (8%)
Query: 110 EVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
           E++IL R   HPN+++L     DGKH +LV E M+ G L D +  + +            
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI--LRQKFFSEREASFVL 127
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLL---SANFEA-KISDFGLAKLMPEGQETY 224
                   YLHS       +VHRD K +N+L    S N E  +I DFG AK +       
Sbjct: 128 HTIGKTVEYLHSQG-----VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           +T      F    PE           D+++ G++L  +L G
Sbjct: 183 MTPCYTANF--VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V     ++SG  +A+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                       E      L  HL G      +   K+                 Y+HS+
Sbjct: 118 VFTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 173
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R      Y  PE  
Sbjct: 174 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 223
Query: 242 -STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
            +     +  D+++ G ++ ELLTGR        +N    ++++
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRL 267

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG F  V +   + +G+  A K +   +    D   +   E  I   L HPN+V L  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD-HQKLEREARICRLLKHPNIVRLHD 70
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             ++    +LV++ +  G L + +  +                      + H +      
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASHCIQQILESVNHCHLNG----- 123
Query: 188 IVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
           IVHRD K  N+LL++  +    K++DFGLA  +   Q+ +      GT GY  PE     
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKD 181
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D++A GV+L  LL G
Sbjct: 182 PYGKPVDMWACGVILYILLVG 202

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 66  DNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLV 123
           D  LG+G F    K    +S +  A+K +   +  EA+ + E    +  L   + HPN+V
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKE----ITALKLCEGHPNIV 69
Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSA 183
            L     D  H FLV E +  G L + +    +                    ++H    
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIK--KKKHFSETEASYIMRKLVSAVSHMHD--- 124
Query: 184 VGIPIVHRDFKSTNVLLS---ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
             + +VHRD K  N+L +    N E KI DFG A+L P   +   T     T  Y  PE 
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPEL 180
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGR 266
            +        D+++ GV+L  +L+G+
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPAFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 19/226 (8%)
Query: 59  ATCSFSDDNFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
           ++  F     LG G +  VYKG  ++ G  VA+K+++L   +E       R E+ ++  L
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIR-EISLMKEL 60
Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNG--IGE-PK-MDWPXXXXXXXXXXX 173
            H N+V L           LV+E+M   +L+ +++   +G  P+ ++             
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 174 XXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
              + H +      I+HRD K  N+L++   + K+ DFGLA+       T+ +  V  T 
Sbjct: 120 GLAFCHENK-----ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TL 172
Query: 234 GYFDPEYTSTGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
            Y  P+     +    S D+++ G +L E++TG+    L  G ND+
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK---PLFPGTNDE 215

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 14/201 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG F  V +   + +G+  A K +   +    D + +   E  I   L HPN+V L  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ-KLEREARICRLLKHPNIVRLHD 70
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             ++    +LV++ +  G L + +  +                      + H +      
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASHCIQQILESVNHCHLNG----- 123
Query: 188 IVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
           IVHRD K  N+LL++  +    K++DFGLA  +   Q+ +      GT GY  PE     
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKD 181
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D++A GV+L  LL G
Sbjct: 182 PYGKPVDMWACGVILYILLVG 202

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGL +   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 17/201 (8%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V++   + +G V   K +  P   +   ++  + E+ I+++L HP L++L  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHD 115
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
              D     L+ E++  G L D +    + KM                 ++H  S     
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMHEHS----- 169
Query: 188 IVHRDFKSTNVLLSAN--FEAKISDFGLA-KLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
           IVH D K  N++         KI DFGLA KL P+      TA    T  +  PE     
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA----TAEFAAPEIVDRE 225
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
            +   +D++A GV+   LL+G
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSG 246

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 19/164 (11%)
Query: 110 EVDILSRLDHPNLVSLIGYCADGK--HRFLVYEYMQKGNLQD--HLNGIGEPKMDWPXXX 165
           E+ IL +LDHPN+V L+    D    H ++V+E + +G + +   L  + E +  +    
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARF---- 141
Query: 166 XXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV 225
                      YLH        I+HRD K +N+L+  +   KI+DFG++    +G +  +
Sbjct: 142 -YFQDLIKGIEYLHYQK-----IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALL 194
Query: 226 TARVLGTFGYFDPEYTSTGKLTLQS---DVYAFGVVLLELLTGR 266
           +  V GT  +  PE  S  +        DV+A GV L   + G+
Sbjct: 195 SNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 139 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI D+GLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 139 YIHSAN-----VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 84
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 141 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 139 YIHSAN-----VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 102
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGLK 158
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 159 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 213
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 18/208 (8%)
Query: 67  NFLGKGGFGRVYKGTLRSGEVV---AIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV 123
           + LG+G +G+V K  L S  +         +    +  +GE   + E+ +L RL H N++
Sbjct: 11  DLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 124 SLIG--YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
            L+   Y  + +  ++V EY   G +Q+ L+ + E +                  YLHS 
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-LMPEGQETYVTARVLGTFGYFDPEY 240
                 IVH+D K  N+LL+     KIS  G+A+ L P   +   T R       F P  
Sbjct: 129 G-----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD--TCRTSQGSPAFQPPE 181
Query: 241 TSTGKLTLQS---DVYAFGVVLLELLTG 265
            + G  T      D+++ GV L  + TG
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNLVSL 125
           +GKG F  V +   R +G+  A+K +++ +F  + G    + + E  I   L HP++V L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 126 I-GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXX--XXXXXXXXXYLHSSS 182
           +  Y +DG   ++V+E+M   +L   +    +    +                 Y H ++
Sbjct: 94  LETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 152
Query: 183 AVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I+HRD K   VLL++   +   K+  FG+A  +  G+   V    +GT  +  PE
Sbjct: 153 -----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 205
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      DV+  GV+L  LL+G
Sbjct: 206 VVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 90
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 146
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 147 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 201
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 202 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 139 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNLVSL 125
           +GKG F  V +   R +G+  A+K +++ +F  + G    + + E  I   L HP++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 126 I-GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXX--XXXXXXXXXYLHSSS 182
           +  Y +DG   ++V+E+M   +L   +    +    +                 Y H ++
Sbjct: 92  LETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 183 AVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I+HRD K   VLL++   +   K+  FG+A  +  G+   V    +GT  +  PE
Sbjct: 151 -----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 203
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      DV+  GV+L  LL+G
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 80
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 137 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 191
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 192 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 80
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 137 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 191
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 192 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 87
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 144 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 198
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 199 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 88
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 144
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 145 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 199
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 200 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 79
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 135
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 136 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 190
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 191 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 143 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 143 YIHSAN-----VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 82
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 139 YIHSAN-----VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 143 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWY 197
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 87
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 144 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWY 198
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 199 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 104/246 (42%), Gaps = 35/246 (14%)
Query: 43  KRHRGSSVFTLKEMEEATCSFS-DDNFLGKGGFGRV-YKGTLRSGEVVAIKKMELPRFKE 100
           K+ R S +  +   E++  +    +  LG G  G V ++G+ + G  VA+K+M +     
Sbjct: 14  KKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDI 72
Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD 160
           A  E +   E D     DHPN++    YC++   RFL Y  ++  NL  +L  + E K  
Sbjct: 73  ALMEIKLLTESD-----DHPNVIRY--YCSETTDRFL-YIALELCNL--NLQDLVESKNV 122
Query: 161 WPXXXXXXXXXXXXXXYLHSSSAVG----IPIVHRDFKSTNVLLSA-------------N 203
                               +S V     + I+HRD K  N+L+S              N
Sbjct: 123 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 182
Query: 204 FEAKISDFGLAKLMPEGQETYVT--ARVLGTFGYFDPEY---TSTGKLTLQSDVYAFGVV 258
               ISDFGL K +  GQ  +        GT G+  PE    ++  +LT   D+++ G V
Sbjct: 183 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242
Query: 259 LLELLT 264
              +L+
Sbjct: 243 FYYILS 248

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYXQRTLR-EIKILLRFRHEN 86
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 143 YIHSAN-----VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 104/246 (42%), Gaps = 35/246 (14%)
Query: 43  KRHRGSSVFTLKEMEEATCSFS-DDNFLGKGGFGRV-YKGTLRSGEVVAIKKMELPRFKE 100
           K+ R S +  +   E++  +    +  LG G  G V ++G+ + G  VA+K+M +     
Sbjct: 14  KKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDI 72
Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD 160
           A  E +   E D     DHPN++    YC++   RFL Y  ++  NL  +L  + E K  
Sbjct: 73  ALMEIKLLTESD-----DHPNVIRY--YCSETTDRFL-YIALELCNL--NLQDLVESKNV 122
Query: 161 WPXXXXXXXXXXXXXXYLHSSSAVG----IPIVHRDFKSTNVLLSA-------------N 203
                               +S V     + I+HRD K  N+L+S              N
Sbjct: 123 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 182
Query: 204 FEAKISDFGLAKLMPEGQETYVT--ARVLGTFGYFDPEY---TSTGKLTLQSDVYAFGVV 258
               ISDFGL K +  GQ  +        GT G+  PE    ++  +LT   D+++ G V
Sbjct: 183 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242
Query: 259 LLELLT 264
              +L+
Sbjct: 243 FYYILS 248

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 86/205 (41%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG--EVVA--IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S   E  A  IKK +    +      E   EV IL ++ HPN+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLH+    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              I H D K  N+ LL  N      K+ DFGLA  + +G E      + GT  +  PE 
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEI 189
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DF LA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 109 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +     V  R      Y  PE  
Sbjct: 165 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WYRAPEIM 214
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 258

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAIKK+  P   +   +   R E+ IL R  H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKCQHLSNDHICYFLYQILRGLK 142
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 143 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 38/226 (16%)
Query: 66  DNFLGKGGFGRV-YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +  LG G  G V ++G+ + G  VA+K+M +     A  E +   E D     DHPN++ 
Sbjct: 20  EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESD-----DHPNVIR 73
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
              YC++   RFL Y  ++  NL  +L  + E K                      +S V
Sbjct: 74  Y--YCSETTDRFL-YIALELCNL--NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 185 G----IPIVHRDFKSTNVLLSA-------------NFEAKISDFGLAKLMPEGQETYVT- 226
                + I+HRD K  N+L+S              N    ISDFGL K +  GQ ++ T 
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 227 -ARVLGTFGYFDPE-------YTSTGKLTLQSDVYAFGVVLLELLT 264
                GT G+  PE         +  +LT   D+++ G V   +L+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 78/201 (38%), Gaps = 11/201 (5%)
Query: 68  FLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LGKG FG+V     + +G   A+K ++       D       E  +L    HP L +L 
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 217
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                      V EY   G L  HL+   E                    YLHS   V  
Sbjct: 218 YSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNV-- 273
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTSTGK 245
             V+RD K  N++L  +   KI+DFGL K   EG +   T +   GT  Y  PE      
Sbjct: 274 --VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDND 328
Query: 246 LTLQSDVYAFGVVLLELLTGR 266
                D +  GVV+ E++ GR
Sbjct: 329 YGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 78/201 (38%), Gaps = 11/201 (5%)
Query: 68  FLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LGKG FG+V     + +G   A+K ++       D       E  +L    HP L +L 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                      V EY   G L  HL+   E                    YLHS   V  
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNV-- 270
Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTSTGK 245
             V+RD K  N++L  +   KI+DFGL K   EG +   T +   GT  Y  PE      
Sbjct: 271 --VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 246 LTLQSDVYAFGVVLLELLTGR 266
                D +  GVV+ E++ GR
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGR 346

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F  V +   L +G   A K +   +    D + +   E  I   L H N+V L  
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ-KLEREARICRLLKHSNIVRLHD 70
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
             ++    +LV++ +  G L + +      +  +                LH      + 
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ---MG 123
Query: 188 IVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
           +VHRD K  N+LL++  +    K++DFGLA  +   Q+ +      GT GY  PE     
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKE 181
Query: 245 KLTLQSDVYAFGVVLLELLTG 265
                 D++A GV+L  LL G
Sbjct: 182 AYGKPVDIWACGVILYILLVG 202

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V        +V VAI+K+  P   +   +   R E+ IL R  H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKIS-PFEHQTYCQRTLR-EIKILLRFRHEN 86
Query: 122 LVSL-----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           ++ +            K  ++V + M+     D    +    +                 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 143 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 19/236 (8%)
Query: 62  SFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           + S    LG G FG+V+K     +G  +A K ++    K+ +   E + E+ ++++LDH 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE---EVKNEISVMNQLDHA 146
Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP-KMDWPXXXXXXXXXXXXXXYLH 179
           NL+ L           LV EY+  G L D +  I E   +                 ++H
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIRHMH 204
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYF 236
                 + I+H D K  N+ L  N +A   KI DFGLA+     ++  V     GT  + 
Sbjct: 205 Q-----MYILHLDLKPENI-LCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFL 255
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK 292
            PE  +   ++  +D+++ GV+   LL+G      +      N +L  R  L D +
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI DFGLA+   +     V  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI  FGLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 69  LGKGGFGRVYKGTLRSGE-VVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V    L++ + V A+K   K E+ +  E      FR E D+L   D   + +
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVNGDSKWITT 138
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     D  + +LV +Y   G+L   L+   E ++                  +H     
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---- 193
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFG-LAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
            +  VHRD K  N+L+  N   +++DFG   KLM +G  T  ++  +GT  Y  PE    
Sbjct: 194 -LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEILQA 250
Query: 244 -----GKLTLQSDVYAFGVVLLELLTG 265
                G+   + D ++ GV + E+L G
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 19/227 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           ++ +N +G+G +G V K  ++ G  +     ++P++   D +  F+ E++I+  LDHPN+
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNI 68
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           + L     D    +LV E    G L + +  + +                    Y H   
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCHK-- 124
Query: 183 AVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
              + + HRD K  N L    S +   K+ DFGLA     G+   +    +GT  Y  P+
Sbjct: 125 ---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQ 178
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH 286
               G    + D ++ GV++  LL G           D  ++L++R 
Sbjct: 179 VLE-GLYGPECDEWSAGVMMYVLLCGYPPF---SAPTDXEVMLKIRE 221

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 131
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 187
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 19/227 (8%)
Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           ++ +N +G+G +G V K  ++ G  +     ++P++   D +  F+ E++I+  LDHPN+
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNI 85
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           + L     D    +LV E    G L + +  + +                    Y H   
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCHK-- 141
Query: 183 AVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
              + + HRD K  N L    S +   K+ DFGLA     G+   +    +GT  Y  P+
Sbjct: 142 ---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQ 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH 286
               G    + D ++ GV++  LL G           D  ++L++R 
Sbjct: 196 VLE-GLYGPECDEWSAGVMMYVLLCGYPPF---SAPTDXEVMLKIRE 238

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+L++   + KI DFGLA++  PE   T      + T  Y
Sbjct: 159 YIHSAN-----VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 131
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 187
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI D GLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 62  SFSDDNFLGKGGFGR-VYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           SF   + LG G  G  VY+G   + +V A+K++    F  AD E +   E D     +HP
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDV-AVKRILPECFSFADREVQLLRESD-----EHP 78
Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
           N++       D + +++  E +    LQ+++       +                 +LHS
Sbjct: 79  NVIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGL-EPITLLQQTTSGLAHLHS 136
Query: 181 SSAVGIPIVHRDFKSTNVLLS-----ANFEAKISDFGLAKLMPEGQETYV-TARVLGTFG 234
                + IVHRD K  N+L+S        +A ISDFGL K +  G+ ++   + V GT G
Sbjct: 137 -----LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 235 YFDPEYTSTG---KLTLQSDVYAFGVVLLELLT 264
           +  PE  S       T   D+++ G V   +++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 100/263 (38%), Gaps = 55/263 (20%)
Query: 69  LGKGGFGRVYKGTLRSGEVV-AIKKMELPRFKEADGE--HEFRVEVDILSRLDHPNLVSL 125
           +G+G +G V          + AIK M   + ++ + +     + EV ++ +L HPN+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLN-----GIGEPKMDW------------------- 161
                D ++  LV E    G+L D LN       G+  MD                    
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 162 --------------PXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSAN--FE 205
                                        YLH+       I HRD K  N L S N  FE
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-----ICHRDIKPENFLFSTNKSFE 208
Query: 206 AKISDFGLAKLMPE--GQETYVTARVLGTFGYFDPEYTSTGKLTL--QSDVYAFGVVLLE 261
            K+ DFGL+K   +    E Y      GT  +  PE  +T   +   + D ++ GV+L  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 262 LLTGRRAVDLNQGVNDQNLVLQV 284
           LL G  AV    GVND + + QV
Sbjct: 269 LLMG--AVPF-PGVNDADTISQV 288

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G +G V   Y   LR  + VA+KK+  P          +R E+ +L  L H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 126 IGY------CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +          D    +LV   M      D  N +    +                 Y+H
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGA----DLNNIVKSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +NV ++ + E +I DFGLA+   E    YV  R      Y  PE
Sbjct: 149 SAG-----IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPE 198
Query: 240 YTSTGKLTLQS-DVYAFGVVLLELLTGR 266
                    Q+ D+++ G ++ ELL G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 78/202 (38%), Gaps = 11/202 (5%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKG FG+V     + +G   A+K ++       D       E  +L    HP L +L
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 73
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
                       V EY   G L  HL+   E                    YLHS   V 
Sbjct: 74  KYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNV- 130
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTSTG 244
              V+RD K  N++L  +   KI+DFGL K   EG +   T +   GT  Y  PE     
Sbjct: 131 ---VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 245 KLTLQSDVYAFGVVLLELLTGR 266
                 D +  GVV+ E++ GR
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI D GLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 78/202 (38%), Gaps = 11/202 (5%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKG FG+V     + +G   A+K ++       D       E  +L    HP L +L
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
                       V EY   G L  HL+   E                    YLHS   V 
Sbjct: 76  KYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNV- 132
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTSTG 244
              V+RD K  N++L  +   KI+DFGL K   EG +   T +   GT  Y  PE     
Sbjct: 133 ---VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 245 KLTLQSDVYAFGVVLLELLTGR 266
                 D +  GVV+ E++ GR
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 28/242 (11%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKK-MELPRFKEADGEHEFRVEVD 112
           K  E+   ++++   +G G FG V++  L   + VAIKK ++  RFK          E+ 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR--------ELQ 84
Query: 113 ILSRLDHPNLVSLIGYC---ADGKHRF---LVYEYMQKG--NLQDHLNGIGEPKMDWPXX 164
           I+  + HPN+V L  +     D K      LV EY+ +       H   + +  M     
Sbjct: 85  IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQ-TMPMLLI 143
Query: 165 XXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLL-SANFEAKISDFGLAKLMPEGQET 223
                       Y+HS     I I HRD K  N+LL   +   K+ DFG AK++  G+  
Sbjct: 144 KLYMYQLLRSLAYIHS-----IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP- 197
Query: 224 YVTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL 282
                 + +  Y  PE        T   D+++ G V+ EL+ G+       G++    ++
Sbjct: 198 --NVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII 255
Query: 283 QV 284
           +V
Sbjct: 256 KV 257

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 78/202 (38%), Gaps = 11/202 (5%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKG FG+V     + +G   A+K ++       D       E  +L    HP L +L
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVG 185
                       V EY   G L  HL+   E                    YLHS   V 
Sbjct: 75  KYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNV- 131
Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTSTG 244
              V+RD K  N++L  +   KI+DFGL K   EG +   T +   GT  Y  PE     
Sbjct: 132 ---VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 245 KLTLQSDVYAFGVVLLELLTGR 266
                 D +  GVV+ E++ GR
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 78/203 (38%), Gaps = 14/203 (6%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKG FG+V     + +G   A+K +        D       E  +L    HP L +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 126 IGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             Y      R   V EY   G L  HL+   E                    YLHS    
Sbjct: 71  -KYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD-- 125
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTST 243
              +V+RD K  N++L  +   KI+DFGL K   EG     T +   GT  Y  PE    
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
                  D +  GVV+ E++ GR
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 78/203 (38%), Gaps = 14/203 (6%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKG FG+V     + +G   A+K +        D       E  +L    HP L +L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 126 IGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             Y      R   V EY   G L  HL+   E                    YLHS    
Sbjct: 74  -KYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD-- 128
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTST 243
              +V+RD K  N++L  +   KI+DFGL K   EG     T +   GT  Y  PE    
Sbjct: 129 ---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 182
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
                  D +  GVV+ E++ GR
Sbjct: 183 NDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 141 YIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 78/203 (38%), Gaps = 14/203 (6%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKG FG+V     + +G   A+K +        D       E  +L    HP L +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 126 IGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             Y      R   V EY   G L  HL+   E                    YLHS    
Sbjct: 71  -KYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD-- 125
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTST 243
              +V+RD K  N++L  +   KI+DFGL K   EG     T +   GT  Y  PE    
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
                  D +  GVV+ E++ GR
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNG------IGEPKMDWPXXXXXXXXXXXXXXYLHSS 181
                +      E      L  HL G      +   K+                 Y+HS+
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+ ++ + E KI D GLA+   +    YV  R      Y  PE  
Sbjct: 145 D-----IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WYRAPEIM 194
Query: 242 STGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
                  Q+ D+++ G ++ ELLTGR        ++   L+L++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G +G V   Y   LR  + VA+KK+  P          +R E+ +L  L H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 126 IGY------CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +          D    +LV   M      D  N +    +                 Y+H
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGA----DLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +NV ++ + E +I DFGLA+   E    YV  R      Y  PE
Sbjct: 141 SAG-----IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPE 190
Query: 240 YTSTGKLTLQS-DVYAFGVVLLELLTGR 266
                    Q+ D+++ G ++ ELL G+
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 42/279 (15%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV--EVDILSR-LDHPNLVS 124
           LG+G +G V K   + SG++ A+K++        + + + R+  ++DI  R +D P  V+
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIR----ATVNSQEQKRLLXDLDISXRTVDCPFTVT 97
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             G        ++  E +   +L      + +     P                H  S +
Sbjct: 98  FYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGL--------AKLMPEGQETYVTARVLGTFGYF 236
            +  +HRD K +NVL++A  + K  DFG+        AK +  G + Y     +      
Sbjct: 157 SV--IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERI------ 208
Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK 296
           +PE    G  +++SD+++ G+  +EL   R   D + G   Q L           K++ +
Sbjct: 209 NPELNQKG-YSVKSDIWSLGITXIELAILRFPYD-SWGTPFQQL-----------KQVVE 255
Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
              P+L    ++ E    F +  S+C++  S ERP+  E
Sbjct: 256 EPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPE 290

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 14/161 (8%)
Query: 110 EVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
           E++IL R   HPN+++L     DGK+ ++V E  + G L D +  + +            
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKI--LRQKFFSEREASAVL 122
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLL---SANFEA-KISDFGLAKLMPEGQETY 224
                   YLH+       +VHRD K +N+L    S N E+ +I DFG AK +    E  
Sbjct: 123 FTITKTVEYLHAQG-----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENG 175
Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           +      T  +  PE           D+++ GV+L   LTG
Sbjct: 176 LLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL-- 125
           +G G +G V     R +G+ VAIKK+        + +   R E+ IL    H N++++  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAIKD 120
Query: 126 -----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
                + Y  + K  ++V + M+  +L   ++   +P +                 Y+HS
Sbjct: 121 ILRPTVPY-GEFKSVYVVLDLME-SDLHQIIHS-SQP-LTLEHVRYFLYQLLRGLKYMHS 176
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK--LMPEGQETYVTARVLGTFGYFDP 238
           +      ++HRD K +N+L++ N E KI DFG+A+       +  Y     + T  Y  P
Sbjct: 177 AQ-----VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231
Query: 239 EYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
           E   S  + T   D+++ G +  E+L  R+       V+   L++ V
Sbjct: 232 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 78/203 (38%), Gaps = 14/203 (6%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKG FG+V     + +G   A+K +        D       E  +L    HP L +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 126 IGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             Y      R   V EY   G L  HL+   E                    YLHS    
Sbjct: 71  -KYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD-- 125
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTST 243
              +V+RD K  N++L  +   KI+DFGL K   EG     T +   GT  Y  PE    
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
                  D +  GVV+ E++ GR
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL-- 125
           +G G +G V     R +G+ VAIKK+        + +   R E+ IL    H N++++  
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAIKD 121
Query: 126 -----IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHS 180
                + Y  + K  ++V + M+  +L   ++   +P +                 Y+HS
Sbjct: 122 ILRPTVPY-GEFKSVYVVLDLME-SDLHQIIHS-SQP-LTLEHVRYFLYQLLRGLKYMHS 177
Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK--LMPEGQETYVTARVLGTFGYFDP 238
           +      ++HRD K +N+L++ N E KI DFG+A+       +  Y     + T  Y  P
Sbjct: 178 AQ-----VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232
Query: 239 EYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
           E   S  + T   D+++ G +  E+L  R+       V+   L++ V
Sbjct: 233 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 279

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 78/203 (38%), Gaps = 14/203 (6%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKG FG+V     + +G   A+K +        D       E  +L    HP L +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 126 IGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             Y      R   V EY   G L  HL+   E                    YLHS    
Sbjct: 71  -KYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD-- 125
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTST 243
              +V+RD K  N++L  +   KI+DFGL K   EG     T +   GT  Y  PE    
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
                  D +  GVV+ E++ GR
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 78/203 (38%), Gaps = 14/203 (6%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKG FG+V     + +G   A+K +        D       E  +L    HP L +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 126 IGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             Y      R   V EY   G L  HL+   E                    YLHS    
Sbjct: 71  -KYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD-- 125
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTST 243
              +V+RD K  N++L  +   KI+DFGL K   EG     T +   GT  Y  PE    
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
                  D +  GVV+ E++ GR
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S         IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLHS    
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS---- 132
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N+ LL  N      KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 188
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 78/203 (38%), Gaps = 14/203 (6%)
Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKG FG+V     + +G   A+K +        D       E  +L    HP L +L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 126 IGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
             Y      R   V EY   G L  HL+   E                    YLHS    
Sbjct: 76  -KYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD-- 130
Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-GTFGYFDPEYTST 243
              +V+RD K  N++L  +   KI+DFGL K   EG     T +   GT  Y  PE    
Sbjct: 131 ---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVLED 184
Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
                  D +  GVV+ E++ GR
Sbjct: 185 NDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
            HRD K  N+L+SA+  A + DFG+A    + + T +    +GT  Y  PE  S    T 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL-GNTVGTLYYXAPERFSESHATY 214
Query: 249 QSDVYAFGVVLLELLTG 265
           ++D+YA   VL E LTG
Sbjct: 215 RADIYALTCVLYECLTG 231

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM-PEGQETYVTARVLGTFGY 235
           Y+HS++     ++HRD K +N+LL+   + KI DFGLA++  P+   T      + T  Y
Sbjct: 141 YIHSAN-----VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 236 FDPEYTSTGK-LTLQSDVYAFGVVLLELLTGR 266
             PE     K  T   D+++ G +L E+L+ R
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 113/282 (40%), Gaps = 35/282 (12%)
Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEH-----EFRVEVDILSRLDHPNL 122
           LG+G F +++KG  R  G+   + + E+   K  D  H      F     ++S+L H +L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEV-LLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V   G C  G    LV E+++ G+L  +L    +  ++                +L  ++
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL--GTFGYFDPEY 240
                ++H +  + N+LL    + K  +    KL   G    V  + +      +  PE 
Sbjct: 134 -----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 241 TSTGK-LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
               K L L +D ++FG  L E+ +G           D+ L       L+ ++KL+   D
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSG----------GDKPL-----SALDSQRKLQFYED 233
Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
               R        A  ANL + C+  E   RPS    +++L 
Sbjct: 234 ----RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G +G V   Y   LR  + VA+KK+  P          +R E+ +L  L H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 126 IGY------CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +          D    +LV   M      D  N +    +                 Y+H
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGA----DLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +NV ++ + E +I DFGLA+   E    YV  R      Y  PE
Sbjct: 149 SAG-----IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPE 198
Query: 240 YTSTGKLTLQS-DVYAFGVVLLELLTGR 266
                    Q+ D+++ G ++ ELL G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD  + N+LLS     KI DFGLA+ + +  +            +  PE       T+
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 249 QSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
           QSDV++FGV+L E+ +         GV  D+    +++     R +      PE+ ++  
Sbjct: 282 QSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRMRAPDYTTPEMYQTML 337
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
                         C   E S+RP+ +E V+ L  ++  N++
Sbjct: 338 D-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 366

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 113/282 (40%), Gaps = 35/282 (12%)
Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEH-----EFRVEVDILSRLDHPNL 122
           LG+G F +++KG  R  G+   + + E+   K  D  H      F     ++S+L H +L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEV-LLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
           V   G C  G    LV E+++ G+L  +L    +  ++                +L  ++
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAWAMHFLEENT 133
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL--GTFGYFDPEY 240
                ++H +  + N+LL    + K  +    KL   G    V  + +      +  PE 
Sbjct: 134 -----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 241 TSTGK-LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
               K L L +D ++FG  L E+ +G           D+ L       L+ ++KL+   D
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSG----------GDKPL-----SALDSQRKLQFYED 233
Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
               R        A  ANL + C+  E   RPS    +++L 
Sbjct: 234 ----RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD  + N+LLS     KI DFGLA+ + +  +            +  PE       T+
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 249 QSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
           QSDV++FGV+L E+ +         GV  D+    +++     R +      PE+ ++  
Sbjct: 280 QSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRMRAPDYTTPEMYQTML 335
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
                         C   E S+RP+ +E V+ L  ++  N++
Sbjct: 336 D-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 364

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 22/204 (10%)
Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G VYK     + E VAIK++ L   +E       R EV +L  L H N++ L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKS 100
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
                    L++EY +  +L+ +++    P +                 + HS       
Sbjct: 101 VIHHNHRLHLIFEYAE-NDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSRRC---- 153
Query: 188 IVHRDFKSTNVLLSANFEA-----KISDFGLAKL--MPEGQETYVTARVLGTFGYFDPE- 239
            +HRD K  N+LLS +  +     KI DFGLA+   +P  Q T+     + T  Y  PE 
Sbjct: 154 -LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH----EIITLWYRPPEI 208
Query: 240 YTSTGKLTLQSDVYAFGVVLLELL 263
              +   +   D+++   +  E+L
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD  + N+LLS     KI DFGLA+ + +  +            +  PE       T+
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 249 QSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
           QSDV++FGV+L E+ +         GV  D+    +++     R +      PE+ ++  
Sbjct: 275 QSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRMRAPDYTTPEMYQTML 330
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
                         C   E S+RP+ +E V+ L  ++  N++
Sbjct: 331 D-------------CWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 17/189 (8%)
Query: 58  EATCSFSDDNFLGKGGFGRVYKGT--LRSGEVVA--IKKMELPR--FKEADGEHEFRVEV 111
           E +  +S  + LG G FG V+      ++ EVV   IKK ++    + E     +  +E+
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 112 DILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG-EPKMDWPXXXXXXXX 170
            ILSR++H N++ ++    +     LV E  + G+  D    I   P++D P        
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 171 XXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL 230
                 YL         I+HRD K  N++++ +F  K+ DFG A  +  G+  Y      
Sbjct: 139 LVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 231 GTFGYFDPE 239
           GT  Y  PE
Sbjct: 191 GTIEYCAPE 199

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 38/226 (16%)
Query: 66  DNFLGKGGFGRV-YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +  LG G  G V ++G+ + G  VA+K+M +     A  E +   E D     DHPN++ 
Sbjct: 20  EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESD-----DHPNVIR 73
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
              YC++   RFL Y  ++  NL  +L  + E K                      +S V
Sbjct: 74  Y--YCSETTDRFL-YIALELCNL--NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 185 G----IPIVHRDFKSTNVLLSA-------------NFEAKISDFGLAKLMPEGQETYVT- 226
                + I+HRD K  N+L+S              N    ISDFGL K +  GQ  +   
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN 188
Query: 227 -ARVLGTFGYFDPE-------YTSTGKLTLQSDVYAFGVVLLELLT 264
                GT G+  PE         +  +LT   D+++ G V   +L+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD  + N+LLS     KI DFGLA+ + +  +            +  PE       T+
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 249 QSDVYAFGVVLLELLTGRRAVDLNQGVN-DQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
           QSDV++FGV+L E+ +         GV  D+    +++     R +      PE+ ++  
Sbjct: 273 QSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRLKE--GTRMRAPDYTTPEMYQTML 328
Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
                         C   E S+RP+ +E V+ L  ++  N+
Sbjct: 329 D-------------CWHGEPSQRPTFSELVEHLGNLLQANA 356

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M       +L+ + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDA-----NLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ GV++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M       +L+ + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDA-----NLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ GV++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 35/225 (15%)
Query: 69  LGKGGFGRV-YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+GGF  V     L  G   A+K++      E     E + E D+    +HPN++ L+ 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 128 YCA---DGKHR-FLVYEYMQKGN-------LQDHLNGIGEPKMDWPXXXXXXXXXXXXXX 176
           YC      KH  +L+  + ++G        L+D  N + E ++ W               
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW--------LLLGICR 145
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG---LAKLMPEGQETYVT----ARV 229
            L +  A G    HRD K TN+LL    +  + D G    A +  EG    +T    A  
Sbjct: 146 GLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 230 LGTFGYFDPEYTSTGKLTL---QSDVYAFGVVLLELLTGRRAVDL 271
             T  Y  PE  S     +   ++DV++ G VL  ++ G    D+
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG--EVVA--IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S   E  A  IKK +    +      E   EV IL ++ H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLH+    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              I H D K  N+ LL  N      K+ DFGLA  + +G E      + GT  +  PE 
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEI 189
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG--EVVA--IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S   E  A  IKK +    +      E   EV IL ++ H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLH+    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              I H D K  N+ LL  N      K+ DFGLA  + +G E      + GT  +  PE 
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEI 189
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG--EVVA--IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S   E  A  IKK +    +      E   EV IL ++ H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLH+    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              I H D K  N+ LL  N      K+ DFGLA  + +G E      + GT  +  PE 
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEI 189
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG--EVVA--IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S   E  A  IKK +    +      E   EV IL ++ H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLH+    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              I H D K  N+ LL  N      K+ DFGLA  + +G E      + GT  +  PE 
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEI 189
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M       +L  + + ++D                +LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDA-----NLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 69  LGKGGFGRVYKGTLRSG--EVVA--IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S   E  A  IKK +    +      E   EV IL ++ H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +                 YLH+    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 185 GIPIVHRDFKSTNV-LLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
              I H D K  N+ LL  N      K+ DFGLA  + +G E      + GT  +  PE 
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEI 189
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
            +   L L++D+++ GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M       +L  + + ++D                +LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDA-----NLXQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 85/202 (42%), Gaps = 20/202 (9%)
Query: 88  VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK------HRFLVYEY 141
           VA+KK+  P   +   +  +R E+ +L  ++H N++SL+      K        +LV E 
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 142 MQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLS 201
           M     Q     +   ++D                +LHS+      I+HRD K +N+++ 
Sbjct: 111 MDANLCQ-----VIHMELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVK 160
Query: 202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLE 261
           ++   KI DFGLA+        ++    + T  Y  PE           D+++ G ++ E
Sbjct: 161 SDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGE 217
Query: 262 LLTGRRAVDLNQGVNDQNLVLQ 283
           L+ G         ++  N V++
Sbjct: 218 LVKGCVIFQGTDHIDQWNKVIE 239

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M     Q     + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPEVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ G ++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 85/202 (42%), Gaps = 20/202 (9%)
Query: 88  VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK------HRFLVYEY 141
           VA+KK+  P   +   +  +R E+ +L  ++H N++SL+      K        +LV E 
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 108
Query: 142 MQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLS 201
           M     Q     +   ++D                +LHS+      I+HRD K +N+++ 
Sbjct: 109 MDANLCQ-----VIHMELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVK 158
Query: 202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLE 261
           ++   KI DFGLA+        ++    + T  Y  PE           D+++ G ++ E
Sbjct: 159 SDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215
Query: 262 LLTGRRAVDLNQGVNDQNLVLQ 283
           L+ G         ++  N V++
Sbjct: 216 LVKGSVIFQGTDHIDQWNKVIE 237

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 48  SSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEF 107
           +S+F L+E +           +GKG FG+VY G    GE VAI+ +++ R  E D    F
Sbjct: 21  TSIF-LQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNE-DQLKAF 76
Query: 108 RVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXX 167
           + EV    +  H N+V  +G C    H   +   + KG     +    +  +D       
Sbjct: 77  KREVMAYRQTRHENVVLFMGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQI 135
Query: 168 XXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL---AKLMPEGQETY 224
                    YLH+       I+H+D KS NV    N +  I+DFGL   + ++  G+   
Sbjct: 136 AQEIVKGMGYLHAKG-----ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED 189
Query: 225 VTARVLGTFGYFDPEY-------TSTGKLTL--QSDVYAFGVVLLEL 262
                 G   +  PE        T   KL     SDV+A G +  EL
Sbjct: 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M       +L+ + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDA-----NLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ G ++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M       +L+ + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDA-----NLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ G ++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M       +L  + + ++D                +LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDA-----NLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 106/259 (40%), Gaps = 41/259 (15%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 182 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 233
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ----------NLVLQ 283
                      D+++ G ++ E      L  GR  +D    V +Q           L   
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293
Query: 284 VRHILNDRKKLRKVIDPEL 302
           VR+ + +R K   +  P+L
Sbjct: 294 VRNYVENRPKYAGLTFPKL 312

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 138 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 189
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 87
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 142
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 143 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 194
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 195 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 145 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 196
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 106/259 (40%), Gaps = 41/259 (15%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 182 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 233
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ----------NLVLQ 283
                      D+++ G ++ E      L  GR  +D    V +Q           L   
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293
Query: 284 VRHILNDRKKLRKVIDPEL 302
           VR+ + +R K   +  P+L
Sbjct: 294 VRNYVENRPKYAGLTFPKL 312

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 145 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 196
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M       +L+ + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDA-----NLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ G ++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M       +L  + + ++D                +LH
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDA-----NLXQVIQMELDHERMSYLLYQMLXGIKHLH 136
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 137 SAG-----IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 188
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 137 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 188
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M       +L+ + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDA-----NLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ G ++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++SL
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 126 IGYCADGK------HRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        +LV E M     Q     + + ++D                +LH
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 138 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 189
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M     Q     + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ G ++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 69  LGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G FG V++    ++G   A+KK+ L  F+          E+   + L  P +V L G
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE--------ELMACAGLTSPRIVPLYG 133
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
              +G    +  E ++ G+L   +   G    D                YLHS       
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPED--RALYYLGQALEGLEYLHSRR----- 186
Query: 188 IVHRDFKSTNVLLSAN-FEAKISDFGLA-KLMPE--GQETYVTARVLGTFGYFDPEYTST 243
           I+H D K+ NVLLS++   A + DFG A  L P+  G++      + GT  +  PE    
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
                + DV++   ++L +L G
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M     Q     + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ G ++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M     Q     + + ++D                +LH
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 145 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 196
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 93/247 (37%), Gaps = 49/247 (19%)
Query: 60  TCSFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD 118
              F +   LG+G FG+V K          AIKK+     K +        EV +L+ L+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLLASLN 60
Query: 119 HP-------------NLVSLIGYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPX 163
           H              N V  +         F+  EY + G L D  H   + + + ++  
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY-- 118
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-------- 215
                        Y+HS       I+HRD K  N+ +  +   KI DFGLAK        
Sbjct: 119 -WRLFRQILEALSYIHSQG-----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 216 ------LMPEGQETYVTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELL----T 264
                  +P   +   +A  +GT  Y   E    TG    + D+Y+ G++  E++    T
Sbjct: 173 LKLDSQNLPGSSDNLTSA--IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
Query: 265 GRRAVDL 271
           G   V++
Sbjct: 231 GMERVNI 237

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 69  LGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVE-VDILSRLDHPNLVSLI 126
           LG+G FG V++    ++G   A+KK+ L           FRVE +   + L  P +V L 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRL---------EVFRVEELVACAGLSSPRIVPLY 130
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G   +G    +  E ++ G+L   +  +G    D                YLH+      
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLGQALEGLEYLHTRR---- 184
Query: 187 PIVHRDFKSTNVLLSAN-FEAKISDFGLA-KLMPEG-QETYVTARVL-GTFGYFDPEYTS 242
            I+H D K+ NVLLS++   A + DFG A  L P+G  ++ +T   + GT  +  PE   
Sbjct: 185 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 243
Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++   ++L +L G
Sbjct: 244 GKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 90
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M       +L  + + ++D                +LH
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMDA-----NLCQVIQMELDHERMSYLLYQMLCGIKHLH 145
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+       +++    + T  Y  PE
Sbjct: 146 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMVPFVVTRYYRAPE 197
Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
                      D+++ G ++ E++ G
Sbjct: 198 VILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 20/202 (9%)
Query: 69  LGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G FG V++    ++G   A+KK+ L  F+          E+   + L  P +V L G
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE--------ELMACAGLTSPRIVPLYG 152
Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIP 187
              +G    +  E ++ G+L   +   G    D                YLHS       
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPED--RALYYLGQALEGLEYLHSRR----- 205
Query: 188 IVHRDFKSTNVLLSAN-FEAKISDFGLA-KLMPE--GQETYVTARVLGTFGYFDPEYTST 243
           I+H D K+ NVLLS++   A + DFG A  L P+  G+       + GT  +  PE    
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
                + DV++   ++L +L G
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 69  LGKGGFG--RVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           +G G FG  R+ +  L + E+VA+K +E    + A  +   + E+     L HPN+V   
Sbjct: 28  IGSGNFGVARLMRDKL-TKELVAVKYIE----RGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                  H  ++ EY   G L + +   G    D                Y HS     +
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSED--EARFFFQQLLSGVSYCHS-----M 135
Query: 187 PIVHRDFKSTNVLL--SANFEAKISDFGLAK---LMPEGQETYVTARVLGTFGYFDPEY- 240
            I HRD K  N LL  S     KI DFG +K   L  + + T      +GT  Y  PE  
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAPEVL 189
Query: 241 ---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 GK+   +DV++ GV L  +L G
Sbjct: 190 LRQEYDGKI---ADVWSCGVTLYVMLVG 214

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 111/283 (39%), Gaps = 35/283 (12%)
Query: 69  LGKGGFGRVYK----GTLRSGEVVAIKKMELPRF-KEADGEHEFRVEVDILSRLDHPNLV 123
           LG G +G+V+         +G++ A+K ++     ++A      R E  +L  +     +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 124 SLIGYCADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSS 182
             + Y    + +  L+ +Y+  G L  HL+     +                  +LH   
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHK-- 177
Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
              + I++RD K  N+LL +N    ++DFGL+K      ET       GT  Y  P+   
Sbjct: 178 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAPDIVR 233
Query: 243 TGKLTLQS--DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
            G        D ++ GV++ ELLTG     ++   N Q  +   R IL            
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILK----------- 280
Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSER----PSMAECVKE 339
             S   Y  E  A+  +L  R +  +  +R    P  A+ +KE
Sbjct: 281 --SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 80/336 (23%), Positives = 126/336 (37%), Gaps = 50/336 (14%)
Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGE 104
           R  S F  + +E           L +GGF  VY+   + SG   A+K++      E +  
Sbjct: 13  RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL---LSNEEEKN 69
Query: 105 HEFRVEVDILSRLD-HPNLVSLIGYCADGKHR-------FLVYEYMQKGNLQDHLNGI-G 155
                EV  + +L  HPN+V      + GK         FL+   + KG L + L  +  
Sbjct: 70  RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES 129
Query: 156 EPKMDWPXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK 215
              +                 ++H       PI+HRD K  N+LLS     K+ DFG A 
Sbjct: 130 RGPLSCDTVLKIFYQTCRAVQHMHRQKP---PIIHRDLKVENLLLSNQGTIKLCDFGSAT 186
Query: 216 LMPEGQETYVTA--RVL--------GTFGYFDPEYT---STGKLTLQSDVYAFGVVLLEL 262
            +    +   +A  R L         T  Y  PE     S   +  + D++A G +L  L
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY-L 245
Query: 263 LTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRC 322
           L  R                  +H   D  KLR +++ + S   +  +   +F +L    
Sbjct: 246 LCFR------------------QHPFEDGAKLR-IVNGKYSIPPHDTQ-YTVFHSLIRAM 285
Query: 323 VRTESSERPSMAECVKELQLIIYTNSKGLNMPLHAL 358
           ++    ER S+AE V +LQ I    +     P+  L
Sbjct: 286 LQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL 321

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 69  LGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVE-VDILSRLDHPNLVSLI 126
           +G+G FG V++    ++G   A+KK+ L           FRVE +   + L  P +V L 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRL---------EVFRVEELVACAGLSSPRIVPLY 116
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G   +G    +  E ++ G+L   +  +G    D                YLH+      
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLGQALEGLEYLHTRR---- 170
Query: 187 PIVHRDFKSTNVLLSAN-FEAKISDFGLA-KLMPEG-QETYVTARVL-GTFGYFDPEYTS 242
            I+H D K+ NVLLS++   A + DFG A  L P+G  ++ +T   + GT  +  PE   
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++   ++L +L G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 69  LGKGGFGRVYK-GTLRSGEVVAIKKMELPRFKEADGEHEFRVE-VDILSRLDHPNLVSLI 126
           +G+G FG V++    ++G   A+KK+ L           FRVE +   + L  P +V L 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRL---------EVFRVEELVACAGLSSPRIVPLY 132
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
           G   +G    +  E ++ G+L   +  +G    D                YLH+      
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLGQALEGLEYLHTRR---- 186
Query: 187 PIVHRDFKSTNVLLSAN-FEAKISDFGLA-KLMPE--GQETYVTARVLGTFGYFDPEYTS 242
            I+H D K+ NVLLS++   A + DFG A  L P+  G+       + GT  +  PE   
Sbjct: 187 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 245
Query: 243 TGKLTLQSDVYAFGVVLLELLTG 265
                 + D+++   ++L +L G
Sbjct: 246 GKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 15/97 (15%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE---------TYVTA 227
           +LHS       ++HRD K +N+  + +   K+ DFGL   M + +E          Y T 
Sbjct: 179 FLHSKG-----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233
Query: 228 R-VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELL 263
              +GT  Y  PE       + + D+++ G++L ELL
Sbjct: 234 XGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%)
Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
            +HRD  + N+LLS N   KI DFGLA+ + +  +            +  PE       +
Sbjct: 220 CIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYS 279
Query: 248 LQSDVYAFGVVLLELLT 264
            +SDV+++GV+L E+ +
Sbjct: 280 TKSDVWSYGVLLWEIFS 296

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 37  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 93
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M     Q     + + ++D                +LH
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 148
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 149 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 200
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 201 VILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 82
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M     Q     + + ++D                +LH
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +T  V+  + Y  PE
Sbjct: 138 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPE 189
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 190 VILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 108/258 (41%), Gaps = 21/258 (8%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEV 111
           +K  E+    +  D+ +GKG FG+V K   R   E VAIK ++  +      + E R+ +
Sbjct: 46  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRL-L 104
Query: 112 DILSRLDHP---NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
           +++++ D      +V L  +     H  LV+E M   NL D L       +         
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLS--ANFEAKISDFGLAKLMPEGQETYVT 226
                   +L +     + I+H D K  N+LL        KI DFG +  +  GQ  Y  
Sbjct: 164 QQMCTALLFLATPE---LSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY-- 216
Query: 227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV-- 284
            + + +  Y  PE        L  D+++ G +L+E+ TG         V+  N +++V  
Sbjct: 217 -QXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 285 ---RHILNDRKKLRKVID 299
               HIL+   K RK  +
Sbjct: 276 IPPAHILDQAPKARKFFE 293

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 86/226 (38%), Gaps = 17/226 (7%)
Query: 50  VFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFR 108
           V  LKE+      F     +G+G F  V    ++ +G+V A+K M      +      FR
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 109 VEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
            E D+L   D   +  L     D  + +LV EY   G+L   L+  GE            
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE------RIPAEM 163
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG-LAKLMPEGQETYVTA 227
                    +   S   +  VHRD K  N+LL      +++DFG   KL  +G    + A
Sbjct: 164 ARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 228 RVLGTFGYFDPEYTSTGKLTL-------QSDVYAFGVVLLELLTGR 266
             +GT  Y  PE                + D +A GV   E+  G+
Sbjct: 224 --VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/314 (22%), Positives = 128/314 (40%), Gaps = 51/314 (16%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPR---FKEADGEHEFRV 109
           K+ E     +     LGKGGFG V+ G   +  + VAIK +   R   +          +
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 110 EVDILSRLD----HPNLVSLIGYCADGKHRFLVYEY-MQKGNLQDHLNGIGEPKMDWPXX 164
           EV +L ++     HP ++ L+ +    +   LV E  +   +L D++   G P  + P  
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSR 142
Query: 165 XXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFE-AKISDFGLAKLMPEGQET 223
                       + HS       +VHRD K  N+L+      AK+ DFG   L+ +  E 
Sbjct: 143 CFFGQVVAAIQ-HCHSRG-----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EP 194
Query: 224 YVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL 282
           Y      GT  Y  PE+ S  +   L + V++ G++L +++ G    + +Q         
Sbjct: 195 YTDFD--GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------- 243
Query: 283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL 342
                        ++++ EL   ++          L  RC+  + S RPS+    +E+ L
Sbjct: 244 -------------EILEAELHFPAHVSPDCCA---LIRRCLAPKPSSRPSL----EEILL 283
Query: 343 IIYTNSKGLNMPLH 356
             +  +   ++PL+
Sbjct: 284 DPWMQTPAEDVPLN 297

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 11/91 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANF---EAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLH ++     IVH D K  N+LLS+ +   + KI DFG+++ +    E      ++GT 
Sbjct: 146 YLHQNN-----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIMGTP 197
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
            Y  PE  +   +T  +D++  G++   LLT
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 108/258 (41%), Gaps = 21/258 (8%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEV 111
           +K  E+    +  D+ +GKG FG+V K   R   E VAIK ++  +      + E R+ +
Sbjct: 46  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRL-L 104
Query: 112 DILSRLDHP---NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
           +++++ D      +V L  +     H  LV+E M   NL D L       +         
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLS--ANFEAKISDFGLAKLMPEGQETYVT 226
                   +L +     + I+H D K  N+LL        KI DFG +  +  GQ  Y  
Sbjct: 164 QQMCTALLFLATPE---LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY-- 216
Query: 227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV-- 284
            + + +  Y  PE        L  D+++ G +L+E+ TG         V+  N +++V  
Sbjct: 217 -QXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 285 ---RHILNDRKKLRKVID 299
               HIL+   K RK  +
Sbjct: 276 IPPAHILDQAPKARKFFE 293

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 108/258 (41%), Gaps = 21/258 (8%)
Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEV 111
           +K  E+    +  D+ +GKG FG+V K   R   E VAIK ++  +      + E R+ +
Sbjct: 27  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRL-L 85
Query: 112 DILSRLDHP---NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXX 168
           +++++ D      +V L  +     H  LV+E M   NL D L       +         
Sbjct: 86  ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFA 144
Query: 169 XXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLS--ANFEAKISDFGLAKLMPEGQETYVT 226
                   +L +     + I+H D K  N+LL        KI DFG +  +  GQ  Y  
Sbjct: 145 QQMCTALLFLATPE---LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY-- 197
Query: 227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV-- 284
            + + +  Y  PE        L  D+++ G +L+E+ TG         V+  N +++V  
Sbjct: 198 -QXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 285 ---RHILNDRKKLRKVID 299
               HIL+   K RK  +
Sbjct: 257 IPPAHILDQAPKARKFFE 274

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M     Q     + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +   V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEPEVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 92/247 (37%), Gaps = 49/247 (19%)
Query: 60  TCSFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD 118
              F +   LG+G FG+V K          AIKK+     K +        EV +L+ L+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLLASLN 60
Query: 119 HP-------------NLVSLIGYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPX 163
           H              N V  +         F+  EY +   L D  H   + + + ++  
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY-- 118
Query: 164 XXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-------- 215
                        Y+HS       I+HRD K  N+ +  +   KI DFGLAK        
Sbjct: 119 -WRLFRQILEALSYIHSQG-----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 216 ------LMPEGQETYVTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELL----T 264
                  +P   +   +A  +GT  Y   E    TG    + D+Y+ G++  E++    T
Sbjct: 173 LKLDSQNLPGSSDNLTSA--IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
Query: 265 GRRAVDL 271
           G   V++
Sbjct: 231 GMERVNI 237

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 31/225 (13%)
Query: 69  LGKGGFGRV---YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +G G  G V   Y   L     VAIKK+  P   +   +  +R E+ ++  ++H N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 126 IGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLH 179
           +      K        ++V E M     Q     + + ++D                +LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S+      I+HRD K +N+++ ++   KI DFGLA+    G    +   V+  + Y  PE
Sbjct: 144 SAG-----IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEPEVVTRY-YRAPE 195
Query: 240 YTSTGKLTLQSDVYAFGVVLLE------LLTGRRAVDLNQGVNDQ 278
                      D+++ G ++ E      L  GR  +D    V +Q
Sbjct: 196 VILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 48/250 (19%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE--HEFRVEVDILSRLDHPN--LVS 124
           +G GG  +V++      ++ AIK + L   +EAD +    +R E+  L++L   +  ++ 
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD---WPXXXXXXXXXXXXXXYLHSS 181
           L  Y    ++ ++V   M+ GN+   LN   + K     W                +H+ 
Sbjct: 93  LYDYEITDQYIYMV---MECGNID--LNSWLKKKKSIDPWERKSYWKNMLEA----VHTI 143
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
              GI  VH D K  N L+      K+ DFG+A  M     + V    +GT  Y  PE  
Sbjct: 144 HQHGI--VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 242 STGKLTLQS-----------DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
                + ++           DV++ G +L  +  G+                  + I+N 
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---------------FQQIINQ 245
Query: 291 RKKLRKVIDP 300
             KL  +IDP
Sbjct: 246 ISKLHAIIDP 255

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 48/250 (19%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE--HEFRVEVDILSRLDH--PNLVS 124
           +G GG  +V++      ++ AIK + L   +EAD +    +R E+  L++L      ++ 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD---WPXXXXXXXXXXXXXXYLHSS 181
           L  Y    ++ ++V   M+ GN+   LN   + K     W                +H+ 
Sbjct: 121 LYDYEITDQYIYMV---MECGNID--LNSWLKKKKSIDPWERKSYWKNMLEA----VHTI 171
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
              GI  VH D K  N L+      K+ DFG+A  M     + V    +GT  Y  PE  
Sbjct: 172 HQHGI--VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 242 STGKLTLQS-----------DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
                + ++           DV++ G +L  +  G+                  + I+N 
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---------------FQQIINQ 273
Query: 291 RKKLRKVIDP 300
             KL  +IDP
Sbjct: 274 ISKLHAIIDP 283

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 48/250 (19%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE--HEFRVEVDILSRLDHPN--LVS 124
           +G GG  +V++      ++ AIK + L   +EAD +    +R E+  L++L   +  ++ 
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIR 76
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD---WPXXXXXXXXXXXXXXYLHSS 181
           L  Y    ++ ++V   M+ GN+   LN   + K     W                +H+ 
Sbjct: 77  LYDYEITDQYIYMV---MECGNID--LNSWLKKKKSIDPWERKSYWKNMLEA----VHTI 127
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
              GI  VH D K  N L+      K+ DFG+A  M     + V    +GT  Y  PE  
Sbjct: 128 HQHGI--VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 242 STGKLTLQS-----------DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
                + ++           DV++ G +L  +  G+                  + I+N 
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---------------FQQIINQ 229
Query: 291 RKKLRKVIDP 300
             KL  +IDP
Sbjct: 230 ISKLHAIIDP 239

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 48/250 (19%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE--HEFRVEVDILSRLDHPN--LVS 124
           +G GG  +V++      ++ AIK + L   +EAD +    +R E+  L++L   +  ++ 
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD---WPXXXXXXXXXXXXXXYLHSS 181
           L  Y    ++ ++V   M+ GN+   LN   + K     W                +H+ 
Sbjct: 74  LYDYEITDQYIYMV---MECGNID--LNSWLKKKKSIDPWERKSYWKNMLEA----VHTI 124
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
              GI  VH D K  N L+      K+ DFG+A  M     + V    +GT  Y  PE  
Sbjct: 125 HQHGI--VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 242 STGKLTLQS-----------DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
                + ++           DV++ G +L  +  G+                  + I+N 
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---------------FQQIINQ 226
Query: 291 RKKLRKVIDP 300
             KL  +IDP
Sbjct: 227 ISKLHAIIDP 236

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 130 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTP 181
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 182 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 234
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 235 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 288
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 289 PLHTSRVL 296

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 136 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTP 187
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 188 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 240
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 241 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 294
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 295 PLHTSRVL 302

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 137 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTP 188
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 189 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 241
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 242 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 295
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 296 PLHTSRVL 303

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 138 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTP 189
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 190 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 242
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 243 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 296
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 297 PLHTSRVL 304

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 69  LGKGGFG--RVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           +G G FG  R+ +   +S E+VA+K +E  R ++ D     + E+     L HPN+V   
Sbjct: 26  IGSGNFGVARLMRDK-QSNELVAVKYIE--RGEKID--ENVKREIINHRSLRHPNIVRFK 80
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                  H  +V EY   G L + +   G    D                Y H+     +
Sbjct: 81  EVILTPTHLAIVMEYASGGELFERICNAGRFSED--EARFFFQQLISGVSYCHA-----M 133
Query: 187 PIVHRDFKSTNVLL--SANFEAKISDFGLAK---LMPEGQETYVTARVLGTFGYFDPEY- 240
            + HRD K  N LL  S     KI DFG +K   L  + + T      +GT  Y  PE  
Sbjct: 134 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAPEVL 187
Query: 241 ---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 GK+   +DV++ GV L  +L G
Sbjct: 188 LKKEYDGKV---ADVWSCGVTLYVMLVG 212

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 146 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTP 197
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 198 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 250
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 251 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 304
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 305 PLHTSRVL 312

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 48/250 (19%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE--HEFRVEVDILSRLDHPN--LVS 124
           +G GG  +V++      ++ AIK + L   +EAD +    +R E+  L++L   +  ++ 
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD---WPXXXXXXXXXXXXXXYLHSS 181
           L  Y    ++ ++V   M+ GN+   LN   + K     W                +H+ 
Sbjct: 93  LYDYEITDQYIYMV---MECGNID--LNSWLKKKKSIDPWERKSYWKNMLEA----VHTI 143
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
              GI  VH D K  N L+      K+ DFG+A  M       V    +GT  Y  PE  
Sbjct: 144 HQHGI--VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200
Query: 242 STGKLTLQS-----------DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
                + ++           DV++ G +L  +  G+                  + I+N 
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---------------FQQIINQ 245
Query: 291 RKKLRKVIDP 300
             KL  +IDP
Sbjct: 246 ISKLHAIIDP 255

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 48/250 (19%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE--HEFRVEVDILSRLDHPN--LVS 124
           +G GG  +V++      ++ AIK + L   +EAD +    +R E+  L++L   +  ++ 
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIR 72
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD---WPXXXXXXXXXXXXXXYLHSS 181
           L  Y    ++ ++V   M+ GN+   LN   + K     W                +H+ 
Sbjct: 73  LYDYEITDQYIYMV---MECGNID--LNSWLKKKKSIDPWERKSYWKNMLEA----VHTI 123
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
              GI  VH D K  N L+      K+ DFG+A  M     + V    +GT  Y  PE  
Sbjct: 124 HQHGI--VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 242 STGKLTLQS-----------DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
                + ++           DV++ G +L  +  G+                  + I+N 
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---------------FQQIINQ 225
Query: 291 RKKLRKVIDP 300
             KL  +IDP
Sbjct: 226 ISKLHAIIDP 235

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 131 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTP 182
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 183 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 235
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 236 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 289
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 290 PLHTSRVL 297

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 130 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTP 181
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 182 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 234
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 235 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 288
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 289 PLHTSRVL 296

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 132 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTP 183
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 184 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 236
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 237 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 290
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 291 PLHTSRVL 298

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 132 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTP 183
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 184 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 236
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 237 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 290
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 291 PLHTSRVL 298

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 48/250 (19%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE--HEFRVEVDILSRLDHPN--LVS 124
           +G GG  +V++      ++ AIK + L   +EAD +    +R E+  L++L   +  ++ 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD---WPXXXXXXXXXXXXXXYLHSS 181
           L  Y    ++ ++V   M+ GN+   LN   + K     W                +H+ 
Sbjct: 121 LYDYEITDQYIYMV---MECGNID--LNSWLKKKKSIDPWERKSYWKNMLEA----VHTI 171
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
              GI  VH D K  N L+      K+ DFG+A  M     + V    +GT  Y  PE  
Sbjct: 172 HQHGI--VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 242 STGKLTLQS-----------DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
                + ++           DV++ G +L  +  G+                  + I+N 
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---------------FQQIINQ 273
Query: 291 RKKLRKVIDP 300
             KL  +IDP
Sbjct: 274 ISKLHAIIDP 283

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 176 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTP 227
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 280
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 334
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 335 PLHTSRVL 342

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           YLHS     I I HRD K  N+L ++   N   K++DFG AK   E            T 
Sbjct: 182 YLHS-----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTP 233
Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
            Y  PE     K     D+++ GV++  LL G      N G       L +   +  R +
Sbjct: 234 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIR 286
Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM 353
           + +   P    S  + E   +  NL    ++TE ++R ++ E +      I  ++K    
Sbjct: 287 MGQYEFPNPEWSEVSEEVKMLIRNL----LKTEPTQRMTITEFMN--HPWIMQSTKVPQT 340
Query: 354 PLHALRMV 361
           PLH  R++
Sbjct: 341 PLHTSRVL 348

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 20/221 (9%)
Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEV-VAIKKMELPR---FKEADGEHEFRV 109
           KE E     +     LG GGFG VY G   S  + VAIK +E  R   + E        +
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 110 EVDILSRLD--HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE-PKMDWPXXXX 166
           EV +L ++      ++ L+ +        L+ E M+   +QD  + I E   +       
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEP--VQDLFDFITERGALQEELARS 118
Query: 167 XXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFGLAKLMPEGQETYV 225
                     + H+       ++HRD K  N+L+  N  E K+ DFG   L+ +     V
Sbjct: 119 FFWQVLEAVRHCHNCG-----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----V 169
Query: 226 TARVLGTFGYFDPEYTSTGKLTLQS-DVYAFGVVLLELLTG 265
                GT  Y  PE+    +   +S  V++ G++L +++ G
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 84/208 (40%), Gaps = 32/208 (15%)
Query: 69  LGKGGFG--RVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           +G G FG  R+ +   +S E+VA+K +E      A+     + E+     L HPN+V   
Sbjct: 27  IGSGNFGVARLMRDK-QSNELVAVKYIERGEKIAAN----VKREIINHRSLRHPNIVRFK 81
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                  H  +V EY   G L + +   G    D                Y H+     +
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAGRFSED--EARFFFQQLISGVSYCHA-----M 134
Query: 187 PIVHRDFKSTNVLL--SANFEAKISDFGLAK---LMPEGQETYVTARVLGTFGYFDPEY- 240
            + HRD K  N LL  S     KI DFG +K   L  + + T      +GT  Y  PE  
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAPEVL 188
Query: 241 ---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 GK+   +DV++ GV L  +L G
Sbjct: 189 LKKEYDGKV---ADVWSCGVTLYVMLVG 213

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 84/205 (40%), Gaps = 26/205 (12%)
Query: 69  LGKGGFG--RVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           +G G FG  R+ +   ++ E+VA+K +E  R ++ D     + E+     L HPN+V   
Sbjct: 27  IGAGNFGVARLMRDK-QANELVAVKYIE--RGEKID--ENVKREIINHRSLRHPNIVRFK 81
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                  H  +V EY   G L + +   G    D                Y H+     +
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAGRFSED--EARFFFQQLISGVSYAHA-----M 134
Query: 187 PIVHRDFKSTNVLL--SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY---- 240
            + HRD K  N LL  S     KI+DFG +K      +       +GT  Y  PE     
Sbjct: 135 QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ---PKSAVGTPAYIAPEVLLKK 191
Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
              GK+   +DV++ GV L  +L G
Sbjct: 192 EYDGKV---ADVWSCGVTLYVMLVG 213

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 93/249 (37%), Gaps = 53/249 (21%)
Query: 60  TCSFSDDNFLGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD 118
              F +   LG+G FG+V K          AIKK+     K +        EV +L+ L+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVXLLASLN 60
Query: 119 HPNLVSLIGYCADGKHR---------------FLVYEYMQKGNLQD--HLNGIGEPKMDW 161
           H  +V    Y A  + R               F+  EY +   L D  H   + + + ++
Sbjct: 61  HQYVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY 118
Query: 162 PXXXXXXXXXXXXXXYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK------ 215
                          Y+HS       I+HR+ K  N+ +  +   KI DFGLAK      
Sbjct: 119 ---WRLFRQILEALSYIHSQG-----IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 216 --------LMPEGQETYVTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELL--- 263
                    +P   +   +A  +GT  Y   E    TG    + D Y+ G++  E +   
Sbjct: 171 DILKLDSQNLPGSSDNLTSA--IGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPF 228
Query: 264 -TGRRAVDL 271
            TG   V++
Sbjct: 229 STGXERVNI 237

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 69  LGKGGFG--RVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           +G G FG  R+ +   +S E+VA+K +E  R ++ D     + E+     L HPN+V   
Sbjct: 27  IGSGNFGVARLMRDK-QSNELVAVKYIE--RGEKID--ENVKREIINHRSLRHPNIVRFK 81
Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXXXXXXXXXXXXXYLHSSSAVGI 186
                  H  +V EY   G L + +   G    D                Y H+     +
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAGRFSED--EARFFFQQLISGVSYCHA-----M 134
Query: 187 PIVHRDFKSTNVLL--SANFEAKISDFGLAK---LMPEGQETYVTARVLGTFGYFDPEY- 240
            + HRD K  N LL  S     KI  FG +K   L  + ++T      +GT  Y  PE  
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT------VGTPAYIAPEVL 188
Query: 241 ---TSTGKLTLQSDVYAFGVVLLELLTG 265
                 GK+   +DV++ GV L  +L G
Sbjct: 189 LKKEYDGKV---ADVWSCGVTLYVMLVG 213

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 98/250 (39%), Gaps = 48/250 (19%)
Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE--HEFRVEVDILSRLDHPN--LVS 124
           +G GG  +V++      ++ AIK + L   +EAD +    +R E+  L++L   +  ++ 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMD---WPXXXXXXXXXXXXXXYLHSS 181
           L  Y    ++ ++V   M+ GN+   LN   + K     W                +H+ 
Sbjct: 121 LYDYEITDQYIYMV---MECGNID--LNSWLKKKKSIDPWERKSYWKNMLEA----VHTI 171
Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
              GI  VH D K  N L+      K+ DFG+A  M     + V    +G   Y  PE  
Sbjct: 172 HQHGI--VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 242 STGKLTLQS-----------DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
                + ++           DV++ G +L  +  G+                  + I+N 
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---------------FQQIINQ 273
Query: 291 RKKLRKVIDP 300
             KL  +IDP
Sbjct: 274 ISKLHAIIDP 283

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/158 (20%), Positives = 70/158 (44%), Gaps = 8/158 (5%)
Query: 106 EFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPXXX 165
           +F+ E+ I++ + +   ++  G   +    +++YEYM+  ++            ++    
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 166 XXXXXXXXXXXYLHSSSAVGIP--IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
                       L+S S +     I HRD K +N+L+  N   K+SDFG ++ M + +  
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-- 206
Query: 224 YVTARVLGTFGYFDPEYTS--TGKLTLQSDVYAFGVVL 259
                  GT+ +  PE+ S  +     + D+++ G+ L
Sbjct: 207 --IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	361
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-149
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-145
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-137
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-92
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-72
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-71
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-67
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-67
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-67
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-67
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-66
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-65
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-64
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-64
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-64
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-63
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-62
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-60
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-45
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-45
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-44
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-44
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-44
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-42
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-42
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-41
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-41
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-41
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-40
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-40
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-39
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-39
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-39
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-38
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-38
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-38
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-37
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-36
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-36
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-35
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-33
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-33
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-32
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-31
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-31
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-30
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-30
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-30
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-29
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-29
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-29
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-29
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-29
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-29
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-28
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-27
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-27
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-27
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-25
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-25
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-23
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-22
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-22
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-22
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-21
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-20
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-19
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-19
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-07

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  421 bits (1086), Expect = e-149
 Identities = 122/311 (39%), Positives = 175/311 (56%), Gaps = 12/311 (3%)

Query: 36  DQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMEL 95
           D  +        S    L ++EEAT +F     +G G FG+VYKG LR G  VA+K+   
Sbjct: 14  DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73

Query: 96  PRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG 155
              +   G  EF  E++ LS   HP+LVSLIG+C +     L+Y+YM+ GNL+ HL G  
Sbjct: 74  ESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130

Query: 156 EPK--MDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL 213
            P   M W  RL++ +GAA+GL YLH+       I+HRD KS N+LL  NF  KI+DFG+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTR-----AIIHRDVKSINILLDENFVPKITDFGI 185

Query: 214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ 273
           +K   E  +T+++  V GT GY DPEY   G+LT +SDVY+FGVVL E+L  R A+  + 
Sbjct: 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245

Query: 274 GVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSM 333
                NL        N+  +L +++DP L       ES+  F + A +C+   S +RPSM
Sbjct: 246 PREMVNLAEWAVESHNNG-QLEQIVDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSM 303

Query: 334 AECVKELQLII 344
            + + +L+  +
Sbjct: 304 GDVLWKLEYAL 314

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  412 bits (1061), Expect = e-145
 Identities = 106/302 (35%), Positives = 174/302 (57%), Gaps = 19/302 (6%)

Query: 50  VFTLKEMEEATCSFSD------DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEAD- 102
            F+  E++  T +F +       N +G+GGFG VYKG + +   VA+KK+        + 
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72

Query: 103 GEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGI-GEPKMDW 161
            + +F  E+ ++++  H NLV L+G+ +DG    LVY YM  G+L D L+ + G P + W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 162 PLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ 221
            +R K+A GAA G+ +LH +       +HRD KS N+LL   F AKISDFGLA+   +  
Sbjct: 133 HMRCKIAQGAANGINFLHENH-----HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 222 ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV 281
           +T +T+R++GT  Y  PE    G++T +SD+Y+FGVVLLE++TG  AVD ++    Q L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLL 244

Query: 282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
                I ++ K +   ID ++  +     S+    ++AS+C+  + ++RP + +  + LQ
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

Query: 342 LI 343
            +
Sbjct: 303 EM 304

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  393 bits (1011), Expect = e-137
 Identities = 130/311 (41%), Positives = 189/311 (60%), Gaps = 13/311 (4%)

Query: 36  DQPTQPQKR-HRGSS-VFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKM 93
           D P +     H G    F+L+E++ A+ +FS+ N LG+GGFG+VYKG L  G +VA+K+ 
Sbjct: 3   DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR- 61

Query: 94  ELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNG 153
            L   +   GE +F+ EV+++S   H NL+ L G+C     R LVY YM  G++   L  
Sbjct: 62  -LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 154 I--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF 211
               +P +DWP R ++ALG+A+GLAYLH        I+HRD K+ N+LL   FEA + DF
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDP--KIIHRDVKAANILLDEEFEAVVGDF 178

Query: 212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDL 271
           GLAKLM     T+VT  V GT G+  PEY STGK + ++DV+ +GV+LLEL+TG+RA DL
Sbjct: 179 GLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237

Query: 272 NQGVNDQ--NLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSE 329
            +  ND    L+  V+ +L + KKL  ++D +L + +Y  E +     +A  C ++   E
Sbjct: 238 ARLANDDDVMLLDWVKGLLKE-KKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPME 295

Query: 330 RPSMAECVKEL 340
           RP M+E V+ L
Sbjct: 296 RPKMSEVVRML 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  276 bits (709), Expect = 9e-92
 Identities = 80/320 (25%), Positives = 117/320 (36%), Gaps = 26/320 (8%)

Query: 42  QKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEA 101
              H        + +   +          +G FG V+K  L   E VA+K        + 
Sbjct: 5   HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIF----PIQD 59

Query: 102 DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH----RFLVYEYMQKGNLQDHLNGIGEP 157
               +   EV  L  + H N++  IG    G       +L+  + +KG+L D L      
Sbjct: 60  KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---N 116

Query: 158 KMDWPLRLKVALGAAKGLAYLHSSSAVG-----IPIVHRDFKSTNVLLSANFEAKISDFG 212
            + W     +A   A+GLAYLH             I HRD KS NVLL  N  A I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176

Query: 213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-----KLTLQSDVYAFGVVLLELLTGRR 267
           LA     G+    T   +GT  Y  PE             L+ D+YA G+VL EL +   
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236

Query: 268 AVDLNQGVNDQNLVLQVRH--ILNDRKKL--RKVIDPELSRSSYTMESIAMFANLASRCV 323
           A D            ++     L D +++   K   P L         +AM       C 
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296

Query: 324 RTESSERPSMAECVKELQLI 343
             ++  R S     + +  +
Sbjct: 297 DHDAEARLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  226 bits (578), Expect = 4e-72
 Identities = 73/333 (21%), Positives = 120/333 (36%), Gaps = 47/333 (14%)

Query: 51  FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVE 110
               E      +      +G+G +G VYKG+L     VA+K      F  A+    F  E
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKV-----FSFAN-RQNFINE 55

Query: 111 VDI--LSRLDHPNLVSLIGYC-----ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPL 163
            +I  +  ++H N+   I               LV EY   G+L  +L+       DW  
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVS 112

Query: 164 RLKVALGAAKGLAYLHSSSAVGI----PIVHRDFKSTNVLLSANFEAKISDFGLAKLM-- 217
             ++A    +GLAYLH+    G      I HRD  S NVL+  +    ISDFGL+  +  
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 218 ----PEGQETYVTARVLGTFGYFDPEY-------TSTGKLTLQSDVYAFGVVLLELLTGR 266
                 G+E       +GT  Y  PE                Q D+YA G++  E+    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 267 RAVDLNQGVND----------QNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFA 316
             +   + V +           +   +   +L  R+K R         +S  + S+    
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL---K 289

Query: 317 NLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
                C   ++  R +     + +  ++    +
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  224 bits (572), Expect = 3e-71
 Identities = 85/277 (30%), Positives = 129/277 (46%), Gaps = 25/277 (9%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG V++     G  VA+K +    F   +  +EF  EV I+ RL HPN+V  +G 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 129 CADGKHRFLVYEYMQKGNLQDHL-NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                +  +V EY+ +G+L   L       ++D   RL +A   AKG+ YLH+      P
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPP 159

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHR+ KS N+L+   +  K+ DFGL++L      +  +A   GT  +  PE        
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSN 217

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            +SDVY+FGV+L EL T ++       +N   +V  V       K  R     E+ R+  
Sbjct: 218 EKSDVYSFGVILWELATLQQP---WGNLNPAQVVAAVGF-----KCKR----LEIPRN-- 263

Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                   A +   C   E  +RPS A  +  L+ +I
Sbjct: 264 ---LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  213 bits (544), Expect = 2e-67
 Identities = 83/295 (28%), Positives = 132/295 (44%), Gaps = 54/295 (18%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKE----ADGEHEFRVEVDILSRLDHPNLV 123
           +GKGGFG V+KG L     VVAIK + L   +      +   EF+ EV I+S L+HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
            L G   +     +V E++  G+L   L     P + W ++L++ L  A G+ Y+ +   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQNQ-- 141

Query: 184 VGIPIVHRDFKSTNVLLS-----ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
              PIVHRD +S N+ L      A   AK++DFGL++     Q  +  + +LG F +  P
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195

Query: 239 E--YTSTGKLTLQSDVYAFGVVLLELLTGRR--------AVDLNQGVNDQNLVLQVRHIL 288
           E         T ++D Y+F ++L  +LTG           +     + ++ L        
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL-------- 247

Query: 289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
             R  + +   P L              N+   C   +  +RP  +  VKEL  +
Sbjct: 248 --RPTIPEDCPPRL-------------RNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  213 bits (544), Expect = 3e-67
 Identities = 81/278 (29%), Positives = 132/278 (47%), Gaps = 33/278 (11%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G+G FG V K   R  + VAIK++E    ++      F VE+  LSR++HPN+V L G 
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERK-----AFIVELRQLSRVNHPNIVKLYGA 69

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIG-EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
           C       LV EY + G+L + L+G    P       +   L  ++G+AYLHS       
Sbjct: 70  CL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK--A 125

Query: 188 IVHRDFKSTNVLLSANFE-AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
           ++HRD K  N+LL A     KI DFG A  +    +T++T    G+  +  PE       
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNK-GSAAWMAPEVFEGSNY 180

Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
           + + DV+++G++L E++T R+  D            ++   ++     R  +   L +  
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFD-----EIGGPAFRIMWAVH--NGTRPPLIKNLPKP- 232

Query: 307 YTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                     +L +RC   + S+RPSM E VK +  ++
Sbjct: 233 --------IESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  213 bits (544), Expect = 3e-67
 Identities = 80/300 (26%), Positives = 132/300 (44%), Gaps = 40/300 (13%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG+  K T R +GEV+ +K++      + + +  F  EV ++  L+HPN++  IG
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                K    + EY++ G L+  +    + +  W  R+  A   A G+AYLHS +     
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMN----- 128

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR------------VLGTFGY 235
           I+HRD  S N L+  N    ++DFGLA+LM + +      R            V+G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV-LQVRHILNDRKKL 294
             PE  +      + DV++FG+VL E++    A        D + +   +   LN R  L
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------DPDYLPRTMDFGLNVRGFL 240

Query: 295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMP 354
            +   P    S         F  +  RC   +  +RPS  +    L+ +    +  L + 
Sbjct: 241 DRYCPPNCPPS---------FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  211 bits (540), Expect = 5e-67
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 36/284 (12%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE-ADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G GGFG+VY+     G+ VA+K       ++ +      R E  + + L HPN+++L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
            C    +  LV E+ + G L   L+G    ++   + +  A+  A+G+ YLH  + V  P
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIV--P 128

Query: 188 IVHRDFKSTNVLLS--------ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           I+HRD KS+N+L+         +N   KI+DFGLA+       T   +   G + +  PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAA-GAYAWMAPE 184

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
                  +  SDV+++GV+L ELLTG       +G++   +   V        KL   I 
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE---VPFRGIDGLAVAYGVAM-----NKLALPIP 236

Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                          FA L   C   +   RPS    + +L  I
Sbjct: 237 STCPEP---------FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  209 bits (535), Expect = 3e-66
 Identities = 56/280 (20%), Positives = 110/280 (39%), Gaps = 34/280 (12%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           L +   G ++KG  + G  + +K +++  +       +F  E   L    HPN++ ++G 
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSR-DFNEECPRLRIFSHPNVLPVLGA 75

Query: 129 CAD--GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
           C      H  L+  +M  G+L + L+      +D    +K AL  A+G+A+LH+      
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EP 132

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE---YTST 243
            I      S +V++  +  A+IS   +                     +  PE       
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM-------YAPAWVAPEALQKKPE 185

Query: 244 GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELS 303
                 +D+++F V+L EL+T          +++  + ++V       + LR  I P +S
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVP---FADLSNMEIGMKVAL-----EGLRPTIPPGIS 237

Query: 304 RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                       + L   C+  + ++RP     V  L+ +
Sbjct: 238 PH---------VSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  207 bits (530), Expect = 3e-65
 Identities = 74/299 (24%), Positives = 122/299 (40%), Gaps = 42/299 (14%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDI--LSRLDHPNLVSLI 126
           +GKG +G V++G+ + GE VA+K      F   D E  +  E ++     L H N++  I
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKI-----FSSRD-EKSWFRETELYNTVMLRHENILGFI 68

Query: 127 GYCADGKHR----FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
                 +H     +L+  Y + G+L D+L       +D    L++ L  A GLA+LH   
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 183 AVGI---PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ---ETYVTARVLGTFGYF 236
                   I HRD KS N+L+  N +  I+D GLA +  +     +     RV GT  Y 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184

Query: 237 DPE------YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG--------VNDQNLVL 282
            PE               + D++AFG+VL E+     +  + +         V +     
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
            +R ++    + R    P +    ++  ++   A L   C     S R +     K L 
Sbjct: 245 DMRKVVC-VDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  205 bits (523), Expect = 2e-64
 Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 28/280 (10%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG    G+V A+K + +           F+ EV +L +  H N++  +GY
Sbjct: 32  IGSGSFGTVYKGKWH-GDV-AVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
                   +V ++ +  +L  HL+   E K +    + +A   A+G+ YLH+       I
Sbjct: 89  STAP-QLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK-----SI 141

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE---YTSTGK 245
           +HRD KS N+ L  +   KI DFGLA        ++   ++ G+  +  PE      +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 246 LTLQSDVYAFGVVLLELLTGRRA-VDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
            + QSDVYAFG+VL EL+TG+    ++N   N   ++  V             +     +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNIN---NRDQIIEMVGR--GSLSPDLSKVRSNCPK 256

Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                        L + C++ +  ERPS    + E++ + 
Sbjct: 257 R---------MKRLMAECLKKKRDERPSFPRILAEIEELA 287

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  206 bits (525), Expect = 5e-64
 Identities = 73/300 (24%), Positives = 117/300 (39%), Gaps = 38/300 (12%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG +G V+ G  R GE VA+K      F   +       E+     + H N++  I  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVF----FTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 129 CADGKHR----FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
              G       +L+ +Y + G+L D+L       +D    LK+A  +  GL +LH+    
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 185 GI---PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG---QETYVTARVLGTFGYFDP 238
                 I HRD KS N+L+  N    I+D GLA          +     RV GT  Y  P
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPP 215

Query: 239 E------YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG--------VNDQNLVLQV 284
           E        +  +  + +D+Y+FG++L E+     +  + +         V        +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275

Query: 285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
           R I+   KKLR    P       + E +     L + C     + R +     K L  + 
Sbjct: 276 REIVC-IKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  204 bits (520), Expect = 1e-63
 Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 41/288 (14%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG+VY G    GEV AI+ +++ R  E   +  F+ EV    +  H N+V  +G 
Sbjct: 41  IGKGRFGQVYHGRWH-GEV-AIRLIDIERDNEDQLK-AFKREVMAYRQTRHENVVLFMGA 97

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
           C    H  ++    +   L   +    +  +D     ++A    KG+ YLH+       I
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK-----GI 151

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLM----PEGQETYVTARVLGTFGYFDPEYTSTG 244
           +H+D KS NV    N +  I+DFGL  +        +E  +  +  G   +  PE     
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN-GWLCHLAPEIIRQL 209

Query: 245 KL---------TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR 295
                      +  SDV+A G +  EL          +    + ++ Q+         ++
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF---KTQPAEAIIWQM------GTGMK 260

Query: 296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
               P LS+     E     +++   C   E  ERP+  + +  L+ +
Sbjct: 261 ----PNLSQIGMGKE----ISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  196 bits (500), Expect = 3e-60
 Identities = 81/311 (26%), Positives = 128/311 (41%), Gaps = 44/311 (14%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDI--LSRLDHPNLVSLI 126
           +GKG FG V++G  R GE VA+K      F   + E  +  E +I     L H N++  I
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKI-----FSSRE-ERSWFREAEIYQTVMLRHENILGFI 102

Query: 127 GYC----ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
                        +LV +Y + G+L D+LN      +     +K+AL  A GLA+LH   
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 183 AVGI---PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET---YVTARVLGTFGYF 236
                   I HRD KS N+L+  N    I+D GLA       +T       RV GT  Y 
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYM 218

Query: 237 DPE------YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG--------VNDQNLVL 282
            PE           +   ++D+YA G+V  E+        +++         V     V 
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL 342
           ++R ++   +KLR    P +     + E++ + A +   C     + R +     K L  
Sbjct: 279 EMRKVVC-EQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

Query: 343 IIYTNSKGLNM 353
           +     +G+ M
Sbjct: 334 LS--QQEGIKM 342

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  158 bits (402), Expect = 2e-45
 Identities = 80/284 (28%), Positives = 129/284 (45%), Gaps = 40/284 (14%)

Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKE---ADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V+ G LR+    VA+K       +E    D + +F  E  IL +  HPN+V 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-----RETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           LIG C   +  ++V E +Q G+    L   G  ++     L++   AA G+ YL S    
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK--- 232

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY--FDPEYTS 242
               +HRD  + N L++     KISDFG+++   +G   Y  +  L         PE  +
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG--VYAASGGLRQVPVKWTAPEALN 288

Query: 243 TGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE 301
            G+ + +SDV++FG++L E  + G         +++Q    Q R  +    +L     PE
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPY---PNLSNQ----QTREFVEKGGRLPC---PE 338

Query: 302 L-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
           L   + +          L  +C   E  +RPS +   +ELQ I 
Sbjct: 339 LCPDAVF---------RLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  156 bits (396), Expect = 5e-45
 Identities = 81/303 (26%), Positives = 131/303 (43%), Gaps = 45/303 (14%)

Query: 69  LGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEA--DGEHEFRVEVDILSRLDHPN 121
           LGKG FG V           +G +VA+K++     + +  D + +F+ E+ IL  L    
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQL-----QHSGPDQQRDFQREIQILKALHSDF 85

Query: 122 LVSLIGYCADGKHR--FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           +V   G       +   LV EY+  G L+D L      ++D    L  +    KG+ YL 
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLG 144

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF--D 237
           S        VHRD  + N+L+ +    KI+DFGLAKL+P  ++ Y   R  G    F   
Sbjct: 145 SRR-----CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY-VVREPGQSPIFWYA 198

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLT-GRR-------AVDLNQGVNDQNLVLQVRHILN 289
           PE  S    + QSDV++FGVVL EL T   +        + +     D   + ++  +L 
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258

Query: 290 DRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
           + ++L     P       + +    M       C      +RPS +    +L  ++++ S
Sbjct: 259 EGQRLPA---PPACPAEVHEL----M-----KLCWAPSPQDRPSFSALGPQLD-MLWSGS 305

Query: 349 KGL 351
           +G 
Sbjct: 306 RGC 308

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  154 bits (392), Expect = 9e-45
 Identities = 77/298 (25%), Positives = 130/298 (43%), Gaps = 36/298 (12%)

Query: 69  LGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPN 121
           LGKG FG V           +GEVVA+KK+     + +  EH  +F  E++IL  L H N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----QHSTEEHLRDFEREIEILKSLQHDN 72

Query: 122 LVSLIGYCADGKHR--FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           +V   G C     R   L+ EY+  G+L+D+L    + ++D    L+      KG+ YL 
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLG 131

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF--D 237
           +        +HRD  + N+L+      KI DFGL K++P+ +E +   +  G    F   
Sbjct: 132 TKR-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF-KVKEPGESPIFWYA 185

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV 297
           PE  +  K ++ SDV++FGVVL EL T             + +    +  +     +  +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 298 IDPELSRSSYTME-----SIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG 350
                 +++  +         ++  + + C     ++RPS  +    +   I  N  G
Sbjct: 246 ------KNNGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQ-IRDNMAG 295

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  154 bits (392), Expect = 1e-44
 Identities = 79/297 (26%), Positives = 126/297 (42%), Gaps = 45/297 (15%)

Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHP 120
           LG+G FG+V           +GE VA+K +     K   G +   + + E++IL  L H 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-----KPESGGNHIADLKKEIEILRNLYHE 83

Query: 121 NLVSLIGYCADGKHR--FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
           N+V   G C +       L+ E++  G+L+++L    + K++   +LK A+   KG+ YL
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYL 142

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF-- 236
            S        VHRD  + NVL+ +  + KI DFGL K +   +E Y T +       F  
Sbjct: 143 GSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-TVKDDRDSPVFWY 196

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNL-------VLQVRHIL 288
            PE     K  + SDV++FGV L ELLT                        V ++ + L
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256

Query: 289 NDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
            + K+L     P       Y          L  +C   + S R S    ++  + ++
Sbjct: 257 KEGKRLPC---PPNCPDEVY---------QLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  155 bits (393), Expect = 1e-44
 Identities = 77/298 (25%), Positives = 129/298 (43%), Gaps = 36/298 (12%)

Query: 69  LGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEH--EFRVEVDILSRLDHPN 121
           LGKG FG V           +GEVVA+KK+     + +  EH  +F  E++IL  L H N
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----QHSTEEHLRDFEREIEILKSLQHDN 103

Query: 122 LVSLIGYCADGKHR--FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           +V   G C     R   L+ EY+  G+L+D+L    + ++D    L+      KG+ YL 
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLG 162

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF--D 237
           +        +HRD  + N+L+      KI DFGL K++P+ +E Y   +  G    F   
Sbjct: 163 TKR-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY-KVKEPGESPIFWYA 216

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV 297
           PE  +  K ++ SDV++FGVVL EL T             + +    +  +     +  +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276

Query: 298 IDPELSRSSYTME-----SIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG 350
                 +++  +         ++  + + C     ++RPS  +    +   I     G
Sbjct: 277 ------KNNGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQ-IRDQMAG 326

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  152 bits (387), Expect = 7e-44
 Identities = 86/300 (28%), Positives = 130/300 (43%), Gaps = 42/300 (14%)

Query: 69  LGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHP 120
           LG+G FG+V           +GE+VA+K +     K   G      ++ E+DIL  L H 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-----KADAGPQHRSGWKQEIDILRTLYHE 93

Query: 121 NLVSLIGYCADGKHR--FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
           +++   G C D       LV EY+  G+L+D+L       +     L  A    +G+AYL
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYL 150

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF-- 236
           H+        +HRD  + NVLL  +   KI DFGLAK +PEG E Y   R  G    F  
Sbjct: 151 HAQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-RVREDGDSPVFWY 204

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLR 295
            PE     K    SDV++FGV L ELLT    +        +   + Q       +  + 
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ------GQMTVL 258

Query: 296 KVIDPELSRSSYTME-----SIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG 350
           ++   EL      +         ++ +L   C  TE+S RP+    +  L+  ++   +G
Sbjct: 259 RLT--ELLERGERLPRPDKCPAEVY-HLMKNCWETEASFRPTFENLIPILK-TVHEKYQG 314

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  155 bits (394), Expect = 3e-43
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 36/285 (12%)

Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKEADGEHE-FRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE   E E F  E  ++  + HPNLV L+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      ++   + L +A   +  + YL   +    
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---- 338

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF--DPEYTSTG 244
             +HR+  + N L+  N   K++DFGL++LM    +TY TA     F      PE  +  
Sbjct: 339 -FIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTY-TAHAGAKFPIKWTAPESLAYN 394

Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-S 303
           K +++SDV+AFGV+L E+ T    +    G++      QV  +L    ++ +   PE   
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT--YGMSPYPGIDLS----QVYELLEKDYRMER---PEGCP 445

Query: 304 RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
              Y +    M       C +   S+RPS AE  +  + +   +S
Sbjct: 446 EKVYEL----MR-----ACWQWNPSDRPSFAEIHQAFETMFQESS 481

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  147 bits (374), Expect = 3e-42
 Identities = 70/279 (25%), Positives = 106/279 (37%), Gaps = 39/279 (13%)

Query: 66  DNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           D  +G+G F  VYKG    +   VA  +++  +  +++    F+ E ++L  L HPN+V 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEMLKGLQHPNIVR 89

Query: 125 LIGYCADGKHR----FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
                           LV E M  G L+ +L       M   +         KGL +LH+
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT 147

Query: 181 SSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                 PI+HRD K  N+ ++      KI D GLA L            V+GT  +  PE
Sbjct: 148 R---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPE 200

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK---LRK 296
                      DVYAFG+ +LE+ T           ++     Q+   +    K     K
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFDK 253

Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
           V  PE                +   C+R    ER S+ +
Sbjct: 254 VAIPE-------------VKEIIEGCIRQNKDERYSIKD 279

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  146 bits (372), Expect = 4e-42
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE-ADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G FG V+ G   + + VAIK +     +E A  E +F  E +++ +L HP LV L G
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTI-----REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
            C +     LV E+M+ G L D+L             L + L   +G+AYL  +      
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC----- 124

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY--FDPEYTSTGK 245
           ++HRD  + N L+  N   K+SDFG+ + + +  + Y T+     F      PE  S  +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQY-TSSTGTKFPVKWASPEVFSFSR 181

Query: 246 LTLQSDVYAFGVVLLELLT-GRR 267
            + +SDV++FGV++ E+ + G+ 
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKI 204

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  146 bits (371), Expect = 9e-42
 Identities = 82/286 (28%), Positives = 132/286 (46%), Gaps = 38/286 (13%)

Query: 69  LGKGGFGRVYKGTLRSGEV-VAIKKMELPRFKE-ADGEHEFRVEVDILSRLDHPNLVSLI 126
           LG G +G VY+G  +   + VA+K +     KE      EF  E  ++  + HPNLV L+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
           G C      +++ E+M  GNL D+L      ++   + L +A   +  + YL   +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---- 131

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF--DPEYTSTG 244
             +HRD  + N L+  N   K++DFGL++LM    +TY TA     F      PE  +  
Sbjct: 132 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY-TAHAGAKFPIKWTAPESLAYN 187

Query: 245 KLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL- 302
           K +++SDV+AFGV+L E+ T G        G++      QV  +L    ++ +   PE  
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPY---PGIDLS----QVYELLEKDYRMER---PEGC 237

Query: 303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
               Y +    M       C +   S+RPS AE  +  + +   +S
Sbjct: 238 PEKVYEL----M-----RACWQWNPSDRPSFAEIHQAFETMFQESS 274

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  146 bits (370), Expect = 1e-41
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 38/285 (13%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE-ADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V  G  R    VAIK +     KE +  E EF  E  ++  L H  LV L G
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
            C   +  F++ EYM  G L ++L      +      L++     + + YL S       
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQ----- 140

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY--FDPEYTSTGK 245
            +HRD  + N L++     K+SDFGL++ + +  + Y T+ V   F      PE     K
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEY-TSSVGSKFPVRWSPPEVLMYSK 197

Query: 246 LTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-S 303
            + +SD++AFGV++ E+ + G+      +   +     +    +    +L +   P L S
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPY---ERFTNS----ETAEHIAQGLRLYR---PHLAS 247

Query: 304 RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS 348
              YT+    M       C   ++ ERP+    +  +  ++   S
Sbjct: 248 EKVYTI----M-----YSCWHEKADERPTFKILLSNILDVMDEES 283

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  146 bits (370), Expect = 2e-41
 Identities = 62/292 (21%), Positives = 110/292 (37%), Gaps = 41/292 (14%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+GGF  V     L  G   A+K++      E     E + E D+    +HPN++ L+ 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVA 93

Query: 128 YCAD----GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR--LKVALGAAKGLAYLHSS 181
           YC          +L+  + ++G L + +  + +          L + LG  +GL  +H+ 
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-------GTFG 234
                   HRD K TN+LL    +  + D G         E    A  L        T  
Sbjct: 154 -----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 235 YFDPE---YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR 291
           Y  PE     S   +  ++DV++ G VL  ++ G    D    V  +   +         
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD---MVFQKGDSVA-------L 258

Query: 292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
               ++  P+  R S  +        L +  +  +  +RP +   + +L+ +
Sbjct: 259 AVQNQLSIPQSPRHSSALW------QLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  145 bits (367), Expect = 3e-41
 Identities = 64/272 (23%), Positives = 111/272 (40%), Gaps = 26/272 (9%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G +GR  K      G+++  K+++     EA+ +     EV++L  L HPN+V    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHPNIVRYYD 72

Query: 128 YCADGKHRFL--VYEYMQKGNLQDHLNGIGEPKMDWPLR--LKVALGAAKGLAYLHSSSA 183
              D  +  L  V EY + G+L   +    + +        L+V       L   H  S 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
            G  ++HRD K  NV L      K+ DFGLA+++    +T      +GT  Y  PE  + 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMSPEQMNR 190

Query: 244 GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELS 303
                +SD+++ G +L EL             + + L  ++R      +++      EL+
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELAGKIRE--GKFRRIPYRYSDELN 245

Query: 304 RSSYTMESIAMFANLASRCVRTESSERPSMAE 335
                         + +R +  +   RPS+ E
Sbjct: 246 -------------EIITRMLNLKDYHRPSVEE 264

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  145 bits (367), Expect = 4e-41
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 15/206 (7%)

Query: 69  LGKGGFGRVYKGTLRSGEV----VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FG V +G   +       VA+K ++     + +   +F  EV+ +  LDH NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           L G         +V E    G+L D L    +         + A+  A+G+ YL S    
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR-- 141

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY--FDPEYTS 242
               +HRD  + N+LL+     KI DFGL + +P+  + Y   +      +    PE   
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAWCAPESLK 197

Query: 243 TGKLTLQSDVYAFGVVLLELLT-GRR 267
           T   +  SD + FGV L E+ T G+ 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQE 223

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  144 bits (365), Expect = 4e-41
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 32/210 (15%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE-ADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V  G  +    VA+K +     KE +  E EF  E   + +L HP LV   G
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMI-----KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
            C+     ++V EY+  G L ++L   G   ++    L++     +G+A+L S       
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ----- 124

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV---------TARVLGTFGYFDP 238
            +HRD  + N L+  +   K+SDFG+ + + + Q             +A          P
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----------P 174

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLT-GRR 267
           E     K + +SDV+AFG+++ E+ + G+ 
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  143 bits (364), Expect = 1e-40
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 24/275 (8%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG GG   VY          VAIK + +P  ++ +    F  EV   S+L H N+VS+I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              +    +LV EY++   L +++   G   +     +        G+ + H        
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR----- 131

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           IVHRD K  N+L+ +N   KI DFG+AK + E   T  T  VLGT  YF PE        
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATD 190

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
             +D+Y+ G+VL E+L G    +      +  + + ++HI +    +   +  ++ +S  
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFN-----GETAVSIAIKHIQDSVPNVTTDVRKDIPQS-- 243

Query: 308 TMESIAMFANLASRCVRTESSERP-SMAECVKELQ 341
                   +N+  R    + + R  ++ E   +L 
Sbjct: 244 -------LSNVILRATEKDKANRYKTIQEMKDDLS 271

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  144 bits (366), Expect = 1e-40
 Identities = 76/308 (24%), Positives = 124/308 (40%), Gaps = 62/308 (20%)

Query: 69  LGKGGFGRVYKGTLRSGE------VVAIKKMELPRFKEA--DGEHEFRVEVDILSRLDHP 120
           LG+G FG+V+     +        +VA+K +     KEA      +F+ E ++L+ L H 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-----KEASESARQDFQREAELLTMLQHQ 103

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHL---------NGIGEPKMDWPLRLK----V 167
           ++V   G C +G+   +V+EYM+ G+L   L            GE     PL L     V
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 168 ALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA 227
           A   A G+ YL          VHRD  + N L+      KI DFG+++ +    + Y   
Sbjct: 164 ASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-DYYRV- 216

Query: 228 RVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLV 281
              G           PE     K T +SDV++FGVVL E+ T G++       +++    
Sbjct: 217 ---GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW---YQLSNT--- 267

Query: 282 LQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
            +    +   ++L +   P       Y          +   C + E  +R S+ +    L
Sbjct: 268 -EAIDCITQGRELER---PRACPPEVY---------AIMRGCWQREPQQRHSIKDVHARL 314

Query: 341 QLIIYTNS 348
           Q +     
Sbjct: 315 QALAQAPP 322

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  144 bits (365), Expect = 2e-40
 Identities = 65/274 (23%), Positives = 114/274 (41%), Gaps = 39/274 (14%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G FG+         G    IK++ + R    + E E R EV +L+ + HPN+V    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE-ESRREVAVLANMKHPNIVQYRE 90

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              +    ++V +Y + G+L   +N            L   +     L ++H        
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----- 145

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE------YT 241
           I+HRD KS N+ L+ +   ++ DFG+A+++    E       +GT  Y  PE      Y 
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYN 203

Query: 242 STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE 301
           +      +SD++A G VL EL T + A +     + +NLVL++         +      +
Sbjct: 204 N------KSDIWALGCVLYELCTLKHAFE---AGSMKNLVLKIIS--GSFPPVSLHYSYD 252

Query: 302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
           L              +L S+  +    +RPS+  
Sbjct: 253 LR-------------SLVSQLFKRNPRDRPSVNS 273

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  146 bits (370), Expect = 3e-40
 Identities = 83/281 (29%), Positives = 128/281 (45%), Gaps = 38/281 (13%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE-FRVEVDILSRLDHPNLVSLIG 127
           LG+G FG V+ GT      VAIK +     K      E F  E  ++ +L H  LV L  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                +  ++V EYM KG+L D L G     +  P  + +A   A G+AY+   +     
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----- 300

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF--DPEYTSTGK 245
            VHRD ++ N+L+  N   K++DFGLA+L+ + +  Y TAR    F      PE    G+
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNE--Y-TARQGAKFPIKWTAPEAALYGR 357

Query: 246 LTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-S 303
            T++SDV++FG++L EL T GR       G+ ++    +V   +    ++     P    
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVP---YPGMVNR----EVLDQVERGYRMPC---PPECP 407

Query: 304 RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
            S +         +L  +C R E  ERP+       L+   
Sbjct: 408 ESLH---------DLMCQCWRKEPEERPTFEYLQAFLEDYF 439

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  147 bits (372), Expect = 5e-40
 Identities = 83/281 (29%), Positives = 128/281 (45%), Gaps = 38/281 (13%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE-FRVEVDILSRLDHPNLVSLIG 127
           LG+G FG V+ GT      VAIK +     K      E F  E  ++ +L H  LV L  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                +  ++V EYM KG+L D L G     +  P  + +A   A G+AY+   +     
Sbjct: 330 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----- 383

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF--DPEYTSTGK 245
            VHRD ++ N+L+  N   K++DFGLA+L+ + +  Y TAR    F      PE    G+
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNE--Y-TARQGAKFPIKWTAPEAALYGR 440

Query: 246 LTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-S 303
            T++SDV++FG++L EL T GR       G+ ++    +V   +    ++     P    
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVP---YPGMVNR----EVLDQVERGYRMPC---PPECP 490

Query: 304 RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
            S +         +L  +C R E  ERP+       L+   
Sbjct: 491 ESLH---------DLMCQCWRKEPEERPTFEYLQAFLEDYF 522

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  142 bits (360), Expect = 6e-40
 Identities = 66/308 (21%), Positives = 118/308 (38%), Gaps = 30/308 (9%)

Query: 36  DQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNF-----LGKGGFGRVYKGT-LRSGEVVA 89
           D+ +Q  +          K +       +  NF     +G+G F  VY+   L  G  VA
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61

Query: 90  IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQD 149
           +KK+++    +A    +   E+D+L +L+HPN++       +     +V E    G+L  
Sbjct: 62  LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121

Query: 150 HLNGIGEPKMDWP--LRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAK 207
            +    + K   P     K  +     L ++HS       ++HRD K  NV ++A    K
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVVK 176

Query: 208 ISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRR 267
           + D GL +          +  ++GT  Y  PE         +SD+++ G +L E+   + 
Sbjct: 177 LGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234

Query: 268 AVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTES 327
                   +  NL    + I            P L    Y+ E       L + C+  + 
Sbjct: 235 PFY----GDKMNLYSLCKKIEQCDY-------PPLPSDHYSEE----LRQLVNMCINPDP 279

Query: 328 SERPSMAE 335
            +RP +  
Sbjct: 280 EKRPDVTY 287

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  142 bits (361), Expect = 6e-40
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 41/218 (18%)

Query: 69  LGKGGFGRVYKGTLRSGE-----VVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHP 120
           LG G FG VYKG            VAIK++     +EA       E   E  +++ +D+P
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEILDEAYVMASVDNP 77

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           ++  L+G C       L+ + M  G L D++    +  +     L   +  AKG+ YL  
Sbjct: 78  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV----------TARVL 230
                  +VHRD  + NVL+      KI+DFGLAKL+   ++ Y            A   
Sbjct: 136 RR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--- 187

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR 267
                   E       T QSDV+++GV + EL+T G +
Sbjct: 188 -------LESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  142 bits (359), Expect = 1e-39
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 58/300 (19%)

Query: 69  LGKGGFGRVYKGTLRSGE------VVAIKKMELPRFKEADGEHE---FRVEVDILSRLDH 119
           LG+G FG VY+G  +          VAIK +      EA    E   F  E  ++   + 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRERIEFLNEASVMKEFNC 87

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL----NGIGEPKMDWPLRLK----VALGA 171
            ++V L+G  + G+   ++ E M +G+L+ +L      +    +  P  L     +A   
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
           A G+AYL+++       VHRD  + N +++ +F  KI DFG+ + + E  + Y      G
Sbjct: 148 ADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-DYYRK----G 197

Query: 232 TFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVR 285
             G        PE    G  T  SDV++FGVVL E+ T   +     QG++++    QV 
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---QGLSNE----QVL 250

Query: 286 HILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
             + +   L K   P+      +          L   C +     RPS  E +  ++  +
Sbjct: 251 RFVMEGGLLDK---PDNCPDMLF---------ELMRMCWQYNPKMRPSFLEIISSIKEEM 298

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  141 bits (358), Expect = 2e-39
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 29/213 (13%)

Query: 69  LGKGGFGRVYKGTLRSGEV-----VAIKKMELPRFKEADGEHE---FRVEVDILSRLDHP 120
           +G G FG VYKG L++        VAIK +     K    E +   F  E  I+ +  H 
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-----KAGYTEKQRVDFLGEAGIMGQFSHH 106

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           N++ L G  +  K   ++ EYM+ G L   L    + +      + +  G A G+ YL +
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF---- 236
            +      VHRD  + N+L+++N   K+SDFGL++++ +  E   T       G      
Sbjct: 166 MN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG----GKIPIRW 216

Query: 237 -DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR 267
             PE  S  K T  SDV++FG+V+ E++T G R
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (354), Expect = 2e-39
 Identities = 69/212 (32%), Positives = 100/212 (47%), Gaps = 40/212 (18%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG V  G  R G  VA+K +     K       F  E  ++++L H NLV L+G 
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 129 CADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
             + K   ++V EYM KG+L D+L   G   +     LK +L   + + YL  ++     
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----- 137

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV-----------TARVLGTFGYF 236
            VHRD  + NVL+S +  AK+SDFGL K      E              TA         
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTA--------- 182

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR 267
            PE     K + +SDV++FG++L E+ + GR 
Sbjct: 183 -PEALREKKFSTKSDVWSFGILLWEIYSFGRV 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  141 bits (357), Expect = 2e-39
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 28/212 (13%)

Query: 69  LGKGGFGRVYKGTLRS---GEV-VAIKKMELPRFKEADGEHE---FRVEVDILSRLDHPN 121
           +G G  G V  G LR     +V VAIK +     K    E +   F  E  I+ + DHPN
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKAL-----KAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           ++ L G    G+   +V EYM+ G+L   L    + +      + +  G   G+ YL   
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF----- 236
                  VHRD  + NVL+ +N   K+SDFGL++++ +  +   T       G       
Sbjct: 171 G-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG----GKIPIRWT 221

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR 267
            PE  +    +  SDV++FGVV+ E+L  G R
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (356), Expect = 3e-39
 Identities = 64/321 (19%), Positives = 107/321 (33%), Gaps = 50/321 (15%)

Query: 31  HWKLEDQPTQPQKRHRGSSVFTLKEMEEAT-CSFSDDNF-----LGKGGFGRVYKGT-LR 83
               + QP +   R   S        + +   SF   +F     LG G +G V+K     
Sbjct: 21  QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKE 80

Query: 84  SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYM 142
            G + A+K+   P     D   +   EV    ++  HP  V L     +G   +L  E  
Sbjct: 81  DGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139

Query: 143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA 202
              +LQ H    G   +               LA+LHS       +VH D K  N+ L  
Sbjct: 140 G-PSLQQHCEAWGAS-LPEAQVWGYLRDTLLALAHLHSQG-----LVHLDVKPANIFLGP 192

Query: 203 NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE-----YTSTGKLTLQSDVYAFGV 257
               K+ DFGL   +       V     G   Y  PE     Y +       +DV++ G+
Sbjct: 193 RGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGSYGTA------ADVFSLGL 243

Query: 258 VLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFAN 317
            +LE+                   +++ H     ++LR+   P    +  + E      +
Sbjct: 244 TILEVACN----------------MELPHGGEGWQQLRQGYLPPEFTAGLSSE----LRS 283

Query: 318 LASRCVRTESSERPSMAECVK 338
           +    +  +   R +    + 
Sbjct: 284 VLVMMLEPDPKLRATAEALLA 304

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  140 bits (356), Expect = 3e-39
 Identities = 59/244 (24%), Positives = 92/244 (37%), Gaps = 27/244 (11%)

Query: 38  PTQPQKRHRGSSVFTLKEMEEATCSFSDDNF--------LGKGGFGRVYKGT-LRSGEVV 88
            +     H    V     M+    S     F        +G+GG G VY+        +V
Sbjct: 3   SSHHHHHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIV 62

Query: 89  AIKKM--EL---PRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ 143
           A+K M   L   P F+        + E     RL  P++V +  +       ++    + 
Sbjct: 63  ALKLMSETLSSDPVFRT-----RMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN 117

Query: 144 KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN 203
             +L   L   G   +  P  + +       L   H++        HRD K  N+L+SA+
Sbjct: 118 GVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG-----ATHRDVKPENILVSAD 170

Query: 204 FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELL 263
             A + DFG+A    + + T      +GT  Y  PE  S    T ++D+YA   VL E L
Sbjct: 171 DFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229

Query: 264 TGRR 267
           TG  
Sbjct: 230 TGSP 233

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  143 bits (363), Expect = 3e-39
 Identities = 78/293 (26%), Positives = 125/293 (42%), Gaps = 66/293 (22%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG V  G  R G  VA+K +     K       F  E  ++++L H NLV L+G 
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 129 CADGKHRF-LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
             + K    +V EYM KG+L D+L   G   +     LK +L   + + YL  ++     
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----- 309

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV-----------TARVLGTFGYF 236
            VHRD  + NVL+S +  AK+SDFGL K      E              TA         
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTA--------- 354

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLR 295
            PE     K + +SDV++FG++L E+ + GR        +  +++V +V           
Sbjct: 355 -PEALREKKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPRVEK--------- 401

Query: 296 KVIDPELSRSSYTMES----IAMFANLASRCVRTESSERPSMAECVKELQLII 344
                      Y M++         ++   C   +++ RP+  +  ++L+ I 
Sbjct: 402 ----------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  139 bits (353), Expect = 3e-39
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 22/208 (10%)

Query: 69  LGKGGFGRVYKGTLR--SGEV-VAIKKMELPRFKEADGEH---EFRVEVDILSRLDHPNL 122
           LG G FG V +G  R    ++ VAIK +     K+   +    E   E  I+ +LD+P +
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL-----KQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
           V LIG C   +   LV E    G L   L G    ++      ++    + G+ YL   +
Sbjct: 73  VRLIGVC-QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN 130

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF--DPEY 240
                 VHRD  + NVLL     AKISDFGL+K +      Y TAR  G +      PE 
Sbjct: 131 -----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPEC 184

Query: 241 TSTGKLTLQSDVYAFGVVLLELLT-GRR 267
            +  K + +SDV+++GV + E L+ G++
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  140 bits (356), Expect = 3e-39
 Identities = 68/296 (22%), Positives = 121/296 (40%), Gaps = 49/296 (16%)

Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LGKG FG V +  L+  +     VA+K ++      +D E EF  E   +   DHP++  
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLREAACMKEFDHPHVAK 89

Query: 125 LIGYCADG------KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLK----VALGAAKG 174
           L+G               ++  +M+ G+L   L      +  + L L+      +  A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
           + YL S +      +HRD  + N +L+ +    ++DFGL++ +    + Y      G   
Sbjct: 150 MEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKI-YSGDYYRQ----GCAS 199

Query: 235 YF-----DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN 289
                    E  +    T+ SDV+AFGV + E++T  R      G+ +     ++ + L 
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT--RGQTPYAGIENA----EIYNYLI 253

Query: 290 DRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
              +L++   P       Y         +L  +C   +  +RPS      EL+ I+
Sbjct: 254 GGNRLKQ---PPECMEEVY---------DLMYQCWSADPKQRPSFTCLRMELENIL 297

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  139 bits (352), Expect = 5e-39
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 16/205 (7%)

Query: 69  LGKGGFGRVYKGTLRSGEV---VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           LG G FG V KG  +  +V   VA+K ++     +   + E   E +++ +LD+P +V +
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
           IG C + +   LV E  + G L  +L       +     +++    + G+ YL  S+   
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN--- 137

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF--GYFDPEYTST 243
              VHRD  + NVLL     AKISDFGL+K +   +  Y  A+  G +   ++ PE  + 
Sbjct: 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINY 194

Query: 244 GKLTLQSDVYAFGVVLLELLT-GRR 267
            K + +SDV++FGV++ E  + G++
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  138 bits (351), Expect = 5e-39
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 18/203 (8%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHE-FRVEVDILSRLDHPNLVSLIG 127
           LG G FG V+ G       VA+K +     K+     + F  E +++ +L H  LV L  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                +  +++ EYM+ G+L D L      K+     L +A   A+G+A++   +     
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----- 129

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY--FDPEYTSTGK 245
            +HRD ++ N+L+S     KI+DFGLA+L+ +    Y TAR    F      PE  + G 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEY-TAREGAKFPIKWTAPEAINYGT 186

Query: 246 LTLQSDVYAFGVVLLELLT-GRR 267
            T++SDV++FG++L E++T GR 
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  139 bits (352), Expect = 7e-39
 Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 63/305 (20%)

Query: 69  LGKGGFGRVYKGTLRSGE------VVAIKKMELPRFKEA--DGEHEFRVEVDILSRLDHP 120
           LG+G FG+V+     +        +VA+K +     K+       +F+ E ++L+ L H 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-----KDPTLAARKDFQREAELLTNLQHE 77

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR--------------LK 166
           ++V   G C DG    +V+EYM+ G+L   L   G   M                   L 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 167 VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT 226
           +A   A G+ YL S        VHRD  + N L+ AN   KI DFG+++ +    + Y  
Sbjct: 138 IASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRV 191

Query: 227 ARVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNL 280
               G           PE     K T +SDV++FGV+L E+ T G++       +++   
Sbjct: 192 ----GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW---FQLSNT-- 242

Query: 281 VLQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE 339
             +V   +   + L +   P +  +  Y         ++   C + E  +R ++ E  K 
Sbjct: 243 --EVIECITQGRVLER---PRVCPKEVY---------DVMLGCWQREPQQRLNIKEIYKI 288

Query: 340 LQLII 344
           L  + 
Sbjct: 289 LHALG 293

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  140 bits (356), Expect = 8e-39
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 28/212 (13%)

Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHPN 121
           +G G FG V  G L+        VAIK +     K    E    +F  E  I+ + DHPN
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASIMGQFDHPN 107

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           ++ L G     K   +V EYM+ G+L   L    + +      + +  G A G+ YL   
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF----- 236
                  VHRD  + N+L+++N   K+SDFGL +++ +  E   T R     G       
Sbjct: 167 G-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG----GKIPIRWT 217

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR 267
            PE  +  K T  SDV+++G+VL E+++ G R
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (351), Expect = 8e-39
 Identities = 83/293 (28%), Positives = 123/293 (41%), Gaps = 42/293 (14%)

Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG VY GTL   +      A+K   L R  +     +F  E  I+    HPN++S
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 125 LIGYCADGKH-RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
           L+G C   +    +V  YM+ G+L++ +             +   L  AKG+ YL S   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK- 148

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF------D 237
                VHRD  + N +L   F  K++DFGLA+ M   +E Y    V    G         
Sbjct: 149 ----FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYY---SVHNKTGAKLPVKWMA 200

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV 297
            E   T K T +SDV++FGV+L EL+T  R       VN       +   L   ++L + 
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTF----DITVYLLQGRRLLQ- 253

Query: 298 IDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
             PE      Y          +  +C   ++  RPS +E V  +  I  T   
Sbjct: 254 --PEYCPDPLY---------EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  139 bits (353), Expect = 1e-38
 Identities = 72/315 (22%), Positives = 121/315 (38%), Gaps = 67/315 (21%)

Query: 69  LGKGGFGRVYKGTLRSGE------VVAIKKMELPRFKEADGEHE---FRVEVDILSRLDH 119
           LG G FG VY+G +           VA+K +      E   E +   F +E  I+S+ +H
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-----PEVCSEQDELDFLMEALIISKFNH 92

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL-NGIGEPKMDWPLRLK----VALGAAKG 174
            N+V  IG       RF++ E M  G+L+  L      P     L +     VA   A G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAKLMPEGQETYVTARVLG 231
             YL  +       +HRD  + N LL+       AKI DFG+A+ +      Y      G
Sbjct: 153 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRK----G 202

Query: 232 TFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVR 285
                      PE    G  T ++D ++FGV+L E+ + G          ++Q ++  V 
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY---PSKSNQEVLEFVT 259

Query: 286 HILNDRKKLRKVIDPELSRSSYTME-----SIAMFANLASRCVRTESSERPSMAECVKEL 340
                                  M+        ++  + ++C + +  +RP+ A  ++ +
Sbjct: 260 S-------------------GGRMDPPKNCPGPVY-RIMTQCWQHQPEDRPNFAIILERI 299

Query: 341 QLIIYTNSKGLNMPL 355
           +     +   +N  L
Sbjct: 300 EYCT-QDPDVINTAL 313

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  138 bits (351), Expect = 1e-38
 Identities = 62/316 (19%), Positives = 113/316 (35%), Gaps = 39/316 (12%)

Query: 34  LEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKM 93
           +            G+     + M      +S    +G GG  +V++      ++ AIK +
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60

Query: 94  ELPRFKEADGEHEFRVEVDILSRLDHPNL--VSLIGYCADGKHRFLVYEYMQKGNLQDHL 151
            L        +  +R E+  L++L   +   + L  Y    ++ ++V E     +L   L
Sbjct: 61  NLEEADNQTLDS-YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWL 118

Query: 152 NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF 211
                  +D   R        + +  +H        IVH D K  N L+  +   K+ DF
Sbjct: 119 KKKK--SIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIV-DGMLKLIDF 170

Query: 212 GLAKLMPEGQETYVTARVLGTFGYFDPE-----------YTSTGKLTLQSDVYAFGVVLL 260
           G+A  M     + V    +GT  Y  PE             S  K++ +SDV++ G +L 
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230

Query: 261 ELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLAS 320
            +  G+                    I+N   KL  +IDP        +       ++  
Sbjct: 231 YMTYGKTPFQ---------------QIINQISKLHAIIDPNHEIEFPDIPE-KDLQDVLK 274

Query: 321 RCVRTESSERPSMAEC 336
            C++ +  +R S+ E 
Sbjct: 275 CCLKRDPKQRISIPEL 290

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  138 bits (349), Expect = 2e-38
 Identities = 63/304 (20%), Positives = 117/304 (38%), Gaps = 65/304 (21%)

Query: 69  LGKGGFGRVYKGTLRSGEV--------VAIKKMELPRFKEA--DGEHEFRVEVDILSRLD 118
           LG+G F +++KG  R            V +K +      +A  +    F     ++S+L 
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-----DKAHRNYSESFFEAASMMSKLS 70

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
           H +LV   G C  G    LV E+++ G+L  +L    +  ++   +L+VA   A  + +L
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFL 129

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFE--------AKISDFGLAKLMPEGQETYV----T 226
             ++     ++H +  + N+LL    +         K+SD G++  +             
Sbjct: 130 EENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184

Query: 227 ARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQV 284
                      PE     K   L +D ++FG  L E+ + G + +     ++ Q    + 
Sbjct: 185 P----------PECIENPKNLNLATDKWSFGTTLWEICSGGDKPL---SALDSQ----RK 227

Query: 285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                DR +L      EL             ANL + C+  E   RPS    +++L  + 
Sbjct: 228 LQFYEDRHQLPAPKAAEL-------------ANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

Query: 345 YTNS 348
             + 
Sbjct: 275 TPDL 278

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  141 bits (358), Expect = 2e-38
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 18/203 (8%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGE-HEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V+  T      VA+K M     K        F  E +++  L H  LV L  
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTM-----KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                +  +++ E+M KG+L D L      K   P  +  +   A+G+A++   +     
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----- 304

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF--DPEYTSTGK 245
            +HRD ++ N+L+SA+   KI+DFGLA+++ +    Y TAR    F      PE  + G 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIED--NEY-TAREGAKFPIKWTAPEAINFGS 361

Query: 246 LTLQSDVYAFGVVLLELLT-GRR 267
            T++SDV++FG++L+E++T GR 
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRI 384

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  137 bits (347), Expect = 2e-38
 Identities = 64/200 (32%), Positives = 94/200 (47%), Gaps = 14/200 (7%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY     +S  ++A+K +   + ++A  EH+ R EV+I S L HPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
           Y  D    +L+ EY   G +   L  +   K D           A  L+Y HS       
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR----- 129

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG-QETYVTARVLGTFGYFDPEYTSTGKL 246
           ++HRD K  N+LL +  E KI+DFG +   P   +         GT  Y  PE       
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPEMIEGRMH 184

Query: 247 TLQSDVYAFGVVLLELLTGR 266
             + D+++ GV+  E L G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (349), Expect = 2e-38
 Identities = 69/295 (23%), Positives = 124/295 (42%), Gaps = 48/295 (16%)

Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG+G FG V +G L+  +     VA+K M+L    + + E EF  E   +    HPN++ 
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE-EFLSEAACMKDFSHPNVIR 100

Query: 125 LIGYCADGK-----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLK----VALGAAKGL 175
           L+G C +          ++  +M+ G+L  +L           + L+      +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 176 AYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            YL + +      +HRD  + N +L  +    ++DFGL+K +    + Y      G    
Sbjct: 161 EYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKI-YSGDYYRQ----GRIAK 210

Query: 236 F-----DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND 290
                   E  +    T +SDV+AFGV + E+ T  R +    GV +     ++   L  
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNH----EMYDYLLH 264

Query: 291 RKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
             +L++   PE      Y          +   C RT+  +RP+ +    +L+ ++
Sbjct: 265 GHRLKQ---PEDCLDELY---------EIMYSCWRTDPLDRPTFSVLRLQLEKLL 307

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  137 bits (347), Expect = 3e-38
 Identities = 74/303 (24%), Positives = 118/303 (38%), Gaps = 64/303 (21%)

Query: 69  LGKGGFGRVYKGTLRSGE------VVAIKKMELPRFKE---ADGEHEFRVEVDILSRLDH 119
           LG+  FG+VYKG L           VAIK +     K+        EFR E  + +RL H
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-----KDKAEGPLREEFRHEAMLRARLQH 71

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL----------NGIGEPKMDWPLRLK--- 166
           PN+V L+G     +   +++ Y   G+L + L          +   +  +   L      
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 167 -VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV 225
            +    A G+ YL S       +VH+D  + NVL+      KISD GL + +    + Y 
Sbjct: 132 HLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV-YAADYYK 185

Query: 226 TARVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQN 279
                            PE    GK ++ SD++++GVVL E+ + G +      G ++Q 
Sbjct: 186 L----LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY---CGYSNQ- 237

Query: 280 LVLQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
               V  ++ +R+ L     P+      Y          L   C     S RP   +   
Sbjct: 238 ---DVVEMIRNRQVLPC---PDDCPAWVY---------ALMIECWNEFPSRRPRFKDIHS 282

Query: 339 ELQ 341
            L+
Sbjct: 283 RLR 285

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  137 bits (346), Expect = 4e-38
 Identities = 74/306 (24%), Positives = 123/306 (40%), Gaps = 50/306 (16%)

Query: 66  DNFLGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEHE---FRVEVDILSRLD 118
           D  +GKG FG VY G            AIK +            +   F  E  ++  L+
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-----SRITEMQQVEAFLREGLLMRGLN 80

Query: 119 HPNLVSLIGYCADGK-HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAY 177
           HPN+++LIG     +    ++  YM  G+L   +    +        +   L  A+G+ Y
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEY 139

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF- 236
           L          VHRD  + N +L  +F  K++DFGLA+ +   +E Y   +         
Sbjct: 140 LAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQ--HRHARLP 191

Query: 237 ----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDR 291
                 E   T + T +SDV++FGV+L ELLT G       + ++       + H L   
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY---RHIDPF----DLTHFLAQG 244

Query: 292 KKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG 350
           ++L +   PE    S Y          +  +C   + + RP+    V E++ I+      
Sbjct: 245 RRLPQ---PEYCPDSLY---------QVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292

Query: 351 --LNMP 354
             + +P
Sbjct: 293 HYVQLP 298

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  137 bits (347), Expect = 7e-38
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 69  LGKGGFGRVYKGTLRSGE-----VVAIKKMELPRFKEADGE---HEFRVEVDILSRLDHP 120
           LG G FG V+KG            V IK +     ++  G          +  +  LDH 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVI-----EDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           ++V L+G C  G    LV +Y+  G+L DH+       +   L L   +  AKG+ YL  
Sbjct: 76  HIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEE 133

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
                  +VHR+  + NVLL +  + +++DFG+A L+P   +  + +       +   E 
Sbjct: 134 HG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 241 TSTGKLTLQSDVYAFGVVLLELLT-GRR 267
              GK T QSDV+++GV + EL+T G  
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  137 bits (347), Expect = 7e-38
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 21/208 (10%)

Query: 69  LGKGGFGRVYKGTLRSGE-----VVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHP 120
           LG G FG VYKG            VAIK++     +EA       E   E  +++ +D+P
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEILDEAYVMASVDNP 77

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           ++  L+G C       L+ + M  G L D++    +  +     L   +  AKG+ YL  
Sbjct: 78  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
                  +VHRD  + NVL+      KI+DFGLAKL+   ++ Y          +   E 
Sbjct: 136 RR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 241 TSTGKLTLQSDVYAFGVVLLELLT-GRR 267
                 T QSDV+++GV + EL+T G +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  138 bits (349), Expect = 8e-38
 Identities = 84/389 (21%), Positives = 140/389 (35%), Gaps = 74/389 (19%)

Query: 6   VSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLK----EMEEATC 61
           +S ++          T   +Y           P     + R S++ T           T 
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTS 60

Query: 62  SFSDD-----------NFLGKGGFGRVYKGTLRSGE------VVAIKKMELPRFKEADGE 104
           S SD              LG G FG VY+G +           VA+K +      E   E
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-----PEVCSE 115

Query: 105 HE---FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL-NGIGEPKMD 160
            +   F +E  I+S+ +H N+V  IG       RF++ E M  G+L+  L      P   
Sbjct: 116 QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 175

Query: 161 WPLRLK----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE---AKISDFGL 213
             L +     VA   A G  YL  +       +HRD  + N LL+       AKI DFG+
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGM 230

Query: 214 AKLMPEGQETYVTARVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR 267
           A+ +      Y      G           PE    G  T ++D ++FGV+L E+ + G  
Sbjct: 231 ARDIYRA-GYYRK----GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 285

Query: 268 AVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTE 326
                   ++Q    +V   +    ++     P+      Y          + ++C + +
Sbjct: 286 PY---PSKSNQ----EVLEFVTSGGRMDP---PKNCPGPVY---------RIMTQCWQHQ 326

Query: 327 SSERPSMAECVKELQLIIYTNSKGLNMPL 355
             +RP+ A  ++ ++     +   +N  L
Sbjct: 327 PEDRPNFAIILERIEYCT-QDPDVINTAL 354

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  135 bits (343), Expect = 1e-37
 Identities = 65/286 (22%), Positives = 108/286 (37%), Gaps = 55/286 (19%)

Query: 67  NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             +G GGFG+V+K      G+   IK+++           +   EV  L++LDH N+V  
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHY 69

Query: 126 IGYCADGKHR----------------FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL 169
            G      +                 F+  E+  KG L+  +      K+D  L L++  
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129

Query: 170 GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
              KG+ Y+HS       +++RD K +N+ L    + KI DFGL   +   +      R 
Sbjct: 130 QITKGVDYIHSKK-----LINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRS 181

Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN 289
            GT  Y  PE  S+     + D+YA G++L ELL                    +R    
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTDLR---- 232

Query: 290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
                  +I     +             L  + +  +  +RP+ +E
Sbjct: 233 -----DGIISDIFDKK---------EKTLLQKLLSKKPEDRPNTSE 264

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  135 bits (343), Expect = 2e-37
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKM--EL---PRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG GG   V+    LR    VA+K +  +L   P F        FR E    + L+HP +
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYL-----RFRREAQNAAALNHPAI 74

Query: 123 VSL--IG--YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
           V++   G      G   ++V EY+    L+D ++  G   M     ++V   A + L + 
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFS 132

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYFD 237
           H +      I+HRD K  N+++SA    K+ DFG+A+ + +   +   TA V+GT  Y  
Sbjct: 133 HQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGRR 267
           PE      +  +SDVY+ G VL E+LTG  
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  135 bits (341), Expect = 3e-37
 Identities = 64/292 (21%), Positives = 112/292 (38%), Gaps = 51/292 (17%)

Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LG+GGFG V++          AIK++ LP  + A    +   EV  L++L+HP +V   
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEHPGIVRYF 69

Query: 127 GYCADGKHR------------FLVYEYMQKGNLQDHLNG-IGEPKMDWPLRLKVALGAAK 173
               +                ++  +  +K NL+D +NG     + +  + L + L  A+
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL--- 230
            + +LHS       ++HRD K +N+  + +   K+ DFGL   M + +E       +   
Sbjct: 130 AVEFLHSKG-----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 231 -------GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ 283
                  GT  Y  PE       + + D+++ G++L ELL             ++   L 
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFST------QMERVRTL- 237

Query: 284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
                     +R +  P L    Y  E       +    +     ERP    
Sbjct: 238 --------TDVRNLKFPPLFTQKYPCEY-----VMVQDMLSPSPMERPEAIN 276

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  136 bits (345), Expect = 3e-37
 Identities = 88/375 (23%), Positives = 140/375 (37%), Gaps = 65/375 (17%)

Query: 10  NKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDN-- 67
            +RR S +     P     ++     ++ +    +  GS     +         S  N  
Sbjct: 15  GRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPE 74

Query: 68  ---------------------FLGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEAD 102
                                 +G+G FG VY GTL   +      A+K   L R  +  
Sbjct: 75  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIG 132

Query: 103 GEHEFRVEVDILSRLDHPNLVSLIGYCADGKH-RFLVYEYMQKGNLQDHLNGIGEPKMDW 161
              +F  E  I+    HPN++SL+G C   +    +V  YM+ G+L++ +          
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV 191

Query: 162 PLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ 221
              +   L  AKG+ +L S        VHRD  + N +L   F  K++DFGLA+ M + +
Sbjct: 192 KDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246

Query: 222 ETYVTARVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGV 275
              V  +   T           E   T K T +SDV++FGV+L EL+T G         V
Sbjct: 247 FDSVHNK---TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDV 300

Query: 276 NDQNLVLQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMA 334
           N       +   L   ++L +   PE      Y          +  +C   ++  RPS +
Sbjct: 301 NTF----DITVYLLQGRRLLQ---PEYCPDPLY---------EVMLKCWHPKAEMRPSFS 344

Query: 335 ECVKELQLIIYTNSK 349
           E V  +  I  T   
Sbjct: 345 ELVSRISAIFSTFIG 359

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  135 bits (343), Expect = 4e-37
 Identities = 59/283 (20%), Positives = 106/283 (37%), Gaps = 39/283 (13%)

Query: 67  NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL--VS 124
             +G GG  +V++      ++ AIK + L        +  +R E+  L++L   +   + 
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS-YRNEIAYLNKLQQHSDKIIR 73

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           L  Y    ++ ++V E     +L   L       +D   R        + +  +H     
Sbjct: 74  LYDYEITDQYIYMVMECGN-IDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG-- 128

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE----- 239
              IVH D K  N L+  +   K+ DFG+A  M     + V    +GT  Y  PE     
Sbjct: 129 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 240 ------YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
                   S  K++ +SDV++ G +L  +  G+                    I+N   K
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------------QIINQISK 229

Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAEC 336
           L  +IDP        +       ++   C++ +  +R S+ E 
Sbjct: 230 LHAIIDPNHEIEFPDIPE-KDLQDVLKCCLKRDPKQRISIPEL 271

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  135 bits (342), Expect = 4e-37
 Identities = 83/313 (26%), Positives = 132/313 (42%), Gaps = 65/313 (20%)

Query: 69  LGKGGFGRVYKGTLRSGEV---VAIKKMELPRFKEADGEHE---FRVEVDILSRL-DHPN 121
           +G+G FG+V K  ++   +    AIK+M     KE   + +   F  E+++L +L  HPN
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHL----------NGIGEPKMDWPLR----LKV 167
           +++L+G C    + +L  EY   GNL D L                     L     L  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 168 ALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA 227
           A   A+G+ YL          +HRD  + N+L+  N+ AKI+DFGL++    GQE YV  
Sbjct: 148 AADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 197

Query: 228 RVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLV 281
               T G         E  +    T  SDV+++GV+L E+++ G        G+      
Sbjct: 198 ---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY---CGMTCA--- 248

Query: 282 LQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
            ++   L    +L K   P       Y         +L  +C R +  ERPS A+ +  L
Sbjct: 249 -ELYEKLPQGYRLEK---PLNCDDEVY---------DLMRQCWREKPYERPSFAQILVSL 295

Query: 341 QLIIYTNSKGLNM 353
             ++      +N 
Sbjct: 296 NRMLEERKTYVNT 308

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  140 bits (353), Expect = 4e-37
 Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 16/205 (7%)

Query: 69  LGKGGFGRVYKGTLR--SGEV-VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           LG G FG V +G  R    ++ VAIK   L +  E     E   E  I+ +LD+P +V L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
           IG C   +   LV E    G L   L G  E ++      ++    + G+ YL   +   
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKN--- 456

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY--FDPEYTST 243
              VHR+  + NVLL     AKISDFGL+K +      Y TAR  G +    + PE  + 
Sbjct: 457 --FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINF 513

Query: 244 GKLTLQSDVYAFGVVLLELLT-GRR 267
            K + +SDV+++GV + E L+ G++
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQK 538

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  135 bits (341), Expect = 5e-37
 Identities = 58/252 (23%), Positives = 99/252 (39%), Gaps = 26/252 (10%)

Query: 27  KPVEHWKLEDQPTQPQKRHRGSSVFTLK------EMEEATCSFSDDNFLGKGGFGRVYKG 80
           K       + Q   P+       + T K      E  E     +    +G+G FG V++ 
Sbjct: 18  KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM 77

Query: 81  T-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY 139
              ++G   A+KK+ L  F+          E+   + L  P +V L G   +G    +  
Sbjct: 78  KDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFM 129

Query: 140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVL 199
           E ++ G+L   +  +G   +     L     A +GL YLH+       I+H D K+ NVL
Sbjct: 130 ELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR-----ILHGDVKADNVL 182

Query: 200 LSAN-FEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYFDPEYTSTGKLTLQSDVYAF 255
           LS++   A + DFG A  +              + GT  +  PE         + D+++ 
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242

Query: 256 GVVLLELLTGRR 267
             ++L +L G  
Sbjct: 243 CCMMLHMLNGCH 254

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  133 bits (337), Expect = 7e-37
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 41/217 (18%)

Query: 69  LGKGGFGRVYKGTLRSGEV----VAIKKMELPRFKE---ADGEHEFRVEVDILSRLDHPN 121
           LG+G FG VY+G   + +     VA+K       K+    D + +F  E  I+  LDHP+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V LIG   + +  +++ E    G L  +L    +  +     +  +L   K +AYL S 
Sbjct: 75  IVKLIGII-EEEPTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESI 132

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV----------TARVLG 231
           +      VHRD    N+L+++    K+ DFGL++ + E ++ Y            +    
Sbjct: 133 N-----CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMS---- 182

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR 267
                 PE  +  + T  SDV+ F V + E+L+ G++
Sbjct: 183 ------PESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  135 bits (341), Expect = 1e-36
 Identities = 58/283 (20%), Positives = 105/283 (37%), Gaps = 39/283 (13%)

Query: 67  NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL--VS 124
             +G GG  +V++      ++ AIK + L        +  +R E+  L++L   +   + 
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS-YRNEIAYLNKLQQHSDKIIR 120

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           L  Y    ++ ++V E     +L   L       +D   R        + +  +H     
Sbjct: 121 LYDYEITDQYIYMVMECGN-IDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG-- 175

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE----- 239
              IVH D K  N L+  +   K+ DFG+A  M     + V    +G   Y  PE     
Sbjct: 176 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 240 ------YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK 293
                   S  K++ +SDV++ G +L  +  G+                    I+N   K
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------------QIINQISK 276

Query: 294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAEC 336
           L  +IDP        +       ++   C++ +  +R S+ E 
Sbjct: 277 LHAIIDPNHEIEFPDIPE-KDLQDVLKCCLKRDPKQRISIPEL 318

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  134 bits (339), Expect = 2e-36
 Identities = 40/221 (18%), Positives = 91/221 (41%), Gaps = 33/221 (14%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKME--------------LPRFKEADGEHEFRVEVDIL 114
           L +G F ++     +  +  A+KK E                +        +F+ E+ I+
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 115 SRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA--- 171
           + + +   ++  G   +    +++YEYM+  ++            ++   + + +     
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 172 ---AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR 228
                  +Y+H+       I HRD K +N+L+  N   K+SDFG ++ M + +     +R
Sbjct: 158 KSVLNSFSYIHNEKN----ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GSR 211

Query: 229 VLGTFGYFDPEYTSTGKLT---LQSDVYAFGVVLLELLTGR 266
             GT+ +  PE+ S  + +    + D+++ G+ L  +    
Sbjct: 212 --GTYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNV 249

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  135 bits (341), Expect = 3e-36
 Identities = 65/292 (22%), Positives = 109/292 (37%), Gaps = 48/292 (16%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HP 120
           SF   + LG G  G +    +     VA+K++    F  AD       EV +L   D HP
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHP 78

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPLRLKVALGAAKGLAYL 178
           N++       D + +++  E      LQ+++         ++    + +      GLA+L
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHL 134

Query: 179 HSSSAVGIPIVHRDFKSTNVLLS-----ANFEAKISDFGLAKLMPEGQETYVTAR-VLGT 232
           HS +     IVHRD K  N+L+S        +A ISDFGL K +  G+ ++     V GT
Sbjct: 135 HSLN-----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

Query: 233 FGYFDPEY---TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI-- 287
            G+  PE          T   D+++ G V   +++                     H   
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG------------------SHPFG 231

Query: 288 -LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
               R+    +    L           +   L  + +  +  +RPS    +K
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  133 bits (337), Expect = 4e-36
 Identities = 68/317 (21%), Positives = 125/317 (39%), Gaps = 73/317 (23%)

Query: 69  LGKGGFGRVYKGTLRSGE--------VVAIKKMELPRFKE---ADGEHEFRVEVDILSRL 117
           LG+G FG+V        +         VA+K +     K+        +   E++++  +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLSDLVSEMEMMKMI 143

Query: 118 -DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL----------NGIGEPKMDWPLRLK 166
             H N+++L+G C      +++ EY  KGNL+++L          +       +  +  K
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 167 ----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE 222
                    A+G+ YL S        +HRD  + NVL++ N   KI+DFGLA+ +    +
Sbjct: 204 DLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINN-ID 257

Query: 223 TYVTARVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND 277
            Y       T G        PE       T QSDV++FGV++ E+ T         G+  
Sbjct: 258 YYKK----TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPV 311

Query: 278 QNLVLQVRHILNDRKKLRKVIDPELSRSSYTME-----SIAMFANLASRCVRTESSERPS 332
           + L   +                   +  + M+     +  ++  +   C     S+RP+
Sbjct: 312 EELFKLL-------------------KEGHRMDKPANCTNELY-MMMRDCWHAVPSQRPT 351

Query: 333 MAECVKELQLIIYTNSK 349
             + V++L  I+   + 
Sbjct: 352 FKQLVEDLDRILTLTTN 368

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  132 bits (335), Expect = 5e-36
 Identities = 72/328 (21%), Positives = 130/328 (39%), Gaps = 79/328 (24%)

Query: 69  LGKGGFGRVYKGTLRSGE--------VVAIKKMELPRFKE---ADGEHEFRVEVDILSRL 117
           LG+G FG+V        +         VA+K +     K+        +   E++++  +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLSDLVSEMEMMKMI 97

Query: 118 -DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL----------NGIGEPKMDWPLRLK 166
             H N+++L+G C      +++ EY  KGNL+++L          +       +  +  K
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 167 ----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE 222
                    A+G+ YL S        +HRD  + NVL++ N   KI+DFGLA+ +    +
Sbjct: 158 DLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINN-ID 211

Query: 223 TYVTARVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVN 276
            Y       T G        PE       T QSDV++FGV++ E+ T G        G+ 
Sbjct: 212 YYKK----TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY---PGIP 264

Query: 277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTME-----SIAMFANLASRCVRTESSERP 331
            + L   +                   +  + M+     +  ++  +   C     S+RP
Sbjct: 265 VEELFKLL-------------------KEGHRMDKPANCTNELY-MMMRDCWHAVPSQRP 304

Query: 332 SMAECVKELQLIIYTNSKG----LNMPL 355
           +  + V++L  I+   +      L+ PL
Sbjct: 305 TFKQLVEDLDRILTLTTNEEYLDLSQPL 332

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  131 bits (331), Expect = 5e-36
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 21/207 (10%)

Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKE---ADGEHEFRVEVDILSRLDHPN 121
           +G+G FG V++G   S E     VAIK       K         +F  E   + + DHP+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTC-----KNCTSDSVREKFLQEALTMRQFDHPH 77

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V LIG        +++ E    G L+  L    +  +D    +  A   +  LAYL S 
Sbjct: 78  IVKLIGVI-TENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK 135

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                  VHRD  + NVL+S+N   K+ DFGL++ M E    Y  ++      +  PE  
Sbjct: 136 R-----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 189

Query: 242 STGKLTLQSDVYAFGVVLLELLT-GRR 267
           +  + T  SDV+ FGV + E+L  G +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVK 216

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  131 bits (333), Expect = 5e-36
 Identities = 76/321 (23%), Positives = 134/321 (41%), Gaps = 86/321 (26%)

Query: 69  LGKGGFGRVYKGTLRSGE------VVAIKKMELPRFKEADGEHE---FRVEVDILSRLDH 119
           LG+G FG+V K T    +       VA+K +     KE     E      E ++L +++H
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML-----KENASPSELRDLLSEFNVLKQVNH 85

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL------------------NGIGEPKMDW 161
           P+++ L G C+      L+ EY + G+L+  L                  +   +   + 
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 162 PLRLK----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM 217
            L +      A   ++G+ YL         +VHRD  + N+L++   + KISDFGL++ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDV 200

Query: 218 PEGQETYVTARVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLN 272
            E +++YV      + G         E       T QSDV++FGV+L E++T      L 
Sbjct: 201 YE-EDSYVK----RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------LG 249

Query: 273 ----QGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTME-----SIAMFANLASRCV 323
                G+  + L   +                   ++ + ME     S  M+  L  +C 
Sbjct: 250 GNPYPGIPPERLFNLL-------------------KTGHRMERPDNCSEEMY-RLMLQCW 289

Query: 324 RTESSERPSMAECVKELQLII 344
           + E  +RP  A+  K+L+ ++
Sbjct: 290 KQEPDKRPVFADISKDLEKMM 310

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (330), Expect = 1e-35
 Identities = 60/300 (20%), Positives = 109/300 (36%), Gaps = 60/300 (20%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G FG+V K          AIKK+        +       EV +L+ L+H  +V    
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIR----HTEEKLSTILSEVMLLASLNHQYVVRYYA 69

Query: 128 YCADGKHR-------------FLVYEYMQKGNLQDHL---NGIGEPKMDWPLRLKVALGA 171
              + ++              F+  EY + G L D +   N   +    W L  ++    
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA- 128

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR--- 228
              L+Y+HS       I+HRD K  N+ +  +   KI DFGLAK +    +         
Sbjct: 129 ---LSYIHSQG-----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 229 ---------VLGTFGYFDPE-YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ 278
                     +GT  Y   E    TG    + D+Y+ G++  E++        + G+   
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FSTGMERV 235

Query: 279 NLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           N++ ++R +            P+   +        +   +    +  + ++RP     + 
Sbjct: 236 NILKKLRSV-------SIEFPPDFDDNKM-----KVEKKIIRLLIDHDPNKRPGARTLLN 283

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  136 bits (343), Expect = 1e-35
 Identities = 77/285 (27%), Positives = 122/285 (42%), Gaps = 41/285 (14%)

Query: 69  LGKGGFGRVYKGTLRSGE----VVAIKKMELPRFKEADGEH---EFRVEVDILSRLDHPN 121
           +G+G FG V++G   S E     VAIK       K    +    +F  E   + + DHP+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTC-----KNCTSDSVREKFLQEALTMRQFDHPH 452

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V LIG        +++ E    G L+  L    +  +D    +  A   +  LAYL S 
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESK 510

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                  VHRD  + NVL+S+N   K+ DFGL++ M E    Y  ++      +  PE  
Sbjct: 511 R-----FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 564

Query: 242 STGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
           +  + T  SDV+ FGV + E+L  G +     QGV +      V   + + ++L     P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPF---QGVKNN----DVIGRIENGERLPM---P 614

Query: 301 EL-SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                + Y         +L ++C   + S RP   E   +L  I+
Sbjct: 615 PNCPPTLY---------SLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  130 bits (328), Expect = 1e-35
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 14/200 (7%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG VY     ++  ++A+K +   + ++   EH+ R E++I S L HPN++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
           Y  D K  +L+ E+  +G L   L   G  + D           A  L Y H        
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK----- 134

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG-QETYVTARVLGTFGYFDPEYTSTGKL 246
           ++HRD K  N+L+    E KI+DFG +   P   + T       GT  Y  PE       
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-----GTLDYLPPEMIEGKTH 189

Query: 247 TLQSDVYAFGVVLLELLTGR 266
             + D++  GV+  E L G 
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  131 bits (332), Expect = 2e-35
 Identities = 82/323 (25%), Positives = 130/323 (40%), Gaps = 72/323 (22%)

Query: 69  LGKGGFGRVYKGTLRSGE------VVAIKKMELPRFKE---ADGEHEFRVEVDILSRLDH 119
           +G+G FGRV++             +VA+K +     KE   AD + +F+ E  +++  D+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADMQADFQREAALMAEFDN 109

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL------------------NGIGEPKMDW 161
           PN+V L+G CA GK   L++EYM  G+L + L                            
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 162 PLR----LKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM 217
           PL     L +A   A G+AYL          VHRD  + N L+  N   KI+DFGL++ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNI 224

Query: 218 PEGQETYVTARVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDL 271
               + Y                  PE     + T +SDV+A+GVVL E+ + G +    
Sbjct: 225 YSA-DYYKA----DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY-- 277

Query: 272 NQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSER 330
             G+  +    +V + + D   L     PE      Y +    M       C     ++R
Sbjct: 278 -YGMAHE----EVIYYVRDGNILAC---PENCPLELYNL----M-----RLCWSKLPADR 320

Query: 331 PSMAECVKELQLIIYTNSKGLNM 353
           PS     + LQ +       + +
Sbjct: 321 PSFCSIHRILQRMCERAEGTVGV 343

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  130 bits (328), Expect = 2e-35
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 10/200 (5%)

Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + ++ +   + EV A K +      +     +  +E+ I   L H ++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
           G+  D    F+V E  ++ +L +         +  P           G  YLH +     
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---- 135

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            ++HRD K  N+ L+ + E KI DFGLA  +    E      + GT  Y  PE  S    
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 192

Query: 247 TLQSDVYAFGVVLLELLTGR 266
           + + DV++ G ++  LL G+
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  129 bits (327), Expect = 2e-35
 Identities = 63/206 (30%), Positives = 93/206 (45%), Gaps = 21/206 (10%)

Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LGKG F  VY+   + +G  VAIK ++     +A      + EV I  +L HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA------AKGLAYLHS 180
            Y  D  + +LV E    G +  +L    +                       G+ YLHS
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-------PFSENEARHFMHQIITGMLYLHS 130

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
                  I+HRD   +N+LL+ N   KI+DFGLA  +    E + T  + GT  Y  PE 
Sbjct: 131 HG-----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGR 266
            +     L+SDV++ G +   LL GR
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  131 bits (332), Expect = 2e-35
 Identities = 74/317 (23%), Positives = 126/317 (39%), Gaps = 75/317 (23%)

Query: 69  LGKGGFGRVYKGTLR--------SGEVVAIKKMELPRFKEADGEHE---FRVEVDILSRL 117
           LG+G FG+V                  VA+K +     K    E +      E++++  +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-----KSDATEKDLSDLISEMEMMKMI 131

Query: 118 -DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL----------NGIGEPKMDWPLRLK 166
             H N+++L+G C      +++ EY  KGNL+++L          +       +  L  K
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 167 ----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE 222
                A   A+G+ YL S        +HRD  + NVL++ +   KI+DFGLA+ +    +
Sbjct: 192 DLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDIHH-ID 245

Query: 223 TYVTARVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVN 276
            Y       T G        PE       T QSDV++FGV+L E+ T G        GV 
Sbjct: 246 YYKK----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY---PGVP 298

Query: 277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTME-----SIAMFANLASRCVRTESSERP 331
            + L   ++                     + M+     +  ++  +   C     S+RP
Sbjct: 299 VEELFKLLKE-------------------GHRMDKPSNCTNELY-MMMRDCWHAVPSQRP 338

Query: 332 SMAECVKELQLIIYTNS 348
           +  + V++L  I+   S
Sbjct: 339 TFKQLVEDLDRIVALTS 355

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  130 bits (328), Expect = 3e-35
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 71/316 (22%)

Query: 69  LGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKE---ADGEHEFRVEVDILSRLD- 118
           LG+G FG+V +          +   VA+K +     KE            E+ IL  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 89

Query: 119 HPNLVSLIGYCAD-GKHRFLVYEYMQKGNLQDHL----------NGIGEPKMDWPLRLK- 166
           H N+V+L+G C   G    ++ E+ + GNL  +L              E      L L+ 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 167 ---VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET 223
               +   AKG+ +L S        +HRD  + N+LLS     KI DFGLA+ + +    
Sbjct: 150 LICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPD 203

Query: 224 YVTARVLGTFGYF-----DPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR---AVDLNQG 274
           YV                 PE       T+QSDV++FGV+L E+ + G      V +++ 
Sbjct: 204 YVR----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 258

Query: 275 VNDQNLVLQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTESSERPSM 333
                   +    L +  ++R    P+  +   Y      M       C   E S+RP+ 
Sbjct: 259 --------EFCRRLKEGTRMRA---PDYTTPEMYQT----M-----LDCWHGEPSQRPTF 298

Query: 334 AECVKELQLIIYTNSK 349
           +E V+ L  ++  N++
Sbjct: 299 SELVEHLGNLLQANAQ 314

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  135 bits (341), Expect = 3e-35
 Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 26/206 (12%)

Query: 69  LGKGGFGRVYKG--TLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           +  GG G +Y       +G  V +K +      +A+ +     E   L+ + HP++V + 
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 127 GYCADGKHR-----FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
            +            ++V EY+   +L+         K+     +   L     L+YLHS 
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS- 200

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
               I +V+ D K  N++L+   + K+ D G    +           + GT G+  PE  
Sbjct: 201 ----IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NS----FGYLYGTPGFQAPE-I 248

Query: 242 STGKLTLQSDVYAFGVVLLELLTGRR 267
                T+ +D+Y  G  L  L     
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLP 274

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  130 bits (328), Expect = 4e-35
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 10/200 (5%)

Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
           FLGKGGF + ++ +   + EV A K +      +     +  +E+ I   L H ++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
           G+  D    F+V E  ++ +L +         +  P           G  YLH +     
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---- 161

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            ++HRD K  N+ L+ + E KI DFGLA  +    E      + GT  Y  PE  S    
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 218

Query: 247 TLQSDVYAFGVVLLELLTGR 266
           + + DV++ G ++  LL G+
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (328), Expect = 5e-35
 Identities = 73/330 (22%), Positives = 124/330 (37%), Gaps = 89/330 (26%)

Query: 69  LGKGGFGRVYKGTLRSGE------VVAIKKMELPRFKEADGEHE---FRVEVDILSRL-D 118
           LG G FG+V   T            VA+K +     KE     E      E+ ++++L  
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKML-----KEKADSSEREALMSELKMMTQLGS 107

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL-----------------NGIGEPKMDW 161
           H N+V+L+G C      +L++EY   G+L ++L                   + E +   
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 162 PLRLK----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM 217
            L  +     A   AKG+ +L   S      VHRD  + NVL++     KI DFGLA+ +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDI 222

Query: 218 PEGQETYV-----------TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-G 265
                 YV            A          PE    G  T++SDV+++G++L E+ + G
Sbjct: 223 MS-DSNYVVRGNARLPVKWMA----------PESLFEGIYTIKSDVWSYGILLWEIFSLG 271

Query: 266 RR---AVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASR 321
                 + ++              ++ +  K+ +   P   +   Y +    M       
Sbjct: 272 VNPYPGIPVDA---------NFYKLIQNGFKMDQ---PFYATEEIYII----M-----QS 310

Query: 322 CVRTESSERPSMAECVKELQLIIYTNSKGL 351
           C   +S +RPS       L   +    + +
Sbjct: 311 CWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  128 bits (324), Expect = 9e-35
 Identities = 71/323 (21%), Positives = 126/323 (39%), Gaps = 84/323 (26%)

Query: 69  LGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHE---FRVEVDILSRL-D 118
           LG G FG+V + T        +   VA+K +     K +    E      E+ +LS L +
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML-----KPSAHLTEREALMSELKVLSYLGN 85

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL------------NGIGEPKMDWPLRLK 166
           H N+V+L+G C  G    ++ EY   G+L + L            +       +  L L+
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 167 ----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE 222
                +   AKG+A+L S +      +HRD  + N+LL+     KI DFGLA+ +     
Sbjct: 146 DLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIKN-DS 199

Query: 223 TYV-----------TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR--- 267
            YV            A          PE       T +SDV+++G+ L EL + G     
Sbjct: 200 NYVVKGNARLPVKWMA----------PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

Query: 268 AVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVRTE 326
            + ++          +   ++ +  ++     PE      Y         ++   C   +
Sbjct: 250 GMPVDS---------KFYKMIKEGFRMLS---PEHAPAEMY---------DIMKTCWDAD 288

Query: 327 SSERPSMAECVKELQLIIYTNSK 349
             +RP+  + V+ ++  I  ++ 
Sbjct: 289 PLKRPTFKQIVQLIEKQISESTN 311

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  127 bits (321), Expect = 3e-34
 Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 33/237 (13%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G    V++G  + +G++ AIK      F           E ++L +L+H N+V L  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74

Query: 128 Y--CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA----AKGLAYLHSS 181
                  +H+ L+ E+   G+L   L    EP   + L     L        G+ +L  +
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLE---EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEA----KISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
                 IVHR+ K  N++     +     K++DFG A+ + + +       + GT  Y  
Sbjct: 132 G-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLH 183

Query: 238 PE--------YTSTGKLTLQSDVYAFGVVLLELLTGRRA-VDLNQGVNDQNLVLQVR 285
           P+             K     D+++ GV      TG            ++ ++ ++ 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  126 bits (320), Expect = 5e-34
 Identities = 72/325 (22%), Positives = 125/325 (38%), Gaps = 92/325 (28%)

Query: 69  LGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKE---ADGEHEFRVEVDILSRLD- 118
           LG G FG+V + T        +   VA+K +     K    AD +     E+ I+S L  
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML-----KSTAHADEKEALMSELKIMSHLGQ 108

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--------NGIGEPKMDWPLRLK---- 166
           H N+V+L+G C  G    ++ EY   G+L + L                +     +    
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 167 VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT 226
            +   A+G+A+L S +      +HRD  + NVLL+    AKI DFGLA+ +         
Sbjct: 169 FSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDI--------- 214

Query: 227 ARVLGTFGYFDPEYTST--GKL---------------TLQSDVYAFGVVLLELLT-GRR- 267
                     D  Y      +L               T+QSDV+++G++L E+ + G   
Sbjct: 215 --------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

Query: 268 --AVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL-SRSSYTMESIAMFANLASRCVR 324
              + +N          +   ++ D  ++ +   P    ++ Y++    M       C  
Sbjct: 267 YPGILVNS---------KFYKLVKDGYQMAQ---PAFAPKNIYSI----M-----QACWA 305

Query: 325 TESSERPSMAECVKELQLIIYTNSK 349
            E + RP+  +    LQ     + +
Sbjct: 306 LEPTHRPTFQQICSFLQEQAQEDRR 330

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  128 bits (323), Expect = 6e-34
 Identities = 55/307 (17%), Positives = 107/307 (34%), Gaps = 48/307 (15%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G    V++G  + +G++ AIK      F           E ++L +L+H N+V L  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74

Query: 128 Y--CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK----GLAYLHSS 181
                  +H+ L+ E+   G+L   L    EP   + L     L   +    G+ +L  +
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLE---EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEA----KISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
                 IVHR+ K  N++     +     K++DFG A+ + + +       + GT  Y  
Sbjct: 132 G-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLH 183

Query: 238 PE--------YTSTGKLTLQSDVYAFGVVLLELLTGRRA-VDLNQGVNDQNLVLQV---- 284
           P+             K     D+++ GV      TG            ++ ++ ++    
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 285 --------RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAEC 336
                   +   N        +    S S      +     + +  +  +  +     + 
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL---TPVLANILEADQEKCWGFDQF 300

Query: 337 VKELQLI 343
             E   I
Sbjct: 301 FAETSDI 307

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  130 bits (329), Expect = 9e-34
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 35/217 (16%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV--EVDILSRLDHPNLVSL 125
           LG GGFG V +     +GE VAIK+      +E   ++  R   E+ I+ +L+HPN+VS 
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 126 I------GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA----AKGL 175
                     A      L  EY + G+L+ +LN   + +    L+           +  L
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN---QFENCCGLKEGPIRTLLSDISSAL 134

Query: 176 AYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQ--ETYVTARVL 230
            YLH +      I+HRD K  N++L    +    KI D G AK + +G+    +V     
Sbjct: 135 RYLHENR-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----- 184

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRR 267
           GT  Y  PE     K T+  D ++FG +  E +TG R
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  127 bits (320), Expect = 3e-33
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 40/225 (17%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIG 127
           LG G  G V       G  VA+K+M +     A       +E+ +L+  D HPN++    
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA------LMEIKLLTESDDHPNVIRYYC 76

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR-----LKVALGAAKGLAYLHSSS 182
                +  ++  E     NLQD +        +  L+     + +    A G+A+LHS  
Sbjct: 77  SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135

Query: 183 AVGIPIVHRDFKSTNVLLS-------------ANFEAKISDFGLAKLMPEGQETYVTAR- 228
                I+HRD K  N+L+S              N    ISDFGL K +  GQ ++ T   
Sbjct: 136 -----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 229 -VLGTFGYFDPE-------YTSTGKLTLQSDVYAFGVVLLELLTG 265
              GT G+  PE         +  +LT   D+++ G V   +L+ 
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  123 bits (312), Expect = 3e-33
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 17/206 (8%)

Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LGKG +G VY G  L +   +AIK++     +++        E+ +   L H N+V  +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHL-NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
           G  ++     +  E +  G+L   L +  G  K +            +GL YLH +    
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142

Query: 186 IPIVHRDFKSTNVLL-SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE---YT 241
             IVHRD K  NVL+ + +   KISDFG +K +        T    GT  Y  PE     
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKG 198

Query: 242 STGKLTLQSDVYAFGVVLLELLTGRR 267
             G     +D+++ G  ++E+ TG+ 
Sbjct: 199 PRGY-GKAADIWSLGCTIIEMATGKP 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  127 bits (322), Expect = 4e-33
 Identities = 73/318 (22%), Positives = 125/318 (39%), Gaps = 35/318 (11%)

Query: 25  VYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR- 83
           ++    H    +             +F   +    +  +     LG G +G V     + 
Sbjct: 1   MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60

Query: 84  SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ 143
           +    AIK +       +    +   EV +L  LDHPN++ L  +  D ++ +LV E  +
Sbjct: 61  THVERAIKIIRKTSVSTSSNS-KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119

Query: 144 KGNLQDHLNGIGE-PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL-- 200
            G L D +    +  ++D  + +K  L     + YLH  +     IVHRD K  N+LL  
Sbjct: 120 GGELFDEIIHRMKFNEVDAAVIIKQVLSG---VTYLHKHN-----IVHRDLKPENLLLES 171

Query: 201 -SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVL 259
              +   KI DFGL+ +    +        LGT  Y  PE     K   + DV++ GV+L
Sbjct: 172 KEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227

Query: 260 LELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFA-NL 318
             LL G                        D++ LRKV   + +  S   ++++  A +L
Sbjct: 228 FILLAGYPPFGGQ----------------TDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271

Query: 319 ASRCVRTESSERPSMAEC 336
             + ++ +S  R S  + 
Sbjct: 272 IKQMLQFDSQRRISAQQA 289

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  126 bits (319), Expect = 9e-33
 Identities = 71/301 (23%), Positives = 120/301 (39%), Gaps = 34/301 (11%)

Query: 42  QKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKE 100
              H    +F        +  +     LGKG FG V     + +G+  A+K +   + K+
Sbjct: 7   DHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ 66

Query: 101 ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE-PKM 159
              +     EV +L +LDHPN++ L  +  D  + +LV E    G L D +       ++
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126

Query: 160 DWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKL 216
           D    ++  L     + Y+H +      IVHRD K  N+LL   S +   +I DFGL+  
Sbjct: 127 DAARIIRQVLSG---ITYMHKNK-----IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178

Query: 217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN 276
               +        +GT  Y  PE    G    + DV++ GV+L  LL+G    +      
Sbjct: 179 FEASK---KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGA---- 230

Query: 277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFA-NLASRCVRTESSERPSMAE 335
                       N+   L+KV   + +      + ++  A +L  + +    S R S  +
Sbjct: 231 ------------NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARD 278

Query: 336 C 336
            
Sbjct: 279 A 279

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  121 bits (305), Expect = 3e-32
 Identities = 60/301 (19%), Positives = 95/301 (31%), Gaps = 65/301 (21%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHP 120
           F +   +G G FG V+K      G + AIK+ + P     D E     EV   + L  H 
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHS 71

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--NGIGEPKMDWPLRLKVALGAAKGLAYL 178
           ++V      A+  H  +  EY   G+L D +  N              + L   +GL Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSAN-------------------FEAKISDFGLAKLMPE 219
           HS S     +VH D K +N+ +S                        KI D G    +  
Sbjct: 132 HSMS-----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 220 GQETYVTARVLGTFGYFDPE-----YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG 274
            Q         G   +   E     YT   K    +D++A  + ++              
Sbjct: 187 PQ-VEE-----GDSRFLANEVLQENYTHLPK----ADIFALALTVVCAAGAEPLPRNGDQ 236

Query: 275 VNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMA 334
                             ++R+   P +     + E    F  L    +  +   RPS  
Sbjct: 237 W----------------HEIRQGRLPRIP-QVLSQE----FTELLKVMIHPDPERRPSAM 275

Query: 335 E 335
            
Sbjct: 276 A 276

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  123 bits (309), Expect = 3e-32
 Identities = 40/253 (15%), Positives = 77/253 (30%), Gaps = 28/253 (11%)

Query: 34  LEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGT------LRSGEV 87
           +   P   + + +  ++    E +  +      + LG+G F +VY+ T       ++ + 
Sbjct: 38  VSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQK 97

Query: 88  VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNL 147
             +K  +     E     +    ++ L        +             LV E    G L
Sbjct: 98  FVLKVQKPANPWEFYIGTQ---LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154

Query: 148 QDHLNGIGEPK---MDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF 204
            + +N         M   L +  A+     +  +H        I+H D K  N +L   F
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE-----IIHGDIKPDNFILGNGF 209

Query: 205 EA-----------KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVY 253
                         + D G +  M    +  +      T G+   E  S      Q D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269

Query: 254 AFGVVLLELLTGR 266
                +  +L G 
Sbjct: 270 GVAATVYCMLFGT 282

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  122 bits (307), Expect = 5e-32
 Identities = 24/255 (9%), Positives = 54/255 (21%), Gaps = 45/255 (17%)

Query: 46  RGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGE 104
           + +       + +          L  G    V+    +   E  A+K   +         
Sbjct: 47  QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106

Query: 105 HEFRVEVDILSRLDHPNLVSLIGYC--------------------------ADGKHRFLV 138
                     +RL   +                                      +  L+
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166

Query: 139 YEYMQKGNLQDHLNGIG-----EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDF 193
                  +L+   + +                 +     +  A L S       +VH  F
Sbjct: 167 MPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG-----LVHGHF 220

Query: 194 KSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT--STGKLTLQSD 251
              N+ +  +    + D      +                 Y   E+   ST   T   +
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWKVGTRGPASS-----VPVTYAPREFLNASTATFTHALN 275

Query: 252 VYAFGVVLLELLTGR 266
            +  G+ +  +    
Sbjct: 276 AWQLGLSIYRVWCLF 290

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (304), Expect = 1e-31
 Identities = 71/310 (22%), Positives = 118/310 (38%), Gaps = 50/310 (16%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLI 126
           L +GGF  VY+   + SG   A+K++      E +       EV  + +L  HPN+V   
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLS---NEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 127 GYCADGKHR-------FLVYEYMQKGNLQDHLNGIGEP-KMDWPLRLKVALGAAKGLAYL 178
              + GK         FL+   + KG L + L  +     +     LK+     + + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL-------- 230
           H       PI+HRD K  N+LLS     K+ DFG A  +    +   +A+          
Sbjct: 153 HRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 231 --GTFGYFDPE---YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR 285
              T  Y  PE     S   +  + D++A G +L  L   +          +    L+  
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-------EDGAKLR-- 260

Query: 286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY 345
            I+N +  +     P             +F +L    ++    ER S+AE V +LQ I  
Sbjct: 261 -IVNGKYSI-----PPHDTQY------TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308

Query: 346 TNSKGLNMPL 355
             +     P+
Sbjct: 309 ARNVNPKSPI 318

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (299), Expect = 3e-31
 Identities = 50/209 (23%), Positives = 100/209 (47%), Gaps = 24/209 (11%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           ++    +G+G  G VY    + +G+ VAI++M L   ++   +     E+ ++    +PN
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL---QQQPKKELIINEILVMRENKNPN 78

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           +V+ +     G   ++V EY+  G+L D      + E ++       V     + L +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLH 133

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYF 236
           S+      ++HRD KS N+LL  +   K++DFG        Q T   ++   ++GT  + 
Sbjct: 134 SNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWM 183

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
            PE  +      + D+++ G++ +E++ G
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (301), Expect = 4e-31
 Identities = 77/344 (22%), Positives = 136/344 (39%), Gaps = 66/344 (19%)

Query: 33  KLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNF-----LGKGGFGRVYKGTLR-SGE 86
           KLE+     Q+R R  +  T K+         DD+F     LG G  G V+K + + SG 
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQ---KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGL 59

Query: 87  VVAIKKMELPRFKEADGEHEFRV--EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK 144
           V+A K + L    E       ++  E+ +L   + P +V   G         +  E+M  
Sbjct: 60  VMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 145 GNLQDHL---NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS 201
           G+L   L     I E  +      KV++   KGL YL         I+HRD K +N+L++
Sbjct: 116 GSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK----IMHRDVKPSNILVN 166

Query: 202 ANFEAKISDFGLAKLMPEGQ-ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLL 260
           +  E K+ DFG++  + +    ++V     GT  Y  PE       ++QSD+++ G+ L+
Sbjct: 167 SRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221

Query: 261 ELLTGR-------------------RAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID-- 299
           E+  GR                              +     +     D +    + +  
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281

Query: 300 --------PELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
                   P+L    +++E    F +  ++C+    +ER  + +
Sbjct: 282 DYIVNEPPPKLPSGVFSLE----FQDFVNKCLIKNPAERADLKQ 321

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  121 bits (306), Expect = 5e-31
 Identities = 62/255 (24%), Positives = 94/255 (36%), Gaps = 31/255 (12%)

Query: 30  EHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVV 88
            H     +    Q       ++  K+  +   S+     LG G +G V     +      
Sbjct: 5   HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64

Query: 89  AIK----------KMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV 138
           AIK          +             E   E+ +L  LDHPN++ L     D K+ +LV
Sbjct: 65  AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLV 124

Query: 139 YEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKS 195
            E+ + G L + +       E          +      G+ YLH  +     IVHRD K 
Sbjct: 125 TEFYEGGELFEQIINRHKFDECDA-----ANIMKQILSGICYLHKHN-----IVHRDIKP 174

Query: 196 TNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDV 252
            N+LL   ++    KI DFGL+    +          LGT  Y  PE     K   + DV
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE-VLKKKYNEKCDV 230

Query: 253 YAFGVVLLELLTGRR 267
           ++ GV++  LL G  
Sbjct: 231 WSCGVIMYILLCGYP 245

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  119 bits (301), Expect = 1e-30
 Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 43/219 (19%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIK-----KMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG G  G V     R   + VAI+     K  +   +EAD       E++IL +L+HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHL---NGIGEPKMDWPLRLKVALGAAK------ 173
           + +  +     + ++V E M+ G L D +     + E                       
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEAT------------CKLYFYQML 249

Query: 174 -GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARV 229
             + YLH +      I+HRD K  NVLLS+  E    KI+DFG +K++ E     +   +
Sbjct: 250 LAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTL 301

Query: 230 LGTFGYFDPE---YTSTGKLTLQSDVYAFGVVLLELLTG 265
            GT  Y  PE      T       D ++ GV+L   L+G
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  120 bits (303), Expect = 1e-30
 Identities = 72/283 (25%), Positives = 111/283 (39%), Gaps = 53/283 (18%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG V K   R + +  A+K +     K  D       EV++L +LDHPN++ L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFE 88

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAK-------GLAY 177
              D    ++V E    G L D +       E              AA+       G+ Y
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD------------AARIIKQVFSGITY 136

Query: 178 LHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
           +H  +     IVHRD K  N+LL     + + KI DFGL+    +          +GT  
Sbjct: 137 MHKHN-----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAY 188

Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
           Y  PE    G    + DV++ GV+L  LL+G                       N+   L
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGK----------------NEYDIL 231

Query: 295 RKVIDPELSRSSYTMESIAMFA-NLASRCVRTESSERPSMAEC 336
           ++V   + +       +I+  A +L  + +    S R +  +C
Sbjct: 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  116 bits (294), Expect = 2e-30
 Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 44/214 (20%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G F  V+    R  G++ A+K ++      A  +     E+ +L ++ H N+V+L  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKK---SPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG------AAK-------G 174
                 H +LV + +  G L D +               +  G      A+         
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRI---------------LERGVYTEKDASLVIQQVLSA 118

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLG 231
           + YLH +      IVHRD K  N+L     E     I+DFGL+K+   G    + +   G
Sbjct: 119 VKYLHENG-----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACG 169

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           T GY  PE  +    +   D ++ GV+   LL G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (294), Expect = 2e-30
 Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 24/209 (11%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
                 +G+G  G V       SG  VA+K M+L   ++         EV I+    H N
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDL---RKQQRRELLFNEVVIMRDYQHFN 103

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           +V +      G+  +++ E++Q G L D      + E ++             + LAYLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCE-----AVLQALAYLH 158

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYF 236
           +       ++HRD KS ++LL+ +   K+SDFG        Q +    +   ++GT  + 
Sbjct: 159 AQG-----VIHRDIKSDSILLTLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWM 208

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
            PE  S      + D+++ G++++E++ G
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDG 237

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  116 bits (293), Expect = 2e-30
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 23/209 (11%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F+    +GKG FG V+KG   R+ +VVAIK ++L   +  D   + + E+ +LS+ D P 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPY 81

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           +    G        +++ EY+  G+  D      + E ++   LR        KGL YLH
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLH 136

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYF 236
           S        +HRD K+ NVLLS + E K++DFG+A     GQ T    +    +GT  + 
Sbjct: 137 SEK-----KIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWM 186

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
            PE         ++D+++ G+  +EL  G
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARG 215

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  116 bits (292), Expect = 3e-30
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 10/153 (6%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +     LG G FG+VYK     +G + A K +E    K  +   ++ VE++IL+  DHP 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET---KSEEELEDYIVEIEILATCDHPY 77

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V L+G        +++ E+   G +   +  +    +  P    V     + L +LHS 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSK 136

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
                 I+HRD K+ NVL++   + +++DFG++
Sbjct: 137 R-----IIHRDLKAGNVLMTLEGDIRLADFGVS 164

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  119 bits (299), Expect = 9e-30
 Identities = 78/265 (29%), Positives = 117/265 (44%), Gaps = 24/265 (9%)

Query: 14  RSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTL----KEMEEATCSFSDDNF- 68
             + +      +++ +     E     P   +  S  F      K +E    + +     
Sbjct: 130 TQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQY 189

Query: 69  --LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             LGKGGFG V    +R +G++ A KK+E  R K+  GE     E  IL +++   +VSL
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 126 IGYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK---GLAYLHSS 181
             Y  + K    LV   M  G+L+ H+  +G+         +    AA+   GL  LH  
Sbjct: 250 A-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRE 305

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 IV+RD K  N+LL  +   +ISD GLA  +PEGQ      RV GT GY  PE  
Sbjct: 306 R-----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI--KGRV-GTVGYMAPEVV 357

Query: 242 STGKLTLQSDVYAFGVVLLELLTGR 266
              + T   D +A G +L E++ G+
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQ 382

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  115 bits (291), Expect = 1e-29
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 25/212 (11%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRF--KEADGEHEFRVEVDILSRLDHPNLVSL 125
           +GKG F  V +   R  G+  A+K +++ +F         + + E  I   L HP++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK----GLAYLHSS 181
           +   +     ++V+E+M   +L   +  +      +     VA    +     L Y H +
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRYCHDN 149

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           +     I+HRD K   VLL++   +   K+  FG+A  + E          +GT  +  P
Sbjct: 150 N-----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAP 202

Query: 239 E---YTSTGKLTLQSDVYAFGVVLLELLTGRR 267
           E       GK     DV+  GV+L  LL+G  
Sbjct: 203 EVVKREPYGK---PVDVWGCGVILFILLSGCL 231

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  115 bits (290), Expect = 1e-29
 Identities = 58/245 (23%), Positives = 88/245 (35%), Gaps = 52/245 (21%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHE--FRVEVDILSRLDHPNLVSL 125
           +G+G +G V       +  + AIK M   + ++ + +     + EV ++ +L HPN+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG--------------- 170
                D ++  LV E    G+L D LN   +          V                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 171 ----------------AAK-------GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA- 206
                            +         L YLH+       I HRD K  N L S N    
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-----ICHRDIKPENFLFSTNKSFE 208

Query: 207 -KISDFGLAKLMPEGQ--ETYVTARVLGTFGYFDPE--YTSTGKLTLQSDVYAFGVVLLE 261
            K+ DFGL+K   +    E Y      GT  +  PE   T+      + D ++ GV+L  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 262 LLTGR 266
           LL G 
Sbjct: 269 LLMGA 273

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  114 bits (288), Expect = 2e-29
 Identities = 61/219 (27%), Positives = 91/219 (41%), Gaps = 43/219 (19%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIK-----KMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG G  G V     R   + VAIK     K  +   +EAD       E++IL +L+HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAK------ 173
           + +  +     + ++V E M+ G L D + G     E                       
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEAT------------CKLYFYQML 124

Query: 174 -GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARV 229
             + YLH +      I+HRD K  NVLLS+  E    KI+DFG +K++ E     +   +
Sbjct: 125 LAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTL 176

Query: 230 LGTFGYFDPE---YTSTGKLTLQSDVYAFGVVLLELLTG 265
            GT  Y  PE      T       D ++ GV+L   L+G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  114 bits (287), Expect = 2e-29
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 20/207 (9%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F     LG+G +G VYK     +G++VAIK++ +          E   E+ I+ + D P+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-----ESDLQEIIKEISIMQQCDSPH 85

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V   G        ++V EY   G++ D +    +  +       +     KGL YLH  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHFM 144

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR---VLGTFGYFDP 238
                  +HRD K+ N+LL+    AK++DFG+A     GQ T   A+   V+GT  +  P
Sbjct: 145 R-----KIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDTMAKRNTVIGTPFWMAP 194

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTG 265
           E          +D+++ G+  +E+  G
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEG 221

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  113 bits (285), Expect = 3e-29
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 21/205 (10%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V+    R SG    IK   + + +      +   E+++L  LDHPN++ +  
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKT--INKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK----GLAYLHSSSA 183
              D  + ++V E  + G L + +  +        L         K     LAY HS   
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERI--VSAQARGKALSEGYVAELMKQMMNALAYFHSQH- 144

Query: 184 VGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
               +VH+D K  N+L    S +   KI DFGLA+L    +    +    GT  Y  PE 
Sbjct: 145 ----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEV 197

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTG 265
                +T + D+++ GVV+  LLTG
Sbjct: 198 FK-RDVTFKCDIWSAGVVMYFLLTG 221

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (290), Expect = 3e-29
 Identities = 31/236 (13%), Positives = 64/236 (27%), Gaps = 45/236 (19%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEV---------------- 111
           LG+       + T   +GE   +          ++   + + EV                
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 112 ---------DILSRLDHPNLVSLIGYCADG--KHRFLVYEYMQKGNLQDHLNGIGE---- 156
                    D++       ++ +     D     RF +Y  MQ  NLQ     +      
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSST 204

Query: 157 -PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK 215
              +    RL++ L   + LA LH        +VH   +  +++L       ++ F    
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 216 LMPEGQETYVTARVLGTFGYFDPE-----YTSTGKLTLQSDVYAFGVVLLELLTGR 266
                  + +                         +T   D +  G+ +  +    
Sbjct: 260 RDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  114 bits (287), Expect = 3e-29
 Identities = 56/157 (35%), Positives = 76/157 (48%), Gaps = 16/157 (10%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           FSD   +G G FG VY    +R+ EVVAIKKM     +  +   +   EV  L +L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQD----HLNGIGEPKMDWPLRLKVALGAAKGLAY 177
            +   G        +LV EY   G+  D    H   + E ++          GA +GLAY
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTH-----GALQGLAY 169

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
           LHS +     ++HRD K+ N+LLS     K+ DFG A
Sbjct: 170 LHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSA 201

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  113 bits (284), Expect = 3e-29
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 41/214 (19%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG F  V +   ++ G   A K +   +    D   +   E  I  +L HPN+V L  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHD 72

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG------AAK-------G 174
              +    +LV++ +  G L + +               VA        A+         
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDI---------------VAREFYSEADASHCIQQILES 117

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLG 231
           +AY HS+      IVHR+ K  N+LL++  +    K++DFGLA  + + +  +      G
Sbjct: 118 IAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAG 169

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           T GY  PE       +   D++A GV+L  LL G
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  113 bits (284), Expect = 5e-29
 Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 44/221 (19%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEA------DGEHEFRVEVDILSRLD-HP 120
           LG+G    V +   +   +  A+K +++            +       EVDIL ++  HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAK---- 173
           N++ L          FLV++ M+KG L D+L       E +              K    
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE------------TRKIMRA 132

Query: 174 ---GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL 230
               +  LH  +     IVHRD K  N+LL  +   K++DFG +  +  G+       V 
Sbjct: 133 LLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVC 184

Query: 231 GTFGYFDPE------YTSTGKLTLQSDVYAFGVVLLELLTG 265
           GT  Y  PE        +      + D+++ GV++  LL G
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  113 bits (285), Expect = 5e-29
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 31/209 (14%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +GKG F +V     + +G  VAIK ++  +      +  FR EV I+  L+HPN+V L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK------GLAYLHSS 181
                K  +L+ EY   G + D+L   G        R+K     +K       + Y H  
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHG--------RMKEKEARSKFRQIVSAVQYCHQK 133

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ--ETYVTARVLGTFGYFDPE 239
                 IVHRD K+ N+LL A+   KI+DFG +     G   + +      G   Y  PE
Sbjct: 134 R-----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAAPE 183

Query: 240 YTSTGKL--TLQSDVYAFGVVLLELLTGR 266
               GK     + DV++ GV+L  L++G 
Sbjct: 184 LFQ-GKKYDGPEVDVWSLGVILYTLVSGS 211

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  114 bits (286), Expect = 6e-29
 Identities = 37/243 (15%), Positives = 73/243 (30%), Gaps = 56/243 (23%)

Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEV--------------- 111
            LG+       + T   +GE   +          ++   + + EV               
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 112 ----------DILSRLDHPNLVSLIGYCADG--KHRFLVYEYMQKGNLQDHLNGIGE--- 156
                     D++       ++ +     D     RF +Y  MQ  NLQ     +     
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSS 198

Query: 157 --PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
               +    RL++ L   + LA LH        +VH   +  +++L       ++ F   
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 215 KLMPEGQETYVTARVLGTFGYFDPEYTST-----------GKLTLQSDVYAFGVVLLELL 263
               +G     +     + G+  PE  +              +T   D +A G+V+  + 
Sbjct: 254 V--RDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 264 TGR 266
              
Sbjct: 308 CAD 310

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  112 bits (282), Expect = 7e-29
 Identities = 62/204 (30%), Positives = 88/204 (43%), Gaps = 22/204 (10%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG V K   R   +  A+K +     K  D       EV++L +LDHPN++ L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFE 88

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
              D    ++V E    G L D +       E   D    +K        + Y+H  +  
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSG---ITYMHKHN-- 141

Query: 185 GIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
              IVHRD K  N+LL +  +    KI DFGL+    +          +GT  Y  PE  
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVL 195

Query: 242 STGKLTLQSDVYAFGVVLLELLTG 265
             G    + DV++ GV+L  LL+G
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSG 218

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  113 bits (285), Expect = 8e-29
 Identities = 62/281 (22%), Positives = 109/281 (38%), Gaps = 57/281 (20%)

Query: 10  NKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGS--SVFTLKEMEEATCSFSDDN 67
           N    +K  +   P   + +    +  +   P           +  K++           
Sbjct: 53  NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDV----------- 101

Query: 68  FLGKGGFGRVYKGTLRS-GEVVAIK-----KMELPRFKEADGEHEFRVEVDILSRL-DHP 120
            +G+G    V +   R+ G   A+K        L   +  +     R E  IL ++  HP
Sbjct: 102 -IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAK---- 173
           ++++LI         FLV++ M+KG L D+L       E +                   
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKE------------TRSIMRS 208

Query: 174 ---GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL 230
               +++LH+++     IVHRD K  N+LL  N + ++SDFG +  +  G++      + 
Sbjct: 209 LLEAVSFLHANN-----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELC 260

Query: 231 GTFGYFDPE------YTSTGKLTLQSDVYAFGVVLLELLTG 265
           GT GY  PE        +      + D++A GV+L  LL G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  112 bits (282), Expect = 9e-29
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 18/209 (8%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G    V         E VAIK++ L   K      E   E+  +S+  HPN+VS   
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHPNIVSYYT 80

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAA------KGLAYLHSS 181
                   +LV + +  G++ D +  I          L  +  A       +GL YLH +
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGL-AKLMPEGQETYVTAR--VLGTFGYFDP 238
                  +HRD K+ N+LL  +   +I+DFG+ A L   G  T    R   +GT  +  P
Sbjct: 141 G-----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

Query: 239 EYTSTGKL-TLQSDVYAFGVVLLELLTGR 266
           E     +    ++D+++FG+  +EL TG 
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGA 224

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  111 bits (281), Expect = 9e-29
 Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 38/215 (17%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVA---IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +  G+  A   IKK  L   +      E   EV+IL  + HPN+++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAK-------G 174
           L     +     L+ E +  G L D L       E +            A +       G
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE------------ATQFLKQILDG 120

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLL-SANFEA---KISDFGLAKLMPEGQETYVTARVL 230
           + YLHS       I H D K  N++L   N      K+ DFG+A  +  G E      + 
Sbjct: 121 VHYLHSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IF 172

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           GT  +  PE  +   L L++D+++ GV+   LL+G
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  111 bits (280), Expect = 2e-28
 Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 38/215 (17%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVA---IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S G   A   IKK +    +      E   EV IL ++ H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAK-------G 174
           L     +     L+ E +  G L D L       E +            A         G
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------------ATSFIKQILDG 127

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLL-SANFEA---KISDFGLAKLMPEGQETYVTARVL 230
           + YLH+       I H D K  N++L   N      K+ DFGLA  + +G E      + 
Sbjct: 128 VNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IF 179

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           GT  +  PE  +   L L++D+++ GV+   LL+G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  111 bits (279), Expect = 4e-28
 Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 17/160 (10%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHP 120
           F     +G G +G+VYKG  +++G++ AIK M++      D E E + E+++L +   H 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQEINMLKKYSHHR 81

Query: 121 NLVSLIG------YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKG 174
           N+ +  G              +LV E+   G++ D +       +       +     +G
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
           L++LH        ++HRD K  NVLL+ N E K+ DFG++
Sbjct: 142 LSHLHQHK-----VIHRDIKGQNVLLTENAEVKLVDFGVS 176

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  111 bits (280), Expect = 5e-28
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 41/214 (19%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG F  V +   ++ G   A K +   +    D + +   E  I  +L HPN+V L  
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHD 95

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG------AAK-------G 174
              +    +LV++ +  G L + +               VA        A+         
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDI---------------VAREFYSEADASHCIQQILES 140

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLG 231
           +AY HS+      IVHR+ K  N+LL++  +    K++DFGLA  + + +  +      G
Sbjct: 141 IAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAG 192

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           T GY  PE       +   D++A GV+L  LL G
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  110 bits (277), Expect = 8e-28
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 22/206 (10%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLI 126
           LG+G F  V +   +S G+  A K ++  R  +     E   E+ +L      P +++L 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILHEIAVLELAKSCPRVINLH 95

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK----GLAYLHSSS 182
               +     L+ EY   G +         P++   +     +   K    G+ YLH ++
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLC----LPELAEMVSENDVIRLIKQILEGVYYLHQNN 151

Query: 183 AVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                IVH D K  N+LLS+ +     KI DFG+++ +    E      ++GT  Y  PE
Sbjct: 152 -----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPE 203

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTG 265
             +   +T  +D++  G++   LLT 
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTH 229

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (279), Expect = 9e-28
 Identities = 42/214 (19%), Positives = 79/214 (36%), Gaps = 28/214 (13%)

Query: 69  LGKG--GFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
           +GKG      V       +GE V ++++ L            + E+ +    +HPN+V  
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNHPNIVPY 91

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
                     ++V  +M  G+ +D +       M+      +  G  K L Y+H      
Sbjct: 92  RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--- 148

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFG-LAKLMPEGQ----ETYVTARVLGTFGYFDPE- 239
              VHR  K++++L+S + +  +S       ++  GQ            +    +  PE 
Sbjct: 149 --YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

Query: 240 -------YTSTGKLTLQSDVYAFGVVLLELLTGR 266
                  Y +      +SD+Y+ G+   EL  G 
Sbjct: 207 LQQNLQGYDA------KSDIYSVGITACELANGH 234

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  110 bits (277), Expect = 1e-27
 Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 38/215 (17%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVA---IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S G   A   IKK +    +      E   EV IL ++ HPN+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAK-------G 174
           L     +     L+ E +  G L D L       E +            A         G
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------------ATSFIKQILDG 127

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLL-SANFEA---KISDFGLAKLMPEGQETYVTARVL 230
           + YLH+       I H D K  N++L   N      K+ DFGLA  + +G E      + 
Sbjct: 128 VNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IF 179

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           GT  +  PE  +   L L++D+++ GV+   LL+G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 2e-27
 Identities = 61/215 (28%), Positives = 87/215 (40%), Gaps = 38/215 (17%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVA---IKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G F  V K   +S G   A   IKK      +      +   EV IL  + HPN+++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAK-------G 174
           L     +     L+ E +  G L D L       E +            A +       G
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE------------ATEFLKQILNG 126

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLL-SANFEA---KISDFGLAKLMPEGQETYVTARVL 230
           + YLHS       I H D K  N++L   N      KI DFGLA  +  G E      + 
Sbjct: 127 VYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           GT  +  PE  +   L L++D+++ GV+   LL+G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  110 bits (278), Expect = 2e-27
 Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 40/214 (18%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG F  V +      G+  A   +   +    D + +   E  I   L HPN+V L  
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKHPNIVRLHD 77

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG------AAK-------G 174
             ++  H +L+++ +  G L + +               VA        A+         
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDI---------------VAREYYSEADASHCIQQILEA 122

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLG 231
           + + H        +VHR+ K  N+LL++  +    K++DFGLA  +   Q+ +      G
Sbjct: 123 VLHCHQMG-----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           T GY  PE           D++A GV+L  LL G
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  108 bits (271), Expect = 2e-27
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 20/202 (9%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G V     + +    A KK  +P++   D +  F+ E++I+  LDHPN++ L  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKK--IPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLYE 73

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGE-PKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
              D    +LV E    G L + +       + D    +K  L A   +AY H  +    
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAYCHKLN---- 126

Query: 187 PIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
            + HRD K  N L   +      K+ DFGLA     G+   +    +GT  Y  P+    
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLE- 181

Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
           G    + D ++ GV++  LL G
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCG 203

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (275), Expect = 3e-27
 Identities = 62/262 (23%), Positives = 109/262 (41%), Gaps = 39/262 (14%)

Query: 11  KRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLG 70
           K +R+ +     P    P +H  +        K+   +S +T+ + E           LG
Sbjct: 55  KSKRTSALAVDIPAPPAPFDHRIVT------AKQGAVNSFYTVSKTEI----------LG 98

Query: 71  KGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYC 129
            G FG+V+K    + G  +A K +   + +    + E + E+ ++++LDH NL+ L    
Sbjct: 99  GGRFGQVHKCEETATGLKLAAKII---KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155

Query: 130 ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK----GLAYLHSSSAVG 185
                  LV EY+  G L D +         + L     +   K    G+ ++H      
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRII-----DESYNLTELDTILFMKQICEGIRHMHQMY--- 207

Query: 186 IPIVHRDFKSTNVLLSANFEA--KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
             I+H D K  N+L         KI DFGLA+     ++  V     GT  +  PE  + 
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNY 262

Query: 244 GKLTLQSDVYAFGVVLLELLTG 265
             ++  +D+++ GV+   LL+G
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSG 284

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  108 bits (273), Expect = 3e-27
 Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 45/214 (21%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G    VY+   +   +  A+K ++    K  D +   R E+ +L RL HPN++ L  
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLK----KTVD-KKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG------AAK-------G 174
                    LV E +  G L D +               V  G      AA         
Sbjct: 116 IFETPTEISLVLELVTGGELFDRI---------------VEKGYYSERDAADAVKQILEA 160

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLG 231
           +AYLH +      IVHRD K  N+L +        KI+DFGL+K++           V G
Sbjct: 161 VAYLHENG-----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---TVCG 212

Query: 232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           T GY  PE         + D+++ G++   LL G
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  107 bits (269), Expect = 4e-27
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 38/213 (17%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG+V  G    +G  VA+K +   + +  D   + + E+  L    HP+++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK------GLAYLHSS 181
             +     F+V EY+  G L D++   G        R++              + Y H  
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHG--------RVEEMEARRLFQQILSAVDYCHRH 130

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ--ET------YVTARVLGTF 233
                 +VHRD K  NVLL A+  AKI+DFGL+ +M +G+   T      Y    V+   
Sbjct: 131 M-----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185

Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
            Y  PE           D+++ GV+L  LL G 
Sbjct: 186 LYAGPE----------VDIWSCGVILYALLCGT 208

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  111 bits (279), Expect = 4e-27
 Identities = 70/263 (26%), Positives = 113/263 (42%), Gaps = 19/263 (7%)

Query: 15  SKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTL----KEMEEATCSFSDDNF-- 68
           ++++      +++P+    L      P +    S  F      K +E             
Sbjct: 132 ARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFR 191

Query: 69  -LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            LG+GGFG V+   ++ +G++ A KK+   R K+  G     VE  IL+++    +VSL 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251

Query: 127 GYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA--AKGLAYLHSSSA 183
            Y  + K    LV   M  G+++ H+  + E    +     +   A    GL +LH  + 
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               I++RD K  NVLL  +   +ISD GLA  +  GQ    T    GT G+  PE    
Sbjct: 310 ----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLG 363

Query: 244 GKLTLQSDVYAFGVVLLELLTGR 266
            +     D +A GV L E++  R
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  107 bits (269), Expect = 4e-27
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 27/208 (12%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V       + E VA+K ++    +  D     + E+ I   L+H N+V   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK-------GLAYLHS 180
           +  +G  ++L  EY   G L D +             +     A +       G+ YLH 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI--------GMPEPD-AQRFFHQLMAGVVYLHG 123

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
                  I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE 
Sbjct: 124 IG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 241 TSTGKL--TLQSDVYAFGVVLLELLTGR 266
               +       DV++ G+VL  +L G 
Sbjct: 179 LK-RREFHAEPVDVWSCGIVLTAMLAGE 205

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  107 bits (270), Expect = 5e-27
 Identities = 60/249 (24%), Positives = 95/249 (38%), Gaps = 48/249 (19%)

Query: 33  KLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIK 91
            L+     PQ R +    F   ++            LG+G F  V       +    AIK
Sbjct: 14  SLQHAQPPPQPRKKRPEDFKFGKI------------LGEGSFSTVVLARELATSREYAIK 61

Query: 92  ---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQ 148
              K  + +  +    +    E D++SRLDHP  V L     D +  +    Y + G L 
Sbjct: 62  ILEKRHIIKENKV--PY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118

Query: 149 DHLNGIG---EPKMDWPLRLKVALGAAK--------GLAYLHSSSAVGIPIVHRDFKSTN 197
            ++  IG   E                +         L YLH        I+HRD K  N
Sbjct: 119 KYIRKIGSFDET-------------CTRFYTAEIVSALEYLHGKG-----IIHRDLKPEN 160

Query: 198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGV 257
           +LL+ +   +I+DFG AK++    +       +GT  Y  PE  +       SD++A G 
Sbjct: 161 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 220

Query: 258 VLLELLTGR 266
           ++ +L+ G 
Sbjct: 221 IIYQLVAGL 229

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  106 bits (268), Expect = 1e-26
 Identities = 39/204 (19%), Positives = 86/204 (42%), Gaps = 24/204 (11%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G FG V++    S  +    K ++     +   +   + E+ IL+   H N++ L  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK----GLAYLHSSSA 183
                +   +++E++   ++ + +N        + L  +  +         L +LHS + 
Sbjct: 69  SFESMEELVMIFEFISGLDIFERIN-----TSAFELNEREIVSYVHQVCEALQFLHSHN- 122

Query: 184 VGIPIVHRDFKSTNVLLSANFEA--KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
               I H D +  N++      +  KI +FG A+ +  G    +   +     Y+ PE  
Sbjct: 123 ----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175

Query: 242 STGKLTLQSDVYAFGVVLLELLTG 265
               ++  +D+++ G ++  LL+G
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  108 bits (272), Expect = 1e-26
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)

Query: 12  RRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEME-EATCSFSDDNFLG 70
           R R+ S  ++   V +P     ++    +   +         +  +     S++D   +G
Sbjct: 4   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63

Query: 71  KGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL--IG 127
            G FG VY+  L  SGE+VAIKK+        D   + R E+ I+ +LDH N+V L    
Sbjct: 64  NGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNR-ELQIMRKLDHCNIVRLRYFF 116

Query: 128 YCADGKHRF----LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA---AKGLAYLHS 180
           Y +  K       LV +Y+ +  +          K   P+   V L      + LAY+HS
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIY-VKLYMYQLFRSLAYIHS 174

Query: 181 SSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFGLAKLMPEGQE--TYVTAR-------VL 230
                  I HRD K  N+LL  +    K+ DFG AK +  G+   +Y+ +R       + 
Sbjct: 175 FG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 229

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           G   Y           T   DV++ G VL ELL G+
Sbjct: 230 GATDY-----------TSSIDVWSAGCVLAELLLGQ 254

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  107 bits (270), Expect = 1e-26
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)

Query: 69  LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V++   ++ G V   K +  P   +       + E+ I+++L HP L++L  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMNQLHHPKLINLHD 115

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK----GLAYLHSSSA 183
              D     L+ E++  G L D +        D+ +     +   +    GL ++H  S 
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIA-----AEDYKMSEAEVINYMRQACEGLKHMHEHS- 169

Query: 184 VGIPIVHRDFKSTNVLLSANFEA--KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
               IVH D K  N++      +  KI DFGLA  +   +   V      T  +  PE  
Sbjct: 170 ----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIV 222

Query: 242 STGKLTLQSDVYAFGVVLLELLTG 265
               +   +D++A GV+   LL+G
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  106 bits (266), Expect = 2e-26
 Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 22/208 (10%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDH--PNL 122
           LG GGFG VY G  +     VAIK   K  +  + E        +EV +L ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 123 VSLIGYCADGKHRFLVYEYMQ-KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           + L+ +        L+ E  +   +L D +   G   +   L         + + + H+ 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC 168

Query: 182 SAVGIPIVHRDFKSTNVLLSAN-FEAKISDFGLAKLMPEGQ-ETYVTARVLGTFGYFDPE 239
                 ++HRD K  N+L+  N  E K+ DFG   L+ +     +      GT  Y  PE
Sbjct: 169 G-----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-----GTRVYSPPE 218

Query: 240 YTSTGKLT-LQSDVYAFGVVLLELLTGR 266
           +    +     + V++ G++L +++ G 
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  105 bits (263), Expect = 3e-26
 Identities = 38/267 (14%), Positives = 72/267 (26%), Gaps = 51/267 (19%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
            G     + ++         VA+  ++       D   E       LSR+D P +  ++ 
Sbjct: 39  HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                    +V E+++ G+LQ+  +    P       ++     A      H     G  
Sbjct: 99  VVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAH---RAG-- 149

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           +       + V         +S  G                 L                 
Sbjct: 150 VALSIDHPSRVR--------VSIDGDVV--------------LAYPATMPDA-------N 180

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            Q D+   G  L  LL  R    L +      L    R       +   + D ++     
Sbjct: 181 PQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAPAERDTAGQPIEPADI-DRDIPFQ-- 235

Query: 308 TMESIAMFANLASRCVRTESSERPSMA 334
                   + +A+R V+ +   R +  
Sbjct: 236 -------ISAVAARSVQGDGGIRSAST 255

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  105 bits (265), Expect = 3e-26
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 27/208 (12%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G +G V       + E VA+K ++    +  D     + E+ I   L+H N+V   G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK-------GLAYLHS 180
           +  +G  ++L  EY   G L D +             +     A +       G+ YLH 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI--------GMPEPD-AQRFFHQLMAGVVYLHG 123

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
                  I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  PE 
Sbjct: 124 IG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 241 TSTGKL--TLQSDVYAFGVVLLELLTGR 266
               +       DV++ G+VL  +L G 
Sbjct: 179 LK-RREFHAEPVDVWSCGIVLTAMLAGE 205

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  105 bits (263), Expect = 5e-26
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLD----HP 120
           LGKGGFG V+ G  L     VAIK   +  +  +          +EV +L ++     HP
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGN-LQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
            ++ L+ +    +   LV E       L D++   G   +               + + H
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH 156

Query: 180 SSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLMPEGQ-ETYVTARVLGTFGYFD 237
           S       +VHRD K  N+L+      AK+ DFG   L+ +     +      GT  Y  
Sbjct: 157 SRG-----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-----GTRVYSP 206

Query: 238 PEYTSTGKLT-LQSDVYAFGVVLLELLTGR 266
           PE+ S  +   L + V++ G++L +++ G 
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGD 236

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  107 bits (270), Expect = 5e-26
 Identities = 65/287 (22%), Positives = 106/287 (36%), Gaps = 43/287 (14%)

Query: 6   VSAWNKRRRSKSQDQTDP-----------WVYKPVEHWKLEDQPTQPQKRHRGSSVFTLK 54
           + A NK  +SK  + T P             Y   E  K+          +        K
Sbjct: 82  IIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWK 141

Query: 55  EMEEATCSFSDDNF---------LGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGE 104
           +          D+          LG G FG V++ T R+ G   A K +  P   + +  
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-- 199

Query: 105 HEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR 164
              R E+  +S L HP LV+L     D     ++YE+M  G L + +           + 
Sbjct: 200 -TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA-----DEHNKMS 253

Query: 165 LKVALGAAK----GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA--KISDFGLAKLMP 218
              A+   +    GL ++H ++      VH D K  N++ +       K+ DFGL   + 
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308

Query: 219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
             Q   V     GT  +  PE      +   +D+++ GV+   LL+G
Sbjct: 309 PKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  107 bits (268), Expect = 6e-26
 Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 38/213 (17%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG+V  G    +G  VA+K +   + +  D   + R E+  L    HP+++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK------GLAYLHSS 181
             +     F+V EY+  G L D++   G        RL              G+ Y H  
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNG--------RLDEKESRRLFQQILSGVDYCHRH 135

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ--ET------YVTARVLGTF 233
                 +VHRD K  NVLL A+  AKI+DFGL+ +M +G+   T      Y    V+   
Sbjct: 136 M-----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 190

Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
            Y  PE           D+++ GV+L  LL G 
Sbjct: 191 LYAGPE----------VDIWSSGVILYALLCGT 213

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  104 bits (262), Expect = 1e-25
 Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 40/212 (18%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLI 126
           LG+G F    K   + S +  A+K   + +  EA+     + E+  L   + HPN+V L 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKI--ISKRMEAN----TQKEITALKLCEGHPNIVKLH 72

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAK-------GLA 176
               D  H FLV E +  G L + +       E +            A+         ++
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE------------ASYIMRKLVSAVS 120

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           ++H        +VHRD K  N+L    + N E KI DFG A+L P   +   T     T 
Sbjct: 121 HMHDVG-----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTL 173

Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
            Y  PE  +        D+++ GV+L  +L+G
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  104 bits (261), Expect = 1e-25
 Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 39/213 (18%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G FG+V   T  ++ + VA+K +     K++D       E+  L  L HP+++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK------GLAYLHSS 181
                    +V EY   G L D++            R+    G          + Y H  
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKK--------RMTEDEGRRFFQQIICAIEYCHRH 127

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ--ET------YVTARVLGTF 233
                 IVHRD K  N+LL  N   KI+DFGL+ +M +G   +T      Y    V+   
Sbjct: 128 K-----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182

Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
            Y  PE           DV++ G+VL  +L GR
Sbjct: 183 LYAGPE----------VDVWSCGIVLYVMLVGR 205

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  105 bits (263), Expect = 2e-25
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 42/248 (16%)

Query: 37  QPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELP 96
            P     +         K  E+   ++++   +G G FG V++  L   + VAIKK+   
Sbjct: 16  NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ- 74

Query: 97  RFKEADGEHEFRVEVDILSRLDHPNLVSL--IGYCADGKHRF----LVYEYMQKGNLQDH 150
                D   + R E+ I+  + HPN+V L    Y    K       LV EY+ +  +   
Sbjct: 75  -----DKRFKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRA 127

Query: 151 LNGIGEPKMDWPLRL-KVAL-GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAK 207
                + K   P+ L K+ +    + LAY+HS       I HRD K  N+LL       K
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-----ICHRDIKPQNLLLDPPSGVLK 182

Query: 208 ISDFGLAKLMPEGQE--TYVTAR-------VLGTFGYFDPEYTSTGKLTLQSDVYAFGVV 258
           + DFG AK++  G+   +Y+ +R       + G        YT+        D+++ G V
Sbjct: 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGA-----TNYTT------NIDIWSTGCV 231

Query: 259 LLELLTGR 266
           + EL+ G+
Sbjct: 232 MAELMQGQ 239

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  103 bits (259), Expect = 2e-25
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 24/209 (11%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIK---KMELPRFKEADGEHEFRV--EVDILSRLDHPNL 122
           LG G FG V+        + V +K   K ++      +     +V  E+ ILSR++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 123 VSLIGYCADGKHRFLVYEYMQKGN-LQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           + ++    +     LV E    G  L   +     P++D PL   +       + YL   
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFI--DRHPRLDEPLASYIFRQLVSAVGYLRLK 149

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ--ETYVTARVLGTFGYFDPE 239
                 I+HRD K  N++++ +F  K+ DFG A  +  G+   T+      GT  Y  PE
Sbjct: 150 D-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-----GTIEYCAPE 199

Query: 240 YTSTGKLTL--QSDVYAFGVVLLELLTGR 266
               G      + ++++ GV L  L+   
Sbjct: 200 VLM-GNPYRGPELEMWSLGVTLYTLVFEE 227

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  102 bits (257), Expect = 3e-25
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 30/213 (14%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRF-KEADGEHEFRVEVDILSRLDHPNLVSL- 125
           LG+G +G+V +     +    A+K ++  +  +  +GE   + E+ +L RL H N++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 126 -IGYCADGKHRFLVYEYMQKGN--LQDHL-NGIGEPKMDWPLRLKVALGAAK------GL 175
            + Y  + +  ++V EY   G   + D +             R  V            GL
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----------RFPVCQAHGYFCQLIDGL 122

Query: 176 AYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
            YLHS       IVH+D K  N+LL+     KIS  G+A+ +             G+  +
Sbjct: 123 EYLHSQG-----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 236 FDPEYTSTGKL--TLQSDVYAFGVVLLELLTGR 266
             PE  +        + D+++ GV L  + TG 
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  105 bits (263), Expect = 5e-25
 Identities = 74/319 (23%), Positives = 126/319 (39%), Gaps = 37/319 (11%)

Query: 1   MPFGLVSAWNKRRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLK---EME 57
                 SA    +    + Q  P +++P      ++      ++   S  FT     +  
Sbjct: 121 SHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNV 180

Query: 58  EATCSFSDDNF-----LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEV 111
           E     + ++F     +G+GGFG VY      +G++ A+K ++  R K   GE     E 
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240

Query: 112 DILSRL---DHPNLVSLIGYCADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKV 167
            +LS +   D P +V +  Y      +   + + M  G+L  HL+  G           +
Sbjct: 241 IMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DM 294

Query: 168 ALGAAK---GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ-ET 223
              AA+   GL ++H+       +V+RD K  N+LL  +   +ISD GLA    + +   
Sbjct: 295 RFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349

Query: 224 YVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL 282
            V     GT GY  PE    G      +D ++ G +L +LL G      ++  +   +  
Sbjct: 350 SV-----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-- 402

Query: 283 QVRHILNDRKKLRKVIDPE 301
             R  L    +L     PE
Sbjct: 403 -DRMTLTMAVELPDSFSPE 420

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (254), Expect = 7e-25
 Identities = 63/281 (22%), Positives = 123/281 (43%), Gaps = 46/281 (16%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDI-LSRLDHPNLVSLI 126
           LG+G +G V K     SG+++A+K++       +  +    +++DI +  +D P  V+  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 127 GYCADGKHRFLVYEYMQKG------NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           G        ++  E M          + D    I E  +      K+A+   K L +LHS
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKALEHLHS 127

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE--GQETYVTARVLGTFGYFDP 238
             +    ++HRD K +NVL++A  + K+ DFG++  + +   ++        G   Y  P
Sbjct: 128 KLS----VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCKPYMAP 178

Query: 239 E----YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
           E      +    +++SD+++ G+ ++EL   R   D            Q++ ++ +    
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQVVEEP--- 230

Query: 295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
                P+L    ++ E    F +  S+C++  S ERP+  E
Sbjct: 231 ----SPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPE 263

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  101 bits (253), Expect = 1e-24
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 36/235 (15%)

Query: 52  TLKEMEEATCSFSDDNF-----LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEH 105
            LK   E    F+ ++      +G+G +G V K     SG+++A+K++      +   + 
Sbjct: 8   KLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--TVDEKEQK 65

Query: 106 EFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYM-------QKGNLQDHLNGIGEP 157
           +  +++D++ R  D P +V   G        ++  E M        K       + I E 
Sbjct: 66  QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125

Query: 158 KMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM 217
            +      K+ L   K L +L  +      I+HRD K +N+LL  +   K+ DFG++   
Sbjct: 126 ILG-----KITLATVKALNHLKENLK----IIHRDIKPSNILLDRSGNIKLCDFGIS--- 173

Query: 218 PEGQ--ETYVTARVLGTFGYFDPE----YTSTGKLTLQSDVYAFGVVLLELLTGR 266
             GQ  ++    R  G   Y  PE      S     ++SDV++ G+ L EL TGR
Sbjct: 174 --GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  100 bits (251), Expect = 2e-24
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 24/208 (11%)

Query: 67  NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSL 125
             +G+G +G V+K     +G++VAIKK           +   R E+ +L +L HPNLV+L
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNL 67

Query: 126 IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVG 185
           +      +   LV+EY     +   L+      +   L   +     + + + H  +   
Sbjct: 68  LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCHKHN--- 122

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
              +HRD K  N+L++ +   K+ DFG A+L+    + Y    V  T  Y  PE      
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-DDEVA-TRWYRSPE------ 172

Query: 246 LTLQS-------DVYAFGVVLLELLTGR 266
           L +         DV+A G V  ELL+G 
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  101 bits (254), Expect = 2e-24
 Identities = 67/247 (27%), Positives = 102/247 (41%), Gaps = 37/247 (14%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +GKG FG+V       T    ++ A+K   K +     E    + F+ E+ I+  L+HP 
Sbjct: 23  IGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEV--RNVFK-ELQIMQGLEHPF 76

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVA-LGAAKGLAY 177
           LV+L     D +  F+V + +  G+L+ HL       E  +    +L +  L  A  L Y
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV----KLFICELVMA--LDY 130

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
           L +       I+HRD K  N+LL  +    I+DF +A ++P   +    A   GT  Y  
Sbjct: 131 LQNQR-----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMA 182

Query: 238 PEYTSTGKLTLQS---DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
           PE  S+ K    S   D ++ GV   ELL GRR        +  +    V          
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH---IRSSTSSKEIVHTFETTVVTY 239

Query: 295 RKVIDPE 301
                 E
Sbjct: 240 PSAWSQE 246

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.7 bits (249), Expect = 5e-24
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 38/242 (15%)

Query: 47  GSSVFTLK-----EMEEATCSFSDDNF-----LGKGGFGRVYKGT-LRSGEVVAIKKMEL 95
           GSS  + K      +         ++      +G G  G+V+K    ++G V+A+K+M  
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60

Query: 96  PRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHL--- 151
                 +      +++D++ +  D P +V   G        F+  E M     +      
Sbjct: 61  S--GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118

Query: 152 NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF 211
             I E  +      K+ +   K L YL         ++HRD K +N+LL    + K+ DF
Sbjct: 119 GPIPERILG-----KMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERGQIKLCDF 169

Query: 212 GLAKLMPE--GQETYVTARVLGTFGY-----FDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
           G++  + +   ++        G   Y      DP   +     +++DV++ G+ L+EL T
Sbjct: 170 GISGRLVDDKAKDRSA-----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224

Query: 265 GR 266
           G+
Sbjct: 225 GQ 226

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 99.3 bits (248), Expect = 6e-24
 Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 45/222 (20%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLI 126
           LG+G   RV       + +  A+K +E  +         FR EV++L +   H N++ LI
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIE--KQPGHIRSRVFR-EVEMLYQCQGHRNVLELI 77

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAK-------GLA 176
            +  +    +LV+E M+ G++  H++      E +            A+         L 
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE------------ASVVVQDVASALD 125

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTAR----- 228
           +LH+       I HRD K  N+L     +    KI DF L   +    +    +      
Sbjct: 126 FLHNKG-----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 229 VLGTFGYFDPE-----YTSTGKLTLQSDVYAFGVVLLELLTG 265
             G+  Y  PE              + D+++ GV+L  LL+G
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 99.6 bits (249), Expect = 7e-24
 Identities = 65/238 (27%), Positives = 102/238 (42%), Gaps = 31/238 (13%)

Query: 42  QKRHRGSSVFTLKEMEEATCSFSDDNF-----LGKGGFGRVYKGT-LRSGEVVAIKKMEL 95
              H  SS   L   E      S + +     +G+G +G V K     +G +VAIKK   
Sbjct: 3   HHHHHHSSGVDLGT-ENLYFQ-SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE 60

Query: 96  PRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG 155
               +   +   R E+ +L +L H NLV+L+  C   K  +LV+E++    + D L    
Sbjct: 61  SDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP 118

Query: 156 EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK 215
              +D+ +  K       G+ + HS +     I+HRD K  N+L+S +   K+ DFG A+
Sbjct: 119 NG-LDYQVVQKYLFQIINGIGFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFAR 172

Query: 216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQS-------DVYAFGVVLLELLTGR 266
            +    E Y    V  T  Y  PE      L +         DV+A G ++ E+  G 
Sbjct: 173 TLAAPGEVY-DDEVA-TRWYRAPE------LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 99.7 bits (249), Expect = 8e-24
 Identities = 51/235 (21%), Positives = 92/235 (39%), Gaps = 52/235 (22%)

Query: 54  KEMEEATCSFSDD----NFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFR 108
           +++   +  F+D       +G G +    +   ++     A+K ++         + +  
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-------KSKRDPT 63

Query: 109 VEVDILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKV 167
            E++IL R   HPN+++L     DGK+ ++V E M+ G L D +               +
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI---------------L 108

Query: 168 ALG------AAK-------GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA----KISD 210
                    A+         + YLH+       +VHRD K +N+L           +I D
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHAQG-----VVHRDLKPSNILYVDESGNPESIRICD 163

Query: 211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           FG AK +       +T     T  +  PE           D+++ GV+L  +LTG
Sbjct: 164 FGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 55/231 (23%), Positives = 85/231 (36%), Gaps = 47/231 (20%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIK---------------------KMELPRFKEADGEHE 106
           +GKG +G V            A+K                         P          
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 107 FRV--EVDILSRLDHPNLVSL--IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWP 162
            +V  E+ IL +LDHPN+V L  +    +  H ++V+E + +G + +            P
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-------LKP 133

Query: 163 LRLKVALG----AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP 218
           L    A        KG+ YLH        I+HRD K +N+L+  +   KI+DFG++    
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQK-----IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 219 EGQETYVTARVLGTFGYFDPEYTSTGKLT---LQSDVYAFGVVLLELLTGR 266
                       GT  +  PE  S  +        DV+A GV L   + G+
Sbjct: 189 GSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 98.0 bits (244), Expect = 2e-23
 Identities = 45/257 (17%), Positives = 90/257 (35%), Gaps = 38/257 (14%)

Query: 91  KKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDH 150
            +                V++  +      N V  +   +   + ++  +  +K NL+D 
Sbjct: 92  DESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDW 151

Query: 151 L-NGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKIS 209
           +         +  + L + +  A+ + +LHS       ++HRD K +N+  + +   K+ 
Sbjct: 152 MNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVKVG 206

Query: 210 DFGLAKLM-----------PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVV 258
           DFGL   M           P       T +V GT  Y  PE       + + D+++ G++
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLI 265

Query: 259 LLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANL 318
           L ELL             ++  ++           +R +  P L    Y  E       +
Sbjct: 266 LFELLYSFST------QMERVRII---------TDVRNLKFPLLFTQKYPQE-----HMM 305

Query: 319 ASRCVRTESSERPSMAE 335
               +    +ERP   +
Sbjct: 306 VQDMLSPSPTERPEATD 322

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 20/77 (25%), Positives = 34/77 (44%), Gaps = 3/77 (3%)

Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI 126
            +G+GGFG V++          AIK++ LP  + A    +   EV  L++L+HP +V   
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEHPGIVRYF 70

Query: 127 GYCADGKHRFLVYEYMQ 143
               +        E  +
Sbjct: 71  NAWLETPPEKWQEEMDE 87

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 97.8 bits (244), Expect = 4e-23
 Identities = 54/211 (25%), Positives = 79/211 (37%), Gaps = 36/211 (17%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G FG         + E+VA+K +E    + A  +   + E+     L HPN+V    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE----RGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK------GLAYLHSS 181
                 H  ++ EY   G L + +   G        R               G++Y HS 
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAG--------RFSEDEARFFFQQLLSGVSYCHSM 135

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEA--KISDFGLAKLMPEGQ--ETYVTARVLGTFGYFD 237
                 I HRD K  N LL  +     KI DFG +K        ++ V     GT  Y  
Sbjct: 136 Q-----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYIA 185

Query: 238 PEYTSTGKL--TLQSDVYAFGVVLLELLTGR 266
           PE     +      +DV++ GV L  +L G 
Sbjct: 186 PEVLL-RQEYDGKIADVWSCGVTLYVMLVGA 215

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 96.0 bits (240), Expect = 5e-23
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 41/216 (18%)

Query: 67  NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE-----ADGEHEFRVEVDILSRLDHPN 121
             +G+G +G VYK     GE  A+KK+ L +  E            R E+ IL  L H N
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-----IR-EISILKELKHSN 61

Query: 122 LVSLIGYCADGKHRFLVYEYMQ---KGNLQDHLNGIGEPKM-DWPLRLKVALGAAKGLAY 177
           +V L       K   LV+E++    K  L     G+       + L+L        G+AY
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL------LNGIAY 115

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
            H        ++HRD K  N+L++   E KI+DFGLA+        Y T  ++ T  Y  
Sbjct: 116 CHDRR-----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRA 168

Query: 238 PEYTSTGKLTLQSDVYAFGV-------VLLELLTGR 266
           P+      + + S  Y+  +       +  E++ G 
Sbjct: 169 PD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.5 bits (241), Expect = 6e-23
 Identities = 62/235 (26%), Positives = 113/235 (48%), Gaps = 45/235 (19%)

Query: 48  SSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE-----AD 102
            +++    ME+    +     +G+G +G VYK     G +VA+K++ L    E     A 
Sbjct: 12  ENLYFQGLMEK----YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA- 66

Query: 103 GEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ---KGNLQDHLNGIGEPKM 159
                R E+ +L  L HPN+VSLI      +   LV+E+M+   K  L ++  G+ + ++
Sbjct: 67  ----IR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQI 121

Query: 160 -DWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP 218
             +  +L       +G+A+ H        I+HRD K  N+L++++   K++DFGLA+   
Sbjct: 122 KIYLYQL------LRGVAHCHQHR-----ILHRDLKPQNLLINSDGALKLADFGLARAFG 170

Query: 219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQS-------DVYAFGVVLLELLTGR 266
               +Y T  V+ T  Y  P+      + + S       D+++ G +  E++TG+
Sbjct: 171 IPVRSY-THEVV-TLWYRAPD------VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 97.0 bits (242), Expect = 8e-23
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 50/225 (22%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +     +G G +G V      RSGE VAIKK+  P   E   +  +R E+ +L  + H N
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHEN 84

Query: 122 LVSLI------GYCADGKHRFLVYEYMQ-------KGNLQD-HLNGIGEPKMDWPLRLKV 167
           ++ L+          +    +LV  +MQ            +  +  +    +   L+   
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL----VYQMLK--- 137

Query: 168 ALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA 227
                 GL Y+HS+      +VHRD K  N+ ++ + E KI DFGLA+        YV  
Sbjct: 138 ------GLKYIHSAG-----VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186

Query: 228 R------VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           R      V+ ++      Y  T       D+++ G ++ E+LTG+
Sbjct: 187 RWYRAPEVILSWM----HYNQT------VDIWSVGCIMAEMLTGK 221

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 97.0 bits (242), Expect = 9e-23
 Identities = 58/240 (24%), Positives = 92/240 (38%), Gaps = 59/240 (24%)

Query: 57  EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKK-MELPRFKEADGEHEFRVEVDIL 114
            +    F  +   G+G FG V  G  + +G  VAIKK ++ PRF+      E +  +  L
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQ-IMQDL 73

Query: 115 SRLDHPNLVSLIGY-CADGKHRF------LVYEYMQKGNLQDHLNGIGEPKMDWP----- 162
           + L HPN+V L  Y    G+         +V EY+    L          ++  P     
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132

Query: 163 ------LRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL-SANFEAKISDFGLAK 215
                 +R          +  LH  S     + HRD K  NVL+  A+   K+ DFG AK
Sbjct: 133 VFLFQLIR---------SIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180

Query: 216 LMPEGQET--YVTAR-------VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
            +   +    Y+ +R       + G   Y           T   D+++ G +  E++ G 
Sbjct: 181 KLSPSEPNVAYICSRYYRAPELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGE 229

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 40/218 (18%)

Query: 67  NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHE-------FRVEVDILSRLD 118
             LG G +  VYKG    +G  VA+K+++L        + E        R E+ ++  L 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKL--------DSEEGTPSTAIR-EISLMKELK 61

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQ---KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGL 175
           H N+V L           LV+E+M    K  +     G     ++  L         +GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 176 AYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
           A+ H +      I+HRD K  N+L++   + K+ DFGLA+       T+ ++ V+ T  Y
Sbjct: 122 AFCHENK-----ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEVV-TLWY 174

Query: 236 FDPEYTSTGKLTLQSDVYAFGV-------VLLELLTGR 266
             P+      + + S  Y+  +       +L E++TG+
Sbjct: 175 RAPD------VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 36/219 (16%)

Query: 67  NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV----EVDILSRL---D 118
             +G G +G VYK     SG  VA+K + +P      G     +    EV +L RL   +
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGGGGGGGLPISTVREVALLRRLEAFE 72

Query: 119 HPNLVSLIGYCADGKHR-----FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK 173
           HPN+V L+  CA  +        LV+E++ + +L+ +L+    P +       +     +
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLR 131

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
           GL +LH++      IVHRD K  N+L+++    K++DFGLA++     +  +T  V+ T 
Sbjct: 132 GLDFLHANC-----IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVVV-TL 183

Query: 234 GYFDPEYTSTGKLTLQS------DVYAFGVVLLELLTGR 266
            Y  PE      + LQS      D+++ G +  E+   +
Sbjct: 184 WYRAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 47/220 (21%), Positives = 82/220 (37%), Gaps = 36/220 (16%)

Query: 12  RRRSKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEME-EATCSFSDDNFLG 70
              + +  Q +      V   + E Q  +     + ++       + +    +   + +G
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62

Query: 71  KGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG-Y 128
            G +G V +        VVAIKK+        D +   R E+ IL+RL+H ++V ++   
Sbjct: 63  TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIV 121

Query: 129 CADGKHRF----LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAA----------KG 174
                 +F    +V E        D    +         R  V L              G
Sbjct: 122 IPKDVEKFDELYVVLEIAD----SD-FKKL--------FRTPVYLTELHIKTLLYNLLVG 168

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA 214
           + Y+HS+      I+HRD K  N L++ +   K+ DFGLA
Sbjct: 169 VKYVHSAG-----ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 47/221 (21%), Positives = 89/221 (40%), Gaps = 41/221 (18%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           + +   +G G  G V           VAIKK+  P   +   +  +R E+ ++  ++H N
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 85

Query: 122 LVSLI------GYCADGKHRFLVYEYMQ-------KGNLQD-HLNGIGEPKMDWPLRLKV 167
           ++ L+          + +  ++V E M        +  L    ++ +    +   L    
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL----LYQMLC--- 138

Query: 168 ALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET--YV 225
                 G+ +LHS+      I+HRD K +N+++ ++   KI DFGLA+          YV
Sbjct: 139 ------GIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187

Query: 226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
             R      Y  PE           D+++ G ++ E++ G 
Sbjct: 188 VTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.3 bits (238), Expect = 3e-22
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 39/222 (17%)

Query: 62  SFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEA-DGEHEFRV----EVDILS 115
            +   +FLG+G F  VYK     + ++VAIKK++L    EA DG          E+ +L 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG---INRTALREIKLLQ 67

Query: 116 RLDHPNLVSLIGYCADGKHRFLVYEYMQ---KGNLQDHLNGIGEPKM-DWPLRLKVALGA 171
            L HPN++ L+       +  LV+++M+   +  ++D+   +    +  + L        
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT------ 121

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG 231
            +GL YLH        I+HRD K  N+LL  N   K++DFGLAK        Y T +V+ 
Sbjct: 122 LQGLEYLHQHW-----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVV- 174

Query: 232 TFGYFDPEYTSTGKLTLQS-------DVYAFGVVLLELLTGR 266
           T  Y  PE      L   +       D++A G +L ELL   
Sbjct: 175 TRWYRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 96.5 bits (240), Expect = 3e-22
 Identities = 48/221 (21%), Positives = 89/221 (40%), Gaps = 41/221 (18%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           + +   +G G  G V           VAIKK+  P   +   +  +R E+ ++  ++H N
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 122

Query: 122 LVSLI------GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKV--ALGAAK 173
           ++SL+          + +  +LV E M      +    I        +   +   L    
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQML---C 175

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET--YVTAR--- 228
           G+ +LHS+      I+HRD K +N+++ ++   KI DFGLA+          YV  R   
Sbjct: 176 GIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 230

Query: 229 ---VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
              V+   GY               D+++ G ++ E++  +
Sbjct: 231 APEVILGMGY-----------KENVDIWSVGCIMGEMVRHK 260

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 94.1 bits (235), Expect = 3e-22
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 42/219 (19%)

Query: 67  NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKE-----ADGEHEFRVEVDILSRLDHP 120
             +G+G +G V+K     + E+VA+K++ L    E     A      R E+ +L  L H 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-----LR-EICLLKELKHK 61

Query: 121 NLVSLIGYCADGKHRFLVYEYMQ---KGNLQDHLNGIGEPKM-DWPLRLKVALGAAKGLA 176
           N+V L       K   LV+E+     K         +    +  +  +L       KGL 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLG 115

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           + HS +     ++HRD K  N+L++ N E K+++FGLA+        Y +A V+ T  Y 
Sbjct: 116 FCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYR 168

Query: 237 DPEYTSTGKLTLQSDVYAFGV-------VLLELLTGRRA 268
            P+      +   + +Y+  +       +  EL    R 
Sbjct: 169 PPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 45/201 (22%), Positives = 76/201 (37%), Gaps = 35/201 (17%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +   + +G+G +G VY      + + VAIKK+        D +   R E+ IL+RL    
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDY 86

Query: 122 LVSLIG-YCADGKHRF----LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAA---- 172
           ++ L      D   +F    +V E        D L  +         +  + L       
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIAD----SD-LKKL--------FKTPIFLTEEHIKT 133

Query: 173 ------KGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT 226
                  G  ++H S      I+HRD K  N LL+ +   K+ DFGLA+ +   ++T + 
Sbjct: 134 ILYNLLLGENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 227 ARVLGTFGYFDPEYTSTGKLT 247
             +               +LT
Sbjct: 189 NDLEENEEPGPHNKNLKKQLT 209

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 94.3 bits (235), Expect = 6e-22
 Identities = 55/240 (22%), Positives = 91/240 (37%), Gaps = 34/240 (14%)

Query: 42  QKRHRGSSVFTLKEM-EEATCSFSDD-----NFLGKGGFGRVYKGTLRS-GEVVAIKKME 94
              H  S +  L +  E    + +DD       LG G  G+V +   R  G+  A+K + 
Sbjct: 4   HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY 63

Query: 95  LPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHR----FLVYEYMQKGNLQD 149
                        R EVD   +    P++V ++    +  H      ++ E M+ G L  
Sbjct: 64  ----DSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS 115

Query: 150 HLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL---SANFEA 206
            +   G+         ++       + +LHS +     I HRD K  N+L      +   
Sbjct: 116 RIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-----IAHRDVKPENLLYTSKEKDAVL 170

Query: 207 KISDFGLAKLMPEGQ-ETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           K++DFG AK   +   +T        T  Y  PE     K     D+++ GV++  LL G
Sbjct: 171 KLTDFGFAKETTQNALQTPC-----YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 52/226 (23%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRV----EVDILSRLDHPNLV 123
           +G+G FG V+K    ++G+ VA+KK+ +    E +G   F +    E+ IL  L H N+V
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEG---FPITALREIKILQLLKHENVV 79

Query: 124 SLIGYCADGKHR--------FLVYEYMQKGNLQDH-LNGI---GEPKMDWPLRLKVALGA 171
           +LI  C              +LV+++       +H L G+      K       +V    
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVMQML 133

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL----MPEGQETYVTA 227
             GL Y+H +      I+HRD K+ NVL++ +   K++DFGLA+            Y T 
Sbjct: 134 LNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-TN 187

Query: 228 RVLGTFGYFDPEYTSTGKLTLQS-------DVYAFGVVLLELLTGR 266
           RV+ T  Y  PE      L L         D++  G ++ E+ T  
Sbjct: 188 RVV-TLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 47/224 (20%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHE-------FRVEVDI 113
           ++   + LG+G +  VYKG  + +  +VA+K++ L        EHE        R EV +
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL--------EHEEGAPCTAIR-EVSL 53

Query: 114 LSRLDHPNLVSLIGYCADGKHRFLVYEYMQ---KGNLQDHLNGIGEPKMDWPLRLKVALG 170
           L  L H N+V+L       K   LV+EY+    K  L D  N I          +K+ L 
Sbjct: 54  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN------VKLFLF 107

Query: 171 -AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
              +GLAY H        ++HRD K  N+L++   E K++DFGLA+      +TY    V
Sbjct: 108 QLLRGLAYCHRQK-----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEV 161

Query: 230 LGTFGYFDPEYTSTGKLTLQS-------DVYAFGVVLLELLTGR 266
           + T  Y  P+      + L S       D++  G +  E+ TGR
Sbjct: 162 V-TLWYRPPD------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 54/246 (21%), Positives = 91/246 (36%), Gaps = 36/246 (14%)

Query: 37  QPTQPQKRHRGSSVFTLKEMEEATCSFSDD-----NFLGKGGFGRVYKGTLR-SGEVVAI 90
               P    +         ++    +  DD       LG G  G+V +   + + E  A+
Sbjct: 33  AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 92

Query: 91  KKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADG----KHRFLVYEYMQKG 145
           K ++             R EV++  R    P++V ++    +     K   +V E +  G
Sbjct: 93  KMLQ----DCPK----ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144

Query: 146 NLQDHLNGIGEPK---MDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA 202
            L   +   G+      +    +K    A   + YLHS +     I HRD K  N+L ++
Sbjct: 145 ELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHSIN-----IAHRDVKPENLLYTS 196

Query: 203 NFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVL 259
                  K++DFG AK       +  T     T  Y  PE     K     D+++ GV++
Sbjct: 197 KRPNAILKLTDFGFAKETTSHN-SLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

Query: 260 LELLTG 265
             LL G
Sbjct: 254 YILLCG 259

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 61/256 (23%), Positives = 100/256 (39%), Gaps = 46/256 (17%)

Query: 30  EHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVV 88
            H    +  TQ       S+  +   ++     +     LG+G +G VYK     + E V
Sbjct: 7   HHMGTLEAQTQGPGSMSVSAAPSATSIDR----YRRITKLGEGTYGEVYKAIDTVTNETV 62

Query: 89  AIKKMELPRFKEADGEHE------FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYM 142
           AIK++ L      + E E       R EV +L  L H N++ L           L++EY 
Sbjct: 63  AIKRIRL------EHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115

Query: 143 QKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA 202
           +  +L+ +++    P +   +          G+ + HS        +HRD K  N+LLS 
Sbjct: 116 EN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR-----CLHRDLKPQNLLLSV 167

Query: 203 NFEA-----KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGV 257
           +  +     KI DFGLA+        + T  ++ T  Y  PE      + L S  Y+  V
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQF-THEII-TLWYRPPE------ILLGSRHYSTSV 219

Query: 258 -------VLLELLTGR 266
                  +  E+L   
Sbjct: 220 DIWSIACIWAEMLMKT 235

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 59/217 (27%), Positives = 88/217 (40%), Gaps = 37/217 (17%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIKKMELPR-FKEADGEHEFRVEVDILSRLDHPNLV 123
           +G+G F  V     K T   G+V A+K M      K  +    FR E D+L   D   + 
Sbjct: 69  IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWIT 124

Query: 124 SLIGYCA--DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA-LGAAK---GLAY 177
            L  + A  D  + +LV EY   G+L   L+     K    +  ++A    A+    +  
Sbjct: 125 QL--HFAFQDENYLYLVMEYYVGGDLLTLLS-----KFGERIPAEMARFYLAEIVMAIDS 177

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-LMPEGQETYVTARVLGTFGYF 236
           +H         VHRD K  N+LL      +++DFG    L  +G    + A  +GT  Y 
Sbjct: 178 VHRLG-----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA--VGTPDYL 230

Query: 237 DPE-------YTSTGKLTLQSDVYAFGVVLLELLTGR 266
            PE          TG    + D +A GV   E+  G+
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 50/228 (21%), Positives = 85/228 (37%), Gaps = 44/228 (19%)

Query: 63  FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG---EHE------FRVEVDI 113
           ++   F+  G +G V  G    G  VAIK++                       R E+ +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRL 82

Query: 114 LSRLDHPNLVSLIG-YCADGKHRF----LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKV- 167
           L+   HPN++ L   +    +       LV E M+  +L   ++          ++  + 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141

Query: 168 -ALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET--Y 224
             L    GL  LH +      +VHRD    N+LL+ N +  I DF LA+          Y
Sbjct: 142 HIL---LGLHVLHEAG-----VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY 193

Query: 225 VTAR------VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           VT R      ++  F      +T         D+++ G V+ E+   +
Sbjct: 194 VTHRWYRAPELVMQFK----GFTKL------VDMWSAGCVMAEMFNRK 231

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 91.5 bits (228), Expect = 5e-21
 Identities = 61/237 (25%), Positives = 113/237 (47%), Gaps = 47/237 (19%)

Query: 56  MEEATCSFSDDNF-----LGKGGFGRVYKG--TLRSGEVVAIKKMELPRFKE-----ADG 103
           ME+     +D  +     +G+G +G+V+K       G  VA+K++ +   +E        
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-- 58

Query: 104 EHEFRVEVDILSRL---DHPNLVSLI----GYCADGKHR-FLVYEYMQKGNLQDHLNGIG 155
               R EV +L  L   +HPN+V L         D + +  LV+E++ + +L  +L+ + 
Sbjct: 59  ---IR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP 113

Query: 156 EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK 215
           EP +       +     +GL +LHS       +VHRD K  N+L++++ + K++DFGLA+
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLADFGLAR 168

Query: 216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQS------DVYAFGVVLLELLTGR 266
           +     +  +T+ V+ T  Y  PE      + LQS      D+++ G +  E+   +
Sbjct: 169 IY--SFQMALTSVVV-TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.5 bits (230), Expect = 6e-21
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 41/218 (18%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +G+G FG V     K      +V A+K   K E+   K A+    FR E D+L   D   
Sbjct: 82  IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEM--LKRAETAC-FREERDVLVNGDSKW 135

Query: 122 LVSLIGYCA--DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA------LGAAK 173
           + +L  + A  D  + +LV +Y   G+L   L+     K +  L  ++A      +  A 
Sbjct: 136 ITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLS-----KFEDRLPEEMARFYLAEMVIA- 187

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
            +  +H         VHRD K  N+L+  N   +++DFG    + E   T  ++  +GT 
Sbjct: 188 -IDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTP 240

Query: 234 GYFDPE-----YTSTGKLTLQSDVYAFGVVLLELLTGR 266
            Y  PE         G+   + D ++ GV + E+L G 
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 35/223 (15%)

Query: 58  EATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR 116
           E    + D   +G G +G V      R+G  VAIKK+  P   E   +  +R E+ +L  
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKH 80

Query: 117 LDHPNLVSLI------GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL- 169
           + H N++ L+          D    +LV  +M      D L  + + +     R++  + 
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVY 135

Query: 170 GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR- 228
              KGL Y+H++      I+HRD K  N+ ++ + E KI DFGLA+        YV  R 
Sbjct: 136 QMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW 190

Query: 229 -----VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
                V+  +      YT T       D+++ G ++ E++TG+
Sbjct: 191 YRAPEVILNW----MRYTQT------VDIWSVGCIMAEMITGK 223

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 35/210 (16%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG G FGRV     + SG   A+K   K ++ + K+   EH    E  IL  ++ P LV 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EH-TLNEKRILQAVNFPFLVK 105

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLK-----VALGAAKGLA 176
           L     D  + ++V EY+  G +  HL  IG   EP        +     + L       
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP------HARFYAAQIVL----TFE 155

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           YLHS       +++RD K  N+L+      +++DFG AK +     T       GT    
Sbjct: 156 YLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEAL 205

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
            PE   +       D +A GV++ E+  G 
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 55/260 (21%), Positives = 103/260 (39%), Gaps = 61/260 (23%)

Query: 35  EDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKM 93
                          V    ++ +    +++ +++G+G +G V       +   VAIKK+
Sbjct: 3   HHHHMAAAAAAGPEMVR--GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60

Query: 94  ELPRF-KEADGEHEFRVEVDILSRLDHPNLVSLIG-YCADGKHRF----LVYEYM----- 142
               F  +   +   R E+ IL R  H N++ +     A    +     +V + M     
Sbjct: 61  S--PFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 117

Query: 143 ---QKGNLQD-HLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNV 198
              +  +L + H+       +   LR         GL Y+HS++     ++HRD K +N+
Sbjct: 118 KLLKTQHLSNDHICYF----LYQILR---------GLKYIHSAN-----VLHRDLKPSNL 159

Query: 199 LLSANFEAKISDFGLAKLMPEGQET------YVTAR------VLGTFGYFDPEYTSTGKL 246
           LL+   + KI DFGLA++     +       YV  R      ++         YT +   
Sbjct: 160 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS----KGYTKS--- 212

Query: 247 TLQSDVYAFGVVLLELLTGR 266
               D+++ G +L E+L+ R
Sbjct: 213 ---IDIWSVGCILAEMLSNR 229

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 67/250 (26%), Positives = 105/250 (42%), Gaps = 38/250 (15%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIKKMELPR-FKEADGEHEFRVEVDILSRLDHPNLV 123
           +G+G FG V     K T    +V A+K +      K +D    F  E DI++  + P +V
Sbjct: 77  IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVV 132

Query: 124 SLIGYCA--DGKHRFLVYEYMQKGNLQDHLN--GIGEPKMDWPLRLKVA-LGAAKGLAYL 178
            L  + A  D ++ ++V EYM  G+L + ++   + E       R   A +  A  L  +
Sbjct: 133 QL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----ARFYTAEVVLA--LDAI 184

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           HS        +HRD K  N+LL  +   K++DFG    M +         V GT  Y  P
Sbjct: 185 HSMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 238

Query: 239 E----YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
           E        G    + D ++ GV L E+L G             +LV     I+N +  L
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY------ADSLVGTYSKIMNHKNSL 292

Query: 295 RKVIDPELSR 304
               D ++S+
Sbjct: 293 TFPDDNDISK 302

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 88.7 bits (221), Expect = 3e-20
 Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 55/220 (25%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           LG G FGRV+    +     G   A+K   K  + R K+   EH    E  +LS + HP 
Sbjct: 14  LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQV--EHT-NDERLMLSIVTHPF 67

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLK-----VALGAAK 173
           ++ + G   D +  F++ +Y++ G L   L        P        K     V L    
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP------VAKFYAAEVCL---- 117

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTF 233
            L YLHS       I++RD K  N+LL  N   KI+DFG AK +P+   T       GT 
Sbjct: 118 ALEYLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTP 167

Query: 234 GYFDPEYTSTGKLTLQS-------DVYAFGVVLLELLTGR 266
            Y  PE        + +       D ++FG+++ E+L G 
Sbjct: 168 DYIAPE-------VVSTKPYNKSIDWWSFGILIYEMLAGY 200

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 41/221 (18%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           + + + +G G +G V      ++G  VA+KK+  P       +  +R E+ +L  + H N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 89

Query: 122 LVSLI------GYCADGKHRFLVYEYMQKGNLQD--HLNGIGEPKMDWPLR--LKVALGA 171
           ++ L+          +    +LV   M   +L +      + +  + + +   L+     
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR----- 143

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR--- 228
             GL Y+HS+      I+HRD K +N+ ++ + E KI DFGLA+   +    YV  R   
Sbjct: 144 --GLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYR 196

Query: 229 ---VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
              ++  +      Y  T       D+++ G ++ ELLTGR
Sbjct: 197 APEIMLNWM----HYNQT------VDIWSVGCIMAELLTGR 227

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 56/227 (24%), Positives = 89/227 (39%), Gaps = 51/227 (22%)

Query: 69  LGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRV-EVDILSRLDHPNLVS 124
           +G+G +G VYK   +     +  A+K++E        G       E+ +L  L HPN++S
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGISMSACREIALLRELKHPNVIS 82

Query: 125 LIGYCADGKHR--FLVYEYMQ---KGNLQDHLNGIGEPKMDWPLRLKVA-------LGAA 172
           L         R  +L+++Y +      +          K    L   +        L   
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWH-IIKFHRASKANKKPVQLPRGMVKSLLYQIL--- 138

Query: 173 KGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA----KISDFGLAKLM--PEGQETYVT 226
            G+ YLH++      ++HRD K  N+L+          KI+D G A+L   P      + 
Sbjct: 139 DGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 227 ARVLGTFGYFDPE-------YTSTGKLTLQSDVYAFGVVLLELLTGR 266
             V+ TF Y  PE       YT         D++A G +  ELLT  
Sbjct: 194 PVVV-TFWYRAPELLLGARHYTK------AIDIWAIGCIFAELLTSE 233

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 62/253 (24%), Positives = 93/253 (36%), Gaps = 30/253 (11%)

Query: 27  KPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFL---GKGGFGRVY----K 79
           K     +++ +   P        +       +   + ++  +L   GKG FG+V     K
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 170

Query: 80  GTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA--DGKHRFL 137
            T   G   A+K ++       D       E  +L    HP L +L    +         
Sbjct: 171 AT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL--KYSFQTHDRLCF 225

Query: 138 VYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFK 194
           V EY   G L  HL+      E +     R   A      L YLHS       +V+RD K
Sbjct: 226 VMEYANGGELFFHLSRERVFSEDRA----RFYGA-EIVSALDYLHSEKN----VVYRDLK 276

Query: 195 STNVLLSANFEAKISDFGLAKL-MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVY 253
             N++L  +   KI+DFGL K  + +G          GT  Y  PE           D +
Sbjct: 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAPEVLEDNDYGRAVDWW 333

Query: 254 AFGVVLLELLTGR 266
             GVV+ E++ GR
Sbjct: 334 GLGVVMYEMMCGR 346

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 60/246 (24%), Positives = 96/246 (39%), Gaps = 80/246 (32%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           F   + LG+G +G V   T   +GE+VAIKK+E P  K        R E+ IL    H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLR-EIKILKHFKHEN 70

Query: 122 LVSLIG-YCADGKHRF----LVYEYMQ-------KGNL--QDH--------LNGIGEPKM 159
           ++++      D    F    ++ E MQ          +   DH        L        
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL-------- 122

Query: 160 DWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE 219
                        + +  LH S+     ++HRD K +N+L+++N + K+ DFGLA+++ E
Sbjct: 123 -------------RAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164

Query: 220 GQET-------------YVTAR------VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLL 260
                            +V  R      V+ T      +Y+         DV++ G +L 
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA----KYSRA------MDVWSCGCILA 214

Query: 261 ELLTGR 266
           EL   R
Sbjct: 215 ELFLRR 220

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 36/213 (16%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LG+G FG+V+         + ++ A+K ++    K  D     ++E DIL  ++HP +V 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVK 90

Query: 125 LIGYCA--DGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLK-----VALGAAKG 174
           L  + A       +L+ ++++ G+L   L+      E        +K     +AL     
Sbjct: 91  L--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLAELAL----A 138

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYVTARVLGTF 233
           L +LHS       I++RD K  N+LL      K++DFGL+K  +   ++ Y      GT 
Sbjct: 139 LDHLHSLG-----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGTV 190

Query: 234 GYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
            Y  PE  +    T  +D ++FGV++ E+LTG 
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 57/259 (22%), Positives = 90/259 (34%), Gaps = 95/259 (36%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKK-MELPRFKEADGEHEFRVEVDILSRLDHPNLVSL- 125
           LG G FG V +     SG+  A+KK ++ PR+K        R E+DI+  LDH N++ L 
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NR-ELDIMKVLDHVNIIKLV 66

Query: 126 -IGYCADGKHRF------------------------------------LVYEYMQKGNLQ 148
              Y    +                                       ++ EY+    L 
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125

Query: 149 DHLNGIGEPKMDWP-----------LRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN 197
             L          P            R          + ++HS       I HRD K  N
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFR---------AVGFIHSLG-----ICHRDIKPQN 171

Query: 198 VLLSAN-FEAKISDFGLAKLMPEGQET--YVTAR-------VLGTFGYFDPEYTSTGKLT 247
           +L+++     K+ DFG AK +   + +  Y+ +R       +LG   Y           T
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEY-----------T 220

Query: 248 LQSDVYAFGVVLLELLTGR 266
              D+++ G V  EL+ G+
Sbjct: 221 PSIDLWSIGCVFGELILGK 239

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 61/241 (25%), Positives = 96/241 (39%), Gaps = 68/241 (28%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           + D   LG GG G V+        + VAIKK  +        +H  R E+ I+ RLDH N
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQSVKHALR-EIKIIRRLDHDN 69

Query: 122 LVSLI--------------GYCADGKHRFLVYEYMQ--------KGNLQD-HLNGIGEPK 158
           +V +               G   +    ++V EYM+        +G L + H        
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF---- 125

Query: 159 MDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL-SANFEAKISDFGLAKLM 217
           M   LR         GL Y+HS++     ++HRD K  N+ + + +   KI DFGLA++M
Sbjct: 126 MYQLLR---------GLKYIHSAN-----VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 218 PEGQET------YVTAR------VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
                        +  +      +L +       YT         D++A G +  E+LTG
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSP----NNYTKA------IDMWAAGCIFAEMLTG 221

Query: 266 R 266
           +
Sbjct: 222 K 222

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 84.9 bits (211), Expect = 8e-19
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 40/216 (18%)

Query: 69  LGKGGFGRVY---KGTLR-SGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           LGKGG+G+V+   K T   +G++ A+K   K  + R    D  H  + E +IL  + HP 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-NAKDTAHT-KAERNILEEVKHPF 82

Query: 122 LVSLIGYCA--DGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLK-----VALGA 171
           +V L    A   G   +L+ EY+  G L   L   G   E               +++  
Sbjct: 83  IVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAEISM-- 132

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYVTARVL 230
              L +LH        I++RD K  N++L+     K++DFGL K  + +G  T+ T    
Sbjct: 133 --ALGHLHQKG-----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH-T--FC 182

Query: 231 GTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           GT  Y  PE           D ++ G ++ ++LTG 
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 60/245 (24%), Positives = 102/245 (41%), Gaps = 68/245 (27%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHP 120
           +     LGKG +G V+K    R+GEVVA+KK+        D +  FR E+ IL+ L  H 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHE 69

Query: 121 NLVSL--IGYCADGKHRFLVYEYMQ-------KGNL--QDH--------LNGIGEPKMDW 161
           N+V+L  +    + +  +LV++YM+       + N+    H        +          
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI---------- 119

Query: 162 PLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ 221
                      K + YLHS       ++HRD K +N+LL+A    K++DFGL++     +
Sbjct: 120 -----------KVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163

Query: 222 ETYVTARVLGTFGYFDP--------EYTST------------GKLTLQSDVYAFGVVLLE 261
                  +       +         +Y +T             K T   D+++ G +L E
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223

Query: 262 LLTGR 266
           +L G+
Sbjct: 224 ILCGK 228

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 82.3 bits (204), Expect = 5e-18
 Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 52/209 (24%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLI 126
           LG G  G+V +   + + E  A+K ++             R EV++  R    P++V ++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ----DCPK----ARREVELHWRASQCPHIVRIV 77

Query: 127 GYCADG----KHRFLVYEYMQKGNLQDHLNGIGEPK---MDWPLRLKVALGAAKGLAYLH 179
               +     K   +V E +  G L   +   G+      +    +K    A   + YLH
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLH 134

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEA---KISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           S +     I HRD K  N+L ++       K++DFG A    E           G   Y 
Sbjct: 135 SIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE---------TTGE-KY- 175

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
           D             D+++ GV++  LL G
Sbjct: 176 DKS----------CDMWSLGVIMYILLCG 194

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 63/214 (29%), Positives = 83/214 (38%), Gaps = 40/214 (18%)

Query: 69  LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           LGKG FG+V     K T   G   A+K +        D       E  +L    HP L +
Sbjct: 13  LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 125 LIGYCA--DGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLKVALGAAKGLAYLH 179
           L    A         V EY   G L  HL+      E +     R   A      L YLH
Sbjct: 70  L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA----RFYGA-EIVSALEYLH 122

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYVTARVLGTF-GYFD 237
           S       +V+RD K  N++L  +   KI+DFGL K  + +G           TF G   
Sbjct: 123 SRD-----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-------TFCG--T 168

Query: 238 PEYTSTGKLTLQS-----DVYAFGVVLLELLTGR 266
           PEY +   L         D +  GVV+ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 69/260 (26%), Positives = 97/260 (37%), Gaps = 60/260 (23%)

Query: 35  EDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFL---GKGGFGRVY----KGTLRSGEV 87
           E     P      S    L          SD +FL   GKG FG+V     K        
Sbjct: 9   ELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE---EVF 65

Query: 88  VAIKKMELPRFKEA-----DGEHEFRVEVDILSR-LDHPNLVSLIGYCA--DGKHRFLVY 139
            A+K ++    K+A     + +H    E ++L + + HP LV L  + +       + V 
Sbjct: 66  YAVKVLQ----KKAILKKKEEKHI-MSERNVLLKNVKHPFLVGL--HFSFQTADKLYFVL 118

Query: 140 EYMQKGNLQDHLNGIG---EPKMDWPLRLK-----VALGAAKGLAYLHSSSAVGIPIVHR 191
           +Y+  G L  HL       EP      R +     +A      L YLHS +     IV+R
Sbjct: 119 DYINGGELFYHLQRERCFLEP------RARFYAAEIASA----LGYLHSLN-----IVYR 163

Query: 192 DFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYVTARVLGTF-G---YFDPEYTSTGKL 246
           D K  N+LL +     ++DFGL K  +     T        TF G   Y  PE       
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS-------TFCGTPEYLAPEVLHKQPY 216

Query: 247 TLQSDVYAFGVVLLELLTGR 266
               D +  G VL E+L G 
Sbjct: 217 DRTVDWWCLGAVLYEMLYGL 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 70/262 (26%), Positives = 108/262 (41%), Gaps = 28/262 (10%)

Query: 17  SQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFL---GKGG 73
              + +  + +  E  K+      P+++   +               +D NFL   GKG 
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGS 353

Query: 74  FGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR-LDHPNLVSLIGY 128
           FG+V     KGT    E+ A+K ++     + D      VE  +L+     P L  L   
Sbjct: 354 FGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-S 409

Query: 129 C-ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGA--AKGLAYLHSSSAVG 185
           C       + V EY+  G+L  H+  +G     +     V   A  A GL +L S     
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSKG--- 462

Query: 186 IPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYVTARVLGTFGYFDPEYTSTG 244
             I++RD K  NV+L +    KI+DFG+ K  + +G  T       GT  Y  PE  +  
Sbjct: 463 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEIIAYQ 517

Query: 245 KLTLQSDVYAFGVVLLELLTGR 266
                 D +AFGV+L E+L G+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQ 539

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 31/190 (16%)

Query: 165 LKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY 224
           +  +   AKG+ +L S        +HRD  + N+LLS     KI DFGLA+ + +  +  
Sbjct: 196 ICYSFQVAKGMEFLAS-----RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250

Query: 225 VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR---AVDLNQGVNDQNL 280
                     +  PE       T+QSDV++FGV+L E+ + G      V +++       
Sbjct: 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------- 303

Query: 281 VLQVRHILNDRKKLRKVIDPELSRSS-YTMESIAMFANLASRCVRTESSERPSMAECVKE 339
             +    L +  ++R    P+ +    Y      M       C   E S+RP+ +E V+ 
Sbjct: 304 --EFCRRLKEGTRMRA---PDYTTPEMYQT----M-----LDCWHGEPSQRPTFSELVEH 349

Query: 340 LQLIIYTNSK 349
           L  ++  N++
Sbjct: 350 LGNLLQANAQ 359

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 16/94 (17%)

Query: 69  LGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEADGEHE---FRVEVDILSRLD- 118
           LG+G FG+V +          +   VA+K +     KE     E      E+ IL  +  
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 84

Query: 119 HPNLVSLIGYCAD-GKHRFLVYEYMQKGNLQDHL 151
           H N+V+L+G C   G    ++ E+ + GNL  +L
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 67/312 (21%), Positives = 115/312 (36%), Gaps = 57/312 (18%)

Query: 19  DQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNF-----LGKGG 73
                  Y       L  Q                +E  +A+ S    +F     +G+G 
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64

Query: 74  FGRVY----KGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR-LDHPNLVSLIGY 128
           + +V     K T     + A++ ++     + +     + E  +  +  +HP LV L   
Sbjct: 65  YAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-S 120

Query: 129 CADGKHR-FLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLK-----VALGAAKGLAYLH 179
           C   + R F V EY+  G+L  H+       E         +     ++L     L YLH
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISL----ALNYLH 170

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYVTARVLGTF-G--- 234
                   I++RD K  NVLL +    K++D+G+ K  +  G  T        TF G   
Sbjct: 171 ERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-------TFCGTPN 218

Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR-----RAVDLNQGVNDQNLVLQVRHILN 289
           Y  PE           D +A GV++ E++ GR          N   N ++ + QV  IL 
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--ILE 276

Query: 290 DRKKLRKVIDPE 301
            + ++ + +  +
Sbjct: 277 KQIRIPRSLSVK 288

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 41/213 (19%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSL- 125
           LG+G +  V++   + + E V +K ++  + K+       R E+ IL  L   PN+++L 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-----KR-EIKILENLRGGPNIITLA 97

Query: 126 -IGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
            I      +   LV+E++   + +     +     D    +   L   K L Y HS    
Sbjct: 98  DIVKDPVSRTPALVFEHVNNTDFKQLYQTL--TDYDIRFYMYEIL---KALDYCHSMG-- 150

Query: 185 GIPIVHRDFKSTNVLL-SANFEAKISDFGLAKLMPEGQE--TYVTARVLGTFGYFDPE-- 239
              I+HRD K  NV++   + + ++ D+GLA+    GQE    V +R      +  PE  
Sbjct: 151 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELL 202

Query: 240 -----YTSTGKLTLQSDVYAFGVVLLELLTGRR 267
                Y  +       D+++ G +L  ++  + 
Sbjct: 203 VDYQMYDYS------LDMWSLGCMLASMIFRKE 229

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 77.6 bits (192), Expect = 3e-16
 Identities = 67/221 (30%), Positives = 94/221 (42%), Gaps = 53/221 (23%)

Query: 69  LGKGGFGRV----YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSR-LDHP 120
           LGKG FG+V    +K T    +  AIK   K  +    +   E    VE  +LS   +HP
Sbjct: 25  LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDV--EC-TMVEKRVLSLAWEHP 78

Query: 121 NLVSLIGYCA--DGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLK-----VALG 170
            L  +  +C     ++ F V EY+  G+L  H+               R       + L 
Sbjct: 79  FLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAAEIIL- 129

Query: 171 AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYVTARV 229
              GL +LHS       IV+RD K  N+LL  +   KI+DFG+ K  M    +T      
Sbjct: 130 ---GLQFLHSKG-----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN----- 176

Query: 230 LGTF-G---YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
             TF G   Y  PE     K     D ++FGV+L E+L G+
Sbjct: 177 --TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 62/265 (23%), Positives = 106/265 (40%), Gaps = 57/265 (21%)

Query: 66  DNF-----LGKGGFGRV----YKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR 116
            +F     +G+G + +V     K T     + A+K ++     + +     + E  +  +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 117 -LDHPNLVSLIGYCADGKHR-FLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLK----- 166
             +HP LV L   C   + R F V EY+  G+L  H+       E         +     
Sbjct: 66  ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAE 118

Query: 167 VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYV 225
           ++L     L YLH        I++RD K  NVLL +    K++D+G+ K  +  G  T  
Sbjct: 119 ISL----ALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS- 168

Query: 226 TARVLGTF-G---YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR-----RAVDLNQGVN 276
                 TF G   Y  PE           D +A GV++ E++ GR          N   N
Sbjct: 169 ------TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222

Query: 277 DQNLVLQVRHILNDRKKLRKVIDPE 301
            ++ + QV  IL  + ++ + +  +
Sbjct: 223 TEDYLFQV--ILEKQIRIPRSLSVK 245

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 44/220 (20%)

Query: 69  LGKGGFGRVY----KGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLDH-P 120
           LG G +G+V+         +G++ A+K   K  + + K    EH  R E  +L  +   P
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHT-RTERQVLEHIRQSP 119

Query: 121 NLVSLIGYCA--DGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLK-----VALG 170
            LV+L  + A        L+ +Y+  G L  HL+      E        ++     + L 
Sbjct: 120 FLVTL--HYAFQTETKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVGEIVL- 170

Query: 171 AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYVTARV 229
               L +LH        I++RD K  N+LL +N    ++DFGL+K  + +  E       
Sbjct: 171 ---ALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER--AYDF 220

Query: 230 LGTFGYFDPE---YTSTGKLTLQSDVYAFGVVLLELLTGR 266
            GT  Y  P+      +G      D ++ GV++ ELLTG 
Sbjct: 221 CGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGA 259

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 66/220 (30%), Positives = 95/220 (43%), Gaps = 51/220 (23%)

Query: 69  LGKGGFGRV----YKGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDILSRLD-HP 120
           LGKG FG+V     KGT    E+ A+K   K  + +  +   E    VE  +L+     P
Sbjct: 28  LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDV--ECT-MVEKRVLALPGKPP 81

Query: 121 NLVSLIGYC-ADGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLK-----VALGA 171
            L  L   C       + V EY+  G+L  H+  +G   EP              +A+  
Sbjct: 82  FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAI-- 132

Query: 172 AKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQETYVTARVL 230
             GL +L S       I++RD K  NV+L +    KI+DFG+ K  + +G  T       
Sbjct: 133 --GLFFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK------ 179

Query: 231 GTF-G---YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
            TF G   Y  PE  +        D +AFGV+L E+L G+
Sbjct: 180 -TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 66/229 (28%), Positives = 91/229 (39%), Gaps = 58/229 (25%)

Query: 66  DNF-----LGKGGFGRVY----KGTLRSGEVVAIK---KMELPRFKEADGEHEFRVEVDI 113
           DNF     LGKG FG+V     K T   G++ A+K   K  + +  +   E     E  I
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDV--ECT-MTEKRI 76

Query: 114 LSR-LDHPNLVSLIGYCA--DGKHRFLVYEYMQKGNLQDHLNGIG---EPKMDWPLRLK- 166
           LS   +HP L  L  +C        F V E++  G+L  H+       E       R + 
Sbjct: 77  LSLARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARF 128

Query: 167 ----VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL-MPEGQ 221
               +       L +LH        I++RD K  NVLL      K++DFG+ K  +  G 
Sbjct: 129 YAAEIIS----ALMFLHDKG-----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179

Query: 222 ETYVTARVLGTF-G---YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
            T        TF G   Y  PE           D +A GV+L E+L G 
Sbjct: 180 TTA-------TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 26/209 (12%)

Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKME-LPRFKEADGEHEFRVEVDILSRL------DH 119
            +GKG FG+V K    +  + VA+K +    RF           E+ IL  L      + 
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ-----AAEEIRILEHLRKQDKDNT 158

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
            N++ ++       H  + +E +   NL + +          PL  K A    + L  LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217

Query: 180 SSSAVGIPIVHRDFKSTNVLL--SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
            +      I+H D K  N+LL        K+ DFG +    +   TY+ +R    F Y  
Sbjct: 218 KNR-----IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F-YRA 267

Query: 238 PEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
           PE     +  +  D+++ G +L ELLTG 
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.1 bits (155), Expect = 1e-11
 Identities = 43/241 (17%), Positives = 66/241 (27%), Gaps = 64/241 (26%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEH-----EFRVEVDILSRL------ 117
           +G+G FG V++        VAIK + +      +G H     E   E+ I   L      
Sbjct: 28  IGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 118 ---DHPNLVSLIG-YCADGKH-----------------------------RFLVYEYMQK 144
                   + L   +C  G +                              F+V E+   
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF 204
           G   + +               +       LA   +S    +   HRD    NVLL    
Sbjct: 147 GIDLEQMR---TKLSSLATAKSILHQLTASLAVAEAS----LRFEHRDLHWGNVLLKKTS 199

Query: 205 EAKISDFGLAKLMPEG-------QETYVTARVL--GTFGYFDPEYTS---TGKLTLQSDV 252
             K+      K               Y  +R+   G   + D        TG    Q D+
Sbjct: 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDI 259

Query: 253 Y 253
           Y
Sbjct: 260 Y 260

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 46/220 (20%), Positives = 82/220 (37%), Gaps = 36/220 (16%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL---------- 117
           LG G F  V+    + +   VA+K   + R  +   E     E+ +L R+          
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDS 82

Query: 118 -DHPNLVSLIGY----CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAA 172
               +++ L+ +      +G H  +V+E +   NL   +       +      +++    
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLL 141

Query: 173 KGLAYLHSSSAVGIPIVHRDFKSTNVLLS------ANFEAKISDFGLAKLMPEGQETYVT 226
            GL Y+H        I+H D K  NVL+          + KI+D G A    E     + 
Sbjct: 142 LGLDYMHRRCG----IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
            R      Y  PE          +D+++   ++ EL+TG 
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 27/167 (16%), Positives = 59/167 (35%), Gaps = 27/167 (16%)

Query: 69  LGKGGFGRVYKGT---------LRSGEVVAIK--------KMELPRFKEADGEHEFRVEV 111
             +   G +Y+               +  ++K          E   F+ A    +     
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 112 DILSRLDHPNLVSLIGY-CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG 170
             L       + + +G+     K+RFLV   + + +LQ  L+   +  +     L+VA  
Sbjct: 110 -KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167

Query: 171 AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI--SDFGLAK 215
               L +LH +       VH +  + N+ +    ++++  + +G A 
Sbjct: 168 LLDALEFLHENE-----YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 56/210 (26%), Positives = 85/210 (40%), Gaps = 24/210 (11%)

Query: 67  NFLGKGGFGRVYKGT-LRSGEVVAIKKME-LPRFKEADGEHEFRVEVDILSRL------D 118
           + +GKG FG+V K       E VAIK ++    F         ++EV +L  +       
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLLELMNKHDTEM 114

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
              +V L  +     H  LV+E +   NL D L       +   L  K A      L +L
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173

Query: 179 HSSSAVGIPIVHRDFKSTNVLL--SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
            +       I+H D K  N+LL        KI DFG +  + +    Y+ +R    F Y 
Sbjct: 174 ATPEL---SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----F-YR 225

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGR 266
            PE        L  D+++ G +L+E+ TG 
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 41/152 (26%), Positives = 64/152 (42%), Gaps = 17/152 (11%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLI 126
           +G G FG +Y GT + +GE VAIK              +  +E  I   +     + ++ 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLE-----CVKTKHPQLHIESKIYKMMQGGVGIPTIR 71

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
              A+G +  +V E +   +L+D  N     K      L +A      + Y+HS +    
Sbjct: 72  WCGAEGDYNVMVMELLGP-SLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN---- 125

Query: 187 PIVHRDFKSTNVLLSANFEAK---ISDFGLAK 215
             +HRD K  N L+    +     I DFGLAK
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 33/169 (19%), Positives = 58/169 (34%), Gaps = 34/169 (20%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV---- 123
           +G GGFG +Y        E  A   +++    E         E+    R+   + +    
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKV----EYQENGPLFSELKFYQRVAKKDCIKKWI 100

Query: 124 -----------SLIGY----CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVA 168
                         G          +RF+V E +   +LQ      G         L++ 
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNG--TFKKSTVLQLG 157

Query: 169 LGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI--SDFGLAK 215
           +     L Y+H +       VH D K+ N+LL      ++  +D+GL+ 
Sbjct: 158 IRMLDVLEYIHENE-----YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.1 bits (141), Expect = 9e-10
 Identities = 36/154 (23%), Positives = 61/154 (39%), Gaps = 19/154 (12%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLI 126
           +G+G FG +++GT L + + VAIK              + R E      L     + ++ 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFE-----PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 72

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
            +  +G H  LV + +   +L+D L+  G  K         A      +  +H  S    
Sbjct: 73  YFGQEGLHNVLVIDLLGP-SLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---- 126

Query: 187 PIVHRDFKSTNVLLSANFEAK-----ISDFGLAK 215
            +V+RD K  N L+            + DFG+ K
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 39/157 (24%), Positives = 62/157 (39%), Gaps = 25/157 (15%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G FG +  G  L + E VAI K+E  + +      E+R             +  +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAI-KLEPMKSRAPQLHLEYRF---YKQLGSGDGIPQVYY 72

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK----GLAYLHSSSA 183
           +   GK+  +V E +   +L+D  +       D    LK  L  A      + Y+HS + 
Sbjct: 73  FGPCGKYNAMVLELLGP-SLEDLFD-----LCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125

Query: 184 VGIPIVHRDFKSTNVLLSANFEAK-----ISDFGLAK 215
               +++RD K  N L+            I DF LAK
Sbjct: 126 ----LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 25/156 (16%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLI 126
           +G G FG +Y GT +++ E VAI K+E  + K     +E +    I   L     + ++ 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAI-KLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAK----GLAYLHSSS 182
            +  +G +  LV + +   +L+D  N          L LK  L  A      + ++HS S
Sbjct: 70  WFGVEGDYNVLVMDLLGP-SLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSKS 123

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAK---ISDFGLAK 215
                 +HRD K  N L+     A    I DFGLAK
Sbjct: 124 -----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 35/168 (20%), Positives = 63/168 (37%), Gaps = 29/168 (17%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLV----- 123
           +G+GGFG +Y   + S E V      + + + +D    F  E+    R   P  +     
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF-TELKFYQRAAKPEQIQKWIR 101

Query: 124 ----------SLIGY----CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVAL 169
                        G          +RF++ +     +LQ       + +      L+++L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAK-RFSRKTVLQLSL 159

Query: 170 GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI--SDFGLAK 215
                L Y+H         VH D K++N+LL+     ++   D+GLA 
Sbjct: 160 RILDILEYIHEHE-----YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 59/362 (16%), Positives = 110/362 (30%), Gaps = 107/362 (29%)

Query: 69  LGKGGFGRVYKG-TLRSGEVVAIK-KMELPRFKEADGEHEFRVEVDILSRL-----DHPN 121
           LG G F  V+    ++  + VA+K       + E         E+ +L  +     + PN
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-----LDEIRLLKSVRNSDPNDPN 99

Query: 122 ---LVSLIGY----CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKG 174
              +V L+        +G H  +V+E +   +L   +       +  P   K+     +G
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLL---------------------------------- 200
           L YLH+       I+H D K  N+LL                                  
Sbjct: 159 LDYLHTKCR----IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 201 ---------------SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
                          +   + KI+D G A  + +     +  R      Y   E      
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSG 269

Query: 246 LTLQSDVYAFGVVLLELLTGRR---AVDLNQGVNDQNLVLQVRHIL-------------- 288
               +D+++   +  EL TG          +   D++ +  +  +L              
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329

Query: 289 ----NDRKKLRKVID------PELSRSSYTM--ESIAMFANLASRCVRTESSERPSMAEC 336
                 +  L+ +         E+    Y    E  A F +     +     +R + AEC
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389

Query: 337 VK 338
           ++
Sbjct: 390 LR 391

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 47/233 (20%), Positives = 83/233 (35%), Gaps = 58/233 (24%)

Query: 68  FLGKGGFGRVYKG--TLRSGEVVAIKKME-LPRFKEADGEHEFRVEVDILSRL------D 118
            LG+G FG+V +     R    VA+K +  + +++EA      R+E+++L ++      +
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLKKIKEKDKEN 80

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
               V +  +     H  + +E + K N  + L          P    +A      L +L
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEA-------------------KISDFGLAKLMPE 219
           H +      + H D K  N+L   +                      +++DFG A    E
Sbjct: 140 HENQ-----LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194

Query: 220 GQETYVTAR-------VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
              T V  R       +L   G+               DV++ G +L E   G
Sbjct: 195 HHTTIVATRHYRPPEVILE-LGW-----------AQPCDVWSIGCILFEYYRG 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.2 bits (124), Expect = 2e-07
 Identities = 61/435 (14%), Positives = 122/435 (28%), Gaps = 157/435 (36%)

Query: 16  KSQDQTD-PWVYKPVEHWKLED-QPTQPQKR--------HRGSSVFT---------LKEM 56
           +   + +  ++  P    K E  QP+   +         +  + VF            ++
Sbjct: 84  EEVLRINYKFLMSP---IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL 140

Query: 57  EEATCSFSDDNFL---GKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRV---- 109
            +A         +   G  G G   K  + + +V            +   + +F++    
Sbjct: 141 RQALLELRPAKNVLIDGVLGSG---KTWV-ALDVC--------LSYKVQCKMDFKIFWLN 188

Query: 110 ---------EVDILSRLDH---PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP 157
                     +++L +L +   PN  S   + ++ K R          ++Q  L  + + 
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI--------HSIQAELRRLLKS 240

Query: 158 KMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM 217
           K       +  L                  +V  + ++     + N   KI       L 
Sbjct: 241 K-----PYENCL------------------LVLLNVQNAKAWNAFNLSCKI-------L- 269

Query: 218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAF----GVVLLELLTGRRAVDLNQ 273
                  +T R      +     T+   ++L              LL      R  DL +
Sbjct: 270 -------LTTRFKQVTDFLSAATTT--HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320

Query: 274 GVNDQN-LVLQV---------------RHILNDRKKLRKVI-------DPELSRSSYTME 310
            V   N   L +               +H+  D  KL  +I       +P   R  +  +
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD--KLTTIIESSLNVLEPAEYRKMF--D 376

Query: 311 SIAMF---------------ANLASRCVR--TESSERPSMAEC-VKELQLIIY-----TN 347
            +++F                ++    V        + S+ E   KE  + I        
Sbjct: 377 RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436

Query: 348 SKGLNMP-LHALRMV 361
            K  N   LH   +V
Sbjct: 437 VKLENEYALHR-SIV 450

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 49/235 (20%), Positives = 86/235 (36%), Gaps = 58/235 (24%)

Query: 68  FLGKGGFGRVYKGT-LRSGEVVAIKKME-LPRFKEADGEHEFRVEVDILSRL-----DHP 120
            +G G FGRV     + + +  A+K +  + ++  +      ++E DIL ++     ++ 
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-----KIEADILKKIQNDDINNN 96

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHL-----NGIGEPKMDWPLRL--KVALGAAK 173
           N+V   G      H  L++E +   +L + +     NG         +       +   K
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGF-------HIEDIKLYCIEILK 148

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV---L 230
            L YL   S     + H D K  N+LL   +  K           +  + Y T      L
Sbjct: 149 ALNYLRKMS-----LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 231 GTFG--YFDPEYTSTGKLTLQS------------------DVYAFGVVLLELLTG 265
             FG   F  +Y  +    + +                  D+++FG VL EL TG
Sbjct: 204 IDFGCATFKSDYHGS---IINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 54/235 (22%), Positives = 87/235 (37%), Gaps = 62/235 (26%)

Query: 68  FLGKGGFGRVYKG--TLRSGEVVAIKKME-LPRFKEADGEHEFRVEVDILSRL------D 118
            LG+G FG+V +       G  VA+K ++ + R+ EA      R E+ +L  L       
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-----RSEIQVLEHLNTTDPNS 75

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRL--KVALGAAKGLA 176
               V ++ +     H  +V+E +   +  D +   G       L    K+A    K + 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPF--RLDHIRKMAYQICKSVN 132

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLS-------------------ANFEAKISDFGLAKLM 217
           +LHS+      + H D K  N+L                      N + K+ DFG A   
Sbjct: 133 FLHSNK-----LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187

Query: 218 PEGQETYVTAR-------VLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG 265
            E   T V+ R       +L   G+  P            DV++ G +L+E   G
Sbjct: 188 DEHHSTLVSTRHYRAPEVILAL-GWSQP-----------CDVWSIGCILIEYYLG 230

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	361
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.32
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.17
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.98
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.83
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.79
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.7
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.68
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.56
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.33
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.28
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.25
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.97
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.85
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.83
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.74
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.72
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.67
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.65
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.65
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.55
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.54
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.54
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.65
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.64
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.1
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.25
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.62
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.05

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.4e-62  Score=439.22  Aligned_cols=254  Identities=24%  Similarity=0.358  Sum_probs=215.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++++.||+|+||+||+|++. +|+.||||++.+...........+.+|+++|+.++|||||+++++|++++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            35999999999999999999987 79999999997654444455678899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||++||+|.+++.+.+  .+++..+..++.||+.||+|||++|     |+||||||+|||++.++++||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~-----IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999998754  7999999999999999999999999     99999999999999999999999999998765


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ........+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||...+   .   ......+......      
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~---~~~~~~i~~~~~~------  252 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---E---GLIFAKIIKLEYD------  252 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHHTCCC------
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---H---HHHHHHHHcCCCC------
Confidence            444444556789999999999999999999999999999999999999996322   1   2222222222111      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                             ++...+.++.+||.+||+.||++|||++|++.+-
T Consensus       253 -------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~  286 (311)
T 4aw0_A          253 -------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG  286 (311)
T ss_dssp             -------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHH
T ss_pred             -------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCH
Confidence                   1222345689999999999999999999975543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-61  Score=443.20  Aligned_cols=255  Identities=23%  Similarity=0.376  Sum_probs=209.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++++.||+|+||+||+|++. +|+.||||++.+.... ......+.+|+.+|+.|+|||||++++++.+++.+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            57999999999999999999987 6999999999876543 334678899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |||+||+|.+++...+...+++..++.++.||+.||+|||++|     |+||||||+||||+.+|++||+|||+|+.+..
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK-----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            9999999999998766667899999999999999999999999     99999999999999999999999999987643


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+      ....+..+....      . 
T Consensus       178 ~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~------~-  242 (350)
T 4b9d_A          178 TV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGS------F-  242 (350)
T ss_dssp             HH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTC------C-
T ss_pred             Cc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCC------C-
Confidence            22  12334689999999999999999999999999999999999999996432      222222222211      0 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           ...+...+..+.+||.+||+.||++|||++|+++|-+
T Consensus       243 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~  279 (350)
T 4b9d_A          243 -----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF  279 (350)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence                 1122234556899999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.6e-61  Score=432.37  Aligned_cols=263  Identities=25%  Similarity=0.420  Sum_probs=216.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      ++|.+.+.||+|+||+||+|++.      ++..||||++...   .....+.|.+|+++|++++|||||+++++|.+++.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            35778899999999999999864      3678999998642   34456789999999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC
Q 018047          135 RFLVYEYMQKGNLQDHLNGIG-----------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN  203 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~  203 (361)
                      +|||||||++|+|.+++...+           ...+++..+..++.|++.||+|||+++     |+||||||+|||++.+
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-----FVHRDLATRNCLVGEN  164 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGG
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCccCHhhEEECCC
Confidence            999999999999999997532           347999999999999999999999999     9999999999999999


Q ss_pred             CcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHH
Q 018047          204 FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVL  282 (361)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~  282 (361)
                      +++||+|||+++...............||+.|||||++....++.++|||||||++|||+| |+.||....   ......
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~  241 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIE  241 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH
Confidence            9999999999987655444333344568999999999999999999999999999999999 899996432   222222


Q ss_pred             HHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                      .+   ....            ....+..++..+.+|+.+||+.||++|||++|+++.|+++......
T Consensus       242 ~i---~~~~------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~  293 (299)
T 4asz_A          242 CI---TQGR------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV  293 (299)
T ss_dssp             HH---HHTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred             HH---HcCC------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence            21   1110            0122334556799999999999999999999999999998776544

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.1e-60  Score=421.68  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=197.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.+...........+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999976 79999999998766555566778999999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+ +|+|.+++...+  .+++..+..++.||+.||+|||++|     |+||||||+|||++.++++||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~-----IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 689999997754  7999999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ..   ...+.+||+.|||||++.+..+ +.++|||||||++|+|+||+.||...+      .......+......     
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~~~-----  230 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGVYT-----  230 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC-----
T ss_pred             CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCC-----
Confidence            33   2335689999999999988776 579999999999999999999996321      22222222222111     


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                              .+...+..+.+|+.+||+.||++|||++|+++|-+
T Consensus       231 --------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw  265 (275)
T 3hyh_A          231 --------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW  265 (275)
T ss_dssp             --------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred             --------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence                    12223456899999999999999999999999876

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.7e-60  Score=433.84  Aligned_cols=263  Identities=26%  Similarity=0.433  Sum_probs=208.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      .+|.+.+.||+|+||+||+|++.      ++..||||++..   ......+.|.+|+++|++++|||||+++++|.+++.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC---CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            35677789999999999999864      477899999864   234456789999999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC
Q 018047          135 RFLVYEYMQKGNLQDHLNGIG-------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS  201 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~  201 (361)
                      +|||||||++|+|.+++....             ...+++..++.++.|++.||+|||+++     |+||||||+||||+
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDLKp~NILl~  192 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVG  192 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC-----eecccccHhhEEEC
Confidence            999999999999999997542             236899999999999999999999999     99999999999999


Q ss_pred             CCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 018047          202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNL  280 (361)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~  280 (361)
                      .++++||+|||+++.+.............||+.|||||++....++.++|||||||++|||+| |+.||....   ....
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~~~~  269 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEA  269 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---HHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---HHHH
Confidence            999999999999987755544444455679999999999999999999999999999999999 899996432   2222


Q ss_pred             HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                      ...   +... .      .     ...+..++..+.+|+.+||+.||++|||++||+++|+.+....+.
T Consensus       270 ~~~---i~~g-~------~-----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~  323 (329)
T 4aoj_A          270 IDC---ITQG-R------E-----LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV  323 (329)
T ss_dssp             HHH---HHHT-C------C-----CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC-
T ss_pred             HHH---HHcC-C------C-----CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcc
Confidence            221   1111 0      0     122334456799999999999999999999999999998876543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-60  Score=436.70  Aligned_cols=252  Identities=24%  Similarity=0.389  Sum_probs=211.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ..|+..+.||+|+||+||+|+++ +|+.||||++.....   ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45999999999999999999987 799999999976432   23456788999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |||++|+|.+++...   .+++..+..++.||+.||+|||++|     |+||||||+||||+.+|++||+|||+|+.+..
T Consensus       151 Ey~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          151 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             CCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            999999999999753   6999999999999999999999999     99999999999999999999999999987754


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  .....+||+.|||||++....|+.++|||||||++|||++|+.||....   .   ...+..+...       ..
T Consensus       223 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~---~~~~~~i~~~-------~~  287 (346)
T 4fih_A          223 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---P---LKAMKMIRDN-------LP  287 (346)
T ss_dssp             SSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---H---HHHHHHHHHS-------SC
T ss_pred             CCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---H---HHHHHHHHcC-------CC
Confidence            332  2345789999999999999999999999999999999999999996322   1   1122222111       11


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +.+   ......+..+.+||.+||+.||++|||+.|+++|-+
T Consensus       288 ~~~---~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~  326 (346)
T 4fih_A          288 PRL---KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  326 (346)
T ss_dssp             CCC---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             CCC---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            111   112234456899999999999999999999999865

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.4e-60  Score=433.80  Aligned_cols=257  Identities=23%  Similarity=0.302  Sum_probs=210.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      +.|+..++||+|+||+||+|+++ +|+.||||++......        .+|+.+|+.++|||||++++++.+++.+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45777889999999999999987 6999999999764321        35999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-cEEEeecCccccCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-EAKISDFGLAKLMP  218 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~  218 (361)
                      |||+||+|.+++...+  .+++..+..++.|++.||+|||+++     |+||||||+||||+.+| .+||+|||+|+.+.
T Consensus       130 Ey~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR-----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             CCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             eccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            9999999999998654  7999999999999999999999999     99999999999999987 69999999998775


Q ss_pred             CCCce---eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          219 EGQET---YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       219 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .....   ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......   .....+   ......+ 
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i---~~~~~~~-  275 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCLKI---ASEPPPI-  275 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHHHH---HHSCCGG-
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHH---HcCCCCc-
Confidence            43221   1223457999999999999999999999999999999999999999654332   122221   1111111 


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                               ...+...+..+.+||.+||+.||++|||+.|++++|..++....
T Consensus       276 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          276 ---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             ---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence                     11223345568999999999999999999999999999887543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-59  Score=424.23  Aligned_cols=262  Identities=27%  Similarity=0.477  Sum_probs=205.6

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      +++.+.+.||+|+||+||+|+++  ..||||+++... ......+.|.+|+.+|++++|||||++++++.+ +.+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            46778899999999999999875  369999986543 334456789999999999999999999998865 56899999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      ||++|+|.+++.... ..+++..+..++.|+|.||+|||+++     ||||||||+||||+.++++||+|||+|+.....
T Consensus       112 y~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~-----IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN-----IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             CCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            999999999997543 47999999999999999999999999     999999999999999999999999999876544


Q ss_pred             CceeeeeecccccCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          221 QETYVTARVLGTFGYFDPEYTST---GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .........+||+.|||||++..   ..|+.++|||||||++|||+||+.||.....   ...   +......     ..
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~---~~~---~~~~~~~-----~~  254 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN---RDQ---IIFMVGR-----GY  254 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHH---HHHHHHT-----TC
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh---HHH---HHHHHhc-----CC
Confidence            43334455689999999998853   4689999999999999999999999964321   111   1111111     01


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      ..|.+  ...+..++..+.+|+.+||+.||++|||+.|++++|+.+-.
T Consensus       255 ~~p~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          255 ASPDL--SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             CCCCS--TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             CCCCc--ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            11211  22334456679999999999999999999999999987643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.4e-60  Score=428.88  Aligned_cols=257  Identities=28%  Similarity=0.433  Sum_probs=211.1

Q ss_pred             CCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      ++++.+.||+|+||+||+|.+.      +++.||||++...  ......+.|.+|+.+|++++|||||+++|+|.+++.+
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC---CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc--cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            3556788999999999999863      4678999998643  2334457899999999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC
Q 018047          136 FLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS  201 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~  201 (361)
                      +||||||++|+|.+++....              ...+++..+..++.|+|.||+|||+++     ||||||||+||||+
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHRDLK~~NILl~  179 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVY  179 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCCccccceEEC
Confidence            99999999999999996432              236899999999999999999999999     99999999999999


Q ss_pred             CCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 018047          202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNL  280 (361)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~  280 (361)
                      .++++||+|||+++.+.............||+.|||||++..+.++.++|||||||++|||+| |..||....   ....
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~~  256 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDV  256 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence            999999999999987654443333445679999999999999999999999999999999998 899996432   2222


Q ss_pred             HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ...+.   .. .           ....+..++..+.+|+.+||+.||++|||+.||+++|+..
T Consensus       257 ~~~i~---~~-~-----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 VEMIR---NR-Q-----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHH---TT-C-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHH---cC-C-----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22211   11 0           1123345566799999999999999999999999999753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-59  Score=419.29  Aligned_cols=251  Identities=27%  Similarity=0.412  Sum_probs=201.4

Q ss_pred             CCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc----CCEEEEE
Q 018047           64 SDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD----GKHRFLV  138 (361)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv  138 (361)
                      +..+.||+|+||+||+|.+. ++..||+|++...... ......+.+|+.+|+.++|||||+++++|.+    ++.+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            56678999999999999987 6899999999765433 3345678999999999999999999999865    3568999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-CCcEEEeecCccccC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLM  217 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~~  217 (361)
                      ||||++|+|.+++.+.  ..+++..+..++.||+.||+|||+++   .+|+||||||+|||++. ++.+||+|||+|+..
T Consensus       108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~---~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            9999999999999764  37999999999999999999999986   24999999999999985 799999999999865


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ...    .....+||+.|||||++. +.|+.++|||||||++|||+||+.||.....     ............      
T Consensus       183 ~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i~~~~------  246 (290)
T 3fpq_A          183 RAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGV------  246 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTC------
T ss_pred             CCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHHHcCC------
Confidence            433    234568999999999886 4699999999999999999999999953221     111112211110      


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..+.+     +...+.++.+||.+||+.||++|||++|+++|-+
T Consensus       247 ~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~  285 (290)
T 3fpq_A          247 KPASF-----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             CCGGG-----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCCCC-----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            00111     1112235889999999999999999999998753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.5e-59  Score=438.62  Aligned_cols=252  Identities=24%  Similarity=0.389  Sum_probs=211.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ..|+..+.||+|+||+||+|+++ +|+.||||++.....   ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            46999999999999999999987 699999999976432   23456889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      |||+||+|.+++...   .+++..+..++.||+.||+|||++|     ||||||||+||||+.+|.+||+|||+|+.+..
T Consensus       228 Ey~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~-----IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          228 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             ECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             eCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            999999999999753   6999999999999999999999999     99999999999999999999999999987754


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  .....+||+.|||||++....|+.++|||||||++|||++|+.||....   .   ...+..+...       ..
T Consensus       300 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~---~~~~~~i~~~-------~~  364 (423)
T 4fie_A          300 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---P---LKAMKMIRDN-------LP  364 (423)
T ss_dssp             SCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---H---HHHHHHHHHS-------CC
T ss_pred             CCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---H---HHHHHHHHcC-------CC
Confidence            332  2345789999999999999999999999999999999999999995322   1   1222222111       11


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +.+   ......+..+.+||.+||..||++|||+.|+|+|-+
T Consensus       365 ~~~---~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~  403 (423)
T 4fie_A          365 PRL---KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  403 (423)
T ss_dssp             CCC---SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             CCC---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence            111   111233456899999999999999999999999865

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.8e-58  Score=426.10  Aligned_cols=274  Identities=24%  Similarity=0.362  Sum_probs=221.6

Q ss_pred             cCHHHHHHHcCCCCCCceecccCceEEEEEEEcC------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC-Ccce
Q 018047           51 FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRS------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLV  123 (361)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv  123 (361)
                      ++.++++...++|++++.||+|+||+||+|.+..      ++.||||++...  ......+.+.+|+.+|.+++| ||||
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~--~~~~~~~~~~~E~~il~~l~hhpnIV  131 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVV  131 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cChHHHHHHHHHHHHHHHcCCCCcEE
Confidence            3445555666789999999999999999998652      357999998653  233445678999999999965 8999


Q ss_pred             eEEEEEEc-CCEEEEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCe
Q 018047          124 SLIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI  188 (361)
Q Consensus       124 ~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i  188 (361)
                      +++++|.+ ++.+|||||||++|+|.++|.+..              ...+++..+..++.|+|.||+|||+++     |
T Consensus       132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~-----i  206 (353)
T 4ase_A          132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----C  206 (353)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT-----C
T ss_pred             EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC-----e
Confidence            99999966 457899999999999999996532              235899999999999999999999999     9


Q ss_pred             EecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCC
Q 018047          189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR  267 (361)
Q Consensus       189 iH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~  267 (361)
                      |||||||+|||++.++.+||+|||+|+.+.............||+.|||||++....|+.++|||||||++|||+| |+.
T Consensus       207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~  286 (353)
T 4ase_A          207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  286 (353)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence            9999999999999999999999999997765544444555679999999999999999999999999999999998 899


Q ss_pred             CCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          268 AVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       268 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ||......  ..+...+    ....      .     ...+..++.++.+|+.+||+.||++|||+.|++++|++++..+
T Consensus       287 Pf~~~~~~--~~~~~~i----~~g~------~-----~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          287 PYPGVKID--EEFCRRL----KEGT------R-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             SSTTCCCS--HHHHHHH----HHTC------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCCCCCHH--HHHHHHH----HcCC------C-----CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            99643221  1111111    1110      0     1123334566899999999999999999999999999998765


Q ss_pred             C
Q 018047          348 S  348 (361)
Q Consensus       348 ~  348 (361)
                      .
T Consensus       350 ~  350 (353)
T 4ase_A          350 A  350 (353)
T ss_dssp             C
T ss_pred             h
Confidence            3

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.6e-59  Score=419.87  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=201.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++++.||+|+||+||+|+..    +++.||||++.+...... ....+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            35999999999999999999863    478899999976533222 2335778999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +|||||+||+|.+++.+.+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.+|++||+|||+|+.
T Consensus       103 ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~-----IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG-----IIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            9999999999999998744  7999999999999999999999999     99999999999999999999999999986


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ......  .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+   .   ......+.....    
T Consensus       176 ~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~---~~~~~~i~~~~~----  243 (304)
T 3ubd_A          176 SIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---R---KETMTMILKAKL----  243 (304)
T ss_dssp             -----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHHCCC----
T ss_pred             ccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---H---HHHHHHHHcCCC----
Confidence            544322  2335689999999999999999999999999999999999999996432   1   222222222211    


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                               ..+...+.++.+|+.+||+.||++|||     ++|+++|-+
T Consensus       244 ---------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~  284 (304)
T 3ubd_A          244 ---------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF  284 (304)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred             ---------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence                     112234456899999999999999998     578888754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-57  Score=412.99  Aligned_cols=274  Identities=26%  Similarity=0.367  Sum_probs=203.9

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC----EEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK----HRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~  136 (361)
                      ++|.+.+.||+|+||+||+|++. |+.||||++...    ......+..|+..+..++|||||++++++.+++    .+|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            35777889999999999999985 899999998532    222223334566667889999999999997653    689


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC---CCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA---VGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      |||||+++|+|.+++...   .++++.+..++.|++.||+|||+++.   ...+|+||||||+||||+.++++||+|||+
T Consensus        78 lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            999999999999999764   68999999999999999999998710   011299999999999999999999999999


Q ss_pred             cccCCCCCcee--eeeecccccCccCcccccCC------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc--------
Q 018047          214 AKLMPEGQETY--VTARVLGTFGYFDPEYTSTG------KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND--------  277 (361)
Q Consensus       214 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------  277 (361)
                      ++.........  .....+||+.|||||++.+.      .++.++|||||||++|||+||+.||........        
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            98765443322  22345799999999988654      367799999999999999999888753322110        


Q ss_pred             hhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          278 QNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ......+....     ....+.|.++......+.+..+.+|+.+||+.||++|||+.|+++.|+++....
T Consensus       235 ~~~~~~~~~~~-----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          235 DPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             SCCHHHHHHHH-----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             cchHHHHHHHH-----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            01111111111     111223333322233456778999999999999999999999999999987654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-56  Score=405.94  Aligned_cols=252  Identities=24%  Similarity=0.420  Sum_probs=191.1

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-------
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-------  133 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------  133 (361)
                      +|++.+.||+|+||+||+|+++ +|+.||||++....  .....+.+.+|+.+|+.++|||||++++++.+.+       
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            5888999999999999999987 79999999997652  3344567889999999999999999999987544       


Q ss_pred             -----EEEEEEEecCCCchhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEE
Q 018047          134 -----HRFLVYEYMQKGNLQDHLNGIGE-PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAK  207 (361)
Q Consensus       134 -----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~k  207 (361)
                           .+|+|||||++|+|.+++..... ...++..++.++.|+++||+|||++|     |+||||||+|||++.++.+|
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~-----IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc-----CccccCcHHHeEECCCCcEE
Confidence                 37999999999999999976532 23566778999999999999999999     99999999999999999999


Q ss_pred             EeecCccccCCCCCcee----------eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 018047          208 ISDFGLAKLMPEGQETY----------VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND  277 (361)
Q Consensus       208 l~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  277 (361)
                      |+|||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||++|||++   ||..     .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~  230 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----Q  230 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----H
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----c
Confidence            99999998775432211          1233579999999999999999999999999999999996   6632     1


Q ss_pred             hhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          278 QNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ......+......          ..  ..........+.+|+.+||+.||++|||+.|+++|-
T Consensus       231 ~~~~~~~~~~~~~----------~~--p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~  281 (299)
T 4g31_A          231 MERVRTLTDVRNL----------KF--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA  281 (299)
T ss_dssp             HHHHHHHHHHHTT----------CC--CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             cHHHHHHHHHhcC----------CC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence            1111111111110          00  001122234567899999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-54  Score=405.78  Aligned_cols=269  Identities=23%  Similarity=0.323  Sum_probs=205.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc------CC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD------GK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~  133 (361)
                      ++|++++.||+|+||+||+|.+. +|+.||||++.... ........+.+|+.+|+.++|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            57999999999999999999987 79999999996543 223345678889999999999999999999753      46


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      .+|||||||+ |+|.+++...  ..+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~-----iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ-----VIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc-----CcCCCcCccccccCCCCCEEEeecce
Confidence            8899999995 6899999764  37999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCc--eeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          214 AKLMPEGQE--TYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       214 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      ++.+.....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+.   ......+......
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~  281 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGT  281 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCC
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCC
Confidence            987643321  1223457899999999987664 568999999999999999999999964322   2222222111110


Q ss_pred             hh-hh---------hhhcCccccCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 RK-KL---------RKVIDPELSRSSYTM-----ESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ~~-~~---------~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .. ..         ...+.........+.     ..+.++.+||.+||..||++|||+.|+|+|-+
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  347 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF  347 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence            00 00         000000000011111     12356889999999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.4e-54  Score=400.74  Aligned_cols=267  Identities=23%  Similarity=0.303  Sum_probs=201.9

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcC
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADG  132 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  132 (361)
                      ...+.|++.+.||+|+||+||+|+.+    +++.||+|++...     .....+.+|+++|+.+ +||||++++++|.++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            45678999999999999999999864    4678999998543     2345678899999998 699999999999999


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEeec
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDF  211 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~Df  211 (361)
                      +.+|+||||+++|+|.+++.     .+++..+..++.|++.||+|||++|     |+||||||+|||++.+ +.+||+||
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g-----IiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG-----IVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCcCCHHHeEEeCCCCeEEECcC
Confidence            99999999999999999984     4899999999999999999999999     9999999999999877 89999999


Q ss_pred             CccccCCCCCce--------------------------eeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHh
Q 018047          212 GLAKLMPEGQET--------------------------YVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLT  264 (361)
Q Consensus       212 g~~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~  264 (361)
                      |+|+...+....                          ......+||+.|+|||++.+. .++.++||||+||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            999865432210                          112345799999999988765 58999999999999999999


Q ss_pred             CCCCCCCCCCCCchhHHHHHHHHhhhhhh------------------------hhhhc------Cccc--------cCCC
Q 018047          265 GRRAVDLNQGVNDQNLVLQVRHILNDRKK------------------------LRKVI------DPEL--------SRSS  306 (361)
Q Consensus       265 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~------~~~~--------~~~~  306 (361)
                      |+.||....+  +......+.........                        ..+.+      .+.+        ....
T Consensus       243 G~~Pf~~~~~--~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  320 (361)
T 4f9c_A          243 GRYPFYKASD--DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE  320 (361)
T ss_dssp             TCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred             CCCCCCCCCC--HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence            9999964332  21222111111100000                        00000      0000        0000


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          307 YTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       307 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .....+.++.+|+.+||+.||++|||++|+|+|-+
T Consensus       321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~  355 (361)
T 4f9c_A          321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF  355 (361)
T ss_dssp             -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence            01122356889999999999999999999998854

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.7e-54  Score=420.45  Aligned_cols=254  Identities=24%  Similarity=0.311  Sum_probs=207.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHH---HHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|+++++||+|+||+||+|+.+ +|+.||||++.+...........+.+   ++.+++.++|||||+++++|++.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            56999999999999999999987 69999999997643322233333333   456667789999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      |||||++||+|.+++...+  .+++..+..++.||+.||+|||++|     ||||||||+||||+.+|++||+|||+|+.
T Consensus       269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g-----IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchHHeEEeCCCCEEecccceeee
Confidence            9999999999999998754  7999999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      +....    ..+.+||+.|||||++.. ..|+.++|||||||++|||++|+.||........   ...........    
T Consensus       342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~~~----  410 (689)
T 3v5w_A          342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTMA----  410 (689)
T ss_dssp             CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHHCC----
T ss_pred             cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcCCC----
Confidence            75433    334689999999999864 5799999999999999999999999964333221   11122221111    


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                               ..++...+.++.+||.+||+.||++|++     ++|+++|-+
T Consensus       411 ---------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf  452 (689)
T 3v5w_A          411 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  452 (689)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred             ---------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence                     1122234456899999999999999998     799998875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5e-53  Score=414.25  Aligned_cols=255  Identities=23%  Similarity=0.326  Sum_probs=211.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++++.||+|+||+||+|.++ +|+.||+|++...   .......+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            357999999999999999999987 7999999999754   233456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC--CcEEEeecCcccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN--FEAKISDFGLAKL  216 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~--~~~kl~Dfg~~~~  216 (361)
                      ||||+||+|.+++... ...+++..+..++.||+.||+|||+++     |+||||||+|||++.+  +.+||+|||+++.
T Consensus       233 ~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~-----iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          233 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            9999999999999653 237999999999999999999999999     9999999999999865  8999999999998


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +.....   ....+||+.|||||++.+..|+.++|||||||++|+|++|..||....   .   ...+..+......+..
T Consensus       307 ~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~---~~~~~~i~~~~~~~~~  377 (573)
T 3uto_A          307 LDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---D---DETLRNVKSCDWNMDD  377 (573)
T ss_dssp             CCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---H---HHHHHHHHTTCCCCCS
T ss_pred             ccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---H---HHHHHHHHhCCCCCCc
Confidence            765442   344689999999999999999999999999999999999999996432   1   1222222221111111


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .         .....+..+.+||.+||+.||++|||+.|+|+|-+
T Consensus       378 ~---------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw  413 (573)
T 3uto_A          378 S---------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW  413 (573)
T ss_dssp             G---------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             c---------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence            1         01122345889999999999999999999999854

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.2e-52  Score=379.02  Aligned_cols=287  Identities=41%  Similarity=0.709  Sum_probs=238.6

Q ss_pred             CHHHHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc
Q 018047           52 TLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD  131 (361)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  131 (361)
                      ...++....++|+..+.||+|+||+||+|.+.+|+.||||++...   .......+.+|+.+++.++||||+++++++.+
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            344555677899999999999999999999888999999987643   23446678899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKIS  209 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~  209 (361)
                      .+..++||||+++|+|.+++....  ...+++..++.++.|++.||+|||++|     ++||||||+|||++.++.+||+
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-----IIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCSTTEEECTTCCEEEC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC-----eecCCCCHHHEEECCCCCEEEe
Confidence            999999999999999999997643  235899999999999999999999999     9999999999999999999999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      |||++................||+.|+|||++....++.++||||||+++|+|++|+.||.............+..... 
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-  260 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-  260 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-
Confidence            9999987544333323344568999999999988899999999999999999999999997665554444444433222 


Q ss_pred             hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      ....+...+++.+. ...+...+..+.+++.+||+.||++|||+.|++++|+.++...+
T Consensus       261 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          261 NNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             TTTCCCSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             ccccHHHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            22334444445443 45678889999999999999999999999999999999987654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-50  Score=371.93  Aligned_cols=287  Identities=43%  Similarity=0.752  Sum_probs=232.9

Q ss_pred             CCcccCHHHHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEE
Q 018047           47 GSSVFTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLI  126 (361)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~  126 (361)
                      ....++..++....++|+..+.||+|+||+||+|...+|+.||||++......  .....+.+|+.+++.++||||++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceE
Confidence            34568889999999999999999999999999999878999999998654322  2223588899999999999999999


Q ss_pred             EEEEcCCEEEEEEEecCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CCCCCCeEecCCCCCCeeeC
Q 018047          127 GYCADGKHRFLVYEYMQKGNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSS---SAVGIPIVHRDFKSTNVLLS  201 (361)
Q Consensus       127 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~iiH~Dikp~Nill~  201 (361)
                      +++.+.+..++||||+++|+|.+++....  ...+++..+..++.|++.||+|||++   |     ++||||||+|||++
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-----ivH~Dlkp~Nil~~  168 (326)
T 3uim_A           94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK-----IIHRDVKAANILLD  168 (326)
T ss_dssp             EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC-----EECCCCSGGGEEEC
T ss_pred             EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEeCCCchhhEEEC
Confidence            99999999999999999999999997653  33599999999999999999999999   8     99999999999999


Q ss_pred             CCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC--CCCchh
Q 018047          202 ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ--GVNDQN  279 (361)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--~~~~~~  279 (361)
                      .++.+||+|||++......... ......||+.|+|||++....++.++||||||+++|+|++|+.||....  ......
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  247 (326)
T 3uim_A          169 EEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM  247 (326)
T ss_dssp             TTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred             CCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence            9999999999999877543322 3334569999999999988889999999999999999999999995221  111222


Q ss_pred             HHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          280 LVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ...++..... ...+....+..+. ...+...+..+.+++.+||+.||++|||+.|++++|+..
T Consensus       248 ~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          248 LLDWVKGLLK-EKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHHHHTTTTS-SCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHHhh-chhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            2222222111 1233333444433 456788889999999999999999999999999999853

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-49  Score=361.52  Aligned_cols=253  Identities=24%  Similarity=0.392  Sum_probs=209.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|+..+.||+|+||+||+|.+. +|+.||+|++....   ......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            357999999999999999999976 69999999987543   23345688899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++...   .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++....
T Consensus        96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            9999999999999764   5899999999999999999999999     9999999999999999999999999998765


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ....   ......       .
T Consensus       168 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~---~~~~~~-------~  232 (297)
T 3fxz_A          168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRAL---YLIATN-------G  232 (297)
T ss_dssp             STTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---HHHHHH-------C
T ss_pred             Cccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhC-------C
Confidence            4332  23345799999999999999999999999999999999999999954321   1111   111110       0


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .+.   ...+...+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       233 ~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  272 (297)
T 3fxz_A          233 TPE---LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF  272 (297)
T ss_dssp             SCC---CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             CCC---CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence            001   1122334456899999999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.2e-50  Score=367.40  Aligned_cols=253  Identities=26%  Similarity=0.375  Sum_probs=210.9

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            3467999999999999999999985 799999999976543 33445678899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++...
T Consensus        92 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR-----IVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             EECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             EEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            999999999999997643  6999999999999999999999999     999999999999999999999999999876


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLT-LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      .....   ....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||....      .............    
T Consensus       165 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~----  231 (328)
T 3fe3_A          165 TVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGKY----  231 (328)
T ss_dssp             SSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC----
T ss_pred             CCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC----
Confidence            54332   2345799999999998877765 78999999999999999999996432      1112222211111    


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                               ..+...+..+.+|+.+||+.||.+|||++|+++|.+
T Consensus       232 ---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          232 ---------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             ---------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence                     112223455889999999999999999999999866

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.7e-48  Score=353.55  Aligned_cols=285  Identities=36%  Similarity=0.637  Sum_probs=234.4

Q ss_pred             cccCHHHHHHHcCCCCCC------ceecccCceEEEEEEEcCCCEEEEEEeecCCC-CcchhHHHHHHHHHHHHhcCCCc
Q 018047           49 SVFTLKEMEEATCSFSDD------NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRF-KEADGEHEFRVEVDILSRLDHPN  121 (361)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~  121 (361)
                      ..++..++..++++|...      +.||+|+||+||+|... ++.||+|++..... ........+.+|+.+++.++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            457888999999888877      89999999999999874 88999999865422 23344677899999999999999


Q ss_pred             ceeEEEEEEcCCEEEEEEEecCCCchhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee
Q 018047          122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG-EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       122 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill  200 (361)
                      |+++++++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++|     ++||||||+||++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dlkp~Nili  166 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH-----HIHRDIKSANILL  166 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEE
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----eecCCCCHHHEEE
Confidence            9999999999999999999999999999986432 346999999999999999999999999     9999999999999


Q ss_pred             CCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 018047          201 SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNL  280 (361)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  280 (361)
                      +.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||........  .
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~  243 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L  243 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence            9999999999999987655443333445678999999998754 588999999999999999999999975443221  1


Q ss_pred             HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      .............+...+++.+  ...+...+..+.+++.+||+.||++|||+.+++++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          244 LDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             THHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1122222223334455555544  3456788889999999999999999999999999999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-49  Score=358.40  Aligned_cols=269  Identities=27%  Similarity=0.411  Sum_probs=215.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|.+. ++..||+|++.............+.+|+.++..++||||+++++++.+++..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            457999999999999999999977 6899999999776555556677899999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++....
T Consensus        90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR-----IVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999997643  6999999999999999999999999     9999999999999999999999999998764


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....     .................. 
T Consensus       163 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~-  235 (294)
T 4eqm_A          163 ETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----VSIAIKHIQDSVPNVTTD-  235 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----HHHHHHHHSSCCCCHHHH-
T ss_pred             ccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhhccCCCcchh-
Confidence            43221 23345789999999999999999999999999999999999999964321     111111111111111111 


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHhhcCCC
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERP-SMAECVKELQLIIYTNSKG  350 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ell~~l~~i~~~~~~~  350 (361)
                              .....+..+.+++.+||+.||++|| +++++.+.|+.++...+..
T Consensus       236 --------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~  280 (294)
T 4eqm_A          236 --------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN  280 (294)
T ss_dssp             --------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred             --------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence                    1122345589999999999999998 9999999999887765543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-49  Score=371.93  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=214.8

Q ss_pred             cCCCCCCceecccCceEEEEEEEc--------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR--------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCA  130 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  130 (361)
                      .++|.+++.||+|+||+||+|.+.        ++..||||++...  ........+.+|+.+++.+ +||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            356888899999999999999863        3457999998654  2344566789999999999 8999999999999


Q ss_pred             cCCEEEEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCC
Q 018047          131 DGKHRFLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKST  196 (361)
Q Consensus       131 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~  196 (361)
                      +.+..|+||||+++|+|.+++....              ...+++..++.++.|++.||+|||++|     |+||||||+
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~  232 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAAR  232 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGG
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccchh
Confidence            9999999999999999999997643              235899999999999999999999999     999999999


Q ss_pred             CeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 018047          197 NVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGV  275 (361)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~  275 (361)
                      |||++.++.+||+|||++..+.............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... 
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-  311 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-  311 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence            99999999999999999987654433222333457889999999988999999999999999999999 9999964321 


Q ss_pred             CchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          276 NDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                        ......+.   ..       .     ....+..++..+.+++.+||+.||++|||+.|++++|++++...+
T Consensus       312 --~~~~~~~~---~~-------~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          312 --EELFKLLK---EG-------H-----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             --GGHHHHHH---TT-------C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             --HHHHHHHh---cC-------C-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence              11111111   10       0     011223345569999999999999999999999999999886543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.4e-49  Score=366.50  Aligned_cols=257  Identities=23%  Similarity=0.327  Sum_probs=210.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc---hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA---DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      .+.|++.+.||+|+||+||+|... +|+.||+|++........   .....+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            456999999999999999999987 699999999986543221   2356788999999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC----cEEEeec
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF----EAKISDF  211 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~----~~kl~Df  211 (361)
                      |+||||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999764  37999999999999999999999999     99999999999998876    7999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      |++..+.....   .....||+.|+|||++....++.++|||||||++|+|++|..||....   ..   .....+....
T Consensus       164 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~---~~~~~i~~~~  234 (361)
T 2yab_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQ---ETLANITAVS  234 (361)
T ss_dssp             SSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HH---HHHHHHHTTC
T ss_pred             CCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HH---HHHHHHHhcC
Confidence            99987755432   234579999999999998899999999999999999999999996432   11   1122222111


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..+....         ....+..+.+||.+||..||++|||+.|+++|.+
T Consensus       235 ~~~~~~~---------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  275 (361)
T 2yab_A          235 YDFDEEF---------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (361)
T ss_dssp             CCCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             CCCCchh---------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence            1110000         0112345899999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.1e-49  Score=364.31  Aligned_cols=253  Identities=24%  Similarity=0.280  Sum_probs=209.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||+||+|+.+ +|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            46889999999999999999987 69999999997543223344567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.....
T Consensus        85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999999764  37899999999999999999999999     99999999999999999999999999986433


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|..||....   ..   .....+....        
T Consensus       158 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~---~~~~~i~~~~--------  221 (337)
T 1o6l_A          158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HE---RLFELILMEE--------  221 (337)
T ss_dssp             TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHCC--------
T ss_pred             CCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HH---HHHHHHHcCC--------
Confidence            221  2334679999999999999999999999999999999999999996322   11   1111211111        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                           ..++...+..+.+|+.+||+.||++||     +++|+++|-+
T Consensus       222 -----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~  263 (337)
T 1o6l_A          222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence                 111223345689999999999999999     9999999854

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.3e-50  Score=371.41  Aligned_cols=273  Identities=24%  Similarity=0.354  Sum_probs=219.2

Q ss_pred             cCHHHHHHHcCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcce
Q 018047           51 FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV  123 (361)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv  123 (361)
                      +....++...++|++.+.||+|+||+||+|.+.      +++.||||++...  ........+.+|+.++..+ +||||+
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCccee
Confidence            455666667788999999999999999999842      4678999999643  2334456789999999999 799999


Q ss_pred             eEEEEEEcCC-EEEEEEEecCCCchhhhcccCCC----------------------------------------------
Q 018047          124 SLIGYCADGK-HRFLVYEYMQKGNLQDHLNGIGE----------------------------------------------  156 (361)
Q Consensus       124 ~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------  156 (361)
                      ++++++.+.+ ..++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999998755 48999999999999999976432                                              


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          157 ------------------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       157 ------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                                        ..+++..++.++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++..+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  244 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIY  244 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence                              12889999999999999999999999     9999999999999999999999999998775


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ............||+.|+|||++....++.++||||||+++|+|++ |..||......  ......+.    ..      
T Consensus       245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~----~~------  312 (359)
T 3vhe_A          245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLK----EG------  312 (359)
T ss_dssp             SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHHHH----HT------
T ss_pred             ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHHHH----cC------
Confidence            5444434445678999999999988999999999999999999998 99999643321  11111111    10      


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ..     ...+...+..+.+++.+||+.||++|||+.|++++|+.++..+
T Consensus       313 ~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          313 TR-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            00     1112223455899999999999999999999999999998754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-49  Score=364.99  Aligned_cols=274  Identities=28%  Similarity=0.366  Sum_probs=212.0

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC----EEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK----HRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~  136 (361)
                      ++|++.+.||+|+||+||+|++. ++.||||++...    .........|+.++..++||||+++++++.+..    .++
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            46899999999999999999877 899999998532    233445666899999999999999999998743    479


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCCCCeEecCCCCCCeeeCCCCcE
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS----------SAVGIPIVHRDFKSTNVLLSANFEA  206 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----------~~~~~~iiH~Dikp~Nill~~~~~~  206 (361)
                      +||||+++|+|.+++...   .+++..+..++.|++.||+|||+.          +     |+||||||+|||++.++.+
T Consensus        99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~-----ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-----ISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE-----EECSCCSGGGEEECTTCCE
T ss_pred             EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC-----EEeCCCChHhEEECCCCeE
Confidence            999999999999999763   599999999999999999999998          8     9999999999999999999


Q ss_pred             EEeecCccccCCCCCceeeeeecccccCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 018047          207 KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  281 (361)
                      ||+|||++..+.............||+.|+|||++.+     ..++.++|||||||++|||++|+.||............
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            9999999987655443333334578999999998876     34567889999999999999999999765443222221


Q ss_pred             HHHHHHhhhh----hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          282 LQVRHILNDR----KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       282 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ..........    ........+.+.........+..+.+|+.+||+.||++|||+.|+++.|+++....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1100000000    00011111111111123355677999999999999999999999999999987654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-49  Score=360.09  Aligned_cols=255  Identities=18%  Similarity=0.283  Sum_probs=210.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|.+.+.||+|+||+||+|.+. +++.+|+|.+...    ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            467999999999999999999987 6889999998632    33456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC--CCcEEEeecCcccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA--NFEAKISDFGLAKL  216 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~--~~~~kl~Dfg~~~~  216 (361)
                      |||+++|+|.+++.... ..+++..+..++.|++.||+|||++|     ++||||||+|||++.  ++.+||+|||++..
T Consensus        80 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g-----ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----CCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            99999999999997642 36999999999999999999999999     999999999999997  78999999999988


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +.....   .....||+.|+|||++....++.++|||||||++|+|++|..||....   ...   ....+.........
T Consensus       154 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~---~~~~i~~~~~~~~~  224 (321)
T 1tki_A          154 LKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQ---IIENIMNAEYTFDE  224 (321)
T ss_dssp             CCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHH---HHHHHHHTCCCCCH
T ss_pred             CCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHH---HHHHHHcCCCCCCh
Confidence            755432   334578999999999988889999999999999999999999996432   111   12222211111100


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ...         ...+..+.+|+.+||..||++|||+.|+++|.+-
T Consensus       225 ~~~---------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  261 (321)
T 1tki_A          225 EAF---------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             HHH---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             hhh---------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence            000         0123458999999999999999999999999873

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=354.12  Aligned_cols=262  Identities=29%  Similarity=0.459  Sum_probs=212.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|..++.||+|+||+||+|.+. +++.||+|++..   ........+.+|+.+++.++||||+++++++.+++..++||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            45888999999999999999987 689999998843   34455678899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.....
T Consensus        87 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           87 EYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN-----IIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             ECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            999999999999764 347999999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCcee------------eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 018047          220 GQETY------------VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       220 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      .....            ......||+.|+|||++.+..++.++||||||+++|+|++|..|+............. ..  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~--  237 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VR--  237 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HH--
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hh--
Confidence            32211            1114579999999999999999999999999999999999999986533221111000 00  


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                          ........+.+         +..+.+++.+||+.||++|||+.++++.|+.+...-
T Consensus       238 ----~~~~~~~~~~~---------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          238 ----GFLDRYCPPNC---------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             ----HHHHHTCCTTC---------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----ccccccCCCCC---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                01111112222         223889999999999999999999999999876543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.5e-49  Score=368.80  Aligned_cols=255  Identities=24%  Similarity=0.362  Sum_probs=210.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|... +++.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            45889999999999999999987 68999999997643333445677889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||++|     |+||||||+|||++.++.+||+|||++..+..
T Consensus        95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR-----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999864  37999999999999999999999999     99999999999999999999999999987754


Q ss_pred             CCceeeeeecccccCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST---GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ..   .....+||+.|+|||++..   ..++.++|||||||++|+|++|+.||..............   .....     
T Consensus       168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~~~~-----  236 (384)
T 4fr4_A          168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---FETTV-----  236 (384)
T ss_dssp             TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH---HHHCC-----
T ss_pred             CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hhhcc-----
Confidence            43   2344679999999998863   4589999999999999999999999975443322222111   11110     


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPS-MAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~ell~~l~  341 (361)
                              ..++...+..+.+|+.+||+.||++||+ ++++++|.+
T Consensus       237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~  274 (384)
T 4fr4_A          237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY  274 (384)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred             --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence                    1122334456899999999999999998 888877543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.6e-49  Score=361.50  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=207.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++.....  ......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            457999999999999999999987 799999999875432  22345688899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++..+.
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            9999999999999764  36999999999999999999999999     9999999999999999999999999998765


Q ss_pred             CCCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ............||+.|+|||++....+ +.++|||||||++|+|++|+.||........ ...    ........    
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~----~~~~~~~~----  227 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS----DWKEKKTY----  227 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHH----HHHTTCTT----
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHH----HHhccccc----
Confidence            4433333445679999999999877665 7789999999999999999999965433211 111    11111000    


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .       ......+..+.+|+.+||+.||++|||+.|++++.+
T Consensus       228 ~-------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~  264 (323)
T 3tki_A          228 L-------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (323)
T ss_dssp             S-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             C-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence            0       001123345789999999999999999999999865

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=367.74  Aligned_cols=254  Identities=26%  Similarity=0.318  Sum_probs=206.5

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  137 (361)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++.+...........+..|..++..+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            467999999999999999999987 6899999999764333344556788899999988 69999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++|+|.+++....  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+++..
T Consensus       102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG-----IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            999999999999997643  6999999999999999999999999     999999999999999999999999999854


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....  .....+||+.|+|||++....++.++|||||||++|||++|+.||....   .   ......+.....     
T Consensus       175 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~---~~~~~~i~~~~~-----  241 (353)
T 3txo_A          175 ICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---E---DDLFEAILNDEV-----  241 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHHCCC-----
T ss_pred             ccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---H---HHHHHHHHcCCC-----
Confidence            33221  2345679999999999988889999999999999999999999996432   1   122222222111     


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSM------AECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~ell~~l~  341 (361)
                              .++...+..+.+|+.+||+.||++||++      .|+++|.+
T Consensus       242 --------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~  283 (353)
T 3txo_A          242 --------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF  283 (353)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred             --------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence                    1122234558999999999999999998      88888764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.3e-49  Score=367.89  Aligned_cols=259  Identities=22%  Similarity=0.326  Sum_probs=207.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ++|++.++||+|+||+||+|+.+ +++.||+|++.+...........+..|..++..+ +||||+++++++.+.+..|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            46899999999999999999987 6889999999876555555556688899999887 899999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++...+  .+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+||+|||+++...
T Consensus       132 ~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999997643  7999999999999999999999999     9999999999999999999999999998632


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc--h-hHHHHHHHHhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND--Q-NLVLQVRHILNDRKKLR  295 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~-~~~~~~~~~~~~~~~~~  295 (361)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........  . ........+....    
T Consensus       205 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----  278 (396)
T 4dc2_A          205 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  278 (396)
T ss_dssp             CTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred             cCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence            2221  23456899999999999999999999999999999999999999964322111  1 1111111111111    


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSM------AECVKELQ  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~ell~~l~  341 (361)
                               ...+...+..+.+|+.+||+.||++||++      .|+++|.+
T Consensus       279 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf  321 (396)
T 4dc2_A          279 ---------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  321 (396)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred             ---------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence                     11222344568999999999999999985      67877754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.7e-49  Score=357.81  Aligned_cols=266  Identities=31%  Similarity=0.469  Sum_probs=206.5

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ...++|++.+.||+|+||+||+|... |+.||||++..... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34457899999999999999999875 88999999875432 33445678899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          138 VYEYMQKGNLQDHLNGIGE-PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      ||||+++|+|.+++..... ..+++..++.++.|++.||+|||++|.   +++||||||+|||++.++.+||+|||++..
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP---PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS---CCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC---CEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            9999999999999976431 238999999999999999999999872   399999999999999999999999999976


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....   ......+.   ...     
T Consensus       189 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~---~~~-----  255 (309)
T 3p86_A          189 KASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVG---FKC-----  255 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHH---HSC-----
T ss_pred             cccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---hcC-----
Confidence            543221  22345789999999999999999999999999999999999999964321   11111110   000     


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                            .....+...+..+.+|+.+||+.||++|||+.++++.|+.++...
T Consensus       256 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 ------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                  011223334456899999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=358.92  Aligned_cols=264  Identities=26%  Similarity=0.442  Sum_probs=211.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-C---CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-S---GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|.+.+.||+|+||+||+|.+. +   +..||||++...  ........+.+|+.+++.++||||+++++++.+++..|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            46888999999999999999985 3   345999998643  23445677899999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++|+|.+++... ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++..
T Consensus       127 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999654 247999999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCcee-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          217 MPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       217 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ........ ......+|+.|+|||++....++.++||||||+++|+|++ |..||....   .......   ....    
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~---~~~~----  270 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT---NRDVISS---VEEG----  270 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHH---HHTT----
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC---HHHHHHH---HHcC----
Confidence            75432221 2223346778999999988899999999999999999999 999995332   1111111   1111    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG  350 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~  350 (361)
                         .     ....+..++..+.+|+.+||+.||++|||+.++++.|+.++...+..
T Consensus       271 ---~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~  318 (325)
T 3kul_A          271 ---Y-----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL  318 (325)
T ss_dssp             ---C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred             ---C-----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence               0     01122334556999999999999999999999999999998876543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.1e-49  Score=364.01  Aligned_cols=253  Identities=25%  Similarity=0.322  Sum_probs=208.8

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|.+.+.||+|+||+||+|.+. +|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            357999999999999999999986 7899999998654322233345788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+ +|+|.+++...+  .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK-----IVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT-----CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 789999987643  7999999999999999999999999     9999999999999999999999999998765


Q ss_pred             CCCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .+..   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........                 ...
T Consensus       160 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------~~~  219 (336)
T 3h4j_B          160 DGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------FKK  219 (336)
T ss_dssp             TSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------BCC
T ss_pred             CCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------HHH
Confidence            4432   234579999999999887776 7899999999999999999999964322110                 000


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      +...  ....+...+..+.+|+.+||+.||.+|||+.|+++|.+-
T Consensus       220 i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  262 (336)
T 3h4j_B          220 VNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF  262 (336)
T ss_dssp             CCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred             HHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence            1110  011223344568999999999999999999999999874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-48  Score=357.63  Aligned_cols=250  Identities=28%  Similarity=0.372  Sum_probs=209.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            46888999999999999999987 69999999997543223344567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.....
T Consensus        86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            9999999999997643  6999999999999999999999999     99999999999999999999999999987643


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      .     ....+||+.|+|||++....++.++|||||||++|||++|..||....      .......+.....       
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~-------  220 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAEL-------  220 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCC-------
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC-------
Confidence            2     234579999999999999999999999999999999999999995432      1122222222111       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                            .++...+..+.+++.+||+.||++||     +++++++|-+
T Consensus       221 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~  261 (318)
T 1fot_A          221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  261 (318)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence                  11222345689999999999999999     9999998854

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=357.07  Aligned_cols=256  Identities=24%  Similarity=0.340  Sum_probs=208.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc---hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA---DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      +.|.+.+.||+|+||+||+|... +|+.||+|++........   .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35889999999999999999987 699999999976543221   23567889999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC----cEEEeecC
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF----EAKISDFG  212 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~----~~kl~Dfg  212 (361)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||++|     ++||||||+|||++.++    .+||+|||
T Consensus        91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC-----eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999764  37999999999999999999999999     99999999999999887    89999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ++........   .....||+.|+|||++....++.++|||||||++|+|++|..||....   .....   ........
T Consensus       164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~---~~~~~~~~  234 (326)
T 2y0a_A          164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL---ANVSAVNY  234 (326)
T ss_dssp             TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHH---HHHHHTCC
T ss_pred             CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHH---HHHHhcCC
Confidence            9987754332   233579999999999988899999999999999999999999995432   11111   11111111


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ......         ....+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       235 ~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  274 (326)
T 2y0a_A          235 EFEDEY---------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  274 (326)
T ss_dssp             CCCHHH---------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             CcCccc---------cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            000000         0112345889999999999999999999998754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2e-49  Score=371.50  Aligned_cols=262  Identities=27%  Similarity=0.420  Sum_probs=212.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++...  ........+.+|+.+|+.++||||+++++++.+++..|+|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            356788899999999999999987 7899999998643  2233445788899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++...+ ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++....
T Consensus       191 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC-----CIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999999999997542 36899999999999999999999999     9999999999999999999999999998654


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ............+++.|+|||.+....++.++|||||||++|||++ |..||....   .......    .....     
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~---~~~~~~~----~~~~~-----  332 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---NQQTREF----VEKGG-----  332 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---HHHHHHH----HHTTC-----
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----HHcCC-----
Confidence            4322211122335778999999988889999999999999999998 999996432   1111111    11100     


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                            ....+..++..+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus       333 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          333 ------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence                  01122334556899999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-48  Score=349.64  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=211.3

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|+..+.||+|+||+||+|.+.+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc----cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            4588889999999999999999888899999997432    234578899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.... ..+++..++.++.|++.||+|||++|     ++||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             CCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC-----eecCCcchheEEEcCCCCEEecccccccccccc
Confidence            999999999997643 36899999999999999999999999     999999999999999999999999999866433


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ... ......+|+.|+|||.+....++.++||||||+++|+|++ |..||....   ..   .........       ..
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~---~~---~~~~~~~~~-------~~  225 (269)
T 4hcu_A          160 QYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NS---EVVEDISTG-------FR  225 (269)
T ss_dssp             HHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH---HHHHHHHTT-------CC
T ss_pred             ccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC---HH---HHHHHHhcC-------cc
Confidence            211 1223456778999999988899999999999999999999 999995322   11   111111111       00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                           ...+...+..+.+++.+||+.||++|||+.+++++|+++...
T Consensus       226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          226 -----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                 111222345589999999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.5e-48  Score=352.37  Aligned_cols=274  Identities=20%  Similarity=0.290  Sum_probs=215.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC--EEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK--HRFL  137 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l  137 (361)
                      ++|.+.+.||+|+||+||+|.+. +|+.||||++.....  ......+.+|+.+++.++||||+++++++....  ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            46889999999999999999987 599999999865422  233567788999999999999999999998755  7899


Q ss_pred             EEEecCCCchhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee----CCCCcEEEeecC
Q 018047          138 VYEYMQKGNLQDHLNGIG-EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL----SANFEAKISDFG  212 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill----~~~~~~kl~Dfg  212 (361)
                      ||||+++|+|.+++.... ...+++..++.++.|++.||+|||++|     |+||||||+|||+    +.++.+||+|||
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            999999999999997643 234999999999999999999999999     9999999999999    778889999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCccccc--------CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTS--------TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  284 (361)
                      ++..+.....   .....||+.|+|||++.        ...++.++|||||||++|||++|+.||........  ....+
T Consensus       162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~  236 (319)
T 4euu_A          162 AARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVM  236 (319)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHH
T ss_pred             CceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHH
Confidence            9987755432   23356899999999875        57789999999999999999999999965433221  12222


Q ss_pred             HHHhhhhhh--hh---h-------hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          285 RHILNDRKK--LR---K-------VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       285 ~~~~~~~~~--~~---~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      .........  ..   .       +..............+..+.+++.+||+.||++|||++|++++..+..-.
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            222211100  00   0       00000111345678888999999999999999999999999999976543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-48  Score=358.81  Aligned_cols=259  Identities=22%  Similarity=0.324  Sum_probs=210.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ++|+..+.||+|+||+||+|+.+ +++.||+|++.+...........+.+|..++..+ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            35888999999999999999987 6899999999876555556667788999999988 899999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++++||+|||+++...
T Consensus        89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999999997643  6999999999999999999999999     9999999999999999999999999998643


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc---hhHHHHHHHHhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND---QNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~  295 (361)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........   .........+....    
T Consensus       162 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----  235 (345)
T 3a8x_A          162 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  235 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred             CCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence            2221  23446799999999999999999999999999999999999999964322111   11111111111111    


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSM------AECVKELQ  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~ell~~l~  341 (361)
                               ...+...+..+.+|+.+||+.||++||++      .|+++|-+
T Consensus       236 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~  278 (345)
T 3a8x_A          236 ---------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  278 (345)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence                     11222344568999999999999999995      78887754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4e-49  Score=359.87  Aligned_cols=263  Identities=24%  Similarity=0.371  Sum_probs=215.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  133 (361)
                      .++|.+.+.||+|+||.||+|.+.      ++..||+|++...  ........+.+|+.+++.++||||+++++++.+++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            456888999999999999999862      3578999998643  23445677889999999999999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEec
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGE----------------------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHR  191 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~  191 (361)
                      ..++||||+++|+|.+++.....                      ..+++..++.++.|++.||+|||++|     ++||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~  174 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHR  174 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-----EECC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-----Cccc
Confidence            99999999999999999976432                      24889999999999999999999999     9999


Q ss_pred             CCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 018047          192 DFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVD  270 (361)
Q Consensus       192 Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~  270 (361)
                      ||||+|||++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987755443333334567889999999988889999999999999999999 999996


Q ss_pred             CCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          271 LNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ....   ......+.   .. .      .     ...+...+..+.+++.+||+.||++|||+.+++++|++++...
T Consensus       255 ~~~~---~~~~~~~~---~~-~------~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  313 (314)
T 2ivs_A          255 GIPP---ERLFNLLK---TG-H------R-----MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR  313 (314)
T ss_dssp             TCCG---GGHHHHHH---TT-C------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCH---HHHHHHhh---cC-C------c-----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence            4332   11111111   00 0      0     1122234456899999999999999999999999999998753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3e-48  Score=361.43  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=210.0

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ..++|++.+.||+|+||+||+|.+. +|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3456999999999999999999987 6899999999765432 3445678899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC---CcEEEeecCcc
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN---FEAKISDFGLA  214 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~  214 (361)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.+   +.+||+|||++
T Consensus       106 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            99999999999998764  36899999999999999999999999     9999999999999865   45999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ........   .....||+.|+|||++....++.++|||||||++|+|++|..||....   .....   ..+......+
T Consensus       179 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~---~~i~~~~~~~  249 (362)
T 2bdw_A          179 IEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY---AQIKAGAYDY  249 (362)
T ss_dssp             BCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHHHTCCCC
T ss_pred             eEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHH---HHHHhCCCCC
Confidence            87754332   234579999999999998899999999999999999999999996432   11121   1111111100


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .         .......+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       250 ~---------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  287 (362)
T 2bdw_A          250 P---------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  287 (362)
T ss_dssp             C---------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred             C---------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            0         0001123455899999999999999999999999866

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.7e-48  Score=355.18  Aligned_cols=264  Identities=23%  Similarity=0.375  Sum_probs=213.5

Q ss_pred             cccCHHHHHHHcCC----------CCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc
Q 018047           49 SVFTLKEMEEATCS----------FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL  117 (361)
Q Consensus        49 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l  117 (361)
                      ..++.+++..+...          |...+.||+|+||+||+|... +|+.||||++....   ....+.+.+|+.+++.+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l   99 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDY   99 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhC
Confidence            34666666665543          566678999999999999987 79999999997542   23456788999999999


Q ss_pred             CCCcceeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCC
Q 018047          118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       118 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~N  197 (361)
                      +||||+++++++...+..++||||+++|+|.+++...   .+++..+..++.|++.||+|||++|     ++||||||+|
T Consensus       100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~N  171 (321)
T 2c30_A          100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG-----VIHRDIKSDS  171 (321)
T ss_dssp             CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGG
T ss_pred             CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHH
Confidence            9999999999999999999999999999999998653   6999999999999999999999999     9999999999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND  277 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  277 (361)
                      ||++.++.+||+|||++........  ......||+.|+|||++....++.++||||||+++|+|++|+.||.....   
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---  246 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---  246 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---
T ss_pred             EEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence            9999999999999999987654322  22345799999999999989999999999999999999999999964321   


Q ss_pred             hhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          278 QNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         .........       ...+.+   ......+..+.+++.+||+.||++|||+.|++++.+
T Consensus       247 ---~~~~~~~~~-------~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          247 ---VQAMKRLRD-------SPPPKL---KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             ---HHHHHHHHH-------SSCCCC---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             ---HHHHHHHhc-------CCCCCc---CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence               111111111       111111   111223456899999999999999999999999865

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.8e-48  Score=369.34  Aligned_cols=257  Identities=23%  Similarity=0.296  Sum_probs=208.7

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|... +|+.+|+|++..... .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            456999999999999999999976 799999999976543 233456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC---CCCcEEEeecCccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS---ANFEAKISDFGLAK  215 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~~  215 (361)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||++|     |+||||||+|||++   .++.+||+|||++.
T Consensus        89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g-----ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG-----VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999999997643  6999999999999999999999999     99999999999998   46889999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .......  ......||+.|+|||++....++.++|||||||++|+|++|..||....   .....   ..+......+.
T Consensus       162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~---~~i~~~~~~~~  233 (444)
T 3soa_A          162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLY---QQIKAGAYDFP  233 (444)
T ss_dssp             CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH---HHHHHTCCCCC
T ss_pred             EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHH---HHHHhCCCCCC
Confidence            7654332  2234579999999999998899999999999999999999999995332   22222   22111111110


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                               .......+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       234 ---------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~  270 (444)
T 3soa_A          234 ---------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW  270 (444)
T ss_dssp             ---------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred             ---------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence                     0011123455899999999999999999999999865

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=364.04  Aligned_cols=268  Identities=24%  Similarity=0.351  Sum_probs=217.5

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc--------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR--------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYC  129 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  129 (361)
                      ..++|.+.+.||+|+||+||+|.+.        .+..||||++...  ........+.+|+++++.+ +||||+++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3457888999999999999999863        2357999998654  3344557788999999999 899999999999


Q ss_pred             EcCCEEEEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCC
Q 018047          130 ADGKHRFLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKS  195 (361)
Q Consensus       130 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp  195 (361)
                      .+++..++||||+++|+|.+++....              ...+++..++.++.|++.||+|||++|     |+||||||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp  219 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAA  219 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCc
Confidence            99999999999999999999997643              235999999999999999999999999     99999999


Q ss_pred             CCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 018047          196 TNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQG  274 (361)
Q Consensus       196 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~  274 (361)
                      +|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.... 
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-  298 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-  298 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence            999999999999999999987754433223334467889999999989999999999999999999999 999995332 


Q ss_pred             CCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 018047          275 VNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGL  351 (361)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~  351 (361)
                        ...   ........       ..     ...+...+..+.+|+.+||+.||++|||+.|++++|++++.......
T Consensus       299 --~~~---~~~~~~~~-------~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          299 --VEE---LFKLLKEG-------HR-----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             --HHH---HHHHHHTT-------CC-----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             --HHH---HHHHHHcC-------CC-----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence              111   11111111       00     11122334568999999999999999999999999999987765443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.3e-49  Score=363.26  Aligned_cols=256  Identities=27%  Similarity=0.357  Sum_probs=208.7

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  135 (361)
                      ...++|.+.+.||+|+||+||+|+++ +|+.||||++.+...........+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34567999999999999999999987 6899999999754322233456677899999887 899999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |+||||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+++
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG-----IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            99999999999999997643  6999999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||....   ..   .....+....    
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~---~~~~~i~~~~----  234 (345)
T 1xjd_A          167 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EE---ELFHSIRMDN----  234 (345)
T ss_dssp             CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHCC----
T ss_pred             hcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HH---HHHHHHHhCC----
Confidence            6533222  2345679999999999999999999999999999999999999996432   11   1122221111    


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMA-ECVKELQ  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ell~~l~  341 (361)
                               ..++...+..+.+|+.+||+.||++||++. ++++|.+
T Consensus       235 ---------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~  272 (345)
T 1xjd_A          235 ---------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL  272 (345)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             ---------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence                     111222345689999999999999999998 7876643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.1e-49  Score=371.47  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=210.1

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      ....++|++.+.||+|+||+||+|+++ +++.||+|++.+...........+.+|+.++..++||||+++++++.+++.+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            334578999999999999999999987 6899999998653222222334577899999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |+||||+++|+|.+++...   .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.
T Consensus       145 ~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999753   5899999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGK----LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      .+..... ......+||+.|+|||++....    ++.++|||||||++|||++|+.||....      .......+....
T Consensus       217 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~  289 (410)
T 3v8s_A          217 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMNHK  289 (410)
T ss_dssp             ECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTHH
T ss_pred             eeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhhHHHHHHhcc
Confidence            7654432 2233568999999999887655    7889999999999999999999996332      122222222211


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSE--RPSMAECVKELQ  341 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~l~  341 (361)
                      ..+.   .+.      ....+..+.+||.+||+.+|.+  ||+++|+++|.+
T Consensus       290 ~~~~---~p~------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~  332 (410)
T 3v8s_A          290 NSLT---FPD------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  332 (410)
T ss_dssp             HHCC---CCT------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred             cccc---CCC------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence            1110   010      0122345899999999999988  999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.3e-48  Score=360.41  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=210.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||+||+|+.. +|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            46889999999999999999987 69999999997543333344567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.....
T Consensus       121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999997643  6999999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..     ...+||+.|+|||++....++.++|||||||++|+|++|+.||....   .   ......+.....       
T Consensus       194 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~---~~~~~~i~~~~~-------  255 (350)
T 1rdq_E          194 RT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---P---IQIYEKIVSGKV-------  255 (350)
T ss_dssp             CB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHHCCC-------
T ss_pred             Cc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---H---HHHHHHHHcCCC-------
Confidence            32     23578999999999999999999999999999999999999996432   1   112222222111       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                            ..+...+..+.+|+.+||+.||++||+     ++++++|-+
T Consensus       256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~  296 (350)
T 1rdq_E          256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence                  112233456899999999999999998     999998865

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.3e-48  Score=354.70  Aligned_cols=266  Identities=25%  Similarity=0.385  Sum_probs=217.4

Q ss_pred             cCCCCCCceecccCceEEEEEEE------cCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTL------RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADG  132 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  132 (361)
                      .++|...+.||+|+||+||+|.+      .+++.||+|++...  ........+.+|+.++..+ +||||+++++++.++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            35688999999999999999985      24678999998654  2234457788999999999 899999999999999


Q ss_pred             CEEEEEEEecCCCchhhhcccCCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGE----------------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKST  196 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~  196 (361)
                      +..++||||+++|+|.+++.....                ..+++..++.++.|++.||+|||++|     ++||||||+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~  174 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAAR  174 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGG
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCccc
Confidence            999999999999999999976532                24899999999999999999999999     999999999


Q ss_pred             CeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 018047          197 NVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGV  275 (361)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~  275 (361)
                      ||+++.++.+||+|||++................||+.|+|||++....++.++||||||+++|+|++ |..||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999987765544333444567889999999988899999999999999999999 99999643321


Q ss_pred             CchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          276 NDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                        ......+.    .      ...     ...+...+..+.+++.+||+.||.+|||+.|++++|++++.+...
T Consensus       255 --~~~~~~~~----~------~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          255 --SKFYKMIK----E------GFR-----MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             --HHHHHHHH----H------TCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             --hHHHHHhc----c------CCC-----CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence              11111111    1      000     111223345689999999999999999999999999999876543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-48  Score=361.36  Aligned_cols=268  Identities=24%  Similarity=0.369  Sum_probs=211.2

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD  131 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  131 (361)
                      ..++|.+.+.||+|+||+||+|.+.      ++..||+|++....  .......+.+|+.++..+ +||||+++++++.+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            3467899999999999999999962      35689999996432  233456788999999999 89999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEe
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGE---------------------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVH  190 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH  190 (361)
                      .+..++||||+++|+|.+++.....                     ..+++..++.++.|++.||+|||++|     |+|
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH  195 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVH  195 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-----EEE
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----ccc
Confidence            9999999999999999999976532                     23799999999999999999999999     999


Q ss_pred             cCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 018047          191 RDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAV  269 (361)
Q Consensus       191 ~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~  269 (361)
                      |||||+|||++.++.+||+|||++................||+.|+|||++....++.++||||||+++|+|+| |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            99999999999999999999999987654443333444567889999999988899999999999999999998 99999


Q ss_pred             CCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          270 DLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                      ......  ......    ....      ..     ...+...+..+.+|+.+||+.||.+|||+.+++++|+.++...+.
T Consensus       276 ~~~~~~--~~~~~~----~~~~------~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          276 PGIPVD--ANFYKL----IQNG------FK-----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             TTCCCS--HHHHHH----HHTT------CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             ccCCcH--HHHHHH----HhcC------CC-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            654321  111111    1110      01     111223345699999999999999999999999999998877654


Q ss_pred             C
Q 018047          350 G  350 (361)
Q Consensus       350 ~  350 (361)
                      .
T Consensus       339 ~  339 (344)
T 1rjb_A          339 A  339 (344)
T ss_dssp             -
T ss_pred             H
Confidence            4

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.6e-48  Score=349.55  Aligned_cols=259  Identities=24%  Similarity=0.375  Sum_probs=209.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .++|++.+.||+|+||+||++.+.++..||+|++....    .....+.+|+.++..++||||+++++++.+.+..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC----CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            34688899999999999999999888899999997432    23456889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||++|     ++||||||+||+++.++.+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           99 EYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            9999999999997632 36999999999999999999999999     99999999999999999999999999987643


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .... ......+|+.|+|||.+....++.++||||||+++|+|++ |+.||.....   .   .........       .
T Consensus       173 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~---~~~~~~~~~-------~  238 (283)
T 3gen_A          173 DEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---S---ETAEHIAQG-------L  238 (283)
T ss_dssp             HHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---H---HHHHHHHTT-------C
T ss_pred             cccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---h---HHHHHHhcc-------c
Confidence            3211 1222346788999999988889999999999999999998 9999954321   1   111111111       0


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      .     ...+...+..+.+++.+||+.||++|||+.+++++|++++...
T Consensus       239 ~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          239 R-----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             C-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             C-----CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            0     1112222456899999999999999999999999999998764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.7e-47  Score=345.26  Aligned_cols=272  Identities=18%  Similarity=0.206  Sum_probs=218.8

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  137 (361)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++....     ....+.+|+.+++.+ +|+|++++++++.++...++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            457999999999999999999975 79999999986432     223577899999999 79999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc-----EEEeecC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE-----AKISDFG  212 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~-----~kl~Dfg  212 (361)
                      ||||+ +++|.+++...+ ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.     +||+|||
T Consensus        84 v~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS-----LVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            99999 999999998653 36999999999999999999999999     999999999999987776     9999999


Q ss_pred             ccccCCCCCce-----eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 018047          213 LAKLMPEGQET-----YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       213 ~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      ++.........     .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..............+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            99876543321     1123457999999999999889999999999999999999999999765443333333222211


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMP  354 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~  354 (361)
                      ... ..... +.     .    ..+..+.+++.+||+.||++|||++++++.|++++.......+.+
T Consensus       237 ~~~-~~~~~-~~-----~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~  292 (298)
T 1csn_A          237 KQS-TPLRE-LC-----A----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN  292 (298)
T ss_dssp             HHH-SCHHH-HT-----T----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSC
T ss_pred             ccC-ccHHH-HH-----h----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCc
Confidence            110 00100 00     1    123458999999999999999999999999999998776554443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.2e-48  Score=349.84  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=200.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc-----------------------hhHHHHHHHHHHHH
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA-----------------------DGEHEFRVEVDILS  115 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~  115 (361)
                      .++|++.+.||+|+||+||+|.+. +++.||||++........                       .....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            357999999999999999999976 689999999976432211                       12356888999999


Q ss_pred             hcCCCcceeEEEEEEc--CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCC
Q 018047          116 RLDHPNLVSLIGYCAD--GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDF  193 (361)
Q Consensus       116 ~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Di  193 (361)
                      .++||||+++++++.+  .+..|+||||+++|+|.+++..   ..+++..+..++.|++.||+|||++|     ++||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK-----IIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCC
Confidence            9999999999999987  5689999999999999997654   37999999999999999999999999     999999


Q ss_pred             CCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCC---CCccchhHHHHHHHHHHHhCCCCCC
Q 018047          194 KSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK---LTLQSDVYAFGVVLLELLTGRRAVD  270 (361)
Q Consensus       194 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~  270 (361)
                      ||+|||++.++.+||+|||++..+.....  ......||+.|+|||++....   ++.++|||||||++|+|++|+.||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999999987754332  233457999999999887654   3778999999999999999999995


Q ss_pred             CCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          271 LNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...      .............        ..   ......+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       242 ~~~------~~~~~~~~~~~~~--------~~---~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~  295 (298)
T 2zv2_A          242 DER------IMCLHSKIKSQAL--------EF---PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW  295 (298)
T ss_dssp             CSS------HHHHHHHHHHCCC--------CC---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred             Ccc------HHHHHHHHhcccC--------CC---CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence            321      1111111111100        00   001123345899999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.7e-48  Score=346.68  Aligned_cols=258  Identities=24%  Similarity=0.386  Sum_probs=210.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .++|++.+.||+|+||+||+|.+.++..||+|++....    .....+.+|+.++..++||||+++++++.+++..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS----MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT----BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC----CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            34688899999999999999998888899999996432    23456889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++...+ ..+++..++.++.|++.||+|||++|     ++||||||+||+++.++.++|+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT-----EEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCcCcceEEECCCCCEEEccCccceecch
Confidence            9999999999997642 35999999999999999999999999     99999999999999999999999999987755


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .... ......+|+.|+|||.+....++.++||||||+++|+|++ |..||.....   ...   ........       
T Consensus       157 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~---~~~~~~~~-------  222 (268)
T 3sxs_A          157 DQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEV---VLKVSQGH-------  222 (268)
T ss_dssp             TCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHH---HHHHHTTC-------
T ss_pred             hhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHH---HHHHHcCC-------
Confidence            4322 2223456778999999988889999999999999999999 9999953321   111   11111110       


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                       .    ...+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus       223 -~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          223 -R----LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -C----CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -C----CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence             0    111122344589999999999999999999999999987544

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.6e-48  Score=363.35  Aligned_cols=262  Identities=28%  Similarity=0.469  Sum_probs=201.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      .+|.+.+.||+|+||+||+|++.    ++..||||++...  ........+.+|+.++.+++||||+++++++.+++..+
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            46999999999999999999865    4678999998653  23445677899999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++|+|.+++... ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++..
T Consensus       123 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999999764 347999999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCcee-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          217 MPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       217 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ........ ......+++.|+|||++....++.++||||||+++|||++ |+.||....   .......   .... .  
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~~~~~---i~~~-~--  267 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQDVIKA---VDEG-Y--  267 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHHHHHH---HHTT-E--
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH---HHcC-C--
Confidence            65432211 1122345778999999988999999999999999999998 999995332   1111111   1110 0  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                               ....+..++..+.+++.+||+.||++|||+.++++.|+.++.+..
T Consensus       268 ---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          268 ---------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             ---------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             ---------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence                     011122345668999999999999999999999999999987643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.4e-48  Score=353.90  Aligned_cols=271  Identities=22%  Similarity=0.306  Sum_probs=206.4

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ...++|++.+.||+|+||+||+|.+.+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+++..++
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            4456799999999999999999999889999999986543 223335678889999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++ +|.+++... ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++...
T Consensus        97 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR-----ILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             EEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             EEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCchHhEEECCCCCEEEccCcCceec
Confidence            9999975 888887654 346999999999999999999999999     999999999999999999999999999876


Q ss_pred             CCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh---
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK---  293 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  293 (361)
                      .....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........   ...+.........   
T Consensus       170 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~  244 (311)
T 3niz_A          170 GIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREW  244 (311)
T ss_dssp             TSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTS
T ss_pred             CCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHh
Confidence            43322  2233568999999998765 5689999999999999999999999975543322   2222221111000   


Q ss_pred             -----hhhhcCcccc-CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          294 -----LRKVIDPELS-RSSYT-----MESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       294 -----~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           +......... ....+     ...+.++.+|+.+||+.||++|||+.|+++|-+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  303 (311)
T 3niz_A          245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY  303 (311)
T ss_dssp             GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence                 0000000000 00000     112346889999999999999999999998743

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-47  Score=352.19  Aligned_cols=265  Identities=18%  Similarity=0.203  Sum_probs=213.2

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  137 (361)
                      .++|++.+.||+|+||+||+|... +|+.||||++.....     ...+.+|+.+++.+ +||||+++++++.+++..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            357999999999999999999975 789999999865421     23577899999999 89999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc-----EEEeecC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE-----AKISDFG  212 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~-----~kl~Dfg  212 (361)
                      ||||+ +++|.+++... ...+++..++.++.|++.||+|||++|     |+||||||+|||++.++.     +||+|||
T Consensus        83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-----iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN-----LIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             EEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            99999 89999999764 347999999999999999999999999     999999999999999887     9999999


Q ss_pred             ccccCCCCCcee-----eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 018047          213 LAKLMPEGQETY-----VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       213 ~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      ++..+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence            998764433211     123467999999999999999999999999999999999999999765433222222222111


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      ...  .......     .    ..+ .+.+++..||+.||.+||+++++++.|++++.+..
T Consensus       236 ~~~--~~~~~~~-----~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          236 KRA--TPIEVLC-----E----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HHH--SCHHHHT-----T----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hcc--CCHHHHh-----c----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            100  0000000     1    112 58999999999999999999999999999887653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.7e-48  Score=358.81  Aligned_cols=258  Identities=23%  Similarity=0.339  Sum_probs=206.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCC--cchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFK--EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      +.|++.+.||+|+||+||+|.+. +|+.||||++......  .......+.+|+.+++.++||||+++++++.+++..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46999999999999999999987 6999999998653211  11235678899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc---EEEeecC
Q 018047          138 VYEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE---AKISDFG  212 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~---~kl~Dfg  212 (361)
                      ||||+++|+|.+++...  ....+++..+..++.|++.||+|||+++     |+||||||+|||++.++.   +||+|||
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-----IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999887543  2335899999999999999999999999     999999999999987654   9999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ++........  ......||+.|+|||++....++.++|||||||++|+|++|..||....    ..   ..........
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~---~~~~i~~~~~  249 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ER---LFEGIIKGKY  249 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HH---HHHHHHHTCC
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HH---HHHHHHcCCC
Confidence            9987754332  2334579999999999998899999999999999999999999996421    11   1111111111


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..    .+... .    ..+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       250 ~~----~~~~~-~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~  289 (351)
T 3c0i_A          250 KM----NPRQW-S----HISESAKDLVRRMLMLDPAERITVYEALNHPW  289 (351)
T ss_dssp             CC----CHHHH-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             CC----Ccccc-c----cCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence            00    00000 0    12345899999999999999999999998865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-48  Score=359.18  Aligned_cols=267  Identities=27%  Similarity=0.444  Sum_probs=214.0

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA  130 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  130 (361)
                      ....++|++.+.||+|+||+||+|.+.      +++.||+|++...  ........+.+|+.+++.++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            344578999999999999999999975      2478999998643  23345677899999999999999999999999


Q ss_pred             cCCEEEEEEEecCCCchhhhcccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCe
Q 018047          131 DGKHRFLVYEYMQKGNLQDHLNGIG----------------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI  188 (361)
Q Consensus       131 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i  188 (361)
                      +++..++||||+++|+|.+++....                      ...+++..++.++.|++.||+|||++|     +
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----i  195 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----F  195 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----C
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----e
Confidence            9999999999999999999997642                      157899999999999999999999999     9


Q ss_pred             EecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCC
Q 018047          189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR  267 (361)
Q Consensus       189 iH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~  267 (361)
                      +||||||+|||++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|+|++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999986643332223334567899999999988889999999999999999999 999


Q ss_pred             CCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          268 AVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       268 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ||....   .....   ......          ..  ...+...+..+.+++.+||+.||++|||+.+++++|+++....
T Consensus       276 p~~~~~---~~~~~---~~~~~~----------~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          276 PYYGMA---HEEVI---YYVRDG----------NI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             TTTTSC---HHHHH---HHHHTT----------CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             cCCCCC---hHHHH---HHHhCC----------Cc--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            995322   11111   111111          00  1122334456999999999999999999999999999987654


Q ss_pred             C
Q 018047          348 S  348 (361)
Q Consensus       348 ~  348 (361)
                      .
T Consensus       338 ~  338 (343)
T 1luf_A          338 E  338 (343)
T ss_dssp             -
T ss_pred             h
Confidence            4

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.3e-48  Score=370.37  Aligned_cols=252  Identities=25%  Similarity=0.381  Sum_probs=209.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+++.||+|+||+||+|.+. +|+.||||++.............+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46899999999999999999987 79999999997543223334567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.....
T Consensus        96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM-----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999764  37999999999999999999999999     99999999999999999999999999987754


Q ss_pred             CCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      +.   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....   .   .....+.....      
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~---~~~~~i~~~~~------  233 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---P---TLFKKICDGIF------  233 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---H---HHHHHHHTTCC------
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---H---HHHHHHhcCCc------
Confidence            43   2334579999999999887765 6899999999999999999999964321   1   11222211110      


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                             ..+...+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       234 -------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~  269 (476)
T 2y94_A          234 -------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW  269 (476)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             -------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence                   111223345899999999999999999999999866

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=365.44  Aligned_cols=264  Identities=25%  Similarity=0.375  Sum_probs=211.2

Q ss_pred             cCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  133 (361)
                      .++|++.+.||+|+||+||+|.+.      ++..||||++...  ........+.+|+.+++.++||||+++++++.+.+
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            356889999999999999999843      4678999998532  33445567888999999999999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC---c
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIG-----EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF---E  205 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~---~  205 (361)
                      ..++||||+++|+|.+++....     ...+++..++.++.|++.||+|||++|     |+||||||+|||++.++   .
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCC
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChhhEEEecCCCCce
Confidence            9999999999999999997542     246899999999999999999999999     99999999999999555   5


Q ss_pred             EEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHH
Q 018047          206 AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~  284 (361)
                      +||+|||+++.+.............||+.|+|||++....++.++|||||||++|||++ |..||....   ....   .
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~---~  296 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEV---L  296 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHH---H
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHH---H
Confidence            99999999975432222222334567899999999988899999999999999999998 999995432   1111   1


Q ss_pred             HHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      .......       .     ...+..++..+.+|+.+||+.||++|||+.+++++|+.+.....
T Consensus       297 ~~i~~~~-------~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          297 EFVTSGG-------R-----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             HHHHTTC-------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             HHHHcCC-------C-----CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            1111110       0     11122334568999999999999999999999999998876554

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.6e-48  Score=377.51  Aligned_cols=259  Identities=30%  Similarity=0.408  Sum_probs=214.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|+..++||+|+||.||+|... +|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888999999999999999987 7999999999764333334456788899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++...+...+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+||+|||++..+.
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g-----IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER-----IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999998766556999999999999999999999999     9999999999999999999999999998775


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....   ....+||+.|+|||++.+..++.++|||||||++|||++|..||.............  ..+...        
T Consensus       338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~--~~i~~~--------  404 (576)
T 2acx_A          338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--RLVKEV--------  404 (576)
T ss_dssp             TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH--HHHHHC--------
T ss_pred             cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH--HHhhcc--------
Confidence            5432   233579999999999998899999999999999999999999997544322211111  111111        


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                      .     ..++...+..+.+|+.+||+.||.+||     ++.|+++|-+
T Consensus       405 ~-----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf  447 (576)
T 2acx_A          405 P-----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL  447 (576)
T ss_dssp             C-----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred             c-----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence            0     112223345689999999999999999     7899998854

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.7e-48  Score=359.25  Aligned_cols=254  Identities=25%  Similarity=0.330  Sum_probs=209.1

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  137 (361)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++.+...........+..|..++..+ +||||+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            457999999999999999999987 5889999999764332334456778899999988 79999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++...
T Consensus        99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            999999999999997643  6999999999999999999999999     999999999999999999999999999864


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....  .....+||+.|+|||++....++.++|||||||++|||++|+.||....   .   ......+.....     
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~---~~~~~~i~~~~~-----  238 (353)
T 2i0e_A          172 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---E---DELFQSIMEHNV-----  238 (353)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHHCCC-----
T ss_pred             ccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---H---HHHHHHHHhCCC-----
Confidence            32221  2344679999999999999999999999999999999999999996432   1   122222222111     


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                              .++...+..+.+|+.+||+.||++||+     +.++++|.+
T Consensus       239 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~  279 (353)
T 2i0e_A          239 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  279 (353)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred             --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence                    122234456899999999999999995     688888753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-48  Score=372.02  Aligned_cols=266  Identities=22%  Similarity=0.323  Sum_probs=212.0

Q ss_pred             HHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC
Q 018047           55 EMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK  133 (361)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  133 (361)
                      ++....++|++.++||+|+||+||+|+++ +++.||+|++.+...........+.+|+.++..++||||++++++|.+++
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            33445678999999999999999999987 58899999986532222223344788999999999999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..|+||||+++|+|.+++... ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEecccCHHHeeEcCCCCEEEcchhh
Confidence            999999999999999999764 247999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      +..+...... .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||....      .......+.
T Consensus       222 a~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~------~~~~~~~i~  294 (437)
T 4aw2_A          222 CLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIM  294 (437)
T ss_dssp             CEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHH
T ss_pred             hhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC------hhHHHHhhh
Confidence            9876544322 233467999999999886     5678999999999999999999999996432      112222222


Q ss_pred             hhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHH
Q 018047          289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSE--RPSMAECVKELQ  341 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~l~  341 (361)
                      .....+  .+ +.     .....+..+.+||++||+.+|++  ||+++|+++|.+
T Consensus       295 ~~~~~~--~~-p~-----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf  341 (437)
T 4aw2_A          295 NHKERF--QF-PT-----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF  341 (437)
T ss_dssp             THHHHC--CC-CS-----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred             hccccc--cC-Cc-----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence            211110  00 11     11123445899999999988888  999999999865

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-47  Score=358.28  Aligned_cols=255  Identities=22%  Similarity=0.310  Sum_probs=208.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .+.|++.+.||+|+||+||+|... +|+.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            357999999999999999999987 68999999987532   23345788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC--CCcEEEeecCcccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA--NFEAKISDFGLAKL  216 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~--~~~~kl~Dfg~~~~  216 (361)
                      |||+++|+|.+++... ...+++..+..++.|++.||+|||++|     |+||||||+|||++.  ++.+||+|||++..
T Consensus       127 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccchHHeEEecCCCCceEEEeccccee
Confidence            9999999999999754 346899999999999999999999999     999999999999984  47899999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +.....   .....||+.|+|||++....++.++|||||||++|+|++|..||....   ..   ............   
T Consensus       201 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~---~~~~~i~~~~~~---  268 (387)
T 1kob_A          201 LNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DL---ETLQNVKRCDWE---  268 (387)
T ss_dssp             CCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HH---HHHHHHHHCCCC---
T ss_pred             cCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HH---HHHHHHHhCCCC---
Confidence            754432   233479999999999998999999999999999999999999996432   11   111111111000   


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       .+     .......+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       269 -~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~  307 (387)
T 1kob_A          269 -FD-----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW  307 (387)
T ss_dssp             -CC-----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             -CC-----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence             01     1111223456899999999999999999999999854

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.5e-48  Score=357.17  Aligned_cols=259  Identities=27%  Similarity=0.410  Sum_probs=202.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCE----EEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEV----VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      ++|+..+.||+|+||+||+|.+. +++.    ||+|.+...  ........+.+|+.+++.++||||+++++++.++. .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            35888999999999999999975 4544    577776532  22344567889999999999999999999998765 7


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+++     |+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCChheEEECCCCCEEEccCccee
Confidence            79999999999999997643 47999999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+.............||+.|+|||++.+..++.++|||||||++|||++ |+.||.....   ......+.    ...  
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~----~~~--  236 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILE----KGE--  236 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHH----TTC--
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---HHHHHHHH----cCC--
Confidence            7755444333344567889999999999999999999999999999999 9999964332   11111111    000  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                               ....+...+..+.+++.+||+.||++|||+.+++++|+.+..+
T Consensus       237 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          237 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                     0112233445689999999999999999999999999998764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-47  Score=353.79  Aligned_cols=269  Identities=24%  Similarity=0.362  Sum_probs=214.5

Q ss_pred             cCCCCCCceecccCceEEEEEEEc--------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR--------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCA  130 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  130 (361)
                      .++|++.+.||+|+||+||+|.+.        ++..||+|++...  ........+.+|+.+++.+ +||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            356889999999999999999863        4678999998643  2334566788999999999 8999999999999


Q ss_pred             cCCEEEEEEEecCCCchhhhcccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCC
Q 018047          131 DGKHRFLVYEYMQKGNLQDHLNGIGE--------------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKST  196 (361)
Q Consensus       131 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~  196 (361)
                      +.+..++||||+++|+|.+++.....              ..+++..++.++.|++.||+|||++|     ++||||||+
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~  186 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAAR  186 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGG
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCccc
Confidence            99999999999999999999976431              34899999999999999999999999     999999999


Q ss_pred             CeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 018047          197 NVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGV  275 (361)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~  275 (361)
                      |||++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|+|++ |..||....  
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--  264 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--  264 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC--
Confidence            99999999999999999987765443333334457889999999988889999999999999999999 999995332  


Q ss_pred             CchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCC
Q 018047          276 NDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNM  353 (361)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~  353 (361)
                       .......   ....       ..     ...+...+..+.+++.+||+.||.+|||+.|++++|++++.........
T Consensus       265 -~~~~~~~---~~~~-------~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~~  326 (334)
T 2pvf_A          265 -VEELFKL---LKEG-------HR-----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYL  326 (334)
T ss_dssp             -HHHHHHH---HHHT-------CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-----
T ss_pred             -HHHHHHH---HhcC-------CC-----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCccc
Confidence             1111111   1111       00     1112233456899999999999999999999999999998876554433

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.9e-49  Score=370.05  Aligned_cols=266  Identities=22%  Similarity=0.265  Sum_probs=210.9

Q ss_pred             HHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC
Q 018047           54 KEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG  132 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  132 (361)
                      .+.....++|++.+.||+|+||+||+|+.+ +|+.||||++.+...........+.+|..++..++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            334445678999999999999999999987 7999999999753222233345578899999999999999999999999


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      +..|+||||+++|+|.+++...+ ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++++||+|||
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG-----YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccCHHHeeecCCCCEEEeech
Confidence            99999999999999999997643 37999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCccccc-------CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTS-------TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      ++..+...... .....+||+.|+|||++.       ...++.++|||||||++|||++|+.||.....      .....
T Consensus       208 la~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~  280 (412)
T 2vd5_A          208 SCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AETYG  280 (412)
T ss_dssp             TCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHH
T ss_pred             hheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HHHHH
Confidence            99877543321 223457999999999876       45789999999999999999999999964321      11122


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSER---PSMAECVKELQ  341 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---pt~~ell~~l~  341 (361)
                      .+......+   ..+     ..+...+..+.+||.+||+ +|.+|   |+++|+++|-+
T Consensus       281 ~i~~~~~~~---~~p-----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf  330 (412)
T 2vd5_A          281 KIVHYKEHL---SLP-----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF  330 (412)
T ss_dssp             HHHTHHHHC---CCC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred             HHHhcccCc---CCC-----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence            222111100   001     1112234568999999999 99998   69999998865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-48  Score=374.24  Aligned_cols=266  Identities=26%  Similarity=0.422  Sum_probs=215.1

Q ss_pred             HHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           55 EMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      ..+...++|.+.+.||+|+||+||+|.+.++..||||++....    ...+.+.+|+.+|+.++||||+++++++. .+.
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence            3344456788899999999999999999888899999997432    34668899999999999999999999986 567


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .|+||||+++|+|.+++.......+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-----YIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            899999999999999997654446899999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      +........ ......+++.|+|||++....++.++||||||+++|||++ |+.||....   .......+.   ..   
T Consensus       332 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~---~~---  401 (454)
T 1qcf_A          332 RVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALE---RG---  401 (454)
T ss_dssp             GGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHH---HT---
T ss_pred             eEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH---cC---
Confidence            876432211 1122346788999999988899999999999999999999 999995322   112211111   11   


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                          ..     ...+..++..+.+|+.+||+.||++|||++++++.|+.+......
T Consensus       402 ----~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~  448 (454)
T 1qcf_A          402 ----YR-----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES  448 (454)
T ss_dssp             ----CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred             ----CC-----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence                00     112233456699999999999999999999999999988765443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.4e-48  Score=348.75  Aligned_cols=266  Identities=28%  Similarity=0.439  Sum_probs=206.5

Q ss_pred             CCCCCCceecccCceEEEEEEE----c-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTL----R-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~----~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~  133 (361)
                      ++|++.+.||+|+||+||+|++    . +++.||||++...   .......+.+|+.+++.++||||+++++++..  ..
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            4688999999999999999984    2 5889999998642   34455678899999999999999999999865  35


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++     ++||||||+|||++.++.+||+|||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHhhEEEcCCCeEEEccCcc
Confidence            6899999999999999997643 35999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCce-eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC---------CCchhHHHH
Q 018047          214 AKLMPEGQET-YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG---------VNDQNLVLQ  283 (361)
Q Consensus       214 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---------~~~~~~~~~  283 (361)
                      +......... .......++..|+|||.+....++.++||||||+++|+|++|..|+.....         .........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            9876543322 122234567889999999889999999999999999999999999853211         000000001


Q ss_pred             HHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      .......          .. ....+..++..+.+|+.+||+.||++|||+.|+++.|+.+..+
T Consensus       241 ~~~~~~~----------~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          241 LIELLKN----------NG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHT----------TC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHhc----------cC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            1111100          00 1222334556799999999999999999999999999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-47  Score=359.93  Aligned_cols=273  Identities=18%  Similarity=0.265  Sum_probs=208.4

Q ss_pred             CCCCCCceeccc--CceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           61 CSFSDDNFLGKG--GFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        61 ~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ++|++.+.||+|  +||+||+|++. +|+.||||++..... .......+.+|+.+++.++||||+++++++.+++..|+
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            469999999999  99999999987 699999999976533 23456678889999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++|+|.+++.......+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||.+...
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG-----YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999998765567999999999999999999999999     999999999999999999999999998654


Q ss_pred             CCCCce-----eeeeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          218 PEGQET-----YVTARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       218 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      ......     .......||+.|+|||++..  ..++.++|||||||++|+|++|+.||........  ...........
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~  256 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPC  256 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCc
Confidence            322111     01122368999999999877  5789999999999999999999999965432211  11100000000


Q ss_pred             h---------------------hhhhhhc--------CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 R---------------------KKLRKVI--------DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ~---------------------~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .                     ..+...+        .........+...+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence            0                     0000000        0000011123334567999999999999999999999998843

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.8e-47  Score=344.52  Aligned_cols=269  Identities=22%  Similarity=0.322  Sum_probs=205.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            46889999999999999999987 689999999976542 3334567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++ +|.+++... ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~-----ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             ECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             ecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            99976 666665443 247999999999999999999999999     99999999999999999999999999987643


Q ss_pred             CCceeeeeecccccCccCcccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh-----h
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGK-LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK-----K  293 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~  293 (361)
                      ...  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....  .......+........     .
T Consensus       154 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          154 PVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTT
T ss_pred             ccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhh
Confidence            322  233457899999999887665 79999999999999999999888643321  2222222221111100     0


Q ss_pred             hhhhcC--------ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          294 LRKVID--------PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       294 ~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .....+        ............+..+.+|+.+||+.||++|||++|+++|-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  285 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence            000000        000001112234456899999999999999999999998743

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.9e-48  Score=347.54  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=217.0

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|++...    ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            3456888999999999999999987 5889999998632    3345678899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++++|.+++.......+++..++.++.|++.||+|||++|     ++|+||||+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT-----CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC-----ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999998766667999999999999999999999999     999999999999999999999999999877


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ...... ......+|+.|+|||.+....++.++||||||+++|+|++ |..||.....   ......+..          
T Consensus       162 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~---~~~~~~~~~----------  227 (288)
T 3kfa_A          162 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEK----------  227 (288)
T ss_dssp             CSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHT----------
T ss_pred             cCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc----------
Confidence            544322 2333457889999999988899999999999999999999 9999864322   111111110          


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ...     ...+...+..+.+|+.+||+.||.+|||+.++++.|+.++...
T Consensus       228 ~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          228 DYR-----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             TCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCC-----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            000     1122334456899999999999999999999999999887654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.8e-47  Score=356.15  Aligned_cols=255  Identities=24%  Similarity=0.290  Sum_probs=197.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+.+.||+|+||+||+++.. +++.||||++.....    ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            46999999999999999999987 799999999975422    2346778999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc--EEEeecCccccC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE--AKISDFGLAKLM  217 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~--~kl~Dfg~~~~~  217 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.  +||+|||++...
T Consensus        96 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~-----ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           96 EYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ-----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            9999999999997643  6999999999999999999999999     999999999999987765  999999999754


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQ-SDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ....   ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........  ....+.........+  
T Consensus       169 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~~~--  241 (361)
T 3uc3_A          169 VLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKYSI--  241 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCCCC--
T ss_pred             cccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCCCC--
Confidence            3222   2234579999999999888777655 8999999999999999999975443222  222222222111100  


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                            +   .....+..+.+|+.+||+.||++|||+.|+++|.+-
T Consensus       242 ------~---~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  278 (361)
T 3uc3_A          242 ------P---DDIRISPECCHLISRIFVADPATRISIPEIKTHSWF  278 (361)
T ss_dssp             ------C---TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred             ------C---CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence                  0   011123458999999999999999999999999764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.6e-48  Score=353.14  Aligned_cols=269  Identities=23%  Similarity=0.378  Sum_probs=197.1

Q ss_pred             HcCCCCCCceecccCceEEEEEEEcC-CC---EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLRS-GE---VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      ..++|++.+.||+|+||+||+|.+.. ++   .||||++..... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            34579999999999999999999763 33   799999865432 33446788999999999999999999999988765


Q ss_pred             E------EEEEEecCCCchhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC
Q 018047          135 R------FLVYEYMQKGNLQDHLNGIG----EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF  204 (361)
Q Consensus       135 ~------~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~  204 (361)
                      .      ++||||+++|+|.+++....    ...+++..++.++.|++.||+|||++|     ++||||||+|||++.++
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTS
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-----cccCCCCcceEEEcCCC
Confidence            5      99999999999999985422    225899999999999999999999999     99999999999999999


Q ss_pred             cEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 018047          205 EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQ  283 (361)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~  283 (361)
                      .+||+|||++................+++.|+|||.+....++.++|||||||++|+|++ |..||.....   ......
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~  251 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIYNY  251 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh---HHHHHH
Confidence            999999999987655443333334456889999999988899999999999999999999 8999964332   111111


Q ss_pred             HHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 018047          284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGL  351 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~  351 (361)
                         .....            ....+...+..+.+|+.+||+.||++|||+.++++.|++++.......
T Consensus       252 ---~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~  304 (323)
T 3qup_A          252 ---LIGGN------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS  304 (323)
T ss_dssp             ---HHTTC------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred             ---HhcCC------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence               11110            011222344568999999999999999999999999999988765443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.7e-47  Score=340.38  Aligned_cols=257  Identities=24%  Similarity=0.336  Sum_probs=209.7

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            467999999999999999999987 689999999976543 233456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc---EEEeecCccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAK  215 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~---~kl~Dfg~~~  215 (361)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+||+++.++.   +||+|||++.
T Consensus        84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            9999999999988764  36999999999999999999999999     999999999999987655   9999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .......   .....||+.|+|||++....++.++||||||+++|+|++|+.||....   .......+   ....... 
T Consensus       157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~---~~~~~~~-  226 (284)
T 3kk8_A          157 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQI---KAGAYDY-  226 (284)
T ss_dssp             ECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHTCCCC-
T ss_pred             EcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHH---HhccccC-
Confidence            7654332   233568999999999999999999999999999999999999995432   11111111   1111100 


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                          +    .......+..+.+|+.+||+.||++|||+.|+++|.+-
T Consensus       227 ----~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (284)
T 3kk8_A          227 ----P----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI  265 (284)
T ss_dssp             ----C----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred             ----C----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence                0    00111233558999999999999999999999998764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-47  Score=342.72  Aligned_cols=255  Identities=29%  Similarity=0.452  Sum_probs=207.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.+. ++..||+|++.............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            46888999999999999999987 57899999986543333334567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.++|+|||++.....
T Consensus        89 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~-----i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT-----CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999997643  6899999999999999999999999     99999999999999999999999999865533


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..    .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....      ............        
T Consensus       162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~--------  223 (279)
T 3fdn_A          162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISRVE--------  223 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTC--------
T ss_pred             cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc------HHHHHHHHHhCC--------
Confidence            22    233578999999999988899999999999999999999999996332      111111111110        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                           ...+...+..+.+|+.+||+.||++|||+.|+++|.+---.
T Consensus       224 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          224 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             -----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence                 11122234558899999999999999999999999874433

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.5e-48  Score=352.69  Aligned_cols=274  Identities=24%  Similarity=0.354  Sum_probs=218.9

Q ss_pred             cCHHHHHHHcCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcce
Q 018047           51 FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLV  123 (361)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv  123 (361)
                      +.........++|++.+.||+|+||+||+|.+.      +++.||||++...  ........+.+|+.++..+ +||||+
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv   94 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVV   94 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCee
Confidence            344455556678999999999999999999842      4688999998654  2334456788999999999 699999


Q ss_pred             eEEEEEEcCC-EEEEEEEecCCCchhhhcccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCe
Q 018047          124 SLIGYCADGK-HRFLVYEYMQKGNLQDHLNGIGE--------------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI  188 (361)
Q Consensus       124 ~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i  188 (361)
                      ++++++.+.+ ..++||||+++|+|.+++.....              ..+++..++.++.|++.||.|||++|     +
T Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i  169 (316)
T 2xir_A           95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----C  169 (316)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-----C
T ss_pred             eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-----c
Confidence            9999987754 58999999999999999976532              12889999999999999999999999     9


Q ss_pred             EecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCC
Q 018047          189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRR  267 (361)
Q Consensus       189 iH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~  267 (361)
                      +||||||+||+++.++.+||+|||++..+.............||+.|+|||++....++.++||||||+++|+|++ |..
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987755444333444567899999999988899999999999999999998 999


Q ss_pred             CCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          268 AVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       268 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ||......  ......+.   .. .      .     ...+...+..+.+++.+||+.||.+|||+.|++++|+.++..+
T Consensus       250 p~~~~~~~--~~~~~~~~---~~-~------~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          250 PYPGVKID--EEFCRRLK---EG-T------R-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             SSTTCCCS--HHHHHHHH---HT-C------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCcccchh--HHHHHHhc---cC-c------c-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            99643321  11111111   10 0      0     1112223455899999999999999999999999999998765


Q ss_pred             C
Q 018047          348 S  348 (361)
Q Consensus       348 ~  348 (361)
                      .
T Consensus       313 ~  313 (316)
T 2xir_A          313 A  313 (316)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-47  Score=349.59  Aligned_cols=269  Identities=22%  Similarity=0.345  Sum_probs=193.5

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|+..+.||+|+||+||+|... +|+.||+|++....  .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            357999999999999999999976 68999999997643  223345678899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          139 YEYMQKGNLQDHLNGIG----EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      |||++ |+|.+++....    ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-----ILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCChHHeEEcCCCCEEECcCccc
Confidence            99998 59999886431    235899999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-h
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-K  292 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~  292 (361)
                      ........  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....   ......+....... .
T Consensus       156 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~  230 (317)
T 2pmi_A          156 RAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLKLIFDIMGTPNE  230 (317)
T ss_dssp             EETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCT
T ss_pred             eecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCh
Confidence            87643322  2233568999999998865 4689999999999999999999999964332   22222222111100 0


Q ss_pred             hh----hh--hcCccccC-----------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 KL----RK--VIDPELSR-----------SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ~~----~~--~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..    ..  ...+.+..           .......+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~  296 (317)
T 2pmi_A          231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW  296 (317)
T ss_dssp             TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence            00    00  00000000           0001122356899999999999999999999999865

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.2e-48  Score=350.94  Aligned_cols=265  Identities=23%  Similarity=0.324  Sum_probs=201.2

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC----E
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK----H  134 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  134 (361)
                      .++|++.+.||+|+||+||+|.+. +++.||||++.............+.+|+.++..++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            457999999999999999999976 78999999997765555555678899999999999999999999987644    3


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .|+||||+++|+|.+++...+  .+++..++.++.|++.||+|||+++     ++||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            499999999999999997643  6999999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCce-eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          215 KLMPEGQET-YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       215 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      ..+...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      .............
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCC
Confidence            876543221 123345689999999999988999999999999999999999999954321      1111111111110


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-HHHHhh
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL-QLIIYT  346 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l-~~i~~~  346 (361)
                      .....         ....+..+.+++.+||+.||++||+..+++.+- .++...
T Consensus       238 ~~~~~---------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          238 PPSAR---------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             CHHHH---------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             Ccccc---------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            00000         111234589999999999999999766666554 444443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=354.45  Aligned_cols=258  Identities=21%  Similarity=0.336  Sum_probs=201.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC--CcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH--PNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~l  137 (361)
                      .+.|++.+.||+|+||+||++...+++.||||++.... ........+.+|+.++..++|  |||+++++++.+++..|+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            34689999999999999999998889999999997653 233445778899999999976  999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||| +.+|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++ ++.+||+|||++..+
T Consensus        87 v~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-----iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            999 5578999999874  37999999999999999999999999     99999999999997 678999999999877


Q ss_pred             CCCCceeeeeecccccCccCcccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTST-----------GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH  286 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  286 (361)
                      .............||+.|+|||++..           ..++.++|||||||++|+|++|+.||.....     .......
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~  232 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA  232 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHH
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHH
Confidence            55443333445679999999998754           6788999999999999999999999963221     1111111


Q ss_pred             HhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ..          ++... ...+...+..+.+|+.+||+.||++|||+.|+++|.+--
T Consensus       233 ~~----------~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          233 II----------DPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             HH----------CTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             Hh----------cCCcc-cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            11          11110 112222234589999999999999999999999998743

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.7e-48  Score=355.75  Aligned_cols=260  Identities=26%  Similarity=0.399  Sum_probs=204.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCE----EEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEV----VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      ++|++.+.||+|+||+||+|.+. +++.    ||+|.+....  .......+.+|+.++..++||||+++++++. ++..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            46888999999999999999976 4554    7777765432  2222345677999999999999999999986 4568


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||+++|+|.+++... ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT-----CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             EEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCccchheEEECCCCeEEECCCCccc
Confidence            8999999999999999764 237899999999999999999999999     9999999999999999999999999999


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+.............|++.|+|||++....++.++||||||+++|+|++ |..||......   .....+.   .. .. 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~---~~-~~-  235 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLLE---KG-ER-  235 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHHH---TT-CB-
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHHH---cC-CC-
Confidence            8765544444445668889999999988899999999999999999999 99999654321   1111111   10 00 


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                                ...+..++..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus       236 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          236 ----------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             ----------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             ----------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                      0111112233789999999999999999999999999987543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3e-47  Score=345.38  Aligned_cols=262  Identities=26%  Similarity=0.390  Sum_probs=203.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHh--cCCCcceeEEEEEEc----CC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR--LDHPNLVSLIGYCAD----GK  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~----~~  133 (361)
                      .++|++.+.||+|+||+||+|.+ +|+.||||++...      ....+..|.+++..  ++||||+++++++.+    ..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            45799999999999999999988 4899999998532      23455667777776  799999999998654    35


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCCCeEecCCCCCCeeeCCCCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH--------SSSAVGIPIVHRDFKSTNVLLSANFE  205 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~~~~~iiH~Dikp~Nill~~~~~  205 (361)
                      ..++||||+++|+|.++++.   ..+++..++.++.|++.||+|||        +++     ++||||||+|||++.++.
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-----ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-----IAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE-----EECSCCCGGGEEECTTSC
T ss_pred             eeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-----eecCCCChHhEEEcCCCC
Confidence            68999999999999999964   36999999999999999999999        888     999999999999999999


Q ss_pred             EEEeecCccccCCCCCcee--eeeecccccCccCcccccCC------CCCccchhHHHHHHHHHHHhC----------CC
Q 018047          206 AKISDFGLAKLMPEGQETY--VTARVLGTFGYFDPEYTSTG------KLTLQSDVYAFGVVLLELLTG----------RR  267 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~  267 (361)
                      +||+|||++..........  ......||+.|+|||++...      .++.++|||||||++|||++|          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            9999999997654433221  12234789999999988766      455789999999999999999          77


Q ss_pred             CCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          268 AVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       268 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ||.........  ..........     ....+.+.....+...+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus       232 pf~~~~~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          232 PFYDVVPNDPS--FEDMRKVVCV-----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTTSCSSCC--HHHHHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCCCCcc--hhhhhHHHhc-----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            87543322211  1111111111     011122221223345778899999999999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=354.39  Aligned_cols=255  Identities=25%  Similarity=0.331  Sum_probs=193.5

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ...+.|++.+.||+|+||+||+|.+. +++.||||++....     ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            34567999999999999999999987 58899999986432     2356778999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---CCcEEEeecCc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGL  213 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---~~~~kl~Dfg~  213 (361)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.   ++.+||+|||+
T Consensus       125 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG-----IVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             EEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            999999999999999764  36899999999999999999999999     999999999999975   88999999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......     ......+......
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~~~~~  269 (349)
T 2w4o_A          198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILNCEYY  269 (349)
T ss_dssp             ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHTTCCC
T ss_pred             ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHhCCCc
Confidence            98764332   223457899999999999889999999999999999999999999643221     1111222211110


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .         ........+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       270 ~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  308 (349)
T 2w4o_A          270 F---------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW  308 (349)
T ss_dssp             C---------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             c---------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            0         01111233456899999999999999999999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.6e-48  Score=361.04  Aligned_cols=251  Identities=25%  Similarity=0.315  Sum_probs=196.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHH-HHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDI-LSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ++|++.+.||+|+||+||+|+.+ +++.||||++.+...........+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            46999999999999999999987 688999999987655444445566677776 4678999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||++|     |+||||||+|||++.+|++||+|||+++...
T Consensus       118 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999997643  6899999999999999999999999     9999999999999999999999999998643


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||....      .......+.....      
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~~------  256 (373)
T 2r5t_A          191 EHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKPL------  256 (373)
T ss_dssp             CCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHHHHHSCC------
T ss_pred             cCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhccc------
Confidence            2221  2345679999999999999999999999999999999999999995322      1122222222111      


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMA----ECVKE  339 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~----ell~~  339 (361)
                             ..+...+..+.+|+.+||+.||.+||++.    ++++|
T Consensus       257 -------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          257 -------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             -------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence                   11122345589999999999999999974    55554

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.5e-47  Score=347.92  Aligned_cols=256  Identities=23%  Similarity=0.325  Sum_probs=208.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc---hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA---DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++.+.||+|+||+||+|... +|+.||+|++........   .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            35899999999999999999987 689999999976543222   23567889999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC----cEEEeecC
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF----EAKISDFG  212 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~----~~kl~Dfg  212 (361)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++    .+||+|||
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~-----ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999764  37899999999999999999999999     99999999999999887    79999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ++........   .....||+.|+|||++....++.++||||||+++|+|++|..||....   ..   ...........
T Consensus       165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~---~~~~~i~~~~~  235 (321)
T 2a2a_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQ---ETLANITSVSY  235 (321)
T ss_dssp             TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HH---HHHHHHHTTCC
T ss_pred             cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HH---HHHHHHHhccc
Confidence            9987754432   233568999999999988899999999999999999999999995432   11   11111111111


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...    +..     ....+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       236 ~~~----~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          236 DFD----EEF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             CCC----HHH-----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             ccC----hhh-----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            100    000     0112345899999999999999999999998754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.6e-48  Score=355.53  Aligned_cols=269  Identities=26%  Similarity=0.364  Sum_probs=215.6

Q ss_pred             HHHHcCCCCCCceecccCceEEEEEEEc-CC-----CEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEE
Q 018047           56 MEEATCSFSDDNFLGKGGFGRVYKGTLR-SG-----EVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGY  128 (361)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  128 (361)
                      ++...++|...+.||+|+||+||+|.+. ++     ..||+|.+...  ........+.+|+.+++.+ +||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc--cChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            3344567999999999999999999975 23     47999998643  2334567788999999999 89999999999


Q ss_pred             EEcCCEEEEEEEecCCCchhhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCC
Q 018047          129 CADGKHRFLVYEYMQKGNLQDHLNGIG------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKST  196 (361)
Q Consensus       129 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~  196 (361)
                      +.+++..++||||+++|+|.+++....            ...+++..++.++.|++.||+|||++|     ++||||||+
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~  193 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAAR  193 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGG
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-----cccCCcccc
Confidence            999999999999999999999986431            346899999999999999999999999     999999999


Q ss_pred             CeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 018047          197 NVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGV  275 (361)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~  275 (361)
                      |||++.++.+||+|||++................||+.|+|||++....++.++||||||+++|+|++ |..||......
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            99999999999999999986644433333344567889999999988899999999999999999998 89999643321


Q ss_pred             CchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          276 NDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                        ......    ....      ..     ...+...+..+.+++.+||+.||.+|||+.|++++|+++....+
T Consensus       274 --~~~~~~----~~~~------~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  329 (333)
T 2i1m_A          274 --SKFYKL----VKDG------YQ-----MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR  329 (333)
T ss_dssp             --HHHHHH----HHHT------CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --HHHHHH----HhcC------CC-----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence              111111    1110      00     11112234568999999999999999999999999998876543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.1e-47  Score=349.90  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=197.8

Q ss_pred             CCCCCCceecccCceEEEEEEE----cCCCEEEEEEeecCCCC-cchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTL----RSGEVVAIKKMELPRFK-EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      ++|++.+.||+|+||+||+|+.    .+|+.||+|++...... .......+.+|+.+++.++||||+++++++.+++..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            4689999999999999999987    36899999999764322 223345677899999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |+||||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG-----IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC-----EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999997643  6899999999999999999999999     9999999999999999999999999997


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .......  ......||+.|+|||++....++.++||||||+++|+|++|+.||.....      ......+.....   
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~---  238 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCKL---  238 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC---
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC---
Confidence            5432221  23345799999999999888999999999999999999999999964321      112222221111   


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                                ..+...+..+.+|+.+||+.||++||     ++.|+++|.+
T Consensus       239 ----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~  279 (327)
T 3a62_A          239 ----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF  279 (327)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred             ----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence                      11222345689999999999999999     8889998765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-47  Score=346.67  Aligned_cols=265  Identities=28%  Similarity=0.490  Sum_probs=198.9

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ...++|++.+.||+|+||+||+|...  ..+|+|++.... ........+.+|+.+++.++||||+++++++ ..+..++
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            34567999999999999999999865  359999986543 2344567789999999999999999999965 5566899


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++++|.+++... ...+++..++.++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++...
T Consensus        97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~-----i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS-----IIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCccceEEECCCCCEEEccceecccc
Confidence            99999999999999654 347999999999999999999999999     999999999999999999999999999866


Q ss_pred             CCCCceeeeeecccccCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTS---TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .............||+.|+|||++.   ...++.++||||||+++|+|++|+.||.....  .......+.    . .  
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~----~-~--  241 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVG----R-G--  241 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHH----H-T--
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhc----c-c--
Confidence            4433333334457899999999876   56788899999999999999999999964322  111111111    1 0  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                        ...+.+  ......++..+.+|+.+||+.||++|||+.++++.|+++..
T Consensus       242 --~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          242 --SLSPDL--SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             --SCCCCT--TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --ccCcch--hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence              011111  11223345669999999999999999999999999998753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.7e-48  Score=374.44  Aligned_cols=259  Identities=27%  Similarity=0.429  Sum_probs=214.1

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..+|++.+.||+|+||+||+|.+. ++..||||.+...    ......+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc----ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            456788899999999999999987 4889999998643    22356789999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++.......+++..++.++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++....
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-----FIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChhhEEECCCCcEEEeecccceecc
Confidence            99999999999998766667999999999999999999999999     9999999999999999999999999998765


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ..... ......+++.|+|||++....++.++|||||||++|||++ |..||.....   ......+.   ..       
T Consensus       370 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~~~~~---~~-------  435 (495)
T 1opk_A          370 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLE---KD-------  435 (495)
T ss_dssp             TCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHH---TT-------
T ss_pred             CCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH---cC-------
Confidence            43221 2223346788999999988899999999999999999999 9999964321   11211111   00       


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      .     ....+..++..+.+|+.+||+.||++|||+.++++.|+.++..
T Consensus       436 ~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          436 Y-----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             C-----CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            0     0112334456689999999999999999999999999987643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.6e-47  Score=364.16  Aligned_cols=253  Identities=29%  Similarity=0.433  Sum_probs=208.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-EEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-HRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|.+. |+.||||++...     .....+.+|+.+|+.++||||+++++++.+.+ ..|+|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC-----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc-----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            356788899999999999999987 789999998643     24567889999999999999999999987655 79999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++...+...+++..++.++.|++.||+|||+++     ++||||||+|||++.++.+||+|||+++...
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            99999999999998765556899999999999999999999999     9999999999999999999999999998543


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ...     ....+++.|+|||++....++.++||||||+++|||++ |+.||......   .....+.   ..       
T Consensus       341 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~---~~-------  402 (450)
T 1k9a_A          341 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE---KG-------  402 (450)
T ss_dssp             -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHHHHH---TT-------
T ss_pred             ccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---cC-------
Confidence            221     12356889999999999999999999999999999998 99999644322   1111111   10       


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      .     ....+..++..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus       403 ~-----~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          403 Y-----KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             C-----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            0     0112334456699999999999999999999999999988653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.1e-47  Score=344.73  Aligned_cols=268  Identities=23%  Similarity=0.352  Sum_probs=203.4

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|++.+.||+|+||+||+|...+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            46888999999999999999998899999999965432 22234667889999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++ +|.+++.... ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR-----VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            9975 9999887642 47899999999999999999999999     999999999999999999999999999866432


Q ss_pred             CceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh-----hh
Q 018047          221 QETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK-----KL  294 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~  294 (361)
                      ..  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....   .......+........     ..
T Consensus       154 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          154 VR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHHCCCChhhchhh
Confidence            21  2233468999999998865 458999999999999999999999996432   2222222221111100     00


Q ss_pred             hh--hcCcccc------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RK--VIDPELS------RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~--~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..  ..++.+.      ........+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  283 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            00  0011100      00011223456889999999999999999999998743

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7e-48  Score=368.87  Aligned_cols=253  Identities=24%  Similarity=0.277  Sum_probs=199.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|... +|+.||||++.............+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            56888999999999999999987 69999999997543333344556778999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||+ +|     |+||||||+|||++.++.+||+|||++....
T Consensus       228 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g-----iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          228 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             CCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC-----CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             eeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC-----EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999997643  79999999999999999999998 88     9999999999999999999999999998643


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  ......||+.|+|||++....++.++|||||||++|||++|+.||.....   .   .....+.....      
T Consensus       301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~---~~~~~i~~~~~------  366 (446)
T 4ejn_A          301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---KLFELILMEEI------  366 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHCCC------
T ss_pred             CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---H---HHHHHHHhCCC------
Confidence            3222  23346799999999999999999999999999999999999999954321   1   11111111111      


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                             ..+...+..+.+|+.+||+.||++||     |++|+++|.+
T Consensus       367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~  407 (446)
T 4ejn_A          367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF  407 (446)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence                   11222345689999999999999999     9999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-47  Score=342.32  Aligned_cols=267  Identities=27%  Similarity=0.401  Sum_probs=215.7

Q ss_pred             CCCCCc-eecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           62 SFSDDN-FLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        62 ~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      +|.+.. .||+|+||+||+|.+.   ++..||+|++...  ........+.+|+.+++.++||||+++++++ ..+..++
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            455555 8999999999999864   5778999999754  3345567889999999999999999999999 4566899


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++++|.+++... ...+++..++.++.|++.||.|||++|     ++||||||+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC-----EeeCCCchheEEEcCCCCEEECcccceeee
Confidence            99999999999999754 346999999999999999999999999     999999999999999999999999999877


Q ss_pred             CCCCcee-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          218 PEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       218 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      ....... ......+|+.|+|||++....++.++||||||+++|+|++ |+.||.....   ......+   ...     
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i---~~~-----  229 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFI---EQG-----  229 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHH---HTT-----
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH---hcC-----
Confidence            5433221 1223356889999999988889999999999999999998 9999964322   1111111   111     


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCCc
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPL  355 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~~  355 (361)
                        ..     ...+...+..+.+++.+||+.||++|||+.+++++|+.++..........-
T Consensus       230 --~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~  282 (287)
T 1u59_A          230 --KR-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH  282 (287)
T ss_dssp             --CC-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred             --Cc-----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCc
Confidence              00     112233456699999999999999999999999999999998877766543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.4e-47  Score=344.68  Aligned_cols=266  Identities=21%  Similarity=0.287  Sum_probs=203.9

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++.............+.+|+.++..++||||+++++++.+++..|+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3468999999999999999999987 688999999875443344445778899999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++++|.+++....  .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++...
T Consensus       112 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG-----ATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc-----CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999997643  6999999999999999999999999     999999999999999999999999999876


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ...... ......|++.|+|||++....++.++||||||+++|+|++|+.||.....       ............... 
T Consensus       185 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~-  255 (309)
T 2h34_A          185 TDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPRPS-  255 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCCGG-
T ss_pred             cccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCCcc-
Confidence            443221 22345689999999999888999999999999999999999999963211       111111111110001 


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHhhcC
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERP-SMAECVKELQLIIYTNS  348 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ell~~l~~i~~~~~  348 (361)
                              ..+...+..+.+++.+||+.||++|| |++++++.|++++....
T Consensus       256 --------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          256 --------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             --------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             --------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence                    11122334589999999999999999 99999999998876654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.5e-47  Score=354.03  Aligned_cols=272  Identities=23%  Similarity=0.304  Sum_probs=211.0

Q ss_pred             cCHHHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-----CCccee
Q 018047           51 FTLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-----HPNLVS  124 (361)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~  124 (361)
                      ++..+.....++|.+.+.||+|+||+||+|.+. +++.||||++..    .......+..|+.+++.++     ||||++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            344444455678999999999999999999986 689999999853    2344566778999999986     999999


Q ss_pred             EEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC--
Q 018047          125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA--  202 (361)
Q Consensus       125 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~--  202 (361)
                      +++++...+..++||||+ +++|.+++.......+++..+..++.|++.||+|||++|     |+||||||+|||++.  
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS-----LTHTDLKPENILLDDPY  174 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCTT
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCcccEEEcccc
Confidence            999999999999999999 889999998766667999999999999999999999999     999999999999975  


Q ss_pred             -----------------------CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHH
Q 018047          203 -----------------------NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVL  259 (361)
Q Consensus       203 -----------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  259 (361)
                                             ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                   7899999999998654322     235789999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh--h--------hhhcCc-----cccCCCCCH---------------
Q 018047          260 LELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK--L--------RKVIDP-----ELSRSSYTM---------------  309 (361)
Q Consensus       260 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~-----~~~~~~~~~---------------  309 (361)
                      |+|++|+.||.....   ......+.........  .        ...+..     ..+......               
T Consensus       250 ~ell~g~~pf~~~~~---~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  326 (360)
T 3llt_A          250 AELYTGSLLFRTHEH---MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI  326 (360)
T ss_dssp             HHHHHSSCSCCCSSH---HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred             HHHHHCCCCCCCCcH---HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence            999999999964332   2222222211110000  0        000000     000000000               


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          310 ESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       310 ~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      .....+.+|+.+||+.||++|||+.|+|+|-
T Consensus       327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~hp  357 (360)
T 3llt_A          327 IKHELFCDFLYSILQIDPTLRPSPAELLKHK  357 (360)
T ss_dssp             CCCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             chHHHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence            0114578999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=345.41  Aligned_cols=271  Identities=25%  Similarity=0.349  Sum_probs=204.2

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCC--cchhHHHHHHHHHHHHhc---CCCcceeEEEEEEcC
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFK--EADGEHEFRVEVDILSRL---DHPNLVSLIGYCADG  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~  132 (361)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++......  .......+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4568999999999999999999976 6899999998754321  111234566677777776   499999999999875


Q ss_pred             C-----EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEE
Q 018047          133 K-----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAK  207 (361)
Q Consensus       133 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~k  207 (361)
                      .     ..++||||+. |+|.+++.......+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC-----IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCEE
Confidence            5     5899999997 59999998776566999999999999999999999999     99999999999999999999


Q ss_pred             EeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 018047          208 ISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      |+|||++.......   ......||+.|+|||++....++.++|||||||++|+|++|+.||....   .......+...
T Consensus       161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~  234 (308)
T 3g33_A          161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGKIFDL  234 (308)
T ss_dssp             ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS---HHHHHHHHHHH
T ss_pred             EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHH
Confidence            99999998764432   2234578999999999988899999999999999999999999996432   22222222111


Q ss_pred             hhhhhh--hh-------hhcCccccC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          288 LNDRKK--LR-------KVIDPELSR--SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       288 ~~~~~~--~~-------~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ......  ..       ..+.+....  .......+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~  299 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY  299 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence            110000  00       000000000  0000123356899999999999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.4e-48  Score=345.73  Aligned_cols=260  Identities=26%  Similarity=0.395  Sum_probs=199.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEcC----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      .++|++.+.||+|+||+||+|.+..    +..||+|.+...  ........+.+|+.+++.++||||+++++++. ++..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            4568899999999999999998752    456999987543  23445667889999999999999999999984 4678


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |+||||+++|+|.+++... ...+++..++.++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccccHHHEEECCCCCEEECcccccc
Confidence            8999999999999999764 346899999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ........ ......+++.|+|||++....++.++||||||+++|+|++ |..||.....   ......+.   .. .  
T Consensus       165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---~~~~~~i~---~~-~--  234 (281)
T 1mp8_A          165 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIE---NG-E--  234 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHH---TT-C--
T ss_pred             ccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH---HHHHHHHH---cC-C--
Confidence            76543221 2223456789999999988899999999999999999997 9999964332   12221111   10 0  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                               ....+...+..+.+++.+||+.||++|||+.|++++|++++...
T Consensus       235 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          235 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                     01122334556899999999999999999999999999988653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.9e-47  Score=370.08  Aligned_cols=259  Identities=25%  Similarity=0.379  Sum_probs=212.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|...++||+|+||+||+|+.+ +|+.||+|++.+...........+..|+.+++.++||||+++++++.+.+.+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888899999999999999987 69999999997643333344567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          140 EYMQKGNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||+++|+|.+++....  ...+++..+..++.||+.||+|||++|     |+||||||+|||++.+|++||+|||++..+
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-----IvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-----IIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC-----CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999987643  446999999999999999999999999     999999999999999999999999999877


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ......+....      
T Consensus       340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~~~------  409 (543)
T 3c4z_A          340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLEQA------  409 (543)
T ss_dssp             CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHHCC------
T ss_pred             cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhhcc------
Confidence            54432  223457999999999999999999999999999999999999999754332221  11112221111      


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSM-----AECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~ell~~l~  341 (361)
                             ..++...+..+.+|+.+||+.||++||++     +++++|.+
T Consensus       410 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf  451 (543)
T 3c4z_A          410 -------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL  451 (543)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred             -------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence                   11223344568999999999999999964     78887653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.9e-47  Score=343.28  Aligned_cols=261  Identities=25%  Similarity=0.415  Sum_probs=211.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .++|++.+.||+|+||+||+|...++..||+|.+....    .....+.+|+++++.++||||+++++++.+ +..++||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            34688899999999999999998888899999986432    235678899999999999999999999864 4588999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++.......+++..+..++.|++.||+|||++|     ++||||||+||+++.++.+||+|||++.....
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            9999999999997643346999999999999999999999999     99999999999999999999999999987754


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      .... ......+++.|+|||.+....++.++||||||+++|+|++ |+.||....   ....   .......       .
T Consensus       162 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~---~~~~~~~-------~  227 (279)
T 1qpc_A          162 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEV---IQNLERG-------Y  227 (279)
T ss_dssp             SCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHH---HHHHHTT-------C
T ss_pred             cccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC---HHHH---HHHHhcc-------c
Confidence            3321 2223456788999999988889999999999999999999 899985322   1111   1111111       0


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                      .     ...+...+..+.+++.+||+.||++|||+.++++.|+.++.....
T Consensus       228 ~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          228 R-----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             C-----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            0     111223345689999999999999999999999999999876543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.2e-47  Score=356.67  Aligned_cols=254  Identities=23%  Similarity=0.322  Sum_probs=195.7

Q ss_pred             CCCCCC-ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHh-cCCCcceeEEEEEEc----CC
Q 018047           61 CSFSDD-NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSR-LDHPNLVSLIGYCAD----GK  133 (361)
Q Consensus        61 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~----~~  133 (361)
                      ++|.+. ++||+|+||+||+|.+. +|+.||||++..        ...+.+|+.++.+ .+||||+++++++..    .+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            356555 68999999999999987 689999999852        1356678888754 589999999999875    56


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---CCcEEEee
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISD  210 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---~~~~kl~D  210 (361)
                      .+|+||||+++|+|.+++.......+++..+..++.|++.||+|||++|     |+||||||+|||++.   ++.+||+|
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCcCcceEEEecCCCCccEEEEe
Confidence            7899999999999999998765567999999999999999999999999     999999999999997   78999999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCch-hHHHHHHHHhh
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ-NLVLQVRHILN  289 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~  289 (361)
                      ||++.......   .....+||+.|+|||++....++.++|||||||++|+|++|+.||......... .....+.   .
T Consensus       208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~  281 (400)
T 1nxk_A          208 FGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---M  281 (400)
T ss_dssp             CTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---H
T ss_pred             cccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---c
Confidence            99998764332   223467899999999999999999999999999999999999999754432211 1111111   1


Q ss_pred             hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ....+     +    .......+..+.+||.+||+.||++|||+.|+++|.+-
T Consensus       282 ~~~~~-----~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  325 (400)
T 1nxk_A          282 GQYEF-----P----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  325 (400)
T ss_dssp             TCCCC-----C----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             CcccC-----C----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence            10000     0    00011234568999999999999999999999999774

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.6e-47  Score=350.35  Aligned_cols=253  Identities=23%  Similarity=0.401  Sum_probs=199.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC------
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK------  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  133 (361)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+..      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            46889999999999999999987 79999999997653  3345677899999999999999999999986543      


Q ss_pred             ---------------------------------------------------EEEEEEEecCCCchhhhcccCCC-CCCCH
Q 018047          134 ---------------------------------------------------HRFLVYEYMQKGNLQDHLNGIGE-PKMDW  161 (361)
Q Consensus       134 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~-~~~~~  161 (361)
                                                                         ..++||||+++|+|.+++..... ...++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               38999999999999999976432 34566


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCce----------eeeeeccc
Q 018047          162 PLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET----------YVTARVLG  231 (361)
Q Consensus       162 ~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~g  231 (361)
                      ..++.++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.........          .......|
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG-----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             HHHHHHHHHHHHHHHHHHhCC-----eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            778999999999999999999     999999999999999999999999999877554221          11233569


Q ss_pred             ccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHH
Q 018047          232 TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMES  311 (361)
Q Consensus       232 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (361)
                      |+.|+|||++.+..++.++||||||+++|+|++|..|+.        ............          ..  .......
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~~~----------~~--~~~~~~~  298 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVRNL----------KF--PLLFTQK  298 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHHTT----------CC--CHHHHHH
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhhcc----------CC--CcccccC
Confidence            999999999988899999999999999999999877641        111111111000          00  1111233


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          312 IAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       312 ~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      +..+.+|+.+||+.||++|||+.|+++|-
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~  327 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIENA  327 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence            45678999999999999999999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-47  Score=340.42  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=210.7

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|+..+.||+|+||+||+|.+.+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            4588889999999999999999888899999997542    234578899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++++|.+++.... ..+++..+..++.|++.||+|||++|     ++|+||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             CCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCchheEEECCCCCEEEcccccccccccc
Confidence            999999999997642 36899999999999999999999999     999999999999999999999999999876432


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      .. .......+++.|+|||++....++.++||||||+++|+|++ |..||....   ..   .........       ..
T Consensus       158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~---~~~~~i~~~-------~~  223 (267)
T 3t9t_A          158 QY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NS---EVVEDISTG-------FR  223 (267)
T ss_dssp             HH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH---HHHHHHHTT-------CC
T ss_pred             cc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HH---HHHHHHhcC-------Cc
Confidence            11 11223456788999999988889999999999999999999 899985322   11   111111111       00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                           ...+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus       224 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          224 -----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                 111222345689999999999999999999999999998754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.2e-47  Score=345.55  Aligned_cols=264  Identities=28%  Similarity=0.416  Sum_probs=207.7

Q ss_pred             CCCCCceecccCceEEEEEEE----c-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTL----R-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KH  134 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~----~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~  134 (361)
                      .|+..+.||+|+||+||+|.+    . +++.||+|++....  .......+.+|+.+++.++||||+++++++.+.  ..
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            488889999999999999984    2 58899999987542  233457788999999999999999999999876  67


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++|     ++||||||+|||++.++.++|+|||++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC-----cccCCCchheEEEcCCCCEEECccccc
Confidence            899999999999999996542 36999999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCce-eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC--------CCCchhHHHHHH
Q 018047          215 KLMPEGQET-YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ--------GVNDQNLVLQVR  285 (361)
Q Consensus       215 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~  285 (361)
                      ......... .......||..|+|||.+.+..++.++||||||+++|+|++|+.|+....        ..........+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            877554332 22334567888999999988889999999999999999999999864221        000111111111


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      .....          .. ....+...+..+.+|+.+||+.||++|||+.++++.|+.++
T Consensus       254 ~~~~~----------~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          254 NTLKE----------GK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHT----------TC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhc----------cC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11110          00 11223344566999999999999999999999999999876

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.5e-47  Score=352.51  Aligned_cols=256  Identities=23%  Similarity=0.346  Sum_probs=205.7

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  137 (361)
                      .++|++.+.||+|+||+||+|.++ +|+.||+|++.....       ...+|++++.++ +||||+++++++.+++..|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            446999999999999999999987 689999999975422       234588888888 79999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC----CcEEEeecCc
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN----FEAKISDFGL  213 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~----~~~kl~Dfg~  213 (361)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||+..+    +.+||+|||+
T Consensus        94 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g-----ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG-----VVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            99999999999999764  36999999999999999999999999     9999999999998543    3599999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      +........  .....+||+.|+|||++....++.++|||||||++|+|++|..||..............   +......
T Consensus       167 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---i~~~~~~  241 (342)
T 2qr7_A          167 AKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR---IGSGKFS  241 (342)
T ss_dssp             CEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH---HHHCCCC
T ss_pred             cccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH---HccCCcc
Confidence            987644332  23345789999999998887889999999999999999999999975433222222222   1111110


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      +        . .......+..+.+|+.+||+.||++|||+.++++|.+-.
T Consensus       242 ~--------~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          242 L--------S-GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             C--------C-STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             c--------C-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence            0        0 111123345689999999999999999999999998853

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=345.96  Aligned_cols=275  Identities=25%  Similarity=0.355  Sum_probs=209.8

Q ss_pred             HHHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc--CCCcceeEEEEEEc
Q 018047           54 KEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL--DHPNLVSLIGYCAD  131 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~  131 (361)
                      .......++|++.+.||+|+||+||+|++. |+.||||++...      ....+..|.+++..+  +||||+++++++.+
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            334445568999999999999999999887 899999998532      223445566666654  89999999999988


Q ss_pred             C----CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCCCCeEecCCCCCCee
Q 018047          132 G----KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS--------SAVGIPIVHRDFKSTNVL  199 (361)
Q Consensus       132 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~~~~~~iiH~Dikp~Nil  199 (361)
                      .    ...++||||+++|+|.+++...   .+++..++.++.|++.||+|||++        +     ++||||||+|||
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-----ivH~Dikp~Nil  174 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA-----IAHRDLKSKNIL  174 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC-----EECSCCCGGGEE
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC-----EEecccchHHEE
Confidence            7    7899999999999999999753   699999999999999999999998        7     999999999999


Q ss_pred             eCCCCcEEEeecCccccCCCCCceee--eeecccccCccCcccccCCCCCcc------chhHHHHHHHHHHHhC------
Q 018047          200 LSANFEAKISDFGLAKLMPEGQETYV--TARVLGTFGYFDPEYTSTGKLTLQ------SDVYAFGVVLLELLTG------  265 (361)
Q Consensus       200 l~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~ell~g------  265 (361)
                      ++.++.+||+|||++..+........  .....||+.|+|||++.......+      +|||||||++|||++|      
T Consensus       175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~  254 (337)
T 3mdy_A          175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI  254 (337)
T ss_dssp             ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence            99999999999999987644332211  124579999999999877766655      9999999999999999      


Q ss_pred             ----CCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          266 ----RRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       266 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                          ..||.........  ..........     ....+..........++..+.+|+.+||+.||++|||+.+++++|+
T Consensus       255 ~~~~~~p~~~~~~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  327 (337)
T 3mdy_A          255 VEEYQLPYHDLVPSDPS--YEDMREIVCI-----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA  327 (337)
T ss_dssp             CCCCCCTTTTTSCSSCC--HHHHHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cccccccHhhhcCCCCc--hhhhHHHHhh-----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence                5555433222111  1111111110     1111121111123377888999999999999999999999999999


Q ss_pred             HHHhhcCCC
Q 018047          342 LIIYTNSKG  350 (361)
Q Consensus       342 ~i~~~~~~~  350 (361)
                      ++....+..
T Consensus       328 ~l~~~~~~~  336 (337)
T 3mdy_A          328 KMSESQDIK  336 (337)
T ss_dssp             HHHHTTTCC
T ss_pred             HHHhhcccC
Confidence            999877653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.5e-47  Score=352.45  Aligned_cols=278  Identities=17%  Similarity=0.177  Sum_probs=210.3

Q ss_pred             HcCCCCCCceecccCceEEEEEEEcC------CCEEEEEEeecCCCCcch--------hHHHHHHHHHHHHhcCCCccee
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLRS------GEVVAIKKMELPRFKEAD--------GEHEFRVEVDILSRLDHPNLVS  124 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~  124 (361)
                      ..++|.+.+.||+|+||+||+|.+..      ++.||||++.........        ....+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34579999999999999999998764      478999998653210000        0112334556677788999999


Q ss_pred             EEEEEEcC----CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee
Q 018047          125 LIGYCADG----KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       125 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill  200 (361)
                      +++++.+.    ...|+||||+ +++|.+++... ...+++..++.++.|++.||+|||++|     |+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~-----iiHrDlkp~Nill  185 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE-----YVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eEEecCCHHHEEE
Confidence            99998764    4689999999 99999999764 347999999999999999999999999     9999999999999


Q ss_pred             C--CCCcEEEeecCccccCCCCCcee-----eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 018047          201 S--ANFEAKISDFGLAKLMPEGQETY-----VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ  273 (361)
Q Consensus       201 ~--~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  273 (361)
                      +  .++.+||+|||++..+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  88999999999998764322111     1123459999999999999899999999999999999999999996432


Q ss_pred             CCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 018047          274 GVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGL  351 (361)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~  351 (361)
                      .  ...........  ....+...+++.+.....    +..+.+++..||+.||++||++.++++.|++++.......
T Consensus       266 ~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~  335 (364)
T 3op5_A          266 K--DPKYVRDSKIR--YRENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD  335 (364)
T ss_dssp             T--CHHHHHHHHHH--HHHCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             c--CHHHHHHHHHH--hhhhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence            2  12222211111  112233333333322222    3458999999999999999999999999999998765443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.9e-47  Score=339.22  Aligned_cols=257  Identities=25%  Similarity=0.351  Sum_probs=208.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|... +++.||+|++.....  ......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            346889999999999999999987 689999999875422  23456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||++|     ++|+||||+||+++.++.++|+|||++..+.
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            9999999999999763  36999999999999999999999999     9999999999999999999999999998764


Q ss_pred             CCCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ............||+.|+|||.+....+ +.++||||||+++|+|++|..||........ ..    .........    
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~~~~~----  227 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY----SDWKEKKTY----  227 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH----HHHHTTCTT----
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH----HHhhhcccc----
Confidence            4333223344678999999999877665 6789999999999999999999965433211 11    111111000    


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                             .......+..+.+|+.+||+.||++|||+.|++++.+
T Consensus       228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (276)
T 2yex_A          228 -------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (276)
T ss_dssp             -------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             -------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence                   0001123445889999999999999999999998743

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.2e-48  Score=353.98  Aligned_cols=267  Identities=26%  Similarity=0.417  Sum_probs=214.0

Q ss_pred             HHHHHHcCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEE
Q 018047           54 KEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG  127 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  127 (361)
                      ++++...++|++.+.||+|+||+||+|.+.      +++.||+|.+...  ........+.+|+.+++.++||||+++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            344455567999999999999999999864      3678999998643  23344567889999999999999999999


Q ss_pred             EEEcCCEEEEEEEecCCCchhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCee
Q 018047          128 YCADGKHRFLVYEYMQKGNLQDHLNGIG--------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVL  199 (361)
Q Consensus       128 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nil  199 (361)
                      ++.+++..++||||+++|+|.+++....        ...+++..++.++.|++.||+|||++|     ++||||||+||+
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dikp~NIl  170 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCM  170 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCSGGGEE
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCccceEE
Confidence            9999999999999999999999996532        236789999999999999999999999     999999999999


Q ss_pred             eCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCch
Q 018047          200 LSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQ  278 (361)
Q Consensus       200 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~  278 (361)
                      ++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||....   ..
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~  247 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NE  247 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---HH
Confidence            99999999999999986644332222333457889999999988889999999999999999999 888885332   11


Q ss_pred             hHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          279 NLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      .   ........          ..  ...+...+..+.+++.+||+.||++|||+.|++++|++++.
T Consensus       248 ~---~~~~~~~~----------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 Q---VLRFVMEG----------GL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             H---HHHHHHTT----------CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             H---HHHHHHcC----------Cc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1   11111111          00  11222344568999999999999999999999999987754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.1e-47  Score=357.23  Aligned_cols=256  Identities=21%  Similarity=0.332  Sum_probs=201.8

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC--CCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD--HPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..|.+.+.||+|+||+||+|...+++.||||++..... .......+.+|+.+|..++  ||||+++++++..++..|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            35999999999999999999988899999999976532 3345677899999999996  59999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      || +.+++|.+++....  .+++..+..++.||+.||+|||+++     |+||||||+|||++ ++.+||+|||++..+.
T Consensus       135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT-----CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 56889999998743  7899999999999999999999999     99999999999995 5899999999998775


Q ss_pred             CCCceeeeeecccccCccCcccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTST-----------GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      ............||+.|+|||++..           ..++.++|||||||++|+|++|+.||.....     ....+...
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~  280 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI  280 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHH
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHH
Confidence            4433333345679999999998754           4688999999999999999999999953221     11112211


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ..          +... ...+...+..+.+|+.+||+.||++|||+.|+++|.+-
T Consensus       281 ~~----------~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~  324 (390)
T 2zmd_A          281 ID----------PNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  324 (390)
T ss_dssp             HC----------TTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             hC----------cccc-CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence            11          1110 11111224568999999999999999999999998763

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=351.75  Aligned_cols=248  Identities=21%  Similarity=0.331  Sum_probs=206.5

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc-----hhHHHHHHHHHHHHhcCCCcceeEEEEEEcC
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA-----DGEHEFRVEVDILSRLDHPNLVSLIGYCADG  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  132 (361)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++........     .....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3457999999999999999999976 689999999986543222     1334567799999999999999999999999


Q ss_pred             CEEEEEEEecCCC-chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          133 KHRFLVYEYMQKG-NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       133 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      +..++||||+.+| +|.+++....  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999777 9999997643  6999999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      |++..+.....   .....||+.|+|||++....+ +.++|||||||++|+|++|..||.....                
T Consensus       175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------  235 (335)
T 3dls_A          175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------  235 (335)
T ss_dssp             TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------
T ss_pred             ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------
Confidence            99987755432   233579999999999887776 7899999999999999999999953211                


Q ss_pred             hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                        ...    ...   ..+...+..+.+|+.+||+.||++|||+.+++++.+
T Consensus       236 --~~~----~~~---~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          236 --TVE----AAI---HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             --GTT----TCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             --HHh----hcc---CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence              000    000   111123455899999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=353.49  Aligned_cols=249  Identities=25%  Similarity=0.327  Sum_probs=198.4

Q ss_pred             CceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           66 DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      .+.||+|+||+||+|... +|..||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            567999999999999976 69999999997532   24456788999999999999999999999999999999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee--CCCCcEEEeecCccccCCCCCc
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL--SANFEAKISDFGLAKLMPEGQE  222 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill--~~~~~~kl~Dfg~~~~~~~~~~  222 (361)
                      |+|.+++... ...+++..+..++.|++.||+|||++|     |+||||||+|||+  +.++.+||+|||++..+.....
T Consensus       171 ~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          171 GELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY-----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             CEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            9999988653 236899999999999999999999999     9999999999999  5678999999999987754432


Q ss_pred             eeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccc
Q 018047          223 TYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL  302 (361)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                         .....||+.|+|||++....++.++|||||||++|+|++|..||.....      ...+..+......+.    .. 
T Consensus       245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~~~----~~-  310 (373)
T 2x4f_A          245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACRWDLE----DE-  310 (373)
T ss_dssp             ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCSC----SG-
T ss_pred             ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCCCC----hh-
Confidence               2234699999999999888999999999999999999999999964321      112222221111100    00 


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       303 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                          .....+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       311 ----~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~  345 (373)
T 2x4f_A          311 ----EFQDISEEAKEFISKLLIKEKSWRISASEALKHPW  345 (373)
T ss_dssp             ----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             ----hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence                00122355899999999999999999999999766

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.7e-47  Score=357.15  Aligned_cols=275  Identities=20%  Similarity=0.292  Sum_probs=216.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC--EEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK--HRFL  137 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l  137 (361)
                      ++|.+.+.||+|+||+||+|.+. +|+.||||++.....  ......+.+|+++++.++||||+++++++.+.+  ..++
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            46889999999999999999987 599999999865322  233567788999999999999999999998755  7899


Q ss_pred             EEEecCCCchhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee----CCCCcEEEeecC
Q 018047          138 VYEYMQKGNLQDHLNGIG-EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL----SANFEAKISDFG  212 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill----~~~~~~kl~Dfg  212 (361)
                      ||||+++|+|.+++.... ...+++..++.++.|++.||+|||++|     |+||||||+|||+    +.++.+||+|||
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            999999999999997643 224999999999999999999999999     9999999999999    777889999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccC--------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTST--------GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  284 (361)
                      ++........   .....||+.|+|||++..        ..++.++|||||||++|+|++|+.||.........  ...+
T Consensus       162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~  236 (396)
T 4eut_A          162 AARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVM  236 (396)
T ss_dssp             GCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHH
T ss_pred             CceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHH
Confidence            9987654332   223568999999998754        56778999999999999999999999654332221  1122


Q ss_pred             HHHhhhhhh--h---hh-------hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          285 RHILNDRKK--L---RK-------VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       285 ~~~~~~~~~--~---~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      .........  .   ..       +..............+..+.+++.+||+.||++|||++++++.++.++...
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            222211100  0   00       000001113455788889999999999999999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-47  Score=340.97  Aligned_cols=255  Identities=28%  Similarity=0.418  Sum_probs=188.8

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|.+.+.||+|+||+||+|... +|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            356899999999999999999985 7999999998654322233356788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++++|.+++... ...+++..++.++.|++.||+|||++|     ++|+||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG-----ILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999999764 247899999999999999999999999     9999999999999999999999999998764


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  ......||+.|+|||.+....++.++||||||+++|+|++|+.||........      .          ....
T Consensus       164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~----------~~~~  225 (278)
T 3cok_A          164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------L----------NKVV  225 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CC
T ss_pred             CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------H----------HHHh
Confidence            3322  12235689999999999888899999999999999999999999965432110      0          0000


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...   ...+...+..+.+++.+||+.||++|||+.++++|.+
T Consensus       226 ~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  265 (278)
T 3cok_A          226 LAD---YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF  265 (278)
T ss_dssp             SSC---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred             hcc---cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence            011   1112233456899999999999999999999998754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.8e-47  Score=348.54  Aligned_cols=266  Identities=26%  Similarity=0.411  Sum_probs=211.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEE--EEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVV--AIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++.+.||+|+||+||+|.+. ++..+  |+|.+...  ........+.+|+.+++.+ +||||+++++++.+.+..|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            35889999999999999999976 56654  99988643  2233455688899999999 8999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC
Q 018047          137 LVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA  202 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~  202 (361)
                      +||||+++|+|.+++....              ...+++..++.++.|++.||+|||++|     ++||||||+|||++.
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE  177 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCccceEEEcC
Confidence            9999999999999997643              246899999999999999999999999     999999999999999


Q ss_pred             CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 018047          203 NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~  281 (361)
                      ++.+||+|||++.......   ......+++.|+|||++....++.++||||||+++|+|++ |+.||.....      .
T Consensus       178 ~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~  248 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------A  248 (327)
T ss_dssp             GGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------H
T ss_pred             CCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------H
Confidence            9999999999997432211   1223456889999999988889999999999999999998 9999954321      1


Q ss_pred             HHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 018047          282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMP  354 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~  354 (361)
                      ....... .      ...     ...+...+..+.+|+.+||+.||++|||+.+++++|+.++.......+..
T Consensus       249 ~~~~~~~-~------~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  309 (327)
T 1fvr_A          249 ELYEKLP-Q------GYR-----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT  309 (327)
T ss_dssp             HHHHHGG-G------TCC-----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCB
T ss_pred             HHHHHhh-c------CCC-----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccc
Confidence            1111111 0      000     11222344568999999999999999999999999999999877666544

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.1e-47  Score=339.09  Aligned_cols=255  Identities=20%  Similarity=0.291  Sum_probs=207.6

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC--CEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG--KHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  138 (361)
                      ++|.+.+.||+|+||+||+|.+. ++.||+|++..... .......+.+|+.+++.++||||+++++++.+.  +..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            35888999999999999999986 88999999976432 234456789999999999999999999999887  788999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++.......+++..++.++.|++.||+|||+++   .+++||||||+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE---PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS---SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC---CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999998766557999999999999999999999976   349999999999999999999999999876543


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCc---cchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTL---QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      ..       ...||+.|+|||.+....++.   ++||||||+++|+|++|+.||.....   .   .........     
T Consensus       165 ~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~---~~~~~~~~~-----  226 (271)
T 3kmu_A          165 SP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---M---EIGMKVALE-----  226 (271)
T ss_dssp             CT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---H---HHHHHHHHS-----
T ss_pred             cc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---H---HHHHHHHhc-----
Confidence            22       235799999999987665554   79999999999999999999963321   1   111111111     


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                       ...     ...+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       227 -~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          227 -GLR-----PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             -CCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -CCC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence             011     1122334456999999999999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=350.59  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=202.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCE----EEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEV----VAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      ++|++.+.||+|+||+||+|.+. +++.    ||+|.+...  ........+.+|+.+++.++||||+++++++.++. .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            46999999999999999999976 4554    466666432  23345677889999999999999999999998765 7


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++|++|+++|+|.+++.... ..+++..++.++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             eEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC-----CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            89999999999999997643 36999999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ...............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......   .....+.    ...  
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~----~~~--  236 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE----KGE--  236 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH----TTC--
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cCC--
Confidence            7754443333334557889999999989999999999999999999999 99999644321   1111111    000  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                               ....+...+..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus       237 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          237 ---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence                     01122234456899999999999999999999999999988543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8e-47  Score=344.41  Aligned_cols=267  Identities=23%  Similarity=0.328  Sum_probs=202.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            57899999999999999999987 69999999986542 23334567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN-----CIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             ECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            999999999988754  36999999999999999999999999     99999999999999999999999999987653


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh--------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND--------  290 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  290 (361)
                      ...  ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....   ......+......        
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          155 PSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD---VDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhcccccccccc
Confidence            322  2234578999999998765 6689999999999999999999999964432   2222222211111        


Q ss_pred             ---hhhhhhhcCccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 ---RKKLRKVIDPELSRSSYT-----MESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ---~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         .........+... ...+     ...+..+.+|+.+||+.||++|||++|+++|.+
T Consensus       230 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  287 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPE-DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY  287 (311)
T ss_dssp             HHTCGGGTTCCCCCCS-SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred             cccccccccCcCCCcc-ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence               0000000000000 0000     123445889999999999999999999998854

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-47  Score=366.63  Aligned_cols=263  Identities=29%  Similarity=0.455  Sum_probs=208.8

Q ss_pred             HcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..++|++.+.||+|+||+||+|.+.++..||||++....    ...+.+.+|+.+|+.++||||+++++++.+ +..++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            445688889999999999999999877889999986532    234678899999999999999999999876 678999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++.......+++..+..++.|++.||+|||+++     ++||||||+|||++.++.+||+|||++....
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            99999999999997643446999999999999999999999999     9999999999999999999999999998765


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ..... ......++..|+|||.+....++.++||||||+++|||++ |+.||....   .......   ....       
T Consensus       332 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~~~~~~---i~~~-------  397 (452)
T 1fmk_A          332 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ---VERG-------  397 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHH---HHTT-------
T ss_pred             CCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHH---HHcC-------
Confidence            43221 2223456789999999988899999999999999999999 999995322   1111111   1111       


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG  350 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~  350 (361)
                      .     ....+..++..+.+|+.+||+.||++|||++++++.|+.++...+..
T Consensus       398 ~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~  445 (452)
T 1fmk_A          398 Y-----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  445 (452)
T ss_dssp             C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             C-----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence            0     01123344566899999999999999999999999999988665543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.2e-47  Score=351.26  Aligned_cols=267  Identities=25%  Similarity=0.314  Sum_probs=205.1

Q ss_pred             HHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCC--CcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC
Q 018047           56 MEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRF--KEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG  132 (361)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  132 (361)
                      +....++|++.+.||+|+||+||+|... ++..||+|++.....  ........+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4455667999999999999999999986 688999999865321  1234457788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCchhhhcccCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIG--------------------------------------EPKMDWPLRLKVALGAAKG  174 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~~~~~~~~~i~~~i~~~  174 (361)
                      +..++||||+++|+|.+++....                                      ...+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999985211                                      1123567888999999999


Q ss_pred             HHHHhcCCCCCCCeEecCCCCCCeeeCCCC--cEEEeecCccccCCCCC--ceeeeeecccccCccCcccccC--CCCCc
Q 018047          175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANF--EAKISDFGLAKLMPEGQ--ETYVTARVLGTFGYFDPEYTST--GKLTL  248 (361)
Q Consensus       175 l~~lH~~~~~~~~iiH~Dikp~Nill~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~  248 (361)
                      |+|||+++     ++||||||+|||++.++  .+||+|||++..+....  .........||+.|+|||++..  ..++.
T Consensus       181 l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          181 LHYLHNQG-----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHTT-----EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHCC-----ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            99999999     99999999999998776  89999999998653321  1112334578999999998864  67889


Q ss_pred             cchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCC
Q 018047          249 QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESS  328 (361)
Q Consensus       249 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  328 (361)
                      ++||||||+++|+|++|+.||.....      ................   +      .....+..+.+|+.+||+.||+
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~---~------~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVND------ADTISQVLNKKLCFEN---P------NYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCTTS---G------GGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcccccCC---c------ccccCCHHHHHHHHHHcCCChh
Confidence            99999999999999999999964321      1122222221111100   0      0111234589999999999999


Q ss_pred             CCCCHHHHHHHHHH
Q 018047          329 ERPSMAECVKELQL  342 (361)
Q Consensus       329 ~Rpt~~ell~~l~~  342 (361)
                      +|||+.++++|.+-
T Consensus       321 ~Rps~~~~l~hp~~  334 (345)
T 3hko_A          321 ERFDAMRALQHPWI  334 (345)
T ss_dssp             TSCCHHHHHHSHHH
T ss_pred             HCCCHHHHhcChhh
Confidence            99999999998763

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-47  Score=346.94  Aligned_cols=248  Identities=22%  Similarity=0.274  Sum_probs=195.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ++|+..+.||+|+||+||+|.+. +|+.||||++....... ........|+..+..+ +||||+++++++.+++..++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            46999999999999999999987 79999999986543222 3333445566666555 899999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+ +++|.+++...+ ..+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++....
T Consensus       136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG-----LVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            9999 679999887653 46999999999999999999999999     9999999999999999999999999998764


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ...   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...      ...   ......      ..
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~---~~~~~~------~~  269 (311)
T 3p1a_A          209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGW---QQLRQG------YL  269 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHH---HHHTTT------CC
T ss_pred             cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHH---HHHhcc------CC
Confidence            432   2233568999999998865 7899999999999999999997776321      111   111110      00


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      .+.+     +...+..+.+++.+||+.||++|||+.|++++.
T Consensus       270 ~~~~-----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  306 (311)
T 3p1a_A          270 PPEF-----TAGLSSELRSVLVMMLEPDPKLRATAEALLALP  306 (311)
T ss_dssp             CHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             Cccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence            1111     111235589999999999999999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.8e-47  Score=351.45  Aligned_cols=252  Identities=30%  Similarity=0.432  Sum_probs=206.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ..|...+.||+|+||+||+|... +|+.||||++.............+.+|+.+++.++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            34888899999999999999975 78999999997654444455677889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+. |+|.+++... ...+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 6888887543 247999999999999999999999999     99999999999999999999999999986643


Q ss_pred             CCceeeeeecccccCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTS---TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      .      ....||+.|+|||++.   ...++.++|||||||++|||++|+.||.....      ...+......      
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~------  268 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN------  268 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS------
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc------
Confidence            2      2356899999999873   56789999999999999999999999953321      1111111111      


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                       ..+...    +...+..+.+|+.+||+.||++|||+.+++++.+-
T Consensus       269 -~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~  309 (348)
T 1u5q_A          269 -ESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  309 (348)
T ss_dssp             -CCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             -CCCCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence             111111    12234558999999999999999999999998764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.8e-47  Score=339.67  Aligned_cols=256  Identities=29%  Similarity=0.521  Sum_probs=195.8

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCc-chhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE-ADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||+||+|.+. |+.||||++....... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            56888999999999999999986 8899999986543222 233567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC--------CCcEEEeec
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA--------NFEAKISDF  211 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~--------~~~~kl~Df  211 (361)
                      ||+++++|.+++..   ..+++..++.++.|++.||+|||++|.  .+++||||||+|||++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~--~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAI--VPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSS--SCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCC--CceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999864   379999999999999999999999872  12789999999999986        778999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      |++........    ....||+.|+|||.+....++.++||||||+++|+|++|+.||.....   ...   ....... 
T Consensus       161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~---~~~~~~~-  229 (271)
T 3dtc_A          161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAV---AYGVAMN-  229 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHH---HHHHHTS-
T ss_pred             Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH---HHhhhcC-
Confidence            99986644322    234689999999999888899999999999999999999999964321   111   1111100 


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                               .. ....+...+..+.+++.+||+.||++|||+.|++++|+.+
T Consensus       230 ---------~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 ---------KL-ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---------CC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---------CC-CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                     00 0122233445699999999999999999999999999754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-46  Score=344.76  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=183.7

Q ss_pred             CceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEEEecC
Q 018047           66 DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVYEYMQ  143 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  143 (361)
                      .+.||+|+||+||+|.+. +|+.||||++...      ....+.+|+.+++.+. ||||+++++++.+++..|+||||++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN   89 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence            478999999999999987 6899999998632      3456778999999997 9999999999999999999999999


Q ss_pred             CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC---cEEEeecCccccCCCC
Q 018047          144 KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF---EAKISDFGLAKLMPEG  220 (361)
Q Consensus       144 ~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~---~~kl~Dfg~~~~~~~~  220 (361)
                      +|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++   .+||+|||++......
T Consensus        90 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           90 GGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG-----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             SCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999999874  37999999999999999999999999     99999999999998765   8999999999866443


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc-hhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND-QNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..  ......||+.|+|||++....++.++||||||+++|+|++|..||........ .........+......+.    
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~----  236 (325)
T 3kn6_A          163 NQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE----  236 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC----
T ss_pred             CC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC----
Confidence            22  23345789999999999999999999999999999999999999975433211 111122222211110000    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           .......+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus       237 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w  273 (325)
T 3kn6_A          237 -----GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW  273 (325)
T ss_dssp             -----SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred             -----cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence                 0000123456899999999999999999999998865

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-46  Score=338.51  Aligned_cols=257  Identities=31%  Similarity=0.508  Sum_probs=204.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchh----HHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADG----EHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++..........    ...+.+|+.+++.++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            46888999999999999999986 78999999986643332221    167889999999999999999999997766  


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc-----EEEee
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE-----AKISD  210 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~-----~kl~D  210 (361)
                      ++||||+++|+|.+++... ...+++..++.++.|++.||+|||++|   .+++||||||+|||++.++.     +||+|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN---PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS---SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC---CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            6999999999999988654 347999999999999999999999987   23999999999999988776     99999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccc--cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYT--STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      ||++......     .....||+.|+|||++  ....++.++||||||+++|+|++|+.||.......    ........
T Consensus       173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~  243 (287)
T 4f0f_A          173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIR  243 (287)
T ss_dssp             CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHH
T ss_pred             CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHh
Confidence            9999754332     2345789999999988  45567899999999999999999999996433211    11111111


Q ss_pred             hhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ..      ...     ...+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       244 ~~------~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 EE------GLR-----PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HS------CCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cc------CCC-----CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            10      011     122333456699999999999999999999999999753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.5e-46  Score=339.92  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=211.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|...+.||+|+||+||+|.+. +++.+|+|++.............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            46888999999999999999987 58899999997765555556778899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+||+++.++.+||+|||++.....
T Consensus        95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR-----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998764  37999999999999999999999999     99999999999999999999999999987643


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ......||+.|+|||.+....++.++||||||+++|+|++|+.||.....      ...........        
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~--------  231 (294)
T 2rku_A          168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNE--------  231 (294)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC--------
T ss_pred             Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhcc--------
Confidence            322  22335689999999999888899999999999999999999999964321      11111111111        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           ...+...+..+.+++.+||+.||++|||+.+++++..
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~  268 (294)
T 2rku_A          232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF  268 (294)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence                 1112223455899999999999999999999999865

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.2e-47  Score=367.23  Aligned_cols=259  Identities=25%  Similarity=0.390  Sum_probs=212.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||+||+|... +|+.||||++.............+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46999999999999999999987 79999999998765555556778999999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee---CCCCcEEEeecCcccc
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAKL  216 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~~~  216 (361)
                      ||+.+|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||+   +.++.+||+|||++..
T Consensus       106 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          106 EVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK-----IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             CCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999999764  37999999999999999999999999     9999999999999   4678999999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      +.....   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....   ....   ...+........ 
T Consensus       179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~---~~~i~~~~~~~~-  247 (484)
T 3nyv_A          179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDI---LKKVEKGKYTFE-  247 (484)
T ss_dssp             BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH---HHHHHHCCCCCC-
T ss_pred             cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHH---HHHHHcCCCCCC-
Confidence            654432   234579999999998865 68999999999999999999999996432   1112   222211111000 


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                        .+      .....+..+.+|+.+||+.||++|||+.|+++|.+-.-.
T Consensus       248 --~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          248 --LP------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             --SG------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             --Cc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence              00      011234568999999999999999999999999885433

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-46  Score=346.17  Aligned_cols=267  Identities=21%  Similarity=0.297  Sum_probs=211.1

Q ss_pred             cCHHHHHHHcCCCCCC-ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEE
Q 018047           51 FTLKEMEEATCSFSDD-NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIG  127 (361)
Q Consensus        51 ~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~  127 (361)
                      +.+...+...+.|.+. +.||+|+||+||+|... +|+.||+|++..... .......+.+|+.++..+. ||||+++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            3344455566678887 88999999999999987 699999999876432 2334567888999999995 699999999


Q ss_pred             EEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---CC
Q 018047          128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---NF  204 (361)
Q Consensus       128 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---~~  204 (361)
                      ++.+.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||++|     ++||||||+|||++.   ++
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g-----ivH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN-----IVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEESCBTTBC
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCcCChHHEEEecCCCCC
Confidence            9999999999999999999999997655568999999999999999999999999     999999999999998   78


Q ss_pred             cEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 018047          205 EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  284 (361)
                      .+||+|||++........   .....||+.|+|||++....++.++||||||+++|+|++|+.||.....   ......+
T Consensus       172 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i  245 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNI  245 (327)
T ss_dssp             CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH
T ss_pred             cEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHH
Confidence            999999999987654322   2345789999999999989999999999999999999999999964321   1111111


Q ss_pred             HHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .   .....        .. .......+..+.+|+.+||+.||++|||++++++|.+
T Consensus       246 ~---~~~~~--------~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          246 S---QVNVD--------YS-EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             H---HTCCC--------CC-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             H---hcccc--------cC-chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence            1   11000        00 1111233456899999999999999999999998865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.3e-46  Score=336.87  Aligned_cols=273  Identities=21%  Similarity=0.257  Sum_probs=212.8

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEE-EcCCEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYC-ADGKHRF  136 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~  136 (361)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++.....     ...+.+|+.+++.++|++++..+..+ .+++..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            4467999999999999999999975 689999998754322     23477899999999988776665554 6778899


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee---CCCCcEEEeecCc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGL  213 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~  213 (361)
                      +||||+ +++|.+++.... ..+++..+..++.|++.||+|||++|     ++||||||+|||+   +.++.+||+|||+
T Consensus        82 lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             EEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            999999 899999997532 36999999999999999999999999     9999999999999   7889999999999


Q ss_pred             cccCCCCCce-----eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          214 AKLMPEGQET-----YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       214 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      +.........     .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..............+....
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            9876543321     11234578999999999999899999999999999999999999997655444333333322211


Q ss_pred             hhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 018047          289 NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMP  354 (361)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~  354 (361)
                      ....  .....     ..    .+..+.+++.+||+.||++|||++++++.|++++.......+.+
T Consensus       235 ~~~~--~~~~~-----~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~  289 (296)
T 4hgt_A          235 MSTP--IEVLC-----KG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV  289 (296)
T ss_dssp             HHSC--HHHHT-----TT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCC
T ss_pred             ccch--hhhhh-----cc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCc
Confidence            1100  00000     11    13458999999999999999999999999999998877665544

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4e-46  Score=339.74  Aligned_cols=267  Identities=21%  Similarity=0.361  Sum_probs=205.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            46999999999999999999976 79999999997654455556678899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          140 EYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       140 e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||+++|+|.+++...  ....+++..++.++.|++.||.|||++|     ++|+||||+||+++.++.++|+|||++...
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999998642  2346899999999999999999999999     999999999999999999999999999866


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....  ......|++.|+|||++....++.++||||||+++|+|++|..||.....    ............       
T Consensus       187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~-------  253 (310)
T 2wqm_A          187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQC-------  253 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTT-------
T ss_pred             cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcc-------
Confidence            43322  22335689999999999888999999999999999999999999964321    111111111110       


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                      ..+...    ....+..+.+|+.+||+.||++|||+.++++.|+++......
T Consensus       254 ~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          254 DYPPLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             CSCCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             cCCCCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            001111    122345689999999999999999999999999998776543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.1e-47  Score=366.40  Aligned_cols=255  Identities=27%  Similarity=0.391  Sum_probs=201.7

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .+.|.+.+.||+|+||+||+|.+. ++..||+|++....... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            346999999999999999999987 68999999997654322 2356788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC---CcEEEeecCccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN---FEAKISDFGLAK  215 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~~  215 (361)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++..   +.+||+|||++.
T Consensus       115 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN-----IVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            9999999999988764  36999999999999999999999999     9999999999999764   559999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .+....   ......||+.|+|||++. ..++.++|||||||++|+|++|..||....   ....   ..........+.
T Consensus       188 ~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~---~~~i~~~~~~~~  257 (494)
T 3lij_A          188 VFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEI---LRKVEKGKYTFD  257 (494)
T ss_dssp             ECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH---HHHHHHTCCCCC
T ss_pred             ECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHH---HHHHHhCCCCCC
Confidence            765433   233457999999999875 568999999999999999999999996432   1122   222111111110


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         .+..      ...+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       258 ---~~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~  294 (494)
T 3lij_A          258 ---SPEW------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW  294 (494)
T ss_dssp             ---SGGG------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             ---chhc------ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence               0000      122345899999999999999999999999865

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-46  Score=336.61  Aligned_cols=253  Identities=22%  Similarity=0.308  Sum_probs=205.5

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|.+. ++..+|+|++.....   ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            446999999999999999999987 578999999875422   3356788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee---CCCCcEEEeecCccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAK  215 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~~  215 (361)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+||++   +.++.++|+|||++.
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           85 MELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN-----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            9999999999998764  36899999999999999999999999     9999999999999   788999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .+....   ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||....   .....   ...........
T Consensus       158 ~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~---~~~~~~~~~~~  227 (277)
T 3f3z_A          158 RFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVM---LKIREGTFTFP  227 (277)
T ss_dssp             ECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHHHCCCCCC
T ss_pred             eccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHH---HHHHhCCCCCC
Confidence            765443   2234568999999998765 48999999999999999999999996432   11111   11111111000


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ....     .    ..+..+.+++.+||+.||++|||+.++++|-+
T Consensus       228 ~~~~-----~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~  264 (277)
T 3f3z_A          228 EKDW-----L----NVSPQAESLIRRLLTKSPKQRITSLQALEHEW  264 (277)
T ss_dssp             HHHH-----T----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             chhh-----h----cCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            0000     0    12356899999999999999999999998765

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-46  Score=345.07  Aligned_cols=265  Identities=28%  Similarity=0.443  Sum_probs=206.4

Q ss_pred             CCCCCCceecccCceEEEEEEEcC-----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS-----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      .+|...+.||+|+||+||+|.+..     +..||+|.+...  ........+.+|+.+++.++||||+++++++.+.+..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            457778999999999999998752     235999998643  2334456788999999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||+++|+|.+++... ...+++..++.++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.
T Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999764 347999999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCcee-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          216 LMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       216 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      ......... ......+|+.|+|||++....++.++||||||+++|+|++ |+.||....   ....   ....... . 
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~---~~~~~~~-~-  267 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEV---MKAINDG-F-  267 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHH---HHHHHTT-C-
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC---HHHH---HHHHHCC-C-
Confidence            765432211 1222346788999999988899999999999999999999 999995332   1111   1111111 0 


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGL  351 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~  351 (361)
                           .     ...+...+..+.+++.+||+.||++||++.+++++|++++.......
T Consensus       268 -----~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~  315 (333)
T 1mqb_A          268 -----R-----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK  315 (333)
T ss_dssp             -----C-----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred             -----c-----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence                 0     11122345568999999999999999999999999999987665443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.4e-46  Score=359.42  Aligned_cols=266  Identities=21%  Similarity=0.253  Sum_probs=200.5

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  132 (361)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++.... ........+.+|+.+++.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            3568999999999999999999977 68999999997542 2344466788999999999999999999999654     


Q ss_pred             -CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          133 -KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       133 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                       ...|+||||+++ +|.+.+..    .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+||
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~-----iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChHhEEEeCCCCEEEEEE
Confidence             467999999976 57666643    5899999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh-
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND-  290 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-  290 (361)
                      |++.......   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.   ......+...... 
T Consensus       209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          209 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTP  282 (464)
T ss_dssp             CCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSC
T ss_pred             EeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence            9998764432   23346799999999999999999999999999999999999999964332   1111111111000 


Q ss_pred             ------------------h-----hhhhhhcCccccCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 ------------------R-----KKLRKVIDPELSRSS--YTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ------------------~-----~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                                        .     ..+...+...+....  .....+..+.+|+.+||..||++|||++|+++|.+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  358 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  358 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence                              0     000011111100000  01122567899999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=350.47  Aligned_cols=276  Identities=22%  Similarity=0.376  Sum_probs=201.8

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHH--HHhcCCCcceeEEEEEEc-----CC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDI--LSRLDHPNLVSLIGYCAD-----GK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~~~~~~~~-----~~  133 (361)
                      ++|++.+.||+|+||+||+|+. +++.||||++...      ....+..|.++  +..++||||+++++.+..     ..
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc------chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            5688999999999999999977 4899999998632      22334445555  445899999999986542     33


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CCCCCCeEecCCCCCCeeeCCCC
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS---------SAVGIPIVHRDFKSTNVLLSANF  204 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---------~~~~~~iiH~Dikp~Nill~~~~  204 (361)
                      ..++||||+++|+|.+++...   ..++..++.++.|++.||+|||++         |     |+||||||+|||++.++
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~-----ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA-----ISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC-----EECSSCSGGGEEECTTS
T ss_pred             eEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc-----eeecccccceEEEcCCC
Confidence            678999999999999999764   458999999999999999999999         8     99999999999999999


Q ss_pred             cEEEeecCccccCCCCCc------eeeeeecccccCccCcccccC-------CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 018047          205 EAKISDFGLAKLMPEGQE------TYVTARVLGTFGYFDPEYTST-------GKLTLQSDVYAFGVVLLELLTGRRAVDL  271 (361)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~p~~~  271 (361)
                      .+||+|||++..+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            999999999987653321      112234579999999998876       3566789999999999999999887754


Q ss_pred             CCCCCchhHH-----------HHHHHHhhhhhhhhhhcCccccC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          272 NQGVNDQNLV-----------LQVRHILNDRKKLRKVIDPELSR-SSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       272 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                      ..........           .........     ....+.+.. .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSR-----EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTT-----SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcc-----cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            3322111110           111111110     001111111 11223466789999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCCCcc
Q 018047          340 LQLIIYTNSKGLNMPLH  356 (361)
Q Consensus       340 l~~i~~~~~~~~~~~~~  356 (361)
                      |+.++..-+...+.+..
T Consensus       313 L~~ll~~~~~~~~~~~~  329 (336)
T 3g2f_A          313 MAELMMIWERNKSVSPT  329 (336)
T ss_dssp             HHHHHHCCCC-------
T ss_pred             HHHHHHHHHhcccCCCc
Confidence            99999877766665544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.4e-46  Score=363.52  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=205.9

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc----------hhHHHHHHHHHHHHhcCCCcceeEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA----------DGEHEFRVEVDILSRLDHPNLVSLIG  127 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~  127 (361)
                      ..++|.+.+.||+|+||+||+|... ++..||+|++........          ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4567999999999999999999987 688999999976543221          33567889999999999999999999


Q ss_pred             EEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC---
Q 018047          128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF---  204 (361)
Q Consensus       128 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~---  204 (361)
                      ++.+++..|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN-----IVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCcHHHEEEecCCCCc
Confidence            999999999999999999999998764  36999999999999999999999999     99999999999999776   


Q ss_pred             cEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 018047          205 EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  284 (361)
                      .+||+|||++.......   ......||+.|+|||++. ..++.++|||||||++|+|++|..||....   ....   .
T Consensus       187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~---~  256 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDI---I  256 (504)
T ss_dssp             SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH---H
T ss_pred             cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHH---H
Confidence            69999999998775443   223457999999999886 568999999999999999999999996432   1122   2


Q ss_pred             HHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      ..+......+.....         ...+..+.+|+.+||+.||.+|||+.|+++|.+-.
T Consensus       257 ~~i~~~~~~~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  306 (504)
T 3q5i_A          257 KKVEKGKYYFDFNDW---------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK  306 (504)
T ss_dssp             HHHHHCCCCCCHHHH---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHcCCCCCCcccc---------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence            221111110000000         01234589999999999999999999999998743

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-46  Score=346.46  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=212.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|++.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            356899999999999999999987 5889999999866555556677889999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++++|.+++...  ..+++..++.++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR-----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999998764  37999999999999999999999999     9999999999999999999999999998764


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  ......||+.|+|||++....++.++||||||+++|+|++|+.||.....      ............      
T Consensus       193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~------  258 (335)
T 2owb_A          193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNEY------  258 (335)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCC------
T ss_pred             cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcCCC------
Confidence            3322  22345689999999999888899999999999999999999999964321      111111111110      


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                             ..+...+..+.+|+.+||+.||++|||+.|++++-+
T Consensus       259 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~  294 (335)
T 2owb_A          259 -------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF  294 (335)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             -------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                   111223345889999999999999999999999865

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.5e-47  Score=355.83  Aligned_cols=271  Identities=24%  Similarity=0.351  Sum_probs=196.1

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCC--
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGK--  133 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--  133 (361)
                      ...++|++.+.||+|+||+||+|.+. +|+.||||++.... ........+.+|+.++..+. ||||+++++++...+  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            34568999999999999999999976 69999999986442 33445567788999999997 999999999997544  


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..|+||||++ |+|.+++...   .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            7899999997 5999998763   6899999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCC-------------------ceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 018047          214 AKLMPEGQ-------------------ETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQ  273 (361)
Q Consensus       214 ~~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~  273 (361)
                      ++.+....                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            98653311                   1112334579999999998865 678999999999999999999999996443


Q ss_pred             CCCchhHHHHHHHHhhhhh--hhhhhcC-----------------ccccCCC------------CCHHHHHHHHHHHHHc
Q 018047          274 GVNDQNLVLQVRHILNDRK--KLRKVID-----------------PELSRSS------------YTMESIAMFANLASRC  322 (361)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~--~~~~~~~-----------------~~~~~~~------------~~~~~~~~l~~li~~c  322 (361)
                      .   ......+........  .+.....                 .......            .....+..+.+|+.+|
T Consensus       236 ~---~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~  312 (388)
T 3oz6_A          236 T---MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL  312 (388)
T ss_dssp             H---HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred             H---HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence            2   111111111110000  0000000                 0000000            0002234689999999


Q ss_pred             cCCCCCCCCCHHHHHHHHH
Q 018047          323 VRTESSERPSMAECVKELQ  341 (361)
Q Consensus       323 l~~dp~~Rpt~~ell~~l~  341 (361)
                      |+.||++|||+.|+++|.+
T Consensus       313 L~~dP~~R~t~~e~l~Hp~  331 (388)
T 3oz6_A          313 LQFNPNKRISANDALKHPF  331 (388)
T ss_dssp             CCSSGGGSCCHHHHTTSTT
T ss_pred             hccCcccCCCHHHHhCCHH
Confidence            9999999999999999965

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.5e-46  Score=336.45  Aligned_cols=256  Identities=24%  Similarity=0.359  Sum_probs=205.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc---hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA---DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++.+.||+|+||+||+|... +|+.||+|++........   .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            35888999999999999999987 699999999976543322   23577899999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC----cEEEeecC
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF----EAKISDFG  212 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~----~~kl~Dfg  212 (361)
                      +||||+++++|.+++...  ..+++..+..++.|++.||.|||++|     ++|+||||+||+++.++    .++|+|||
T Consensus        85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999763  36899999999999999999999999     99999999999999877    89999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ++........   .....|++.|+|||++....++.++||||||+++|+|++|..||.....   .   ...........
T Consensus       158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~~~~  228 (283)
T 3bhy_A          158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---Q---ETLTNISAVNY  228 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHHHHTTCC
T ss_pred             cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---H---HHHHHhHhccc
Confidence            9987654322   2334689999999999888999999999999999999999999964321   1   11111111110


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..    .+..     ....+..+.+++.+||+.||++|||+.|+++|.+
T Consensus       229 ~~----~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  268 (283)
T 3bhy_A          229 DF----DEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW  268 (283)
T ss_dssp             CC----CHHH-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred             CC----cchh-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence            00    0000     0112345899999999999999999999999765

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-46  Score=339.65  Aligned_cols=266  Identities=25%  Similarity=0.347  Sum_probs=209.8

Q ss_pred             CCCCCceecccCceEEEEEEEc-CC---CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE-E
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SG---EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR-F  136 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~  136 (361)
                      .|...+.||+|+||+||+|.+. ++   ..+|+|.+...  ......+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            3556688999999999999864 23   37999998642  3344567888999999999999999999999876654 9


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+.+|+|.+++... ...+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++..
T Consensus       100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            999999999999999764 347899999999999999999999999     99999999999999999999999999986


Q ss_pred             CCCCCce--eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          217 MPEGQET--YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       217 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .......  .......+++.|+|||.+....++.++||||||+++|+|++|..|+.....  .......+..   . .  
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~---~-~--  245 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLAQ---G-R--  245 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHHT---T-C--
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhhc---C-C--
Confidence            6443211  122334678899999999999999999999999999999996666532221  1112111110   0 0  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCC
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLN  352 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~  352 (361)
                               ....+...+..+.+++.+||+.||.+|||+.++++.|++++..-.....
T Consensus       246 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~  294 (298)
T 3pls_A          246 ---------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY  294 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred             ---------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence                     0111223345689999999999999999999999999999887655443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-46  Score=338.65  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=209.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+.+.||+|+||+||+|... ++..||+|++.............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999987 58899999986543222333567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||.|||++|     ++||||||+||+++.++.++|+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK-----VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999997643  6899999999999999999999999     99999999999999999999999999976543


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..    .....|++.|+|||++.+..++.++||||||+++|+|++|..||.....      ...........        
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~--------  228 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNVD--------  228 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC--------
T ss_pred             cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhccc--------
Confidence            22    2235689999999999988999999999999999999999999964321      11111111110        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      .     ..+...+..+.+++.+||+.||++|||+.++++|.+--
T Consensus       229 ~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          229 L-----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             C-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             c-----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence            1     11222345689999999999999999999999987643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.4e-46  Score=334.75  Aligned_cols=272  Identities=21%  Similarity=0.257  Sum_probs=214.8

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEE-EcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYC-ADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~l  137 (361)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.....     ...+.+|+.+++.++|++++..+.++ .+++..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            467999999999999999999975 799999999865422     23578899999999988766655554 67788899


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC---CCCcEEEeecCcc
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS---ANFEAKISDFGLA  214 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~  214 (361)
                      ||||+ +++|.+++.... ..+++..++.++.|++.||+|||++|     ++||||||+|||++   .++.+||+|||++
T Consensus        83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            99999 899999997432 47999999999999999999999999     99999999999994   7899999999999


Q ss_pred             ccCCCCCcee-----eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          215 KLMPEGQETY-----VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       215 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      ..........     ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..............+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            8765443211     12345789999999999998999999999999999999999999976544333333333222111


Q ss_pred             hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 018047          290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMP  354 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~  354 (361)
                      ...  ...+.     .    ..+..+.+++.+||+.||++|||+.++++.|++++.........+
T Consensus       236 ~~~--~~~~~-----~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~  289 (296)
T 3uzp_A          236 STP--IEVLC-----K----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV  289 (296)
T ss_dssp             HSC--HHHHT-----T----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCC
T ss_pred             CCc--hHHHH-----h----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccc
Confidence            000  00011     1    123458999999999999999999999999999998877655443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.9e-47  Score=341.65  Aligned_cols=252  Identities=27%  Similarity=0.437  Sum_probs=205.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--------
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--------  131 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------  131 (361)
                      .+|+..+.||+|+||.||+|.+. +|+.||+|++....       ..+.+|+.+++.++||||+++++++..        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            46899999999999999999987 79999999986431       246679999999999999999998864        


Q ss_pred             --------CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC
Q 018047          132 --------GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN  203 (361)
Q Consensus       132 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~  203 (361)
                              ....++||||+++|+|.+++.......+++..++.++.|++.||.|||++|     ++|+||||+|||++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-----LINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEET
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCHHHEEEcCC
Confidence                    456899999999999999997654557999999999999999999999999     9999999999999999


Q ss_pred             CcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 018047          204 FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ  283 (361)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  283 (361)
                      +.+||+|||++........   .....||+.|+|||.+....++.++||||||+++|+|++|..|+..     .   ...
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~---~~~  227 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----T---SKF  227 (284)
T ss_dssp             TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----H---HHH
T ss_pred             CCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----H---HHH
Confidence            9999999999987754332   2234689999999999888899999999999999999999988731     0   011


Q ss_pred             HHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 018047          284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG  350 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~  350 (361)
                      .....          ...     .+...+..+.+++.+||+.||++|||+.|++++|+.+....+..
T Consensus       228 ~~~~~----------~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          228 FTDLR----------DGI-----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             HHHHH----------TTC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             HHHhh----------ccc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence            11110          001     11122345889999999999999999999999999987766554

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.9e-47  Score=341.32  Aligned_cols=253  Identities=26%  Similarity=0.372  Sum_probs=198.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+.+.||+|+||+||+|... ++..+|+|++....  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            35889999999999999999986 68999999997643  2334577889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee---CCCCcEEEeecCcc
Q 018047          140 EYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLA  214 (361)
Q Consensus       140 e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~  214 (361)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||++|     ++||||||+|||+   +.++.+||+|||++
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH-----VVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-----EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            999999999988542  2347999999999999999999999999     9999999999999   45688999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ..+....   ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.....   .   .........    
T Consensus       175 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~---~~~~~~~~~----  240 (285)
T 3is5_A          175 ELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---E---EVQQKATYK----  240 (285)
T ss_dssp             CC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHC----
T ss_pred             eecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---H---HHHhhhccC----
Confidence            8764432   223456899999999875 5688999999999999999999999964321   1   111111100    


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                          .+.....  ....+..+.+|+.+||+.||++|||+.|++++-
T Consensus       241 ----~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  280 (285)
T 3is5_A          241 ----EPNYAVE--CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE  280 (285)
T ss_dssp             ----CCCCCC----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred             ----Ccccccc--cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence                0110000  001234588999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.1e-46  Score=341.08  Aligned_cols=271  Identities=30%  Similarity=0.424  Sum_probs=210.9

Q ss_pred             CCCCceecccCceEEEEEEEc-----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CCEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR-----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GKHR  135 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~  135 (361)
                      |++.+.||+|+||+||++.+.     +++.||||++...  ........+.+|+.+++.++||||+++++++.+  ....
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            488899999999999988643     5789999999754  333456778999999999999999999999987  4688


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||+++|+|.+++...   .+++..++.++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~-----ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCchheEEEcCCCCEEECCccccc
Confidence            9999999999999999764   4999999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCcee-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH--HHhhhhh
Q 018047          216 LMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR--HILNDRK  292 (361)
Q Consensus       216 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~  292 (361)
                      ......... ......||+.|+|||++....++.++||||||+++|+|++|+.||......    ......  .......
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~  258 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK----FLELIGIAQGQMTVL  258 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh----hhhhhcccccchhHH
Confidence            876543321 233456788899999998888999999999999999999999998532110    000000  0000000


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      .+...+.... ....+...+..+.+|+.+||+.||++|||+.|+++.|+.+...-.
T Consensus       259 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          259 RLTELLERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            0111111111 122233445669999999999999999999999999999876654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-46  Score=343.42  Aligned_cols=266  Identities=24%  Similarity=0.382  Sum_probs=200.8

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-  133 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-  133 (361)
                      ..++|.+.+.||+|+||+||+|...    ++..||+|.+..... .......+.+|+.+++.++||||+++++++.+.+ 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            3456888899999999999999865    245899999865432 3344567889999999999999999999998755 


Q ss_pred             ----EEEEEEEecCCCchhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc
Q 018047          134 ----HRFLVYEYMQKGNLQDHLNG----IGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE  205 (361)
Q Consensus       134 ----~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~  205 (361)
                          ..++||||+++|+|.+++..    .....+++..++.++.|++.||.|||++|     ++||||||+|||++.++.
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT-----CCCCCCSGGGEEECTTSC
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCc
Confidence                35999999999999999842    22357999999999999999999999999     999999999999999999


Q ss_pred             EEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHH
Q 018047          206 AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~  284 (361)
                      +||+|||++................+++.|+|||.+....++.++||||||+++|+|++ |..||.....   ......+
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~  262 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDYL  262 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHH
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHH
Confidence            99999999987654433223334457889999999988899999999999999999999 8888864322   1111111


Q ss_pred             HHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                         ...       ..     ...+...+..+.+++.+||+.||++|||+.+++++|++++..-+
T Consensus       263 ---~~~-------~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          263 ---LHG-------HR-----LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             ---HTT-------CC-----CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ---HcC-------CC-----CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence               111       00     11122334568999999999999999999999999999987643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.6e-47  Score=348.09  Aligned_cols=280  Identities=27%  Similarity=0.380  Sum_probs=209.6

Q ss_pred             CCCCCCceecccCceEEEEEEE----c-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE--cCC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTL----R-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA--DGK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~----~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~  133 (361)
                      ++|++.+.||+|+||+||+|.+    . +++.||||++...   .....+.+.+|+.+++.++||||+++++++.  +.+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            3688899999999999999984    2 5889999998643   3444567899999999999999999999986  456


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++|     ++||||||+|||++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR-----CVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCChhhEEECCCCCEEEccccc
Confidence            7899999999999999997632 26999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCcee-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH--HHHhhh
Q 018047          214 AKLMPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV--RHILND  290 (361)
Q Consensus       214 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~--~~~~~~  290 (361)
                      +.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......    .....  ......
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~  249 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVPA  249 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CCH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhccccccccc
Confidence            98775443322 222345788899999998888999999999999999999999998532110    00000  000000


Q ss_pred             hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 018047          291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMP  354 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~  354 (361)
                      ...+...+.... ....+...+..+.+|+.+||+.||++|||+.|++++|+.++.........+
T Consensus       250 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~  312 (327)
T 3lxl_A          250 LSRLLELLEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA  312 (327)
T ss_dssp             HHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----------
T ss_pred             HHHHHHHhhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccc
Confidence            000000111111 112233445669999999999999999999999999999988776665443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-47  Score=352.40  Aligned_cols=272  Identities=16%  Similarity=0.199  Sum_probs=212.5

Q ss_pred             CCCCCCceecccCceEEEEEEEcC---------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCccee-------
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS---------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS-------  124 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-------  124 (361)
                      ++|.+.+.||+|+||+||+|.+..         ++.||+|++...        ..+.+|+.+++.++||||++       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            579999999999999999999763         789999998643        35778999999999999987       


Q ss_pred             --------EEEEEEc-CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCC
Q 018047          125 --------LIGYCAD-GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKS  195 (361)
Q Consensus       125 --------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp  195 (361)
                              +++++.. ++..|+||||+ +++|.+++.......+++..++.++.|++.||+|||++|     ++||||||
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dikp  187 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE-----YVHGNVTA  187 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCCG
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCCH
Confidence                    6777765 78999999999 999999998754457999999999999999999999999     99999999


Q ss_pred             CCeeeCCCC--cEEEeecCccccCCCCCcee-----eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 018047          196 TNVLLSANF--EAKISDFGLAKLMPEGQETY-----VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRA  268 (361)
Q Consensus       196 ~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  268 (361)
                      +|||++.++  .+||+|||++..+.......     ......||+.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999998  99999999998764322111     11234789999999999888999999999999999999999999


Q ss_pred             CCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          269 VDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      |...... ..............   .........    .....+..+.+|+.+||+.||++|||+.++++.|++++....
T Consensus       268 f~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          268 WTNCLPN-TEDIMKQKQKFVDK---PGPFVGPCG----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             TGGGTTC-HHHHHHHHHHHHHS---CCCEECTTS----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cccCCcC-HHHHHHHHHhccCC---hhhhhhhcc----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            9643321 11111111111111   111111100    001123558999999999999999999999999999998887


Q ss_pred             CCCCCC
Q 018047          349 KGLNMP  354 (361)
Q Consensus       349 ~~~~~~  354 (361)
                      .....|
T Consensus       340 ~~~~~~  345 (352)
T 2jii_A          340 VSPYDP  345 (352)
T ss_dssp             CCTTSC
T ss_pred             CCcCcc
Confidence            665544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.7e-46  Score=341.68  Aligned_cols=258  Identities=22%  Similarity=0.300  Sum_probs=198.8

Q ss_pred             CCCCCC-ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEE
Q 018047           61 CSFSDD-NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        61 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  137 (361)
                      +.|.+. +.||+|+||+||+|.+. +++.||||++....   ......+.+|+.++.++ +||||+++++++.+++..|+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            457774 78999999999999976 69999999997542   23456788899999985 79999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc---EEEeecCcc
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE---AKISDFGLA  214 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~---~kl~Dfg~~  214 (361)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||+++     ++||||||+|||++.++.   +||+|||++
T Consensus        89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG-----IAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             EEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            99999999999999764  36899999999999999999999999     999999999999998776   999999999


Q ss_pred             ccCCCCCc-----eeeeeecccccCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchh-----
Q 018047          215 KLMPEGQE-----TYVTARVLGTFGYFDPEYTST-----GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN-----  279 (361)
Q Consensus       215 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-----  279 (361)
                      ........     ........||+.|+|||++..     ..++.++|||||||++|+|++|+.||..........     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            86542211     111223468999999998764     557899999999999999999999997544322100     


Q ss_pred             ----HHHHHHHHhhhhhhhhhhcCccccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          280 ----LVLQVRHILNDRKKLRKVIDPELSRSSYTM----ESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       280 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                          .......+.....             ..+.    ..+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       242 ~~~~~~~~~~~i~~~~~-------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  298 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKY-------------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW  298 (316)
T ss_dssp             CHHHHHHHHHHHHHCCC-------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred             chhHHHHHHHHHhccCc-------------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence                0011111111100             1111    12345899999999999999999999999865

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.2e-46  Score=335.62  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=200.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357999999999999999999987 7999999998654322333456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||++|     ++|+||||+||+++.++.++|+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM-----VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC-----SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999997643  6899999999999999999999999     9999999999999999999999999998765


Q ss_pred             CCCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ...   ......|++.|+|||.+....+ +.++||||||+++|+|++|..||....   .   ...........      
T Consensus       163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~---~~~~~~~~~~~------  227 (276)
T 2h6d_A          163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---V---PTLFKKIRGGV------  227 (276)
T ss_dssp             C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHHCC------
T ss_pred             CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---H---HHHHHHhhcCc------
Confidence            432   1233468999999999877665 689999999999999999999995321   1   11111111110      


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                             ...+...+..+.+++.+||+.||++|||+.++++|-+
T Consensus       228 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~  264 (276)
T 2h6d_A          228 -------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW  264 (276)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             -------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence                   0112223455899999999999999999999999855

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.2e-46  Score=336.69  Aligned_cols=258  Identities=22%  Similarity=0.320  Sum_probs=204.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCc-chhHHHHHHHHHHHHhcCCCcceeEEEEEE--cCCEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKE-ADGEHEFRVEVDILSRLDHPNLVSLIGYCA--DGKHR  135 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~  135 (361)
                      .++|.+.+.||+|+||.||+|.+. ++..||+|++....... ......+.+|+.+++.++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999986 68999999986532111 234567889999999999999999999984  45688


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||++++ |.+++.......+++..+..++.|++.||+|||++|     ++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG-----IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999875 777777665668999999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGK--LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      ...............||+.|+|||++....  ++.++||||||+++|+|++|+.||....      .......+....  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~~--  229 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKGS--  229 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCC--
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcCC--
Confidence            765433332334457899999999886543  3779999999999999999999996422      111111111111  


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                                 ...+...+..+.+++.+||+.||++|||+.|+++|.+-
T Consensus       230 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  267 (305)
T 2wtk_C          230 -----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF  267 (305)
T ss_dssp             -----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred             -----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence                       01122234558899999999999999999999998663

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-46  Score=346.03  Aligned_cols=264  Identities=25%  Similarity=0.380  Sum_probs=207.5

Q ss_pred             cCCCCCCceecccCceEEEEEEE-----c-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTL-----R-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-----~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  133 (361)
                      .++|++.+.||+|+||+||+|.+     . ++..||||++...  ........+.+|+.+++.++||||+++++++.+.+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            45799999999999999999983     2 4778999998633  33445567889999999999999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---CCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGE-----PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---NFE  205 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---~~~  205 (361)
                      ..|+||||+++|+|.+++.....     ..+++..++.++.|++.||.|||++|     ++||||||+|||++.   +..
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCC
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-----eecCcCCHhHEEEecCCCcce
Confidence            99999999999999999976432     35899999999999999999999999     999999999999994   456


Q ss_pred             EEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHH
Q 018047          206 AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~  284 (361)
                      ++|+|||++................||+.|+|||++....++.++||||||+++|+|++ |..||....   .....   
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~---  255 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVL---  255 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHH---
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHH---
Confidence            99999999976543332223334567899999999988899999999999999999998 999985332   11111   


Q ss_pred             HHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      ...... .      .     ...+...+..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus       256 ~~~~~~-~------~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          256 EFVTSG-G------R-----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             HHHHTT-C------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             HHHhcC-C------C-----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence            111111 0      0     11122334568999999999999999999999999998876554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.5e-46  Score=361.98  Aligned_cols=257  Identities=25%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|.+. +++.||||++...... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            346999999999999999999987 7999999998653222 22356788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC---CCCcEEEeecCccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS---ANFEAKISDFGLAK  215 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~~  215 (361)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||++|     |+||||||+|||++   .++.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN-----IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            9999999999988764  37999999999999999999999999     99999999999995   45689999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .+....   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||....   ..   ..............
T Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~---~~~~~i~~~~~~~~  242 (486)
T 3mwu_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EY---DILKRVETGKYAFD  242 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHTCCCSC
T ss_pred             ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HH---HHHHHHHhCCCCCC
Confidence            765433   2334579999999999865 58999999999999999999999996432   11   12222211111000


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                         .+      .....+..+.+|+.+||+.||++|||+.|+++|.+--
T Consensus       243 ---~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~  281 (486)
T 3mwu_A          243 ---LP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ  281 (486)
T ss_dssp             ---SG------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHH
T ss_pred             ---Cc------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhc
Confidence               00      0112345589999999999999999999999997743

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.3e-47  Score=341.00  Aligned_cols=256  Identities=24%  Similarity=0.389  Sum_probs=201.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CC-------CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SG-------EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG  132 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  132 (361)
                      ++|.+.+.||+|+||+||+|.+. ++       ..||+|++...   .......+.+|+.+++.++||||+++++++.++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            46888999999999999999876 34       46999998542   234456788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc-------
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE-------  205 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~-------  205 (361)
                      +..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.       
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC-----eECCCcCcceEEEecCCcccccccc
Confidence            99999999999999999997643 34899999999999999999999999     999999999999998887       


Q ss_pred             -EEEeecCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 018047          206 -AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ  283 (361)
Q Consensus       206 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  283 (361)
                       +||+|||++......      ....||+.|+|||++.. ..++.++||||||+++|+|++|..|+.....  ..   ..
T Consensus       159 ~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~---~~  227 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQ---RK  227 (289)
T ss_dssp             EEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HH---HH
T ss_pred             eeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hH---HH
Confidence             999999999765322      22457899999998876 6789999999999999999996555432211  11   11


Q ss_pred             HHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 018047          284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG  350 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~  350 (361)
                       .........    +....         +..+.+|+.+||+.||++|||+.+++++|+.++......
T Consensus       228 -~~~~~~~~~----~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~  280 (289)
T 4fvq_A          228 -LQFYEDRHQ----LPAPK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP  280 (289)
T ss_dssp             -HHHHHTTCC----CCCCS---------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred             -HHHhhccCC----CCCCC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence             111111111    11111         223789999999999999999999999999988755443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-46  Score=338.11  Aligned_cols=258  Identities=25%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             CCCCCCceecccCceEEEEEEEcC----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|.+.+.||+|+||+||+|.+..    +..||+|.+...  ........+.+|+.+++.++||||+++++++.++ ..+
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT--SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc--cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            468889999999999999998652    335999998654  2334567889999999999999999999998754 568


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++++|.+++.... ..+++..+..++.|++.||.|||++|     ++||||||+||+++.++.+||+|||++..
T Consensus        89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCccceEEECCCCcEEeCccCCCcc
Confidence            9999999999999997642 36899999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      ....... ......+++.|+|||++....++.++||||||+++|+|++ |+.||.....   ......+..   . .   
T Consensus       163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~---~~~~~~~~~---~-~---  231 (281)
T 3cc6_A          163 IEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN---KDVIGVLEK---G-D---  231 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG---GGHHHHHHH---T-C---
T ss_pred             ccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh---HHHHHHHhc---C-C---
Confidence            6543221 2223456889999999988899999999999999999998 9999964322   122211111   0 0   


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                         .     ...+...+..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus       232 ---~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          232 ---R-----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ---C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---C-----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence               0     111222345589999999999999999999999999988764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-46  Score=356.05  Aligned_cols=259  Identities=25%  Similarity=0.380  Sum_probs=196.5

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCC-----cchhHHHHHHHHHHHHhcCCCcceeEEEEEEc
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFK-----EADGEHEFRVEVDILSRLDHPNLVSLIGYCAD  131 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  131 (361)
                      ...++|.+.+.||+|+||+||+|.+. +++.||||++......     .......+.+|+.+|+.++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45678999999999999999999987 6899999999764322     11223357889999999999999999999854


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC---cEEE
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF---EAKI  208 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~---~~kl  208 (361)
                       +..|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||+++     |+||||||+|||++.++   .+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEecCCCcceEEE
Confidence             5679999999999999998764  37999999999999999999999999     99999999999997544   5999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS---TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      +|||++.......   ......||+.|+|||++.   ...++.++|||||||++|+|++|..||.......  .....+.
T Consensus       284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~  358 (419)
T 3i6u_A          284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT  358 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHH
T ss_pred             eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHh
Confidence            9999998765432   233467999999999875   3667889999999999999999999996543221  1111111


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         ......    .+..     ....+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       359 ---~~~~~~----~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  402 (419)
T 3i6u_A          359 ---SGKYNF----IPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW  402 (419)
T ss_dssp             ---TTCCCC----CHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             ---cCCCCC----Cchh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence               100000    0000     0012345899999999999999999999999754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4e-46  Score=336.80  Aligned_cols=260  Identities=26%  Similarity=0.421  Sum_probs=206.5

Q ss_pred             CCCCCCc-eecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDN-FLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      .+|.+.+ .||+|+||+||+|.+.   +++.||||++.... ........+.+|+.+++.++||||+++++++ ..+..+
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            3577777 8999999999999643   47889999986542 2233467789999999999999999999999 566789


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++++|.+++...  ..+++..++.++.|++.||+|||++|     ++||||||+||+++.++.+||+|||++..
T Consensus        94 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC-----eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            999999999999999864  36999999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCcee-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          217 MPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       217 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ........ ......+++.|+|||.+....++.++||||||+++|+|++ |..||.....   ......    .....  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~----~~~~~--  237 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAM----LEKGE--  237 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHH----HHTTC--
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCC--
Confidence            75443321 1222346788999999988889999999999999999999 9999964321   111111    11100  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                          .     ...+...+..+.+++.+||+.||++|||+.++++.|+.++...
T Consensus       238 ----~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          238 ----R-----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             ----C-----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ----C-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                0     1122334556999999999999999999999999999987654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.8e-46  Score=351.02  Aligned_cols=266  Identities=21%  Similarity=0.272  Sum_probs=208.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC--------CCcceeEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD--------HPNLVSLIGYCA  130 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~~~~~~  130 (361)
                      .++|++.+.||+|+||+||+|.+. +++.||||++..    .......+.+|+.+++.++        |+||+++++++.
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            467999999999999999999976 688999999863    2344567888999999985        788999999987


Q ss_pred             ----cCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeEecCCCCCCeeeCCCC-
Q 018047          131 ----DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS-SAVGIPIVHRDFKSTNVLLSANF-  204 (361)
Q Consensus       131 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~iiH~Dikp~Nill~~~~-  204 (361)
                          ++...++||||+ +++|.+++.......+++..+..++.||+.||+|||++ |     |+||||||+|||++.++ 
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g-----ivHrDikp~NIll~~~~~  185 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR-----IIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECCCCSGGGEEECCCHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHeeEeccch
Confidence                566899999999 56777777655445799999999999999999999998 8     99999999999999775 


Q ss_pred             ------------------------------------------------cEEEeecCccccCCCCCceeeeeecccccCcc
Q 018047          205 ------------------------------------------------EAKISDFGLAKLMPEGQETYVTARVLGTFGYF  236 (361)
Q Consensus       205 ------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  236 (361)
                                                                      .+||+|||++......     .....||+.|+
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~  260 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYR  260 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGC
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCccc
Confidence                                                            7999999999876433     22346899999


Q ss_pred             CcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh-----------hhcCcc----
Q 018047          237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR-----------KVIDPE----  301 (361)
Q Consensus       237 aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~----  301 (361)
                      |||++.+..++.++|||||||++|+|++|+.||..............+.......+...           ..+...    
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            99999888999999999999999999999999976554432222222222211111000           000000    


Q ss_pred             --------------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          302 --------------LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       302 --------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                                    ......+...+..+.+|+.+||+.||++|||+.|+++|-
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  393 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP  393 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence                          001134567788899999999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-45  Score=341.35  Aligned_cols=275  Identities=26%  Similarity=0.370  Sum_probs=214.6

Q ss_pred             CHHHHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHh--cCCCcceeEEEEE
Q 018047           52 TLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSR--LDHPNLVSLIGYC  129 (361)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~  129 (361)
                      .........++|.+.+.||+|+||+||+|.+. |+.||||++..      .....+.+|.+++..  ++||||+++++++
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS------REERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG------GGHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc------hhHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            34444556678999999999999999999985 89999999853      234567788998887  7899999999999


Q ss_pred             EcCC----EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCCCeEecCCCCCC
Q 018047          130 ADGK----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH--------SSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       130 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~~~~~iiH~Dikp~N  197 (361)
                      .+..    ..++||||+++|+|.+++...   .+++..++.++.|++.||+|||        +++     ++||||||+|
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-----ivH~Dlkp~N  177 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-----IAHRDLKSKN  177 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-----EECSCCSGGG
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC-----eeeCCCCHHH
Confidence            8876    889999999999999999763   6899999999999999999999        788     9999999999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCcee--eeeecccccCccCcccccCCC------CCccchhHHHHHHHHHHHhC----
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETY--VTARVLGTFGYFDPEYTSTGK------LTLQSDVYAFGVVLLELLTG----  265 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g----  265 (361)
                      ||++.++.+||+|||++..........  ......||+.|+|||++....      ++.++||||||+++|+|++|    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            999999999999999998765443221  123457899999999886652      33689999999999999999    


Q ss_pred             ------CCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          266 ------RRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       266 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                            ..||........ ........ ..     .....+.+.........+..+.+|+.+||+.||++|||+.+++++
T Consensus       258 ~~~~~~~~p~~~~~~~~~-~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDP-SVEEMRKV-VC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSC-CHHHHHHH-HT-----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcccccccCccccCcCcc-cHHHHHHH-HH-----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                  677754332211 11111111 11     111122222111234667789999999999999999999999999


Q ss_pred             HHHHHhhcC
Q 018047          340 LQLIIYTNS  348 (361)
Q Consensus       340 l~~i~~~~~  348 (361)
                      |+++.....
T Consensus       331 L~~i~~~~~  339 (342)
T 1b6c_B          331 LSQLSQQEG  339 (342)
T ss_dssp             HHHHHHTTC
T ss_pred             HHHHHHHhc
Confidence            999987654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.7e-46  Score=340.20  Aligned_cols=262  Identities=27%  Similarity=0.401  Sum_probs=205.6

Q ss_pred             CCCCCCceecccCceEEEEEEEcC----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE-cCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA-DGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~  135 (361)
                      ..|++.+.||+|+||+||+|.+.+    +..+|+|.+...  ........+.+|+.+++.++||||+++++++. .++..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            358888999999999999998652    235899988642  33445677889999999999999999999864 56688


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||+++|+|.+++... ...+++..++.++.|++.||+|||++|     ++||||||+||+++.++.+||+|||++.
T Consensus       103 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             EEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC-----ccCCCCchheEEECCCCCEEECcccccc
Confidence            9999999999999999764 346899999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCce--eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          216 LMPEGQET--YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTG-RRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       216 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ........  .......||+.|+|||.+....++.++||||||+++|+|++| .+||......   ......   .... 
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~---~~~~-  249 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYL---LQGR-  249 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHHH---HTTC-
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHH---hcCC-
Confidence            76543221  122234578899999999888999999999999999999994 5555433221   111111   1110 


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                             .    ...+...+..+.+++.+||+.||++|||+.|+++.|+.++....
T Consensus       250 -------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          250 -------R----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             -------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             -------C----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                   0    11122234568999999999999999999999999999987643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-46  Score=360.44  Aligned_cols=273  Identities=21%  Similarity=0.266  Sum_probs=190.8

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc-----CC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD-----GK  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~  133 (361)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++... .........+.+|+.+|+.++||||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            467999999999999999999977 6999999998653 2344456778899999999999999999999843     35


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      .+|+||||+ +|+|.+++...  ..+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+||+|||+
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~-----iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG-----ILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cCCCCCChhhEEECCCCCEeeccccc
Confidence            789999998 57999999764  37999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCce-------------------------eeeeecccccCccCcccc-cCCCCCccchhHHHHHHHHHHHh---
Q 018047          214 AKLMPEGQET-------------------------YVTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLT---  264 (361)
Q Consensus       214 ~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~---  264 (361)
                      ++.+......                         ......+||+.|+|||++ ....++.++|||||||++|||++   
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            9876432110                         122345789999999975 56679999999999999999999   


Q ss_pred             --------CCCCCCCCCCCC--------------chhHHHHHHHHhhhhhh----------------hhhhcCccc--cC
Q 018047          265 --------GRRAVDLNQGVN--------------DQNLVLQVRHILNDRKK----------------LRKVIDPEL--SR  304 (361)
Q Consensus       265 --------g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~----------------~~~~~~~~~--~~  304 (361)
                              |+++|.......              .......+..+....+.                ....+....  ..
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL  362 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence                    566664322100              00001111111110000                000000000  00


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       305 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .......+..+.+|+.+||..||++|||++|+|+|-+
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~  399 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF  399 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence            0000122456899999999999999999999999876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-47  Score=353.14  Aligned_cols=264  Identities=27%  Similarity=0.411  Sum_probs=199.7

Q ss_pred             CCCCceecccCceEEEEEEEc--CC--CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc-CCEEEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLR--SG--EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD-GKHRFL  137 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l  137 (361)
                      |...+.||+|+||+||+|.+.  ++  ..||+|.+...  ........+.+|+.+++.++||||+++++++.+ ++..++
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            556688999999999999864  22  35899988642  334556788999999999999999999998754 568899


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++..+
T Consensus       169 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCccchheEEECCCCCEEEeeccccccc
Confidence            99999999999999764 346889999999999999999999999     999999999999999999999999999866


Q ss_pred             CCCCcee--eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          218 PEGQETY--VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       218 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .......  ......+|+.|+|||++....++.++||||||+++|||++ |.+||......   .....+.   ...   
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~~---~~~---  313 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLL---QGR---  313 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHHH---TTC---
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHHH---cCC---
Confidence            4332111  1223456789999999988999999999999999999999 67777543322   1111111   110   


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCC
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLN  352 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~  352 (361)
                               ....+..++..+.+++.+||+.||++|||+.|++++|+.++........
T Consensus       314 ---------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~  362 (373)
T 3c1x_A          314 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY  362 (373)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence                     0111223345689999999999999999999999999999887665443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.2e-46  Score=336.24  Aligned_cols=253  Identities=27%  Similarity=0.430  Sum_probs=209.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ..|+..+.||+|+||+||+|... +++.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            35888999999999999999976 689999999976532  334678899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++..   ..+++..+..++.|++.||.|||++|     ++|+||||+||+++.++.++|+|||++.....
T Consensus       100 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          100 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK-----KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             ECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCChheEEECCCCCEEEeecccceecCc
Confidence            99999999999865   36899999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  ......||+.|+|||++....++.++||||||+++|+|++|..||.....   ......   ....       ..
T Consensus       172 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~---~~~~-------~~  236 (303)
T 3a7i_A          172 TQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFL---IPKN-------NP  236 (303)
T ss_dssp             TBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH---HHHS-------CC
T ss_pred             ccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHH---hhcC-------CC
Confidence            321  22345789999999999888999999999999999999999999964321   111111   1110       01


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                      +     ..+...+..+.+|+.+||+.||++|||+.+++++.+-.
T Consensus       237 ~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          237 P-----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             C-----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             C-----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence            1     11222344589999999999999999999999987643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=339.60  Aligned_cols=255  Identities=31%  Similarity=0.484  Sum_probs=199.8

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|++.+.||+|+||+||+|.+. ++.||+|++..     ......+.+|+.+++.++||||+++++++.+  ..++|||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES-----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS-----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC-----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence            35888899999999999999886 78999999853     2345678899999999999999999998874  4789999


Q ss_pred             ecCCCchhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHhc---CCCCCCCeEecCCCCCCeeeCCCCc-EEEeecCccc
Q 018047          141 YMQKGNLQDHLNGIGE-PKMDWPLRLKVALGAAKGLAYLHS---SSAVGIPIVHRDFKSTNVLLSANFE-AKISDFGLAK  215 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~iiH~Dikp~Nill~~~~~-~kl~Dfg~~~  215 (361)
                      |+++|+|.+++..... ..+++..++.++.|+++||+|||+   +|     ++||||||+|||++.++. +||+|||++.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-----LIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC-----CCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC-----eecCCCChhHEEEeCCCCEEEEccccccc
Confidence            9999999999976432 357889999999999999999999   77     999999999999998886 7999999997


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .....     .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......    ...........     
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~-----  220 (307)
T 2eva_A          155 DIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHNG-----  220 (307)
T ss_dssp             ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHTT-----
T ss_pred             ccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhcC-----
Confidence            65332     12346899999999999889999999999999999999999999643221    11111111110     


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                        ..     .......+..+.+++.+||+.||++|||+.+++++|+.+......
T Consensus       221 --~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          221 --TR-----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             --CC-----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             --CC-----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence              01     111122345589999999999999999999999999998765543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=368.62  Aligned_cols=260  Identities=28%  Similarity=0.427  Sum_probs=206.7

Q ss_pred             eecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecCC
Q 018047           68 FLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        68 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      .||+|+||+||+|.+.   ++..||||++...  ........+.+|+.+|+.++||||+++++++.+ +..++||||+++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCC--CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC--CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            7999999999999865   3567999998754  233456789999999999999999999999976 568999999999


Q ss_pred             CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCcee
Q 018047          145 GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY  224 (361)
Q Consensus       145 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (361)
                      |+|.+++... ...+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||+++.+.......
T Consensus       420 g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          420 GPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             CBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             CcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            9999999754 347999999999999999999999999     9999999999999999999999999998765432211


Q ss_pred             -eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccc
Q 018047          225 -VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL  302 (361)
Q Consensus       225 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (361)
                       ......+++.|+|||++....++.++|||||||++|||++ |+.||.....   ......+.   .. .          
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~---~~-~----------  556 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIE---QG-K----------  556 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHHH---TT-C----------
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH---cC-C----------
Confidence             1122345689999999988999999999999999999998 9999964332   22221111   11 0          


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 018047          303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMP  354 (361)
Q Consensus       303 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~  354 (361)
                       ....+..++..+.+|+.+||+.||++|||+.++++.|+.++.........+
T Consensus       557 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~  607 (613)
T 2ozo_A          557 -RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG  607 (613)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCS
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCc
Confidence             012233445669999999999999999999999999999988876655443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.4e-46  Score=338.00  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=205.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|.+.+.||+|+||+||+|... +|+.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            346899999999999999999987 79999999997532   12235678899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee---CCCCcEEEeecCccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLAK  215 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~~  215 (361)
                      |||+++++|.+++...+  .+++..+..++.|++.||+|||++|     ++|+||||+||++   +.++.++|+|||++.
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           85 MQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG-----IVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             ECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            99999999999987643  6899999999999999999999999     9999999999999   778999999999997


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      ......    .....||+.|+|||++....++.++||||||+++|+|++|..||....   ....   ...+........
T Consensus       158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~---~~~i~~~~~~~~  227 (304)
T 2jam_A          158 MEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKL---FEKIKEGYYEFE  227 (304)
T ss_dssp             CCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHH---HHHHHHCCCCCC
T ss_pred             ecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHH---HHHHHcCCCCCC
Confidence            654321    223468999999999999999999999999999999999999995432   1111   111111111100


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                               .......+..+.+++.+||+.||++|||+.|+++|.+
T Consensus       228 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (304)
T 2jam_A          228 ---------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW  264 (304)
T ss_dssp             ---------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             ---------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence                     1111233456899999999999999999999999865

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.3e-46  Score=374.35  Aligned_cols=253  Identities=25%  Similarity=0.337  Sum_probs=210.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  137 (361)
                      .++|++.++||+|+||+||+|... +++.||||++.+...........+..|..++..+ +||+|+++++++.+.+.+||
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467888999999999999999987 6889999999754333334456778899999988 79999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++|+|.+++...+  .+++..+..++.||+.||+|||++|     |+||||||+||||+.++++||+|||+++..
T Consensus       420 V~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g-----IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS-----EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999998643  6999999999999999999999999     999999999999999999999999999864


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....  .....+||+.|+|||++....++.++|||||||++|||++|..||....   .   ......+....      
T Consensus       493 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~---~~~~~~i~~~~------  558 (674)
T 3pfq_A          493 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---E---DELFQSIMEHN------  558 (674)
T ss_dssp             CCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHSSC------
T ss_pred             ccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---H---HHHHHHHHhCC------
Confidence            33222  2345689999999999999999999999999999999999999996432   1   22222222221      


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSM-----AECVKEL  340 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~ell~~l  340 (361)
                             ..++...+..+.+||.+||+.||++||++     +|+++|-
T Consensus       559 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~  599 (674)
T 3pfq_A          559 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  599 (674)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred             -------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence                   11223345568999999999999999998     8888764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.6e-46  Score=343.37  Aligned_cols=268  Identities=25%  Similarity=0.394  Sum_probs=204.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|+..+.||+|+||+||+|.+. +|+.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            46888999999999999999987 58999999986543 23334566788999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||++|     ++||||||+|||++.++.+||+|||++..+..
T Consensus       104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC-----EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            999999999887653  36999999999999999999999999     99999999999999999999999999986644


Q ss_pred             CCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH-----------
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI-----------  287 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-----------  287 (361)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......   .....+...           
T Consensus       177 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          177 PGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI---DQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHHH
T ss_pred             Ccc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhhhH
Confidence            322  22345689999999988765 7899999999999999999999999644321   111111111           


Q ss_pred             hhhhhhhhhhcCccccCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          288 LNDRKKLRKVIDPELSRSSY----TMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ............+.......    ....+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  309 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF  309 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence            11111111111111111100    0123456899999999999999999999999865

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.1e-46  Score=347.67  Aligned_cols=261  Identities=25%  Similarity=0.384  Sum_probs=207.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.+. ++..||+|++...  ........+.+|+.+++.++||||+++++++.+++..++||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            46889999999999999999987 6899999998754  23445677889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS-SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||.|||++ |     ++||||||+|||++.++.++|+|||++....
T Consensus       111 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             ECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC-----EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999999997643  689999999999999999999996 8     9999999999999999999999999997542


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh----------
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL----------  288 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~----------  288 (361)
                      ..    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   ..........          
T Consensus       184 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          184 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK---ELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             HH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH---HHHHHHC-------------
T ss_pred             cc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccCCCCCCC
Confidence            21    223357899999999999999999999999999999999999999643211   1100000000          


Q ss_pred             ----------------------hhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          289 ----------------------NDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       289 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                                            .....+.....+...    ....+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP----SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCC----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCC----cccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                                  000000000111111    1123456899999999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-45  Score=343.97  Aligned_cols=260  Identities=26%  Similarity=0.440  Sum_probs=207.4

Q ss_pred             HHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCc-----chhHHHHHHHHHHHHhc-CCCcceeEEEE
Q 018047           56 MEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKE-----ADGEHEFRVEVDILSRL-DHPNLVSLIGY  128 (361)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  128 (361)
                      .....++|.+.+.||+|+||+||+|.+. +|+.||||++.......     ......+.+|+.+++.+ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445567999999999999999999987 79999999987643211     11245678899999999 79999999999


Q ss_pred             EEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEE
Q 018047          129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI  208 (361)
Q Consensus       129 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl  208 (361)
                      +...+..|+||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|     ++|+||||+|||++.++.++|
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g-----i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN-----IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999764  36999999999999999999999999     999999999999999999999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCccccc------CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS------TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL  282 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  282 (361)
                      +|||++..+.....   .....||+.|+|||++.      ...++.++|||||||++|+|++|..||....   ..   .
T Consensus       242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~---~  312 (365)
T 2y7j_A          242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QI---L  312 (365)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HH---H
T ss_pred             EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HH---H
Confidence            99999987754432   23457999999999875      3368889999999999999999999996422   11   1


Q ss_pred             HHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ....+.........   +..  .    ..+..+.+++.+||+.||++|||+.|+++|-
T Consensus       313 ~~~~i~~~~~~~~~---~~~--~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  361 (365)
T 2y7j_A          313 MLRMIMEGQYQFSS---PEW--D----DRSSTVKDLISRLLQVDPEARLTAEQALQHP  361 (365)
T ss_dssp             HHHHHHHTCCCCCH---HHH--S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHHHHHhCCCCCCC---ccc--c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence            11111111100000   000  0    1234589999999999999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-47  Score=348.57  Aligned_cols=267  Identities=24%  Similarity=0.332  Sum_probs=197.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|.+.+.||+|+||+||+|... +++.||+|++.....  ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            46888999999999999999987 789999999865321  111223456999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||++ |+|.+++...+ ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++.....
T Consensus        80 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK-----VLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             ECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT-----EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            9997 59999887653 36999999999999999999999999     99999999999999999999999999986543


Q ss_pred             CCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh--hhh-
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK--KLR-  295 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~-  295 (361)
                      ...  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....   ......+........  ... 
T Consensus       153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~  227 (324)
T 3mtl_A          153 PTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPG  227 (324)
T ss_dssp             ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTT
T ss_pred             Ccc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchh
Confidence            322  2233568999999998765 5689999999999999999999999964332   222222222111000  000 


Q ss_pred             --------hhcCccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          296 --------KVIDPELSRSS---YTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       296 --------~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                              ....+......   .....+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  284 (324)
T 3mtl_A          228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF  284 (324)
T ss_dssp             GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence                    00000000000   00122356889999999999999999999999876

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-46  Score=344.24  Aligned_cols=269  Identities=25%  Similarity=0.327  Sum_probs=200.3

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc--hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA--DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      ...++|++.+.||+|+||+||+|.+. +|+.||||++........  .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34567999999999999999999986 689999999865432211  123467789999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .++||||+++ +|.+++... ...+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW-----ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            9999999975 898888754 346889999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      ..+.....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....   ...   .+..+......
T Consensus       160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~---~~~---~~~~i~~~~~~  231 (346)
T 1ua2_A          160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLD---QLTRIFETLGT  231 (346)
T ss_dssp             STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHH---HHHHHHHHHCC
T ss_pred             eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHH---HHHHHHHHcCC
Confidence            87644322  2234578999999998865 458899999999999999999999986432   111   12222211110


Q ss_pred             hhhhcCcc-------cc---CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          294 LRKVIDPE-------LS---RSSYT-----MESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       294 ~~~~~~~~-------~~---~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ......+.       ..   ....+     ...+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence            00000000       00   00011     123456899999999999999999999999865

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.9e-46  Score=344.90  Aligned_cols=270  Identities=21%  Similarity=0.273  Sum_probs=196.3

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ...++|++.+.||+|+||+||+|.+. +++.||||++..... .......+.+|+.+++.++||||+++++++.+++..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34557999999999999999999976 689999999865432 2233456778999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC-----CCCcEEEeec
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS-----ANFEAKISDF  211 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~-----~~~~~kl~Df  211 (361)
                      +||||++ |+|.+++....  .+++..+..++.|++.||+|||++|     |+||||||+|||++     .++.+||+||
T Consensus       110 lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR-----CLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----EECCCCCHHHEEEecCCCCccceEEECcC
Confidence            9999997 59999997643  6999999999999999999999999     99999999999994     4556999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      |++..+.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....   ......+......
T Consensus       182 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~  256 (329)
T 3gbz_A          182 GLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGL  256 (329)
T ss_dssp             THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCC
T ss_pred             CCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCC
Confidence            99987643322  22335689999999988764 589999999999999999999999964321   1111111111100


Q ss_pred             hhh--------hhhhc--CccccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 RKK--------LRKVI--DPELSRSS----YTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ~~~--------~~~~~--~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...        .....  .+......    .+...+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  321 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY  321 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence            000        00000  00000000    00012356889999999999999999999998753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-46  Score=337.35  Aligned_cols=252  Identities=29%  Similarity=0.424  Sum_probs=199.8

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-CEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-KHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||++... |+.||+|++...     ...+.+.+|+.+++.++||||+++++++.+. +..++||
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            46888999999999999999876 889999998532     2456788999999999999999999997654 4789999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++.......+++..+..++.|++.||+|||++|     ++||||||+||+++.++.++|+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999997654334889999999999999999999999     99999999999999999999999999976543


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ..     ....+++.|+|||.+....++.++||||||+++|+|++ |+.||.....   ......   ....       .
T Consensus       170 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~---~~~~-------~  231 (278)
T 1byg_A          170 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR---VEKG-------Y  231 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHH---HTTT-------C
T ss_pred             cc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---HhcC-------C
Confidence            22     12357889999999988899999999999999999998 9999964322   111111   1110       0


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      .     ...+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       232 ~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          232 K-----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            0     112233445689999999999999999999999999988654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=344.88  Aligned_cols=259  Identities=19%  Similarity=0.216  Sum_probs=210.2

Q ss_pred             HHHcCCCCCCceecccCceEEEEEE------EcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC---CCcceeEEE
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGT------LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD---HPNLVSLIG  127 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~  127 (361)
                      ....++|.+.+.||+|+||+||+|.      ..+++.||||++...      ....+..|+.++..++   |+||+++++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            3345679999999999999999994      336899999998532      2446777888888886   899999999


Q ss_pred             EEEcCCEEEEEEEecCCCchhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC--
Q 018047          128 YCADGKHRFLVYEYMQKGNLQDHLNGI---GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA--  202 (361)
Q Consensus       128 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~--  202 (361)
                      ++..++..|+||||+++|+|.+++...   ....+++..++.++.|++.||+|||++|     |+||||||+|||++.  
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~-----ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE-----IIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCSGGGEEECGGG
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-----eecCCCCHHHEEecccc
Confidence            999999999999999999999999642   2457999999999999999999999999     999999999999998  


Q ss_pred             ---------CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 018047          203 ---------NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQ  273 (361)
Q Consensus       203 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  273 (361)
                               ++.+||+|||++..+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence                     89999999999976543222334455679999999999999999999999999999999999999995332


Q ss_pred             CCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHHHHhhcCC
Q 018047          274 GVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSER-PSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-pt~~ell~~l~~i~~~~~~  349 (361)
                      ...               ..    +...+...    .....+.+++..||+.+|.+| |+++++.+.|++.+..+..
T Consensus       290 ~~~---------------~~----~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~  343 (365)
T 3e7e_A          290 GGE---------------CK----PEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT  343 (365)
T ss_dssp             TTE---------------EE----ECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred             CCc---------------ee----echhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence            210               00    11111111    124457899999999999999 7899999999998877543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=344.97  Aligned_cols=260  Identities=24%  Similarity=0.429  Sum_probs=201.7

Q ss_pred             HHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc
Q 018047           54 KEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD  131 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  131 (361)
                      .++....++|++.+.||+|+||+||+|.+. +|+.||||++....    .....+.+|+.+++.+ +||||+++++++..
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            344445678999999999999999999986 68999999987532    2345788899999999 79999999999977


Q ss_pred             ------CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc
Q 018047          132 ------GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE  205 (361)
Q Consensus       132 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~  205 (361)
                            .+..++||||+++|+|.+++.......+++..+..++.|++.||.|||++|     ++|+||||+|||++.++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-----VIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTCC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCcHHHEEEcCCCC
Confidence                  568999999999999999998755557999999999999999999999999     999999999999999999


Q ss_pred             EEEeecCccccCCCCCceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 018047          206 AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNL  280 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  280 (361)
                      +||+|||++........  ......||+.|+|||++.     ...++.++|||||||++|+|++|..||.....   .. 
T Consensus       168 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~-  241 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MR-  241 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HH-
T ss_pred             EEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HH-
Confidence            99999999987643221  223356899999999876     56788999999999999999999999953321   11 


Q ss_pred             HHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                        ........       ..+.....    ..+..+.+++.+||..||.+|||+.++++|.+
T Consensus       242 --~~~~~~~~-------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~  289 (326)
T 2x7f_A          242 --ALFLIPRN-------PAPRLKSK----KWSKKFQSFIESCLVKNHSQRPATEQLMKHPF  289 (326)
T ss_dssp             --HHHHHHHS-------CCCCCSCS----CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred             --HHHHhhcC-------ccccCCcc----ccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence              11111111       11111111    22345899999999999999999999999754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-46  Score=337.69  Aligned_cols=261  Identities=22%  Similarity=0.353  Sum_probs=205.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE--cCCEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA--DGKHRF  136 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~  136 (361)
                      .++|++.+.||+|+||+||+|... +|+.||+|.+..... .......+.+|+.+++.++||||+++++++.  .++..+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            346889999999999999999987 689999999976543 2344667889999999999999999999875  467899


Q ss_pred             EEEEecCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          137 LVYEYMQKGNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      +||||+++|+|.+++....  ...+++..++.++.|++.||+|||+++..+.+++||||||+||+++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999999997532  34599999999999999999999998733334999999999999999999999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ........  ......|++.|+|||++....++.++||||||+++|+|++|..||....   .......   +....   
T Consensus       164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~---i~~~~---  232 (279)
T 2w5a_A          164 RILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGK---IREGK---  232 (279)
T ss_dssp             HHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---HHHTC---
T ss_pred             eeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHHH---Hhhcc---
Confidence            87644322  1223568999999999988889999999999999999999999996432   1111111   11110   


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                          .     ...+...+..+.+++.+||+.||++|||+.|++++++
T Consensus       233 ----~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          233 ----F-----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ----C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ----c-----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                0     1122234456899999999999999999999998765

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.1e-47  Score=368.63  Aligned_cols=262  Identities=29%  Similarity=0.452  Sum_probs=212.3

Q ss_pred             HcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ..++|++.+.||+|+||+||+|.+.++..||||++....    ...+.+.+|+.+|+.++||||+++++++.+ +..|+|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            345688889999999999999999877889999997532    234678899999999999999999999876 678999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++.......+++..++.++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++..+.
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            99999999999997543446899999999999999999999999     9999999999999999999999999998764


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .... .......++..|+|||++....++.++|||||||++|||++ |+.||....   .......   ....       
T Consensus       415 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~---~~~~~~~---i~~~-------  480 (535)
T 2h8h_A          415 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ---VERG-------  480 (535)
T ss_dssp             CHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC---HHHHHHH---HHTT-------
T ss_pred             CCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH---HHcC-------
Confidence            3211 11122346788999999988899999999999999999999 899995322   1111111   1111       


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                      .     ....+..++..+.+||.+||+.||++|||+.++++.|+.++.....
T Consensus       481 ~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          481 Y-----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             C-----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence            0     0112233456689999999999999999999999999988765543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-45  Score=333.39  Aligned_cols=252  Identities=28%  Similarity=0.440  Sum_probs=201.1

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc----CCEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD----GKHRF  136 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~  136 (361)
                      .|.+.+.||+|+||+||+|.+. ++..||+|++..... .......+.+|+.+++.++||||+++++++.+    ....+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4777889999999999999986 688999999876443 23446778899999999999999999999875    45789


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC-CCCcEEEeecCccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS-ANFEAKISDFGLAK  215 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~  215 (361)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||+++.   +++|+||||+|||++ .++.+||+|||++.
T Consensus       106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~---~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTP---PIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSS---CCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCC---CEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999999764  368999999999999999999999862   399999999999998 78999999999997


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      ......    .....||+.|+|||++. +.++.++||||||+++|+|++|+.||.....     ...........     
T Consensus       181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~-----  245 (290)
T 1t4h_A          181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSG-----  245 (290)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTT-----
T ss_pred             cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHHhcc-----
Confidence            654432    23356899999999876 4589999999999999999999999964321     11111111111     


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                        ..+.    ..+...+..+.+++.+||+.||++|||+.|+++|.
T Consensus       246 --~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  284 (290)
T 1t4h_A          246 --VKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  284 (290)
T ss_dssp             --CCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             --CCcc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence              0000    01111123589999999999999999999999874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=345.69  Aligned_cols=270  Identities=19%  Similarity=0.170  Sum_probs=201.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCCcc--------hhHHHHHHHHHHHHhcCCCcceeEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEA--------DGEHEFRVEVDILSRLDHPNLVSLIG  127 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~  127 (361)
                      .++|.+.+.||+|+||+||+|.+.    ++..+|+|++........        .....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            356999999999999999999976    478899999875421100        01234567888999999999999999


Q ss_pred             EEEc----CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC
Q 018047          128 YCAD----GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN  203 (361)
Q Consensus       128 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~  203 (361)
                      ++.+    ....|+||||+ +++|.+++...+  .+++..++.++.|++.||+|||++|     |+||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE-----YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCcCHHHEEEccC
Confidence            9987    78899999999 999999998754  7999999999999999999999999     9999999999999988


Q ss_pred             C--cEEEeecCccccCCCCCce-----eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 018047          204 F--EAKISDFGLAKLMPEGQET-----YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN  276 (361)
Q Consensus       204 ~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  276 (361)
                      +  .+||+|||++..+......     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....  
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--  265 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK--  265 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT--
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--
Confidence            7  9999999999876432211     011335789999999999888999999999999999999999999953221  


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      .............  ..+...+.....    ....+..+.+++.+||+.||++|||++++++.|+++..
T Consensus       266 ~~~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          266 DPVAVQTAKTNLL--DELPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             CHHHHHHHHHHHH--HTTTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             ccHHHHHHHHhhc--ccccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1111111111110  111111111110    01223458999999999999999999999999987654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-45  Score=351.93  Aligned_cols=201  Identities=24%  Similarity=0.355  Sum_probs=169.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----C
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----K  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  133 (361)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++... .........+.+|+.+|+.++||||+++++++...     +
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            457999999999999999999987 6889999999653 23344567788999999999999999999999766     5


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..|+||||+. |+|.+++...  ..+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCHHHeEECCCCCEEEccCCC
Confidence            7899999986 5999999764  36999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCce--------------------eeeeecccccCccCcccc-cCCCCCccchhHHHHHHHHHHHhCCCCC
Q 018047          214 AKLMPEGQET--------------------YVTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAV  269 (361)
Q Consensus       214 ~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~p~  269 (361)
                      ++........                    ......+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            9876543221                    122456899999999975 5667999999999999999999865444

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.5e-45  Score=342.00  Aligned_cols=263  Identities=21%  Similarity=0.275  Sum_probs=198.2

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-----
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-----  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  133 (361)
                      .++|++.+.||+|+||+||+|... +++.||||++.... ........+.+|+.+++.++||||+++++++...+     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            467999999999999999999977 68999999997543 23344567889999999999999999999997665     


Q ss_pred             -EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          134 -HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       134 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                       ..|+||||++ |+|.+++..    .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||
T Consensus       103 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          103 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             CEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC-----eecccCCHHHEEEcCCCCEEEEEee
Confidence             7899999997 488888853    5899999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ..+..+....+
T Consensus       173 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~  243 (371)
T 2xrw_A          173 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI------DQWNKVIEQLG  243 (371)
T ss_dssp             C-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHC-CC
T ss_pred             ccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhC
Confidence            998664322   223457899999999998889999999999999999999999999643221      11111111000


Q ss_pred             ---------------------------hhhhhcCccccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          293 ---------------------------KLRKVIDPELSRS--SYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       293 ---------------------------~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                                                 .+...+.......  ......+..+.+|+.+||+.||++|||++|+++|.+-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  322 (371)
T 2xrw_A          244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  322 (371)
T ss_dssp             CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence                                       0000000000000  0112336679999999999999999999999999873

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.7e-46  Score=343.59  Aligned_cols=267  Identities=18%  Similarity=0.282  Sum_probs=208.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchh--------------HHHHHHHHHHHHhcCCCcceeE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADG--------------EHEFRVEVDILSRLDHPNLVSL  125 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l~h~~iv~~  125 (361)
                      .++|.+.+.||+|+||+||+|.. +|+.||+|++..........              ...+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            45799999999999999999999 79999999987543222111              2788999999999999999999


Q ss_pred             EEEEEcCCEEEEEEEecCCCchhhh------cccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCe
Q 018047          126 IGYCADGKHRFLVYEYMQKGNLQDH------LNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNV  198 (361)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Ni  198 (361)
                      ++++.+.+..++||||+++|+|.++      +.......+++..++.++.|++.||+|||+ +|     ++|+||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-----i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-----ICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC-----EECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC-----EeecCCChHhE
Confidence            9999999999999999999999999      665445689999999999999999999999 99     99999999999


Q ss_pred             eeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCC-CCCc-cchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 018047          199 LLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTL-QSDVYAFGVVLLELLTGRRAVDLNQGVN  276 (361)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~ell~g~~p~~~~~~~~  276 (361)
                      +++.++.++|+|||++......    ......|++.|+|||++... .++. ++||||||+++|+|++|..||...... 
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-  258 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-  258 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred             EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence            9999999999999999876443    23345789999999998776 5666 999999999999999999999754321 


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCc---ccc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDP---ELS---RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       ..   ...........+......   ...   ........+..+.+|+.+||+.||.+|||+.|+++|-+
T Consensus       259 -~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          259 -VE---LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             -HH---HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             -HH---HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence             11   111111111110000000   000   00001234456899999999999999999999998743

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=348.98  Aligned_cols=258  Identities=25%  Similarity=0.344  Sum_probs=205.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCC-cchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFK-EADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  134 (361)
                      ++|++.+.||+|+||+||+|...    +|+.||||++...... .......+.+|+.++..+ +||||+++++++.+.+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            46999999999999999999873    6899999998643211 122334566799999999 69999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||.|||+++     |+||||||+|||++.++.+||+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999997643  6999999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      +.+...... ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.........  ........... 
T Consensus       207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~-  282 (355)
T 1vzo_A          207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE-  282 (355)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC-
T ss_pred             eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC-
Confidence            876433221 2334579999999998875  45788999999999999999999999654332221  11111111110 


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                                  ...+...+..+.+|+.+||..||++||     |++|+++|..
T Consensus       283 ------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          283 ------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             ------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence                        112233445689999999999999999     9999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.8e-46  Score=334.36  Aligned_cols=248  Identities=23%  Similarity=0.295  Sum_probs=200.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++...... ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            46899999999999999999987 7999999999765333 33456778899999999 899999999999999999999


Q ss_pred             EEecCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-------------
Q 018047          139 YEYMQKGNLQDHLNGIG--EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-------------  203 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-------------  203 (361)
                      |||+++|+|.+++....  ...+++..+..++.|++.||+|||++|     ++||||||+|||++.+             
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-----LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEC---------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999997532  146899999999999999999999999     9999999999999844             


Q ss_pred             ------CcEEEeecCccccCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 018047          204 ------FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVN  276 (361)
Q Consensus       204 ------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  276 (361)
                            ..++|+|||++.......      ...||+.|+|||++... .++.++||||||+++|+|++|..++...    
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----  234 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----  234 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----
Confidence                  479999999998765432      23589999999988765 5668999999999999999999876321    


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                        ....   .....       ..+     ..+...+..+.+++.+||+.||++|||+.|+++|.+
T Consensus       235 --~~~~---~~~~~-------~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  282 (289)
T 1x8b_A          235 --DQWH---EIRQG-------RLP-----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV  282 (289)
T ss_dssp             --HHHH---HHHTT-------CCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred             --hHHH---HHHcC-------CCC-----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence              1111   11110       011     112223456899999999999999999999998754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-46  Score=345.35  Aligned_cols=264  Identities=22%  Similarity=0.337  Sum_probs=199.1

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-----
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-----  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  133 (361)
                      .++|+..+.||+|+||+||+|.+. +|+.||||++.... ........+.+|+.+++.++||||+++++++...+     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            457999999999999999999986 69999999986543 33344567889999999999999999999997653     


Q ss_pred             -EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          134 -HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       134 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                       ..|+||||+ +++|.+++..   ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCcCHHHEEEcCCCCEEEEeee
Confidence             469999999 7899999876   36899999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      ++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....   ......+.......
T Consensus       174 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~~  245 (367)
T 1cm8_A          174 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTP  245 (367)
T ss_dssp             TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCC
T ss_pred             cccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence            99876432     223578999999998766 6789999999999999999999999964332   11111111111000


Q ss_pred             -hhhhhhc-----------Ccccc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 -KKLRKVI-----------DPELS---RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 -~~~~~~~-----------~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       ..+...+           .+...   ........+..+.+|+.+||..||++|||+.|+++|..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~  310 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  310 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence             0000000           00000   00111223456899999999999999999999999865

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.6e-45  Score=350.51  Aligned_cols=265  Identities=21%  Similarity=0.284  Sum_probs=206.3

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc------CCCcceeEEEEEEc
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL------DHPNLVSLIGYCAD  131 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~  131 (361)
                      ...+|++.+.||+|+||+||+|.+. +++.||||++..    .......+.+|+.+++.+      +|+||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3457999999999999999999977 589999999863    234456677888888887      57799999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc--EEEe
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE--AKIS  209 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~--~kl~  209 (361)
                      .+..++||||+. ++|.+++.......+++..+..++.|++.||+|||+++     |+||||||+|||++.++.  +||+
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR-----IIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT-----EECSCCSGGGEEESSTTSCCEEEC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEEccCCCcceEEe
Confidence            999999999996 69999998766667999999999999999999999999     999999999999999887  9999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      |||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|..||.....   ......+.....
T Consensus       245 DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~---~~~l~~i~~~~~  316 (429)
T 3kvw_A          245 DFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE---GDQLACMIELLG  316 (429)
T ss_dssp             CCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHC
T ss_pred             ecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcC
Confidence            999997654322     235789999999999888999999999999999999999999964432   222222211111


Q ss_pred             h--------hhhhhhhcCccc-----------------------------cCCCCCH------HHHHHHHHHHHHccCCC
Q 018047          290 D--------RKKLRKVIDPEL-----------------------------SRSSYTM------ESIAMFANLASRCVRTE  326 (361)
Q Consensus       290 ~--------~~~~~~~~~~~~-----------------------------~~~~~~~------~~~~~l~~li~~cl~~d  326 (361)
                      .        .......++..-                             .......      ..+..+.+|+.+||+.|
T Consensus       317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d  396 (429)
T 3kvw_A          317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD  396 (429)
T ss_dssp             CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence            0        000000000000                             0000000      11356899999999999


Q ss_pred             CCCCCCHHHHHHHHH
Q 018047          327 SSERPSMAECVKELQ  341 (361)
Q Consensus       327 p~~Rpt~~ell~~l~  341 (361)
                      |++|||+.|+|+|.+
T Consensus       397 P~~Rpta~e~L~Hpw  411 (429)
T 3kvw_A          397 PAVRMTPGQALRHPW  411 (429)
T ss_dssp             TTTSCCHHHHHTSTT
T ss_pred             hhhCCCHHHHhCChh
Confidence            999999999999866

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.1e-46  Score=338.19  Aligned_cols=263  Identities=27%  Similarity=0.385  Sum_probs=199.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc--CCC--EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR--SGE--VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++.+.||+|+||+||+|.+.  +++  .||+|++.............+.+|+.+++.++||||+++++++.++. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            46889999999999999999864  333  68999987654445556778999999999999999999999998765 78


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||.|||++|     ++|+||||+||+++.++.+||+|||++..
T Consensus        97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCchheEEEcCCCCEEEcccccccc
Confidence            9999999999999997542 36899999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCcee-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          217 MPEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       217 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      ........ ......+|+.|+|||++....++.++||||||+++|+|++ |..||.....   .   ...........  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~---~~~~~~~~~~~--  242 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---S---QILHKIDKEGE--  242 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H---HHHHHHHTSCC--
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---H---HHHHHHHccCC--
Confidence            75443322 2233457888999999988889999999999999999999 9999954321   1   11111111100  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                               ....+...+..+.+++.+||+.||++|||+.+++++|+++....
T Consensus       243 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          243 ---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                     01122234566999999999999999999999999999876543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.2e-47  Score=356.58  Aligned_cols=247  Identities=15%  Similarity=0.199  Sum_probs=193.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHH---HHHhcCCCcceeEE-------EE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVD---ILSRLDHPNLVSLI-------GY  128 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~~iv~~~-------~~  128 (361)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+.+|+.   .++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            356888899999999999999975 69999999998654455556778899995   45555899999988       77


Q ss_pred             EEcCCE-----------------EEEEEEecCCCchhhhcccCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCC
Q 018047          129 CADGKH-----------------RFLVYEYMQKGNLQDHLNGIGE-----PKMDWPLRLKVALGAAKGLAYLHSSSAVGI  186 (361)
Q Consensus       129 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~  186 (361)
                      +.+.+.                 .|+||||+ +|+|.+++...+.     ..+++..++.++.|++.||+|||++|    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----  226 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----  226 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT----
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC----
Confidence            776543                 78999999 6899999975321     12335888899999999999999999    


Q ss_pred             CeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCC-----------CCCccchhHHH
Q 018047          187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-----------KLTLQSDVYAF  255 (361)
Q Consensus       187 ~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Diwsl  255 (361)
                       |+||||||+|||++.++.+||+|||++.....     ......| +.|+|||++...           .++.++|||||
T Consensus       227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl  299 (377)
T 3byv_A          227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL  299 (377)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred             -eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence             99999999999999999999999999986432     2234567 999999998877           89999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 018047          256 GVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE  335 (361)
Q Consensus       256 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e  335 (361)
                      ||++|||++|+.||........                ...... ..  .    ..+..+.+|+.+||+.||++|||+.|
T Consensus       300 G~il~elltg~~Pf~~~~~~~~----------------~~~~~~-~~--~----~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          300 GLVIYWIWCADLPITKDAALGG----------------SEWIFR-SC--K----NIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHHHSSCCC------CC----------------SGGGGS-SC--C----CCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHHHCCCCCcccccccc----------------hhhhhh-hc--c----CCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            9999999999999954322111                001110 00  1    12345899999999999999999999


Q ss_pred             HHHHHH
Q 018047          336 CVKELQ  341 (361)
Q Consensus       336 ll~~l~  341 (361)
                      +++|.+
T Consensus       357 ~l~hp~  362 (377)
T 3byv_A          357 AMETPE  362 (377)
T ss_dssp             HHTSHH
T ss_pred             HhhChH
Confidence            998654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=336.95  Aligned_cols=254  Identities=23%  Similarity=0.371  Sum_probs=202.5

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      ..+.|++.+.||+|+||+||+|.+. +|+.||+|.+...     .....+.+|+.++..++||||+++++++.+.+..++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            4457999999999999999999987 6899999998653     224568889999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++|+|.+++... ...+++..+..++.|++.||.|||++|     ++|+||||+||+++.++.++|+|||++...
T Consensus       102 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR-----KIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            99999999999998643 347999999999999999999999999     999999999999999999999999999876


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....  ......|++.|+|||.+....++.++||||||+++|+|++|..||.....   .   .........       
T Consensus       176 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~~-------  240 (314)
T 3com_A          176 TDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---M---RAIFMIPTN-------  240 (314)
T ss_dssp             BTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHHHHHHHS-------
T ss_pred             hhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---H---HHHHHHhcC-------
Confidence            44322  22335689999999999888999999999999999999999999963321   1   111111110       


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..+.+   ..+...+..+.+|+.+||+.||.+|||+.+++++.+
T Consensus       241 ~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~  281 (314)
T 3com_A          241 PPPTF---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF  281 (314)
T ss_dssp             CCCCC---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             CCccc---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence            01111   112223456899999999999999999999998765

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.8e-46  Score=338.14  Aligned_cols=264  Identities=23%  Similarity=0.347  Sum_probs=204.7

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE----cCCE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA----DGKH  134 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~  134 (361)
                      .++|++.+.||+|+||.||++... +|+.||||++...   .......+.+|+.+++.++||||+++++++.    ....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            457999999999999999999985 7999999998642   3445677889999999999999999999986    3457


Q ss_pred             EEEEEEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          135 RFLVYEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      .++||||+++|+|.+++...  ....+++..++.++.|++.||+|||+++     ++||||||+|||++.++.+||+|||
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-----YAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEcCCCCEEEEecC
Confidence            89999999999999998752  2347999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCcee-------eeeecccccCccCcccccCCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 018047          213 LAKLMPEGQETY-------VTARVLGTFGYFDPEYTSTGK---LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL  282 (361)
Q Consensus       213 ~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  282 (361)
                      ++..........       ......||+.|+|||++....   ++.++||||||+++|+|++|+.||........ ....
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~  258 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL  258 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH
Confidence            987653211100       011235799999999886544   68899999999999999999999942111100 0100


Q ss_pred             HHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ..    ..          ... .......+..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus       259 ~~----~~----------~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          259 AV----QN----------QLS-IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             HH----HC----------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             Hh----hc----------cCC-CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            00    00          000 1111223456999999999999999999999999999875433

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.3e-45  Score=335.21  Aligned_cols=264  Identities=21%  Similarity=0.302  Sum_probs=208.2

Q ss_pred             cCCCCCCceecccCceEEEEEEE-c-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCC------cceeEEEEEEc
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTL-R-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP------NLVSLIGYCAD  131 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~  131 (361)
                      .++|++.+.||+|+||+||+|.+ . +++.||||++..    .......+.+|+.+++.++|+      +++++++++.+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            45799999999999999999987 3 588999999853    234456788899999988665      49999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---------
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---------  202 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---------  202 (361)
                      .+..++||||+ +++|.+++.......+++..+..++.|++.||+|||++|     ++||||||+|||++.         
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK-----LTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESCCCEEEEEC-
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHHHEEEeccccccccCC
Confidence            99999999999 889999998766567999999999999999999999999     999999999999987         


Q ss_pred             ----------CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 018047          203 ----------NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLN  272 (361)
Q Consensus       203 ----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  272 (361)
                                ++.+||+|||++.......     ....||+.|+|||++....++.++|||||||++|+|++|..||...
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                      6689999999998654322     2357899999999998889999999999999999999999999643


Q ss_pred             CCCCchhHHHHHHHHhhhhhh----------------------------hhhhcCccccCCCCCHHHHHHHHHHHHHccC
Q 018047          273 QGVNDQNLVLQVRHILNDRKK----------------------------LRKVIDPELSRSSYTMESIAMFANLASRCVR  324 (361)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  324 (361)
                      ..   ......+.........                            ......+...........+..+.+|+.+||+
T Consensus       238 ~~---~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          238 DS---KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             CH---HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             Ch---HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            32   2222222221110000                            0000011111122234567789999999999


Q ss_pred             CCCCCCCCHHHHHHHHH
Q 018047          325 TESSERPSMAECVKELQ  341 (361)
Q Consensus       325 ~dp~~Rpt~~ell~~l~  341 (361)
                      .||++|||+.|+++|-+
T Consensus       315 ~dP~~Rpt~~ell~hp~  331 (339)
T 1z57_A          315 YDPAKRITLREALKHPF  331 (339)
T ss_dssp             SSTTTSCCHHHHTTSGG
T ss_pred             cCcccccCHHHHhcCHH
Confidence            99999999999998743

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-45  Score=345.10  Aligned_cols=266  Identities=23%  Similarity=0.303  Sum_probs=198.0

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc----
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD----  131 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  131 (361)
                      +...++|++.+.||+|+||+||+|.+. +|+.||||++.....       ...+|+.+++.++||||+++++++..    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            345678999999999999999999976 799999999864321       12369999999999999999999843    


Q ss_pred             ----------------------------------CCEEEEEEEecCCCchhhhccc--CCCCCCCHHHHHHHHHHHHHHH
Q 018047          132 ----------------------------------GKHRFLVYEYMQKGNLQDHLNG--IGEPKMDWPLRLKVALGAAKGL  175 (361)
Q Consensus       132 ----------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~l  175 (361)
                                                        ....++||||++ |+|.+.+..  .....+++..+..++.|++.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              334889999998 587777653  2244799999999999999999


Q ss_pred             HHHhcCCCCCCCeEecCCCCCCeeeC-CCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCC-CCCccchhH
Q 018047          176 AYLHSSSAVGIPIVHRDFKSTNVLLS-ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVY  253 (361)
Q Consensus       176 ~~lH~~~~~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw  253 (361)
                      +|||++|     |+||||||+|||++ .++.+||+|||++..+.....   .....||+.|+|||++.+. .++.++|||
T Consensus       155 ~~LH~~g-----i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          155 GFIHSLG-----ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHTTT-----EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHCc-----CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            9999999     99999999999998 689999999999987654432   2335689999999987664 589999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh---------hhhhhhcCccccCCC----CCHHHHHHHHHHHH
Q 018047          254 AFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR---------KKLRKVIDPELSRSS----YTMESIAMFANLAS  320 (361)
Q Consensus       254 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~----~~~~~~~~l~~li~  320 (361)
                      ||||++|+|++|+.||.....   ......+.......         .......-+......    .+...+..+.+|+.
T Consensus       227 slG~il~ell~g~~pf~~~~~---~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  303 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETS---IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE  303 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence            999999999999999964322   11111111111000         000000001110000    12224456899999


Q ss_pred             HccCCCCCCCCCHHHHHHHHH
Q 018047          321 RCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       321 ~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +||+.||++|||+.|+++|-+
T Consensus       304 ~~L~~dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          304 QILRYEPDLRINPYEAMAHPF  324 (383)
T ss_dssp             HHCCSSGGGSCCHHHHHTSGG
T ss_pred             HHccCChhhCCCHHHHhcCHH
Confidence            999999999999999998765

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.7e-45  Score=341.45  Aligned_cols=267  Identities=22%  Similarity=0.344  Sum_probs=203.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--------
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--------  131 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------  131 (361)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++...... ......+.+|+.+++.++||||+++++++.+        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46999999999999999999986 7999999998665332 2334567789999999999999999999877        


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      .+..|+||||+++ +|.+.+.... ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCHHHEEEcCCCCEEEccc
Confidence            4578999999975 7777776542 36999999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCce--eeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          212 GLAKLMPEGQET--YVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       212 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      |++..+......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....   .......+....
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~  245 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQLALISQLC  245 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHH
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHh
Confidence            999876432211  12234578999999998765 568999999999999999999999996432   222222222211


Q ss_pred             hhhhhhhhhcCccc------------cCCCCCH--H-----HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          289 NDRKKLRKVIDPEL------------SRSSYTM--E-----SIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       289 ~~~~~~~~~~~~~~------------~~~~~~~--~-----~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..   ......+..            .......  .     .+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus       246 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  314 (351)
T 3mi9_A          246 GS---ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  314 (351)
T ss_dssp             CC---CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CC---CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence            11   100000000            0000000  0     1245889999999999999999999999865

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=337.92  Aligned_cols=266  Identities=28%  Similarity=0.439  Sum_probs=209.1

Q ss_pred             CCCCCCceecccCceEEEEEEE-----cCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC--
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTL-----RSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK--  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  133 (361)
                      ++|++.+.||+|+||+||+|..     .+|+.||+|++...   .......+.+|+.+++.++||||+++++++...+  
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            4588899999999999999984     25889999998642   3345667899999999999999999999987654  


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++|     ++||||||+|||++.++.+||+|||+
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR-----YIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCCCcceEEEcCCCcEEEecCcc
Confidence            7899999999999999997653 36999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCceee-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC---------CCchhHHHH
Q 018047          214 AKLMPEGQETYV-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG---------VNDQNLVLQ  283 (361)
Q Consensus       214 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---------~~~~~~~~~  283 (361)
                      +........... .....++..|+|||.+....++.++||||||+++|+|++|..|+.....         .........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            987755432211 2234567789999999888899999999999999999999998853210         000000001


Q ss_pred             HHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      +.....          ... ....+..++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       272 ~~~~~~----------~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          272 LIELLK----------NNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHH----------TTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhh----------cCC-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            111110          000 0112333456699999999999999999999999999988653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-45  Score=337.20  Aligned_cols=255  Identities=27%  Similarity=0.401  Sum_probs=198.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCC-----cchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFK-----EADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  133 (361)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++......     .......+.+|+.+++.++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            346999999999999999999987 6899999998654321     1223346788999999999999999999997765


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc---EEEee
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE---AKISD  210 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~---~kl~D  210 (361)
                       .|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     ++||||||+|||++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEecCCCCCeEEEcc
Confidence             89999999999999998764  47999999999999999999999999     999999999999987654   99999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYT---STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      ||++.......   ......||+.|+|||++   ....++.++|||||||++|+|++|..||.......  .....+.. 
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-  234 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS-  234 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH-
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh-
Confidence            99998764432   12235689999999986   35678899999999999999999999996543321  11111111 


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE  339 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~  339 (361)
                        .....    .+..     ....+..+.+|+.+||+.||++|||+.++++|
T Consensus       235 --~~~~~----~~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          235 --GKYNF----IPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             --TCCCC----CHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --Ccccc----Cchh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence              10000    0000     01123458999999999999999999999965

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.4e-45  Score=328.37  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=200.1

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .|....+||+|+||+||+|.+. ++..||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            3556668999999999999976 6889999998753   23345678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-CCcEEEeecCccccCC
Q 018047          141 YMQKGNLQDHLNGIG-EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLMP  218 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~~~  218 (361)
                      |+++++|.+++.... ...+++..+..++.|++.||+|||++|     ++|+||||+||+++. ++.+||+|||++....
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC-----EEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            999999999997642 335678999999999999999999999     999999999999987 8999999999998764


Q ss_pred             CCCceeeeeecccccCccCcccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGK--LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ....  ......|++.|+|||++....  ++.++||||||+++|+|++|+.||.....   .... ......       .
T Consensus       175 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~-~~~~~~-------~  241 (295)
T 2clq_A          175 GINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE---PQAA-MFKVGM-------F  241 (295)
T ss_dssp             C-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS---HHHH-HHHHHH-------H
T ss_pred             CCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc---hhHH-HHhhcc-------c
Confidence            4321  223456899999999886543  78999999999999999999999953221   1111 101000       0


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...+     ..+...+..+.+++.+||+.||++|||+.+++++-.
T Consensus       242 ~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~  281 (295)
T 2clq_A          242 KVHP-----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF  281 (295)
T ss_dssp             CCCC-----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred             cccc-----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence            0111     122334456899999999999999999999998744

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-45  Score=365.98  Aligned_cols=253  Identities=26%  Similarity=0.425  Sum_probs=201.4

Q ss_pred             ceecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecC
Q 018047           67 NFLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ  143 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (361)
                      +.||+|+||+||+|.+.   +++.||||++.... ......+.+.+|+.+|..++||||+++++++.+ +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            47999999999999653   46789999986532 223446789999999999999999999999975 45789999999


Q ss_pred             CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCce
Q 018047          144 KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET  223 (361)
Q Consensus       144 ~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (361)
                      +|+|.+++...  ..+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+||+|||+++.+......
T Consensus       453 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~-----iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          453 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999999764  37999999999999999999999999     999999999999999999999999999877543321


Q ss_pred             -eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          224 -YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       224 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                       .......+|+.|+|||++....++.++|||||||++|||++ |+.||.....   ......+.   .. .         
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~---~~-~---------  589 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLE---KG-E---------  589 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH---TT-C---------
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH---cC-C---------
Confidence             12223456789999999998999999999999999999998 9999964321   11111111   10 0         


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                        ....+..++..+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus       590 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          590 --RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence              0122334456699999999999999999999999999998765

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.1e-45  Score=335.90  Aligned_cols=259  Identities=20%  Similarity=0.316  Sum_probs=202.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEc--CCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCAD--GKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~  136 (361)
                      ++|++.+.||+|+||+||+|.+. +++.||||++...      ....+.+|+.+++.++ ||||+++++++.+  ....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            46899999999999999999976 6899999998532      2457889999999997 9999999999988  67889


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-cEEEeecCccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-EAKISDFGLAK  215 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~  215 (361)
                      +||||+++++|.+++.     .+++..+..++.|++.||+|||++|     ++||||||+|||++.++ .+||+|||++.
T Consensus       110 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             EEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            9999999999999985     3889999999999999999999999     99999999999999776 89999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .......   .....|++.|+|||++.. ..++.++|||||||++|+|++|+.||.....  .......+...... ..+
T Consensus       180 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~-~~~  253 (330)
T 3nsz_A          180 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGT-EDL  253 (330)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCH-HHH
T ss_pred             EcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCC-chh
Confidence            7654432   233468999999998866 6789999999999999999999999954322  11111111111110 000


Q ss_pred             hhhc-------Cc---------------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          295 RKVI-------DP---------------ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       295 ~~~~-------~~---------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...+       ++               ...........+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~  322 (330)
T 3nsz_A          254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  322 (330)
T ss_dssp             HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred             hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence            0000       00               00001111223566899999999999999999999998753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=339.00  Aligned_cols=268  Identities=24%  Similarity=0.325  Sum_probs=194.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEE-------
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCA-------  130 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-------  130 (361)
                      ..+|++.+.||+|+||+||+|.+. +++.||||++...   .......+.+|+.++..+. ||||+++++++.       
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            346899999999999999999986 6899999998543   3345567889999999996 999999999984       


Q ss_pred             -cCCEEEEEEEecCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEE
Q 018047          131 -DGKHRFLVYEYMQKGNLQDHLNGI-GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI  208 (361)
Q Consensus       131 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl  208 (361)
                       .....+++|||+. |+|.+++... ....+++..++.++.|++.||+|||+++.   +++||||||+|||++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~---~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP---PIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS---CCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC---CEEEccCCcccEEECCCCCEEE
Confidence             3456899999996 7999988642 23469999999999999999999999762   3999999999999999999999


Q ss_pred             eecCccccCCCCCcee----------eeeecccccCccCcccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 018047          209 SDFGLAKLMPEGQETY----------VTARVLGTFGYFDPEYT---STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGV  275 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  275 (361)
                      +|||++..........          ......||+.|+|||++   ....++.++||||||+++|+|++|..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998765432211          11134589999999987   5667889999999999999999999999532211


Q ss_pred             CchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCCCCc
Q 018047          276 NDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMPL  355 (361)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~~~~  355 (361)
                            .....    ...           .......+..+.+|+.+||+.||++|||+.|++++|+.+..........+.
T Consensus       260 ------~~~~~----~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~  318 (337)
T 3ll6_A          260 ------RIVNG----KYS-----------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI  318 (337)
T ss_dssp             ----------------CC-----------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred             ------HhhcC----ccc-----------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccH
Confidence                  00000    000           000111122378999999999999999999999999999887665554443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.8e-45  Score=332.12  Aligned_cols=259  Identities=24%  Similarity=0.346  Sum_probs=207.2

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCc------chhHHHHHHHHHHHHhcC-CCcceeEEEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKE------ADGEHEFRVEVDILSRLD-HPNLVSLIGYC  129 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~  129 (361)
                      ...++|++.+.||+|+||+||+|.+. +|+.||||++.......      ......+.+|+.+++.+. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34567999999999999999999987 68999999997643211      123456788999999995 99999999999


Q ss_pred             EcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 018047          130 ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKIS  209 (361)
Q Consensus       130 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~  209 (361)
                      .+++..++||||+++++|.+++...  ..+++..+..++.|++.||.|||++|     ++|+||||+||+++.++.+||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEEC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEEcCCCcEEEe
Confidence            9999999999999999999999764  37999999999999999999999999     9999999999999999999999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCccccc------CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS------TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ  283 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  283 (361)
                      |||++........   .....|++.|+|||++.      ...++.++||||||+++|+|++|..||.....      ...
T Consensus       167 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~  237 (298)
T 1phk_A          167 DFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLM  237 (298)
T ss_dssp             CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH
T ss_pred             cccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHH
Confidence            9999987654332   23356899999999874      45688999999999999999999999954321      111


Q ss_pred             HHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...........        . .......+..+.+++.+||+.||++|||+.|+++|-+
T Consensus       238 ~~~~~~~~~~~--------~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (298)
T 1phk_A          238 LRMIMSGNYQF--------G-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF  286 (298)
T ss_dssp             HHHHHHTCCCC--------C-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             HHHHhcCCccc--------C-cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence            11111111000        0 0111233456899999999999999999999998643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.7e-46  Score=340.70  Aligned_cols=268  Identities=23%  Similarity=0.385  Sum_probs=189.0

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ...++|++.+.||+|+||+||+|... +++.||||++.....  ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            34567999999999999999999975 689999998864421  233567888999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 018047          137 LVYEYMQKGNLQDHLNGI------GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISD  210 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~D  210 (361)
                      +||||+++|+|.+++...      ....+++..+..++.|++.||.|||++|     ++||||||+||+++.++.+||+|
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-----QIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTCCEEECC
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCCCCChhhEEEcCCCCEEEEe
Confidence            999999999999998631      2346899999999999999999999999     99999999999999999999999


Q ss_pred             cCccccCCCCCce---eeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 018047          211 FGLAKLMPEGQET---YVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH  286 (361)
Q Consensus       211 fg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  286 (361)
                      ||++.........   .......||+.|+|||++.. ..++.++||||||+++|+|++|+.||......   ....  ..
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~--~~  239 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM---KVLM--LT  239 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHH--HH
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh---hHHH--HH
Confidence            9999876433211   12234568999999998765 56889999999999999999999999654321   1111  11


Q ss_pred             HhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..........    ...........+..+.+++.+||+.||++|||+.++++|.+
T Consensus       240 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  290 (303)
T 2vwi_A          240 LQNDPPSLET----GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF  290 (303)
T ss_dssp             HTSSCCCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred             hccCCCcccc----ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence            1111111100    00001111223356899999999999999999999998753

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.3e-44  Score=346.21  Aligned_cols=268  Identities=20%  Similarity=0.244  Sum_probs=212.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC-CcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l  137 (361)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++.....     ...+..|+++++.++| +++..+..++.+.+..++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            467999999999999999999976 699999998865432     2347789999999986 566667777788889999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee---CCCCcEEEeecCcc
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL---SANFEAKISDFGLA  214 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~  214 (361)
                      ||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|     |+||||||+||||   +.++.+||+|||++
T Consensus        81 vme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g-----IvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            99999 899999997542 37999999999999999999999999     9999999999999   57899999999999


Q ss_pred             ccCCCCCcee-----eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          215 KLMPEGQETY-----VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       215 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      ..+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            8765433211     12246799999999999999999999999999999999999999976544433333332222111


Q ss_pred             hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 018047          290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG  350 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~  350 (361)
                      . ..+.. +.     .    ..+.++.+|+..||+.||++||++.+|++.|++++......
T Consensus       234 ~-~~~~~-l~-----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~  283 (483)
T 3sv0_A          234 A-TSIEA-LC-----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ  283 (483)
T ss_dssp             H-SCHHH-HH-----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             c-ccHHH-Hh-----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence            0 00100 00     1    11345899999999999999999999999999998765433

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.3e-46  Score=333.81  Aligned_cols=258  Identities=23%  Similarity=0.358  Sum_probs=190.8

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|.+. +|+.||+|++.... ........+..+...++.++||||+++++++.+++..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            356889999999999999999986 78999999986542 2222333444555567888999999999999999999999


Q ss_pred             EEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          139 YEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSS-SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      |||++ |+|.+++...  ....+++..+..++.|++.||+|||++ |     ++||||||+||+++.++.+||+|||++.
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-----VIHRDVKPSNVLINALGQVKMCDFGISG  158 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC-----CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence            99997 5888877541  234799999999999999999999998 8     9999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccc----cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYT----STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      .......   .....||+.|+|||++    ....++.++||||||+++|+|++|+.||.....     ....+...... 
T Consensus       159 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~-  229 (290)
T 3fme_A          159 YLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEE-  229 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHS-
T ss_pred             ccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhcc-
Confidence            7644322   2234689999999985    566788999999999999999999999963221     11111111111 


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                            ..+...    ....+..+.+++.+||+.||++|||+.|+++|.+--
T Consensus       230 ------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~  271 (290)
T 3fme_A          230 ------PSPQLP----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT  271 (290)
T ss_dssp             ------CCCCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             ------CCCCcc----cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence                  011111    122345589999999999999999999999987643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.4e-46  Score=348.92  Aligned_cols=259  Identities=13%  Similarity=0.045  Sum_probs=188.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc--CCCcceeEE-------EEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL--DHPNLVSLI-------GYCA  130 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~~~  130 (361)
                      ..|...+.||+|+||+||+|.+. +|+.||||++.............+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            34888999999999999999987 7899999999876554555667788886555555  699988865       5554


Q ss_pred             cC-----------------CEEEEEEEecCCCchhhhcccCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCCC
Q 018047          131 DG-----------------KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLR------LKVALGAAKGLAYLHSSSAVGIP  187 (361)
Q Consensus       131 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~------~~i~~~i~~~l~~lH~~~~~~~~  187 (361)
                      ..                 ...|+||||++ |+|.+++...+. .+.+..+      ..++.|++.||+|||++|     
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-----  214 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG-----  214 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-----
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-----
Confidence            33                 34899999998 899999976422 3455555      677899999999999999     


Q ss_pred             eEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhC
Q 018047          188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTG  265 (361)
Q Consensus       188 iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g  265 (361)
                      |+||||||+|||++.++.+||+|||++......     .....+|+.|+|||++..  ..++.++|||||||++|+|++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999876422     113457799999999877  6789999999999999999999


Q ss_pred             CCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          266 RRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       266 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +.||...........         .............. .......+..+.+|+.+||+.||++|||+.++++|.+
T Consensus       290 ~~Pf~~~~~~~~~~~---------~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  355 (371)
T 3q60_A          290 FLPFGLVTPGIKGSW---------KRPSLRVPGTDSLA-FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE  355 (371)
T ss_dssp             SCSTTBCCTTCTTCC---------CBCCTTSCCCCSCC-CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred             CCCCCCcCcccccch---------hhhhhhhccccccc-hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence            999965432211000         00000000001111 0111234566999999999999999999999998765

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.4e-45  Score=343.02  Aligned_cols=266  Identities=18%  Similarity=0.252  Sum_probs=205.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-----------CCcceeEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-----------HPNLVSLIGY  128 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~  128 (361)
                      ++|.+.+.||+|+||+||+|.+. +++.||||++..    .......+.+|+.+++.++           ||||++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            46999999999999999999976 689999999863    2334567788999999886           8999999999


Q ss_pred             EEcCC----EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeEecCCCCCCeeeC--
Q 018047          129 CADGK----HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS-SAVGIPIVHRDFKSTNVLLS--  201 (361)
Q Consensus       129 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~iiH~Dikp~Nill~--  201 (361)
                      +...+    ..++||||+ +++|.+++.......+++..+..++.|++.||+|||++ |     |+||||||+|||++  
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~-----ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG-----IIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECSCCSGGGEEEEEE
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC-----EEecCCChHHeEEecc
Confidence            87654    789999999 88999999876666799999999999999999999998 8     99999999999994  


Q ss_pred             ----CCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 018047          202 ----ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND  277 (361)
Q Consensus       202 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  277 (361)
                          ..+.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence                44589999999998764322     234689999999999888999999999999999999999999975443221


Q ss_pred             hhHHHHHHHHhhhhhhhhh-----------hcCc------------------cccCCCCCHHHHHHHHHHHHHccCCCCC
Q 018047          278 QNLVLQVRHILNDRKKLRK-----------VIDP------------------ELSRSSYTMESIAMFANLASRCVRTESS  328 (361)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~-----------~~~~------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~  328 (361)
                      ......+.......+....           .+..                  .......+...+..+.+|+.+||+.||+
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence            1111122111111010000           0000                  0001235567888999999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 018047          329 ERPSMAECVKELQ  341 (361)
Q Consensus       329 ~Rpt~~ell~~l~  341 (361)
                      +|||+.|+++|.+
T Consensus       324 ~Rpt~~ell~hp~  336 (373)
T 1q8y_A          324 KRADAGGLVNHPW  336 (373)
T ss_dssp             TCBCHHHHHTCGG
T ss_pred             ccCCHHHHhhChh
Confidence            9999999999865

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.6e-46  Score=336.86  Aligned_cols=254  Identities=22%  Similarity=0.365  Sum_probs=199.5

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .+.|++.+.||+|+||+||+|.+. +++.||+|++...   .......+.+|+.++..++||||+++++++.+++..++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            356999999999999999999987 6899999998643   233456788899999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++++|.+++... ...+++..+..++.|++.||.|||++|     ++||||||+||+++.++.+||+|||++....
T Consensus        95 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR-----IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999999988653 236999999999999999999999999     9999999999999999999999999875321


Q ss_pred             CCCceeeeeecccccCccCcccc-----cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          219 EGQETYVTARVLGTFGYFDPEYT-----STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      ...  .......||+.|+|||++     ....++.++||||||+++|+|++|..||.....      ...........  
T Consensus       169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~--  238 (302)
T 2j7t_A          169 KTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSD--  238 (302)
T ss_dssp             HHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC--
T ss_pred             ccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccC--
Confidence            111  112234689999999987     467788999999999999999999999964321      11111111110  


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                           .+.   ...+...+..+.+++.+||+.||++|||+.++++|.
T Consensus       239 -----~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  277 (302)
T 2j7t_A          239 -----PPT---LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP  277 (302)
T ss_dssp             -----CCC---CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred             -----Ccc---cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence                 000   111223345689999999999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.4e-45  Score=338.54  Aligned_cols=277  Identities=19%  Similarity=0.259  Sum_probs=204.2

Q ss_pred             CHHHHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCc--------chhHHHHHHHHHHHHhcCCCcce
Q 018047           52 TLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKE--------ADGEHEFRVEVDILSRLDHPNLV  123 (361)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv  123 (361)
                      ...++....++|.+.+.||+|+||+||+|...+|..||||++.......        ......+.+|+.+++.++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            4567788899999999999999999999998889999999986532221        12246788999999999999999


Q ss_pred             eEEEEEEc-----CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCe
Q 018047          124 SLIGYCAD-----GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNV  198 (361)
Q Consensus       124 ~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Ni  198 (361)
                      ++++++..     ....|+||||++ |+|.+++... ...+++..+..++.|++.||.|||++|     ++||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG-----VVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc-----CEecCCChHHE
Confidence            99999843     347899999997 6888888754 347999999999999999999999999     99999999999


Q ss_pred             eeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 018047          199 LLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND  277 (361)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  277 (361)
                      |++.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....   
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---  239 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF---  239 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred             EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH---
Confidence            99999999999999997543332   2234568999999998766 6789999999999999999999999964321   


Q ss_pred             hhHHHHHHHHhhhh----------hhhhhhcCccccCC-C-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          278 QNLVLQVRHILNDR----------KKLRKVIDPELSRS-S-----YTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       278 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~-~-----~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ......+.......          ......+....... .     .....+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            11111111111100          00001111111000 0     01122355899999999999999999999999865

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.4e-45  Score=336.70  Aligned_cols=261  Identities=21%  Similarity=0.330  Sum_probs=201.8

Q ss_pred             HHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC--CCcceeEEEEEEcCC
Q 018047           56 MEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD--HPNLVSLIGYCADGK  133 (361)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~  133 (361)
                      +....++|++.+.||+|+||.||++...+++.||+|++..... .......+.+|+.++..++  ||||+++++++.+++
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            3344567999999999999999999988899999999976432 3345677889999999997  599999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..++||| +.+++|.+++...  ..+++..+..++.|++.||.|||+++     ++||||||+|||++. +.+||+|||+
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG-----IVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             EEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcccEEEEC-CeEEEeeccc
Confidence            9999999 5688999999864  37899999999999999999999999     999999999999964 8999999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTST-----------GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL  282 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  282 (361)
                      +..+.............||+.|+|||++..           ..++.++||||||+++|+|++|+.||.....     ...
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~  247 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QIS  247 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHH
Confidence            987654433323344578999999998764           4688899999999999999999999953321     111


Q ss_pred             HHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ......          .+... ...+...+..+.+++.+||+.||++|||+.|++++.+-
T Consensus       248 ~~~~~~----------~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~  296 (313)
T 3cek_A          248 KLHAII----------DPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  296 (313)
T ss_dssp             HHHHHH----------CTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHHHH----------hcccc-cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence            111111          11110 11112224568999999999999999999999998764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-45  Score=343.05  Aligned_cols=265  Identities=22%  Similarity=0.339  Sum_probs=187.7

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----  132 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  132 (361)
                      ..++|+..+.||+|+||+||+|.+. +|+.||||++.... ........+.+|+.+++.++||||+++++++...     
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            3468999999999999999999976 68999999986542 3334456788999999999999999999998654     


Q ss_pred             -CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          133 -KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       133 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                       ...|+|||++ +++|.+++..   ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECC-
T ss_pred             CCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHhhEEECCCCCEEEeec
Confidence             5679999999 6899999875   36999999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      |+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....   ......+......
T Consensus       177 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~  248 (367)
T 2fst_X          177 GLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGT  248 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCS
T ss_pred             ccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Confidence            999865432     223578999999998766 6789999999999999999999999964332   1112221111110


Q ss_pred             h-hhhhhhcC--------cccc-CCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 R-KKLRKVID--------PELS-RSSYTM-----ESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ~-~~~~~~~~--------~~~~-~~~~~~-----~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      . ......+.        ..+. ....+.     ..+..+.+|+.+||..||++|||+.|+++|.+
T Consensus       249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~  314 (367)
T 2fst_X          249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  314 (367)
T ss_dssp             CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence            0 00000000        0000 000010     12356899999999999999999999999865

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.1e-44  Score=337.74  Aligned_cols=268  Identities=21%  Similarity=0.300  Sum_probs=204.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----C
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----K  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  133 (361)
                      .++|++.+.||+|+||+||+|.+. ++..||||++...  ........+.+|+.++..++||||+++++++...     .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            457999999999999999999977 6889999998643  3344456788999999999999999999999764     4


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..|+||||+. |+|.+++...   .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCChHhEEECCCCCEEEEeCcc
Confidence            7899999997 5999998753   6999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCcee-eeeecccccCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          214 AKLMPEGQETY-VTARVLGTFGYFDPEYTS-TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       214 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      +.......... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......   .....+.......
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~  251 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSP  251 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG---GHHHHHHHHHCSC
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHHHhCCC
Confidence            98764332211 123457899999999754 455899999999999999999999999654332   2222221111100


Q ss_pred             hh--hhh--------hcCccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 KK--LRK--------VIDPELSRSSYT-----MESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 ~~--~~~--------~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..  ...        ...........+     ...+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  316 (364)
T 3qyz_A          252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  316 (364)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            00  000        000000000011     112356899999999999999999999999876

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.7e-45  Score=333.03  Aligned_cols=270  Identities=21%  Similarity=0.354  Sum_probs=204.6

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc--CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc---CCCcceeEEEEEE---
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL---DHPNLVSLIGYCA---  130 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~---  130 (361)
                      ..++|++.+.||+|+||+||+|.+.  +|+.||+|++....... .....+.+|+.+++.+   +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3457999999999999999999984  58899999987543221 1123455677777766   8999999999987   


Q ss_pred             --cCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEE
Q 018047          131 --DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI  208 (361)
Q Consensus       131 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl  208 (361)
                        .....++||||++ |+|.+++.......+++..+..++.|++.||.|||++|     ++||||||+||+++.++.+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g-----i~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCHHHeEEcCCCCEEE
Confidence              5668899999997 69999998766567999999999999999999999999     999999999999999999999


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      +|||++.......   ......||+.|+|||++....++.++||||||+++|+|++|+.||.....   ......+....
T Consensus       162 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~  235 (326)
T 1blx_A          162 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVI  235 (326)
T ss_dssp             CSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHH
T ss_pred             ecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHc
Confidence            9999998664322   22335689999999999888999999999999999999999999964322   11111111111


Q ss_pred             hhhh--hhhh-------hcCc--cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          289 NDRK--KLRK-------VIDP--ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       289 ~~~~--~~~~-------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ....  ....       ....  ...........+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  299 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  299 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            0000  0000       0000  00000111233456899999999999999999999998754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-44  Score=328.36  Aligned_cols=255  Identities=21%  Similarity=0.347  Sum_probs=195.5

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc-------
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD-------  131 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------  131 (361)
                      .++|++.+.||+|+||+||+|... +|+.||||++..    .......+.+|+.+++.++||||+++++++.+       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            346889999999999999999986 799999999853    23455778899999999999999999998865       


Q ss_pred             ------CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc
Q 018047          132 ------GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE  205 (361)
Q Consensus       132 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~  205 (361)
                            .+..|+||||+++|+|.+++... ...+++..++.++.|++.||+|||++|     ++||||||+|||++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG-----IIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC-----eecccCCHHhEEEcCCCC
Confidence                  45789999999999999999754 246788999999999999999999999     999999999999999999


Q ss_pred             EEEeecCccccCCCCCc------------eeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 018047          206 AKISDFGLAKLMPEGQE------------TYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLN  272 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~  272 (361)
                      +||+|||++........            ........||+.|+|||++.+. .++.++||||||+++|+|++   ||.. 
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~-  230 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST-  230 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS-
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC-
Confidence            99999999987643211            1122345689999999988754 68999999999999999998   4431 


Q ss_pred             CCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          273 QGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                          ...............        ..++ ...+...+..+.+++.+||+.||++|||+.++++|.+
T Consensus       231 ----~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  286 (303)
T 1zy4_A          231 ----GMERVNILKKLRSVS--------IEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW  286 (303)
T ss_dssp             ----HHHHHHHHHHHHSTT--------CCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred             ----chhHHHHHHhccccc--------cccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence                111111111111110        1111 2233344556899999999999999999999998753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-44  Score=326.20  Aligned_cols=257  Identities=25%  Similarity=0.372  Sum_probs=205.9

Q ss_pred             HHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           58 EATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ...++|++.+.||+|+||+||+|... +++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            34567999999999999999999987 6899999998764322 234567889999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC---CcEEEeecCc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN---FEAKISDFGL  213 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~  213 (361)
                      +||||+++++|.+++....  .+++..++.++.|++.||.|||++|     ++|+||||+||+++.+   +.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN-----IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCChhhEEEecCCCcccEEEeccCc
Confidence            9999999999999886543  6899999999999999999999999     9999999999999764   4799999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      +........   .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||....   ...   ...........
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~---~~~~~~~~~~~  240 (287)
T 2wei_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYD---ILKRVETGKYA  240 (287)
T ss_dssp             GGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH---HHHHHHHCCCC
T ss_pred             ceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHH---HHHHHHcCCCC
Confidence            987654332   223468999999998765 48999999999999999999999996432   111   11111111100


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .      ...   .....+..+.+++.+||+.||++|||+.|++++.+
T Consensus       241 ~------~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  279 (287)
T 2wei_A          241 F------DLP---QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (287)
T ss_dssp             C------CSG---GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             C------Cch---hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence            0      000   00122345899999999999999999999999765

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.1e-45  Score=345.26  Aligned_cols=262  Identities=27%  Similarity=0.372  Sum_probs=195.4

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC------C
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG------K  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  133 (361)
                      .+|+..+.||+|+||+||+|++. +|+.||||++....       ....+|+++|+.++||||+++++++...      .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            35888999999999999999987 69999999986432       1233699999999999999999998542      2


Q ss_pred             EEEEEEEecCCCchhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEee
Q 018047          134 HRFLVYEYMQKGNLQDHLNG--IGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISD  210 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~D  210 (361)
                      .+++||||+++ +|.+.+..  .....+++..+..++.|++.||+|||++|     |+||||||+|||++.+ +.+||+|
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECSCCSGGGEEEETTTTEEEECC
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCChhhEEEeCCCCeEEecc
Confidence            46799999975 66665542  12457999999999999999999999999     9999999999999965 6789999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      ||+++.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....   ......+.....
T Consensus       201 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~l~~i~~~lg  274 (420)
T 1j1b_A          201 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLG  274 (420)
T ss_dssp             CTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHC
T ss_pred             chhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhC
Confidence            999987654332   2235789999999988654 789999999999999999999999964322   111111111110


Q ss_pred             hh--hhhhh-------hcCccccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          290 DR--KKLRK-------VIDPELSRSS----YTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       290 ~~--~~~~~-------~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..  ..+..       ...+.+....    ++...+..+.+|+.+||..||.+|||+.|+++|.+
T Consensus       275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~  339 (420)
T 1j1b_A          275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  339 (420)
T ss_dssp             SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence            00  00100       0001110000    11223467899999999999999999999999866

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.3e-44  Score=335.91  Aligned_cols=267  Identities=25%  Similarity=0.296  Sum_probs=205.8

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CC-----cceeEEEEE
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HP-----NLVSLIGYC  129 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~  129 (361)
                      ....++|++.+.||+|+||+||+|.+. +++.||||++..    .......+..|+.+++.++ |+     +++++++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            344578999999999999999999987 688999999863    2334566778999988885 55     499999999


Q ss_pred             EcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc--CCCCCCCeEecCCCCCCeeeC--CCCc
Q 018047          130 ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS--SSAVGIPIVHRDFKSTNVLLS--ANFE  205 (361)
Q Consensus       130 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~iiH~Dikp~Nill~--~~~~  205 (361)
                      ...+..++||||++ |+|.+++.......+++..+..++.|++.||.|||+  .|     |+||||||+|||++  .++.
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~-----ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS-----IIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC-----EECCCCSGGGEEESSTTSCC
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC-----EEcCCCCcccEEEecCCCCc
Confidence            99999999999996 599999987655679999999999999999999995  56     99999999999995  4788


Q ss_pred             EEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 018047          206 AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  285 (361)
                      +||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ......+.
T Consensus       200 ~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~i~  271 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE---VDQMNKIV  271 (382)
T ss_dssp             EEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred             EEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence            9999999998764332     235789999999999988999999999999999999999999964332   12222221


Q ss_pred             HHhhhh--------hhhhhhcCc----c------------------------------------ccCCCCCHHHHHHHHH
Q 018047          286 HILNDR--------KKLRKVIDP----E------------------------------------LSRSSYTMESIAMFAN  317 (361)
Q Consensus       286 ~~~~~~--------~~~~~~~~~----~------------------------------------~~~~~~~~~~~~~l~~  317 (361)
                      ......        ......+..    .                                    .............+.+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  351 (382)
T 2vx3_A          272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD  351 (382)
T ss_dssp             HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred             HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence            111100        000000000    0                                    0001122334457899


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHH
Q 018047          318 LASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       318 li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      |+.+||+.||++|||+.|+|+|-+
T Consensus       352 li~~mL~~dP~~Rpta~e~L~hp~  375 (382)
T 2vx3_A          352 LILRMLDYDPKTRIQPYYALQHSF  375 (382)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             HHHHhcCCChhhCCCHHHHhcCcc
Confidence            999999999999999999998754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=342.76  Aligned_cols=268  Identities=21%  Similarity=0.293  Sum_probs=184.2

Q ss_pred             CCCC-CceecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE--cCCEE
Q 018047           62 SFSD-DNFLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA--DGKHR  135 (361)
Q Consensus        62 ~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~  135 (361)
                      .|.+ +++||+|+||+||+|.+.   +++.||||++....     ....+.+|+.+|+.++||||+++++++.  .+...
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            3655 568999999999999965   47899999986432     2345778999999999999999999995  47789


Q ss_pred             EEEEEecCCCchhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee----CCCC
Q 018047          136 FLVYEYMQKGNLQDHLNGI-------GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL----SANF  204 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill----~~~~  204 (361)
                      |+||||+. |+|.+++...       ....+++..+..++.||+.||+|||++|     |+||||||+|||+    +.++
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECCSSTTTT
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----EeCCCcCHHHeEEecCCCCCC
Confidence            99999996 5888877522       1225999999999999999999999999     9999999999999    6778


Q ss_pred             cEEEeecCccccCCCCCce-eeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc---hh
Q 018047          205 EAKISDFGLAKLMPEGQET-YVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND---QN  279 (361)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---~~  279 (361)
                      .+||+|||++..+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........   ..
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  249 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  249 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence            9999999999876543211 12334678999999998876 4589999999999999999999999965432110   00


Q ss_pred             HHHHHHHHhhhhhhhhh-----------------hcCccccCCCCCH---------HHHHHHHHHHHHccCCCCCCCCCH
Q 018047          280 LVLQVRHILNDRKKLRK-----------------VIDPELSRSSYTM---------ESIAMFANLASRCVRTESSERPSM  333 (361)
Q Consensus       280 ~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~Rpt~  333 (361)
                      ....+..+....+....                 .+..... .....         ..+..+.+|+.+||+.||++|||+
T Consensus       250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY-TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGG-TTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCC-CcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence            01111111110000000                 0000000 00000         013457899999999999999999


Q ss_pred             HHHHHHHH
Q 018047          334 AECVKELQ  341 (361)
Q Consensus       334 ~ell~~l~  341 (361)
                      .|+|+|-+
T Consensus       329 ~e~L~hp~  336 (405)
T 3rgf_A          329 EQAMQDPY  336 (405)
T ss_dssp             HHHHTSGG
T ss_pred             HHHhcChh
Confidence            99999876

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.5e-44  Score=331.74  Aligned_cols=264  Identities=20%  Similarity=0.291  Sum_probs=205.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CC-CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc------ceeEEEEEEc
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SG-EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN------LVSLIGYCAD  131 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~~  131 (361)
                      .++|++.+.||+|+||+||+|... ++ ..||+|++..    .......+.+|+.+++.++|++      ++.+++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            457999999999999999999976 44 6899999863    2344567888999999997655      8999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee-----------
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL-----------  200 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill-----------  200 (361)
                      .+..++||||+ +++|.+++.......+++..+..++.|++.||+|||++|     |+||||||+|||+           
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~-----ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ-----LTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEESCCCEEEEECC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEecccccccccc
Confidence            99999999999 667878777655567999999999999999999999999     9999999999999           


Q ss_pred             --------CCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 018047          201 --------SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLN  272 (361)
Q Consensus       201 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  272 (361)
                              +.++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                    567899999999998654322     2356899999999998889999999999999999999999999643


Q ss_pred             CCCCchhHHHHHHHHhhhhhh----------------------------hhhhcCccccCCCCCHHHHHHHHHHHHHccC
Q 018047          273 QGVNDQNLVLQVRHILNDRKK----------------------------LRKVIDPELSRSSYTMESIAMFANLASRCVR  324 (361)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  324 (361)
                      ..   ......+.........                            ......+...........+..+.+|+.+||+
T Consensus       243 ~~---~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          243 EN---REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             SH---HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CH---HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            32   2222222221110000                            0000001011112233445679999999999


Q ss_pred             CCCCCCCCHHHHHHHHH
Q 018047          325 TESSERPSMAECVKELQ  341 (361)
Q Consensus       325 ~dp~~Rpt~~ell~~l~  341 (361)
                      .||++|||+.|+++|-+
T Consensus       320 ~dP~~Rpt~~e~l~hp~  336 (355)
T 2eu9_A          320 FDPAQRITLAEALLHPF  336 (355)
T ss_dssp             SSTTTSCCHHHHTTSGG
T ss_pred             CChhhCcCHHHHhcChh
Confidence            99999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.8e-44  Score=335.60  Aligned_cols=272  Identities=21%  Similarity=0.267  Sum_probs=192.4

Q ss_pred             HHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC
Q 018047           54 KEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG  132 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  132 (361)
                      .......++|++.+.||+|+||+||+|.+. +|+.||||++....    .......+++..+..++||||+++++++...
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            445566778999999999999999999986 68999999986432    2223455688888899999999999998653


Q ss_pred             C-------EEEEEEEecCCCchhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCCCeEecCCCCCCeeeC
Q 018047          133 K-------HRFLVYEYMQKGNLQDHLNG--IGEPKMDWPLRLKVALGAAKGLAYLH--SSSAVGIPIVHRDFKSTNVLLS  201 (361)
Q Consensus       133 ~-------~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~iiH~Dikp~Nill~  201 (361)
                      +       ..++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||  ++|     |+||||||+|||++
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~-----ivH~Dlkp~NIll~  165 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-----VCHRDIKPHNVLVN  165 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-----CBCSCCCGGGEEEE
T ss_pred             ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC-----eecCcCCHHHEEEe
Confidence            3       37899999986 54443322  22447899999999999999999999  888     99999999999999


Q ss_pred             C-CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 018047          202 A-NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN  279 (361)
Q Consensus       202 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  279 (361)
                      . ++.+||+|||++..+.....   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....   ..
T Consensus       166 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~  239 (360)
T 3e3p_A          166 EADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS---AG  239 (360)
T ss_dssp             TTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred             CCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh---HH
Confidence            7 89999999999987754432   2345789999999987654 489999999999999999999999964322   11


Q ss_pred             HHHHHHHHhh-hhhhhhhhcCccc------c---------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          280 LVLQVRHILN-DRKKLRKVIDPEL------S---------RSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       280 ~~~~~~~~~~-~~~~~~~~~~~~~------~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ....+..... ........+.+..      .         ........+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  317 (360)
T 3e3p_A          240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY  317 (360)
T ss_dssp             HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred             HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence            2222111110 0000000000000      0         01111224567999999999999999999999999866

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.4e-46  Score=339.55  Aligned_cols=271  Identities=24%  Similarity=0.358  Sum_probs=203.3

Q ss_pred             CHHHHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc
Q 018047           52 TLKEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD  131 (361)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  131 (361)
                      ...+.+...++|++.+.||+|+||+||+|.+.  ..+|+|++...... ......+.+|+.+++.++||||+++++++.+
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            33444455678999999999999999999876  35999998754322 2233456779999999999999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      .+..++||||+++++|.+++... ...+++..+..++.|++.||+|||++|     ++||||||+|||++ ++.++|+||
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG-----ILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCSTTEEEC---CCEECCC
T ss_pred             CCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCChhhEEEe-CCCEEEeec
Confidence            99999999999999999999764 346899999999999999999999999     99999999999998 679999999


Q ss_pred             CccccCCCCCc---eeeeeecccccCccCcccccC---------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 018047          212 GLAKLMPEGQE---TYVTARVLGTFGYFDPEYTST---------GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN  279 (361)
Q Consensus       212 g~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  279 (361)
                      |++........   ........|++.|+|||++..         ..++.++||||||+++|+|++|+.||....   ...
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~  250 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---AEA  250 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC---HHH
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHH
Confidence            99875532111   111223458999999998764         457889999999999999999999995332   111


Q ss_pred             HHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          280 LVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                      .   .......       ..+.....    ..+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus       251 ~---~~~~~~~-------~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          251 I---IWQMGTG-------MKPNLSQI----GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             H---HHHHHTT-------CCCCCCCS----SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             H---HHHhccC-------CCCCCCcC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            1   1111111       11111111    1223489999999999999999999999999988776543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-44  Score=335.43  Aligned_cols=268  Identities=24%  Similarity=0.347  Sum_probs=202.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----C
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----K  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  133 (361)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++...  ........+.+|+.+++.++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            457999999999999999999987 6899999998542  3344456778899999999999999999987654     6


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..++||||+. |+|.+++...   .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||+
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEEcCCCcEEEEeccc
Confidence            7899999997 6999998763   6999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCcee--------eeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 018047          214 AKLMPEGQETY--------VTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV  284 (361)
Q Consensus       214 ~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  284 (361)
                      +..+.......        ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.....   ......+
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~  235 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY---RHQLLLI  235 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHH
Confidence            98765332111        1123468999999997654 6789999999999999999999999964431   1111111


Q ss_pred             HHHhhhhh-----------hhhhhcC--ccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          285 RHILNDRK-----------KLRKVID--PELSRS---SYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       285 ~~~~~~~~-----------~~~~~~~--~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ........           .....+.  +.....   ......+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY  308 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence            11111000           0000000  000000   000123456889999999999999999999999866

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-44  Score=340.31  Aligned_cols=263  Identities=24%  Similarity=0.338  Sum_probs=194.5

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC------E
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK------H  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~  134 (361)
                      .+|...+.||+|+||+||+|++..+..+|+|++.....       ...+|+.+++.++||||+++++++...+      .
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            46999999999999999999988767799998864321       1235999999999999999999986533      3


Q ss_pred             EEEEEEecCCCchhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC-CCCcEEEeecC
Q 018047          135 RFLVYEYMQKGNLQDHLN-GIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS-ANFEAKISDFG  212 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg  212 (361)
                      .++||||++++.+..... ......+++..+..++.|++.||+|||++|     |+||||||+|||++ .++.+||+|||
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-----ICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            789999998754333221 112347999999999999999999999999     99999999999999 78999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh-
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND-  290 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-  290 (361)
                      +++.+..+..   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......   .....+...... 
T Consensus       188 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p  261 (394)
T 4e7w_A          188 SAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI---DQLVEIIKVLGTP  261 (394)
T ss_dssp             TCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCC
T ss_pred             CcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence            9987644432   2245789999999987654 5899999999999999999999999643321   111111111100 


Q ss_pred             --------hhhhhhhcCccccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 --------RKKLRKVIDPELSRS----SYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 --------~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                              ........-+.....    ..+...+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF  324 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence                    000000000000000    011123456899999999999999999999999865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.5e-44  Score=333.94  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=200.7

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE--
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR--  135 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--  135 (361)
                      ..++|...+.||+|+||+||+|.+. +|+.||||++.... ........+.+|+.+++.++||||+++++++...+..  
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            3467999999999999999999987 68999999997543 2334456788999999999999999999999887655  


Q ss_pred             ----EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          136 ----FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       136 ----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                          |+||||+. ++|.+++..    .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+||
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG-----VVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECST
T ss_pred             ceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCcCHHHeEECCCCCEEEEec
Confidence                99999997 699888743    5999999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      |++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....   ......+......
T Consensus       189 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~  260 (371)
T 4exu_A          189 GLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGV  260 (371)
T ss_dssp             TCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred             CcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Confidence            999865332     233578999999998876 6789999999999999999999999964321   1111111111100


Q ss_pred             h-hh------------hhhhcCccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 R-KK------------LRKVIDPELSRSS---YTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ~-~~------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      . ..            ....+.... ...   .....+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  326 (371)
T 4exu_A          261 PGTEFVQKLNDKAAKSYIQSLPQTP-RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  326 (371)
T ss_dssp             CCHHHHTTCSCHHHHHHHHHSCCCC-CCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             CcHHHHHHhhhhhhhhhhhccCCCc-chhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence            0 00            000000000 000   00122456899999999999999999999999866

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=329.67  Aligned_cols=265  Identities=24%  Similarity=0.333  Sum_probs=196.2

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE--------
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA--------  130 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--------  130 (361)
                      .++|.+.+.||+|+||+||+|.+. +|+.||+|++...   .......+.+|+.+++.++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            457999999999999999999987 5899999998643   3445677889999999999999999999874        


Q ss_pred             ------cCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC-CC
Q 018047          131 ------DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS-AN  203 (361)
Q Consensus       131 ------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~-~~  203 (361)
                            +....|+||||++ |+|.+++..   ..+++..+..++.|++.||+|||++|     ++||||||+|||++ .+
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN-----VLHRDLKPANLFINTED  157 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTT
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCC
Confidence                  4468899999997 699999865   36899999999999999999999999     99999999999997 56


Q ss_pred             CcEEEeecCccccCCCCCce-eeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 018047          204 FEAKISDFGLAKLMPEGQET-YVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV  281 (361)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  281 (361)
                      +.+||+|||++......... .......+|+.|+|||.+.. ..++.++||||||+++|+|++|+.||.....   .   
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~---  231 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---L---  231 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---H---
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---H---
Confidence            79999999999876432111 12233467999999997754 6789999999999999999999999964432   1   


Q ss_pred             HHHHHHhhhhh--------hhhh----hcCccccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          282 LQVRHILNDRK--------KLRK----VIDPELSRSSY-----TMESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       282 ~~~~~~~~~~~--------~~~~----~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                      ...........        .+..    .+.........     ....+..+.+|+.+||+.||++|||+.|+++|.+-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (320)
T 2i6l_A          232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM  309 (320)
T ss_dssp             HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred             HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence            11111111100        0000    00000000000     11234568999999999999999999999998764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.9e-44  Score=332.61  Aligned_cols=255  Identities=21%  Similarity=0.264  Sum_probs=176.6

Q ss_pred             cCCCCCC-ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc----CC
Q 018047           60 TCSFSDD-NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD----GK  133 (361)
Q Consensus        60 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~  133 (361)
                      .++|.+. ++||+|+||+||+|.+. +|+.||||++...    .   .........++.++||||+++++++..    +.
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            3468884 46999999999999987 6999999998532    1   122223334566799999999999876    45


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---CCcEEEee
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISD  210 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---~~~~kl~D  210 (361)
                      ..++||||+++|+|.+++.......+++..++.++.|++.||.|||++|     ++||||||+|||++.   ++.+||+|
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-----ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-----IAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEEecCCCceEEEec
Confidence            6899999999999999998766668999999999999999999999999     999999999999986   45699999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      ||++.......    .....||+.|+|||++....++.++||||||+++|+|++|..||...........  ........
T Consensus       175 fg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~  248 (336)
T 3fhr_A          175 FGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLG  248 (336)
T ss_dssp             CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             cccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhcc
Confidence            99998664322    2335689999999999888899999999999999999999999964332211000  00000000


Q ss_pred             hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..        ... .......+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus       249 ~~--------~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          249 QY--------GFP-NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             ----------CCC-TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             cc--------ccC-chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            00        000 0111223456899999999999999999999999876

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=331.61  Aligned_cols=263  Identities=23%  Similarity=0.320  Sum_probs=201.1

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE----
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH----  134 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----  134 (361)
                      .++|...+.||+|+||+||+|.+. +|+.||||++.... ........+.+|+.+++.++||||+++++++...+.    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            457899999999999999999987 69999999986543 233445678899999999999999999999987654    


Q ss_pred             --EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          135 --RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       135 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                        .|+||||+. |+|.+++..    .+++..+..++.|++.||+|||++|     ++||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~-----ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG-----VVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             eeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEeECCCCcEEEeecc
Confidence              499999997 699988753    5999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      ++......     .....||+.|+|||++.. ..++.++||||||+++|+|++|+.||.....   ......+.......
T Consensus       172 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~  243 (353)
T 3coi_A          172 LARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVP  243 (353)
T ss_dssp             CTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBC
T ss_pred             cccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence            99865332     223568999999998766 6789999999999999999999999964321   11111111111000


Q ss_pred             -hh------------hhhhcCc--cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 -KK------------LRKVIDP--ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 -~~------------~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       ..            ....+..  ...........+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  308 (353)
T 3coi_A          244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  308 (353)
T ss_dssp             CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence             00            0000000  00001112234567999999999999999999999999866

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.8e-44  Score=358.28  Aligned_cols=263  Identities=26%  Similarity=0.390  Sum_probs=207.7

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEcC----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG  132 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  132 (361)
                      +...++|++.+.||+|+||+||+|.+..    +..||+|.+...  ........+.+|+.+++.++||||+++++++. +
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            3344568888999999999999998752    457999987543  23344567889999999999999999999985 4


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      +..|+||||+++|+|.+++... ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchHhEEEeCCCCEEEEecC
Confidence            5689999999999999999754 346899999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      ++......... ......+|+.|+|||++....++.++||||||+++|||++ |..||....   .......+   ... 
T Consensus       537 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~---~~~~~~~i---~~~-  608 (656)
T 2j0j_A          537 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRI---ENG-  608 (656)
T ss_dssp             CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHH---HHT-
T ss_pred             CCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHH---HcC-
Confidence            99877543322 2223456789999999988899999999999999999997 999995432   11121111   111 


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      .           ....+..++..+.+|+.+||+.||++|||+.++++.|+.++...
T Consensus       609 ~-----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          609 E-----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             C-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C-----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            0           01122334556899999999999999999999999999998653

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.9e-44  Score=329.05  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=183.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHH-HHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVD-ILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ++|+..+.||+|+||+||+|... +|+.||||++....  .......+..|+. +++.++||||+++++++.+++..++|
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            56889999999999999999986 68999999997542  2233445555665 67778999999999999999999999


Q ss_pred             EEecCCCchhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          139 YEYMQKGNLQDHLNG---IGEPKMDWPLRLKVALGAAKGLAYLHSS-SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      |||+++ +|.+++..   .....+++..+..++.|++.||.|||++ |     ++||||||+|||++.++.+||+|||++
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-----IIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS-----CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC-----EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            999975 88877752   2245799999999999999999999998 9     999999999999999999999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccc----cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYT----STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      .......   ......||+.|+|||++    ....++.++||||||+++|+|++|+.||.......     ....     
T Consensus       174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~-----  240 (327)
T 3aln_A          174 GQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLT-----  240 (327)
T ss_dssp             CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C-----
T ss_pred             eeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHH-----
Confidence            8764432   12234689999999988    45678999999999999999999999996432110     0000     


Q ss_pred             hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                        .......+.+. .......+..+.+|+.+||+.||++|||+.+++++.+-...
T Consensus       241 --~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          241 --QVVKGDPPQLS-NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             --CCCCSCCCCCC-CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             --HHhcCCCCCCC-CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence              00000011111 11112234568999999999999999999999998764433

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-44  Score=331.79  Aligned_cols=254  Identities=22%  Similarity=0.357  Sum_probs=202.9

Q ss_pred             CHHHHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc---hhHHHHHHHHHHHHhcC--CCcceeE
Q 018047           52 TLKEMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA---DGEHEFRVEVDILSRLD--HPNLVSL  125 (361)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~~  125 (361)
                      ...+.....++|++.+.||+|+||+||+|.+. +++.||||++........   .....+.+|+.+++.++  |+||+++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            33445556778999999999999999999976 689999999976543321   12245667999999996  5999999


Q ss_pred             EEEEEcCCEEEEEEEecCC-CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC-CC
Q 018047          126 IGYCADGKHRFLVYEYMQK-GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS-AN  203 (361)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~-~~  203 (361)
                      ++++.+++..++|||++.+ ++|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++ .+
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG-----VLHRDIKDENILIDLNR  186 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTT
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeCCCCHHHEEEeCCC
Confidence            9999999999999999976 8999999764  37899999999999999999999999     99999999999999 78


Q ss_pred             CcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 018047          204 FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVL  282 (361)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  282 (361)
                      +.+||+|||++.......    .....||+.|+|||++....+ +.++||||||+++|+|++|+.||....         
T Consensus       187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------  253 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------  253 (320)
T ss_dssp             TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred             CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------
Confidence            999999999998775432    223568999999998876665 678999999999999999999995311         


Q ss_pred             HHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          283 QVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         ......             ...+...+..+.+|+.+||+.||++|||+.|++++.+
T Consensus       254 ---~~~~~~-------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~  296 (320)
T 3a99_A          254 ---EIIRGQ-------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW  296 (320)
T ss_dssp             ---HHHHCC-------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             ---hhhccc-------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence               000000             0011122345899999999999999999999998753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=330.77  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=194.2

Q ss_pred             HHHHHcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc---hhHHHHHHHHHHHHhc----CCCcceeEE
Q 018047           55 EMEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA---DGEHEFRVEVDILSRL----DHPNLVSLI  126 (361)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~iv~~~  126 (361)
                      +.+...++|++.+.||+|+||+||+|.+. +++.||||++........   .....+.+|+.++..+    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            44556678999999999999999999876 689999999865433221   1223455699999988    899999999


Q ss_pred             EEEEcCCEEEEEEEe-cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC-CCC
Q 018047          127 GYCADGKHRFLVYEY-MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS-ANF  204 (361)
Q Consensus       127 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~-~~~  204 (361)
                      +++.+.+..++|||+ +.+++|.+++....  .+++..++.++.|++.||+|||++|     ++||||||+||+++ .++
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG-----VVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT-----EECCCCSGGGEEEETTTT
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChhhEEEeCCCC
Confidence            999999999999999 78999999997643  6999999999999999999999999     99999999999999 889


Q ss_pred             cEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 018047          205 EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT-LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQ  283 (361)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  283 (361)
                      .+||+|||++.......    .....|++.|+|||++....+. .++||||||+++|+|++|+.||....          
T Consensus       178 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------  243 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------  243 (312)
T ss_dssp             EEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred             eEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------
Confidence            99999999998775432    2335689999999988766664 58999999999999999999995210          


Q ss_pred             HHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          284 VRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                        ......             ...+...+..+.+++.+||+.||++|||+.|++++.+
T Consensus       244 --~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          244 --EILEAE-------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             --HHHHTC-------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             --HHhhhc-------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence              001100             1112223455899999999999999999999998754

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.6e-44  Score=340.00  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=189.0

Q ss_pred             CCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .|...++||+|+||+||.+...+|+.||||++...      ..+.+.+|+.++..+ +||||+++++++.+++..|+|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            35556889999999998776667999999998642      234577899999886 89999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCC-----CCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC------------
Q 018047          141 YMQKGNLQDHLNGIGEPK-----MDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN------------  203 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~------------  203 (361)
                      |+. |+|.+++.......     .++..++.++.|++.||+|||++|     |+||||||+|||++.+            
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-----IIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC-----ccccCCChHhEEEecCcccccccccCCC
Confidence            995 69999997653211     123345789999999999999999     9999999999999754            


Q ss_pred             -CcEEEeecCccccCCCCCcee--eeeecccccCccCcccccC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 018047          204 -FEAKISDFGLAKLMPEGQETY--VTARVLGTFGYFDPEYTST-------GKLTLQSDVYAFGVVLLELLT-GRRAVDLN  272 (361)
Q Consensus       204 -~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~p~~~~  272 (361)
                       +.+||+|||++..+.......  ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence             489999999999875543221  1234579999999998865       678899999999999999999 99999533


Q ss_pred             CCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          273 QGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ...    . .   .....      ...............+..+.+|+.+||+.||++|||+.++++|.
T Consensus       244 ~~~----~-~---~i~~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp  297 (434)
T 2rio_A          244 YSR----E-S---NIIRG------IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP  297 (434)
T ss_dssp             TTH----H-H---HHHHT------CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             hhh----H-H---HHhcC------CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence            211    0 1   11111      11111111223456778899999999999999999999999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.6e-44  Score=325.14  Aligned_cols=256  Identities=22%  Similarity=0.377  Sum_probs=182.6

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|+..+.||+|+||+||+|.+. +|+.||||++..... .......+..+..+++.++||||+++++++.+++..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            346888999999999999999987 699999999975432 222233444555677888999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS-SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      |||+ ++.+..+.... ...+++..+..++.|++.||.|||++ |     ++|+||||+||+++.++.+||+|||++...
T Consensus       103 ~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG-----VIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             ECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             Eecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC-----EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999 44555554432 34799999999999999999999995 8     999999999999999999999999999766


Q ss_pred             CCCCceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ....   ......||+.|+|||++.     ...++.++||||||+++|+|++|+.||.....  .   ........... 
T Consensus       176 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~---~~~~~~~~~~~-  246 (318)
T 2dyl_A          176 VDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--D---FEVLTKVLQEE-  246 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--H---HHHHHHHHHSC-
T ss_pred             cCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--c---HHHHHHHhccC-
Confidence            4432   223346899999999884     55688999999999999999999999964221  1   11112211111 


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                            .+.+.   .....+..+.+++.+||+.||.+|||+.++++|..
T Consensus       247 ------~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (318)
T 2dyl_A          247 ------PPLLP---GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF  286 (318)
T ss_dssp             ------CCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             ------CCCCC---ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence                  11111   01123345899999999999999999999998755

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=334.17  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=187.6

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .+|...++||+|+||+|+.....+|+.||||++.....      ..+.+|+.+++.+ +||||+++++++.+....|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            35888899999999997755556799999999864321      2345799999999 7999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-----CcEEEeecCcc
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-----FEAKISDFGLA  214 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-----~~~kl~Dfg~~  214 (361)
                      ||+. |+|.+++..... ......+..++.|++.||+|||++|     |+||||||+|||++.+     ..+||+|||++
T Consensus        98 E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN-----IVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             ECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT-----CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             ECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc-----CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9996 599999976532 3455566789999999999999999     9999999999999532     35889999999


Q ss_pred             ccCCCCCce-eeeeecccccCccCccccc---CCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          215 KLMPEGQET-YVTARVLGTFGYFDPEYTS---TGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       215 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      ..+...... .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.....    .   .......
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----~---~~~~~~~  243 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----R---QANILLG  243 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT----H---HHHHHTT
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH----H---HHHHHhc
Confidence            877543221 1233457999999999887   4567789999999999999999 8888843211    0   0110000


Q ss_pred             hhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      .         ............+..+.+|+.+||+.||++|||+.|+++|.
T Consensus       244 ~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp  285 (432)
T 3p23_A          244 A---------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP  285 (432)
T ss_dssp             C---------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred             c---------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence            0         00111112234556688999999999999999999999763

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.8e-43  Score=314.96  Aligned_cols=239  Identities=14%  Similarity=0.078  Sum_probs=187.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.............+.+|+.++..++||||+++++++.+++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999987 58999999997665444555678899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++++|.+++..    ......+..++.|++.||+|||++|     |+||||||+|||++.++.+||+++|       
T Consensus       111 e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~g-----ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAG-----VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCC-----CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            99999999999954    2456678899999999999999999     9999999999999999999997443       


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                                     |++|       ++.++|||||||++|+|++|+.||.............         ........
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---------~~~~~~~~  223 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---------RDTAGQPI  223 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---------BCTTSCBC
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---------HHhccCCC
Confidence                           3332       6788999999999999999999997544321100000         00000000


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG  350 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~  350 (361)
                      +   ........+..+.+|+.+||+.||++| |+.|+++.|+++.......
T Consensus       224 ~---~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~  270 (286)
T 3uqc_A          224 E---PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRT  270 (286)
T ss_dssp             C---HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-----
T ss_pred             C---hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCcc
Confidence            0   000111233558999999999999999 9999999999988766543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6e-43  Score=344.30  Aligned_cols=272  Identities=25%  Similarity=0.364  Sum_probs=207.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc------CC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD------GK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~  133 (361)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++...  ........+.+|+.+++.++||||+++++++..      ++
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            67999999999999999999976 6899999998643  234456678899999999999999999999765      67


Q ss_pred             EEEEEEEecCCCchhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCc---EEEe
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIG-EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFE---AKIS  209 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~---~kl~  209 (361)
                      ..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++|     ++||||||+||+++.++.   +||+
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g-----IVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR-----IIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT-----BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHeEeecCCCceeEEEc
Confidence            7899999999999999997643 236899999999999999999999999     999999999999997765   9999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH--
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI--  287 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--  287 (361)
                      |||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||......     ..+....  
T Consensus       167 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~  238 (676)
T 3qa8_A          167 DLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVRE  238 (676)
T ss_dssp             SCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-
T ss_pred             ccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhc
Confidence            9999987754432   23457899999999999899999999999999999999999999643110     0000000  


Q ss_pred             -hhh----hhhhhhh--cCcc-ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHHHHHhhc
Q 018047          288 -LND----RKKLRKV--IDPE-LSRSSYTMESIAMFANLASRCVRTESSERPSMAE-----CVKELQLIIYTN  347 (361)
Q Consensus       288 -~~~----~~~~~~~--~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e-----ll~~l~~i~~~~  347 (361)
                       ...    .......  .... ..........+..+.+++.+||..||++|||+.+     +.+.++.++...
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence             000    0000000  0000 0112344567788999999999999999999998     556777777654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-41  Score=308.59  Aligned_cols=230  Identities=23%  Similarity=0.340  Sum_probs=181.9

Q ss_pred             CCCCCC-ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHH-HhcCCCcceeEEEEEEc----CC
Q 018047           61 CSFSDD-NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDIL-SRLDHPNLVSLIGYCAD----GK  133 (361)
Q Consensus        61 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~  133 (361)
                      ++|.+. +.||+|+||+||+|... +++.||+|++..        ...+.+|+.++ +.++||||+++++++.+    ..
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            356666 78999999999999986 689999999853        23566788888 55689999999999877    67


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---CCcEEEee
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISD  210 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---~~~~kl~D  210 (361)
                      ..++||||+++|+|.+++.......+++..++.++.|++.||+|||++|     ++||||||+|||++.   ++.+||+|
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEecCCCCCcEEEec
Confidence            8899999999999999998766667999999999999999999999999     999999999999998   78999999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      ||++....                        ...++.++|||||||++|+|++|+.||.........            
T Consensus       164 fg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------  207 (299)
T 3m2w_A          164 FGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------  207 (299)
T ss_dssp             CTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------
T ss_pred             cccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------
Confidence            99986442                        234667899999999999999999999643221100            


Q ss_pred             hhhhhhhcCccccCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 018047          291 RKKLRKVIDPELSRSSYT----MESIAMFANLASRCVRTESSERPSMAECVKELQL  342 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~  342 (361)
                       ......+...  ....+    ...+..+.+|+.+||+.||++|||+.|+++|.+-
T Consensus       208 -~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~  260 (299)
T 3m2w_A          208 -PGMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  260 (299)
T ss_dssp             -CCSCCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             -HHHHHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence             0000000000  00111    1234568999999999999999999999998763

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-42  Score=344.62  Aligned_cols=242  Identities=21%  Similarity=0.368  Sum_probs=195.1

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc--CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE--
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH--  134 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--  134 (361)
                      ..++|++.+.||+|+||+||+|.+.  +|+.||||++...  ........+.+|+.++..++||||+++++++.+.+.  
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            3468999999999999999999976  5899999988643  233455678899999999999999999999987654  


Q ss_pred             ---EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          135 ---RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       135 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                         .|+||||+++++|.+++..    .+++..++.++.|++.||.|||++|     |+||||||+|||++.+ .+||+||
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g-----iiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG-----LVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECSS-CEEECCC
T ss_pred             CceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CeecccChHHeEEeCC-cEEEEec
Confidence               7999999999999998754    6999999999999999999999999     9999999999999986 9999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      |++......      ....||+.|+|||++.... +.++|||||||++|+|++|..||.......               
T Consensus       226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------  283 (681)
T 2pzi_A          226 GAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------  283 (681)
T ss_dssp             TTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------
T ss_pred             ccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------
Confidence            999876443      2346899999999886554 889999999999999999998885321100               


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP-SMAECVKELQLII  344 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ell~~l~~i~  344 (361)
                                +.........+..+.+|+.+||+.||++|| +++++.+.|..++
T Consensus       284 ----------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 ----------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ----------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                      000111112335688999999999999999 5666666666654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.3e-42  Score=316.15  Aligned_cols=246  Identities=16%  Similarity=0.147  Sum_probs=189.1

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCC-----cchhHHHHHHHHHHHHhcC---------CCcceeEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFK-----EADGEHEFRVEVDILSRLD---------HPNLVSLI  126 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~iv~~~  126 (361)
                      ++|++.+.||+|+||+||+|++ +|+.||||++......     .......+.+|+.+++.++         ||||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4588899999999999999998 5899999999865432     2233467888999999885         88888887


Q ss_pred             EEEE------------------------------cCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHH
Q 018047          127 GYCA------------------------------DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA  176 (361)
Q Consensus       127 ~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~  176 (361)
                      +++.                              +.+..|+||||+++|++.+.+.+   ..+++..+..++.|++.||+
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence            7643                              26789999999999987777744   36899999999999999999


Q ss_pred             HHh-cCCCCCCCeEecCCCCCCeeeCCCC--------------------cEEEeecCccccCCCCCceeeeeecccccCc
Q 018047          177 YLH-SSSAVGIPIVHRDFKSTNVLLSANF--------------------EAKISDFGLAKLMPEGQETYVTARVLGTFGY  235 (361)
Q Consensus       177 ~lH-~~~~~~~~iiH~Dikp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y  235 (361)
                      ||| ++|     |+||||||+|||++.++                    .+||+|||+++.....       ...||+.|
T Consensus       176 ~lH~~~~-----ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          176 VAEASLR-----FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHC-----CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHhCC-----EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            999 899     99999999999999887                    9999999999876432       23789999


Q ss_pred             cCcccccCCCCCccchhHHHHHH-HHHHHhCCCCCCCCCCCCchhHHHHH-HHHhhhhhhhhhhcCccccCCCCCHHHHH
Q 018047          236 FDPEYTSTGKLTLQSDVYAFGVV-LLELLTGRRAVDLNQGVNDQNLVLQV-RHILNDRKKLRKVIDPELSRSSYTMESIA  313 (361)
Q Consensus       236 ~aPE~~~~~~~~~~~DiwslG~i-l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (361)
                      +|||++.+.. +.++||||||++ .+++++|..||..      ....... .....      ................+.
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLK------QMTFKTKCNTPAMKQIKR  310 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHH------TCCCSSCCCSHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhh------hhccCcccchhhhhhcCH
Confidence            9999987666 889999998777 7788899998831      0000001 11110      000111111122346778


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHH-HHH
Q 018047          314 MFANLASRCVRTESSERPSMAECV-KEL  340 (361)
Q Consensus       314 ~l~~li~~cl~~dp~~Rpt~~ell-~~l  340 (361)
                      .+.+|+.+||+.|     |+.|++ +|-
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l~~Hp  333 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLLCQHS  333 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred             HHHHHHHHHhccC-----CHHHHHhcCC
Confidence            8999999999977     999999 763

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-41  Score=318.38  Aligned_cols=243  Identities=17%  Similarity=0.195  Sum_probs=180.7

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC-Ccc---------e-------
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNL---------V-------  123 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i---------v-------  123 (361)
                      .|...++||+|+||+||+|.+. +|+.||||++...........+.+.+|+.+++.++| +|.         +       
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            4677789999999999999976 799999999875443444446778999999999987 221         1       


Q ss_pred             -----eEEEEEEc-----CCEEEEEEEecCCCchhhhcc-----cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCe
Q 018047          124 -----SLIGYCAD-----GKHRFLVYEYMQKGNLQDHLN-----GIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI  188 (361)
Q Consensus       124 -----~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i  188 (361)
                           .+..++..     ....+++|+++ +++|.+++.     ......+++..++.++.|++.||+|||++|     |
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----i  232 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-----L  232 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-----E
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----c
Confidence                 11111111     22457777766 679999884     222335778899999999999999999999     9


Q ss_pred             EecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccc----------cCCCCCccchhHHHHHH
Q 018047          189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT----------STGKLTLQSDVYAFGVV  258 (361)
Q Consensus       189 iH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~i  258 (361)
                      +||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999999865322     334567 999999988          55668889999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 018047          259 LLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK  338 (361)
Q Consensus       259 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~  338 (361)
                      +|||++|+.||........                ....+...   ..    .+..+.+|+.+||+.||++|||+.++++
T Consensus       307 l~elltg~~Pf~~~~~~~~----------------~~~~~~~~---~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG----------------SEWIFRSC---KN----IPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC----------------SGGGGSSC---CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHCCCCCCCcchhhh----------------HHHHHhhc---cc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999999964332111                11111100   11    2355899999999999999999877765


Q ss_pred             H
Q 018047          339 E  339 (361)
Q Consensus       339 ~  339 (361)
                      +
T Consensus       364 ~  364 (413)
T 3dzo_A          364 T  364 (413)
T ss_dssp             S
T ss_pred             C
Confidence            4

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3.7e-35  Score=287.58  Aligned_cols=187  Identities=18%  Similarity=0.131  Sum_probs=133.2

Q ss_pred             ecccCceEEEEEEEc-CCCEEEEEEeecCCCCc-------chhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEEEEE
Q 018047           69 LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKE-------ADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .+.|+.|.+..++.. .|+.+|+|++.+.....       ....+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            567777777766644 68999999997653221       22345789999999999 6999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||++|++|.++|...+  .++..   .|+.||+.||+|+|++|     ||||||||+|||++.+|++||+|||+|+.+..
T Consensus       322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G-----IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG-----FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT-----CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC-----ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999998754  56654   47899999999999999     99999999999999999999999999987654


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRA  268 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  268 (361)
                      ...  .....+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            322  2345689999999998864 467789999999998887666544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.3e-30  Score=253.93  Aligned_cols=188  Identities=16%  Similarity=0.216  Sum_probs=146.5

Q ss_pred             CCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcch-----hHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           64 SDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEAD-----GEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ...+.||+|+||+||+|... ++.+++|+..........     ..+.+.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            44678999999999999544 788999987554332221     234578999999999999999555555566777999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++++|.+++..          +..++.|+++||+|||+++     |+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g-----IiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND-----VIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT-----EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc-----CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999975          4579999999999999999     999999999999999  99999999999875


Q ss_pred             CCCcee-----eeeecccccCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCC
Q 018047          219 EGQETY-----VTARVLGTFGYFDPEYTST--GKLTLQSDVYAFGVVLLELLTGRRAV  269 (361)
Q Consensus       219 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~  269 (361)
                      ......     ......||+.|||||++..  ..|+..+|+||..+-..+-+.++.+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            432211     1234679999999998876  56788899999999999988887766

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.1e-26  Score=208.17  Aligned_cols=153  Identities=16%  Similarity=0.030  Sum_probs=119.2

Q ss_pred             HHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcc---------------hhHHHHHHHHHHHHhcCCC
Q 018047           56 MEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEA---------------DGEHEFRVEVDILSRLDHP  120 (361)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~  120 (361)
                      +......|.+++.||+|+||.||+|.+.+|+.||+|.+........               .....+.+|+.+++.++| 
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-  163 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-  163 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence            3334455777799999999999999997799999999864321111               134568899999999994 


Q ss_pred             cceeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeee
Q 018047          121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLL  200 (361)
Q Consensus       121 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill  200 (361)
                        +++.+++.. +..|+||||+++|+|.+ +..        .....++.|++.||.|||++|     |+||||||+|||+
T Consensus       164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g-----iiHrDlkp~NILl  226 (282)
T 1zar_A          164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG-----IVHGDLSQYNVLV  226 (282)
T ss_dssp             --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEE
T ss_pred             --CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC-----CEeCCCCHHHEEE
Confidence              455554433 45699999999999998 422        124469999999999999999     9999999999999


Q ss_pred             CCCCcEEEeecCccccCCCCCceeeeeecccccCccCccccc
Q 018047          201 SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS  242 (361)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  242 (361)
                      + ++.+||+|||++..               +..++|||++.
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            9 99999999999963               34578899764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=6.9e-22  Score=174.85  Aligned_cols=139  Identities=14%  Similarity=0.134  Sum_probs=107.1

Q ss_pred             CCCCceecccCceEEEEEEE-cCCCE--EEEEEeecCCC--Cc-------------------chhHHHHHHHHHHHHhcC
Q 018047           63 FSDDNFLGKGGFGRVYKGTL-RSGEV--VAIKKMELPRF--KE-------------------ADGEHEFRVEVDILSRLD  118 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~--~~-------------------~~~~~~~~~E~~~l~~l~  118 (361)
                      |.+.+.||+|+||.||+|.+ .+|+.  ||||++.....  ..                   ......+.+|+.+|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            66788999999999999998 57888  99998754311  10                   011236788999999998


Q ss_pred             CCcc--eeEEEEEEcCCEEEEEEEecCC-C----chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCCCeEe
Q 018047          119 HPNL--VSLIGYCADGKHRFLVYEYMQK-G----NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH-SSSAVGIPIVH  190 (361)
Q Consensus       119 h~~i--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~~~iiH  190 (361)
                      |+++  +.+++.    +..+|||||+.+ |    +|.++...     .++..+..++.|++.||.||| +.|     |+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g-----ivH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE-----LVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC-----EEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC-----EEe
Confidence            8753  445543    346899999942 4    56655432     234567789999999999999 999     999


Q ss_pred             cCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          191 RDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       191 ~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=2.7e-18  Score=158.31  Aligned_cols=140  Identities=15%  Similarity=0.120  Sum_probs=103.9

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCC--c---------c----hh----HHHHHHHHHHHHhcCCCc
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFK--E---------A----DG----EHEFRVEVDILSRLDHPN  121 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~---------~----~~----~~~~~~E~~~l~~l~h~~  121 (361)
                      .-|.++..||+|++|.||+|...+|+.||||++......  .         .    .+    .....+|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            348899999999999999999888999999987542110  0         0    00    112245777888885544


Q ss_pred             c--eeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCee
Q 018047          122 L--VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVL  199 (361)
Q Consensus       122 i--v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nil  199 (361)
                      +  ...++..    ..+|||||++|++|..+...        +....++.|++.+|.+||+.|     ||||||||.|||
T Consensus       175 v~vp~p~~~~----~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g-----IVHrDLKp~NIL  237 (397)
T 4gyi_A          175 FPVPEPIAQS----RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG-----LIHGDFNEFNIL  237 (397)
T ss_dssp             CSCCCEEEEE----TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEE
T ss_pred             CCCCeeeecc----CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHHHEE
Confidence            3  2333331    23699999999998776432        123567899999999999999     999999999999


Q ss_pred             eCCCC----------cEEEeecCccccC
Q 018047          200 LSANF----------EAKISDFGLAKLM  217 (361)
Q Consensus       200 l~~~~----------~~kl~Dfg~~~~~  217 (361)
                      ++.++          .+.|+||+-+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98876          3899999988654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=2.2e-13  Score=120.21  Aligned_cols=148  Identities=12%  Similarity=0.060  Sum_probs=113.7

Q ss_pred             HHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEE
Q 018047           57 EEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHR  135 (361)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  135 (361)
                      ......|.....++.|+.+.||++... ++.+++|.......   .....+.+|+.+++.+. +..+.++++++.+.+..
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            344456888888899999999999755 78999999864211   11235888999999985 67788999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--------------------------------
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA--------------------------------  183 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--------------------------------  183 (361)
                      |+||||++|.+|.+.+..       ......++.+++++|..||+...                                
T Consensus        86 ~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            999999999999876421       11234678899999999998210                                


Q ss_pred             ----------------------CCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          184 ----------------------VGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       184 ----------------------~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                                            ....++|+|++|.||+++.++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  01238999999999999876667799998774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=2.7e-12  Score=112.77  Aligned_cols=137  Identities=13%  Similarity=0.100  Sum_probs=100.5

Q ss_pred             CCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc--ceeEEEEEEcCCEEEEEEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN--LVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e  140 (361)
                      +....+.+.|..+.||++...+|..+++|.....      ....+..|+.+++.+.+.+  +.+++++..+++..++|||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CceEecccCCCCceEEEEecCCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            4333333466679999998767788999987532      1235778999999986444  5668998888888999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-------------------------------------
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA-------------------------------------  183 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-------------------------------------  183 (361)
                      |++|.+|.  ...     .+   ...++.+++..|..||+...                                     
T Consensus        96 ~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           96 EVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             ecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            99999884  211     12   23567788888888887531                                     


Q ss_pred             ----------------CCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          184 ----------------VGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       184 ----------------~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                                      ....++|+|++|.||+++.++.+.|+|||.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                            01129999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.32  E-value=8.4e-12  Score=115.28  Aligned_cols=145  Identities=17%  Similarity=0.254  Sum_probs=107.9

Q ss_pred             CCceecccCceEEEEEEEcCCCEEEEEEee--cCCCCcchhHHHHHHHHHHHHhcC--CCcceeEEEEEEcC---CEEEE
Q 018047           65 DDNFLGKGGFGRVYKGTLRSGEVVAIKKME--LPRFKEADGEHEFRVEVDILSRLD--HPNLVSLIGYCADG---KHRFL  137 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~l  137 (361)
                      ..+.|+.|.++.||++... +..+++|+..  ...  .......+.+|+.+++.+.  +..+++++.++.+.   +..|+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~--~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK--LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC--CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            3567899999999998876 5688888764  221  1122457888999999997  45578899988776   45899


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------------------------------
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV---------------------------------  184 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~---------------------------------  184 (361)
                      ||||++|.++.+...    ..++......++.+++.+|..||+....                                 
T Consensus       119 vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          119 IMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999999988865321    2477888889999999999999983110                                 


Q ss_pred             --------------------CCCeEecCCCCCCeeeCCCCc--EEEeecCcccc
Q 018047          185 --------------------GIPIVHRDFKSTNVLLSANFE--AKISDFGLAKL  216 (361)
Q Consensus       185 --------------------~~~iiH~Dikp~Nill~~~~~--~kl~Dfg~~~~  216 (361)
                                          ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                134999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.17  E-value=1.3e-11  Score=111.42  Aligned_cols=185  Identities=18%  Similarity=0.195  Sum_probs=123.5

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCc--ceeEEEEEEcCC---EEEEEE
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPN--LVSLIGYCADGK---HRFLVY  139 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~  139 (361)
                      .+.++.|....||++.    ..+++|+...     ......+.+|..+|+.+. +..  +.+++......+   ..|+||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            4568999999999863    5688887532     234567889999999883 332  445555544333   458999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC------------------------------------
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA------------------------------------  183 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~------------------------------------  183 (361)
                      ++++|.+|.+....    .++.+....++.+++..+..||+...                                    
T Consensus        96 ~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             ECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            99999888754322    46778888889999999999987221                                    


Q ss_pred             -----------------CCCCeEecCCCCCCeeeCC--CCcEEEeecCccccCCCCCceeeeeecccccCc---cCcccc
Q 018047          184 -----------------VGIPIVHRDFKSTNVLLSA--NFEAKISDFGLAKLMPEGQETYVTARVLGTFGY---FDPEYT  241 (361)
Q Consensus       184 -----------------~~~~iiH~Dikp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~  241 (361)
                                       ....++|+|++|.||+++.  +..+.|+||+.+..-......   .   ....+   ..|+..
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl---~---~~~~~~~~~~~~~~  245 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF---I---SLMEDDEEYGMEFV  245 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH---H---TTCCTTTSCCHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH---H---HHHhhccccCHHHH
Confidence                             0134899999999999998  556889999988643211000   0   00011   122211


Q ss_pred             cC-----CC---------CCccchhHHHHHHHHHHHhCCCCC
Q 018047          242 ST-----GK---------LTLQSDVYAFGVVLLELLTGRRAV  269 (361)
Q Consensus       242 ~~-----~~---------~~~~~DiwslG~il~ell~g~~p~  269 (361)
                      ..     +.         .....+.|++|.++|.+.+|..+|
T Consensus       246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            00     00         112268999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.83  E-value=5.3e-08  Score=87.64  Aligned_cols=138  Identities=18%  Similarity=0.149  Sum_probs=98.6

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCC---cceeEEEEEE-cCCEEEEEEEe
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP---NLVSLIGYCA-DGKHRFLVYEY  141 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~  141 (361)
                      .+.++.|....||+.    |+.+++|+..     .......+..|..+|+.+.+.   .+.+++.+.. ..+..++||||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            356888998999988    5778888742     223456788999999999642   3566777764 45667899999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--------------------------------------
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA--------------------------------------  183 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--------------------------------------  183 (361)
                      ++|.+|.+..-.    .++......++.+++..|..||+...                                      
T Consensus        95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            999888763211    34555666666677777776665431                                      


Q ss_pred             -----------------CCCCeEecCCCCCCeeeCC---CCc-EEEeecCcccc
Q 018047          184 -----------------VGIPIVHRDFKSTNVLLSA---NFE-AKISDFGLAKL  216 (361)
Q Consensus       184 -----------------~~~~iiH~Dikp~Nill~~---~~~-~kl~Dfg~~~~  216 (361)
                                       ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             1123799999999999997   455 58999998863

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.79  E-value=3.7e-08  Score=86.86  Aligned_cols=135  Identities=16%  Similarity=0.096  Sum_probs=99.3

Q ss_pred             ecccCce-EEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEEEEEecCCC
Q 018047           69 LGKGGFG-RVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFLVYEYMQKG  145 (361)
Q Consensus        69 lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g  145 (361)
                      +..|..| .||+.... ++..+++|+-..      .....+.+|...|+.+. +--+.++++++.+++..|+|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            4445554 79988765 466789998642      24567888999999884 333678899999999999999999998


Q ss_pred             chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-----------------------------------------
Q 018047          146 NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV-----------------------------------------  184 (361)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-----------------------------------------  184 (361)
                      ++.+.....      ......+..+++..|..||+....                                         
T Consensus       106 ~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          106 TAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             EHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            887765321      122345667777888888863210                                         


Q ss_pred             ------------CCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          185 ------------GIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       185 ------------~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                                  ...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        1227999999999999988777899999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.56  E-value=2.7e-07  Score=84.74  Aligned_cols=149  Identities=11%  Similarity=0.029  Sum_probs=90.7

Q ss_pred             cee-cccCceEEEEEEEc-------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-C--CcceeEEEEEEcC---
Q 018047           67 NFL-GKGGFGRVYKGTLR-------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-H--PNLVSLIGYCADG---  132 (361)
Q Consensus        67 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~---  132 (361)
                      +.| +.|....+|+....       +++.+++|...............+.+|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 88889999988754       25678888754321000001235677999988884 3  3567888887665   


Q ss_pred             CEEEEEEEecCCCchhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGI----GEPKMDWPLRLKVALGAAKGLAYLHSSS--------------------------  182 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------  182 (361)
                      +..|+||||++|.++.+.+...    ....++......++.+++..|.-||+..                          
T Consensus       106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV  185 (357)
T ss_dssp             SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred             CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence            4578999999988776532100    0001222222233333333333333210                          


Q ss_pred             ----------------------------C-----CCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          183 ----------------------------A-----VGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       183 ----------------------------~-----~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                                                  .     ....++|+|+.|.||+++.+..+.|+||+.+.
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence                                        0     02349999999999999965557999999885

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.33  E-value=2.4e-06  Score=79.55  Aligned_cols=78  Identities=18%  Similarity=0.127  Sum_probs=49.5

Q ss_pred             CceecccCceEEEEEEEc-CCCEEEEEEeecCCC--Cc--chhHHHHHHHHHHHHhcCC--Cc-ceeEEEEEEcCCEEEE
Q 018047           66 DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRF--KE--ADGEHEFRVEVDILSRLDH--PN-LVSLIGYCADGKHRFL  137 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~--~~~~~~~~~E~~~l~~l~h--~~-iv~~~~~~~~~~~~~l  137 (361)
                      .+.||.|..+.||++... +++.+++|.......  ..  ......+..|.++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999765 478899998643210  00  1123456778999888742  33 4456654  3445689


Q ss_pred             EEEecCCC
Q 018047          138 VYEYMQKG  145 (361)
Q Consensus       138 v~e~~~~g  145 (361)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.28  E-value=1e-05  Score=73.45  Aligned_cols=141  Identities=20%  Similarity=0.288  Sum_probs=77.6

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-----CCcceeEE-E--EEEcCCEEEEE
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-----HPNLVSLI-G--YCADGKHRFLV  138 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~-~--~~~~~~~~~lv  138 (361)
                      +.|+.|..+.||++...+ +.+++|+....       ...+..|..+++.|.     .|.++... +  +....+..+++
T Consensus        38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l  109 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV  109 (346)
T ss_dssp             EECC----CEEEEEEETT-EEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred             eeccccccCcEEEEEeCC-CCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence            346667789999998764 45899988531       123444566665552     24444310 0  12346778999


Q ss_pred             EEecCCCchhh-----------hc-------ccCCCC--------CCCHHH-----------------------------
Q 018047          139 YEYMQKGNLQD-----------HL-------NGIGEP--------KMDWPL-----------------------------  163 (361)
Q Consensus       139 ~e~~~~g~L~~-----------~l-------~~~~~~--------~~~~~~-----------------------------  163 (361)
                      |+|++|.++..           .+       ......        ...|..                             
T Consensus       110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  189 (346)
T 2q83_A          110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL  189 (346)
T ss_dssp             EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred             EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence            99999865530           01       011000        012211                             


Q ss_pred             --HHHHHHHHHHHHHHHhc--------CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          164 --RLKVALGAAKGLAYLHS--------SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       164 --~~~i~~~i~~~l~~lH~--------~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                        +..+...+..++++|+.        .......++|+|+++.||+++.++.+.|+||+.+.
T Consensus       190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              01111123345666653        00001239999999999999888899999999774

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.25  E-value=1.4e-05  Score=71.86  Aligned_cols=75  Identities=24%  Similarity=0.239  Sum_probs=60.3

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC---CCcceeEEEEEEcCCEEEEEEEec
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD---HPNLVSLIGYCADGKHRFLVYEYM  142 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~  142 (361)
                      .+.|+.|....+|+.... ++.+++|+...      .....+..|...|+.|.   ...+++++.+....+..++||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINER------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEG------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCc------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            356899999999998764 67889998653      13567888999999883   356888999988888999999999


Q ss_pred             CCCch
Q 018047          143 QKGNL  147 (361)
Q Consensus       143 ~~g~L  147 (361)
                      ++.++
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            98765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.97  E-value=3.3e-05  Score=68.52  Aligned_cols=78  Identities=18%  Similarity=0.181  Sum_probs=55.5

Q ss_pred             CCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC---CcceeEEEEEEcCCEEEEEE
Q 018047           63 FSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH---PNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ....+.+|.|..+.||+.+..+|+.+.+|+.....   ......+..|+..|+.|..   --+.+++++.    .-++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            44456789999999999999999999999864321   2223467889999998842   2345666652    236899


Q ss_pred             EecCCCch
Q 018047          140 EYMQKGNL  147 (361)
Q Consensus       140 e~~~~g~L  147 (361)
                      ||++++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99887643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.85  E-value=0.00013  Score=65.66  Aligned_cols=159  Identities=11%  Similarity=0.121  Sum_probs=86.6

Q ss_pred             cCHHHHHHHcCCCCCC-----ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc--ce
Q 018047           51 FTLKEMEEATCSFSDD-----NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN--LV  123 (361)
Q Consensus        51 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv  123 (361)
                      ++.+++......|...     +.|+.|....+|++...+| .+++|.....     .....+..|..+++.|...+  +.
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            4555666666667653     3466788899999987644 6889987542     11234556777777763212  22


Q ss_pred             eEEEE------EEcCCEEEEEEEecCCCchhhh------------------cccCCCCC---CC---HHHHHH-------
Q 018047          124 SLIGY------CADGKHRFLVYEYMQKGNLQDH------------------LNGIGEPK---MD---WPLRLK-------  166 (361)
Q Consensus       124 ~~~~~------~~~~~~~~lv~e~~~~g~L~~~------------------l~~~~~~~---~~---~~~~~~-------  166 (361)
                      +++..      ....+..+++|+|++|..+...                  ........   ..   |.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            33211      1234677899999998654210                  01111110   11   111000       


Q ss_pred             -----HHHHHHHHHHHHhcCC--CCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          167 -----VALGAAKGLAYLHSSS--AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       167 -----i~~~i~~~l~~lH~~~--~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                           +...+...++.+...-  .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 0011334455554321  112239999999999999987666899998775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.83  E-value=8.1e-05  Score=66.40  Aligned_cols=130  Identities=12%  Similarity=0.055  Sum_probs=75.8

Q ss_pred             CceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcc-eeEEEEEEcCCEEEEEEEec-C
Q 018047           66 DNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL-VSLIGYCADGKHRFLVYEYM-Q  143 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~  143 (361)
                      .+.|+.|....+|++     +.+++|+.....    ........|+.+++.+...++ .+++++.  .+.-++++||+ +
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT----EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCc----cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            677999999999998     568888875321    111123458888877742222 4666553  33346899999 6


Q ss_pred             CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 018047          144 KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS-----------------------------------------  182 (361)
Q Consensus       144 ~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----------------------------------------  182 (361)
                      +.+|.......         ...++.++++.|+-||+.+                                         
T Consensus        92 g~~l~~~~~~~---------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  162 (301)
T 3dxq_A           92 AQTMSPEKFKT---------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGV  162 (301)
T ss_dssp             CEECCHHHHHH---------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHH
T ss_pred             CccCCHhhHhh---------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHH
Confidence            65553210000         0001222222222222211                                         


Q ss_pred             -------CCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          183 -------AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       183 -------~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                             .....++|+|+.|.||+ ..++.+.++||..+..
T Consensus       163 ~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          163 RSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                   11233899999999999 5667889999998863

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.83  E-value=0.00013  Score=68.37  Aligned_cols=75  Identities=16%  Similarity=0.246  Sum_probs=45.7

Q ss_pred             eEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeeccc--ccCccCcccccCCC---CCccchhHHHHHHHHHH
Q 018047          188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLG--TFGYFDPEYTSTGK---LTLQSDVYAFGVVLLEL  262 (361)
Q Consensus       188 iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DiwslG~il~el  262 (361)
                      ++|+|++|.|||++.++ +.++||+.+..-....   .......  ...|++|+......   .....++.++...+|+.
T Consensus       234 liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             EECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            99999999999999876 9999999886432111   0111111  13456665443111   11234556777788877


Q ss_pred             HhCC
Q 018047          263 LTGR  266 (361)
Q Consensus       263 l~g~  266 (361)
                      .++.
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.74  E-value=0.00044  Score=62.25  Aligned_cols=141  Identities=14%  Similarity=0.110  Sum_probs=80.5

Q ss_pred             ceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc--ceeEEEE-----EEcCCEEEEEE
Q 018047           67 NFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN--LVSLIGY-----CADGKHRFLVY  139 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~-----~~~~~~~~lv~  139 (361)
                      ..|+ |....||++...+|+.+++|......    .....+..|..+++.+....  +++++..     ...++..+++|
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~  106 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  106 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence            4566 88889999877667789999985321    12345667888888774212  3333332     22355678999


Q ss_pred             EecCCCchhh-----------hc-------ccCC---CCCCCHHHH----------------------HHHHHHHHHHHH
Q 018047          140 EYMQKGNLQD-----------HL-------NGIG---EPKMDWPLR----------------------LKVALGAAKGLA  176 (361)
Q Consensus       140 e~~~~g~L~~-----------~l-------~~~~---~~~~~~~~~----------------------~~i~~~i~~~l~  176 (361)
                      +|++|.++..           .+       ....   ....++...                      ...+..++..+.
T Consensus       107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~  186 (328)
T 1zyl_A          107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT  186 (328)
T ss_dssp             ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence            9998865431           00       0000   111222111                      111112222222


Q ss_pred             HHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       177 ~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      .+-.. .....++|+|+++.||+++ + .+.++||+.+.
T Consensus       187 ~~~~~-~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          187 AHWRE-DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             HHCCS-CSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHhhh-cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            22111 0122389999999999999 5 89999998875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.72  E-value=0.00016  Score=67.95  Aligned_cols=74  Identities=18%  Similarity=0.143  Sum_probs=50.1

Q ss_pred             CceecccCceEEEEEEEcC--------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc-ceeEEEEEEcCCEEE
Q 018047           66 DNFLGKGGFGRVYKGTLRS--------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN-LVSLIGYCADGKHRF  136 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~  136 (361)
                      .+.|+.|....+|++...+        ++.+++|+...+     .....+..|..+++.|...+ ..++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            3567888899999998653        478999987321     11134557999998885333 3577776543    2


Q ss_pred             EEEEecCCCchh
Q 018047          137 LVYEYMQKGNLQ  148 (361)
Q Consensus       137 lv~e~~~~g~L~  148 (361)
                      +|+||++|.+|.
T Consensus       149 ~v~e~l~G~~l~  160 (429)
T 1nw1_A          149 RLEEYIPSRPLS  160 (429)
T ss_dssp             EEECCCCEEECC
T ss_pred             EEEEEeCCcccC
Confidence            899999875553

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.67  E-value=0.00018  Score=65.07  Aligned_cols=141  Identities=17%  Similarity=0.119  Sum_probs=71.6

Q ss_pred             eecccCceE-EEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC--CcceeEEEEEEcCCEEEEEEEecCC
Q 018047           68 FLGKGGFGR-VYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH--PNLVSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        68 ~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      .|+.|+... +|+....+|+.+++|......      ...+..|+.+++.+..  -.+.+++.+..+.+  +++||++.+
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~   96 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD   96 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence            455554444 667765446777777543221      0234457777777642  23556777644444  689999977


Q ss_pred             CchhhhcccC---------------------C---CCCCCHHHHH-------HHH-------------HHHHHHHHHHhc
Q 018047          145 GNLQDHLNGI---------------------G---EPKMDWPLRL-------KVA-------------LGAAKGLAYLHS  180 (361)
Q Consensus       145 g~L~~~l~~~---------------------~---~~~~~~~~~~-------~i~-------------~~i~~~l~~lH~  180 (361)
                      .++.+++...                     .   ...++.....       .+.             ..+...++.+..
T Consensus        97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~  176 (333)
T 3csv_A           97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS  176 (333)
T ss_dssp             CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred             cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence            6665433210                     0   0112221110       000             011112222211


Q ss_pred             C-CCCCCCeEecCCCCCCeeeCCC----CcEEEeecCcccc
Q 018047          181 S-SAVGIPIVHRDFKSTNVLLSAN----FEAKISDFGLAKL  216 (361)
Q Consensus       181 ~-~~~~~~iiH~Dikp~Nill~~~----~~~kl~Dfg~~~~  216 (361)
                      . ......++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            0 0011239999999999999875    6899999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.65  E-value=0.00016  Score=60.43  Aligned_cols=103  Identities=9%  Similarity=0.023  Sum_probs=68.1

Q ss_pred             chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceee
Q 018047          146 NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV  225 (361)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (361)
                      ||.+.+..++ .+++++++|.++.|.+.+|.-+-.+..    -..+=+.|..|++..+|+|.+.+ +.+.          
T Consensus        34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~----~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQ----PRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC----CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhccc----CCceecCCcceEEecCCceeccc-cccc----------
Confidence            7888887764 589999999999999999887722110    01222457899999999988864 1110          


Q ss_pred             eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 018047          226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV  269 (361)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~  269 (361)
                          .....+.|||... ...+.+.=|||||+++|..+-...|-
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence                0123467888652 34567788999999999999876654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.65  E-value=0.00034  Score=66.18  Aligned_cols=74  Identities=16%  Similarity=0.041  Sum_probs=48.1

Q ss_pred             ceecccCceEEEEEEEcC-CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcc-eeEEEEEEcCCEEEEEEEecCC
Q 018047           67 NFLGKGGFGRVYKGTLRS-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL-VSLIGYCADGKHRFLVYEYMQK  144 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~  144 (361)
                      +.|+.|-...+|++...+ +..+++|+.....    ...-+...|..++..|...++ .++++.+. +   .+||||++|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~----~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G  185 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT----DEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDG  185 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C----CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCS
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh----hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCC
Confidence            457788889999998764 4788898864321    111122569999999865444 57777763 2   259999988


Q ss_pred             Cchh
Q 018047          145 GNLQ  148 (361)
Q Consensus       145 g~L~  148 (361)
                      .+|.
T Consensus       186 ~~l~  189 (458)
T 2qg7_A          186 YALS  189 (458)
T ss_dssp             EECC
T ss_pred             ccCC
Confidence            6653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.55  E-value=0.00055  Score=63.07  Aligned_cols=140  Identities=16%  Similarity=0.211  Sum_probs=82.9

Q ss_pred             ceecccCceEEEEEEEc--------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEE
Q 018047           67 NFLGKGGFGRVYKGTLR--------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  137 (361)
                      +.|..|-...+|++...        +++.+.+|+...    .......+.+|..+++.|. +.-..++++.+.++    +
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~----~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA----ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----R  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC----ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----c
Confidence            45777888899998864        247899988522    1123456678999998884 33346677776542    9


Q ss_pred             EEEecCCCchhhh-cc----------------cCC---CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 018047          138 VYEYMQKGNLQDH-LN----------------GIG---EPKMD--WPLRLKVALGAAK-------------------GLA  176 (361)
Q Consensus       138 v~e~~~~g~L~~~-l~----------------~~~---~~~~~--~~~~~~i~~~i~~-------------------~l~  176 (361)
                      ||||++|.+|..- +.                ...   .....  +.++.++..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999998666421 10                000   11122  3455555443321                   122


Q ss_pred             HH----hcCCCCCCCeEecCCCCCCeeeCCC----CcEEEeecCccc
Q 018047          177 YL----HSSSAVGIPIVHRDFKSTNVLLSAN----FEAKISDFGLAK  215 (361)
Q Consensus       177 ~l----H~~~~~~~~iiH~Dikp~Nill~~~----~~~kl~Dfg~~~  215 (361)
                      .|    ...+ ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       208 ~L~~~L~~~~-~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          208 NLRKLLESTP-SPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHTSC-CCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHhhcC-CCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            22    2221 12349999999999999876    789999999885

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.54  E-value=0.00027  Score=64.96  Aligned_cols=73  Identities=11%  Similarity=0.075  Sum_probs=44.1

Q ss_pred             ceecccCceEEEEEEEcC---------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc-ceeEEEEEEcCCEEE
Q 018047           67 NFLGKGGFGRVYKGTLRS---------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN-LVSLIGYCADGKHRF  136 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~  136 (361)
                      ..|+.|....+|++...+         ++.+++|+....    .....+...|..+++.+...+ ..++++..  .+  +
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~  110 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH----VDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--G  110 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT----GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC----ccceecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence            457788888999998653         267888876432    111113456888888875333 44676654  22  6


Q ss_pred             EEEEecCCCch
Q 018047          137 LVYEYMQKGNL  147 (361)
Q Consensus       137 lv~e~~~~g~L  147 (361)
                      +||||++|.++
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999987654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.54  E-value=0.00061  Score=61.83  Aligned_cols=30  Identities=27%  Similarity=0.348  Sum_probs=26.8

Q ss_pred             CeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          187 PIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       187 ~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            499999999999999888899999987753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.65  E-value=0.012  Score=54.85  Aligned_cols=74  Identities=11%  Similarity=0.086  Sum_probs=48.5

Q ss_pred             ceecccCceEEEEEEEcC--------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEE
Q 018047           67 NFLGKGGFGRVYKGTLRS--------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  137 (361)
                      +.|..|-...+|++...+        ++.+++++....    .....+..+|..+++.+. +.-..++++.+.  +  ++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~----t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~  147 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH----VGKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GR  147 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC----C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC----cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CE
Confidence            457778889999998763        578889886432    111223456888888884 333456666442  2  68


Q ss_pred             EEEecCCCchh
Q 018047          138 VYEYMQKGNLQ  148 (361)
Q Consensus       138 v~e~~~~g~L~  148 (361)
                      ||||++|.+|.
T Consensus       148 I~efI~G~~l~  158 (424)
T 3mes_A          148 IEEFIDGEPLT  158 (424)
T ss_dssp             EEECCCSEECC
T ss_pred             EEEEeCCccCC
Confidence            99999987653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.10  E-value=0.16  Score=46.80  Aligned_cols=28  Identities=29%  Similarity=0.463  Sum_probs=24.7

Q ss_pred             eEecCCCCCCeee------CCCCcEEEeecCccc
Q 018047          188 IVHRDFKSTNVLL------SANFEAKISDFGLAK  215 (361)
Q Consensus       188 iiH~Dikp~Nill------~~~~~~kl~Dfg~~~  215 (361)
                      ++|+|+.+.|||+      +.+..+.++||.+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6899999999999      456789999999886

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.25  E-value=0.23  Score=41.36  Aligned_cols=116  Identities=9%  Similarity=0.101  Sum_probs=79.6

Q ss_pred             CCCcceeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCC
Q 018047          118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       118 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~N  197 (361)
                      .||+++.. .+-.+.+.+.+.++.-+.+.=...+.     .++....++++.+++....++++       -+|--++|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~-------r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRT-------RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGS-------SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcC-------ceEEEEecce
Confidence            68889877 56667777666665443222222232     57888999999999988866665       4788899999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVD  270 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~  270 (361)
                      ++++.++.+++.-.|+-..+                   +|.     ..+...=.-.+=|++..+++++..|.
T Consensus       110 L~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999876654322                   222     11112224467788899999988873

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.62  E-value=0.4  Score=39.99  Aligned_cols=114  Identities=11%  Similarity=0.036  Sum_probs=77.9

Q ss_pred             CCCcceeEEEEEEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCCCeEecCCCCC
Q 018047          118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA-YLHSSSAVGIPIVHRDFKST  196 (361)
Q Consensus       118 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~-~lH~~~~~~~~iiH~Dikp~  196 (361)
                      .||++  -..+-.+++.+.+.++--+++.=...++     .++....++++.+++.... ++++       -+|--++|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-------r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-------RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-------SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-------ceeEEEeCc
Confidence            57888  3444467788777777654443333443     5788899999999988777 5655       578889999


Q ss_pred             CeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 018047          197 NVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAV  269 (361)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~  269 (361)
                      ||+++.++.+++.-.|+-..                   ++|.-.     +..-=.-++=|++..++.++..|
T Consensus       114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             eEEEeCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999999987665432                   333211     11112345677888888988776

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.05  E-value=0.13  Score=48.50  Aligned_cols=62  Identities=5%  Similarity=-0.011  Sum_probs=17.2

Q ss_pred             CCceecccCceEEEEEEEcC-CCEEEE------EEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEE
Q 018047           65 DDNFLGKGGFGRVYKGTLRS-GEVVAI------KKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCA  130 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  130 (361)
                      ..+.||   ||.||+|.+.. ..+||+      |...... ...+....+.+|..++..++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCcccccccc-ccccccccccccccccccccccccCCCcceEE
Confidence            345666   99999999863 467888      6554322 12233446777889999999999999887754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	361
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-74
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-69
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-67
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-66
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-64
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-64
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-63
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-63
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-60
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-60
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-60
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-59
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-58
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-55
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-53
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-51
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-51
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-51
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-50
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-50
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-46
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-43
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-43
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-42
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-42
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (582), Expect = 7e-74
 Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 26/278 (9%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG VYKG       VA+K + +           F+ EV +L +  H N++  +GY
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 72

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
                   +V ++ +  +L  HL+ I E K +    + +A   A+G+ YLH+       I
Sbjct: 73  S-TAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK-----SI 125

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY---TSTGK 245
           +HRD KS N+ L  +   KI DFGLA +      ++   ++ G+  +  PE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185

Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS 305
            + QSDVYAFG+VL EL+TG+         +    ++   ++  D  K+R      +   
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM--- 242

Query: 306 SYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                       L + C++ +  ERP   + +  ++L+
Sbjct: 243 ----------KRLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 4e-69
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 28/273 (10%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V+ G       VA+K ++    + +     F  E +++ +L H  LV L   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
                  +++ EYM+ G+L D L      K+     L +A   A+G+A++          
Sbjct: 77  VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-----NY 130

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD ++ N+L+S     KI+DFGLA+L+ +  E            +  PE  + G  T+
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 249 QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYT 308
           +SDV++FG++L E++T  R      G+ +  ++  +       +  R V           
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPY--PGMTNPEVIQNL------ERGYRMVRPDNCPEE--- 238

Query: 309 MESIAMFANLASRCVRTESSERPSMAECVKELQ 341
                    L   C +    +RP+       L+
Sbjct: 239 ------LYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 5e-67
 Identities = 67/276 (24%), Positives = 126/276 (45%), Gaps = 28/276 (10%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G G FG V+ G   + + VAIK +     + A  E +F  E +++ +L HP LV L G 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
           C +     LV+E+M+ G L D+              L + L   +G+AYL  +      +
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEA-----CV 122

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD  + N L+  N   K+SDFG+ + + + Q T  +        +  PE  S  + + 
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSS 181

Query: 249 QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYT 308
           +SDV++FGV++ E+ +  +    N+  ++         ++ D     ++  P L+ +   
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLASTH-- 230

Query: 309 MESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                    + + C +    +RP+ +  +++L  I 
Sbjct: 231 ------VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 8e-66
 Identities = 72/303 (23%), Positives = 119/303 (39%), Gaps = 28/303 (9%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG V++G  R GE VA+K          +       E+     L H N++  I  
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 129 CADG----KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
                      +LV +Y + G+L D+LN      +     +K+AL  A GLA+LH     
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 185 GI---PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA--RVLGTFGYFDPE 239
                 I HRD KS N+L+  N    I+D GLA       +T   A    +GT  Y  PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 240 Y------TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND--- 290
                      +   ++D+YA G+V  E+        +++        L       +   
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG 350
           +    + + P +     + E++ + A +   C     + R +     K L  +  +  +G
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL--SQQEG 300

Query: 351 LNM 353
           + M
Sbjct: 301 IKM 303

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 9e-66
 Identities = 73/282 (25%), Positives = 118/282 (41%), Gaps = 36/282 (12%)

Query: 63  FSDDNF-----LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSR 116
           ++ ++F     LGKG FG VY    + S  ++A+K +   + ++A  EH+ R EV+I S 
Sbjct: 3   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62

Query: 117 LDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA 176
           L HPN++ L GY  D    +L+ EY   G +   L  +   K D           A  L+
Sbjct: 63  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 120

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           Y HS       ++HRD K  N+LL +  E KI+DFG +   P  +       + GT  Y 
Sbjct: 121 YCHSK-----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYL 171

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK 296
            PE         + D+++ GV+  E L G+   +              + I         
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVEFTFPD 225

Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
            +                  +L SR ++   S+RP + E ++
Sbjct: 226 FVTEGA-------------RDLISRLLKHNPSQRPMLREVLE 254

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (528), Expect = 2e-65
 Identities = 70/310 (22%), Positives = 125/310 (40%), Gaps = 41/310 (13%)

Query: 51  FTLKEMEEATCSFSD---------DNFLGKGGFGRVYKGTLRS----GEVVAIKKMELPR 97
           FT ++  EA   F+          +  +G G FG V  G L+        VAIK   L  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT--LKS 64

Query: 98  FKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP 157
                   +F  E  I+ + DHPN++ L G         ++ E+M+ G+L D      + 
Sbjct: 65  GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDG 123

Query: 158 KMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM 217
           +      + +  G A G+ YL       +  VHRD  + N+L+++N   K+SDFGL++ +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD-----MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 218 PEGQETYVTARVLG---TFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQG 274
            +          LG      +  PE     K T  SDV+++G+V+ E+++          
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWD 236

Query: 275 VNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMA 334
           + +Q+++  +       +  R     +   +            L   C + + + RP   
Sbjct: 237 MTNQDVINAI------EQDYRLPPPMDCPSA---------LHQLMLDCWQKDRNHRPKFG 281

Query: 335 ECVKELQLII 344
           + V  L  +I
Sbjct: 282 QIVNTLDKMI 291

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 2e-65
 Identities = 80/280 (28%), Positives = 125/280 (44%), Gaps = 28/280 (10%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           S   +  LG+G FG V+ GT      VAIK ++            F  E  ++ +L H  
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEK 73

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           LV L       +  ++V EYM KG+L D L G     +  P  + +A   A G+AY+   
Sbjct: 74  LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                  VHRD ++ N+L+  N   K++DFGLA+L+ + + T           +  PE  
Sbjct: 133 -----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK-FPIKWTAPEAA 186

Query: 242 STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE 301
             G+ T++SDV++FG++L EL T  R      G+ ++ ++ QV       +  R    PE
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPY--PGMVNREVLDQV------ERGYRMPCPPE 238

Query: 302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
              S           +L  +C R E  ERP+       L+
Sbjct: 239 CPES---------LHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 3e-65
 Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 34/276 (12%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +GKG FG V  G  R G  VA+K ++     +      F  E  ++++L H NLV L+G 
Sbjct: 15  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 68

Query: 129 CADGKHR-FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
             + K   ++V EYM KG+L D+L   G   +     LK +L   + + YL  +      
Sbjct: 69  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-----N 123

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
            VHRD  + NVL+S +  AK+SDFGL K     Q+T           +  PE     K +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREKKFS 178

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            +SDV++FG++L E+ +  R       +  +++V +V      +        P +     
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPY--PRIPLKDVVPRVEK--GYKMDAPDGCPPAV----- 229

Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVKELQLI 343
                     +   C   +++ RPS  +  ++L+ I
Sbjct: 230 --------YEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-65
 Identities = 63/273 (23%), Positives = 109/273 (39%), Gaps = 28/273 (10%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           LG G FG V  G  R    VAIK ++    + +  E EF  E  ++  L H  LV L G 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
           C   +  F++ EYM  G L ++L      +      L++     + + YL S        
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK-----QF 121

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD  + N L++     K+SDFGL++ + +  E   +        +  PE     K + 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 249 QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYT 308
           +SD++AFGV++ E+ +  +     +   +      +       + LR       S     
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEHI------AQGLRLYRPHLASEK--- 229

Query: 309 MESIAMFANLASRCVRTESSERPSMAECVKELQ 341
                    +   C   ++ ERP+    +  + 
Sbjct: 230 ------VYTIMYSCWHEKADERPTFKILLSNIL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-64
 Identities = 65/309 (21%), Positives = 119/309 (38%), Gaps = 38/309 (12%)

Query: 56  MEEATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDIL 114
           ME     F   + LG G  G V+K + + SG V+A K + L    +    ++   E+ +L
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVL 58

Query: 115 SRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKG 174
              + P +V   G         +  E+M  G+L   L   G  ++   +  KV++   KG
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKG 116

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
           L YL         I+HRD K +N+L+++  E K+ DFG++  + +          +GT  
Sbjct: 117 LTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRS 168

Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV---------- 284
           Y  PE       ++QSD+++ G+ L+E+  GR  +        + +              
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228

Query: 285 ---------------RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSE 329
                                  +L   I  E      +      F +  ++C+    +E
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288

Query: 330 RPSMAECVK 338
           R  + + + 
Sbjct: 289 RADLKQLMV 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 2e-64
 Identities = 64/283 (22%), Positives = 119/283 (42%), Gaps = 31/283 (10%)

Query: 66  DNF-----LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH 119
           +++     +G G +GR  K   +  G+++  K+++     EA+ +     EV++L  L H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKH 62

Query: 120 PNLVSLIGYCADGKHR--FLVYEYMQKGNLQDHLNGIGEPK--MDWPLRLKVALGAAKGL 175
           PN+V       D  +   ++V EY + G+L   +    + +  +D    L+V       L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 176 AYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGY 235
              H  S  G  ++HRD K  NV L      K+ DFGLA+++    +T      +GT  Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYY 180

Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR 295
             PE  +      +SD+++ G +L EL             + + L  ++R      +++ 
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIRE--GKFRRIP 235

Query: 296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
                EL               + +R +  +   RPS+ E ++
Sbjct: 236 YRYSDEL-------------NEIITRMLNLKDYHRPSVEEILE 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  203 bits (517), Expect = 8e-64
 Identities = 79/319 (24%), Positives = 128/319 (40%), Gaps = 52/319 (16%)

Query: 53  LKEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHE 106
           L  +E    +      +G+G FGRV++             +VA+K   L     AD + +
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQAD 62

Query: 107 FRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE---------- 156
           F+ E  +++  D+PN+V L+G CA GK   L++EYM  G+L + L  +            
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 157 ------------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF 204
                       P +    +L +A   A G+AYL          VHRD  + N L+  N 
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-----RKFVHRDLATRNCLVGENM 177

Query: 205 EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT 264
             KI+DFGL++ +                 +  PE     + T +SDV+A+GVVL E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 265 GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVR 324
                    G+  + ++  VR    +     +    EL              NL   C  
Sbjct: 238 YGL--QPYYGMAHEEVIYYVRD--GNILACPENCPLEL-------------YNLMRLCWS 280

Query: 325 TESSERPSMAECVKELQLI 343
              ++RPS     + LQ +
Sbjct: 281 KLPADRPSFCSIHRILQRM 299

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  201 bits (513), Expect = 2e-63
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 28/277 (10%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G +G VY+G  +     VA+K ++    ++     EF  E  ++  + HPNLV L+G
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 80

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
            C      +++ E+M  GNL D+L      ++   + L +A   +  + YL         
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-----N 135

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
            +HRD  + N L+  N   K++DFGL++LM     T   A       +  PE  +  K +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFS 194

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
           ++SDV+AFGV+L E+ T   +                     D  ++ ++++ +  R   
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYELLEKDY-RMER 237

Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                     L   C +   S+RPS AE  +  + + 
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (515), Expect = 2e-63
 Identities = 74/280 (26%), Positives = 115/280 (41%), Gaps = 34/280 (12%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           FSD   +G G FG VY    +R+ EVVAIKKM     +  +   +   EV  L +L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
            +   G        +LV EY            + +  +       V  GA +GLAYLHS 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY- 240
           +     ++HRD K+ N+LLS     K+ DFG A +M            +GT  +  PE  
Sbjct: 135 N-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWMAPEVI 183

Query: 241 --TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
                G+   + DV++ G+  +EL   +  +       + N +  + HI  +  +   + 
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQN--ESPALQ 235

Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
               S           F N    C++    +RP+    +K
Sbjct: 236 SGHWSEY---------FRNFVDSCLQKIPQDRPTSEVLLK 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 5e-63
 Identities = 68/281 (24%), Positives = 118/281 (41%), Gaps = 30/281 (10%)

Query: 65  DDNFLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +D  LG G FG V KG  +     + VA+K ++     +   + E   E +++ +LD+P 
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPY 69

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V +IG C + +   LV E  + G L  +L       +     +++    + G+ YL  S
Sbjct: 70  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES 126

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA-RVLGTFGYFDPEY 240
                  VHRD  + NVLL     AKISDFGL+K +   +  Y           ++ PE 
Sbjct: 127 -----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
            +  K + +SDV++FGV++ E  +  +     +G+    +   +     +R         
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLEK--GERMGCPAGCPR 237

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
           E+              +L + C   +   RP  A     L+
Sbjct: 238 EM-------------YDLMNLCWTYDVENRPGFAAVELRLR 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-62
 Identities = 75/289 (25%), Positives = 115/289 (39%), Gaps = 30/289 (10%)

Query: 65  DDNFLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
            D  LG G FG V +G  R       VAIK   L +  E     E   E  I+ +LD+P 
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPY 70

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           +V LIG C   +   LV E    G L   L G  E  +      ++    + G+ YL   
Sbjct: 71  IVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK 128

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETY-VTARVLGTFGYFDPEY 240
                  VHRD  + NVLL     AKISDFGL+K +      Y   +       ++ PE 
Sbjct: 129 -----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
            +  K + +SDV+++GV + E L+  +     + +    ++  +      R +      P
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQ--GKRMECPPECPP 239

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
           EL               L S C   +  +RP      + ++   Y+ + 
Sbjct: 240 EL-------------YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-61
 Identities = 66/299 (22%), Positives = 114/299 (38%), Gaps = 46/299 (15%)

Query: 69  LGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPN 121
           LG G FG+V + T        +   VA+K   L              E+ +LS L +H N
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIG----------------EPKMDWPLRL 165
           +V+L+G C  G    ++ EY   G+L + L                    E  +D    L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 166 KVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV 225
             +   AKG+A+L S        +HRD  + N+LL+     KI DFGLA+ +       V
Sbjct: 149 SFSYQVAKGMAFLASK-----NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR 285
                    +  PE       T +SDV+++G+ L EL +   +           +  +  
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----PGMPVDSKFY 258

Query: 286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
            ++  ++  R +                   ++   C   +  +RP+  + V+ ++  I
Sbjct: 259 KMI--KEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 3e-61
 Identities = 71/282 (25%), Positives = 106/282 (37%), Gaps = 31/282 (10%)

Query: 63  FSDD----NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL 117
           F +D      LG+G +G V     R + E VA+K +++ R    D     + E+ I   L
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKML 60

Query: 118 DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAY 177
           +H N+V   G+  +G  ++L  EY   G L D +       M  P   +       G+ Y
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVY 118

Query: 178 LHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFD 237
           LH        I HRD K  N+LL      KISDFGLA +        +  ++ GT  Y  
Sbjct: 119 LHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173

Query: 238 PEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK 296
           PE     +      DV++ G+VL  +L G    D     +D                  K
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWK 230

Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
            ID                  L  + +    S R ++ +  K
Sbjct: 231 KIDSAP-------------LALLHKILVENPSARITIPDIKK 259

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 8e-61
 Identities = 76/291 (26%), Positives = 120/291 (41%), Gaps = 32/291 (10%)

Query: 66  DNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +  +G+G FG VY GTL          A+K   L R  +     +F  E  I+    HPN
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 122 LVSLIGYCADGK-HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           ++SL+G C   +    +V  YM+ G+L++               +   L  AKG+ +L S
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ--ETYVTARVLGTFGYFDP 238
                   VHRD  + N +L   F  K++DFGLA+ M + +    +          +   
Sbjct: 149 K-----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
           E   T K T +SDV++FGV+L EL+T            D N      ++L  R+ L+   
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQPEY 258

Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK 349
            P+                +  +C   ++  RPS +E V  +  I  T   
Sbjct: 259 CPD------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-60
 Identities = 74/281 (26%), Positives = 111/281 (39%), Gaps = 37/281 (13%)

Query: 66  DNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           D  +G+G F  VYKG    +   VA  +++  +  +++ +  F+ E ++L  L HPN+V 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIVR 72

Query: 125 LIGYCAD----GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
                       K   LV E M  G L+ +L       M   +         KGL +LH+
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT 130

Query: 181 SSAVGIPIVHRDFKSTNVLLSA-NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                 PI+HRD K  N+ ++      KI D GLA L            V+GT  +  PE
Sbjct: 131 R---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPE 183

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK--KLRKV 297
                K     DVYAFG+ +LE+ T             QN     R + +  K     KV
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYS-----ECQNAAQIYRRVTSGVKPASFDKV 237

Query: 298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
             PE+               +   C+R    ER S+ + + 
Sbjct: 238 AIPEV-------------KEIIEGCIRQNKDERYSIKDLLN 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-60
 Identities = 76/289 (26%), Positives = 124/289 (42%), Gaps = 31/289 (10%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLRSGE-----VVAIKKMELPRFKEADGEHEFRVEVDILSR 116
             +    +G G FG VYKG L++        VAIK   L          +F  E  I+ +
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDFLGEAGIMGQ 65

Query: 117 LDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA 176
             H N++ L G  +  K   ++ EYM+ G L   L    + +      + +  G A G+ 
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMK 124

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQE-TYVTARVLGTFGY 235
           YL +        VHRD  + N+L+++N   K+SDFGL++++ +  E TY T+       +
Sbjct: 125 YLANM-----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 236 FDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR 295
             PE  S  K T  SDV++FG+V+ E++T                            ++ 
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------------LSNHEVM 223

Query: 296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
           K I+    R    M+  +    L  +C + E + RP  A+ V  L  +I
Sbjct: 224 KAINDGF-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 3e-60
 Identities = 55/276 (19%), Positives = 115/276 (41%), Gaps = 33/276 (11%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG+VYK   + +  + A K ++    +E +   ++ VE+DIL+  DHPN+V L+ 
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMVEIDILASCDHPNIVKLLD 76

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                 + +++ E+   G +   +  +  P +       V       L YLH +      
Sbjct: 77  AFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHDNK----- 130

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY-----TS 242
           I+HRD K+ N+L + + + K++DFG++       +   +   +GT  +  PE      + 
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSK 188

Query: 243 TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL 302
                 ++DV++ G+ L+E+         +  +N   ++L++                  
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVLLKIAKSEPPTLAQPSRWSSN- 244

Query: 303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
                       F +   +C+      R + ++ ++
Sbjct: 245 ------------FKDFLKKCLEKNVDARWTTSQLLQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 3e-60
 Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 33/292 (11%)

Query: 60  TCSFSDDNF-----LGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVE 110
           TC   + +      LG G FG V +G   +       VA+K ++     + +   +F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 111 VDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG 170
           V+ +  LDH NL+ L G         +V E    G+L D L    +         + A+ 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQ 119

Query: 171 AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV-TARV 229
            A+G+ YL S        +HRD  + N+LL+     KI DFGL + +P+  + YV     
Sbjct: 120 VAEGMGYLESK-----RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174

Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN 289
              F +  PE   T   +  SD + FGV L E+ T  +      G+N   ++ ++     
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW--IGLNGSQILHKI----- 227

Query: 290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
           D++  R     +  +            N+  +C   +  +RP+       L 
Sbjct: 228 DKEGERLPRPEDCPQD---------IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 3e-59
 Identities = 58/271 (21%), Positives = 115/271 (42%), Gaps = 30/271 (11%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G  G VY    + +G+ VAI++M     ++   +     E+ ++    +PN+V+ + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
               G   ++V EY+  G+L D +    E  MD      V     + L +LHS+      
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQ----- 136

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD KS N+LL  +   K++DFG    +   Q    T  ++GT  +  PE  +     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 194

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
            + D+++ G++ +E++ G          N    +  +        +  + +         
Sbjct: 195 PKVDIWSLGIMAIEMIEGEP---PYLNENPLRALYLIATNGTPELQNPEKLSAI------ 245

Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVK 338
                  F +  +RC+  +  +R S  E ++
Sbjct: 246 -------FRDFLNRCLDMDVEKRGSAKELLQ 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-59
 Identities = 70/310 (22%), Positives = 126/310 (40%), Gaps = 41/310 (13%)

Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHP 120
               + +G+G FG+V K  ++  G  +      +  +   D   +F  E+++L +L  HP
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 121 NLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNG--------------IGEPKMDWPLRLK 166
           N+++L+G C    + +L  EY   GNL D L                     +     L 
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 167 VALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVT 226
            A   A+G+ YL          +HRD  + N+L+  N+ AKI+DFGL++      +  + 
Sbjct: 132 FAADVARGMDYLSQK-----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 227 ARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH 286
                   +   E  +    T  SDV+++GV+L E+++         G+    L  ++  
Sbjct: 187 R---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLPQ 241

Query: 287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT 346
               R +     D E+              +L  +C R +  ERPS A+ +  L  ++  
Sbjct: 242 --GYRLEKPLNCDDEV-------------YDLMRQCWREKPYERPSFAQILVSLNRMLEE 286

Query: 347 NSKGLNMPLH 356
               +N  L+
Sbjct: 287 RKTYVNTTLY 296

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 5e-59
 Identities = 72/295 (24%), Positives = 114/295 (38%), Gaps = 27/295 (9%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKM--ELPRFKEADGEHEFRVEVDILSRLDH 119
           F     LG G FG VYKG  +  GE V I     EL          E   E  +++ +D+
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           P++  L+G C       L+ + M  G L D++    +  +     L   +  AKG+ YL 
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                   +VHRD  + NVL+      KI+DFGLAKL+   ++ Y          +   E
Sbjct: 129 DR-----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
                  T QSDV+++GV + EL+T         G+    +   +       K  R    
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSIL------EKGERLPQP 235

Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLNMP 354
           P  +              +  +C   ++  RP   E + E   +     + L + 
Sbjct: 236 PICTID---------VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 281

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 5e-59
 Identities = 64/301 (21%), Positives = 110/301 (36%), Gaps = 51/301 (16%)

Query: 69  LGKGGFGRVYKGTLRS------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPN 121
           LG G FG+V   T            VA+K   L    ++        E+ ++++L  H N
Sbjct: 45  LGSGAFGKVMNATAYGISKTGVSIQVAVKM--LKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP---------------------KMD 160
           +V+L+G C      +L++EY   G+L ++L    E                       + 
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 161 WPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG 220
           +   L  A   AKG+ +L          VHRD  + NVL++     KI DFGLA+ +   
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFK-----SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNL 280
               V         +  PE    G  T++SDV+++G++L E+ +               +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY-----PGIPV 272

Query: 281 VLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL 340
                 ++ +  K+        +              +   C   +S +RPS       L
Sbjct: 273 DANFYKLIQNGFKMD--QPFYATEE---------IYIIMQSCWAFDSRKRPSFPNLTSFL 321

Query: 341 Q 341
            
Sbjct: 322 G 322

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 3e-58
 Identities = 64/275 (23%), Positives = 104/275 (37%), Gaps = 27/275 (9%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G F  V     L +    AIK +E     + +       E D++SRLDHP  V L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              D +  +    Y + G L  ++  IG    D              L YLH        
Sbjct: 76  TFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG-----KG 128

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           I+HRD K  N+LL+ +   +I+DFG AK++    +       +GT  Y  PE  +     
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
             SD++A G ++ +L+ G             N  L  + I+       +   P+      
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKLEYDFPEKFFPKA----- 237

Query: 308 TMESIAMFANLASRCVRTESSERPSMAECVKELQL 342
                    +L  + +  ++++R    E      L
Sbjct: 238 --------RDLVEKLLVLDATKRLGCEEMEGYGPL 264

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 4e-56
 Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 31/280 (11%)

Query: 69  LGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVS 124
           +G+G FG V++G   S       VAIK  +           +F  E   + + DHP++V 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           LIG   +    +++ E    G L+     + +  +D    +  A   +  LAYL S    
Sbjct: 73  LIGVITEN-PVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLESK--- 127

Query: 185 GIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTG 244
               VHRD  + NVL+S+N   K+ DFGL++ M +    Y  ++      +  PE  +  
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFR 184

Query: 245 KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSR 304
           + T  SDV+ FGV + E+L         QGV + +++ ++ +   +R  +     P L  
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRIEN--GERLPMPPNCPPTL-- 238

Query: 305 SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                       +L ++C   + S RP   E   +L  I+
Sbjct: 239 -----------YSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 4e-55
 Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 38/287 (13%)

Query: 69  LGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG+G FG VY+G  +          VAIK   +          EF  E  ++   +  ++
Sbjct: 28  LGQGSFGMVYEGVAKGVVKDEPETRVAIKT--VNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGE--------PKMDWPLRLKVALGAAKG 174
           V L+G  + G+   ++ E M +G+L+ +L  +                  +++A   A G
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 175 LAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFG 234
           +AYL+++       VHRD  + N +++ +F  KI DFG+ + + E        + L    
Sbjct: 146 MAYLNAN-----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 235 YFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL 294
           +  PE    G  T  SDV++FGVVL E+ T        QG++++ ++  V          
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVLRFVME--GGLLDK 256

Query: 295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
                  L               L   C +     RPS  E +  ++
Sbjct: 257 PDNCPDML-------------FELMRMCWQYNPKMRPSFLEIISSIK 290

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  178 bits (451), Expect = 2e-54
 Identities = 67/277 (24%), Positives = 109/277 (39%), Gaps = 28/277 (10%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG GG   V+    LR    VA+K +     ++      FR E    + L+HP +V++  
Sbjct: 15  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74

Query: 128 YCAD----GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
                   G   ++V EY+    L+D ++  G   M     ++V   A + L + H +  
Sbjct: 75  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN-- 130

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-LMPEGQETYVTARVLGTFGYFDPEYTS 242
               I+HRD K  N+++SA    K+ DFG+A+ +   G     TA V+GT  Y  PE   
Sbjct: 131 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 243 TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPEL 302
              +  +SDVY+ G VL E+LTG             + V      + +           L
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 303 SRSSYTMESIAMFANLASRCVRTESSERPSMAECVKE 339
           S              +  + +      R   A  ++ 
Sbjct: 242 SAD---------LDAVVLKALAKNPENRYQTAAEMRA 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  179 bits (456), Expect = 3e-54
 Identities = 62/273 (22%), Positives = 112/273 (41%), Gaps = 30/273 (10%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V++ T R +G   A K +  P   + +     R E+  +S L HP LV+L  
Sbjct: 34  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE---TVRKEIQTMSVLRHPTLVNLHD 90

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              D     ++YE+M  G L + +       M     ++      KGL ++H ++     
Sbjct: 91  AFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN----- 144

Query: 188 IVHRDFKSTNVLLSA--NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
            VH D K  N++ +   + E K+ DFGL   +   Q   VT    GT  +  PE      
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 201

Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS 305
           +   +D+++ GV+   LL+G        G ND      +R++ +    +       +S  
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLS---PFGGENDDE---TLRNVKSCDWNMDDSAFSGISED 255

Query: 306 SYTMESIAMFANLASRCVRTESSERPSMAECVK 338
                      +   + +  + + R ++ + ++
Sbjct: 256 ---------GKDFIRKLLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  179 bits (454), Expect = 8e-54
 Identities = 57/273 (20%), Positives = 109/273 (39%), Gaps = 30/273 (10%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FG V++     +G V   K +  P   +   ++  + E+ I+++L HP L++L  
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHD 93

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              D     L+ E++  G L D +       M     +     A +GL ++H  S     
Sbjct: 94  AFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHS----- 147

Query: 188 IVHRDFKSTNVLLSANF--EAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
           IVH D K  N++         KI DFGLA  +   +   VT     T  +  PE      
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREP 204

Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS 305
           +   +D++A GV+   LL+G            ++ +  ++++     +  +     +S  
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFA------GEDDLETLQNVKRCDWEFDEDAFSSVSPE 258

Query: 306 SYTMESIAMFANLASRCVRTESSERPSMAECVK 338
                      +     ++ E  +R ++ + ++
Sbjct: 259 ---------AKDFIKNLLQKEPRKRLTVHDALE 282

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 4e-53
 Identities = 68/299 (22%), Positives = 118/299 (39%), Gaps = 47/299 (15%)

Query: 69  LGKGGFGRVYKGTLRS--------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DH 119
           LG+G FG+V                  VA+K   L          +   E++++  +  H
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEP--------------KMDWPLRL 165
            N+++L+G C      +++ EY  KGNL+++L     P              ++     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 166 KVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYV 225
             A   A+G+ YL S        +HRD  + NVL++ +   KI+DFGLA+ +        
Sbjct: 139 SCAYQVARGMEYLASK-----KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 226 TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVR 285
           T        +  PE       T QSDV++FGV+L E+ T   +     GV  + L   + 
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEELFKLL- 250

Query: 286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII 344
                ++  R       +              +   C     S+RP+  + V++L  I+
Sbjct: 251 -----KEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 6e-53
 Identities = 46/273 (16%), Positives = 104/273 (38%), Gaps = 31/273 (11%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG+G FG V++     S +    K ++     +   +   + E+ IL+   H N++ L  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                +   +++E++   ++ + +N      ++    +       + L +LHS       
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSH-----N 122

Query: 188 IVHRDFKSTNVLLSANFEA--KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGK 245
           I H D +  N++      +  KI +FG A+ +  G    +         Y+ PE      
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDV 179

Query: 246 LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRS 305
           ++  +D+++ G ++  LL+G            +     + +I+N      +    E+S  
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFL------AETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 306 SYTMESIAMFANLASRCVRTESSERPSMAECVK 338
                      +   R +  E   R + +E ++
Sbjct: 234 ---------AMDFVDRLLVKERKSRMTASEALQ 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (434), Expect = 2e-51
 Identities = 65/289 (22%), Positives = 111/289 (38%), Gaps = 31/289 (10%)

Query: 54  KEMEEATCSFSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVD 112
           K+ E+    +   + LG G F  V      R+ ++VAIK +     +    E     E+ 
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIA 59

Query: 113 ILSRLDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAA 172
           +L ++ HPN+V+L      G H +L+ + +  G L D +   G          ++     
Sbjct: 60  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVL 117

Query: 173 KGLAYLHSSSAVGIPIVHRDFKSTNVLLS---ANFEAKISDFGLAKLMPEGQETYVTARV 229
             + YLH      + IVHRD K  N+L      + +  ISDFGL+K+   G         
Sbjct: 118 DAVKYLHD-----LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---TA 169

Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN 289
            GT GY  PE  +    +   D ++ GV+   LL G           D+N       IL 
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY------DENDAKLFEQILK 223

Query: 290 DRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
              +       ++S S           +     +  +  +R +  + ++
Sbjct: 224 AEYEFDSPYWDDISDS---------AKDFIRHLMEKDPEKRFTCEQALQ 263

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 3e-51
 Identities = 70/273 (25%), Positives = 107/273 (39%), Gaps = 30/273 (10%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSR-LDHPNLVSLI 126
           LGKG FG+V+    + + +  AIK ++       D      VE  +LS   +HP L  + 
Sbjct: 10  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
                 ++ F V EY+  G+L  H+      K D       A     GL +LHS      
Sbjct: 70  CTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---- 123

Query: 187 PIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL 246
            IV+RD K  N+LL  +   KI+DFG+ K    G     T    GT  Y  PE     K 
Sbjct: 124 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKY 180

Query: 247 TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSS 306
               D ++FGV+L E+L G+           Q+       I  D     + ++ E     
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFH------GQDEEELFHSIRMDNPFYPRWLEKEA---- 230

Query: 307 YTMESIAMFANLASRCVRTESSERPSMAECVKE 339
                     +L  +    E  +R  +   +++
Sbjct: 231 ---------KDLLVKLFVREPEKRLGVRGDIRQ 254

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  169 bits (429), Expect = 5e-51
 Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 43/294 (14%)

Query: 63  FSDD----NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGE------HEFRVEV 111
           F ++      LG+G    V +     + +  A+K +++        E           EV
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 112 DILSRL-DHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALG 170
           DIL ++  HPN++ L          FLV++ M+KG L D+L       +      K+   
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRA 118

Query: 171 AAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVL 230
             + +  LH        IVHRD K  N+LL  +   K++DFG +  +  G++      V 
Sbjct: 119 LLEVICALHKL-----NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVC 170

Query: 231 GTFGYFDPEYTSTG------KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV 284
           GT  Y  PE               + D+++ GV++  LL G            +  +L +
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLML 224

Query: 285 RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           R I++   +       + S +           +L SR +  +  +R +  E + 
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDT---------VKDLVSRFLVVQPQKRYTAEEALA 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 8e-51
 Identities = 63/301 (20%), Positives = 117/301 (38%), Gaps = 43/301 (14%)

Query: 69  LGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL 122
           LG+G FG+V +          +   VA+K ++      ++          ++    H N+
Sbjct: 21  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNV 79

Query: 123 VSLIGYCA-DGKHRFLVYEYMQKGNLQDHLNG--------------IGEPKMDWPLRLKV 167
           V+L+G C   G    ++ E+ + GNL  +L                + +  +     +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 168 ALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA 227
           +   AKG+ +L S        +HRD  + N+LLS     KI DFGLA+ + +  +     
Sbjct: 140 SFQVAKGMEFLASR-----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 228 RVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI 287
                  +  PE       T+QSDV++FGV+L E+ +   +           +  +    
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRR 249

Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN 347
           L +  ++R       +                  C   E S+RP+ +E V+ L  ++  N
Sbjct: 250 LKEGTRMR--APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298

Query: 348 S 348
           +
Sbjct: 299 A 299

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  169 bits (428), Expect = 2e-50
 Identities = 72/279 (25%), Positives = 114/279 (40%), Gaps = 37/279 (13%)

Query: 63  FSDDNF-----LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSR 116
           +S  +F     LG G FGRV+    R +G   A+K ++               E  +LS 
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 117 LDHPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLA 176
           + HP ++ + G   D +  F++ +Y++ G L   L      +   P+    A      L 
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALE 118

Query: 177 YLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYF 236
           YLHS       I++RD K  N+LL  N   KI+DFG AK +P+   T       GT  Y 
Sbjct: 119 YLHSK-----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYI 168

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK 296
            PE  ST       D ++FG+++ E+L G           D N +     ILN   +   
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP------FYDSNTMKTYEKILNAELRFPP 222

Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
             + ++              +L SR +  + S+R    +
Sbjct: 223 FFNEDV-------------KDLLSRLITRDLSQRLGNLQ 248

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  169 bits (430), Expect = 3e-50
 Identities = 64/278 (23%), Positives = 105/278 (37%), Gaps = 32/278 (11%)

Query: 63  FSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEF---RVEVDILSRLD 118
           FS    +G+GGFG VY      +G++ A+K ++  R K   GE      R+ + ++S  D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 119 HPNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYL 178
            P +V +            + + M  G+L  HL+               A     GL ++
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHM 123

Query: 179 HSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDP 238
           H+       +V+RD K  N+LL  +   +ISD GLA    + +         GT GY  P
Sbjct: 124 HNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAP 174

Query: 239 EYTSTGK-LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV 297
           E    G      +D ++ G +L +LL G            ++     R  L    +L   
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR---QHKTKDKHEIDRMTLTMAVELPDS 231

Query: 298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
             PEL              +L    ++ + + R     
Sbjct: 232 FSPEL-------------RSLLEGLLQRDVNRRLGCLG 256

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  166 bits (421), Expect = 9e-50
 Identities = 61/283 (21%), Positives = 117/283 (41%), Gaps = 25/283 (8%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGY 128
           +G+G +G VYK     GE  A+KK+ L +  E         E+ IL  L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-PSTTIREISILKELKHSNIVKLYDV 68

Query: 129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPI 188
               K   LV+E++ +   +     + E  ++        L    G+AY H        +
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR-----RV 121

Query: 189 VHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTL 248
           +HRD K  N+L++   E KI+DFGLA+        Y    ++  +         + K + 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKKYST 180

Query: 249 QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND-------------RKKLR 295
             D+++ G +  E++ G     L  GV++ + ++++  IL               +    
Sbjct: 181 TIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
             +   L   S+         +L S+ ++ + ++R +  + ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 66/285 (23%), Positives = 111/285 (38%), Gaps = 22/285 (7%)

Query: 67  NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADG--EHEFRVEVDILSRLDHPNLV 123
           +FLG+G F  VYK   + + ++VAIKK++L    EA          E+ +L  L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 124 SLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA 183
            L+       +  LV+++M+        +      +         L   +GL YLH    
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119

Query: 184 VGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTST 243
               I+HRD K  N+LL  N   K++DFGLAK        Y     + T  Y  PE    
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFG 174

Query: 244 GKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV-----RHILNDRKKLRKV 297
            ++  +  D++A G +L ELL     +  +  ++    + +           D   L   
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 298 ID----PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           +     P +        +     +L           R +  + +K
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 64/297 (21%), Positives = 122/297 (41%), Gaps = 31/297 (10%)

Query: 64  SDDNF-----LGKGGFGRVYKGTLR--SGEVVAIKKMELPRFKEADGEHEFRVEVDILSR 116
           +D  +     +G+G +G+V+K       G  VA+K++ +   +E       R EV +L  
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRH 63

Query: 117 L---DHPNLVSLIGYCADGKHRFLVYEYMQ----KGNLQDHLNGIGEPKMDWPLRLKVAL 169
           L   +HPN+V L   C   +        +       +L  +L+ + EP +       +  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 170 GAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARV 229
              +GL +LHS       +VHRD K  N+L++++ + K++DFGLA++            V
Sbjct: 124 QLLRGLDFLHSH-----RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SV 175

Query: 230 LGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN 289
           + T  Y  PE           D+++ G +  E+   +     +  V+    +L V  +  
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235

Query: 290 DRKKLRKVIDPELSRSSYTMESI--------AMFANLASRCVRTESSERPSMAECVK 338
           +    R V  P  +  S + + I         +  +L  +C+    ++R S    + 
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 9e-47
 Identities = 60/278 (21%), Positives = 103/278 (37%), Gaps = 33/278 (11%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGE---HEFRVEVDILSRLDHPNLVS 124
           LG G F  V K     +G   A K ++  R K +       +   EV IL  + HPN+++
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 125 LIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV 184
           L     +     L+ E +  G L D L    +  +      +       G+ YLHS    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS---- 131

Query: 185 GIPIVHRDFKSTNVLLS----ANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEY 240
            + I H D K  N++L          KI DFGLA  +  G E      + GT  +  PE 
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEI 187

Query: 241 TSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
            +   L L++D+++ GV+   LL+G                  + ++     +       
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFL------GDTKQETLANVSAVNYEFEDEYFS 241

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
             S             +   R +  +  +R ++ + ++
Sbjct: 242 NTSAL---------AKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-46
 Identities = 66/291 (22%), Positives = 125/291 (42%), Gaps = 28/291 (9%)

Query: 66  DNF-----LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH 119
           +NF     +G+G +G VYK   + +GEVVA+KK+ L    E         E+ +L  L+H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 60

Query: 120 PNLVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
           PN+V L+         +LV+E++ + +L+  ++      +  PL         +GLA+ H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
           S       ++HRD K  N+L++     K++DFGLA+       TY T  V+  +      
Sbjct: 120 SH-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEI 173

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGR------------RAVDLNQGVNDQNLVLQVRHI 287
                  +   D+++ G +  E++T R              +    G  D+ +   V  +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
            + +    K    + S+    ++      +L S+ +  + ++R S    + 
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGR--SLLSQMLHYDPNKRISAKAALA 282

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 5e-45
 Identities = 60/279 (21%), Positives = 103/279 (36%), Gaps = 36/279 (12%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLI 126
           LG G  G+V +    R+ E  A+K +            + R EV++  R    P++V ++
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 71

Query: 127 GYC----ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
                  A  K   +V E +  G L   +   G+         ++     + + YLHS +
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131

Query: 183 AVGIPIVHRDFKSTNVLLSANFE---AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPE 239
                I HRD K  N+L ++       K++DFG AK                T  Y  PE
Sbjct: 132 -----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183

Query: 240 YTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID 299
                K     D+++ GV++  LL G      N G+     +     I   + +      
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW 241

Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
            E+S              L    ++TE ++R ++ E + 
Sbjct: 242 SEVSEE---------VKMLIRNLLKTEPTQRMTITEFMN 271

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 7e-45
 Identities = 55/283 (19%), Positives = 95/283 (33%), Gaps = 33/283 (11%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G FG +Y GT + +GE VAIK              +  +E  I   +     +  I 
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLE-----CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69

Query: 128 YC-ADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
           +C A+G +  +V E +               K      L +A      + Y+HS +    
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---- 123

Query: 187 PIVHRDFKSTNVLLS---ANFEAKISDFGLAKLMPEGQET-----YVTARVLGTFGYFDP 238
             +HRD K  N L+          I DFGLAK   + +            + GT  Y   
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 239 EYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
                 + + + D+ + G VL+    G       +    +    +         + +   
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-------ISEKKMST 235

Query: 299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
             E+    Y  E    FA   + C      ++P  +   +  +
Sbjct: 236 PIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 9e-44
 Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 33/296 (11%)

Query: 62  SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHP 120
           S++D   +G G FG VY+  L  SGE+VAIKK+          +     E+ I+ +LDH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-------QDKRFKNRELQIMRKLDHC 73

Query: 121 NLVSLIGYC------ADGKHRFLVYEYMQKGNLQDHLNGI-GEPKMDWPLRLKVALGAAK 173
           N+V L  +        D  +  LV +Y+ +   +   +    +  +             +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 174 GLAYLHSSSAVGIPIVHRDFK-STNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGT 232
            LAY+HS       I HRD K    +L       K+ DFG AK +  G+       +   
Sbjct: 134 SLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSR 186

Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV------RH 286
           +             T   DV++ G VL ELL G+     + GV+    +++V        
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

Query: 287 ILNDRKKLRKVIDPELSRSSYTMESI----AMFANLASRCVRTESSERPSMAECVK 338
           I        +   P++    +T             L SR +    + R +  E   
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-43
 Identities = 56/278 (20%), Positives = 102/278 (36%), Gaps = 43/278 (15%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPR---FKEADGEHEFRVEVDILSRLD--HPNL 122
           LG GGFG VY G  +     VAIK +E  R   + E        +EV +L ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
           + L+ +        L+ E  +               +   L         + + + H+  
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC- 129

Query: 183 AVGIPIVHRDFKSTNVLLSAN-FEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                ++HRD K  N+L+  N  E K+ DFG   L+ +   T       GT  Y  PE+ 
Sbjct: 130 ----GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWI 181

Query: 242 STGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP 300
              +     + V++ G++L +++ G    + ++             I+  +   R+ +  
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVFFRQRVSS 229

Query: 301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
           E               +L   C+    S+RP+  E   
Sbjct: 230 EC-------------QHLIRWCLALRPSDRPTFEEIQN 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 8e-43
 Identities = 63/295 (21%), Positives = 118/295 (40%), Gaps = 33/295 (11%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G FG V+K   R +G+ VA+KK+ +   KE         E+ IL  L H N+V+LI 
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIE 76

Query: 128 YCADGKHR--------FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLH 179
            C              +LV+++ +        N + +  +    R  V      GL Y+H
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYIH 134

Query: 180 SSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTAR--VLGTFGYFD 237
                   I+HRD K+ NVL++ +   K++DFGLA+     + +        + T  Y  
Sbjct: 135 R-----NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 238 PEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV------------ 284
           PE     +      D++  G ++ E+ T    +  N   +   L+ Q+            
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 285 -RHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVK 338
             + L ++ +L K    ++              +L  + +  + ++R    + + 
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (374), Expect = 9e-43
 Identities = 49/285 (17%), Positives = 87/285 (30%), Gaps = 35/285 (12%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLI 126
           +G+G FG +++GT L + + VAIK              + R E      L     + ++ 
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFE-----PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 127 GYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGI 186
            +  +G H  LV + +  G   + L  +   K         A      +  +H  S    
Sbjct: 68  YFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---- 121

Query: 187 PIVHRDFKSTNVLLSANFE-----AKISDFGLAKLMPEGQET-----YVTARVLGTFGYF 236
            +V+RD K  N L+            + DFG+ K   +              + GT  Y 
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 237 DPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK 296
                   + + + D+ A G V +  L G       QG+       +   I     + ++
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLP---WQGLKAATNKQKYERI----GEKKQ 233

Query: 297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ 341
                   + +  E    F               P          
Sbjct: 234 STPLRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 9e-43
 Identities = 63/268 (23%), Positives = 92/268 (34%), Gaps = 29/268 (10%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LGKG FG+V       +G   A+K +        D       E  +L    HP L +L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                     V EY   G L  HL+   E                  L YLHS       
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHS-----RD 125

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           +V+RD K  N++L  +   KI+DFGL K       T       GT  Y  PE        
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYG 183

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
              D +  GVV+ E++ GR          +Q+       IL +  +  + + PE      
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP------FYNQDHERLFELILMEEIRFPRTLSPEA----- 232

Query: 308 TMESIAMFANLASRCVRTESSERPSMAE 335
                    +L +  ++ +  +R     
Sbjct: 233 --------KSLLAGLLKKDPKQRLGGGP 252

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-42
 Identities = 56/295 (18%), Positives = 111/295 (37%), Gaps = 29/295 (9%)

Query: 63  FSDDNFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN 121
           +++ +++G+G +G V       +   VAIKK+    F+          E+ IL R  H N
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHEN 67

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNL-QDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS 180
           ++ +           +   Y+    +  D    +    +             +GL Y+HS
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 127

Query: 181 SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTA-RVLGTFGYFDPE 239
           +      ++HRD K +N+LL+   + KI DFGLA++     +        + T  Y  PE
Sbjct: 128 A-----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 240 YTSTGKLTLQS-DVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI 298
                K   +S D+++ G +L E+L+ R    +  G +  + +  +  IL    +     
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 299 DPELSRSSYTMESIAM---------------FANLASRCVRTESSERPSMAECVK 338
              L   +Y +                      +L  + +     +R  + + + 
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (370), Expect = 3e-42
 Identities = 62/284 (21%), Positives = 118/284 (41%), Gaps = 25/284 (8%)

Query: 69  LGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G+G +G V+K   R + E+VA+K++ L    E       R E+ +L  L H N+V L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
                K   LV+E+  +   +   +  G   +D  +         KGL + HS       
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR-----N 121

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           ++HRD K  N+L++ N E K+++FGLA+        Y +A V+  +             +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYS 180

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL--------NDRKKLRKVID 299
              D+++ G +  EL    R   L  G +  + + ++  +L            KL     
Sbjct: 181 TSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 300 PELSRSSYTMESI-----AMFANLASRCVRTESSERPSMAECVK 338
             +  ++ ++ ++     A   +L    ++    +R S  E ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (357), Expect = 9e-40
 Identities = 58/268 (21%), Positives = 99/268 (36%), Gaps = 32/268 (11%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G FGRV       SG   A+K ++  +  +         E  IL  ++ P LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 128 YCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP 187
              D  + ++V EY+  G +  HL  IG  +   P     A        YLHS     + 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS-----LD 161

Query: 188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLT 247
           +++RD K  N+L+      +++DFG AK +     T       GT     PE   +    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPEIILSKGYN 216

Query: 248 LQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSY 307
              D +A GV++ E+  G               +     I++ + +       +L     
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP------FFADQPIQIYEKIVSGKVRFPSHFSSDLK---- 266

Query: 308 TMESIAMFANLASRCVRTESSERPSMAE 335
                    +L    ++ + ++R    +
Sbjct: 267 ---------DLLRNLLQVDLTKRFGNLK 285

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 5e-38
 Identities = 66/311 (21%), Positives = 127/311 (40%), Gaps = 37/311 (11%)

Query: 51  FTLKEMEEATCSFSDD----NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEH 105
           F  +E+ +              +G G +G V      R+G  VAIKK+  P   E   + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 106 EFRVEVDILSRLDHPNLVSLIGYCADGKHR------FLVYEYMQKGNLQDHLNGIGEPKM 159
            +R E+ +L  + H N++ L+      +        +LV  +M  G     L  +   K+
Sbjct: 64  AYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKL--MKHEKL 118

Query: 160 DWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE 219
                  +     KGL Y+H++      I+HRD K  N+ ++ + E KI DFGLA+    
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAA-----GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173

Query: 220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQN 279
               YV  R    +        +  + T   D+++ G ++ E++TG+     +  ++   
Sbjct: 174 EMTGYVVTR----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229

Query: 280 LVLQV---------RHILNDRKKLRKVIDPELSR---SSYTMESIAMFANLASRCVRTES 327
            +++V         + + +D  K      PEL +   +S    +  +  NL  + +  ++
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289

Query: 328 SERPSMAECVK 338
            +R +  E + 
Sbjct: 290 EQRVTAGEALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 6e-35
 Identities = 60/276 (21%), Positives = 103/276 (37%), Gaps = 33/276 (11%)

Query: 69  LGKGGFGRVYKGTL----RSGEVVAIKKMELPRF-KEADGEHEFRVEVDILSRLDH-PNL 122
           LG G +G+V+         +G++ A+K ++     ++A      R E  +L  +   P L
Sbjct: 32  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91

Query: 123 VSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSS 182
           V+L           L+ +Y+  G L  HL+     +                L +LH   
Sbjct: 92  VTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHK-- 147

Query: 183 AVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTS 242
              + I++RD K  N+LL +N    ++DFGL+K      ET       GT  Y  P+   
Sbjct: 148 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVR 203

Query: 243 TGK--LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV-RHILNDRKKLRKVID 299
            G        D ++ GV++ ELLTG           ++N   ++ R IL       + + 
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSEPPYPQEMS 260

Query: 300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAE 335
                            +L  R +  +  +R     
Sbjct: 261 ALA-------------KDLIQRLLMKDPKKRLGCGP 283

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 62/349 (17%), Positives = 127/349 (36%), Gaps = 60/349 (17%)

Query: 15  SKSQDQTDPWVYKPVEHWKLEDQPTQPQKRHRGSSVFTLKEMEEATCSFSDDNFLGKGGF 74
           S+++  TD   ++P E+W  E    +   +      + L               LG+G +
Sbjct: 5   SRARVYTDVNTHRPREYWDYESHVVEWGNQDD----YQLVRK------------LGRGKY 48

Query: 75  GRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADG 132
             V++   + + E V +K ++  + K      + + E+ IL  L   PN+++L     D 
Sbjct: 49  SEVFEAINITNNEKVVVKILKPVKKK------KIKREIKILENLRGGPNIITLADIVKDP 102

Query: 133 KHR--FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVH 190
             R   LV+E++   + +          +             K L Y HS     + I+H
Sbjct: 103 VSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS-----MGIMH 152

Query: 191 RDFKSTNVLL-SANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL-TL 248
           RD K  NV++   + + ++ D+GLA+    GQE       + +  +  PE     ++   
Sbjct: 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDY 209

Query: 249 QSDVYAFGVVLLELLTGRRAVDLNQGVNDQNL----VLQVRHILNDRKKLRKVIDPELSR 304
             D+++ G +L  ++  +          DQ +    VL    + +   K    +DP  + 
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269

Query: 305 SSYTMESIAM---------------FANLASRCVRTESSERPSMAECVK 338
                                      +   + +R +   R +  E ++
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 6e-34
 Identities = 58/300 (19%), Positives = 116/300 (38%), Gaps = 44/300 (14%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           +G G  G V           VAIKK+  P   +   +  +R E+ ++  ++H N++SL+ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83

Query: 128 YCA------DGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
                    + +  +LV E M     Q         ++D      +      G+ +LHS 
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS- 137

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYT 241
                 I+HRD K +N+++ ++   KI DFGLA+              + T  Y  PE  
Sbjct: 138 ----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVVTRYYRAPEVI 190

Query: 242 STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQV----------------R 285
                    D+++ G ++ E++  +        ++  N V++                 R
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 286 HILNDRKKLRKVIDPELSRSSYTMESI-------AMFANLASRCVRTESSERPSMAECVK 338
           + + +R K   +  P+L   S             +   +L S+ +  + ++R S+ + ++
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 8e-33
 Identities = 57/310 (18%), Positives = 125/310 (40%), Gaps = 35/310 (11%)

Query: 51  FTLKEMEEATCSFSDD----NFLGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEH 105
           F  +E+ +      +     + +G G +G V      ++G  VA+KK+  P       + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 106 EFRVEVDILSRLDHPNLVSLIGYCADGK-----HRFLVYEYMQKGNLQDHLNGIGEPKMD 160
            +R E+ +L  + H N++ L+      +     +   +  ++   +L + +      K+ 
Sbjct: 64  TYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLT 119

Query: 161 WPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG 220
                 +     +GL Y+HS+      I+HRD K +N+ ++ + E KI DFGLA+   + 
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174

Query: 221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR------------RA 268
              YV  R    +        +        D+++ G ++ ELLTGR            + 
Sbjct: 175 MTGYVATR----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

Query: 269 VDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESS 328
           +    G     L+ ++               P+++ ++  + +  +  +L  + +  +S 
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290

Query: 329 ERPSMAECVK 338
           +R + A+ + 
Sbjct: 291 KRITAAQALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (274), Expect = 7e-28
 Identities = 43/315 (13%), Positives = 94/315 (29%), Gaps = 53/315 (16%)

Query: 69  LGKGGFGRVYKGT-LRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIG 127
           LG G F  V+    + +   VA+K +      +         E+ +L R++  +      
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVR----GDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 128 YCADGKHRFLVYEYMQKGNL--------------QDHLNGIGEPKMDWPLRLKVALGAAK 173
             A+   + L +   +  N                  +       +      +++     
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 174 GLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDFGLAKLMPEGQETYVTARVLGT 232
           GL Y+H        I+H D K  NVL+        +    +A L             + T
Sbjct: 137 GLDYMHRRC----GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 233 FGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN--- 289
             Y  PE          +D+++   ++ EL+TG    + ++G +       +  I+    
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 290 --------------------------DRKKLRKVIDPELSRSSYTMESIAMFANLASRCV 323
                                      + K   + D    +  ++ +     ++  S  +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 324 RTESSERPSMAECVK 338
           + +  +R      V 
Sbjct: 313 QLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.1 bits (207), Expect = 7e-20
 Identities = 33/180 (18%), Positives = 56/180 (31%), Gaps = 19/180 (10%)

Query: 69  LGKGGFGRVYKGTLRSGEVVAIKKMELPR-------FKEADGEHEFRVEVDILSRLDHPN 121
           +G+G    V+           +K  ++          K   G+  F V     +R +   
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 122 LVSLIGYCADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSS 181
           L  L G           Y +     L + ++     ++      +V     + +A  +  
Sbjct: 68  LQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122

Query: 182 SAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK-LMPEGQETYVTARVLGTFGYFDPEY 240
                 IVH D    NVL+S      I DF  +  +  EG    +   V     YF   Y
Sbjct: 123 -----GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY 176

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	361
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.79
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.53
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.94
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.53
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.47
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.44

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-60  Score=419.29  Aligned_cols=256  Identities=25%  Similarity=0.347  Sum_probs=208.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.....  ....+.+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            46899999999999999999987 699999999976532  233457889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        83 Ey~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~-----IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          83 EYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             ECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             eccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC-----CccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            999999999999764  37999999999999999999999999     99999999999999999999999999998755


Q ss_pred             CCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ..........+||+.|||||++.+..+ +.++|||||||++|||++|+.||........  ...   ....... .    
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~---~~~~~~~-~----  225 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYS---DWKEKKT-Y----  225 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHH---HHHTTCT-T----
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHH---HHhcCCC-C----
Confidence            444444456789999999999887776 5789999999999999999999965432211  111   1111100 0    


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                            .......+..+.+|+.+||+.||++|||++|+++|-+
T Consensus       226 ------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw  262 (271)
T d1nvra_         226 ------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  262 (271)
T ss_dssp             ------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             ------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence                  0111123455889999999999999999999998753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-59  Score=413.61  Aligned_cols=251  Identities=29%  Similarity=0.456  Sum_probs=212.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++++.||+|+||+||+|+++ +|+.||+|++.+...........+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            35888999999999999999987 68999999987644334445667889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+||+|||++.....
T Consensus        86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~-----ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999997643  7999999999999999999999999     99999999999999999999999999987654


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....   .   ......+....        
T Consensus       159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~---~~~~~~i~~~~--------  220 (263)
T d2j4za1         159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---Y---QETYKRISRVE--------  220 (263)
T ss_dssp             CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---H---HHHHHHHHTTC--------
T ss_pred             Cc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---H---HHHHHHHHcCC--------
Confidence            32    234679999999999999999999999999999999999999995322   1   11222221111        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           ...+...+..+.+|+.+||+.||++|||++|+++|-+
T Consensus       221 -----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~  257 (263)
T d2j4za1         221 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  257 (263)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred             -----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence                 1122234456899999999999999999999999865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-58  Score=414.01  Aligned_cols=252  Identities=24%  Similarity=0.393  Sum_probs=210.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.....   ...+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            46999999999999999999976 799999999976432   23467889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...   .+++..+..++.|++.||+|||++|     |+||||||+|||++.++++||+|||+++.+..
T Consensus        97 Ey~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~-----iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999999999988653   6999999999999999999999999     99999999999999999999999999988754


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....   ..   ..+.......       .
T Consensus       169 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~---~~~~~~~~~~-------~  233 (293)
T d1yhwa1         169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PL---RALYLIATNG-------T  233 (293)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HH---HHHHHHHHHC-------S
T ss_pred             ccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC---HH---HHHHHHHhCC-------C
Confidence            332  2344679999999999999999999999999999999999999995322   11   1111111110       0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      +.   ...+...+..+.+||.+||+.||++|||++|+++|-+
T Consensus       234 ~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~  272 (293)
T d1yhwa1         234 PE---LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (293)
T ss_dssp             CC---CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred             CC---CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            11   1122334556899999999999999999999998854

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-59  Score=416.24  Aligned_cols=255  Identities=24%  Similarity=0.355  Sum_probs=209.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++++.||+|+||+||+|++. +|+.||||++.+...........+.+|+++|++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            35999999999999999999986 79999999997644333445677899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~-----iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc-----EEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999987654  7999999999999999999999999     99999999999999999999999999998765


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+      .......+.....       
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~~~~-------  227 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EYLIFQKIIKLEY-------  227 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHTTCC-------
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC------HHHHHHHHHcCCC-------
Confidence            444334445689999999999999999999999999999999999999996432      1122222222111       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                            ..+...+..+.+||.+||+.||++|||++|++++.+
T Consensus       228 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~  263 (288)
T d1uu3a_         228 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP  263 (288)
T ss_dssp             ------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence                  112233456899999999999999999999876544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-58  Score=407.58  Aligned_cols=264  Identities=28%  Similarity=0.500  Sum_probs=206.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      .++|++.+.||+|+||+||+|+++  ..||||++..... .....+.+.+|+.+|++++|||||++++++.+ +.+++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            357999999999999999999865  4699999875533 33456789999999999999999999998754 5689999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++.... ..+++..+..++.|+++||+|||+++     |+||||||+|||++.++.+||+|||+++....
T Consensus        83 Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~-----ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS-----IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             ECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             ecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC-----EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            9999999999997543 36999999999999999999999999     99999999999999999999999999987755


Q ss_pred             CCceeeeeecccccCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          220 GQETYVTARVLGTFGYFDPEYTST---GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      ...........||+.|||||++..   ..++.++|||||||++|||+||+.||.....   ......   ....     .
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~---~~~~~~---~~~~-----~  225 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIF---MVGR-----G  225 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHH---HHHH-----T
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh---HHHHHH---HHhc-----C
Confidence            444334455679999999998754   3578999999999999999999999964322   111111   1111     0


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                      ...+.+  ...+..++..+.+|+.+||+.||++|||++|++++|+.+..+
T Consensus       226 ~~~p~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         226 YLSPDL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             SCCCCG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCcc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            111111  112233455699999999999999999999999999988764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-58  Score=405.81  Aligned_cols=258  Identities=26%  Similarity=0.426  Sum_probs=202.3

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|+..+.||+|+||+||+|.+.+++.||||++...    ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC----cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            468888999999999999999988889999998643    2334678999999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++... ...+++..+..++.|++.||+|||+++     |+||||||+|||++.++++||+|||+++.+...
T Consensus        81 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~-----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             CCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             ecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc-----eeecccchhheeecCCCCeEecccchheeccCC
Confidence            99999999998764 347899999999999999999999999     999999999999999999999999999877544


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ... ......||+.|+|||++....++.++|||||||++|||+|+..|+....  ........+.   ..       .. 
T Consensus       155 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~---~~-------~~-  220 (263)
T d1sm2a_         155 QYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDIS---TG-------FR-  220 (263)
T ss_dssp             -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHH---HT-------CC-
T ss_pred             Cce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHH---hc-------CC-
Confidence            322 2334578999999999999999999999999999999999654443221  1122222211   11       00 


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                          ...+..++..+.+|+.+||+.||++|||++|++++|+++..+
T Consensus       221 ----~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         221 ----LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence                112223345689999999999999999999999999998754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-58  Score=414.95  Aligned_cols=260  Identities=27%  Similarity=0.418  Sum_probs=215.2

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++...    ....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc----cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            45888899999999999999987 5889999998643    233567899999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++.......+++..+..++.|++.||+|||++|     |+||||||+|||++.++++||+|||+++....
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC-----cccCccccCeEEECCCCcEEEccccceeecCC
Confidence            9999999999997766678999999999999999999999999     99999999999999999999999999987755


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      .... ......|++.|+|||++....++.++|||||||++|||++|..||.....  ....    .......      ..
T Consensus       168 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~----~~~i~~~------~~  234 (287)
T d1opja_         168 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQV----YELLEKD------YR  234 (287)
T ss_dssp             SSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHH----HHHHHTT------CC
T ss_pred             CCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHH----HHHHhcC------CC
Confidence            4332 23334588999999999999999999999999999999998777643221  1111    1111110      11


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                           ...+..++..+.+|+.+||+.||++|||++|+++.|+.++...
T Consensus       235 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         235 -----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             -----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence                 1223334566999999999999999999999999999876543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-58  Score=408.62  Aligned_cols=259  Identities=23%  Similarity=0.371  Sum_probs=198.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--CCEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--GKHRFL  137 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l  137 (361)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...... ......+.+|+++|++++|||||++++++.+  ++.+|+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            46899999999999999999987 6999999999776443 3345678899999999999999999999865  456899


Q ss_pred             EEEecCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          138 VYEYMQKGNLQDHLNGI--GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ||||+++|+|.+++...  ....+++..++.++.|++.||+|||+++....+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998642  2347999999999999999999999975333349999999999999999999999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .+.....  ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+   ......   .+...  .. 
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~---~i~~~--~~-  231 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG---KIREG--KF-  231 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHH---HHHHT--CC-
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHH---HHHcC--CC-
Confidence            8754322  2334679999999999999999999999999999999999999996322   222211   11111  00 


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                               ...+...+.++.+|+.+||+.||++|||++|+++|.
T Consensus       232 ---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp  267 (269)
T d2java1         232 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  267 (269)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             ---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence                     112223445699999999999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=406.10  Aligned_cols=259  Identities=24%  Similarity=0.413  Sum_probs=211.0

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|++.+.||+|+||+||+|.+++++.||||++...    ....+.+.+|+.+|++++|||||++++++.+ +..|+|||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC----cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            357888999999999999999988889999998643    2334678999999999999999999998755 56789999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.......+++..+..++.|+++||+|||+++     |+||||||+||||+.++.+||+|||+++.+...
T Consensus        88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~-----ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCccchhheeeecccceeeccccceEEccCC
Confidence            999999999887655556999999999999999999999999     999999999999999999999999999987654


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ... ......||+.|+|||++..+.++.++|||||||++|||+||..|+....  .....   ...+...       .. 
T Consensus       163 ~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~---~~~i~~~-------~~-  228 (272)
T d1qpca_         163 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEV---IQNLERG-------YR-  228 (272)
T ss_dssp             CEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHH---HHHHHTT-------CC-
T ss_pred             ccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHH---HHHHHhc-------CC-
Confidence            322 2334568999999999988999999999999999999999766553221  11111   1111111       11 


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                          ...+..++..+.+|+.+||+.||++|||++|+++.|+.++..+
T Consensus       229 ----~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst  271 (272)
T d1qpca_         229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (272)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence                1122334556899999999999999999999999999987654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-58  Score=409.95  Aligned_cols=252  Identities=21%  Similarity=0.368  Sum_probs=206.4

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .|++.+.||+|+||+||+|++. +|..||||++...   .....+.+.+|+++|+.++|||||++++++.+++..|+|||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            5888999999999999999987 6899999999754   23345678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.+.. ..+++..+..++.||+.||+|||++|     |+||||||+|||++.++++||+|||++......
T Consensus        90 y~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~-----ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          90 FCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK-----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             cCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            999999999976532 36999999999999999999999999     999999999999999999999999999765322


Q ss_pred             CceeeeeecccccCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          221 QETYVTARVLGTFGYFDPEYTS-----TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      .  .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.....   ......   +....    
T Consensus       164 ~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~~~~---i~~~~----  231 (288)
T d2jfla1         164 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRVLLK---IAKSE----  231 (288)
T ss_dssp             H--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHH---HHHSC----
T ss_pred             c--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHH---HHcCC----
Confidence            1  1223457999999999873     45688999999999999999999999964322   222211   11110    


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                         .+.   ...+...+..+.+|+.+||+.||++|||++|+++|-
T Consensus       232 ---~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp  270 (288)
T d2jfla1         232 ---PPT---LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP  270 (288)
T ss_dssp             ---CCC---CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred             ---CCC---CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence               011   112233456689999999999999999999999874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-57  Score=408.97  Aligned_cols=261  Identities=26%  Similarity=0.461  Sum_probs=201.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCC---EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGE---VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++.++||+|+||+||+|.++ +++   .||||.+...  ......+.+.+|+.+|++++|||||++++++.+++..|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            35777889999999999999976 333   5888887543  23445567999999999999999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++|+|.+++... ...+++..+..++.|++.||+|||+++     ++||||||+||||+.++++||+|||+++.
T Consensus       104 iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             EEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC-----CccCccccceEEECCCCcEEECCcccceE
Confidence            999999999999988764 336999999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCceee---eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          217 MPEGQETYV---TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       217 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      +........   .....||+.|||||++..+.++.++|||||||++|||+| |+.||....   .......+   ... .
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~i---~~~-~  250 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINAI---EQD-Y  250 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHH---HTT-C
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC---HHHHHHHH---HcC-C
Confidence            754332211   112457899999999999999999999999999999998 899995332   12222111   111 0


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                                 ....+..++..+.+|+.+||+.||++|||+.|+++.|++++.+.
T Consensus       251 -----------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         251 -----------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -----------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                       01223345567999999999999999999999999999998754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-57  Score=411.60  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=194.2

Q ss_pred             HcCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           59 ATCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      +.+.|++.+.||+|+||+||+|+++ +|+.||||++.+....  .....+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3456999999999999999999987 6899999999765432  223567889999999999999999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC---CCCcEEEeecCcc
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS---ANFEAKISDFGLA  214 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~  214 (361)
                      ||||++||+|.+++...  ..+++..+..++.||+.||+|||++|     |+||||||+|||++   .++.+||+|||++
T Consensus        85 vmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~-----iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG-----IVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             EECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             EEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce-----eeeEEecccceeecccCCCceEEEecccee
Confidence            99999999999999764  37999999999999999999999999     99999999999995   4789999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      +......   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....   ..   .....+......+
T Consensus       158 ~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~---~~~~~i~~~~~~~  228 (307)
T d1a06a_         158 KMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DA---KLFEQILKAEYEF  228 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HH---HHHHHHHTTCCCC
T ss_pred             EEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HH---HHHHHHhccCCCC
Confidence            8764433   2334679999999999999999999999999999999999999995322   11   1222222211111


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      .         .......+..+.+|+.+||+.||++|||++|+++|-
T Consensus       229 ~---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  265 (307)
T d1a06a_         229 D---------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP  265 (307)
T ss_dssp             C---------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             C---------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence            1         111223445689999999999999999999999974

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=396.28  Aligned_cols=254  Identities=25%  Similarity=0.389  Sum_probs=212.1

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|+..+.||+|+||+||+|++++++.||||++....    ...+++.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc----CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            5799999999999999999999888899999997543    234678999999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++... ...+++..+..++.|+++||+|||++|     |+||||||+|||++.++.+||+|||+++.+...
T Consensus        80 y~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~-----iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          80 YMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             CCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT-----BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             ccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcC-----cccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            99999999997654 237899999999999999999999999     999999999999999999999999999876554


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ... ......||+.|+|||++....++.++|||||||++|||+| |+.||....   .....   ..+... .       
T Consensus       154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~---~~i~~~-~-------  218 (258)
T d1k2pa_         154 EYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETA---EHIAQG-L-------  218 (258)
T ss_dssp             SCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHH---HHHHTT-C-------
T ss_pred             Cce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HHHHH---HHHHhC-C-------
Confidence            332 2334568999999999999999999999999999999998 899995432   11111   111111 0       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                          ....+...+..+.+|+.+||+.||++|||++|++++|.+|
T Consensus       219 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         219 ----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ----CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                0112233445699999999999999999999999998653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-57  Score=399.34  Aligned_cols=250  Identities=28%  Similarity=0.420  Sum_probs=200.3

Q ss_pred             CCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc----CCEEEEE
Q 018047           64 SDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD----GKHRFLV  138 (361)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv  138 (361)
                      +..+.||+|+||+||+|++. ++..||+|++...... ......+.+|+++|++++|||||++++++.+    +..+|+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            56678999999999999987 6889999999765432 3345678899999999999999999999865    4578999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC-CCCcEEEeecCccccC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS-ANFEAKISDFGLAKLM  217 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~  217 (361)
                      |||+++|+|.+++.+..  .+++..+..++.||++||+|||+++   .+|+||||||+|||++ .++.+||+|||+++..
T Consensus        91 mE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~---~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC---CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            99999999999997643  7999999999999999999999986   2399999999999997 5789999999999865


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      ....    ....+||+.|||||++.+ .++.++|||||||++|||++|+.||.....     .............     
T Consensus       166 ~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~~~i~~~~~-----  230 (270)
T d1t4ha_         166 RASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVK-----  230 (270)
T ss_dssp             CTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCC-----
T ss_pred             cCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHHHHHHcCCC-----
Confidence            4332    234689999999998864 699999999999999999999999953221     1111122211110     


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                       .+.+     +...+.++.+|+.+||+.||++|||++|+++|-
T Consensus       231 -~~~~-----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp  267 (270)
T d1t4ha_         231 -PASF-----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  267 (270)
T ss_dssp             -CGGG-----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             -Cccc-----CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence             0111     111233488999999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-57  Score=412.68  Aligned_cols=265  Identities=24%  Similarity=0.376  Sum_probs=208.2

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++.+.||+|+||+||+|++. +|+.||+|++....  .......+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            457999999999999999999986 68999999997642  334456788999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      |||+++|+|.+++.+.+  .+++..+..++.|++.||+|||+ +|     |+||||||+|||++.++++||+|||+|..+
T Consensus        83 mEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~-----IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC-----CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC-----EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            99999999999997643  69999999999999999999997 48     999999999999999999999999999865


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHH-HHHHHHhhh------
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLV-LQVRHILND------  290 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~-~~~~~~~~~------  290 (361)
                      .+.    .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .........      
T Consensus       156 ~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         156 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             CCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            332    223468999999999999999999999999999999999999999654322110000 000000000      


Q ss_pred             ----------------------hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 ----------------------RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                                            ...+.....+.+.    ....+.++.+|+.+||+.||++|||++|+|+|-+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf  300 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP----SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  300 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCC----BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence                                  0000000011111    1112346899999999999999999999999855

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-57  Score=408.08  Aligned_cols=250  Identities=29%  Similarity=0.400  Sum_probs=207.2

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      .|+..+.||+|+||+||+|++. +|+.||||++.............+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            3888999999999999999976 688999999987655555566789999999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      ||++|+|..++...  ..+++..+..++.||+.||.|||++|     |+||||||+|||++.++.+||+|||++......
T Consensus        96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~-----iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            99999998776553  37999999999999999999999999     999999999999999999999999999865432


Q ss_pred             CceeeeeecccccCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          221 QETYVTARVLGTFGYFDPEYTS---TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                            ....||+.|||||++.   .+.|+.++|||||||++|||++|..||....   .   ...+......       
T Consensus       169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~---~~~~~~i~~~-------  229 (309)
T d1u5ra_         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---A---MSALYHIAQN-------  229 (309)
T ss_dssp             ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---H---HHHHHHHHHS-------
T ss_pred             ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---H---HHHHHHHHhC-------
Confidence                  2357999999999875   3468999999999999999999999995322   1   1112211111       


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..+.+.    +...+..+.+|+.+||+.||++|||++|+++|-+
T Consensus       230 ~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~  269 (309)
T d1u5ra_         230 ESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (309)
T ss_dssp             CCCCCS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             CCCCCC----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence            111111    1223456899999999999999999999998643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=400.82  Aligned_cols=257  Identities=24%  Similarity=0.337  Sum_probs=211.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc---hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA---DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      .+.|++++.||+|+||+||+|+++ +|+.||||++.+......   ...+.+.+|+.+|++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357999999999999999999986 799999999976543322   2457789999999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC----cEEEeec
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF----EAKISDF  211 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~----~~kl~Df  211 (361)
                      |+||||+++|+|.+++...+  .+++..+..++.|++.||+|||+++     |+||||||+|||++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~-----ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc-----eeecccccceEEEecCCCcccceEecch
Confidence            99999999999999997643  7999999999999999999999999     99999999999998776    5999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      |++..+..+..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...   ....+....
T Consensus       162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~---~~~~i~~~~  232 (293)
T d1jksa_         162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQE---TLANVSAVN  232 (293)
T ss_dssp             TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH---HHHHHHTTC
T ss_pred             hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHH---HHHHHHhcC
Confidence            99988754432   234578999999999999999999999999999999999999996432   111   222222211


Q ss_pred             hhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 KKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ........         ...+..+.+||.+||+.||++|||++|+++|-+
T Consensus       233 ~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  273 (293)
T d1jksa_         233 YEFEDEYF---------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  273 (293)
T ss_dssp             CCCCHHHH---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             CCCCchhc---------CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            11111110         112345889999999999999999999998753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.2e-56  Score=408.70  Aligned_cols=254  Identities=23%  Similarity=0.331  Sum_probs=209.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...   .....+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            47999999999999999999986 7999999999653   2334567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC--CCcEEEeecCccccC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA--NFEAKISDFGLAKLM  217 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~--~~~~kl~Dfg~~~~~  217 (361)
                      ||+++|+|.+++.... ..+++..+..++.||+.||+|||++|     |+||||||+|||++.  ++.+||+|||+++.+
T Consensus       103 E~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~-----iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         103 EFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             CCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC-----CeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999999999986542 36999999999999999999999999     999999999999964  578999999999987


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....   .....||+.|||||++.+..++.++|||||||++|+|++|+.||....   ..   ..+..+......+...
T Consensus       177 ~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~---~~~~~i~~~~~~~~~~  247 (350)
T d1koaa2         177 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DD---ETLRNVKSCDWNMDDS  247 (350)
T ss_dssp             CTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHTCCCSCCG
T ss_pred             ccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HH---HHHHHHHhCCCCCCcc
Confidence            55432   334679999999999999999999999999999999999999996332   12   2222222211111111


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                               .....+..+.+||.+||+.||++|||++|+++|-+
T Consensus       248 ---------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  282 (350)
T d1koaa2         248 ---------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW  282 (350)
T ss_dssp             ---------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred             ---------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                     11123345899999999999999999999999843

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-56  Score=397.17  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=210.1

Q ss_pred             CCCCCce-ecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEE
Q 018047           62 SFSDDNF-LGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        62 ~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (361)
                      +|.+.+. ||+|+||+||+|.++   ++..||||++...  ......+.+.+|+++|++++|||||++++++.+ +.+|+
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            4555564 999999999999865   3457999998654  334456789999999999999999999999875 45789


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLM  217 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~  217 (361)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||+++.+
T Consensus        86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~-----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCcCchhheeeccCCceeeccchhhhcc
Confidence            99999999999998654 247999999999999999999999999     999999999999999999999999999987


Q ss_pred             CCCCcee-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          218 PEGQETY-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       218 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      ....... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||....   .......+.   .. .   
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~---~~~~~~~i~---~~-~---  229 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIE---QG-K---  229 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHHH---TT-C---
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHHH---cC-C---
Confidence            6543322 2234468999999999998999999999999999999998 899996432   222222211   11 0   


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                         .     ...+..++.++.+|+.+||+.||++|||+.++++.|+.+..+-.
T Consensus       230 ---~-----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         230 ---R-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             ---C-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---C-----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence               0     12233445679999999999999999999999999998776543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=409.73  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=207.7

Q ss_pred             CCCCCCceecccCceEEEEEEEcC-C-----CEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS-G-----EVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  133 (361)
                      ++|+++++||+|+||+||+|++.. +     ..||+|.+....  .......+.+|+.+|.++ +|||||++++++.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            468889999999999999998752 2     268999886432  233456788999999998 8999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecC
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGE---------------------PKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRD  192 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~D  192 (361)
                      ..|+||||+++|+|.+++.....                     ..+++..++.++.|++.||+|||+++     |+|||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-----IiHRD  189 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRD  189 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-----EEETT
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecc
Confidence            99999999999999999975431                     35899999999999999999999999     99999


Q ss_pred             CCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 018047          193 FKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDL  271 (361)
Q Consensus       193 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~  271 (361)
                      |||+|||++.++.+||+|||+|+...............||+.|||||++..+.++.++|||||||++|||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987655544444445678999999999999999999999999999999998 8999964


Q ss_pred             CCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          272 NQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ....  ..+.    .......      .     ...+..++..+.+||.+||+.||++|||++||+++|.
T Consensus       270 ~~~~--~~~~----~~~~~~~------~-----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPVD--ANFY----KLIQNGF------K-----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCCS--HHHH----HHHHTTC------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHH--HHHH----HHHhcCC------C-----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3321  1111    1111111      0     1223344567999999999999999999999999996

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-56  Score=406.46  Aligned_cols=252  Identities=24%  Similarity=0.284  Sum_probs=212.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++++.||+|+||+||+|+.+ +|+.||||++.+...........+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            46899999999999999999986 79999999997654334445677889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.+|.+||+|||+|+....
T Consensus        85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~-----iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC-----ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            9999999999998754  7899999999999999999999999     99999999999999999999999999987644


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+   ..   .....+.....       
T Consensus       158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~---~~~~~i~~~~~-------  222 (337)
T d1o6la_         158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HE---RLFELILMEEI-------  222 (337)
T ss_dssp             TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHCCC-------
T ss_pred             CCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HH---HHHHHHhcCCC-------
Confidence            322  2345689999999999999999999999999999999999999996432   11   11222222111       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKEL  340 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l  340 (361)
                            .++...+.++.+||.+||+.||++||+     ++|+++|-
T Consensus       223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp  262 (337)
T d1o6la_         223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence                  122233456899999999999999994     89999874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.8e-56  Score=407.62  Aligned_cols=253  Identities=22%  Similarity=0.312  Sum_probs=209.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++....   ......+.+|+.+|++++|||||+++++|.+++.+|+||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46999999999999999999986 79999999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeC--CCCcEEEeecCccccC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLS--ANFEAKISDFGLAKLM  217 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~--~~~~~kl~Dfg~~~~~  217 (361)
                      ||+++|+|.+++... ...+++..+..++.||+.||+|||++|     |+||||||+|||++  .++.+||+|||++..+
T Consensus       106 E~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~-----iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         106 EFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             ECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccccccccccccCCCeEEEeecccceec
Confidence            999999999988654 346999999999999999999999999     99999999999998  5689999999999987


Q ss_pred             CCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhh
Q 018047          218 PEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKV  297 (361)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (361)
                      .....   .....||+.|+|||++.+..++.++|||||||++|+|+||+.||....   ..   ..+..+......+.  
T Consensus       180 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~---~~~~~i~~~~~~~~--  248 (352)
T d1koba_         180 NPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DL---ETLQNVKRCDWEFD--  248 (352)
T ss_dssp             CTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HH---HHHHHHHHCCCCCC--
T ss_pred             CCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HH---HHHHHHHhCCCCCC--
Confidence            65432   334578999999999999999999999999999999999999995332   11   22222222111111  


Q ss_pred             cCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          298 IDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                             .......+..+.+||.+||+.||.+|||++|+++|-
T Consensus       249 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp  284 (352)
T d1koba_         249 -------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  284 (352)
T ss_dssp             -------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             -------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence                   111223345689999999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=394.05  Aligned_cols=252  Identities=27%  Similarity=0.428  Sum_probs=202.1

Q ss_pred             ceecccCceEEEEEEEc---CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEecC
Q 018047           67 NFLGKGGFGRVYKGTLR---SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQ  143 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (361)
                      +.||+|+||+||+|.++   +++.||||++.... ......+.+.+|+.+|++++|||||++++++.++ ..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            56999999999999865   35689999986543 3344467899999999999999999999999654 5789999999


Q ss_pred             CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCCce
Q 018047          144 KGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQET  223 (361)
Q Consensus       144 ~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (361)
                      +|+|.+++...  ..+++..+..++.||+.||+|||+++     |+||||||+|||++.++.+||+|||+++.+......
T Consensus        91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~-----iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC-----cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            99999999764  37999999999999999999999999     999999999999999999999999999877554333


Q ss_pred             e-eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCcc
Q 018047          224 Y-VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPE  301 (361)
Q Consensus       224 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (361)
                      . ......||+.|+|||++....++.++|||||||++|||+| |+.||....   .......+.   .. .         
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~~~i~---~~-~---------  227 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLE---KG-E---------  227 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHH---TT-C---------
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHHHHHHHH---cC-C---------
Confidence            2 2334568999999999999999999999999999999998 899996432   112211111   11 0         


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          302 LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       302 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                        ....+..++..+.+|+.+||+.||++|||++++++.|+....
T Consensus       228 --~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         228 --RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence              112233445679999999999999999999999998887654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-56  Score=396.66  Aligned_cols=263  Identities=28%  Similarity=0.476  Sum_probs=205.3

Q ss_pred             CCCCCCceecccCceEEEEEEEcC-C----CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS-G----EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      +.|+..++||+|+||+||+|.+++ +    ..||||++...  ........+.+|+.++++++|||||+++|++.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            357888999999999999998763 2    36999998643  2334456788999999999999999999999999999


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+++     |+||||||+||||+.++.+||+|||+++
T Consensus        85 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          85 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc-----cccCccccceEEECCCCeEEEcccchhh
Confidence            9999999999999988654 347999999999999999999999999     9999999999999999999999999998


Q ss_pred             cCCCCCce-eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQET-YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+...... .......||+.|+|||++..+.++.++|||||||++|||++|..|+....  ......   .. ....   
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~---~~-i~~~---  229 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVM---KA-INDG---  229 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHH---HH-HHTT---
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHH---HH-Hhcc---
Confidence            77543322 12233568999999999999999999999999999999999766664221  111111   11 1111   


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                         .     ....+..++..+.+|+.+||+.||++|||+.|+++.|++++...+
T Consensus       230 ---~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~  275 (283)
T d1mqba_         230 ---F-----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  275 (283)
T ss_dssp             ---C-----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ---C-----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence               1     112233455679999999999999999999999999999887543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-55  Score=400.02  Aligned_cols=250  Identities=27%  Similarity=0.369  Sum_probs=210.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++++.||+|+||+||+|+++ +|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            35889999999999999999986 69999999997543333445677889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||++||+|..++....  .+++..+..++.||+.||+|||++|     |+||||||+|||++.+|.+||+|||+++....
T Consensus        84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~-----iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc-----EEccccCchheeEcCCCCEEEecCccceEecc
Confidence            9999999999987743  6889999999999999999999999     99999999999999999999999999988754


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..     ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+      .......+.....       
T Consensus       157 ~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~-------  218 (316)
T d1fota_         157 VT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAEL-------  218 (316)
T ss_dssp             CB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCC-------
T ss_pred             cc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHcCCC-------
Confidence            32     24579999999999999999999999999999999999999996422      1222222222111       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                            ..+...+..+.+++.+||+.||.+|+     |++++++|.+
T Consensus       219 ------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~  259 (316)
T d1fota_         219 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  259 (316)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence                  11223345589999999999999996     9999998843

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.4e-55  Score=390.67  Aligned_cols=263  Identities=24%  Similarity=0.340  Sum_probs=208.2

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC----E
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK----H  134 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  134 (361)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++......+......+.+|+.+++.++||||+++++++.+.+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            357999999999999999999976 79999999998766555666678999999999999999999999987643    4


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .|+||||+++|+|.+++...+  .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.++++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~-----iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCccccCcccccCccccceeehhhhh
Confidence            899999999999999987654  7999999999999999999999999     999999999999999999999999998


Q ss_pred             ccCCCCCce-eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh
Q 018047          215 KLMPEGQET-YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK  293 (361)
Q Consensus       215 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  293 (361)
                      ......... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||....      ..............
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCC
Confidence            765433221 23344679999999999999999999999999999999999999996332      11222222222111


Q ss_pred             hhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHH
Q 018047          294 LRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP-SMAECVKELQLII  344 (361)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ell~~l~~i~  344 (361)
                      ....         .....+..+.+++.+||+.||++|| |++++++.|.++.
T Consensus       233 ~~~~---------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 PPSA---------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CGGG---------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCch---------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            1111         1122345589999999999999998 8999999998875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=393.32  Aligned_cols=260  Identities=30%  Similarity=0.452  Sum_probs=206.4

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|++++.||+|+||+||+|++++++.||||++....    ...+.+.+|+.++++++|||||++++++.+ +..++|||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc----CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence            3688999999999999999999888889999986432    234678999999999999999999999855 56789999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++.......+++..++.++.||+.||+|||+++     |+||||||+||||+.++++||+|||+++.+...
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~-----ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh-----eecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            999999999987654557999999999999999999999999     999999999999999999999999999876544


Q ss_pred             CceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCc
Q 018047          221 QETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDP  300 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (361)
                      ... ......||+.|+|||++..+.++.++|||||||++|||++|..|+.....  .......+   ...       .  
T Consensus       167 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i---~~~-------~--  231 (285)
T d1fmka3         167 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQV---ERG-------Y--  231 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH---HTT-------C--
T ss_pred             Cce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHH---Hhc-------C--
Confidence            322 23345689999999999999999999999999999999997766643221  11122111   111       0  


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          301 ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       301 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                         ....+..++..+.+|+.+||+.||++|||+++|++.|+..+....
T Consensus       232 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         232 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ---CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence               112333455679999999999999999999999999998775543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=395.03  Aligned_cols=254  Identities=18%  Similarity=0.272  Sum_probs=209.3

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      .++|++++.||+|+||+||+|.++ +|+.||||++...    ......+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            457999999999999999999987 6889999999653    23345688999999999999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC--CcEEEeecCcccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN--FEAKISDFGLAKL  216 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~--~~~kl~Dfg~~~~  216 (361)
                      ||||+||+|.+++...+ ..+++..+..++.||+.||+|||++|     |+||||||+|||++.+  +.+||+|||++..
T Consensus        80 mE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~-----iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC-----CCcccccccceeecCCCceEEEEcccchhhc
Confidence            99999999999997643 36999999999999999999999999     9999999999999854  5899999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRK  296 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (361)
                      .....   ......||+.|+|||...+..++.++|||||||++|+|++|..||....   ..   .....+......+..
T Consensus       154 ~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~---~~---~~~~~i~~~~~~~~~  224 (321)
T d1tkia_         154 LKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQ---QIIENIMNAEYTFDE  224 (321)
T ss_dssp             CCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HH---HHHHHHHHTCCCCCH
T ss_pred             cccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC---HH---HHHHHHHhCCCCCCh
Confidence            75443   2334578999999999999999999999999999999999999996432   11   222222222111111


Q ss_pred             hcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          297 VIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ...+         ..+.++.+|+.+||..||++|||++|+++|-+
T Consensus       225 ~~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~  260 (321)
T d1tkia_         225 EAFK---------EISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             HHHT---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             hhcc---------CCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            1111         12345899999999999999999999999854

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-55  Score=400.50  Aligned_cols=250  Identities=23%  Similarity=0.315  Sum_probs=210.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+...........+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            36999999999999999999987 79999999997544333445567889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+.+|+|.+++...+  .+++..+..++.||+.||.|||++|     |+||||||+|||++.++++||+|||+++.+..
T Consensus       121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~-----iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999997654  7999999999999999999999999     99999999999999999999999999998754


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcC
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVID  299 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (361)
                      ..     ....||+.|||||++.+..++.++|||||||++|+|+||+.||....      .......+.....       
T Consensus       194 ~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~-------  255 (350)
T d1rdqe_         194 RT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKV-------  255 (350)
T ss_dssp             CB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC-------
T ss_pred             cc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcCCC-------
Confidence            32     23579999999999999999999999999999999999999996321      1222222222111       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          300 PELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                            ..+...+..+.+|+.+||+.||.+|+     |++++++|-+
T Consensus       256 ------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~  296 (350)
T d1rdqe_         256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence                  11223345689999999999999994     9999998754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.3e-54  Score=384.87  Aligned_cols=255  Identities=24%  Similarity=0.355  Sum_probs=208.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcch------hHHHHHHHHHHHHhcC-CCcceeEEEEEEcC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEAD------GEHEFRVEVDILSRLD-HPNLVSLIGYCADG  132 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  132 (361)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.+.......      ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57999999999999999999986 7899999999876443221      2346788999999997 99999999999999


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      +..|+||||+++|+|.+++...+  .+++..+..++.||++||+|||++|     |+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC-----CcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999997643  7999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCccccc------CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTS------TGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRH  286 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  286 (361)
                      +++.+.....   .....||+.|+|||.+.      ...++.++||||+||++|+|++|+.||....   .   ......
T Consensus       156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~---~~~~~~  226 (277)
T d1phka_         156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---Q---MLMLRM  226 (277)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHH
T ss_pred             heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---H---HHHHHH
Confidence            9998755432   23457999999999764      3457889999999999999999999996432   1   112222


Q ss_pred             HhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          287 ILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      +........         .......+.++.+|+.+||+.||++|||++|+++|-
T Consensus       227 i~~~~~~~~---------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~  271 (277)
T d1phka_         227 IMSGNYQFG---------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  271 (277)
T ss_dssp             HHHTCCCCC---------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             HHhCCCCCC---------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence            222211110         111223445699999999999999999999999873

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=395.33  Aligned_cols=259  Identities=27%  Similarity=0.411  Sum_probs=205.0

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCC----EEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGE----VVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHR  135 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  135 (361)
                      .+|+++++||+|+||+||+|.+. +|+    .||+|++...  ......+.+.+|+.++++++|||||+++++|.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            35899999999999999999976 454    5888887543  2334467899999999999999999999999875 45


Q ss_pred             EEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          136 FLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       136 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                      ++++||+.+|+|.+++... ...+++..++.++.|++.||+|||+++     |+||||||+|||++.++++||+|||+++
T Consensus        86 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~-----iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC-----cccCcchhhcceeCCCCCeEeeccccce
Confidence            7888999999999988764 347999999999999999999999999     9999999999999999999999999999


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      .+.............||+.|+|||++.++.++.++|||||||++|||+| |..||....   .......+..    ..  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~---~~~~~~~i~~----~~--  230 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILEK----GE--  230 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---GGGHHHHHHH----TC--
T ss_pred             ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC---HHHHHHHHHc----CC--
Confidence            8765554444445578999999999999999999999999999999998 788885432   2222222211    00  


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                               ....+..++..+.+|+.+||+.||++|||+.|++++|+++..+
T Consensus       231 ---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         231 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             ---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ---------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                     0122334456689999999999999999999999999988654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-55  Score=394.70  Aligned_cols=264  Identities=27%  Similarity=0.440  Sum_probs=213.1

Q ss_pred             HHHHcCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEE
Q 018047           56 MEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYC  129 (361)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  129 (361)
                      ++...++|++.+.||+|+||+||+|+++      +++.||||++...  .......++.+|+.+|+.++||||+++++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            4445567999999999999999999864      3568999998643  2334567799999999999999999999999


Q ss_pred             EcCCEEEEEEEecCCCchhhhcccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCC
Q 018047          130 ADGKHRFLVYEYMQKGNLQDHLNGIG----------------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIP  187 (361)
Q Consensus       130 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~  187 (361)
                      .+.+..+++|||+++|+|.+++....                      ...+++..+..++.|++.||+|||+++     
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~-----  160 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----  160 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-----
Confidence            99999999999999999999986421                      235889999999999999999999999     


Q ss_pred             eEecCCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCC-
Q 018047          188 IVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR-  266 (361)
Q Consensus       188 iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-  266 (361)
                      ++||||||+|||++.++.+||+|||+++.+.............||+.|+|||.+....++.++|||||||++|||++|. 
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            9999999999999999999999999998765544443444567899999999999999999999999999999999996 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 018047          267 RAVDLNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLII  344 (361)
Q Consensus       267 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~  344 (361)
                      +||....   ......   .....          .  ....+...+.++.+|+.+||+.||++|||+.||++.|++++
T Consensus       241 ~p~~~~~---~~e~~~---~v~~~----------~--~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         241 QPYYGMA---HEEVIY---YVRDG----------N--ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CTTTTSC---HHHHHH---HHHTT----------C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCC---HHHHHH---HHHcC----------C--CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            4564321   112211   11111          0  01223334456899999999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-54  Score=400.93  Aligned_cols=254  Identities=24%  Similarity=0.312  Sum_probs=204.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHH---HHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRV---EVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.+...........+.+   |+.+++.++|||||++++++.+++.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999987 69999999986543322222333334   466777778999999999999999999


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++|+|.+++....  .+++..+..++.||+.||+|||++|     |+||||||+|||++.+|.+||+|||+|+.
T Consensus        84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~-----iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC-----ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            9999999999999997643  7899999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      +....    .....||+.|+|||++.. ..++.++|||||||++|||+||+.||........   .........      
T Consensus       157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~~------  223 (364)
T d1omwa3         157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLT------  223 (364)
T ss_dssp             CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHHSSS------
T ss_pred             cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccc------
Confidence            75442    234579999999998864 5689999999999999999999999975433221   111111000      


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPS-----MAECVKELQ  341 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~~l~  341 (361)
                          ..   ...+...+..+.+||.+||+.||++|||     ++|+++|-+
T Consensus       224 ----~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~  267 (364)
T d1omwa3         224 ----MA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  267 (364)
T ss_dssp             ----CC---CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred             ----CC---CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence                00   1122233456899999999999999999     799998754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-55  Score=394.01  Aligned_cols=270  Identities=24%  Similarity=0.349  Sum_probs=204.6

Q ss_pred             HHHHHHcCCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEE
Q 018047           54 KEMEEATCSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLI  126 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~  126 (361)
                      +.++...++|++.+.||+|+||+||+|.+.      +++.||||++...  ........+..|...+.++ +|+||+.++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            334334467999999999999999999864      2468999998643  2234456677788888877 689999999


Q ss_pred             EEEEcC-CEEEEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEec
Q 018047          127 GYCADG-KHRFLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHR  191 (361)
Q Consensus       127 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~  191 (361)
                      +++.+. ...++||||+++|+|.+++....              ...+++..+..++.|++.||+|||+++     |+||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-----ivHr  158 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHR  158 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-----CCCS
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC-----CcCC
Confidence            998654 57899999999999999996432              235889999999999999999999999     9999


Q ss_pred             CCCCCCeeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCC-CCCC
Q 018047          192 DFKSTNVLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR-RAVD  270 (361)
Q Consensus       192 Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~p~~  270 (361)
                      ||||+|||++.++++||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||. .||.
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998765544433444567999999999999999999999999999999999975 5664


Q ss_pred             CCCCCCchhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          271 LNQGVNDQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ....  ...+...+.    ..      ..     ...+...+..+.+|+.+||+.||++|||++|++++|++++..+
T Consensus       239 ~~~~--~~~~~~~~~----~~------~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         239 GVKI--DEEFCRRLK----EG------TR-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             TCCC--SHHHHHHHH----HT------CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCH--HHHHHHHHh----cC------CC-----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            3322  111111111    11      01     1122334456899999999999999999999999999998765

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-55  Score=395.40  Aligned_cols=252  Identities=28%  Similarity=0.387  Sum_probs=206.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHH-hcCCCcceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILS-RLDHPNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv  138 (361)
                      ++|++++.||+|+||+||+|+++ +|+.||||++.+...........+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            47899999999999999999987 69999999997543333344556667777765 68999999999999999999999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCC
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMP  218 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~  218 (361)
                      |||+++|+|.+++....  .+++..+..++.||+.||+|||+++     ++||||||+|||++.++++||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~-----iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG-----IVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999997643  6899999999999999999999999     9999999999999999999999999998764


Q ss_pred             CCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          219 EGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....   ...   ....+....       
T Consensus       155 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~---~~~~i~~~~-------  219 (320)
T d1xjda_         155 LGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEE---LFHSIRMDN-------  219 (320)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH---HHHHHHHCC-------
T ss_pred             cccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHH---HHHHHHcCC-------
Confidence            4332  2334679999999999999999999999999999999999999996432   111   122221111       


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHH
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMA-ECVKEL  340 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ell~~l  340 (361)
                       +     ..+...+..+.+|+++||+.||++|||+. |+++|-
T Consensus       220 -~-----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp  256 (320)
T d1xjda_         220 -P-----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP  256 (320)
T ss_dssp             -C-----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred             -C-----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence             1     11223345589999999999999999995 787653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-55  Score=386.16  Aligned_cols=251  Identities=29%  Similarity=0.431  Sum_probs=199.2

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc-CCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD-GKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|.++ |+.||||++...     ...+.+.+|++++++++||||+++++++.+ .+.+|+||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            35778899999999999999986 789999998532     344678999999999999999999999855 46689999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+++|+|.+++.......+++..++.++.|++.||+|||+++     ++||||||+|||++.++.+||+|||+++....
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~-----ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc-----eeccccchHhheecCCCCEeecccccceecCC
Confidence            9999999999997654446899999999999999999999999     99999999999999999999999999986543


Q ss_pred             CCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ..     ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||....   .......+.   +.       .
T Consensus       156 ~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i~---~~-------~  217 (262)
T d1byga_         156 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVE---KG-------Y  217 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHHT---TT-------C
T ss_pred             CC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC---HHHHHHHHH---cC-------C
Confidence            22     23457899999999988999999999999999999998 677775332   222222211   11       1


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      .     ...+...+..+.+|+.+||+.||++|||+.+++++|+++..
T Consensus       218 ~-----~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         218 K-----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C-----CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            1     12233344668999999999999999999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=384.58  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=199.5

Q ss_pred             CCCCCCceecccCceEEEEEEEcC----CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS----GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++++.||+|+||+||+|.+..    +..||||.+...  ........+.+|+.+|++++||||+++++++. .+..|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            468889999999999999998752    345888887532  34455677999999999999999999999986 46789


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++|+|.+++... ...+++..++.++.|+++||+|||+++     ++||||||+||+++.++.+||+|||+++.
T Consensus        84 iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~-----iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC-----eeccccchhheeecCCCcEEEccchhhee
Confidence            999999999999987654 347899999999999999999999999     99999999999999999999999999987


Q ss_pred             CCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhhh
Q 018047          217 MPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKLR  295 (361)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (361)
                      +...... ......||+.|+|||++....++.++|||||||++|||++ |.+||.....   ......+.   .. .   
T Consensus       158 ~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~---~~-~---  226 (273)
T d1mp8a_         158 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIE---NG-E---  226 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHH---TT-C---
T ss_pred             ccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHHH---cC-C---
Confidence            6543322 3334568999999999999999999999999999999998 8888864332   22222211   11 0   


Q ss_pred             hhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhh
Q 018047          296 KVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYT  346 (361)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~  346 (361)
                              ....+..++..+.+|+.+||+.||++|||++|++++|+.++..
T Consensus       227 --------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         227 --------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                    0122334456699999999999999999999999999998765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=390.46  Aligned_cols=253  Identities=23%  Similarity=0.297  Sum_probs=202.1

Q ss_pred             CCCCCC-ceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc----CC
Q 018047           61 CSFSDD-NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD----GK  133 (361)
Q Consensus        61 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~  133 (361)
                      ++|.+. ++||+|+||+||+|++. +|+.||||++..        ...+.+|+.++.++ +|||||+++++|++    +.
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            468776 46999999999999986 799999999853        23567899987655 89999999999875    46


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---CCcEEEee
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISD  210 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---~~~~kl~D  210 (361)
                      .+|+|||||+||+|.+++...+...+++..+..++.|++.||+|||++|     |+||||||+|||++.   ++.+||+|
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~-----iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC-----Cccccccccccccccccccccccccc
Confidence            7899999999999999998766668999999999999999999999999     999999999999985   46799999


Q ss_pred             cCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          211 FGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      ||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.........   ..+..    
T Consensus       158 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~----  227 (335)
T d2ozaa1         158 FGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKT----  227 (335)
T ss_dssp             CTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred             cceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHH----
Confidence            999987755432   33457999999999999999999999999999999999999999643322110   00000    


Q ss_pred             hhhhhhhcCccccC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 RKKLRKVIDPELSR-SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                           ......... .......+.++.+|+++||+.||++|||+.|+++|-+
T Consensus       228 -----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  274 (335)
T d2ozaa1         228 -----RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  274 (335)
T ss_dssp             -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred             -----HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence                 000001100 1111244567999999999999999999999999854

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=385.86  Aligned_cols=259  Identities=26%  Similarity=0.379  Sum_probs=198.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc--CC--CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR--SG--EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|++.+.||+|+||+||+|++.  ++  ..||||++...........+.+.+|+.+|+.++||||+++++++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45888999999999999999864  23  3689999876655556667789999999999999999999999976 4678


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKL  216 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~  216 (361)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++     |+||||||+|||++.++.+||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~-----iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC-----EeeeeecHHHhccccccceeeccchhhhh
Confidence            9999999999999876542 36999999999999999999999999     99999999999999999999999999998


Q ss_pred             CCCCCceee-eeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhhhhhh
Q 018047          217 MPEGQETYV-TARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVNDQNLVLQVRHILNDRKKL  294 (361)
Q Consensus       217 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (361)
                      +........ .....|+..|+|||++....++.++||||||+++|||+| |+.||....   ..   ..+..+...... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~---~~~~~i~~~~~~-  233 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GS---QILHKIDKEGER-  233 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH---HHHHHHHTSCCC-
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HH---HHHHHHHhCCCC-
Confidence            755443322 233457889999999999999999999999999999998 899995321   22   222222221110 


Q ss_pred             hhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 018047          295 RKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLI  343 (361)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i  343 (361)
                                ...+...+..+.+|+.+||+.||++|||+.|+++.|.++
T Consensus       234 ----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 ----------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                      112233445699999999999999999999999988764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=387.45  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=207.1

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCC--EEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGE--VVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  136 (361)
                      ++|+++++||+|+||+||+|+++ +|.  .||||++...  ......+.+.+|+++|.++ +|||||++++++.+++..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            35888899999999999999987 454  4677777533  2233456789999999999 7999999999999999999


Q ss_pred             EEEEecCCCchhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC
Q 018047          137 LVYEYMQKGNLQDHLNGI--------------GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA  202 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~  202 (361)
                      +||||+++|+|.+++...              ....+++..+..++.|++.||.|||+++     ++||||||+|||++.
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~-----iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE  162 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-----ccccccccceEEEcC
Confidence            999999999999999643              2357999999999999999999999999     999999999999999


Q ss_pred             CCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCCchhHH
Q 018047          203 NFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRR-AVDLNQGVNDQNLV  281 (361)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~-p~~~~~~~~~~~~~  281 (361)
                      ++.+||+|||+++......   ......||..|+|||.+..+.++.++|||||||++|||++|.. ||...   ..... 
T Consensus       163 ~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~-  235 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL-  235 (309)
T ss_dssp             GGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH-
T ss_pred             CCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHH-
Confidence            9999999999998654322   2223468999999999999999999999999999999999765 55321   11111 


Q ss_pred             HHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 018047          282 LQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKG  350 (361)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~  350 (361)
                        ...+...       ..     ...+...+..+.+|+.+||+.||++|||++|++++|++++......
T Consensus       236 --~~~i~~~-------~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~  290 (309)
T d1fvra_         236 --YEKLPQG-------YR-----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  290 (309)
T ss_dssp             --HHHGGGT-------CC-----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred             --HHHHHhc-------CC-----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCC
Confidence              1111111       01     1223344567999999999999999999999999999998765543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=387.67  Aligned_cols=265  Identities=25%  Similarity=0.387  Sum_probs=214.5

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEcCC
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCADGK  133 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  133 (361)
                      ++|++++.||+|+||+||+|++.      +++.||||++...  ........+.+|+.++..+ +|||||++++++.+++
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc--cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            46888899999999999999863      3568999999754  2344556788999999999 6999999999999999


Q ss_pred             EEEEEEEecCCCchhhhcccCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCC
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIG----------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~N  197 (361)
                      ..++||||+++|+|.+++....                ...+++..+..++.||+.||+|||+++     ++||||||+|
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-----ivHrDLKp~N  175 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARN  175 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGG
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccccccc
Confidence            9999999999999999986532                236899999999999999999999999     9999999999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVND  277 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  277 (361)
                      ||++.++.+|++|||+++...............||+.|+|||++....++.++|||||||++|||+|+..|+....... 
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999998766554444555688999999999999999999999999999999999555543222111 


Q ss_pred             hhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          278 QNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                       ..   +.......      ..     ...+...+..+.+|+.+||+.||++|||++|+++.|++++.+.+
T Consensus       255 -~~---~~~~i~~~------~~-----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~  310 (311)
T d1t46a_         255 -SK---FYKMIKEG------FR-----MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (311)
T ss_dssp             -HH---HHHHHHHT------CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             -HH---HHHHHhcC------CC-----CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence             11   11111111      01     11222334569999999999999999999999999999887643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=384.17  Aligned_cols=265  Identities=25%  Similarity=0.305  Sum_probs=198.8

Q ss_pred             CCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcc--hhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEEe
Q 018047           65 DDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEA--DGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYEY  141 (361)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (361)
                      .+++||+|+||+||+|+++ +|+.||||++........  .....+.+|+.+|+.++|||||++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999986 699999999875432221  1234688899999999999999999999999999999999


Q ss_pred             cCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCCC
Q 018047          142 MQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEGQ  221 (361)
Q Consensus       142 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (361)
                      +.++++..+...  ...+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~-----iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW-----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc-----eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            998887777654  347899999999999999999999999     9999999999999999999999999998765443


Q ss_pred             ceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh--hhhhc
Q 018047          222 ETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK--LRKVI  298 (361)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  298 (361)
                      .  .....+||+.|+|||++.. ..++.++|||||||++|||++|..||....   +.+....+.........  .....
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~---~~~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         155 R--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             C--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             c--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC---HHHHHHHHHHhcCCCChhhccchh
Confidence            2  2234579999999998764 467999999999999999999999996432   22222222221110000  00000


Q ss_pred             ---C-cccc-CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          299 ---D-PELS-RSSYT-----MESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       299 ---~-~~~~-~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                         . .... ....+     ...+..+.+|+.+||+.||++|||++|+|+|-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~  282 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  282 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence               0 0000 00011     122356899999999999999999999999854

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=384.19  Aligned_cols=262  Identities=25%  Similarity=0.377  Sum_probs=208.4

Q ss_pred             CCCCCCceecccCceEEEEEEEcC--------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc-CCCcceeEEEEEEc
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRS--------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRL-DHPNLVSLIGYCAD  131 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  131 (361)
                      ++|++++.||+|+||+||+|+...        +..||||++...  .......++.+|...+.++ +|||||+++++|.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc--cChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            368888999999999999998642        237999998654  2334456788899999888 79999999999999


Q ss_pred             CCEEEEEEEecCCCchhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCC
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIG--------------EPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTN  197 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~N  197 (361)
                      ++..++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+++     |+||||||+|
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-----ivHrDiKp~N  165 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARN  165 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGG
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-----EEeeeecccc
Confidence            999999999999999999997543              246899999999999999999999999     9999999999


Q ss_pred             eeeCCCCcEEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 018047          198 VLLSANFEAKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLT-GRRAVDLNQGVN  276 (361)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  276 (361)
                      ||++.++.+||+|||++................||+.|+|||.+.++.++.++||||||+++|||++ |..||....   
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---  242 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---  242 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC---
Confidence            9999999999999999987755444334445678999999999999999999999999999999998 688875322   


Q ss_pred             chhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhc
Q 018047          277 DQNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTN  347 (361)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~  347 (361)
                      ....    ........      .     ...+...+..+.+|+.+||+.||++|||+.|+++.|++++.-+
T Consensus       243 ~~~~----~~~i~~~~------~-----~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~  298 (299)
T d1fgka_         243 VEEL----FKLLKEGH------R-----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  298 (299)
T ss_dssp             HHHH----HHHHHTTC------C-----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHH----HHHHHcCC------C-----CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence            1111    11111111      1     1122234456999999999999999999999999999997643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-53  Score=379.80  Aligned_cols=270  Identities=26%  Similarity=0.380  Sum_probs=203.2

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC----EEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK----HRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~  136 (361)
                      .+|...+.||+|+||+||+|++. |+.||||++...    .........|+..+..++||||+++++++.+.+    .+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            35777889999999999999875 899999998532    121222233444555789999999999997643    689


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc--------CCCCCCCeEecCCCCCCeeeCCCCcEEE
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS--------SSAVGIPIVHRDFKSTNVLLSANFEAKI  208 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--------~~~~~~~iiH~Dikp~Nill~~~~~~kl  208 (361)
                      +||||+++|+|.+++++.   .+++..++.++.|++.||+|||+        +|     |+||||||+||||+.++.+||
T Consensus        78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~-----IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-----IAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-----EECSCCCGGGEEECTTSCEEE
T ss_pred             EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC-----eeccccCccceEEcCCCCeEE
Confidence            999999999999999864   69999999999999999999997        46     999999999999999999999


Q ss_pred             eecCccccCCCCCcee--eeeecccccCccCcccccCCC------CCccchhHHHHHHHHHHHhCCCCCCCCCCCCc---
Q 018047          209 SDFGLAKLMPEGQETY--VTARVLGTFGYFDPEYTSTGK------LTLQSDVYAFGVVLLELLTGRRAVDLNQGVND---  277 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---  277 (361)
                      +|||++..........  ......||+.|+|||++....      ++.++|||||||++|||+||..||........   
T Consensus       150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            9999998775443322  233467999999999876542      56789999999999999999988754322111   


Q ss_pred             -----hhHHHHHHHHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          278 -----QNLVLQVRHILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       278 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                           ...........     ......|.+.....+.+....+.+|+.+||+.||++|||+.|++++|+++.....
T Consensus       230 ~~~~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             TTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hcccccchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence                 01111111111     1112223332222234566779999999999999999999999999999886654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=378.60  Aligned_cols=265  Identities=24%  Similarity=0.379  Sum_probs=201.9

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++.+.||+|+||+||+|++. +|+.||||++..... .......+.+|+.+|++++|||||++++++.+++..|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            47899999999999999999986 799999999965432 2233567888999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      ||+.+ ++.+++.......+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~-----IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC-----EEccccCchheeecccCcceeccCCcceeccC
Confidence            99965 5555554444557999999999999999999999999     99999999999999999999999999987654


Q ss_pred             CCceeeeeecccccCccCcccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGK-LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ...  ......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+.   ......+....   +...+..
T Consensus       155 ~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~---~~~~~~~  226 (298)
T d1gz8a_         155 PVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTL---GTPDEVV  226 (298)
T ss_dssp             CSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHH---CCCCTTT
T ss_pred             Ccc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhc---CCCchhh
Confidence            332  233357999999999876655 57899999999999999999999964321   11111111111   1100000


Q ss_pred             Ccc----------ccC-CCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          299 DPE----------LSR-SSY-----TMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       299 ~~~----------~~~-~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      .+.          ... ...     ....+..+.+|+++||+.||++|||++|+++|-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~  284 (298)
T d1gz8a_         227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP  284 (298)
T ss_dssp             STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence            000          000 000     012235689999999999999999999999983

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=376.90  Aligned_cols=258  Identities=28%  Similarity=0.425  Sum_probs=205.6

Q ss_pred             CceecccCceEEEEEEEcC--C--CEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc-CCEEEEEEE
Q 018047           66 DNFLGKGGFGRVYKGTLRS--G--EVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD-GKHRFLVYE  140 (361)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  140 (361)
                      .++||+|+||+||+|++..  +  ..||||++...  ........+.+|+++|++++||||++++|++.+ ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4689999999999999753  2  25899998642  345556789999999999999999999999765 568999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      |+++|+|.+++... ....++..++.++.|++.||.|||+.+     |+||||||+|||+++++.+||+|||+++.+...
T Consensus       110 ~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~-----iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         110 YMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             CCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC-----cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            99999999998764 346788899999999999999999999     999999999999999999999999999876543


Q ss_pred             Ccee--eeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhhhhhhc
Q 018047          221 QETY--VTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKKLRKVI  298 (361)
Q Consensus       221 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (361)
                      ....  ......||+.|+|||.+....++.++||||||+++|||+||+.||......  ......+   ....       
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i---~~g~-------  251 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL---LQGR-------  251 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTC-------
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH---HcCC-------
Confidence            3221  122346899999999999999999999999999999999988887543221  1111111   1110       


Q ss_pred             CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcC
Q 018047          299 DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNS  348 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~  348 (361)
                      .     ...+..++..+.+|+.+||+.||++|||+.||+++|+.++....
T Consensus       252 ~-----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         252 R-----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             C-----CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence            0     11122334568999999999999999999999999999987643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-53  Score=374.70  Aligned_cols=246  Identities=22%  Similarity=0.368  Sum_probs=200.7

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcch---hHHHHHHHHHHHHhcC--CCcceeEEEEEEcCC
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEAD---GEHEFRVEVDILSRLD--HPNLVSLIGYCADGK  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~  133 (361)
                      .++|++++.||+|+||+||+|++. +|+.||||++.+.......   ....+.+|+.+|++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            457999999999999999999986 7999999999765433221   1234567999999996  899999999999999


Q ss_pred             EEEEEEEecCC-CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCC-CcEEEeec
Q 018047          134 HRFLVYEYMQK-GNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSAN-FEAKISDF  211 (361)
Q Consensus       134 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~-~~~kl~Df  211 (361)
                      ..|+||||+.+ +++.+++...  ..+++..+..++.|+++||+|||++|     |+||||||+|||++.+ +.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~-----iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG-----VLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----CccccCcccceEEecCCCeEEECcc
Confidence            99999999976 6788888664  37999999999999999999999999     9999999999999854 79999999


Q ss_pred             CccccCCCCCceeeeeecccccCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          212 GLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKL-TLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      |++.......    .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....            .....
T Consensus       156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~  219 (273)
T d1xwsa_         156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG  219 (273)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC
T ss_pred             ccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhc
Confidence            9998764432    234679999999999876665 567899999999999999999995311            01111


Q ss_pred             hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..             ..+...+.++.+|+.+||+.||++|||++|+++|-+
T Consensus       220 ~~-------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~  257 (273)
T d1xwsa_         220 QV-------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW  257 (273)
T ss_dssp             CC-------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             cc-------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence            00             111123456899999999999999999999998743

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=380.17  Aligned_cols=260  Identities=25%  Similarity=0.406  Sum_probs=211.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc------CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR------SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  134 (361)
                      ++|+..+.||+|+||+||+|.+.      ++..||||++...  ........+.+|+.++++++||||+++++++..++.
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            46888899999999999999864      2578999998643  333445678899999999999999999999999999


Q ss_pred             EEEEEEecCCCchhhhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcE
Q 018047          135 RFLVYEYMQKGNLQDHLNGI--------GEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEA  206 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~  206 (361)
                      .++||||+++|+|.+++...        ....+++..+..++.|+++||.|||+++     |+||||||+|||++.++++
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-----ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCSGGGEEECTTCCE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeeceEcCCceeecCCceE
Confidence            99999999999999988632        1235789999999999999999999999     9999999999999999999


Q ss_pred             EEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCchhHHHHHH
Q 018047          207 KISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGR-RAVDLNQGVNDQNLVLQVR  285 (361)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~p~~~~~~~~~~~~~~~~~  285 (361)
                      ||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||. .||...   .....   ..
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~---~~  246 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQV---LR  246 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHH---HH
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHH---HH
Confidence            999999998775554444445557899999999999999999999999999999999985 566322   11111   11


Q ss_pred             HHhhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHh
Q 018047          286 HILNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIY  345 (361)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~  345 (361)
                      .+...          .  ....+..++..+.+|+.+||+.||++|||+++++++|++.+.
T Consensus       247 ~i~~~----------~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FVMEG----------G--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHTT----------C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHhC----------C--CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11111          0  011223344669999999999999999999999999987654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.7e-52  Score=371.73  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=203.7

Q ss_pred             CCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVYE  140 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (361)
                      ++|++.+.||+|+||+||+|++++|+.||||++..... .......+.+|+.+|++++||||+++++++.+++..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            47889999999999999999999899999999976542 23345678899999999999999999999999999999999


Q ss_pred             ecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCCC
Q 018047          141 YMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPEG  220 (361)
Q Consensus       141 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~  220 (361)
                      ++.++.+..+....  ..+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~-----IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          81 HLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR-----VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             eehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc-----EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            99887777776543  47999999999999999999999999     999999999999999999999999999876443


Q ss_pred             CceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh--------
Q 018047          221 QETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR--------  291 (361)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  291 (361)
                      ..  ......|++.|+|||.+.. ..++.++|||||||++|||++|+.||....   .......+.......        
T Consensus       154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         154 VR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCCChhhccch
Confidence            22  2334468999999998765 456899999999999999999999996432   222222221111100        


Q ss_pred             hhhhhhcCcc-----ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          292 KKLRKVIDPE-----LSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       292 ~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ..........     ..........+..+.+|+++||+.||++|||++|+++|-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp  282 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            0000000000     000011122345689999999999999999999999873

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=370.95  Aligned_cols=269  Identities=21%  Similarity=0.322  Sum_probs=201.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-C-CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhc---CCCcceeEEEEEEc---
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-S-GEVVAIKKMELPRFKEADGEHEFRVEVDILSRL---DHPNLVSLIGYCAD---  131 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~---  131 (361)
                      .++|++++.||+|+||+||+|++. + ++.||||++........ ....+.+|+.+|+.|   +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            357999999999999999999975 4 56799999876433222 223455677777766   79999999999853   


Q ss_pred             --CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 018047          132 --GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKIS  209 (361)
Q Consensus       132 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~  209 (361)
                        ....+++|||+.+|++...... ....+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~-----ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEecCCCccEEEEcCCCCeeec
Confidence              3578999999988776544433 3457999999999999999999999999     9999999999999999999999


Q ss_pred             ecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 018047          210 DFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN  289 (361)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  289 (361)
                      |||++.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+.....
T Consensus       159 dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~  232 (305)
T d1blxa_         159 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIG  232 (305)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHC
T ss_pred             chhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC---HHHHHHHHHHhhC
Confidence            999998654332   2345679999999999999999999999999999999999999996432   2222222221111


Q ss_pred             hhhhhh---------hhcCc--cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          290 DRKKLR---------KVIDP--ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       290 ~~~~~~---------~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ......         .....  ...........+..+.+|+.+||+.||++|||++|+|+|.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf  295 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  295 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence            100000         00000  00001112233456889999999999999999999999853

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=364.50  Aligned_cols=267  Identities=22%  Similarity=0.312  Sum_probs=199.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc--------
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD--------  131 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------  131 (361)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...... ......+.+|+.+|+.++|||++++++++..        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            57999999999999999999986 7999999998765433 2344667889999999999999999998855        


Q ss_pred             CCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 018047          132 GKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDF  211 (361)
Q Consensus       132 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Df  211 (361)
                      .+..|+||||+.++.+..+...  ...+++..+..++.|++.||.|||++|     |+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~-----ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC-----EEecCcCchheeecCCCcEEeeec
Confidence            3468999999988777665544  347899999999999999999999999     999999999999999999999999


Q ss_pred             CccccCCCCCcee--eeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 018047          212 GLAKLMPEGQETY--VTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHIL  288 (361)
Q Consensus       212 g~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  288 (361)
                      |++..+.......  .....+||+.|+|||++... .++.++|||||||++|||++|+.||....   .......+....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~---~~~~~~~i~~~~  238 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQLALISQLC  238 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC---HHHHHHHHHHhc
Confidence            9998765432221  22235799999999987654 68999999999999999999999996432   222222222222


Q ss_pred             hhhhhhhhhcCccc------------cCCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          289 NDRKKLRKVIDPEL------------SRSSYTM-------ESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       289 ~~~~~~~~~~~~~~------------~~~~~~~-------~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      ..   .........            .......       .....+.+|+.+||+.||++|||++|+++|-+
T Consensus       239 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf  307 (318)
T d3blha1         239 GS---ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  307 (318)
T ss_dssp             CC---CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             CC---CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence            11   000000000            0000000       11245778999999999999999999999875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.7e-49  Score=355.57  Aligned_cols=270  Identities=18%  Similarity=0.210  Sum_probs=215.2

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC-CcceeEEEEEEcCCEEEE
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-PNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l  137 (361)
                      .++|++++.||+|+||+||+|++. +|+.||||++....     ....+.+|++.++.++| +|++.+++++.++...++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            357999999999999999999987 68999999886432     12346779999999975 899999999999999999


Q ss_pred             EEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC-----CCcEEEeecC
Q 018047          138 VYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA-----NFEAKISDFG  212 (361)
Q Consensus       138 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~-----~~~~kl~Dfg  212 (361)
                      ||||+ +|+|.+++...+ ..++...+..++.|++.||+|||++|     |+||||||+|||++.     ++.+||+|||
T Consensus        79 vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g-----iiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS-----LVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC-----ceeccCCccceeecCcccccCCceEEcccc
Confidence            99999 689999887643 47999999999999999999999999     999999999999974     5789999999


Q ss_pred             ccccCCCCCce-----eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 018047          213 LAKLMPEGQET-----YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHI  287 (361)
Q Consensus       213 ~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  287 (361)
                      +++.+......     .......||+.|||||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~  231 (293)
T d1csna_         152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  231 (293)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence            99876543221     1233467999999999999999999999999999999999999999755444333333222221


Q ss_pred             hhhhhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCCCCC
Q 018047          288 LNDRKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSKGLN  352 (361)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~~~~  352 (361)
                      ... ....+ +.     ..    .+.++.+++..|+..+|++||+++.+.+.|++++.+.....+
T Consensus       232 ~~~-~~~~~-l~-----~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~  285 (293)
T d1csna_         232 KQS-TPLRE-LC-----AG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED  285 (293)
T ss_dssp             HHH-SCHHH-HT-----TT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred             cCC-CChHH-hc-----CC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCC
Confidence            110 11111 11     11    234589999999999999999999999999999877655443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-50  Score=367.73  Aligned_cols=262  Identities=26%  Similarity=0.350  Sum_probs=194.8

Q ss_pred             CCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC------CE
Q 018047           62 SFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG------KH  134 (361)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~  134 (361)
                      +|+..++||+|+||+||+|++. +|+.||||++.....       ...+|+.+|+.++||||++++++|...      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            4888899999999999999987 699999999975421       123699999999999999999998543      35


Q ss_pred             EEEEEEecCCCchhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-cEEEeecC
Q 018047          135 RFLVYEYMQKGNLQDHLN-GIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-EAKISDFG  212 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg  212 (361)
                      +|+||||+++|.+..... ......+++..+..++.||+.||+|||++|     |+||||||+|||++.++ .+||+|||
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~-----IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CcccCCCcceEEEecCCCceeEeccc
Confidence            799999998754333322 122447999999999999999999999999     99999999999999775 89999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh-
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND-  290 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-  290 (361)
                      ++..+.....   .....||+.|+|||.+.. ..++.++|||||||++|||++|+.||.....   ......+...... 
T Consensus       169 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~---~~~l~~i~~~~g~~  242 (350)
T d1q5ka_         169 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTP  242 (350)
T ss_dssp             TCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCC
T ss_pred             chhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence            9987754432   234579999999997654 5789999999999999999999999964332   1111111111000 


Q ss_pred             --------hhhhhhhcCccccC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          291 --------RKKLRKVIDPELSR----SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       291 --------~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                              ........-+....    .......+..+.+|+.+||..||++|||+.|+|+|-+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  305 (350)
T d1q5ka_         243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  305 (350)
T ss_dssp             CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence                    00000000000000    0111233456899999999999999999999999843

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=370.37  Aligned_cols=268  Identities=19%  Similarity=0.286  Sum_probs=197.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC----E
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK----H  134 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  134 (361)
                      ..+|++++.||+|+||+||+|.+. +|+.||||++.+.  ........+.+|+.+|+.++||||+++++++....    .
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            456999999999999999999976 7999999999653  23444567889999999999999999999987643    2


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .+++++++.+|+|.+++...   .+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~-----iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCcceEEECCCCCEEEcccCce
Confidence            34445566799999999753   6999999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCcee-eeeecccccCccCcccc-cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          215 KLMPEGQETY-VTARVLGTFGYFDPEYT-STGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       215 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      .......... .....+||+.|+|||++ ....++.++||||+||++|+|++|+.||......   ..............
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~---~~~~~~~~~~~~~~  233 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPS  233 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCC
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH---HHHHHHhhhccCCC
Confidence            8764332211 22345789999999987 4456789999999999999999999999644321   11111111110000


Q ss_pred             hh----------hhhcCccccCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          293 KL----------RKVIDPELSRSSYTM-----ESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       293 ~~----------~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      ..          .............+.     ..+.++.+|+.+||+.||++|||++|+|+|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp  296 (345)
T d1pmea_         234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  296 (345)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            00          000000000000111     1224588999999999999999999999984

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=356.22  Aligned_cols=268  Identities=22%  Similarity=0.295  Sum_probs=209.8

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCCEEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGKHRFLVY  139 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (361)
                      ++|++++.||+|+||+||+|++. +|+.||||++.... ........+.+|+.+|+.++||||+++++++.+....++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            47899999999999999999986 78999999997654 33445678889999999999999999999999999999999


Q ss_pred             EecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccccCCC
Q 018047          140 EYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAKLMPE  219 (361)
Q Consensus       140 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~  219 (361)
                      +++.+++|..++...  ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||.+.....
T Consensus        81 ~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~-----IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          81 EFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             ECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC-----EeeecccCcccccccCCceeeeecchhhcccC
Confidence            999999998887654  47899999999999999999999999     99999999999999999999999999987754


Q ss_pred             CCceeeeeecccccCccCcccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhhh-----
Q 018047          220 GQETYVTARVLGTFGYFDPEYTSTGK-LTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRKK-----  293 (361)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  293 (361)
                      ....  .....+++.|+|||++.... ++.++|||||||++|||++|+.||.....  .......+.........     
T Consensus       154 ~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         154 PVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTT
T ss_pred             CCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhh
Confidence            4322  22345788999999876654 68999999999999999999999853322  22222222222111000     


Q ss_pred             hhhhc--------CccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          294 LRKVI--------DPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       294 ~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                      .....        .............+..+.+|+++||+.||++|||++|+|+|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp  284 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence            00000        000011112223345688999999999999999999999874

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-50  Score=367.44  Aligned_cols=263  Identities=23%  Similarity=0.348  Sum_probs=197.0

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcCC-----
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADGK-----  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  133 (361)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.... ........+.+|+.+|+.++|||||+++++|...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            457999999999999999999986 69999999997543 33344567889999999999999999999997654     


Q ss_pred             -EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          134 -HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       134 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                       .+|+||||+ +++|..++..   ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~-----IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC-----CcccccCcchhhccccccccccccc
Confidence             579999999 5678777754   26999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTST-GKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR  291 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  291 (361)
                      ++.......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....   ..............
T Consensus       167 ~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~---~~~~~~~~~~~~~~  238 (346)
T d1cm8a_         167 LARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTP  238 (346)
T ss_dssp             TCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCC
T ss_pred             ceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh---HHHHHHHHhccCCC
Confidence            998764432     23578999999998765 4578999999999999999999999965432   11111111110000


Q ss_pred             -h------------hhhhhcCccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 -K------------KLRKVIDPELSR---SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 -~------------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                       .            .....+ +....   .......+..+.+|+.+||..||++|||++|+|+|-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~  303 (346)
T d1cm8a_         239 PAEFVQRLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  303 (346)
T ss_dssp             CHHHHHTCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             cHHHHhhhcchhhhhhhccC-CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence             0            000000 00000   0111123345889999999999999999999999843

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-49  Score=357.46  Aligned_cols=266  Identities=20%  Similarity=0.243  Sum_probs=202.7

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCc-ceeEEEEEEcCCEEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPN-LVSLIGYCADGKHRFLV  138 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv  138 (361)
                      ++|++++.||+|+||+||+|++. +|+.||||++.....     ...+..|+++++.++|+| |+.+.+++.+++..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            46999999999999999999986 689999999875422     234678999999998766 45556667888899999


Q ss_pred             EEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCC---CCcEEEeecCccc
Q 018047          139 YEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSA---NFEAKISDFGLAK  215 (361)
Q Consensus       139 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~---~~~~kl~Dfg~~~  215 (361)
                      |||+. |+|.+.+... ...+++..+..++.|++.||+|||++|     |+||||||+|||++.   +..++|+|||+++
T Consensus        82 me~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          82 MELLG-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EECCC-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEcC-Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHhhccccccCCCceeeeeccCcce
Confidence            99994 5776666543 347999999999999999999999999     999999999999864   4579999999999


Q ss_pred             cCCCCCce-----eeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhh
Q 018047          216 LMPEGQET-----YVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILND  290 (361)
Q Consensus       216 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  290 (361)
                      .+.+....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            87543322     1233457999999999999999999999999999999999999999755443332222221111000


Q ss_pred             hhhhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 018047          291 RKKLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKELQLIIYTNSK  349 (361)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~~i~~~~~~  349 (361)
                       .... .+.     .    ..+.++.+++.+||+.||++||+++++.+.|+.++....-
T Consensus       235 -~~~~-~~~-----~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~  282 (299)
T d1ckia_         235 -TPIE-VLC-----K----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  282 (299)
T ss_dssp             -SCHH-HHT-----T----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             -CChh-Hhc-----c----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence             0000 011     1    1234589999999999999999999999999988765443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=365.68  Aligned_cols=258  Identities=25%  Similarity=0.356  Sum_probs=206.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc----CCCEEEEEEeecCCCC-cchhHHHHHHHHHHHHhcCC-CcceeEEEEEEcCCE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR----SGEVVAIKKMELPRFK-EADGEHEFRVEVDILSRLDH-PNLVSLIGYCADGKH  134 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~  134 (361)
                      ++|++.+.||+|+||+||+|...    +|+.||||++.+.... +....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            45999999999999999999863    4789999998654321 22334567889999999976 899999999999999


Q ss_pred             EEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCcc
Q 018047          135 RFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLA  214 (361)
Q Consensus       135 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~  214 (361)
                      .+++|||+.+|+|.+++...+  .+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~-----ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC-----EEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999999997754  6788999999999999999999999     999999999999999999999999999


Q ss_pred             ccCCCCCceeeeeecccccCccCcccccCC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhhh
Q 018047          215 KLMPEGQETYVTARVLGTFGYFDPEYTSTG--KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDRK  292 (361)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  292 (361)
                      ..+...... ......|++.|+|||.+...  .++.++|||||||++|+|++|+.||...........+..  .....  
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~--~~~~~--  251 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKS--  251 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHHC--
T ss_pred             hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hcccC--
Confidence            877543322 23346799999999987654  467899999999999999999999976544332222111  11111  


Q ss_pred             hhhhhcCccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 018047          293 KLRKVIDPELSRSSYTMESIAMFANLASRCVRTESSERP-----SMAECVKELQ  341 (361)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~l~  341 (361)
                            .     ...+...+.++.+|+.+||+.||++||     |++|+++|.+
T Consensus       252 ------~-----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf  294 (322)
T d1vzoa_         252 ------E-----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  294 (322)
T ss_dssp             ------C-----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             ------C-----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence                  0     112233456699999999999999999     5899998744

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4e-49  Score=360.46  Aligned_cols=259  Identities=18%  Similarity=0.298  Sum_probs=199.6

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEc--CCEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCAD--GKHRF  136 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~  136 (361)
                      ++|++++.||+|+||+||+|++. +|+.||||++...      ....+.+|+.+|+.++ ||||+++++++..  ....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            36999999999999999999986 7999999998532      2456888999999995 9999999999974  45789


Q ss_pred             EEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCC-cEEEeecCccc
Q 018047          137 LVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANF-EAKISDFGLAK  215 (361)
Q Consensus       137 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~  215 (361)
                      +||||+++|+|..+..     .+++..+..++.||+.||+|||++|     |+||||||+|||++.++ .+||+|||++.
T Consensus       109 ~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~g-----IvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             EEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             EEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcc-----cccccccccceEEcCCCCeeeecccccce
Confidence            9999999999987743     5899999999999999999999999     99999999999998755 69999999998


Q ss_pred             cCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh---
Q 018047          216 LMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR---  291 (361)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  291 (361)
                      .......   .....||+.|+|||.+... .++.++|||||||++|+|++|+.||....+..  .....+.......   
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~  253 (328)
T d3bqca1         179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLY  253 (328)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHH
T ss_pred             eccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhh
Confidence            7754432   3345789999999987654 57999999999999999999999996544321  1111111111100   


Q ss_pred             -----------hhhhhhcCc-------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 018047          292 -----------KKLRKVIDP-------ELSRSSYTMESIAMFANLASRCVRTESSERPSMAECVKEL  340 (361)
Q Consensus       292 -----------~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l  340 (361)
                                 ..+......       ...........+.++.+||++||+.||++|||++|+|+|-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp  320 (328)
T d3bqca1         254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP  320 (328)
T ss_dssp             HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence                       000000000       0011111123345689999999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=358.92  Aligned_cols=265  Identities=20%  Similarity=0.239  Sum_probs=195.4

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEc------C
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCAD------G  132 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~  132 (361)
                      .++|++.++||+|+||+||+|.+. +|+.||||++..... .......+.+|+.+++.++||||++++++|..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            357999999999999999999987 699999999976543 34445678899999999999999999999963      4


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFG  212 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg  212 (361)
                      ..+|+||||+.++.+ +.+.    ..+++..++.++.|++.||+|||++|     |+||||||+|||++.++.++++|||
T Consensus        95 ~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g-----iiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          95 QDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             CEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             ceeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc-----cccccCCccccccccccceeeechh
Confidence            688999999976554 4443    26899999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh---
Q 018047          213 LAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILN---  289 (361)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---  289 (361)
                      ++.......   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.   ......+.....   
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~~~i~~~~~~~~  238 (355)
T d2b1pa1         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPC  238 (355)
T ss_dssp             C------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred             hhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---HHHHHHHHHhccCCC
Confidence            988664433   23345789999999999999999999999999999999999999964321   111111111000   


Q ss_pred             ----------------hhh-----hhhhhcCccccC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          290 ----------------DRK-----KLRKVIDPELSR--SSYTMESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       290 ----------------~~~-----~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                                      ...     .....+......  .......+..+.+|+++||..||++|||++|+|+|-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw  313 (355)
T d2b1pa1         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  313 (355)
T ss_dssp             HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence                            000     000011111100  0112345678899999999999999999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=358.44  Aligned_cols=265  Identities=21%  Similarity=0.306  Sum_probs=197.9

Q ss_pred             cCCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcceeEEEEEEcC-----C
Q 018047           60 TCSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNLVSLIGYCADG-----K  133 (361)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  133 (361)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+.. ........+.+|+.+|+.++|||+|++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            457999999999999999999976 79999999997543 3334456788999999999999999999998643     3


Q ss_pred             EEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCc
Q 018047          134 HRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGL  213 (361)
Q Consensus       134 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~  213 (361)
                      ..+++++++.+|+|.+++...   .+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g-----iiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             ceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC-----CcccccCCccccccccccccccccch
Confidence            446667788899999998643   6999999999999999999999999     99999999999999999999999999


Q ss_pred             cccCCCCCceeeeeecccccCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhhh-
Q 018047          214 AKLMPEGQETYVTARVLGTFGYFDPEYTSTG-KLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQNLVLQVRHILNDR-  291 (361)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  291 (361)
                      +......     .....||+.|+|||..... .++.++|||||||++|+|++|+.||...+.   ......+....... 
T Consensus       168 a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~~~~~~i~~~~~~~~  239 (348)
T d2gfsa1         168 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPG  239 (348)
T ss_dssp             --CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCC
T ss_pred             hcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCC
Confidence            9765332     2335689999999976554 568899999999999999999999964322   11112111111100 


Q ss_pred             hhhhh---------hcCccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 018047          292 KKLRK---------VIDPELSRSSYT-----MESIAMFANLASRCVRTESSERPSMAECVKELQ  341 (361)
Q Consensus       292 ~~~~~---------~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~l~  341 (361)
                      .....         ............     ...+..+.+||.+||+.||++|||++|+|+|-+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~  303 (348)
T d2gfsa1         240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  303 (348)
T ss_dssp             HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence            00000         000000000000     112345889999999999999999999999854

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-43  Score=325.99  Aligned_cols=267  Identities=18%  Similarity=0.232  Sum_probs=195.3

Q ss_pred             CCCCCCceecccCceEEEEEEEc-CCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-----------CCcceeEEEE
Q 018047           61 CSFSDDNFLGKGGFGRVYKGTLR-SGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-----------HPNLVSLIGY  128 (361)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~  128 (361)
                      ++|+++++||+|+||+||+|++. +|+.||||++.+.    ....+.+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            35999999999999999999986 7999999999643    233456778998888775           5789999988


Q ss_pred             EEc--CCEEEEEEEecCCCc-hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCCCeEecCCCCCCeeeCCCC
Q 018047          129 CAD--GKHRFLVYEYMQKGN-LQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHS-SSAVGIPIVHRDFKSTNVLLSANF  204 (361)
Q Consensus       129 ~~~--~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~iiH~Dikp~Nill~~~~  204 (361)
                      +..  ....+++|+++..+. ............+++..+..++.|++.||+|||+ .|     |+||||||+|||++.++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~-----IvHrDlKp~NIll~~~~  163 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG-----IIHTDIKPENVLMEIVD  163 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECSCCSGGGEEEEEEE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC-----cccccCChhHeeeeccC
Confidence            754  456677777765543 3334444445689999999999999999999998 77     99999999999998765


Q ss_pred             c------EEEeecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCch
Q 018047          205 E------AKISDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVLLELLTGRRAVDLNQGVNDQ  278 (361)
Q Consensus       205 ~------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  278 (361)
                      .      ++++|||.+.......     ....||+.|+|||++....++.++|||||||++++|++|+.||.........
T Consensus       164 ~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         164 SPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence            3      9999999998654322     3357999999999999999999999999999999999999999754332222


Q ss_pred             hHHHHHHHHhhhh-----------hhhhhhcCc-----cc-------------cCCCCCHHHHHHHHHHHHHccCCCCCC
Q 018047          279 NLVLQVRHILNDR-----------KKLRKVIDP-----EL-------------SRSSYTMESIAMFANLASRCVRTESSE  329 (361)
Q Consensus       279 ~~~~~~~~~~~~~-----------~~~~~~~~~-----~~-------------~~~~~~~~~~~~l~~li~~cl~~dp~~  329 (361)
                      .............           .......+.     .+             .........+..+.+|+.+||..||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence            1111111111000           000000000     00             012345667788999999999999999


Q ss_pred             CCCHHHHHHHHH
Q 018047          330 RPSMAECVKELQ  341 (361)
Q Consensus       330 Rpt~~ell~~l~  341 (361)
                      |||++|+|+|-+
T Consensus       319 Rpta~e~L~Hp~  330 (362)
T d1q8ya_         319 RADAGGLVNHPW  330 (362)
T ss_dssp             CBCHHHHHTCGG
T ss_pred             CcCHHHHhcCcc
Confidence            999999999853

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=6.7e-27  Score=195.68  Aligned_cols=172  Identities=16%  Similarity=0.096  Sum_probs=121.8

Q ss_pred             CCCceecccCceEEEEEEEcCCCEEEEEEeecCCCC-----c----------chhHHHHHHHHHHHHhcCCCcceeEEEE
Q 018047           64 SDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFK-----E----------ADGEHEFRVEVDILSRLDHPNLVSLIGY  128 (361)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~  128 (361)
                      .+++.||+|+||+||+|.+.+|+.||||++......     .          .........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            356889999999999999888999999987532110     0          0112344568889999999999998876


Q ss_pred             EEcCCEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEE
Q 018047          129 CADGKHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKI  208 (361)
Q Consensus       129 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl  208 (361)
                      ..    .+++|||++++.+.++         +......++.|++.+|+|||++|     |+||||||+|||++.+ .++|
T Consensus        83 ~~----~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~g-----iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 EG----NAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHRG-----IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             ET----TEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEEETT-EEEE
T ss_pred             cC----CEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhCC-----EEEccCChhheeeeCC-CEEE
Confidence            32    2699999988765443         33345678999999999999999     9999999999999965 5899


Q ss_pred             eecCccccCCCCCceeeeeecccccCccCcccccCCCCCccchhHHHHHHH
Q 018047          209 SDFGLAKLMPEGQETYVTARVLGTFGYFDPEYTSTGKLTLQSDVYAFGVVL  259 (361)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  259 (361)
                      +|||+|.............+-+..    -.+.+ ...|+.++|+||+.--+
T Consensus       144 iDFG~a~~~~~~~~~~~l~rd~~~----~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWREILERDVRN----IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHHHHHHHHHHH----HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcHHHHHHHHHH----HHHHH-cCCCCCcccHHHHHHHH
Confidence            999999876433221110000000    00111 35678889999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.79  E-value=3e-08  Score=84.84  Aligned_cols=151  Identities=13%  Similarity=0.081  Sum_probs=104.0

Q ss_pred             HHHHHHcCCCCCCceecccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcC
Q 018047           54 KEMEEATCSFSDDNFLGKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADG  132 (361)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  132 (361)
                      .++......|+..+..+-++.+.||+.... ++.+.+|+......   .....+.+|...+..+. +--+.+++.+..++
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            455555666776665555556799988644 66778888754321   12234677888888774 33367788888888


Q ss_pred             CEEEEEEEecCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------------------------
Q 018047          133 KHRFLVYEYMQKGNLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSAV----------------------------  184 (361)
Q Consensus       133 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~----------------------------  184 (361)
                      +..++||++++|.++.+.....    ..   ...++.++++.+..||+....                            
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             CceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            9999999999998887654321    11   233556677777777763211                            


Q ss_pred             --------------------------CCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          185 --------------------------GIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       185 --------------------------~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                                                ...++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                      1127999999999999987767799999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.53  E-value=2.6e-07  Score=78.36  Aligned_cols=131  Identities=15%  Similarity=0.122  Sum_probs=89.4

Q ss_pred             ecccCc-eEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC--CcceeEEEEEEcCCEEEEEEEecCCC
Q 018047           69 LGKGGF-GRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH--PNLVSLIGYCADGKHRFLVYEYMQKG  145 (361)
Q Consensus        69 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g  145 (361)
                      +..|.. +.||+....++..+.+|.....      ....+..|...++.+..  -.+.+++.+..+++..++||++++|.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCcc------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            444443 6899998877778888876432      12346678888887743  33667888888888999999999987


Q ss_pred             chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC------------------------------------------
Q 018047          146 NLQDHLNGIGEPKMDWPLRLKVALGAAKGLAYLHSSSA------------------------------------------  183 (361)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~------------------------------------------  183 (361)
                      ++.+..       ....   ..+.++...|.-||+...                                          
T Consensus        92 ~~~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          92 DLLSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             ETTTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccccc-------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            765432       1111   223445555555554210                                          


Q ss_pred             -----------CCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          184 -----------VGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       184 -----------~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                                 ....++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                       01227999999999999988777899998774

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.94  E-value=1.5e-05  Score=71.83  Aligned_cols=79  Identities=16%  Similarity=0.105  Sum_probs=48.9

Q ss_pred             ceecccCceEEEEEEEc-CCCEEEEEEeecCC-C-C--cchhHHHHHHHHHHHHhcC-C--CcceeEEEEEEcCCEEEEE
Q 018047           67 NFLGKGGFGRVYKGTLR-SGEVVAIKKMELPR-F-K--EADGEHEFRVEVDILSRLD-H--PNLVSLIGYCADGKHRFLV  138 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~-~--~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~lv  138 (361)
                      +.||.|....||++... +++.++||.-.... . .  -.........|.+.|+.+. +  ..+++++.+  ++...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            46899999999999876 46788998653210 0 0  0112334556888888763 2  345566655  44455799


Q ss_pred             EEecCCCch
Q 018047          139 YEYMQKGNL  147 (361)
Q Consensus       139 ~e~~~~g~L  147 (361)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999977543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.53  E-value=0.00031  Score=63.03  Aligned_cols=73  Identities=16%  Similarity=0.109  Sum_probs=50.1

Q ss_pred             ceecccCceEEEEEEEcC--------CCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcC-CCcceeEEEEEEcCCEEEE
Q 018047           67 NFLGKGGFGRVYKGTLRS--------GEVVAIKKMELPRFKEADGEHEFRVEVDILSRLD-HPNLVSLIGYCADGKHRFL  137 (361)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  137 (361)
                      +.|+-|-.-.+|++...+        .+.|.+++.-.     ........+|..+++.+. +.-..++++++.+    .+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-----~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-----PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-----CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-----cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            568888889999998653        24577776531     222345667999999885 4334578887753    58


Q ss_pred             EEEecCCCchh
Q 018047          138 VYEYMQKGNLQ  148 (361)
Q Consensus       138 v~e~~~~g~L~  148 (361)
                      |+||++|.+|.
T Consensus       119 I~efi~g~~l~  129 (395)
T d1nw1a_         119 LEEYIPSRPLS  129 (395)
T ss_dssp             EECCCCEEECC
T ss_pred             EEEEeccccCC
Confidence            99999876554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.47  E-value=0.00028  Score=61.50  Aligned_cols=70  Identities=11%  Similarity=0.051  Sum_probs=46.6

Q ss_pred             ceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCCCcc--eeEE-----EEEEcCCEEEEEEEecCCCc
Q 018047           74 FGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDHPNL--VSLI-----GYCADGKHRFLVYEYMQKGN  146 (361)
Q Consensus        74 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~g~  146 (361)
                      .-.||++...+|..+++|+....    ....+++..|...+..|...++  +..+     ..+...+..+.++++++|..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC----CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            35899999988999999987532    2234567788888888742222  1111     12344677889999997754


Q ss_pred             h
Q 018047          147 L  147 (361)
Q Consensus       147 L  147 (361)
                      +
T Consensus       111 ~  111 (325)
T d1zyla1         111 F  111 (325)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.44  E-value=0.00015  Score=62.85  Aligned_cols=158  Identities=11%  Similarity=0.047  Sum_probs=85.5

Q ss_pred             cCHHHHHHHcCCCCCCcee-----cccCceEEEEEEEcCCCEEEEEEeecCCCCcchhHHHHHHHHHHHHhcCC-----C
Q 018047           51 FTLKEMEEATCSFSDDNFL-----GKGGFGRVYKGTLRSGEVVAIKKMELPRFKEADGEHEFRVEVDILSRLDH-----P  120 (361)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-----~  120 (361)
                      ++.+++.....+|.+++..     ..|.--+.|+.+..+| .+++|++...     ....++..|++++..|..     |
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~-----~~~~~l~~~~~~l~~L~~~g~pvp   76 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCP   76 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC-----CCHHHHHHHHHHHHhhhhcccccc
Confidence            4667888888889886554     3566678999887754 5899988532     122345567777777632     2


Q ss_pred             cceeEE---EEEEcCCEEEEEEEecCCCchhhhcc------------------cCCC---CCCCH---------------
Q 018047          121 NLVSLI---GYCADGKHRFLVYEYMQKGNLQDHLN------------------GIGE---PKMDW---------------  161 (361)
Q Consensus       121 ~iv~~~---~~~~~~~~~~lv~e~~~~g~L~~~l~------------------~~~~---~~~~~---------------  161 (361)
                      ..+...   .+....+....++.+..+......-.                  ....   .....               
T Consensus        77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (316)
T d2ppqa1          77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  156 (316)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence            222110   01223455667777776643321110                  0000   00000               


Q ss_pred             ---HHHHHHHHHHHHHHHHHhcCCCCCCCeEecCCCCCCeeeCCCCcEEEeecCccc
Q 018047          162 ---PLRLKVALGAAKGLAYLHSSSAVGIPIVHRDFKSTNVLLSANFEAKISDFGLAK  215 (361)
Q Consensus       162 ---~~~~~i~~~i~~~l~~lH~~~~~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~  215 (361)
                         ......+......+...+..+ ....+||+|+.++||+++.+...-++||+.+.
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~-L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         157 EVEKGLREEIRPEIDYLAAHWPKD-LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCS-SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hcchhHHHHHHHHHHhhhccCccc-cccccccCCcchhhhhcccccceeEecccccc
Confidence               001112222233333333211 12339999999999999988878899999885